PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kolstoe, SE; Shanahan, DR; Wisely, J				Kolstoe, Simon E.; Shanahan, Daniel R.; Wisely, Janet			Should research ethics committees police reporting bias?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kolstoe, Simon E.] Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England; [Shanahan, Daniel R.] BioMed Cent, Hlth Sci, London, England; [Wisely, Janet] Hlth Res Author, London, England	University of Portsmouth	Kolstoe, SE (corresponding author), Univ Portsmouth, Inst Biomed & Biomol Sci, Portsmouth, Hants, England.	simon.kolstoe@port.ac.uk; Janet.wisely@nhs.net; Janet.wisely@nhs.net	Kolstoe, Simon/O-4996-2019	Kolstoe, Simon/0000-0003-1472-3966; Shanahan, Daniel/0000-0002-6588-7947	Health Research Authority	Health Research Authority	All authors have read and understood BMJ policy on declaration of interests and declare SEK's pilot study was funded as an audit by the Health Research Authority. SEK chairs the Hampshire A and MOD research ethics committees. Both SEK and DRS are members of the HRA transparency forum.	[Anonymous], 2014, LANCET SERIES; Begum R, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0042-8; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Dickersin K, 2011, J ROY SOC MED, V104, P532, DOI 10.1258/jrsm.2011.11k042; GSK, 2014, PUBL POL POS PUBL DI; Health Research Authority, 2017, STAND OP PROC RES ET; Health Research Authority, RES TRANSP; National Audit Office, 2013, ACC CLIN TRIAL INF S; National Institute for Health Research, 2014, NIHR POL OP ACC ITS; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Tompson AC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009285	11	2	2	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2017	356								j1501	10.1136/bmj.j1501	http://dx.doi.org/10.1136/bmj.j1501			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4JB	28348019				2022-12-28	WOS:000397345700002
J	Guilliams, M				Guilliams, Martin			DEVELOPMENTAL BIOLOGY Macrophage, a long-distance middleman	SCIENCE			English	Editorial Material							RECOGNITION RECEPTORS; MONOCYTES; PATHWAYS		[Guilliams, Martin] VIB Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University	Guilliams, M (corresponding author), VIB Ctr Inflammat Res, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.		Guilliams, Martin/N-7803-2013	Guilliams, Martin/0000-0003-3525-7570				Buszczak M, 2016, TRENDS CELL BIOL, V26, P526, DOI 10.1016/j.tcb.2016.03.003; Eom DS, 2017, SCIENCE, V355, P1317, DOI 10.1126/science.aal2745; Eom DS, 2015, ELIFE, V4, DOI 10.7554/eLife.12401; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Penberthy KK, 2016, IMMUNOL REV, V269, P44, DOI 10.1111/imr.12376; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	14	2	2	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1258	1259		10.1126/science.aam9743	http://dx.doi.org/10.1126/science.aam9743			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336621				2022-12-28	WOS:000397082900014
J	Lau, WCY; Chan, EW; Cheung, CL; Sing, CW; Man, KKC; Lip, GYH; Siu, CW; Lam, JKY; Lee, ACH; Wong, ICK				Lau, Wallis C. Y.; Chan, Esther W.; Cheung, Ching-Lung; Sing, Chor Wing; Man, Kenneth K. C.; Lip, Gregory Y. H.; Siu, Chung-Wah; Lam, Joanne K. Y.; Lee, Alan C. H.; Wong, Ian C. K.			Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL ANTICOAGULANTS; HIP FRACTURE; THERAPY; FLUOROQUINOLONES; VALIDATION; DERIVATION; OUTCOMES; DENSITY; WOMEN; OLDER	IMPORTANCE The risk of osteoporotic fracture with dabigatran use in patients with nonvalvular atrial fibrillation (NVAF) is unknown. OBJECTIVE To investigate the risk of osteoporotic fracture with dabigatran vs warfarin in patients with NVAF. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study using a population-wide database managed by the Hong Kong Hospital Authority. Patients newly diagnosed with NVAF from 2010 through 2014 and prescribed dabigatran or warfarin were matched by propensity score at a 1: 2 ratio with follow-up until July 31, 2016. EXPOSURES Dabigatran or warfarin use during the study period. MAIN OUTCOMES AND MEASURES Risk of osteoporotic hip fracture and vertebral fracture was compared between dabigatran and warfarin users using Poisson regression. The corresponding incidence rate ratio (IRR) and absolute risk difference (ARD) with 95% CIs were calculated. RESULTS Among 51 496 patients newly diagnosed with NVAF, 8152 new users of dabigatran (n = 3268) and warfarin (n = 4884) were matched by propensity score (50% women; mean [SD] age, 74 [11] years). Osteoporotic fracture developed in 104 (1.3%) patients during follow-up (32 dabigatran users [1.0%]; 72 warfarin users [1.5%]). Results of Poisson regression analysis showed that dabigatran use was associated with a significantly lower risk of osteoporotic fracture compared with warfarin (0.7 vs 1.1 per 100 person-years; ARD per 100 person-years, -0.68 [95% CI, -0.38 to -0.86]; IRR, 0.38 [95% CI, 0.22 to 0.66]). The association with lower risk was statistically significant in patients with a history of falls, fractures, or both (dabigatran vs warfarin, 1.6 vs 3.6 per 100 person-years; ARD per 100 person-years, -3.15 [95% CI, -2.40 to -3.45]; IRR, 0.12 [95% CI, 0.04 to 0.33]), but not in those without a history (0.6 vs 0.7 per 100 person-years; ARD per 100 person-years, -0.04 [95% CI, 0.67 to -0.39]; IRR, 0.95 [95% CI, 0.45 to 1.96]) (P value for interaction, <.001). CONCLUSIONS AND RELEVANCE Among adults with NVAF receiving anticoagulation, the use of dabigatran compared with warfarin was associated with a lower risk of osteoporotic fracture. Additional study, perhaps including randomized clinical trials, may be warranted to further understand the relationship between use of dabigatran vs warfarin and risk of fracture.	[Lau, Wallis C. Y.; Chan, Esther W.; Cheung, Ching-Lung; Sing, Chor Wing; Man, Kenneth K. C.; Wong, Ian C. K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Cheung, Ching-Lung] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Man, Kenneth K. C.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Aalborg, Denmark; [Siu, Chung-Wah] Univ Hong Kong, Queen Mary Hosp, Div Cardiol, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Lam, Joanne K. Y.; Lee, Alan C. H.] Univ Hong Kong, Queen Mary Hosp, Dept Med, Osteoporosis Ctr, Hong Kong, Hong Kong, Peoples R China; [Wong, Ian C. K.] UCL Sch Pharm, Res Dept Practice & Policy, London, England	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Birmingham; Aalborg University; University of Hong Kong; University of Hong Kong; University of London; University College London	Wong, ICK (corresponding author), UCL Sch Pharm, Room 305,29-39 Brunswick Sq, London WC1N 1AX, England.	i.wong@ucl.ac.uk	Man, Kenneth/H-3194-2017; Cheung, Ching-Lung/C-2529-2012; Siu, Chung Wah/C-6947-2011; Man, Kenneth/AAD-2846-2019; Lau, Wallis/J-3800-2018; Chan, Esther Wai Yin/B-3522-2012	Man, Kenneth/0000-0001-8645-1942; Cheung, Ching-Lung/0000-0002-6233-9144; Man, Kenneth/0000-0001-8645-1942; Lau, Wallis/0000-0003-2320-0470; Wong, Ian Chi Kei/0000-0001-8242-0014; Sing, Chor Wing/0000-0002-2180-3676; Chan, Esther Wai Yin/0000-0002-7602-9470	Bristol-Myers Squibb; Pfizer; Janssen; Hong Kong Research Grants Council; Hong Kong Health and Medical Research Fund	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Health and Medical Research Fund	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Wong and Chan report receipt of research funding from Bristol-Myers Squibb, Pfizer, Janssen, the Hong Kong Research Grants Council, and the Hong Kong Health and Medical Research Fund. Dr Lip reports provision of consultancy services for Bayer/Janssen, BMS/Pfizer, Biotronik, Medtronic, Boehringer Ingelheim, Microlife, and Daiichi-Sankyo; and speaker's bureau services for Bayer, BMS/Pfizer, Medtronic, Boehringer Ingelheim, Microlife, Roche, and Daiichi-Sankyo. No other disclosures were reported.	Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; Benzinger P, 2015, OSTEOPOROSIS INT, V26, P1341, DOI 10.1007/s00198-014-3005-x; Caraballo PJ, 1999, ARCH INTERN MED, V159, P1750, DOI 10.1001/archinte.159.15.1750; Chan EW, 2016, HEART RHYTHM, V13, P1581, DOI 10.1016/j.hrthm.2016.03.049; Chan EW, 2015, GASTROENTEROLOGY, V149, P586, DOI 10.1053/j.gastro.2015.05.002; Cheung SK, 2013, HONG KONG MED J S2, V19, P1; Chui CSL, 2016, NEUROLOGY, V86, P1708, DOI 10.1212/WNL.0000000000002633; Chui CSL, 2014, J ANTIMICROB CHEMOTH, V69, P2563, DOI 10.1093/jac/dku145; Feskanich D, 1999, AM J CLIN NUTR, V69, P74; Fusaro M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133847; Gage BF, 2006, ARCH INTERN MED, V166, P241, DOI 10.1001/archinte.166.2.241; Gage BF, 2005, AM J MED, V118, P612, DOI 10.1016/j.amjmed.2005.02.022; Henau K, 2015, CANCER EPIDEMIOL, V39, P55, DOI 10.1016/j.canep.2014.10.009; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Ivaska KK, 2007, J BONE MINER RES, V22, P1155, DOI 10.1359/JBMR.070505; Jamal SA, 1998, ANN INTERN MED, V128, P829, DOI 10.7326/0003-4819-128-10-199805150-00006; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; Leslie WD, 2011, J BONE MINER RES, V26, P460, DOI 10.1002/jbmr.248; Man KKC, 2017, J ATTEN DISORD, V21, P1161, DOI 10.1177/1087054714536047; Man KKC, 2015, PEDIATRICS, V135, P40, DOI 10.1542/peds.2014-1738; Misra D, 2014, OSTEOPOROSIS INT, V25, P1677, DOI 10.1007/s00198-014-2662-0; Panula J, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-105; Pasternak B, 2013, JAMA-J AM MED ASSOC, V310, P2184, DOI 10.1001/jama.2013.280500; Pilon D, 2004, PHARMACOEPIDEM DR S, V13, P289, DOI 10.1002/pds.888; Rejnmark L, 2007, INT J CARDIOL, V118, P338, DOI 10.1016/j.ijcard.2006.07.022; Sato Y, 2010, CEREBROVASC DIS, V29, P73, DOI 10.1159/000256650; Stuart EA, 2013, J CLIN EPIDEMIOL, V66, pS84, DOI 10.1016/j.jclinepi.2013.01.013; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Sugiyama T, 2015, OSTEOPOROSIS INT, V26, P1231, DOI 10.1007/s00198-014-2912-1; SZULC P, 1994, J BONE MINER RES, V9, P1591; Tufano A, 2015, SEMIN THROMB HEMOST, V41, P382, DOI 10.1055/s-0034-1543999; Wong AYS, 2016, JAMA INTERN MED, V176, P828, DOI 10.1001/jamainternmed.2016.1586; Wong AYS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.h6926; Woo C, 2008, J AM GERIATR SOC, V56, P1171, DOI 10.1111/j.1532-5415.2008.01786.x	35	114	115	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1151	1158		10.1001/jama.2017.1363	http://dx.doi.org/10.1001/jama.2017.1363			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324091	Green Submitted, Green Published			2022-12-28	WOS:000396987200019
J	Perales, M; Artal, R; Lucia, A				Perales, Mara; Artal, Raul; Lucia, Alejandro			Exercise During Pregnancy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BIRTH		[Perales, Mara] Hosp 12 Octubre I 12, Res Inst, Madrid, Spain; [Perales, Mara] Camilo Jose Cela Univ, Madrid, Spain; [Artal, Raul] St Louis Univ, Dept Obstet Gynecol & Womens Hlth, St Louis, MO 63103 USA; [Lucia, Alejandro] Univ Europea Madrid, Calle Tajo S-N, Madrid 28670, Spain; [Lucia, Alejandro] Ctr Invest Biomed Red Fragilidad & Envejecimiento, Madrid, Spain	Hospital Universitario 12 de Octubre; Camilo Jose Cela University; Saint Louis University; European University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERFES	Lucia, A (corresponding author), Univ Europea Madrid, Calle Tajo S-N, Madrid 28670, Spain.	alejandro.lucia@universidadeuropea.es		Lucia, Alejandro/0000-0002-5565-0997; Perales, Maria/0000-0001-9998-1408				Artal R, EXERCISE PREGNANCY P; Barakat R, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.11.039; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; Di Mascio D, 2016, AM J OBSTET GYNECOL, V215, P561, DOI 10.1016/j.ajog.2016.06.014; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Muktabhant B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007145.pub3; Tyrrell J, 2016, JAMA-J AM MED ASSOC, V315, P1129, DOI 10.1001/jama.2016.1975; Wiebe HW, 2015, OBSTET GYNECOL, V125, P1185, DOI 10.1097/AOG.0000000000000801	8	19	23	1	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1113	1114		10.1001/jama.2017.0593	http://dx.doi.org/10.1001/jama.2017.0593			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324098				2022-12-28	WOS:000396987200011
J	Ederhof, M; Ginsburg, PB				Ederhof, Merle; Ginsburg, Paul B.			Improving Hospital Incentives with Better Cost Data	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ederhof, Merle] Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA; [Ginsburg, Paul B.] Univ Southern Calif, Sol Price Sch Publ Policy, Los Angeles, CA USA; [Ginsburg, Paul B.] Brookings Inst, Ctr Hlth Policy, Washington, DC 20036 USA	Stanford University; University of Southern California; Brookings Institution	Ederhof, M (corresponding author), Stanford Univ, Sch Med, Clin Excellence Res Ctr, Stanford, CA 94305 USA.							[Anonymous], DOR COMPL INT HEALTH, DOI [10.1056/NEJMp1613181, DOI 10.1056/NEJMP1613181]; Berenson RA, 2006, HEALTH AFFAIR, V25, pW337, DOI 10.1377/hlthaff.25.w337; Dobson A., 2005, STUDY HOSP CHARGE SE; Gamble M., 2012, BECKERS HOSP RE 0405; Labro E, 2007, ACCOUNT REV, V82, P939, DOI 10.2308/accr.2007.82.4.939	5	6	6	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1010	1011		10.1056/NEJMp1613181	http://dx.doi.org/10.1056/NEJMp1613181			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QT	28296605				2022-12-28	WOS:000396403700004
J	Lyon, J				Lyon, Jeff			Improper Medicaid Payments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1009	1009		10.1001/jama.2017.1974	http://dx.doi.org/10.1001/jama.2017.1974			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291875				2022-12-28	WOS:000396713400006
J	Sun, EC; Dixit, A; Humphreys, K; Darnall, BD; Baker, LC; Mackey, S				Sun, Eric C.; Dixit, Anjali; Humphreys, Keith; Darnall, Beth D.; Baker, Laurence C.; Mackey, Sean			Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG-MONITORING PROGRAMS; UNITED-STATES; ATTRIBUTABLE FRACTION; PRESCRIBING PATTERNS; GEOGRAPHIC-VARIATION; SUBSTANCE USE; CHRONIC PAIN; VETERANS; COHORT; RATES	OBJECTIVES To identify trends in concurrent use of a benzodiazepine and an opioid and to identify the impact of these trends on admissions to hospital and emergency room visits for opioid overdose. DESIGN Retrospective analysis of claims data, 2001-13. SETTING Administrative health claims database. PARTICIPANTS 315 428 privately insured people aged 18-64 who were continuously enrolled in a health plan with medical and pharmacy benefits during the study period and who also filled at least one prescription for an opioid. INTERVENTIONS Concurrent benzodiazepine/opioid use, defined as an overlap of at least one day in the time periods covered by prescriptions for each drug. MAIN OUTCOME MEASURES Annual percentage of opioid users with concurrent benzodiazepine use; annual incidence of visits to emergency room and inpatient admissions for opioid overdose. RESULTS 9% of opioid users also used a benzodiazepine in 2001, increasing to 17% in 2013 (80% relative increase). This increase was driven mainly by increases among intermittent, as opposed to chronic, opioid users. Compared with opioid users who did not use benzodiazepines, concurrent use of both drugs was associated with an increased risk of an emergency room visit or inpatient admission for opioid overdose (adjusted odds ratio 2.14, 95% confidence interval 2.05 to 2.24; P< 0.001) among all opioid users. The adjusted odds ratio for an emergency room visit or inpatient admission for opioid overdose was 1.42 (1.33 to 1.51; P< 0.001) for intermittent opioid users and 1.81 (1.67 to 1.96; P< 0.001) chronic opioid users. If this association is causal, elimination of concurrent benzodiazepine/opioid use could reduce the risk of emergency room visits related to opioid use and inpatient admissions for opioid overdose by an estimated 15% (95% confidence interval 14 to 16). CONCLUSIONS From 2001 to 2013, concurrent benzodiazepine/opioid use sharply increased in a large sample of privately insured patients in the US and significantly contributed to the overall population risk of opioid overdose.	[Sun, Eric C.; Darnall, Beth D.; Mackey, Sean] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Sch Med, 300 Pasteur Dr,H3580, Stanford, CA 94305 USA; [Dixit, Anjali] Univ Calif San Francisco, Dept Anesthesiol & Perioperat Care, 521 Parnassus Ave, San Francisco, CA 94131 USA; [Humphreys, Keith] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, 401 N Quarry Rd,MC 5717, Stanford, CA 94305 USA; [Humphreys, Keith] Stanford Univ, Dept Psychiat, Sch Med, 401 N Quarry Rd,MC 5717, Stanford, CA 94305 USA; [Baker, Laurence C.] Stanford Univ, Sch Med, Dept Hlth Res & Policy, 150 Governors Lane,HRP Redwood Bldg, Stanford, CA 94305 USA; [Baker, Laurence C.] Natl Bur Econ Res, 150 Governors Lane,HRP Redwood Bldg, Stanford, CA 94305 USA	Stanford University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University; National Bureau of Economic Research	Sun, EC (corresponding author), Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Sch Med, 300 Pasteur Dr,H3580, Stanford, CA 94305 USA.	esun1@stanford.edu	Mackey, Sean/AAF-3314-2019; Sun, Eric/K-3900-2019	Mackey, Sean/0000-0001-7744-5348; Dixit, Anjali/0000-0002-4327-4832; Darnall, Beth D./0000-0003-3590-511X	Foundation for Anesthesia Education and Research; Anesthesia Quality Institute; Veterans Affairs health services research and development service	Foundation for Anesthesia Education and Research; Anesthesia Quality Institute; Veterans Affairs health services research and development service(US Department of Veterans Affairs)	ECS was supported by a mentored research training grant from the Foundation for Anesthesia Education and Research and the Anesthesia Quality Institute. KNH was supported by funding from the Veterans Affairs health services research and development service. The research conducted was independent of any involvement from the sponsors of the study. Study sponsors were not involved in study design, data interpretation, writing, or the decision to submit the article for publication.	Aizcorbe Ana, 2012, Stat J IAOS, V28, P43, DOI 10.3233/SJI-2012-0743; Alam A, 2012, ARCH INTERN MED, V172, P425, DOI 10.1001/archinternmed.2011.1827; Baker L, 2013, HEALTH AFFAIR, V32, P1583, DOI 10.1377/hlthaff.2013.0309; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Brady AR, 1998, STATA TECHNICAL B, P8; Carroll I, 2012, ANESTH ANALG, V115, P694, DOI 10.1213/ANE.0b013e31825c049f; Chen JH, 2016, JAMA INTERN MED, V176, P259, DOI 10.1001/jamainternmed.2015.6662; Chernew ME, 2010, AM J MANAG CARE, V16, P131; Clarke Hance, 2014, BMJ, V348, pg1251, DOI 10.1136/bmj.g1251; DARKE S, 1992, DRUG ALCOHOL DEPEN, V31, P31, DOI 10.1016/0376-8716(92)90005-W; Dasgupta N, 2016, PAIN MED, V17, P85, DOI 10.1111/pme.12907; Dor A, 2012, CANCER-AM CANCER SOC, V118, P5741, DOI 10.1002/cncr.27573; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; Dunn A, 2013, HEALTH SERV RES, V48, P1173, DOI 10.1111/1475-6773.12008; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Sobrino AMF, 2009, ADICCIONES, V21, P143, DOI 10.20882/adicciones.241; Friedly J, 2008, ARCH PHYS MED REHAB, V89, P1011, DOI 10.1016/j.apmr.2007.10.037; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Gugelmann HM, 2011, JAMA-J AM MED ASSOC, V306, P2258, DOI 10.1001/jama.2011.1712; Hermos JA, 2004, ARCH INTERN MED, V164, P2361, DOI 10.1001/archinte.164.21.2361; Jones JD, 2012, DRUG ALCOHOL DEPEN, V125, P8, DOI 10.1016/j.drugalcdep.2012.07.004; Karaca-Mandic P, 2012, JAMA-J AM MED ASSOC, V307, P1284, DOI 10.1001/jama.2012.340; Lan CW, 2016, AM J ADDICTION, V25, P7, DOI 10.1111/ajad.12319; Leider HL, 2011, AM J MANAG CARE, V17, P32; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; McDonald DC, 2014, PHARMACOEPIDEM DR S, V23, P1258, DOI 10.1002/pds.3690; McDonald DC, 2012, J PAIN, V13, P988, DOI 10.1016/j.jpain.2012.07.007; Meiler A, 2005, SCHWEIZ ARCH NEUROL, V156, P310, DOI DOI 10.4414/sanp.2005.01626; Morasco BJ, 2010, PAIN, V151, P625, DOI 10.1016/j.pain.2010.08.002; Ojima T, 2004, PEDIATR INT, V46, P264, DOI 10.1111/j.1442-200x.2004.01881.x; Park TW, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2698; Paulozzi LJ, 2014, MMWR-MORBID MORTAL W, V63, P563; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; Paulozzi LJ, 2011, PAIN MED, V12, P747, DOI 10.1111/j.1526-4637.2011.01062.x; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Raebel MA, 2013, JAMA-J AM MED ASSOC, V310, P1369, DOI 10.1001/jama.2013.278344; Ross J, 2000, ADDICTION, V95, P1785, DOI 10.1046/j.1360-0443.2000.951217858.x; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Saunders KW, 2012, J PAIN, V13, P266, DOI 10.1016/j.jpain.2011.11.004; Sehgal N, 2013, J PAIN, V14, pS85, DOI 10.1016/j.jpain.2013.01.676; Vazan P, 2013, SUBST USE MISUSE, V48, P880, DOI 10.3109/10826084.2013.796989; WAGNER TH, 2007, PSYCHOL SERVICES, V0004	44	271	272	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2017	356								j760	10.1136/bmj.j760	http://dx.doi.org/10.1136/bmj.j760			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NH	28292769	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000397014900002
J	Szreter, S; Kinmonth, AL; Kriznik, NM; Kelly, MP				Szreter, Simon; Kinmonth, Ann Louise; Kriznik, Natasha M.; Kelly, Michael P.			The art of medicine Health, welfare, and the state-the dangers of forgetting history	LANCET			English	Editorial Material									[Szreter, Simon] Univ Cambridge, Fac Hist, Cambridge, England; [Kinmonth, Ann Louise; Kriznik, Natasha M.; Kelly, Michael P.] Univ Cambridge, Primary Care Unit, Inst Publ Hlth, Cambridge, England; [Szreter, Simon; Kinmonth, Ann Louise; Kelly, Michael P.] Univ Cambridge, St Johns Coll, Cambridge CB2 1TP, England	University of Cambridge; University of Cambridge; University of Cambridge	Kriznik, NM (corresponding author), Univ Cambridge, Primary Care Unit, Inst Publ Hlth, Cambridge, England.	nmk33@medschl.cam.ac.uk		Kriznik, Natasha/0000-0002-4291-0614; Szreter, Simon/0000-0001-6903-2447	Arts and Humanities Research Council [AH/M005917/1] Funding Source: researchfish; AHRC [AH/M005917/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		Charlesworth L., 2010, WELFARES FORGOTTEN S; Smith Richard M., 2011, HIST HIST DEV POLICY, P75; SOLAR PM, 1995, ECON HIST REV, V48, P1; Szreter S, 2007, WORLD DEV, V35, P67, DOI 10.1016/j.worlddev.2006.09.004; Williams S, 2011, POVERTY GENDER LIFE	5	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2734	2735		10.1016/S0140-6736(16)32429-1	http://dx.doi.org/10.1016/S0140-6736(16)32429-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FB	28328477	Green Submitted			2022-12-28	WOS:000389629800014
J	DeWitt, DE				DeWitt, Dawn E.			A Tale of Two Countries: How I Saw More Patients With More Joy in Internal Medicine Practice	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[DeWitt, Dawn E.] Washington State Univ, Elson S Floyd Coll Med, Spokane, WA USA	Washington State University	DeWitt, DE (corresponding author), Spokane Acad Ctr, POB 1495, Spokane, WA 99210 USA.	dawn.dewitt@wsu.edu	DeWitt, Dawn E/ABX-0983-2022	DeWitt, Dawn E/0000-0002-9352-3104				Erickson SM, 2017, ANN INTERN MED, V166, P659, DOI 10.7326/M16-2697; Goss EJ, 2011, J GEN INTERN MED, V26, pS211; Macinko J, 2003, HEALTH SERV RES, V38, P831, DOI 10.1111/1475-6773.00149; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Wenger N, 2017, ANN INTERN MED, V166, P579, DOI 10.7326/M16-2238	6	6	6	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					669	+		10.7326/M17-0244	http://dx.doi.org/10.7326/M17-0244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28346950				2022-12-28	WOS:000400395500014
J	Nguyen, C; Boutron, I; Baron, G; Sanchez, K; Palazzo, C; Benchimol, R; Paris, G; James-Belin, E; Lefevre-Colau, MM; Beaudreuil, J; Laredo, JD; Bera-Louville, A; Cotten, A; Drape, JL; Feydy, A; Ravaud, P; Rannou, F; Poiraudeau, S				Nguyen, Christelle; Boutron, Isabelle; Baron, Gabriel; Sanchez, Katherine; Palazzo, Clemence; Benchimol, Raphael; Paris, Guillaume; James-Belin, Etienne; Lefevre-Colau, Marie-Martine; Beaudreuil, Johann; Laredo, Jean-Denis; Bera-Louville, Anne; Cotten, Anne; Drape, Jean-Luc; Feydy, Antoine; Ravaud, Philippe; Rannou, Francois; Poiraudeau, Serge			Intradiscal Glucocorticoid Injection for Patients With Chronic Low Back Pain Associated With Active Discopathy A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							ISSLS PRIZE WINNER; PLATE MODIC I; SIGNAL CHANGES; DOUBLE-BLIND; SUBCHONDRAL BONE; DISCOGENIC PAIN; MRI; TYPE-1; DISCOGRAPHY; COHORT	Background: Active discopathy is associated with a specific phenotype of chronic low back pain (LBP). Local inflammation has a role in active discopathy-associated symptoms. Objective: To assess the efficacy of a single glucocorticoid intradiscal injection (GC IDI) in patients with chronic LBP with active discopathy. Design: Prospective, parallel-group, double-blind, randomized, controlled study. (ClinicalTrials.gov: NCT00804531) Setting: 3 tertiary care centers in France. Patients: 135 patients with chronic LBP with active discopathy on magnetic resonance imaging (MRI). Intervention: A single GC IDI (25 mg prednisolone acetate) during discography (n = 67) or discography alone (n = 68). Measurements: The primary outcome was the percentage of patients with LBP intensity less than 40 on an 11-point numerical rating scale (0 [no pain] to 100 [maximum pain] in 10-point increments) in the previous 48 hours at 1 month after the intervention. The main secondary outcomes were LBP intensity and persistent active discopathy on MRI at 12 months and spine-specific limitations in activities, health-related quality of life, anxiety and depression, employment status, and use of analgesics and nonsteroidal anti-inflammatory drugs at 1 and 12 months. Results: All randomly assigned patients were included in the primary efficacy analysis. At 1 month after the intervention, the percentage of responders (LBP intensity < 40) was higher in the GC IDI group (36 of 65 [55.4%]) than the control group (21 of 63 [33.3%]) (absolute risk difference, 22.1 percentage points [95% Cl, 5.5 to 38.7 percentage points]; P = 0.009). The groups did not differ in LBP intensity at 12 months and in most secondary outcomes at 1 and 12 months. Limitation: Tertiary care setting. Conclusion: In chronic LBP associated with active discopathy, a single GC IDI reduces LBP at 1 month but not at 12 months.	Univ Paris 05, Univ Paris Diderot,Sorbonne Paris Cite,Hop Univ S, Hop Univ Paris Ctr,Hop Hotel Dieu,INSERM UMR 1153, AP HP,Grp Hosp Cochin,INSERM UMR 1124,UFR Biomed, Paris, France; CHRU Lille, Hop Roger Salengro, Lille, France; [Nguyen, Christelle; Sanchez, Katherine; Palazzo, Clemence; Paris, Guillaume; James-Belin, Etienne; Lefevre-Colau, Marie-Martine; Rannou, Francois; Poiraudeau, Serge] Hop Univ Paris Ctr, Grp Hosp Cochin, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, 27 Rue Faubourg St Jacques, F-75014 Paris, France; [Boutron, Isabelle; Baron, Gabriel; Ravaud, Philippe] Hop Hotel Dieu, Ctr Epidemiol Clin, 1 Pl Parvis Notre Dame, F-75004 Paris, France; [Benchimol, Raphael; Drape, Jean-Luc; Feydy, Antoine] Hop Univ Paris Ctr, Grp Hosp Cochin, Serv Radiol B, 27 Rue Faubourg St Jacques, F-75014 Paris, France; [Beaudreuil, Johann] Hop Lariboisiere, Serv Rhumatol, 2 Rue Ambroise Pare, F-75010 Paris, France; [Laredo, Jean-Denis] Hop Lariboisiere, Serv Radiol Osteo Articulaire, 2 Rue Ambroise Pare, F-75010 Paris, France; [Bera-Louville, Anne] CHRU Lille, Serv Rhumatol, 2 Ave Oscar Lambret, F-59000 Lille, France; [Cotten, Anne] CHRU Lille, Serv Radiol Osteo Articulaire, 2 Ave Oscar Lambret, F-59000 Lille, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Hotel-Dieu - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille	Poiraudeau, S (corresponding author), Hop Univ Paris Ctr, Grp Hosp Cochin, Serv Reeduc & Readaptat Appareil Locomoteur & Pat, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	gabriel.baron@aphp.fr; francois.rannou@aphp.fr; serge.poiraudeau@aphp.fr	FEYDY, ANTOINE/P-5289-2016; ravaud, philippe/C-1694-2009	Ravaud, Philippe/0000-0001-8264-9206; Boutron, Isabelle/0000-0002-5263-6241; Nguyen, MD, PhD, Christelle/0000-0001-7141-3230; Beaudreuil, Johann/0000-0003-2478-6362; lefevre-colau, marie-martine/0000-0002-7493-1225	French Ministry of Health	French Ministry of Health	French Ministry of Health.	Albert HB, 2013, EUR SPINE J, V22, P697, DOI 10.1007/s00586-013-2675-y; Bailly F, 2014, EUR SPINE J, V23, P493, DOI 10.1007/s00586-013-3036-6; Beaudreuil J., 2012, Annals of Physical and Rehabilitation Medicine, V55, P139, DOI 10.1016/j.rehab.2012.01.004; Benyahya R., 2004, Annales de Readaptation et de Medecine Physique, V47, P621, DOI 10.1016/S0168-6054(04)00193-X; Buttermann Glenn R, 2004, Spine J, V4, P495, DOI 10.1016/j.spinee.2004.03.024; Cao P, 2011, SPINE J, V11, P100, DOI 10.1016/j.spinee.2010.07.001; Carragee EJ, 2006, SPINE, V31, P505, DOI 10.1097/01.brs.0000201242.85984.76; Carragee EJ, 2006, SPINE, V31, P2115, DOI 10.1097/01.brs.0000231436.30262.dd; Carragee EJ, 2009, SPINE, V34, P2338, DOI 10.1097/BRS.0b013e3181ab5432; Nguyen C, 2011, ARTHRITIS RHEUM-US, V63, P2828, DOI 10.1002/art.30443; Cohen SP, 2007, ANESTHESIOLOGY, V107, P99, DOI 10.1097/01.anes.0000267518.20363.0d; DUQUESNOY B, 1992, PRESSE MED, V21, P1801; Eder C, 2013, SPINE J, V13, P1556, DOI 10.1016/j.spinee.2013.03.021; Fayad F, 2007, EUR SPINE J, V16, P925, DOI 10.1007/s00586-006-0301-y; Fitzmaurice G., 2011, APPL LONGITUDINAL AN, V2nd ed, P128; Fraser RD, 2011, SPINE J, V11, P107, DOI 10.1016/j.spinee.2010.09.016; Jensen RK, 2012, EUR SPINE J, V21, P2271, DOI 10.1007/s00586-012-2309-9; Jensen TS, 2008, EUR SPINE J, V17, P1407, DOI 10.1007/s00586-008-0770-2; Khot A, 2004, SPINE, V29, P833, DOI 10.1097/00007632-200404150-00002; Kjaer P, 2006, EUR SPINE J, V15, P1312, DOI 10.1007/s00586-006-0185-x; Liang K-Y, 2000, SANKHYA INDIAN J S B, P134, DOI [DOI 10.2307/25053123, DOI 10.2337/DB12-0868]; Liu GHF, 2009, STAT MED, V28, P2509, DOI 10.1002/sim.3639; Mitra D, 2004, EUR RADIOL, V14, P1574, DOI 10.1007/s00330-004-2314-4; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Nguyen C, 2012, OSTEOPOROSIS INT, V23, pS857, DOI 10.1007/s00198-012-2164-x; Nguyen C, 2015, ANN RHEUM DIS, V74, P1488, DOI 10.1136/annrheumdis-2015-207317; Nguyen C, 2010, J RHEUMATOL, V37, P2334, DOI 10.3899/jrheum.100165; O'Neill C, 2011, SPINE J, V11, P109, DOI 10.1016/j.spinee.2010.08.032; Ohtori S, 2006, SPINE, V31, P1026, DOI 10.1097/01.brs.0000215027.87102.7c; Palazzo C, 2017, JOINT BONE SPINE, V84, P507, DOI 10.1016/j.jbspin.2016.08.001; Rannou F, 2007, ARTHRIT RHEUM-ARTHR, V57, P1311, DOI 10.1002/art.22985; Revel M, 1990, REV MED ORTHOP, V20, P19; Sainoh T, 2016, PAIN MED, V17, P40, DOI 10.1111/pme.12892; Sainoh T, 2016, J ORTHOP SCI, V21, P2, DOI 10.1016/j.jos.2015.10.005; SIMMONS JW, 1992, SPINE, V17, pS172, DOI 10.1097/00007632-199206001-00019; Tubach F, 2007, J RHEUMATOL, V34, P1188; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2	38	42	45	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					547	+		10.7326/M16-1700	http://dx.doi.org/10.7326/M16-1700			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28319997				2022-12-28	WOS:000399304000014
J	Bradshaw, R; Pordes, BAJ; Trippier, H; Kosky, N; Pilling, S; O'Brien, F				Bradshaw, Richard; Pordes, Ben A. J.; Trippier, Hannah; Kosky, Nick; Pilling, Steve; O'Brien, Fionnuala		NICE Guideline Mental Health Adult	GUIDELINES The health of prisoners: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bradshaw, Richard] Offender Hlth, Dept Hlth, London, England; [Bradshaw, Richard] Natl Offender Management Serv, London, England; [Pordes, Ben A. J.; Trippier, Hannah] Natl Guideline Ctr, London W1W 5QZ, England; [Kosky, Nick] Dorset Healthcare Univ Fdn Trust, Forston Clin, London, England; [Pilling, Steve] UCL, Dept Clin Educ & Hlth Psychol, London WC1E 6BT, England; [O'Brien, Fionnuala] Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London NW1 4RG, England	University of London; University College London	Kosky, N (corresponding author), Dorset Healthcare Univ Fdn Trust, Forston Clin, London, England.	Nick.Kosky@dhuft.nhs.uk			National Institute for Health and Care Excellence; NICE	National Institute for Health and Care Excellence; NICE	The National Guideline Alliance and the National Guideline Centre were commissioned and funded by the National Institute for Health and Care Excellence to develop these guidelines. BAJP and HT are employees of the National Guideline Centre, which is commissioned and funded by NICE to develop guidelines.	[Anonymous], CORONARY ANGIOGRAPHY; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Ministry of Justice, 2016, ENGL WAL; National Institute for Health and Care Excellence, 2017, MENT HLTH CAR EXC M; National Institute for Health and Care Excellence, 2016, PER PRIS; National Institute for Health and Care Excellence, 2016, DEV NICE GUID MAN; NICE, 2015, MED OPT SAF EFF US M	7	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2017	356								j1378	10.1136/bmj.j1378	http://dx.doi.org/10.1136/bmj.j1378			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4JB	28348003	Green Submitted			2022-12-28	WOS:000397345700001
J	Mason, B				Mason, Betsy			SEISMOLOGY New Zealand temblor points to threat of compound quakes	SCIENCE			English	News Item																			0	0	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1250	1251		10.1126/science.355.6331.1250	http://dx.doi.org/10.1126/science.355.6331.1250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336617				2022-12-28	WOS:000397082900010
J	Descours, B; Petitjean, G; Loez-Zaragoza, JL; Bruel, T; Raffel, R; Psomas, C; Reynes, J; Lacabaratz, C; Levy, Y; Schwartz, O; Lelievre, JD; Benkirane, M				Descours, Benjamin; Petitjean, Gael; Loepez-Zaragoza, Jose-Luis; Bruel, Timothee; Raffel, Raoul; Psomas, Christina; Reynes, Jacques; Lacabaratz, Christine; Levy, Yves; Schwartz, Olivier; Lelievre, Jean Daniel; Benkirane, Monsef			CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent proviruses	NATURE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; ACTIVE ANTIRETROVIRAL THERAPY; FC-GAMMA RECEPTORS; LATENT RESERVOIR; SAMHD1; INFECTION; MACROPHAGES; INTEGRATION; VPX	The persistence of the HIV reservoir in infected individuals is a major obstacle to the development of a cure for HIV1-3. Here, using an in vitro model of HIV-infected quiescent CD4 T cells, we reveal a gene expression signature of 103 upregulated genes that are specific for latently infected cells, including genes for 16 transmembrane proteins. In vitro screening for surface expression in HIV-infected quiescent CD4 T cells shows that the low-affinity receptor for the immunoglobulin G Fc fragment, CD32a, is the most highly induced, with no detectable expression in bystander cells. Notably, productive HIV-1 infection of T-cell-receptor-stimulated CD4 T cells is not associated with CD32a expression, suggesting that a quiescence-dependent mechanism is required for its induction. Using blood samples from HIV-1-positive participants receiving suppressive antiretroviral therapy, we identify a subpopulation of 0.012% of CD4 T cells that express CD32a and host up to three copies of HIV DNA per cell. This CD32a(+) reservoir was highly enriched in inducible replication-competent proviruses and can be predominant in some participants. Our discovery that CD32a(+) lymphocytes represent the elusive HIV-1 reservoir may lead to insights that will facilitate the specific targeting and elimination of this reservoir.	[Descours, Benjamin; Petitjean, Gael; Raffel, Raoul; Benkirane, Monsef] Univ Montpellier, CNRS, UMR9002, Inst Genet Humaine,Lab Virol Moleculaire, Montpellier, France; [Loepez-Zaragoza, Jose-Luis; Bruel, Timothee; Lacabaratz, Christine; Levy, Yves; Schwartz, Olivier; Lelievre, Jean Daniel] Univ Paris Est, Fac Med, Vaccine Res Inst, INSERM U955, Creteil, France; [Loepez-Zaragoza, Jose-Luis; Bruel, Timothee; Lacabaratz, Christine; Levy, Yves; Schwartz, Olivier; Lelievre, Jean Daniel] Serv Immunol Clin, Assistance Publ Hopitaux Paris, Grp Henri Mondor Albert Chenevier, Creteil, France; [Loepez-Zaragoza, Jose-Luis; Lacabaratz, Christine; Levy, Yves; Lelievre, Jean Daniel] INSERM, Equipe 16, Creteil, France; [Loepez-Zaragoza, Jose-Luis; Lacabaratz, Christine; Levy, Yves; Lelievre, Jean Daniel] Hop Henri Mondor Albert Chenevier, AP HP, Serv Immunol Clin & Malad Infectieuses, F-94000 Creteil, France; [Bruel, Timothee; Schwartz, Olivier] CNRS, URA 3015, Inst Pasteur, Virus & Immun Unit, Paris, France; [Psomas, Christina; Reynes, Jacques] Hop Univ, Dept Malad Infectieuses & Trop, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universite de Montpellier; CHU de Montpellier	Descours, B; Petitjean, G; Benkirane, M (corresponding author), Univ Montpellier, CNRS, UMR9002, Inst Genet Humaine,Lab Virol Moleculaire, Montpellier, France.	benjamin.descours@igh.cnrs.fr; gael.petitjean@igh.cnrs.fr; monsef.benkirane@igh.cnrs.fr	, Lelievre/AAB-1398-2020; Bruel, Timothée/AAI-4632-2020; Schwartz, Olivier/AAZ-3765-2021	Schwartz, Olivier/0000-0002-0729-1475; Lelievre, Jean-Daniel/0000-0002-8182-3628; Lacabaratz, Christine/0000-0001-6925-0225; Bruel, Timothee/0000-0002-3952-4261	European FP7 [201412]; MSDAvenir; ANRS; FRM 'equipe labellisee'; Labex EpiGenMed; FRM; Vaccine Research Institute (VRI); VRI; Labex IBEID; Sidaction; Institut Pasteur	European FP7; MSDAvenir; ANRS(ANRSFrench National Research Agency (ANR)); FRM 'equipe labellisee'; Labex EpiGenMed; FRM(Fondation pour la Recherche Medicale); Vaccine Research Institute (VRI); VRI; Labex IBEID; Sidaction; Institut Pasteur(European Commission)	We thank the participants enrolled in this study. We thank members of the Molecular Virology laboratory for critical reading of the manuscript, J. Venables for editing the manuscript, MRI platform for FACSAria cell sorting. We are grateful to J.-F. Delfraissy and F. Barre-Sinoussi for their continuous support. This work was supported by grants from the European FP7 contract 201412, MSDAvenir, ANRS and FRM 'equipe labellisee' and Labex EpiGenMed to M.B. G.P was supported by FRM fellowships; B.D. and R.R. by ANRS fellowships. T.B. was supported by a Vaccine Research Institute (VRI) fellowship. O.S was supported by grants from ANRS, VRI, Labex IBEID, Sidaction, European FP7 contract 201412 and Institut Pasteur.	Avettand-Fenol V, 2009, J MED VIROL, V81, P217, DOI 10.1002/jmv.21390; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Bruel T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10844; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cohn LB, 2015, CELL, V160, P420, DOI 10.1016/j.cell.2015.01.020; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Laird GM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003398; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Passaes CPB, 2017, J VIROL, V91, DOI [10.1128/JVI.02296-16, 10.1128/jvi.02296-16]; Rosenbloom DIS, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv123; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	23	156	164	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					564	+		10.1038/nature21710	http://dx.doi.org/10.1038/nature21710			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28297712				2022-12-28	WOS:000397018000054
J	Krishnan, V; Stoppel, DC; Nong, Y; Johnson, MA; Nadler, MJS; Ozkaynak, E; Teng, BL; Nagakura, I; Mohammad, F; Silva, MA; Peterson, S; Cruz, TJ; Kasper, EM; Arnaout, R; Anderson, MP				Krishnan, Vaishnav; Stoppel, David C.; Nong, Yi; Johnson, Mark A. .; Nadler, Monica J. S.; Ozkaynak, Ekim; Teng, Brian L.; Nagakura, Ikue; Mohammad, Fahim; Silva, Michael A.; Peterson, Sally; Cruz, Tristan J.; Kasper, Ekkehard M.; Arnaout, Ramy; Anderson, Matthew P.			Autism gene Ube3a and seizures impair sociability by repressing VTA Cbln1	NATURE			English	Article							UBIQUITIN-PROTEIN LIGASE; ANGELMAN-SYNDROME; MOUSE MODEL; E6-ASSOCIATED PROTEIN; EXCITATORY NEURONS; GABAERGIC NEURONS; SPECTRUM DISORDER; SYNAPSE FORMATION; ENERGY-BALANCE; COPY NUMBER	Maternally inherited 15q11-13 chromosomal triplications cause a frequent and highly penetrant type of autism linked to increased gene dosages of UBE3A, which encodes a ubiquitin ligase with transcriptional co-regulatory functions. Here, using in vivo mouse genetics, we show that increasing UBE3A in the nucleus downregulates the glutamatergic synapse organizer Cbln1, which is needed for sociability in mice. Epileptic seizures also repress Cbln1 and are found to expose sociability impairments in mice with asymptomatic increases in UBE3A. This Ube3a-seizure synergy maps to glutamate neurons of the midbrain ventral tegmental area (VTA), where Cbln1 deletions impair sociability and weaken glutamatergic transmission. We provide preclinical evidence that viral-vector-based chemogenetic activation of, or restoration of Cbln1 in, VTA glutamatergic neurons reverses the sociability deficits induced by Ube3a and/ or seizures. Our results suggest that gene and seizure interactions in VTA glutamatergic neurons impair sociability by downregulating Cbln1, a key node in the expanding protein interaction network of autism genes.	[Krishnan, Vaishnav; Stoppel, David C.; Nong, Yi; Johnson, Mark A. .; Nadler, Monica J. S.; Ozkaynak, Ekim; Teng, Brian L.; Nagakura, Ikue; Silva, Michael A.; Peterson, Sally; Cruz, Tristan J.; Anderson, Matthew P.] Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave, Boston, MA 02115 USA; [Stoppel, David C.; Nong, Yi; Johnson, Mark A. .; Nadler, Monica J. S.; Ozkaynak, Ekim; Teng, Brian L.; Nagakura, Ikue; Mohammad, Fahim; Silva, Michael A.; Peterson, Sally; Cruz, Tristan J.; Arnaout, Ramy; Anderson, Matthew P.] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02115 USA; [Stoppel, David C.; Anderson, Matthew P.] Harvard Med Sch, Program Neurosci, 300 Longwood Ave, Boston, MA 02115 USA; [Kasper, Ekkehard M.] Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02115 USA; [Arnaout, Ramy] Beth Israel Deaconess Med Ctr, Dept Internal Med, Div Clin Informat, 330 Brookline Ave, Boston, MA 02115 USA; [Arnaout, Ramy] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Anderson, Matthew P.] Boston Childrens Hosp, Intellectual & Dev Disabil Res Ctr, 300 Longwood Ave, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Anderson, MP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave, Boston, MA 02115 USA.; Anderson, MP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02115 USA.; Anderson, MP (corresponding author), Harvard Med Sch, Program Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.; Anderson, MP (corresponding author), Boston Childrens Hosp, Intellectual & Dev Disabil Res Ctr, 300 Longwood Ave, Boston, MA 02115 USA.	matthew_anderson@bidmc.harvard.edu	Core, Vector/CAF-4832-2022; Kasper, Ekkehard M/AAF-8357-2020	Anderson, Matthew/0000-0003-4602-1811	NINDS [NS07203]; American Academy of Neurology; NIH [1R01NS08916, 1R21MH100868, 1R21HD079249]; Nancy Lurie Marks Family Foundation; Landreth Foundation; Simons Foundation; Autism Speaks/National Alliance for Autism Research; Klarman Family Foundation;  [1R25NS070682]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD079249, U54HD090255, P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH114858, R21MH100868] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R25NS070682, R01NS081916, P30NS072030] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Academy of Neurology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nancy Lurie Marks Family Foundation; Landreth Foundation; Simons Foundation; Autism Speaks/National Alliance for Autism Research; Klarman Family Foundation; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank O. DiStefano, G. Salimando and R. Broadhurst for colony work and the Harvard Medical School Neurobiology Imaging Facility (NINDS P30 Core Center Grant NS07203) and Boston Children's Hospital IDDRC (1U54HD090255, P30HD18655). Supported by funding to V.K. (1R25NS070682 and an American Academy of Neurology Research Training Fellowship) and to M.P.A. from the NIH (1R01NS08916, 1R21MH100868, 1R21HD079249), Nancy Lurie Marks Family Foundation, Landreth Foundation, Simons Foundation, and Autism Speaks/National Alliance for Autism Research. R.A. was supported by Klarman Family Foundation.	Allensworth M, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-7; Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bao DS, 2006, MOL CELL BIOL, V26, P9327, DOI 10.1128/MCB.01161-06; Basu SN, 2009, NUCLEIC ACIDS RES, V37, pD832, DOI 10.1093/nar/gkn835; Berrios J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10702; Chen JA, 2015, ANNU REV PATHOL-MECH, V10, P111, DOI 10.1146/annurev-pathol-012414-040405; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; El Achkar CM, 2015, EPILEPSY BEHAV, V47, P183, DOI 10.1016/j.yebeh.2014.12.022; Elegheert J, 2016, SCIENCE, V353, P295, DOI 10.1126/science.aae0104; Ferraro TN, 1999, J NEUROSCI, V19, P6733, DOI 10.1523/JNEUROSCI.19-16-06733.1999; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gossan NC, 2014, NUCLEIC ACIDS RES, V42, P5765, DOI 10.1093/nar/gku225; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Grier MD, 2015, BEHAV BRAIN RES, V291, P260, DOI 10.1016/j.bbr.2015.05.045; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Iijima T, 2009, J NEUROSCI, V29, P5425, DOI 10.1523/JNEUROSCI.4473-08.2009; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kaphzan H, 2013, CELL REP, V4, P405, DOI 10.1016/j.celrep.2013.07.005; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khan OY, 2006, MOL ENDOCRINOL, V20, P544, DOI 10.1210/me.2005-0110; Kim S, 2013, BIOCHEM BIOPH RES CO, V437, P67, DOI 10.1016/j.bbrc.2013.06.036; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Kuhnle S, 2013, P NATL ACAD SCI USA, V110, P8888, DOI 10.1073/pnas.1302792110; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu M, 2012, ACTA BIOCH BIOPH SIN, V44, P476, DOI 10.1093/abbs/gms023; Lyst MJ, 2013, NAT NEUROSCI, V16, P898, DOI 10.1038/nn.3434; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Matsuda K, 2011, EUR J NEUROSCI, V33, P1447, DOI 10.1111/j.1460-9568.2011.07638.x; Matsuda K, 2010, SCIENCE, V328, P363, DOI 10.1126/science.1185152; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; McClelland S, 2014, ELIFE, V3, DOI 10.7554/eLife.01267; Nawaz Z, 1999, MOL CELL BIOL, V19, P1182; Riday TT, 2012, J CLIN INVEST, V122, P4544, DOI 10.1172/JCI61888; Ronchi VP, 2014, J BIOL CHEM, V289, P1033, DOI 10.1074/jbc.M113.517805; Rose MF, 2009, P NATL ACAD SCI USA, V106, P22462, DOI 10.1073/pnas.0911579106; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryu K, 2012, BIOCHEM BIOPH RES CO, V417, P157, DOI 10.1016/j.bbrc.2011.11.075; Salvat C, 2004, J BIOL CHEM, V279, P18935, DOI 10.1074/jbc.M312201200; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Scoles HA, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-19; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Silverman JL, 2015, NEUROPSYCHOPHARMACOL, V40, P2228, DOI 10.1038/npp.2015.66; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takechi K, 2016, EUR J PHARMACOL, V775, P57, DOI 10.1016/j.ejphar.2016.02.021; Taylor SR, 2014, J COMP NEUROL, V522, P3308, DOI 10.1002/cne.23603; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Uemura T, 2010, CELL, V141, P1068, DOI 10.1016/j.cell.2010.04.035; Vong L, 2011, NEURON, V71, P142, DOI 10.1016/j.neuron.2011.05.028; Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036; Wei P, 2012, J NEUROCHEM, V121, P717, DOI 10.1111/j.1471-4159.2012.07648.x; Yadav R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032969; Yamaguchi T, 2015, EUR J NEUROSCI, V41, P760, DOI 10.1111/ejn.12818; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yi JJ, 2015, CELL, V162, P795, DOI 10.1016/j.cell.2015.06.045; Zhang SL, 2015, NAT NEUROSCI, V18, P386, DOI 10.1038/nn.3945; Zhou YD, 2009, NAT MED, V15, P1208, DOI 10.1038/nm.2019; Zhuang XX, 2005, J NEUROSCI METH, V143, P27, DOI 10.1016/j.jneumeth.2004.09.020	67	86	89	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					507	+		10.1038/nature21678	http://dx.doi.org/10.1038/nature21678			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28297715	Green Accepted, Green Submitted			2022-12-28	WOS:000397018000042
J	Latorraca, NR; Fastman, NM; Venkatakrishnan, AJ; Frommer, WB; Dror, RO; Feng, L				Latorraca, Naomi R.; Fastman, Nathan M.; Venkatakrishnan, A. J.; Frommer, Wolf B.; Dror, Ron O.; Feng, Liang			Mechanism of Substrate Translocation in an Alternating Access Transporter	CELL			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; MEMBRANE TRANSPORTERS; BACTERIAL HOMOLOG; CONFORMATIONAL DYNAMICS; SWEET TRANSPORTERS; ESCHERICHIA-COLI; FORCE-FIELD; PROTEIN	Transporters shuttle molecules across cell membranes by alternating among distinct conformational states. Fundamental questions remain about how transporters transition between states and how such structural rearrangements regulate substrate translocation. Here, we capture the translocation process by crystallography and unguided molecular dynamics simulations, providing an atomic-level description of alternating access transport. Simulations of a SWEET-family transporter initiated from an outward-open, glucose-bound structure reported here spontaneously adopt occluded and inward-open conformations. Strikingly, these conformations match crystal structures, including our inwardopen structure. Mutagenesis experiments further validate simulation predictions. Our results reveal that state transitions are driven by favorable interactions formed upon closure of extracellular and intracellular "gates'' and by an unfavorable transmembrane helix configuration when both gates are closed. This mechanism leads to tight allosteric coupling between gates, preventing them from opening simultaneously. Interestingly, the substrate appears to take a "free ride'' across the membrane without causing major structural rearrangements in the transporter.	[Latorraca, Naomi R.; Fastman, Nathan M.; Dror, Ron O.; Feng, Liang] Stanford Univ, Biophys Program, Stanford, CA 94305 USA; [Latorraca, Naomi R.; Venkatakrishnan, A. J.; Dror, Ron O.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Latorraca, Naomi R.; Fastman, Nathan M.; Venkatakrishnan, A. J.; Dror, Ron O.; Feng, Liang] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Latorraca, Naomi R.; Venkatakrishnan, A. J.; Dror, Ron O.] Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA; [Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Frommer, Wolf B.] Heinrich Heine Univ Dusseldorf, Inst Mol Physiol, D-50829 Cologne, Germany; [Frommer, Wolf B.] Max Planck Inst Plant Breeding Res, D-50829 Cologne, Germany	Stanford University; Stanford University; Stanford University; Stanford University; Carnegie Institution for Science; Heinrich Heine University Dusseldorf; Max Planck Society	Fastman, NM; Dror, RO; Feng, L (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.; Dror, RO (corresponding author), Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA.; Fastman, NM; Dror, RO; Feng, L (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Dror, RO (corresponding author), Stanford Univ, Inst Computat & Math Engn, Stanford, CA 94305 USA.	nfastman@stanford.edu; ron.dror@stanford.edu; liangf@stanford.edu	Frommer, Wolf B/A-8256-2008; Frommer, Wolf B/K-5042-2017	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Dror, Ron/0000-0002-6418-2793	Stanford University; Harold and Leila Y. Mathers Charitable Foundation; Alfred P. Sloan Foundation; NIH [R01 GM117108]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences at the US Department of Energy [DE-FG02-04ER15542]; Stanford Terman Faculty Fellowship; Stanford Bio-X Interdisciplinary Initiative Program [IIP8-70]; National Science Foundation Graduate Research Fellowships; Direct For Biological Sciences [1258018] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117108, T32GM008294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [DP2AG052940] Funding Source: NIH RePORTER	Stanford University(Stanford University); Harold and Leila Y. Mathers Charitable Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences at the US Department of Energy; Stanford Terman Faculty Fellowship; Stanford Bio-X Interdisciplinary Initiative Program; National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank the staff at Beamline 23ID-B/D and 24ID-C/E (APS, Argonne National Laboratory), at Beamline 12-2 (SSRL, SLAC National Laboratory), and at Beamline 5.0.2 (Advanced Light Source), particularly K. Perry, for assistance at the synchrotron. This work was made possible by support from Stanford University, the Harold and Leila Y. Mathers Charitable Foundation, the Alfred P. Sloan Foundation, NIH (R01 GM117108) to L.F., the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences at the US Department of Energy under grant number DE-FG02-04ER15542 to W.B.F., a Stanford Terman Faculty Fellowship to R.O.D., and the Stanford Bio-X Interdisciplinary Initiative Program (IIP8-70) to L.F. and R.O.D. N.M.F. and N.R.L. were supported by National Science Foundation Graduate Research Fellowships. L.F. was an NIH Director's New Innovator awardee. We thank M. Maduke for helpful comments, Y. Xu, Z. He, and J. Fang for technical assistance, and R. Betz for assistance with MD simulation analysis.		0	54	55	6	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					96	+		10.1016/j.cell.2017.03.010	http://dx.doi.org/10.1016/j.cell.2017.03.010			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340354	Green Accepted, Bronze			2022-12-28	WOS:000397090000011
J	Borges, FK; Devereaux, PJ				Borges, Flavia Kessler; Devereaux, P. J.			PCI with drug-eluting stents <= 12 months before surgery was linked to increased MI and cardiac death after surgery	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NONCARDIAC SURGERY		[Borges, Flavia Kessler; Devereaux, P. J.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Borges, FK (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Devereaux, PJ/AAY-1757-2021; Devereaux, PJ/AAF-2862-2019; Borges, Flavia Kessler/V-7681-2019	Borges, Flavia Kessler/0000-0001-5377-7612				Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113; Wijeysundera DN, 2012, CIRCULATION, V126, P1355, DOI 10.1161/CIRCULATIONAHA.112.102715	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC35	JC35		10.7326/ACPJC-2017-166-6-035	http://dx.doi.org/10.7326/ACPJC-2017-166-6-035			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320009				2022-12-28	WOS:000397025800012
J	Campbell, MJ				Campbell, Michael J.			The Definitive Management of Primary Hyperparathyroidism Who Needs an Operation?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PARATHYROIDECTOMY; PREVALENCE		[Campbell, Michael J.] Univ Calif Davis, Ctr Comprehens Canc, 4501 X St, Sacramento, CA 95817 USA	University of California System; University of California Davis	Campbell, MJ (corresponding author), Univ Calif Davis, Ctr Comprehens Canc, 4501 X St, Sacramento, CA 95817 USA.	mjcampb@ucdavis.edu						Barr DP, 1929, J AMER MED ASSOC, V92, P951, DOI 10.1001/jama.1929.02700380009002; Heath H 3rd, 1991, J Bone Miner Res, V6 Suppl 2, pS63; Morita SY, 2008, SURGERY, V144, P862, DOI 10.1016/j.surg.2008.07.029; Press DM, 2013, SURGERY, V154, P1232, DOI 10.1016/j.surg.2013.06.051; Stavrakis AI, 2007, SURGERY, V142, P887, DOI 10.1016/j.surg.2007.09.003; Wilhelm SM, 2016, JAMA SURG, V151, P959, DOI 10.1001/jamasurg.2016.2310; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Zanocco K, 2006, SURGERY, V140, P874, DOI 10.1016/j.surg.2006.07.032	8	10	10	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1167	1168		10.1001/jama.2017.1620	http://dx.doi.org/10.1001/jama.2017.1620			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324077				2022-12-28	WOS:000396987200021
J	[Anonymous]				[Anonymous]			Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial (vol 350, h2958, 2015)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Ormerod AD, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2958	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2017	356								j1462	10.1136/bmj.j1462	http://dx.doi.org/10.1136/bmj.j1462			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IT	28325754	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000397344900006
J	Gitler, AD; Jarosz, DF				Gitler, Aaron D.; Jarosz, Daniel F.			AGING Old moms say, no Sir Asymmetric distribution of an aggregated protein controls yeast cell aging	SCIENCE			English	Editorial Material							SACCHAROMYCES-CEREVISIAE; CAUSES STERILITY		[Gitler, Aaron D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Jarosz, Daniel F.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Jarosz, Daniel F.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Gitler, AD (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	agitler@stanford.edu; jarosz@stanford.edu		Jarosz, Daniel/0000-0003-3497-5888; Gitler, Aaron/0000-0001-8603-1526				Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; RINE J, 1987, GENETICS, V116, P9; Schlissel G, 2017, SCIENCE, V355, P1184, DOI 10.1126/science.aaj2103; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789	10	0	0	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1126	1127		10.1126/science.aam9740	http://dx.doi.org/10.1126/science.aam9740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302810				2022-12-28	WOS:000396351200020
J	Papke, B; Der, CJ				Papke, Bjoern; Der, Channing J.			Drugging RAS: Know the enemy	SCIENCE			English	Review							K-RAS; PLASMA-MEMBRANE; SMALL MOLECULES; CANCER; INHIBITION; BRAF; ERK; ASSOCIATION; DISCOVERY; ONCOGENES	The three RAS oncogenes make up the most frequently mutated gene family in human cancer. The well-validated role of mutationally activated RAS genes in driving cancer development and growth has stimulated comprehensive efforts to develop therapeutic strategies to block mutant RAS function for cancer treatment. Disappointingly, despite more than three decades of research effort, clinically effective anti-RAS therapies have remained elusive, prompting a perception that RAS may be undruggable. However, with a greater appreciation of the complexities of RAS that thwarted past efforts, and armed with new technologies and directions, the field is experiencing renewed excitement that mutant RAS may finally be conquered. Here we summarize where these efforts stand.	[Papke, Bjoern; Der, Channing J.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Der, CJ (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	cjder@med.unc.edu		Papke, Bjoern/0000-0001-8156-7508; Der, Channing/0000-0002-7751-2747	Astex Pharmaceutics; Novartis; LifeSci Advisors; Cullinan Pharmaceuticals; NATIONAL CANCER INSTITUTE [R01CA175747, U01CA199235, R01CA042978, P01CA203657] Funding Source: NIH RePORTER	Astex Pharmaceutics; Novartis(Novartis); LifeSci Advisors; Cullinan Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	C.J.D. is on the Scientific Advisory Boards of Warp Drive Bio, a company developing therapeutics for proteins that cannot be targeted by conventional drug discovery approaches, and Kyras Therapeutics, a company developing RAS-targeted drugs. C.J.D. is also a paid consultant for Astex Pharmaceutics, Novartis, LifeSci Advisors, and Cullinan Pharmaceuticals.	Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Bryant KL, 2014, TRENDS BIOCHEM SCI, V39, P91, DOI 10.1016/j.tibs.2013.12.004; Chen SH, 2016, CANCER DISCOV, V6, P300, DOI 10.1158/2159-8290.CD-15-0896; Cho KJ, 2016, MOL CELL BIOL, V36, P363, DOI 10.1128/MCB.00719-15; Cox AD, 2015, CLIN CANCER RES, V21, P1819, DOI 10.1158/1078-0432.CCR-14-3214; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; Downward J, 2015, CLIN CANCER RES, V21, P1802, DOI 10.1158/1078-0432.CCR-14-2180; Duncan JS, 2012, CELL, V149, P307, DOI 10.1016/j.cell.2012.02.053; Foster SA, 2016, CANCER CELL, V29, P477, DOI 10.1016/j.ccell.2016.02.010; Guerra C, 2013, MOL ONCOL, V7, P232, DOI 10.1016/j.molonc.2013.02.002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hunter JC, 2014, P NATL ACAD SCI USA, V111, P8895, DOI 10.1073/pnas.1404639111; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lazo JS, 2016, ANNU REV PHARMACOL, V56, P23, DOI 10.1146/annurev-pharmtox-010715-103440; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Papke B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11360; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Peng SB, 2015, CANCER CELL, V28, P384, DOI 10.1016/j.ccell.2015.08.002; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ritt DA, 2016, MOL CELL, V64, P875, DOI 10.1016/j.molcel.2016.10.029; Ryan MB, 2015, TRENDS CANCER, V1, P183, DOI 10.1016/j.trecan.2015.10.001; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Schmick M, 2014, CELL, V157, P459, DOI 10.1016/j.cell.2014.02.051; Shima F, 2013, P NATL ACAD SCI USA, V110, P8182, DOI 10.1073/pnas.1217730110; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Spiegel J, 2014, NAT CHEM BIOL, V10, P613, DOI 10.1038/nchembio.1560; Stephen AG, 2014, CANCER CELL, V25, P272, DOI 10.1016/j.ccr.2014.02.017; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Thompson H, 2013, NAT MED, V19, P949, DOI 10.1038/nm0813-949; Tsai FD, 2015, P NATL ACAD SCI USA, V112, P779, DOI 10.1073/pnas.1412811112; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Witkiewicz AK, 2016, CELL REP, V16, P2017, DOI 10.1016/j.celrep.2016.07.023; Wong KK, 2010, CURR OPIN GENET DEV, V20, P87, DOI 10.1016/j.gde.2009.11.002; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Zeitouni D, 2016, CANCERS, V8, DOI 10.3390/cancers8040045; Zhang C, 2015, NATURE, V526, P583, DOI 10.1038/nature14982; Zimmermann G, 2013, NATURE, V497, P638, DOI 10.1038/nature12205	49	216	230	5	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1158	1163		10.1126/science.aam7622	http://dx.doi.org/10.1126/science.aam7622			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302824				2022-12-28	WOS:000396351200033
J	Stern, AD; Alexander, BM; Chandra, A				Stern, A. D.; Alexander, B. M.; Chandra, A.			BIOMEDICAL INNOVATION How economics can shape precision medicines Innovation incentives, pricing, and access are critical	SCIENCE			English	Editorial Material							BREAST-CANCER; ADAPTIVE RANDOMIZATION; MARKET-SIZE; TRIAL		[Stern, A. D.; Chandra, A.] Harvard Sch Business, Boston, MA 02163 USA; [Stern, A. D.] Brigham & Womens Hosp, Ariadne Labs, Boston, MA 02215 USA; [Stern, A. D.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02215 USA; [Alexander, B. M.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Alexander, B. M.] Harvard Med Sch, Harvard Program Therapeut Sci, Boston, MA 02115 USA; [Chandra, A.] Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Chandra, A.] Natl Bur Econ Res, Cambridge, MA 02138 USA	Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; National Bureau of Economic Research	Stern, AD (corresponding author), Harvard Sch Business, Boston, MA 02163 USA.; Stern, AD (corresponding author), Brigham & Womens Hosp, Ariadne Labs, Boston, MA 02215 USA.; Stern, AD (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02215 USA.	astern@hbs.edu	Stern, Ariel Dora/AGJ-7029-2022	Stern, Ariel Dora/0000-0002-3586-1041				Acemoglu D, 2004, Q J ECON, V119, P1049, DOI 10.1162/0033553041502144; Bach PB, 2014, JAMA-J AM MED ASSOC, V312, P1629, DOI 10.1001/jama.2014.13235; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316; Chandra A, 2015, JAMA-J AM MED ASSOC, V314, P225, DOI 10.1001/jama.2015.6170; Chandra A, 2011, J ECON PERSPECT, V25, P27, DOI 10.1257/jep.25.2.27; COCHRANE JH, 1995, J POLIT ECON, V103, P445, DOI 10.1086/261991; Dubois P, 2015, RAND J ECON, V46, P844, DOI 10.1111/1756-2171.12113; FDA, 2016, NOV DRUGS SUMM; FDA, 2012, 209 FDA GFI; Food and Drug Administration, 2014, GUID IND EXP PROGR S; Montazerhodjat V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6913; Park JW, 2016, NEW ENGL J MED, V375, P11, DOI 10.1056/NEJMoa1513750; Rugo HS, 2016, NEW ENGL J MED, V375, P23, DOI 10.1056/NEJMoa1513749; The Henry J. Kaiser Family Foundation, 2016, MED PARD D PRESCR DR; Yin W, 2009, J HEALTH ECON, V28, P950, DOI 10.1016/j.jhealeco.2009.06.011	16	15	15	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1131	1133		10.1126/science.aai8707	http://dx.doi.org/10.1126/science.aai8707			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302813				2022-12-28	WOS:000396351200023
J	Buhagiar, MA; Naylor, JM; Harris, IA; Xuan, W; Kohler, F; Wright, R; Fortunato, R				Buhagiar, Mark A.; Naylor, Justine M.; Harris, Ian A.; Xuan, Wei; Kohler, Friedbert; Wright, Rachael; Fortunato, Renee			Effect of Inpatient Rehabilitation vs a Monitored Home-Based Program on Mobility in Patients With Total Knee Arthroplasty The HIHO Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							6-MINUTE WALK TEST; TOTAL HIP; REPLACEMENT; HOSPITALS	IMPORTANCE Formal rehabilitation programs, including inpatient programs, are often assumed to optimize recovery among patients after undergoing total knee arthroplasty. However, these programs have not been compared with any outpatient or home-based programs. OBJECTIVE To determine whether 10 days of inpatient rehabilitation followed by a monitored home-based program after total knee arthroplasty provided greater improvements than a monitored home-based program alone in mobility, function, and quality of life. DESIGN, SETTING, AND PARTICIPANTS In this 2-group, parallel, randomized clinical trial, including a nonrandomized observational group, conducted at 2 public, high-volume arthroplasty hospitals in Sydney, Australia (July 2012-December 2015), 940 patients with osteoarthritis undergoing primary total knee arthroplasty were screened for eligibility. Of the 525 eligible patients consecutively invited to participate, 165 were randomized either to receive inpatient hospital rehabilitation and home-based rehabilitation or to receive home-based rehabilitation alone, and 87 patients enrolled in the observation group. INTERVENTIONS Eighty-one patients were randomized to receive 10 days of hospital inpatient rehabilitation followed by an 8-week clinician-monitored home-based program, 84 were randomized to receive the home-based program alone, and 87 agreed to be in the observational group, which included only the home-based program. MAIN OUTCOMES AND MEASURES Mobility at 26 weeks after surgery, measured with the 6-minute walk test. Secondary outcomes included the Oxford Knee Score, which ranges from 0 (worst) to 48 (best) and has a minimal clinically important difference of 5 points; and EuroQol Group 5-Dimension Self-Report Questionnaire (EQ-5D) visual analog scale, which ranges from 0 (worst) to 100 (best), and has a minimal clinically important difference of 23 points. RESULTS Among the 165 randomized participants, 68% were women, and the cohort had a mean age, 66.9 years (SD, 8.4 years). There was no significant difference in the 6-minute walk test between the inpatient rehabilitation and either of the 2 home program groups (mean difference, -1.01; 95% CI, -25.56 to 23.55), nor in patient-reported pain and function (knee score mean difference, 2.06; 95% CI, -0.59 to 4.71), or quality of life (EQ-5D visual analog scale mean difference, 1.41; 95% CI, -6.42 to 3.60). The number of postdischarge complications for the inpatient group was 12 vs 9 among the home group, and there were no adverse events reported that were a result of trial participation. CONCLUSIONS AND RELEVANCE Among adults undergoing uncomplicated total knee arthroplasty, the use of inpatient rehabilitation compared with a monitored home-based program did not improve mobility at 26 weeks after surgery. These findings do not support inpatient rehabilitation for this group of patients.	[Buhagiar, Mark A.; Kohler, Friedbert] HammondCare, Braeside Hosp, Sydney, NSW, Australia; [Buhagiar, Mark A.; Naylor, Justine M.; Harris, Ian A.; Xuan, Wei; Kohler, Friedbert] Univ New South Wales, Liverpool Hosp, South West Sydney Clin Sch, Liverpool, NSW 2170, Australia; [Naylor, Justine M.; Harris, Ian A.; Kohler, Friedbert; Wright, Rachael; Fortunato, Renee] South West Sydney Local Hlth Dist, Frederick, MD 21701 USA; [Naylor, Justine M.; Harris, Ian A.] Whitlam Orthopaed Res Ctr, Liverpool, NSW, Australia; [Naylor, Justine M.; Harris, Ian A.; Xuan, Wei] Ingham Inst Appl Med Res, Liverpool, NSW 2170, Australia	Liverpool Hospital; University of New South Wales Sydney; Ingham Institute for Applied Medical Research	Naylor, JM (corresponding author), Liverpool Hosp, Dept Orthopaed, Locked Bag 7103, Liverpool Bc, NSW 1871, Australia.	justine.naylor@sswahs.nsw.gov.au	Buhagiar, Mark/R-9008-2019; Naylor, Justine/R-8459-2019	Buhagiar, Mark/0000-0001-6358-0485; Naylor, Justine/0000-0002-9147-1312	HCF Research Foundation; South Western Sydney Local Health District through the Whitlam Orthopaedic Research Centre; HammondCare; Ingham Institute	HCF Research Foundation; South Western Sydney Local Health District through the Whitlam Orthopaedic Research Centre; HammondCare; Ingham Institute(Ingham Institute for Applied Medical Research)	This study was funded in part by a competitive grant from the HCF Research Foundation and was supported by the South Western Sydney Local Health District through the Whitlam Orthopaedic Research Centre and by HammondCare and the Ingham Institute.	Adamson SJ, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1864; Adie S, 2012, ANZ J SURG, V82, P616, DOI 10.1111/j.1445-2197.2012.06113.x; Arthroplasty Clinical Outcomes Registry, 2016, ARTHR CLIN OUTC REG; Artz N, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0469-6; Artz N, 2013, MUSCULOSKELET CARE, V11, P31, DOI 10.1002/msc.1027; Australasian Faculty of Rehabilitation Medicine, 2012, STAND PROV INP AD RE; Australian Orthopaedic Association National Joint Replacement Registry, 2016, AN STAT TERR HLTH DA; Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR), 2016, ANN REPORT; Bade MJ, 2017, ARTHRIT CARE RES, V69, P1360, DOI 10.1002/acr.23139; Benz T, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0780-2; Buhagiar MA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-432; Clement ND, 2014, KNEE SURG SPORT TR A, V22, P1933, DOI 10.1007/s00167-013-2776-5; Dawson J, 1998, J BONE JOINT SURG BR, V80B, P63, DOI 10.1302/0301-620X.80B1.7859; DeJong G, 2009, ARCH PHYS MED REHAB, V90, P1269, DOI 10.1016/j.apmr.2008.11.021; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Federal Register, 2015, FED REGISTER, V80, P73273; Hart A, 2015, JAMA SURG, V150, P990, DOI 10.1001/jamasurg.2015.1239; Katz P, 2001, J AM GERIATR SOC, V49, P808; Ko V, 2013, J BONE JOINT SURG AM, V95A, P1942, DOI 10.2106/JBJS.L.00964; Ko V, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-145; Kramer JF, 2003, CLIN ORTHOP RELAT R, P225, DOI 10.1097/01.blo.0000063600.67412.11; Kremers HM, 2015, J BONE JOINT SURG AM, V97A, P1386, DOI 10.2106/JBJS.N.01141; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Lavernia CJ, 2006, J ARTHROPLASTY, V21, P144, DOI 10.1016/j.arth.2006.05.003; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Madsen M, 2013, DAN MED J, V60; Mahomed NN, 2008, J BONE JOINT SURG AM, V90A, P1673, DOI 10.2106/JBJS.G.01108; National Joint Registry for England and Wales, 2015, NAT JOINT REG ENGL W; Naylor JM, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1249-7; Naylor J, 2006, PHYSIOTHER RES INT, V11, P35, DOI 10.1002/pri.40; Naylor JM, 2012, J ARTHROPLASTY, V27, P1100, DOI 10.1016/j.arth.2011.09.023; Nelson ME, 2007, MED SCI SPORT EXER, V39, P1435, DOI 10.1161/CIRCULATIONAHA.107.185650; Paulsen A, 2014, ACTA ORTHOP, V85, P39, DOI 10.3109/17453674.2013.867782; Pezzin LE, 2011, AM J PHYS MED REHAB, V90, P954, DOI 10.1097/PHM.0b013e3182241531; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Royal Australian College of Surgeons, 2015, SURG PRACT VAR REP O; Troosters T, 2002, PHYS THER, V82, P826, DOI 10.1093/ptj/82.8.826; Wilson NA, 2008, HEALTH AFFAIR, V27, P1587, DOI 10.1377/hlthaff.27.6.1587; Xie F, 2010, VALUE HEALTH, V13, P873, DOI 10.1111/j.1524-4733.2010.00770.x	40	89	91	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1037	1046		10.1001/jama.2017.1224	http://dx.doi.org/10.1001/jama.2017.1224			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291891				2022-12-28	WOS:000396713400016
J	Rowan, KM; Angus, DC; Bailey, M; Barnato, AE; Bellomo, R; Canter, RR; Coats, TJ; Delaney, A; Gimbel, E; Grieve, RD; Harrison, DA; Higgins, AM; Howe, B; Huang, DT; Kellum, JA; Mouncey, PR; Music, E; Peake, SL; Pike, F; Reade, MC; Sadique, MZ; Singer, M; Yealy, DM				Rowan, Kathryn M.; Angus, Derek C.; Bailey, Michael; Barnato, Amber E.; Bellomo, Rinaldo; Canter, Ruth R.; Coats, Timothy J.; Delaney, Anthony; Gimbel, Elizabeth; Grieve, Richard D.; Harrison, David A.; Higgins, Alisa M.; Howe, Belinda; Huang, David T.; Kellum, John A.; Mouncey, Paul R.; Music, Edvin; Peake, Sandra L.; Pike, Francis; Reade, Michael C.; Sadique, M. Zia; Singer, Mervyn; Yealy, Donald M.		PRISM Investigators	Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE SEPSIS; PERSONALIZED MEDICINE; OUTCOMES; TRIAL	BACKGROUND After a single-center trial and observational studies suggesting that early, goal-directed therapy (EGDT) reduced mortality from septic shock, three multicenter trials (ProCESS, ARISE, and ProMISe) showed no benefit. This meta-analysis of individual patient data from the three recent trials was designed prospectively to improve statistical power and explore heterogeneity of treatment effect of EGDT. METHODS We harmonized entry criteria, intervention protocols, outcomes, resource-use measures, and data collection across the trials and specified all analyses before unblinding. After completion of the trials, we pooled data, excluding the protocol-based standard-therapy group from the ProCESS trial, and resolved residual differences. The primary outcome was 90-day mortality. Secondary outcomes included 1-year survival, organ support, and hospitalization costs. We tested for treatment-by-subgroup interactions for 16 patient characteristics and 6 care-delivery characteristics. RESULTS We studied 3723 patients at 138 hospitals in seven countries. Mortality at 90 days was similar for EGDT (462 of 1852 patients [24.9%]) and usual care (475 of 1871 patients [25.4%]); the adjusted odds ratio was 0.97 (95% confidence interval, 0.82 to 1.14; P = 0.68). EGDT was associated with greater mean (+/-SD) use of intensive care (5.3+/-7.1 vs. 4.9+/-7.0 days, P = 0.04) and cardiovascular support (1.9+/-3.7 vs. 1.6+/-2.9 days, P = 0.01) than was usual care; other outcomes did not differ significantly, although average costs were higher with EGDT. Subgroup analyses showed no benefit from EGDT for patients with worse shock (higher serum lactate level, combined hypotension and hyperlactatemia, or higher predicted risk of death) or for hospitals with a lower propensity to use vasopressors or fluids during usual resuscitation. CONCLUSIONS In this meta-analysis of individual patient data, EGDT did not result in better outcomes than usual care and was associated with higher hospitalization costs across a broad range of patient and hospital characteristics.	[Rowan, Kathryn M.; Canter, Ruth R.; Harrison, David A.; Mouncey, Paul R.] Intens Care Natl Audit & Res Ctr, Napier House,24 High Holborn, London WC1V 6AZ, England; [Grieve, Richard D.; Sadique, M. Zia] London Sch Hyg & Trop Med, London, England; [Singer, Mervyn] UCL, London, England; [Coats, Timothy J.] Univ Leicester, Leicester, Leics, England; [Angus, Derek C.; Barnato, Amber E.; Gimbel, Elizabeth; Huang, David T.; Kellum, John A.; Music, Edvin; Yealy, Donald M.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Bailey, Michael; Bellomo, Rinaldo; Higgins, Alisa M.; Howe, Belinda; Peake, Sandra L.] Monash Univ, Melbourne, Vic, Australia; [Delaney, Anthony] Univ Sydney, Sydney, NSW, Australia; [Peake, Sandra L.] Univ Adelaide, Adelaide, SA, Australia; [Peake, Sandra L.] Queen Elizabeth Hosp, Adelaide, SA, Australia; [Reade, Michael C.] Univ Queensland, Brisbane, Qld, Australia; [Pike, Francis] Eli Lilly, Indianapolis, IN USA	Intensive Care National Audit & Research Centre; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Leicester; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Monash University; University of Sydney; University of Adelaide; University of Queensland; Eli Lilly	Rowan, KM (corresponding author), Intens Care Natl Audit & Res Ctr, Napier House,24 High Holborn, London WC1V 6AZ, England.	kathy.rowan@icnarc.org	Angus, Derek C/E-9671-2012; Kellum, John/AAP-3072-2020; Limkakeng, Alexander T./AAH-7733-2020; Kellum, John A/HCH-2944-2022; Reade, Michael/G-7035-2012; Higgins, Alisa/AAM-8088-2020; Singer, Mervyn/Q-6142-2019; Harrison, David A/O-4355-2018; Bailey, Michael J/A-4499-2012; Coats, Timothy/AAW-1254-2021; McCurdy, Michael/T-5518-2019; Delaney, Anthony/AAE-3365-2019	Kellum, John/0000-0003-1995-2653; Limkakeng, Alexander T./0000-0002-9822-5595; Kellum, John A/0000-0003-1995-2653; Reade, Michael/0000-0003-1570-0707; Higgins, Alisa/0000-0001-8295-7559; Singer, Mervyn/0000-0002-1042-6350; Harrison, David A/0000-0002-9002-9098; Bailey, Michael J/0000-0002-5551-1401; Coats, Timothy/0000-0003-2736-2784; McCurdy, Michael/0000-0001-5319-0475; Kulstad, Erik/0000-0002-9331-8266; Mouncey, Paul/0000-0002-8510-8517; Nichol, Alistair/0000-0002-4689-1238; Sadique, Zia/0000-0001-5814-0258; Bion, Julian/0000-0003-0344-5403; Delaney, Anthony/0000-0002-1015-7146; Chawla, Lakhmir/0000-0001-5987-8318; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Self, Wesley/0000-0002-9300-3045; Huang, David/0000-0001-7649-1633; Wilkman, Erika/0000-0003-4250-7523; Myburgh, John/0000-0003-4088-7016; Grieve, Richard/0000-0001-8899-1301; Micallef, Sharon/0000-0002-8496-2324; Bajwa, Ednan/0000-0001-9026-1009; Rowan, Kathryn/0000-0001-8217-5602; Brealey, David/0000-0002-1982-3379; Harvey, Daniel/0000-0002-5165-3277	National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076659] Funding Source: NIH RePORTER; National Institute for Health Research [07/37/47] Funding Source: researchfish	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Institute of General Medical Sciences and others; PRISM ClinicalTrials.gov number, NCT02030158.	Angus DC, 2015, INTENS CARE MED, V41, P1549, DOI 10.1007/s00134-015-3822-1; Davenport EE, 2016, LANCET RESP MED, V4, P259, DOI 10.1016/S2213-2600(16)00046-1; De Backer D, 2016, INTENS CARE MED, V42, P1048, DOI 10.1007/s00134-016-4295-6; Grieve R, 2005, HEALTH ECON, V14, P185, DOI 10.1002/hec.916; Huang DT, 2013, INTENS CARE MED, V39, P1760, DOI 10.1007/s00134-013-3024-7; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Nguyen HB, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1288-3; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Puskarich MA, 2009, CRIT CARE, V13, DOI 10.1186/cc8138; Reade MC, 2010, INTENS CARE MED, V36, P11, DOI 10.1007/s00134-009-1650-x; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Shankar-Hari M, 2016, CRIT CARE MED, V44, P2223, DOI 10.1097/CCM.0000000000001876; Sivayoham N, 2012, EUR J EMERG MED, V19, P235, DOI 10.1097/MEJ.0b013e32834bbea6; Vincent JL, 2016, LANCET RESP MED, V4, P242, DOI 10.1016/S2213-2600(16)00068-0; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843; Wong HR, 2015, AM J RESP CRIT CARE, V191, P309, DOI 10.1164/rccm.201410-1864OC; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	20	281	295	2	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 8	2017	376	23					2223	2234		10.1056/NEJMoa1701380	http://dx.doi.org/10.1056/NEJMoa1701380			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW8WG	28320242	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000402798200006
J	Joly, P; Maho-Vaillant, M; Prost-Squarcioni, C; Hebert, V; Houivet, E; Calbo, S; Caillot, F; Golinski, ML; Labeille, B; Picard-Dahan, C; Paul, C; Richard, MA; Bouaziz, JD; Duvert-Lehembre, S; Bernard, P; Caux, F; Alexandre, M; Ingen-Housz-Oro, S; Vabres, P; Delaporte, E; Quereux, G; Dupuy, A; Debarbieux, S; Avenel-Audran, M; D'Incan, M; Bedane, C; Beneton, N; Jullien, D; Dupin, N; Misery, L; Machet, L; Beylot-Barry, M; Dereure, O; Sassolas, B; Vermeulin, T; Benichou, J; Musette, P				Joly, Pascal; Maho-Vaillant, Maud; Prost-Squarcioni, Catherine; Hebert, Vivien; Houivet, Estelle; Calbo, Sebastien; Caillot, Frederique; Golinski, Marie Laure; Labeille, Bruno; Picard-Dahan, Catherine; Paul, Carle; Richard, Marie-Aleth; Bouaziz, Jean David; Duvert-Lehembre, Sophie; Bernard, Philippe; Caux, Frederic; Alexandre, Marina; Ingen-Housz-Oro, Saskia; Vabres, Pierre; Delaporte, Emmanuel; Quereux, Gaelle; Dupuy, Alain; Debarbieux, Sebastien; Avenel-Audran, Martine; D'Incan, Michel; Bedane, Christophe; Beneton, Nathalie; Jullien, Denis; Dupin, Nicolas; Misery, Laurent; Machet, Laurent; Beylot-Barry, Marie; Dereure, Olivier; Sassolas, Bruno; Vermeulin, Thomas; Benichou, Jacques; Musette, Philippe		French Study Grp Autoimmune	First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial	LANCET			English	Article							INTENSITY SCORE ABSIS; MYCOPHENOLATE-MOFETIL; SINGLE-CYCLE; VULGARIS; THERAPY; DISEASE; ADJUVANT; CORTICOSTEROIDS; COMBINATION; DERMATOLOGY	Background High doses of corticosteroids are considered the standard treatment for pemphigus. Because long-term corticosteroid treatment can cause severe and even life-threatening side-effects in patients with this disease, we assessed whether first-line use of rituximab as adjuvant therapy could improve the proportion of patients achieving complete remission off-therapy, compared with corticosteroid treatment alone, while decreasing treatment side-effects of corticosteroids. Methods We did a prospective, multicentre, parallel-group, open-label, randomised trial in 25 dermatology hospital departments in France (Ritux 3). Eligible participants were patients with newly diagnosed pemphigus aged 18-80 years being treated for the first time (not at the time of a relapse). We randomly assigned participants (1: 1) to receive either oral prednisone alone, 1.0 or 1.5 mg/kg per day tapered over 12 or 18 months (prednisone alone group), or 1000 mg of intravenous rituximab on days 0 and 14, and 500 mg at months 12 and 18, combined with a short-term prednisone regimen, 0.5 or 1.0 mg/kg per day tapered over 3 or 6 months (rituximab plus short-term prednisone group). Follow-up was for 3 years (study visits were scheduled weekly during the first month of the study, then monthly until month 24, then an additional visit at month 36). Treatment was assigned through central computer-generated randomisation, with stratification according to disease-severity (severe or moderate, based on Harman's criteria). The primary endpoint was the proportion of patients who achieved complete remission off-therapy at month 24 (intention-to-treat analysis). This study is registered with ClinicalTrials.gov, number NCT00784589. Findings Between May 10, 2010, and Dec 7, 2012, we enrolled 91 patients and randomly assigned 90 to treatment (90 were analysed; 1 patient withdrew consent before the random assignment). At month 24, 41 (89%) of 46 patients assigned to rituximab plus short-term prednisone were in complete remission off-therapy versus 15 (34%) of 44 assigned to prednisone alone (absolute difference 55 percentage points, 95% CI 38.4-71.7; p<0.0001. This difference corresponded to a relative risk of success of 2.61 (95% CI 1.71-3.99, p<0.0001), corresponding to 1.82 patients (95% CI 1.39-2.60) who would need to be treated with rituximab plus prednisone (rather than prednisone alone) for one additional success. No patient died during the study. More severe adverse events of grade 3-4 were reported in the prednisone-alone group (53 events in 29 patients; mean 1.20 [SD 1.25]) than in the rituximab plus prednisone group (27 events in 16 patients; mean 0.59 [1.15]; p=0.0021). The most common of these events in both groups were diabetes and endocrine disorder (11 [21%] with prednisone alone vs six [22%] with rituximab plus prednisone), myopathy (ten [19%] vs three [11%]), and bone disorders (five [9%] vs five [19%]). Interpretation Data from our trial suggest that first-line use of rituximab plus short-term prednisone for patients with pemphigus is more effective than using prednisone alone, with fewer adverse events.	[Joly, Pascal; Maho-Vaillant, Maud; Hebert, Vivien; Calbo, Sebastien; Caillot, Frederique; Golinski, Marie Laure; Duvert-Lehembre, Sophie; Musette, Philippe] Normandie Univ, Rouen Univ Hosp, Dept Dermatol, Rouen, France; [Joly, Pascal; Maho-Vaillant, Maud; Hebert, Vivien; Calbo, Sebastien; Caillot, Frederique; Golinski, Marie Laure; Duvert-Lehembre, Sophie; Musette, Philippe] Normandie Univ, Ctr Reference Malad Bulleuses Autoimmunes, INSERM U1234, Rouen, France; [Prost-Squarcioni, Catherine; Caux, Frederic; Alexandre, Marina] Univ Paris VIII, Dept Dermatol, Bobigny, France; [Houivet, Estelle; Benichou, Jacques] Normandie Univ, Rouen Univ Hosp, Dept Biostat, Rouen, France; [Houivet, Estelle; Benichou, Jacques] Normandie Univ, INSERM U1219, Rouen, France; [Labeille, Bruno] Univ St Etienne, Dept Dermatol, St Etienne, France; [Picard-Dahan, Catherine] Univ Paris X, Bichat Hosp, Dept Dermatol, Paris, France; [Paul, Carle] Univ Toulouse, Dept Dermatol, Toulouse, France; [Richard, Marie-Aleth] Aix Marseille Univ, UMR 911, INSERM CRO2, Dept Dermatol,AP HM, Marseille, France; [Bouaziz, Jean David] Paris 7 Sorbonne Paris Cite Univ, Dept Dermatol, St Louis Hosp, Paris, France; [Bernard, Philippe] Univ Reims, Dept Dermatol, Reims, France; [Ingen-Housz-Oro, Saskia] Henri Mondor Hosp, APHP, Dept Dermatol, Creteil, France; [Vabres, Pierre] Dijon Univ Hosp, Dept Dermatol, Dijon, France; [Delaporte, Emmanuel] Univ Lille, Dept Dermatol, Lille, France; [Quereux, Gaelle] Univ Nantes, Dept Dermatol, Nantes, France; [Dupuy, Alain] Univ Rennes, Dept Dermatol, Rennes, France; [Debarbieux, Sebastien] Ctr Hosp Lyon Sud, Dept Dermatol, Lyon, France; [Avenel-Audran, Martine] Univ Angers, Dept Dermatol, Angers, France; [D'Incan, Michel] Univ Clermont Ferrand, Dept Dermatol, Clermont Ferrand, France; [Bedane, Christophe] Univ Limoges, Dept Dermatol, Limoges, France; [Beneton, Nathalie] Le Mans Gen Hosp, Dept Dermatol, Le Mans, France; [Jullien, Denis] Lyon Claude Bernard Univ, Edouard Herriot Hosp, Dept Dermatol, Lyon, France; [Dupin, Nicolas] Univ Paris V, Dept Dermatol, Paris, France; [Misery, Laurent] Brest Univ Hosp, Dept Dermatol, Brest, France; [Machet, Laurent] Tours Univ Hosp, Dept Dermatol, Tours, France; [Beylot-Barry, Marie] Univ Bordeaux, Dept Dermatol, Bordeaux, France; [Dereure, Olivier] Univ Montpellier, Dept Dermatol, Montpellier, France; [Sassolas, Bruno] Brest Univ Hosp, Dept Internal Med, Brest, France; [Vermeulin, Thomas] Rouen Univ Hosp, Dept Med Informat & Informat, Rouen, France	CHU de Rouen; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Nanterre; Universite de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHU Dijon Bourgogne; Universite de Lille - ISITE; Universite de Lille; Nantes Universite; Universite de Rennes; CHU Lyon; Universite d'Angers; Universite de Limoges; Centre Hospitalier Le Mans; CHU Lyon; UDICE-French Research Universities; Universite Paris Cite; CHU Brest; CHU Tours; UDICE-French Research Universities; Universite de Bordeaux; Universite de Montpellier; CHU Brest; CHU de Rouen	Joly, P (corresponding author), Rouen Univ Hosp, Clin Dermatol, F-76031 Rouen, France.	Pascal.Joly@chu-rouen.fr	Vermeulin, Thomas/AAG-3741-2020; Vabres, Pierre/D-3906-2011; JULLIEN, Denis/D-5654-2014; Musette, Philippe/AAY-9916-2021; Vabres, Pierre/V-3850-2019; Machet, Laurent/A-2976-2010; Misery, Laurent/I-1186-2019; Beylot-Barry, Marie/AHC-3163-2022; Dupuy, Alain/AFU-6822-2022	Vabres, Pierre/0000-0001-8693-3183; JULLIEN, Denis/0000-0002-2995-7928; Vabres, Pierre/0000-0001-8693-3183; Machet, Laurent/0000-0001-5985-878X; Sempe, Christine/0000-0001-6903-1575; Paul, Carle/0000-0003-0165-5263; Beylot-Barry, Marie/0000-0001-6150-1229; Dupin, Nicolas/0000-0002-6237-4951	French Ministry of Health; French Society of Dermatology; Roche; Programme Hospitalier de Recherche Clinique, French Ministry of Health [2008-005266-31]	French Ministry of Health; French Society of Dermatology; Roche(Roche Holding); Programme Hospitalier de Recherche Clinique, French Ministry of Health	French Ministry of Health, French Society of Dermatology, Roche.; The study was supported by a grant from the Programme Hospitalier de Recherche Clinique, French Ministry of Health (No 2008-005266-31), and a grant from the French Society of Dermatology. We thank Jean Claude Roujeau, and Jean Claude Guillaume for their help in designing the study, Michael Hertl and Rudiger Eming (Marburg Germany) who provided the recombinant desmoglein 1 and 3, Vincent Ferranti and Natacha Colliou for technical assistance, Rob Stern for commenting on the results, and Nikki Sabourin-Gibbs for her help with editing the manuscript.	Ahmed AR, 2016, INT IMMUNOPHARMACOL, V34, P25, DOI 10.1016/j.intimp.2016.02.013; Ahmed AR, 2015, AUTOIMMUN REV, V14, P323, DOI 10.1016/j.autrev.2014.12.002; Ahmed AR, 2006, NEW ENGL J MED, V355, P1772, DOI 10.1056/NEJMoa062930; Almugairen N, 2013, J AM ACAD DERMATOL, V69, P583, DOI 10.1016/j.jaad.2013.05.016; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; Atzmony L, 2015, J AM ACAD DERMATOL, V73, P264, DOI 10.1016/j.jaad.2015.04.038; Beissert S, 2010, J INVEST DERMATOL, V130, P2041, DOI 10.1038/jid.2010.91; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Boulard C, 2016, BRIT J DERMATOL, V175, P142, DOI 10.1111/bjd.14405; Chams-Davatchi C, 2007, J AM ACAD DERMATOL, V57, P622, DOI 10.1016/j.jaad.2007.05.024; Cho YT, 2014, ACTA DERM-VENEREOL, V94, P472, DOI 10.2340/00015555-1746; Chrysomallis Fotis, 1994, International Journal of Dermatology, V33, P803, DOI 10.1111/j.1365-4362.1994.tb01003.x; Cianchini G, 2012, J AM ACAD DERMATOL, V67, P617, DOI 10.1016/j.jaad.2011.11.007; Colliou N, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005166; Common Terminology Criteria for Adverse Events version 4. 0, 2009, COMM TERM CRIT ADV E; Deddens JA, 2003, P 28 ANN SAS US GROU, V30, P270; Eming R, 2008, J INVEST DERMATOL, V128, P2850, DOI 10.1038/jid.2008.172; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Guillevin L, 2014, NEW ENGL J MED, V371, P1771, DOI 10.1056/NEJMoa1404231; Hammers CM, 2015, J INVEST DERMATOL, V135, P742, DOI 10.1038/jid.2014.291; Harman KE, 2001, BRIT J DERMATOL, V144, P775, DOI 10.1046/j.1365-2133.2001.04132.x; Heelan K, 2015, J CUTAN MED SURG, V19, P274, DOI 10.2310/7750.2014.14092; Heelan K, 2014, JAMA DERMATOL, V150, P703, DOI 10.1001/jamadermatol.2013.6739; Hertl M, 2006, J CLIN INVEST, V116, P1159, DOI 10.1172/JCI28547; Hertl M, 2015, J EUR ACAD DERMATOL, V29, P405, DOI 10.1111/jdv.12772; Ingen-Housz-Oro S, 2015, JAMA DERMATOL, V151, P200, DOI 10.1001/jamadermatol.2014.2421; Ioannides D, 2000, ARCH DERMATOL, V136, P868, DOI 10.1001/archderm.136.7.868; Ioannides D, 2012, J EUR ACAD DERMATOL, V26, P855, DOI 10.1111/j.1468-3083.2011.04170.x; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Kim JH, 2011, BRIT J DERMATOL, V165, P646, DOI 10.1111/j.1365-2133.2011.10411.x; Langan SM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a180; Leplege A, 2003, ANN DERMATOL VENER, V130, P177; Leshem YA, 2014, J AM ACAD DERMATOL, V71, P284, DOI 10.1016/j.jaad.2014.03.020; Leshem YA, 2013, J AM ACAD DERMATOL, V68, P404, DOI 10.1016/j.jaad.2012.08.010; LEVER WF, 1969, ARCH DERMATOL, V100, P70, DOI 10.1001/archderm.100.1.70; Lott JP, 2014, J AM ACAD DERMATOL, V70, P47, DOI 10.1016/j.jaad.2013.09.039; Lunardon L, 2012, ARCH DERMATOL, V148, P1031, DOI 10.1001/archdermatol.2012.1522; Martin LK, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006263.pub2; Matsukura S, 2012, ARCH DERMATOL, V148, P734, DOI 10.1001/archdermatol.2011.3320; Murrell DE, 2008, J AM ACAD DERMATOL, V58, P1043, DOI 10.1016/j.jaad.2008.01.012; Pfutze M, 2007, EUR J DERMATOL, V17, P4; Rosenbach M, 2009, J INVEST DERMATOL, V129, P2404, DOI 10.1038/jid.2009.72; Sharma VK, 2013, CLIN EXP DERMATOL, V38, P659, DOI 10.1111/ced.12073; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; STANLEY JR, 1989, J CLIN INVEST, V83, P1443, DOI 10.1172/JCI114036; Wu H, 2000, NEW ENGL J MED, V343, P31, DOI 10.1056/NEJM200007063430105; Zambruno G, 2008, J INVEST DERMATOL, V128, P2745, DOI 10.1038/jid.2008.330; Zhao CY, 2015, DRUGS, V75, P271, DOI 10.1007/s40265-015-0353-6	49	297	306	4	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2017	389	10083					2031	2040		10.1016/S0140-6736(17)30070-3	http://dx.doi.org/10.1016/S0140-6736(17)30070-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV1OH	28342637				2022-12-28	WOS:000401515300025
J	Ridker, PM; Tardif, JC; Amarenco, P; Duggan, W; Glynn, RJ; Jukema, JW; Kastelein, JJP; Kim, AM; Koenig, W; Nissen, S; Revkin, J; Rose, LM; Santos, RD; Schwartz, PF; Shear, CL; Yunis, C				Ridker, Paul M.; Tardif, Jean-Claude; Amarenco, Pierre; Duggan, William; Glynn, Robert J.; Jukema, J. Wouter; Kastelein, John J. P.; Kim, Albert M.; Koenig, Wolfgang; Nissen, Steven; Revkin, James; Rose, Lynda M.; Santos, Raul D.; Schwartz, Pamela F.; Shear, Charles L.; Yunis, Carla		SPIRE Investigators	Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR EVENTS; MONOCLONAL-ANTIBODY; VASCULAR EVENTS; REDUCING LIPIDS; STATIN THERAPY; EFFICACY; SAFETY; RISK	BACKGROUND Bococizumab, a humanized monoclonal antibody targeting proprotein convertase subtilisin-kexin type 9 (PCSK9), reduces levels of low-density lipoprotein (LDL) cholesterol. However, the variability and durability of this effect are uncertain. METHODS We conducted six parallel, multinational lipid-lowering trials enrolling 4300 patients with hyperlipidemia who were randomly assigned to receive 150 mg of bococizumab or placebo subcutaneously every 2 weeks and who were followed for up to 12 months; 96% were receiving statin therapy at the time of enrollment. The patients were assessed for lipid changes over time, stratified according to the presence or absence of antidrug antibodies detected during the treatment period. RESULTS At 12 weeks, patients who received bococizumab had a reduction of 54.2% in the LDL cholesterol level from baseline, as compared with an increase of 1.0% among those who received placebo (absolute between-group difference, -55.2 percentage points). Significant between-group differences were also observed in total cholesterol, non-high-density lipoprotein cholesterol, apolipoprotein B, and lipoprotein(a) (P<0.001 for all comparisons). However, high-titer antidrug antibodies developed in a substantial proportion of the patients who received bococizumab, which markedly diminished the magnitude and durability of the reduction in LDL cholesterol levels. In addition, among patients with no antidrug antibodies, there was wide variability in the reduction in LDL cholesterol levels at both 12 weeks and 52 weeks. Major cardiovascular events occurred in 57 patients (2.5%) who received bococizumab and in 55 (2.7%) who received placebo (hazard ratio, 0.96; 95% confidence interval, 0.66 to 1.39; P = 0.83). The most common adverse event among patients who received bococizumab was injection-site reaction (12.7 per 100 person-years). CONCLUSIONS In six multinational trials evaluating bococizumab, antidrug antibodies developed in a large proportion of the patients and significantly attenuated the lowering of LDL cholesterol levels. Wide variation in the relative reduction in cholesterol levels was also observed among patients in whom antidrug antibodies did not develop.	[Ridker, Paul M.; Glynn, Robert J.; Rose, Lynda M.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Amarenco, Pierre] Pierre & Marie Curie Univ, Paris, France; [Duggan, William; Kim, Albert M.; Revkin, James; Schwartz, Pamela F.; Shear, Charles L.; Yunis, Carla] Pfizer, New York, NY USA; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Leiden, Netherlands; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, DZHK German Ctr Cardiovasc Res, Munich Heart Alliance, Munich, Germany; [Nissen, Steven] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Santos, Raul D.] Univ Sao Paulo Med Sch Hosp, Lipid Clin Heart Inst, Sao Paulo, Brazil	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universite de Montreal; UDICE-French Research Universities; Sorbonne Universite; Pfizer; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; German Centre for Cardiovascular Research; German Heart Centre Munich; Munich Heart Alliance; Technical University of Munich; Cleveland Clinic Foundation; Universidade de Sao Paulo	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA.; Tardif, JC (corresponding author), Montreal Heart Inst, 5000 Belanger St, Montreal, PQ H1T 1C8, Canada.	pridker@partners.org; jean-claude.tardif@icm-mhi.org	Kastelein, John/AAF-7950-2020; Santos, Raul/A-1170-2010; Urina-Triana, Miguel A/H-2605-2016; Nikolaev, Konstantin/P-4750-2017; Jukema, J. Wouter/ABD-6503-2021; Kjaerulf Jensen, Henrik/A-7980-2018	Santos, Raul/0000-0002-9860-6582; Urina-Triana, Miguel A/0000-0001-6003-4622; Nikolaev, Konstantin/0000-0003-4601-6203; Jukema, J. Wouter/0000-0002-3246-8359; Kjaerulf Jensen, Henrik/0000-0003-1802-4302; Civeira, Fernando/0000-0001-7043-0952; Demirci, Deniz/0000-0002-1571-7034; Koenig, Wolfgang/0000-0002-2064-9603; Kim, Albert/0000-0002-5269-2155; Venkatasubramanian, Siddharth/0000-0002-5860-0768	Pfizer; Novartis; Kowa; Amgen; Sanofi; Amarin; AstraZeneca; Eli Lilly; Esperion; Merck; DalCor; Servier; Sanofi-Regeneron; AFFiRiS; Cerenis; Corvidia; CSL Behring; Esperion Therapeutics; Gemphire Therapeutics; Ionis; Regeneron; Akarna Therapeutics; Catabasis; Cymabay Therapeutics; Madrigal; Roche; Medicines Company; GlaxoSmithKline; Berlin-Chemie; Roche Diagnostics; Genzyme; Praxis; Aegerion; Torrent; Akcea Therapeutics; Boehringer Ingelheim; BioLab; Cerenis Therapeutics; Unilever	Pfizer(Pfizer); Novartis(Novartis); Kowa; Amgen(Amgen); Sanofi; Amarin; AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); Esperion; Merck(Merck & Company); DalCor; Servier(Servier); Sanofi-Regeneron(Regeneron); AFFiRiS; Cerenis; Corvidia; CSL Behring; Esperion Therapeutics; Gemphire Therapeutics; Ionis; Regeneron(Regeneron); Akarna Therapeutics; Catabasis; Cymabay Therapeutics; Madrigal; Roche(Roche Holding); Medicines Company; GlaxoSmithKline(GlaxoSmithKline); Berlin-Chemie; Roche Diagnostics; Genzyme(Sanofi-AventisGenzyme Corporation); Praxis; Aegerion; Torrent; Akcea Therapeutics; Boehringer Ingelheim(Boehringer Ingelheim); BioLab; Cerenis Therapeutics; Unilever(Unilever)	Supported by Pfizer.; Dr. Ridker reports receiving grant support and fees for serving on an advisory board from Novartis, grant support from Kowa and Amgen, fees for serving on an advisory board from Sanofi, and being a coinventor of an issued patent (US 6,040,147), licensed to Siemens and AstraZeneca, about the use of inflammatory biomarkers in cardiovascular disease and diabetes; Dr. Tardif, receiving grant support to his institution from Amarin, AstraZeneca, Eli Lilly, Esperion, and Merck, receiving grant support to his institution and honoraria from DalCor and having an equity interest in the company, receiving grant support to his institution and honoraria from Pfizer, Sanofi, and Servier, and having a pending patent about genetic markers for predicting responsiveness to therapy (Application No. US14863148) and a pending patent about genotyping tests and methods for evaluating plasma creatine kinase levels (Application No. US15029387); Dr. Glynn, receiving grant support from Novartis, Kowa, and AstraZeneca; Dr. Jukema, receiving consulting fees, lecture fees, and fees for serving on a steering committee for the SPIRE program from Pfizer, receiving consulting fees, lecture fees, and fees for serving on a steering committee for the Odyssey Outcomes trial from Sanofi-Regeneron, receiving fees for serving on a steering committee for the ASCVD lipid trial from Eli Lilly, and receiving consulting fees, lecture fees, and fees for serving as national coordinator of the Fourier trial from Amgen; Dr. Kastelein, receiving consulting fees and fees for serving on an advisory board from AFFiRiS, AstraZeneca, Cerenis, Corvidia, CSL Behring, Esperion Therapeutics, Gemphire Therapeutics, Novartis, Eli Lilly, and Pfizer, receiving consulting fees, lecture fees, and fees for serving on an advisory board from Amgen, Ionis, Regeneron, and Sanofi, and receiving consulting fees from Akarna Therapeutics, Catabasis, Cymabay Therapeutics, Kowa, Madrigal, and Roche; Dr. Koenig, receiving consulting fees and lecture fees from AstraZeneca, consulting fees from Novartis, Pfizer, the Medicines Company, GlaxoSmithKline, DalCor, Kowa, and Amgen, lecture fees from Sanofi and Berlin-Chemie, and grant support and donation of reagents for biomarker measurements from Roche Diagnostics, Dr. Beckmann Pharma, Singulex, and Abbott; Dr. Nissen, receiving grant support from AstraZeneca, Amgen, Esperion, and the Medicines Company; Dr. Santos, receiving consulting fees and lecture fees from Amgen, AstraZeneca, Genzyme, Eli Lilly, Merck, Sanofi-Regeneron, and Praxis, lecture fees from Aegerion and Torrent, and consulting fees from Akcea Therapeutics, Boehringer Ingelheim, BioLab, Cerenis Therapeutics, Kowa, and Unilever; and Drs. Duggan, Kim, Revkin, Schwartz, Shear, and Yunis, being employees of Pfizer. Dr. Kim also reports having a pending patent about treatment with anti-PCSK9 antibodies (US Provisional Patent No. 62/093,885). No other potential conflict of interest relevant to this article was reported.	Amgen, 2015, EV PRES FDAS END MET; Ballantyne CM, 2015, AM J CARDIOL, V115, P1212, DOI 10.1016/j.amjcard.2015.02.006; Boekholdt SM, 2014, J AM COLL CARDIOL, V64, P485, DOI 10.1016/j.jacc.2014.02.615; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Ference BA, 2012, J AM COLL CARDIOL, V60, P2631, DOI 10.1016/j.jacc.2012.09.017; Foltz IN, 2013, CIRCULATION, V127, P2222, DOI 10.1161/CIRCULATIONAHA.113.002033; Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Ridker PM, 2017, NEW ENGL J MED, V376, P1527, DOI 10.1056/NEJMoa1701488; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2016, AM HEART J, V178, P135, DOI 10.1016/j.ahj.2016.05.010; Ridker PM, 2016, EUR HEART J, V37, P1373, DOI 10.1093/eurheartj/ehw046; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Roth EM, 2017, NEW ENGL J MED, V376, P1589, DOI 10.1056/NEJMc1616623; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699	15	223	229	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 20	2017	376	16					1517	1526		10.1056/NEJMoa1614062	http://dx.doi.org/10.1056/NEJMoa1614062			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES4VV	28304227	Green Published			2022-12-28	WOS:000399534600006
J	Ndeh, D; Rogowski, A; Cartmell, A; Luis, AS; Basle, A; Gray, J; Venditto, I; Briggs, J; Zhang, XY; Labourel, A; Terrapon, N; Buffetto, F; Nepogodiev, S; Xiao, Y; Field, RA; Zhu, YP; O'Neill, MA; Urbanowicz, BR; York, WS; Davies, GJ; Abbott, DW; Ralet, MC; Martens, EC; Henrissat, B; Gilbert, HJ				Ndeh, Didier; Rogowski, Artur; Cartmell, Alan; Luis, Ana S.; Basle, Arnaud; Gray, Joseph; Venditto, Immacolata; Briggs, Jonathon; Zhang, Xiaoyang; Labourel, Aurore; Terrapon, Nicolas; Buffetto, Fanny; Nepogodiev, Sergey; Xiao, Yao; Field, Robert A.; Zhu, Yanping; O'Neill, Malcolm A.; Urbanowicz, Breeanna R.; York, William S.; Davies, Gideon J.; Abbott, D. Wade; Ralet, Marie-Christine; Martens, Eric C.; Henrissat, Bernard; Gilbert, Harry J.			Complex pectin metabolism by gut bacteria reveals novel catalytic functions	NATURE			English	Article							RHAMNOGALACTURONAN-II; MACROMOLECULAR CRYSTALLOGRAPHY; STRUCTURAL BASIS; SIDE-CHAINS; POLYSACCHARIDE; MECHANISM; MONOSACCHARIDE; IDENTIFICATION; MICROBIOTA; FRAGMENTS	The metabolism of carbohydrate polymers drives microbial diversity in the human gut microbiota. It is unclear, however, whether bacterial consortia or single organisms are required to depolymerize highly complex glycans. Here we show that the gut bacterium Bacteroides thetaiotaomicron uses the most structurally complex glycan known: the plant pectic polysaccharide rhamnogalacturonan-II, cleaving all but 1 of its 21 distinct glycosidic linkages. The deconstruction of rhamnogalacturonan-II side chains and backbone are coordinated to overcome steric constraints, and the degradation involves previously undiscovered enzyme families and catalytic activities. The degradation system informs revision of the current structural model of rhamnogalacturonan-II and highlights how individual gut bacteria orchestrate manifold enzymes to metabolize the most challenging glycan in the human diet.	[Ndeh, Didier; Rogowski, Artur; Cartmell, Alan; Luis, Ana S.; Basle, Arnaud; Gray, Joseph; Venditto, Immacolata; Briggs, Jonathon; Zhang, Xiaoyang; Labourel, Aurore; Gilbert, Harry J.] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Terrapon, Nicolas; Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Buffetto, Fanny; Ralet, Marie-Christine] INRA, UR Biopolymeres Interact Assemblages 1268, F-44300 Nantes, France; [Nepogodiev, Sergey; Field, Robert A.] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Xiao, Yao; Martens, Eric C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Zhu, Yanping; O'Neill, Malcolm A.; Urbanowicz, Breeanna R.; York, William S.] Univ Georgia, Complex Carbohydrate Res Ctr, 315 Riverbend Rd, Athens, GA 30602 USA; [Davies, Gideon J.] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Abbott, D. Wade] Lethbridge Res Ctr, Lethbridge, AB T1J 4B1, Canada; [Henrissat, Bernard] INRA, USC AFMB 1408, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia; [Rogowski, Artur] Megazyme Bray Co, Wicklow A98 YV29, Ireland; [Buffetto, Fanny] Univ Stellenbosch, Dept Viticulture & Oenol, Inst Wine Biotechnol, ZA-7602 Matieland, South Africa	Newcastle University - UK; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Michigan System; University of Michigan; University System of Georgia; University of Georgia; University of York - UK; INRAE; King Abdulaziz University; Stellenbosch University	Gilbert, HJ (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	harry.gilbert@ncl.ac.uk	Terrapon, Nicolas/O-3630-2014; Davies, Gideon J/A-9042-2011; Luis, Ana/ABE-5158-2020; Henrissat, Bernard/J-2475-2012; Briggs, Jonathon/AAT-5145-2020; Terrapon, Nicolas/AAA-9033-2019	Terrapon, Nicolas/0000-0002-3693-6017; Davies, Gideon J/0000-0002-7343-776X; Luis, Ana/0000-0002-5086-7353; Henrissat, Bernard/0000-0002-3434-8588; Briggs, Jonathon/0000-0003-4181-2809; Terrapon, Nicolas/0000-0002-3693-6017; Ndeh, Didier/0000-0001-7875-1638; VENDITTO, IMMACOLATA/0000-0003-0392-2871; Cartmell, Alan/0000-0002-5512-249X; Abbott, Wade/0000-0003-4893-5799; , Breeanna/0000-0001-5247-4513; Basle, Arnaud/0000-0002-4899-3086; Field, Rob/0000-0001-8574-0275; Labourel, Aurore/0000-0002-4762-5804; Gray, Joseph/0000-0003-2338-0301	European Research Council [322820]; Agence Nationale de la Recherche [ANR 12-BIME-0006-01]; Biotechnology and Biological Research Council [BB/K020358/1, BB/K001949/1]; Wellcome Trust [WT097907MA]; European Union Seventh Framework Programme under the WallTraC project [263916]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-12ER16324]; Marie Sklodowska-Curie Fellowship [707922]; Beef and Cattle Research Council [FDE.15.13]; BBSRC [BBS/E/J/000PR9790, BBS/E/J/000C0618] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9790, BBS/E/J/000C0618] Funding Source: researchfish	European Research Council(European Research Council (ERC)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Biotechnology and Biological Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); European Union Seventh Framework Programme under the WallTraC project; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); Marie Sklodowska-Curie Fellowship; Beef and Cattle Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by a grant to H.J.G. and B.H. from the European Research Council (grant no. 322820). B.H. was also funded by Agence Nationale de la Recherche under grant number ANR 12-BIME-0006-01. H.J.G was also supported by Biotechnology and Biological Research Council (grant numbers BB/K020358/1 and BB/K001949/1), the Wellcome Trust (grant no. WT097907MA) and, with X.Z., M.-C.R. and F.B., was funded by the European Union Seventh Framework Programme under the WallTraC project (grant agreement number 263916). M.A.O and B.R.U. were supported in part by grant DE-FG02-12ER16324 from The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy. I.V. was in receipt of a Marie Sklodowska-Curie Fellowship (grant no. 707922). G.J.D. is a Royal Society Ken Murray Research Professor. D.W.A. was supported by a grant from the Beef and Cattle Research Council (FDE.15.13). We thank Diamond Light Source for access to beamline I02, I04-1 and I24 (mx1960, mx7854 and mx9948) that contributed to the results presented here, and to T. Doco and S.J. Charnock who supplied the partially purified apple RG-II.	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Apolinar-Valiente R, 2013, J AGR FOOD CHEM, V61, P2538, DOI 10.1021/jf304987m; Bourlard T, 1997, PLANT PHYSIOL BIOCH, V35, P623; Buffetto F, 2014, ANN BOT-LONDON, V114, P1327, DOI 10.1093/aob/mcu097; Cartmell A, 2011, J BIOL CHEM, V286, P15483, DOI 10.1074/jbc.M110.215962; Charnock SJ, 2000, BIOCHEMISTRY-US, V39, P5013, DOI 10.1021/bi992821q; Chauvin AL, 2005, J ORG CHEM, V70, P960, DOI 10.1021/jo0482864; Chauvin AL, 2004, CARBOHYD RES, V339, P21, DOI 10.1016/j.carres.2003.09.031; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cowtan K, 2008, ACTA CRYSTALLOGR D, V64, P83, DOI 10.1107/S0907444907033938; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; Davis BG, 1999, TETRAHEDRON, V55, P4489, DOI 10.1016/S0040-4020(99)00137-4; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fujita K, 2011, J BIOL CHEM, V286, P5143, DOI 10.1074/jbc.M110.190512; Glenwright AJ, 2017, NATURE, V541, P407, DOI 10.1038/nature20828; Glushka JN, 2003, CARBOHYD RES, V338, P341, DOI 10.1016/S0008-6215(02)00461-5; Guerardel Y, 2001, BIOCHEM J, V357, P167, DOI 10.1042/0264-6021:3570167; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larsbrink J, 2014, NATURE, V506, P498, DOI 10.1038/nature12907; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nagae M, 2007, J BIOL CHEM, V282, P18497, DOI 10.1074/jbc.M702246200; Nepogodiev SA, 2011, ORG BIOMOL CHEM, V9, P6670, DOI 10.1039/c1ob05587a; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; Pabst M, 2013, PLANT J, V76, P61, DOI 10.1111/tpj.12271; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pellerin P, 1996, CARBOHYD RES, V290, P183, DOI 10.1016/0008-6215(96)00139-5; Raman R, 2006, GLYCOBIOLOGY, V16, p82R, DOI 10.1093/glycob/cwj080; Rogowski A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8481; RUSSA R, 1991, FEMS MICROBIOL LETT, V84, P337, DOI 10.1111/j.1574-6968.1991.tb04620.x; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Speciale G, 2014, CURR OPIN STRUC BIOL, V28, P1, DOI 10.1016/j.sbi.2014.06.003; SPELLMAN MW, 1983, CARBOHYD RES, V122, P115, DOI 10.1016/0008-6215(83)88412-2; Sulzenbacher G, 2004, J BIOL CHEM, V279, P13119, DOI 10.1074/jbc.M313783200; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; Terrapon N, 2014, BIOINFORMATICS, V30, P274, DOI 10.1093/bioinformatics/btt379; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Waterman DG, 2016, ACTA CRYSTALLOGR D, V72, P558, DOI 10.1107/S2059798316002187; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Wissing C, 2016, QUATERN INT, V411, P327, DOI 10.1016/j.quaint.2015.09.091	47	305	315	28	454	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					65	+		10.1038/nature21725	http://dx.doi.org/10.1038/nature21725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ8GQ	28329766	Green Accepted, Green Submitted			2022-12-28	WOS:000398323300033
J	Weitz, JI; Lensing, AWA; Prins, MH; Bauersachs, R; Beyer-Westendorf, J; Bounameaux, H; Brighton, TA; Cohen, AT; Davidson, BL; Decousus, H; Freitas, MCS; Holberg, G; Kakkar, AK; Haskell, L; van Bellen, B; Pap, AF; Berkowitz, SD; Verhamme, P; Wells, PS; Prandoni, P				Weitz, J. I.; Lensing, A. W. A.; Prins, M. H.; Bauersachs, R.; Beyer-Westendorf, J.; Bounameaux, H.; Brighton, T. A.; Cohen, A. T.; Davidson, B. L.; Decousus, H.; Freitas, M. C. S.; Holberg, G.; Kakkar, A. K.; Haskell, L.; van Bellen, B.; Pap, A. F.; Berkowitz, S. D.; Verhamme, P.; Wells, P. S.; Prandoni, P.		EINSTEIN CHOICE Investigators	Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSITY WARFARIN THERAPY; LONG-TERM; PREVENTION; ENOXAPARIN; THROMBOPROPHYLAXIS; ARTHROPLASTY; DEFINITION; DISEASE; VTE	BACKGROUND Although many patients with venous thromboembolism require extended treatment, it is uncertain whether it is better to use full- or lower-intensity anticoagulation therapy or aspirin. METHODS In this randomized, double-blind, phase 3 study, we assigned 3396 patients with venous thromboembolism to receive either once-daily rivaroxaban (at doses of 20 mg or 10 mg) or 100 mg of aspirin. All the study patients had completed 6 to 12 months of anticoagulation therapy and were in equipoise regarding the need for continued anticoagulation. Study drugs were administered for up to 12 months. The primary efficacy outcome was symptomatic recurrent fatal or nonfatal venous thromboembolism, and the principal safety outcome was major bleeding. RESULTS A total of 3365 patients were included in the intention-to-treat analyses (median treatment duration, 351 days). The primary efficacy outcome occurred in 17 of 1107 patients (1.5%) receiving 20 mg of rivaroxaban and in 13 of 1127 patients (1.2%) receiving 10 mg of rivaroxaban, as compared with 50 of 1131 patients (4.4%) receiving aspirin (hazard ratio for 20 mg of rivaroxaban vs. aspirin, 0.34; 95% confidence interval [ CI], 0.20 to 0.59; hazard ratio for 10 mg of rivaroxaban vs. aspirin, 0.26; 95% CI, 0.14 to 0.47; P<0.001 for both comparisons). Rates of major bleeding were 0.5% in the group receiving 20 mg of rivaroxaban, 0.4% in the group receiving 10 mg of rivaroxaban, and 0.3% in the aspirin group; the rates of clinically relevant nonmajor bleeding were 2.7%, 2.0%, and 1.8%, respectively. The incidence of adverse events was similar in all three groups. CONCLUSIONS Among patients with venous thromboembolism in equipoise for continued anticoagulation, the risk of a recurrent event was significantly lower with rivaroxaban at either a treatment dose (20 mg) or a prophylactic dose (10 mg) than with aspirin, without a significant increase in bleeding rates.	[Weitz, J. I.] Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada; [Weitz, J. I.] McMaster Univ, Hamilton, ON, Canada; [Wells, P. S.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wells, P. S.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Lensing, A. W. A.; Freitas, M. C. S.; Holberg, G.; Pap, A. F.; Berkowitz, S. D.] Bayer Pharmaceut, Leverkusen, Germany; [Bauersachs, R.] Klinikum Darmstadt, Vasc Med, Darmstadt, Germany; [Bauersachs, R.] Univ Med Ctr Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Beyer-Westendorf, J.] Univ Hosp Carl Gustav Carus, Med Clin 1, Dept Hematol, Dresden, Germany; [Prins, M. H.] Maastricht Univ, Dept Epidemiol & Technol Assessment, Maastricht, Netherlands; [Bounameaux, H.] Univ Geneva, Div Angiol & Hemostasis, CH-1211 Geneva 4, Switzerland; [Bounameaux, H.] Univ Geneva, Fac Med, CH-1211 Geneva 4, Switzerland; [Brighton, T. A.] Prince Wales Hosp, Dept Haematol, Sydney, NSW, Australia; [Beyer-Westendorf, J.] Kings Coll London, Dept Haematol & Oncol, London, England; [Cohen, A. T.] Kings Coll Hosp London, Guys & St Thomas Hosp, Dept Haematol Med, London, England; [Kakkar, A. K.] Thrombosis Res Inst, London, England; [Kakkar, A. K.] UCL, London, England; [Davidson, B. L.] Univ Washington, Sch Med, Seattle, WA USA; [Decousus, H.] Hop Nord St Etienne, Ctr Hosp Univ, Serv Med Vasc & Therapeut, Ctr Invest Clin 1408,Sainbiose U1059,Invest Netwo, St Etienne, France; [Haskell, L.] Janssen Res & Dev, Raritan, NJ USA; [van Bellen, B.] Hosp Beneficencia Portuguesa, Sao Paulo, Brazil; [Verhamme, P.] Univ Leuven, Vasc Med & Hemostasis, Leuven, Belgium; [Prandoni, P.] Univ Padua, Vasc Med Unit, Dept Cardiothorac & Vasc Sci, Padua, Italy	McMaster University; McMaster University; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Bayer AG; Bayer Healthcare Pharmaceuticals; Klinikum Darmstadt; Johannes Gutenberg University of Mainz; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Maastricht University; University of Geneva; University of Geneva; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital; Thrombosis Research Institute; University of London; University College London; University of Washington; University of Washington Seattle; CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Johnson & Johnson; Janssen Pharmaceuticals; KU Leuven; University of Padua	Weitz, JI (corresponding author), Thrombosis & Atherosclerosis Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	weitzj@taari.ca	Beyer-Westendorf, Jan/K-7569-2019; Kovacs, Michael/G-3315-2011; Weitz, Jeffrey/AAD-1929-2019; Karpenko, Andrei/AAH-1725-2020; Gislason, Gunnar/B-7561-2009; Berkowitz, Scott Darrell/AAS-9397-2021; Hainaut, Pierre/B-6018-2012	Beyer-Westendorf, Jan/0000-0002-6983-9993; Weitz, Jeffrey/0000-0002-1092-7550; Gislason, Gunnar/0000-0002-0548-402X; Berkowitz, Scott Darrell/0000-0002-9428-4408; Farkas, Katalin/0000-0001-5577-6808; dai, xiangchen/0000-0001-9074-6452; Marschang, Peter/0000-0002-8239-3447; Ghanima, Waleed/0000-0003-2225-6165; Hainaut, Pierre/0000-0002-1303-1610; SANCHEZ, Olivier/0000-0003-1633-8391; Ritchie, Bruce/0000-0003-4754-1050; ten Cate, Hugo/0000-0001-7796-4463; Pap, Akos Ferenc/0000-0002-2161-3151; chetter, ian/0000-0002-2566-6859	Bayer Pharmaceuticals; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Ionis Pharmaceuticals; Janssen; Merck; Novartis; Portola; Pfizer; Sanofi Aventis; Novo Nordisk; GlaxoSmithKline; Johnson Johnson; Sanofi; Ono Pharmaceuticals; Aspen; LEO Pharma; Janssen Scientific Affairs; Novo Nordisk Fonden [NNF12OC1015957] Funding Source: researchfish	Bayer Pharmaceuticals(Bayer AG); Bayer(Bayer AG); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Daiichi Sankyo(Daiichi Sankyo Company Limited); Ionis Pharmaceuticals; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Novartis(Novartis); Portola; Pfizer(Pfizer); Sanofi Aventis(Sanofi-Aventis); Novo Nordisk(Novo Nordisk); GlaxoSmithKline(GlaxoSmithKline); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Sanofi; Ono Pharmaceuticals; Aspen; LEO Pharma(LEO Pharma); Janssen Scientific Affairs; Novo Nordisk Fonden(Novo Nordisk Foundation)	Supported by Bayer Pharmaceuticals.; Dr. Weitz reports receiving consulting fees from Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Daiichi Sankyo, Ionis Pharmaceuticals, Janssen, Merck, Novartis, Portola, and Pfizer; Drs. Lensing, Freitas, Holberg, Pap, and Berkowitz, being employees of Bayer; Dr. Prins, receiving consulting fees from Pfizer and Daiichi Sankyo; Dr. Bauersachs, receiving consulting and lecture fees from Boehringer Ingelheim, Bristol-Myers Squibb, and Daiichi Sankyo; Dr. Beyer-Westendorf, receiving grant support, lecture fees, and fees for serving on advisory boards from Boehringer Ingelheim, Daiichi Sankyo, and Pfizer; Dr. Bounameaux, receiving grant support and fees for serving on the Thrombosis Research Institute Garfield Registry steering committee, fees for serving on the Bayer EINSTEIN CHOICE Study steering committee, consulting fees from Amgen, and fees for serving on advisory boards from Bayer, Pfizer, and Sanofi Aventis; Dr. Brighton, receiving lecture fees from Bayer, Novo Nordisk, and GlaxoSmithKline; Dr. Cohen, receiving fees for serving on a committee for Boehringer Ingelheim, grant support and fees for serving on committees from Bristol-Myers Squibb and Daiichi Sankyo, consulting fees and fees for serving on steering committees from Johnson & Johnson and Portola, grant support, consulting fees, and fees for serving on committees from Pfizer, and consulting fees from Sanofi, Janssen, and Ono Pharmaceuticals; Dr. Davidson, receiving consulting fees from Janssen and Portola; Dr. Decousus, receiving fees for attending symposia from Aspen, fees for serving on advisory boards from Pfizer and Bristol-Myers Squibb, and grant support and fees for board membership from Daiichi Sankyo and Bayer; Dr. Kakkar, receiving grant support, consulting fees, and lecture fees from Bayer and consulting and lecture fees from Sanofi, Janssen, Boehringer Ingelheim, and Daiichi Sankyo; Dr. Haskell, being an employee of Johnson & Johnson; Dr. van Bellen, receiving lecture fees and fees for serving on an advisory board from Bayer and Daiichi Sankyo and for serving on an advisory board from Bristol-Myers Squibb; Dr. Verhamme, receiving grant support, lecture fees, and fees for serving on an advisory board from Boehringer Ingelheim and LEO Pharma, lecture fees from Pfizer and Bristol-Myers Squibb, grant support from Sanofi, lecture fees and fees for serving on an advisory board from Daiichi Sankyo, and fees for serving on an advisory board from Portola Pharmaceuticals; Dr. Wells, receiving grant support, lecture fees, and fees for serving on an advisory board from Bayer, fees for serving on a writing committee from Itreas, consulting fees from Janssen Scientific Affairs, grant support from Bristol-Myers Squibb and Pfizer, and lecture fees from Daiichi Sankyo; and Dr. Prandoni, receiving consulting and lecture fees from Bayer, Sanofi, Daiichi Sankyo, and Pfizer. No other potential conflict of interest relevant to this article was reported.	Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Eriksson BI, 2008, NEW ENGL J MED, V358, P2765, DOI 10.1056/NEJMoa0800374; Kaatz S, 2015, J THROMB HAEMOST, V13, P2119, DOI 10.1111/jth.13140; Kakkar AK, 2008, LANCET, V372, P31, DOI 10.1016/S0140-6736(08)60880-6; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Lassen MR, 2008, NEW ENGL J MED, V358, P2776, DOI 10.1056/NEJMoa076016; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Prandoni P, 2003, NEW ENGL J MED, V348, P1435, DOI 10.1056/NEJMoa022157; Prandoni P, 1996, ANN INTERN MED, V125, P1, DOI 10.7326/0003-4819-125-1-199607010-00001; Prins MH, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-21; Raskob GE, 2014, THROMB RES, V134, P931, DOI 10.1016/j.thromres.2014.08.014; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Spencer FA, 2008, ARCH INTERN MED, V168, P425, DOI 10.1001/archinternmed.2007.69; Turpie AGG, 2009, LANCET, V373, P1673, DOI 10.1016/S0140-6736(09)60734-0; Weitz JI, 2015, THROMB HAEMOSTASIS, V114, P645, DOI 10.1160/TH15-02-0131; Yusuf Hussain R., 2012, Morbidity and Mortality Weekly Report, V61, P401	27	403	430	2	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2017	376	13					1211	1222		10.1056/NEJMoa1700518	http://dx.doi.org/10.1056/NEJMoa1700518			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP8KS	28316279	Green Published, Bronze			2022-12-28	WOS:000397624900005
J	Worm, B				Worm, Boris			MARINE CONSERVATION How to heal an ocean	NATURE			English	Editorial Material							PROTECTED AREAS; RESERVES		[Worm, Boris] Dalhousie Univ, Dept Biol, Halifax, NS B3H4R2, Canada	Dalhousie University	Worm, B (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H4R2, Canada.	bworm@dal.ca		Worm, Boris/0000-0002-5742-8716				Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Gill DA, 2017, NATURE, V543, P665, DOI 10.1038/nature21708; Gutierrez NL, 2011, NATURE, V470, P386, DOI 10.1038/nature09689; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lubchenco J, 2015, SCIENCE, V350, P382, DOI 10.1126/science.aad5443; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; Micheli F, 2004, ECOL APPL, V14, P1709, DOI 10.1890/03-5260; Selig ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082898	10	26	26	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					630	631		10.1038/nature21895	http://dx.doi.org/10.1038/nature21895			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EP8IS	28329755				2022-12-28	WOS:000397619700037
J	[Anonymous]				[Anonymous]			Avoiding Unnecessary Prostate Biopsies With MRI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1206	1206		10.1001/jama.2017.2745	http://dx.doi.org/10.1001/jama.2017.2745			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350925				2022-12-28	WOS:000397557800008
J	Gottschling, DE; Nystrom, T				Gottschling, Daniel E.; Nystrom, Thomas			The Upsides and Downsides of Organelle Interconnectivity	CELL			English	Review							MITOCHONDRIAL QUALITY-CONTROL; ASYMMETRIC INHERITANCE; ENDOPLASMIC-RETICULUM; LIFE-SPAN; INTERACTION NETWORKS; MISFOLDED PROTEINS; DAMAGED PROTEINS; V-ATPASE; YEAST; ACTIN	Interconnectivity and feedback control are hallmarks of biological systems. This includes communication between organelles, which allows them to function and adapt to changing cellular environments. While the specific mechanisms for all communications remain opaque, unraveling the wiring of organelle networks is critical to understand how biological systems are built and why they might collapse, as occurs in aging. A comprehensive understanding of all the routes involved in interorganelle communication is still lacking, but important themes are beginning to emerge, primarily in budding yeast. These routes are reviewed here in the context of sub- system proteostasis and complex adaptive systems theory.	[Gottschling, Daniel E.] Calico Life Sci, San Francisco, CA 94080 USA; [Nystrom, Thomas] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, S-40530 Gothenburg, Sweden	University of Gothenburg	Gottschling, DE (corresponding author), Calico Life Sci, San Francisco, CA 94080 USA.; Nystrom, T (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, S-40530 Gothenburg, Sweden.	dang@calicolabs.com; thomas.nystrom@cmb.gu.se			Swedish Natural Research Council [VR 2010-4609]; Knut and Alice Wallenberg Foundation; ERC; Swedish Cancer Foundation; Sahlgrenska Academy; NATIONAL INSTITUTE ON AGING [R01AG023779, R01AG037512] Funding Source: NIH RePORTER	Swedish Natural Research Council(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); ERC(European Research Council (ERC)European Commission); Swedish Cancer Foundation; Sahlgrenska Academy; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	To the memory of Frederick C. Neidhardt, mentor, friend, and pioneer in the quest for a holistic understanding of the cell. T.N. thanks Charles Boone, University of Toronto, for continued intellectual and technical support and colleagues and students for all their input. T.N. is supported by grants from the Swedish Natural Research Council (VR 2010-4609), the Knut and Alice Wallenberg Foundation (Wallenberg Scholar), ERC (Advanced Grant; QualiAge), the Swedish Cancer Foundation (Cancerfonden), and the Sahlgrenska Academy. D.E.G. thanks his colleagues and lab members at Fred Hutchinson Cancer Research Center and Calico Life Sciences for discussions and support at every level. D.E.G. is an employee of Calico, LLC.	Agostini F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074244; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Alberts B, 2014, MOL BIOL CELL, DOI DOI 10.1201/9780203833445; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baryshnikova A, 2013, ANNU REV GENOM HUM G, V14, P111, DOI 10.1146/annurev-genom-082509-141730; Berendzen KM, 2016, CELL, V166, P1553, DOI 10.1016/j.cell.2016.08.042; Botstein D, 2011, GENETICS, V189, P695, DOI 10.1534/genetics.111.130765; Brocker C, 2010, CURR BIOL, V20, pR943, DOI 10.1016/j.cub.2010.09.015; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Caballero A, 2011, MOL CELL, V42, P390, DOI 10.1016/j.molcel.2011.03.021; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; Capra F., 1996, WEB LIFE; Cilliers P., 1998, COMPLEXITY POSTMODER; Clay L, 2014, ELIFE, V3, DOI 10.7554/eLife.01883; Cohen AA, 2016, BIOGERONTOLOGY, V17, P205, DOI 10.1007/s10522-015-9584-x; Cohen Y, 2011, METHODS MOL BIOL, V781, P127, DOI 10.1007/978-1-61779-276-2_8; Coonrod EM, 2013, DEV CELL, V27, P462, DOI 10.1016/j.devcel.2013.10.014; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Douglas PM, 2008, P NATL ACAD SCI USA, V105, P7206, DOI 10.1073/pnas.0802593105; Eisenberg-Bord M, 2016, DEV CELL, V39, P395, DOI 10.1016/j.devcel.2016.10.022; Eitzen G, 2002, J CELL BIOL, V158, P669, DOI 10.1083/jcb.200204089; Elbaz Y, 2011, TRENDS BIOCHEM SCI, V36, P616, DOI 10.1016/j.tibs.2011.08.004; Erjavec N, 2013, FREE RADICAL BIO MED, V56, P9, DOI 10.1016/j.freeradbiomed.2012.11.019; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Eves PT, 2012, J CELL BIOL, V198, P69, DOI 10.1083/jcb.201201024; Felix MA, 2015, NAT REV GENET, V16, P483, DOI 10.1038/nrg3949; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giaever G, 2014, GENETICS, V197, P451, DOI 10.1534/genetics.114.161620; Gleick J., 1988, CHAOS; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Gurkan C, 2007, ADV EXP MED BIOL, V607, P73; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Henderson KA, 2014, ELIFE, V3, DOI 10.7554/eLife.03504; Higuchi R, 2013, CURR BIOL, V23, P2417, DOI 10.1016/j.cub.2013.10.022; Hill SM, 2016, CELL REP, V16, P826, DOI 10.1016/j.celrep.2016.06.016; Hughes AL, 2016, ELIFE, V5, DOI 10.7554/eLife.13943; Hughes AL, 2012, NATURE, V492, P261, DOI 10.1038/nature11654; Hughes TR, 2013, GENETICS, V195, P9, DOI 10.1534/genetics.113.153262; Johnson S, 2012, EMERGENCE; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kirkwood TBL, 2011, PHILOS T R SOC B, V366, P64, DOI 10.1098/rstb.2010.0275; Kulawiak B, 2013, BBA-BIOENERGETICS, V1827, P612, DOI 10.1016/j.bbabio.2012.12.004; Kumar R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006324; Lahiri S, 2015, CURR OPIN CELL BIOL, V33, P82, DOI 10.1016/j.ceb.2014.12.004; Lewis V, 2011, FRONT BIOSCI-LANDMRK, V16, P151, DOI 10.2741/3681; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lippuner AD, 2014, FEMS MICROBIOL REV, V38, P300, DOI 10.1111/1574-6976.12060; Liu BD, 2011, CELL, V147, P959, DOI 10.1016/j.cell.2011.11.018; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143; Machida K, 1999, FEBS LETT, V462, P108, DOI 10.1016/S0014-5793(99)01506-9; Mackay TFC, 2014, NAT REV GENET, V15, P22, DOI 10.1038/nrg3627; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; Mangel M, 2001, J THEOR BIOL, V213, P559, DOI 10.1006/jtbi.2001.2431; MATTHEW JB, 1985, CRC CR REV BIOCH MOL, V18, P91, DOI 10.3109/10409238509085133; McMurray MA, 2003, SCIENCE, V301, P1908, DOI 10.1126/science.1087706; Meriin AB, 2003, MOL CELL BIOL, V23, P7554, DOI 10.1128/MCB.23.21.7554-7565.2003; Meriin AB, 2007, FASEB J, V21, P1915, DOI 10.1096/fj.06-6878com; Miller J.H., 2015, CRUDE LOOK WHOLE SCI; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Murley A, 2016, MOL CELL, V61, P648, DOI 10.1016/j.molcel.2016.01.031; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Nystrom T, 2013, CURR BIOL, V23, pR1037, DOI 10.1016/j.cub.2013.10.049; Odorizzi G, 2000, TRENDS BIOCHEM SCI, V25, P229, DOI 10.1016/S0968-0004(00)01543-7; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Pelham HRB, 1999, PHILOS T ROY SOC B, V354, P1471, DOI 10.1098/rstb.1999.0491; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Raffaello A, 2016, TRENDS BIOCHEM SCI, V41, P1035, DOI 10.1016/j.tibs.2016.09.001; Russnak R, 2001, J BIOL CHEM, V276, P23849, DOI 10.1074/jbc.M008028200; Scheckhuber CQ, 2007, NAT CELL BIOL, V9, P99, DOI 10.1038/ncb1524; Smaczynska-de Rooij II, 2010, J CELL SCI, V123, P3496, DOI 10.1242/jcs.070508; Snider J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156351; Song J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004539; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Styles E.B., 2016, COLD SPRING HARB PRO; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Sun MGF, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-235; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Thayer NH, 2014, P NATL ACAD SCI USA, V111, P14019, DOI 10.1073/pnas.1416079111; Toju H, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0024; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wilson E.B., 1906, CELL DEV INHERITANCE; Yang JS, 2016, ELIFE, V5, DOI 10.7554/eLife.11792; Zhao L, 2016, SCI REP-UK, V6, DOI 10.1038/srep30134; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026	94	55	55	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					24	34		10.1016/j.cell.2017.02.030	http://dx.doi.org/10.1016/j.cell.2017.02.030			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340346	Green Accepted, Bronze			2022-12-28	WOS:000397090000005
J	Isanaka, S; Guindo, O; Langendorf, C; Seck, AM; Plikaytis, BD; Sayinzoga-Makombe, N; McNeal, MM; Meyer, N; Adehossi, E; Djibo, A; Jochum, B; Grais, RF				Isanaka, Sheila; Guindo, Ousmane; Langendorf, Celine; Seck, Amadou Matar; Plikaytis, Brian D.; Sayinzoga-Makombe, Nathan; McNeal, Monica M.; Meyer, Nicole; Adehossi, Eric; Djibo, Ali; Jochum, Bruno; Grais, Rebecca F.			Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							1ST 2 YEARS; DOUBLE-BLIND; EUROPEAN INFANTS; GASTROENTERITIS; CHILDREN; IMMUNOGENICITY; SAFETY; DIARRHEA; AFRICAN; AGE	BACKGROUND Each year, rotavirus gastroenteritis is responsible for about 37% of deaths from diarrhea among children younger than 5 years of age worldwide, with a disproportionate effect in sub-Saharan Africa. METHODS We conducted a randomized, placebo-controlled trial in Niger to evaluate the efficacy of a live, oral bovine rotavirus pentavalent vaccine (BRV-PV, Serum Institute of India) to prevent severe rotavirus gastroenteritis. Healthy infants received three doses of the vaccine or placebo at 6, 10, and 14 weeks of age. Episodes of gastroenteritis were assessed through active and passive surveillance and were graded on the basis of the score on the Vesikari scale (which ranges from 0 to 20, with higher scores indicating more severe disease). The primary end point was the efficacy of three doses of vaccine as compared with placebo against a first episode of laboratory-confirmed severe rotavirus gastroenteritis (Vesikari score, >= 11) beginning 28 days after dose 3. RESULTS Among the 3508 infants who were included in the per-protocol efficacy analysis, there were 31 cases of severe rotavirus gastroenteritis in the vaccine group and 87 cases in the placebo group (2.14 and 6.44 cases per 100 person-years, respectively), for a vaccine efficacy of 66.7% (95% confidence interval [CI], 49.9 to 77.9). Similar efficacy was seen in the intention-to-treat analyses, which showed a vaccine efficacy of 69.1% (95% CI, 55.0 to 78.7). There was no significant between-group difference in the risk of adverse events, which were reported in 68.7% of the infants in the vaccine group and in 67.2% of those in the placebo group, or in the risk of serious adverse events (in 8.3% in the vaccine group and in 9.1% in the placebo group); there were 27 deaths in the vaccine group and 22 in the placebo group. None of the infants had confirmed intussusception. CONCLUSIONS Three doses of BRV-PV, an oral rotavirus vaccine, had an efficacy of 66.7% against severe rotavirus gastroenteritis among infants in Niger.	[Isanaka, Sheila; Langendorf, Celine; Grais, Rebecca F.] Epictr, Dept Res, Paris, France; [Isanaka, Sheila] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA; [Isanaka, Sheila] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Guindo, Ousmane; Seck, Amadou Matar; Sayinzoga-Makombe, Nathan] Epictr, Niamey, Niger; [Adehossi, Eric] Natl Hosp, Niamey, Niger; [Djibo, Ali] Univ Niamey, Niamey, Niger; [Plikaytis, Brian D.] BioStat Consulting, Jasper, GA USA; [McNeal, Monica M.; Meyer, Nicole] Cincinnati Childrens Hosp Med Ctr, Lab Specialized Clin Studies, Cincinnati, OH 45229 USA; [Jochum, Bruno] Med Sans Frontieres Operat Ctr, Geneva, Switzerland	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Cincinnati Children's Hospital Medical Center; Doctors Without Borders	Grais, RF (corresponding author), 8 Rue St Sabin, F-75011 Paris, France.	rebecca.grais@epicentre.msf.org	Isanaka, Sheila/AAQ-9056-2020	McNeal, Monica/0000-0002-3784-9062; CELINE, LANGENDORF/0000-0002-0811-7540; Freeman Grais, Rebecca/0000-0002-5037-8218	Medecins sans Frontieres Operational Center in Geneva; Kavli Foundation; Medecins sans Frontieres	Medecins sans Frontieres Operational Center in Geneva; Kavli Foundation; Medecins sans Frontieres	Supported by Medecins sans Frontieres Operational Center in Geneva and the Kavli Foundation. Epicentre receives core funding from Medecins sans Frontieres.	Aliabadi N, 2016, CLIN MICROBIOL INFEC, V22, pS128, DOI 10.1016/j.cmi.2016.03.007; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P49; [Anonymous], 2009, WKLY EPIDEMIOL REC, V84, P533; [Anonymous], 2016, ROT VACC SUPP; Armah GE, 2013, J INFECT DIS, V208, P423, DOI 10.1093/infdis/jit174; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Buttery JP, 2011, PEDIATR INFECT DIS J, V30, pS25, DOI 10.1097/INF.0b013e3181fefdee; Ciarlet M, 2008, PEDIATR INFECT DIS J, V27, P874, DOI 10.1097/INF.0b013e3181782780; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Glass RI, 2014, J INFECTION, V68, pS9, DOI 10.1016/j.jinf.2013.09.010; Global WHO, 2020, GLOB VACC ACT PLAN M; Gosselin V, 2016, HUM VACC IMMUNOTHER, V12, P2572, DOI 10.1080/21645515.2016.1189038; Grais RF, 2014, INT HEALTH, V6, P1, DOI 10.1093/inthealth/ihu005; do Carmo GMI, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001024; JOHN TJ, 1976, BRIT MED J, V1, P812, DOI 10.1136/bmj.1.6013.812; Lee BY, 2012, AM J PUBLIC HEALTH, V102, P269, DOI 10.2105/AJPH.2011.300218; Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662; Levine MM, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-129; Lewis K., 2011, VESIKARI CLIN SEVERI; Linhares AC, 2008, LANCET, V371, P1181, DOI 10.1016/S0140-6736(08)60524-3; MacLennan CA, 2014, P NATL ACAD SCI USA, V111, P12307, DOI 10.1073/pnas.1400473111; Madhi SA, 2012, VACCINE, V30, pA44, DOI 10.1016/j.vaccine.2011.08.080; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; Page AL, 2014, EMERG INFECT DIS, V20, P573, DOI 10.3201/eid2004.131328; Page AL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-389; Parashar UD, 2016, CLIN INFECT DIS, V62, pS91, DOI 10.1093/cid/civ1015; Patel M, 2009, J INFECT DIS, V200, pS39, DOI 10.1086/605035; Patel MM, 2012, LANCET INFECT DIS, V12, P561, DOI 10.1016/S1473-3099(12)70029-4; Richardson V, 2011, NEW ENGL J MED, V365, P772, DOI 10.1056/NEJMc1100062; Rid A, 2014, VACCINE, V32, P4708, DOI 10.1016/j.vaccine.2014.04.022; Ruiz-Palacios GM, 2006, NEW ENGL J MED, V354, P11, DOI 10.1056/NEJMoa052434; Steele AD, 2016, HUM VACC IMMUNOTHER, V12, P2406, DOI 10.1080/21645515.2016.1179412; SUHARYONO, 1992, LANCET, V340, P689, DOI 10.1016/0140-6736(92)92231-4; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Tate JE, 2011, PEDIATR INFECT DIS J, V30, pS30, DOI 10.1097/INF.0b013e3181ffe3eb; Vesikari T, 2007, LANCET, V370, P1757, DOI 10.1016/S0140-6736(07)61744-9; Vesikari T, 2006, NEW ENGL J MED, V354, P23, DOI 10.1056/NEJMoa052664; Vesikari T, 2012, PEDIATR INFECT DIS J, V31, P509, DOI 10.1097/INF.0b013e3182489cac; Zade JK, 2014, VACCINE, V32, pA124, DOI 10.1016/j.vaccine.2014.03.003; Zaman K, 2010, LANCET, V376, P615, DOI 10.1016/S0140-6736(10)60755-6; Zaman K, 2009, VACCINE, V27, P1333, DOI 10.1016/j.vaccine.2008.12.059; Zou GY, 2008, STAT MED, V27, P1693, DOI 10.1002/sim.3095	42	113	116	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1121	1130		10.1056/NEJMoa1609462	http://dx.doi.org/10.1056/NEJMoa1609462			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NB	28328346				2022-12-28	WOS:000397014300008
J	Moutsopoulos, NM; Zerbe, CS; Wild, T; Dutzan, N; Brenchley, L; DiPasquale, G; Uzel, G; Axelrod, KC; Lisco, A; Notarangelo, LD; Hajishengallis, G; Notarangelo, LD; Holland, SM				Moutsopoulos, Niki M.; Zerbe, Christa S.; Wild, Teresa; Dutzan, Nicolas; Brenchley, Laurie; DiPasquale, Giovanni; Uzel, Gulbu; Axelrod, Karen C.; Lisco, Andrea; Notarangelo, Lucia D.; Hajishengallis, George; Notarangelo, Luigi D.; Holland, Steven M.			Interleukin-12 and Interleukin-23 Blockade in Leukocyte Adhesion Deficiency Type 1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PYODERMA-GANGRENOSUM; DOUBLE-BLIND; USTEKINUMAB; THERAPY; GRANULOPOIESIS; NEUTROPHILS; INHIBITION; EFFICACY; ANTIBODY; DISEASE	A patient with leukocyte adhesion deficiency type 1 (LAD1) had severe periodontitis and an intractable, deep, nonhealing sacral wound. We had previously found a dominant interleukin-23-interleukin-17 signature at inflamed sites in humans with LAD1 and in mouse models of the disorder. Blockade of this pathway in mouse models has resulted in resolution of the immunopathologic condition. We treated our patient with ustekinumab, an antibody that binds the p40 subunit of interleukin-23 and interleukin-12 and thereby blocks the activity of these cytokines, inhibiting interleukin-23-dependent production of interleukin-17. After 1 year of therapy, our patient had resolution of his inflammatory lesions without serious infections or adverse reactions. Inhibition of interleukin-23 and interleukin-17 may have a role in the management of LAD1.	[Moutsopoulos, Niki M.; Wild, Teresa; Dutzan, Nicolas; Brenchley, Laurie; DiPasquale, Giovanni] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA; [Zerbe, Christa S.; Uzel, Gulbu; Holland, Steven M.] NIH, Lab Clin Infect Dis, Bldg 10, Bethesda, MD 20892 USA; [Axelrod, Karen C.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Axelrod, Karen C.] NIH, Wound Ostomy Care Nursing Serv, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Notarangelo, Lucia D.] Spedali Civili Brescia, Childrens Hosp, Pediat Oncohematol & Bone Marrow Transplantat Uni, Brescia, Italy; [Hajishengallis, George] Univ Penn, Dept Microbiol, Sch Dent Med, Philadelphia, PA 19104 USA; [Notarangelo, Lucia D.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Notarangelo, Lucia D.] Harvard Med Sch, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Hospital Spedali Civili Brescia; University of Pennsylvania; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Holland, SM (corresponding author), NIH, Bldg 10-11N248 MSC 1960, Bethesda, MD 20892 USA.	smh@nih.gov	Hajishengallis, George N./K-1117-2019; Dutzan, Nicolas/I-8838-2019; Lisco, Andrea/L-2105-2019; Moutsopoulos, Niki/A-9538-2019	Hajishengallis, George N./0000-0001-7392-8852; Dutzan, Nicolas/0000-0001-8343-0214; Lisco, Andrea/0000-0002-1475-356X; 	Intramural Programs of the National Institute of Allergy and Infectious Diseases; National Institute of Dental and Craniofacial Research; U.S. Public Health Service [DE024153]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001222, ZIAAI000646, ZIAAI000647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000732, R01DE024153] Funding Source: NIH RePORTER	Intramural Programs of the National Institute of Allergy and Infectious Diseases; National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); U.S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Supported by the Intramural Programs of the National Institute of Allergy and Infectious Diseases, the National Institute of Dental and Craniofacial Research, and the U.S. Public Health Service (grant DE024153 to Dr. Hajishengallis).	Forlow SB, 2001, BLOOD, V98, P3309, DOI 10.1182/blood.V98.12.3309; Hajishengallis G, 2016, SEMIN IMMUNOL, V28, P146, DOI 10.1016/j.smim.2016.02.002; Hajishengallis G, 2016, MICROB PATHOGENESIS, V94, P21, DOI 10.1016/j.micpath.2015.09.003; Hanna S, 2012, ANN NY ACAD SCI, V1250, P50, DOI 10.1111/j.1749-6632.2011.06389.x; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; McGovern JL, 2012, ARTHRITIS RHEUM-US, V64, P3129, DOI 10.1002/art.34565; McInnes IB, 2013, LANCET, V382, P780, DOI 10.1016/S0140-6736(13)60594-2; Moutsopoulos NM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004698; Nord KM, 2011, PEDIATR DERMATOL, V28, P156, DOI 10.1111/j.1525-1470.2010.01123.x; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Smith E, 2007, J IMMUNOL, V179, P8274, DOI 10.4049/jimmunol.179.12.8274; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sugita S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3824; Vahlquist A, 2015, ACTA DERM-VENEREOL, V95, P349, DOI 10.2340/00015555-1929	14	81	87	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1141	1146		10.1056/NEJMoa1612197	http://dx.doi.org/10.1056/NEJMoa1612197			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NB	28328326	Green Accepted			2022-12-28	WOS:000397014300010
J	Sharabi, K; Lin, H; Tavares, CDJ; Dominy, JE; Camporez, JP; Perry, RJ; Schilling, R; Rines, AK; Lee, J; Hickey, M; Bennion, M; Palmer, M; Nag, PP; Bittker, JA; Perez, J; Jedrychowski, MP; Ozcan, U; Gygi, SP; Kamenecka, TM; Shulman, GI; Schreiber, SL; Griffin, PR; Puigserver, P				Sharabi, Kfir; Lin, Hua; Tavares, Clint D. J.; Dominy, John E.; Camporez, Joao Paulo; Perry, Rachel J.; Schilling, Roger; Rines, Amy K.; Lee, Jaemin; Hickey, Marc; Bennion, Melissa; Palmer, Michelle; Nag, Partha P.; Bittker, Joshua A.; Perez, Jose; Jedrychowski, Mark P.; Ozcan, Umut; Gygi, Steve P.; Kamenecka, Theodore M.; Shulman, Gerald I.; Schreiber, Stuart L.; Griffin, Patrick R.; Puigserver, Pere			Selective Chemical Inhibition of PGC-1 alpha Gluconeogenic Activity Ameliorates Type 2 Diabetes	CELL			English	Article							CONTROLS GLUCOSE-METABOLISM; HEPATIC INSULIN-RESISTANCE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; RECEPTOR; GCN5; HYPERGLYCEMIA; DISSOCIATION; PATHOGENESIS; ACETYLATION; SUPPRESSION	Type 2 diabetes (T2D) is a worldwide epidemic with a medical need for additional targeted therapies. Suppression of hepatic glucose production (HGP) effectively ameliorates diabetes and can be exploited for its treatment. We hypothesized that targeting PGC-1 alpha acetylation in the liver, a chemical modification known to inhibit hepatic gluconeogenesis, could be potentially used for treatment of T2D. Thus, we designed a high-throughput chemical screen platformto quantify PGC-1 alpha acetylation in cells and identified small molecules that increase PGC-1 alpha acetylation, suppress gluconeogenic gene expression, and reduce glucose production in hepatocytes. Onthe basis of potency and bioavailability, we selected a small molecule, SR-18292, that reduces blood glucose, strongly increases hepatic insulin sensitivity, and improves glucose homeostasis in dietary and genetic mouse models of T2D. These studies have important implications for understanding the regulatory mechanisms of glucose metabolism and treatment of T2D.	[Sharabi, Kfir; Tavares, Clint D. J.; Dominy, John E.; Rines, Amy K.; Puigserver, Pere] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Sharabi, Kfir; Tavares, Clint D. J.; Dominy, John E.; Rines, Amy K.; Jedrychowski, Mark P.; Gygi, Steve P.; Puigserver, Pere] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Lin, Hua; Kamenecka, Theodore M.; Griffin, Patrick R.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Camporez, Joao Paulo; Perry, Rachel J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Lee, Jaemin; Ozcan, Umut] Harvard Med Sch, Boston Childrens Hosp, Div Endocrinol, Boston, MA 02130 USA; [Schilling, Roger; Hickey, Marc; Bennion, Melissa; Palmer, Michelle; Nag, Partha P.; Bittker, Joshua A.; Perez, Jose; Schreiber, Stuart L.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Scripps Research Institute; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Puigserver, P (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA.; Puigserver, P (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	pere_puigserver@dfci.harvard.edu	Lee, Jaemin/AAP-4875-2021; Shulman, Gerald I./P-7176-2019; Lin, Hua/U-1529-2019	Shulman, Gerald I./0000-0003-1529-5668; Camporez, Joao Paulo/0000-0003-3486-4301; Perry, Rachel/0000-0003-0748-8064; Sharabi, Kfir/0000-0002-7810-6521; Lin, Hua/0000-0002-0840-6553; Lee, Jaemin/0000-0002-0224-7141	AHA [15POST22880002]; ADA [1-16-PDF-111, 7-12-MN-68]; NIH/NIDDK [F32 DK102293-01, R24DK080261, R01DK-40936 9, 2U2CDK059635]; NIH [U54HG005032];  [R03DA032468];  [R01 DK069966]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG005032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, R24DK080261, U2CDK059635, F32DK102293, R01DK069966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA032468] Funding Source: NIH RePORTER	AHA(American Heart Association); ADA(American Diabetes Association); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	K.S. was partially funded by a post-doctoral fellowship from the AHA (15POST22880002). C.D.J.T. was partially funded by a post-doctoral fellowship from the ADA (1-16-PDF-111). A.K.R. received a post-doctoral fellowship from NIH/NIDDK (F32 DK102293-01). The HTS was funded by a grant from NIH to the Broad Institute as a MLPCN Center (S.L.S.) (U54HG005032). P.P. and P.R.G. were funded by the NIH/NIDDK (R24DK080261). G.I.S. was funded by NIH/NIDDK (R01DK-40936 9 and 2U2CDK059635). P.P. was funded by R03DA032468, R01 DK069966, and the ADA (7-12-MN-68).	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Bailey T, 2013, AM J MED, V126, pS10, DOI 10.1016/j.amjmed.2013.06.009; BODO M, 1977, ARCH GESCHWULSTFORSC, V47, P624; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cherrington AD, 1999, DIABETES, V48, P1198, DOI 10.2337/diabetes.48.5.1198; DeFronzo RA, 2004, MED CLIN N AM, V88, P787, DOI 10.1016/j.mcna.2004.04.013; DITULLIO NW, 1974, BIOCHEM J, V138, P387, DOI 10.1042/bj1380387; Dominy JE, 2011, COLD SH Q B, V76, P203, DOI 10.1101/sqb.2012.76.010843; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Estall JL, 2009, DIABETES, V58, P1499, DOI 10.2337/db08-1571; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; He L, 2015, CELL METAB, V21, P159, DOI 10.1016/j.cmet.2015.01.003; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kahn SE, 2014, LANCET, V383, P1068, DOI 10.1016/S0140-6736(13)62154-6; Kim JH, 2010, GENE DEV, V24, P2766, DOI 10.1101/gad.1979710; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lee YJ, 2014, NATURE, V510, P547, DOI 10.1038/nature13267; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lustig Y, 2011, GENE DEV, V25, P1232, DOI 10.1101/gad.2054711; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Moore MC, 2012, ADV NUTR, V3, P286, DOI 10.3945/an.112.002089; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Ramnanan CJ, 2010, DIABETES, V59, P1302, DOI 10.2337/db09-1625; Ravnskjaer K, 2013, J CLIN INVEST, V123, P4318, DOI 10.1172/JCI69035; Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100; Rizza RA, 2010, DIABETES, V59, P2697, DOI 10.2337/db10-1032; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Rodgers JT, 2010, CELL METAB, V11, P23, DOI 10.1016/j.cmet.2009.11.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Samuel VT, 2009, P NATL ACAD SCI USA, V106, P12121, DOI 10.1073/pnas.0812547106; Sugiyama T, 2000, J BIOL CHEM, V275, P3446, DOI 10.1074/jbc.275.5.3446; Sun CC., 2014, J SOLID STATE LIGHT, V1, P19, DOI [10.1186/s40539-014-0019-0, DOI 10.1186/S40539-014-0019-0]; Yasgar A, 2016, METHODS MOL BIOL, V1439, P77, DOI 10.1007/978-1-4939-3673-1_5; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	46	113	119	5	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					148	+		10.1016/j.cell.2017.03.001	http://dx.doi.org/10.1016/j.cell.2017.03.001			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340340	Bronze, Green Accepted			2022-12-28	WOS:000397090000015
J	Sorokowski, P; Kulczycki, E; Sorokowska, A; Pisanski, K				Sorokowski, Piotr; Kulczycki, Emanuel; Sorokowska, Agnieszka; Pisanski, Katarzyna			Predatory journals recruit fake editor	NATURE			English	Editorial Material							OPEN ACCESS		[Sorokowski, Piotr; Sorokowska, Agnieszka; Pisanski, Katarzyna] Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland; [Kulczycki, Emanuel] Adam Mickiewicz Univ, Inst Philosophy, Scholarly Commun Res Grp, Poznan, Poland; [Sorokowska, Agnieszka] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Pisanski, Katarzyna] Univ Sussex, Sch Psychol, Brighton, E Sussex, England	University of Wroclaw; Adam Mickiewicz University; Technische Universitat Dresden; University of Sussex	Pisanski, K (corresponding author), Univ Wroclaw, Inst Psychol, PL-50138 Wroclaw, Poland.; Pisanski, K (corresponding author), Univ Sussex, Sch Psychol, Brighton, E Sussex, England.	k.pisanski@sussex.ac.uk	Pisanski, Katarzyna/F-7291-2019; Kulczycki, Emanuel/F-7470-2012	Pisanski, Katarzyna/0000-0003-0992-2477; Kulczycki, Emanuel/0000-0001-6530-3609; Sorokowski, Piotr/0000-0001-9225-9965; Sorokowska, Agnieszka/0000-0003-3999-8851				Bartholomew RE, 2014, J ROY SOC MED, V107, P384, DOI 10.1177/0141076814548526; Beall J, 2013, LEARN PUBL, V26, P79, DOI 10.1087/20130203; Beall J, 2012, NATURE, V489, P179, DOI 10.1038/489179a; Bohannon J, 2013, SCIENCE, V342, P60, DOI 10.1126/science.342.6154.60; Shen CY, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0469-2; Xia JF, 2015, J ASSOC INF SCI TECH, V66, P1406, DOI 10.1002/asi.23265	6	123	128	6	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					481	483		10.1038/543481a	http://dx.doi.org/10.1038/543481a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO9OM	28332542	Green Accepted, Bronze			2022-12-28	WOS:000397018000026
J	Ding, M; Huang, T; Bergholdt, HKM; Nordestgaard, BG; Ellervik, C; Qi, L; Frazier-Wood, AC; Aslibekyan, S; North, KE; Voortman, T; Graff, M; Smith, CE; Lai, CQ; Varbo, A; Lemaitre, RN; de Jonge, EAL; Fumeron, F; Corella, D; Wang, CA; Tjonneland, A; Overvad, K; Sorensen, TIA; Feitosa, MF; Wojczynski, MK; Kahonen, M; Ahmad, S; Renstrom, F; Psaty, BM; Siscovick, DS; Barroso, I; Johansson, I; Hernandez, D; Ferrucci, L; Bandinelli, S; Linneberg, A; Sandholt, CH; Pedersen, O; Hansen, T; Schulz, CA; Sonestedt, E; Orho-Melander, M; Chen, TA; Rotter, JI; Allison, MA; Rich, SS; Sorli, JV; Coltell, O; Pennell, CE; Eastwood, PR; Hofman, A; Uitterlinden, AG; Zillikens, M; van Rooij, FJA; Chu, AY; Rose, LM; Ridker, PM; Viikari, J; Raitakari, O; Lehtimaki, T; Mikkila, V; Willett, WC; Wang, YJ; Tucker, KL; Ordovas, JM; Kilpelainen, TO; Province, MA; Franks, PW; Arnett, DK; Tanaka, T; Toft, U; Ericso, U; Franco, OH; Mozaffarian, D; Hu, FB; Chasman, DI				Ding, Ming; Huang, Tao; Bergholdt, Helle K. M.; Nordestgaard, Borge G.; Ellervik, Christina; Qi, Lu; Frazier-Wood, Alexis C.; Aslibekyan, Stella; North, Kari E.; Voortman, Trudy; Graff, Mariaelisa; Smith, Caren E.; Lai, Chao-Qiang; Varbo, Anette; Lemaitre, Rozenn N.; de Jonge, Ester A. L.; Fumeron, Frederic; Corella, Dolores; Wang, Carol A.; Tjonneland, Anne; Overvad, Kim; Sorensen, Thorkild I. A.; Feitosa, Mary F.; Wojczynski, Mary K.; Kahonen, Mika; Ahmad, Shafqat; Renstrom, Frida; Psaty, Bruce M.; Siscovick, David S.; Barroso, Ines; Johansson, Ingegerd; Hernandez, Dena; Ferrucci, Luigi; Bandinelli, Stefania; Linneberg, Allan; Sandholt, Camilla Helene; Pedersen, Oluf; Hansen, Torben; Schulz, Christina-Alexandra; Sonestedt, Emily; Orho-Melander, Marju; Chen, Tzu-An; Rotter, Jerome I.; Allison, Mathew A.; Rich, Stephen S.; Sorli, Jose V.; Coltell, Oscar; Pennell, Craig E.; Eastwood, Peter R.; Hofman, Albert; Uitterlinden, Andre G.; Zillikens, MCarola; van Rooij, Frank J. A.; Chu, Audrey Y.; Rose, Lynda M.; Ridker, Paul M.; Viikari, Jorma; Raitakari, Olli; Lehtimaki, Terho; Mikkila, Vera; Willett, Walter C.; Wang, Yujie; Tucker, Katherine L.; Ordovas, Jose M.; Kilpelainen, Tuomas O.; Province, Michael A.; Franks, Paul W.; Arnett, Donna K.; Tanaka, Toshiko; Toft, Ulla; Ericso, Ulrika; Franco, Oscar H.; Mozaffarian, Dariush; Hu, Frank B.; Chasman, Daniel I.		CHARGE Consortium	Dairy consumption, systolic blood pressure, and risk of hypertension: Mendelian randomization study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOSE-RESPONSE METAANALYSIS; CARDIOVASCULAR-DISEASE; INCIDENT HYPERTENSION; GENETIC-VARIANTS; BODY-WEIGHT; MILK; FAT; ASSOCIATION; PRODUCTS; DIETARY	OBJECTIVE To examine whether previous observed inverse associations of dairy intake with systolic blood pressure and risk of hypertension were causal. DESIGN Mendelian randomization study using the single nucleotide polymorphism rs4988235 related to lactase persistence as an instrumental variable. SETTING CHARGE (Cohorts for Heart and Aging Research in Genomic Epidemiology) Consortium. PARTICIPANTS Data from 22 studies with 171 213 participants, and an additional 10 published prospective studies with 26 119 participants included in the observational analysis. MAIN OUTCOME MEASURES The instrumental variable estimation was conducted using the ratio of coefficients approach. Using metaanalysis, an additional eight published randomized clinical trials on the association of dairy consumption with systolic blood pressure were summarized. RESULTS Compared with the CC genotype (CC is associated with complete lactase deficiency), the CT/TT genotype (TT is associated with lactose persistence, and CT is associated with certain lactase deficiency) of LCT-13910 (lactase persistence gene) rs4988235 was associated with higher dairy consumption (0.23 (about 55 g/day), 95% confidence interval 0.17 to 0.29) serving/day; P<0.001) and was not associated with systolic blood pressure (0.31, 95% confidence interval -0.05 to 0.68 mm Hg; P=0.09) or risk of hypertension (odds ratio 1.01, 95% confidence interval 0.97 to 1.05; P=0.27). Using LCT-13910 rs4988235 as the instrumental variable, genetically determined dairy consumption was not associated with systolic blood pressure (beta=1.35, 95% confidence interval -0.28 to 2.97 mm Hg for each serving/day) or risk of hypertension (odds ratio 1.04, 0.88 to 1.24). Moreover, meta-analysis of the published clinical trials showed that higher dairy intake has no significant effect on change in systolic blood pressure for interventions over one month to 12 months (intervention compared with control groups: beta=-0.21, 95% confidence interval -0.98 to 0.57 mm Hg). In observational analysis, each serving/day increase in dairy consumption was associated with -0.11 (95% confidence interval -0.20 to -0.02 mm Hg; P=0.02) lower systolic blood pressure but not risk of hypertension (odds ratio 0.98, 0.97 to 1.00; P=0.11). CONCLUSION The weak inverse association between dairy intake and systolic blood pressure in observational studies was not supported by a comprehensive instrumental variable analysis and systematic review of existing clinical trials.	[Ding, Ming; Huang, Tao; Qi, Lu; Ahmad, Shafqat; Franks, Paul W.; Hu, Frank B.] Harvard Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Huang, Tao] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Epidemiol Domain, Singapore, Singapore; [Huang, Tao] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Huang, Tao; Qi, Lu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA; [Bergholdt, Helle K. M.] Naestved Hosp, Dept Clin Biochem, Naestved, Denmark; [Bergholdt, Helle K. M.] Univ Copenhagen, Bispebjerg Hosp, Dept Clin Pharmacol, Copenhagen, Denmark; [Bergholdt, Helle K. M.; Nordestgaard, Borge G.; Ellervik, Christina] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nordestgaard, Borge G.; Varbo, Anette] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Copenhagen, Denmark; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Copenhagen Gen Populat Study, Copenhagen, Denmark; [Nordestgaard, Borge G.] Copenhagen Univ Hosp, Frederiksberg Hosp, Copenhagen City Heart Study, Copenhagen, Denmark; [Ellervik, Christina] Region Sjaelland, Dept Prod Res & Innovat, Soro, Denmark; [Ellervik, Christina] Boston Childrens Hosp, Dept Lab Med, Boston, MA USA; [Frazier-Wood, Alexis C.; Chen, Tzu-An] USDA ARS, Childrens Nutr Res Ctr, Baylor Coll Med, Houston, TX USA; [Aslibekyan, Stella; Arnett, Donna K.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [North, Kari E.; Graff, Mariaelisa; Wang, Yujie] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [North, Kari E.] Sci Univ N Carolina, Carolina Ctr Genome, Chapel Hill, NC USA; [Voortman, Trudy; de Jonge, Ester A. L.; Hofman, Albert; van Rooij, Frank J. A.; Franco, Oscar H.] Univ Med Ctr, Dept Epidemiol Erasmus MC, Rotterdam, Netherlands; [Smith, Caren E.; Lai, Chao-Qiang; Ordovas, Jose M.] Tufts Univ, Jean Mayer USDA Human Nut Res Ctr Aging, Boston, MA 02111 USA; [Varbo, Anette] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Lemaitre, Rozenn N.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [de Jonge, Ester A. L.; Uitterlinden, Andre G.; Zillikens, MCarola] Univ Med Ctr, Dept Int Med Erasmus MC, Rotterdam, Netherlands; [Fumeron, Frederic] INSERM, UMR S 1138, Ctr Rech Cordeliers, Paris, France; [Fumeron, Frederic] Univ Paris Diderot Sorbonne Paris Cite, UMR S 1138, Ctr Rech Cordeliers, Paris, France; [Fumeron, Frederic] Sorbonne Univ UPMC Univ Paris 06, UMR S 1138, Ctr Rech Cordeliers, Paris, France; [Fumeron, Frederic; Psaty, Bruce M.] Univ Paris 05, Sorbonne Paris Cite, UMR S 1138, Ctr Rech Cordeliers, Paris, France; [Corella, Dolores; Sorli, Jose V.] Univ Valencia, Dept Prevent Med & Publ Hlth, Valencia, Spain; [Corella, Dolores; Sorli, Jose V.; Coltell, Oscar] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr, Madrid, Spain; [Wang, Carol A.; Pennell, Craig E.] Univ Western Australia, Sch Womens & Infants Hlth, Nedlands, WA, Australia; [Tjonneland, Anne] Danish Canc Soc, Res Ctr, Copenhagen, Denmark; [Overvad, Kim] Aarhus Univ, Dept Publ Hlth, Epidemiol Sect, Aarhus C, Denmark; [Overvad, Kim] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark; [Sorensen, Thorkild I. A.; Sandholt, Camilla Helene; Pedersen, Oluf; Hansen, Torben; Kilpelainen, Tuomas O.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, Sect Metab Genet, Fac Hlth & Med Sci, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Capital Reg, Inst Prevent Med Bispebjerg, Copenhagen, Denmark; [Sorensen, Thorkild I. A.] Capital Reg, Frederiksberg Hosp, Copenhagen, Denmark; [Feitosa, Mary F.; Wojczynski, Mary K.; Province, Michael A.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Kahonen, Mika] Tampere Univ Hosp, Dept Clin Psychol, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Sch Med, Dept Clin Psychol, FIN-33101 Tampere, Finland; [Ahmad, Shafqat; Renstrom, Frida; Franks, Paul W.] Lund Univ, Dept Clin Sci, Genet & Mol Epidemiol Unit, Malmo, Sweden; [Renstrom, Frida; Johansson, Ingegerd] Umea Univ, Dept Biobank Res, Umea, Sweden; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Sci, Seattle, WA 98195 USA; [Siscovick, David S.] New York Acad Med, New York, NY USA; [Barroso, Ines] Wellcome Trust Genome Campus, Wellcome Trust Sanger Inst, Cambridge, England; [Barroso, Ines] Addenbrookes Hosp, NIHR Cambridge Biomed Res Ctr, Inst Metab Sci, Cambridge, England; [Barroso, Ines] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge, England; [Hernandez, Dena] NIA, Neurogenet Lab, Bethesda, MD 20892 USA; [Ferrucci, Luigi; Tanaka, Toshiko] Translat Gerontol Branch, Baltimore, MD USA; [Bandinelli, Stefania] LHTC, Geriatr Unit, Florence, Italy; [Linneberg, Allan; Toft, Ulla] Capital Reg Denmark, Res Ctr Prevent & Hlth, Copenhagen, Denmark; [Linneberg, Allan] Rigshosp, Dept Expt Clin Res, Glostrup, Denmark; [Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, Aarhus, Denmark; [Hansen, Torben] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark; [Schulz, Christina-Alexandra; Sonestedt, Emily; Orho-Melander, Marju; Ericso, Ulrika] Lund Univ, Dept Clin Sci Malmo, Lund, Sweden; [Rotter, Jerome I.] UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA USA; [Rotter, Jerome I.] UCLA Med Ctr, Dept Pediat, Torrance, CA USA; [Allison, Mathew A.] Univ Calif San Diego, Div Prevent Med, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Rich, Stephen S.] Univ Virginia, Ctr Publ Hlth Genom, 3232 West Complex, Charlottesville, VA USA; [Coltell, Oscar] Univ Jaume 1, Dept Comp Languages & Syst, Castellon de La Plana, Spain; [Eastwood, Peter R.] Univ Western Australia, Ctr Sleep Sci, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [Hofman, Albert; Willett, Walter C.; Hu, Frank B.] Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Chu, Audrey Y.; Rose, Lynda M.; Ridker, Paul M.; Chasman, Daniel I.] Brigham & Womens Hosp, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA; [Chu, Audrey Y.; Rose, Lynda M.; Ridker, Paul M.; Willett, Walter C.; Hu, Frank B.; Chasman, Daniel I.] Harvard Med Sch, Boston, MA USA; [Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Viikari, Jorma] Turku Univ Hosp, Div Med, Turku, Finland; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Raitakari, Olli] Turku Univ Hosp, Dept Clin Physiol & Nucl Med, Turku, Finland; [Raitakari, Olli; Mikkila, Vera] Univ Turku, Dept Clin Chem Fimlab Labs, Turku, Finland; [Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, Tampere, Finland; [Mikkila, Vera] Univ Helsinki, Dept Food &nd Environm Sci, Helsinki, Finland; [Willett, Walter C.; Hu, Frank B.] Brigham & Womens Hosp, Channing Div Network Med, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Tucker, Katherine L.] Univ Massachusetts, Dept Biochem & Nutr Sci, Ctr Populat Hlth, Lowell, MA USA; [Ordovas, Jose M.] Ctr Nacl Investigac Cardiovasc, Dept Epidemiol & Populat Genet, Madrid, Spain; [Ordovas, Jose M.] Inst Madrilno Estudios Avanzados Alimentac, Madrid, Spain; [Franks, Paul W.] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Chasman, Daniel I.] Brigham & Womens Hosp, Dept Genet, 75 Francis St, Boston, MA 02115 USA; [Chasman, Daniel I.] Broad Inst MIT & Harvard, Cambridge, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; National University of Singapore; National University of Singapore; Tulane University; Naestved Hospital; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Harvard University; Boston Children's Hospital; Baylor College of Medicine; United States Department of Agriculture (USDA); University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Tufts University; University of Copenhagen; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Western Australia; Danish Cancer Society; Aarhus University; Aalborg University; Aalborg University Hospital; Novo Nordisk Foundation; University of Copenhagen; Washington University (WUSTL); Tampere University; Tampere University Hospital; Tampere University; Lund University; Umea University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; New York Academy of Medicine; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Rigshospitalet; Aarhus University; University of Southern Denmark; Lund University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California San Diego; University of Virginia; Universitat Jaume I; University of Western Australia; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Turku; University of Turku; University of Turku; University of Turku; Tampere University; University of Helsinki; Harvard University; Brigham & Women's Hospital; University of Massachusetts System; University of Massachusetts Lowell; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Umea University; Tufts University; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Qi, L (corresponding author), Harvard Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Qi, L (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.	lqi1@tulane.edu	Coltell, Oscar/AAA-9936-2019; Franco, Óscar H/ABE-2305-2020; Voortman, Trudy/C-2963-2015; Franks, Paul/AAA-3300-2020; Ellervik, Christina/H-2977-2019; Pedersen, Oluf/AAG-8015-2020; Rotter, Jerome/AAY-6598-2021; Raitakari, Olli/AAQ-7389-2021; Mozaffarian, Dariush/ABC-2822-2020; Toft, Ulla/AAH-2589-2020; Wood, Lekki/B-8053-2010; Kilpeläinen, Tuomas/F-8569-2012; Pedersen, Oluf/Z-1731-2019; bandinelli, stefania/AAL-4570-2020; Fumeron, Frederic/AAC-6882-2019; Eastwood, Peter R/H-9129-2014; Pennell, Craig/ABD-6902-2020; Feitosa, Mary F/K-8044-2012; Ahmad, Shafqat/AAV-5329-2020; Lehtimäki, Terho/AAD-1094-2022; Nordestgaard, Borge Gronne/ABF-1310-2020; Sorlí, José V/L-8758-2014	Coltell, Oscar/0000-0002-4518-8495; Franco, Óscar H/0000-0002-4606-4929; Voortman, Trudy/0000-0003-2830-6813; Ellervik, Christina/0000-0002-3088-4375; Toft, Ulla/0000-0001-7770-8419; Wood, Lekki/0000-0001-7616-2119; Kilpeläinen, Tuomas/0000-0002-8349-3028; Pedersen, Oluf/0000-0002-3321-3972; Fumeron, Frederic/0000-0002-7916-4619; Eastwood, Peter R/0000-0002-4490-4138; Pennell, Craig/0000-0002-0937-6165; Feitosa, Mary F/0000-0002-0933-2410; Lehtimäki, Terho/0000-0002-2555-4427; Sorlí, José V/0000-0002-0130-2006; Hansen, Torben/0000-0001-8748-3831; Overvad, Kim/0000-0001-6429-7921; Franks, Paul/0000-0002-0520-7604; Nordestgaard, Borge/0000-0002-1954-7220; Linneberg, Allan/0000-0002-0994-0184	National Heart, Lung, and Blood Institute [HL071981, HL034594, HL126024, HL043851, HL080467, HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C]; National Institute of Diabetes and Digestive and Kidney Diseases [DK091718, DK100383, DK078616]; Boston Obesity Nutrition Research Center [DK46200]; United States-Israel Binational Science Foundation [2011036]; American Heart Association Scientist Development Award [0730094N]; Danish Council for Independent Research; Medical Sciences (FSS); Herlev Hospital; Copenhagen University Hospital; Copenhagen County Foundation; Chief Physician Johan Boserup and Lise Boserup's Fund, Denmark; Region Zealand Foundation; Naestved Hospital Foundation; Edith and Henrik Henriksens Memorial Scholarship; Johan and Lise Boserup Foundation; TrygFonden; Johannes Fog's Foundation, Region Zealand; Naestved Hospital; National Board of Health; Local Government Denmark Foundation; National Cancer Institute [CA047988]; Donald W Reynolds Foundation; Fondation Leducq; Amgen; National Institutes of Health [UM1 CA186107, P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521, UM1 CA167552, R01 HL35464, HL073168, CA87969, CA49449]; Merck Research Laboratories, North Wales, PA; Arthur Ashley Williams Foundation; Harvard ophthalmology scholar award (Harvard Medical School) from the Harvard Glaucoma Center of Excellence; National Human Genome Research Institute [U01HG004402]; NIH roadmap for medical research; Danish Research Councils; Health Foundation; Danish Centre for Evaluation and Health Technology Assessment; Copenhagen County; Danish Heart Foundation; Ministry of Health and Prevention; Association of Danish Pharmacies; Augustinus Foundation; Novo Nordisk; Velux Foundation; Becket Foundation; Ib Henriksens Foundation; INSERM; CNAMTS; Lilly; Novartis Pharma; Sanofi-Aventis; INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; CNIEL; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Pierre Fabre; Roche; Topcon; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NWO [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/ Netherlands Organisation for Scientific Research (NWO) [050-060-810]; Region Skane; City of Malmo; Pahlsson Foundation; Swedish Heart and Lung Foundation; Swedish Heart-Lung Foundation; Swedish Diabetes Association; Pahlsson's Foundation; Swedish Research Council; Umea Medical Research Foundation; Heart Foundation of Northern Sweden; Wellcome Trust [WT098051]; NCRR [UL1-TR-000040, UL1-TR-001079]; NHLBI [HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, U01HL080295]; National Institute of Neurological Disorders and Stroke (NINDS); National Institute on Aging (NIA) [R01AG023629]; National Center for Advancing Translational Sciences, CTSI grant [UL1TR000124]; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant [DK063491]; Academy of Finland [286284, 134309, 126925, 121584, 124282, 129378, 117787, 41071]; Social Insurance Institution of Finland; Kuopio University Hospital Medical Fund [X51001]; Tampere University Hospital Medical Fund [X51001]; Turku University Hospital Medical Fund [X51001]; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation; Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Danish Ministry of Science, Technology and Innovation; Danish Council for Independent Research [DFF-333-00124, DFF-1331-00730B]; Spanish Ministry of Health (Instituto de Salud Carlos III); Ministerio de Economia y Competitividad [G03/140, CIBER 06/03, RD06/0045 PI07-0954, CNIC-06, PI11/02505, SAF2009-12304, AGL2010-22319-C03-03, PRX14/00527]; Fondo Europeo de Desarrollo Regional; University Jaume I [P1-1B2013-54]; Generalitat Valenciana [AP111/10, AP-042/11, BEST/2015/087, GVACOMP2011-151, ACOMP/2011/145, ACOMP/2012/190, ACOMP/2013/159]; National Heart, Lung, and Blood Institute (NHLBI) [U01HL072524, R01 HL091357, HL54776, HL078885]; US Department of Agriculture, Agriculture Research Service [53-K06-5-10, 58-1950-9-001]; National Health and Medical Research Council of Australia [403981, 003209]; Canadian Institutes of Health Research [MOP-82893]; NHMRC [1027449, 1044840, 1021855]; Safework Australia; Italian Ministry of Health [ICS110.1/RF97.71]; US National Institute on Aging [263 MD 9164, 263 MD 821336]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL130114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Boston Obesity Nutrition Research Center; United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); American Heart Association Scientist Development Award(American Heart Association); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Medical Sciences (FSS)(Danish Medical Research Council); Herlev Hospital; Copenhagen University Hospital; Copenhagen County Foundation; Chief Physician Johan Boserup and Lise Boserup's Fund, Denmark; Region Zealand Foundation; Naestved Hospital Foundation; Edith and Henrik Henriksens Memorial Scholarship; Johan and Lise Boserup Foundation; TrygFonden; Johannes Fog's Foundation, Region Zealand; Naestved Hospital; National Board of Health; Local Government Denmark Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W Reynolds Foundation; Fondation Leducq(Leducq Foundation); Amgen(Amgen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories, North Wales, PA(Merck & Company); Arthur Ashley Williams Foundation; Harvard ophthalmology scholar award (Harvard Medical School) from the Harvard Glaucoma Center of Excellence; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH roadmap for medical research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Research Councils(Det Frie Forskningsrad (DFF)); Health Foundation; Danish Centre for Evaluation and Health Technology Assessment; Copenhagen County; Danish Heart Foundation; Ministry of Health and Prevention; Association of Danish Pharmacies; Augustinus Foundation; Novo Nordisk(Novo Nordisk); Velux Foundation(Velux Fonden); Becket Foundation; Ib Henriksens Foundation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis Pharma; Sanofi-Aventis(Sanofi-Aventis); INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; CNIEL; ONIVINS; Societe Francophone du Diabete; Ardix Medical; Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Pierre Fabre; Roche(Roche Holding); Topcon; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; Netherlands Organisation of Scientific Research NWO(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/ Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Region Skane; City of Malmo; Pahlsson Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Diabetes Association; Pahlsson's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea Medical Research Foundation; Heart Foundation of Northern Sweden; Wellcome Trust(Wellcome Trust); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Advancing Translational Sciences, CTSI grant; National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant; Academy of Finland(Academy of Finland); Social Insurance Institution of Finland; Kuopio University Hospital Medical Fund; Tampere University Hospital Medical Fund; Turku University Hospital Medical Fund; Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Tampere Tuberculosis Foundation; Emil Aaltonen Foundation; Yrjo Jahnsson Foundation; Danish Ministry of Science, Technology and Innovation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Spanish Ministry of Health (Instituto de Salud Carlos III)(Instituto de Salud Carlos IIISpanish Government); Ministerio de Economia y Competitividad(Spanish Government); Fondo Europeo de Desarrollo Regional(European Commission); University Jaume I; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Agriculture, Agriculture Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Safework Australia; Italian Ministry of Health(Ministry of Health, Italy); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: LQ is recipient of the National Heart, Lung, and Blood Institute (HL071981, HL034594, HL126024), the National Institute of Diabetes and Digestive and Kidney Diseases (DK091718, DK100383, DK078616), the Boston Obesity Nutrition Research Center (DK46200), the United States-Israel Binational Science Foundation grant (2011036), and the American Heart Association Scientist Development Award (0730094N) for the Mendelian randomization study. The CGPS is was funded by the Danish Council for Independent Research; Medical Sciences (FSS); Herlev Hospital, Copenhagen University Hospital; Copenhagen County Foundation; and Chief Physician Johan Boserup and Lise Boserup's Fund, Denmark. The GESUS was funded by the Region Zealand Foundation, Naestved Hospital Foundation. Edith and Henrik Henriksens Memorial Scholarship, Johan and Lise Boserup Foundation, TrygFonden, Johannes Fog's Foundation, Region Zealand, Naestved Hospital, National Board of Health, and Local Government Denmark Foundation. The WGHS is supported by HL043851 and HL080467 from the National Heart, Lung, and Blood Institute and CA047988 from the National Cancer Institute, the Donald W Reynolds Foundation and the Fondation Leducq, with collaborative scientific support and funding for genotyping provided by Amgen. The NHS and the HPFS was supported by grants UM1 CA186107, P01 CA87969, R01 CA49449, R01 HL034594, R01 HL088521, UM1 CA167552, R01 HL35464, HL073168, CA87969, CA49449, CA055075, HL34594, HL088521, U01HG004399, DK080140, P30, U01CA137088, U54CA155626, DK58845, DK098311, U01HG004728, EY015473, CA134958, DK70756, and DK46200 from the National Institutes of Health, with additional support for genotyping from Merck Research Laboratories, North Wales, PA. LRP is supported by the Arthur Ashley Williams Foundation and a Harvard ophthalmology scholar award (Harvard Medical School) from the Harvard Glaucoma Center of Excellence. ATC is a Damon Runyon Cancer Foundation clinical investigator. The funding sources had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. ARIC is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Infrastructure was partly supported by grant No UL1RR025005, a component of the National Institutes of Health and NIH roadmap for medical research. The Inter99 study was funded by the Danish Research Councils, Health Foundation, Danish Centre for Evaluation and Health Technology Assessment, Copenhagen County, Danish Heart Foundation, Ministry of Health and Prevention, Association of Danish Pharmacies, Augustinus Foundation, Novo Nordisk, Velux Foundation, Becket Foundation, and Ib Henriksens Foundation. The D.E.S.I.R.; r study has been supported by INSERM contracts with CNAMTS, Lilly, Novartis Pharma, and Sanofi-Aventis; by INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante, Cohortes Sante TGIR 2008), the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, CNIEL, ONIVINS, Societe Francophone du Diabete, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche, Topcon. The funding sources had no role in the design or conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. The D.E.S.I.R. Study Group: INSERM CESP U1018: B Balkau, P Ducimetiere, E Eschwege; INSERM U367: F. Alhenc-Gelas; CHU d'Angers: A Girault; Bichat Hospital: F Fumeron, M Marre, R Roussel; CHU de Rennes: F Bonnet; CNRS UMR8090, Lille: S Cauchi P Froguel; Centres d'Examens de Sante: Alencon, Angers, Blois, Caen, Chartres, Chateauroux, Cholet, Le Mans, Orleans, Tours; Institute de Recherche Medecine Generale: J Cogneau; General practitioners of the region; Institute inter-Regional pour la Sante: C Born, E Caces, N Copin, JG Moreau, O Lantieri, F Rakotozafy, J Tichet, S Vol. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (No 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/ Netherlands Organisation for Scientific Research (NWO) project No 050-060-810. The MDCS was initiated and planned in collaboration with the International Agency for Research on Cancer, the Swedish Cancer Society, and Swedish Medical Research Council and the Faculty of Medicine Lund University, Sweden. The study is also funded by Region Skane, City of Malmo, Pahlsson Foundation and the Swedish Heart and Lung Foundation.r The GLACIER Study was funded by project grants from the Swedish Heart-Lung Foundation, the Swedish Diabetes Association, the Pahlsson's Foundation, Region Skane, the Swedish Research Council, the Umea Medical Research Foundation, Novo Nordisk, The Heart Foundation of Northern Sweden (all to PWF), and Wellcome Trust WT098051. The MESA study was supported by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute, and by grants UL1-TR-000040 and UL1-TR-001079 from NCRR. The FamHS was supported by grants DK089256 and HL117078 from the National Institutes of Health. Infrastructure for the CHARGE Consortium is supported in part by the National Heart, Lung, and Blood Institute grant R01HL105756.; This CHS research was supported by NHLBI contracts HHSN268201200036C, HHSN268200800007C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086; and NHLBI grants U01HL080295, R01HL087652, R01HL105756, R01HL103612, and R01HL120393 with additional contribution from the National Institute of Neurological Disorders and Stroke (NINDS). Additional support was provided through R01AG023629 from the National Institute on Aging (NIA). A full list of principal CHS investigators and institutions can be found at CHS-NHLBI.org. The provision of genotyping data was supported in part by the National Center for Advancing Translational Sciences, CTSI grant UL1TR000124, and the National Institute of Diabetes and Digestive and Kidney Disease Diabetes Research Center (DRC) grant DK063491 to the Southern California Diabetes Endocrinology Research Center. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The YFS has been financially supported by the Academy of Finland: grants 286284 (TL), 134309 (Eye), 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi); the Social Insurance Institution of Finland; Kuopio, Tampere and Turku University Hospital Medical Funds (grant X51001 for T.L.); Juho Vainio Foundation; Paavo Nurmi Foundation; Finnish Foundation of Cardiovascular Research (T.L.); Finnish Cultural Foundation; Tampere Tuberculosis Foundation (TL); Emil Aaltonen Foundation (TL); and Yrjo Jahnsson Foundation (TL). The DCH and the DIOGENES cohorts were a part of the research program of the UNIK: Food, Fitness and Pharma for Health and Disease (see www.foodfitnesspharma.ku.dk). The UNIK project was supported by the Danish Ministry of Science, Technology and Innovation. Tuomas O Kilpelainen was supported by the Danish Council for Independent Research (DFF-333-00124 and Sapere Aude program grant DFF-1331-00730B). The PREDIMED-VALENCIA study was supported by the Spanish Ministry of Health (Instituto de Salud Carlos III) and the Ministerio de Economia y Competitividad (projects G03/140, CIBER 06/03, RD06/0045 PI07-0954, CNIC-06, PI11/02505, SAF2009-12304, AGL2010-22319-C03-03 and PRX14/00527), Fondo Europeo de Desarrollo Regional, by the University Jaume I (Project P1-1B2013-54) and by the Generalitat Valenciana (AP111/10, AP-042/11, BEST/2015/087, GVACOMP2011-151, ACOMP/2011/145, ACOMP/2012/190 and ACOMP/2013/159.r The BPRHS was supported by the National Institutes of Health grants P01 AG023394 and P50 HL105185. The GOLDN Study was supported by National Heart, Lung, and Blood Institute (NHLBI) grant No U01HL072524 (Genetic and Environmental Determinants of Triglycerides), NHLBI R01 HL091357 (Genomewide Association Study of Lipid Response to Fenofibrate and Dietary Fat), NHLBI grant Nos HL54776 and HL078885; and by contracts 53-K06-5-10 and 58-1950-9-001 from the US Department of Agriculture, Agriculture Research Service. The Raine Study was supported by the National Health and Medical Research Council of Australia (grant Nos 403981 and 003209) and the Canadian Institutes of Health Research (grant No MOP-82893). The 22 year Raine Study follow-up was funded by NHMRC project grants 1027449, 1044840 and 1021855. Funding was also provided by Safework Australia. The InCHIANTI study baseline (1998-2000) was supported as a "targeted project" (ICS110.1/RF97.71) by the Italian Ministry of Health and in part by the US National Institute on Aging (contracts: 263 MD 9164 and 263 MD 821336).; The sponsors have no role in: the study design; the collection, analysis, or interpretation of data; the writing of the report; or in the decision to submit the article for publication.	Alonso A, 2005, AM J CLIN NUTR, V82, P972, DOI 10.1093/ajcn/82.5.972; Barr SI, 2000, J AM DIET ASSOC, V100, P810, DOI 10.1016/S0002-8223(00)00236-4; Bergholdt Helle K M, 2015, Am J Clin Nutr, V102, P487, DOI 10.3945/ajcn.114.105049; Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758; Chen M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0215-1; Cicero AFG, 2013, AM J HYPERTENS, V26, P442, DOI 10.1093/ajh/hps044; Crichton GE, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-19; Dauchet L, 2007, AM J CLIN NUTR, V85, P1650, DOI 10.1093/ajcn/85.6.1650; Djousse L, 2006, HYPERTENSION, V48, P335, DOI 10.1161/01.HYP.0000229668.73501.e8; Dong JY, 2013, BRIT J NUTR, V110, P1188, DOI 10.1017/S0007114513001712; Drouin-Chartier JP, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-12; Drouin-Chartier JP, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-83; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Engberink MF, 2009, J NUTR, V139, P582, DOI 10.3945/jn.108.093088; Gijsbers L, 2016, AM J CLIN NUTR, V103, P1111, DOI 10.3945/ajcn.115.123216; Heraclides A, 2012, EUR J NUTR, V51, P583, DOI 10.1007/s00394-011-0242-z; Ingram CJE, 2009, HUM GENET, V124, P579, DOI 10.1007/s00439-008-0593-6; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Livingstone KM, 2013, HYPERTENSION, V61, P42, DOI 10.1161/HYPERTENSIONAHA.111.00026; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; Petitti DB, 2001, STAT MED, V20, P3625, DOI 10.1002/sim.1091; Ralston RA, 2012, J HUM HYPERTENS, V26, P3, DOI 10.1038/jhh.2011.3; Rideout TC, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-56; Ruidavets JB, 2006, J HYPERTENS, V24, P671, DOI 10.1097/01.hjh.0000217849.10831.16; Samara A, 2013, NUTRITION, V29, P519, DOI 10.1016/j.nut.2012.08.013; Schmidheiny K., 2016, SHORT GUIDES MICROEC; Snijder MB, 2008, OBESITY, V16, P706, DOI 10.1038/oby.2007.93; Snijder MB, 2007, AM J CLIN NUTR, V85, P989, DOI 10.1093/ajcn/85.4.989; Soedamah-Muthu SS, 2012, HYPERTENSION, V60, P1131, DOI 10.1161/HYPERTENSIONAHA.112.195206; Soedamah-Muthu SS, 2011, AM J CLIN NUTR, V93, P158, DOI 10.3945/ajcn.2010.29866; Tanaka S, 2014, J NUTR SCI VITAMINOL, V60, P305, DOI 10.3177/jnsv.60.305; Thomas DC, 2007, ANN EPIDEMIOL, V17, P511, DOI 10.1016/j.annepidem.2006.12.005; Thomopoulos C, 2016, J HYPERTENS, V34, P613, DOI 10.1097/HJH.0000000000000881; Tobin MD, 2005, STAT MED, V24, P2911, DOI 10.1002/sim.2165; van Meijl LEC, 2011, NUTR METAB CARDIOVAS, V21, P355, DOI 10.1016/j.numecd.2009.10.008; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P427, DOI 10.1097/EDE.0000000000000081; Vimaleswaran KS, 2014, LANCET DIABETES ENDO, V2, P719, DOI 10.1016/S2213-8587(14)70113-5; Wang HF, 2015, BRIT J NUTR, V114, P1887, DOI 10.1017/S0007114515003578; Wennersberg MH, 2009, AM J CLIN NUTR, V90, P960, DOI 10.3945/ajcn.2009.27664; Xu JY, 2008, NUTRITION, V24, P933, DOI 10.1016/j.nut.2008.04.004; Zong G, 2014, DIABETES CARE, V37, P56, DOI 10.2337/dc13-0975	43	61	61	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2017	356								j1000	10.1136/bmj.j1000	http://dx.doi.org/10.1136/bmj.j1000			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NO	28302601	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000397015600001
J	Hughes, TP; Kerry, JT; Alvarez-Noriega, M; Alvarez-Romero, JG; Anderson, KD; Baird, AH; Babcock, RC; Beger, M; Bellwood, DR; Berkelmans, R; Bridge, TC; Butler, IR; Byrne, M; Cantin, NE; Comeau, S; Connolly, SR; Cumming, GS; Dalton, SJ; Diaz-Pulido, G; Eakin, CM; Figueira, WF; Gilmour, JP; Harrison, HB; Heron, SF; Hoey, AS; Hobbs, JPA; Hoogenboom, MO; Kennedy, EV; Kuo, CY; Lough, JM; Lowe, RJ; Liu, G; Cculloch, MTM; Malcolm, HA; Mcwilliam, MJ; Pandolfi, JM; Pears, RJ; Pratchett, MS; Schoepf, V; Simpson, T; Skirving, WJ; Sommer, B; Torda, G; Wachenfeld, DR; Willis, BL; Wilson, SK				Hughes, Terry P.; Kerry, James T.; Alvarez-Noriega, Mariana; Alvarez-Romero, Jorge G.; Anderson, Kristen D.; Baird, Andrew H.; Babcock, Russell C.; Beger, Maria; Bellwood, David R.; Berkelmans, Ray; Bridge, Tom C.; Butler, Ian R.; Byrne, Maria; Cantin, Neal E.; Comeau, Steeve; Connolly, Sean R.; Cumming, Graeme S.; Dalton, Steven J.; Diaz-Pulido, Guillermo; Eakin, C. Mark; Figueira, Will F.; Gilmour, James P.; Harrison, Hugo B.; Heron, Scott F.; Hoey, Andrew S.; Hobbs, Jean-Paul A.; Hoogenboom, Mia O.; Kennedy, Emma V.; Kuo, Chao-yang; Lough, Janice M.; Lowe, Ryan J.; Liu, Gang; Cculloch, Malcolm T. M.; Malcolm, Hamish A.; Mcwilliam, Michael J.; Pandolfi, John M.; Pears, Rachel J.; Pratchett, Morgan S.; Schoepf, Verena; Simpson, Tristan; Skirving, William J.; Sommer, Brigitte; Torda, Gergely; Wachenfeld, David R.; Willis, Bette L.; Wilson, Shaun K.			Global warming and recurrent mass bleaching of corals	NATURE			English	Article							GREAT-BARRIER-REEF; CLIMATE-CHANGE; RECOVERY; RESILIENCE; MORTALITY; IMPACTS; TRENDS; SPACE	During 2015-2016, record temperatures triggered a pan-tropical episode of coral bleaching, the third global-scale event since mass bleaching was first documented in the 1980s. Here we examine how and why the severity of recurrent major bleaching events has varied at multiple scales, using aerial and underwater surveys of Australian reefs combined with satellite-derived sea surface temperatures. The distinctive geographic footprints of recurrent bleaching on the Great Barrier Reef in 1998, 2002 and 2016 were determined by the spatial pattern of sea temperatures in each year. Water quality and fishing pressure had minimal effect on the unprecedented bleaching in 2016, suggesting that local protection of reefs affords little or no resistance to extreme heat. Similarly, past exposure to bleaching in 1998 and 2002 did not lessen the severity of bleaching in 2016. Consequently, immediate global action to curb future warming is essential to secure a future for coral reefs.	[Hughes, Terry P.; Kerry, James T.; Alvarez-Noriega, Mariana; Alvarez-Romero, Jorge G.; Anderson, Kristen D.; Baird, Andrew H.; Bellwood, David R.; Bridge, Tom C.; Connolly, Sean R.; Cumming, Graeme S.; Harrison, Hugo B.; Hoey, Andrew S.; Hoogenboom, Mia O.; Kuo, Chao-yang; Lough, Janice M.; Mcwilliam, Michael J.; Pratchett, Morgan S.; Torda, Gergely; Willis, Bette L.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Alvarez-Noriega, Mariana; Bellwood, David R.; Connolly, Sean R.; Hoogenboom, Mia O.; Willis, Bette L.] James Cook Univ, Coll Sci & Engn, Townsville, Qld 4811, Australia; [Babcock, Russell C.] Commonwealth Sci & Ind Res Org, GPO Box 2583, Brisbane, Qld 4001, Australia; [Beger, Maria] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Berkelmans, Ray] 24 Hanwood Court, Gilston, Qld 4211, Australia; [Bridge, Tom C.] Queensland Museum, 70-102 Flinders St, Townsville, Qld 4810, Australia; [Butler, Ian R.; Pandolfi, John M.; Sommer, Brigitte] Univ Queensland, Sch Biol Sci, Australian Res Council, Ctr Excellence Coral Reef Studies, Brisbane, Qld 4072, Australia; [Byrne, Maria] Univ Sydney, Sch Med Sci, Sydney, NSW 2006, Australia; [Cantin, Neal E.; Lough, Janice M.; Torda, Gergely] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia; [Comeau, Steeve; Lowe, Ryan J.; Cculloch, Malcolm T. M.; Schoepf, Verena] Univ Western Australia, Australian Res Council, Ctr Excellence Coral Reef Studies, Oceans Inst, Crawley, WA 6009, Australia; [Comeau, Steeve; Lowe, Ryan J.; Cculloch, Malcolm T. M.; Schoepf, Verena] Univ Western Australia, Sch Earth & Environm, Crawley, WA 6009, Australia; [Dalton, Steven J.; Malcolm, Hamish A.] Fisheries Res, Dept Primary Ind, POB 4291, Coffs Harbour, NSW 2450, Australia; [Diaz-Pulido, Guillermo; Kennedy, Emma V.] Griffith Univ, Sch Environm, Brisbane, Qld 4111, Australia; [Diaz-Pulido, Guillermo; Kennedy, Emma V.] Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia; [Eakin, C. Mark; Heron, Scott F.; Liu, Gang; Skirving, William J.] US NOAA, Coral Reef Watch, College Pk, MD 20740 USA; [Figueira, Will F.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Gilmour, James P.] Univ Western Australia, Indian Oceans Marine Res Ctr, Australian Inst Marine Sci, Crawley, WA 6009, Australia; [Heron, Scott F.; Liu, Gang; Skirving, William J.] Global Sci & Technol Inc, Greenbelt, MD 20770 USA; [Heron, Scott F.] James Cook Univ, Coll Sci Technol & Engn, Marine Geophys Lab, Townsville, Qld 4811, Australia; [Hobbs, Jean-Paul A.] Curtin Univ, Dept Environm & Agr, Perth, WA 6845, Australia; [Pears, Rachel J.; Wachenfeld, David R.] Great Barrier Reef Marine Pk Author, POB 1379, Townsville, Qld 4810, Australia; [Simpson, Tristan] Torres Strait Reg Author, POB 261, Thursday Isl, Qld 4875, Australia; [Wilson, Shaun K.] Dept Parks & Wildlife, Perth, WA 6151, Australia	James Cook University; James Cook University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Leeds; Queensland Museum; University of Queensland; University of Sydney; Australian Institute of Marine Science; University of Western Australia; University of Western Australia; Griffith University; Griffith University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Sydney; Australian Institute of Marine Science; University of Western Australia; National Aeronautics & Space Administration (NASA); James Cook University; Curtin University	Hughes, TP (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	terry.hughes@jcu.edu.au	Hoey, Andrew S/B-5457-2015; Heron, Scott F/E-7928-2011; Baird, Andrew Hamilton/C-8449-2009; Hoogenboom, Mia O/D-3664-2012; Torda, Gergely/ABE-6388-2020; Pratchett, Morgan/AAW-5179-2020; Schoepf, Verena/H-5786-2014; Pandolfi, John M/A-3121-2009; Lough, Janice M/L-1682-2013; Torda, Gergely/ABE-6400-2020; Kennedy, Emma V/M-3193-2014; Diaz-Pulido, Guillermo/B-3648-2013; Harrison, Hugo/F-6830-2012; Babcock, Russell C/A-3794-2012; Cumming, Graeme S./B-6551-2008; Beger, Maria/ABC-5975-2022; Liu, Gang/E-7921-2011; McWilliam, Mike/AAB-1179-2019; Figueira, Will/A-5163-2009; Beger, Maria/F-9049-2013; Alvarez-Romero, Jorge G./A-4557-2009; Hughes, Terry/L-4721-2013; McCulloch, Malcolm Thomas/C-3651-2009; Byrne, Maria/K-6355-2016; Lowe, Ryan/A-5032-2012; Eakin, C. Mark/F-5585-2010; Skirving, William/E-7927-2011	Baird, Andrew Hamilton/0000-0001-8504-4077; Hoogenboom, Mia O/0000-0003-3709-6344; Pratchett, Morgan/0000-0002-1862-8459; Schoepf, Verena/0000-0002-9467-1088; Pandolfi, John M/0000-0003-3047-6694; Lough, Janice M/0000-0002-3789-1009; Torda, Gergely/0000-0002-4585-3045; Kennedy, Emma V/0000-0003-1821-9740; Harrison, Hugo/0000-0001-8831-0086; Babcock, Russell C/0000-0002-7756-1290; Cumming, Graeme S./0000-0002-3678-1326; Beger, Maria/0000-0003-1363-3571; Figueira, Will/0000-0001-9472-8710; Beger, Maria/0000-0003-1363-3571; Alvarez-Romero, Jorge G./0000-0002-1141-0588; Wilson, Shaun/0000-0002-4590-0948; Pears, Rachel/0000-0001-8092-0365; Hughes, Terry/0000-0002-5257-5063; Anderson, Kristen/0000-0002-1576-6979; McCulloch, Malcolm Thomas/0000-0003-1538-1558; Heron, Scott/0000-0001-5262-6978; Byrne, Maria/0000-0002-8902-9808; Sommer, Brigitte/0000-0003-0617-7790; Lowe, Ryan/0000-0002-7080-8406; Hoey, Andrew/0000-0002-4261-5594; Eakin, C. Mark/0000-0002-5987-0858; McWilliam, Mike/0000-0001-5748-0859; Diaz-Pulido, Guillermo/0000-0002-0901-3727; Skirving, William/0000-0003-0167-6427	Australian Research Council's Centre of Excellence Program; Australian Commonwealth Government; European Union; USA National Oceanographic & Atmospheric Administration; USA National Science Foundation	Australian Research Council's Centre of Excellence Program(Australian Research Council); Australian Commonwealth Government(Australian Government); European Union(European Commission); USA National Oceanographic & Atmospheric Administration; USA National Science Foundation(National Science Foundation (NSF))	The authors acknowledge the 21 institutions that supported this research, in Australia, the UK, and the USA. Twenty-six of the authors are supported by funding from the Australian Research Council's Centre of Excellence Program. Other funding support includes the Australian Commonwealth Government, the European Union, the USA National Oceanographic & Atmospheric Administration, and USA National Science Foundation. GlobColour data (http://globcolour. info) used in this study has been developed, validated, and distributed by ACRI-ST, France. The contents in this manuscript are solely the opinions of the authors and do not constitute a statement of policy, decision or position on behalf of NOAA or the US Government. We thank the many student volunteers who participated in field studies.	Ainsworth TD, 2016, SCIENCE, V352, P338, DOI 10.1126/science.aac7125; Australian Bureau of Meteorology (BOM), 2016, TROP CYCL STAN TRACK; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Carrigan AD, 2014, GLOBAL CHANGE BIOL, V20, P1604, DOI 10.1111/gcb.12541; Connell JH, 1997, ECOL MONOGR, V67, P461, DOI 10.1890/0012-9615(1997)067[0461:AYSOCA]2.0.CO;2; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Eakin CM., 2016, REEF CURR, V31, P1; Feng M., 2003, J GEOPHYS RES, V108, P2156; Gilmour JP, 2013, SCIENCE, V340, P69, DOI 10.1126/science.1232310; Globcolour, 2016, REM SENS CHLOR CONC; GLYNN PW, 1984, ENVIRON CONSERV, V11, P133, DOI 10.1017/S0376892900013825; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Heron S. F., 2015, 145 NOAA NOAANESDIS; Heron SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38402; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Kayanne H, 2002, MAR ECOL PROG SER, V239, P93, DOI 10.3354/meps239093; Leahy SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070400; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Oliver J. K., 2009, V205, P21; Pratchett MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070443; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Scheffer M, 2015, SCIENCE, V347, P1317, DOI 10.1126/science.aaa3769; Spalding MD, 2015, SCIENCE, V350, P769, DOI 10.1126/science.aad0349; Swain TD, 2016, GLOBAL CHANGE BIOL, V22, P2475, DOI 10.1111/gcb.13276; van de Leemput IA, 2016, CORAL REEFS, V35, P857, DOI 10.1007/s00338-016-1439-7; van Hooidonk R, 2016, SCI REP-UK, V6, DOI 10.1038/srep39666; West JM, 2003, CONSERV BIOL, V17, P956, DOI 10.1046/j.1523-1739.2003.02055.x; Wooldridge SA, 2017, MAR POLLUT BULL, V114, P343, DOI 10.1016/j.marpolbul.2016.09.045	35	1594	1623	132	2588	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					373	+		10.1038/nature21707	http://dx.doi.org/10.1038/nature21707			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28300113	Green Accepted, Green Submitted			2022-12-28	WOS:000396337400041
J	Scheres, B; van der Putten, WH				Scheres, Ben; van der Putten, Wim H.			The plant perceptron connects environment to development	NATURE			English	Review							GROWTH-DEFENSE TRADEOFFS; SIGNAL-TRANSDUCTION; AUXIN BIOSYNTHESIS; RAPID RESPONSES; SALICYLIC-ACID; ENEMY RELEASE; ARABIDOPSIS; TRAITS; RESISTANCE; HORMONE	Plants cope with the environment in a variety of ways, and ecological analyses attempt to capture this through life-history strategies or trait-based categorization. These approaches are limited because they treat the trade-off mechanisms that underlie plant responses as a black box. Approaches that involve the molecular or physiological analysis of plant responses to the environment have elucidated intricate connections between developmental and environmental signals, but in only a few well-studied model species. By considering diversity in the plant response to the environment as the adaptation of an information-processing network, new directions can be found for the study of life-history strategies, trade-offs and evolution in plants.	[Scheres, Ben] Wageningen Univ, Lab Plant Dev Biol, POB 8123, NL-6700 ES Wageningen, Netherlands; [van der Putten, Wim H.] Netherlands Inst Ecol, Dept Terr Ecol, POB 50, NL-6700 AB Wageningen, Netherlands; [van der Putten, Wim H.] Wageningen Univ, Lab Nematol, POB 8123, NL-6700 ES Wageningen, Netherlands	Wageningen University & Research; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Scheres, B (corresponding author), Wageningen Univ, Lab Plant Dev Biol, POB 8123, NL-6700 ES Wageningen, Netherlands.	ben.scheres@wur.nl	van der Putten, Wim H/C-3707-2011; KNAW, NIOO-KNAW/A-4320-2012	van der Putten, Wim H/0000-0002-9341-4442; KNAW, NIOO-KNAW/0000-0002-3835-159X				Abley K, 2016, ANN BOT-LONDON, V117, P733, DOI 10.1093/aob/mcw016; Agrawal AA, 2012, SCIENCE, V338, P113, DOI 10.1126/science.1225977; Agrawal AA, 2011, FUNCT ECOL, V25, P420, DOI 10.1111/j.1365-2435.2010.01796.x; Albert CH, 2010, FUNCT ECOL, V24, P1192, DOI 10.1111/j.1365-2435.2010.01727.x; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; Andres F, 2012, NAT REV GENET, V13, P627, DOI 10.1038/nrg3291; Araya T, 2014, P NATL ACAD SCI USA, V111, P2029, DOI 10.1073/pnas.1319953111; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Ballare CL, 2014, ANNU REV PLANT BIOL, V65, P335, DOI 10.1146/annurev-arplant-050213-040145; Banta JA, 2012, ECOL LETT, V15, P769, DOI 10.1111/j.1461-0248.2012.01796.x; Barberon M, 2016, CELL, V164, P447, DOI 10.1016/j.cell.2015.12.021; Bardgett RD, 2014, TRENDS ECOL EVOL, V29, P692, DOI 10.1016/j.tree.2014.10.006; Baxendale C, 2014, NEW PHYTOL, V204, P408, DOI 10.1111/nph.12915; Belkhadirl Y, 2014, TRENDS BIOCHEM SCI, V39, P447, DOI 10.1016/j.tibs.2014.06.006; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Besnard F, 2014, NATURE, V505, P417, DOI 10.1038/nature12791; Biere A, 2013, FUNCT ECOL, V27, P567, DOI 10.1111/1365-2435.12100; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Birnbaum K, 2005, NAT METHODS, V2, P615, DOI 10.1038/nmeth0805-615; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Blumenthal DM, 2006, ECOL LETT, V9, P887, DOI 10.1111/j.1461-0248.2006.00934.x; Box MS, 2015, CURR BIOL, V25, P194, DOI 10.1016/j.cub.2014.10.076; BRAY D, 1995, NATURE, V376, P307, DOI 10.1038/376307a0; Campos ML, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12570; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575; Claeys H, 2013, PLANT PHYSIOL, V162, P1768, DOI 10.1104/pp.113.220921; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Coen Enrico, 2012, CELLS CIVILIZATIONS; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Davies PJ., 2013, PLANT HORMONES PHYSL; de la Pena E, 2014, ECOL EVOL, V4, P3309, DOI 10.1002/ece3.1172; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; De Rybel B, 2014, SCIENCE, V345, DOI 10.1126/science.1255215; De Vleesschauwer D, 2013, TRENDS PLANT SCI, V18, P555, DOI 10.1016/j.tplants.2013.07.002; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Depuydt S, 2011, CURR BIOL, V21, pR365, DOI 10.1016/j.cub.2011.03.013; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Diaz S, 2016, NATURE, V529, P167, DOI 10.1038/nature16489; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Ding ZJ, 2011, NAT CELL BIOL, V13, P447, DOI 10.1038/ncb2208; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Djakovic-Petrovic T, 2007, PLANT J, V51, P117, DOI 10.1111/j.1365-313X.2007.03122.x; Domagalska MA, 2011, NAT REV MOL CELL BIO, V12, P211, DOI 10.1038/nrm3088; Dostal P, 2011, AM NAT, V177, P655, DOI 10.1086/659060; Fine PVA, 2006, ECOLOGY, V87, pS150, DOI 10.1890/0012-9658(2006)87[150:TGTAHS]2.0.CO;2; Fitzpatrick CR, 2015, ECOLOGY, V96, P2632, DOI [10.1890/14-2333.1.sm, 10.1890/14-2333.1]; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Franklin KA, 2011, P NATL ACAD SCI USA, V108, P20231, DOI 10.1073/pnas.1110682108; Freschet GT, 2015, NEW PHYTOL, V206, P1247, DOI 10.1111/nph.13352; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Geng Y, 2013, PLANT CELL, V25, P2132, DOI 10.1105/tpc.113.112896; Haga K, 2005, PLANT CELL, V17, P103, DOI 10.1105/tpc.104.028357; Harlan JR, 1992, CROPS MAN, V2nd; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hawkes CV, 2007, AM NAT, V170, P832, DOI 10.1086/522842; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; HERMS DA, 1992, Q REV BIOL, V67, P283, DOI 10.1086/417659; Heywood V.H., 2007, FLOWERING PLANTS WOR; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Julkowska MM, 2015, TRENDS PLANT SCI, V20, P586, DOI 10.1016/j.tplants.2015.06.008; Kaiserli E, 2015, DEV CELL, V35, P311, DOI 10.1016/j.devcel.2015.10.008; Karasov TL, 2014, NATURE, V512, P436, DOI 10.1038/nature13439; Kazan K, 2013, ANN BOT-LONDON, V112, P1655, DOI 10.1093/aob/mct229; Kellermeier F, 2014, PLANT CELL, V26, P1480, DOI 10.1105/tpc.113.122101; Kempel A, 2011, P NATL ACAD SCI USA, V108, P5685, DOI 10.1073/pnas.1016508108; Kostenko O., 2016, J ECOL; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Kumar SV, 2012, NATURE, V484, P242, DOI 10.1038/nature10928; Lambers H, 2008, TRENDS ECOL EVOL, V23, P95, DOI 10.1016/j.tree.2007.10.008; Lau JA, 2012, P NATL ACAD SCI USA, V109, P14058, DOI 10.1073/pnas.1202319109; Laughlin DC, 2014, J ECOL, V102, P186, DOI 10.1111/1365-2745.12187; Lavorel S, 2013, J VEG SCI, V24, P942, DOI 10.1111/jvs.12083; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Li L, 2012, GENE DEV, V26, P785, DOI 10.1101/gad.187849.112; Lozano-Duran R, 2013, ELIFE, V2, DOI 10.7554/eLife.00983; MAC ARTHUR ROBERT H., 1967; Machado RAR, 2015, NEW PHYTOL, V207, P91, DOI 10.1111/nph.13337; Mahonen AP, 2014, NATURE, V515, P125, DOI 10.1038/nature13663; Matsuzaki Y, 2010, SCIENCE, V329, P1065, DOI 10.1126/science.1191132; Meiners S.J., 2015, INTEGRATIVE APPROACH; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Mitra S, 2014, NEW PHYTOL, V201, P1385, DOI 10.1111/nph.12591; Mommer L, 2016, TRENDS PLANT SCI, V21, P209, DOI 10.1016/j.tplants.2016.01.009; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nieto C, 2015, CURR BIOL, V25, P187, DOI 10.1016/j.cub.2014.10.070; P Grime J., 2012, EVOLUTIONARY STRATEG, DOI [DOI 10.1002/9781118223246, 10.1002/9781118223246]; Patel D, 2013, PLANT J, V73, P980, DOI 10.1111/tpj.12088; Perez-Jaramillo JE, 2016, PLANT MOL BIOL, V90, P635, DOI 10.1007/s11103-015-0337-7; Perez-Torres CA, 2008, PLANT CELL, V20, P3258, DOI 10.1105/tpc.108.058719; Pierik R, 2014, PLANT PHYSIOL, V166, P5, DOI 10.1104/pp.114.239160; Pieterse CMJ, 2014, NEW PHYTOL, V204, P261, DOI 10.1111/nph.13029; Pieterse CMJ, 2014, ANNU REV PHYTOPATHOL, V52, P347, DOI 10.1146/annurev-phyto-082712-102340; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Poelman EH, 2008, MOL ECOL, V17, P3352, DOI 10.1111/j.1365-294X.2008.03838.x; Pozo MJ, 2007, CURR OPIN PLANT BIOL, V10, P393, DOI 10.1016/j.pbi.2007.05.004; Prusinkiewicz P, 2009, P NATL ACAD SCI USA, V106, P17431, DOI 10.1073/pnas.0906696106; Qu AL, 2013, BIOCHEM BIOPH RES CO, V432, P203, DOI 10.1016/j.bbrc.2013.01.104; Rasmann S, 2005, NATURE, V434, P732, DOI 10.1038/nature03451; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Rellan-Alvarez R, 2016, ANNU REV PLANT BIOL, V67, P619, DOI 10.1146/annurev-arplant-043015-111848; Rizzini L, 2011, SCIENCE, V332, P103, DOI 10.1126/science.1200660; Rodriguez E, 2016, FEBS J, V283, P1385, DOI 10.1111/febs.13613; Rohde A, 2007, TRENDS PLANT SCI, V12, P217, DOI 10.1016/j.tplants.2007.03.012; ROSENBLATT F, 1958, PSYCHOL REV, V65, P386, DOI 10.1037/h0042519; Santner A, 2009, NATURE, V459, P1071, DOI 10.1038/nature08122; Scheres B, 2007, NAT REV MOL CELL BIO, V8, P345, DOI 10.1038/nrm2164; Seabloom EW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8710; Searle IR, 2003, SCIENCE, V299, P109, DOI 10.1126/science.1077937; Shinohara H, 2016, P NATL ACAD SCI USA, V113, P3897, DOI 10.1073/pnas.1522639113; Shinohara N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001474; Smakowska E, 2016, CURR OPIN PLANT BIOL, V29, P129, DOI 10.1016/j.pbi.2015.12.005; Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Sun Y, 2010, DEV CELL, V19, P765, DOI 10.1016/j.devcel.2010.10.010; Tabata R, 2014, SCIENCE, V346, P343, DOI 10.1126/science.1257800; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; van Dam NM, 2011, J ECOL, V99, P77, DOI 10.1111/j.1365-2745.2010.01761.x; van der Heijden MGA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002378; Van Nuland ME, 2016, FUNCT ECOL, V30, P1032, DOI 10.1111/1365-2435.12690; van Velzen E, 2015, J THEOR BIOL, V372, P89, DOI 10.1016/j.jtbi.2015.02.027; Vitasse Y, 2013, OECOLOGIA, V171, P663, DOI 10.1007/s00442-012-2580-9; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; Wang RH, 2009, NATURE, V459, P423, DOI 10.1038/nature07988; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Wooliver R, 2016, FUNCT ECOL, V30, P1099, DOI 10.1111/1365-2435.12648; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996; Yoshida T, 2015, PLANT CELL ENVIRON, V38, P35, DOI 10.1111/pce.12351; Zhu DL, 2015, J MOL BIOL, V427, P659, DOI 10.1016/j.jmb.2014.08.025	138	63	67	8	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					337	345		10.1038/nature22010	http://dx.doi.org/10.1038/nature22010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28300110				2022-12-28	WOS:000396337400037
J	Xian, Y; O'Brien, EC; Liang, L; Xu, HL; Schwamm, LH; Fonarow, GC; Bhatt, DL; Smith, EE; Olson, DM; Maisch, L; Hannah, D; Lindholm, B; Lytle, BL; Pencina, MJ; Hernandez, AF; Peterson, ED				Xian, Ying; O'Brien, Emily C.; Liang, Li; Xu, Haolin; Schwamm, Lee H.; Fonarow, Gregg C.; Bhatt, Deepak L.; Smith, Eric E.; Olson, DaiWai M.; Maisch, Lesley; Hannah, Deidre; Lindholm, Brianna; Lytle, Barbara L.; Pencina, Michael J.; Hernandez, Adrian F.; Peterson, Eric D.			Association of Preceding Antithrombotic Treatment With Acute Ischemic Stroke Severity and In-Hospital Outcomes Among Patients With Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUIDELINES-STROKE; CENTERED RESEARCH; PATIENTS PREFER; PREDICTING STROKE; ELDERLY-PATIENTS; HIGH-RISK; WARFARIN; ANTICOAGULATION; PREVENTION; THERAPY	IMPORTANCE Antithrombotic therapies are known to prevent stroke for patients with atrial fibrillation (AF) but are often underused in community practice. OBJECTIVES To examine the prevalence of patients with acute ischemic stroke with known history of AF who were not receiving guideline-recommended antithrombotic treatment before stroke and to determine the association of preceding antithrombotic therapy with stroke severity and in-hospital outcomes. DESIGN, SETTING, AND PARTICIPANTS Retrospective observational study of 94 474 patients with acute ischemic stroke and known history of AF admitted from October 2012 through March 2015 to 1622 hospitals participating in the Get With the Guidelines-Stroke program. EXPOSURES Antithrombotic therapy before stroke. MAIN OUTCOMES AND MEASURES Stroke severity as measured by the National Institutes of Health Stroke Scale (NIHSS; range of 0-42, with a higher score indicating greater stroke severity and a score >= 16 indicating moderate or severe stroke), and in-hospital mortality. RESULTS Of 94 474 patients (mean [SD] age, 79.9 [11.0] years; 57.0% women), 7176 (7.6%) were receiving therapeuticwarfarin (international normalized ratio [INR] >= 2) and 8290(8.8%) were receiving non-vitamin K antagonist oral anticoagulants (NOACs) preceding the stroke. A total of 79 008patients (83.6%) were not receiving therapeutic anticoagulation; 12 751 (13.5%) had subtherapeuticwarfarin anticoagulation (INR <2) at the time of stroke, 37 674 (39.9%) were receiving antiplatelet therapy only, and 28 583 (30.3%) were not receiving any antithrombotic treatment. Among 91 155 high-risk patients (prestroke CHA(2)DS(2)-VASc score >= 2), 76071 (83.5%) were not receiving therapeuticwarfarin orNOACs before stroke. The unadjusted rates of moderate or severe stroke were lower among patients receiving therapeuticwarfarin (15.8% [95% CI, 14.8%-16.7%]) andNOACs (17.5%[95% CI, 16.6%-18.4%]) than among those receiving no antithrombotic therapy (27.1%[95% CI, 26.6%-27.7%]), antiplatelet therapy only (24.8%[95% CI, 24.3%-25.3%]), or subtherapeuticwarfarin (25.8% [95% CI, 25.0%-26.6%]); unadjusted rates of in-hospital mortality also were lower for those receiving therapeuticwarfarin (6.4%[95% CI, 5.8%-7.0%]) andNOACs (6.3%[95% CI, 5.7%-6.8%]) compared with those receiving no antithrombotic therapy (9.3%[95% CI, 8.9%-9.6%]), antiplatelet therapy only (8.1%[95% CI, 7.8%-8.3%]), or subtherapeuticwarfarin (8.8% [95% CI, 8.3%-9.3%]). After adjusting for potential confounders, compared with no antithrombotic treatment, preceding use of therapeuticwarfarin, NOACs, or antiplatelet therapy was associated with lower odds of moderate or severe stroke (adjusted odds ratio [95% CI], 0.56 [0.51-0.60], 0.65 [0.61-0.71], and 0.88 [0.84-0.92], respectively) and in-hospital mortality (adjusted odds ratio [95% CI], 0.75 [0.67-0.85], 0.79 [0.72-0.88], and 0.83 [0.78-0.88], respectively). CONCLUSIONS AND RELEVANCE Among patients with atrial fibrillation who had experienced an acute ischemic stroke, inadequate therapeutic anticoagulation preceding the stroke was prevalent. Therapeutic anticoagulation was associated with lower odds of moderate or severe stroke and lower odds of in-hospital mortality.	[Xian, Ying] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Xian, Ying; O'Brien, Emily C.; Liang, Li; Xu, Haolin; Lytle, Barbara L.; Pencina, Michael J.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Schwamm, Lee H.] Harvard Med Sch, Massachusetts Gen Hosp, Cambridge, MA USA; [Fonarow, Gregg C.] Univ Calif Los Angeles, Los Angeles, CA USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA USA; [Smith, Eric E.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Olson, DaiWai M.] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA	Duke University; Duke University; Harvard University; Massachusetts General Hospital; University of California System; University of California Los Angeles; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Calgary; University of Texas System; University of Texas Southwestern Medical Center Dallas	Xian, Y (corresponding author), Duke Clin Res Inst, Dept Neurol, 2400 Pratt St, Durham, NC 27705 USA.	ying.xian@duke.edu	Olson, DaiWai/I-5932-2019; Xian, Ying/O-1956-2019; Hernandez, Adrian F/A-7818-2016; Smith, Eric E/C-5443-2012; Fonarow, Gregg C/D-5988-2014; Peterson, Eric David/ABF-5033-2021	Olson, DaiWai/0000-0002-9280-078X; Hernandez, Adrian F/0000-0003-3387-9616; Smith, Eric E/0000-0003-3956-1668; Fonarow, Gregg C/0000-0002-3192-8093; Xu, Haolin/0000-0003-1069-9567; Xian, Ying/0000-0002-1237-1162	Patient-Centered Outcomes Research Institute [CE-1304-7073]; Alberta Innovates [201300690] Funding Source: researchfish	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); Alberta Innovates	This work was supported by award CE-1304-7073 from the Patient-Centered Outcomes Research Institute.	Adams HP, 1999, NEUROLOGY, V53, P126, DOI 10.1212/WNL.53.1.126; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dlott JS, 2014, CIRCULATION, V129, P1407, DOI 10.1161/CIRCULATIONAHA.113.002601; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garwood CL, 2008, ANN PHARMACOTHER, V42, P523, DOI 10.1345/aph.1K498; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hannah D, 2014, CIRC-CARDIOVASC QUAL, V7, P968, DOI 10.1161/CIRCOUTCOMES.114.001315; Hart RG, 2008, STROKE, V39, P1901, DOI 10.1161/STROKEAHA.107.501825; Hsu JC, 2016, J AM COLL CARDIOL, V67, P2913, DOI 10.1016/j.jacc.2016.03.581; Hylek EM, 2003, NEW ENGL J MED, V349, P1019, DOI 10.1056/NEJMoa022913; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Kooistra HAM, 2016, JAMA INTERN MED, V176, P1176, DOI 10.1001/jamainternmed.2016.3057; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Man-Son-Hing M, 1999, ARCH INTERN MED, V159, P677, DOI 10.1001/archinte.159.7.677; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; O'Brien EC, 2015, CIRCULATION, V132, P1404, DOI 10.1161/CIRCULATIONAHA.115.016183; O'Donnell M, 2006, LANCET NEUROL, V5, P749, DOI 10.1016/S1474-4422(06)70536-1; Ogilvie IM, 2010, AM J MED, V123, P638, DOI 10.1016/j.amjmed.2009.11.025; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Reeves MJ, 2012, STROKE, V43, P44, DOI 10.1161/STROKEAHA.111.626978; Schwamm LH, 2009, CIRCULATION, V119, P107, DOI 10.1161/CIRCULATIONAHA.108.783688; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Waldo AL, 2005, J AM COLL CARDIOL, V46, P1729, DOI 10.1016/j.jacc.2005.06.077; Xian Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3786; Xian Y, 2015, AM HEART J, V170, P36, DOI 10.1016/j.ahj.2015.04.008; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012	34	128	130	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1057	1067		10.1001/jama.2017.1371	http://dx.doi.org/10.1001/jama.2017.1371			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291892				2022-12-28	WOS:000396713400018
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2017: Primary Care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2017	356								j1249	10.1136/bmj.j1249	http://dx.doi.org/10.1136/bmj.j1249			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NF	28288982				2022-12-28	WOS:000397014700004
J	Salam, AP; Rojek, A; Dunning, J; Horby, PW				Salam, Alex P.; Rojek, Amanda; Dunning, Jake; Horby, Peter W.			Clinical Trials of Therapeutics for the Prevention of Congenital Zika Virus Disease: Challenges and Potential Solutions	ANNALS OF INTERNAL MEDICINE			English	Article							BRAIN-DEVELOPMENT; CYTOMEGALOVIRUS-INFECTION; PREGNANT-WOMEN; IDENTIFICATION; IMMUNIZATION; ACTIVATION; INHIBITORS; PERFUSION; IMMUNITY; OUTCOMES	Zika virus (ZIKV) infection in pregnancy is associated with adverse fetal outcomes, such as microcephaly and other congenital malformations. No therapeutic options are available to pregnant women with ZIKV infection to prevent these effects. Drug trials in pregnancy raise several scientific, ethical, and logistic challenges, which are compounded further in ZIKV because of limited knowledge of the disease pathophysiology and a product development pipeline in its infancy. We evaluate the major challenges in choosing therapeutics to prevent congenital ZIKV disease and conducting clinical trials of these treatments, with a focus on preventing congenital central nervous system malformations. These challenges must be characterized and planned for now so that clinical trials can progress expediently and effectively in the future.	Univ Oxford, Oxford, England; [Salam, Alex P.; Rojek, Amanda; Dunning, Jake; Horby, Peter W.] Univ Oxford, Nuffield Dept Med Res Bldg, Ctr Trop Med & Global Hlth, Epidem Dis Res Grp Oxford, Old Rd Campus,Roosevelt Dr, Oxford OX3 7FZ, England	University of Oxford; University of Oxford	Salam, AP (corresponding author), Univ Oxford, Nuffield Dept Med Res Bldg, Ctr Trop Med & Global Hlth, Epidem Dis Res Grp Oxford, Old Rd Campus,Roosevelt Dr, Oxford OX3 7FZ, England.	alexsalam@doctors.org.uk	Dunning, Jake/U-7181-2019	Dunning, Jake/0000-0002-4035-4562; Horby, Peter/0000-0002-9822-1586; Rojek, Amanda/0000-0002-3948-0756	Wellcome Trust of Great Britain [107834/Z/15/Z, 106491/Z/14/Z]; European Union FP7 project PREPARE (Platform for European Preparedness Against [Re-]emerging Epidemics) [602525]; Medical Research Council UK [MC_PC_15001]; Rhodes Scholarship	Wellcome Trust of Great Britain(Wellcome Trust); European Union FP7 project PREPARE (Platform for European Preparedness Against [Re-]emerging Epidemics); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rhodes Scholarship	Peter Horby is supported by the Wellcome Trust of Great Britain (grants 107834/Z/15/Z and 106491/Z/14/Z), European Union FP7 project PREPARE (Platform for European Preparedness Against [Re-]emerging Epidemics; grant 602525), and Medical Research Council UK (MC_PC_15001). Dr. Rojek is funded by a Rhodes Scholarship.	Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772; Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4; Ala-Kokko TI, 2000, INT J OBSTET ANESTH, V9, P26, DOI 10.1054/ijoa.1999.0312; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004; BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709; Ben-Hur H, 2005, INT J MOL MED, V16, P401; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Carty M, 2014, TRENDS IMMUNOL, V35, P79, DOI 10.1016/j.it.2013.10.012; Casadevall A, 2003, TRENDS IMMUNOL, V24, P474, DOI 10.1016/S1471-4906(03)00228-X; Centers for Disease Prevention and Control Division of Vector-Borne Diseases, 2016, REV DIAGN TEST ZIK C; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Costantine MM, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00065; Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990; Custer DA, 2000, J DEV BEHAV PEDIATR, V21, P12, DOI 10.1097/00004703-200002000-00003; Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Delorme-Axford E, 2013, AUTOPHAGY, V9, P2173, DOI 10.4161/auto.26558; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1; Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618; Gilmore EC, 2013, WIRES DEV BIOL, V2, P461, DOI 10.1002/wdev.89; Griffiths SK, 2015, BJA EDUC, V15, P84, DOI 10.1093/bjaceaccp/mku013; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x; Hutson JR, 2011, CLIN PHARMACOL THER, V90, P67, DOI 10.1038/clpt.2011.66; Ilekis JV, 2016, AM J OBSTET GYNECOL, V215, pS1, DOI 10.1016/j.ajog.2016.03.001; Ji R, 2013, J IMMUNOL, V191, P6165, DOI 10.4049/jimmunol.1302229; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Keller MA, 2000, CLIN MICROBIOL REV, V13, P602, DOI 10.1128/CMR.13.4.602-614.2000; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88; Lazzarotto T, 2000, J PEDIATR-US, V137, P90, DOI 10.1067/mpd.2000.107110; Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; MANKARIOUS S, 1988, J LAB CLIN MED, V112, P634; Marin M, 2013, MMWR-MORBID MORTAL W, V62, P574; McLean HQ, 2015, MMWR-MORBID MORTAL W, V64, P259; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; Nigro G, 2012, J INFECT DIS, V205, P215, DOI 10.1093/infdis/jir718; Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Pierce AM, 2014, BRAIN RES, V1542, P206, DOI 10.1016/j.brainres.2013.10.049; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Rasmussen SA, 2014, CLIN INFECT DIS, V59, pS428, DOI 10.1093/cid/ciu738; Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Robinson DP, 2012, HORM BEHAV, V62, P263, DOI 10.1016/j.yhbeh.2012.02.023; Sacramento CQ, 2016, CLIN APPROVED ANTIVI; Schachter AD, 2011, REPROD TOXICOL, V31, P562, DOI 10.1016/j.reprotox.2010.11.008; SELLS CJ, 1977, PEDIATRICS, V59, P262; Sheffield JS, 2014, CLIN INFECT DIS, V59, pS437, DOI 10.1093/cid/ciu709; Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1; Situation Report, 2016, SIT REP ZIK VIR MICR; Solozobova V, 2012, STEM CELL REV REP, V8, P813, DOI 10.1007/s12015-012-9381-8; Stricker RB., 2002, CLIN APPL IMMUNOL RE, V2, P187; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Teixeira MG, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002520; Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901; Visentin S, 2012, CLIN INFECT DIS, V55, P497, DOI 10.1093/cid/cis423; WHO, 2016, SCREEN ASS MAN NEON; World Health Organization, 2016, ZIK STRAT RESP FRAM; Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184; Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695	69	5	6	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					725	+		10.7326/M16-2530	http://dx.doi.org/10.7326/M16-2530			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU7UM	28319995				2022-12-28	WOS:000401240200016
J	Khodadoust, MS; Olsson, N; Wagar, LE; Haabeth, OAW; Chen, BB; Swaminathan, K; Rawson, K; Liu, CL; Steiner, D; Lund, P; Rao, S; Zhang, LC; Marceau, C; Stehr, H; Newman, AM; Czerwinski, DK; Carlton, VEH; Moorhead, M; Faham, M; Kohrt, HE; Carette, J; Green, MR; Davis, MM; Levy, R; Elias, JE; Alizadeh, AA				Khodadoust, Michael S.; Olsson, Niclas; Wagar, Lisa E.; Haabeth, Ole A. W.; Chen, Binbin; Swaminathan, Kavya; Rawson, Keith; Liu, Chih Long; Steiner, David; Lund, Peder; Rao, Samhita; Zhang, Lichao; Marceau, Caleb; Stehr, Henning; Newman, Aaron M.; Czerwinski, Debra K.; Carlton, Victoria E. H.; Moorhead, Martin; Faham, Malek; Kohrt, Holbrook E.; Carette, Jan; Green, Michael R.; Davis, Mark M.; Levy, Ronald; Elias, Joshua E.; Alizadeh, Ash A.			Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens	NATURE			English	Article							MANTLE CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; CD4(+) T-CELLS; FOLLICULAR LYMPHOMA; MASS-SPECTROMETRY; IMMUNE-RESPONSES; SOMATIC MUTATIONS; SEQUENCING DATA; HUMAN-MELANOMA; NEO-ANTIGENS	Cancer somatic mutations can generate neoantigens that distinguish malignant from normal cells(1-7). However, the personalized identification and validation of neoantigens remains a major challenge. Here we discover neoantigens in human mantle-cell lymphomas by using an integrated genomic and proteomic strategy that interrogates tumour antigen peptides presented by major histocompatibility complex (MHC) class I and class II molecules. We applied this approach to systematically characterize MHC ligands from 17 patients. Remarkably, all discovered neoantigenic peptides were exclusively derived from the lymphoma immunoglobulin heavy-or light-chain variable regions. Although we identified MHC presentation of private polymorphic germline alleles, no mutated peptides were recovered from non-immunoglobulin somatically mutated genes. Somatic mutations within the immunoglobulin variable region were almost exclusively presented by MHC class II. We isolated circulating CD4(+) T cells specific for immunoglobulin-derived neoantigens and found these cells could mediate killing of autologous lymphoma cells. These results demonstrate that an integrative approach combining MHC isolation, peptide identification, and exome sequencing is an effective platform to uncover tumour neoantigens. Application of this strategy to human lymphoma implicates immunoglobulin neoantigens as targets for lymphoma immunotherapy.	[Khodadoust, Michael S.; Haabeth, Ole A. W.; Chen, Binbin; Liu, Chih Long; Stehr, Henning; Newman, Aaron M.; Czerwinski, Debra K.; Kohrt, Holbrook E.; Green, Michael R.; Levy, Ronald; Alizadeh, Ash A.] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Olsson, Niclas; Swaminathan, Kavya; Rawson, Keith; Rao, Samhita; Zhang, Lichao; Elias, Joshua E.] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Wagar, Lisa E.; Lund, Peder; Marceau, Caleb; Carette, Jan; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Chen, Binbin] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Steiner, David] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Newman, Aaron M.; Alizadeh, Ash A.] Stanford Univ, Ctr Canc Syst Biol, Stanford, CA 94305 USA; [Carlton, Victoria E. H.; Moorhead, Martin; Faham, Malek] Adapt Biotechnol, San Francisco, CA 94080 USA; [Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Alizadeh, Ash A.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Green, Michael R.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; University of Nebraska System; University of Nebraska Medical Center	Alizadeh, AA (corresponding author), Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA.; Elias, JE (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Alizadeh, AA (corresponding author), Stanford Univ, Ctr Canc Syst Biol, Stanford, CA 94305 USA.; Alizadeh, AA (corresponding author), Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	josh.elias@stanford.edu; arasha@stanford.edu	Newman, Aaron M/ABE-1620-2021; Khodadoust, Michael/K-7764-2019; Khodadoust, Michael/AAU-3936-2020; Alizadeh, Ash A/C-5594-2009	Newman, Aaron M/0000-0002-1857-8172; Khodadoust, Michael/0000-0001-9061-7351; Khodadoust, Michael/0000-0001-9061-7351; Alizadeh, Ash A/0000-0002-5153-5625; Levy, Ronald/0000-0003-2061-0650; Olsson, Niclas/0000-0002-9746-0542; Carette, Jan/0000-0002-5187-8070; Haabeth, Ole Audun Werner/0000-0002-1153-9250; Wagar, Lisa/0000-0001-5980-3586; Davis, Mark/0000-0001-6868-657X; Swaminathan, Kavya/0000-0001-7715-5375; Chen, Binbin/0000-0003-2973-2718	National Institutes of Health (NIH) [U01 CA194389]; NIH PPG [CA49605]; American Society of Hematology Scholar Award; V-Foundation; Damon Runyon Cancer Research Foundation; Damon Runyon-Rachleff Innovation Award; W.M. Keck Foundation Medical Research Grant; Conquer Cancer Foundation Young Investigator Award; Leukemia & Lymphoma Society; Knut and Alice Wallenberg Foundation Postdoctoral Fellowship; Stanford Translational Research and Applied Medicine Pilot Grant; NIH [S10 RR02933801]; NATIONAL CANCER INSTITUTE [U01CA194389, T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH PPG(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Hematology Scholar Award; V-Foundation; Damon Runyon Cancer Research Foundation; Damon Runyon-Rachleff Innovation Award; W.M. Keck Foundation Medical Research Grant; Conquer Cancer Foundation Young Investigator Award; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); Knut and Alice Wallenberg Foundation Postdoctoral Fellowship; Stanford Translational Research and Applied Medicine Pilot Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to the patients and their families who participated in this study, as well as to M. Diehn, S. Levy, and members of their laboratories for feedback. This work was supported by the following grants: National Institutes of Health (NIH) U01 CA194389 (M.M.D., R.L., J.E.E., A. A. A.), NIH PPG CA49605 (R.L.); American Society of Hematology Scholar Award (A. A. A.), V-Foundation (A. A. A.), Damon Runyon Cancer Research Foundation (A. A. A.); Damon Runyon-Rachleff Innovation Award (J.E.E.), W.M. Keck Foundation Medical Research Grant (J.E.E.); Conquer Cancer Foundation Young Investigator Award (M.S.K.), Fellow Award from the Leukemia & Lymphoma Society (M.S.K.); Knut and Alice Wallenberg Foundation Postdoctoral Fellowship (N.O.); Stanford Translational Research and Applied Medicine Pilot Grant (M.R.G., H.E.K., and A. A. A.); NIH S10 RR02933801. We thank the NIH Tetramer Facility for providing recombinant HLA-A0201 for tetramer experiments.	Bai Y, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-325; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Bea S, 2014, BLOOD, V123, P1979, DOI 10.1182/blood-2014-02-553057; Bea S, 2013, P NATL ACAD SCI USA, V110, P18250, DOI 10.1073/pnas.1314608110; Berlin C, 2015, LEUKEMIA, V29, P647, DOI 10.1038/leu.2014.233; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Day CL, 2003, J CLIN INVEST, V112, P831, DOI 10.1172/JCI200318509; Dutoit V, 2012, BRAIN, V135, P1042, DOI 10.1093/brain/aws042; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Freedman A, 2009, J CLIN ONCOL, V27, P3036, DOI 10.1200/JCO.2008.19.8903; Gilar M, 2005, ANAL CHEM, V77, P6426, DOI 10.1021/ac050923i; Green MR, 2015, P NATL ACAD SCI USA, V112, pE1116, DOI 10.1073/pnas.1501199112; Green MR, 2013, BLOOD, V121, P1604, DOI 10.1182/blood-2012-09-457283; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Kalaora S, 2016, ONCOTARGET, V7, P5110, DOI 10.18632/oncotarget.6960; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Khodadoust MS, 2014, IMMUNOL RES, V58, P292, DOI 10.1007/s12026-014-8505-4; Kirsch IR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9122; Koboldt D. C., 2013, CURR PROTOC BIOINFOR, V44; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kowalewski DJ, 2015, P NATL ACAD SCI USA, V112, pE166, DOI 10.1073/pnas.1416389112; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Kridel R, 2012, BLOOD, V119, P1963, DOI 10.1182/blood-2011-11-391474; KWAK LW, 1992, NEW ENGL J MED, V327, P1209, DOI 10.1056/NEJM199210223271705; LAMPSON LA, 1980, J IMMUNOL, V125, P293; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Levy R, 2014, J CLIN ONCOL, V32, P1797, DOI 10.1200/JCO.2012.43.9273; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Linnemann C, 2015, NAT MED, V21, P81, DOI 10.1038/nm.3773; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; Neelapu SS, 2005, NAT MED, V11, P986, DOI 10.1038/nm1290; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nielsen M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000796; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Rajasagi M, 2014, BLOOD, V124, P453, DOI 10.1182/blood-2014-04-567933; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Schuster SJ, 2011, J CLIN ONCOL, V29, P2787, DOI 10.1200/JCO.2010.33.3005; Strothmeyer AM, 2010, BLOOD, V116, P1734, DOI 10.1182/blood-2010-02-270199; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Trojan A, 2000, NAT MED, V6, P667, DOI 10.1038/76243; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938; Walz S, 2015, BLOOD, V126, P1203, DOI 10.1182/blood-2015-04-640532; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang YX, 2011, PROTEOMICS, V11, P2019, DOI 10.1002/pmic.201000722; Wisniewski JR, 2014, MOL CELL PROTEOMICS, V13, P3497, DOI 10.1074/mcp.M113.037309; Yadav M, 2014, NATURE, V515, P572, DOI 10.1038/nature14001; Zangani MM, 2007, J EXP MED, V204, P1181, DOI 10.1084/jem.20061220; Zhang J, 2014, BLOOD, V123, P2988, DOI 10.1182/blood-2013-07-517177; Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI [10.1074/mcp.M111.010587, 10.1074/mcp.M111.015032]	63	158	159	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					723	+		10.1038/nature21433	http://dx.doi.org/10.1038/nature21433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28329770	Green Accepted			2022-12-28	WOS:000397619700057
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2017: Palliative and Hospice Care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											No Org, London, England.	nigel.hawkes1@btinternet.com			Marie Curie; Hospice UK	Marie Curie(European Commission); Hospice UK	The Palliative and Hospice Care Team of the Year award is sponsored by Marie Curie and Hospice UK. The awards ceremony takes place on 4 May at the Park Plaza Hotel, Westminster. To find out more go to thebmjawards.bmj.com.		0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2017	356								j1563	10.1136/bmj.j1563	http://dx.doi.org/10.1136/bmj.j1563			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4DL	28351892				2022-12-28	WOS:000398024200009
J	Chaiyachati, KH; Asch, DA; Grande, DT				Chaiyachati, Krisda H.; Asch, David A.; Grande, David T.			Patient Inducements - High Graft or High Value?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chaiyachati, Krisda H.; Asch, David A.; Grande, David T.] Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA; [Chaiyachati, Krisda H.; Asch, David A.] Cpl Michael J Crescent Vet Affairs Med Ctr, Philadelphia, PA 19104 USA	Robert Wood Johnson Foundation (RWJF); University of Pennsylvania	Chaiyachati, KH (corresponding author), Univ Penn, Robert Wood Johnson Fdn, Clin Scholars Program, Philadelphia, PA 19104 USA.; Chaiyachati, KH (corresponding author), Cpl Michael J Crescent Vet Affairs Med Ctr, Philadelphia, PA 19104 USA.		Grande, David/AAJ-8191-2021	Grande, David/0000-0002-6717-6735; Chaiyachati, Krisda/0000-0003-3326-6641; Asch, David/0000-0002-7970-286X				Asch DA, 2016, NEW ENGL J MED, V374, P606, DOI 10.1056/NEJMp1512297; Asch DA, 2015, JAMA-J AM MED ASSOC, V314, P1926, DOI 10.1001/jama.2015.14850; Dafny LS, 2016, NEW ENGL J MED, V375, P2013, DOI 10.1056/NEJMp1607378; Powers BW, 2016, JAMA-J AM MED ASSOC, V316, P921, DOI 10.1001/jama.2016.9970	4	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1107	1109		10.1056/NEJMp1613274	http://dx.doi.org/10.1056/NEJMp1613274			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28328335				2022-12-28	WOS:000397014300006
J	Mitchell, F				Mitchell, Fiona			Profile: Centre for Clinical Brain Sciences, Edinburgh, UK	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1090	1090						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28322810				2022-12-28	WOS:000396408700012
J	Haynes, BF; Burton, DR				Haynes, Barton F.; Burton, Dennis R.			HIV Developing an HIV vaccine What are the paths and obstacles to a practical vaccine?	SCIENCE			English	Editorial Material							BROADLY NEUTRALIZING ANTIBODIES; IG KNOCKIN MICE; DESIGN; INFECTION		[Haynes, Barton F.] Duke Univ, Sch Med, Duke Human Vaccine Inst, Duke Ctr HIV AIDS Vaccine Immunol Immunogen Disco, Durham, NC 27708 USA; [Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, Scripps Ctr HIV AIDS Vaccine Immunol Immunogen Di, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA USA	Duke University; International AIDS Vaccine Initiative; Scripps Research Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Haynes, BF (corresponding author), Duke Univ, Sch Med, Duke Human Vaccine Inst, Duke Ctr HIV AIDS Vaccine Immunol Immunogen Disco, Durham, NC 27708 USA.	barton.haynes@duke.edu; burton@scripps.edu			National Institute of Allergy and Infectious Diseases; Division of AIDS, the Centers for HIV/AIDS Vaccine Immunology-Immunogen Discovery Grants at Duke School of Medicine, Durham, NC [AI000645]; Scripps Research Institute, La Jolla, CA [AI 100663]; Bill & Melinda Gates Foundation; Collaboration for AIDS Vaccine Discovery Grants [OPP52282, OPP1114721, OPP1094352, OPP1084519]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI100645, UM1AI100663, Z01AI000645] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of AIDS, the Centers for HIV/AIDS Vaccine Immunology-Immunogen Discovery Grants at Duke School of Medicine, Durham, NC; Scripps Research Institute, La Jolla, CA; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Collaboration for AIDS Vaccine Discovery Grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases, the Division of AIDS, the Centers for HIV/AIDS Vaccine Immunology-Immunogen Discovery Grants at Duke School of Medicine, Durham, NC (AI000645) and at The Scripps Research Institute, La Jolla, CA (AI 100663); and the Bill & Melinda Gates Foundation with Collaboration for AIDS Vaccine Discovery Grants OPP52282, OPP1114721, and OPP1094352 to B.F.H., and OPP1084519 to D.R.B. Many important references were not cited because of space limitations. See the supplementary materials for additional references.	Bonsignori M, 2017, IMMUNOL REV, V275, P145, DOI [10., 10.1111/imr.12509]; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Corey L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7732; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Hansen SG, 2013, SCIENCE, V340, P940, DOI 10.1126/science.1237874; Havenar-Daughton C, 2017, IMMUNOL REV, V275, P49, DOI 10.1111/imr.12512; Haynes BF, 2016, CELL HOST MICROBE, V19, P292, DOI 10.1016/j.chom.2016.02.002; Kelsoe G, 2017, IMMUNOL REV, V275, P79, DOI 10.1111/imr.12508; Li H, 2016, P NATL ACAD SCI USA, V113, pE3413, DOI 10.1073/pnas.1606636113; McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484; Sanders RW, 2017, IMMUNOL REV, V275, P161, DOI 10.1111/imr.12481; Stephenson KE, 2016, CURR OPIN IMMUNOL, V41, P39, DOI 10.1016/j.coi.2016.05.011; Verkoczy L, 2017, IMMUNOL REV, V275, P89, DOI 10.1111/imr.12505; Ward AB, 2017, IMMUNOL REV, V275, P21, DOI 10.1111/imr.12507	15	60	63	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1129	1130		10.1126/science.aan0662	http://dx.doi.org/10.1126/science.aan0662			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302812	Green Accepted			2022-12-28	WOS:000396351200022
J	Rizwan, SB; Vernall, AJ				Rizwan, Shakila B.; Vernall, Andrea J.			To prohibit or regulate psychoactive substances: has New Zealand got the right approach?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rizwan, Shakila B.; Vernall, Andrea J.] Univ Otago, Sch Pharm, Dunedin, New Zealand	University of Otago	Rizwan, SB (corresponding author), Univ Otago, Sch Pharm, Dunedin, New Zealand.	shakila.rizwan@otago.ac.nz		Shakila, Rizwan/0000-0001-5099-4443; Vernall, Andrea/0000-0001-8056-0726				[Anonymous], 2013, PREVENTION PROTECTIO; Buchanan RT, 2015, INDEPENDENT; Clayton R., 2016, STUFF; Coulson C, 2012, ADDICTION, V107, P766, DOI 10.1111/j.1360-0443.2011.03697.x; Domoslawski A, 2011, DRUG POLICY PORTUGAL; Fisher H., HIGH HOPES; Glue P, 2015, NEW ZEAL MED J, V128, P15; Glue P, 2013, NEW ZEAL MED J, V126, P18; Greenwald G, 2009, CATO I WHITEPAPER SE, DOI DOI 10.2139/SSRN.1464837; Hess C, 2016, FORENSIC TOXICOL, V34, P329, DOI 10.1007/s11419-016-0320-2; Hughes CE, 2012, DRUG ALCOHOL REV, V31, P101, DOI 10.1111/j.1465-3362.2011.00383.x; Irish Parliament. Oireachtas Joint Committee on Justice DaE, 2015, REP HARM RED REH APP; Kikura-Hanajiri R, 2014, DRUG TEST ANAL, V6, P832, DOI 10.1002/dta.1584; O'Keeffe C, 2015, IRISH EXAMINER  1105; Parrott AC, 2004, PSYCHOPHARMACOLOGY, V173, P234, DOI 10.1007/s00213-003-1712-7; Psychoactive Substances Regulatory Authority, 2016, FULL LIC; Psychoactive Substances Regulatory Authority, 2013, PSYCH SUBST; Roudik P, 2016, DECRIMINALIZATION NA; Sheridan J, 2007, DRUG ALCOHOL REV, V26, P335, DOI 10.1080/09595230701255791; Stevens A., 2016, MOUVEMENTS, V2016, P22; Swist M, 2005, FORENSIC SCI INT, V152, P175, DOI 10.1016/j.forsciint.2004.08.003; Travis A, 2015, GUARDIAN; UNODC, 2016, WORLD DRUG REPORT 20; Wilkins C, 2013, DRUG ALCOHOL DEPEN, V127, P72, DOI 10.1016/j.drugalcdep.2012.06.014; Wilkins C, 2008, DRUG ALCOHOL REV, V27, P633, DOI 10.1080/09595230801956140	25	5	5	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2017	356								j1195	10.1136/bmj.j1195	http://dx.doi.org/10.1136/bmj.j1195			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NR	28314708				2022-12-28	WOS:000397015900006
J	Han, T; Goralski, M; Gaskill, N; Capota, E; Kim, J; Ting, TC; Xie, Y; Williams, NS; Nijhawan, D				Han, Ting; Goralski, Maria; Gaskill, Nicholas; Capota, Emanuela; Kim, Jiwoong; Ting, Tabitha C.; Xie, Yang; Williams, Noelle S.; Nijhawan, Deepak			Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15	SCIENCE			English	Article							CELL LUNG-CANCER; SODIUM LY573636 SODIUM; EVERY 3 WEEKS; PHASE-I; SOLID TUMORS; CHLOROQUINOXALINE SULFONAMIDE; UBIQUITIN LIGASE; NEDD8-ACTIVATING ENZYME; METASTATIC MELANOMA; CYCLE INHIBITOR		[Han, Ting; Williams, Noelle S.; Nijhawan, Deepak] Univ Texas Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Goralski, Maria; Gaskill, Nicholas; Capota, Emanuela; Nijhawan, Deepak] Univ Texas Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; [Kim, Jiwoong; Xie, Yang] Univ Texas Southwestern Med Ctr, Dept Clin Sci, Quantitat Biomed Res Ctr, Dallas, TX 75390 USA; [Kim, Jiwoong; Xie, Yang; Williams, Noelle S.; Nijhawan, Deepak] Univ Texas Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Ting, Tabitha C.] Univ Texas Southwestern Med Ctr, Med Scientist Training Program, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Nijhawan, D (corresponding author), Univ Texas Southwestern Med Ctr, Dept Biochem, Dallas, TX 75390 USA.; Nijhawan, D (corresponding author), Univ Texas Southwestern Med Ctr, Dept Internal Med, Dallas, TX 75390 USA.; Nijhawan, D (corresponding author), Univ Texas Southwestern Med Ctr, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.	deepak.nijhawan@utsouthwestern.edu		Williams, Noelle/0000-0003-1894-5742; Ting, Tabitha/0000-0001-5206-9243; Han, Ting/0000-0003-3168-8699	Cancer Prevention and Research Institute of Texas [RP150596]; Harold C. Simmons Cancer Center Startup Award; Disease-Oriented Clinical Scholar award; Damon Runyon Clinical Investigator award [CI-68-13]; Welch Foundation [I-1879]	Cancer Prevention and Research Institute of Texas; Harold C. Simmons Cancer Center Startup Award; Disease-Oriented Clinical Scholar award; Damon Runyon Clinical Investigator award; Welch Foundation(The Welch Foundation)	We thank J. Ready, S. McKnight, and M. Brown for critically evaluating our manuscript. We thank S. Elledge for suggesting the use of MLN4924 as a tool compound, B. Kaelin for providing the His-tagged ubiquitin construct, and D. McFadden for providing a plasmid containing the TIR1 sequence. R. Tomaino and colleagues at the Harvard Medical School Taplin Mass Spectrometry Facility performed shotgun mass spectrometry on RBM39-bound proteins. We are grateful to J. McKnight, who provided assistance in cloning RBM39 repair templates; K. Klein for support with Sf9 cell culture; Z. Otwinowski, who confirmed the presence of RBM39 mutations through an independent analysis of whole-exome sequencing data; and U. Tambar and P. Le for synthesizing and providing indisulam. CQS (NSC 339004) was obtained from the National Cancer Institute (NCI), Division of Cancer Treatment and Diagnosis, Developmental Therapeutics Program. T.H. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. J. K. is supported by the Cancer Prevention and Research Institute of Texas (grant RP150596). D.N. is supported by a Harold C. Simmons Cancer Center Startup Award, a Disease-Oriented Clinical Scholar award, a Damon Runyon Clinical Investigator award (CI-68-13), and a grant from the Welch Foundation (I-1879). The University of Texas Southwestern Medical Center and the authors (D.N., T.H., and N.G.) have filed a patent application (U. S. Provisional Patent Application no. 62/425,732) related to the use of tasisulam, CQS, or indisulam in cancer patients whose tumors harbor mutations in splicing factors or express DCAF15. Exome-sequencing and RNA-sequencing data from this study have been deposited at the National Center for Biotechnology Information Sequence Read Archive under accession numbers SRP068238 and SRP096666. T.H. designed the study, executed experiments, made the figures, and wrote the manuscript. M.G. performed the initial HCT-116 screen and the validation experiments. N.G. purified RBM39 complex, leading to the discovery of DCAF15 as the substrate receptor for RBM39 (Figs. 2D, 3E, and 4A). E.C. expressed and purified recombinant RBM39D150 protein. J. K. and Y.X. performed bioinformatics analyses of exome sequencing and RNA sequencing. T.C.T. expressed and purified DDB1-DCAF15 and performed gel filtration analysis of DDB1-DCAF15-RBM39 complex (fig. S9). N.S.W. performed the mouse xenograft experiment (Fig. 1H) and mass spectrometry quantification of indisulam (Fig. 4D). D.N. designed and supervised the study, performed correlation analysis of indisulam sensitivity with basal gene expression and copy number variation, and wrote the manuscript.	Abbate F, 2004, BIOORG MED CHEM LETT, V14, P217, DOI 10.1016/j.bmcl.2003.09.062; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; Bekaii-Saab TS, 2006, INVEST NEW DRUG, V24, P343, DOI 10.1007/s10637-005-4827-3; Dittrich C, 2003, CLIN CANCER RES, V9, P5195; Domanski M., 2012, BIOTECHNIQUES, DOI [10.2144/000113864, DOI 10.2144/000113864(2012).]; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fukuoka K, 2001, INVEST NEW DRUG, V19, P219, DOI 10.1023/A:1010608317361; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Haddad RI, 2004, CLIN CANCER RES, V10, P4680, DOI 10.1158/1078-0432.CCR-04-0229; Han T, 2016, NAT CHEM BIOL, V12, P511, DOI [10.1038/NCHEMBIO.2082, 10.1038/nchembio.2082]; Haritunians T, 2008, ONCOL REP, V20, P1237, DOI 10.3892/or_00000135; IMAI H, 1993, J CLIN INVEST, V92, P2419, DOI 10.1172/JCI116848; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirkwood JM, 2011, CANCER-AM CANCER SOC, V117, P4732, DOI 10.1002/cncr.26068; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; LaCava J, 2015, BIOTECHNIQUES, V58, P103, DOI 10.2144/000114262; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; Miller VA, 1997, CANCER CHEMOTH PHARM, V40, P415, DOI 10.1007/s002800050679; Natsume T, 2016, CELL REP, V15, P210, DOI 10.1016/j.celrep.2016.03.001; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Owa T, 1999, J MED CHEM, V42, P3789, DOI 10.1021/jm9902638; Ozawa Y, 2001, EUR J CANCER, V37, P2275, DOI 10.1016/S0959-8049(01)00275-1; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Peng JM, 2001, J MASS SPECTROM, V36, P1083, DOI 10.1002/jms.229; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Petzold G., 2016, NATURE, V532, P127, DOI DOI 10.1038/NATURE16979;PMID:26909574; Punt CJA, 2001, ANN ONCOL, V12, P1289, DOI 10.1023/A:1012287111922; Raymond E, 2002, J CLIN ONCOL, V20, P3508, DOI 10.1200/JCO.2002.09.030; Rees MG, 2016, NAT CHEM BIOL, V12, P109, DOI [10.1038/NCHEMBIO.1986, 10.1038/nchembio.1986]; RIGAS JR, 1992, CANCER RES, V52, P6619; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Simon GR, 2011, CANCER CHEMOTH PHARM, V68, P1233, DOI 10.1007/s00280-011-1593-0; Smyth JF, 2005, ANN ONCOL, V16, P158, DOI 10.1093/annonc/mdi016; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Talbot DC, 2007, CLIN CANCER RES, V13, P1816, DOI 10.1158/1078-0432.CCR-06-0249; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Terret C, 2003, EUR J CANCER, V39, P1097, DOI 10.1016/S0959-8049(03)00128-X; Toth JI, 2012, CELL REP, V1, P309, DOI 10.1016/j.celrep.2012.02.006; Wacker SA, 2012, NAT CHEM BIOL, V8, P235, DOI [10.1038/NCHEMBIO.779, 10.1038/nchembio.779]; Yamada Y, 2005, CANCER SCI, V96, P721, DOI 10.1111/j.1349-7006.2005.00109.x; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780	53	272	278	11	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2017	356	6336							eaal3755	10.1126/science.aal3755	http://dx.doi.org/10.1126/science.aal3755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET2YU	28302793				2022-12-28	WOS:000400143000044
J	Miall, L; Darling, J; Harrison, C				Miall, Lawrence; Darling, Jonathan; Harrison, Catherine			Simon J Newell OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item													Darling, Jonathan C/A-6288-2012	Darling, Jonathan C/0000-0001-7176-5957; Harrison, Cath/0000-0003-4268-4562				NEWELL SJ, PUBLICATION LIST, P62659	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2017	356								j1519	10.1136/bmj.j1519	http://dx.doi.org/10.1136/bmj.j1519			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4JB	28348020				2022-12-28	WOS:000397345700005
J	Toska, E; Osmanbeyoglu, HU; Castel, P; Chan, C; Hendrickson, RC; Elkabets, M; Dickler, MN; Scaltriti, M; Leslie, CS; Armstrong, SA; Baselga, J				Toska, Eneda; Osmanbeyoglu, Hatice U.; Castel, Pau; Chan, Carmen; Hendrickson, Ronald C.; Elkabets, Moshe; Dickler, Maura N.; Scaltriti, Maurizio; Leslie, Christina S.; Armstrong, Scott A.; Baselga, Jose			CANCER THERAPY PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D	SCIENCE			English	Article							H3K4 MONOMETHYLATION; COMPASS FAMILY; PHASE-I; FOXA1; METHYLTRANSFERASE; METHYLATION; DISRUPTION; MECHANISMS; CHROMATIN; STRATEGY	Activating mutations in PIK3CA, the gene encoding phosphoinositide-(3)-kinase alpha (PI3K alpha), are frequently found in estrogen receptor (ER)-positive breast cancer. PI3Ka inhibitors, now in late-stage clinical development, elicit a robust compensatory increase in ER-dependent transcription that limits therapeutic efficacy. We investigated the chromatin-based mechanisms leading to the activation of ER upon PI3K alpha inhibition. We found that PI3Ka inhibition mediates an open chromatin state at the ER target loci in breast cancer models and clinical samples. KMT2D, a histone H3 lysine 4 methyltransferase, is required for FOXA1, PBX1, and ER recruitment and activation. AKT binds and phosphorylates KMT2D, attenuating methyltransferase activity and ER function, whereas PI3K alpha inhibition enhances KMT2D activity. These findings uncover a mechanism that controls the activation of ER by the posttranslational modification of epigenetic regulators, providing a rationale for epigenetic therapy in ER-positive breast cancer.	[Toska, Eneda; Castel, Pau; Chan, Carmen; Elkabets, Moshe; Scaltriti, Maurizio; Baselga, Jose] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave,Box 20, New York, NY 10065 USA; [Osmanbeyoglu, Hatice U.; Leslie, Christina S.] Computat Biol Program, Mem Sloan Kettering Canc Ctr, 1275 York Ave,Box 460, New York, NY 10065 USA; [Castel, Pau] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 1450 3rd St, San Francisco, CA 94158 USA; [Hendrickson, Ronald C.] Mem Sloan Kettering Canc Ctr, Microchemistry & Prote Core Lab, New York, NY 10065 USA; [Elkabets, Moshe] Ben Gurion Univ Negev, Shraga Segal Dept Microbiol, Immunol & Genet, Fac Hlth Sci, IL-84105 Beer Sheva, Israel; [Dickler, Maura N.; Baselga, Jose] Dept Med, Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Scaltriti, Maurizio] Dept Pathol, Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Armstrong, Scott A.] Canc Biol & Genet Program, Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Armstrong, Scott A.] Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave, Boston, MA 02215 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Memorial Sloan Kettering Cancer Center; Ben Gurion University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Baselga, J (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave,Box 20, New York, NY 10065 USA.; Baselga, J (corresponding author), Dept Med, Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.; Armstrong, SA (corresponding author), Canc Biol & Genet Program, Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA.; Armstrong, SA (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 450 Brookline Ave, Boston, MA 02215 USA.	scott_armstrong@dfci.harvard.edu; baselgaj@mskcc.org	Osmanbeyoglu, Hatice Ulku/Q-1822-2019; Toska, Eneda/AAQ-4369-2020; Castel, Pau/AAL-5791-2020; Toska, Eneda/AAO-1711-2020; elkabets, moshe/R-6822-2019	Toska, Eneda/0000-0002-8974-9792; Castel, Pau/0000-0002-4972-4347; Osmanbeyoglu, Hatice/0000-0002-3175-1777; Chan, Carmen/0000-0001-9086-6622; Scaltriti, Maurizio/0000-0002-5522-1447	NIH [RO1CA190642-01A1, CA66996, CA140575]; Breast Cancer Research Foundation; Geoffrey Beene Cancer Research Center; National Cancer Institute (NCI) Cancer Center Support Grant [P30CA08748]; NCI [K99 CA207871]; Novartis Pharmaceuticals; Epizyme; Imago Biosciences; Vitae Pharmaceuticals; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA176745, R01CA140575, P01CA066996, R01CA190642, K99CA207871] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; Geoffrey Beene Cancer Research Center; National Cancer Institute (NCI) Cancer Center Support Grant; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Novartis Pharmaceuticals(Novartis); Epizyme; Imago Biosciences; Vitae Pharmaceuticals; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to L. Pasqualucci, who provided the pCMV-HA-KMT2D and the corresponding mutants, the N5437S and R5432W KMT2D plasmids. We also thank A. Shilatifard, who provided the KMT2D antibody for our preliminary experiments; P. Giresi, A. Krivtsov, and Y. Li for help with ATAC-seq; Y. Zou for help with ChIP-seq; N. Morse for help with xenograft establishment; and N. Socci for help with microarray analysis. This work was supported by NIH grant RO1CA190642-01A1, the Breast Cancer Research Foundation, and the Geoffrey Beene Cancer Research Center (to J. B.); National Cancer Institute (NCI) Cancer Center Support Grant P30CA08748 to the Microchemistry and Proteomics Core Laboratory of the Memorial Sloan Kettering Cancer Center; and NIH grants CA66996 and CA140575 to S. A. A. We are also grateful for the support of T. and B. Weinstein. E. T. holds a fellowship from the Terri Brodeur Breast Cancer Foundation. H. U. O. is supported by NCI award K99 CA207871. J. B. and M. N. D. are paid consultants for Novartis Pharmaceuticals. S. A. A. is a paid consultant for Epizyme, Imago Biosciences, and Vitae Pharmaceuticals. Memorial Sloan Kettering Cancer Center and the authors (E. T., S. A. A., and J. B.) have filed a patent application (U. S. patent registration number 62/420324) related to KMT2D inhibition as a treatment for breast cancer. The sequencing data have been deposited in the Gene Expression Omnibus database under accession numbers GEO GSE84515, GSE84593, GSE84594, and GSE95366.	Andre F, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.TPS618; Nguyen AT, 2011, BLOOD, V117, P6912, DOI 10.1182/blood-2011-02-334359; Baselga J, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.TPS617; Bosch A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4442; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Costa C, 2015, CANCER CELL, V27, P97, DOI 10.1016/j.ccell.2014.11.007; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Fritsch C, 2014, MOL CANCER THER, V13, P1117, DOI 10.1158/1535-7163.MCT-13-0865; Green KA, 2007, NAT REV CANCER, V7, P713, DOI 10.1038/nrc2211; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Janku F, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.SABCS14-PD5-5; Jozwik KM, 2016, CELL REP, V17, P2715, DOI 10.1016/j.celrep.2016.11.028; Juric D, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-PD1-3; JURIC D, 2013, CANCER RES, V73, DOI DOI 10.1158/1538-7445.AM2013-LB-64; Juric D, 2015, NATURE, V518, P240, DOI 10.1038/nature13948; Kim W, 2013, NAT CHEM BIOL, V9, P643, DOI [10.1038/NCHEMBIO.1331, 10.1038/nchembio.1331]; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Magnani L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002368; Mayer IA, 2017, CLIN CANCER RES, V23, P26, DOI 10.1158/1078-0432.CCR-16-0134; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Shah PD, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-CT330; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Spangle JM, 2016, CELL REP, V15, P2692, DOI 10.1016/j.celrep.2016.05.046; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940	33	152	156	1	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1324	1329		10.1126/science.aah6893	http://dx.doi.org/10.1126/science.aah6893			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336670	Green Accepted			2022-12-28	WOS:000397082900042
J	Mathieson, S; Maher, CG; McLachlan, AJ; Latimer, J; Koes, BW; Hancock, MJ; Harris, I; Day, RO; Billot, L; Pik, J; Jan, S; Lin, CWC				Mathieson, Stephanie; Maher, Christopher G.; McLachlan, Andrew J.; Latimer, Jane; Koes, Bart W.; Hancock, Mark J.; Harris, Ian; Day, Richard O.; Billot, Laurent; Pik, Justin; Jan, Stephen; Lin, C. -W. Christine			Trial of Pregabalin for Acute and Chronic Sciatica	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BACK-PAIN; NEUROPATHIC PAIN; USUAL CARE; GABAPENTIN; GUIDELINES; EFFICACY; PRECISE; HEALTH; MISUSE	BACKGROUND Sciatica can be disabling, and evidence regarding medical treatments is limited. Pregabalin is effective in the treatment of some types of neuropathic pain. This study examined whether pregabalin may reduce the intensity of sciatica. METHODS We conducted a randomized, double-blind, placebo-controlled trial of pregabalin in patients with sciatica. Patients were randomly assigned to receive either pregabalin at a dose of 150 mg per day that was adjusted to a maximum dose of 600 mg per day or matching placebo for up to 8 weeks. The primary outcome was the leg-pain intensity score on a 10-point scale (with 0 indicating no pain and 10 the worst possible pain) at week 8; the leg-pain intensity score was also evaluated at week 52, a secondary time point for the primary outcome. Secondary outcomes included the extent of disability, back-pain intensity, and quality-of-life measures at prespecified time points over the course of 1 year. RESULTS A total of 209 patients underwent randomization, of whom 108 received pregabalin and 101 received placebo; after randomization, 2 patients in the pregabalin group were determined to be ineligible and were excluded from the analyses. At week 8, the mean unadjusted leg-pain intensity score was 3.7 in the pregabalin group and 3.1 in the placebo group (adjusted mean difference, 0.5; 95% confidence interval [CI], -0.2 to 1.2; P = 0.19). At week 52, the mean unadjusted leg-pain intensity score was 3.4 in the pregabalin group and 3.0 in the placebo group (adjusted mean difference, 0.3; 95% CI, -0.5 to 1.0; P = 0.46). No significant between-group differences were observed with respect to any secondary outcome at either week 8 or week 52. A total of 227 adverse events were reported in the pregabalin group and 124 in the placebo group. Dizziness was more common in the pregabalin group than in the placebo group. CONCLUSIONS Treatment with pregabalin did not significantly reduce the intensity of leg pain associated with sciatica and did not significantly improve other outcomes, as compared with placebo, over the course of 8 weeks. The incidence of adverse events was significantly higher in the pregabalin group than in the placebo group.	[Mathieson, Stephanie; Maher, Christopher G.; Latimer, Jane; Billot, Laurent; Jan, Stephen; Lin, C. -W. Christine] George Inst Global Hlth, Sydney, NSW, Australia; [Mathieson, Stephanie; Maher, Christopher G.; Latimer, Jane; Billot, Laurent; Jan, Stephen; Lin, C. -W. Christine] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [McLachlan, Andrew J.] Univ Sydney, Fac Pharm, Sydney, NSW, Australia; [McLachlan, Andrew J.] Univ Sydney, Ctr Educ & Res Ageing, Sydney, NSW, Australia; [Hancock, Mark J.] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Harris, Ian] Univ New South Wales, Ingham Inst Appl Med Res, South Western Sydney Clin Sch, Fac Med, Sydney, NSW, Australia; [Day, Richard O.] Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia; [Pik, Justin] Australian Capital Terr NeuroSpine Clin, Deakin, ACT, Australia; [Koes, Bart W.] Erasmus Univ, Med Ctr, Dept Gen Practice, Rotterdam, Netherlands	George Institute for Global Health; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Macquarie University; Ingham Institute for Applied Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; Erasmus University Rotterdam; Erasmus MC	Lin, CWC (corresponding author), George Inst Global Hlth, 1 King St, Newtown, NSW 2042, Australia.	clin@georgeinstitute.org.au	Lin, Chung-Wei Christine/S-8840-2019; Billot, Laurent/Y-1241-2019; Koes, Bart w/K-4614-2016; Day, Richard/D-8699-2011; Mathieson, Stephanie/H-4067-2019; Jan, Stephen/AAG-3333-2021; Maher, Christopher/AAC-6267-2019	Lin, Chung-Wei Christine/0000-0001-6192-7238; Billot, Laurent/0000-0002-4975-9793; Koes, Bart w/0000-0002-0450-9969; Day, Richard/0000-0002-6045-6937; Mathieson, Stephanie/0000-0002-7335-8842; Maher, Christopher/0000-0002-1628-7857; Hancock, Mark/0000-0002-9277-5377; Jan, Stephen/0000-0003-2839-1405	National Health and Medical Research Council of Australia [APP1042073]; Pfizer; GlaxoSmithKline Australia; ReumaFonds [COI-1] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Pfizer(Pfizer); GlaxoSmithKline Australia(GlaxoSmithKline); ReumaFonds	Supported by a grant (ID APP1042073) from the National Health and Medical Research Council of Australia.; Dr. Maher reports receiving lecture fees from Pfizer; Dr. McLachlan, receiving grant support from GlaxoSmithKline Australia; and Dr. Day, receiving consulting fees, paid to his institution, from GlaxoSmithKline Australia, and fees for meeting participation from Reckitt Benckiser. No other potential conflict of interest relevant to this article was reported.	Arana A, 2010, NEW ENGL J MED, V363, P542, DOI 10.1056/NEJMoa0909801; Asomaning K, 2016, INT J CLIN PRACT, V70, P380, DOI 10.1111/ijcp.12791; Atkinson JH, 2016, PAIN, V157, P1499, DOI 10.1097/j.pain.0000000000000554; Baron R, 2010, PAIN, V150, P420, DOI 10.1016/j.pain.2010.04.013; Ben-Menachem E, 2004, EPILEPSIA, V45, P13, DOI 10.1111/j.0013-9580.2004.455003.x; Bombardier C, 2001, J RHEUMATOL, V28, P431; Brazier J, 2002, J HEALTH ECON, V21, P271, DOI 10.1016/S0167-6296(01)00130-8; Chiappini S, 2016, CNS DRUGS, V30, P647, DOI 10.1007/s40263-016-0359-y; Deyo RA, 2016, NEW ENGL J MED, V374, P1763, DOI 10.1056/NEJMcp1512658; Ehrlich GE, 2003, B WORLD HEALTH ORGAN, V81, P671; Finnerup Nanna B, 2015, Lancet Neurol, V14, P162, DOI 10.1016/S1474-4422(14)70251-0; Food and Drug Administration, 2008, STAT REV EV ANT DRUG; Freynhagen R, 2006, CURR MED RES OPIN, V22, P1911, DOI 10.1185/030079906X132488; Koes BW, 2007, BMJ-BRIT MED J, V334, P1313, DOI 10.1136/bmj.39223.428495.BE; Koes BW, 2010, EUR SPINE J, V19, P2075, DOI 10.1007/s00586-010-1502-y; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lin CWC, 2013, EUR J P; Mangaiarkkarasi A, 2015, J CLIN DIAGN RES, V9, pFF11, DOI 10.7860/JCDR/2015/13373.5955; Mathieson S, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1174-y; Mathieson S, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-213; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Moore R Andrew, 2009, Cochrane Database Syst Rev, pCD007076, DOI 10.1002/14651858.CD007076.pub2; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Pfizer, 2016, LYR PRESCR INF; Ropper AH, 2015, NEW ENGL J MED, V372, P1240, DOI 10.1056/NEJMra1410151; Scholten PM, 2015, PM&R, V7, pS257, DOI 10.1016/j.pmrj.2015.08.014; Stahl SM, 2013, TRENDS PHARMACOL SCI, V34, P332, DOI 10.1016/j.tips.2013.04.001; Stannard C, 2016, ADDICTION, V111, P1699, DOI 10.1111/add.13408; Wettermark B, 2014, INT J CLIN PRACT, V68, P104, DOI 10.1111/ijcp.12182; Yildirim K, 2009, J BACK MUSCULOSKELET, V22, P17, DOI 10.3233/BMR-2009-0210; Zaccara G, 2011, EPILEPSIA, V52, P826, DOI 10.1111/j.1528-1167.2010.02966.x	32	112	119	1	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1111	1120		10.1056/NEJMoa1614292	http://dx.doi.org/10.1056/NEJMoa1614292			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NB	28328324	Green Published, Bronze			2022-12-28	WOS:000397014300007
J	Wouters, P				Wouters, Paul			Eugene Garfield (1925-2017) OBITUARY	NATURE			English	Biographical-Item									[Wouters, Paul] Leiden Univ, Scientometr, NL-2300 RA Leiden, Netherlands; [Wouters, Paul] Leiden Univ, Ctr Sci & Technol Studies, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Wouters, P (corresponding author), Leiden Univ, Scientometr, NL-2300 RA Leiden, Netherlands.; Wouters, P (corresponding author), Leiden Univ, Ctr Sci & Technol Studies, NL-2300 RA Leiden, Netherlands.	p.f.wouters@cwts.leidenuniv.nl		Wouters, Paul/0000-0002-4324-5732					0	13	14	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					492	492		10.1038/543492a	http://dx.doi.org/10.1038/543492a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28332532	Green Submitted, Bronze			2022-12-28	WOS:000397018000035
J	Stafford, N				Stafford, Ned			John Kenyon ("Ken") French Mason	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.de							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1432	10.1136/bmj.j1432	http://dx.doi.org/10.1136/bmj.j1432			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330836				2022-12-28	WOS:000397345200014
J	Kahn, SR				Kahn, Susan R.			Review: Thrombolysis for DVT reduces postthrombotic syndrome but increases bleeding complications	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kahn, Susan R.] Jewish Gen Hosp, Montreal, PQ, Canada; [Kahn, Susan R.] McGill Univ, Montreal, PQ, Canada	McGill University; McGill University	Kahn, SR (corresponding author), Jewish Gen Hosp, Montreal, PQ, Canada.; Kahn, SR (corresponding author), McGill Univ, Montreal, PQ, Canada.							Enden T, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002984; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC30	JC30		10.7326/ACPJC-2017-166-6-030	http://dx.doi.org/10.7326/ACPJC-2017-166-6-030			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320004				2022-12-28	WOS:000397025800007
J	Vangipuram, R; Tong, Y; Tyring, SK				Vangipuram, Ramya; Tong, Yun; Tyring, Stephen K.			A Tender Rash on the Hand	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HERPES		[Vangipuram, Ramya; Tong, Yun; Tyring, Stephen K.] Ctr Clin Studies, 451 N Texas Ave, Webster, TX 77598 USA; [Tyring, Stephen K.] Univ Texas Hlth Sci Ctr Houston, Dept Dermatol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Vangipuram, R (corresponding author), Ctr Clin Studies, 451 N Texas Ave, Webster, TX 77598 USA.	rvangip@gmail.com		Tong, Yun/0000-0003-2003-1843				Franko OI, 2013, ORTHOP CLIN N AM, V44, P625, DOI 10.1016/j.ocl.2013.06.014; Gnann JW, 2016, NEW ENGL J MED, V375, P666, DOI 10.1056/NEJMcp1603178; Juckett G, 2013, AM FAM PHYSICIAN, V88, P841; Mendoza N, 2012, DERMATOLOGY; Patel Ramnik, 2013, BMJ Case Rep, V2013, DOI 10.1136/bcr-2013-010207; Ross K, 2011, SEX TRANSM INFECT, V87, P594, DOI 10.1136/sextrans-2011-050099; Rubright JH, 2011, J HAND SURG-AM, V36A, P340, DOI 10.1016/j.jhsa.2010.10.014; Simmons A, 2002, J INFECT DIS, V186, pS71, DOI 10.1086/342967	8	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1169	1170		10.1001/jama.2017.0224	http://dx.doi.org/10.1001/jama.2017.0224			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324071				2022-12-28	WOS:000396987200022
J	Deng, YF; Wang, ZV; Gordillo, R; An, Y; Zhang, C; Liang, QR; Yoshino, J; Cautivo, KM; De Brabander, J; Elmquist, JK; Horton, JD; Hill, JA; Klein, S; Scherer, PE				Deng, Yingfeng; Wang, Zhao V.; Gordillo, Ruth; An, Yu; Zhang, Chen; Liang, Qiren; Yoshino, Jun; Cautivo, Kelly M.; De Brabander, Jef; Elmquist, Joel K.; Horton, Jay D.; Hill, Joseph A.; Klein, Samuel; Scherer, Philipp E.			An adipo-biliary-uridine axis that regulates energy homeostasis	SCIENCE			English	Article							MOUSE MODEL; PYRIMIDINE NUCLEOSIDES; PLASMA-MEMBRANE; OBESITY; ACID; METABOLISM; MICE; BODY; N-(PHOSPHONACETYL)-L-ASPARTATE; THERMOGENESIS		[Deng, Yingfeng; Gordillo, Ruth; An, Yu; Zhang, Chen; Scherer, Philipp E.] UT Southwestern Med Ctr, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA; [Wang, Zhao V.; Hill, Joseph A.] UT Southwestern Med Ctr, Dept Internal Med, Div Cardiol, Dallas, TX USA; [Liang, Qiren; De Brabander, Jef] UT Southwestern Med Ctr, Dept Biochem & Simmons Comprehens Canc, Dallas, TX USA; [Yoshino, Jun; Klein, Samuel] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO USA; [Cautivo, Kelly M.; Horton, Jay D.] UT Southwestern Med Ctr, Dept Mol Genet, Dallas, TX USA; [Elmquist, Joel K.] UT Southwestern Med Ctr, Dept Internal Med, Div Hypothalam Res, Dallas, TX USA; [Hill, Joseph A.] UT Southwestern Med Ctr, Dept Mol Biol, Dallas, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Scherer, PE (corresponding author), UT Southwestern Med Ctr, Dept Internal Med, Touchstone Diabet Ctr, Dallas, TX 75390 USA.	philipp.scherer@utsouthwestern.edu	Scherer, Philipp E/K-7819-2012; Deng, Yingfeng/AAB-8962-2019; An, Yu/O-2966-2013	Scherer, Philipp E/0000-0003-0680-3392; Deng, Yingfeng/0000-0003-1314-5105; Yoshino, Jun/0000-0001-9833-4356; An, Yu/0000-0002-9678-3382; Wang, Zhao/0000-0002-9904-9538; Cautivo, Kelly/0000-0003-4434-2814; Gordillo, Ruth/0000-0001-6533-2493	American Diabetes Association [7-08-MN-53]; American Heart Association scientist development grant [14SDG18440002]; NIH [R01-DK55758, R01-DK099110, P01DK088761, R01-DK101578, HL-120732, HL-100401, HL-126012]; Robert A. Welch Foundation [I-1422]; American Heart Association [14SFRN20740000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126012, U01HL100401, R01HL120732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101578, R01DK055758, P01DK088761, P30DK056341, R01DK099110] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); American Heart Association scientist development grant(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Li, W. Tan (Division of Cardiology, UT Southwestern Medical Center), M.-Y. Wang (Touchstone Diabetes Center, UT Southwestern Medical Center), and S. Shah (Metabolic Phenotyping Core, UT Southwestern Medical Center) for excellent technical assistance with animal studies. Author contributions: Y.D. conceived the study, designed and performed the experiments, and analyzed data; Z.V.W. helped with uridine clearance study and tolerance tests; R.G. performed uridine analysis with HPLC-MS/MS; Y.A. performed the studies using the FAT-ATTAC mice; K.M.C. performed studies using the Agpat2 KO mice; C.Z. helped with gallbladder and tissue collection; Q.L. and J.D.B. synthesized PALA; J.Y. and S.K. provided the human samples and contributed to the discussion; J.K.E. and J.D.H. contributed to the discussion; J.A.H. contributed to the discussion and edited the manuscript; P.E.S. conceived the study; and Y.D. and P.E.S. wrote the manuscript with suggestions from all authors. Supported by American Diabetes Association postdoctoral fellowship 7-08-MN-53 (Y.D.), American Heart Association scientist development grant 14SDG18440002 (Z.V.W.), NIH grants R01-DK55758 and R01-DK099110 (P.E.S.), NIH grant P01DK088761 (P.E.S., J.K.E., J.D.H.), NIH grant R01-DK101578 (S.K.), Robert A. Welch Foundation grant I-1422 (J.D.B.), and American Heart Association grant 14SFRN20740000 and NIH grants HL-120732, HL-100401, and HL-126012 (J.A.H.). The authors have no conflicting financial interests.	Begriche K, 2008, OBESITY, V16, P2053, DOI 10.1038/oby.2008.337; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; Cass C. E., 2011, XPHARM COMPREHENSIVE, P1, DOI [10.1016/B978-008055232-3.60461-1, DOI 10.1016/B978-008055232-3.60461-1]; COLLINS KD, 1971, J BIOL CHEM, V246, P6599; Connolly GP, 1996, TRENDS PHARMACOL SCI, V17, P106, DOI 10.1016/0165-6147(96)20001-X; Connolly GP, 1999, TRENDS PHARMACOL SCI, V20, P218, DOI 10.1016/S0165-6147(99)01298-5; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Domingo P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013896; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Errasti-Murugarren E, 2009, FASEB J, V23, P172, DOI 10.1096/fj.08-113902; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; GREM JL, 1988, CANCER RES, V48, P4441; HE YP, 1994, J NUTR, V124, P1942, DOI 10.1093/jn/124.10.1942; Jones M E, 1970, Adv Enzyme Regul, V9, P19; JUNG RT, 1979, NATURE, V279, P322, DOI 10.1038/279322a0; Kenny Glen P, 2016, Temperature (Austin), V3, P119, DOI 10.1080/23328940.2015.1131506; Kenny GP, 2013, COMPR PHYSIOL, V3, P1689, DOI 10.1002/cphy.c130011; Kim JG, 2014, NAT NEUROSCI, V17, P908, DOI 10.1038/nn.3725; LANDSBERG L, 1981, LIFE SCI, V28, P1801, DOI 10.1016/0024-3205(81)90352-0; LANDSBERG L, 1986, Journal of Clinical Hypertension, V2, P166; Larder R, 2012, NAT MED, V18, P666, DOI 10.1038/nm.2747; Lee SH, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.25; Liu MP, 1998, AM J PHYSIOL-GASTR L, V274, pG1018, DOI 10.1152/ajpgi.1998.274.6.G1018; MACKINNON AM, 1973, BIOCHIM BIOPHYS ACTA, V319, P1, DOI 10.1016/0005-2787(73)90034-8; MAYFIELD KP, 1994, AM J PHYSIOL, V266, pR1615, DOI 10.1152/ajpregu.1994.266.5.R1615; Molina-Arcas M., 2013, PHARMACOGENOMICS HUM, V11, P243, DOI [10.1002/9781118353240.ch11, DOI 10.1002/9781118353240.CH11]; Morris AD, 1997, SYNTHETIC COMMUN, V27, P1259, DOI 10.1080/00397919708003363; MOYER JD, 1981, CANCER RES, V41, P3010; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; PETERS GJ, 1987, CANCER CHEMOTH PHARM, V20, P101, DOI 10.1007/BF00253962; PETERS GJ, 1987, PHARMACEUT RES, V4, P113, DOI 10.1023/A:1016410817898; Pinilla-Macua I, 2014, FEBS LETT, V588, P4382, DOI 10.1016/j.febslet.2014.10.006; Pinilla-Macua I, 2012, BIOCHEM J, V442, P517, DOI 10.1042/BJ20110605; Pizzorno G, 2002, BBA-MOL BASIS DIS, V1587, P133, DOI 10.1016/S0925-4439(02)00076-5; Ramos-Jimenez Arnulfo, 2008, Clin Med Circ Respirat Pulm Med, V2, P1; SIMONSON DC, 1990, AM J PHYSIOL, V258, pE399, DOI 10.1152/ajpendo.1990.258.3.E399; Steculorum SM, 2015, CELL, V162, P1404, DOI 10.1016/j.cell.2015.08.032; TSENG J, 1971, AM J PHYSIOL, V221, P869, DOI 10.1152/ajplegacy.1971.221.3.869; Urasaki Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146994; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Wang ZV, 2008, DIABETES, V57, P2137, DOI 10.2337/db07-1631; Yamamoto T, 2011, CLIN CHIM ACTA, V412, P1712, DOI 10.1016/j.cca.2011.06.006; Ye RS, 2014, ELIFE, V3, DOI 10.7554/eLife.03851; Yoshino J, 2014, J CLIN ENDOCR METAB, V99, pE1666, DOI 10.1210/jc.2014-1579	47	61	65	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI				eaaf5375	10.1126/science.aaf5375	http://dx.doi.org/10.1126/science.aaf5375			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302796	Green Accepted			2022-12-28	WOS:000396351200001
J	Malakoff, D				Malakoff, David			US POLICY A battle over the 'best science' In separate moves, Congress sets out to shape how regulators use science, and whose advice they listen to	SCIENCE			English	News Item																			0	3	3	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1108	1109		10.1126/science.355.6330.1108	http://dx.doi.org/10.1126/science.355.6330.1108			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302801				2022-12-28	WOS:000396351200011
J	Schlissel, G; Krzyzanowski, MK; Caudron, F; Barral, Y; Rine, J				Schlissel, Gavin; Krzyzanowski, Marek K.; Caudron, Fabrice; Barral, Yves; Rine, Jasper			Aggregation of the Whi3 protein, not loss of heterochromatin, causes sterility in old yeast cells	SCIENCE			English	Article							LIFE-SPAN EXTENSION; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; TELOMERES	In yeast, heterochromatin silencing is reported to decline in aging mother cells, causing sterility in old cells. This process is thought to reflect a decrease in the activity of the NAD(+) (oxidized nicotinamide adenine dinucleotide)-dependent deacetylase Sir2. We tested whether Sir2 becomes nonfunctional gradually or precipitously during aging. Unexpectedly, silencing of the heterochromatic HML and HMR loci was not lost during aging. Old cells could initiate a mating response; however, they were less sensitive to mating pheromone than were young cells because of age-dependent aggregation of Whi3, an RNA-binding protein controlling S-phase entry. Removing the polyglutamine domain of Whi3 restored the pheromone sensitivity of old cells. We propose that aging phenotypes previously attributed to loss of heterochromatin silencing are instead caused by aggregation of the Whi3 cell cycle regulator.	[Schlissel, Gavin; Rine, Jasper] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Krzyzanowski, Marek K.; Caudron, Fabrice; Barral, Yves] Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland; [Caudron, Fabrice] Kings Coll London, London, England	University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; King's College London	Rine, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.; Barral, Y (corresponding author), Swiss Fed Inst Technol, Inst Biochem, Zurich, Switzerland.	yves.barral@bc.biol.ethz.ch; jrine@berkeley.edu	Caudron, Fabrice/AAE-3039-2021	Caudron, Fabrice/0000-0001-5159-1507; Schlissel, Gavin/0000-0003-0490-7438; Barral, Yves/0000-0002-0989-3373; Rine, Jasper/0000-0003-2297-9814	National Institutes of Health [GM31105]; ETH Zurich; European Research Council project BarrAge; iPHD fellowship from SystemsX.ch; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031105, R01GM031105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ETH Zurich(ETH Zurich); European Research Council project BarrAge; iPHD fellowship from SystemsX.ch; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Delarue, N. Azgui, and the University of California-Berkeley biotechnology nanofabrication facility for assistance in fabricating microfluidic devices; E. Unal and G. Brar for microscopy support; S. Guetg for providing the hml::GFP reporter; S. S. Lee for advice on microfluidics; the light microscopy center of ETH Zurich (ScopeM); T. Schwarz for technical support; and T. Kruitwagen for critical reading of the manuscript. RNA sequencing data from Ellahi et al. (11) are available from the National Center for Biotechnology Information (NCBI) under accession numbers SRX884375, SRX885291, SRX885292, SRX885297, SRX885304, and SRX885305, and RNA sequencing data from Sen et al. (12) are available from NCBI as series GSE65767. This work was supported by a grant from the National Institutes of Health (GM31105 to G. S. and J.R.), ETH Zurich and the European Research Council project BarrAge (to Y.B.), and an iPHD fellowship from SystemsX.ch (to M.R.K.).	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Ashrafi K, 1999, P NATL ACAD SCI USA, V96, P9100, DOI 10.1073/pnas.96.16.9100; Caudron F, 2013, CELL, V155, P1244, DOI 10.1016/j.cell.2013.10.046; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Dodson AE, 2015, ELIFE, V4, DOI 10.7554/eLife.05007; Ellahi A, 2015, GENETICS, V200, P505, DOI 10.1534/genetics.115.175711; Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Lindstrom DL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002015; MULLER I, 1985, A VAN LEEUW J MICROB, V51, P1, DOI 10.1007/BF00444223; Sen P, 2015, GENE DEV, V29, P1362, DOI 10.1101/gad.263707.115; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7	14	33	35	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1184	1187		10.1126/science.aaj2103	http://dx.doi.org/10.1126/science.aaj2103			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302853	Green Submitted, Green Accepted			2022-12-28	WOS:000396351200038
J	Bloom, SL; Leveno, KJ				Bloom, Steven L.; Leveno, Kenneth J.			Unproven Technologies in Maternal-Fetal Medicine and the High Cost of US Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRETERM BIRTH; DOUBLE-BLIND; SHORT CERVIX; PROGESTERONE; WOMEN; MULTICENTER; TRIAL; RISK		[Bloom, Steven L.; Leveno, Kenneth J.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Bloom, SL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.bloom@utsouthwestern.edu						[Anonymous], 2011, LEAD HLTH IND HLTH P; Behrman RE, 2007, PRETERM BIRTH CAUSES; Berghella V, 2012, AM J OBSTET GYNECOL, V206, P376, DOI 10.1016/j.ajog.2012.03.010; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Committee on Practice BulletinsObstetrics The American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P964; Esplin MS, 2017, JAMA-J AM MED ASSOC, V317, P1047, DOI 10.1001/jama.2017.1373; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Frey HA, 2016, SEMIN FETAL NEONAT M, V21, P68, DOI 10.1016/j.siny.2015.12.011; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Khalifeh A, 2016, OBSTET GYNECOL, V127, p7S, DOI 10.1097/01.AOG.0000483635.97512.65; Martin AB, 2017, HEALTH AFFAIR, V36, P166, DOI 10.1377/hlthaff.2016.1330; Matthews T J, 2015, Natl Vital Stat Rep, V64, P1; McIntosh J, 2016, AM J OBSTET GYNECOL, V215, pB2, DOI 10.1016/j.ajog.2016.04.027; Norman JE, 2016, LANCET, V387, P2106, DOI 10.1016/S0140-6736(16)00350-0; Obama B, 2016, JAMA-J AM MED ASSOC, V316, P525, DOI 10.1001/jama.2016.9797; Squires D., 2015, US HLTH CARE GLOBAL	16	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1025	1026		10.1001/jama.2017.1218	http://dx.doi.org/10.1001/jama.2017.1218			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291876				2022-12-28	WOS:000396713400014
J	Loewenberg, S				Loewenberg, Sam			Trump's foreign aid proposal rattles global health advocates	LANCET			English	Editorial Material																			0	0	0	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					994	995		10.1016/S0140-6736(17)30696-7	http://dx.doi.org/10.1016/S0140-6736(17)30696-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN9UN	28291002				2022-12-28	WOS:000396345200006
J	Young, MJ; Scheinberg, E				Young, Michael J.; Scheinberg, Ethan			The Rise of Crowdfunding for Medical Care Promises and Perils	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Young, Michael J.] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA; [Scheinberg, Ethan] Harvard Law Sch, 260 Longwood Ave, Cambridge, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Young, MJ (corresponding author), Harvard Law Sch, 260 Longwood Ave, Cambridge, MA 02115 USA.	michael.young@mgh.harvard.edu						Ambagtsheer F, 2016, AM J TRANSPLANT, V16, P2800, DOI 10.1111/ajt.13766; Daniels Norman, 2008, JUST HLTH M HLTH NEE; Giones F, 2017, REVOLUTION INNOVATIO, V1, P43; Halpern SD, 2010, ANN INTERN MED, V152, P358, DOI 10.7326/0003-4819-152-6-201003160-00005; Hopkins BR, 2013, LAW FUNDRAISING; Petrow S., 2016, US TODAY; Young MJ, 2012, CRIT CARE MED, V40, P261, DOI 10.1097/CCM.0b013e31822d750d	7	53	54	3	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2017	317	16					1623	1624		10.1001/jama.2017.3078	http://dx.doi.org/10.1001/jama.2017.3078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET1FW	28334321				2022-12-28	WOS:000400014000009
J	Ridker, PM; Revkin, J; Amarenco, P; Brunell, R; Curto, M; Civeira, F; Flather, M; Glynn, RJ; Gregoire, J; Jukema, JW; Karpov, Y; Kastelein, JJP; Koenig, W; Lorenzatti, A; Manga, P; Masiukiewicz, U; Miller, M; Mosterd, A; Murin, J; Nicolau, JC; Nissen, S; Ponikowski, P; Santos, RD; Schwartz, PF; Soran, H; White, H; Wright, RS; Vrablik, M; Yunis, C; Shear, CL; Tardif, JC; Conde, D; Colquhoun, D; Missault, L; Gregoire, J; Gao, RL; Urina, M; Solar, M; Jensen, HK; Grobbee, D; Savolainen, M; Schiele, F; Montalescot, G; Edes, I; Blake, G; Lotan, C; Maggioni, A; Savonitto, S; Lee, CW; Pons, JLL; Dan, GA; Cortada, JB; Mellbin, L; Kahan, T; Noble, S; Hwang, JJ; Sritara, P; Tokgozoglu, L; Revkin, J; Tarasenko, L; Borer, JS; Black, H; Carmena, R; Furie, KL; McMurray, J; Neaton, J; Zannad, F; O'Neill, B; Welty, F; McNamara, R; Chun, H; Abbott, JD; Jacoby, D; McPherson, C; Jadbabaie, F; Pinto, D; McCullough, L; Silverman, IE; Sansing, LH; Dearborn-Tomazos, J; Foody, J; Schindler, J; Piazza, G; Chakrabarti, A; Pride, Y; Gelfand, E; Baultrukonis, D; Chaudhuri, S; Frederich, R; Johnson, M; Mridha, K; Powell, C; Wang, E; Wei, CM; Anderson, P; Buonanno, M; Epsley, C; Evans, B; Frolova, M; Goetsch, M; Hessinger, D; Ikehara, E; Ivanac, K; Kizko, J; Le, K; McNally-Dufort, C; Morocco, T; Nadkarni, S; Nissen, T; Nye, R; Pak, R; Pence, D; Redifer, P; Schwartz, W; Sattler, C; Schade, R; Sullivan, B; Wegner, J; Alvarez, CA; Budassi, N; Vogel, DR; Avaca, H; Conde, DG; Estol, CCCJ; Gelersztein, E; Glenny, JA; Hershson, AR; Bruno, RL; Maffei, LE; Soler, JMP; Zaidman, CJ; Carnero, GS; Colombo, HR; Jure, HO; Luquez, HA; Ramos, HR; Resk, JH; Rusculleda, MM; Ulla, MR; Caccavo, A; Farias, EF; Wenetz, LMM; Cabella, PRF; Cuadrado, JA; Chahin, M; Mackinnon, IJ; Zarandon, RBS; Schmidberg, J; Fernandez, AA; Montana, O; Codutti, OR; Gorosito, VM; Maldonado, N; Sala, J; De La Fuente, RAL; Casabella, TES; Di Gennaro, JPA; Guerrero, RAA; Alvarez, MS; Berli, M; Botta, CE; Montenegro, EE; Vico, ML; Begg, A; Lehman, R; Gilfillan, CP; d'Emden, M; Markovic, TP; Sullivan, D; Aroney, C; Stranks, SN; Crimmins, DS; Arstall, M; Van Gaal, W; Davis, T; Aylward, PE; Amerena, J; William, M; Proietto, J; Purnell, PW; Singh, B; Arya, KW; Dart, AM; Colquhoun, D; Thompson, P; Davis, SM; Carroll, PA; De Looze, F; Jayasinghe, R; Bhindi, R; Buysschaert, I; Sarens, T; van de Borne, P; Scott, BP; Roosen, J; Cools, F; Missault, LH; Debroye, C; Schoors, DF; Hollanders, G; Schroe, HH; De Sutter, J; Hermans, K; Carlier, M; van Landegem, P; Verwerft, J; Mulleners, T; Delforge, MD; Soufflet, V; Elegeert, I; Descamps, OS; Janssens, S; Lemmens, RC; Desfontaines, P; Scheen, A; Heijmans, S; Capiau, L; Vervoort, G; Carlier, SG; Faes, D; Alzand, B; Keuleers, S; De Wolf, L; Thoeng, J; De Bruyne, L; de Santos, MON; Felicio, JS; Areas, CAF; Figueiredo, EL; Michalaros, YL; Neuenschwander, FC; Reis, G; Saad, JA; Kormann, APM; Nascimento, CV; Precoma, DB; Abib, E; dos Santos, FR; Mello, YG; Saraiva, JFK; Rech, RL; Cerci, R; Fortes, JAR; Rossi, PRF; Silva, FADE; Hissa, M; Silva, RP; de Souza, WKSB; Filho, FVG; Mangili, OC; Paiva, MSMD; Tumelero, R; Abrantes, JAM; Caramori, PR; Dutra, OP; Leaes, PE; Manenti, ER; Polanczyk, CA; Farias, FABE; Moraes, JBX; Russo, LA; Alves, AR; Dracoulakis, MDA; Ritt, LEF; Saporito, WF; Herdy, AH; Maia, LN; Sternieri, MVBB; Ayoub, JCA; Bianco, HT; da Costa, FA; Eliaschewitz, FG; Fonseca, FAH; Nakandakare, ER; Bonansea, TCP; Castro, NMS; Silva, PGMDE; Smith, P; Botelho, RV; Resende, ES; Barbieri, DSG; Hernandes, ME; Bajaj, H; Beaudry, P; Berlingieri, JC; Salter, TJ; Ajala, B; Anderson, TJ; Nanji, A; Pandey, S; Desrosiers, D; Gaudet, D; Moran, G; Csanadi, MA; StAmour, E; Cusimano, S; Halperin, FA; Babapulle, M; Vizel, S; Petrella, J; Spence, JD; Gupta, N; Tellier, G; Bourgeois, R; Gregoire, JC; Wesson, T; Zadra, R; Twum-Barima, DY; Cha, JY; Hartleib, MC; Bergeron, J; Chouinard, G; McPherson, TP; Searles, G; Peterson, SR; Mukherjee, A; Lepage, S; Conway, JR; Kouz, SM; Dion, D; Pesant, Y; Cheung, SS; Goldenberg, RM; Aronson, R; Gupta, AK; O'Mahoney, M; Pliamm, L; Teitelbaum, I; Hoag, GN; Nadra, IJ; Yared, Z; Yao, LC; Nguyen, T; Saunders, KK; Li, Y; Wang, D; Li, J; Yang, X; Du, Y; Wang, G; Yang, P; Zhang, X; Xu, P; Zhao, Y; Chen, J; Li, S; Li, W; Zhang, L; Zhu, Y; Zhang, Y; Zhou, C; Wang, Y; Liu, F; Ma, Y; Ti, Z; Zeng, X; Zhou, Y; Cui, G; Li, D; Xue, L; Jiang, J; Lian, Y; He, Y; Mendoza, JA; Bonfanti, JAC; Dada, FAT; Urina-Triana, MA; Rodriguez, WRB; Sanchez, MLJ; Lozno, HY; Triana, EH; Arambula, RMS; Rico-Carrillo, AE; Gallo, HJH; Catano, JSV; Jattin, FGM; Plazas, JAR; Gomez, JEF; Botero-Lopez, R; Gomez, NIJ; Munoz, CFJ; Pelaez, SV; Eraso, AM; Goyes, ARB; Elbl, L; Fiserova, N; Vesely, J; Wasserburger, B; Blaha, V; Vojacek, J; Maskova, P; Hutyra, M; Vrkoc, J; Hala, T; Vodnansky, P; Bocek, P; Cifkova, R; Bufka, V; Ceska, R; Machkova, M; Zidkova, E; Lukac, M; Mikusova, T; Kellnerova, I; Kuchar, L; Ferkl, R; Cech, V; Zemek, S; Monhart, Z; Davidsen, F; Joensen, A; Lihn, AS; Rasmussen, TK; Wiggers, H; Lindgren, LM; Schmidt, U; Galatius, S; Sillesen, H; Schou, JB; Thomsen, KK; Urhammer, S; Jeppensen, J; Schou, M; May, O; Steffensen, R; Nielsen, WB; Nielesen, T; Jepsen, JM; Rai, A; Sykulski, R; Andersen, LT; Rickers, H; Frost, L; Lomholdt, J; Egstrup, K; Wermuth, S; Klausen, C; Lassus, J; Palomaki, A; Khari, J; Tatlisumak, T; Kekki, S; Vanttinen, E; Strandberg, A; Valtonen, M; Sia, SM; Nerg, O; Puhakka, M; Savolainen, M; Strand, J; Timonen, M; Levola, J; Arstila, L; Taurio, J; Kantola, I; Suomi, J; Humaloja, K; Askonen, K; Schiele, F; Sibon, I; Zemour, G; Goube, P; Petit, C; Chati, Z; Range, G; Rabahi, F; Rihani, R; Bergerot, C; Roubille, F; Boye, A; Probst, V; Ferrari, E; Cayla, G; Thouvenot, E; Delarche, N; Couffinhal, T; Coisne, D; Paillard, F; Elbaz, M; Decoulx, E; Angoulvant, D; Agraou, B; Caudmont, S; Berrouschot, J; Lauer, B; Schoell, I; Trenk, D; Derwahl, KM; Khariouzov, A; Proepper, F; Stawowy, P; Stephan, UD; Stoessel, J; Voehringer, HF; Dorsel, T; Stellbrink, C; Rinke, A; Northroff, J; Bourhaial, H; Stratmann, M; Wetzel, T; Axthelm, C; Guenzel, A; Weigmann, I; Faghih, M; Hagemann, D; Schaefer, A; Weber, D; Luedemann, J; Contzen, C; Kornmann, MO; Winkelmann, B; Simon, J; Felix, S; Brauer, C; Laufs, U; Schmidt, E; Marten, I; Licka, M; Heisters, J; Appel, KF; Kleinecke-Pohl, U; Klein, C; Von Hodenberg, EF; Maus, O; Sigal, H; Taeschner, H; Schwimmbeck, P; Lemke, B; Perings, C; Illies, G; Pfuetzner, A; Salbach, P; Hengstenberg, C; Kohler, A; Mudra, H; Behnke, T; Baar, M; Jeserich, M; Scholz, G; Naudts, I; Voller, H; Herrmann, HJ; Von Engelhardt, CB; Gerke, S; Pohlmeier, L; Schaufele, T; Woehrle, J; Al-Zoebi, A; Horacek, T; Peterfai, E; Kemeny, V; Lakatos, F; Bod, E; Andrassy, P; Andreka, P; Balo, T; Davidovits, Z; Laszlo, Z; Nagy, K; Papp, A; Somogyi, A; Toldy-Schedel, E; Vertes, A; Voros, P; Paragh, G; Martyin, T; Hajdu, C; Deak, L; Farago, K; Nagy, A; Kirschner, R; Koszegi, Z; Zilahi, Z; Toth, K; Wittmann, I; Bajcsi, D; Reiber, I; Toth, L; Benczur, B; Nagy, L; Sydo, T; Lupkovics, G; Oroszlan, T; Crean, P; Mahon, NG; McAdam, B; MacNeill, B; Katz, A; Tsalihin, D; Vazan, A; Eitan, A; Lewis, BS; Gavish, D; Wainstein, J; Mosenzon, O; Mosseri, M; Vishlitzky, V; Atar, S; Nseir, WB; Brenner, H; Elis, A; Fuchs, S; Shimon, I; Solodky, A; Goldhaber, A; Tanne, D; Knobler, H; Kracoff, OH; Hussein, O; Auriel, E; Chorin, E; Sharir, T; Bitzur, R; Shechter, M; Antonicelli, R; Franceschini, E; Porcu, M; Sesti, G; Maggiolini, S; Salvioni, A; Filardi, PP; Trimarco, B; Averna, M; Pasqualini, L; Pirro, M; Pantaleoni, M; Piovaccari, G; Arca, M; Fedele, F; Roncon, L; Anselmi, M; Sganzerla, P; Morocutti, G; Bonora, E; Dimas, AL; Esperon, GAL; Morales-Villegas, E; Isunza, JMR; Beltran, LGM; Molina, CAA; Garcia, DK; Ruiz, LAN; Reyna, LS; Ibarra, MOD; Soto, JRL; Gonzalez-Ortiz, M; Herrera-Marmolejo, M; Ramos, SAJ; Ramos-Lopez, GA; Stobschinski, CA; AguilarSalinas, CA; Alpizar-Salazar, M; Jimenez-Sanchez, M; Mijangos, JHS; Moreno, ERE; Castillo, AG; Hernandez, PAG; Gonzalez-Gonzalez, JG; Charles, CMR; Lopez, HGV; Escobar, PLN; del Campo, ALM; Montes, BEC; Bucio, AM; Rodriguez-Briones, I; Amione, GT; Ortiz, RV; Ceballos, RIL; Rosas, EL; Bax, WA; Alhakim, M; van de Wiel, A; Liem, SS; Groutars, RGEJ; Herrman, JPR; Hovingh, GK; van de Wetering, ML; van Royen, N; Groenemeijer, BE; Hoedemaker, G; Schaap, J; Ronner, E; Angun, M; Mairuhu, AT; Van Alem, AP; Martens, FMAC; Heijmeriks, JA; van Hal, JMC; Schoofs, MW; den Hartog, FR; Kentgens, S; Post, JC; Louwerenburg, JW; van Rossum, P; Viergever, EP; Donders, SH; Kamphuisen, PW; van Beek, E; Nijmeijer, R; Lenderink, T; Schreuder, T; Kuijper, AF; The, SH; Hof-Wiersma, JJV; Tichelaar, P; Westerndorp, I; Breedveld, RW; Romer, TJ; Bogaard, K; Van Koningsbruggen, P; Kroon, AA; Hoogslag, PA; Rensing, BJ; Cramer, E; Remmen, JJ; Riksen, NP; Bokern, MJ; Cabezas, MC; Mulder, H; Nierop, PR; van Kempen, WW; Zoet-Nugteren, SK; van Daele, ME; Swart, HP; van der Zwaan, CT; Hermans, WR; Magro, M; van de Wal, RMA; Hassink, RJ; Visseren, FL; Veenendaal, A; De Nooijer, C; Troquay, RP; Imholz, BP; van der Meer, P; Visser, RP; van Leendert, RJ; Gosselink, MA; Baker, J; Benatar, JR; Kerr, J; Pryke, JR; Scott, RS; Millar-Corte, GD; Williams, M; Montgomery, B; Venter, DJ; Ternouth, IF; DeCaigney, SC; Hart, HH; Corin, A; Garden, PI; Sheahan, D; Harding, SA; Korecki, J; Supronik, J; Styczkiewicz, M; Bijata-Bronisz, R; Rusicka, T; Walczak, M; Krolikowski, Z; Ostrowski, J; Lukaszewicz, M; Przekwas-Jaruchowska, M; Zieba, B; Miekus, P; Orkwiszewska-Nalewajko, A; Piepiorka, M; Kubalski, P; Wychota, K; Blach, E; Ochala, A; Okopien, B; Wronska, D; Janion, M; Czarnecka, D; Kolodziejczyk, J; Konieczynska, M; Landa, K; Mirek-Bryniarska, E; Necki, M; Pasternak, DA; Rozpondek, P; Trebacz, J; Walczewska, J; Sidor, M; Broncel, M; Drozdz, J; Kosmider, M; SaryuszWolska, M; Kucharska, D; Opalinska, E; Pijanowski, Z; Wozniak, I; Banaszkiewicz, K; Klecha, A; Horodecki, M; Piskorz-Wapinska, J; Kobielusz-Gembala, I; Kim, MH; Kim, DK; Cho, BR; Kim, KS; Her, SH; Lee, S; Rhee, MY; Kim, K; Kang, WC; Kim, DH; Cho, YS; Kim, SH; Lee, CW; Rim, SJ; Tahk, SJ; Jeon, HK; Yoon, J; Mociran, M; Pop, CF; Minescu, B; Andrei, LD; Radoi, M; Calin, A; Ciomag, RM; Copaci, I; Dan, GA; Fruntelata, AG; Popescu, M; Tivadar, S; Roman, G; Avram, RI; Mistodie, CV; Morosanu, M; Popa, AR; Popescu, ML; Popoviciu, MS; Tase, A; Busegeanu, M; Popescu, A; Szilagyi, I; Sitterli-Natea, CN; Maximov, DM; Munteanu, M; Negrisanu, GD; Kuzin, A; Popov, D; Shapovalova, J; Vishneva, E; Shutemova, E; Pasechnik, E; Bogdanov, E; Khasanov, N; Barbarash, OL; Shangina, OA; Tarasov, N; Solonev, O; Kosmacheva, E; Chernyatina, MA; Ginzburg, M; Blokhin, A; Bulanova, N; Drapkina, OM; Gordeev, IG; Libov, IA; Lomakin, N; Panchenko, E; Shogenov, ZS; Zateyshchikov, D; Klein, G; Motylev, I; Belenkiy, DI; Demin, A; Nikolaev, KY; Oleynikov, V; Zrazhevskiy, K; Katelnitskiy, I; Khaisheva, L; Aksentiev, S; Nedoshivin, A; Popova, VB; Agafina, AS; Ballyuzek, M; Baranova, E; Burova, N; Eryshev, S; Filippov, A; Goloshchekin, BM; Konstantinov, V; Kostenko, VA; Simanenkov, VI; Volkova, A; Duplyakov, D; Reshetko, O; Shvarts, Y; Kuznetsov, VA; Samoylova, YG; Tolkacheva, V; Shalaev, SV; Khokhlov, AL; Malygin, A; Shilkina, NP; Yakusevich, VV; Margoczy, R; Zubek, V; Dzupina, A; Dubrava, J; Dulkova, K; Fabryova, L; Gaspar, L; Kamensky, G; Kokles, M; Raslova, K; Soosova, I; Stevlik, J; Strbova, J; Sumbal, J; Uhliar, R; Micik, J; Truban, J; Fedacko, J; Pastrnakova, E; Pella, D; Fazekas, F; Ambrovicova, V; Kycina, P; Martinka, E; Nociar, J; Belicova, M; Banik, M; Kanderkova, D; Hranai, M; Duris, T; Krahulec, B; Benacka, J; Vinanska, D; Roskova, E; Skripova, D; Macek, V; Vohnout, B; Buganova, I; Engelbrecht, JM; Pretorius, MM; Ebrahim, IO; Bayat, J; Ganesh, S; Ranjith, N; Coetzer, TF; Jacovides, A; Distiller, LA; Hellig, FS; Engelbrecht, IV; Mahomed, AA; Blignault, SC; Burgess, LJ; Kotze, HJ; van Nieuwenhuizen, E; Musungaie, DB; Emanuel, S; van der Walt, E; Pretorius, CE; Roos, JS; Roux, SM; Badat, AE; Fouche, L; Vahed, YAK; van Resburg, DJ; van Zyl, LJ; Gonzalez, AS; Diaz, JL; Segura, T; Serrano, MB; Rodrigues, JB; Molto-Jorda, JM; Escribano, JRRD; Garri, FS; Coronado, JLB; Saenz, MSG; Cuixart, CB; Marimon, XGM; Morgaez, JDG; Santos, OM; Gonzalez, JR; Sobrino-Martinez, J; Fernandez, JEC; Narejos, S; Garcia, SS; Martinez, PP; Camos, RF; Martinez, VM; Guerrero, DB; Deben, FM; Belmonte, AV; Garcia, JDM; Hinojosa, JAR; Mateu, EM; Fillat, ARC; Sala, XP; Martori, RA; Diez, MB; Cano, CL; Diz, FW; Juanatey, CG; Walther, LAAS; Diaz, JDG; Puig, JG; Gimeno, EJ; Perez, IP; Suarez-Fernandez, C; Tunon, J; Gomez, JLZ; Sanfiel, MAB; Villa, JME; Martin, MD; Lopez, MD; Garcia, JMH; Madueno, FJT; Paredes, MP; Villar, JA; Gonzalez, MJB; Vera, TVR; Povedano, ST; Alvarez, JS; Via, LM; Iniesta, AR; Masana, L; Bargallo, EV; Gomez, CC; Juanatey, JRG; Fernandez, JMC; Mayor, CD; Garcia, SD; Hernandez, MDJ; Portillo, CM; Grijalvo, OM; De Castro, R; Llaurado, ET; Amate, JMP; Riera, MT; Murillo, FC; Linderfalk, C; Curiac, D; Saldeen-Nilehn, K; Koskinen, P; Khalili, P; Tortensson, I; Lindholm, CJ; Luts, A; Koskinen, PT; Gottsater, A; Persson, BE; Mooe, T; Larnefeldt, H; Boman, K; Crisby, M; Rasmanis, G; Tengmark, BO; Witt, N; Hagstrom, E; Viklund, J; Muller, C; Mach, F; Burnier, M; Nanchen, D; Wuerzner, G; Banyai, M; Moccetti, T; Miserez, AR; Bilz, S; Weber, K; Lai, WT; Chang, KC; Ueng, KC; Tsai, WC; Chiang, CE; Hou, C; Pei, D; Krittayaphong, R; Kiatchoosakun, S; Srimahachota, S; Boonyavarakul, A; Jintapakorn, W; Gullu, H; Onrat, E; Erkan, AF; Demirci, D; Sari, R; Ceyhan, C; Ari, H; Araz, M; Degertekin, M; Goktekin, O; Uresin, AY; Yigit, Z; Akdeniz, B; Comlekci, A; Kayikcioglu, M; Sahin, T; Ozcan, T; Durakoglugil, E; Asamoah-Owusu, N; Reed, R; Bakhai, A; Dixon, L; Sharma, R; Avornyo, AA; Jones, AF; Lip, G; Clark, R; Banerjee, M; Wakeling, J; Arden, C; Blagden, MD; Walukiewica, P; Marshall, A; Maxwell, TG; Gunstone, AE; Kadr, HH; Patle, R; Arif, I; Jhund, PS; McKaig, G; Douglas, F; Mierzejewski, L; Turner, W; Sathyapalan, T; Ivan, P; Manoj, A; Rice, S; Collier, DJ; Nair, DR; Thom, S; Fiore, G; De Belder, M; Price, D; Sobolewska, J; Martin, S; Takhar, A; Moriarty, A; Kondagunta, V; Myhill, T; Gibson, JM; Cecil, JT; Halcox, J; Annamalai, N; Gorog, DA; McCormack, T; Pegge, N; Field, A; Adams, F; Klein, JJ; Busch, RS; Bretton, EM; Jaffrani, N; Salacata, A; Assadourian, A; Gogia, HS; Dyke, CK; Rubenfire, M; Essandoh, LK; Welker, JA; Ledesma, G; Lupovitch, S; Delgado, JP; Hendrix, EL; Quyyumi, AA; Riesenberg, RA; Robertson, DG; Weinstein, DL; Weiss, R; Casaubon, L; Gammon, RS; Brar, HS; Bittar, GD; Guarnieri, TT; Incer, CS; Quraishi, AM; Saeed, S; Albert, M; Sotolongo, RP; Bernard, JV; Karlsbergg, RP; Lepor, NE; Kirby, WE; McLean, B; Miller, AP; Ovalle, F; Townsend, JC; Beckett, PL; Eaves, WB; West, SH; Kosinski, EJ; Zarich, SW; Mahal, SS; Maw, K; Maynard, KM; Chen, JC; Gelormini, J; Gottlieb, DW; Gabra, NW; Narayan, P; Sparks, J; Field, JC; Willits, VL; O'Steen, MB; Pasquini, JA; Sensebrenner, JW; Yarows, SA; Hiotis, L; Jagielo, TJ; Levinson, DJ; Diller, PM; Kereiakes, DJ; Turner, TA; Vincent, S; Camp, AD; Denker, PS; Manning, MB; Rocco, MB; Stamps, HB; Strader, JR; Uusinarkaus, KT; Kennett, JD; Leichter, SB; McNeil, DL; Schumacher, DR; Chang, AR; Ellison, HS; Updegrove, JD; Hamroff, GS; Kay, JS; Marar, IE; Flores, E; Saini, S; Abdullah, S; Berk, MR; Fordan, S; Joshi, PH; McCullough, PAA; Reynolds, RD; Rosenstock, J; Sachson, RA; Shammas, N; Fishbein, GJ; Randall, WJ; Henderson, DA; Nash, ML; Barker, BA; Cohen, SS; Seidman, B; Odekirk, LL; Grillo, RS; Martinez, LM; Multani, P; Alwine, LK; McGarvey, JF; Mollerus, ME; Miller, AB; Kotek, LW; Changlani, M; Zavaro, SH; Munoz, F; Mehta, PM; Helm, RJ; Farhat, NZ; Farsad, R; Raoof, TJ; Shultz, JH; Geohas, JG; Allaw, MA; Dela Llana, A; Gutmann, JE; Inzerello, AT; Alappat, P; George, AR; Haddad, TM; Lillestol, MJ; Grodman, R; Peniston, JH; Wadud, K; Garcia, B; Hamilton, ME; Lerman, S; Perloff, DE; Graff, A; Saxena, S; Alvarado, OP; Malik, A; Reddy, RD; Kinzfogl, G; Cornett, GM; Norwood, PC; Gilbert, JM; Willis, JG; McGrew, F; Sharma, S; Castro, MA; Cucher, FH; Altafullah, IM; Khurana, S; Knutson, TJ; Kinnaman, SJ; Stuckey, T; Pudi, KK; Mayfield, RK; Funk, GS; Nixon, WA; Dor, I; Boyett, BE; Srivastava, S; Elosegui, AM; Isserman, SM; Cheek, HB; Promisloff, SD; Tami, LF; Zeig, S; Fitz-Patrick, D; Dave, KN; Ahmad, A; Arain, S; Ballantyne, CM; Doshi, A; El Hafi, SE; Feldman, J; Fragoso, VG; Gilford, T; Hoffman, AS; Pouzar, JE; Vivekananthan, K; Ansari, SH; Strzinek, RA; Crater, TA; Robinson, JG; Fulmer, JJ; Patel, AM; Pereira, ES; Stich, MA; Sultan, S; Geskin, G; Ruoff, GE; Gillespie, E; Bybee, KA; Moriarty, PM; Savin, V; Agaiby, JM; Melucci, MB; Jantzi, CM; Davidson, E; Smith, WB; Treasure, CB; Wakefield, PH; Deck, K; Edris, MA; Gilmore, RM; Seep, MK; Andersen, JL; Detweiler, RO; Rosenfeld, JC; Strobl, DJ; Steinhoff, JP; Adams, A; Estevez, R; Molin, CJ; Kim, CY; Dy, J; Fox, KE; Farris, NR; Wayne, JD; Whitney, RT; Randhawa, PM; Mego, DM; MacDolnald, L; Caputo, RP; Rigolosi, R; VanNatta, B; Pacheco, TR; El-Shahawy, M; Gonzalez, EJ; Guice, MJ; Cherlin, RS; Bays, HE; Shoukfeh, M; Morris, FH; Loy, J; Vora, SK; Staab, PK; Frisoli, A; Kimmel, MA; Cohen, AJ; Green, CB; Whitlock, L; Butuk, DJ; McCartney, MJ; Ables, LR; Acosta, R; Alvarez, JG; Barrera, CM; Benitez, O; Berenguer, RA; Breton, CF; Chiong, R; Delgado, MI; Dufreny, A; Fialkow, JA; Franczek, S; Frias, JJ; Iglesias, C; Landron-Garcia, L; Llerena, SN; Martinez, RF; Miranda, AA; Morytko, JA; Rodriguez, IJ; Sotolongo, R; Suarez-Sarmiento, A; Terrelonge, AE; Vaca, CE; Venereo, JM; Verdeza, C; Zeno, ML; Chilka, S; Felten, WR; Hartman, AN; Shayani, SS; Duprez, D; Knickelbine, T; Chambers, JD; Cone, CL; Broughton, R; Napoli, MC; Seaton, BL; Smith, SK; Reedy, MA; Kesani, MK; Nicol, PR; Stringam, SO; Talano, JV; Barnum, O; Desai, V; Montero, M; Jacks, RK; Kostis, JB; Owen, JG; Makam, SK; Grosman, I; Underberg, JA; Masri, BE; Peters, SS; Serje, J; Lenhard, MJJ; Glover, R; Paraboschi, CF; Lim, EH; Connery, L; Kipgen, W; Bravo, P; DiGiovanna, MJ; Tayoum, H; Gabriel, JD; Ariani, MK; Robinson, MF; Clemens, PC; Corder, CN; Schifferdecker, B; Tahirkheli, NK; Hurling, RT; Rendell, MS; Shivaswamy, V; Madu, IJ; Dahl, CF; Ayesu, K; Kim, C; Barettella, MB; Jamidar, HA; Bloom, SA; Vora, KN; Ong, ST; Aggarwala, G; Sack, G; Blaze, K; Krichmar, P; Murcia, A; Teltser, M; Villaman-Bencosme, Y; Fahdi, IE; Williams, DG; Lain, EL; Garcia, HL; Karim, SN; Francyk, DM; Gordon, MB; Palchick, BA; McKenzie, ME; Gimness, MP; Greiff, J; Ruiz-R, L; Vazquez-Tanus, JB; Schlager, D; Connelly, T; Soroka, E; Hastings, WL; O'Dea, DJ; Purdy, DA; Jackson, B; Arcanese, ML; Strain, JE; Schmedtje, JF; Davis, MG; Labroo, A; Prasada, S; Scott, DL; Vukotic, G; Akhtar, N; Larsen, DC; Rhudy, JM; Zebrack, JS; Bailey, SR; Grant, DC; Mora, A; Perez, JA; Reyes, RG; Sutton, JC; Brandon, DM; First, BP; Brian; Risser, JA; Claudio, J; Figueroa-Cruz, WL; Sosa-Padilla, MA; Tan, AE; Traboulssi, MA; Morcos, NC; Glaser, LA; Bredlau, CE; Ramos, MJ; Kandath, DD; Kaluski, E; Akright, L; Rictor, KW; Pluto, TM; Hermany, PR; Bellingar, B; Clark, GB; Herrod, JN; Goisse, M; Hook, M; Barrington, P; Lentz, JD; Singal, DK; Gleason, GP; Lipetz, RS; Schuchard, TN; Bonner, JH; Forgosh, LB; Lefebvre, GC; Pierpoint, BE; Radin, DM; Stoller, SR; Segall, N; Shah, SA; Ramstad, DS; Nisnisan, JM; Trippett, JM; Benjamin, SA; Labissiere, JC; Nashed, AN; Maaieh, M; Aslam, AA; Mandviwala, M; Budoff, MJ; French, WJ; Vlach, JJ; DeStefano, P; Bayron, CJ; Fraser, NJ; Sandberg, JH; Fagan, TC; Peart, BC; Suryanarayana, PG; Gupta, DK; Lee, MW; Bertolet, BD; Hartley, PA; Kelberman, M; Behmanesh, B; Buynak, RJ; Chochinov, RH; Steinberg, AA; Chandna, H; Bjasker, KR; Perlman, RL; Ball, EM; Pock, J; Singh, S; Baldari, D; Kaster, S; Lovell, JP; Horowitz, BS; Gorman, TA; Pham, DN; Landzberg, JS; Mootoo, KI; Moon, E; Krawczyk, J; Alfieri, AD; Janik, MJ; Herrington, DM; Koilpillai, RN; Waxler, AR; Hoffman, DA; Sahul, ZH; Gumbiner, B; Cropp, A; Fujita, K; Garzone, P; Imai, K; Levisetti, M; Plowchalk, D; Sasson, S; Skaggs, J; Sweeney, K; Vincent, J				Ridker, P. M.; Revkin, J.; Amarenco, P.; Brunell, R.; Curto, M.; Civeira, F.; Flather, M.; Glynn, R. J.; Gregoire, J.; Jukema, J. W.; Karpov, Y.; Kastelein, J. J. P.; Koenig, W.; Lorenzatti, A.; Manga, P.; Masiukiewicz, U.; Miller, M.; Mosterd, A.; Murin, J.; Nicolau, J. C.; Nissen, S.; Ponikowski, P.; Santos, R. D.; Schwartz, P. F.; Soran, H.; White, H.; Wright, R. S.; Vrablik, M.; Yunis, C.; Shear, C. L.; Tardif, J. -C.; Conde, Diego; Colquhoun, David; Missault, Luc; Gregoire, Jean; Gao, Runlin; Urina, Miguel; Solar, Miroslav; Jensen, Henrik Kjaerulf; Grobbee, Diederick; Savolainen, Markku; Schiele, Francois; Montalescot, Gilles; Edes, Istvan; Blake, Gavin; Lotan, Chaim; Maggioni, Aldo; Savonitto, Stefano; Lee, Cheol Whan; Leiva Pons, Jose Luis; Dan, Gheorghe-Andrei; Bruguera Cortada, Jordi; Mellbin, Linda; Kahan, Thomas; Noble, Stephane; Hwang, Juey-Jen; Sritara, Piyamitr; Tokgozoglu, Lale; Revkin, Jim; Tarasenko, Lisa; Borer, Jeffrey S.; Black, Henry; Carmena, Rafael; Furie, Karen L.; McMurray, John; Neaton, James; Zannad, Faiez; O'Neill, Blair; Welty, Francine; McNamara, Robert; Chun, Hyung; Abbott, J. Dawn; Jacoby, Daniel; McPherson, Craig; Jadbabaie, Farid; Pinto, Duane; McCullough, Louise; Silverman, Isaac E.; Sansing, Lauren H.; Dearborn-Tomazos, Jennifer; Foody, Joanne; Schindler, Joseph; Piazza, Gregory; Chakrabarti, Anjan; Pride, Yuri; Gelfand, Eli; Baultrukonis, Dan; Chaudhuri, Sandip; Frederich, Robert; Johnson, Margot; Mridha, Khurshid; Powell, Coralie; Wang, Ellen; Wei, Caimiao; Anderson, Patricia; Buonanno, Marjorie; Epsley, Charlotte; Evans, Barbara; Frolova, Martina; Goetsch, Martina; Hessinger, Diane; Ikehara, Edson; Ivanac, Karen; Kizko, Jan; Le, Kim; McNally-Dufort, Christine; Morocco, Tamara; Nadkarni, Sharayu; Nissen, Thor; Nye, Regina; Pak, Raphael; Pence, Debbie; Redifer, Patricia; Schwartz, Whitney; Sattler, Catherine; Schade, Robin; Sullivan, Beth; Wegner, John; Alvarez, C. A.; Budassi, N.; Vogel, D. R.; Avaca, H.; Conde, D. G.; Estol, C. C. C. J.; Gelersztein, E.; Glenny, J. A.; Hershson, A. R.; Bruno, R. L.; Maffei, L. E.; Soler, J. M. P.; Zaidman, C. J.; Carnero, G. S.; Colombo, H. R.; Jure, H. O.; Luquez, H. A.; Ramos, H. R.; Resk, J. H.; Rusculleda, M. M.; Ulla, M. R.; Caccavo, A.; Farias, E. F.; Wenetz, L. M. M.; Cabella, P. R. F.; Cuadrado, J. A.; Chahin, M.; Mackinnon, I. J.; Zarandon, R. B. S.; Schmidberg, J.; Fernandez, A. A.; Montana, O.; Codutti, O. R.; Gorosito, V. M.; Maldonado, N.; Sala, J.; De La Fuente, R. A. L.; Casabella, T. E. S.; Di Gennaro, J. P. A.; Guerrero, R. A. A.; Alvarez, M. S.; Berli, M.; Botta, C. E.; Montenegro, E. E.; Vico, M. L.; Begg, A.; Lehman, R.; Gilfillan, C. P.; d'Emden, M.; Markovic, T. P.; Sullivan, D.; Aroney, C.; Stranks, S. N.; Crimmins, D. S.; Arstall, M.; Van Gaal, W.; Davis, T.; Aylward, P. E.; Amerena, J.; William, M.; Proietto, J.; Purnell, P. W.; Singh, B.; Arya, K. W.; Dart, A. M.; Colquhoun, D.; Thompson, P.; Davis, S. M.; Carroll, P. A.; De Looze, F.; Jayasinghe, R.; Bhindi, R.; Buysschaert, I.; Sarens, T.; van de Borne, P.; Scott, B. P.; Roosen, J.; Cools, F.; Missault, L. H.; Debroye, C.; Schoors, D. F.; Hollanders, G.; Schroe, H. H.; De Sutter, J.; Hermans, K.; Carlier, M.; van Landegem, P.; Verwerft, J.; Mulleners, T.; Delforge, M. D.; Soufflet, V.; Elegeert, I.; Descamps, O. S.; Janssens, S.; Lemmens, R. C.; Desfontaines, P.; Scheen, A.; Heijmans, S.; Capiau, L.; Vervoort, G.; Carlier, S. G.; Faes, D.; Alzand, B.; Keuleers, S.; De Wolf, L.; Thoeng, J.; De Bruyne, L.; de Santos, M. O. N.; Felicio, J. S.; Areas, C. A. F.; Figueiredo, E. L.; Michalaros, Y. L.; Neuenschwander, F. C.; Reis, G.; Saad, J. A.; Kormann, A. P. M.; Nascimento, C. V.; Precoma, D. B.; Abib, E., Jr.; dos Santos, F. R.; Mello, Y. G.; Saraiva, J. F. K.; Rech, R. L.; Cerci, R.; Fortes, J. A. R.; Rossi, P. R. F.; de Lima e Silva, F. A.; Hissa, M.; Silva, R. P.; de Souza, W. K. S. B.; Filho, F. V. Guimaraes; Mangili, O. C.; de Oliveira Paiva, M. S. M.; Tumelero, R.; Abrantes, J. A. M.; Caramori, P. R.; Dutra, O. P.; Leaes, P. E.; Manenti, E. R.; Polanczyk, C. A.; Farias, F. A. Bandeira e; de Moraes, J. B. X. Junior; Russo, L. A.; Alves, A. R., Jr.; Dracoulakis, M. D. A.; Ritt, L. E. F.; Saporito, W. F.; Herdy, A. H.; Maia, L. N.; Sternieri, M. V. B. B.; Ayoub, J. C. A.; Bianco, H. T.; da Costa, F. A.; Eliaschewitz, F. G.; Fonseca, F. A. H.; Nakandakare, E. R.; Bonansea, T. C. P.; Castro, N. M. S.; de Barros e Silva, P. G. M.; Smith, P.; Botelho, R. V.; Resende, E. S.; Barbieri, D. S. G.; Hernandes, M. E.; Bajaj, H.; Beaudry, P.; Berlingieri, J. C.; Salter, T. J.; Ajala, B.; Anderson, T. J.; Nanji, A.; Pandey, S.; Desrosiers, D.; Gaudet, D.; Moran, G.; Csanadi, M. A.; StAmour, E.; Cusimano, S.; Halperin, F. A.; Babapulle, M.; Vizel, S.; Petrella, J.; Spence, J. D.; Gupta, N.; Tellier, G.; Bourgeois, R.; Gregoire, J. C.; Wesson, T.; Zadra, R.; Twum-Barima, D. Y.; Cha, J. Y.; Hartleib, M. C.; Bergeron, J.; Chouinard, G.; McPherson, T. P.; Searles, G.; Peterson, S. R.; Mukherjee, A.; Lepage, S.; Conway, J. R.; Kouz, S. M.; Dion, D.; Pesant, Y.; Cheung, S. S.; Goldenberg, R. M.; Aronson, R.; Gupta, A. K.; O'Mahoney, M.; Pliamm, L.; Teitelbaum, I.; Hoag, G. N.; Nadra, I. J.; Yared, Z.; Yao, L. C.; Nguyen, T.; Saunders, K. K.; Li, Y.; Wang, D.; Li, J.; Yang, X.; Du, Y.; Wang, G.; Yang, P.; Zhang, X.; Xu, P.; Zhao, Y.; Chen, J.; Li, S.; Li, W.; Zhang, L.; Zhu, Y.; Zhang, Y.; Zhou, C.; Wang, Y.; Liu, F.; Ma, Y.; Ti, Z.; Zeng, X.; Zhou, Y.; Cui, G.; Li, D.; Xue, L.; Jiang, J.; Lian, Y.; He, Y.; Mendoza, J. A.; Bonfanti, J. A. C.; Dada, F. A. T.; Urina-Triana, M. A.; Rodriguez, W. R. B.; Sanchez, M. L. J.; Lozno, H. Y.; Triana, E. H.; Arambula, R. M. S.; Rico-Carrillo, A. E.; Gallo, H. J. H.; Catano, J. S. V.; Jattin, F. G. M.; Plazas, J. A. R.; Gomez, J. E. F.; Botero-Lopez, R.; Gomez, N. I. J.; Munoz, C. F. J.; Pelaez, S. V.; Eraso, A. M.; Goyes, A. R. B.; Elbl, L.; Fiserova, N.; Vesely, J.; Wasserburger, B.; Blaha, V.; Vojacek, J.; Maskova, P.; Hutyra, M.; Vrkoc, J.; Hala, T.; Vodnansky, P.; Bocek, P.; Cifkova, R.; Bufka, V.; Ceska, R.; Machkova, M.; Zidkova, E.; Lukac, M.; Mikusova, T.; Kellnerova, I.; Kuchar, L.; Ferkl, R.; Cech, V.; Zemek, S.; Monhart, Z.; Davidsen, F.; Joensen, A.; Lihn, A. S.; Rasmussen, T. K.; Wiggers, H.; Lindgren, L. M.; Schmidt, U.; Galatius, S.; Sillesen, H.; Schou, J. Bronnum; Thomsen, K. K.; Urhammer, S.; Jeppensen, J.; Schou, M.; May, O.; Steffensen, R.; Nielsen, W. B.; Nielesen, T.; Jepsen, J. M.; Rai, A.; Sykulski, R.; Andersen, L. T.; Rickers, H.; Frost, L.; Lomholdt, Js; Egstrup, K.; Wermuth, S.; Klausen, C.; Lassus, J.; Palomaki, A.; Khari, J.; Tatlisumak, T.; Kekki, S.; Vanttinen, E.; Strandberg, A.; Valtonen, M.; Sia, S. M.; Nerg, O.; Puhakka, M.; Savolainen, M.; Strand, J.; Timonen, M.; Levola, J.; Arstila, L.; Taurio, J.; Kantola, I.; Suomi, J.; Humaloja, K.; Askonen, K.; Schiele, F.; Sibon, I.; Zemour, G.; Goube, P.; Petit, C.; Chati, Z.; Range, G.; Rabahi, F.; Rihani, R.; Bergerot, C.; Roubille, F.; Boye, A.; Probst, V.; Ferrari, E.; Cayla, G.; Thouvenot, E.; Delarche, N.; Couffinhal, T.; Coisne, D.; Paillard, F.; Elbaz, M.; Decoulx, E.; Angoulvant, D.; Agraou, B.; Caudmont, S.; Berrouschot, J.; Lauer, B.; Schoell, I.; Trenk, D.; Derwahl, K-M; Khariouzov, A.; Proepper, F.; Stawowy, P.; Stephan, U. Da; Stoessel, J.; Voehringer, H-F; Dorsel, T.; Stellbrink, C.; Rinke, A.; Northroff, J.; Bourhaial, H.; Stratmann, M.; Wetzel, T.; Axthelm, C.; Guenzel, A.; Weigmann, I.; Faghih, M.; Hagemann, D.; Schaefer, A.; Weber, D.; Luedemann, J.; Contzen, C.; Kornmann, M. O.; Winkelmann, B.; Simon, J.; Felix, S.; Brauer, C.; Laufs, U.; Schmidt, E.; Marten, I.; Licka, M.; Heisters, J.; Appel, K. F.; Kleinecke-Pohl, U.; Klein, C.; von Hodenberg, E. F.; Maus, O.; Sigal, H.; Taeschner, H.; Schwimmbeck, P.; Lemke, B.; Perings, C.; Illies, G.; Pfuetzner, A.; Salbach, P.; Hengstenberg, C.; Kohler, A.; Mudra, H.; Behnke, T.; Baar, M.; Jeserich, M.; Scholz, G.; Naudts, I.; Voller, H.; Herrmann, H-J; von Engelhardt, C. B.; Gerke, S.; Pohlmeier, L.; Schaufele, T.; Woehrle, J.; Al-Zoebi, A.; Horacek, T.; Peterfai, E.; Kemeny, V.; Lakatos, F.; Bod, E.; Andrassy, P.; Andreka, P.; Balo, T.; Davidovits, Z.; Laszlo, Z.; Nagy, K.; Papp, A.; Somogyi, A.; Toldy-Schedel, E.; Vertes, A.; Voros, P.; Paragh, G.; Martyin, T.; Hajdu, C.; Deak, L.; Farago, K.; Nagy, A.; Kirschner, R.; Koszegi, Z.; Zilahi, Z.; Toth, K.; Wittmann, I.; Bajcsi, D.; Reiber, I.; Toth, L.; Benczur, B.; Nagy, L.; Sydo, T.; Lupkovics, G.; Oroszlan, T.; Crean, P.; Mahon, N. G.; McAdam, B.; MacNeill, B.; Katz, A.; Tsalihin, D.; Vazan, A.; Eitan, A.; Lewis, B. S.; Gavish, D.; Wainstein, J.; Mosenzon, O.; Mosseri, M.; Vishlitzky, V.; Atar, S.; Nseir, W. B.; Brenner, H.; Elis, A.; Fuchs, S.; Shimon, I.; Solodky, A.; Goldhaber, A.; Tanne, D.; Knobler, H.; Kracoff, O. H.; Hussein, O.; Auriel, E.; Chorin, E.; Sharir, T.; Bitzur, R.; Shechter, M.; Antonicelli, R.; Franceschini, E.; Porcu, M.; Sesti, G.; Maggiolini, S.; Salvioni, A.; Filardi, P. P.; Trimarco, B.; Averna, M.; Pasqualini, L.; Pirro, M.; Pantaleoni, M.; Piovaccari, G.; Arca, M.; Fedele, F.; Roncon, L.; Anselmi, M.; Sganzerla, P.; Morocutti, G.; Bonora, E.; Dimas, A. L.; Esperon, G. A. L.; Morales-Villegas, E.; Isunza, J. M. R.; Beltran, L. G. M.; Molina, C. A. A.; Garcia, D. K.; Ruiz, L. A. N.; Reyna, L. S.; De los Rios Ibarra, M. O.; Soto, J. R. L.; Gonzalez-Ortiz, M.; Herrera-Marmolejo, M.; Ramos, S. A. J.; Ramos-Lopez, G. A.; Stobschinski, C. A.; AguilarSalinas, C. A.; Alpizar-Salazar, M.; Jimenez-Sanchez, M.; Sanchez Mijangos, J. H.; Elizondo Moreno, E. R.; Garcia Castillo, A.; Garcia Hernandez, P. A.; Gonzalez-Gonzalez, J. G.; Riojas Charles, C. M.; Valdez Lopez, H. G.; Nuriulu Escobar, P. L.; Lechuga Martin del Campo, A.; Castro Montes, B. E.; Mendez Bucio, A.; Rodriguez-Briones, I.; Torre Amione, G.; Violante Ortiz, R.; Luna Ceballos, R. I.; Lopez Rosas, E.; Bax, W. A.; Alhakim, M.; van de Wiel, A.; Liem, S-S; Groutars, R. G. E. J.; Herrman, J-P R.; Hovingh, G. K.; van de Wetering, M. L.; van Royen, N.; Groenemeijer, B. E.; Hoedemaker, G.; Schaap, J.; Ronner, E.; Angun, M.; Mairuhu, A. T.; Van Alem, A. P.; Martens, F. M. A. C.; Heijmeriks, J. A.; van Hal, J. M. C.; Schoofs, M. W.; den Hartog, F. R.; Kentgens, S.; Post, J. C.; Louwerenburg, J. W.; van Rossum, P.; Viergever, E. P.; Donders, S. H.; Kamphuisen, P. W.; van Beek, E.; Nijmeijer, R.; Lenderink, T.; Schreuder, T.; Kuijper, A. F.; The, S. H.; Hof-Wiersma, J. J. Van Het; Tichelaar, P.; Westerndorp, I.; Breedveld, R. W.; Romer, T. J.; Bogaard, K.; Van Koningsbruggen, P.; Kroon, A. A.; Hoogslag, P. A.; Rensing, B. J.; Cramer, E.; Remmen, J. J.; Riksen, N. P.; Bokern, M. J.; Cabezas, M. C.; Mulder, H.; Nierop, P. R.; van Kempen, W. W.; Zoet-Nugteren, S. K.; van Daele, M. E.; Swart, H. P.; van der Zwaan, C. T.; Hermans, W. R.; Magro, M.; van de Wal, R. M. A.; Hassink, R. J.; Visseren, F. L.; Veenendaal, A.; De Nooijer, C.; Troquay, R. P.; Imholz, B. P.; van der Meer, P.; Visser, Rieuwk P.; van Leendert, R. J.; Gosselink, M. A.; Baker, J.; Benatar, J. R.; Kerr, J.; Pryke, J. R.; Scott, R. S.; Millar-Corte, G. D.; Williams, M.; Montgomery, B.; Venter, D. J.; Ternouth, I. F.; DeCaigney, S. C.; Hart, H. H.; Corin, A.; Garden, P. I.; Sheahan, D.; Harding, Sc A.; Korecki, J.; Supronik, J.; Styczkiewicz, M.; Bijata-Bronisz, R.; Rusicka, T.; Walczak, M.; Krolikowski, Z.; Ostrowski, J.; Lukaszewicz, M.; Przekwas-Jaruchowska, M.; Zieba, B.; Miekus, P.; Orkwiszewska-Nalewajko, A.; Piepiorka, M.; Kubalski, P.; Wychota, K.; Blach, E.; Ochala, A.; Okopien, B.; Wronska, D.; Janion, M.; Czarnecka, D.; Kolodziejczyk, J.; Konieczynska, M.; Landa, K.; Mirek-Bryniarska, E.; Necki, M.; Pasternak, D. A.; Rozpondek, P.; Trebacz, J.; Walczewska, J.; Sidor, M.; Broncel, M.; Drozdz, J.; Kosmider, M.; SaryuszWolska, M.; Kucharska, D.; Opalinska, E.; Pijanowski, Z.; Wozniak, I.; Banaszkiewicz, K.; Klecha, A.; Horodecki, M.; Piskorz-Wapinska, J.; Kobielusz-Gembala, I.; Kim, M. H.; Kim, D-K; Cho, B. R.; Kim, K-S; Her, S-H; Lee, S. Y.; Rhee, M. Y.; Kim, K.; Kang, W-C; Kim, D. H.; Cho, Y-S; Kim, S. H.; Lee, C. W.; Rim, S. J.; Tahk, S-J; Jeon, H. K.; Yoon, J.; Mociran, M.; Pop, C. F.; Minescu, B.; Andrei, L. D.; Radoi, M.; Calin, A.; Ciomag, R. M.; Copaci, I.; Dan, G. A.; Fruntelata, A-G; Popescu, M.; Tivadar, S.; Roman, G.; Avram, R. I.; Mistodie, C. V.; Morosanu, M.; Popa, A. R.; Popescu, M. L.; Popoviciu, M. S.; Tase, A.; Busegeanu, M.; Popescu, A.; Szilagyi, I.; Sitterli-Natea, C. N.; Maximov, D. M.; Munteanu, M.; Negrisanu, G. D.; Kuzin, A.; Popov, D.; Shapovalova, J.; Vishneva, E.; Shutemova, E.; Pasechnik, E.; Bogdanov, E.; Khasanov, N.; Barbarash, O. L.; Shangina, O. A.; Tarasov, N.; Solonev, O.; Kosmacheva, E.; Chernyatina, M. A.; Ginzburg, M.; Blokhin, A.; Bulanova, N.; Drapkina, O. M.; Gordeev, I. G.; Libov, I. A.; Lomakin, N.; Panchenko, E.; Shogenov, Z. S.; Zateyshchikov, D.; Klein, G.; Motylev, I.; Belenkiy, D. I.; Demin, A.; Nikolaev, K. Y.; Oleynikov, V.; Zrazhevskiy, K.; Katelnitskiy, I.; Khaisheva, L.; Aksentiev, S.; Nedoshivin, A.; Popova, V. B.; Agafina, A. S.; Ballyuzek, M.; Baranova, E.; Burova, N.; Eryshev, S.; Filippov, A.; Goloshchekin, B. M.; Konstantinov, V.; Kostenko, V. A.; Simanenkov, V. I.; Volkova, A.; Duplyakov, D.; Reshetko, O.; Shvarts, Y.; Kuznetsov, V. A.; Samoylova, Y. G.; Tolkacheva, V.; Shalaev, S. V.; Khokhlov, A. L.; Malygin, A.; Shilkina, N. P.; Yakusevich, V. V.; Margoczy, R.; Zubek, V.; Dzupina, A.; Dubrava, J.; Dulkova, K.; Fabryova, L.; Gaspar, L.; Kamensky, G.; Kokles, M.; Raslova, K.; Soosova, I.; Stevlik, J.; Strbova, J.; Sumbal, J.; Uhliar, R.; Micik, J.; Truban, J.; Fedacko, J.; Pastrnakova, E.; Pella, D.; Fazekas, F.; Ambrovicova, V.; Kycina, P.; Martinka, E.; Nociar, J.; Belicova, M.; Banik, M.; Kanderkova, D.; Hranai, M.; Duris, T.; Krahulec, B.; Benacka, J.; Vinanska, D.; Roskova, E.; Skripova, D.; Macek, V.; Vohnout, B.; Buganova, I.; Engelbrecht, J. M.; Pretorius, M. M.; Ebrahim, I. O.; Bayat, J.; Ganesh, S.; Ranjith, N.; Coetzer, T. F.; Jacovides, A.; Distiller, L. A.; Hellig, F. S.; Engelbrecht, I. V.; Mahomed, A. A.; Blignault, S. C.; Burgess, L. J.; Kotze, H. J.; van Nieuwenhuizen, E.; Musungaie, D. B.; Emanuel, S.; van der Walt, E.; Pretorius, C. E.; Roos, J. S.; Roux, S. M.; Badat, A. E.; Fouche, L.; Vahed, Y. A. K.; van Resburg, D. Jansen; van Zyl, L. J.; Soto Gonzalez, A.; Diaz, J. L.; Segura, T.; Botella Serrano, M.; Botas Rodrigues, J.; Molto-Jorda, J. M.; Dominguez Escribano, J. R. R.; Sogorb Garri, F.; Blanco Coronado, J. L.; Gaztambide Saenz, M. S.; Brotons Cuixart, C.; Garcia-Moll Marimon, X.; Gonzalbez Morgaez, J. D.; Maisterra Santos, O.; Roquer Gonzalez, J.; Sobrino-Martinez, J.; Chueca Fernandez, J. E.; Narejos, S.; Suarez Garcia, S.; Perez Martinez, P.; Figueras Camos, R.; Medrano Martinez, V.; Bellido Guerrero, D.; Martinez Deben, F.; Vila Belmonte, A.; Mediavilla Garcia, J. D.; Romero Hinojosa, J. A.; Martorell Mateu, E.; Cequier Fillat, A. R.; Pinto Sala, X.; Adroer Martori, R.; Bueno Diez, M.; Lopez Cano, C.; Worner Diz, F.; Gonzalez Juanatey, C.; Alvarez-Sala Walther, L. A.; Garcia Diaz, J. De Dios; Garcia Puig, J.; Jodar Gimeno, E.; Plaza Perez, I.; Suarez-Fernandez, C.; Tunon, J.; Zamorano Gomez, J. L.; Brito Sanfiel, M. A.; Escudier Villa, J. M.; de Mora Martin, M.; Dominguez Lopez, M.; Hernandez Garcia, J. M.; Tinahones Madueno, F. J.; Perez Paredes, M.; Aracil Villar, J.; Barreda Gonzalez, M. J.; Ripoll Vera, T. V.; Tofe Povedano, S.; Sanchez Alvarez, J.; Martinez Via, L.; Robles Iniesta, A.; Masana, L.; Vinyoles Bargallo, E.; Calvo Gomez, C.; Gonzalez Juanatey, J. R.; Cruz Fernandez, J. M.; De La Cuesta Mayor, C.; Duran Garcia, S.; Jimenez Hernandez, M. D.; Morales Portillo, C.; Muniz Grijalvo, O.; De Castro, R.; Taverna Llaurado, E.; Pons Amate, J. M.; Terns Riera, M.; Civeira Murillo, F.; Linderfalk, C.; Curiac, D.; Saldeen-Nilehn, K.; Koskinen, P.; Khalili, P.; Tortensson, I.; Lindholm, C-J; Luts, A.; Koskinen, P. T.; Gottsater, A.; Persson, B. E.; Mooe, T.; Larnefeldt, H.; Boman, K.; Crisby, M.; Rasmanis, G.; Tengmark, B-O; Witt, N.; Hagstrom, E.; Viklund, J.; Muller, C.; Mach, F.; Burnier, M.; Nanchen, D.; Wuerzner, G.; Banyai, M.; Moccetti, T.; Miserez, A. R.; Bilz, S.; Weber, K.; Lai, W-T; Chang, K-C; Ueng, K-C; Tsai, W-C; Chiang, C-E; Hou, C.; Pei, D.; Krittayaphong, R.; Kiatchoosakun, S.; Srimahachota, S.; Boonyavarakul, A.; Jintapakorn, W.; Gullu, H.; Onrat, E.; Erkan, A. F.; Demirci, D.; Sari, R.; Ceyhan, C.; Ari, H.; Araz, M.; Degertekin, M.; Goktekin, O.; Uresin, A. Y.; Yigit, Z.; Akdeniz, B.; Comlekci, A.; Kayikcioglu, M.; Sahin, T.; Ozcan, T.; Durakoglugil, E.; Asamoah-Owusu, N.; Reed, R.; Bakhai, A.; Dixon, L.; Sharma, R.; Avornyo, A. A.; Jones, A. F.; Lip, G.; Clark, R.; Banerjee, M.; Wakeling, J.; Arden, C.; Blagden, M. D.; Walukiewica, P.; Marshall, A.; Maxwell, T. G.; Gunstone, A. E.; Kadr, H. H.; Patle, R.; Arif, I.; Jhund, P. S.; McKaig, G.; Douglas, F.; Mierzejewski, L.; Turner, W.; Sathyapalan, T.; Ivan, P.; Manoj, A.; Rice, S.; Collier, D. J.; Nair, D. R.; Thom, S.; Fiore, G.; De Belder, M.; Price, D.; Sobolewska, J.; Martin, S.; Takhar, A.; Moriarty, A.; Kondagunta, V.; Myhill, T.; Gibson, J. M.; Cecil, J. T.; Halcox, J.; Annamalai, N.; Gorog, D. A.; McCormack, T.; Pegge, N.; Field, A.; Adams, F.; Klein, J. J.; Busch, R. S.; Bretton, E. M.; Jaffrani, N.; Salacata, A.; Assadourian, A.; Gogia, H. S.; Dyke, C. K.; Rubenfire, M.; Essandoh, L. K.; Welker, J. A.; Ledesma, G.; Lupovitch, S.; Delgado, J. P.; Hendrix, E. L.; Quyyumi, A. A.; Riesenberg, R. A.; Robertson, D. G.; Weinstein, D. L.; Weiss, R.; Casaubon, L.; Gammon, R. S.; Brar, H. S.; Bittar, G. D.; Guarnieri, T. T.; Incer, C. S., Jr.; Quraishi, A. M.; Saeed, S.; Albert, M.; Sotolongo, R. P.; Bernard, J. V.; Karlsbergg, R. P.; Lepor, N. E.; Kirby, W. E.; McLean, B.; Miller, A. P.; Ovalle, F.; Townsend, J. C.; Beckett, P. L.; Eaves, W. B.; West, S. H.; Kosinski, E. J.; Zarich, S. W.; Mahal, S. S.; Maw, K.; Maynard, K. M.; Chen, J. C.; Gelormini, J.; Gottlieb, D. W.; Gabra, N. W.; Narayan, P.; Sparks, J.; Field, J. C.; Willits, V. L.; O'Steen, M. B.; Pasquini, J. A.; Sensebrenner, J. W.; Yarows, S. A.; Hiotis, L.; Jagielo, T. J.; Levinson, D. J.; Diller, P. M.; Kereiakes, D. J.; Turner, T. A.; Vincent, S.; Camp, A. D.; Denker, P. S.; Manning, M. B.; Rocco, M. B.; Stamps, H. B.; Strader, J. R.; Uusinarkaus, K. T.; Kennett, J. D.; Leichter, S. B.; McNeil, D. L.; Schumacher, D. R.; Chang, A. R.; Ellison, H. S.; Updegrove, J. D.; Hamroff, G. S.; Kay, J. S.; Marar, I. E.; Flores, E.; Saini, S.; Abdullah, S.; Berk, M. R.; Fordan, S.; Joshi, P. H.; McCullough, P. A. A.; Reynolds, R. D.; Rosenstock, J.; Sachson, R. A.; Shammas, N.; Fishbein, G. J.; Randall, W. J.; Henderson, D. A.; Nash, M. L.; Barker, B. A.; Cohen, S. S.; Seidman, B.; Odekirk, L. L.; Grillo, R. S.; Martinez, L. M.; Multani, P.; Alwine, L. K.; McGarvey, J. F.; Mollerus, M. E.; Miller, A. B.; Kotek, L. W.; Changlani, M.; Zavaro, S. H.; Munoz, F.; Mehta, P. M.; Helm, R. J.; Farhat, N. Z.; Farsad, R.; Raoof, T. J.; Shultz, J. H.; Geohas, J. G.; Allaw, M. A.; Dela Llana, A.; Gutmann, J. E.; Inzerello, A. T.; Alappat, P.; George, A. R.; Haddad, T. M.; Lillestol, M. J.; Grodman, R.; Peniston, J. H.; Wadud, K.; Garcia, B.; Hamilton, M. E.; Lerman, S.; Perloff, D. E.; Graff, A.; Saxena, S.; Alvarado, O. P.; Malik, A.; Reddy, R. D.; Kinzfogl, G.; Cornett, G. M.; Norwood, P. C.; Gilbert, J. M.; Willis, J. G.; McGrew, F.; Sharma, S.; Castro, M. A.; Cucher, F. H.; Altafullah, I. M.; Khurana, S.; Knutson, T. J.; Kinnaman, S. J.; Stuckey, T.; Pudi, K. K.; Mayfield, R. K.; Funk, G. S.; Nixon, W. A.; Dor, I.; Boyett, B. E.; Srivastava, S.; Elosegui, A. M.; Isserman, S. M.; Cheek, H. B.; Promisloff, S. D.; Tami, L. F.; Zeig, S.; Fitz-Patrick, D.; Dave, K. N.; Ahmad, A.; Arain, S.; Ballantyne, C. M.; Doshi, A.; El Hafi, S. E.; Feldman, J.; Fragoso, V. G.; Gilford, T.; Hoffman, A. S.; Pouzar, J. E.; Vivekananthan, K.; Ansari, S. H.; Strzinek, R. A.; Crater, T. A.; Robinson, J. G.; Fulmer, J. J.; Patel, A. M.; Pereira, E. S.; Stich, M. A.; Sultan, S.; Geskin, G.; Ruoff, G. E.; Gillespie, E.; Bybee, K. A.; Moriarty, P. M.; Savin, V.; Agaiby, J. M.; Melucci, M. B.; Jantzi, C. M.; Davidson, E.; Smith, W. B.; Treasure, C. B.; Wakefield, P. H.; Deck, K.; Edris, M. A.; Gilmore, R. M.; Seep, M. K.; Andersen, J. L.; Detweiler, R. O.; Rosenfeld, J. C.; Strobl, D. J.; Steinhoff, J. P.; Adams, A.; Estevez, R.; Molin, C. J.; Kim, C. Y.; Dy, J.; Fox, K. E.; Farris, N. R.; Wayne, J. D.; Whitney, R. T.; Randhawa, P. M.; Mego, D. M.; MacDolnald, L.; Caputo, R. P.; Rigolosi, R.; VanNatta, B.; Pacheco, T. R.; El-Shahawy, M.; Gonzalez, E. J.; Guice, M. J.; Cherlin, R. S.; Bays, H. E.; Shoukfeh, M.; Morris, F. H.; Loy, J.; Vora, S. K.; Staab, P. K.; Frisoli, A.; Kimmel, M. A.; Cohen, A. J.; Green, C. B.; Whitlock, L.; Butuk, D. J.; McCartney, M. J.; Ables, L. R.; Acosta, R.; Alvarez, J. G.; Barrera, C. M.; Benitez, O.; Berenguer, R. A.; Breton, C. F.; Chiong, R.; Delgado, M. I.; Dufreny, A.; Fialkow, J. A.; Franczek, S.; Frias, J. J.; Iglesias, C.; Landron-Garcia, L.; Llerena, S. N.; Martinez, R. F.; Miranda, A. A.; Morytko, J. A.; Rodriguez, I. J.; Sotolongo, R.; Suarez-Sarmiento, A.; Terrelonge, A. E.; Vaca, C. E.; Venereo, J. M.; Verdeza, C.; Zeno, M. L.; Chilka, S.; Felten, W. R.; Hartman, A. N.; Shayani, S. S.; Duprez, D.; Knickelbine, T.; Chambers, J. D.; Cone, C. L.; Broughton, R.; Napoli, M. C.; Seaton, B. L.; Smith, S. K.; Reedy, M. A.; Kesani, M. K.; Nicol, P. R.; Stringam, S. O.; Talano, J. V.; Barnum, O.; Desai, V.; Montero, M.; Jacks, R. K.; Kostis, J. B.; Owen, J. G.; Makam, S. K.; Grosman, I.; Underberg, J. A.; Masri, B. E.; Peters, S. S.; Serje, J.; Lenhard, M. J. J.; Glover, R.; Paraboschi, C. F.; Lim, E. H.; Connery, L.; Kipgen, W.; Bravo, P.; DiGiovanna, M. J.; Tayoum, H.; Gabriel, J. D.; Ariani, M. K.; Robinson, M. F.; Clemens, P. C.; Corder, C. N.; Schifferdecker, B.; Tahirkheli, N. K.; Hurling, R. T.; Rendell, M. S.; Shivaswamy, V.; Madu, I-J; Dahl, C. F.; Ayesu, K.; Kim, C.; Barettella, M. B.; Jamidar, H. A.; Bloom, S. A.; Vora, K. N.; Ong, S. T.; Aggarwala, G.; Sack, G.; Blaze, K.; Krichmar, P.; Murcia, A.; Teltser, M.; Villaman-Bencosme, Y.; Fahdi, I. E.; Williams, D. G.; Lain, E. L.; Garcia, H. L.; Karim, S. N.; Francyk, D. M.; Gordon, M. B.; Palchick, B. A.; McKenzie, M. E.; Gimness, M. P.; Greiff, J.; Ruiz-R, L.; Vazquez-Tanus, J. B.; Schlager, D.; Connelly, T.; Soroka, E.; Hastings, W. L.; O'Dea, D. J.; Purdy, D. A.; Jackson, B.; Arcanese, M. L.; Strain, J. E.; Schmedtje, J. F., Jr.; Davis, M. G.; Labroo, A.; Prasada, S.; Scott, D. L.; Vukotic, G.; Akhtar, N.; Larsen, D. C.; Rhudy, J. M.; Zebrack, J. S.; Bailey, S. R.; Grant, D. C.; Mora, A.; Perez, J. A.; Reyes, R. G.; Sutton, J. C.; Brandon, D. M.; First, B. P.; Brian; Risser, J. A.; Claudio, J.; Figueroa-Cruz, W. L.; Sosa-Padilla, M. A.; Tan, A. E.; Traboulssi, M. A.; Morcos, N. C.; Glaser, L. A.; Bredlau, C. E.; Ramos, M. J.; Kandath, D. D.; Kaluski, E.; Akright, L.; Rictor, K. W.; Pluto, T. M.; Hermany, P. R.; Bellingar, B.; Clark, G. B.; Herrod, J. N.; Goisse, M.; Hook, M.; Barrington, P.; Lentz, J. D.; Singal, D. K.; Gleason, G. P.; Lipetz, R. S.; Schuchard, T. N.; Bonner, J. H.; Forgosh, L. B.; Lefebvre, G. C.; Pierpoint, B. E.; Radin, D. M.; Stoller, S. R.; Segall, N.; Shah, S. A.; Ramstad, D. S.; Nisnisan, J. M.; Trippett, J. M.; Benjamin, S. A.; Labissiere, J-C; Nashed, A. N.; Maaieh, M.; Aslam, A. A.; Mandviwala, M.; Budoff, M. J.; French, W. J.; Vlach, J. J.; DeStefano, P.; Bayron, C. J.; Fraser, N. J.; Sandberg, J. H.; Fagan, T. C.; Peart, B. C.; Suryanarayana, P. G.; Gupta, D. K.; Lee, M. W.; Bertolet, B. D.; Hartley, P. A.; Kelberman, M.; Behmanesh, B.; Buynak, R. J.; Chochinov, R. H.; Steinberg, A. A.; Chandna, H.; Bjasker, K. R.; Perlman, R. L.; Ball, E. M.; Pock, J.; Singh, S.; Baldari, D.; Kaster, Sr; Lovell, J. P.; Horowitz, B. S.; Gorman, T. A.; Pham, D. N.; Landzberg, J. S.; Mootoo, K. I.; Moon, E.; Krawczyk, J.; Alfieri, A. D.; Janik, M. J.; Herrington, D. M.; Koilpillai, R. N.; Waxler, A. R.; Hoffman, D. A.; Sahul, Z. H.; Gumbiner, Barry; Cropp, Anne; Fujita, Kayo; Garzone, Pamela; Imai, Keiji; Levisetti, Matteo; Plowchalk, David; Sasson, Stephen; Skaggs, Judy; Sweeney, Kevin; Vincent, John		SPIRE Cardiovascular Outcome Inve; Boston Clinical Res Inst; C5; Julius Clinical; Acurian; COVANCE; ICON Analytical Lab; ICON; IMI; Miller Tanner Associates	Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STATIN THERAPY; GENETIC-VARIANTS; REDUCING LIPIDS; PCSK9; REDUCTION; EVENTS	BACKGROUND Bococizumab is a humanized monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) and reduces levels of low-density lipoprotein (LDL) cholesterol. We sought to evaluate the efficacy of bococizumab in patients at high cardiovascular risk. METHODS In two parallel, multinational trials with different entry criteria for LDL cholesterol levels, we randomly assigned the 27,438 patients in the combined trials to receive bococizumab (at a dose of 150 mg) subcutaneously every 2 weeks or placebo. The primary end point was nonfatal myocardial infarction, nonfatal stroke, hospitalization for unstable angina requiring urgent revascularization, or cardiovascular death; 93% of the patients were receiving statin therapy at baseline. The trials were stopped early after the sponsor elected to discontinue the development of bococizumab owing in part to the development of high rates of antidrug antibodies, as seen in data from other studies in the program. The median follow-up was 10 months. RESULTS At 14 weeks, patients in the combined trials had a mean change from baseline in LDL cholesterol levels of -56.0% in the bococizumab group and +2.9% in the placebo group, for a between-group difference of -59.0 percentage points (P<0.001) and a median reduction from baseline of 64.2% (P<0.001). In the lower-risk, shorter-duration trial (in which the patients had a baseline LDL cholesterol level of >= 70 mg per deciliter [1.8 mmol per liter] and the median follow-up was 7 months), major cardiovascular events occurred in 173 patients each in the bococizumab group and the placebo group (hazard ratio, 0.99; 95% confidence interval [CI], 0.80 to 1.22; P = 0.94). In the higher-risk, longer-duration trial (in which the patients had a baseline LDL cholesterol level of = 100 mg per deciliter [2.6 mmol per liter] and the median follow-up was 12 months), major cardiovascular events occurred in 179 and 224 patients, respectively (hazard ratio, 0.79; 95% CI, 0.65 to 0.97; P=0.02). The hazard ratio for the primary end point in the combined trials was 0.88 (95% CI, 0.76 to 1.02; P=0.08). Injection-site reactions were more common in the bococizumab group than in the placebo group (10.4% vs. 1.3%, P<0.001). CONCLUSIONS In two randomized trials comparing the PCSK9 inhibitor bococizumab with placebo, bococizumab had no benefit with respect to major adverse cardiovascular events in the trial involving lower-risk patients but did have a significant benefit in the trial involving higher-risk patients.	[Ridker, P. M.; Glynn, R. J.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Ridker, P. M.; Glynn, R. J.] Harvard Med Sch, Boston, MA USA; [Revkin, J.; Brunell, R.; Curto, M.; Masiukiewicz, U.; Schwartz, P. F.; Yunis, C.; Shear, C. L.] Pfizer, New York, NY USA; [Amarenco, P.] Sorbonne Paris Cite Univ, Paris Diderot, Paris, France; [Civeira, F.] Univ Zaragoza, IIS Aragon, Zaragoza, Spain; [Flather, M.] Univ East Anglia, Norwich, Norfolk, England; [Soran, H.] Cent Manchester Univ Hosp, Manchester, Lancs, England; [Gregoire, J.; Tardif, J. -C.] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Jukema, J. W.] Leiden Univ, Med Ctr, Leiden, Netherlands; [Kastelein, J. J. P.] Univ Amsterdam, Acad Med Ctr, Amsterdam, Netherlands; [Mosterd, A.] Meander Med Ctr, Amersfoort, Netherlands; [Karpov, Y.] Russian Cardiol Res & Prod Ctr, Moscow, Russia; [Koenig, W.] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich Heart Alliance, Munich, Germany; [Lorenzatti, A.] Cordoba Hosp, Cordoba, Argentina; [Manga, P.] Univ Witwatersrand, Johannesburg, South Africa; [Miller, M.] Univ Maryland, Baltimore, MD 21201 USA; [Murin, J.] Univ Comenius, Bratislava, Slovakia; [Nicolau, J. C.] Univ Sao Paulo, Med Sch, Inst Heart, Sao Paulo, Brazil; [Santos, R. D.] Univ Sao Paulo Med Sch Hosp, Lipid Clin Heart Inst, Sao Paulo, Brazil; [Nissen, S.] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Ponikowski, P.] Wroclaw Med Univ, Wroclaw, Poland; [White, H.] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand; [Wright, R. S.] Mayo Clin, Rochester, MN USA; [Vrablik, M.] Charles Univ Prague, Fac Med 1, Prague, Czech Republic	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Pfizer; University of Zaragoza; University of East Anglia; Universite de Montreal; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Meander Medisch Centrum; National Medical Research Center of Cardiology; German Heart Centre Munich; Munich Heart Alliance; Technical University of Munich; University of Witwatersrand; University System of Maryland; University of Maryland Baltimore; Comenius University Bratislava; Universidade de Sao Paulo; Universidade de Sao Paulo; Cleveland Clinic Foundation; Wroclaw Medical University; Auckland City Hospital; Mayo Clinic; Charles University Prague	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA.	pridker@partners.org	Drapkina, Oxana/G-8443-2016; Lepor, Norman/AAP-2488-2021; Perrone Filardi, Pasquale/AAC-7590-2022; Khokhlov, Alexander L./E-2765-2017; Miserez, André R./A-8581-2008; Angoulvant, Denis/Q-9743-2019; Ponikowski, Piotr/O-6454-2015; LA Khaisheva, Larisa/T-8418-2017; Carlier, Stéphane/AAA-5117-2019; GUERRERO, DIEGO BELLIDO/C-9446-2017; Abbott, J/AAU-4065-2021; Couffinhal, Thierry/M-6857-2014; Spence, J. David/K-6396-2013; Miller, Michael/AGX-6773-2022; Underberg, James/AAO-7011-2020; Urina-Triana, Miguel A/H-2605-2016; Bianco, Henrique Tria/L-3895-2014; Drapkina, Oksana/AAE-5376-2021; , Jennifer/AAD-8336-2019; Budoff, Matthew/ABD-5175-2021; Kosmacheva, Elena/AAY-4841-2020; van Royen, Niels/Q-1097-2017; Antonicelli, Roberto/AAB-3233-2021; Maia, Lilia Nigro/AAV-6938-2021; Ripoll-Vera, Tomas/AAT-3535-2021; Alvarez, Juan/GSD-7155-2022; Brenner, Hermann/ABE-6383-2020; Salinas, Carlos A Aguilar/AAL-4491-2020; Ochala, Andrzej/AAH-3855-2020; MASANA, LUIS/M-7002-2019; Sillesen, Henrik/ABB-5668-2020; Shalaev, Sergei V./D-4321-2018; Elbl, Lubomir/AAM-1074-2020; Libov, Igor/GRN-8152-2022; Panchenko, Elizaveta/AAN-1884-2020; Stellbrink, Christoph/AAX-7701-2021; Bulanova, Natalia A/E-9917-2017; Kahan, Thomas/CAE-8515-2022; Cífková, Renata/O-5731-2017; ARCA, Marcello/AAC-3883-2022; SIBON, IGOR/AAJ-2503-2020; Nakandakare, Edna R/D-6625-2012; Dan, G.Andrei/N-6744-2015; Mellbin, Linda/L-8779-2017; Shvarts, Yury Григорьевич/AAB-4929-2022; Sathyapalan, Thozhukat/J-5212-2012; Blaha, Vladimir/C-1151-2016; Maggioni, Aldo Pietro/AAL-5334-2020; Kastelein, John/AAF-7950-2020; Brotons, Carlos/AAG-8365-2020; de Barros e Silva, Pedro G M/U-5183-2017; Reshetko, Olga/I-7011-2013; Trimarco, Bruno BT/K-7851-2016; Zateyshchikov, Dmitry A/D-6575-2012; LLAURADO, ELISABET/L-3316-2016; Solar, Miroslav/Q-1707-2017; Brenner, Hermann/B-4627-2017; Ballantyne, Christie/A-6599-2008; ÜRESİN, YAĞIZ/AAT-5676-2020; Nicolau, Jose C/E-1487-2012; Pintó, Xavier/AGI-4297-2022; KAYIKCIOGLU, Meral/AAH-6687-2020; mcmurray, John/B-2467-2013; Khasanov, Niiaz/W-7678-2019; Santos, Raul/A-1170-2010; Díaz, José Luis JLDD Díaz/Q-2523-2015; Nikolaev, Konstantin/P-4750-2017; Riksen, Niels P/G-8260-2015; Averna, Maurizio/U-9527-2017; Juanatey, Carlos González/AAB-1680-2020; Tunon, Jose/ABA-8847-2020; Drozdz, Jaroslaw/K-8951-2012; Zateyshchikov, Dmitry/AGN-8590-2022; Field, Alison/AAA-4508-2021; Jhund, Pardeep/GLS-9508-2022; Underberg, James/AAO-7007-2020; Bonora, Enzo/AAA-5300-2022; Precoma, Dalton B/D-5674-2013; chun, hyung/AAE-1463-2020; Jukema, J. Wouter/ABD-6503-2021; Perlman, Robert/GZH-2102-2022; Durakoglugil, Emre/Q-3547-2019; Reis, Gilmar/I-4500-2013; Koszegi, Zsolt/L-1856-2013; Kjaerulf Jensen, Henrik/A-7980-2018; Barbarash, Olga/A-4834-2017	Drapkina, Oxana/0000-0002-4453-8430; Khokhlov, Alexander L./0000-0002-0032-0341; Angoulvant, Denis/0000-0003-0788-8092; Ponikowski, Piotr/0000-0002-3391-7064; GUERRERO, DIEGO BELLIDO/0000-0003-0631-2710; Couffinhal, Thierry/0000-0002-9217-2533; Spence, J. David/0000-0001-7478-1098; Miller, Michael/0000-0002-1679-2095; Underberg, James/0000-0002-6615-8535; Urina-Triana, Miguel A/0000-0001-6003-4622; Bianco, Henrique Tria/0000-0001-6746-8327; Drapkina, Oksana/0000-0002-4453-8430; Budoff, Matthew/0000-0002-9616-1946; Antonicelli, Roberto/0000-0002-5921-1828; Brenner, Hermann/0000-0002-6129-1572; MASANA, LUIS/0000-0002-0789-4954; Shalaev, Sergei V./0000-0003-2724-4016; Bulanova, Natalia A/0000-0001-7559-7030; Cífková, Renata/0000-0003-2765-3821; ARCA, Marcello/0000-0003-3786-0883; SIBON, IGOR/0000-0002-1171-4215; Dan, G.Andrei/0000-0001-9867-2582; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Sathyapalan, Thozhukat/0000-0003-3544-2231; Blaha, Vladimir/0000-0001-8088-9919; Maggioni, Aldo Pietro/0000-0003-2764-6779; Brotons, Carlos/0000-0001-9388-6581; de Barros e Silva, Pedro G M/0000-0003-1940-4470; Reshetko, Olga/0000-0003-3107-7636; Trimarco, Bruno BT/0000-0002-0701-6449; Zateyshchikov, Dmitry A/0000-0001-7065-2045; LLAURADO, ELISABET/0000-0002-7439-9531; Solar, Miroslav/0000-0002-5542-552X; Brenner, Hermann/0000-0002-6129-1572; Nicolau, Jose C/0000-0002-9680-3689; Pintó, Xavier/0000-0002-2216-2444; mcmurray, John/0000-0002-6317-3975; Khasanov, Niiaz/0000-0002-7760-0763; Santos, Raul/0000-0002-9860-6582; Nikolaev, Konstantin/0000-0003-4601-6203; Riksen, Niels P/0000-0001-9197-8124; Zateyshchikov, Dmitry/0000-0001-7065-2045; Jhund, Pardeep/0000-0003-4306-5317; Jukema, J. Wouter/0000-0002-3246-8359; Durakoglugil, Emre/0000-0001-5268-4262; Reis, Gilmar/0000-0002-4847-1034; Bilz, Stefan/0000-0002-7716-2791; Aylward, Philip/0000-0002-5358-8552; Banerjee, Moulinath/0000-0003-0456-1967; Shutemova, Elena/0000-0002-5324-3570; Koszegi, Zsolt/0000-0002-2817-6900; Torre-Amione, Guillermo/0000-0001-9950-0416; Mahon, Niall/0000-0002-2872-2297; Violante-Ortiz, Rafael/0000-0002-2440-2915; Sansing, Lauren/0000-0002-6898-1680; Kosmacheva, Elena/0000-0001-8600-0199; Polanczyk, Carisi/0000-0002-2447-2577; Carlier, Stephane/0000-0001-7787-1937; Tunon, Jose/0000-0002-1373-0999; DEMIN, Aleksandr/0000-0003-1052-1451; Fedacko, Jan/0000-0002-4940-0393; Martens, Fabrice/0000-0002-0977-7276; Gilfillan, Christopher/0000-0002-8193-8994; Palomaki, Ari/0000-0001-9759-4332; Pella, Daniel/0000-0001-9999-6271; van der Meer, Piet/0000-0001-6991-5493; Janion, Marianna/0000-0002-8811-4568; Bueno, Marta/0000-0001-9488-4553; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Ballantyne, Christie/0000-0002-6432-1730; Kamphuisen, Pieter/0000-0002-6263-0177; Pijanowski, Zbigniew/0000-0002-6624-7642; Kjaerulf Jensen, Henrik/0000-0003-1802-4302; Tinahones, Francisco J/0000-0001-6871-4403; Pride, Yuri/0000-0002-5884-0964; Morales Portillo, Cristobal Jesus/0000-0003-0348-826X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Samoilova, Iuliia/0000-0002-2667-4842; Baranova, Ekaterina/0000-0003-3211-7134; ELBAZ, Meyer/0000-0002-3520-7883; Owen, Jonathan/0000-0003-2187-4957; Nerg, Ossi/0000-0002-2401-9078; Mulder, Hindrik/0000-0002-6593-8417; Barbarash, Olga/0000-0002-4642-3610; Gonzalez-Gonzalez, Jose Gerardo/0000-0002-6609-9483; zhou, chunyang/0000-0001-9946-6158; Lopez-Cano, Carolina/0000-0001-7458-5871; Katz, Amos/0000-0003-0422-934X; RIPOLL-VERA, TOMAS/0000-0001-9222-325X; Wuerzner, Gregoire/0000-0002-6424-7630; Sharma, Ravi/0000-0001-5273-5453; Markovic, Tania/0000-0003-2521-0357; Demirci, Deniz/0000-0002-1571-7034; Koenig, Wolfgang/0000-0002-2064-9603; Nanchen, David/0000-0002-2493-3505; Civeira, Fernando/0000-0001-7043-0952; Molto Jorda, Jose Manuel/0000-0002-3861-6295; Gorog, Diana/0000-0002-9286-1451; Vojacek, Jan F/0000-0001-7724-9734; Lassus, Johan/0000-0003-4033-3232; Visseren, Frank/0000-0003-3951-5223; Lomakin, Nikita/0000-0001-8830-7231; Kroon, Abraham/0000-0001-7750-8249	Pfizer	Pfizer(Pfizer)	Supported by Pfizer.	Boekholdt SM, 2014, J AM COLL CARDIOL, V64, P485, DOI 10.1016/j.jacc.2014.02.615; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304; Lotta LA, 2016, JAMA-J AM MED ASSOC, V316, P1383, DOI 10.1001/jama.2016.14568; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Ridker PM, 2017, NEW ENGL J MED, V376, P1517, DOI 10.1056/NEJMoa1614062; Ridker PM, 2016, AM HEART J, V178, P135, DOI 10.1016/j.ahj.2016.05.010; Ridker PM, 2016, EUR HEART J, V37, P1373, DOI 10.1093/eurheartj/ehw046; Ridker PM, 2012, LANCET, V380, P565, DOI 10.1016/S0140-6736(12)61190-8; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Schmidt AF, 2017, LANCET DIABETES ENDO, V5, P97, DOI 10.1016/S2213-8587(16)30396-5; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699	13	413	423	8	137	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 20	2017	376	16					1527	1539		10.1056/NEJMoa1701488	http://dx.doi.org/10.1056/NEJMoa1701488			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES4VV	28304242	Green Published, Green Accepted			2022-12-28	WOS:000399534600007
J	Oberlander, J				Oberlander, Jonathan			The Mirage of Reform - Republicans' Struggle to Dismantle Obamacare	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Oberlander, Jonathan] Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.							Congressional Budget Office, 2017, COST EST; Cox C., 2017, AFFORDABLE CARE ACT; Starr P, 1982, SOCIAL TRANSFORMATIO	3	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2017	376	15								10.1056/NEJMp1703322	http://dx.doi.org/10.1056/NEJMp1703322			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER6EX	28328283				2022-12-28	WOS:000398899200007
J	Reardon, MJ; Van Mieghem, NM; Popma, JJ; Kleiman, NS; Sondergaard, L; Mumtaz, M; Adams, DH; Deeb, GM; Maini, B; Gada, H; Chetcuti, S; Gleason, T; Heiser, J; Lange, R; Merhi, W; Oh, JK; Olsen, PS; Piazza, N; Williams, M; Windecker, S; Yakubov, SJ; Grube, E; Makkar, R; Lee, JS; Conte, J; Vang, E; Nguyen, H; Chang, Y; Mugglin, AS; Serruys, PWJC; Kappetein, AP				Reardon, M. J.; Van Mieghem, N. M.; Popma, J. J.; Kleiman, N. S.; Sondergaard, L.; Mumtaz, M.; Adams, D. H.; Deeb, G. M.; Maini, B.; Gada, H.; Chetcuti, S.; Gleason, T.; Heiser, J.; Lange, R.; Merhi, W.; Oh, J. K.; Olsen, P. S.; Piazza, N.; Williams, M.; Windecker, S.; Yakubov, S. J.; Grube, E.; Makkar, R.; Lee, J. S.; Conte, J.; Vang, E.; Nguyen, H.; Chang, Y.; Mugglin, A. S.; Serruys, P. W. J. C.; Kappetein, A. P.		SURTAVI Investigators	Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SELF-EXPANDING BIOPROSTHESIS; OUTCOMES; STENOSIS; IMPLANTATION; SURGERY; MORTALITY; US	BACKGROUND Although transcatheter aortic-valve replacement (TAVR) is an accepted alternative to surgery in patients with severe aortic stenosis who are at high surgical risk, less is known about comparative outcomes among patients with aortic stenosis who are at intermediate surgical risk. METHODS We evaluated the clinical outcomes in intermediate-risk patients with severe, symptomatic aortic stenosis in a randomized trial comparing TAVR (performed with the use of a self-expanding prosthesis) with surgical aortic-valve replacement. The primary end point was a composite of death from any cause or disabling stroke at 24 months in patients undergoing attempted aortic-valve replacement. We used Bayesian analytical methods (with a margin of 0.07) to evaluate the noninferiority of TAVR as compared with surgical valve replacement. RESULTS A total of 1746 patients underwent randomization at 87 centers. Of these patients, 1660 underwent an attempted TAVR or surgical procedure. The mean (+/- SD) age of the patients was 79.8 +/- 6.2 years, and all were at intermediate risk for surgery (Society of Thoracic Surgeons Predicted Risk of Mortality, 4.5 +/- 1.6%). At 24 months, the estimated incidence of the primary end point was 12.6% in the TAVR group and 14.0% in the surgery group (95% credible interval [Bayesian analysis] for difference, -5.2 to 2.3%; posterior probability of noninferiority, >0.999). Surgery was associated with higher rates of acute kidney injury, atrial fibrillation, and transfusion requirements, whereas TAVR had higher rates of residual aortic regurgitation and need for pacemaker implantation. TAVR resulted in lower mean gradients and larger aortic-valve areas than surgery. Structural valve deterioration at 24 months did not occur in either group. CONCLUSIONS TAVR was a noninferior alternative to surgery in patients with severe aortic stenosis at intermediate surgical risk, with a different pattern of adverse events associated with each procedure. (Funded by Medtronic; SURTAVI ClinicalTrials.gov number, NCT01586910.)	[Reardon, M. J.; Kleiman, N. S.] Methodist DeBakey Heart & Vasc Ctr, 6550 Fannin St, Houston, TX 77030 USA; [Van Mieghem, N. M.; Serruys, P. W. J. C.; Kappetein, A. P.] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Popma, J. J.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Sondergaard, L.; Olsen, P. S.] Rigshosp, Ctr Heart, Copenhagen, Denmark; [Mumtaz, M.; Gada, H.] Pinnacle Hlth Hosp, Harrisburg, PA USA; [Gleason, T.; Lee, J. S.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Adams, D. H.] Mt Sinai Hlth Syst, New York, NY USA; [Williams, M.] NYU, Langone Med Ctr, New York, NY USA; [Deeb, G. M.; Chetcuti, S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Heiser, J.; Merhi, W.] Spectrum Hlth Hosp, Grand Rapids, MI USA; [Maini, B.] Tenet Healthcare, Delray Beach, FL USA; [Lange, R.] German Heart Ctr, Munich, Germany; [Grube, E.] Siegburg Heart Ctr, Siegburg, Germany; [Oh, J. K.] Mayo Clin, Rochester, MN USA; [Vang, E.; Nguyen, H.; Chang, Y.] Medtron, Minneapolis, MN USA; [Mugglin, A. S.] Paradigm Biostat, Anoka, MN USA; [Piazza, N.] McGill Univ, Med Ctr, Montreal, PQ, Canada; [Windecker, S.] Univ Hosp Bern, Bern, Switzerland; [Yakubov, S. J.] Riverside Methodist Hosp, Columbus, OH 43214 USA; [Makkar, R.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Conte, J.] Johns Hopkins Univ, Baltimore, MD USA	The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center; Erasmus University Rotterdam; Erasmus MC; Harvard University; Beth Israel Deaconess Medical Center; Rigshospitalet; University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; University of Michigan System; University of Michigan; German Heart Centre Munich; Mayo Clinic; McGill University; University of Bern; University Hospital of Bern; Cedars Sinai Medical Center; Johns Hopkins University	Reardon, MJ (corresponding author), Methodist DeBakey Heart & Vasc Ctr, 6550 Fannin St, Houston, TX 77030 USA.	mreardon@houstonmethodist.org	Siepe, Matthias/AAF-9846-2019; Avanzas, Pablo/B-6811-2008; Beyersdorf, Friedhelm/AAK-3718-2020; van Geuns, Robert-Jan M/N-7976-2017; Reardon, Michael/ABF-8880-2021; Doğan, Ali/AAN-5331-2020	Siepe, Matthias/0000-0003-3305-9343; Avanzas, Pablo/0000-0002-4958-6108; Beyersdorf, Friedhelm/0000-0003-2975-2751; van Geuns, Robert-Jan M/0000-0003-2943-5932; Williams, Mathew/0000-0003-2055-8741; Wang, Dee Dee/0000-0002-5784-9924; DEO, SALIL/0000-0002-4729-1461; Ruge, Hendrik/0000-0001-6886-3660; Spies, Claudia/0000-0002-1062-0495; Nazif, Tamim/0000-0003-1239-2489; Huber, Christoph/0000-0001-9048-849X	Medtronic	Medtronic(Medtronic)	Funded by Medtronic; SURTAVI ClinicalTrials.gov number, NCT01586910.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Arnold SV, 2015, JACC-CARDIOVASC INTE, V8, P1207, DOI 10.1016/j.jcin.2015.04.018; Deeb GM, 2016, J AM COLL CARDIOL, V67, P2565, DOI 10.1016/j.jacc.2016.03.506; Green P, 2012, JACC-CARDIOVASC INTE, V5, P974, DOI 10.1016/j.jcin.2012.06.011; Guadiani V, 2017, J THORAC CARDIOVASC; Hermiller JB, 2016, J AM COLL CARDIOL, V68, P343, DOI 10.1016/j.jacc.2016.04.057; Holmes DR, 2016, ANN THORAC SURG, V101, P789, DOI 10.1016/j.athoracsur.2015.10.049; Iturra SA, 2014, J THORAC CARDIOV SUR, V147, P127, DOI 10.1016/j.jtcvs.2013.08.036; Kappetein AP, 2013, J THORAC CARDIOV SUR, V145, P6, DOI 10.1016/j.jtcvs.2012.09.002; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Manoharan G, 2015, JACC-CARDIOVASC INTE, V8, P1359, DOI 10.1016/j.jcin.2015.05.015; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Piazza N, 2013, JACC-CARDIOVASC INTE, V6, P443, DOI 10.1016/j.jcin.2013.01.136; Popma JJ, 2017, JACC-CARDIOVASC INTE, V10, P268, DOI 10.1016/j.jcin.2016.08.050; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Reardon MJ, 2015, J AM COLL CARDIOL, V66, P113, DOI 10.1016/j.jacc.2015.05.017; Siontis GCM, 2016, EUR HEART J, V37, P3503, DOI 10.1093/eurheartj/ehw225; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2015, J AM COLL CARDIOL, V66, P804, DOI 10.1016/j.jacc.2015.06.013	20	1661	1708	5	84	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2017	376	14					1321	1331		10.1056/NEJMoa1700456	http://dx.doi.org/10.1056/NEJMoa1700456			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ9SJ	28304219	Green Published, Bronze			2022-12-28	WOS:000398424800006
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Barry, MJ; Davidson, K; Doubeni, CA; Ebell, M; Epling, JW; Herzstein, J; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; Mangione, CM; Phipps, MG; Silverstein, M; Simon, MA; Tseng, CW				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Barry, Michael J.; Davidson, KarinaW.; Doubeni, Chyke A.; Ebell, Mark; Epling, John W., Jr.; Herzstein, Jessica; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen		US Preventive Serv Task Force	Screening for Celiac Disease US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GLUTEN-FREE DIET; CLINICAL PRESENTATION; AT-RISK; PREVALENCE; MORTALITY; POPULATION; DIAGNOSIS	IMPORTANCE Celiac disease is caused by an immune response in persons who are genetically susceptible to dietary gluten, a protein complex found in wheat, rye, and barley. Ingestion of gluten by persons with celiac disease causes immune-mediated inflammatory damage to the small intestine. OBJECTIVE To issue a new US Preventive Services Task Force (USPSTF) recommendation on screening for celiac disease. EVIDENCE REVIEW The USPSTF reviewed the evidence on the accuracy of screening in asymptomatic adults, adolescents, and children; the potential benefits and harms of screening vs not screening and targeted vs universal screening; and the benefits and harms of treatment of screen-detected celiac disease. The USPSTF also reviewed contextual information on the prevalence of celiac disease among patients without obvious symptoms and the natural history of subclinical celiac disease. FINDINGS The USPSTF found inadequate evidence on the accuracy of screening for celiac disease, the potential benefits and harms of screening vs not screening or targeted vs universal screening, and the potential benefits and harms of treatment of screen-detected celiac disease. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for celiac disease in asymptomatic persons. (I statement)	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Davidson, KarinaW.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Ebell, Mark] Univ Georgia, Athens, GA 30602 USA; [Epling, John W., Jr.] Virginia Tech, Carilion Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Manoa, HI USA	University of California System; University of California San Francisco; University of Iowa; Harvard University; Harvard Medical School; Columbia University; University of Pennsylvania; University System of Georgia; University of Georgia; Virginia Polytechnic Institute & State University; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Brown University; Boston University; Northwestern University; University of Hawaii System; University of Hawaii Manoa	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	chair@uspstf.net	Davidson, Karina/AAG-2388-2019; Davidson, Karina/GWC-0996-2022; Epling, John W/J-1097-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	American Academy of Family Physicians, CLIN PREV SERV REC; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Chou R, 2017, SCREENING CELIAC DIS, V14-05215-EF-1; Chou R, 2017, JAMA-J AM MED ASSOC, V317, P1258, DOI 10.1001/jama.2016.10395; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Fasano A, 2005, GASTROENTEROLOGY, V128, pS68, DOI 10.1053/j.gastro.2005.02.015; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2012, NEW ENGL J MED, V367, P2419, DOI 10.1056/NEJMcp1113994; Godfrey JD, 2010, GASTROENTEROLOGY, V139, P763, DOI 10.1053/j.gastro.2010.05.041; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; Green PHR, 2001, AM J GASTROENTEROL, V96, P126, DOI 10.1111/j.1572-0241.2001.03462.x; Hill ID, 2005, J PEDIATR GASTR NUTR, V40, P1, DOI 10.1097/00005176-200501000-00001; Kurppa K, 2014, GASTROENTEROLOGY, V147, P610, DOI 10.1053/j.gastro.2014.05.003; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; Maglione MA, 2016, AHRQ PUBLICATION, V15(16)-EHC032-EF; Maki M, 2003, NEW ENGL J MED, V348, P2517, DOI 10.1056/NEJMoa021687; Mansour Abbas Ali, 2011, Arab J Gastroenterol, V12, P103, DOI 10.1016/j.ajg.2011.04.007; Murray JA, 2005, GASTROENTEROLOGY, V128, pS52, DOI 10.1053/j.gastro.2005.02.029; National Institute of Diabetes and Digestive and Kidney Diseases, CELIAC DIS; Nevoral J, 2014, EUR J PEDIATR, V173, P497, DOI 10.1007/s00431-013-2215-0; Rampertab SD, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.08.044; Richey R, 2009, BMJ-BRIT MED J, V338, P1684; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Tio M, 2012, ALIMENT PHARM THER, V35, P540, DOI 10.1111/j.1365-2036.2011.04972.x; Tursi A, 2009, DIGEST DIS SCI, V54, P2175, DOI 10.1007/s10620-008-0595-1; van Koppen EJ, 2009, PEDIATRICS, V123, pE582, DOI 10.1542/peds.2008-2221	28	54	54	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1252	1257		10.1001/jama.2017.1462	http://dx.doi.org/10.1001/jama.2017.1462			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350936				2022-12-28	WOS:000397557800022
J	Ferket, BS; Feldman, Z; Zhou, J; Oei, EH; Bierma-Zeinstra, SMA; Mazumdar, M				Ferket, Bart S.; Feldman, Zachary; Zhou, Jing; Oei, Edwin H.; Bierma-Zeinstra, Sita M. A.; Mazumdar, Madhu			Impact of total knee replacement practice: cost effectiveness analysis of data from the Osteoarthritis Initiative	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY-OF-LIFE; INDIVIDUAL RADIOGRAPHIC FEATURES; PATIENT-RELEVANT OUTCOMES; TOTAL JOINT ARTHROPLASTY; SHORT-FORM 12; UNITED-STATES; TOTAL HIP; ELDERLY-PATIENTS; HEALTH; POPULATION	OBJECTIVES To evaluate the impact of total knee replacement on quality of life in people with knee osteoarthritis and to estimate associated differences in lifetime costs and quality adjusted life years (QALYs) according to use by level of symptoms. DESIGN Marginal structural modeling and cost effectiveness analysis based on lifetime predictions for total knee replacement and death from population based cohort data. SETTING Data from two studies-Osteoarthritis Initiative (OAI) and the Multicenter Osteoarthritis Study (MOST)-within the US health system. PARTICIPANTS 4498 participants with or at high risk for knee osteoarthritis aged 45-79 from the OAI with no previous knee replacement (confirmed by baseline radiography) followed up for nine years. Validation cohort comprised 2907 patients from MOST with two year follow-up. INTERVENTION Scenarios ranging from current practice, defined as total knee replacement practice as performed in the OAI (with procedural rates estimated by a prediction model), to practice limited to patients with severe symptoms to no surgery. MAIN OUTCOME MEASURES Generic (SF-12) and osteoarthritis specific quality of life measured over 96 months, model based QALYs, costs, and incremental cost effectiveness ratios over a lifetime horizon. RESULTS In the OAI, total knee replacement showed improvements in quality of life with small absolute changes when averaged across levels of confounding variables: 1.70 (95% uncertainty interval 0.26 to 3.57) for SF-12 physical component summary (PCS); -10.69 (-13.39 to -8.01) for Western Ontario and McMaster Universities arthritis index (WOMAC); and 9.16 (6.35 to 12.49) for knee injury and osteoarthritis outcome score (KOOS) quality of life subscale. These improvements became larger with decreasing functional status at baseline. Provision of total knee replacement to patients with SF-12 PCS scores < 35 was the optimal scenario given a cost effectiveness threshold of $ 200 000/QALY, with cost savings of $ 6974 ($ 5789 to $ 8269) and a minimal loss of 0.008 (-0.056 to 0.043) QALYs compared with current practice. These findings were reproduced among patients with knee osteoarthritis from the MOST cohort and were robust against various scenarios including increased rates of total knee replacement and mortality and inclusion of non-healthcare costs but were sensitive to increased deterioration in quality of life without surgery. In a threshold analysis, total knee replacement would become cost effective in patients with SF-12 PCS scores <= 40 if the associated hospital admission costs fell below $ 14 000 given a cost effectiveness threshold of $ 200 000/QALY. CONCLUSION Current practice of total knee replacement as performed in a recent US cohort of patients with knee osteoarthritis had minimal effects on quality of life and QALYs at the group level. If the procedure were restricted to more severely affected patients, its effectiveness would rise, with practice becoming economically more attractive than its current use.	[Ferket, Bart S.; Zhou, Jing; Mazumdar, Madhu] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Inst Healthcare Delivery Sci, One Gustave L Levy Pl,Box 1077, New York, NY 10029 USA; [Feldman, Zachary] Icahn Sch Med Mt Sinai, One Gustave L Levy Pl,Box 1077, New York, NY 10029 USA; [Oei, Edwin H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Radiol, Postbus 2040, NL-3000 CA Rotterdam, Netherlands; [Bierma-Zeinstra, Sita M. A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Orthoped, Postbus 2040, NL-3000 CA Rotterdam, Netherlands; [Bierma-Zeinstra, Sita M. A.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, Postbus 2040, NL-3000 CA Rotterdam, Netherlands	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Ferket, BS (corresponding author), Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, Inst Healthcare Delivery Sci, One Gustave L Levy Pl,Box 1077, New York, NY 10029 USA.	bart.ferket@mountsinai.org	Oei, Edwin HG/E-8174-2013; Bierma-Zeinstra, Sita/AAF-2122-2019	Ferket, Bart/0000-0003-2754-545X	National Institutes of Health, a branch of the Department of Health and Human Services [N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, N01-AR-2-2262, AG18820, AG18832, AG18947, AG19069]; Merck Research Laboratories; Novartis Pharmaceuticals Corporation; GlaxoSmithKline; Pfizer; American Heart Association [16MCPRP31030016]; ReumaFonds [LLP-11, COI-1] Funding Source: researchfish	National Institutes of Health, a branch of the Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck Research Laboratories(Merck & Company); Novartis Pharmaceuticals Corporation(Novartis); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); American Heart Association(American Heart Association); ReumaFonds	The Osteoarthritis Initiative (OAI) is a public-private partnership comprised of five contracts (N01-AR-2-2258; N01-AR-2-2259; N01-AR-2-2260; N01-AR-2-2261; N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories, Novartis Pharmaceuticals Corporation, GlaxoSmithKline, and Pfizer. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared with an OAI public use dataset and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners. Multicenter Osteoarthritis Study (MOST) receives four cooperative grants (Felson, AG18820; Torner, AG18832; Lewis, AG18947; and Nevitt, AG19069) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by MOST study investigators. This manuscript was prepared with MOST data and does not necessarily reflect the opinions or views of MOST investigators. BF is supported in part by American Heart Association grant No 16MCPRP31030016.	Alentorn-Geli E, 2013, ORTHOPEDICS, V36, pE415, DOI 10.3928/01477447-20130327-15; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; [Anonymous], 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18190; Baker P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059079; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Beswick AD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000435; Bouchet C, 1996, J CLIN EPIDEMIOL, V49, P15, DOI 10.1016/0895-4356(95)00540-4; Brazier JE, 2004, MED CARE, V42, P851, DOI 10.1097/01.mlr.0000135827.18610.0d; Cherian JJ, 2015, J ARTHROPLASTY, V30, P1372, DOI 10.1016/j.arth.2015.03.032; Clement ND, 2013, KNEE, V20, P437, DOI 10.1016/j.knee.2013.07.009; Clement ND, 2013, BONE JOINT J, V95B, P52, DOI 10.1302/0301-620X.95B1.29749; Collins NJ, 2011, ARTHRIT CARE RES, V63, pS208, DOI 10.1002/acr.20632; Conner-Spady BL, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-454; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Cushnaghan J, 2009, ANN RHEUM DIS, V68, P642, DOI 10.1136/ard.2008.093229; Silva Robson Rocha da, 2014, Rev. bras. ortop., V49, P520, DOI 10.1016/j.rboe.2014.09.007; Daigle ME, 2012, BEST PRACT RES CL RH, V26, P649, DOI 10.1016/j.berh.2012.07.013; Dakin H, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000332; Davis AM, 2009, OSTEOARTHR CARTILAGE, V17, P843, DOI 10.1016/j.joca.2009.01.005; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Felson DT, 2004, RHEUM DIS CLIN N AM, V30, P783, DOI 10.1016/j.rdc.2004.07.005; Franks P, 2006, MED CARE, V44, P478, DOI 10.1097/01.mlr.0000207464.61661.05; George LK, 2008, ARTHRITIS RHEUM-US, V58, P3166, DOI 10.1002/art.23888; Gore M, 2012, PAIN PRACT, V12, P550, DOI 10.1111/j.1533-2500.2012.00532.x; Greidanus NV, 2011, J ARTHROPLASTY, V26, P615, DOI 10.1016/j.arth.2010.04.026; Hamel MB, 2008, ARCH INTERN MED, V168, P1430, DOI 10.1001/archinte.168.13.1430; Hartley RC, 2002, J BONE JOINT SURG BR, V84B, P994, DOI 10.1302/0301-620X.84B7.12607; Hernan MA, 2002, STAT MED, V21, P1689, DOI 10.1002/sim.1144; Jacobson AF, 2008, AM J NURS, V108, P54, DOI 10.1097/01.NAJ.0000318000.62786.fb; Katz JN, 1996, MED CARE, V34, P73, DOI 10.1097/00005650-199601000-00006; Keurentjes JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056785; Khanna D, 2011, QUAL LIFE RES, V20, P1131, DOI 10.1007/s11136-011-9849-z; Losina E, 2015, ARTHRIT CARE RES, V67, P203, DOI 10.1002/acr.22412; Losina E, 2012, J BONE JOINT SURG AM, V94A, P201, DOI [10.2106/JBJS.J.01958, 10.2106/JBJS.K.00009, 10.2106/JBJS.J.101958]; Losina E, 2009, ARCH INTERN MED, V169, P1113, DOI 10.1001/archinternmed.2009.136; Mandzuk LL, 2015, INT J ORTHOP TRAUMA, V19, P102, DOI 10.1016/j.ijotn.2014.07.001; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; National Institute for Health and Care Excellence, 2014, OST CAR MAN AD CLIN; National Joint Registry, 2014, 11 NAT JOINT REG ENG; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Nevitt M., 2006, OSTEOARTHRITIS INITI; Nilsdotter AK, 2009, OSTEOARTHR CARTILAGE, V17, P601, DOI 10.1016/j.joca.2008.11.007; Nuesch E, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1165; Ong KL, 2010, CLIN ORTHOP RELAT R, V468, P3070, DOI 10.1007/s11999-010-1399-0; Pivec R, 2015, J ARTHROPLASTY, V30, P374, DOI 10.1016/j.arth.2014.10.013; Robins JM, 2007, AM J EPIDEMIOL, V166, P994, DOI 10.1093/aje/kwm231; Sansom A, 2010, ARTHRIT CARE RES, V62, P1252, DOI 10.1002/acr.20218; Segal NA, 2013, PM&R, V5, P647, DOI 10.1016/j.pmrj.2013.04.014; Seng CS, 2011, J ARTHROPLASTY, V26, P1025, DOI 10.1016/j.arth.2010.09.006; Shan L, 2015, J BONE JOINT SURG AM, V97A, P156, DOI 10.2106/JBJS.M.00372; Singh JA, 2010, MAYO CLIN PROC, V85, P898, DOI 10.4065/mcp.2010.0115; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Weinstein MC, 1997, HEALTH ECON, V6, P505, DOI 10.1002/(SICI)1099-1050(199709)6:5<505::AID-HEC294>3.0.CO;2-I; Wylde V, 2007, KNEE, V14, P417, DOI 10.1016/j.knee.2007.06.001; Yang L, 2001, AM STAT, V55, P314, DOI 10.1198/000313001753272466	60	89	91	2	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2017	356								j1131	10.1136/bmj.j1131	http://dx.doi.org/10.1136/bmj.j1131			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FY4WY	28351833	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000426829100002
J	Travers, CP; Clark, RH; Spitzer, AR; Das, A; Garite, TJ; Carlo, WA				Travers, Colm P.; Clark, Reese H.; Spitzer, Alan R.; Das, Abhik; Garite, Thomas J.; Carlo, Waldemar A.			Exposure to any antenatal corticosteroids and outcomes in preterm infants by gestational age: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BRONCHOPULMONARY DYSPLASIA; PERIVIABLE BIRTH; PERINATAL-CARE; RISK; BORN; METAANALYSIS; ASSOCIATION; MATURATION; SURVIVAL; DEATH	OBJECTIVE To determine whether exposure to any antenatal corticosteroids is associated with a lower rate of death at each gestational age at which administration is currently recommended. DESIGN Prospective cohort study. SETTINGS 300 participating neonatal intensive care units of the Pediatrix Medical Group in the United States. PARTICIPANTS 117 941 infants 23 0/7 to 34 6/7 weeks' gestational age born between 1 January 2009 and 31 December 2013. EXPOSURE Any antenatal corticosteroids. MAIN OUTCOMES MEASURES Death or major hospital morbidities analyzed by gestational age and exposure to antenatal corticosteroids with models adjusted for birth weight, sex, mode of delivery, and multiple births. RESULTS Infants exposed to antenatal corticosteroids (n= 81 832) had a significantly lower rate of death before discharge at each gestation 29 weeks or less, 31 weeks, and 33-34 weeks compared with infants without exposure (range of adjusted odds ratios 0.32 to 0.55). The number needed to treat with antenatal corticosteroids to prevent one death before discharge increased from six at 23 and 24 weeks' gestation to 798 at 34 weeks' gestation. The rate of survival without major hospital morbidity was higher among infants exposed to antenatal corticosteroids at the lowest gestations. Infants exposed to antenatal corticosteroids had lower rates of severe intracranial hemorrhage or death, necrotizing enterocolitis stage 2 or above or death, and severe retinopathy of prematurity or death compared with infants without exposure at all gestations less than 30 weeks and most gestations for infants born at 30 weeks' gestation or later. CONCLUSION Among infants born from 23 to 34 weeks' gestation, antenatal exposure to corticosteroids compared with no exposure was associated with lower mortality and morbidity at most gestations. The effect size of exposure to antenatal corticosteroids on mortality seems to be larger in infants born at the lowest gestations.	[Travers, Colm P.; Carlo, Waldemar A.] Univ Alabama Birmingham, Div Neonatol, Birmingham, AL 35233 USA; [Clark, Reese H.; Spitzer, Alan R.; Garite, Thomas J.] Pediatrix Med Grp, Ctr Res Educ & Qual, Sunrise, FL USA; [Clark, Reese H.; Spitzer, Alan R.; Garite, Thomas J.] MEDNAX, Sunrise, FL USA; [Das, Abhik] RTI Int, Social Stat & Environm Sci Unit, Res Triangle Pk, NC USA; [Garite, Thomas J.] Univ Calif Irvine, Dept Obstet & Gynecol, Irvine, CA 92717 USA	University of Alabama System; University of Alabama Birmingham; Research Triangle Institute; University of California System; University of California Irvine	Carlo, WA (corresponding author), Univ Alabama Birmingham, Div Neonatol, Birmingham, AL 35233 USA.	wcarlo@peds.uab.edu	Das, Abhik/AAF-1883-2020; Clark, Reese/L-5392-2019	Das, Abhik/0000-0003-2722-0479; Clark, Reese/0000-0002-7363-4640	Agency for Healthcare Research and Quality [5T32HS013852-14]; Perinatal Health and Human Development Research Program of the University of Alabama at Birmingham; Children's of Alabama Centennial Scholar Fund; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS013852] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Perinatal Health and Human Development Research Program of the University of Alabama at Birmingham; Children's of Alabama Centennial Scholar Fund; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	CPT is supported by the Agency for Healthcare Research and Quality grant number 5T32HS013852-14, the Perinatal Health and Human Development Research Program of the University of Alabama at Birmingham, and the Children's of Alabama Centennial Scholar Fund. These funders had no role in: the study design; the collection, analysis, or interpretation of data; the writing of the report; or in the decision to submit the article for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Agency for Healthcare Research and Quality.	Ambalavanan N, 2008, J PERINATOL, V28, P420, DOI 10.1038/jp.2008.18; Austeng D, 2010, ACTA PAEDIATR, V99, P978, DOI 10.1111/j.1651-2227.2010.01846.x; Bottoms SF, 1997, AM J OBSTET GYNECOL, V176, P960, DOI 10.1016/S0002-9378(97)70386-7; Brownfoot FC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006764.pub3; Carlo WA, 2011, JAMA-J AM MED ASSOC, V306, P2348, DOI 10.1001/jama.2011.1752; Davidson C, 2010, J REPROD MED, V55, P14; Ecker JL, 2015, AM J OBSTET GYNECOL, V213, P604, DOI 10.1016/j.ajog.2015.08.035; Ellsbury DL, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-0389; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Fischer HS, 2013, PEDIATRICS, V132, pE1351, DOI 10.1542/peds.2013-1880; GARITE TJ, 1992, AM J OBSTET GYNECOL, V166, P646, DOI 10.1016/0002-9378(92)91691-3; GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Manktelow BN, 2010, ARCH DIS CHILD-FETAL, V95, pF95, DOI 10.1136/adc.2009.170340; McKinlay CJD, 2012, AM J OBSTET GYNECOL, V206, P187, DOI 10.1016/j.ajog.2011.07.042; Melamed N, 2015, OBSTET GYNECOL, V125, P1377, DOI 10.1097/AOG.0000000000000840; Mori R, 2011, J PEDIATR-US, V159, P110, DOI 10.1016/j.jpeds.2010.12.039; Onland W, 2011, AM J PERINAT, V28, P33, DOI 10.1055/s-0030-1262509; Park CK, 2016, OBSTET GYNECOL, V127, P715, DOI 10.1097/AOG.0000000000001355; Patel RM, 2015, NEW ENGL J MED, V372, P331, DOI 10.1056/NEJMoa1403489; Raju TNK, 2014, AM J OBSTET GYNECOL, V210, P406, DOI 10.1016/j.ajog.2014.02.027; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Royal College of Obstetricians and Gynaecologists, 2010, ANT CORT RED NEON MO; Rysavy MA, 2015, NEW ENGL J MED, V372, P1801, DOI 10.1056/NEJMoa1410689; Serenius F, 2015, PEDIATRICS, V135, pE1163, DOI 10.1542/peds.2014-2988; Smith PB, 2012, PEDIATRICS, V129, pE1508, DOI 10.1542/peds.2011-2216; Spitzer AR, 2015, INDIAN J PEDIATR, V82, P71, DOI 10.1007/s12098-014-1585-2; Tolia VN, 2015, NEW ENGL J MED, V372, P2118, DOI 10.1056/NEJMsa1500439; Tyson JE, 2008, NEW ENGL J MED, V358, P1672, DOI 10.1056/NEJMoa073059; Walsh Michele C, 2003, J Perinatol, V23, P451, DOI 10.1038/sj.jp.7210963; Wong D, 2014, ARCH DIS CHILD-FETAL, V99, pF12, DOI 10.1136/archdischild-2013-304705; Zephyrin LC, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.06.009	32	78	81	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2017	356								j1039	10.1136/bmj.j1039	http://dx.doi.org/10.1136/bmj.j1039			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4WY	28351838	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000426829100001
J	Bakr, OM				Bakr, Osman M.			APPLIED PHYSICS Powering up perovskite photoresponse	SCIENCE			English	Editorial Material							SOLAR-CELLS; DIFFUSION; CRYSTALS		[Bakr, Osman M.] King Abdullah Univ Sci & Technol KAUST, KAUST Solar Ctr KSC, Div Phys Sci & Engn PSE, Thuwal 239556900, Saudi Arabia	King Abdullah University of Science & Technology	Bakr, OM (corresponding author), King Abdullah Univ Sci & Technol KAUST, KAUST Solar Ctr KSC, Div Phys Sci & Engn PSE, Thuwal 239556900, Saudi Arabia.		Bakr, Osman M./R-4963-2019	Bakr, Osman M./0000-0002-3428-1002				Berhe TA, 2016, ENERG ENVIRON SCI, V9, P323, DOI 10.1039/c5ee02733k; Blancon JC, 2017, SCIENCE, V355, P1288, DOI 10.1126/science.aal4211; deQuilettes DW, 2015, SCIENCE, V348, P683, DOI 10.1126/science.aaa5333; Kagan CR, 1999, SCIENCE, V286, P945, DOI 10.1126/science.286.5441.945; Li X, 2016, SCIENCE, V353, P58, DOI 10.1126/science.aaf8060; Murali B, 2016, ACS ENERGY LETT, V1, P1119, DOI 10.1021/acsenergylett.6b00517; NREL, 2017, BEST RES CELL EFF; Shi D, 2015, SCIENCE, V347, P519, DOI 10.1126/science.aaa2725; Stourripos CC, 2017, INORG CHEM, V56, P56, DOI 10.1021/acs.inorgchem.6b02764; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982; Tsai HH, 2016, NATURE, V536, P312, DOI 10.1038/nature18306; Yuan MJ, 2016, NAT NANOTECHNOL, V11, P872, DOI [10.1038/nnano.2016.110, 10.1038/NNANO.2016.110]	12	19	19	3	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1260	1261		10.1126/science.aam7154	http://dx.doi.org/10.1126/science.aam7154			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336622				2022-12-28	WOS:000397082900015
J	Castellano, BM; Thelen, AM; Moldavski, O; Feltes, M; van der Welle, REN; Mydock-McGrane, L; Jiang, X; Van Eijkeren, RJ; Davis, OB; Louie, SM; Perera, RM; Covey, DF; Nomura, DK; Ory, DS; Zoncu, R				Castellano, Brian M.; Thelen, Ashley M.; Moldavski, Ofer; Feltes, McKenna; van der Welle, Reini E. N.; Mydock-McGrane, Laurel; Jiang, Xuntian; Van Eijkeren, Robert J.; Davis, Oliver B.; Louie, Sharon M.; Perera, Rushika M.; Covey, Douglas F.; Nomura, Daniel K.; Ory, Daniel S.; Zoncu, Roberto			CHOLESTEROL SENSING Lysosomal cholesterol activates mTORC1 via an SLC38A9-Niemann-Pick C1 signaling complex	SCIENCE			English	Article							RAG GTPASES; AMINO-ACIDS; INSULIN; METABOLISM; RAGULATOR; TRANSPORT; REQUIRES; BINDING; OBESITY; DOMAIN	The mechanistic target of rapamycin complex 1 (mTORC1) protein kinase is a master growth regulator that becomes activated at the lysosome in response to nutrient cues. Here, we identify cholesterol, an essential building block for cellular growth, as a nutrient input that drives mTORC1 recruitment and activation at the lysosomal surface. The lysosomal transmembrane protein, SLC38A9, is required for mTORC1 activation by cholesterol through conserved cholesterol-responsive motifs. Moreover, SLC38A9 enables mTORC1 activation by cholesterol independently from its arginine-sensing function. Conversely, the Niemann-Pick C1 (NPC1) protein, which regulates cholesterol export from the lysosome, binds to SLC38A9 and inhibits mTORC1 signaling through its sterol transport function. Thus, lysosomal cholesterol drives mTORC1 activation and growth signaling through the SLC38A9-NPC1 complex.	[Castellano, Brian M.; Thelen, Ashley M.; Moldavski, Ofer; van der Welle, Reini E. N.; Van Eijkeren, Robert J.; Davis, Oliver B.; Louie, Sharon M.; Nomura, Daniel K.; Zoncu, Roberto] Univ Calif, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Castellano, Brian M.; Thelen, Ashley M.; Moldavski, Ofer; van der Welle, Reini E. N.; Van Eijkeren, Robert J.; Davis, Oliver B.; Zoncu, Roberto] Univ Calif, Paul F Glenn Ctr Aging Res, Berkeley, CA 94720 USA; [Louie, Sharon M.; Nomura, Daniel K.] Univ Calif, Dept Nutrit Sci & Toxicol, Berkeley, CA 94720 USA; [Feltes, McKenna; Jiang, Xuntian] Washington Univ Sch Med, Diabet Cardiovasc Dis Ctr, St Louis, MO 63110 USA; [Mydock-McGrane, Laurel; Covey, Douglas F.] Washington Univ Sch Med, Dept Dev Biol & Biochem, St Louis, MO 63110 USA; [Perera, Rushika M.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Pathol, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Zoncu, R (corresponding author), Univ Calif, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Zoncu, R (corresponding author), Univ Calif, Paul F Glenn Ctr Aging Res, Berkeley, CA 94720 USA.	rzoncu@berkeley.edu		Castellano, Brian/0000-0001-6545-6429; Feltes, McKenna/0000-0002-4178-8055; van der Welle, Reini Eline Noraly/0000-0002-5591-2846	NATIONAL CANCER INSTITUTE [DP2CA195761] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NCI NIH HHS [DP2 CA195761] Funding Source: Medline; NHLBI NIH HHS [R01 HL067773] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341, P30 DK020579] Funding Source: Medline; NIGMS NIH HHS [T32 GM007232] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bar-Peled L, 2012, CELL, V150, P1196, DOI 10.1016/j.cell.2012.07.032; Berneis KK, 2002, J LIPID RES, V43, P1363, DOI 10.1194/jlr.R200004-JLR200; Derler I, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad7808; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; Fantini J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00031; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Jelinek D, 2011, HUM MOL GENET, V20, P312, DOI 10.1093/hmg/ddq466; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Millard EE, 2005, J BIOL CHEM, V280, P28581, DOI 10.1074/jbc.M414024200; Nohturfft A, 2009, ANNU REV CELL DEV BI, V25, P539, DOI 10.1146/annurev.cellbio.24.110707.175344; Ory DS, 2004, TRENDS CARDIOVAS MED, V14, P66, DOI 10.1016/j.tcm.2003.12.003; Owen JL, 2012, P NATL ACAD SCI USA, V109, P16184, DOI 10.1073/pnas.1213343109; Perera RM, 2016, ANNU REV CELL DEV BI, V32, P223, DOI 10.1146/annurev-cellbio-111315-125125; Radhakrishnan A, 2008, CELL METAB, V8, P512, DOI 10.1016/j.cmet.2008.10.008; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	30	260	264	10	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1306	1311		10.1126/science.aag1417	http://dx.doi.org/10.1126/science.aag1417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336668	Green Accepted			2022-12-28	WOS:000397082900038
J	Colangelo, G; Ciurana, FM; Bianchet, LC; Sewell, RJ; Mitchell, MW				Colangelo, Giorgio; Ciurana, Ferran Martin; Bianchet, Lorena C.; Sewell, Robert J.; Mitchell, Morgan W.			Simultaneous tracking of spin angle and amplitude beyond classical limits	NATURE			English	Article							QUANTUM-NONDEMOLITION MEASUREMENTS; ATOMIC MAGNETOMETER; SENSITIVITY; ENTANGLEMENT; TIMES	Measurement of spin precession is central to extreme sensing in physics(1,2), geophysics(3), chemistry(4), nanotechnology5 and neuroscience6, and underlies magnetic resonance spectroscopy(7). Because there is no spin-angle operator, any measurement of spin precession is necessarily indirect, for example, it may be inferred from spin projectors at different times. Such projectors do not commute, and so quantum measurement back-action-the random change in a quantum state due to measurement-necessarily enters the spin measurement record, introducing errors and limiting sensitivity. Here we show that this disturbance in the spin projector can be reduced below N-1/2-the classical limit for N spins-by directing the quantum measurement back-action almost entirely into an unmeasured spin component. This generates a planar squeezed state(8) that, because spins obey non-Heisenberg uncertainty relations(9,10), enables simultaneous precise knowledge of spin angle and spin amplitude. We use high-dynamic-range optical quantum non-demolition measurements(11-13) applied to a precessing magnetic spin ensemble to demonstrate spin tracking with steady-state angular sensitivity 2,9 decibels below the standard quantum limit, simultaneously with amplitude sensitivity 7.0 decibels below the Poissonian variance14. The standard quantum limit and Poissonian variance indicate the best possible sensitivity with independent particles. Our method surpasses these limits in non-commuting observables, enabling orders-of-magnitude improvements in sensitivity for state-of-the-art sensing(15-18) and spectroscopy(19,20).	[Colangelo, Giorgio; Ciurana, Ferran Martin; Bianchet, Lorena C.; Sewell, Robert J.; Mitchell, Morgan W.] Barcelona Inst Sci & Technol, ICFO, Barcelona, Spain; [Mitchell, Morgan W.] Inst Catalana Rec Estudis Avancats, ICREA, Barcelona 08015, Spain	Barcelona Institute of Science & Technology; Universitat Politecnica de Catalunya; Institut de Ciencies Fotoniques (ICFO); ICREA	Colangelo, G; Mitchell, MW (corresponding author), Barcelona Inst Sci & Technol, ICFO, Barcelona, Spain.; Mitchell, MW (corresponding author), Inst Catalana Rec Estudis Avancats, ICREA, Barcelona 08015, Spain.	giorgio.colangelo@icfo.eu; morgan.mitchell@icfo.eu	Colangelo, Giorgio/V-9567-2017; Colangelo, Giorgio/P-5615-2019; Mitchell, Morgan W/I-9027-2012; Sewell, Robert/C-4718-2013	Colangelo, Giorgio/0000-0003-2454-9076; Colangelo, Giorgio/0000-0003-2454-9076; Mitchell, Morgan W/0000-0001-8949-9407; Sewell, Robert/0000-0002-2754-2956; Bianchet, Lorena C./0000-0003-2564-231X	MINECO/ FEDER; MINECO project MAQRO [FIS2015-68039-P]; MINECO project XPLICA [FIS2014-62181-EXP]; Severo Ochoa grant [SEV-2015-0522]; Catalan [2014-SGR-1295]; European Union Project QUIC [641122]; European Research Council project AQUMET [280169]; European Research Council project ERIDIAN [713682]; Fundacio Privada CELLEX; International Fellowship Programme 'La Caixa' - Severo Ochoa; 'La Caixa' Foundation; ICREA Funding Source: Custom	MINECO/ FEDER(Spanish Government); MINECO project MAQRO; MINECO project XPLICA; Severo Ochoa grant(Spanish Government); Catalan; European Union Project QUIC; European Research Council project AQUMET(European Research Council (ERC)); European Research Council project ERIDIAN; Fundacio Privada CELLEX(Foundation CELLEX); International Fellowship Programme 'La Caixa' - Severo Ochoa; 'La Caixa' Foundation(La Caixa Foundation); ICREA(ICREA)	We thank G. Vitagliano, M. D. Reid, P. D. Drummond, G. Toth, N. Behbood, M. Napolitano, S. Palacios, X. Menino and the ICFO mechanical workshop, and J.-C. Cifuentes and the ICFO electronic workshop. We also thank D. T. Campbell and M. M. Fria. Work supported by MINECO/ FEDER, MINECO projects MAQRO (reference FIS2015-68039-P), XPLICA (FIS2014-62181-EXP) and Severo Ochoa grant SEV-2015-0522, Catalan 2014-SGR-1295, by the European Union Project QUIC (grant agreement 641122), European Research Council project AQUMET (grant agreement 280169) and ERIDIAN (grant agreement 713682), and by Fundacio Privada CELLEX. L.C.B. was supported by the International Fellowship Programme 'La Caixa' - Severo Ochoa, awarded by the 'La Caixa' Foundation.	Appel J, 2009, P NATL ACAD SCI USA, V106, P10960, DOI 10.1073/pnas.0901550106; Beguin JB, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.263603; Behbood N, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.093601; Bienfait A, 2016, NAT NANOTECHNOL, V11, P253, DOI [10.1038/NNANO.2015.282, 10.1038/nnano.2015.282]; Bohnet JG, 2014, NAT PHOTONICS, V8, P731, DOI [10.1038/nphoton.2014.151, 10.1038/NPHOTON.2014.151]; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; Budker D, 2007, NAT PHYS, V3, P227, DOI 10.1038/nphys566; Ciurana FM, 2016, OPT LETT, V41, P2946, DOI 10.1364/OL.41.002946; Colangelo G, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/10/103007; Dammeier L, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/9/093046; Dang HB, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3491215; Deutsch IH, 2010, OPT COMMUN, V283, P681, DOI 10.1016/j.optcom.2009.10.059; Gajdacz M, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.073604; Gomes MD, 2016, J AM CHEM SOC, V138, P9747, DOI 10.1021/jacs.6b02758; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; Guhne O, 2009, PHYS REP, V474, P1, DOI 10.1016/j.physrep.2009.02.004; Hall LT, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.220802; He QY, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.022107; Hofmann CS, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.203601; Hosten O, 2016, NATURE, V529, P505, DOI 10.1038/nature16176; Jensen K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29638; Kendall M., 1979, ADV THEORY STAT, V1; Kominis IK, 2003, NATURE, V422, P596, DOI 10.1038/nature01484; Koschorreck M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.093602; Koschorreck M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.093602; Kubasik M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.043815; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Lodewyck J, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.061401; Ludlow AD, 2015, REV MOD PHYS, V87, P637, DOI 10.1103/RevModPhys.87.637; Madsen LB, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.052324; Miffre A, 2006, PHYS SCRIPTA, V74, pC15, DOI 10.1088/0031-8949/74/2/N01; Moller C. B., 2016, PREPRINT; Plewes DB, 2012, J MAGN RESON IMAGING, V35, P1038, DOI 10.1002/jmri.23642; Polzik ES, 2015, ANN PHYS-BERLIN, V527, pA15, DOI 10.1002/andp.201400099; Robertson HP, 1929, PHYS REV, V34, P163, DOI 10.1103/PhysRev.34.163; Sander TH, 2012, BIOMED OPT EXPRESS, V3, P981, DOI 10.1364/BOE.3.000981; Schleier-Smith MH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.073604; Schlosser N, 2001, NATURE, V411, P1024, DOI 10.1038/35082512; Sewell RJ, 2013, NAT PHOTONICS, V7, P517, DOI 10.1038/nphoton.2013.100; Sewell RJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.253605; Sheng D, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.160802; Smith GA, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.163602; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; Stockton J. K., 2007, THESIS; Takano T, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.033601; Tsang M, 2012, PHYS REV X, V2, DOI 10.1103/PhysRevX.2.031016; Wolf T, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041001; YURKE B, 1986, PHYS REV A, V33, P4033, DOI 10.1103/PhysRevA.33.4033	48	43	43	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					525	+		10.1038/nature21434	http://dx.doi.org/10.1038/nature21434			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28332519	Green Accepted, Green Submitted			2022-12-28	WOS:000397018000045
J	Kurnosov, A; Marquardt, H; Frost, DJ; Ballaran, TB; Ziberna, L				Kurnosov, A.; Marquardt, H.; Frost, D. J.; Ballaran, T. Boffa; Ziberna, L.			Evidence for a Fe3+-rich pyrolitic lower mantle from (Al,Fe)-bearing bridgmanite elasticity data	NATURE			English	Article							EQUATION-OF-STATE; SINGLE-CRYSTAL ELASTICITY; EARTHS LOWER MANTLE; HIGH-PRESSURE; MGSIO3 PEROVSKITE; BRILLOUIN-SCATTERING; SOUND VELOCITIES; FERRIC IRON; TEMPERATURE; GPA	The chemical composition of Earth's lower mantle can be constrained by combining seismological observations with mineral physics elasticity measurements(1-3). However, the lack of laboratory data for Earth's most abundant mineral, (Mg, Fe, Al)(Si, Al, Fe)O-3 bridgmanite (also known as silicate perovskite), has hampered any conclusive result. Here we report single-crystal elasticity data on (Al, Fe)-bearing bridgmanite (Mg0.9Fe0.1Si0.9Al0.1)O-3 measured using high-pressure Brillouin spectroscopy and X-ray diffraction. Our measurements show that the elastic behaviour of (Al, Fe)-bearing bridgmanite is markedly different from the behaviour of the MgSiO3 endmember2,4. We use our data to model seismic wave velocities in the top portion of the lower mantle, assuming a pyrolitic(5) mantle composition and accounting for depth-dependent changes in iron partitioning between bridgmanite and ferropericlase(6,7). We find excellent agreement between our mineral physics predictions and the seismic Preliminary Reference Earth Model(8) down to at least 1,200 kilometres depth, indicating chemical homogeneity of the upper and shallow lower mantle. A high Fe3+/Fe2+ ratio of about two in shallow-lower-mantle bridgmanite is required to match seismic data, implying the presence of metallic iron in an isochemical mantle. Our calculated velocities are in increasingly poor agreement with those of the lower mantle at depths greater than 1,200 kilometres, indicating either a change in bridgmanite cation ordering or a decrease in the ferric iron content of the lower mantle.	[Kurnosov, A.; Marquardt, H.; Frost, D. J.; Ballaran, T. Boffa; Ziberna, L.] Univ Bayreuth, Bayer Geoinst BGI, D-95440 Bayreuth, Germany; [Ziberna, L.] Univ Bristol, Sch Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bayreuth; University of Bristol	Marquardt, H (corresponding author), Univ Bayreuth, Bayer Geoinst BGI, D-95440 Bayreuth, Germany.	hauke.marquardt@uni-bayreuth.de	; Frost, Daniel/B-7526-2016	Ziberna, Luca/0000-0002-4718-3030; Frost, Daniel/0000-0002-4443-8149	projects 'GeoMaX' under Emmy-Noether Program of the German Science Foundation [MA4534/3-1]; ERC through EU [227893]; Bavarian Academy of Sciences;  [INST 91/315-1 FUGG]	projects 'GeoMaX' under Emmy-Noether Program of the German Science Foundation; ERC through EU; Bavarian Academy of Sciences; 	This research was supported through the projects 'GeoMaX' funded under the Emmy-Noether Program of the German Science Foundation (MA4534/3-1) and the ERC advanced grant number 227893 'DEEP' funded through the EU 7th Framework Programme. The FEI Scios FIB machine at BGI Bayreuth is supported by grant INST 91/315-1 FUGG. H.M. acknowledges support from the Bavarian Academy of Sciences. We thank J. Buchen for assistance in creating Fig. 1c, H. Schulze for sample polishing and K. Marquardt for help with the FIB device.	Angel RJ, 2011, J APPL CRYSTALLOGR, V44, P247, DOI 10.1107/S0021889810042305; Ballaran TB, 2012, EARTH PLANET SC LETT, V333, P181, DOI 10.1016/j.epsl.2012.03.029; BROWN JM, 1981, GEOPHYS J ROY ASTR S, V66, P579, DOI 10.1111/j.1365-246X.1981.tb04891.x; Cammarano F, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL041583; Canil D, 1996, J PETROL, V37, P609, DOI 10.1093/petrology/37.3.609; Catalli K, 2011, EARTH PLANET SC LETT, V310, P293, DOI 10.1016/j.epsl.2011.08.018; Chantel J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053075; Cobden L, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006262; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Fischer RA, 2011, EARTH PLANET SC LETT, V304, P496, DOI 10.1016/j.epsl.2011.02.025; Frost DJ, 2004, NATURE, V428, P409, DOI 10.1038/nature02413; Fukao Y., 2013, J GEOPHYS RES, V118; Irifune T, 2010, SCIENCE, V327, P193, DOI 10.1126/science.1181443; Jackson I, 1998, GEOPHYS J INT, V134, P291, DOI 10.1046/j.1365-246x.1998.00560.x; Jackson JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023522; Kantor I, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4768541; Kurnosov A, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2902506; Li BS, 2005, PHYS EARTH PLANET IN, V151, P143, DOI 10.1016/j.pepi.2005.02.004; Li L, 2005, EARTH PLANET SC LETT, V240, P529, DOI 10.1016/j.epsl.2005.09.030; Lin JF, 2005, SCIENCE, V308, P1892, DOI 10.1126/science.1111724; Lin JF, 2013, REV GEOPHYS, V51, P244, DOI 10.1002/rog.20010; Marquardt H, 2015, AM MINERAL, V100, P1932, DOI 10.2138/am-2015-5198; Marquardt H, 2012, AM MINERAL, V97, P299, DOI 10.2138/am.2012.3911; Marquardt H, 2009, EARTH PLANET SC LETT, V287, P345, DOI 10.1016/j.epsl.2009.08.017; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; Murakami M, 2007, EARTH PLANET SC LETT, V256, P47, DOI 10.1016/j.epsl.2007.01.011; Murakami M, 2012, NATURE, V485, P90, DOI 10.1038/nature11004; Nakajima Y, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2012JB009151; Pamato MG, 2016, EARTH PLANET SC LETT, V451, P114, DOI 10.1016/j.epsl.2016.07.019; RINGWOOD AE, 1962, J GEOPHYS RES, V67, P857, DOI 10.1029/JZ067i002p00857; Rudolph ML, 2015, SCIENCE, V350, P1349, DOI 10.1126/science.aad1929; Schulze K., HIGH PRESS IN PRESS; Shukla G, 2016, GEOPHYS RES LETT, V43, P5661, DOI 10.1002/2016GL069332; Sinmyo R, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008179; Sinogeikin SV, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019559; Sinogeikin SV, 2000, PHYS EARTH PLANET IN, V120, P43, DOI 10.1016/S0031-9201(00)00143-6; Smith EM, 2016, SCIENCE, V354, P1403, DOI 10.1126/science.aal1303; Speziale S, 2001, J GEOPHYS RES-SOL EA, V106, P515, DOI 10.1029/2000JB900318; Speziale S, 2014, REV MINERAL GEOCHEM, V78, P543, DOI 10.2138/rmg.2014.78.14; Stixrude L, 2005, GEOPHYS J INT, V162, P610, DOI 10.1111/j.1365-246X.2005.02642.x; Stixrude L, 2011, GEOPHYS J INT, V184, P1180, DOI 10.1111/j.1365-246X.2010.04890.x; Tackley PJ, 2000, SCIENCE, V288, P2002, DOI 10.1126/science.288.5473.2002; Tange Y, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005891; Trots DM, 2011, PHYS CHEM MINER, V38, P561, DOI 10.1007/s00269-011-0428-1; Walter MJ, 2011, SCIENCE, V334, P54, DOI 10.1126/science.1209300; Wang XL, 2015, NAT GEOSCI, V8, P556, DOI [10.1038/NGEO2458, 10.1038/ngeo2458]; WHITFIELD CH, 1976, REV SCI INSTRUM, V47, P942, DOI 10.1063/1.1134778; Wolf AS, 2015, J GEOPHYS RES-SOL EA, V120, P7460, DOI 10.1002/2015JB012108; Xu WB, 2008, EARTH PLANET SC LETT, V275, P70, DOI 10.1016/j.epsl.2008.08.012; Xu YS, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000677; YEGANEHHAERI A, 1994, PHYS EARTH PLANET IN, V87, P111, DOI 10.1016/0031-9201(94)90025-6; Zhang S, 2016, EARTH PLANET SC LETT, V434, P264, DOI 10.1016/j.epsl.2015.11.030; Zhang ZG, 2013, EARTH PLANET SC LETT, V379, P1, DOI 10.1016/j.epsl.2013.07.034	54	61	63	0	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					543	+		10.1038/nature21390	http://dx.doi.org/10.1038/nature21390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28289289	Green Submitted			2022-12-28	WOS:000397018000049
J	Nagarur, A; Axelrod, L; Dighe, AS				Nagarur, Amulya; Axelrod, Lloyd; Dighe, Anand S.			Case 9-2017: A 27-Year-Old Woman with Nausea, Vomiting, Confusion, and Hyponatremia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADRENAL INSUFFICIENCY; VASOPRESSIN RELEASE; ADDISONS-DISEASE; EDEMATOUS DISORDERS; WATER-EXCRETION; SECRETION; HORMONE; HEALTH; WOMEN; RISK		[Nagarur, Amulya; Axelrod, Lloyd] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Dighe, Anand S.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Nagarur, Amulya; Axelrod, Lloyd] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Dighe, Anand S.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Nagarur, A (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Nagarur, A (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		Dighe, Anand/AAP-9640-2020	Dighe, Anand/0000-0003-4130-0758				Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Bensing S, 2008, CLIN ENDOCRINOL, V69, P697, DOI 10.1111/j.1365-2265.2008.03340.x; Campbell GA, 2008, CLIN J AM SOC NEPHRO, V3, P1852, DOI 10.2215/CJN.02080508; FELLOWS RE, 1962, NEW ENGL J MED, V267, P215, DOI 10.1056/NEJM196208022670501; FICHMAN MP, 1971, ANN INTERN MED, V75, P853, DOI 10.7326/0003-4819-75-6-853; Forss M, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-8; Gagnon RF, 2001, NEPHROL DIAL TRANSPL, V16, P1280, DOI 10.1093/ndt/16.6.1280; Kalogeras KT, 1996, J CLIN INVEST, V97, P2045, DOI 10.1172/JCI118640; Moritz ML, 2013, NEPHROL DIAL TRANSPL, V28, P2206, DOI 10.1093/ndt/gft192; OELKERS W, 1989, NEW ENGL J MED, V321, P492, DOI 10.1056/NEJM198908243210802; Oelkers W, 1996, NEW ENGL J MED, V335, P1206, DOI 10.1056/NEJM199610173351607; PAPANEK PE, 1994, AM J PHYSIOL, V266, pR1744, DOI 10.1152/ajpregu.1994.266.6.R1744; Purnell JQ, 2004, J CLIN ENDOCR METAB, V89, P281, DOI 10.1210/jc.2003-030440; Quax RA, 2013, NAT REV ENDOCRINOL, V9, P670, DOI 10.1038/nrendo.2013.183; Schrier RW, 2006, J AM SOC NEPHROL, V17, P1820, DOI 10.1681/ASN.2006030240; SCHRIER RW, 1980, YALE J BIOL MED, V53, P525; Soule S, 1999, CLIN ENDOCRINOL, V50, P115, DOI 10.1046/j.1365-2265.1999.00625.x; SPRY C, 1976, YALE J BIOL MED, V49, P411; SZATALOWICZ VL, 1982, CLIN SCI, V62, P235, DOI 10.1042/cs0620235; Thorn G, 1951, DIAGNOSIS TREATMENT; van der Hoek J, 2009, CLIN CHEM, V55, P1905, DOI 10.1373/clinchem.2009.125575	21	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1159	1167		10.1056/NEJMcpc1616024	http://dx.doi.org/10.1056/NEJMcpc1616024			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NB	28328333				2022-12-28	WOS:000397014300013
J	Oliver, D				Oliver, David			David Oliver: Getting real about care closer to home	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2017, FINANCIAL TIMES; Appleby J., 2017, SPRING BUDGET 2017 G; Bostock N., 2017, BUDGET REACTION GPS; Campbell D, 2017, GUARDIAN; Dunhill L., 2017, HLTH SERV J, P356; King's Fund, 2017, SUST TRANSF PLANS; Knox A., 2017, PUBLIC PERSPECTIVES; Lintern S., 2017, HLTH SERV J, P356; NHS Confederation, 2016, GROW OLD TOG SHAR NE; Royal College of GPs, 2015, STEPP FORW COMM PRIN; Triggle N., 2017, BBC HLTH NEWS   0319	11	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2017	356								j1428	10.1136/bmj.j1428	http://dx.doi.org/10.1136/bmj.j1428			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4VX	28336510	Green Published, Bronze			2022-12-28	WOS:000426826300001
J	FitzGerald, JM; Emery, P				FitzGerald, J. Mark; Emery, Paul			Modifying the trajectory of asthma-are there lessons from the use of biologics in rheumatology?	LANCET			English	Editorial Material							EOSINOPHILIC ASTHMA; MEPOLIZUMAB; OMALIZUMAB; ARTHRITIS; REMISSION; EFFICACY; THERAPY; PLACEBO; ADULTS		[FitzGerald, J. Mark] Univ British Columbia, Gordon & Leslie Diamond Hlth Care Ctr, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada; [Emery, Paul] Univ Leeds, Leeds Teaching Hosp Trust, Leeds Musculoskeletal Biomed Res Unit, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England	University of British Columbia; University of Leeds	FitzGerald, JM (corresponding author), Univ British Columbia, Gordon & Leslie Diamond Hlth Care Ctr, Inst Heart & Lung Hlth, Vancouver, BC V5Z 1M9, Canada.	mark.fitzgerald@vch.ca	emery, paul/B-3560-2013		AstraZeneca; GlaxoSmithKline; Pfizer; MSD; AbbVie; Bristol-Myers Squibb; UCB; Roche; Novartis; Samsung; Lilly; National Institute for Health Research [NF-SI-0513-10139, NF-SI-0508-10299, RC-PG-0407-10054] Funding Source: researchfish; Versus Arthritis [20639, 18475] Funding Source: researchfish	AstraZeneca(AstraZeneca); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); MSD; AbbVie(AbbVie); Bristol-Myers Squibb(Bristol-Myers Squibb); UCB(UCB Pharma SA); Roche(Roche Holding); Novartis(Novartis); Samsung(Samsung); Lilly(Eli Lilly); National Institute for Health Research(National Institute for Health Research (NIHR)); Versus Arthritis(Versus Arthritis)	JMF has been involved in the evaluation of treatment strategies for more severe asthma as discussed in this Comment. He has received research funding, including for biologics being evaluated to treat severe asthma, paid directly to the University of British Columbia, from AstraZeneca and GlaxoSmithKline; has received speakers' fees for participating at symposia on severe asthma and biologics funded by AstraZeneca; and has participated in the protocol development of studies funded by AstraZeneca evaluating biologics in severe asthma. PE has had no involvement in the development of biologics for asthma; he has undertaken clinical trials funded by, and provided expert advice for, Pfizer, MSD, AbbVie, Bristol-Myers Squibb, UCB, Roche, Novartis, Samsung, and Lilly.	Castro M, 2015, LANCET RESP MED, V3, P355, DOI [10.1016/S2213-2600(15)00042-9, 10.1016/S2213-2600(15)00119-8]; Charriot J, 2016, EUR RESPIR REV, V25, DOI 10.1183/16000617.0069-2015; Combe B, 2017, ANN RHEUM DIS, V76, P948, DOI 10.1136/annrheumdis-2016-210602; EMERY P, 1995, ANN RHEUM DIS, V54, P944, DOI 10.1136/ard.54.12.944; Emery P, 2014, NEW ENGL J MED, V371, P1781, DOI 10.1056/NEJMoa1316133; FitzGerald JM, 2016, LANCET, V388, P2128, DOI [10.1016/s0140-6736(16)31322-8, 10.1016/S0140-6736(16)31322-8]; Gibeon D, 2015, CHEST, V148, P870, DOI 10.1378/chest.14-3056; Global Initiative for Asthma, 2016, ASTHMA; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Her M, 2015, NAT REV GASTRO HEPAT, V12, P363, DOI 10.1038/nrgastro.2015.65; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Maselli DJ, 2013, ANN ALLERG ASTHMA IM, V110, P457, DOI 10.1016/j.anai.2013.04.011; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Ortega HG, 2014, NEW ENGL J MED, V371, P1198, DOI 10.1056/NEJMoa1403290; Pavord ID, 2013, J ALLERGY CLIN IMMUN, V132, P828, DOI 10.1016/j.jaci.2013.07.045; Rodrigo GJ, 2011, CHEST, V139, P28, DOI 10.1378/chest.10-1194; Sadatsafavi M, 2016, ALLERGY, V71, P371, DOI 10.1111/all.12803; Zafari Z, 2014, J ALLERGY CLIN IMMUN, V134, P908, DOI 10.1016/j.jaci.2014.04.009	18	3	3	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1082	1084						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28322805				2022-12-28	WOS:000396408700007
J	Mishra, B				Mishra, Bet			Radha Mohan Mishra OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		MISHRA RM, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2017	356								j1144	10.1136/bmj.j1144	http://dx.doi.org/10.1136/bmj.j1144			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NR	28314723				2022-12-28	WOS:000397015900005
J	Tseng, R; Goularte, NF; Chavan, A; Luu, J; Cohen, SE; Chang, YG; Heisler, J; Li, S; Michael, AK; Tripathi, S; Golden, SS; LiWang, A; Partch, CL				Tseng, Roger; Goularte, Nicolette F.; Chavan, Archana; Luu, Jansen; Cohen, Susan E.; Chang, Yong-Gang; Heisler, Joel; Li, Sheng; Michael, Alicia K.; Tripathi, Sarvind; Golden, Susan S.; LiWang, Andy; Partch, Carrie L.			Structural basis of the day-night transition in a bacterial circadian clock	SCIENCE			English	Article							KAIC PHOSPHORYLATION; PROTEIN KAIA; SYNECHOCOCCUS-ELONGATUS; GENE-EXPRESSION; COMPLEX; OSCILLATOR; RHYTHMS; DOMAIN; TIME; MECHANISMS	Circadian clocks are ubiquitous timing systems that induce rhythms of biological activities in synchrony with night and day. In cyanobacteria, timing is generated by a posttranslational clock consisting of KaiA, KaiB, and KaiC proteins and a set of output signaling proteins, SasA and CikA, which transduce this rhythm to control gene expression. Here, we describe crystal and nuclear magnetic resonance structures of KaiB-KaiC, KaiA-KaiB-KaiC, and CikA-KaiB complexes. They reveal how the metamorphic properties of KaiB, a protein that adopts two distinct folds, and the post-adenosine triphosphate hydrolysis state of KaiC create a hub around which nighttime signaling events revolve, including inactivation of KaiA and reciprocal regulation of the mutually antagonistic signaling proteins, SasA and CikA.	[Tseng, Roger; LiWang, Andy] Univ Calif, Quantitat & Syst Biol, Merced, CA 95343 USA; [Goularte, Nicolette F.; Luu, Jansen; Michael, Alicia K.; Tripathi, Sarvind; Partch, Carrie L.] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA; [Chavan, Archana; Chang, Yong-Gang; LiWang, Andy] Univ Calif, Sch Nat Sci, Merced, CA 95343 USA; [Cohen, Susan E.; Golden, Susan S.; LiWang, Andy; Partch, Carrie L.] Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA; [Golden, Susan S.] Univ Calif San Diego, Dept Biol Sci, La Jolla, CA 92093 USA; [Heisler, Joel; LiWang, Andy] Univ Calif, Chem & Chem Biol, Merced, CA 95343 USA; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [LiWang, Andy] Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA	University of California System; University of California Merced; University of California System; University of California Santa Cruz; University of California System; University of California Merced; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Merced; University of California System; University of California San Diego; University of California System; University of California Merced	LiWang, A (corresponding author), Univ Calif, Quantitat & Syst Biol, Merced, CA 95343 USA.; Partch, CL (corresponding author), Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA.; LiWang, A (corresponding author), Univ Calif, Sch Nat Sci, Merced, CA 95343 USA.; LiWang, A; Partch, CL (corresponding author), Univ Calif San Diego, Ctr Circadian Biol, La Jolla, CA 92093 USA.; LiWang, A (corresponding author), Univ Calif, Chem & Chem Biol, Merced, CA 95343 USA.; LiWang, A (corresponding author), Univ Calif, Hlth Sci Res Inst, Merced, CA 95343 USA.	aliwang@ucmerced.edu; cpartch@ucsc.edu	Tripathi, Sarvind/Y-5229-2019; LiWang, Andy/AAE-5205-2020; Tripathi, sarvind/F-6959-2015	Tripathi, Sarvind/0000-0002-6959-0577; LiWang, Andy/0000-0003-4741-6946; Tripathi, sarvind/0000-0002-6959-0577; Heisler, Joel/0000-0002-2703-3035; Chavan, Archana/0000-0002-5691-8094; Michael, Alicia/0000-0002-6080-839X; Goularte, Nicolette/0000-0001-6557-9349; Tseng, Roger/0000-0002-2188-0321; Partch, Carrie/0000-0002-4677-2861	Sandler Foundation; University of California Office of the President Multicampus Research Programs and Initiatives [MR-15-328599]; U.S. Department of Energy [DE-AC02-05CH11231, DE-AC02-06CH11357]; Air Force Office of Scientific Research [FA9550-13-1-0154]; U.S. National Institutes of Health [R01GM107521, R01GM107069, F31CA189660, R35GM118290, 1U19AI117905, R01GM020501, R01AI101436]; National Science Foundation Graduate Research Fellowship; American Cancer Society Postdoctoral Fellowship [PF-12-262-01-MPC]; NIGMS [P41-GM103311]; NATIONAL CANCER INSTITUTE [F31CA189660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI117905, R01AI101436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121507, P41GM103311, R01GM107521, R35GM118290, R01GM020501, R01GM107069] Funding Source: NIH RePORTER; Direct For Education and Human Resources [1547848] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1523910] Funding Source: National Science Foundation	Sandler Foundation; University of California Office of the President Multicampus Research Programs and Initiatives; U.S. Department of Energy(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); American Cancer Society Postdoctoral Fellowship(American Cancer Society); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Education and Human Resources(National Science Foundation (NSF)NSF - Directorate for STEM Education (EDU)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank staff at the 8.3.1 beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory, and the 23-ID-B beamline at the Advanced Photon Source, Argonne National Laboratory for help with data collection. Access to the 8.3.1 beamline was provided by the University of California Office of the President Multicampus Research Programs and Initiatives grant MR-15-328599 and the Program for Breakthrough Biomedical Research, which is partly funded by the Sandler Foundation. The Advanced Light Source (contract DE-AC02-05CH11231) and Advanced Photon Source (contract DE-AC02-06CH11357) are supported by the U.S. Department of Energy. This work was supported by grants from the Air Force Office of Scientific Research (FA9550-13-1-0154 to A.L.), U.S. National Institutes of Health (R01GM107521 to A.L., R01GM107069 to C.L.P., F31CA189660 to A.K.M., and R35GM118290 to S.S.G.). R.T. was supported by the National Science Foundation Graduate Research Fellowship, and S.E.C. was supported by the American Cancer Society Postdoctoral Fellowship PF-12-262-01-MPC. S.L. and the Biomolecular/Proteomics Mass Spectrometry Facility are supported by the U.S. National Institutes of Health (1U19AI117905, R01GM020501, and R01AI101436). We thank M. Lutz for facility support; S. Grimaldi for maintaining the NMR cryoplatform; D. Rice for maintaining the NMR Facility; D. Garrett at the U.S. National Institutes of Health for providing NMR software XIPP; C. Schwieters for Xplor-NIH support; and National Magnetic Resonance Facility at Madison (NMRFAM) Advanced Workshop instructors M. Westler, G. Cornilescu, V. Chen, and W. Lee at the NMRFAM. Molecular graphics and analyses were performed with the UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311). We thank L. Zhang for RDC NMR guidance and R. Peterson, F. Delaglio, M. Paddock, and J. Boyd for helpful discussions. C.L.P., A. L., S. S. G., S. L., R.T., A. C., and S.E.C. designed the experiments and contributed reagents. R.T., N.F.G., A. C., J. L., S.E.C., Y.-G.C., J.H., S. L., and S.T. performed the experiments. Data were analyzed by R.T., N.F.G, A. C., J. L., S.E.C., Y.-G.C., J.H., S. L., S.T., C.L.P., A. L., and S.S.G. A.K.M. contributed to some experiments and discussions. R.T., A. L., and C.L.P wrote the paper. All authors approve of the conclusions and final version of the paper. The atomic coordinates and structure factors for KaiB<INF>fs-cryst</INF>-CI<INF>cryst</INF>, KaiB<INF>fs-cryst*</INF>-KaiC<INF>S431E</INF>, KaiA<INF>cryst</INF>-KaiB<INF>fs-cryst</INF>-CI<INF>cryst</INF>, and CikA<INF>PsR</INF>-KaiB<INF>fs-nmr</INF> complexes have been deposited in the Protein Data Bank under accession codes 5JWO, 5JWQ, 5JWR, and 5JYV, respectively. Free CikA<INF>PsR</INF> and KaiB<INF>fs-nmr</INF> structures are deposited under 5JYU and 5JYT, respectively. Structural statistics are provided in the supplementary materials (tables S2 and S3). The authors declare no competing financial interests.	Abe J, 2015, SCIENCE, V349, P312, DOI 10.1126/science.1261040; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Chang YG, 2015, SCIENCE, V349, P324, DOI 10.1126/science.1260031; Chang YG, 2012, P NATL ACAD SCI USA, V109, P16847, DOI 10.1073/pnas.1211508109; Chang YG, 2011, P NATL ACAD SCI USA, V108, P14431, DOI 10.1073/pnas.1104221108; Cohen SE, 2015, MICROBIOL MOL BIOL R, V79, P373, DOI 10.1128/MMBR.00036-15; Diamond S, 2015, P NATL ACAD SCI USA, V112, pE1916, DOI 10.1073/pnas.1504576112; Dong GG, 2010, CELL, V140, P529, DOI 10.1016/j.cell.2009.12.042; Dunlap J.C., 2004, CHRONOBIOLOGY BIOL T; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Egli M, 2012, BIOCHEMISTRY-US, V51, P1547, DOI 10.1021/bi201525n; Garces RG, 2004, EMBO J, V23, P1688, DOI 10.1038/sj.emboj.7600190; Gutu A, 2013, MOL CELL, V50, P288, DOI 10.1016/j.molcel.2013.02.022; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Kageyama H, 2006, MOL CELL, V23, P161, DOI 10.1016/j.molcel.2006.05.039; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Lambert G, 2016, BIOPHYS J, V111, P883, DOI 10.1016/j.bpj.2016.07.008; Lin J, 2014, P NATL ACAD SCI USA, V111, pE3937, DOI 10.1073/pnas.1408692111; Mori T, 2007, PLOS BIOL, V5, P841, DOI 10.1371/journal.pbio.0050093; Murakami R, 2016, GENES CELLS, V21, P890, DOI 10.1111/gtc.12392; Murakami R, 2012, J BIOL CHEM, V287, P29506, DOI 10.1074/jbc.M112.349092; Murzin AG, 2008, SCIENCE, V320, P1725, DOI 10.1126/science.1158868; Musiek ES, 2016, SCIENCE, V354, P1004, DOI 10.1126/science.aah4968; Mutoh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080200; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Nishiwaki T, 2012, J BIOL CHEM, V287, P18030, DOI 10.1074/jbc.M112.350660; Paddock ML, 2013, P NATL ACAD SCI USA, V110, pE3849, DOI 10.1073/pnas.1315170110; Panda S, 2016, SCIENCE, V354, P1008, DOI 10.1126/science.aah4967; Papazyan R, 2016, NAT STRUCT MOL BIOL, V23, P1045, DOI 10.1038/nsmb.3324; Pattanayek R, 2015, BIOCHEMISTRY-US, V54, P4575, DOI 10.1021/acs.biochem.5b00694; Pattanayek R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023697; Pattanayek R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007529; Phong C, 2013, P NATL ACAD SCI USA, V110, P1124, DOI 10.1073/pnas.1212113110; PITTENDRIGH CS, 1954, P NATL ACAD SCI USA, V40, P1018, DOI 10.1073/pnas.40.10.1018; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Snijder J, 2014, P NATL ACAD SCI USA, V111, P1379, DOI 10.1073/pnas.1314326111; Sugiyama M, 2016, SCI REP-UK, V6, DOI 10.1038/srep35567; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Tseng R, 2014, J MOL BIOL, V426, P389, DOI 10.1016/j.jmb.2013.09.040; Vakonakis I, 2004, P NATL ACAD SCI USA, V101, P10925, DOI 10.1073/pnas.0403037101; Vakonakis I, 2001, J BIOMOL NMR, V21, P179, DOI 10.1023/A:1012478912174; Vakonakis L, 2004, P NATL ACAD SCI USA, V101, P1479, DOI 10.1073/pnas.0305516101; Vijayan V, 2009, P NATL ACAD SCI USA, V106, P22564, DOI 10.1073/pnas.0912673106; Villarreal SA, 2013, J MOL BIOL, V425, P3311, DOI 10.1016/j.jmb.2013.06.018; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Whitehead K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005485; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Xu HY, 2015, NAT STRUCT MOL BIOL, V22, P476, DOI 10.1038/nsmb.3018; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200; Zhang XF, 2006, MOL MICROBIOL, V60, P658, DOI 10.1111/j.1365-2958.2006.05138.x	61	80	82	4	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1174	1180		10.1126/science.aag2516	http://dx.doi.org/10.1126/science.aag2516			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302851	Green Accepted, Green Published			2022-12-28	WOS:000396351200036
J	Wade, L				Wade, Lizzie			UNEARTHING DEMOCRACY'S ROOTS In some ancient Mesoamerican societies, rulers shared power and ordinary people had a voice	SCIENCE			English	Editorial Material																			0	4	4	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1114	1118		10.1126/science.355.6330.1114	http://dx.doi.org/10.1126/science.355.6330.1114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302805				2022-12-28	WOS:000396351200015
J	Wakeman, SE				Wakeman, Sarah E.			Another Senseless Death - The Case for Supervised Injection Facilities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OVERDOSE DEATHS; DRUG		[Wakeman, Sarah E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Wakeman, Sarah E.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wakeman, SE (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.; Wakeman, SE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Bayoumi AM, 2008, CAN MED ASSOC J, V179, P1143, DOI 10.1503/cmaj.080808; Kinnard EN, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-29; Milloy MJS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003351; Potier C, 2014, DRUG ALCOHOL DEPEN, V145, P48, DOI 10.1016/j.drugalcdep.2014.10.012; Rudd RA, 2016, MMWR-MORBID MORTAL W, V65, P1445, DOI 10.15585/mmwr.mm655051e1	5	9	9	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1011	1013		10.1056/NEJMp1613651	http://dx.doi.org/10.1056/NEJMp1613651			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QT	28296603				2022-12-28	WOS:000396403700005
J	Zipfel, C; Oldroyd, GED				Zipfel, Cyril; Oldroyd, Giles E. D.			Plant signalling in symbiosis and immunity	NATURE			English	Review							RECEPTOR-LIKE KINASE; ARBUSCULAR MYCORRHIZAL SYMBIOSIS; DEPENDENT PROTEIN-KINASE; PATTERN-RECOGNITION RECEPTORS; LEGUME MEDICAGO-TRUNCATULA; NODULE EARLY SENESCENCE; CONFERS BROAD-SPECTRUM; DEFENSE-LIKE REACTIONS; NADPH OXIDASE RBOHD; ROOT HAIR-CELLS	Plants encounter a myriad of microorganisms, particularly at the root-soil interface, that can invade with detrimental or beneficial outcomes. Prevalent beneficial associations between plants and microorganisms include those that promote plant growth by facilitating the acquisition of limiting nutrients such as nitrogen and phosphorus. But while promoting such symbiotic relationships, plants must restrict the formation of pathogenic associations. Achieving this balance requires the perception of potential invading microorganisms through the signals that they produce, followed by the activation of either symbiotic responses that promote microbial colonization or immune responses that limit it.	[Zipfel, Cyril] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Oldroyd, Giles E. D.] John Innes Ctr, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Zipfel, C (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	cyril.zipfel@tsl.ac.uk	Oldroyd, Giles/ABA-7501-2020; ZIPFEL, CYRIL B/D-7103-2011; ZIPFEL, CYRIL/ABD-5076-2021; Oldroyd, Giles/ABD-8143-2021	ZIPFEL, CYRIL B/0000-0003-4935-8583; ZIPFEL, CYRIL/0000-0003-4935-8583; Oldroyd, Giles/0000-0002-5245-6355	Gatsby Charitable Foundation; European Research Council (PHOSPHinnATE); 2Blades Foundation; UK Biotechnology and Biological Sciences Research Council [BB/J004553/1]; Bill and Melinda Gates Foundation; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9795, BBS/E/J/000PR9796] Funding Source: researchfish; BBSRC [BBS/E/J/000PR9796, BBS/E/J/000PR9795] Funding Source: UKRI	Gatsby Charitable Foundation; European Research Council (PHOSPHinnATE)(European Research Council (ERC)); 2Blades Foundation; UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Research on this topic in the authors' laboratories is supported by: the Gatsby Charitable Foundation (C.Z.); the European Research Council (PHOSPHinnATE; C.Z.); the 2Blades Foundation (C.Z.); the UK Biotechnology and Biological Sciences Research Council (BB/J004553/1; C.Z. and G.O.); and the Bill and Melinda Gates Foundation (G.O.). The authors thank members of their laboratories for continuous discussions and P. Kalo for providing the images presented in Fig. 4. We apologize to our colleagues whose work could not be cited owing to space limitations.	Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487; Albert I, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.140, 10.1038/nplants.2015.140]; Andrio E, 2013, NEW PHYTOL, V198, P190, DOI 10.1111/nph.12120; Antolin-Llovera M, 2014, CURR BIOL, V24, P422, DOI 10.1016/j.cub.2013.12.053; Ao Y, 2014, PLANT J, V80, P1072, DOI 10.1111/tpj.12710; Ben Amor B, 2003, PLANT J, V34, P495, DOI 10.1046/j.1365-313X.2003.01743.x; Ben C, 2013, J EXP BOT, V64, P317, DOI 10.1093/jxb/ers337; Berrabah F, 2015, J EXP BOT, V66, P1977, DOI 10.1093/jxb/eru545; Berrabah F, 2014, NEW PHYTOL, V203, P1305, DOI 10.1111/nph.12881; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boudsocq M, 2010, NATURE, V464, P418, DOI 10.1038/nature08794; Bourcy M, 2013, NEW PHYTOL, V197, P1250, DOI 10.1111/nph.12091; Bressendorff S, 2016, PLANT CELL, V28, P1328, DOI 10.1105/tpc.15.00774; Broghammer A, 2012, P NATL ACAD SCI USA, V109, P13859, DOI 10.1073/pnas.1205171109; Buendia L, 2016, NEW PHYTOL, V210, P184, DOI 10.1111/nph.13753; Capoen W, 2011, P NATL ACAD SCI USA, V108, P14348, DOI 10.1073/pnas.1107912108; Cardenas L, 1999, PLANT J, V19, P347, DOI 10.1046/j.1365-313X.1999.00517.x; Cardenas L, 2008, PLANT J, V56, P802, DOI 10.1111/j.1365-313X.2008.03644.x; Charpentier M, 2016, SCIENCE, V352, P1102, DOI 10.1126/science.aae0109; Charpentier M, 2008, PLANT CELL, V20, P3467, DOI 10.1105/tpc.108.063255; Chen T, 2012, PLANT CELL, V24, P823, DOI 10.1105/tpc.112.095984; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Czaja LF, 2012, PLANT PHYSIOL, V159, P1671, DOI 10.1104/pp.112.195990; De Mita S, 2014, NEW PHYTOL, V201, P961, DOI 10.1111/nph.12549; Deakin WJ, 2009, NAT REV MICROBIOL, V7, P312, DOI 10.1038/nrmicro2091; den Camp RO, 2011, SCIENCE, V331, P909, DOI 10.1126/science.1198181; Denarie J, 1996, ANNU REV BIOCHEM, V65, P503, DOI 10.1146/annurev.bi.65.070196.002443; Domonkos A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-157; Downie JA, 2010, FEMS MICROBIOL REV, V34, P150, DOI 10.1111/j.1574-6976.2009.00205.x; Du J, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.34, 10.1038/nplants.2015.34]; Dubiella U, 2013, P NATL ACAD SCI USA, V110, P8744, DOI 10.1073/pnas.1221294110; Endre G, 2002, NATURE, V417, P962, DOI 10.1038/nature00842; Evans MJ, 2016, PLANT PHYSIOL, V171, P1771, DOI 10.1104/pp.16.00215; Faulkner C, 2013, P NATL ACAD SCI USA, V110, P9166, DOI 10.1073/pnas.1203458110; Feng F, 2012, NATURE, V485, P114, DOI 10.1038/nature10962; Fischer I, 2016, PLANT PHYSIOL, V170, P1595, DOI 10.1104/pp.15.01470; Fliegmann J, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.136, 10.1038/nplants.2016.136]; Fliegmann J, 2016, FEBS LETT, V590, P1477, DOI 10.1002/1873-3468.12191; Fliegmann J, 2013, ACS CHEM BIOL, V8, P1900, DOI 10.1021/cb400369u; Floss DS, 2013, P NATL ACAD SCI USA, V110, pE5025, DOI 10.1073/pnas.1308973110; Fonouni-Farde C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12636; Furukawa T, 2014, MOL PLANT MICROBE IN, V27, P113, DOI 10.1094/MPMI-10-13-0304-R; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Gaude N, 2012, PLANT J, V69, P510, DOI 10.1111/j.1365-313X.2011.04810.x; Genre A, 2013, NEW PHYTOL, V198, P179, DOI 10.1111/nph.12146; Gilroy S, 2016, PLANT PHYSIOL, V171, P1606, DOI 10.1104/pp.16.00434; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Gomez SK, 2009, PEST MANAG SCI, V65, P504, DOI 10.1002/ps.1715; Gourion B, 2015, TRENDS PLANT SCI, V20, P186, DOI 10.1016/j.tplants.2014.11.008; Gully D, 2016, MOL PLANT MICROBE IN, V29, P447, DOI 10.1094/MPMI-03-16-0052-R; Gust AA, 2012, TRENDS PLANT SCI, V17, P495, DOI 10.1016/j.tplants.2012.04.003; Halter T, 2014, CURR BIOL, V24, P134, DOI 10.1016/j.cub.2013.11.047; Hao GX, 2016, MOL PLANT MICROBE IN, V29, P132, DOI 10.1094/MPMI-09-15-0211-R; Hegenauer V, 2016, SCIENCE, V353, P478, DOI 10.1126/science.aaf3919; Hind SR, 2016, NAT PLANTS, V2, DOI [10.1038/NPLANTS.2016.128, 10.1038/nplants.2016.128]; Hogekamp C, 2011, PLANT PHYSIOL, V157, P2023, DOI 10.1104/pp.111.186635; Hurni S, 2015, P NATL ACAD SCI USA, V112, P8780, DOI 10.1073/pnas.1502522112; Ivleva NB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160951; Jin Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12433; Kadota Y, 2014, MOL CELL, V54, P43, DOI 10.1016/j.molcel.2014.02.021; Kawaharada Y, 2015, NATURE, V523, P308, DOI 10.1038/nature14611; Keinath NF, 2015, MOL PLANT, V8, P1188, DOI 10.1016/j.molp.2015.05.006; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Kouzai Y, 2014, MOL PLANT MICROBE IN, V27, P975, DOI 10.1094/MPMI-03-14-0068-R; Lacombe S, 2010, NAT BIOTECHNOL, V28, P365, DOI 10.1038/nbt.1613; Le MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102245; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Li L, 2014, CELL HOST MICROBE, V15, P329, DOI 10.1016/j.chom.2014.02.009; Liang Y, 2013, SCIENCE, V341, P1384, DOI 10.1126/science.1242736; Limpens E, 2015, ANNU REV PHYTOPATHOL, V53, P311, DOI 10.1146/annurev-phyto-080614-120149; Liu TT, 2012, SCIENCE, V336, P1160, DOI 10.1126/science.1218867; Liu YQ, 2015, NAT BIOTECHNOL, V33, P301, DOI 10.1038/nbt.3069; Lopez-Gomez M, 2012, J EXP BOT, V63, P393, DOI 10.1093/jxb/err291; Lopez-Torrejon G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11426; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Lu F, 2015, J INTEGR PLANT BIOL, V57, P641, DOI 10.1111/jipb.12306; Ma XY, 2016, TRENDS PLANT SCI, V21, P1017, DOI 10.1016/j.tplants.2016.08.014; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Maekawa T, 2009, PLANT J, V58, P183, DOI 10.1111/j.1365-313X.2008.03774.x; Maillet F, 2011, NATURE, V469, P58, DOI 10.1038/nature09622; Malkov N, 2016, BIOCHEM J, V473, P1369, DOI 10.1042/BCJ20160073; Manosalva P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8795; Marchetti M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000280; Marino D, 2011, NEW PHYTOL, V189, P580, DOI 10.1111/j.1469-8137.2010.03509.x; Mendes BMJ, 2010, PLANT PATHOL, V59, P68, DOI 10.1111/j.1365-3059.2009.02148.x; Messinese E, 2007, MOL PLANT MICROBE IN, V20, P912, DOI 10.1094/MPMI-20-8-0912; Miller JB, 2013, PLANT CELL, V25, P5053, DOI 10.1105/tpc.113.116921; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; Miyata K, 2016, PLANT CELL PHYSIOL, V57, P2283, DOI 10.1093/pcp/pcw144; Miyata K, 2014, PLANT CELL PHYSIOL, V55, P1864, DOI 10.1093/pcp/pcu129; Montiel J, 2012, PLANT CELL PHYSIOL, V53, P1751, DOI 10.1093/pcp/pcs120; Morieri G, 2013, NEW PHYTOL, V200, P656, DOI 10.1111/nph.12475; Muller DB, 2016, ANNU REV GENET, V50, P211, DOI 10.1146/annurev-genet-120215-034952; Nakagawa T, 2011, PLANT J, V65, P169, DOI 10.1111/j.1365-313X.2010.04411.x; Nars A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075039; Narusaka Y, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.25345; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Niehl A, 2016, NEW PHYTOL, V211, P1008, DOI 10.1111/nph.13944; Okazaki S, 2013, P NATL ACAD SCI USA, V110, P17131, DOI 10.1073/pnas.1302360110; Oldroyd GED, 2001, PLANT J, V28, P191, DOI 10.1046/j.1365-313X.2001.01149.x; Oldroyd GED, 2013, NAT REV MICROBIOL, V11, P252, DOI 10.1038/nrmicro2990; Pietraszewska-Bogiel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065055; Pimprikar P, 2016, CURR BIOL, V26, P987, DOI [10.1016/j.cub.2016.04.021, 10.1016/j.cub.2016.01.069]; Prince DC, 2014, PLANT PHYSIOL, V164, P2207, DOI 10.1104/pp.114.235598; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Ranf S, 2011, PLANT J, V68, P100, DOI 10.1111/j.1365-313X.2011.04671.x; Rey T, 2015, NEW PHYTOL, V206, P497, DOI 10.1111/nph.13233; Rey T, 2013, NEW PHYTOL, V198, P875, DOI 10.1111/nph.12198; Ried MK, 2014, ELIFE, V3, DOI 10.7554/eLife.03891; Schoonbeek HJ, 2015, NEW PHYTOL, V206, P606, DOI 10.1111/nph.13356; Schwessinger B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004809; Seybold H, 2014, NEW PHYTOL, V204, P782, DOI 10.1111/nph.13031; Shaw SL, 2003, PLANT PHYSIOL, V131, P976, DOI 10.1104/pp.005546; Shinya T, 2015, CURR OPIN PLANT BIOL, V26, P64, DOI 10.1016/j.pbi.2015.05.032; Shinya T, 2014, PLANT J, V79, P56, DOI 10.1111/tpj.12535; Shinya T, 2012, PLANT CELL PHYSIOL, V53, P1696, DOI 10.1093/pcp/pcs113; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Singh S, 2014, CELL HOST MICROBE, V15, P139, DOI 10.1016/j.chom.2014.01.011; Sreekanta S, 2015, NEW PHYTOL, V207, P78, DOI 10.1111/nph.13345; Stokstad E, 2016, SCIENCE, V353, P1225, DOI 10.1126/science.353.6305.1225; Stracke S, 2002, NATURE, V417, P959, DOI 10.1038/nature00841; Sun JH, 2015, PLANT CELL, V27, P823, DOI 10.1105/tpc.114.131326; Takeda N, 2012, PLANT CELL, V24, P810, DOI 10.1105/tpc.111.091827; Thor K, 2014, NEW PHYTOL, V204, P873, DOI 10.1111/nph.13064; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; Tripathi JN, 2014, PLANT BIOTECHNOL J; Venkateshwaran M, 2015, P NATL ACAD SCI USA, V112, P9781, DOI 10.1073/pnas.1413762112; Walker SA, 2000, P NATL ACAD SCI USA, V97, P13413, DOI 10.1073/pnas.230440097; Wang C, 2016, NEW PHYTOL, V212, P176, DOI 10.1111/nph.14017; Wang ET, 2012, CURR BIOL, V22, P2242, DOI 10.1016/j.cub.2012.09.043; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Yamada K, 2016, EMBO J, V35, P2468, DOI 10.15252/embj.201694248; Yamaguchi K, 2013, CELL HOST MICROBE, V13, P347, DOI 10.1016/j.chom.2013.02.007; Yang SM, 2010, P NATL ACAD SCI USA, V107, P18735, DOI 10.1073/pnas.1011957107; Yano K, 2008, P NATL ACAD SCI USA, V105, P20540, DOI 10.1073/pnas.0806858105; Yeh YH, 2016, PLANT CELL, V28, P1701, DOI 10.1105/tpc.16.00313; Yu F, 2014, MOL PLANT, V7, P1501, DOI 10.1093/mp/ssu092; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zhang XW, 2015, PLANT J, V81, P258, DOI 10.1111/tpj.12723; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	145	355	373	21	568	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					328	336		10.1038/nature22009	http://dx.doi.org/10.1038/nature22009			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28300100				2022-12-28	WOS:000396337400036
J	Winslow, RL; Milligan, ID; Voysey, M; Luhn, K; Shukarev, G; Douoguih, M; Snape, MD				Winslow, Rebecca L.; Milligan, Iain D.; Voysey, Merryn; Luhn, Kerstin; Shukarev, Georgi; Douoguih, Macaya; Snape, Matthew D.			Immune Responses to Novel Adenovirus Type 26 and Modified Vaccinia Virus Ankara-Vectored Ebola Vaccines at 1 Year	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DISEASE		[Winslow, Rebecca L.; Milligan, Iain D.; Snape, Matthew D.] Univ Oxford, Dept Paediat, Oxford, England; [Voysey, Merryn] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Luhn, Kerstin; Shukarev, Georgi; Douoguih, Macaya] Janssen, Leiden, Netherlands	University of Oxford; University of Oxford; Johnson & Johnson; Janssen Pharmaceuticals	Snape, MD (corresponding author), Churchill Hosp, Oxford Vaccine Grp, Ctr Clin Vaccinol & Trop Med, Headington OX3 7LE, England.	matthew.snape@paediatrics.ox.ac.uk		Milligan, Iain D/0000-0002-6501-5524; Voysey, Merryn/0000-0001-6324-6559; Snape, Matthew/0000-0003-0531-5426; Shukarev, Georgi/0000-0001-5154-7047	European Union's Innovative Medicines Initiative, as part of the EBOVAC1 consortium [115854]; European Union; European Federation of Pharmaceutical Industries and Associations; National Institute for Health Research Oxford Biomedical Research Centre	European Union's Innovative Medicines Initiative, as part of the EBOVAC1 consortium; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations; National Institute for Health Research Oxford Biomedical Research Centre(National Institute for Health Research (NIHR))	This trial was funded by grant 115854 from the European Union's Innovative Medicines Initiative, as part of the EBOVAC1 consortium. This joint undertaking receives support from the European Union's Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associations. The study sponsor was Janssen Vaccines and Prevention BV. Dr Snape receives salary support from the National Institute for Health Research Oxford Biomedical Research Centre.	Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; Deen G.F., 2015, N ENGL J MED; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218; Osterholm M, 2016, LANCET INFECT DIS, V16, pE1, DOI [10.1016/S1473-3099(15)00416-8, 10.1016/S1473-3099(15)00547-2]	6	51	52	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1074	1077		10.1001/jama.2016.20644	http://dx.doi.org/10.1001/jama.2016.20644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291882	Green Submitted, Bronze			2022-12-28	WOS:000396713400022
J	Marmot, M				Marmot, Michael			The art of medicine Post-truth and science	LANCET			English	Editorial Material									[Marmot, Michael] UCL Inst Hlth Equ, London WC1E 7HB, England	University of London; University College London	Marmot, M (corresponding author), UCL Inst Hlth Equ, London WC1E 7HB, England.	m.marmot@ucl.ac.uk	Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419					0	18	18	2	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 4	2017	389	10068					497	498		10.1016/S0140-6736(17)30207-6	http://dx.doi.org/10.1016/S0140-6736(17)30207-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ5UH	28327342				2022-12-28	WOS:000393283400021
J	Watts, G				Watts, Geoff			Quentin David Young Obituary	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2472	2472		10.1016/S0140-6736(16)32183-3	http://dx.doi.org/10.1016/S0140-6736(16)32183-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC5IA	28328463	Bronze			2022-12-28	WOS:000388166300016
J	Davies, JE; Sen, S; Dehbi, HM; Al-Lamee, R; Petraco, R; Nijjer, SS; Bhindi, R; Lehman, SJ; Walters, D; Sapontis, J; Janssens, L; Vrints, CJ; Khashaba, A; Laine, M; Van Belle, E; Krackhardt, F; Bojara, W; Going, O; Harle, T; Indolfi, C; Niccoli, G; Ribichini, F; Tanaka, N; Yokoi, H; Takashima, H; Kikuta, Y; Erglis, A; Vinhas, H; Silva, PC; Baptista, SB; Alghamdi, A; Hellig, F; Koo, BK; Nam, CW; Shin, ES; Doh, JH; Brugaletta, S; Alegria-Barrero, E; Meuwissen, M; Piek, JJ; van Royen, N; Sezer, M; Di Mario, C; Gerber, RT; Malik, IS; Sharp, ASP; Talwar, S; Tang, K; Samady, H; Altman, J; Seto, AH; Singh, J; Jeremias, A; Matsuo, H; Kharbanda, RK; Patel, MR; Serruys, P; Escaned, J				Davies, J. E.; Sen, S.; Dehbi, H. -M.; Al-Lamee, R.; Petraco, R.; Nijjer, S. S.; Bhindi, R.; Lehman, S. J.; Walters, D.; Sapontis, J.; Janssens, L.; Vrints, C. J.; Khashaba, A.; Laine, M.; Van Belle, E.; Krackhardt, F.; Bojara, W.; Going, O.; Harle, T.; Indolfi, C.; Niccoli, G.; Ribichini, F.; Tanaka, N.; Yokoi, H.; Takashima, H.; Kikuta, Y.; Erglis, A.; Vinhas, H.; Silva, P. Canas; Baptista, S. B.; Alghamdi, A.; Hellig, F.; Koo, B. -K.; Nam, C. -W.; Shin, E. -S.; Doh, J. -H.; Brugaletta, S.; Alegria-Barrero, E.; Meuwissen, M.; Piek, J. J.; van Royen, N.; Sezer, M.; Di Mario, C.; Gerber, R. T.; Malik, I. S.; Sharp, A. S. P.; Talwar, S.; Tang, K.; Samady, H.; Altman, J.; Seto, A. H.; Singh, J.; Jeremias, A.; Matsuo, H.; Kharbanda, R. K.; Patel, M. R.; Serruys, P.; Escaned, J.			Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; DIAGNOSTIC-ACCURACY; ADENOSINE; PRESSURE; ANGIOGRAPHY; WARFARIN; SURGERY; FFR; ANGIOPLASTY; MULTICENTER	BACKGROUND Coronary revascularization guided by fractional flow reserve (FFR) is associated with better patient outcomes after the procedure than revascularization guided by angiography alone. It is unknown whether the instantaneous wave-free ratio (iFR), an alternative measure that does not require the administration of adenosine, will offer benefits similar to those of FFR. METHODS We randomly assigned 2492 patients with coronary artery disease, in a 1: 1 ratio, to undergo either iFR-guided or FFR-guided coronary revascularization. The primary end point was the 1-year risk of major adverse cardiac events, which were a composite of death from any cause, nonfatal myocardial infarction, or unplanned revascularization. The trial was designed to show the noninferiority of iFR to FFR, with a margin of 3.4 percentage points for the difference in risk. RESULTS At 1 year, the primary end point had occurred in 78 of 1148 patients (6.8%) in the iFR group and in 83 of 1182 patients (7.0%) in the FFR group (difference in risk, -0.2 percentage points; 95% confidence interval [CI], -2.3 to 1.8; P<0.001 for noninferiority; hazard ratio, 0.95; 95% CI, 0.68 to 1.33; P = 0.78). The risk of each component of the primary end point and of death from cardiovascular or non-cardiovascular causes did not differ significantly between the groups. The number of patients who had adverse procedural symptoms and clinical signs was significantly lower in the iFR group than in the FFR group (39 patients [3.1%] vs. 385 patients [30.8%], P<0.001), and the median procedural time was significantly shorter (40.5 minutes vs. 45.0 minutes, P = 0.001). CONCLUSIONS Coronary revascularization guided by iFR was noninferior to revascularization guided by FFR with respect to the risk of major adverse cardiac events at 1 year. The rate of adverse procedural signs and symptoms was lower and the procedural time was shorter with iFR than with FFR.	[Davies, J. E.; Sen, S.; Al-Lamee, R.; Petraco, R.; Nijjer, S. S.; Malik, I. S.; Serruys, P.] Hammersmith Hosp, London, England; [Di Mario, C.] Royal Brompton Hosp, London, England; [Dehbi, H. -M.] Imperial Coll London, Canc Res UK, London, England; [Dehbi, H. -M.] UCL, Canc Trials Ctr, London, England; [Gerber, R. T.] Conquest Hosp, St Leonards On Sea, England; [Sharp, A. S. P.] Royal Devon & Exeter Hosp, Exeter, Devon, England; [Sharp, A. S. P.] Univ Exeter, Exeter, Devon, England; [Talwar, S.] Royal Bournemouth Gen Hosp, Bournemouth, Dorset, England; [Tang, K.] Essex Cardiothorac Ctr, Basildon, England; [Tang, K.] Anglia Ruskin Univ, Chelmsford, Essex, England; [Kharbanda, R. K.] Oxford Univ Hosp Fdn Trust, John Radcliffe Hosp, Oxford, England; [Bhindi, R.] Royal North Shore Hosp, Sydney, NSW, Australia; [Lehman, S. J.] Flinders Univ S Australia, Adelaide, SA, Australia; [Walters, D.] Prince Charles Hosp, Brisbane, Qld, Australia; [Walters, D.] MonashHeart, Melbourne, Vic, Australia; [Walters, D.] Monash Univ, Melbourne, Vic, Australia; [Janssens, L.] Imelda Hosp, Bonheiden, Belgium; [Vrints, C. J.] Antwerp Univ Hosp, Antwerp, Belgium; [Khashaba, A.] Ain Shams Univ, Cairo, Egypt; [Laine, M.] Helsinki Univ Hosp, Helsinki, Finland; [Van Belle, E.] Lille Univ Hosp, Inst Coeur Poumon, Lille, France; [Van Belle, E.] INSERM, Unite 1011, Lille, France; [Krackhardt, F.] Univ Med, Charite Campus Virchow Klinikum, Berlin, Germany; [Bojara, W.] Kemperhof Koblenz, Gemeinschaftsklinikum Mittelrhein, Koblenz, Germany; [Going, O.] Sana Klinikum Lichtenberg, Lichtenberg, Germany; [Harle, T.] Carl von Ossietzky Univ Oldenburg, European Med Sch, Klinikum Oldenburg, Oldenburg, Germany; [Indolfi, C.] Magna Graecia Univ Catanzaro, Catanzaro, Italy; [Niccoli, G.] Cathol Univ Sacred Heart, Rome, Italy; [Ribichini, F.] Univ Hosp Verona, Verona, Italy; [Di Mario, C.] Univ Florence, Florence, Italy; [Tanaka, N.] Tokyo Med Univ, Tokyo, Japan; [Yokoi, H.] Fukuoka Sannou Hosp, Fukuoka, Japan; [Takashima, H.] Aichi Med Univ Hosp, Aichi, Japan; [Kikuta, Y.] Fukuyama Cardiovasc Hosp, Fukuyama, Hiroshima, Japan; [Matsuo, H.] Gifu Heart Ctr, Gifu, Japan; [Erglis, A.] Pauls Stradins Clin Univ Hosp, Riga, Latvia; [Vinhas, H.] Hosp Garcia de Horta, Lisbon, Portugal; [Silva, P. Canas] Hosp Santa Maria, Lisbon, Portugal; [Baptista, S. B.] Hosp Prof Doutor Fernando Fonseca, Amadora, Portugal; [Alghamdi, A.] King Abdulaziz Med City Cardiac Ctr, Riyadh, Saudi Arabia; [Hellig, F.] Sunninghill Hosp, Johannesburg, South Africa; [Koo, B. -K.] Seoul Natl Univ Hosp, Seoul, South Korea; [Nam, C. -W.] Keimyung Univ, Dongsan Med Ctr, Daegu, South Korea; [Shin, E. -S.] Univ Ulsan, Coll Med, Ulsan Univ Hosp, Ulsan, South Korea; [Doh, J. -H.] Inje Univ Ilsan Paik Hosp, Daehwa Dong, South Korea; [Brugaletta, S.] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Hosp Clin, Cardiovasc Inst, Barcelona, Spain; [Alegria-Barrero, E.] Hosp Univ Torrejon, Madrid, Spain; [Alegria-Barrero, E.] Univ Francisco de Vitoria, Madrid, Spain; [Escaned, J.] Hosp Clinico San Carlos, Madrid, Spain; [Escaned, J.] Univ Complutense Madrid, Madrid, Spain; [Meuwissen, M.] Amphia Hosp, Breda, Netherlands; [Piek, J. J.] Acad Med Ctr, AMC Heart Ctr, Amsterdam, Netherlands; [van Royen, N.] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Sezer, M.] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkey; [Samady, H.] Emory Univ, Atlanta, GA 30322 USA; [Altman, J.] Colorado Heart & Vasc, Lakewood, CO USA; [Seto, A. H.] Vet Affairs Long Beach Healthcare Syst, Long Beach, CA USA; [Singh, J.] Washington Univ, Sch Med, St Louis, MO USA; [Jeremias, A.] SUNY Stony Brook, Med Ctr, Stony Brook, NY USA; [Patel, M. R.] Duke Univ, Durham, NC USA	Imperial College London; Royal Brompton Hospital; Cancer Research UK; Imperial College London; University of London; University College London; University of Exeter; University of Exeter; Anglia Ruskin University; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Royal North Shore Hospital; Flinders University South Australia; Prince Charles Hospital; Monash University; Imeldaziekenhuis; University of Antwerp; Egyptian Knowledge Bank (EKB); Ain Shams University; University of Helsinki; Helsinki University Central Hospital; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Carl von Ossietzky Universitat Oldenburg; Klinikum Oldenburg; Magna Graecia University of Catanzaro; Catholic University of the Sacred Heart; University of Florence; Tokyo Medical University; Aichi Medical University; Pauls Stradins Clinical University Hospital; Hospital Garcia de Orta; Universidade de Lisboa; Hospital Santa Maria; Hospital Professor Doutor Fernando Fonseca, EPE; Seoul National University (SNU); Seoul National University Hospital; Keimyung University; University of Ulsan; Ulsan University Hospital; Inje University; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidad Francisco de Vitoria; Hospital Clinico San Carlos; Complutense University of Madrid; Amphia Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Istanbul University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Duke University	Davies, JE (corresponding author), Hammersmith Hosp, Imperial Coll London, London W12 OHS, England.	justindavies@heart123.com	Alegria-Barrero, Eduardo/AAP-6945-2020; Krackhardt, Florian/AAK-7561-2020; Patel, Manesh/AAC-5385-2019; van Royen, Niels/Q-1097-2017; Niccoli, Giampaolo/K-3784-2018; Brugaletta, Salvatore/AAJ-2090-2020; Hellig, Farrel/ABD-8652-2020; Dehbi, Hakim-Moulay/AAU-4736-2020; Sezer, Murat/AAE-5807-2020; Escaned, Javier/I-5424-2017; Brugaletta, Salvatore/E-1310-2018; Ribichini, Flavio/AAB-7767-2022; Meuwissen, martijn/GWV-1891-2022; Khashaba, Ahmed/F-3054-2015	Krackhardt, Florian/0000-0001-5965-8817; Niccoli, Giampaolo/0000-0002-3187-6262; Brugaletta, Salvatore/0000-0001-5845-1435; Bravo Baptista, Sergio/0000-0002-4546-5261; Nijjer, Sukhjinder/0000-0001-9146-1037; Piek, Jan/0000-0001-8666-7129; Khashaba, Ahmed/0000-0002-9967-2784; VAN BELLE, ERIC/0000-0001-6509-443X; Erglis, Andrejs/0000-0002-3999-0182; Harle, Tobias/0000-0002-0492-7044; Kharbanda, Rajesh/0000-0002-5356-2395	Philips Volcano; Cancer Research UK [15953] Funding Source: researchfish; Medical Research Council [G1100443] Funding Source: researchfish; National Institute for Health Research [CL-2015-21-001] Funding Source: researchfish; MRC [G1100443] Funding Source: UKRI	Philips Volcano; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Philips Volcano; DEFINE-FLAIR ClinicalTrials. gov number, NCT02053038.	CERQUEIRA MD, 1994, J AM COLL CARDIOL, V23, P384, DOI 10.1016/0735-1097(94)90424-3; Di Mario C, 2000, CIRCULATION, V102, P2938; Dilsizian V, 2015, J NUCL CARDIOL, V22, P1198, DOI 10.1007/s12350-015-0141-4; Escaned J, 2015, JACC-CARDIOVASC INTE, V8, P824, DOI 10.1016/j.jcin.2015.01.029; Fearon WF, 2013, CIRCULATION, V128, P1335, DOI 10.1161/CIRCULATIONAHA.113.003059; Gotberg M, 2017, NEW ENGL J MED, V376, P1813, DOI 10.1056/NEJMoa1616540; GOULD KL, 1990, J AM COLL CARDIOL, V15, P459, DOI 10.1016/S0735-1097(10)80078-6; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; KERN MJ, 1995, J AM COLL CARDIOL, V25, P178, DOI 10.1016/0735-1097(94)00328-N; Kern MJ, 2016, CATHETER CARDIO INTE, V87, P270, DOI 10.1002/ccd.26419; Layland J, 2015, EUR HEART J, V36, P100, DOI 10.1093/eurheartj/ehu338; Makikallio T, 2016, LANCET, V388, P2742; Mallet ML, 2004, EMERG MED J, V21, P408, DOI 10.1136/emj.2004.016048; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Patel Manesh R, 2012, J Am Coll Cardiol, V59, P857, DOI 10.1016/j.jacc.2011.12.001; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Petraco R, 2014, CIRC-CARDIOVASC INTE, V7, P492, DOI 10.1161/CIRCINTERVENTIONS.113.000926; Petraco R, 2013, EUROINTERVENTION, V8, P1157, DOI 10.4244/EIJV8I10A179; PIJLS NHJ, 1993, CIRCULATION, V87, P1354, DOI 10.1161/01.CIR.87.4.1354; Pijls NHJ, 2011, JACC-CARDIOVASC INTE, V4, P1093, DOI 10.1016/j.jcin.2011.08.007; Sen S, 2013, J AM COLL CARDIOL, V62, P566, DOI 10.1016/j.jacc.2013.03.076; Sen S, 2013, J AM COLL CARDIOL, V61, P1409, DOI 10.1016/j.jacc.2013.01.034; SERRUYS PW, 1993, AM J CARDIOL, V71, pD41, DOI 10.1016/0002-9149(93)90133-W; Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; van de Hoef TP, 2015, EUROINTERVENTION, V11, P914, DOI 10.4244/EIJY14M08_17; van de Hoef TP, 2014, CIRC-CARDIOVASC INTE, V7, P301, DOI 10.1161/CIRCINTERVENTIONS.113.001049; von Birgelen C, 2012, J AM COLL CARDIOL, V59, P1350, DOI 10.1016/j.jacc.2012.01.008; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	30	513	519	2	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					1824	1834		10.1056/NEJMoa1700445	http://dx.doi.org/10.1056/NEJMoa1700445			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WR	28317458	Green Published			2022-12-28	WOS:000400891100008
J	Acheson, JF; Bailey, LJ; Brunold, TC; Fox, BG				Acheson, Justin F.; Bailey, Lucas J.; Brunold, Thomas C.; Fox, Brian G.			In-crystal reaction cycle of a toluene-bound diiron hydroxylase	NATURE			English	Article							XYLENE MONOOXYGENASE HYDROXYLASE; REDUCED METHANE MONOOXYGENASE; ACTIVE-SITE CLUSTERS; AROMATIC HYDROXYLATION; DEOXYHYPUSINE HYDROXYLASE; DIOXYGEN ACTIVATION; 4-MONOOXYGENASE; INTERMEDIATE; MECHANISM; COMPLEX	Electrophilic aromatic substitution is one of the most important and recognizable classes of organic chemical transformation. Enzymes create the strong electrophiles that are needed for these highly energetic reactions by using O-2, electrons, and metals or other cofactors. Although the nature of the oxidants that carry out electrophilic aromatic substitution has been deduced from many approaches, it has been difficult to determine their structures. Here we show the structure of a diiron hydroxylase intermediate formed during a reaction with toluene. Density functional theory geometry optimizations of an active site model reveal that the intermediate is an arylperoxo Fe2+/Fe3+ species with delocalized aryl radical character. The structure suggests that a carboxylate ligand of the diiron centre may trigger homolytic cleavage of the O-O bond by transferring a proton from a metal-bound water. Our work provides the spatial and electronic constraints needed to propose a comprehensive mechanism for diiron enzyme arene hydroxylation that accounts for many prior experimental results.	[Acheson, Justin F.; Bailey, Lucas J.; Fox, Brian G.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Brunold, Thomas C.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fox, BG (corresponding author), Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA.	bgfox@biochem.wisc.edu		Acheson, Justin/0000-0001-5051-9984	National Science Foundation [MCB-0843239]; US Department of Energy, Office of Science [W-31-109-ENG-38]; Wisconsin Distinguished Graduate Fellowship	National Science Foundation(National Science Foundation (NSF)); US Department of Energy, Office of Science(United States Department of Energy (DOE)); Wisconsin Distinguished Graduate Fellowship	This work was funded by the National Science Foundation MCB-0843239 (B.G.F.). Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science Contract No. W-31-109-ENG-38. Use of the Life Science Collaborative Access Team (LS-CAT) was supported by the College of Agricultural and Life Sciences, Department of Biochemistry, and Graduate School of the University of Wisconsin. J.F.A. received a Wisconsin Distinguished Graduate Fellowship in support of this work.	Acheson JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6009; Adams PD, 2013, ANNU REV BIOPHYS, V42, P265, DOI 10.1146/annurev-biophys-083012-130253; Bailey LJ, 2012, BIOCHEMISTRY-US, V51, P1101, DOI 10.1021/bi2018333; Bailey LJ, 2009, BIOCHEMISTRY-US, V48, P8932, DOI 10.1021/bi901150a; Bailey LJ, 2008, P NATL ACAD SCI USA, V105, P19194, DOI 10.1073/pnas.0807948105; Banerjee R, 2015, NATURE, V518, P431, DOI 10.1038/nature14160; Bathelt CM, 2003, J AM CHEM SOC, V125, P15004, DOI 10.1021/ja035590q; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Broadwater JA, 1998, BIOCHEMISTRY-US, V37, P14664, DOI 10.1021/bi981839i; Capece L, 2012, J PHYS CHEM B, V116, P1401, DOI 10.1021/jp2082825; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Darbyshire JF, 1996, DRUG METAB DISPOS, V24, P1038; DeLano W.L, PYMOL MOL GRAPHICS S; Elsen NL, 2007, BIOCHEMISTRY-US, V46, P976, DOI 10.1021/bi0616145; Elsen NL, 2009, BIOCHEMISTRY-US, V48, P3838, DOI 10.1021/bi900144a; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gherman BF, 2004, J AM CHEM SOC, V126, P2978, DOI 10.1021/ja036506+; GUROFF G, 1967, SCIENCE, V157, P1524, DOI 10.1126/science.157.3796.1524; Han ZG, 2015, STRUCTURE, V23, P882, DOI 10.1016/j.str.2015.03.002; Knoot CJ, 2016, J BIOL INORG CHEM, V21, P589, DOI 10.1007/s00775-016-1363-x; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Liang AD, 2014, BIOCHEMISTRY-US, V53, P3585, DOI 10.1021/bi500387y; Lovell T, 2001, INORG CHEM, V40, P5267, DOI 10.1021/ic010116b; Lovell T, 2001, INORG CHEM, V40, P5251, DOI 10.1021/ic010115j; Mitchell KH, 2003, P NATL ACAD SCI USA, V100, P3784, DOI 10.1073/pnas.0636619100; Mitchell KH, 2002, BIOCHEMISTRY-US, V41, P3176, DOI 10.1021/bi012036p; Moche M, 2003, J BIOL CHEM, V278, P25072, DOI 10.1074/jbc.M301662200; Moe LA, 2004, BIOCHEMISTRY-US, V43, P15688, DOI 10.1021/bi040033h; Moenne-Loccoz P, 1999, BIOCHEMISTRY-US, V38, P5290, DOI 10.1021/bi990095l; Murray LJ, 2007, J AM CHEM SOC, V129, P14500, DOI 10.1021/ja076121h; ORCA, 2014, ORCA AB IN DENS FUNC; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rivard BS, 2015, BIOCHEMISTRY-US, V54, P4652, DOI 10.1021/acs.biochem.5b00573; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roberts KM, 2013, IUBMB LIFE, V65, P350, DOI 10.1002/iub.1144; Sazinsky MH, 2004, J BIOL CHEM, V279, P30600, DOI 10.1074/jbc.M400710200; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Shan XP, 2005, P NATL ACAD SCI USA, V102, P5340, DOI 10.1073/pnas.0409640102; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Solomon EI, 2016, J BIOL INORG CHEM, V21, P575, DOI 10.1007/s00775-016-1372-9; Solomon EI, 2013, ACCOUNTS CHEM RES, V46, P2725, DOI 10.1021/ar400149m; Song WJ, 2010, J AM CHEM SOC, V132, P13582, DOI 10.1021/ja1063795; Taylor R., 1990, ELECTROPHILIC AROMAT; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vu VV, 2009, P NATL ACAD SCI USA, V106, P14814, DOI 10.1073/pnas.0904553106; Worsdorfer B, 2013, P NATL ACAD SCI USA, V110, P18874, DOI 10.1073/pnas.1315927110; Xing G, 2006, P NATL ACAD SCI USA, V103, P6130, DOI 10.1073/pnas.0508473103; Yun D, 2007, BIOCHEMISTRY-US, V46, P1925, DOI 10.1021/bi061717n	49	32	32	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2017	544	7649					191	+		10.1038/nature21681	http://dx.doi.org/10.1038/nature21681			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6EK	28346937				2022-12-28	WOS:000398897900029
J	Kuehn, BM				Kuehn, Bridget M.			Resetting the Circadian Clock Might Boost Metabolic Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	16	16	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2017	317	13					1303	1305		10.1001/jama.2017.0653	http://dx.doi.org/10.1001/jama.2017.0653			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ9VR	28296999				2022-12-28	WOS:000398434200002
J	[Anonymous]				[Anonymous]			Notification of Infectious Diseases (Reprinted from Vol 18, pg 399, 1892)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1892, BRIT MED J, P469; [Anonymous], 1892, JAMA-J AM MED ASSOC, V18, P399	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1280	1280		10.1001/jama.2017.0641	http://dx.doi.org/10.1001/jama.2017.0641			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350915				2022-12-28	WOS:000397557800034
J	Ramaswami, R; Ghogawala, Z; Weinstein, JN				Ramaswami, Ramya; Ghogawala, Zoher; Weinstein, James N.			Management of Sciatica	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							LUMBAR-DISK HERNIATION; RESEARCH TRIAL SPORT; NONOPERATIVE TREATMENT; PAIN; RADICULOPATHY; EFFICACY; SURGERY		[Ramaswami, Ramya; Ghogawala, Zoher] Tufts Univ, Sch Med, Dept Neurosurg, Boston, MA 02111 USA; [Ramaswami, Ramya; Ghogawala, Zoher] Lahey Hosp & Med Ctr, Burlington, MA USA; [Weinstein, James N.] Dartmouth Hitchcock Med Ctr, Lebanon, NH 03766 USA	Tufts University; Lahey Hospital & Medical Center; Dartmouth College	Ramaswami, R (corresponding author), Tufts Univ, Sch Med, Dept Neurosurg, Boston, MA 02111 USA.							Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Ghahreman A, 2010, PAIN MED, V11, P1149, DOI 10.1111/j.1526-4637.2010.00908.x; Ghogawala Z, 2013, J NEUROSURG-SPINE, V19, P555, DOI 10.3171/2013.7.SPINE1362; Kreiner DS, 2014, SPINE J, V14, P180, DOI 10.1016/j.spinee.2013.08.003; Lurie JD, 2014, SPINE, V39, P3, DOI 10.1097/BRS.0000000000000088; Mathieson S, 2017, NEW ENGL J MED, V376, P1111, DOI 10.1056/NEJMoa1614292; Pearson A, 2012, SPINE, V37, P140, DOI 10.1097/BRS.0b013e3182276b2b; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Pinto RZ, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e497; SAAL JA, 1989, SPINE, V14, P431, DOI 10.1097/00007632-198904000-00018; Weeks WB, 2015, HARVARD BUSINESS REV; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2451, DOI 10.1001/jama.296.20.2451; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441	13	10	11	3	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1175	1177		10.1056/NEJMclde1701008	http://dx.doi.org/10.1056/NEJMclde1701008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28328334				2022-12-28	WOS:000397014300017
J	Hirsch, C				Hirsch, Calvin			Review: 1-time ultrasonography screening reduces abdominal aortic aneurysm-related mortality and rupture	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hirsch, Calvin] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA.							Calonge N, 2005, ANN INTERN MED, V142, P198, DOI 10.7326/0003-4819-142-3-200502010-00011; Guirguis-Blake JM, 2014, PRIMARY CARE SCREENI; Jones GT, 2016, BRIT J SURG, V103, P1139, DOI 10.1002/bjs.10224; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lindholt JS, 2007, EUR J VASC ENDOVASC, V34, P53, DOI 10.1016/j.ejvs.2006.12.031; Scott RAP, 2002, BRIT J SURG, V89, P283, DOI 10.1046/j.0007-1323.2001.02014.x; Zarrouk M, 2016, EUR J VASC ENDOVASC, V51, P766, DOI 10.1016/j.ejvs.2015.12.048	7	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC27	JC27		10.7326/ACPJC-2017-166-6-027	http://dx.doi.org/10.7326/ACPJC-2017-166-6-027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320001				2022-12-28	WOS:000397025800004
J	Diard, M; Bakkeren, E; Cornuault, JK; Moor, K; Hausmann, A; Sellin, ME; Loverdo, C; Aertsen, A; Ackermann, M; De Paepe, M; Slack, E; Hardt, WD				Diard, Mederic; Bakkeren, Erik; Cornuault, Jeffrey K.; Moor, Kathrin; Hausmann, Annika; Sellin, Mikael E.; Loverdo, Claude; Aertsen, Abram; Ackermann, Martin; De Paepe, Marianne; Slack, Emma; Hardt, Wolf-Dietrich			Inflammation boosts bacteriophage transfer between Salmonella spp.	SCIENCE			English	Article							LYSOGENIC CONVERSION; FELS-2 PROPHAGE; COLIPHAGE 186; PHAGE; TYPHIMURIUM; PROTEIN; TOXIN; GENE; SOPE; PHENOTYPE	Bacteriophage transfer (lysogenic conversion) promotes bacterial virulence evolution. There is limited understanding of the factors that determine lysogenic conversion dynamics within infected hosts. Amurine Salmonella Typhimurium (S.Tm) diarrhea model was used to study the transfer of SopEF, a prophage from S.Tm SL1344, to S.Tm ATCC14028S. Gut inflammation and enteric disease triggered >55% lysogenic conversion of ATCC14028S within 3 days. Without inflammation, SopEF transfer was reduced by up to 10(5)-fold. This was because inflammation (e.g., reactive oxygen species, reactive nitrogen species, hypochlorite) triggers the bacterial SOS response, boosts expression of the phage antirepressor Tum, and thereby promotes free phage production and subsequent transfer. Mucosal vaccination prevented a dense intestinal S.Tm population from inducing inflammation and consequently abolished SopEF transfer. Vaccination may be a general strategy for blocking pathogen evolution that requires disease-driven transfer of temperate bacteriophages.	[Diard, Mederic; Bakkeren, Erik; Moor, Kathrin; Hausmann, Annika; Sellin, Mikael E.; Slack, Emma; Hardt, Wolf-Dietrich] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Cornuault, Jeffrey K.; De Paepe, Marianne] Univ Paris Saclay, AgroParisTech, INRA, Micalis Inst, F-78350 Jouy En Josas, France; [Loverdo, Claude] UPMC, CNRS, Lab Jean Perrin, UMR 8237, F-75005 Paris, France; [Aertsen, Abram] Katholieke Univ Leuven, Dept Microbial & Mol Syst, Leuven, Belgium; [Ackermann, Martin] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland; [Ackermann, Martin] Eawag, Dept Environm Microbiol, Dubendorf, Switzerland; [Sellin, Mikael E.] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab, Uppsala, Sweden	Swiss Federal Institutes of Technology Domain; ETH Zurich; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; KU Leuven; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG); Uppsala University	Diard, M; Hardt, WD (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland.	mederic.diard@micro.biol.ethz.ch; wolf-dietrich.hardt@micro.biol.ethz.ch	Bakkeren, Erik/AAF-4391-2021; Ackermann, Martin/V-4554-2017; Hausmann, Annika/ABB-5379-2022; Diard, Mederic/AAA-3067-2020; Slack, Emma/AAD-5837-2019	Bakkeren, Erik/0000-0001-7970-7890; Ackermann, Martin/0000-0003-0087-4819; Hausmann, Annika/0000-0001-8852-3444; Slack, Emma/0000-0002-2473-1145; Aertsen, Abram/0000-0002-1897-2305; Loverdo, Claude/0000-0002-0888-1717; Hardt, Wolf-Dietrich/0000-0002-9892-6420; Cornuault, Jeffrey/0000-0001-8790-128X; Sellin, Mikael/0000-0002-8355-0803; Moor, Kathrin/0000-0002-2799-3837	Swiss National Foundation (SNF) [31003053074, Sinergia CRSII_154414/1]; Novartis FreeNovation program; Swedish Research Council [2012-262: 2015-00635]; SNF Ambizione fellowship [PZ00P3_136712]; SNF Muse Heim-Voglin stipend; ETH Excellence Scholarship and Opportunity Program stipend	Swiss National Foundation (SNF)(Swiss National Science Foundation (SNSF)); Novartis FreeNovation program; Swedish Research Council(Swedish Research CouncilEuropean Commission); SNF Ambizione fellowship; SNF Muse Heim-Voglin stipend; ETH Excellence Scholarship and Opportunity Program stipend	We are grateful to Hardt lab members and A. Buckling for helpful discussions and to the RCHCI and EPIC team for excellent support of our animal work. This work has been funded by grants from the Swiss National Foundation (SNF, 31003053074; Sinergia CRSII_154414/1) and the Novartis FreeNovation program to W.-D.H., the Swedish Research Council (2012-262: 2015-00635) to M.E.S., the SNF Ambizione fellowship PZ00P3_136712 and a SNF Muse Heim-Voglin stipend to E.S., and an ETH Excellence Scholarship and Opportunity Program stipend to E.B. The data presented in this study are in the main text and in the supplementary materials.	Acheson DWK, 1998, INFECT IMMUN, V66, P4496; Bearson BL, 2015, INT J ANTIMICROB AG, V46, P201, DOI 10.1016/j.ijantimicag.2015.04.008; Broudy TB, 2003, INFECT IMMUN, V71, P3782, DOI 10.1128/IAI.71.7.3782-3786.2003; Brumby AM, 1996, VIROLOGY, V219, P105, DOI 10.1006/viro.1996.0227; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Bunny K, 2002, J BACTERIOL, V184, P6235, DOI 10.1128/JB.184.22.6235-6249.2002; Davies EV, 2016, ISME J, V10, P2553, DOI 10.1038/ismej.2016.51; Davies EV, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw015; De Paepe M, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005861; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Goerke C, 2004, J INFECT DIS, V189, P724, DOI 10.1086/381502; Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7; Maier L, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004557; Miki T, 2012, J BIOL CHEM, V287, P34844, DOI 10.1074/jbc.M112.399998; Mirold S, 1999, P NATL ACAD SCI USA, V96, P9845, DOI 10.1073/pnas.96.17.9845; Monaco CL, 2016, CELL HOST MICROBE, V19, P311, DOI 10.1016/j.chom.2016.02.011; Moor K, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00034; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Oppenheim AB, 2005, ANNU REV GENET, V39, P409, DOI 10.1146/annurev.genet.39.073003.113656; Pelludat C, 2003, J BACTERIOL, V185, P5182, DOI 10.1128/JB.185.17.5182-5191.2003; Petrovska L, 2016, EMERG INFECT DIS, V22, P617, DOI 10.3201/eid2204.150531; Schmidt H, 2001, RES MICROBIOL, V152, P687, DOI 10.1016/S0923-2508(01)01249-9; Shearwin KE, 1998, J BIOL CHEM, V273, P5708, DOI 10.1074/jbc.273.10.5708; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Tyler JS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003236; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wood MW, 1996, MOL MICROBIOL, V22, P327, DOI 10.1046/j.1365-2958.1996.00116.x; Zhang SP, 2002, FEMS MICROBIOL LETT, V217, P243, DOI 10.1111/j.1574-6968.2002.tb11482.x	30	108	109	4	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1211	1215		10.1126/science.aaf8451	http://dx.doi.org/10.1126/science.aaf8451			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302859				2022-12-28	WOS:000396351200045
J	Borel, B				Borel, Brooke			CRISPR, microbes and more are joining the war against crop killers	NATURE			English	Editorial Material															Alicia Patterson Foundation	Alicia Patterson Foundation	This work was partially supported by a 2016 fellowship at the Alicia Patterson Foundation.	de Toledo Thomazella D. P., 2016, PREPRINT BIORXIV; Li HC, 2015, PLANT CELL ENVIRON, V38, P2277, DOI 10.1111/pce.12546; Lundgren JG, 2013, BIOSCIENCE, V63, P657, DOI 10.1525/bio.2013.63.8.8; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969	4	44	46	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					302	304		10.1038/543302a	http://dx.doi.org/10.1038/543302a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9RN	28300126	Bronze			2022-12-28	WOS:000396337400012
J	Moore, RH; Thornhill, KL; Weinzierl, B; Sauer, D; D'Ascoli, E; Kim, J; Lichtenstern, M; Scheibe, M; Beaton, B; Beyersdorf, AJ; Barrick, J; Bulzan, D; Corr, CA; Crosbie, E; Jurkat, T; Martin, R; Riddick, D; Shook, M; Slover, G; Voigt, C; White, R; Winstead, E; Yasky, R; Ziemba, LD; Brown, A; Schlager, H; Anderson, BE				Moore, Richard H.; Thornhill, Kenneth L.; Weinzierl, Bernadett; Sauer, Daniel; D'Ascoli, Eugenio; Kim, Jin; Lichtenstern, Michael; Scheibe, Monika; Beaton, Brian; Beyersdorf, Andreas J.; Barrick, John; Bulzan, Dan; Corr, Chelsea A.; Crosbie, Ewan; Jurkat, Tina; Martin, Robert; Riddick, Dean; Shook, Michael; Slover, Gregory; Voigt, Christiane; White, Robert; Winstead, Edward; Yasky, Richard; Ziemba, Luke D.; Brown, Anthony; Schlager, Hans; Anderson, Bruce E.			Biofuel blending reduces particle emissions from aircraft engines at cruise conditions	NATURE			English	Article							IN-SITU OBSERVATIONS; YOUNG CONTRAILS; CLIMATE IMPACT; AVIATION; FUEL; ABSORPTION	Aviation-related aerosol emissions contribute to the formation of contrail cirrus clouds that can alter upper tropospheric radiation and water budgets, and therefore climate(1). The magnitude of air-traffic-related aerosol-cloud interactions and the ways in which these interactions might change in the future remain uncertain(1). Modelling studies of the present and future effects of aviation on climate require detailed information about the number of aerosol particles emitted per kilogram of fuel burned and the microphysical properties of those aerosols that are relevant for cloud formation(2). However, previous observational data at cruise altitudes are sparse for engines burning conventional fuels2,3, and no data have previously been reported for biofuel use in-flight. Here we report observations from research aircraft that sampled the exhaust of engines onboard a NASA DC-8 aircraft as they burned conventional Jet A fuel and a 50: 50 (by volume) blend of Jet A fuel and a biofuel derived from Camelina oil. We show that, compared to using conventional fuels, biofuel blending reduces particle number and mass emissions immediately behind the aircraft by 50 to 70 per cent. Our observations quantify the impact of biofuel blending on aerosol emissions at cruise conditions and provide key microphysical parameters, which will be useful to assess the potential of biofuel use in aviation as a viable strategy to mitigate climate change.	[Moore, Richard H.; Thornhill, Kenneth L.; Beaton, Brian; Beyersdorf, Andreas J.; Barrick, John; Corr, Chelsea A.; Crosbie, Ewan; Martin, Robert; Riddick, Dean; Shook, Michael; Slover, Gregory; White, Robert; Winstead, Edward; Yasky, Richard; Ziemba, Luke D.; Anderson, Bruce E.] NASA, Langley Res Ctr, Hampton, VA 23665 USA; [Thornhill, Kenneth L.; Barrick, John; Shook, Michael; Winstead, Edward] SSAI, Hampton, VA USA; [Weinzierl, Bernadett; Sauer, Daniel; D'Ascoli, Eugenio; Kim, Jin; Lichtenstern, Michael; Scheibe, Monika; Jurkat, Tina; Voigt, Christiane; Schlager, Hans] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Atmospher Phys, Oberpfaffenhofen, Germany; [Weinzierl, Bernadett] Univ Vienna, Vienna, Austria; [Sauer, Daniel; D'Ascoli, Eugenio] Ludwig Maximillians Univ, Munich, Germany; [Beyersdorf, Andreas J.] Calif State Univ San Bernardino, San Bernardino, CA 92407 USA; [Bulzan, Dan] NASA, Glenn Res Ctr, Cleveland, OH USA; [Corr, Chelsea A.] Bennington Coll, Bennington, VT USA; [Crosbie, Ewan] NASA, Postdoctoral Program, Columbia, MD USA; [Voigt, Christiane] Johannes Gutenberg Univ Mainz, Mainz, Germany; [Brown, Anthony] Natl Res Council Canada, Ottawa, ON, Canada	National Aeronautics & Space Administration (NASA); NASA Langley Research Center; Helmholtz Association; German Aerospace Centre (DLR); University of Vienna; University of Munich; California State University System; California State University San Bernardino; National Aeronautics & Space Administration (NASA); NASA Glenn Research Center; National Aeronautics & Space Administration (NASA); Johannes Gutenberg University of Mainz; National Research Council Canada	Moore, RH (corresponding author), NASA, Langley Res Ctr, Hampton, VA 23665 USA.	richard.h.moore@nasa.gov	Sauer, Daniel N/A-3033-2012; Voigt, Christiane/G-3279-2010; Moore, Richard/ABI-4522-2020; Weinzierl, Bernadett/G-5319-2012; Moore, Richard/E-9653-2010; 1294, HALO SPP/AAA-7658-2021	Sauer, Daniel N/0000-0002-0317-5063; Voigt, Christiane/0000-0001-8925-7731; Moore, Richard/0000-0003-2911-4469; Weinzierl, Bernadett/0000-0003-4555-5686; Moore, Richard/0000-0003-2911-4469; Shook, Michael/0000-0003-2659-484X	NASA Advanced Air Vehicles Program, Advanced Air Transport Technology Project; DLR Aeronautics Research Programme; Transport Canada Clean Transportation Initiative; National Research Council Canada CAAFER Project [46FA-JA12]; NASA Postdoctoral Program fellowship; Helmholtz Association [VH-NG-606, W2/W3-060]; European Research Council [640458]; German Science Foundation (DFG) [JU3059/1-1]	NASA Advanced Air Vehicles Program, Advanced Air Transport Technology Project; DLR Aeronautics Research Programme; Transport Canada Clean Transportation Initiative; National Research Council Canada CAAFER Project; NASA Postdoctoral Program fellowship; Helmholtz Association(Helmholtz Association); European Research Council(European Research Council (ERC)European Commission); German Science Foundation (DFG)(German Research Foundation (DFG))	We thank the flight crew of the NASA DC-8 and DLR Falcon, W. Ringelberg, D. Fedors, T. Asher, M. Berry, B. Elit, T. Sandon, P. Weber, R. Welser, S. Kaufmann, T. Klausner, A. Reiter, A. Roiger, R. Schlage and U. Schumann for providing meteorological forecasts, and B. Karcher and P. Le Clercq for discussions. This work was supported by the NASA Advanced Air Vehicles Program, Advanced Air Transport Technology Project, the DLR Aeronautics Research Programme, the Transport Canada Clean Transportation Initiative, and the National Research Council Canada CAAFER Project (46FA-JA12). R.H.M. was supported, in part, by a NASA Postdoctoral Program fellowship. B. W. was supported by the Helmholtz Association (grant number VH-NG-606) and by the European Research Council grant agreement number 640458. C.V. and T.J. were supported by the Helmholtz Association (grant number W2/W3-060) and the German Science Foundation (DFG grant number JU3059/1-1).	Anderson B.E, 2011, NASATM2011217059; Anderson BE, 1998, GEOPHYS RES LETT, V25, P1689, DOI 10.1029/98GL00063; [Anonymous], 2012, AGR AV PARTN PROSP; [Anonymous], 2010, AV OUTL; [Anonymous], 2016, ANN EN OUTL 2016 PET; ASTM International, 2016, D1655 ASTM INT; ASTM International, 2016, D7566 ASTM INT; Beyersdorf AJ, 2014, ATMOS CHEM PHYS, V14, P11, DOI 10.5194/acp-14-11-2014; Bond TC, 2006, AEROSOL SCI TECH, V40, P27, DOI 10.1080/02786820500421521; Boucher O., 2013, CONTRIBUTION WORKING; Brasseur GP, 2016, B AM METEOROL SOC, V97, P561, DOI 10.1175/BAMS-D-13-00089.1; Brock CA, 2000, J GEOPHYS RES-ATMOS, V105, P26555, DOI 10.1029/2000JD900360; Burkhardt U, 2011, NAT CLIM CHANGE, V1, P54, DOI [10.1038/NCLIMATE1068, 10.1038/nclimate1068]; Corporan E, 2007, ENERG FUEL, V21, P2615, DOI 10.1021/ef070015j; Corporan E, 2011, ENERG FUEL, V25, P955, DOI 10.1021/ef101520v; DeWitt MJ, 2008, ENERG FUEL, V22, P2411, DOI 10.1021/ef8001179; Gettelman A, 2013, GEOPHYS RES LETT, V40, P2785, DOI 10.1002/grl.50520; Jessberger P, 2013, ATMOS CHEM PHYS, V13, P11965, DOI 10.5194/acp-13-11965-2013; Karcher B, 2016, J GEOPHYS RES-ATMOS, V121, P3497, DOI 10.1002/2015JD024696; Karcher B, 2015, J GEOPHYS RES-ATMOS, V120, P7893, DOI 10.1002/2015JD023491; Law CK, 2012, AIAA J, V50, P19, DOI 10.2514/1.J051328; Lee DS, 2010, ATMOS ENVIRON, V44, P4678, DOI 10.1016/j.atmosenv.2009.06.005; Lewellen DC, 2014, J ATMOS SCI, V71, P26, DOI 10.1175/JAS-D-13-0317.1; Lobo P, 2011, ENVIRON SCI TECHNOL, V45, P10744, DOI 10.1021/es201902e; Moore RH, 2015, ENERG FUEL, V29, P2591, DOI 10.1021/ef502618w; Moore RH, 2014, AEROSOL SCI TECH, V48, P467, DOI 10.1080/02786826.2014.890694; Moses CA, 2009, J ENG GAS TURB POWER, V131, DOI 10.1115/1.3028234; Onasch TB, 2009, J PROPUL POWER, V25, P1121, DOI 10.2514/1.36371; Peck J, 2013, J AIR WASTE MANAGE, V63, P367, DOI 10.1080/10962247.2012.751467; Petzold A, 1999, J GEOPHYS RES-ATMOS, V104, P22171, DOI 10.1029/1999JD900460; Petzold A, 1998, AEROSOL SCI TECH, V29, P355, DOI 10.1080/02786829808965575; Ringbeck J, 2010, BIOFUELS-UK, V1, P519, DOI 10.4155/BFS.10.35; Rye L, 2010, ENERG ENVIRON SCI, V3, P17, DOI 10.1039/b918197k; Savage N, 2011, NATURE, V474, pS9, DOI 10.1038/474S09a; Schroder FP, 1998, GEOPHYS RES LETT, V25, P2789, DOI 10.1029/98GL02078; Schumann U, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000813; Schumann U, 1996, J GEOPHYS RES-ATMOS, V101, P6853, DOI 10.1029/95JD03405; Schumann U, 2013, GEOPHYS RES LETT, V40, P2867, DOI 10.1002/grl.50539; Stettler MEJ, 2013, ENVIRON SCI TECHNOL, V47, P10397, DOI 10.1021/es401356v; Tesche M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12016; Toon OB, 1998, GEOPHYS RES LETT, V25, P1109, DOI 10.1029/98GL00839; Unterstrasser S, 2016, ATMOS CHEM PHYS, V16, P2059, DOI 10.5194/acp-16-2059-2016; Virkkula A, 2010, AEROSOL SCI TECH, V44, P706, DOI 10.1080/02786826.2010.482110; Voigt C, 2010, ATMOS CHEM PHYS, V10, P9039, DOI 10.5194/acp-10-9039-2010; von der Weiden SL, 2009, ATMOS MEAS TECH, V2, P479, DOI 10.5194/amt-2-479-2009; Warshay B, 2011, BIOFUELS-UK, V2, P33, DOI [10.4155/bfs.10.70, 10.4155/BFS.10.70]; Wey CC, 2007, J PROPUL POWER, V23, P898, DOI 10.2514/1.26406	47	157	162	13	195	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					411	+		10.1038/nature21420	http://dx.doi.org/10.1038/nature21420			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28300096	Green Accepted			2022-12-28	WOS:000396337400048
J	Lyon, J				Lyon, Jeff			Rules for Home Care Get Long-Awaited Revamp	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1009	1009		10.1001/jama.2017.1972	http://dx.doi.org/10.1001/jama.2017.1972			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291874				2022-12-28	WOS:000396713400005
J	Webster, R; Castellano, JM; Onuma, OK				Webster, Ruth; Castellano, Jose M.; Onuma, Oyere K.			Putting polypills into practice: challenges and lessons learned	LANCET			English	Article							CARDIOVASCULAR-DISEASE; HIGH-RISK; SECONDARY PREVENTION; DATA METAANALYSIS; USUAL CARE; STRATEGY; ADHERENCE; TRIAL; WORLD	Regulatory approvals for cardiovascular polypills are increasing rapidly across more than 30 countries. The evidence clearly shows polypills improve adherence and cardiovascular disease risk factors for patients with indications for use of polypill components-ie, those with established cardiovascular disease or at high risk. However, the implementation of polypills into clinical practice has many challenges. The clinical trials literature provides insights into the clinical impact of a polypill strategy, including cost-effectiveness, safety of use, substantial improvement in adherence, and better risk factor control than usual care. Despite the clear need for such a strategy and the available clinical data backing up the use of the polypill in different patient populations, challenges to widespread implementation, such as an absence of government reimbursement and poor physician uptake (identified from on the ground experience in countries following commercial rollout), have greatly obstructed real-world implementation. Obtaining the full public health benefit of polypills will require education, advocacy, endorsement, and implementation by key global agencies such as WHO and national clinical bodies, as well as endorsement from governments.	[Webster, Ruth] Univ Sydney, George Inst Global Hlth, POB M201, Sydney, NSW 2050, Australia; [Castellano, Jose M.] Carlos III Inst Hlth, Natl Ctr Cardiovasc Res, Madrid, Spain; [Castellano, Jose M.] Monteprincipe Univ Hosp, HM Grp, Madrid, Spain; [Castellano, Jose M.] CEU San Pablo Sch Med, Madrid, Spain; [Onuma, Oyere K.] World Hlth Org, Geneva, Switzerland	George Institute for Global Health; University of Sydney; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Instituto de Salud Carlos III; San Pablo CEU University; World Health Organization	Webster, R (corresponding author), Univ Sydney, George Inst Global Hlth, POB M201, Sydney, NSW 2050, Australia.	rwebster@georgeinstitute.org.au	Castellano, José María/L-8097-2014	Castellano, José María/0000-0003-3624-1298; Onuma, Oyere/0000-0003-1186-7104; Webster, Ruth/0000-0002-7444-3037	National Health and Medical Research Council; EU; Ferrer	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); EU(European Commission); Ferrer	RW is funded by National Health and Medical Research Council Early Career Fellowship. George Health Enterprises, the social enterprise arm of The George Institute for Global Health, has received investment to develop combination products containing aspirin, statin, and blood-pressure lowering drugs. JMC was Scientific Coordinator of the FOCUS trial (funded by the EU FP7 programme) and is currently Co-Principal Investigator of the SECURE trial (funded by the EU H2020 programme). Additionally, JMC has received speaker fees and travel support from Ferrer. OKO is a staff member of WHO. The authors alone are responsible for the views expressed in this review and they do not necessarily represent the decisions, policy, or views of WHO.	Addae-Mensah I, 2005, WHO TECH REP SER, V929, P1; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; [Anonymous], 2003, FIN PUSH STRAT EL LE; Bryant L, 2013, J PRIM HEALTH CARE, V5, P28; Castellano JM, 2014, J AM COLL CARDIOL, V64, P2071, DOI 10.1016/j.jacc.2014.08.021; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Huffman MD, 2017, LANCET, V389, P953; Jamison J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010458; Kellermann AL, 2015, JAMA-J AM MED ASSOC, V314, P1447, DOI 10.1001/jama.2015.10114; Laba TL, 2015, ANN PHARMACOTHER, V49, P528, DOI 10.1177/1060028015570468; Liu HM, 2015, CIRC-CARDIOVASC QUAL, V8, P301, DOI 10.1161/CIRCOUTCOMES.115.001483; New Zealand Guidelines Group, 2005, NZ CARD GUID HDB SUM; Patel A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001986; Patel A, 2015, EUR J PREV CARDIOL, V22, P920, DOI 10.1177/2047487314530382; Piepoli MF, 2016, EUR HEART J, V37, P2315, DOI 10.1093/eurheartj/ehw106; Gonzalez-Juanatey JR, 2016, REV ESP CARDIOL, V69, P547, DOI 10.1016/j.rec.2016.02.008; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Selak V, 2016, EUR J PREV CARDIOL, V23, P1393, DOI 10.1177/2047487316638216; Selak V, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3318; Soliman EZ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-3; Tamargo J, 2015, INT J CARDIOL, V201, pS15, DOI 10.1016/S0167-5273(15)31028-7; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P918, DOI 10.1001/jama.2013.277064; Truelove M, 2015, CARDIOVASC THER, V33, P347, DOI 10.1111/1755-5922.12151; Viera AJ, 2011, PREV MED, V52, P10, DOI 10.1016/j.ypmed.2010.09.016; Virdee SK, 2015, BRIT J GEN PRACT, V65, pE447, DOI 10.3399/bjgp15X685657; Virdee SK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002498; Webster R, 2016, INT J CARDIOL, V205, P147, DOI 10.1016/j.ijcard.2015.12.015; Webster R, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0673-x; Webster R, 2013, INT J CARDIOL, V170, P30, DOI 10.1016/j.ijcard.2013.10.007; WHO, 2002, 2 PREV NONC DIS LOW; WHO, 2016, HEARTS TECHN PACK CA; WHO, 2017, WHO GUID DOC; Wood F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008018; World Health Organization, 2014, GLOB HLTH EST 2014 S; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4	39	51	51	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					1066	1074		10.1016/S0140-6736(17)30558-5	http://dx.doi.org/10.1016/S0140-6736(17)30558-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN9UN	28290996				2022-12-28	WOS:000396345200028
J	Leme, AC; Hajjar, LA; Volpe, MS; Fukushima, JT; Santiago, RRD; Osawa, EA; de Almeida, JP; Gerent, AM; Franco, RA; Feltrim, MIZ; Nozawa, E; Coimbra, VRD; Ianotti, RD; Hashizume, CS; Kalil, R; Auler, JOC; Jatene, FB; Galas, FRBG; Amato, MBP				Leme, Alcino Costa; Hajjar, Ludhmila Abrahao; Volpe, Marcia S.; Fukushima, Julia Tizue; De Santis Santiago, Roberta Ribeiro; Osawa, Eduardo A.; de Almeida, Juliano Pinheiro; Gerent, Aline Muller; Franco, Rafael Alves; Zanetti Feltrim, Maria Ignez; Nozawa, Emilia; de Moraes Coimbra, Vera Regina; Ianotti, Rafael de Moraes; Hashizume, Clarice Shiguemi; Kalil Filho, Roberto; Costa Auler, Jose Otavio, Jr.; Jatene, Fabio Biscegli; Barbosa Gomes Galas, Filomena Regina; Passos Amato, Marcelo Britto			Effect of Intensive vs Moderate Alveolar Recruitment Strategies Added to Lung-Protective Ventilation on Postoperative Pulmonary Complications A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TIDAL-VOLUME VENTILATION; CARDIAC-SURGERY PATIENTS; END-EXPIRATORY-PRESSURE; MECHANICAL VENTILATION; GENERAL-ANESTHESIA; ABDOMINAL-SURGERY; CARDIOPULMONARY BYPASS; DRIVING PRESSURE; RISK; INFLAMMATION	IMPORTANCE Perioperative lung-protective ventilation has been recommended to reduce pulmonary complications after cardiac surgery. The protective role of a small tidal volume (VT) has been established, whereas the added protection afforded by alveolar recruiting strategies remains controversial. OBJECTIVE To determine whether an intensive alveolar recruitment strategy could reduce postoperative pulmonary complications, when added to a protective ventilation with small VT. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial of patients with hypoxemia after cardiac surgery at a single ICU in Brazil (December 2011-2014). INTERVENTIONS Intensive recruitment strategy (n=157) or moderate recruitment strategy (n=163) plus protective ventilation with small VT. MAIN OUTCOMES AND MEASURES Severity of postoperative pulmonary complications computed until hospital discharge, analyzed with a common odds ratio (OR) to detect ordinal shift in distribution of pulmonary complication severity score (0-to-5 scale, 0, no complications; 5, death). Prespecified secondary outcomes were length of stay in the ICU and hospital, incidence of barotrauma, and hospital mortality. RESULTS All 320 patients (median age, 62 years; IQR, 56-69 years; 125 women [39%]) completed the trial. The intensive recruitment strategy group had a mean 1.8 (95% CI, 1.7 to 2.0) and a median 1.7 (IQR, 1.0-2.0) pulmonary complications score vs 2.1 (95% CI, 2.0-2.3) and 2.0 (IQR, 1.5-3.0) for the moderate strategy group. Overall, the distribution of primary outcome scores shifted consistently in favor of the intensive strategy, with a common OR for lower scores of 1.86 (95% CI, 1.22 to 2.83; P =.003). The mean hospital stay for the moderate group was 12.4 days vs 10.9 days in the intensive group (absolute difference, -1.5 days; 95% CI, -3.1 to -0.3; P =.04). The mean ICU stay for the moderate group was 4.8 days vs 3.8 days for the intensive group (absolute difference, -1.0 days; 95% CI, -1.6 to -0.2; P =.01). Hospital mortality (2.5% in the intensive group vs 4.9% in the moderate group; absolute difference, -2.4%, 95% CI, -7.1% to 2.2%) and barotrauma incidence (0% in the intensive group vs 0.6% in the moderate group; absolute difference, -0.6%; 95% CI, -1.8% to 0.6%; P =.51) did not differ significantly between groups. CONCLUSIONS AND RELEVANCE Among patients with hypoxemia after cardiac surgery, the use of an intensive vs a moderate alveolar recruitment strategy resulted in less severe pulmonary complications while in the hospital.	[De Santis Santiago, Roberta Ribeiro; Passos Amato, Marcelo Britto] Univ Sao Paulo, Hosp Clin, Heart Inst Incor, Cardiopulm Dept,Pulm Div,FMUSP, Ave Dr Arnaldo 455,Sala 2144, BR-01246903 Sao Paulo, SP, Brazil; [Leme, Alcino Costa; Volpe, Marcia S.; Fukushima, Julia Tizue; Osawa, Eduardo A.; de Almeida, Juliano Pinheiro; Gerent, Aline Muller; Franco, Rafael Alves; Zanetti Feltrim, Maria Ignez; Nozawa, Emilia; de Moraes Coimbra, Vera Regina; Ianotti, Rafael de Moraes; Hashizume, Clarice Shiguemi; Kalil Filho, Roberto; Costa Auler, Jose Otavio, Jr.; Barbosa Gomes Galas, Filomena Regina] Univ Sao Paulo, Hosp Clin, Heart Inst Incor, Dept Anesthesia & Intens Care,FMUSP, Sao Paulo, Brazil; [Hajjar, Ludhmila Abrahao; Jatene, Fabio Biscegli] Univ Sao Paulo, Hosp Clin, Heart Inst Incor, Heart Div,Cardiopulm Dept,FMUSP, Sao Paulo, Brazil; [Volpe, Marcia S.] Univ Fed Triangulo Mineiro, Dept Appl Physiotherapy, Uberaba, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal do Triangulo Mineiro	Amato, MBP (corresponding author), Univ Sao Paulo, Hosp Clin, Heart Inst Incor, Cardiopulm Dept,Pulm Div,FMUSP, Ave Dr Arnaldo 455,Sala 2144, BR-01246903 Sao Paulo, SP, Brazil.	amato.marcelo.bp@gmail.com	amato, Marcelo Britto Passo/L-5001-2016; Ribeiro De Santis Santiago, Roberta/AAV-7359-2020; Filho, Roberto Kalil/D-4994-2014; Leme, Alcino Costa/S-7153-2019; Leme, Alcino C/C-6394-2016; Osawa, Eduardo/AFR-2834-2022; Hajjar, Ludhmila A/K-3512-2017; Auler, José Otavio Costa/C-4492-2017	amato, Marcelo Britto Passo/0000-0003-3525-8282; Ribeiro De Santis Santiago, Roberta/0000-0002-5818-0361; Leme, Alcino C/0000-0002-3476-2068; Osawa, Eduardo/0000-0002-1590-8658; Auler, José Otavio Costa/0000-0002-3919-1743; Ianotti, Rafael de Moraes/0000-0003-1738-0372; Abrahao Hajjar, Ludhmila/0000-0001-5645-2055	FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo); FINEP (Financiadora de Estudos e Projetos)	FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FINEP (Financiadora de Estudos e Projetos)(Financiadora de Inovacao e Pesquisa (Finep))	This study was partially supported by FAPESP (Fundacao de Amparo e Pesquisa do Estado de Sao Paulo) and FINEP (Financiadora de Estudos e Projetos).	Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; Bartz RR, 2015, J CRIT CARE, V30, P940, DOI 10.1016/j.jcrc.2015.04.125; Bashour CA, 2000, CRIT CARE MED, V28, P3847, DOI 10.1097/00003246-200012000-00018; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Futier E, 2013, NEW ENGL J MED, V369, P428, DOI 10.1056/NEJMoa1301082; Garcia-Delgado M, 2014, CURR OPIN ANESTHESIO, V27, P146, DOI 10.1097/ACO.0000000000000059; Goligher EC, 2015, AM J RESP CRIT CARE, V192, P1416, DOI 10.1164/rccm.201410-1832CP; Guldner A, 2015, ANESTHESIOLOGY, V123, P692, DOI 10.1097/ALN.0000000000000754; Hemmes SNT, 2014, LANCET, V384, P495, DOI 10.1016/S0140-6736(14)60416-5; Hulzebos EHJ, 2006, JAMA-J AM MED ASSOC, V296, P1851, DOI 10.1001/jama.296.15.1851; KROENKE K, 1992, ARCH INTERN MED, V152, P967, DOI 10.1001/archinte.152.5.967; Lim SC, 2004, CRIT CARE MED, V32, P2378, DOI 10.1097/01.CCM.0000147444.58070.72; Miranda DR, 2007, J CARDIOTHOR VASC AN, V21, P279, DOI 10.1053/j.jvca.2006.02.007; Miranda DR, 2006, CRIT CARE, V10, DOI 10.1186/cc4944; Miranda DR, 2006, CRIT CARE MED, V34, P2555, DOI 10.1097/01.CCM.0000239118.05093.EE; Miranda DR, 2005, CRIT CARE MED, V33, P2253, DOI 10.1097/01.CCM.0000181674.71237.3B; Neto AS, 2016, LANCET RESP MED, V4, P272, DOI 10.1016/S2213-2600(16)00057-6; Neto AS, 2012, JAMA-J AM MED ASSOC, V308, P1651, DOI 10.1001/jama.2012.13730; Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5; ROTHEN HU, 1995, ANESTHESIOLOGY, V82, P832, DOI 10.1097/00000542-199504000-00004; ROTHEN HU, 1995, LANCET, V345, P1387, DOI 10.1016/S0140-6736(95)92595-3; ROTHEN HU, 1993, BRIT J ANAESTH, V71, P788, DOI 10.1093/bja/71.6.788; Severgnini P, 2013, ANESTHESIOLOGY, V118, P1307, DOI 10.1097/ALN.0b013e31829102de; Sundar S, 2011, ANESTHESIOLOGY, V114, P1102, DOI 10.1097/ALN.0b013e318215e254; Wrigge H, 2005, INTENS CARE MED, V31, P1379, DOI 10.1007/s00134-005-2767-1; Zarbock A, 2009, CHEST, V135, P1252, DOI 10.1378/chest.08-1602; Zupancich E, 2005, J THORAC CARDIOV SUR, V130, P378, DOI 10.1016/j.jtcvs.2004.11.061	27	70	71	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2017	317	14					1422	1432		10.1001/jama.2017.2297	http://dx.doi.org/10.1001/jama.2017.2297			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6FQ	28322416				2022-12-28	WOS:000398901200016
J	[Anonymous]				[Anonymous]			Bezlotoxumab Protects Against Recurrent C difficile Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1206	1206		10.1001/jama.2017.2747	http://dx.doi.org/10.1001/jama.2017.2747			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350926				2022-12-28	WOS:000397557800009
J	Adam, BU; Cosford, P; Anderson, SR; Abubakar, I				Adam, Bilaal U.; Cosford, Paul; Anderson, Sarah R.; Abubakar, Ibrahim			Sustaining tuberculosis decline in the UK	LANCET			English	Editorial Material									[Adam, Bilaal U.; Cosford, Paul; Abubakar, Ibrahim] Publ Hlth England, Med Directorate, London, England; [Anderson, Sarah R.] Publ Hlth England, TB Sect, Natl Infect Serv, London, England; [Abubakar, Ibrahim] UCL, Inst Global Hlth, London WC1N 1EH, England	Public Health England; Public Health England; University of London; University College London	Abubakar, I (corresponding author), Publ Hlth England, Med Directorate, London, England.	i.abubakar@ucl.ac.uk	Bilal, Adam/Q-5557-2019	Abubakar, Ibrahim/0000-0002-0370-1430				Aldridge RW, 2016, LANCET INFECT DIS, V16, P962, DOI 10.1016/S1473-3099(16)00072-4; Anderson C, 2014, THORAX, V69, P187, DOI 10.1136/thoraxjnl-2013-203751; [Anonymous], 2015, IMPL END TB STRAT ES; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5376; Maguire H, 2011, EUROSURVEILLANCE, V16, P11; Public Health England, 2016, TUB ENGL 2016 ANN RE; REICHMAN LB, 1991, AM REV RESPIR DIS, V144, P741, DOI 10.1164/ajrccm/144.4.741; Zenner D, 2013, LANCET, V382, P1311, DOI 10.1016/S0140-6736(13)62113-3	8	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1176	1177		10.1016/S0140-6736(17)30755-9	http://dx.doi.org/10.1016/S0140-6736(17)30755-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28353429	Green Submitted			2022-12-28	WOS:000397143700012
J	Tomasetti, C; Li, L; Vogelstein, B				Tomasetti, Cristian; Li, Lu; Vogelstein, Bert			CANCER ETIOLOGY Stem cell divisions, somatic mutations, cancer etiology, and cancer prevention	SCIENCE			English	Article							RISK-FACTORS; TISSUES; TRENDS; DNA	Cancers are caused by mutations that may be inherited, induced by environmental factors, or result from DNA replication errors (R). We studied the relationship between the number of normal stem cell divisions and the risk of 17 cancer types in 69 countries throughout the world. The data revealed a strong correlation (median = 0.80) between cancer incidence and normal stem cell divisions in all countries, regardless of their environment. The major role of R mutations in cancer etiology was supported by an independent approach, based solely on cancer genome sequencing and epidemiological data, which suggested that R mutations are responsible for two-thirds of the mutations in human cancers. All of these results are consistent with epidemiological estimates of the fraction of cancers that can be prevented by changes in the environment. Moreover, they accentuate the importance of early detection and intervention to reduce deaths from the many cancers arising from unavoidable R mutations.	[Tomasetti, Cristian] Johns Hopkins Univ Sch Med, Div Biostatist & Bioinformat, Dept Oncol, Sidney Kimmel Canc Ctr, Baltimore, MD 21205 USA; [Tomasetti, Cristian; Li, Lu] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostatist, 615 N Wolfe St, Baltimore, MD 21205 USA; [Vogelstein, Bert] Ludwig Ctr & Howard Hughes Med Inst, Johns Hopkins Kimmel Canc Ctr, 1650 Orleans St, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Tomasetti, C (corresponding author), Johns Hopkins Univ Sch Med, Div Biostatist & Bioinformat, Dept Oncol, Sidney Kimmel Canc Ctr, Baltimore, MD 21205 USA.; Tomasetti, C (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostatist, 615 N Wolfe St, Baltimore, MD 21205 USA.; Vogelstein, B (corresponding author), Ludwig Ctr & Howard Hughes Med Inst, Johns Hopkins Kimmel Canc Ctr, 1650 Orleans St, Baltimore, MD 21205 USA.	ctomasetti@jhu.edu; vogelbe@jhmi.edu		Li, Lu/0000-0002-1920-4965	John Templeton Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; NIH [P30-CA006973, R37-CA43460, P50-CA62924]; NATIONAL CANCER INSTITUTE [P50CA062924, P30CA006973, R37CA043460] Funding Source: NIH RePORTER	John Templeton Foundation; Virginia and D. K. Ludwig Fund for Cancer Research; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Center for Pancreatic Cancer Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank W. F. Anderson [Biostatistics branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute (NCI)], N. Chatterjee [Johns Hopkins University (JHU)], K. W. Kinzler (JHU), B. Mensh [Howard Hughes Medical Institute (HHMI)], and J. T. Vogelstein (JHU) for their comments. We thank A. Blackford (JHU) and R. H. Hruban (JHU) for providing the pancreatic cancer data set. This work was made possible through the support of grants from the John Templeton Foundation, the Virginia and D. K. Ludwig Fund for Cancer Research, the Lustgarten Foundation for Pancreatic Cancer Research, The Sol Goldman Center for Pancreatic Cancer Research, and NIH grants P30-CA006973, R37-CA43460, and P50-CA62924. The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. C. T. conceived the ideas for determining the proportions of drivers and developed the mathematical methods and their application. C. T. and B. V. designed and performed the research. C.T. performed the world data analysis. L.L. obtained the estimates in tables S5 and S6. C.T. and B.V. wrote the paper. C.T. and L.L. have nothing to disclose. B.V. is on the scientific advisory boards of Morphotek, Exelixis GP, and Sysmex Inostics, and is a founder of PapGene and Personal Genome Diagnostics. Morphotek, Sysmex Inostics, PapGene, and Personal Genome Diagnostics, as well as other companies, have licensed technologies from JHU on which B.V. is an inventor. These licenses and relationships are associated with equity or royalty payments to B.V. The terms of these arrangements are being managed by JHU in accordance with its conflict of interest policies.	Ashford NA, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6246; Cancer Research UK, STAT CANC TYP; Cancer Research UK, INH CANC GEN INCR CA; Cancer Research UK, STAT PREV CANC; Cancer Research UK, LUNG CANC RISKS CAUS; Collins AR, 2005, EUR J CANCER, V41, P1923, DOI 10.1016/j.ejca.2005.06.004; Edgren G, 2013, GUT, V62, P1406, DOI 10.1136/gutjnl-2012-302412; Edwards BK, 2010, CANCER-AM CANCER SOC, V116, P544, DOI 10.1002/cncr.24760; Ferguson LR, 2015, SEMIN CANCER BIOL, V35, pS5, DOI 10.1016/j.semcancer.2015.03.005; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Gotay C, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6462; HOEL DG, 1983, AM J EPIDEMIOL, V118, P78, DOI 10.1093/oxfordjournals.aje.a113619; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mucci LA, 2016, JAMA-J AM MED ASSOC, V315, P68, DOI 10.1001/jama.2015.17703; NORDLING CO, 1953, BRIT J CANCER, V7, P68, DOI 10.1038/bjc.1953.8; Parkin DM, 2011, J EPIDEMIOL COMMUN H, V65, pA143, DOI 10.1136/jech.2011.142976e.69; Potter JD, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6507; Song MY, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6094; Stadler ZK, 2010, J CLIN ONCOL, V28, P4255, DOI 10.1200/JCO.2009.25.7816; Stewart B. W., 2003, World Cancer Report; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tomasetti C, 2015, SCIENCE, V347, P729, DOI 10.1126/science.aaa6592; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; U.S. Office of the Surgeon General and U.S. Office on Smoking and Health, 2004, HLTH CONS SMOK REP U; van den Bergh RCN, 2009, CANCER-AM CANCER SOC, V115, P3868, DOI 10.1002/cncr.24446; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wild C, 2015, SCIENCE, V347, P728, DOI 10.1126/science.aaa6799; Zhu LQ, 2016, CELL, V166, P1132, DOI 10.1016/j.cell.2016.07.045	32	529	546	14	347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1330	1334		10.1126/science.aaf9011	http://dx.doi.org/10.1126/science.aaf9011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336671	Green Accepted			2022-12-28	WOS:000397082900043
J	Soyka, M				Soyka, Michael			Treatment of Benzodiazepine Dependence	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LONG-TERM; WITHDRAWING BENZODIAZEPINES; UNITED-STATES; Z-DRUGS; DISCONTINUATION; ABUSE; PRESCRIPTIONS; SCHIZOPHRENIA; PREVALENCE; METHADONE	Traditionally, various terms have been used to define substance use-related disorders. These include "addiction," "misuse" (in the Diagnostic and Statistical Manual of Mental Disorders, fourth edition [DSM-IV] 1), "harmful use" (in the International Classification of Diseases, 10th Revision [ICD-10] 2), and "dependence." 3 Long-term intake of a drug can induce tolerance of the drug's effects (i. e., increased amounts are needed to achieve intoxication, or the person experiences diminished effects with continued use4) and physical dependence. Addiction is defined by compulsive drug-seeking behavior or an intense desire to take a drug despite severe medical or social consequences. The DSM-IV and ICD-10 define misuse and harmful use, respectively, on the basis of various somatic or psychological consequences of substance use and define dependence on the basis of a cluster of somatic, psychological, and behavioral symptoms. According to the ICD-10, dependence is diagnosed if 3 or more of the following criteria were met in the previous year: a strong desire or compulsion to take the drug, difficulties in controlling drug use, withdrawal symptoms, evidence of tolerance, neglect of alternative pleasures or interests, and persistent drug use despite harmful consequences. The latest edition of the DSM (DSM-5) 4 has abandoned the categorical distinction between abuse and dependence in favor of a dimensional approach, specifying 11 criteria for substanceuse disorders, which range from mild (in patients meeting 2 or 3 criteria) to severe (in patients meeting 6 or more criteria). Key elements of substance-use disorders are dose increases, tolerance of and craving for the drug's effects, and loss of control. These diagnostic criteria and definitions are used for all classes of abused drugs, including prescription drugs such as benzodiazepines. However, the criteria may be less appropriate - or even problematic - in the case of mentally ill patients who use or are dependent on prescription drugs than in the case of mentally healthy persons who take drugs primarily for recreational purposes.	[Soyka, Michael] Ludwig Maximilians Univ Munchen, Dept Psychiat & Psychotherapy, Munich, Germany; [Soyka, Michael] Med Pk Chiemseeblick, Rasthausstr 25, D-83233 Bernau, Germany; [Soyka, Michael] Privatklin Meiringen, Meiringen, Switzerland	University of Munich	Soyka, M (corresponding author), Med Pk Chiemseeblick, Rasthausstr 25, D-83233 Bernau, Germany.	m.soyka@medicalpark.de			Lundbeck; Indivior; Novartis Pharmaceuticals; Mepha Pharma	Lundbeck(Lundbeck Corporation); Indivior; Novartis Pharmaceuticals(Novartis); Mepha Pharma(Dexcel Pharma)	Dr. Soyka reports receiving consulting fees from Lundbeck, Indivior, and Novartis Pharmaceuticals, lecture fees from Mepha Pharma, Lundbeck, and Indivior, and travel support from Lundbeck. No other potential conflict of interest relevant to this article was reported.	Amato L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005063.pub3; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Ashton H., 2002, DRINK DRUGS DEPENDEN, P197; Baandrup L, 2016, PSYCHIAT RES, V240, P163, DOI 10.1016/j.psychres.2016.04.031; Baandrup L, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-160; Bachhuber MA, 2016, AM J PUBLIC HEALTH, V106, P686, DOI 10.2105/AJPH.2016.303061; Backmund M, 2005, J ADDICT DIS, V24, P17, DOI 10.1300/J69v24n0402; Baillie AL, 2007, CLIN HDB COEXISTING, P197; Baldwin DS, 2013, J PSYCHOPHARMACOL, V27, P967, DOI 10.1177/0269881113503509; Benkert O, 2013, KOMPENDIUM PSYCHIAT; Berglund M, 2003, TREATING ALCOHOL DRU; Berryman Sandra N, 2012, Medsurg Nurs, V21, P129; Buffett-Jerrott SE, 2002, CURR PHARM DESIGN, V8, P45, DOI 10.2174/1381612023396654; Darker CD, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009652.pub2; de Gier NAH, 2011, FAM PRACT, V28, P253, DOI 10.1093/fampra/cmq113; de las Cuevas C, 2003, PSYCHOPHARMACOLOGY, V167, P297, DOI 10.1007/s00213-002-1376-8; Department of Health Scottish Government Welsh Assembly Government Northern Ireland Executive, 2007, DRUG MIS DEP UK GUID; Diaper AM, 2014, BRIT J CLIN PHARMACO, V77, P302, DOI 10.1111/bcp.12245; Dutra L, 2008, AM J PSYCHIAT, V165, P179, DOI 10.1176/appi.ajp.2007.06111851; Faccini M, 2016, J PSYCHOPHARMACOL, V30, P1047, DOI 10.1177/0269881116647505; FDA, 2016, FDA UPD WARN OR INJ; Frankle WG, 2015, AM J PSYCHIAT, V172, P1148, DOI 10.1176/appi.ajp.2015.14081031; Guerlais M, 2015, SUBST USE MISUSE, V50, P320, DOI 10.3109/10826084.2014.980952; Gustavsen I, 2008, SLEEP MED, V9, P818, DOI 10.1016/j.sleep.2007.11.011; HOLLISTER LE, 1961, PSYCHOPHARMACOLOGIA, V2, P63, DOI 10.1007/BF00429621; Huang BJ, 2006, J CLIN PSYCHIAT, V67, P1062, DOI 10.4088/JCP.v67n0708; Hunt GE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001088.pub3; Jones JD, 2012, DRUG ALCOHOL DEPEN, V125, P8, DOI 10.1016/j.drugalcdep.2012.07.004; Julien RM, 1997, DROGEN PSYCHOPHARMAK; Koyama A, 2013, J AM GERIATR SOC, V61, P258, DOI 10.1111/jgs.12093; Kurko TAT, 2015, EUR PSYCHIAT, V30, P1037, DOI 10.1016/j.eurpsy.2015.09.003; Lader M, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-015-0642-5; Lader M, 2014, BRIT J CLIN PHARMACO, V77, P295, DOI 10.1111/j.1365-2125.2012.04418.x; Lader M, 2011, ADDICTION, V106, P2086, DOI 10.1111/j.1360-0443.2011.03563.x; Lader M, 2009, CNS DRUGS, V23, P19, DOI 10.2165/0023210-200923010-00002; Liebrenz M, 2010, ADDICTION, V105, P1870, DOI 10.1111/j.1360-0443.2010.02933.x; Lingford-Hughes AR, 2012, J PSYCHOPHARMACOL, V26, P899, DOI 10.1177/0269881112444324; Lintzeris N, 2010, AM J ADDICTION, V19, P59, DOI 10.1111/j.1521-0391.2009.00007.x; Lohse MJ, 2013, ARZNEIVERORDNUNGS RE, P641; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Mariani JJ, 2016, AM J DRUG ALCOHOL AB, V42, P333, DOI 10.3109/00952990.2015.1125493; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Moore N, 2015, JAMA PSYCHIAT, V72, P110, DOI 10.1001/jamapsychiatry.2014.2190; Morgan K, 2004, HEALTH TECHNOL ASSES, V8, pIII; MORIN CM, 1994, AM J PSYCHIAT, V151, P1172; Mugunthan K, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X593857; Mura T, 2013, EUR NEUROPSYCHOPHARM, V23, P212, DOI 10.1016/j.euroneuro.2012.05.004; Neutel CI, 2005, INT REV PSYCHIATR, V17, P189, DOI 10.1080/09540260500071863; Nielsen S, 2007, ADDICTION, V102, P616, DOI 10.1111/j.1360-0443.2006.01731.x; Nissen C, 2014, NERVENARZT, V85, P67, DOI 10.1007/s00115-013-3893-6; Okumura Y, 2016, DRUG ALCOHOL DEPEN, V158, P118, DOI 10.1016/j.drugalcdep.2015.11.010; Olfson M, 2015, JAMA PSYCHIAT, V72, P136, DOI 10.1001/jamapsychiatry.2014.1763; Oliver I, 2012, IEEE IC COMP COM NET; Otto C, 2009, DRUG ALCOHOL DEPEN, V105, P221, DOI 10.1016/j.drugalcdep.2009.07.010; Pabst A, 2013, SUCHT, V59, P321, DOI [DOI 10.1024/0939-5911.a000275, 10.1024/0939-5911.a000275, DOI 10.1024/0939-5911.A000275]; Pariente A, 2016, CNS DRUGS, V30, P1, DOI 10.1007/s40263-015-0305-4; Parr JM, 2009, ADDICTION, V104, P13, DOI 10.1111/j.1360-0443.2008.02364.x; Petitjean S, 2007, INT CLIN PSYCHOPHARM, V22, P292, DOI 10.1097/YIC.0b013e328105e0f2; Pisani MA, 2009, CRIT CARE MED, V37, P177, DOI 10.1097/CCM.0b013e318192fcf9; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; Sirdifield C, 2017, PATIENT, V10, P1, DOI 10.1007/s40271-016-0182-z; Smink BE, 2010, CNS DRUGS, V24, P639, DOI 10.2165/11533170-000000000-00000; Soyka M, 2005, NERVENARZT, V76, P72, DOI 10.1007/s00115-004-1828-y; SOYKA M, 1988, NERVENARZT, V59, P744; Soyka M, 2014, THERAPIE PSYCHISCHER, P55; Soyka M., 2015, MEDIKAMENTENABHANGIG; Takeshima N, 2016, PSYCHIAT RES, V237, P201, DOI 10.1016/j.psychres.2016.01.040; Tan KR, 2010, NATURE, V463, P769, DOI 10.1038/nature08758; Ten Wolde GB, 2008, ADDICTION, V103, P662, DOI 10.1111/j.1360-0443.2008.02141.x; Voshaar RCO, 2006, BRIT J PSYCHIAT, V188, P188, DOI 10.1192/bjp.bp.105.012039; Voshaar RCO, 2003, BRIT J PSYCHIAT, V182, P498, DOI 10.1192/bjp.182.6.498; Wagner AK, 2004, ARCH INTERN MED, V164, P1567, DOI 10.1001/archinte.164.14.1567; World Health Organization, 1992, ICD 10 CLASS MENT BE, DOI DOI 10.1002/1520-6505(2000)9:5%3C201::AID-EVAN2%3E3.3.CO;2-P	75	144	149	1	44	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1147	1157		10.1056/NEJMra1611832	http://dx.doi.org/10.1056/NEJMra1611832			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28328330				2022-12-28	WOS:000397014300011
J	Campos, L				Campos, Luis			Synthetic How Life Got Made	SCIENCE			English	Book Review									[Campos, Luis] Univ New Mexico, Dept Hist, Astrobiol, Albuquerque, NM 87131 USA	University of New Mexico	Campos, L (corresponding author), Univ New Mexico, Dept Hist, Astrobiol, Albuquerque, NM 87131 USA.	luiscampos@unm.edu						Roosth Sophia, 2017, SYNTHETIC LIFE GOT M	1	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1136	1136		10.1126/science.aam6893	http://dx.doi.org/10.1126/science.aam6893			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302815				2022-12-28	WOS:000396351200025
J	Dawson, MA				Dawson, Mark A.			The cancer epigenome: Concepts, challenges, and therapeutic opportunities	SCIENCE			English	Review							TERT PROMOTER MUTATIONS; ACUTE MYELOID-LEUKEMIA; STEM-CELLS; MYELODYSPLASTIC SYNDROME; SELECTIVE-INHIBITION; CLONAL HEMATOPOIESIS; HISTONE METHYLATION; CBX FAMILY; RESISTANCE; PLASTICITY	Cancer biology is profoundly influenced by changes in the epigenome. Because the dynamic plasticity of the epigenome lends itself well to therapeutic manipulation, the past few years have witnessed an unprecedented investment in the development, characterization, and translation of targeted epigenetic therapies. In this review, I provide a broad context for recent developments that offer a greater understanding of how epigenetic regulators facilitate the initiation, maintenance, and evolution of cancer. I discuss newly developed epigenetic therapies and the cellular and molecular mechanisms that may govern sensitivity and resistance to these agents. I also review the rationale for future combination therapies involving existing and emerging epigenetic drugs.	[Dawson, Mark A.] Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic, Australia; [Dawson, Mark A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Dawson, Mark A.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia; [Dawson, Mark A.] Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center	Dawson, MA (corresponding author), Peter MacCallum Canc Ctr, Canc Res Div, Melbourne, Vic, Australia.; Dawson, MA (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.; Dawson, MA (corresponding author), Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia.; Dawson, MA (corresponding author), Peter MacCallum Canc Ctr, Dept Haematol, Melbourne, Vic, Australia.	mark.dawson@petermac.org	Dawson, Mark A/B-9317-2017	Dawson, Mark A/0000-0002-5464-5029	National Health and Medical Research Council of Australia; Cancer Council Victoria; Snowdome Foundation; Celgene; Pfizer	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Snowdome Foundation; Celgene(Bristol-Myers SquibbCelgene Corporation); Pfizer(Pfizer)	The scope and space limitations of this review have unfortunately meant that I have not been able to separately cite many of the original publications that have contributed substantially to the literature. I sincerely apologize to the authors of these publications. I thank S.-J. Dawson for critical appraisal of the manuscript and all of the members of the Dawson laboratory for helpful discussions. M.A.D. is the senior fellow for Leukaemia Foundation Australia. The National Health and Medical Research Council of Australia, Cancer Council Victoria, and the Snowdome Foundation support research in the Dawson laboratory. M.A.D. is on the scientific advisory board of Cancer Therapeutics CRC (CTx), a company developing new cancer drugs, and is a paid consultant for Celgene and Pfizer.	Allis C, 2015, EPIGENETICS-US; Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Cerchietti L., 2017, J CLIN ONCOL; Chan SM, 2015, NAT MED, V21, P178, DOI 10.1038/nm.3788; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Daley GQ, 2012, CELL, V151, P1151, DOI 10.1016/j.cell.2012.11.016; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Fellmann C, 2014, NAT CELL BIOL, V16, P10, DOI 10.1038/ncb2895; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Flavahan WA, 2016, NATURE, V529, P110, DOI 10.1038/nature16490; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Gilan O, 2016, NAT STRUCT MOL BIOL, V23, P673, DOI 10.1038/nsmb.3249; Groschel S, 2014, CELL, V157, P369, DOI 10.1016/j.cell.2014.02.019; Halley-Stott RP, 2013, BRIEF FUNCT GENOMICS, V12, P164, DOI 10.1093/bfgp/elt011; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Issa JP, 2015, CANCER-AM CANCER SOC, V121, P556, DOI 10.1002/cncr.29085; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Kadoch C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500447; Kagoya Y, 2016, J CLIN INVEST, V126, P3479, DOI 10.1172/JCI86437; Katainen R, 2015, NAT GENET, V47, P818, DOI 10.1038/ng.3335; Klauke K, 2013, NAT CELL BIOL, V15, P353, DOI 10.1038/ncb2701; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Lu C, 2016, SCIENCE, V352, P844, DOI 10.1126/science.aac7272; Luger K, 2012, NAT REV MOL CELL BIO, V13, P436, DOI 10.1038/nrm3382; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Morris KV, 2014, NAT REV GENET, V15, P423, DOI 10.1038/nrg3722; Shyh-Chang N, 2013, SCIENCE, V339, P222, DOI 10.1126/science.1226603; Oldridge DA, 2015, NATURE, V528, P418, DOI 10.1038/nature15540; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Pleyer L, 2015, DRUG METAB REV, V47, P252, DOI 10.3109/03602532.2014.995379; Prebet T, 2014, J CLIN ONCOL, V32, P1242, DOI 10.1200/JCO.2013.50.3102; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Rodriguez R, 2014, NAT REV GENET, V15, P783, DOI 10.1038/nrg3796; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Sanchez-Rivera FJ, 2015, NAT REV CANCER, V15, P387, DOI 10.1038/nrc3950; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Sciacovelli M, 2016, NATURE, V537, P544, DOI 10.1038/nature19353; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Sigalotti L, 2014, PHARMACOL THERAPEUT, V142, P339, DOI 10.1016/j.pharmthera.2013.12.015; Stein EM, 2016, BLOOD, V127, P71, DOI 10.1182/blood-2015-07-604538; Sturm D, 2014, NAT REV CANCER, V14, P92, DOI 10.1038/nrc3655; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Woods BA, 2015, IMMUNOL REV, V263, P22, DOI 10.1111/imr.12246; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yamazaki H, 2014, CANCER CELL, V25, P415, DOI 10.1016/j.ccr.2014.02.008; Zhu HR, 2016, CELL REP, V16, P2829, DOI 10.1016/j.celrep.2016.08.032; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	74	209	213	3	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1147	1152		10.1126/science.aam7304	http://dx.doi.org/10.1126/science.aam7304			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302822				2022-12-28	WOS:000396351200031
J	Khan, U; Hadid, T				Khan, Uqba; Hadid, Tarik			Plasmacytomas and Plasma-Cell Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Khan, Uqba; Hadid, Tarik] St John Hosp & Med Ctr, Detroit, MI 48236 USA	St. John Hospital & Medical Center	Khan, U (corresponding author), St John Hosp & Med Ctr, Detroit, MI 48236 USA.	uqba.md@gmail.com	Khan, Uqba/N-4069-2019	Khan, Uqba/0000-0002-4740-2256; Hadid, Tarik/0000-0002-5423-4211					0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					E19	E19		10.1056/NEJMicm1611205	http://dx.doi.org/10.1056/NEJMicm1611205			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QT	28296609				2022-12-28	WOS:000396403700001
J	Chaker, L; Bianco, AC; Jonklaas, J; Peeters, RP				Chaker, Layal; Bianco, Antonio C.; Jonklaas, Jacqueline; Peeters, Robin P.			Hypothyroidism	LANCET			English	Review							QUALITY-OF-LIFE; SUBCLINICAL THYROID-DYSFUNCTION; THYROXINE PLUS TRIIODOTHYRONINE; UNITED-STATES POPULATION; CORONARY-HEART-DISEASE; DOUBLE-BLIND; SERUM THYROTROPIN; NATIONAL-HEALTH; IODINE INTAKE; LEVOTHYROXINE MONOTHERAPY	Hypothyroidism is a common condition of thyroid hormone deficiency, which is readily diagnosed and managed but potentially fatal in severe cases if untreated. The definition of hypothyroidism is based on statistical reference ranges of the relevant biochemical parameters and is increasingly a matter of debate. Clinical manifestations of hypothyroidism range from life threatening to no signs or symptoms. The most common symptoms in adults are fatigue, lethargy, cold intolerance, weight gain, constipation, change in voice, and dry skin, but clinical presentation can differ with age and sex, among other factors. The standard treatment is thyroid hormone replacement therapy with levothyroxine. However, a substantial proportion of patients who reach biochemical treatment targets have persistent complaints. In this Seminar, we discuss the epidemiology, causes, and symptoms of hypothyroidism; summarise evidence on diagnosis, long-term risk, treatment, and management; and highlight future directions for research.	[Chaker, Layal; Peeters, Robin P.] Erasmus Univ, Med Ctr, Acad Ctr Thyroid Dis, NL-3000 CA Rotterdam, Netherlands; [Bianco, Antonio C.] Rush Univ, Med Ctr, Div Endocrinol & Metab, Chicago, IL 60612 USA; [Jonklaas, Jacqueline] Georgetown Univ, Div Endocrinol, Washington, DC USA	Erasmus University Rotterdam; Erasmus MC; Rush University; Georgetown University	Peeters, RP (corresponding author), Erasmus Univ, Med Ctr, Acad Ctr Thyroid Dis, NL-3000 CA Rotterdam, Netherlands.	r.peeters@erasmusmc.nl	Jonklaas, Jacqueline/G-2807-2010; Bianco, Antonio/AAK-6336-2020	Jonklaas, Jacqueline/0000-0002-2238-2666; Bianco, Antonio/0000-0001-7737-6813; Peeters, Robin/0000-0001-7732-9371	GoodLife Fertility BV; Institut Biochemique SA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065055] Funding Source: NIH RePORTER	GoodLife Fertility BV; Institut Biochemique SA; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	RPP received lecture fees from GoodLife Fertility BV and Institut Biochemique SA. All other authors declare no competing interests.	Abdalla SM, 2014, CLIN ENDOCRINOL, V81, P633, DOI 10.1111/cen.12538; Abrahamsen B, 2015, J BONE MINER RES, V30, P898, DOI 10.1002/jbmr.2416; Alevizaki M, 2006, CLIN ENDOCRINOL, V65, P369, DOI 10.1111/j.1365-2265.2006.02606.x; Alexander EK, 2004, NEW ENGL J MED, V351, P241, DOI 10.1056/NEJMoa040079; Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068; [Anonymous], 2007, ASS IOD DEF DIS MON; Aoki Y, 2007, THYROID, V17, P1211, DOI 10.1089/thy.2006.0235; Appelhof BC, 2005, J CLIN ENDOCR METAB, V90, P2666, DOI 10.1210/jc.2004-2111; Asvold BO, 2007, ARCH INTERN MED, V167, P1428, DOI 10.1001/archinte.167.13.1428; Asvold BO, 2013, EUR J ENDOCRINOL, V169, P613, DOI 10.1530/EJE-13-0459; Bano A, 2016, J CLIN ENDOCR METAB, V101, P3204, DOI 10.1210/jc.2016-1300; Bath SC, 2013, LANCET, V382, P331, DOI 10.1016/S0140-6736(13)60436-5; Belin RM, 2004, J CLIN ENDOCR METAB, V89, P6077, DOI 10.1210/jc.2004-0431; Beynon J, 2008, CRIT CARE, V12, DOI 10.1186/cc6218; Boas M, 2012, MOL CELL ENDOCRINOL, V355, P240, DOI 10.1016/j.mce.2011.09.005; Boeving A, 2011, THYROID, V21, P355, DOI 10.1089/thy.2010.0315; Bolk N, 2010, ARCH INTERN MED; Bougma K, 2013, NUTRIENTS, V5, P1384, DOI 10.3390/nu5041384; Brenta G, 2013, ARQ BRAS ENDOCRINOL, V57, P265, DOI 10.1590/S0004-27302013000400003; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; Caldwell KL, 2013, THYROID, V23, P927, DOI 10.1089/thy.2013.0012; Canaris GJ, 2000, ARCH INTERN MED, V160, P526, DOI 10.1001/archinte.160.4.526; Canaris GJ, 1997, J GEN INTERN MED, V12, P544, DOI 10.1046/j.1525-1497.1997.07109.x; Cappelli C, 2016, THYROID, V26, P197, DOI 10.1089/thy.2015.0422; Cappola AR, 2015, J CLIN ENDOCR METAB, V100, P1088, DOI 10.1210/jc.2014-3586; Carle A, 2016, AM J MED, V129, P1082, DOI 10.1016/j.amjmed.2016.06.013; Carle A, 2015, CLIN ENDOCRINOL, V83, P717, DOI 10.1111/cen.12787; Carle A, 2014, EUR J ENDOCRINOL, V171, P593, DOI 10.1530/EJE-14-0481; Carle A, 2012, EUR J ENDOCRINOL, V167, P483, DOI 10.1530/EJE-12-0356; Chaker L, 2016, J CLIN ENDOCR METAB, V101, P4270, DOI 10.1210/jc.2016-2255; Chaker L, 2016, NEUROLOGY, V87, P1688, DOI 10.1212/WNL.0000000000003227; Chaker L, 2016, THYROID, V26, P1195, DOI 10.1089/thy.2016.0133; Chaker L, 2016, CIRCULATION, V134, P713, DOI 10.1161/CIRCULATIONAHA.115.020789; Chaker L, 2015, J CLIN ENDOCR METAB, V100, P2181, DOI 10.1210/jc.2015-1438; Chan S, 2015, CLIN ENDOCRINOL, V82, P313, DOI 10.1111/cen.12605; Collet TH, 2014, J CLIN ENDOCR METAB, V99, P3353, DOI 10.1210/jc.2014-1250; Cooper DS, 2012, LANCET, V379, P1142, DOI 10.1016/S0140-6736(11)60276-6; de Castro JPW, 2015, J CLIN INVEST, V125, P769, DOI 10.1172/JCI77588; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Dumitrescu AM, 2013, BBA-GEN SUBJECTS, V1830, P3987, DOI 10.1016/j.bbagen.2012.08.005; Effraimidis G, 2011, EUR J ENDOCRINOL, V164, P107, DOI 10.1530/EJE-10-0785; Effraimidis G, 2009, J CLIN ENDOCR METAB, V94, P1324, DOI 10.1210/jc.2008-1548; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Escobar-Morreale HF, 2005, ANN INTERN MED, V142, P412, DOI 10.7326/0003-4819-142-6-200503150-00007; EscobarMorreale HF, 1996, ENDOCRINOLOGY, V137, P2490, DOI 10.1210/en.137.6.2490; Fliers E, 2015, LANCET DIABETES ENDO, V3, P816, DOI 10.1016/S2213-8587(15)00225-9; Freitas BCG, 2010, J CLIN INVEST, V120, P2206, DOI 10.1172/JCI41977; Gao X, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151266; Garber JR, 2012, ENDOCR PRACT, V18, P989, DOI 10.4158/EP12280.GL; Madariaga AG, 2014, J CLIN ENDOCR METAB, V99, P923, DOI 10.1210/jc.2013-2409; Gencer B, 2012, CIRCULATION, V126, P1040, DOI 10.1161/CIRCULATIONAHA.112.096024; Graeppi-Dulac J, 2014, EUR J ENDOCRINOL, V170, pR253, DOI 10.1530/EJE-13-0920; Gronich N, 2015, DIABETES CARE, V38, P1657, DOI 10.2337/dc14-2515; Grossman A, 2016, AM J MED, V129, P423, DOI 10.1016/j.amjmed.2015.11.027; Grozinsky-Glasberg S, 2006, J CLIN ENDOCR METAB, V91, P2592, DOI 10.1210/jc.2006-0448; Grunenwald S, 2015, PITUITARY, V18, P169, DOI 10.1007/s11102-014-0559-8; Gullo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022552; Gussekloo J, 2004, JAMA-J AM MED ASSOC, V292, P2591, DOI 10.1001/jama.292.21.2591; Hansen PS, 2004, J CLIN ENDOCR METAB, V89, P1181, DOI 10.1210/jc.2003-031641; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Huang SA, 2000, NEW ENGL J MED, V343, P185, DOI 10.1056/NEJM200007203430305; Inoue K, 2016, THYROID, V26, P1457, DOI 10.1089/thy.2016.0156; Ito M, 2012, EUR J ENDOCRINOL, V167, P373, DOI 10.1530/EJE-11-1029; Jaume JC, 1996, THYROID, V6, P79, DOI 10.1089/thy.1996.6.79; Jo SR, 2012, J NEUROSCI, V32, P8491, DOI 10.1523/JNEUROSCI.6514-11.2012; Jonklaas J, 2008, JAMA-J AM MED ASSOC, V299, P769, DOI 10.1001/jama.299.7.769; Jonklaas J, 2014, THYROID, V24, P1670, DOI 10.1089/thy.2014.0028; Kahapola-Arachchige KM, 2012, CLIN ENDOCRINOL, V77, P773, DOI 10.1111/j.1365-2265.2012.04463.x; Kahraman D, 2012, CLIN ENDOCRINOL, V76, P297, DOI 10.1111/j.1365-2265.2011.04204.x; Khawaja Nahla M, 2006, Endocr Pract, V12, P29; Kim TH, 2013, J CLIN ENDOCR METAB, V98, P3420, DOI 10.1210/jc.2013-1607; Koulouri O, 2013, BEST PRACT RES CL EN, V27, P745, DOI 10.1016/j.beem.2013.10.003; Krohn T, 2014, J CLIN ENDOCR METAB, V99, P4109, DOI 10.1210/jc.2014-1347; Laurberg P, 2010, BEST PRACT RES CL EN, V24, P13, DOI 10.1016/j.beem.2009.08.013; Lee V, 2016, CLIN ONCOL-UK, V28, pE52, DOI 10.1016/j.clon.2016.05.004; LeFevre ML, 2015, ANN INTERN MED, V162, P641, DOI 10.7326/M15-0483; Leung AM, 2016, THYROID, V26, P479, DOI 10.1089/thy.2016.0077; McAninch EA, 2015, LANCET DIABETES ENDO, V3, P756, DOI 10.1016/S2213-8587(15)00325-3; McAninch EA, 2015, J CLIN ENDOCR METAB, V100, P920, DOI 10.1210/jc.2014-4092; McLeod DSA, 2014, JAMA-J AM MED ASSOC, V311, P1563, DOI 10.1001/jama.2013.285606; Medici M, 2015, CLIN CHEM, V61, P704, DOI 10.1373/clinchem.2014.236646; Medici M, 2015, ENDOCR REV, V36, P214, DOI 10.1210/er.2014-1081; Medici M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004123; Muangpaisan W, 2012, GERIATR GERONTOL INT, V12, P59, DOI 10.1111/j.1447-0594.2011.00728.x; Nygaard B, 1999, CLIN ENDOCRINOL, V50, P197, DOI 10.1046/j.1365-2265.1999.00635.x; Nygaard B, 2009, EUR J ENDOCRINOL, V161, P895, DOI 10.1530/EJE-09-0542; Ott J, 2002, CLIN ENDOCRINOL, V57, P577; Panicker V, 2008, CLIN ENDOCRINOL, V68, P652, DOI 10.1111/j.1365-2265.2007.03079.x; Panicker V, 2009, J CLIN ENDOCR METAB, V94, P1623, DOI 10.1210/jc.2008-1301; Pasqualetti G, 2015, J CLIN ENDOCR METAB, V100, P4240, DOI 10.1210/jc.2015-2046; Pearce SHS, 2013, EUR THYROID J, V2, P215, DOI 10.1159/000356507; Persani L, 2000, J CLIN ENDOCR METAB, V85, P3631, DOI 10.1210/jc.85.10.3631; Persani L, 2012, J CLIN ENDOCR METAB, V97, P3068, DOI 10.1210/jc.2012-1616; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Porcu E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003266; Rieben C, 2016, J CLIN ENDOCR METAB, V101, P4945, DOI 10.1210/jc.2016-2129; Robison CD, 2014, J CLIN LIPIDOL, V8, P401, DOI 10.1016/j.jacl.2014.05.005; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Roelfsema F, 2010, J CLIN ENDOCR METAB, V95, P928, DOI 10.1210/jc.2009-1959; Roos A, 2005, ARCH INTERN MED, V165, P1714, DOI 10.1001/archinte.165.15.1714; Salerno M, 2016, NAT REV ENDOCRINOL, V12, P734, DOI 10.1038/nrendo.2016.100; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Schultheiss UT, 2015, J CLIN ENDOCR METAB, V100, pE799, DOI 10.1210/jc.2014-4352; Shin YW, 2016, THYROID, V26, P641, DOI 10.1089/thy.2015.0452; Shine B, 2015, LANCET, V386, P461, DOI 10.1016/S0140-6736(14)61842-0; Shu M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147048; Shulman KL, 2005, AM J GERIAT PSYCHIAT, V13, P299, DOI 10.1176/appi.ajgp.13.4.299; Sichieri R, 2007, CLIN ENDOCRINOL, V66, P803, DOI 10.1111/j.1365-2265.2007.02816.x; Somwaru LL, 2009, J CLIN ENDOCR METAB, V94, P1342, DOI 10.1210/jc.2008-1696; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Surks MI, 2013, ENDOCR PRACT, V19, P1066, DOI 10.4158/EP13246.CO; Surks MI, 2010, J CLIN ENDOCR METAB, V95, P496, DOI 10.1210/jc.2009-1845; Tan ZS, 2008, ARCH INTERN MED, V168, P1514, DOI 10.1001/archinte.168.14.1514; Taylor PN, 2014, JAMA INTERN MED, V174, P32, DOI 10.1001/jamainternmed.2013.11312; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; Teng WP, 2013, LANCET DIABETES ENDO, V1, P228, DOI 10.1016/S2213-8587(13)70109-8; Teng XC, 2011, EUR J ENDOCRINOL, V164, P943, DOI 10.1530/EJE-10-1041; Tiller D, 2016, THYROID, V26, P1205, DOI 10.1089/thy.2015.0410; Tseng FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122955; Vadiveloo T, 2013, J CLIN ENDOCR METAB, V98, P1147, DOI 10.1210/jc.2012-3191; van Deventer HE, 2011, CLIN CHEM, V57, P122, DOI 10.1373/clinchem.2010.154088; Vanderpump MPJ, 1996, BMJ-BRIT MED J, V313, P539; VANHAELST L, 1967, LANCET, V2, P800, DOI 10.1016/S0140-6736(67)92235-0; Verloop H, 2012, J CLIN ENDOCR METAB, V97, P2243, DOI 10.1210/jc.2012-1063; Vita R, 2014, J CLIN ENDOCR METAB, V99, P4481, DOI 10.1210/jc.2014-2684; Vogelius IR, 2011, CANCER-AM CANCER SOC, V117, P5250, DOI 10.1002/cncr.26186; Walker JN, 2013, EUR J ENDOCRINOL, V168, P913, DOI 10.1530/EJE-12-1035; Walsh JP, 2006, J CLIN ENDOCR METAB, V91, P2624, DOI 10.1210/jc.2006-0099; Walsh JP, 2010, J CLIN ENDOCR METAB, V95, P1095, DOI 10.1210/jc.2009-1977; Walsh JP, 2003, J CLIN ENDOCR METAB, V88, P4543, DOI 10.1210/jc.2003-030249; Wartofsky L, 2005, J CLIN ENDOCR METAB, V90, P5483, DOI 10.1210/jc.2005-0455; Wiersinga WM, 2012, EUR THYROID J, V1, P55, DOI [10.1159/000339444, 10.1159/000337020]; Wiersinga WM, 2014, NAT REV ENDOCRINOL, V10, P164, DOI 10.1038/nrendo.2013.258; Wiersinga WM, 2000, ENDOTEXT; Wouters HJCM, 2017, THYROID, V27, P147, DOI 10.1089/thy.2016.0199; Wu Q, 2015, J CLIN ENDOCR METAB, V100, P4037, DOI 10.1210/jc.2015-2222; Yue CS, 2015, J PHARM PHARM SCI, V18, P844, DOI 10.18433/J36P5M; Zhang M, 2016, EUR HEART J, V37, P2055, DOI 10.1093/eurheartj/ehv737; Zhang YY, 2014, INT J EPIDEMIOL, V43, P1624, DOI 10.1093/ije/dyu126; Zhong B, 2016, CARDIOLOGY, V134, P366, DOI 10.1159/000444578; Zimmermann MB, 2015, LANCET DIABETES ENDO, V3, P286, DOI 10.1016/S2213-8587(14)70225-6	141	422	449	9	126	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1550	1562		10.1016/S0140-6736(17)30703-1	http://dx.doi.org/10.1016/S0140-6736(17)30703-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7BS	28336049	Green Accepted			2022-12-28	WOS:000411337100029
J	Erickson, SM; Rockwern, B; Koltov, M; McLean, RM				Erickson, Shari M.; Rockwern, Brooke; Koltov, Michelle; McLean, Robert M.		Amer Coll Phys	Putting Patients First by Reducing Administrative Tasks in Health Care: A Position Paper of the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							ELECTRONIC MEDICAL-RECORDS; WORK-LIFE BALANCE; UNITED-STATES; COST; BURNOUT; TIME; QUALITY; SATISFACTION; IMPACT; MOTION	This American College of Physicians (ACP) position paper, initiated and written by ACP's Medical Practice and Quality Committee and approved by the Board of Regents on 21 January 2017, reports policy recommendations to address the issue of administrative tasks to mitigate or eliminate their adverse effects on physicians, their patients, and the health care system as a whole. The paper outlines a cohesive framework for analyzing administrative tasks through several lenses to better understand any given task that a clinician and his or her staff may be required to perform. In addition, a scoping literature review and environmental scan were done to assess the effects on physician time, practice and system cost, and patient care due to the increase in administrative tasks. The findings from the scoping review, in addition to the framework, provide the backbone of detailed policy recommendations from the ACP to external stakeholders (such as payers, governmental oversight organizations, and vendors) regarding how any given administrative requirement, regulation, or program should be assessed, then potentially revised or removed entirely.	[Erickson, Shari M.; Rockwern, Brooke; Koltov, Michelle; McLean, Robert M.] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA	American College of Physicians	Erickson, SM (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	serickson@acponline.org			ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Agency for Healthcare Research and Quality, 2014, WORKSH CURR TOOL 2; Alternative Payment Model Frame-work and Progress Tracking (APM FPT) Work Group, 2016, ALT PAYM MOD APM FRA; American College of Physicians, 2011, ROL PERF ASS REF HLT; American Medical Association, 2011, STAND PRIOR AUTH PRO; Anhang Price R, 2015, EXAMINING ROLE PATIE; [Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; [Anonymous], 2016, COR MEAS; Babbott S, 2014, J AM MED INFORM ASSN, V21, pE100, DOI 10.1136/amiajnl-2013-001875; Basch P, 2015, HLTH POLICY ISSUE BR; Berenson RA, 2016, NEW ENGL J MED, V374, P1306, DOI 10.1056/NEJMp1600999; Berenson RA, 2011, NEW ENGL J MED, V364, P1892, DOI 10.1056/NEJMp1102099; Blanchfield BB, 2010, HEALTH AFFAIR, V29, P1248, DOI 10.1377/hlthaff.2009.0075; Bodenheimer T, 2014, ANN FAM MED, V12, P573, DOI 10.1370/afm.1713; Brot-Goldberg ZC., 2015, WHAT DOES DEDUCTIBLE; Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; Casalino LP, 2009, HEALTH AFFAIR, V28, pW533, DOI 10.1377/hlthaff.28.4.w533; Centers for Medicare & Medicaid Services, 2016, T OV; Christino Melissa A, 2013, J Grad Med Educ, V5, P600, DOI 10.4300/JGME-D-12-00377.1; Collins SR, 2016, NEW US CENSUS DATA S; Cutler D, 2012, NEW ENGL J MED, V367, P1875, DOI 10.1056/NEJMp1209711; Cutler DM, 2011, J ECON PERSPECT, V25, P3, DOI 10.1257/jep.25.2.3; Daniel H, 2016, ANN INTERN MED, V165, P50, DOI 10.7326/M15-2768; Department of Health and Human Services Centers for Medicare & Medicaid Services, 2016, MED CHIP JUL 2016 MO; Dolan R., 2016, HLTH POLICY BRIEF HI; Dyer N, 2012, PSYCHOMETRIC PROPERT; Eisenstat SA, 2016, AM J MED QUAL; Friedberg M.W., 2013, FACTORS AFFECTING PH; Friedberg MW, 2018, EFFECTS HLTH CARE PA; Goetz Goldberg Debora, 2012, Am J Manag Care, V18, pe48; Grant RW, 2016, CONTEMP CLIN TRIALS, V47, P196, DOI 10.1016/j.cct.2016.01.012; Halladay JR, 2009, ANN FAM MED, V7, P495, DOI 10.1370/afm.1050; Hamel L, 2015, EXPERIENCES ATTITUDE; Hill RG, 2013, AM J EMERG MED, V31, P1591, DOI 10.1016/j.ajem.2013.06.028; Institute of Medicine Committee on a National Surveillance System for Cardiovascular and Select Chronic Diseases, 2011, NAT FRAM SURV CARD C; Ix Megan, 2008, Find Brief, V11, P1; Jiwani A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0556-7; Kahn JG, 2005, HEALTH AFFAIR, V24, P1629, DOI 10.1377/hlthaff.24.6.1629; Kuhn T, 2015, ANN INTERN MED, V162, P301, DOI 10.7326/M14-2128; Linzer M, 2016, J GEN INTERN MED, V31, P1004, DOI 10.1007/s11606-016-3720-4; Linzer M, 2014, J GEN INTERN MED, V29, P18, DOI 10.1007/s11606-013-2597-8; Linzer M, 2009, ANN INTERN MED, V151, P28, DOI 10.7326/0003-4819-151-1-200907070-00006; Long SK, 2013, HEALTH AFFAIR, V32, P1560, DOI 10.1377/hlthaff.2012.1010; McDonald CJ, 2014, JAMA INTERN MED, V174, P1860, DOI 10.1001/jamainternmed.2014.4506; McLean R, 2016, COMMUNICATION   0301; Medical Group Management Association, 2005, POS PAP ADM SIMPL ME; Morley CP, 2013, J AM BOARD FAM MED, V26, P93, DOI 10.3122/jabfm.2013.01.120062; Morra D, 2011, HEALTH AFFAIR, V30, P1443, DOI 10.1377/hlthaff.2010.0893; National Committee for Quality Assurance, 2016, LAT EV BEN NCQA PAT; Nemeth LS, 2012, J AM BOARD FAM MED, V25, P594, DOI 10.3122/jabfm.2012.05.110214; O'Malley AS, 2015, J GEN INTERN MED, V30, P183, DOI 10.1007/s11606-014-3065-9; Ozkaynak M, 2016, CLIN INFORM STUDY GU, P135; Patient-Centered Primary Care Collaborative, 2016, RES EV RES DEM MED H; Ryskina KL, 2015, ACAD MED, V90, P1373, DOI 10.1097/ACM.0000000000000791; Sakowski JA, 2009, HEALTH AFFAIR, V28, pW544, DOI 10.1377/hlthaff.28.4.w544; Sandhu AT, 2015, ANN INTERN MED, V163, P401, DOI 10.7326/M15-1011; Shanafelt TD, 2016, MAYO CLIN PROC, V91, P836, DOI 10.1016/j.mayocp.2016.05.007; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Shipman SA, 2013, HEALTH AFFAIR, V32, P1990, DOI 10.1377/hlthaff.2013.0539; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961; Sinsky Christine A, 2015, Fam Pract Manag, V22, P34; Stammen LA, 2015, JAMA-J AM MED ASSOC, V314, P2384, DOI 10.1001/jama.2015.16353; The Commonwealth Fund Commission on a High Performance Health System, 2013, CONFR COSTS STAB US; The Joint Commission, 2016, 184 JOINT COMM AMB C; Tipping MD, 2010, J HOSP MED, V5, P323, DOI 10.1002/jhm.790; United States Government Accountability Office, 2013, MED PROGR INT INCR C; UnitedHealth Group, 2009, HLTH CAR COST CONT T; Ventola C Lee, 2011, P T, V36, P669; Weinick RM, 2014, JT COMM J QUAL PATIE, V40, P418, DOI 10.1016/S1553-7250(14)40054-0; West DR, 2012, J AM BOARD FAM MED, V25, P275, DOI 10.3122/jabfm.2012.03.110049; Wikler Elizabeth, 2012, PAPER CUTS REDUCING; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033; Woolhandler S, 2014, INT J HEALTH SERV, V44, P635, DOI 10.2190/HS.44.4.a; Yong PL, 2010, HEALTHCARE IMPERATIV, P141	74	108	108	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					659	+		10.7326/M16-2697	http://dx.doi.org/10.7326/M16-2697			22	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28346948				2022-12-28	WOS:000400395500010
J	DeLancey, JO; Barnard, C; Bilimoria, KY				DeLancey, John O.; Barnard, Cynthia; Bilimoria, Karl Y.			Retained Lumbar Catheter Tip	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[DeLancey, John O.; Bilimoria, Karl Y.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Surg Outcomes & Qual Improvement Ctr, Chicago, IL 60611 USA; [DeLancey, John O.; Bilimoria, Karl Y.] Northwestern Mem Hosp, Chicago, IL 60611 USA; [Barnard, Cynthia] Northwestern Mem Hosp, Div Qual, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern Memorial Hospital; Northwestern Memorial Hospital	DeLancey, JO (corresponding author), Northwestern Univ, Surg Outcomes & Qual Improvement Ctr, Dept Surg & Urol, Feinberg Sch Med,Northwestern Mem Hosp, 633 St Clair St,20th Floor, Chicago, IL 60611 USA.	johnoliver.delancey@northwestern.edu			National Institutes of Health; Agency for Healthcare Research and Quality; American Board of Surgery; American College of Surgeons; Accreditation Council for Graduate Medical Education; Health Care Services Corporation; Mallinkrdot; Northwestern University Robert H. Lurie Comprehensive Cancer Center; Northwestern Memorial Foundation; Northwestern Memorial Hospital	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); American Board of Surgery; American College of Surgeons; Accreditation Council for Graduate Medical Education; Health Care Services Corporation; Mallinkrdot; Northwestern University Robert H. Lurie Comprehensive Cancer Center; Northwestern Memorial Foundation; Northwestern Memorial Hospital	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bilimoria reported having received support from the National Institutes of Health, Agency for Healthcare Research and Quality, American Board of Surgery, American College of Surgeons, Accreditation Council for Graduate Medical Education, Health Care Services Corporation, Mallinkrdot, Northwestern University Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial Foundation, and Northwestern Memorial Hospital. No other disclosures were reported.	Forsythe A, 2009, REGION ANESTH PAIN M, V34, P375, DOI 10.1097/AAP.0b013e3181ac9e8a; Levinson W, 2016, JAMA-J AM MED ASSOC, V316, P764, DOI 10.1001/jama.2016.9136; National Patient Safety Foundation, 2016, RCA2 IMPR ROOT CAUS; Olivar H, 2007, CAN J ANAESTH, V54, P829, DOI 10.1007/BF03021711; Shekelle PG, 2013, COMP EFFECTIVENESS R	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1269	1270		10.1001/jama.2017.1713	http://dx.doi.org/10.1001/jama.2017.1713			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350931				2022-12-28	WOS:000397557800024
J	Slater, BCS				Slater, Basil C. S.			Basil C S Slater OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		SLATER BCS, PUBLICATION LIST, P62659	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2017	356								j1517	10.1136/bmj.j1517	http://dx.doi.org/10.1136/bmj.j1517			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4JB	28347988				2022-12-28	WOS:000397345700004
J	Rockstrom, J; Gaffney, O; Rogelj, J; Meinshausen, M; Nakicenovic, N; Schellnhuber, HJ				Rockstroem, Johan; Gaffney, Owen; Rogelj, Joeri; Meinshausen, Malte; Nakicenovic, Nebojsa; Schellnhuber, Hans Joachim			CLIMATE POLICY A roadmap for rapid decarbonization	SCIENCE			English	Editorial Material									[Rockstroem, Johan; Gaffney, Owen; Schellnhuber, Hans Joachim] Stockholm Univ, Stockholm Resilience Ctr, S-11418 Stockholm, Sweden; [Gaffney, Owen] Royal Swedish Acad Sci, Future Earth, S-10405 Stockholm, Sweden; [Rogelj, Joeri] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Rogelj, Joeri; Nakicenovic, Nebojsa] Potsdam Inst Climate Impact Res, D-14473 Potsdam, Germany; [Meinshausen, Malte; Schellnhuber, Hans Joachim] Univ Melbourne, Australian German Climate & Energy Coll, Victoria 3010, Australia	Stockholm University; Royal Swedish Academy of Sciences; International Institute for Applied Systems Analysis (IIASA); Potsdam Institut fur Klimafolgenforschung; University of Melbourne	Rockstrom, J (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-11418 Stockholm, Sweden.		Meinshausen, Malte/AAG-6505-2019; Meinshausen, Malte/A-7037-2011; Rogelj, Joeri/I-7108-2012; Schellnhuber, Hans Joachim/O-3873-2019; Meinshausen, Malte/AAG-7985-2019; Schellnhuber, Hans Joachim/B-2607-2012	Meinshausen, Malte/0000-0003-4048-3521; Meinshausen, Malte/0000-0003-4048-3521; Rogelj, Joeri/0000-0003-2056-9061; Schellnhuber, Hans Joachim/0000-0001-7453-4935; Schellnhuber, Hans Joachim/0000-0001-7453-4935; gaffney, owen/0000-0001-6244-991X; Rockstrom, Johan/0000-0001-8988-2983	Australian Research Council [FT130100809]; Directorate For Geosciences [1450554] Funding Source: National Science Foundation; ICER [1450657] Funding Source: National Science Foundation	Australian Research Council(Australian Research Council); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); ICER(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors draw on dialogues with Earth League members (www.the-earth-league.org) on a carbon roadmap. The authors thank J. Falk (Intel IoT Ignition Lab) for discussions on exponential approaches to decarbonization. M.M. was supported by Australian Research Council Future Fellowship grant no. FT130100809.	[Anonymous], 2013, CAPITAL 21 CENTURY; BP p.l.c, 2016, BP GLOB; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Erb KH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11382; German Advisory Council on Global Change, 2016, DEV JUST TRANSF BIG; Global Energy Assessment Writing Team, 2012, GLOBAL ENERGY ASSESS; Hic C, 2016, ENVIRON SCI TECHNOL, V50, P4269, DOI 10.1021/acs.est.5b05088; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; Meinshausen M, 2011, ATMOS CHEM PHYS, V11, P1417, DOI 10.5194/acp-11-1417-2011; Rogelj J, 2015, NAT CLIM CHANGE, V5, P519, DOI 10.1038/nclimate2572; Schellnhuber HJ, 2016, NAT CLIM CHANGE, V6, P649, DOI 10.1038/nclimate3013; Williamson P, 2016, NATURE, V530, P153, DOI 10.1038/530153a	12	531	539	12	237	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1269	1271		10.1126/science.aah3443	http://dx.doi.org/10.1126/science.aah3443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EP0NB	28336628	Green Accepted			2022-12-28	WOS:000397082900021
J	Galarza-Munoz, G; Briggs, FBS; Evsyukova, I; Schott-Lerner, G; Kennedy, EM; Nyanhete, T; Wang, LY; Bergamaschi, L; Widen, SG; Tomaras, GD; Ko, DC; Bradrick, SS; Barcellos, LF; Gregory, SG; Garcia-Blanco, MA				Galarza-Munoz, Gaddiel; Briggs, Farren B. S.; Evsyukova, Irina; Schott-Lerner, Geraldine; Kennedy, Edward M.; Nyanhete, Tinashe; Wang, Liuyang; Bergamaschi, Laura; Widen, Steven G.; Tomaras, Georgia D.; Ko, Dennis C.; Bradrick, Shelton S.; Barcellos, Lisa F.; Gregory, Simon G.; Garcia-Blanco, Mariano A.			Human Epistatic Interaction Controls IL7R Splicing and Increases Multiple Sclerosis Risk	CELL			English	Article							GENOME-WIDE ASSOCIATION; INTERLEUKIN-7 RECEPTOR; MESSENGER-RNA; HAPLOTYPE MAP; IL-7; EXPRESSION; GENE; SUSCEPTIBILITY; TRANSCRIPTION; METAANALYSIS	Multiple sclerosis (MS) is an autoimmune disorder where T cells attack neurons in the central nervous system (CNS) leading to demyelination and neurological deficits. A driver of increased MS risk is the soluble form of the interleukin- 7 receptor alpha chain gene (sIL7R) produced by alternative splicing of IL7R exon 6. Here, we identified the RNA helicase DDX39B as a potent activator of this exon and consequently a repressor of sIL7R, and we found strong genetic association of DDX39B with MS risk. Indeed, we showed that a genetic variant in the 50 UTR of DDX39B reduces translation of DDX39B mRNAs and increases MS risk. Importantly, this DDX39B variant showed strong genetic and functional epistasis with allelic variants in IL7R exon 6. This study establishes the occurrence of biological epistasis in humans and provides mechanistic insight into the regulation of IL7R exon 6 splicing and its impact on MS risk.	[Galarza-Munoz, Gaddiel; Kennedy, Edward M.; Wang, Liuyang; Tomaras, Georgia D.; Ko, Dennis C.; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA; [Galarza-Munoz, Gaddiel; Evsyukova, Irina; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Duke Univ, Ctr RNA Biol, Durham, NC 27710 USA; [Galarza-Munoz, Gaddiel; Schott-Lerner, Geraldine; Widen, Steven G.; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Briggs, Farren B. S.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Nyanhete, Tinashe; Tomaras, Georgia D.] Duke Univ, Dept Immunol, Durham, NC 27710 USA; [Nyanhete, Tinashe; Tomaras, Georgia D.] Duke Univ, Dept Surg, Durham, NC 27710 USA; [Bergamaschi, Laura; Gregory, Simon G.] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Ko, Dennis C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Barcellos, Lisa F.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol, Berkeley, CA 94720 USA; [Gregory, Simon G.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA	Duke University; Duke University; University of Texas System; University of Texas Medical Branch Galveston; Case Western Reserve University; Duke University; Duke University; Duke University; Duke University; University of California System; University of California Berkeley; Duke University	Garcia-Blanco, MA (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA.; Garcia-Blanco, MA (corresponding author), Duke Univ, Ctr RNA Biol, Durham, NC 27710 USA.; Garcia-Blanco, MA (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Gregory, SG (corresponding author), Duke Univ, Duke Mol Physiol Inst, Durham, NC 27701 USA.; Gregory, SG (corresponding author), Duke Univ, Med Ctr, Dept Neurol, Durham, NC 27710 USA.	simon.gregory@duke.edu; maragarc@utmb.edu	Wang, Liuyang/A-7833-2011; Briggs, Farren/Q-2164-2019; Bergamaschi, Laura/ABE-1175-2020	Wang, Liuyang/0000-0001-9556-2361; Briggs, Farren/0000-0003-0903-1359; Kennedy, Edward/0000-0002-2817-4809; Gregory, Simon/0000-0002-7805-1743	NIH [R01-NS060925, R01-ES017080, F32-NS087899]; National MS Society Pilot Award [PP2299]; Duke University Whitehead Scholarship; National MS Society research grant [RG 4083A1/1]; Duke University School of Medicine; UTMB; Mr. Herman Stone and family for MS research fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060925, F32NS087899] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National MS Society Pilot Award; Duke University Whitehead Scholarship; National MS Society research grant; Duke University School of Medicine; UTMB; Mr. Herman Stone and family for MS research fund; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. M. Skeen (Duke) and L.K. Newby (Duke MURDOCK study) for providing DNA and RNA samples from patients and healthy individuals, S. Arvai (Duke) for technical assistance with these samples, the IMSGC for sharing imputed whole genome genotype data, Dr. T.G. Wood and the UTMBNGS Facility for RNA-seq data, and Drs. B.R. Cullen and S. M. Horner (Duke) for reagents, advice, and generosity related to experiments with primary CD4<SUP>+</SUP> T cells. Finally, we express our appreciation for individuals participating in the MURDOCK-MS study. This work was supported by NIH grants R01-NS060925 (S.G.G. and M. A.G.-B.) and R01-ES017080 (L.F.B.), National MS Society Pilot Award #PP2299 and Duke University Whitehead Scholarship (D.C.K. and L. W.), National MS Society research grant RG 4083A1/1 (S.G.G.), Ruth and A. Morris Williams Faculty Research Prize funds from Duke University School of Medicine (G.D.T.), start-up funds from UTMB (M. A.G.-B.), funds from Mr. Herman Stone and family for MS research fund (S.G.G.), and NIH F32-NS087899 postdoctoral fellowship (G.G.M.). M.A.G.-B. and S.G.G. have filed invention disclosures with Duke University for matters related to the work described and consultant agreements with Pfizer, Inc. related to the development of animal models indirectly related to the work described. They attest that in no way did these interests influence the planning, execution or interpretation of the results, or the writing of this manuscript. The other authors have no competing interests or other interests that might be perceived to influence the results and/or discussion reported in this paper.	Allcock RJN, 2001, GENES CELLS, V6, P487, DOI 10.1046/j.1365-2443.2001.00435.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Alves NL, 2008, J IMMUNOL, V180, P5201, DOI 10.4049/jimmunol.180.8.5201; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Badot V, 2011, J CELL MOL MED, V15, P2335, DOI 10.1111/j.1582-4934.2010.01228.x; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bilal MY, 2015, IMMUNOL CELL BIOL, V93, P896, DOI 10.1038/icb.2015.59; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Cheong KY, 2001, HUM IMMUNOL, V62, P1363, DOI 10.1016/S0198-8859(01)00351-2; Crawley AM, 2010, J IMMUNOL, V184, P4679, DOI 10.4049/jimmunol.0903758; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DEGLIESPOSTI MA, 1992, EUR J IMMUNOGENET, V19, P121, DOI 10.1111/j.1744-313X.1992.tb00051.x; Dooms H, 2013, J AUTOIMMUN, V45, P40, DOI 10.1016/j.jaut.2013.06.007; Evsyukova I, 2013, RNA, V19, P103, DOI 10.1261/rna.035410.112; Fleckner J, 1997, GENE DEV, V11, P1864, DOI 10.1101/gad.11.14.1864; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Honig A, 2002, MOL CELL BIOL, V22, P5698, DOI 10.1128/MCB.22.16.5698-5707.2002; Huang W, 2015, NATURE, V528, P517, DOI 10.1038/nature16193; Irimia M, 2014, CELL, V159, P1511, DOI 10.1016/j.cell.2014.11.035; Kaiser C, 2008, RNA, V14, P2170, DOI 10.1261/rna.1171808; Kilding R, 2004, ARTHRITIS RHEUM-US, V50, P763, DOI 10.1002/art.20043; Lauwerys BR, 2014, LUPUS SCI MED, V1, DOI 10.1136/lupus-2014-000036; Lawson BR, 2015, CLIN IMMUNOL, V161, P260, DOI 10.1016/j.clim.2015.08.007; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; Maraskovsky E, 1996, J IMMUNOL, V157, P5315; Masuda S, 2005, GENE DEV, V19, P1512, DOI 10.1101/gad.1302205; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Monti P, 2013, DIABETES, V62, P2500, DOI 10.2337/db12-1726; Moutsianas L, 2015, NAT GENET, V47, P1107, DOI 10.1038/ng.3395; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; Nakamura M, 2012, AM J HUM GENET, V91, P721, DOI 10.1016/j.ajhg.2012.08.010; Okamoto K, 2003, AM J HUM GENET, V72, P303, DOI 10.1086/346067; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; Patsopoulos NA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003926; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Perdigones N, 2010, ARTHRITIS RHEUM-US, V62, P705, DOI 10.1002/art.27292; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Price P, 2004, HUM MOL GENET, V13, P967, DOI 10.1093/hmg/ddh113; Puel A, 1998, NAT GENET, V20, P394, DOI 10.1038/3877; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinones-Lombrana A, 2008, J RHEUMATOL, V35, P741; Raychaudhuri S, 2012, NAT GENET, V44, P291, DOI 10.1038/ng.1076; Roifman CM, 2000, BLOOD, V96, P2803; Shahbazi M, 2011, CLIN IMMUNOL, V139, P277, DOI 10.1016/j.clim.2011.02.012; Shen HH, 2008, GENE DEV, V22, P1796, DOI 10.1101/gad.1657308; Shen JP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702304200; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Teigelkamp S, 1997, RNA, V3, P1313; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Wong AML, 2003, GENES CELLS, V8, P403, DOI 10.1046/j.1365-2443.2002.00641.x; Wu LF, 2013, NATURE, V499, P79, DOI 10.1038/nature12223; Yuan Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep07960; Zhou XJ, 2012, ARTHRITIS RHEUM-US, V64, P222, DOI 10.1002/art.33318	63	54	55	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					72	+		10.1016/j.cell.2017.03.007	http://dx.doi.org/10.1016/j.cell.2017.03.007			26	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340352	Green Accepted, Bronze			2022-12-28	WOS:000397090000009
J	Hunter, ECM; Charlton, J; David, AS				Hunter, Elaine C. M.; Charlton, Jane; David, Anthony S.			PRACTICE POINTER Depersonalisation and derealisation: assessment and management	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISORDER		[Hunter, Elaine C. M.] Maudsley Hosp & Inst Psychiat, Depersonalisat Disorder Serv, London, England; [Charlton, Jane] Rethink Mental Illness, London, England; [David, Anthony S.] Inst Psychiat Psychol & Neurosci, London, England	South London & Maudsley NHS Trust; University of London; King's College London	Hunter, ECM (corresponding author), Maudsley Hosp & Inst Psychiat, Depersonalisat Disorder Serv, London, England.	Elaine.hunter@slam.nhs.uk	David, Anthony S/C-1315-2011; David, Anthony/O-1750-2019	David, Anthony S/0000-0003-0967-774X; David, Anthony/0000-0003-0967-774X; Hunter, Elaine/0000-0002-6479-2954	MRC [MR/J004162/1] Funding Source: UKRI; Medical Research Council [MR/J004162/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aderibigbe YA, 2001, SOC PSYCHIAT EPIDEMI, V356, P63, DOI 10.1007/s001270050291; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Anand A, 2000, ARCH GEN PSYCHIAT, V57, P270, DOI 10.1001/archpsyc.57.3.270; Baker D, 2003, BRIT J PSYCHIAT, V182, P428, DOI 10.1192/bjp.182.5.428; Foote B, 2006, AM J PSYCHIAT, V163, P623, DOI 10.1176/appi.ajp.163.4.623; Guralnik O, 2007, J NERV MENT DIS, V195, P983, DOI 10.1097/NMD.0b013e31815c19cd; Hunter ECM, 2004, SOC PSYCH PSYCH EPID, V39, P9, DOI 10.1007/s00127-004-0701-4; Hunter ECM, 2005, BEHAV RES THER, V43, P1121, DOI 10.1016/j.brat.2004.08.003; Hunter ECM, 2003, BEHAV RES THER, V41, P1451, DOI 10.1016/S0005-7967(03)00066-4; Jay EL, 2016, PSYCHIAT RES, V240, P118, DOI 10.1016/j.psychres.2016.04.027; Lambert MV, 2002, J NEUROPSYCHIATRY CL, V356, P141, DOI 10.1176/jnp.14.2.141; Mantovani A, 2011, PSYCHIAT RES, V186, P138, DOI 10.1016/j.psychres.2010.08.022; Michal M, 2013, PLOS ONE, V356, DOI 10.1371/journal.pone.0074331; Michal M, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0908-4; Nuller YL, 2001, J PSYCHOPHARMACOL, V15, P93, DOI 10.1177/026988110101500205; Schoenberg PLA, 2012, J TRAUMA DISSOCIATIO, V13, P311, DOI 10.1080/15299732.2011.606742; SHORVON HJ, 1946, P ROY SOC MED, V39, P779, DOI 10.1177/003591574603901206; Sierra M, 1998, BIOL PSYCHIAT, V44, P898, DOI 10.1016/S0006-3223(98)00015-8; Sierra M, 2003, J PSYCHOPHARMACOL, V17, P103, DOI 10.1177/0269881103017001712; Sierra M, 2000, PSYCHIAT RES, V93, P153, DOI 10.1016/S0165-1781(00)00100-1; Sierra M, 2006, CLIN NEUROPHARMACOL, V29, P253, DOI 10.1097/01.WNF.0000228368.17970.DA; Simeon D, 2005, J CLIN PSYCHOPHARM, V25, P267, DOI 10.1097/01.jcp.0000162803.61700.4f; Simeon D, 2004, BRIT J PSYCHIAT, V185, P31, DOI 10.1192/bjp.185.1.31; Simeon D, 2003, J CLIN PSYCHIAT, V64, P990, DOI 10.4088/JCP.v64n0903; Somer Eli, 2013, BMC Psychol, V1, P20, DOI 10.1186/2050-7283-1-20	25	11	11	2	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2017	356								j745	10.1136/bmj.j745	http://dx.doi.org/10.1136/bmj.j745			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP4IZ	28336554				2022-12-28	WOS:000397345500012
J	Nishimura, Y; Gautam, R; Chun, TW; Sadjadpour, R; Foulds, KE; Shingai, M; Klein, F; Gazumyan, A; Golijanin, J; Donaldson, M; Donau, OK; Plishka, RJ; Buckler-White, A; Seaman, MS; Lifson, JD; Koup, RA; Fauci, AS; Nussenzweig, MC; Martin, MA				Nishimura, Yoshiaki; Gautam, Rajeev; Chun, Tae-Wook; Sadjadpour, Reza; Foulds, Kathryn E.; Shingai, Masashi; Klein, Florian; Gazumyan, Anna; Golijanin, Jovana; Donaldson, Mitzi; Donau, Olivia K.; Plishka, Ronald J.; Buckler-White, Alicia; Seaman, Michael S.; Lifson, Jeffrey D.; Koup, Richard A. .; Fauci, Anthony S.; Nussenzweig, Michel C. .; Martin, Malcolm A.			Early antibody therapy can induce long-lasting immunity to SHIV	NATURE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; PRIMARY HIV-1 INFECTION; CD4(+) T-CELLS; MONOCLONAL-ANTIBODIES; HUMANIZED MICE; RHESUS-MONKEYS; IN-VIVO; MACAQUES	Highly potent and broadly neutralizing anti-HIV-1 antibodies (bNAbs) have been used to prevent and treat lentivirus infections in humanized mice, macaques, and humans(1-12). In immunotherapy experiments, administration of bNAbs to chronically infected animals transiently suppresses virus replication, which invariably returns to pre-treatment levels and results in progression to clinical disease. Here we show that early administration of bNAbs in a macaque simian/human immunodeficiency virus (SHIV) model is associated with very low levels of persistent viraemia, which leads to the establishment of T-cell immunity and resultant longterm infection control. Animals challenged with SHIVAD8-EO by mucosal or intravenous routes received a single 2-week course of two potent passively transferred bNAbs (3BNC117 and 10-1074 (refs 13, 14)). Viraemia remained undetectable for 56-177 days, depending on bNAb half-life in vivo. Moreover, in the 13 treated monkeys, plasma virus loads subsequently declined to undetectable levels in 6 controller macaques. Four additional animals maintained their counts of T cells carrying the CD4 antigen (CD4+) and very low levels of viraemia persisted for over 2 years. The frequency of cells carrying replication-competent virus was less than 1 per 106 circulating CD4(+) T cells in the six controller macaques. Infusion of a T-cell-depleting anti-CD8 beta monoclonal antibody to the controller animals led to a specific decline in levels of CD8(+) T cells and the rapid reappearance of plasma viraemia. In contrast, macaques treated for 15 weeks with combination anti-retroviral therapy, beginning on day 3 after infection, experienced sustained rebound plasma viraemia when treatment was interrupted. Our results show that passive immunotherapy during acute SHIV infection differs from combination anti-retroviral therapy in that it facilitates the emergence of potent CD8(+) T-cell immunity able to durably suppress virus replication.	[Nishimura, Yoshiaki; Gautam, Rajeev; Sadjadpour, Reza; Shingai, Masashi; Donau, Olivia K.; Plishka, Ronald J.; Buckler-White, Alicia; Martin, Malcolm A.] Natl Inst Allergy & Infect Dis, Lab Mol Microbiol, Natl Inst Hlth, Bethesda, MD 20892 USA; [Chun, Tae-Wook; Fauci, Anthony S.] Natl Inst Allergy & Infect Dis, Lab Immunoregulat, Natl Inst Hlth, Bethesda, MD 20892 USA; [Foulds, Kathryn E.; Donaldson, Mitzi; Koup, Richard A. .] Natl Inst Allergy & Infect Dis, Vaccine Res Ctr, Natl Inst Hlth, Bethesda, MD 20892 USA; [Klein, Florian] Univ Cologne, Inst Virol, D-50931 Cologne, Germany; [Klein, Florian] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Gazumyan, Anna; Golijanin, Jovana; Nussenzweig, Michel C. .] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Seaman, Michael S.] Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Lifson, Jeffrey D.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Frederick, MD 21702 USA; [Nussenzweig, Michel C. .] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cologne; University of Cologne; Rockefeller University; Harvard University; Beth Israel Deaconess Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Rockefeller University	Martin, MA (corresponding author), Natl Inst Allergy & Infect Dis, Lab Mol Microbiol, Natl Inst Hlth, Bethesda, MD 20892 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	nussen@rockefeller.edu; malm@nih.gov	Chun, Tae-Wook/AAC-3101-2020; Chun, Tae-Wook/W-9187-2019; Nussenzweig, Michel/AAE-7292-2019	Chun, Tae-Wook/0000-0001-5153-7340; 	National Institutes of Health (NIH) Nonhuman Primate Reagent Resource [HHSN272200900037C, OD10976]; Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIH); Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIH); National Cancer Institute (NIH) [HHSN261200800001E]; Collaboration for AIDS Vaccine Discovery grant [OPP1033115]; NIH Clinical and Translational Science Award (CTSA) program; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) [1UM1 AI100663-01]; Bill and Melinda Gates Foundation [OPP1092074, OPP1124068]; NIH HIVRAD [P01 AI100148]; Robertson Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000851, UM1AI100663, ZIAAI005014, ZIAAI001213, P01AI100148] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD010976] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Nonhuman Primate Reagent Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIH); National Cancer Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Collaboration for AIDS Vaccine Discovery grant; NIH Clinical and Translational Science Award (CTSA) program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH HIVRAD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robertson Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. Peach and T. Lewis for determining plasma viral RNA loads, and K. Rice, R. Engel, R. Petros, and S. Fong for assisting in the maintenance of animals and performing procedures. We thank R. Fast for technical assistance with ultrasensitive viral load assays, and J. Brenchley for performing FACS analyses. We are indebted to Gilead Sciences for providing tenofovir and emtricitabine. The anti-CD8 mAbs, MT807R1 and CD8b255R1, were obtained from the National Institutes of Health (NIH) Nonhuman Primate Reagent Resource supported by HHSN272200900037C and OD10976. We thank the NIH AIDS Research and Reference Reagent Program for TZM-bl cells. This work was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases (NIH), Vaccine Research Center of the National Institute of Allergy and Infectious Diseases (NIH), and, in part, with federal funds from the National Cancer Institute (NIH) under contract number HHSN261200800001E (J.D.L.). The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. The research was also funded in part by the following grants: Collaboration for AIDS Vaccine Discovery grant OPP1033115 (M.C.N.); NIH Clinical and Translational Science Award (CTSA) program; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M.C.N.); Bill and Melinda Gates Foundation grants OPP1092074 and OPP1124068 (M.C.N.); NIH HIVRAD P01 AI100148 (M.C.N.); the Robertson Foundation to M.C.N. M.C.N. is a Howard Hughes Medical Institute Investigator.	Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Bolton DL, 2016, J VIROL, V90, P1321, DOI 10.1128/JVI.02454-15; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buzon MJ, 2014, J VIROL, V88, P10056, DOI 10.1128/JVI.01046-14; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chun TW, 1999, NAT MED, V5, P651, DOI 10.1038/9498; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Endo Y, 2000, J VIROL, V74, P6935, DOI 10.1128/JVI.74.15.6935-6945.2000; Foulds KE, 2012, CYTOM PART A, V81A, P360, DOI 10.1002/cyto.a.22008; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Gautam R, 2012, J VIROL, V86, P8516, DOI 10.1128/JVI.00644-12; Halper-Stromberg A, 2014, CELL, V158, P989, DOI 10.1016/j.cell.2014.07.043; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Igarashi T, 1999, NAT MED, V5, P211, DOI 10.1038/5576; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; MYERS LE, 1994, J CLIN MICROBIOL, V32, P732, DOI 10.1128/JCM.32.3.732-739.1994; Nishimura Y, 2010, J VIROL, V84, P4769, DOI 10.1128/JVI.02279-09; Saez-Cirion A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003211; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Shingai M, 2012, P NATL ACAD SCI USA, V109, P19769, DOI 10.1073/pnas.1217443109	36	179	182	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					559	+		10.1038/nature21435	http://dx.doi.org/10.1038/nature21435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28289286	Green Accepted			2022-12-28	WOS:000397018000053
J	Ramdas, K; Darzi, A				Ramdas, Kamalini; Darzi, Ara			Adopting Innovations in Care Delivery - The Case of Shared Medical Appointments	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ramdas, Kamalini] London Business Sch, London, England; [Darzi, Ara] Imperial Coll London, St Marys Hosp, Dept Surg, London, England	University of London; London Business School; Imperial College London	Ramdas, K (corresponding author), London Business Sch, London, England.		ramdas, kamalini/M-9798-2014					ANGRIST JD, 1991, Q J ECON, V106, P979, DOI 10.2307/2937954; Miller AR, 2011, J POLIT ECON, V119, P289, DOI 10.1086/660083; Oddone E, 2012, SHARED MED APPOINTME; Ramdas K, 2012, HARVARD BUS REV, V90, P98	4	26	27	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1105	1107		10.1056/NEJMp1612803	http://dx.doi.org/10.1056/NEJMp1612803			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28328325	Green Published, Green Accepted			2022-12-28	WOS:000397014300005
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2017: Clinical leadership	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1360	10.1136/bmj.j1360	http://dx.doi.org/10.1136/bmj.j1360			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330834				2022-12-28	WOS:000397345200003
J	Friedrich, MJ				Friedrich, M. J.			Cervicovaginal Bacteria May Influence HIV Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1109	1109		10.1001/jama.2017.2349	http://dx.doi.org/10.1001/jama.2017.2349			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324101				2022-12-28	WOS:000396987200006
J	Pennisi, E				Pennisi, Elizabeth			EVOLUTION How plants learned to breathe Even early plants likely had sophisticated pores to regulate water and swap gases with their environment	SCIENCE			English	News Item																			0	1	1	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1110	1111		10.1126/science.355.6330.1110	http://dx.doi.org/10.1126/science.355.6330.1110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302803				2022-12-28	WOS:000396351200013
J	Raissig, MT; Matos, JL; Gil, MXA; Kornfeld, A; Bettadapur, A; Abrash, E; Allison, HR; Badgley, G; Vogel, JP; Berry, JA; Bergmann, DC				Raissig, Michael T.; Matos, Juliana L.; Gil, M. Ximena Anleu; Kornfeld, Ari; Bettadapur, Akhila; Abrash, Emily; Allison, Hannah R.; Badgley, Grayson; Vogel, John P.; Berry, Joseph A.; Bergmann, Dominique C.			Mobile MUTE specifies subsidiary cells to build physiologically improved grass stomata	SCIENCE			English	Article							DIFFERENTIATION; ARABIDOPSIS; DIVISION; PROTEIN; TRAFFICKING; ESTABLISH; EVOLUTION; MOVEMENT; MAIZE	Plants optimize carbon assimilation while limiting water loss by adjusting stomatal aperture. In grasses, a developmental innovation-the addition of subsidiary cells (SCs) flanking two dumbbell-shaped guard cells (GCs)-is linked to improved stomatal physiology. Here, we identify a transcription factor necessary and sufficient for SC formation in the wheat relative Brachypodium distachyon. Unexpectedly, the transcription factor is an ortholog of the stomatal regulator AtMUTE, which defines GC precursor fate in Arabidopsis. The novel role of BdMUTE in specifying lateral SCs appears linked to its acquisition of cell-to-cell mobility in Brachypodium. Physiological analyses on SC-less plants experimentally support classic hypotheses that SCs permit greater stomatal responsiveness and larger range of pore apertures. Manipulation of SC formation and function in crops, therefore, may be an effective approach to enhance plant performance.	[Raissig, Michael T.; Matos, Juliana L.; Abrash, Emily; Allison, Hannah R.; Bergmann, Dominique C.] Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA; [Gil, M. Ximena Anleu; Bettadapur, Akhila; Bergmann, Dominique C.] Stanford Univ, HHMI, 371 Serra Mall, Stanford, CA 94305 USA; [Kornfeld, Ari; Badgley, Grayson; Berry, Joseph A.] Carnegie Inst Sci, Dept Global Ecol, 260 Panama St, Stanford, CA 94305 USA; [Vogel, John P.] US Dept Energy Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Carnegie Institution for Science; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Raissig, MT; Bergmann, DC (corresponding author), Stanford Univ, Dept Biol, 371 Serra Mall, Stanford, CA 94305 USA.; Bergmann, DC (corresponding author), Stanford Univ, HHMI, 371 Serra Mall, Stanford, CA 94305 USA.	raissig@stanford.edu; dbergmann@stanford.edu	Berry, Joseph/ABA-8496-2020; Badgley, Grayson/J-8910-2018; Raissig, Michael T/AGF-0291-2022; Raissig, Michael T/AAO-9557-2020	Berry, Joseph/0000-0002-5849-6438; Anleu Gil, Maria Ximena/0000-0002-9871-4954; Raissig, Michael/0000-0003-3179-9372; Kornfeld, Ari/0000-0003-1646-307X; Badgley, Grayson/0000-0003-1011-4573; Vogel, John/0000-0003-1786-2689; Bergmann, Dominique/0000-0003-0873-3543	Swiss National Science Foundation [P2ZHP3_151598]; Gordon and Betty Moore Foundation [GMBF2550.05]; Office of Science of the DOE [DE-AC02-05CH1123]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Office of Science of the DOE(United States Department of Energy (DOE))	This work is supported by Swiss National Science Foundation (P2ZHP3_151598 to M.T.R.) and through a grant from The Gordon and Betty Moore Foundation (GMBF2550.05) to the Life Science Research Foundation (to M.T.R.). The work conducted by the U.S. Department of Energy (DOE) Joint Genome Institute is supported no the Office of Science of the DOE under contract no. DE-AC02-05CH1123. E.A. was a NSF graduate research fellow and D.C.D. is a GBMF Investigator of the HHMI. Supplement contains additional data.	Cartwright HN, 2009, SCIENCE, V323, P649, DOI 10.1126/science.1161686; Chen ZH, 2017, TRENDS PLANT SCI, V22, P124, DOI 10.1016/j.tplants.2016.09.005; Facette MR, 2015, NAT PLANTS, V1, DOI [10.1038/nplants.2014.24, 10.1038/NPLANTS.2014.24]; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Franks PJ, 2007, PLANT PHYSIOL, V143, P78, DOI 10.1104/pp.106.089367; Gallagher KL, 2014, ANNU REV CELL DEV BI, V30, P207, DOI 10.1146/annurev-cellbio-100913-012915; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; JONES RJ, 1970, J EXP BOT, V21, P714, DOI 10.1093/jxb/21.3.714; Kanaoka MM, 2008, PLANT CELL, V20, P1775, DOI 10.1105/tpc.108.060848; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Liu T, 2009, DEVELOPMENT, V136, P2265, DOI 10.1242/dev.032938; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Raissig MT, 2016, P NATL ACAD SCI USA, V113, P8326, DOI 10.1073/pnas.1606728113; Rudall PJ, 2013, NEW PHYTOL, V200, P598, DOI 10.1111/nph.12406; SQUIRE GR, 1974, NEW PHYTOL, V73, P433, DOI 10.1111/j.1469-8137.1974.tb02120.x; STEBBINS GL, 1960, DEV BIOL, V2, P477, DOI 10.1016/0012-1606(60)90050-6; Vaten A, 2011, DEV CELL, V21, P1144, DOI 10.1016/j.devcel.2011.10.006; Wu S, 2014, P NATL ACAD SCI USA, V111, P16184, DOI 10.1073/pnas.1407371111	21	103	104	3	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1215	1218		10.1126/science.aal3254	http://dx.doi.org/10.1126/science.aal3254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302860				2022-12-28	WOS:000396351200046
J	Scheben, A; Edwards, D				Scheben, Armin; Edwards, David			PLANT BREEDING Genome editors take on crops Genome editing technologies may help to enhance global food security	SCIENCE			English	Editorial Material									[Scheben, Armin] Univ Western Australia, Sch Biol Sci, Perth, WA, Australia; Univ Western Australia, Inst Agr, Perth, WA, Australia	University of Western Australia; University of Western Australia	Scheben, A (corresponding author), Univ Western Australia, Sch Biol Sci, Perth, WA, Australia.	armin.scheben@research.uwa.edu.au; dave.edwards@uwa.edu.au	Scheben, Armin/AAS-2136-2020; Edwards, David/H-3710-2015	Scheben, Armin/0000-0002-2230-2013; Edwards, David/0000-0001-7599-6760	International Postgraduate Research Scholarship - Australian government; Australian Research Council [LP130100925]	International Postgraduate Research Scholarship - Australian government(Australian Government); Australian Research Council(Australian Research Council)	A.S. was supported by an International Postgraduate Research Scholarship awarded by the Australian government and Australian Research Council project LP130100925.	Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Evenson RE, 2003, SCIENCE, V300, P758, DOI 10.1126/science.1078710; IPCC, 2013, CLIMATE CHANGE 2022; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Porter JR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P485; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Shi JR, 2017, PLANT BIOTECHNOL J, V15, P207, DOI 10.1111/pbi.12603; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; United Nations, 2015, WORLD POP PROSP 2015; Wang YP, 2014, NAT BIOTECHNOL, V32, P947, DOI 10.1038/nbt.2969	15	46	50	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1122	1123		10.1126/science.aal4680	http://dx.doi.org/10.1126/science.aal4680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302807				2022-12-28	WOS:000396351200017
J	Stokstad, E				Stokstad, Erik			SCIENTIFIC COMMUNITY UK scientists gird for future break with EU Government largesse may ease Brexit-at least for applied science	SCIENCE			English	News Item																			0	1	1	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1107	1108		10.1126/science.355.6330.1107	http://dx.doi.org/10.1126/science.355.6330.1107			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302800				2022-12-28	WOS:000396351200010
J	[Anonymous]				[Anonymous]			Commentary: "I've lost count of the times my door has been broken by the police"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2017	356								j1165	10.1136/bmj.j1165	http://dx.doi.org/10.1136/bmj.j1165			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NL	28298328				2022-12-28	WOS:000397015300003
J	Hoofnagle, JH; Sherker, AH				Hoofnagle, Jay H.; Sherker, Averell H.			Hepatitis C: Down but Not Out	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							6 INFECTION; GENOTYPE 1; VIRUS; SOFOSBUVIR		[Hoofnagle, Jay H.; Sherker, Averell H.] NIDDK, NIH, Bethesda, MD 20892 USA; [Hoofnagle, Jay H.; Sherker, Averell H.] NIDDK, Liver Dis Res Branch, Div Digest Dis & Nutr, Room 6005,6707 Democracy Blvd,MSC 5450, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hoofnagle, JH (corresponding author), NIDDK, Liver Dis Res Branch, Div Digest Dis & Nutr, Room 6005,6707 Democracy Blvd,MSC 5450, Bethesda, MD 20892 USA.		Sherker, Averell H/A-2889-2013	Sherker, Averell H/0000-0003-0409-6938				[Anonymous], 2016, MED LETT DRUGS THER, V58, P107; Collins JM, 2015, CLIN INFECT DIS, V61, P1304, DOI 10.1093/cid/civ474; Dyson JK, 2016, J HEPATOL, V64, P234, DOI 10.1016/j.jhep.2015.07.041; Falade-Nwulia O, 2017, ANN INTERN MED, V166, P637, DOI [10.7326/M16-2575, 10.7326/m16-2575]; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Innes H, 2017, J HEPATOL, V66, P19, DOI 10.1016/j.jhep.2016.08.004; Nault JC, 2016, J HEPATOL, V65, P663, DOI 10.1016/j.jhep.2016.07.004; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; United States Food and Drug Administration, 2016, FDA DRUG SAF COMM FD; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785	10	3	3	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					675	+		10.7326/M17-0567	http://dx.doi.org/10.7326/M17-0567			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28319998				2022-12-28	WOS:000400395500017
J	Belfort, MA; Clark, SL				Belfort, Michael A.; Clark, Steven L.			Computerised cardiotocography-study design hampers findings	LANCET			English	Editorial Material							AIDED-DIAGNOSIS; PERFORMANCE		[Belfort, Michael A.; Clark, Steven L.] Baylor Coll Med, Dept Obstet & Gynecol, Texas Med Ctr, 6651 Main St,Texas Childrens Pavil Women, Houston, TX 77030 USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Belfort, MA (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Texas Med Ctr, 6651 Main St,Texas Childrens Pavil Women, Houston, TX 77030 USA.	belfort@bcm.edu						Meinel LA, 2007, J MAGN RESON IMAGING, V25, P89, DOI 10.1002/jmri.20794; Clark SL, 2016, AM J OBSTET GYNECOL, DOI [10.1016/j.ajog.2016.10.009, DOI 10.1016/J.AJOG.2016.10.009]; Clark SL, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.019; Clark SL, 2013, AM J OBSTET GYNECOL, V209, P89, DOI 10.1016/j.ajog.2013.04.030; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Hambrock T, 2013, RADIOLOGY, V266, P521, DOI 10.1148/radiol.12111634; HAVERKAMP AD, 1979, AM J OBSTET GYNECOL, V134, P399, DOI 10.1016/S0002-9378(16)33082-4; Kshivets O, 2016, J THORAC ONCOL, V11, pS293, DOI 10.1016/j.jtho.2016.09.075; The INFANT collaborative group, 2017, LANCET; Vemulapalli V, 2016, ARTIF INTELL MED, V74, P1, DOI 10.1016/j.artmed.2016.11.001	10	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2017	389	10080					1674	1676		10.1016/S0140-6736(17)30762-6	http://dx.doi.org/10.1016/S0140-6736(17)30762-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET3BG	28341516	hybrid			2022-12-28	WOS:000400151000006
J	Flume, PA; VanDevanter, DR				Flume, Patrick A.; VanDevanter, Donald R.			The Cystic Fibrosis Survival Gap: Why Do Canadians Fare Better Than Americans?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LUNG TRANSPLANTATION; UNITED-STATES; OUTCOMES; HEALTH; CARE; ERA		[Flume, Patrick A.] Med Univ South Carolina, 96 Jonathan Lucas St,Room 816 CSB MSC 630, Charleston, SC 29425 USA; [VanDevanter, Donald R.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [VanDevanter, Donald R.] Case Western Reserve Univ, Sch Med, 12520 33rd St Court East, Edgewood, WA 98372 USA	Medical University of South Carolina; Case Western Reserve University; Case Western Reserve University	Flume, PA (corresponding author), Med Univ South Carolina, 96 Jonathan Lucas St,Room 816 CSB MSC 630, Charleston, SC 29425 USA.	flumepa@musc.edu						COREY M, 1988, J CLIN EPIDEMIOL, V41, P583, DOI 10.1016/0895-4356(88)90063-7; Goss CH, 2015, THORAX, V70, P229, DOI 10.1136/thoraxjnl-2014-205718; MacKenzie T, 2014, ANN INTERN MED, V161, P233, DOI 10.7326/M13-0636; Merlo CA, 2015, AM J TRANSPLANT, V15, P1948, DOI 10.1111/ajt.13226; Schechter MS, 2012, CURR OPIN PULM MED, V18, P596, DOI 10.1097/MCP.0b013e328358d533; Schechter MS, 2001, AM J RESP CRIT CARE, V163, P1331, DOI 10.1164/ajrccm.163.6.9912100; Siddiqi A, 2013, INT J HEALTH SERV, V43, P193, DOI 10.2190/HS.43.2.b; Stephenson AL, 2017, ANN INTERN MED, V166, P537, DOI 10.7326/M16-0858; Stephenson AL, 2015, J HEART LUNG TRANSPL, V34, P1139, DOI 10.1016/j.healun.2015.05.003; Vock DM, 2017, ANN AM THORAC SOC, V14, P172, DOI 10.1513/AnnalsATS.201606-507OC	10	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					599	+		10.7326/M17-0564	http://dx.doi.org/10.7326/M17-0564			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28289748				2022-12-28	WOS:000399304000023
J	[Anonymous]				[Anonymous]			Waiting to Clamp Cords Reduces Anemia in High-Risk Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1206	1206		10.1001/jama.2017.2007	http://dx.doi.org/10.1001/jama.2017.2007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350924				2022-12-28	WOS:000397557800007
J	Gaffney, A; Berger, ZD; Jha, S				Gaffney, Adam; Berger, Zackary D.; Jha, Saurabh			Should US doctors mourn for Obamacare?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY; CARE		[Gaffney, Adam] Harvard Med Sch, Boston, MA USA; [Gaffney, Adam] Cambridge Hlth Alliance, Cambridge, MA USA; [Berger, Zackary D.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA; [Berger, Zackary D.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Jha, Saurabh] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA	Harvard University; Harvard Medical School; Harvard University; Cambridge Health Alliance; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine	Berger, ZD (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.; Berger, ZD (corresponding author), Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA.; Jha, S (corresponding author), Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA.	Zberger1@jhmi.edu; Saurabh.Jha@uphs.upenn.edu	Berger, Zackary/AAW-5761-2020; Berger, Zackary/I-7032-2013	Gaffney, Adam/0000-0001-7326-0661; Berger, Zackary/0000-0002-5871-0342				Collins Sara R, 2015, Issue Brief (Commonw Fund), V13, P1; Congressional Budget Office, 2016, FED SUBS HLTH INS CO; Dickman S, 2014, HLTH AFFAIRS BLOG; Gaffney A, 2016, AM J PUBLIC HEALTH, V106, P987, DOI 10.2105/AJPH.2015.303157; Sommers BD, 2012, NEW ENGL J MED, V367, P1025, DOI 10.1056/NEJMsa1202099; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2017	356								j1441	10.1136/bmj.j1441	http://dx.doi.org/10.1136/bmj.j1441			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP4JA	28341784				2022-12-28	WOS:000397345600001
J	Wu, KT; Hishamunda, JB; Chen, DTN; DeCamp, SJ; Chang, YW; Fernandez-Nieves, A; Fraden, S; Dogic, Z				Wu, Kun-Ta; Hishamunda, Jean Bernard; Chen, Daniel T. N.; DeCamp, Stephen J.; Chang, Ya-Wen; Fernandez-Nieves, Alberto; Fraden, Seth; Dogic, Zvonimir			ACTIVE MATTER Transition from turbulent to coherent flows in confined three-dimensional active fluids	SCIENCE			English	Article							SELF-ORGANIZATION; LIQUID-CRYSTALS; MOTORS; HYDRODYNAMICS; PURIFICATION; MICROTUBULES; CYTOSKELETON; SUSPENSIONS; BEHAVIOR; MOTION	Transport of fluid through a pipe is essential for the operation of macroscale machines and microfluidic devices. Conventional fluids only flow in response to external pressure. We demonstrate that an active isotropic fluid, composed of microtubules and molecular motors, autonomously flows through meter-long three-dimensional channels. We establish control over the magnitude, velocity profile, and direction of the self-organized flows and correlate these to the structure of the extensile microtubule bundles. The inherently three-dimensional transition from bulk-turbulent to confined-coherent flows occurs concomitantly with a transition in the bundle orientational order near the surface and is controlled by a scale-invariant criterion related to the channel profile. The nonequilibrium transition of confined isotropic active fluids can be used to engineer self-organized soft machines.	[Wu, Kun-Ta; Hishamunda, Jean Bernard; Chen, Daniel T. N.; DeCamp, Stephen J.; Fraden, Seth; Dogic, Zvonimir] Brandeis Univ, Dept Phys, 415 South St, Waltham, MA 02453 USA; [Chang, Ya-Wen; Fernandez-Nieves, Alberto] Georgia Inst Technol, Sch Phys, 837 State St, Atlanta, GA 30339 USA	Brandeis University; University System of Georgia; Georgia Institute of Technology	Fraden, S; Dogic, Z (corresponding author), Brandeis Univ, Dept Phys, 415 South St, Waltham, MA 02453 USA.	fraden@brandeis.edu; zdogic@brandeis.edu	Wu, Kun-Ta/W-8260-2018; Chang, Ya-Wen/P-3540-2016; Fraden, Seth/G-9520-2018; Fernandez-Nieves, Alberto/S-1955-2018	Wu, Kun-Ta/0000-0002-7705-693X; Chang, Ya-Wen/0000-0002-5626-7391; Fraden, Seth/0000-0002-2420-9939; Fernandez-Nieves, Alberto/0000-0002-1286-9809; Dogic, Zvonimir/0000-0003-0142-1838; DeCamp, Stephen/0000-0001-7002-7370				Aghvami SA, 2017, SENSOR ACTUAT B-CHEM, V247, P940, DOI 10.1016/j.snb.2017.03.023; Batchelor G.K., 2012, INTRO FLUID DYNAMICS, DOI [10.1017/CBO9780511800955, DOI 10.1017/CBO9780511800955]; Bricard A, 2013, NATURE, V503, P95, DOI 10.1038/nature12673; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Castoldi M, 2003, PROTEIN EXPRES PURIF, V32, P83, DOI 10.1016/S1046-5928(03)00218-3; Creppy A, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0575; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Di Leonardo R, 2010, P NATL ACAD SCI USA, V107, P9541, DOI 10.1073/pnas.0910426107; Doxzen K, 2013, INTEGR BIOL-UK, V5, P1026, DOI 10.1039/c3ib40054a; Fily Y, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.235702; Furthauer S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023001; Giomi L, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.198101; Henkin G, 2014, PHILOS T R SOC A, V372, DOI 10.1098/rsta.2014.0142; Hentrich C, 2010, J CELL BIOL, V189, P465, DOI 10.1083/jcb.200910125; Hilitski F, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.138102; HUANG TG, 1994, J BIOL CHEM, V269, P16493; HURD AJ, 1985, J PHYS-PARIS, V46, P905, DOI 10.1051/jphys:01985004606090500; Kirby B.J., 2010, MICRO NANOSCALE FLUI; Kumar A, 2014, SCI REP-UK, V4, DOI 10.1038/srep03781; Lopez HM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.028301; Lushi E, 2014, P NATL ACAD SCI USA, V111, P9733, DOI 10.1073/pnas.1405698111; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Marenduzzo D, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031921; Martin DS, 2010, P NATL ACAD SCI USA, V107, P5453, DOI 10.1073/pnas.0914924107; Naganathan SR, 2014, ELIFE, V3, DOI 10.7554/eLife.04165; Nedelec FJ, 1997, NATURE, V389, P305, DOI 10.1038/38532; Ouellette NT, 2006, EXP FLUIDS, V40, P301, DOI 10.1007/s00348-005-0068-7; Pairam E, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.021002; Pairam E, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.234501; Palacci J, 2013, SCIENCE, V339, P936, DOI 10.1126/science.1230020; PIERANSKI P, 1973, J PHYS-PARIS, V34, P35, DOI 10.1051/jphys:0197300340103500; Prost J, 2015, NAT PHYS, V11, P111, DOI [10.1038/nphys3224, 10.1038/NPHYS3224]; Ranft J, 2010, P NATL ACAD SCI USA, V107, P20863, DOI 10.1073/pnas.1011086107; Riedel IH, 2005, SCIENCE, V309, P300, DOI 10.1126/science.1110329; Saintillan D, 2013, CR PHYS, V14, P497, DOI 10.1016/j.crhy.2013.04.001; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Schaller V, 2010, NATURE, V467, P73, DOI 10.1038/nature09312; SCHROEDER TE, 1985, J CELL BIOL, V100, P1056, DOI 10.1083/jcb.100.4.1056; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; Simha RA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.058101; Sokolov A, 2010, P NATL ACAD SCI USA, V107, P969, DOI 10.1073/pnas.0913015107; Stenhammar J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501850; Surrey T, 2001, SCIENCE, V292, P1167, DOI 10.1126/science.1059758; Tee YH, 2015, NAT CELL BIOL, V17, P445, DOI 10.1038/ncb3137; Thampi SP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501854; Theurkauff I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.268303; Thielicke W., 2014, J OPEN RES STW, V2, P30, DOI [10.5334/JORS.BL, DOI 10.5334/JORS.BL]; Toner J, 2005, ANN PHYS-NEW YORK, V318, P170, DOI 10.1016/j.aop.2005.04.011; van der Beek D, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.087801; Voituriez R, 2005, EUROPHYS LETT, V70, P404, DOI 10.1209/epl/i2004-10501-2; WANKA G, 1994, MACROMOLECULES, V27, P4145, DOI 10.1021/ma00093a016; Wensink HH, 2012, P NATL ACAD SCI USA, V109, P14308, DOI 10.1073/pnas.1202032109; Wioland H, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/7/075002; Wioland H, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.268102; Woodhouse FG, 2013, P NATL ACAD SCI USA, V110, P14132, DOI 10.1073/pnas.1302736110; Woodhouse FG, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.168105; Xu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09081; Zhou S, 2014, P NATL ACAD SCI USA, V111, P1265, DOI 10.1073/pnas.1321926111	59	159	164	6	127	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331							eaal1979	10.1126/science.aal1979	http://dx.doi.org/10.1126/science.aal1979			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336609	Green Submitted			2022-12-28	WOS:000397082900031
J	Fuyuno, I				Fuyuno, Ichiko			WHAT PRICE WILL SCIENCE PAY FOR AUSTERITY?	NATURE			English	Editorial Material																			0	6	6	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					S10	S13		10.1038/543S10a	http://dx.doi.org/10.1038/543S10a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO9OM	28328909	Bronze			2022-12-28	WOS:000397018000004
J	Krimpenfort, P; Berns, A				Krimpenfort, Paul; Berns, Anton			Rejuvenation by Therapeutic Elimination of Senescent Cells	CELL			English	Editorial Material							SECRETION	In this issue of Cell, Baar et al. show how FOXO4 protects senescent cell viability by keeping p53 sequestered in nuclear bodies, preventing it from inducing apoptosis. Disrupting this interaction with an all-D amino acid peptide (FOXO4-DRI) restores p53' s apoptotic role and ameliorates the consequences of senescence-associated loss of tissue homeostasis.	[Krimpenfort, Paul; Berns, Anton] Netherlands Canc Inst, Div Mol Genet, Amsterdam, Netherlands	Netherlands Cancer Institute	Berns, A (corresponding author), Netherlands Canc Inst, Div Mol Genet, Amsterdam, Netherlands.	a.berns@nki.nl						Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; DiLoreto R, 2015, MOL BIOL CELL, V26, P4524, DOI 10.1091/mbc.E14-06-1084; GUICHARD G, 1994, P NATL ACAD SCI USA, V91, P9765, DOI 10.1073/pnas.91.21.9765; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340	9	7	9	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					3	5		10.1016/j.cell.2017.03.014	http://dx.doi.org/10.1016/j.cell.2017.03.014			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340347	Bronze			2022-12-28	WOS:000397090000002
J	Arie, S				Arie, Sophie			PUBLIC HEALTH Is the UK government still serious about reducing smoking?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sarie@bmj.com						All Party Parliamentary Group on Smoking and Health, 2015, REC SPEND REV; All Party Parliamentary Group on Smoking and Health, 2017, BURN INJ RED TOB DRI; Cancer Research UK, CUTT REAL BUDG CUTS; Department of Health, HLTH LIV HLTH PEOPL; Hanson M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j762; Hopkinson NS, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j342; NHS Digital, 2014, SMOK DRINK DRUG US Y; NHS Digital, 2015, HLTH SURV ENGL	8	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1426	10.1136/bmj.j1426	http://dx.doi.org/10.1136/bmj.j1426			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330906				2022-12-28	WOS:000397345200013
J	Jha, AK				Jha, Ashish K.			Value-Based Purchasing: Time for Reboot or Time to Move On?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Jha, Ashish K.] Harvard TH Chan Sch Publ Hlth, Int Hlth & Hlth Policy, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard TH Chan Sch Publ Hlth, Int Hlth & Hlth Policy, Boston, MA 02115 USA.	ajha@hsph.harvard.edu							0	11	11	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1107	1108		10.1001/jama.2017.1170	http://dx.doi.org/10.1001/jama.2017.1170			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324079				2022-12-28	WOS:000396987200003
J	Normile, D				Normile, Dennis			REGENERATIVE MEDICINE iPS cell therapy reported safe Researchers no longer envision replacement tissues tailor-made from each patient's cells	SCIENCE			English	News Item																			0	11	11	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1109	1110		10.1126/science.355.6330.1109	http://dx.doi.org/10.1126/science.355.6330.1109			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302802				2022-12-28	WOS:000396351200012
J	Salami, J; Crews, CM				Salami, Jemilat; Crews, Craig M.			Waste disposal-An attractive strategy for cancer therapy	SCIENCE			English	Review							RESISTANT PROSTATE-CANCER; BET BROMODOMAIN PROTEIN; MULTIPLE-MYELOMA CELLS; ANDROGEN RECEPTOR; BREAST-CANCER; SELECTIVE DEGRADATION; MEDIATED DEGRADATION; SMALL MOLECULES; TARGET; UBIQUITINATION	Targeted therapies for cancer are typically small molecules or monoclonal antibodies that act by inhibiting the activity of specific proteins that drive tumor growth. Although many of these drugs are effective in cancer patients, the response is often not durable because tumor cells develop resistance to the drugs. Another limitation of this strategy is that not all oncogenic driver proteins are "druggable" enzymes or receptors with activities that can be inhibited. Here we describe an alternative approach to targeted therapy that is based on co-opting the cellular quality-control machinery-the ubiquitin-proteasome system-to remove specific cancer-causing proteins from the cell. We first discuss examples of existing cancer drugs that work by degrading specific proteins and then review recent progress in the rational design and preclinical testing of small molecules that induce selective degradation of specific target proteins.	[Salami, Jemilat; Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Crews, CM (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Crews, CM (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.; Crews, CM (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA.	craig.crews@yale.edu	Crews, Craig M./ABH-9346-2020; 高, 雨莉/HGU-8187-2022	Crews, Craig M./0000-0002-8456-2005; 	Leukemia and Lymphoma Society; NIH [R35CA197589]; Arvinas; NATIONAL CANCER INSTITUTE [R35CA197589] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arvinas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	C.M.C. is the chief scientific adviser of and is a shareholder in Arvinas, a biotechnology company focused on developing protein degradation therapeutics for cancer and other diseases. C.M.C. is an inventor on patent US7041298 B2 and patent applications PCT/US2013/040551, PCT/US2013/021136, EP20150180508, and PCT/US2011/063401 (submitted by Yale University) and PCT/US2015/025813 (submitted by Arvinas), which cover targeted protein degradation. C.M.C. acknowledges support from the Leukemia and Lymphoma Society and the NIH (grant R35CA197589). C.M.C. also receives research funding from Arvinas.	Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Baratta MG, 2015, P NATL ACAD SCI USA, V112, P232, DOI 10.1073/pnas.1422165112; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Bill A, 2014, J BIOL CHEM, V289, P11029, DOI 10.1074/jbc.M114.549188; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; Buckley DL, 2012, ANGEW CHEM INT EDIT, V51, P11463, DOI 10.1002/anie.201206231; Chauhan D, 2012, CANCER CELL, V22, P345, DOI 10.1016/j.ccr.2012.08.007; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Citri A, 2002, EMBO J, V21, P2407, DOI 10.1093/emboj/21.10.2407; Cyrus K, 2010, CHEMBIOCHEM, V11, P1531, DOI 10.1002/cbic.201000222; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; Garner F, 2015, ANTI-CANCER DRUG, V26, P948, DOI 10.1097/CAD.0000000000000271; Gustafson JL, 2015, ANGEW CHEM INT EDIT, V54, P9659, DOI 10.1002/anie.201503720; Howell A, 2003, CANCER CHEMOTH PHARM, V52, pS39, DOI 10.1007/s00280-003-0645-5; Howell A, 2006, ENDOCR-RELAT CANCER, V13, P689, DOI 10.1677/erc.1.00846; Huang XD, 2016, CELL RES, V26, P484, DOI 10.1038/cr.2016.31; Itoh Y, 2010, J AM CHEM SOC, V132, P5820, DOI 10.1021/ja100691p; Johnson DS, 2010, FUTURE MED CHEM, V2, P949, DOI 10.4155/FMC.10.21; Korpal M, 2013, CANCER DISCOV, V3, P1030, DOI 10.1158/2159-8290.CD-13-0142; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lai AC, 2016, ANGEW CHEM INT EDIT, V55, P807, DOI 10.1002/anie.201507634; Lebraud H, 2016, ACS CENTRAL SCI, V2, P927, DOI 10.1021/acscentsci.6b00280; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lu J, 2015, CHEM BIOL, V22, P755, DOI 10.1016/j.chembiol.2015.05.009; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mi LX, 2009, J BIOL CHEM, V284, P17039, DOI 10.1074/jbc.M901789200; Neklesa TK, 2011, NAT CHEM BIOL, V7, P538, DOI [10.1038/nchembio.597, 10.1038/NCHEMBIO.597]; Okuhira K, 2013, CANCER SCI, V104, P1492, DOI 10.1111/cas.12272; Prinjha RK, 2012, TRENDS PHARMACOL SCI, V33, P146, DOI 10.1016/j.tips.2011.12.002; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Sakamoto KM, 2003, MOL CELL PROTEOMICS, V2, P1350, DOI 10.1074/mcp.T300009-MCP200; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schneekloth AR, 2008, BIOORG MED CHEM LETT, V18, P5904, DOI 10.1016/j.bmcl.2008.07.114; Sekine K, 2008, J BIOL CHEM, V283, P8961, DOI 10.1074/jbc.M709525200; Skaar JR, 2014, NAT REV DRUG DISCOV, V13, P889, DOI 10.1038/nrd4432; Teicher BA, 2015, BIOCHEM PHARMACOL, V96, P1, DOI 10.1016/j.bcp.2015.04.008; Tovar C, 2013, CANCER RES, V73, P2587, DOI 10.1158/0008-5472.CAN-12-2807; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Winter GE, 2015, SCIENCE, V348, P1376, DOI 10.1126/science.aab1433; Xie T, 2014, NAT CHEM BIOL, V10, P1006, DOI 10.1038/nchembio.1658; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216; Zhang TD, 2001, ONCOGENE, V20, P7146, DOI 10.1038/sj.onc.1204762; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203	49	144	169	9	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1163	1167		10.1126/science.aam7340	http://dx.doi.org/10.1126/science.aam7340			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302825				2022-12-28	WOS:000396351200034
J	Chung, DDL				Chung, D. D. L.			Mildred S. Dresselhaus (1930-2017) OBITUARY	NATURE			English	Biographical-Item									[Chung, D. D. L.] SUNY Buffalo, Mech & Aerosp Engn, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Chung, DDL (corresponding author), SUNY Buffalo, Mech & Aerosp Engn, Buffalo, NY 14260 USA.	ddlchung@buffalo.edu	Chung, D.D.L./H-3810-2019						0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					316	316		10.1038/543316a	http://dx.doi.org/10.1038/543316a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28300109	Bronze			2022-12-28	WOS:000396337400026
J	Tolle, SW; Teno, JM				Tolle, Susan W.; Teno, Joan M.			Lessons from Oregon in Embracing Complexity in End-of-Life Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUSTAINING TREATMENT; PHYSICIAN ORDERS; TRANSITIONS; RESIDENTS; SURVIVAL; DEATH		[Tolle, Susan W.] Oregon Hlth & Sci Univ, Div Gen Internal Med & Geriatr, Portland, OR 97201 USA; [Tolle, Susan W.] Oregon Hlth & Sci Univ, Ctr Eth Hlth Care, Portland, OR 97201 USA; [Teno, Joan M.] Univ Washington, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Teno, Joan M.] Univ Washington, Cambia Palliat Care Ctr Excellence, Seattle, WA 98195 USA	Oregon Health & Science University; Oregon Health & Science University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Tolle, SW (corresponding author), Oregon Hlth & Sci Univ, Div Gen Internal Med & Geriatr, Portland, OR 97201 USA.; Tolle, SW (corresponding author), Oregon Hlth & Sci Univ, Ctr Eth Hlth Care, Portland, OR 97201 USA.							Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Fromme EK, 2014, J AM GERIATR SOC, V62, P1246, DOI 10.1111/jgs.12889; Gozalo P, 2011, NEW ENGL J MED, V365, P1212, DOI 10.1056/NEJMsa1100347; Hickman SE, 2011, J AM GERIATR SOC, V59, P2091, DOI 10.1111/j.1532-5415.2011.03656.x; Institute of Medicine, 2015, DYING AM IMPR QUAL H; Lee MA, 1996, ANN INTERN MED, V124, P267, DOI 10.7326/0003-4819-124-2-199601150-00014; Mitchell SL, 2000, J GERONTOL A-BIOL, V55, pM735, DOI 10.1093/gerona/55.12.M735; Teno JM, 2014, JAMA-J AM MED ASSOC, V312, P1868, DOI 10.1001/jama.2014.14949; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Teno JM, 2012, J AM GERIATR SOC, V60, P1918, DOI 10.1111/j.1532-5415.2012.04148.x; Teno JM, 2012, ARCH INTERN MED, V172, P697, DOI 10.1001/archinternmed.2012.1200; The Dartmouth Atlas of Health Care, 2012, PERC DEC DEM REC FEE; Tolle S, 1994, SUNDAY OREGONIA 1113, pC1; Tolle S., 1994, SUNDAY OREGONIA 1113, pC4; Tolle SW, 2015, NEW ENGL J MED, V372, P667, DOI 10.1056/NEJMclde1411152; Zive DM, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0605-3	16	30	30	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1078	1082		10.1056/NEJMsb1612511	http://dx.doi.org/10.1056/NEJMsb1612511			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QT	28296604				2022-12-28	WOS:000396403700015
J	Sinsky, CA				Sinsky, Christine A.			Designing and Regulating Wisely: Removing Barriers to Joy in Practice	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BURNOUT; PHYSICIANS		[Sinsky, Christine A.] Amer Med Assoc, 330 North Wabash Ave,Suite 39300, Chicago, IL 60611 USA	American Medical Association	Sinsky, CA (corresponding author), Amer Med Assoc, 330 North Wabash Ave,Suite 39300, Chicago, IL 60611 USA.	christine.sinsky@ama-assn.org						Casalino LP, 2016, HEALTH AFFAIR, V35, P401, DOI 10.1377/hlthaff.2015.1258; Erickson SM, 2017, ANN INTERN MED, V166, P659, DOI 10.7326/M16-2697; Friedberg M.W., 2013, FACTORS AFFECTING PH; Halbesleben JRB, 2008, HEALTH CARE MANAGE R, V33, P29, DOI 10.1097/01.HMR.0000304493.87898.72; Kushnir T, 2014, FAM PRACT, V31, P44, DOI 10.1093/fampra/cmt060; Shanafelt TD, 2016, MAYO CLIN PROC, V91, P1667, DOI 10.1016/j.mayocp.2016.08.016; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Shanafelt TD, 2010, ANN SURG, V251, P995, DOI 10.1097/SLA.0b013e3181bfdab3; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961	9	13	13	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					677	678		10.7326/M17-0524	http://dx.doi.org/10.7326/M17-0524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28346949				2022-12-28	WOS:000400395500018
J	Stevens, TJ; Lando, D; Basu, S; Atkinson, LP; Cao, Y; Lee, SF; Leeb, M; Wohlfahrt, KJ; Boucher, W; O'Shaughnessy-Kirwan, A; Cramard, J; Faure, AJ; Ralser, M; Blanco, E; Morey, L; Sanso, M; Palayret, MGS; Lehner, B; Di Croce, L; Wutz, A; Hendrich, B; Klenerman, D; Laue, ED				Stevens, Tim J.; Lando, David; Basu, Srinjan; Atkinson, Liam P.; Cao, Yang; Lee, Steven F.; Leeb, Martin; Wohlfahrt, Kai J.; Boucher, Wayne; O'Shaughnessy-Kirwan, Aoife; Cramard, Julie; Faure, Andre J.; Ralser, Meryem; Blanco, Enrique; Morey, Lluis; Sanso, Miriam; Palayret, Matthieu G. S.; Lehner, Ben; Di Croce, Luciano; Wutz, Anton; Hendrich, Brian; Klenerman, Dave; Laue, Ernest D.			3D structures of individual mammalian genomes studied by single-cell Hi-C	NATURE			English	Article							CHROMOSOME CONFORMATION CAPTURE; NUCLEAR LAMINA INTERACTIONS; EMBRYONIC STEM-CELLS; SPATIAL-ORGANIZATION; PLURIPOTENCY FACTORS; LINEAGE COMMITMENT; CHROMATIN DOMAINS; GENE-EXPRESSION; TRANSCRIPTION; REVEALS	The folding of genomic DNA from the beads-on-a-string-like structure of nucleosomes into higher-order assemblies is crucially linked to nuclear processes. Here we calculate 3D structures of entire mammalian genomes using data from a new chromosome conformation capture procedure that allows us to first image and then process single cells. The technique enables genome folding to be examined at a scale of less than 100 kb, and chromosome structures to be validated. The structures of individual topological-associated domains and loops vary substantially from cell to cell. By contrast, A and B compartments, lamina-associated domains and active enhancers and promoters are organized in a consistent way on a genome-wide basis in every cell, suggesting that they could drive chromosome and genome folding. By studying genes regulated by pluripotency factor and nucleosome remodelling deacetylase (NuRD), we illustrate how the determination of single-cell genome structure provides a new approach for investigating biological processes.	[Stevens, Tim J.; Lando, David; Basu, Srinjan; Atkinson, Liam P.; Cao, Yang; Wohlfahrt, Kai J.; Boucher, Wayne; O'Shaughnessy-Kirwan, Aoife; Hendrich, Brian; Laue, Ernest D.] Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England; [Stevens, Tim J.] MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England; [Lee, Steven F.; Palayret, Matthieu G. S.; Klenerman, Dave] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Leeb, Martin; O'Shaughnessy-Kirwan, Aoife; Cramard, Julie; Ralser, Meryem; Wutz, Anton; Hendrich, Brian] Univ Cambridge, Wellcome Trust MRC Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England; [Faure, Andre J.; Blanco, Enrique; Morey, Lluis; Sanso, Miriam; Lehner, Ben; Di Croce, Luciano] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Unit, Barcelona 08003, Spain; [Lehner, Ben; Di Croce, Luciano] Univ Pompeu Fabra, Barcelona 08003, Spain; [Lehner, Ben; Di Croce, Luciano] ICREA, Barcelona 08010, Spain; [Leeb, Martin] Univ Vienna, Max F Perutz Labs, Vienna Bioctr, Dr Bohr Gasse 9-3, A-1030 Vienna, Austria; [Morey, Lluis] Univ Miami, Miller Sch Med, Dept Human Genet, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Wutz, Anton] Swiss Fed Inst Technol, Inst Mol Hlth Sci, HPL E 12,Otto Stern Weg 7, Zurich, Switzerland	University of Cambridge; MRC Laboratory Molecular Biology; University of Cambridge; University of Cambridge; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; ICREA; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Miami; Swiss Federal Institutes of Technology Domain; ETH Zurich	Laue, ED (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	e.d.laue@bioc.cam.ac.uk	Lando, David/AAH-3052-2019; Leeb, Martin/N-3861-2015; Lehner, Ben/L-3413-2014; Basu, Srinjan/M-7835-2016; Basu, Srinjan/AGQ-3666-2022; Di Croce, Luciano/E-7759-2015; Hendrich, Brian/AAG-5898-2020; Leeb, Martin/AAE-7498-2020; Blanco, Enrique/I-5902-2015	Lando, David/0000-0001-5783-8769; Leeb, Martin/0000-0001-5114-4782; Lehner, Ben/0000-0002-8817-1124; Basu, Srinjan/0000-0002-1080-979X; Basu, Srinjan/0000-0002-1080-979X; Di Croce, Luciano/0000-0003-3488-6228; Hendrich, Brian/0000-0002-0231-3073; Leeb, Martin/0000-0001-5114-4782; Blanco, Enrique/0000-0001-6261-7370; Stevens, Tim/0000-0001-6475-2074; Klenerman, David/0000-0001-7116-6954; Morey, Lluis/0000-0001-9851-4066; Cramard, Julie/0000-0003-1041-8913; Laue, Ernest/0000-0002-7476-4148; Palayret, Matthieu/0000-0002-5343-8378; Wohlfahrt, Kai/0000-0002-0970-5539	Wellcome Trust [082010/Z/07/Z]; EC FP7 4DCellFate project [277899]; MRC [MR/M010082/1]; ICREA Funding Source: Custom; MRC [MC_U105178783, MR/P019471/1] Funding Source: UKRI; Medical Research Council [MR/M010082/1, MR/P019471/1, MC_PC_12009, MC_U105178783] Funding Source: researchfish; Wellcome Trust [206291/Z/17/Z] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EC FP7 4DCellFate project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ICREA(ICREA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank A. Riddell for cell sorting, P. Humphreys for confocal microscopy, A. Peter Gunnarson for the density mapping software, the CRUK Cambridge Institute for DNA sequencing, T. Nagano and P. Fraser for processing the preliminary haploid mouse ES cells, and W. Dean, S. Schoenfelder and S. Wingett for advice. We thank the Wellcome Trust (082010/Z/07/Z), the EC FP7 4DCellFate project (277899) and the MRC (MR/M010082/1) for financial support.	Bickmore WA, 2013, CELL, V152, P1270, DOI 10.1016/j.cell.2013.02.001; Cremer T, 2015, FEBS LETT, V589, P2931, DOI 10.1016/j.febslet.2015.05.037; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Denholtz M, 2013, CELL STEM CELL, V13, P602, DOI 10.1016/j.stem.2013.08.013; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Foti R, 2016, MOL CELL, V61, P260, DOI 10.1016/j.molcel.2015.12.001; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; Giorgetti L, 2016, NATURE, V535, P575, DOI 10.1038/nature18589; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Guo Y, 2015, CELL, V162, P900, DOI 10.1016/j.cell.2015.07.038; Julienne H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003233; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kind J, 2013, CELL, V153, P178, DOI 10.1016/j.cell.2013.02.028; Kouzine F, 2013, NAT STRUCT MOL BIOL, V20, P396, DOI 10.1038/nsmb.2517; Kruger AV, 2015, DEV BIOL, V398, P153, DOI 10.1016/j.ydbio.2014.10.014; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Naughton C, 2013, NAT STRUCT MOL BIOL, V20, P387, DOI 10.1038/nsmb.2509; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Sanborn AL, 2015, P NATL ACAD SCI USA, V112, pE6456, DOI 10.1073/pnas.1518552112; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sofueva S, 2013, EMBO J, V32, P3119, DOI 10.1038/emboj.2013.237; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Tjong H, 2016, P NATL ACAD SCI USA, V113, pE1663, DOI 10.1073/pnas.1512577113; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; Wang SY, 2016, SCIENCE, V353, P598, DOI 10.1126/science.aaf8084; Wei Z, 2013, CELL STEM CELL, V13, P36, DOI 10.1016/j.stem.2013.05.010; Zhang W, 2016, J MOL BIOL, V428, P2931, DOI 10.1016/j.jmb.2016.04.025; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002; Zhimulev IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101631; Zuin J, 2014, P NATL ACAD SCI USA, V111, P996, DOI 10.1073/pnas.1317788111	40	432	442	8	200	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					59	+		10.1038/nature21429	http://dx.doi.org/10.1038/nature21429			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ8GQ	28289288	Green Accepted			2022-12-28	WOS:000398323300032
J	Kawazoe, Y; Miyamoto, K; Morimoto, T; Yamamoto, T; Fuke, A; Hashimoto, A; Koami, H; Beppu, S; Katayama, Y; Itoh, M; Ohta, Y; Yamamura, H				Kawazoe, Yu; Miyamoto, Kyohei; Morimoto, Takeshi; Yamamoto, Tomonori; Fuke, Akihiro; Hashimoto, Atsunori; Koami, Hiroyuki; Beppu, Satoru; Katayama, Yoichi; Itoh, Makoto; Ohta, Yoshinori; Yamamura, Hitoshi		Dexmedetomidine Sepsis Intensive	Effect of Dexmedetomidine on Mortality and Ventilator-Free Days in Patients Requiring Mechanical Ventilation With Sepsis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; ENDOTOXIN-INDUCED SHOCK; CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; INFLAMMATORY RESPONSES; CARDIAC EVENTS; HEART-RATE; SEDATION; DELIRIUM; RATS	IMPORTANCE Dexmedetomidine provides sedation for patients undergoing ventilation; however, its effects onmortality and ventilator-free days have not been well studied among patients with sepsis. OBJECTIVES To examine whether a sedation strategy with dexmedetomidine can improve clinical outcomes in patients with sepsis undergoing ventilation. DESIGN, SETTING, AND PARTICIPANTS Open-label, multicenter randomized clinical trial conducted at 8 intensive care units in Japan from February 2013 until January 2016 among 201 consecutive adult patients with sepsis requiring mechanical ventilation for at least 24 hours. INTERVENTIONS Patients were randomized to receive either sedation with dexmedetomidine (n = 100) or sedation without dexmedetomidine (control group; n = 101). Other agents used in both groups were fentanyl, propofol, and midazolam. MAIN OUTCOMES AND MEASURES The co-primary outcomes were mortality and ventilator-free days (over a 28-day duration). Sequential Organ Failure Assessment score (days 1, 2, 4, 6, 8), sedation control, occurrence of delirium and coma, intensive care unit stay duration, renal function, inflammation, and nutrition state were assessed as secondary outcomes. RESULTS Of the 203 screened patients, 201 were randomized. The mean age was 69 years (SD, 14 years); 63% were male. Mortality at 28 days was not significantly different in the dexmedetomidine group vs the control group (19 patients [22.8%] vs 28 patients [30.8%]; hazard ratio, 0.69; 95% CI, 0.38-1.22; P = .20). Ventilator-free days over 28 days were not significantly different between groups (dexmedetomidine group: median, 20 [interquartile range, 5-24] days; control group: median, 18 [interquartile range, 0.5-23] days; P = .20). The dexmedetomidine group had a significantly higher rate of well-controlled sedation during mechanical ventilation (range, 17%-58% vs 20%-39%; P = .01); other outcomes were not significantly different between groups. Adverse events occurred in 8 (8%) and 3 (3%) patients in the dexmedetomidine and control groups, respectively. CONCLUSIONS AND RELEVANCE Among patients requiring mechanical ventilation, the use of dexmedetomidine compared with no dexmedetomidine did not result in statistically significant improvement in mortality or ventilator-free days. However, the study may have been underpowered for mortality, and additional research may be needed to evaluate this further.	[Kawazoe, Yu] Tohoku Univ, Grad Sch Med, Div Emergency & Crit Care Med, Sendai, Miyagi, Japan; [Miyamoto, Kyohei] Wakayama Med Univ, Dept Emergency & Crit Care Med, Wakayama, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Clin Epidemiol, Nishinomiya, Hyogo, Japan; [Yamamoto, Tomonori] Osaka City Univ, Grad Sch Med, Dept Trauma & Crit Care Med, Osaka, Japan; [Fuke, Akihiro] Osaka City Gen Hosp, Emergency & Urgent Med Care Ctr, Osaka, Japan; [Hashimoto, Atsunori] Hyogo Coll Med, Emergency & Crit Care Ctr, Nishinomiya, Hyogo, Japan; [Koami, Hiroyuki] Saga Univ Hosp, Adv Emergency Care Ctr, Saga, Japan; [Beppu, Satoru] Natl Hosp Org, Kyoto Med Ctr, Dept Emergency Med & Crit Care Med, Kyoto, Japan; [Katayama, Yoichi] Sapporo Med Univ, Dept Emergency Med, Sapporo, Hokkaido, Japan; [Itoh, Makoto] Yamaguchi Grand Med Ctr, Dept Anesthesiol, Hofu, Japan; [Ohta, Yoshinori] Hyogo Coll Med, Dept Internal Med, Div Gen Med, Nishinomiya, Hyogo, Japan; [Yamamura, Hitoshi] Hirosaki Univ, Grad Sch Med, Dept Disaster & Crit Care Med, 5 Zaifuchou, Hirosaki, Aomori 0368562, Japan	Tohoku University; Wakayama Medical University; Hyogo College of Medicine; Osaka Metropolitan University; Osaka City General Hospital; Hyogo College of Medicine; Saga University; Sapporo Medical University; Hyogo College of Medicine; Hirosaki University	Yamamura, H (corresponding author), Hirosaki Univ, Grad Sch Med, Dept Disaster & Crit Care Med, 5 Zaifuchou, Hirosaki, Aomori 0368562, Japan.	yamamura@hirosaki-u.ac.jp	Koami, Hiroyuki/L-7981-2018	Koami, Hiroyuki/0000-0001-6268-4602; BEPPU, SATORU/0000-0002-1434-5697	Hospira Japan	Hospira Japan	This study was supported in part by a noncontractual research grant to Wakayama Medical University provided by Hospira Japan.	Ackland GL, 2010, CRIT CARE MED, V38, P388, DOI 10.1097/CCM.0b013e3181c03dfa; Aydin C, 2009, WORLD J GASTROENTERO, V15, P1620, DOI 10.3748/wjg.15.1620; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Frumento RJ, 2006, J CLIN ANESTH, V18, P422, DOI 10.1016/j.jclinane.2006.02.005; Frumento RJ, 2013, J CLIN ANESTH, V25, P432, DOI 10.1016/j.jclinane.2013.08.001; Girard TD, 2008, LANCET, V371, P126, DOI 10.1016/S0140-6736(08)60105-1; Herr DL, 2003, J CARDIOTHOR VASC AN, V17, P576, DOI 10.1016/S1053-0770(03)00200-3; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kushimoto S, 2008, THROMB HAEMOSTASIS, V100, P1099, DOI 10.1160/TH08-05-0306; Morelli A, 2013, JAMA-J AM MED ASSOC, V310, P1683, DOI 10.1001/jama.2013.278477; Oda S, 2014, J INTENSIVE CARE, V2, DOI 10.1186/s40560-014-0055-2; Pandharipande PP, 2010, CRIT CARE, V14, DOI 10.1186/cc8916; Reade MC, 2016, JAMA-J AM MED ASSOC, V315, P1460, DOI 10.1001/jama.2016.2707; Riker RR, 2009, JAMA-J AM MED ASSOC, V301, P489, DOI 10.1001/jama.2009.56; Sander O, 2005, CRIT CARE MED, V33, P81, DOI 10.1097/01.CCM.0000150028.64264.14; Schmittinger CA, 2013, SHOCK, V39, P329, DOI 10.1097/SHK.0b013e318289376b; Schmittinger CA, 2012, INTENS CARE MED, V38, P950, DOI 10.1007/s00134-012-2531-2; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Skrobik Y, 2010, ANESTH ANALG, V111, P451, DOI 10.1213/ANE.0b013e3181d7e1b8; Stolk RF, 2016, AM J RESP CRIT CARE, V194, P550, DOI 10.1164/rccm.201604-0862CP; Taniguchi T, 2004, CRIT CARE MED, V32, P1322, DOI 10.1097/01.CCM.0000128579.84228.2A; Taniguchi T, 2008, J ANESTH, V22, P221, DOI 10.1007/s00540-008-0611-9; Vasilevskis EE, 2010, CHEST, V138, P1224, DOI 10.1378/chest.10-0466; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016	31	130	138	2	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2017	317	13					1321	1328		10.1001/jama.2017.2088	http://dx.doi.org/10.1001/jama.2017.2088			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ9VR	28322414	Green Published			2022-12-28	WOS:000398434200016
J	Keckesova, Z; Donaher, JL; De Cock, J; Freinkman, E; Lingrell, S; Bachovchin, DA; Bierie, B; Tischler, V; Noske, A; Okondo, MC; Reinhardt, F; Thiru, P; Golub, TR; Vance, JE; Weinberg, RA				Keckesova, Zuzana; Donaher, Joana Liu; De Cock, Jasmine; Freinkman, Elizaveta; Lingrell, Susanne; Bachovchin, Daniel A.; Bierie, Brian; Tischler, Verena; Noske, Aurelia; Okondo, Marian C.; Reinhardt, Ferenc; Thiru, Prathapan; Golub, Todd R.; Vance, Jean E.; Weinberg, Robert A.			LACTB is a tumour suppressor that modulates lipid metabolism and cell state	NATURE			English	Article							HAMSTER OVARY CELLS; MUTANT MOUSE MODEL; MYOGENIC DIFFERENTIATION; PHOSPHOLIPASE-D; LYSOPHOSPHATIDYLETHANOLAMINE ACYLTRANSFERASE; PHOSPHATIDYLSERINE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; CANCER-CELLS; PROTEIN; PHOSPHATIDYLETHANOLAMINE	Post-mitotic, differentiated cells exhibit a variety of characteristics that contrast with those of actively growing neoplastic cells, such as the expression of cell-cycle inhibitors and differentiation factors. We hypothesized that the gene expression profiles of these differentiated cells could reveal the identities of genes that may function as tumour suppressors. Here we show, using in vitro and in vivo studies in mice and humans, that the mitochondrial protein LACTB potently inhibits the proliferation of breast cancer cells. Its mechanism of action involves alteration of mitochondrial lipid metabolism and differentiation of breast cancer cells. This is achieved, at least in part, through reduction of the levels of mitochondrial phosphatidylserine decarboxylase, which is involved in the synthesis of mitochondrial phosphatidylethanolamine. These observations uncover a novel mitochondrial tumour suppressor and demonstrate a connection between mitochondrial lipid metabolism and the differentiation program of breast cancer cells, thereby revealing a previously undescribed mechanism of tumour suppression.	[Keckesova, Zuzana; Donaher, Joana Liu; De Cock, Jasmine; Freinkman, Elizaveta; Bierie, Brian; Reinhardt, Ferenc; Thiru, Prathapan; Weinberg, Robert A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Lingrell, Susanne; Vance, Jean E.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada; [Lingrell, Susanne; Vance, Jean E.] Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB T6G 2S2, Canada; [Bachovchin, Daniel A.; Golub, Todd R.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Bachovchin, Daniel A.; Okondo, Marian C.] Mem Sloan Kettering Canc Ctr, Chem Biol Program, New York, NY 10065 USA; [Tischler, Verena; Noske, Aurelia] Univ Zurich Hosp, Inst Surg Pathol, Zurich, Switzerland; [Weinberg, Robert A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Freinkman, Elizaveta] Metabolon Inc, POB 110407, Res Triangle Pk, NC 27709 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Alberta; University of Alberta; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Memorial Sloan Kettering Cancer Center; University of Zurich; University Zurich Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Metabolon	Keckesova, Z; Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Weinberg, RA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Weinberg, RA (corresponding author), MIT, Ludwig Ctr Mol Oncol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	keckesov@wi.mit.edu; weinberg@wi.mit.edu	Tischler, Verena/Q-7263-2017	Tischler, Verena/0000-0002-6673-8329; Okondo, Marian/0000-0003-0065-8155	NIH [R01 CA078461]; Samuel Waxman Cancer Research Foundation; Josie Robertson Foundation; MSKCC Core Grant [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA078461] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samuel Waxman Cancer Research Foundation; Josie Robertson Foundation; MSKCC Core Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K.-J. Kah for the FUW-LPT2 plasmid, T. DiCesare for graphical assistance with Extended Data Fig. 10h, R. Bronson for histopathology analysis, B. Yuan for statistical analysis, N. Watson for electron microscopy analysis, G. Daum, M. Spinazzi, A. Jourdain for discussions, members of the Weinberg laboratory for comments, the Whitehead Institute Flow Cytometry and Keck Imaging Facilities, MIT Koch Institute Histology and Animal Imaging Facilities and Ludwig Center for Molecular Oncology at MIT. This work was supported by grants from NIH R01 CA078461, Samuel Waxman Cancer Research Foundation, Josie Robertson Foundation and the MSKCC Core Grant (P30 CA008748) (D.A.B.). R.A.W. is an American Cancer Society research professor and a Daniel K. Ludwig Foundation cancer research professor.	Ahler E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064561; Bachovchin DA, 2014, NAT CHEM BIOL, V10, P656, DOI [10.1038/NCHEMBIO.1578, 10.1038/nchembio.1578]; Bird SS, 2011, ANAL CHEM, V83, P6648, DOI 10.1021/ac201195d; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; CIFONE MA, 1980, P NATL ACAD SCI-BIOL, V77, P1039, DOI 10.1073/pnas.77.2.1039; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Fotheringham J, 2000, BBA-MOL CELL BIOL L, V1485, P1, DOI 10.1016/S1388-1981(00)00025-1; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Jaafar R, 2011, J BIOL CHEM, V286, P22609, DOI 10.1074/jbc.M110.203885; KASID A, 1985, SCIENCE, V228, P725, DOI 10.1126/science.4039465; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Komati H, 2005, MOL BIOL CELL, V16, P1232, DOI 10.1091/mbc.E04-06-0459; Kuge O, 1998, P NATL ACAD SCI USA, V95, P4199, DOI 10.1073/pnas.95.8.4199; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200; McFadden DG, 2014, P NATL ACAD SCI USA, V111, pE1600, DOI 10.1073/pnas.1404357111; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Moullan N, 2015, CELL REP, V15, P180; NISHIJIMA M, 1986, J BIOL CHEM, V261, P5784; Nishina A, 2006, J LIPID RES, V47, P1434, DOI 10.1194/jlr.M600045-JLR200; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Park KS, 2007, FEBS LETT, V581, P4411, DOI 10.1016/j.febslet.2007.08.014; Peitsaro N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-26; Polianskyte Z, 2009, P NATL ACAD SCI USA, V106, P18960, DOI 10.1073/pnas.0906734106; Riekhof WR, 2007, J BIOL CHEM, V282, P28344, DOI 10.1074/jbc.M705256200; Riekhof WR, 2006, J BIOL CHEM, V281, P36588, DOI 10.1074/jbc.M608851200; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Ruzicka J., 2014, AM SOC MASS SPECTROM; Ryu SB, 1997, P NATL ACAD SCI USA, V94, P12717, DOI 10.1073/pnas.94.23.12717; SEELY S, 1980, MED HYPOTHESES, V6, P133, DOI 10.1016/0306-9877(80)90079-1; Smith TS, 2001, GENOMICS, V78, P12, DOI 10.1006/geno.2001.6643; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Theurillat JP, 2007, INT J CANCER, V120, P2411, DOI 10.1002/ijc.22376; Vance JE, 2013, BBA-MOL CELL BIOL L, V1831, P543, DOI 10.1016/j.bbalip.2012.08.016; VANDENBOGERT C, 1987, BIOCHEM PHARMACOL, V36, P1555, DOI 10.1016/0006-2952(87)90126-2; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325	42	99	107	2	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					681	+		10.1038/nature21408	http://dx.doi.org/10.1038/nature21408			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28329758	Green Accepted			2022-12-28	WOS:000397619700048
J	Alderwick, H; Ham, C				Alderwick, Hugh; Ham, Chris			Sustainability and transformation plans for the NHS in England: what do they say and what happens next?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												h.alderwick@kingsfund.org.uk		Alderwick, Hugh/0000-0002-9362-2567				Alderwick H, 2015, BETTER VALUE NHS ROL; Alderwick H, 2016, SUSTAINABILITY TRANS; Alderwick H, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1022; Baird B, 2016, UNDERSTANDING PRESSU; Bardsley M, 2013, EVALUATING INTEGRATE; Blunt I., 2013, FOCUS PREVENTABLE AD; Davies A., 2016, FOCUS PUBLIC HLTH PR; Department of Health, 2008, HIGH QUALITY CARE AL; Dunn P, 2016, DEFICITS NHS 2016; Gainsbury S., 2016, FEELING CRUNCH NHS F; Gilburt H., 2015, MENTAL HLTH PRESSURE; Ham C, 2017, DELIVERING SUSTAINAB; Humphries R., 2016, SOCIAL CARE OLDER PE; Imison C, 2014, RECONFIGURATION CLIN; Maybin J., 2016, UNDERSTANDING QUALIT; Murray R, 2016, 20 KINGS FUND; NHS England, 2014, 5 YEAR FORW VIEW; NHS England, 2015, SUST TRANSF PLAN FOO; NHS England NHS Improvement, 2015, NHS OP PLANN CONTR G; NHS Providers, 2016, STATE NHS PROV SECT; Royal College of General Practitioners, 2017, GP FORW VIEW INT ASS; St John of God Health Care, 2019, OUR VIS; Steventon A, 2011, EVALUATION IMPACT CO; UK Government, 2021, GP IT FUTURES SYSTEM; Valentino L, 2022, RSF-RUS SAGE J SOC S, V8, P89, DOI [10.18311/ti/2021/v28i1/24809, 10.1097/QAD.0000000000003368, 10.1016/j.vaccine.2022.07.056, 10.7758/RSF.2022.8.7.05]; West North and East Cumbria, 2016, SUST TRANSF PLAN 201	26	15	15	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2017	356								j1541	10.1136/bmj.j1541	http://dx.doi.org/10.1136/bmj.j1541			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4DL	28351887				2022-12-28	WOS:000398024200004
J	Carvell, C; Bourke, AFG; Dreier, S; Freeman, SN; Hulmes, S; Jordan, WC; Redhead, JW; Sumner, S; Wang, J; Heard, MS				Carvell, Claire; Bourke, Andrew F. G.; Dreier, Stephanie; Freeman, Stephen N.; Hulmes, Sarah; Jordan, William C.; Redhead, John W.; Sumner, Seirian; Wang, Jinliang; Heard, Matthew S.			Bumblebee family lineage survival is enhanced in high-quality landscapes	NATURE			English	Article							AGRI-ENVIRONMENT SCHEMES; COLONY GROWTH; LAND-USE; HABITAT; CONSERVATION; POLLINATORS; RESOURCES; QUEENS; SCALE; BEES	Insect pollinators such as bumblebees (Bombus spp.) are in global decline(1,2). A major cause of this decline is habitat loss due to agricultural intensification(3). A range of global and national initiatives aimed at restoring pollinator habitats and populations have been developed(4,5). However, the success of these initiatives depends critically upon understanding how landscape change affects key population-level parameters, such as survival between lifecycle stages(6), in target species. This knowledge is lacking for bumblebees, because of the difficulty of systematically finding and monitoring colonies in the wild. We used a combination of habitat manipulation, land-use and habitat surveys, molecular genetics(7) and demographic and spatial modelling to analyse between-year survival of family lineages in field populations of three bumblebee species. Here we show that the survival of family lineages from the summer worker to the spring queen stage in the following year increases significantly with the proportion of high-value foraging habitat, including spring floral resources, within 250-1,000 m of the natal colony. This provides evidence for a positive impact of habitat quality on survival and persistence between successive colony cycle stages in bumblebee populations. These findings also support the idea that conservation interventions that increase floral resources at a landscape scale and throughout the season have positive effects on wild pollinators in agricultural landscapes.	[Carvell, Claire; Freeman, Stephen N.; Hulmes, Sarah; Redhead, John W.; Heard, Matthew S.] NERC Ctr Ecol Hydrol, Benson Lane, Wallingford OX10 8BB, Oxon, England; [Bourke, Andrew F. G.] Univ East Anglia, Sch Biol Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Dreier, Stephanie; Jordan, William C.; Sumner, Seirian; Wang, Jinliang] Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England; [Dreier, Stephanie; Sumner, Seirian] Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England; [Sumner, Seirian] UCL, Ctr Biodivers & Environm Res, Gower St, London WC1E 6BT, England	UK Centre for Ecology & Hydrology (UKCEH); University of East Anglia; Zoological Society of London; University of Bristol; University of London; University College London	Carvell, C (corresponding author), NERC Ctr Ecol Hydrol, Benson Lane, Wallingford OX10 8BB, Oxon, England.	ccar@ceh.ac.uk	Bourke, Andrew F. G./E-5271-2011; Redhead, John/E-6750-2012	Redhead, John/0000-0002-2233-3848; Sumner, Seirian/0000-0003-0213-2018	Insect Pollinators Initiative [BB/I000925/1]; Biotechnology and Biological Sciences Research Council; Department for Environment, Food and Rural Affairs; Natural Environment Research Council; Scottish Government; Wellcome Trust; Syngenta Plc; Biotechnology and Biological Sciences Research Council [BB/I000720/2, BB/I001069/1, BB/I000925/1, BB/I000720/1] Funding Source: researchfish; BBSRC [BB/I001069/1, BB/I000720/1, BB/I000720/2, BB/I000925/1] Funding Source: UKRI	Insect Pollinators Initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission); Syngenta Plc(Syngenta); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the CEH field team (L. Hulmes, J. Peyton, J. Savage, S. Amy, R. Chapman, G. Baron and R. MacDonald) for sampling bumblebees and conducting habitat surveys; R. Faccenda and R. Franklin of Faccenda Farms, and other landowners, for access to the Hillesden Estate and surroundings; R. Pywell and M. Nowakowski for access to the Hillesden Experimental Platform; H. Dean for data management; C. Harrower for help with graphics; H. M. Lattorff for use of his primers for the molecular discrimination of B. terrestris and B. lucorum workers; I. Warren for assistance with laboratory work; and J. Bullock and K. Schonrogge for comments on an earlier version of the manuscript. This research was supported by the Insect Pollinators Initiative (grant BB/I000925/1). The Insect Pollinators Initiative was funded jointly by the Biotechnology and Biological Sciences Research Council, the Department for Environment, Food and Rural Affairs, the Natural Environment Research Council, The Scottish Government and The Wellcome Trust, under the Living with Environmental Change Partnership. Acquisition of remote sensing data was funded by Syngenta Plc.	Baude M, 2016, NATURE, V530, P85, DOI 10.1038/nature16532; Beekman M, 1998, ENTOMOL EXP APPL, V89, P207, DOI 10.1023/A:1003595306816; Benton T., 2006, BUMBLEBEES NATURAL H; Bourke AFG, 1997, PHILOS T ROY SOC B, V352, P1921, DOI 10.1098/rstb.1997.0179; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Carvell C, 2011, ECOL APPL, V21, P1760, DOI 10.1890/10-0677.1; Carvell C., 2014, LOCATION DATA WORKER; Carvell C., 2016, FAMILY LINEAGE LANDS; Carvell C, 2015, BASIC APPL ECOL, V16, P519, DOI 10.1016/j.baae.2015.05.006; Carvell C, 2012, OIKOS, V121, P734, DOI 10.1111/j.1600-0706.2011.19832.x; Department for Environment Food and Rural Affairs, 2014, NAT POLL STRAT BEES; Dicks LV, 2015, ECOL ENTOMOL, V40, P22, DOI 10.1111/een.12226; Dreier S., 2014, MICROSATELLITE GENOT; Dreier S, 2014, MOL ECOL, V23, P3384, DOI 10.1111/mec.12823; Garibaldi LA, 2011, ECOL LETT, V14, P1062, DOI 10.1111/j.1461-0248.2011.01669.x; Garratt MPD, 2014, BIOL CONSERV, V169, P128, DOI 10.1016/j.biocon.2013.11.001; Gill Richard J., 2016, Advances in Ecological Research, V54, P135; Goulson D, 2002, OECOLOGIA, V130, P267, DOI 10.1007/s004420100803; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Holehouse KA, 2003, INSECT SOC, V50, P277, DOI 10.1007/s00040-003-0672-6; Jha S, 2013, MOL ECOL, V22, P2483, DOI 10.1111/mec.12275; Jha S, 2013, P NATL ACAD SCI USA, V110, P555, DOI 10.1073/pnas.1208682110; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lepais O, 2010, MOL ECOL, V19, P819, DOI 10.1111/j.1365-294X.2009.04500.x; Lopez-Vaamonde C, 2009, J EVOLUTION BIOL, V22, P983, DOI 10.1111/j.1420-9101.2009.01706.x; Lye GC, 2009, BIOL CONSERV, V142, P2023, DOI 10.1016/j.biocon.2009.03.032; M'Gonigle LK, 2015, ECOL APPL, V25, P1557, DOI 10.1890/14-1863.1; Natural England, 2015, COUNTR STEW MAN; Nieto A., 2014, EUROPEAN RED LIST BE; Pywell RF, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1740; Redhead J. W., 2014, MAP LAND USE LAND CO; Redhead JW, 2016, ECOL APPL, V26, P726, DOI 10.1890/15-0546; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Williams NM, 2012, ECOLOGY, V93, P1049, DOI 10.1890/11-1006.1; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1; Wood TJ, 2015, MOL ECOL, V24, P1668, DOI 10.1111/mec.13144	42	124	125	8	217	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					547	+		10.1038/nature21709	http://dx.doi.org/10.1038/nature21709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28297711	Green Accepted, Green Submitted			2022-12-28	WOS:000397018000050
J	Bell, S; Daskalopoulou, M; Rapsomaniki, E; George, J; Britton, A; Bobak, M; Casas, JP; Dale, CE; Denaxas, S; Shah, AD; Hemingway, H				Bell, Steven; Daskalopoulou, Marina; Rapsomaniki, Eleni; George, Julie; Britton, Annie; Bobak, Martin; Casas, Juan P.; Dale, Caroline E.; Denaxas, Spiros; Shah, Anoop D.; Hemingway, Harry			Association between clinically recorded alcohol consumption and initial presentation of 12 cardiovascular diseases: population based cohort study using linked health records	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ISCHEMIC-HEART-DISEASE; DOSE-RESPONSE METAANALYSIS; SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; RISK-FACTORS; MENDELIAN RANDOMIZATION; DRINKING PATTERNS; PHYSICAL-ACTIVITY; ANGINA-PECTORIS; LIFETIME RISKS	OBJECTIVES To investigate the association between alcohol consumption and cardiovascular disease at higher resolution by examining the initial lifetime presentation of 12 cardiac, cerebrovascular, abdominal, or peripheral vascular diseases among five categories of consumption. DESIGN Population based cohort study of linked electronic health records covering primary care, hospital admissions, and mortality in 1997-2010 (median follow-up six years). SETTING CALIBER (ClinicAl research using LInked Bespoke studies and Electronic health Records). PARTICIPANTS 1937360 adults (51% women), aged >= 30 who were free from cardiovascular disease at baseline. MAIN OUTCOME MEASURES 12 common symptomatic manifestations of cardiovascular disease, including chronic stable angina, unstable angina, acute myocardial infarction,	[Bell, Steven] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Bell, Steven; Britton, Annie; Bobak, Martin] UCL, Res Dept Epidemiol & Publ Hlth, London WC1E 7HB, England; [Daskalopoulou, Marina] UCL, Royal Free Hosp, Dept Infect & Populat Hlth, London NW3 2PF, England; [Rapsomaniki, Eleni; George, Julie; Casas, Juan P.; Dale, Caroline E.; Denaxas, Spiros; Shah, Anoop D.; Hemingway, Harry] UCL, Farr Inst Hlth Informat Res London, London NW1 2DA, England	University of Cambridge; University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London	Bell, S (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England.; Bell, S (corresponding author), UCL, Res Dept Epidemiol & Publ Hlth, London WC1E 7HB, England.	scb81@medschl.cam.ac.uk	Shah, Anoop Dinesh/D-4396-2014; Hemingway, Harry/C-1219-2009	Shah, Anoop Dinesh/0000-0002-8907-5724; Denaxas, Spiros/0000-0001-9612-7791; Daskalopoulou, Marina/0000-0001-9927-0358; Bobak, Martin/0000-0002-2633-6851; Hemingway, Harry/0000-0003-2279-0624; Bell, Steven/0000-0001-6774-3149; Dale, Caroline/0000-0002-3889-8974	National Institute for Health Research [RP-PG-0407-10314]; Wellcome Trust [WT 086091/Z/08/Z, MR/K006584/1, 0938/30/Z/10/Z]; Medical Research Council prognosis research strategy (PROGRESS) Partnership [G0902393/99558]; Medical Research Council; Arthritis Research UK; British Heart Foundation; Cancer Research UK; Chief Scientist Office; Economic and Social Research Council; Engineering and Physical Sciences Research Council; National Institute for Health Research; National Institute for Social Care and Health Research; European Research Council [ERC-StG-2012-309337_AlcoholLifecourse]; Medical Research Council/Alcohol Research UK [MR/M006638/1]; NIHR [DRF-2009-02-50]; NIHR; MRC [MR/K013351/1, MR/L003120/1, MR/M006638/1] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/M006638/1, MR/L003120/1, MR/K013351/1] Funding Source: researchfish; National Institute for Health Research [DRF-2009-02-50, NF-SI-0512-10165] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); Medical Research Council prognosis research strategy (PROGRESS) Partnership(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Chief Scientist Office; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Social Care and Health Research; European Research Council(European Research Council (ERC)European Commission); Medical Research Council/Alcohol Research UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the National Institute for Health Research (RP-PG-0407-10314), Wellcome Trust (WT 086091/Z/08/Z), the Medical Research Council prognosis research strategy (PROGRESS) Partnership (G0902393/99558), and awards to establish the Farr Institute of Health Informatics Research at UCLPartners, from the Medical Research Council, Arthritis Research UK, British Heart Foundation, Cancer Research UK, Chief Scientist Office, Economic and Social Research Council, Engineering and Physical Sciences Research Council, National Institute for Health Research, National Institute for Social Care and Health Research, and Wellcome Trust (grant MR/K006584/1). SB and AB were supported by grants from the European Research Council (ERC-StG-2012-309337_AlcoholLifecourse) and the Medical Research Council/Alcohol Research UK (MR/M006638/1). JG was funded by a NIHR doctoral fellowship (DRF-2009-02-50). ADS is supported by a clinical research training fellowship from the Wellcome Trust (0938/30/Z/10/Z). This article presents independent research funded in part by the NIHR. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The funders had no role in study design, data collection, analysis or interpretation, decision to publish, or preparation of the manuscript.	Albert CM, 1999, CIRCULATION, V100, P944, DOI 10.1161/01.CIR.100.9.944; American Heart Association, 2015, ALC HEART HLTH; Andreasen TH, 2013, STROKE, V44, P3607, DOI 10.1161/STROKEAHA.113.001575; [Anonymous], 2009, AUSTR GUID RED HLTH, P1; [Anonymous], 1995, SENS DRINK REP INT W; Arber S, 2004, BRIT J GEN PRACT, V54, P673; Bell S, 2017, J INTERN MED, V281, P75, DOI 10.1111/joim.12544; Bell S, 2015, ADDICTION, V110, P183, DOI 10.1111/add.12708; Bellis MA, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0337-0; Bergmann MM, 2013, INT J EPIDEMIOL, V42, P1772, DOI 10.1093/ije/dyt154; Breslow RA, 2013, ALCOHOL RES-CURR REV, V35, P250; Brien SE, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d636; Britton A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0656-9; Britton A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0273-z; Camargo CA, 1997, CIRCULATION, V95, P577, DOI 10.1161/01.CIR.95.3.577; Camargo CA, 1997, ANN INTERN MED, V126, P372, DOI 10.7326/0003-4819-126-5-199703010-00005; Chikritzhs T, 2015, ADDICTION, V110, P726, DOI 10.1111/add.12828; Chiuve SE, 2010, HEART RHYTHM, V7, P1374, DOI 10.1016/j.hrthm.2010.05.035; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Dam MK, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2314; Daskalopoulou M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153838; Delude CM, 2015, NATURE, V527, pS14, DOI 10.1038/527S14a; Denaxas Spiros C, 2012, Int J Epidemiol, V41, P1625, DOI 10.1093/ije/dys188; Fat LN, 2015, ALCOHOL CLIN EXP RES, V39, P166, DOI 10.1111/acer.12596; Fekjaer HO, 2013, ADDICTION, V108, P2051, DOI 10.1111/add.12104; Fernandez-Sola J, 2015, NAT REV CARDIOL, V12, P576, DOI 10.1038/nrcardio.2015.91; Ferrari P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005245; Gallagher AM, 2011, PHARMACOEPIDEM DR S, V20, pS230; George J, 2015, CIRCULATION, V132, P1320, DOI 10.1161/CIRCULATIONAHA.114.013797; Glymour MM, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4334; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; Herrett E, 2010, HEART, V96, P1264, DOI 10.1136/hrt.2009.192328; Holmes MV, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4164; Kyu HH, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3857; Larsson SC, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0721-4; Larsson SC, 2015, EUR J HEART FAIL, V17, P367, DOI 10.1002/ejhf.228; Mathews MJ, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0011-6; Mathur R, 2014, J PUBLIC HEALTH-UK, V36, P684, DOI 10.1093/pubmed/fdt116; Merry AHH, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-13; Mons U, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1551; Mortensen EL, 2001, ARCH INTERN MED, V161, P1844, DOI 10.1001/archinte.161.15.1844; Movva R, 2013, INT J CARDIOL, V164, P267, DOI 10.1016/j.ijcard.2012.01.030; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Mukamal K, 2007, ANN EPIDEMIOL, V17, pS8, DOI 10.1016/j.annepidem.2007.01.003; Mukamal KJ, 2008, CURR ATHEROSCLER REP, V10, P536, DOI 10.1007/s11883-008-0083-2; Mukamal KJ, 2005, ANN INTERN MED, V142, P11, DOI 10.7326/0003-4819-142-1-200501040-00007; Mukamal KJ, 2003, NEW ENGL J MED, V348, P109, DOI 10.1056/NEJMoa022095; National Health Service, 2013, OPCS 4 CLASS NHS CON; Newby LK, 2015, CIRCULATION, V132, P1303, DOI 10.1161/CIRCULATIONAHA.115.018750; Noble M, 2007, ENGLISH INDICES DEPR; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Orrow G, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1389; Pujades-Rodriguez M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151245; Pujades-Rodriguez M, 2016, HEART, V102, P383, DOI 10.1136/heartjnl-2015-308514; Pujades-Rodriguez M, 2015, INT J EPIDEMIOL, V44, P129, DOI 10.1093/ije/dyu218; Pujades-Rodriguez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104671; Rapsomaniki E, 2014, LANCET, V383, P1899, DOI 10.1016/S0140-6736(14)60685-1; Rehm J, 2008, AM J EPIDEMIOL, V168, P866, DOI 10.1093/aje/kwn093; Rehm J, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3026-9; Reynolds K, 2003, JAMA-J AM MED ASSOC, V289, P579, DOI 10.1001/jama.289.5.579; Roerecke M, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0182-6; Roerecke M, 2012, ADDICTION, V107, P1246, DOI 10.1111/j.1360-0443.2012.03780.x; Roerecke M, 2011, AM J EPIDEMIOL, V173, P245, DOI 10.1093/aje/kwq364; Romelsjo A, 2012, ALCOHOL ALCOHOLISM, V47, P322, DOI 10.1093/alcalc/ags021; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Ruidavets JB, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6077; Shah AD, 2015, LANCET DIABETES ENDO, V3, P105, DOI 10.1016/S2213-8587(14)70219-0; Silverwood RJ, 2014, INT J EPIDEMIOL, V43, P1781, DOI 10.1093/ije/dyu187; Smyth A, 2015, LANCET, V386, P1945, DOI 10.1016/S0140-6736(15)00235-4; Stackelberg O, 2014, CIRCULATION, V130, P646, DOI 10.1161/CIRCULATIONAHA.113.008279; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Stockwell T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2276; UK Department of Health, 2016, UK CHIEF MED OFF LOW; Weikert C, 2007, J NEUROL, V254, P315, DOI 10.1007/s00415-006-0358-x; Zheng YL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2081-y	78	166	170	3	34	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j909	10.1136/bmj.j909	http://dx.doi.org/10.1136/bmj.j909			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP4IW	28331015	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000397345200022
J	Newell, L				Newell, Lesley			Stephen John Newell OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2017	356								j1136	10.1136/bmj.j1136	http://dx.doi.org/10.1136/bmj.j1136			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NR	28314709				2022-12-28	WOS:000397015900003
J	Snijder, J; Schuller, JM; Wiegard, A; Lossl, P; Schmelling, N; Axmann, IM; Plitzko, JM; Forster, F; Heck, AJR				Snijder, Joost; Schuller, Jan M.; Wiegard, Anika; Lossl, Philip; Schmelling, Nicolas; Axmann, Ilka M.; Plitzko, Juergen M.; Foerster, Friedrich; Heck, Albert J. R.			Structures of the cyanobacterial circadian oscillator frozen in a fully assembled state	SCIENCE			English	Article							CLOCK PROTEIN KAIB; CRYSTAL-STRUCTURE; PHOSPHORYLATION; DYNAMICS; COMPLEX; KAIABC; RHYTHM; EXPRESSION	Cyanobacteria have a robust circadian oscillator, known as the Kai system. Reconstituted from the purified protein components KaiC, KaiB, and KaiA, it can tick autonomously in the presence of adenosine 5'-triphosphate (ATP). The KaiC hexamers enter a natural 24-hour reaction cycle of autophosphorylation and assembly with KaiB and KaiA in numerous diverse forms. We describe the preparation of stoichiometrically well-defined assemblies of KaiCB and KaiCBA, as monitored by native mass spectrometry, allowing for a structural characterization by single-particle cryo-electron microscopy and mass spectrometry. Our data reveal details of the interactions between the Kai proteins and provide a structural basis to understand periodic assembly of the protein oscillator.	[Snijder, Joost; Lossl, Philip; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Snijder, Joost; Lossl, Philip; Heck, Albert J. R.] Univ Utrecht, Netherlands Prote Ctr, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Snijder, Joost; Lossl, Philip; Heck, Albert J. R.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Schuller, Jan M.; Plitzko, Juergen M.; Foerster, Friedrich] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Wiegard, Anika; Schmelling, Nicolas; Axmann, Ilka M.] Heinrich Heine Univ Dusseldorf, Inst Synthet Microbiol, Cluster Excellence Plant Sci CEPLAS, D-40225 Dusseldorf, Germany; [Foerster, Friedrich] Univ Utrecht, Bijvoet Ctr Biomol Res, Cryoelectron Microscopy, Padualaan 8, NL-3584 CH Utrecht, Netherlands; [Snijder, Joost] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Schuller, Jan M.] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany	Utrecht University; Utrecht University; Utrecht University; Max Planck Society; Heinrich Heine University Dusseldorf; University of Cologne; Utrecht University; University of Washington; University of Washington Seattle; Max Planck Society	Heck, AJR (corresponding author), Univ Utrecht, Biomol Mass Spectrometry & Prote, Padualaan 8, NL-3584 CH Utrecht, Netherlands.; Heck, AJR (corresponding author), Univ Utrecht, Netherlands Prote Ctr, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.; Heck, AJR (corresponding author), Univ Utrecht, Utrecht Inst Pharmaceut Sci, Padualaan 8, NL-3584 CH Utrecht, Netherlands.; Forster, F (corresponding author), Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany.; Forster, F (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Cryoelectron Microscopy, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	f.g.forster@uu.nl; a.j.r.heck@uu.nl	Heck, Albert/D-7098-2011; Plitzko, Juergen M/H-9576-2014	Heck, Albert/0000-0002-2405-4404; Plitzko, Juergen M/0000-0002-6402-8315; Lossl, Philip/0000-0001-5062-7723; Schuller, Jan Michael/0000-0002-9121-1764; Wiegard, Anika/0000-0001-9674-0510; Foerster, Friedrich/0000-0002-6044-2746; Schmelling, Nicolas/0000-0002-6981-397X	Netherlands Organisation for Scientific Research (NWO) Roadmap Initiative Proteins@Work grant [184.032.201]; German Research Foundation [GRK1721, AX 84/1-3, EXC 1028]	Netherlands Organisation for Scientific Research (NWO) Roadmap Initiative Proteins@Work grant; German Research Foundation(German Research Foundation (DFG))	We thank J. Andres and M. Yazdanyar for help with protein expression, O. Mihalache for help with sample preparation, F. Beck and A. Aufderheide for assistance with image processing, and C. Benda for help with PHENIX software. This work was supported by the Netherlands Organisation for Scientific Research (NWO) Roadmap Initiative Proteins@Work grant 184.032.201 to A.J.R.H., the European Union Seventh Framework Programme ManiFold grant 317371 to A.J.R.H. and P.L., and the German Research Foundation grant GRK1721 to F. F., and grants AX 84/1-3 and EXC 1028 to A.W., N.S., and I.M.A.	Abe J, 2015, SCIENCE, V349, P312, DOI 10.1126/science.1261040; Akiyama S, 2008, MOL CELL, V29, P703, DOI 10.1016/j.molcel.2008.01.015; Brettschneider C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.44; Chang YG, 2015, SCIENCE, V349, P324, DOI 10.1126/science.1260031; Chang YG, 2012, P NATL ACAD SCI USA, V109, P16847, DOI 10.1073/pnas.1211508109; Egli M, 2014, J BIOL CHEM, V289, P21267, DOI 10.1074/jbc.R114.579607; Egli M, 2013, CURR OPIN NEUROBIOL, V23, P732, DOI 10.1016/j.conb.2013.02.012; Hitomi K, 2005, J BIOL CHEM, V280, P19127, DOI 10.1074/jbc.M411284200; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ito H, 2007, NAT STRUCT MOL BIOL, V14, P1084, DOI 10.1038/nsmb1312; Iwase R, 2005, J BIOL CHEM, V280, P43141, DOI 10.1074/jbc.M503360200; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Markson JS, 2013, CELL, V155, P1396, DOI 10.1016/j.cell.2013.11.005; Murakami R, 2012, J BIOL CHEM, V287, P29506, DOI 10.1074/jbc.M112.349092; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Pattanayek R, 2004, MOL CELL, V15, P375, DOI 10.1016/j.molcel.2004.07.013; Pattanayek R, 2008, EMBO J, V27, P1767, DOI 10.1038/emboj.2008.104; Pattanayek R, 2006, EMBO J, V25, P2017, DOI 10.1038/sj.emboj.7601086; Pattanayek R, 2015, BIOCHEMISTRY-US, V54, P4575, DOI 10.1021/acs.biochem.5b00694; Pattanayek R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023697; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Snijder J, 2014, ANNU REV ANAL CHEM, V7, P43, DOI 10.1146/annurev-anchem-071213-020015; Snijder J, 2014, P NATL ACAD SCI USA, V111, P1379, DOI 10.1073/pnas.1314326111; Tseng R, 2014, J MOL BIOL, V426, P389, DOI 10.1016/j.jmb.2013.09.040; Villarreal SA, 2013, J MOL BIOL, V425, P3311, DOI 10.1016/j.jmb.2013.06.018; Ye S, 2004, J BIOL CHEM, V279, P20511, DOI 10.1074/jbc.M400077200	28	62	63	3	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1181	1184		10.1126/science.aag3218	http://dx.doi.org/10.1126/science.aag3218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302852				2022-12-28	WOS:000396351200037
J	Voosen, P				Voosen, Paul			Q&A Earth science a 'no-brainer' for NASA's science chief Thomas Zurbuchen talks risk, trust, and small satellites	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1112	1112		10.1126/science.355.6330.1112	http://dx.doi.org/10.1126/science.355.6330.1112			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302804				2022-12-28	WOS:000396351200014
J	Li, SQ; Liang, LY				Li, Saiqun; Liang, Lingyi			Protruding Iris Collarette	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Li, Saiqun; Liang, Lingyi] Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China		Liang, LY (corresponding author), Zhongshan Ophthalm Ctr, Guangzhou, Guangdong, Peoples R China.	lingyiliang@qq.com							0	1	2	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1064	1064		10.1056/NEJMicm1516330	http://dx.doi.org/10.1056/NEJMicm1516330			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QT	28296615				2022-12-28	WOS:000396403700011
J	Lenzer, J				Lenzer, Jeanne			Trump to nominate Scott Gottlieb as FDA commissioner despite industry links	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jlenzer@bmj.com						Brill S, 2017, AXIOS           0124; Gottlieb S, 2007, HEALTH AFFAIR, V26, P664, DOI 10.1377/hlthaff.26.3.664; Kaplan S, 2017, STAT; Kleinke JD, 1998, BRIT MED J, V317, P899; McGinley L, 2017, WASHINGTON POST	5	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2017	356								j1339	10.1136/bmj.j1339	http://dx.doi.org/10.1136/bmj.j1339			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NL	28298314				2022-12-28	WOS:000397015300011
J	Esplin, MS; Elovitz, MA; Iams, JD; Parker, CB; Wapner, RJ; Grobman, WA; Simhan, HN; Wing, DA; Haas, DM; Silver, RM; Hoffman, MK; Peaceman, AM; Caritis, SN; Parry, S; Wadhwa, P; Foroud, T; Mercer, BM; Hunter, SM; Saade, GR; Reddy, UM				Esplin, M. Sean; Elovitz, Michal A.; Iams, Jay D.; Parker, Corette B.; Wapner, Ronald J.; Grobman, William A.; Simhan, Hyagriv N.; Wing, Deborah A.; Haas, David M.; Silver, Robert M.; Hoffman, Matthew K.; Peaceman, Alan M.; Caritis, Steve N.; Parry, Samuel; Wadhwa, Pathik; Foroud, Tatiana; Mercer, Brian M.; Hunter, Shannon M.; Saade, George R.; Reddy, Uma M.		NuMoMb Network	Predictive Accuracy of Serial Transvaginal Cervical Lengths and Quantitative Vaginal Fetal Fibronectin Levels for Spontaneous Preterm Birth Among Nulliparous Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASYMPTOMATIC WOMEN; LOW-RISK; DELIVERY; PROGESTERONE; PREVENTION; LABOR	IMPORTANCE Spontaneous preterm birth is a leading cause of infant mortality. Prediction, largely based on prior pregnancy outcomes, is not possible in women pregnant for the first time. OBJECTIVE To assess the accuracy of universal screening to predict spontaneous preterm birth in nulliparous women using serial measurements of vaginal fetal fibronectin levels and cervical length. DESIGN, SETTINGS, AND PARTICIPANTS A prospective observational cohort study of nulliparous women with singleton pregnancies, from 8 clinical sites across the United States between October 2010 and May 2014. Women and clinicians were blinded to results unless cervical shortening less than 15 mm was identified. EXPOSURES Transvaginal cervical length and quantitative vaginal fetal fibronectin levels were reviewed at 2 study visits 4 or more weeks apart. MAIN OUTCOMES AND MEASURES Spontaneous preterm birth at less than 37 weeks was the primary outcome. Cervical length and quantitative fetal fibronectin were considered independently and together at each visit. Measurement distributions were compared for spontaneous preterm birth vs all other births. Spontaneous preterm birth before 32 weeks was a secondary outcome. RESULTS The study included 9410 women (median age, 27.0 [interquartile range, 9.0] years; 60.7% non-Hispanic white, 13.8% non-Hispanic black, 16.5% Hispanic, 4.0% Asian, and 5.1% other), of whom 474 (5.0%) had spontaneous preterm births, 335 (3.6%) had medically indicated preterm births, and 8601 (91.4%) had term births. Among women with spontaneous preterm birth, cervical length of 25 mm or less occurred in 35 of 439 (8.0%) at 16 to 22 weeks' gestation and in 94 of 403 (23.3%) at 22 to 30 weeks' gestation. Fetal fibronectin levels of 50 ng/mL or greater at 16 to 22 weeks identified 30 of 410 women (7.3%) with spontaneous preterm birth and 31 of 384 (8.1%) at 22 to 30 weeks. The area under the receiver operating characteristic curve for screening between 22 and 30 weeks for fetal fibronectin level alone was 0.59 (95% CI, 0.56-0.62), for transvaginal cervical length alone was 0.67 (95% CI, 0.64-0.70), and for the combination as continuous variables was 0.67 (95% CI, 0.64-0.70). CONCLUSIONS AND RELEVANCE Among nulliparous women with singleton pregnancies, quantitative vaginal fetal fibronectin and serial transvaginal ultrasound cervical length had low predictive accuracy for spontaneous preterm birth. These findings do not support routine use of these tests in such women.	[Esplin, M. Sean; Silver, Robert M.] Intermt Healthcare, Salt Lake City, UT USA; [Esplin, M. Sean; Silver, Robert M.] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA; [Elovitz, Michal A.; Parry, Samuel] Univ Penn, Philadelphia, PA 19104 USA; [Iams, Jay D.] Ohio State Univ, Columbus, OH 43210 USA; [Parker, Corette B.; Hunter, Shannon M.] RTI Int, Res Triangle Pk, NC USA; [Wapner, Ronald J.] Columbia Univ, New York, NY USA; [Grobman, William A.; Peaceman, Alan M.] Northwestern Univ, Evanston, IL USA; [Simhan, Hyagriv N.; Caritis, Steve N.] Univ Pittsburgh, Pittsburgh, PA USA; [Wing, Deborah A.; Wadhwa, Pathik] Univ Calif Irvine, Irvine, CA 92717 USA; [Haas, David M.; Foroud, Tatiana] Indiana Univ, Bloomington, IN 47405 USA; [Hoffman, Matthew K.] Christiana Care, Newark, DE USA; [Mercer, Brian M.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Saade, George R.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	Intermountain Healthcare; Intermountain Medical Center; Utah System of Higher Education; University of Utah; University of Pennsylvania; University System of Ohio; Ohio State University; Research Triangle Institute; Columbia University; Northwestern University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Irvine; Indiana University System; Indiana University Bloomington; Christiana Care Health System; Case Western Reserve University; University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Esplin, MS (corresponding author), Intermt Healthcare, 5121 S Cottonwood St,Ste 100, Murray, UT 84107 USA.	sean.esplin@imail.org	Gicquel, Coralie/AAW-2310-2021	Parker, Corette/0000-0002-6822-6845; Wapner, Ronald/0000-0003-0727-1244; Elovitz, Michal/0000-0001-7554-7180	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [U10 HD063036]; Case Western Reserve University [U10 HD063072]; Columbia University [U10 HD063047]; Indiana University [U10 HD063037]; Magee-Women's Hospital [U10 HD063041]; Northwestern University [U10 HD063020]; University of California at Irvine [U10 HD063046]; University of Pennsylvania [U10 HD063048]; University of Utah [U10 HD063053]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD063048, U10HD063041, U10HD063020, U10HD063072, U10HD063053, U10HD063037, U10HD063047, U10HD063036, U10HD063046] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001414] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Case Western Reserve University; Columbia University; Indiana University; Magee-Women's Hospital; Northwestern University; University of California at Irvine; University of Pennsylvania; University of Utah; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study is supported by grant funding from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) to Research Triangle Institute (U10 HD063036); Case Western Reserve University (U10 HD063072); Columbia University (U10 HD063047); Indiana University (U10 HD063037); Magee-Women's Hospital (U10 HD063041); Northwestern University (U10 HD063020); University of California at Irvine (U10 HD063046); University of Pennsylvania (U10 HD063048); and University of Utah (U10 HD063053). Hologic USA (Marlborough, Massachusetts) provided fetal fibronectin collection kits and prepaid shipping materials and performed the fetal fibronectin assays in a blinded fashion and without charge.	Abbott DS, 2015, OBSTET GYNECOL, V125, P1168, DOI 10.1097/AOG.0000000000000754; Behrman RE, 2007, PRETERM BIRTH CAUSES; Berghella V, 2012, OBSTET GYNECOL SURV, V67, P653, DOI 10.1097/OGX.0b013e318270d5b2; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Bolt LA, 2011, J MATERN-FETAL NEO M, V24, P928, DOI 10.3109/14767058.2010.535872; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Crane JMG, 2008, ULTRASOUND OBST GYN, V31, P579, DOI 10.1002/uog.5323; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deshpande SN, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17400; Faron G, 1997, BRIT J OBSTET GYNAEC, V104, P697, DOI 10.1111/j.1471-0528.1997.tb11980.x; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; Foster C, 2014, BIOMARK MED, V8, P471, DOI 10.2217/bmm.14.28; Goldenberg RL, 1996, OBSTET GYNECOL, V87, P643, DOI 10.1016/0029-7844(96)00035-X; Goldenberg RL, 2006, AM J OBSTET GYNECOL, V195, P792, DOI 10.1016/j.ajog.2006.05.050; Greenhagen JB, 1996, AM J OBSTET GYNECOL, V175, P1054, DOI 10.1016/S0002-9378(96)80052-4; Haas DM, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.019; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; HELLEMANS P, 1995, BRIT J OBSTET GYNAEC, V102, P207, DOI 10.1111/j.1471-0528.1995.tb09095.x; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Iams JD, 2013, AM J OBSTET GYNECOL, V209; Khalifeh A, 2017, J MATERN-FETAL NEO M, V30, P1500, DOI 10.1080/14767058.2016.1220521; Kuhrt K, 2016, ULTRASOUND OBST GYN, V47, P104, DOI 10.1002/uog.14865; Kurtzman J, 2009, AM J OBSTET GYNECOL, V200; Miller ES, 2015, OBSTET GYNECOL, V126, P61, DOI 10.1097/AOG.0000000000000864; Orzechowski KM, 2014, OBSTET GYNECOL, V124, P520, DOI 10.1097/AOG.0000000000000428; Parry S, 2014, CLIN OBSTET GYNECOL, V57, P537, DOI 10.1097/GRF.0000000000000051; To MS, 2004, LANCET, V363, P1849, DOI 10.1016/S0140-6736(04)16351-4	28	96	108	2	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1047	1056		10.1001/jama.2017.1373	http://dx.doi.org/10.1001/jama.2017.1373			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291893	Green Submitted, Green Accepted			2022-12-28	WOS:000396713400017
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Punishing individuals won't prevent errors	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2017	356								j1279	10.1136/bmj.j1279	http://dx.doi.org/10.1136/bmj.j1279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4VK	28292771	Green Published, Bronze			2022-12-28	WOS:000426824900001
J	Costa, F; van Klaveren, D; James, S; Heg, D; Raber, L; Feres, F; Pilgrim, T; Hong, MK; Kim, HS; Colombo, A; Steg, PG; Zanchin, T; Palmerini, T; Wallentin, L; Bhatt, DL; Stone, GW; Windecker, S; Steyerberg, EW; Valgimigli, M				Costa, Francesco; van Klaveren, David; James, Stefan; Heg, Dik; Raber, Lorenz; Feres, Fausto; Pilgrim, Thomas; Hong, Myeong-Ki; Kim, Hyo-Soo; Colombo, Antonio; Steg, Philippe Gabriel; Zanchin, Thomas; Palmerini, Tullio; Wallentin, Lars; Bhatt, Deepak L.; Stone, Gregg W.; Windecker, Stephan; Steyerberg, Ewout W.; Valgimigli, Marco		PRECISE-DAPT Study Investigators	Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials	LANCET			English	Article							ACUTE CORONARY SYNDROMES; DRUG-ELUTING STENTS; ACUTE MYOCARDIAL-INFARCTION; BARE-METAL STENTS; RISK STRATIFICATION; DURATION; CLOPIDOGREL; EFFICACY; IMPACT; INTERVENTION	Background Dual antiplatelet therapy (DAPT) with aspirin plus a P2Y(12) inhibitor prevents ischaemic events after coronary stenting, but increases bleeding. Guidelines support weighting bleeding risk before the selection of treatment duration, but no standardised tool exists for this purpose. Methods A total of 14 963 patients treated with DAPT after coronary stenting-largely consisting of aspirin and clopidogrel and without indication to oral anticoagulation-were pooled at a single-patient level from eight multicentre randomised clinical trials with independent adjudication of events. Using Cox proportional hazards regression, we identified predictors of out-of-hospital Thrombosis in Myocardial Infarction (TIMI) major or minor bleeding stratified by trial, and developed a numerical bleeding risk score. The predictive performance of the novel score was assessed in the derivation cohort and validated in patients treated with percutaneous coronary intervention from the PLATelet inhibition and patient Outcomes (PLATO) trial (n=8595) and BernPCI registry (n=6172). The novel score was assessed within patients randomised to different DAPT durations (n=10 081) to identify the effect on bleeding and ischaemia of a long (12-24 months) or short (3-6 months) treatment in relation to baseline bleeding risk. Findings The PRECISE-DAPT score (age, creatinine clearance, haemoglobin, white-blood-cell count, and previous spontaneous bleeding) showed a c-index for out-of-hospital TIMI major or minor bleeding of 0.73 (95% CI 0.61-0.85) in the derivation cohort, and 0.70 (0.65-0.74) in the PLATO trial validation cohort and 0.66 (0.61-0.71) in the BernPCI registry validation cohort. A longer DAPT duration significantly increased bleeding in patients at high risk (score >= 25), but not in those with lower risk profiles (p(interaction)=0.007), and exerted a significant ischaemic benefit only in this latter group. Interpretation The PRECISE-DAPT score is a simple five-item risk score, which provides a standardised tool for the prediction of out-of-hospital bleeding during DAPT. In the context of a comprehensive clinical evaluation process, this tool can support clinical decision making for treatment duration.	[Costa, Francesco; Raber, Lorenz; Pilgrim, Thomas; Zanchin, Thomas; Windecker, Stephan; Valgimigli, Marco] Univ Hosp Bern, Swiss Cardiovasc Ctr Bern, CH-3010 Bern, Switzerland; [Costa, Francesco; van Klaveren, David; Steyerberg, Ewout W.; Valgimigli, Marco] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [van Klaveren, David] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Costa, Francesco] Univ Messina, Policlin G Martino, Dept Clin & Expt Med, Messina, Italy; [James, Stefan; Wallentin, Lars] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [James, Stefan; Wallentin, Lars] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Heg, Dik] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Feres, Fausto] Ist Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Kim, Hyo-Soo] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea; [Colombo, Antonio] EMO GVM Ctr Cuore Columbus, Milan, Italy; [Colombo, Antonio] Ist Sci San Raffaele, Intervent Cardiol Dept, Milan, Italy; [Steg, Philippe Gabriel] Hop Xavier Bichat, AP HP, Dept Cardiol, Paris, France; [Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Cardiovasc Hosp, Seoul, South Korea; [Hong, Myeong-Ki] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Palmerini, Tullio] Univ Bologna, Dipartimento Cardiotoracovasc, Bologna, Italy; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Bhatt, Deepak L.] Harvard Med Sch, Boston, MA USA; [Stone, Gregg W.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA; [Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA	University of Bern; University Hospital of Bern; Erasmus University Rotterdam; Erasmus MC; Tufts Medical Center; AOU Policlinico Gaetano Martino; University of Messina; Uppsala University; Uppsala University; University of Bern; Seoul National University (SNU); Seoul National University Hospital; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Bologna; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Columbia University; NewYork-Presbyterian Hospital; Cardiovascular Research Foundation (CRF)	Valgimigli, M (corresponding author), Univ Hosp Bern, Swiss Cardiovasc Ctr Bern, CH-3010 Bern, Switzerland.	marco.valgimigli@insel.ch	Palmerini, Tullio/K-4543-2016; James, Stefan K/J-4554-2014; Costa, Francesco/O-1304-2019; STEG, Philippe Gabriel/Z-1567-2019; Colombo, Antonio/N-2960-2015; Pilgrim, Thomas/AAS-9120-2021; Valgimigli, Marco/AAE-9103-2019; van Klaveren, David/ABF-3020-2021	Costa, Francesco/0000-0002-3097-2834; Colombo, Antonio/0000-0002-2940-2455; Pilgrim, Thomas/0000-0001-8721-4068; Valgimigli, Marco/0000-0002-4353-7110; van Klaveren, David/0000-0002-2096-606X; Hong, Myeong-Ki/0000-0002-2090-2031; STEG, Philippe Gabriel/0000-0001-6896-2941; Heg, Dik/0000-0002-8766-7945	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS086294] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amin AP, 2013, J AM COLL CARDIOL, V61, P2130, DOI 10.1016/j.jacc.2013.02.044; Angiolillo DJ, 2012, DRUGS, V72, P2087, DOI 10.2165/11640880-000000000-00000; Baber U, 2016, J AM COLL CARDIOL, V67, P2224, DOI 10.1016/j.jacc.2016.02.064; Bohula EA, 2016, CIRCULATION, V134, P304, DOI 10.1161/CIRCULATIONAHA.115.019861; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Colombo A, 2014, J AM COLL CARDIOL, V64, P2086, DOI 10.1016/j.jacc.2014.09.008; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Genereux P, 2015, J AM COLL CARDIOL, V66, P1036, DOI 10.1016/j.jacc.2015.06.1323; Gurm HS, 2003, HEART, V89, P1200, DOI 10.1136/heart.89.10.1200; Gwon HC, 2012, CIRCULATION, V125, P505, DOI 10.1161/CIRCULATIONAHA.111.059022; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hijazi Z, 2016, LANCET, V387, P2302, DOI 10.1016/S0140-6736(16)00741-8; Kang L, 2015, STAT MED, V34, P685, DOI 10.1002/sim.6370; Kim BK, 2012, J AM COLL CARDIOL, V60, P1340, DOI 10.1016/j.jacc.2012.06.043; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; Navarese EP, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1618; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pilgrim T, 2014, LANCET, V384, P2111, DOI 10.1016/S0140-6736(14)61038-2; Raber L, 2012, JAMA-J AM MED ASSOC, V308, P777, DOI 10.1001/jama.2012.10065; Steyerberg E.W., 2019, CLIN PREDICTION MODE, DOI [10.1007/978-3-030-16399-0, DOI 10.1007/978-3-030-16399-0]; Subherwal S, 2009, CIRCULATION, V119, P1873, DOI 10.1161/CIRCULATIONAHA.108.828541; Tickoo S, 2016, AM J CARDIOL, V117, P201, DOI 10.1016/j.amjcard.2015.10.027; Valgimigli M, 2015, EUROINTERVENTION, V11, P68, DOI 10.4244/EIJV11I1A11; Valgimigli M, 2015, J AM COLL CARDIOL, V65, P805, DOI 10.1016/j.jacc.2014.11.053; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; van Klaveren D, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-5; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775; Yusuf S, 2001, NEW ENGL J MED, V345, P494	32	629	654	3	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					1025	1034		10.1016/S0140-6736(17)30397-5	http://dx.doi.org/10.1016/S0140-6736(17)30397-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN9UN	28290994				2022-12-28	WOS:000396345200024
J	Mehta, RH; Leimberger, JD; van Diepen, S; Meza, J; Wang, A; Jankowich, R; Harrison, RW; Hay, D; Fremes, S; Duncan, A; Soltesz, EG; Luber, J; Park, S; Argenziano, M; Murphy, E; Marcel, R; Kalavrouziotis, D; Nagpal, D; Bozinovski, J; Toller, W; Heringlake, M; Goodman, SG; Levy, JH; Harrington, RA; Anstrom, KJ; Alexander, JH				Mehta, R. H.; Leimberger, J. D.; van Diepen, S.; Meza, J.; Wang, A.; Jankowich, R.; Harrison, R. W.; Hay, D.; Fremes, S.; Duncan, A.; Soltesz, E. G.; Luber, J.; Park, S.; Argenziano, M.; Murphy, E.; Marcel, R.; Kalavrouziotis, D.; Nagpal, D.; Bozinovski, J.; Toller, W.; Heringlake, M.; Goodman, S. G.; Levy, J. H.; Harrington, R. A.; Anstrom, K. J.; Alexander, J. H.		LEVO-CTS Investigators	Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTERY-BYPASS SURGERY; CARDIOPULMONARY BYPASS; CALCIUM SENSITIZER; RANDOMIZED-TRIAL; OUTPUT SYNDROME; HEART-FAILURE; RATIONALE; DESIGN; MORTALITY; INFUSION	BACKGROUND Levosimendan is an inotropic agent that has been shown in small studies to prevent or treat the low cardiac output syndrome after cardiac surgery. METHODS In a multicenter, randomized, placebo-controlled, phase 3 trial, we evaluated the efficacy and safety of levosimendan in patients with a left ventricular ejection fraction of 35% or less who were undergoing cardiac surgery with the use of cardiopulmonary bypass. Patients were randomly assigned to receive either intravenous levosimendan (at a dose of 0.2 mu g per kilogram of body weight per minute for 1 hour, followed by a dose of 0.1 mu g per kilogram per minute for 23 hours) or placebo, with the infusion started before surgery. The two primary end points were a four-component composite of death through day 30, renal-replacement therapy through day 30, perioperative myocardial infarction through day 5, or use of a mechanical cardiac assist device through day 5; and a two-component composite of death through day 30 or use of a mechanical cardiac assist device through day 5. RESULTS A total of 882 patients underwent randomization, 849 of whom received levosimendan or placebo and were included in the modified intention-to-treat population. The four-component primary end point occurred in 105 of 428 patients (24.5%) assigned to receive levosimendan and in 103 of 421 (24.5%) assigned to receive placebo (adjusted odds ratio, 1.00; 99% confidence interval [ CI], 0.66 to 1.54; P = 0.98). The two-component primary end point occurred in 56 patients (13.1%) assigned to receive levosimendan and in 48 (11.4%) assigned to receive placebo (adjusted odds ratio, 1.18; 96% CI, 0.76 to 1.82; P = 0.45). The rate of adverse events did not differ significantly between the two groups. CONCLUSIONS Prophylactic levosimendan did not result in a rate of the short-term composite end point of death, renal-replacement therapy, perioperative myocardial infarction, or use of a mechanical cardiac assist device that was lower than the rate with placebo among patients with a reduced left ventricular ejection fraction who were undergoing cardiac surgery with the use of cardiopulmonary bypass. (Funded by Tenax Therapeutics; LEVO-CTS ClinicalTrials.gov number, NCT02025621.)	[Mehta, R. H.; Leimberger, J. D.; Meza, J.; Wang, A.; Harrison, R. W.; Levy, J. H.; Anstrom, K. J.; Alexander, J. H.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Jankowich, R.; Hay, D.] Tenax Therapeut, Morrisville, NC USA; [van Diepen, S.; Goodman, S. G.] Univ Alberta, Canadian VIGOUR Virtual Coordinating Ctr Global C, Edmonton, AB, Canada; [Fremes, S.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Kalavrouziotis, D.] Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Nagpal, D.] London Hlth Sci Ctr, London, ON, Canada; [Bozinovski, J.] Victoria Heart Inst Fdn, Victoria, BC, Canada; [Duncan, A.; Soltesz, E. G.] Cleveland Clin Fdn, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Park, S.] Univ Hosp Cleveland, Med Ctr, Cleveland, OH 44106 USA; [Luber, J.] Franciscan Hlth Syst, Tacoma, WA USA; [Argenziano, M.] Columbia Univ, Med Ctr, New York, NY USA; [Murphy, E.] Spectrum Hlth, Grand Rapids, MI USA; [Marcel, R.] Heart Hosp Baylor Plano, Plano, TX USA; [Toller, W.] Med Univ Graz, Graz, Austria; [Heringlake, M.] Univ Lubeck, Lubeck, Germany; [Harrington, R. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Duke University; University of Alberta; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Quebec Heart & Lung Institute; London Health Sciences Centre; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Columbia University; Michigan State University; Michigan State University College of Human Medicine; Medical University of Graz; University of Lubeck; Stanford University	Mehta, RH (corresponding author), Duke Hlth, Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	raj.mehta@duke.edu	Fremes, Stephen E/P-7928-2015; Heringlake, Matthias/AAJ-8249-2020; Alexander, John/GVS-7271-2022	Fremes, Stephen E/0000-0003-1723-3049; Meza, James/0000-0001-6462-4750; Murphy, Edward/0000-0001-8854-3736; Mazer, Cyril David/0000-0003-2566-4308; Alexander, John/0000-0002-1444-2462	Tenax Therapeutics; LEVO-CTS	Tenax Therapeutics; LEVO-CTS	Funded by Tenax Therapeutics; LEVO-CTS ClinicalTrials.gov number, NCT02025621.	Algarni KD, 2011, ANN THORAC SURG, V92, P1678, DOI 10.1016/j.athoracsur.2011.06.017; Antila S, 2007, CLIN PHARMACOKINET, V46, P535, DOI 10.2165/00003088-200746070-00001; Baysal A, 2014, J CARDIOTHOR VASC AN, V28, P586, DOI 10.1053/j.jvca.2013.09.004; Bridgewater B, 2007, HEART, V93, P744, DOI 10.1136/hrt.2006.106393; Caruba T, 2016, J CARDIOTHORAC SURG, V11, DOI 10.1186/s13019-016-0530-z; Cholley B, 2016, SFAR C FRENCH SOC AN; De Hert SG, 2007, ANESTH ANALG, V104, P766, DOI 10.1213/01.ane.0000256863.92050.d3; Ersoy O, 2013, CARDIOVASC J AFR, V24, P260, DOI 10.5830/CVJA-2013-047; Harrison RW, 2013, J CARDIOTHOR VASC AN, V27, P1224, DOI 10.1053/j.jvca.2013.03.027; Hillis LD, 2011, CIRCULATION, V124, pE652, DOI 10.1161/CIR.0b013e31823c074e; Leppikangas H, 2011, BRIT J ANAESTH, V106, P298, DOI 10.1093/bja/aeq402; Levin R, 2012, EXP CLIN CARDIOL, V17, P125; Levin RL, 2008, REV ESP CARDIOL, V61, P471; Lilleberg J, 1998, EUR HEART J, V19, P660, DOI 10.1053/euhj.1997.0806; Mehta RH, 2008, CIRCULATION, V117, P876, DOI 10.1161/CIRCULATIONAHA.107.728147; Mehta RH, 2016, AM HEART J, V182, P62, DOI 10.1016/j.ahj.2016.09.001; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nishimura RA, 2014, J THORAC CARDIOV SUR, V148, pE1, DOI 10.1016/j.jtcvs.2014.05.014; Prior David L, 2006, Heart Lung Circ, V15, P56, DOI 10.1016/j.hlc.2005.03.008; Thackray S, 2002, EUR J HEART FAIL, V4, P515, DOI 10.1016/S1388-9842(02)00041-7; Toller W, 2015, INT J CARDIOL, V184, P323, DOI 10.1016/j.ijcard.2015.02.022; Ukkonen H, 2000, CLIN PHARMACOL THER, V68, P522, DOI 10.1067/mcp.2000.110972; Zangrillo A, 2016, AM HEART J, V177, P66, DOI 10.1016/j.ahj.2016.03.021	23	158	172	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2017	376	21					2032	2042		10.1056/NEJMoa1616218	http://dx.doi.org/10.1056/NEJMoa1616218			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV7MC	28316276	Bronze			2022-12-28	WOS:000401959600006
J	Adashi, EY; Abelman, RHO				Adashi, Eli Y.; Abelman, Rachel H. Occhiogrosso			The Hyde Amendment at 40 Years and Reproductive Rights in the United States Perennial and Panoptic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Adashi, Eli Y.; Abelman, Rachel H. Occhiogrosso] Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, 101 Dudley St, Providence, RI 02905 USA.	eli_adashi@brown.edu						Shimabukuro JO, ABORTION JUDICIAL HI	1	9	9	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2017	317	15					1523	1524		10.1001/jama.2017.2742	http://dx.doi.org/10.1001/jama.2017.2742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES2YN	28301642				2022-12-28	WOS:000399393900007
J	Wang, XY; Moazed, D				Wang, Xiaoyi; Moazed, Danesh			DNA sequence-dependent epigenetic inheritance of gene silencing and histone H3K9 methylation	SCIENCE			English	Article							FISSION YEAST; HETEROCHROMATIN; RNAI; MAINTENANCE; NUCLEATION; DROSOPHILA; DYNAMICS; COMPLEX; STATES	Epigenetic inheritance mechanisms play fundamental roles in maintaining cellular memory of gene expression states. In fission yeast, histone H3 lysine 9 (H3K9) is methylated (H3K9me) at heterochromatic domains. These domains can be epigenetically inherited when epe1(+), encoding an enzyme that promotes H3K9 demethylation, is deleted. How native epigenetic states are stably maintained in epe1+ cells remains unknown. Here, we developed a system to examine the role of DNA sequence and genomic context in propagation of a cis-heritable H3K9me-dependent silenced state. We show that in epe1(+) cells, in addition to sequence-independent mechanisms that propagate H3K9me, epigenetic inheritance of silencing requires binding sites for sequence-dependent activating transcription factor (ATF)-adenosine 3',5'-monophosphate (cAMP) response element-binding protein (CREB) family transcription factors within their native chromosomal context. Thus, specific DNA sequences contribute to cis inheritance of H3K9me and silent epigenetic states.	[Wang, Xiaoyi; Moazed, Danesh] Harvard Med Sch, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Wang, Xiaoyi/AAD-9977-2019	Wang, Xiaoyi/0000-0001-9373-8730	NIH [GM072805]; China Scholarship Council award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072805] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China Scholarship Council award(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Thon for a gift of strain SPY6707, members of the Moazed lab for helpful discussions, and R. Behrouzi, M. Currie, N. Iglesias, G. Jih, and K. Ragunathan for comments on the manuscript. This work was supported by a grant from the NIH (GM072805) to D.M. and a China Scholarship Council award to X.W. D.M. is an investigator of the Howard Hughes Medical Institute.	Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Busturia A, 1997, DEVELOPMENT, V124, P4343; Cheng TH, 2000, GENE DEV, V14, P452; Ekwall K, 1997, CELL, V91, P1021, DOI 10.1016/S0092-8674(00)80492-4; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Radman-Livaja M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001075; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang JY, 2016, TRENDS GENET, V32, P284, DOI 10.1016/j.tig.2016.02.005; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	20	72	73	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2017	356	6333					88	91		10.1126/science.aaj2114	http://dx.doi.org/10.1126/science.aaj2114			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER3IA	28302794	Green Accepted			2022-12-28	WOS:000398689100044
J	Brouwer, I; Sitters, G; Candelli, A; Heerema, SJ; Heller, I; de, AJM; Zhang, HS; Normanno, D; Modesti, M; Peterman, EJG; Wuite, GJL				Brouwer, Ineke; Sitters, Gerrit; Candelli, Andrea; Heerema, Stephanie J.; Heller, Iddo; de, Abinadabe J. Melo; Zhang, Hongshan; Normanno, Davide; Modesti, Mauro; Peterman, Erwin J. G.; Wuite, Gijs J. L.			Sliding sleeves of XRCC4-XLF bridge DNA and connect fragments of broken DNA (vol 535, pg 566, 2016)	NATURE			English	Correction													Zhang, Hongshan/AAW-5348-2021; Candelli, Andrea/AAQ-1890-2020; Normanno, Davide/GLU-5689-2022; Brouwer, Ineke/AAU-4213-2020; Modesti, Mauro/D-6258-2017	Normanno, Davide/0000-0003-4740-5542; Brouwer, Ineke/0000-0002-9571-0966; Modesti, Mauro/0000-0002-4964-331X; wuite, gijs/0000-0002-5706-043X				Brouwer I, 2016, NATURE, V535, P566, DOI 10.1038/nature18643	1	1	1	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647								10.1038/nature22028	http://dx.doi.org/10.1038/nature22028			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28329769	Bronze			2022-12-28	WOS:000397619700062
J	Lu, X; Horner, JW; Paul, E; Shang, XY; Troncoso, P; Deng, PN; Jiang, S; Chang, Q; Spring, DJ; Sharma, P; Zebala, JA; Maeda, DY; Wang, YA; DePinho, RA				Lu, Xin; Horner, James W.; Paul, Erin; Shang, Xiaoying; Troncoso, Patricia; Deng, Pingna; Jiang, Shan; Chang, Qing; Spring, Denise J.; Sharma, Padmanee; Zebala, John A.; Maeda, Dean Y.; Wang, Y. Alan; DePinho, Ronald A.			Effective combinatorial immunotherapy for castration-resistant prostate cancer	NATURE			English	Article							TYROSINE KINASE INHIBITOR; SUPPRESSOR-CELLS; DOUBLE-BLIND; CHECKPOINT BLOCKADE; PHASE-III; DASATINIB; PLACEBO; MICROSATELLITE; IPILIMUMAB; SENESCENCE	A significant fraction of patients with advanced prostate cancer treated with androgen deprivation therapy experience relapse with relentless progression to lethal metastatic castration-resistant prostate cancer (mCRPC)(1). Immune checkpoint blockade using antibodies against cytotoxic-T-lymphocyte-associated protein 4 (CTLA4) or programmed cell death 1/programmed cell death 1 ligand 1 (PD1/PD-L1) generates durable therapeutic responses in a significant subset of patients across a variety of cancer types(2). However, mCRPC showed overwhelming de novo resistance to immune checkpoint blockade(3-5), motivating a search for targeted therapies that overcome this resistance. Myeloid-derived suppressor cells (MDSCs) are known to play important roles in tumour immune evasion(6). The abundance of circulating MDSCs correlates with prostate-specific antigen levels and metastasis in patients with prostate cancer(7-9). Mouse models of prostate cancer show that MDSCs (CD11b(+)Gr1(+)) promote tumour initiation(10) and progression(11). These observations prompted us to hypothesize that robust immunotherapy responses in mCRPC may be elicited by the combined actions of immune checkpoint blockade agents together with targeted agents that neutralize MDSCs yet preserve T-cell function. Here we develop a novel chimaeric mouse model of mCRPC to efficiently test combination therapies in an autochthonous setting. Combination of anti-CTLA4 and anti-PD1 engendered only modest efficacy. Targeted therapy against mCRPC-infiltrating MDSCs, using multikinase inhibitors such as cabozantinib and BEZ235, also showed minimal anti-tumour activities. Strikingly, primary and metastatic CRPC showed robust synergistic responses when immune checkpoint blockade was combined with MDSC-targeted therapy. Mechanistically, combination therapy efficacy stemmed from the upregulation of interleukin-1 receptor antagonist and suppression of MDSC-promoting cytokines secreted by prostate cancer cells. These observations illuminate a clinical path hypothesis for combining immune checkpoint blockade with MDSC-targeted therapies in the treatment of mCRPC.	[Lu, Xin; Shang, Xiaoying; Deng, Pingna; Spring, Denise J.; Wang, Y. Alan; DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Horner, James W.; Paul, Erin; Jiang, Shan; Chang, Qing] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Troncoso, Patricia] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Sharma, Padmanee] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Zebala, John A.; Maeda, Dean Y.] Syntrix Biosyst Inc, Auburn, WA 98001 USA; [Lu, Xin] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Notre Dame	Wang, YA; DePinho, RA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	yalanwang@mdanderson.org; rdepinho@mdanderson.org	Maeda, Dean/AAB-8973-2020	Maeda, Dean/0000-0002-9304-6846; Spring, Denise J./0000-0002-4593-0901	Department of Defense Prostate Cancer Research Program (PCRP) Idea Development Award-New Investigator Option [W81XWH-14-1-0576]; National Institutes of Health [R44HL072614]; Clayton & Modesta Williams Cancer Research Fund; Cancer Center Support Grant [P30CA016672];  [U01CA141508];  [P01CA117969]; NATIONAL CANCER INSTITUTE [U01CA141508, P01CA117969, P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL072614] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research Program (PCRP) Idea Development Award-New Investigator Option; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton & Modesta Williams Cancer Research Fund; Cancer Center Support Grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank N. Feng for advice on preclinical drug dosing; X. Xu and K. O'Connor for technical support on mES cells and chimaera generation; P. Jones and C. Carroll for providing <SUP>19</SUP>F NMR spectroscopy data; K. Zhao, Z. Xu, and Z. Fang for animal husbandry; F. Giancotti for suggestions on manuscript writing; A. Varma and J. W. Han for technical assistance; G. Wang, E.-J. Jin, P. Dey, and all members of the DePinho laboratory for a variety of technical support and suggestions. The project was supported by U01CA141508 (R.A.D.), P01CA117969 (R.A.D.), Department of Defense Prostate Cancer Research Program (PCRP) Idea Development Award-New Investigator Option W81XWH-14-1-0576 (X.L.), National Institutes of Health grant R44HL072614 (D.Y.M.), and the Clayton & Modesta Williams Cancer Research Fund (R.A.D.). Facility-based experimental support was provided by the Small Animal Imaging Facility (C. Kingsley, V. Tran, K. Maldonado, C. Kaffes), Flow Cytometry and Cellular Imaging Core Facility (J. Burks, D. Mak, and K. Dwyer), and Laboratory Animal Genetic Services (F. Benavides) at The University of Texas MD Anderson Cancer Center (Cancer Center Support Grant P30CA016672).	Ali K, 2014, NATURE, V510, P407, DOI 10.1038/nature13444; Araujo JC, 2013, LANCET ONCOL, V14, P1307, DOI 10.1016/S1470-2045(13)70479-0; Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Beer TM, 2017, J CLIN ONCOL, V35, P40, DOI 10.1200/JCO.2016.69.1584; Benavides F, 2000, MOL CARCINOGEN, V28, P191, DOI 10.1002/1098-2744(200008)28:4<191::AID-MC1>3.0.CO;2-K; Birbach A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053501; Bjornson ZB, 2013, CURR OPIN IMMUNOL, V25, P484, DOI 10.1016/j.coi.2013.07.004; Brusa D, 2013, INT J UROL, V20, P971, DOI 10.1111/iju.12086; Carlo MI, 2016, ONCOLOGIST, V21, P787, DOI 10.1634/theoncologist.2016-0145; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Costa C, 2015, CANCER CELL, V27, P97, DOI 10.1016/j.ccell.2014.11.007; De Henau O, 2016, NATURE, V539, P443, DOI 10.1038/nature20554; Di Mitri D, 2014, NATURE, V515, P134, DOI 10.1038/nature13638; Ding ZH, 2012, CELL, V148, P896, DOI 10.1016/j.cell.2012.01.039; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Fazio N, 2016, ANTICANCER RES, V36, P713; Frick A, 2015, PHARMACOGEN PERS MED, V8, P81, DOI 10.2147/PGPM.S73312; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Nguyen HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063219; Hossain DMS, 2015, CLIN CANCER RES, V21, P3771, DOI 10.1158/1078-0432.CCR-14-3145; Jia SD, 2013, CANCER DISCOV, V3, P44, DOI 10.1158/2159-8290.CD-12-0262; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kim K, 2014, P NATL ACAD SCI USA, V111, P11774, DOI 10.1073/pnas.1410626111; Kwon ED, 2014, LANCET ONCOL, V15, P700, DOI 10.1016/S1470-2045(14)70189-5; Lu X, 2011, CANCER CELL, V20, P701, DOI 10.1016/j.ccr.2011.11.002; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Peng WY, 2016, CANCER DISCOV, V6, P202, DOI 10.1158/2159-8290.CD-15-0283; Rivera LB, 2015, CELL REP, V11, P577, DOI 10.1016/j.celrep.2015.03.055; Saha BK, 1996, J IMMUNOL METHODS, V194, P77, DOI 10.1016/0022-1759(96)00065-8; Schade AE, 2008, BLOOD, V111, P1366, DOI 10.1182/blood-2007-04-084814; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Smith M, 2016, J CLIN ONCOL, V34, P3005, DOI 10.1200/JCO.2015.65.5597; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Tu S, 2008, CANCER CELL, V14, P408, DOI 10.1016/j.ccr.2008.10.011; Vitali R, 2009, INT J CANCER, V125, P2547, DOI 10.1002/ijc.24606; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; Wang GC, 2016, CANCER DISCOV, V6, P80, DOI 10.1158/2159-8290.CD-15-0224; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Yuen AKL, 2005, TETRAHEDRON LETT, V46, P7899, DOI 10.1016/j.tetlet.2005.09.101	43	299	318	8	243	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					728	+		10.1038/nature21676	http://dx.doi.org/10.1038/nature21676			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28321130	Green Accepted			2022-12-28	WOS:000397619700058
J	Pastorek, NJ				Pastorek, Norman J.			The Female Beautiful Face	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pastorek, Norman J.] Weill Cornell Ctr, Clin New York Presbyterian Hosp, Facial Plast Surg, New York, NY 10065 USA	Cornell University; NewYork-Presbyterian Hospital; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Pastorek, NJ (corresponding author), Weill Cornell Ctr, Clin New York Presbyterian Hosp, Facial Plast Surg, New York, NY 10065 USA.	drpastorek@gmail.com							0	1	1	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1198	1200		10.1001/jama.2017.1797	http://dx.doi.org/10.1001/jama.2017.1797			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350904				2022-12-28	WOS:000397557800001
J	Enserink, M				Enserink, Martin			FISHY BUSINESS	SCIENCE			English	Editorial Material																			0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1254	1257		10.1126/science.355.6331.1254	http://dx.doi.org/10.1126/science.355.6331.1254			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336620				2022-12-28	WOS:000397082900013
J	Belle, M; Godefroy, D; Couly, G; Malone, SA; Collier, F; Giacobini, P; Chedotal, A				Belle, Morgane; Godefroy, David; Couly, Gerard; Malone, Samuel A.; Collier, Francis; Giacobini, Paolo; Chedotal, Alain			Tridimensional Visualization and Analysis of Early Human Development	CELL			English	Article							HUMAN-EMBRYOS; ANATOMICAL ONTOLOGY; MULLERIAN DUCT; SPINAL-CORD; SYSTEM; EXPRESSION; CELL; GENE; MECHANISMS; MOUSE	Generating a precise cellular and molecular cartography of the human embryo is essential to our understanding of the mechanisms of organogenesis in normal and pathological conditions. Here, we have combined whole-mount immunostaining, 3DISCO clearing, and light-sheet imaging to start building a 3D cellular map of the human development during the first trimester of gestation. We provide high-resolution 3D images of the developing peripheral nervous, muscular, vascular, cardiopulmonary, and urogenital systems. We found that the adult-like pattern of skin innervation is established before the end of the first trimester, showing important intra-and inter- individual variations in nerve branches. We also present evidence for a differential vascularization of the male and female genital tracts concomitant with sex determination. This work paves the way for a cellular and molecular reference atlas of human cells, which will be of paramount importance to understanding human development in health and disease.	[Belle, Morgane; Godefroy, David; Couly, Gerard; Chedotal, Alain] UPMC Univ Paris 06, Sorbonne Univ, CNRS, Inst Vis,INSERM, 17 Rue Moreau, F-75012 Paris, France; [Malone, Samuel A.; Giacobini, Paolo] Univ Lille, UMR S 1172, JPArc Ctr Rech Jean Pierre AUBERT Neurosci & Canc, F-59000 Lille, France; [Malone, Samuel A.; Giacobini, Paolo] INSERM, Lab Dev & Plast Neuroendocrine Brain, UMR S 1172, F-59000 Lille, France; [Collier, Francis; Giacobini, Paolo] Univ Lille, Sch Med, FHU Days Hlth 1000, F-5900 Lille, France; [Collier, Francis] CHU Lille, Hosp Jeanne Flandres, Gynaecol Serv, F-59000 Lille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Franche-Comte; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Universite de Lille - ISITE; CHU Lille	Chedotal, A (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, Inst Vis,INSERM, 17 Rue Moreau, F-75012 Paris, France.	alain.chedotal@inserm.fr	giacobini, paolo/P-5451-2015; Giacobini, Paolo/P-9878-2019; Chedotal, Alain/F-2750-2017	giacobini, paolo/0000-0002-3075-1441; Giacobini, Paolo/0000-0002-3075-1441; Chedotal, Alain/0000-0001-7577-3794; Malone, Samuel/0000-0002-6824-6854; Belle, Morgane/0000-0003-2081-061X; Godefroy, David/0000-0003-4706-2711	Institut National de la Sante et de la Recherche Medicale (INSERM), France [U1172]; Agence Nationale de la Recherche (ANR), France [ANR-14-CE12-0015-01, ANR-14-CE13-0004-01]; French state funds [ANR-10-LABX-65, ANR-11-IDEX-0004-02]; midwives of the Gynaecology Department; Jeanne de Flandres Hospital of Lille (Centre d'Orthogenie), France	Institut National de la Sante et de la Recherche Medicale (INSERM), France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche (ANR), France(French National Research Agency (ANR)); French state funds; midwives of the Gynaecology Department; Jeanne de Flandres Hospital of Lille (Centre d'Orthogenie), France	We thank the midwives of the Gynaecology Department, Jeanne de Flandres Hospital of Lille (Centre d'Orthogenie), France, for their assistance and support. We also thank Robin Vigouroux, Reha Erzurumlu, and Peter Kozulin for correcting the manuscript, Yorick Gitton and Stephane Fouquet (Institut de la Vision, Imaging Facility) for their help with the database, and Olivier Pourquie, Domna Karagogeos, William Stallcup, Carmen Birchmeier, and Jean-Francois Brunet for kindly providing some antibodies. Myog and Pax7 antibodies were obtained from the Developmental Studies Hybridoma Bank. We are also grateful to Olivier Pourquie, Jose Sahel, Constantino Sotelo, and Nicole Le Douarin for helpful discussions. This work was supported by the Institut National de la Sante et de la Recherche Medicale (INSERM), France (grant number U1172), Agence Nationale de la Recherche (ANR), France (ANR-14-CE12-0015-01 to P.G., ANR-14-CE13-0004-01 to A.C.). It was performed in the frame of the LABEX LIFESENSES (reference ANR-10-LABX-65) supported by French state funds managed by the ANR within the Investissements d'Avenir programme under reference ANR-11-IDEX-0004-02.	Abe S, 2010, J ANAT, V217, P167, DOI 10.1111/j.1469-7580.2010.01246.x; Aven L, 2013, ORGANOGENESIS, V9, P194, DOI 10.4161/org.24842; Baken L, 2015, J CLIN ULTRASOUND, V43, P164, DOI 10.1002/jcu.22207; Bastide P, 2007, J CELL BIOL, V178, P635, DOI 10.1083/jcb.200704152; Belle M, 2014, CELL REP, V9, P1191, DOI 10.1016/j.celrep.2014.10.037; Betters E, 2010, DEV BIOL, V344, P578, DOI 10.1016/j.ydbio.2010.05.012; Blechschmidt E., 1977, BEGINNINGS HUMAN LIF; Bondurand N, 1998, FEBS LETT, V432, P168, DOI 10.1016/S0014-5793(98)00843-6; Bondurand N, 2013, DEV BIOL, V382, P330, DOI 10.1016/j.ydbio.2013.04.024; Breiteneder-Geleff S, 1999, AM J PATHOL, V154, P385, DOI 10.1016/S0002-9440(10)65285-6; Brennan J, 2002, DEV BIOL, V244, P418, DOI 10.1006/dbio.2002.0578; Bryson-Richardson RJ, 2008, NAT REV GENET, V9, P632, DOI 10.1038/nrg2369; Casoni F, 2016, DEVELOPMENT, V143, P3969, DOI 10.1242/dev.139444; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; de Bakker BS, 2016, SCIENCE, V354, DOI 10.1126/science.aag0053; De la Cuadra-Blanco C, 2013, SCI WORLD J, DOI 10.1155/2013/716962; des Portes V, 1998, HUM MOL GENET, V7, P1063, DOI 10.1093/hmg/7.7.1063; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Elima K., 2005, HEMATOLOGY, V106, P1; Erturk A, 2012, NAT MED, V18, P166, DOI 10.1038/nm.2600; Espinosa-Medina I, 2014, SCIENCE, V345, P87, DOI 10.1126/science.1253286; Fritsch H, 2012, J ANAT, V220, P363, DOI 10.1111/j.1469-7580.2011.01472.x; Fujimoto Toyoaki, 2001, Congenital Anomalies, V41, P67, DOI 10.1111/j.1741-4520.2001.tb00875.x; Galambos C, 2007, PEDIATR DEVEL PATHOL, V10, P1, DOI 10.2350/06-06-0122.1; GASSER RF, 1967, AM J ANAT, V120, P357, DOI 10.1002/aja.1001200207; Georgas KM, 2015, DEVELOPMENT, V142, P1893, DOI 10.1242/dev.117903; GILBERT PERRY W., 1957, CARNEGIE INST WASHINGTON PUBL 611 CONTR EMBRYOL, V36, P59; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Hanley NA, 2000, MECH DEVELOP, V91, P403, DOI 10.1016/S0925-4773(99)00307-X; Hashimoto R, 2003, ANAT REC PART A, V272A, P514, DOI 10.1002/ar.a.10061; Hassan BA, 2015, CELL, V163, P285, DOI 10.1016/j.cell.2015.09.031; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; HERSCH M, 1980, CHEM SENSES, V5, P331, DOI 10.1093/chemse/5.4.331; His W., 1881, ANATOMIE MENSCHLICHE; Jacob M., 2012, THE HUMAN EMBRYO, P143; Jakab A, 2015, NEUROIMAGE, V111, P277, DOI 10.1016/j.neuroimage.2015.02.038; Kanahashi T, 2016, ANAT REC, V299, P8, DOI 10.1002/ar.23281; Karagogeos D, 1997, J COMP NEUROL, V379, P415, DOI 10.1002/(SICI)1096-9861(19970317)379:3<415::AID-CNE7>3.0.CO;2-6; Keibel F, 1908, NORMENTAFELN ENTWICK; Keibel F., 1910, MANUAL HUMAN EMBRYOL, V1; KING DF, 1986, AM J DERMATOPATH, V8, P168, DOI 10.1097/00000372-198604000-00013; Little MH, 2007, GENE EXPR PATTERNS, V7, P680, DOI 10.1016/j.modgep.2007.03.002; Locher H, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-20; Ludwig K, 2005, ANAT EMBRYOL, V209, P439, DOI 10.1007/s00429-005-0460-3; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Mall FP, 1904, AM J ANAT, V4, P1; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Morgan Lynn, 2009, ICONS LIFE CULTURAL, DOI DOI 10.1525/9780520944725; Nakayama A, 2015, CELL TISSUE RES, V359, P743, DOI 10.1007/s00441-014-2076-5; Norman J. R., 1923, Journal of the Royal Microscopical Society, V1923, P37; O'Brien LL, 2016, DEVELOPMENT, V143, P595, DOI 10.1242/dev.127175; O'Rahilly R., 1987, CARNEGIE I WASHINGT, V637; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; ORAHILLY R, 1983, ANAT EMBRYOL, V166, P247, DOI 10.1007/BF00305086; Orvis GD, 2007, DEV BIOL, V306, P493, DOI 10.1016/j.ydbio.2007.03.027; Pan CC, 2016, NAT METHODS, V13, P859, DOI 10.1038/nmeth.3964; Parera MC, 2005, AM J PHYSIOL-LUNG C, V288, pL141, DOI 10.1152/ajplung.00148.2004; PARYSEK LM, 1988, NEURON, V1, P395, DOI 10.1016/0896-6273(88)90189-4; Pooh RK, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.07.028; Renier N, 2016, CELL, V165, P1789, DOI 10.1016/j.cell.2016.05.007; Renier N, 2014, CELL, V159, P896, DOI 10.1016/j.cell.2014.10.010; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; Sabin FR, 1909, AM J ANAT, V9, P43, DOI 10.1002/aja.1000090104; Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007; Sparrow MP, 1999, AM J RESP CELL MOL, V20, P550, DOI 10.1165/ajrcmb.20.4.3385; Tellier AL, 2000, AM J MED GENET, V93, P85, DOI 10.1002/1096-8628(20000717)93:2<85::AID-AJMG1>3.0.CO;2-B; Unver Dogan N, 2010, CLIN ANAT, V23, P234, DOI 10.1002/ca.20906; Weisstanner C, 2015, CLIN NEURORADIOL, V25, P189, DOI 10.1007/s00062-015-0413-z; Yamada S, 2010, DEV DYNAM, V239, P1585, DOI 10.1002/dvdy.22316; Yang Y, 2014, J CLIN INVEST, V124, P888, DOI 10.1172/JCI71609; Zawilinski J, 2001, ANN ANAT, V183, P331, DOI 10.1016/S0940-9602(01)80175-8	74	163	169	3	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1								10.1016/j.cell.2017.03.008	http://dx.doi.org/10.1016/j.cell.2017.03.008			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340341	Green Submitted, Bronze			2022-12-28	WOS:000397090000016
J	Hnisz, D; Shrinivas, K; Young, RA; Chakraborty, AK; Sharp, PA				Hnisz, Denes; Shrinivas, Krishna; Young, Richard A.; Chakraborty, Arup K.; Sharp, Phillip A.			A Phase Separation Model for Transcriptional Control	CELL			English	Review							STOCHASTIC GENE-EXPRESSION; CELL-FREE FORMATION; RNA-POLYMERASE-II; SUPER-ENHANCERS; ACTIVATION; RESISTANCE; IDENTITY; GRANULES; MEDIATOR; DOMAINS	Phase-separated multi-molecular assemblies provide a general regulatory mechanism to compartmentalize biochemical reactions within cells. We propose that a phase separation model explains established and recently described features of transcriptional control. These features include the formation of super-enhancers, the sensitivity of super-enhancers to perturbation, the transcriptional bursting patterns of enhancers, and the ability of an enhancer to produce simultaneous activation at multiple genes. This model provides a conceptual framework to further explore principles of gene control in mammals.	[Hnisz, Denes; Young, Richard A.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Shrinivas, Krishna; Chakraborty, Arup K.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Young, Richard A.; Sharp, Phillip A.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Chakraborty, Arup K.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shrinivas, Krishna; Chakraborty, Arup K.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Shrinivas, Krishna; Chakraborty, Arup K.] MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA; [Shrinivas, Krishna; Chakraborty, Arup K.] Harvard Univ, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Chakraborty, AK (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Young, RA; Sharp, PA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, Cambridge, MA 02139 USA.; Chakraborty, AK (corresponding author), Harvard Univ, Cambridge, MA 02139 USA.; Sharp, PA (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	young@wi.mit.edu; arupc@mit.edu; sharppa@mit.edu	Shrinivas, Krishna/ABF-1250-2020; Hnisz, Denes/AAE-9592-2019; Young, Richard A/F-6495-2012	Shrinivas, Krishna/0000-0002-4167-9385; Hnisz, Denes/0000-0002-6256-1693; Young, Richard A/0000-0001-8855-8647	NIH [HG002668, P01-CA042063]; Austrian Science Fund FWF [J3490]; Margaret and Herman Sokol Postdoctoral Award; National Cancer Institute [P30-CA14051]; NATIONAL CANCER INSTITUTE [R01CA133404, P30CA014051, P01CA042063] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Science Fund FWF(Austrian Science Fund (FWF)); Margaret and Herman Sokol Postdoctoral Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	P.A.S. and R.A.Y. thank the MIT students in their course "Structure and Functions of the Nucleus'' for discussions. We are grateful to Mehran Kardar, Steve McKnight, Ben Sabari, and Tony Lee for comments. The work was supported by an NIH grant (HG002668) (to R.A.Y.), an Erwin Schrodinger Fellowship (J3490) from the Austrian Science Fund FWF (to D.H.), a Margaret and Herman Sokol Postdoctoral Award (to D.H.), and an NIH grant (P01-CA042063) (to P.A.S.). This work was supported, in part, by a Koch Institute Support (core) grant (P30-CA14051) from the National Cancer Institute (to P.A.S). R.A.Y. is a founder of Syros Pharmaceuticals and Marauder Therapeutics.	Banani S. F., 2017, NAT REV MOL CELL BIO; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; BENOIST C, 1981, NATURE, V290, P304, DOI 10.1038/290304a0; Bergeron-Sandoval LP, 2016, CELL, V165, P1067, DOI 10.1016/j.cell.2016.05.026; Berry J, 2015, P NATL ACAD SCI USA, V112, pE5237, DOI 10.1073/pnas.1509317112; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Bulger M, 2011, CELL, V144, P327, DOI 10.1016/j.cell.2011.01.024; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chen HM, 2016, GENE DEV, V30, P1796, DOI 10.1101/gad.281725.116; Chipumuro E, 2014, CELL, V159, P1126, DOI 10.1016/j.cell.2014.10.024; Cho WK, 2016, ELIFE, V5, DOI 10.7554/eLife.13617; Christensen CL, 2014, CANCER CELL, V26, P909, DOI 10.1016/j.ccell.2014.10.019; Cisse II, 2013, SCIENCE, V341, P664, DOI 10.1126/science.1239053; COHEN RJ, 1982, J PHYS CHEM-US, V86, P3696, DOI 10.1021/j100216a005; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Falvo JV, 1995, CELL, V83, P1101, DOI 10.1016/0092-8674(95)90137-X; Feric M, 2016, CELL, V165, P1686, DOI 10.1016/j.cell.2016.04.047; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Fukaya T, 2016, CELL, V166, P358, DOI 10.1016/j.cell.2016.05.025; Gemayel R, 2015, MOL CELL, V59, P615, DOI 10.1016/j.molcel.2015.07.003; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; GRUSS P, 1981, P NATL ACAD SCI-BIOL, V78, P943, DOI 10.1073/pnas.78.2.943; Hah N, 2015, P NATL ACAD SCI USA, V112, pE297, DOI 10.1073/pnas.1424028112; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hay D, 2016, NAT GENET, V48, P895, DOI 10.1038/ng.3605; Hnisz D, 2016, SCIENCE, V351, P1454, DOI 10.1126/science.aad9024; Hnisz D, 2015, MOL CELL, V58, P362, DOI 10.1016/j.molcel.2015.02.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007; Jiang TT, 2016, NUCLEIC ACIDS RES, V44, P8714, DOI 10.1093/nar/gkw568; JOHNSON AD, 1979, P NATL ACAD SCI USA, V76, P5061, DOI 10.1073/pnas.76.10.5061; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Lai F, 2014, CURR OPIN GENET DEV, V25, P38, DOI 10.1016/j.gde.2013.11.017; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Merika M, 1998, MOL CELL, V1, P277, DOI 10.1016/S1097-2765(00)80028-3; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Pefanis E, 2015, CELL, V161, P774, DOI 10.1016/j.cell.2015.04.034; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Proudhon C, 2016, CELL REP, V15, P2159, DOI 10.1016/j.celrep.2016.04.087; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Semenov AN, 1998, MACROMOLECULES, V31, P1373, DOI 10.1021/ma970616h; Shin HY, 2016, NAT GENET, V48, P904, DOI 10.1038/ng.3606; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Shu SK, 2016, NATURE, V529, P413, DOI 10.1038/nature16508; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Sigova AA, 2013, P NATL ACAD SCI USA, V110, P2876, DOI 10.1073/pnas.1221904110; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stathis A, 2016, CANCER DISCOV, V6, P492, DOI 10.1158/2159-8290.CD-15-1335; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Thanos D, 1995, CELL, V83, P1091, DOI 10.1016/0092-8674(95)90136-1; TJIAN R, 1994, CELL, V77, P5, DOI 10.1016/0092-8674(94)90227-5; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Wang YB, 2015, CELL, V163, P174, DOI 10.1016/j.cell.2015.08.063; Wheeler JR, 2016, ELIFE, V5, DOI 10.7554/eLife.18413; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Zhu L, 2015, CURR OPIN CELL BIOL, V34, P23, DOI 10.1016/j.ceb.2015.04.003; Zoller B, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156257	81	831	842	11	208	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					13	23		10.1016/j.cell.2017.02.007	http://dx.doi.org/10.1016/j.cell.2017.02.007			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340338	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000397090000004
J	Tan, TSE; Abdulla, O				Tan, Timothy Shao Ern; Abdulla, Omar			SPOT DIAGNOSIS An easily mistaken pulmonary opacity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Tan, Timothy Shao Ern; Abdulla, Omar] Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Preston, Lancs, England	Royal Preston Hospital	Tan, TSE (corresponding author), Lancashire Teaching Hosp NHS Fdn Trust, Royal Preston Hosp, Preston, Lancs, England.	timothy.tan.shao.ern@doctors.org.uk		Tan, Timothy Shao Ern/0000-0001-9297-4598				Agarwal R, 2008, RESP MED, V102, P382, DOI 10.1016/j.rmed.2007.10.017; Gude D, 2011, INDIAN J MED PAEDIAT, V32, P204, DOI 10.4103/0971-5851.95141; Karkhanis VS, 2012, OPEN ACCESS EMERG M, V4, P31, DOI 10.2147/OAEM.S29942	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2017	356								j1188	10.1136/bmj.j1188	http://dx.doi.org/10.1136/bmj.j1188			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IZ	28336512				2022-12-28	WOS:000397345500002
J	Snowdon, CT				Snowdon, Charles T.			LANGUAGE DEVELOPMENT Learning from monkey "talk" Nonhuman primates are capable of several key elements of human language	SCIENCE			English	Editorial Material							TURN-TAKING; COMMUNICATION		[Snowdon, Charles T.] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Snowdon, CT (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	snowdon@wisc.edu						Boe LJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169321; Calcutt SE, 2014, BEHAVIOUR, V151, P1967, DOI 10.1163/1568539X-00003225; Chow CP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0069; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; Fitch WT, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600723; Frohlich M, 2016, SCI REP-UK, V6, DOI 10.1038/srep25887; Goldstein MH, 2003, P NATL ACAD SCI USA, V100, P8030, DOI 10.1073/pnas.1332441100; Janik VM, 1997, ADV STUD BEHAV, V26, P59, DOI 10.1016/S0065-3454(08)60377-0; Levinson SC, 2016, TRENDS COGN SCI, V20, P6, DOI 10.1016/j.tics.2015.10.010; LIEBERMAN PH, 1969, SCIENCE, V164, P1185, DOI 10.1126/science.164.3884.1185; Melis AP, 2016, PSYCHOL SCI, V27, P987, DOI 10.1177/0956797616644070; Pfennig A. R., 2014, SCIENCE, V346; Snowdon CT, 2009, ADV STUD BEHAV, V40, P239, DOI 10.1016/S0065-3454(09)40007-X; Takahashi DY, 2015, SCIENCE, V349, P734, DOI 10.1126/science.aab1058; Takahashi DY, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0370	15	22	22	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1120	1122		10.1126/science.aam7443	http://dx.doi.org/10.1126/science.aam7443			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302806				2022-12-28	WOS:000396351200016
J	Holler, M; Guizar-Sicairos, M; Tsai, EHR; Dinapoli, R; Muller, E; Bunk, O; Raabe, J; Aeppli, G				Holler, Mirko; Guizar-Sicairos, Manuel; Tsai, Esther H. R.; Dinapoli, Roberto; Muller, Elisabeth; Bunk, Oliver; Raabe, Jorg; Aeppli, Gabriel			High-resolution non-destructive three-dimensional imaging of integrated circuits	NATURE			English	Article							COMPUTED-TOMOGRAPHY	Modern nanoelectronics(1,2) has advanced to a point at which it is impossible to image entire devices and their interconnections non-destructively because of their small feature sizes and the complex three-dimensional structures resulting from their integration on a chip. This metrology gap implies a lack of direct feedback between design and manufacturing processes, and hampers quality control during production, shipment and use. Here we demonstrate that X-ray ptychography(3,4)-a high-resolution coherent diffractive imaging technique-can create three-dimensional images of integrated circuits of known and unknown designs with a lateral resolution in all directions down to 14.6 nanometres. We obtained detailed device geometries and corresponding elemental maps, and show how the devices are integrated with each other to form the chip. Our experiments represent a major advance in chip inspection and reverse engineering over the traditional destructive electron microscopy and ion milling techniques(5-7). Foreseeable developments in X-ray sources(8), optics(9) and detectors(10), as well as adoption of an instrument geometry(11) optimized for planar rather than cylindrical samples, could lead to a thousand-fold increase in efficiency, with concomitant reductions in scan times and voxel sizes.	[Holler, Mirko; Guizar-Sicairos, Manuel; Tsai, Esther H. R.; Dinapoli, Roberto; Muller, Elisabeth; Bunk, Oliver; Raabe, Jorg; Aeppli, Gabriel] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Aeppli, Gabriel] ETH, Dept Phys, CH-8093 Zurich, Switzerland; [Aeppli, Gabriel] Ecole Polytech Fed Lausanne, Inst Phys, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Holler, M (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	mirko.holler@psi.ch	Holler, Mirko/I-3962-2014; Bunk, Oliver/B-7602-2013; Guizar-Sicairos, Manuel/I-4899-2013; Guizar-Sicairos, Manuel/AAB-3793-2019; Raabe, Jörg/C-4818-2012; Dinapoli, Roberto/E-6194-2010	Holler, Mirko/0000-0001-8141-0148; Bunk, Oliver/0000-0001-6563-4053; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Guizar-Sicairos, Manuel/0000-0002-8293-3634; Raabe, Jörg/0000-0002-2071-6896; Muller, Elisabeth/0000-0001-8239-7109; Tsai, Esther/0000-0002-5885-6317	Swiss National Science Foundation [200021_152554]; R'EQUIP [145056]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); R'EQUIP	We thank S. Stutz and S. Finizio for helping with the preparation of the Intel sample, and B. Schmitt, X. Shi and A. F. J. Levi for discussions. The measurements were performed at the cSAXS beamline of the Swiss Light Source (SLS) at the Paul Scherrer Institut (PSI). We thank ScopeM, the scientific centre for optical and electron microscopy, for providing access to the xenon FIB/SEM (Tescan, Fera3). This work was supported by the Swiss National Science Foundation (grant no. 200021_152554) and R'EQUIP (project number 145056).	Auth C., 2012, P IEEE 2012 CUST INT; Baker R. J., 2010, CMOS CIRCUIT DESIGN; BILDERBACK DH, 1983, NUCL INSTRUM METHODS, V208, P251, DOI 10.1016/0167-5087(83)91132-8; Carballo J. A., 2014, P IEEE 2014 INT COMP; Diaz A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.020104; Dierolf M, 2010, NATURE, V467, P436, DOI 10.1038/nature09419; Eriksson M, 2008, NUCL INSTRUM METH A, V587, P221, DOI 10.1016/j.nima.2008.01.068; Gignac L. M., 2014, MICROSC MICROANAL, V20, P8; Guizar-Sicairos M, 2015, OPTICA, V2, P259, DOI 10.1364/OPTICA.2.000259; Guizar-Sicairos M, 2014, OPT EXPRESS, V22, P14859, DOI 10.1364/OE.22.014859; Guizar-Sicairos M, 2011, OPT EXPRESS, V19, P21345, DOI 10.1364/OE.19.021345; Guo Z, 2005, ISLPED '05: PROCEEDINGS OF THE 2005 INTERNATIONAL SYMPOSIUM ON LOW POWER ELECTRONICS AND DESIGN, P2, DOI 10.1109/LPE.2005.195476; Helfen L, 2007, PHYS STATUS SOLIDI A, V204, P2760, DOI 10.1002/pssa.200775676; Helmstaedter M, 2013, NAT METHODS, V10, P501, DOI [10.1038/nmeth.2476, 10.1038/NMETH.2476]; Henrich B, 2009, NUCL INSTRUM METH A, V607, P247, DOI 10.1016/j.nima.2009.03.200; Holler M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03857; Holler M, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4737624; Holler M, 2015, OPT ENG, V54, DOI 10.1117/1.OE.54.5.054101; Holzner L., 2012, NANOFABRICATION USIN; Huang XJ, 2014, OPT EXPRESS, V22, P12634, DOI 10.1364/OE.22.012634; Ingerly D, 2012, IEEE INT INTERC TECH; James D, 2014, ASMC PROC, P431, DOI 10.1109/ASMC.2014.6846970; Jungmann-Smith JH, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4938166; Karvinen P, 2014, OPT EXPRESS, V22, P16676, DOI 10.1364/OE.22.016676; KIRKPATRICK P, 1948, J OPT SOC AM, V38, P766, DOI 10.1364/JOSA.38.000766; KIRZ J, 1974, J OPT SOC AM, V64, P301, DOI 10.1364/JOSA.64.000301; Liu Y, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/49/494001; Pelz PM, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4904943; Rossi L., 2006, PAR ACC DET; Servanton G, 2013, J PHYS CONF SER, V471, DOI 10.1088/1742-6596/471/1/012026; Sze S. M., 2006, PHYS SEMICONDUCTOR D; Thibault P, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/6/063004; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; Xuejue Huang, 1999, International Electron Devices Meeting 1999. Technical Digest (Cat. No.99CH36318), P67, DOI 10.1109/IEDM.1999.823848; Yamauchi K, 2011, J PHYS-CONDENS MAT, V23, DOI 10.1088/0953-8984/23/39/394206	36	210	212	22	229	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					402	+		10.1038/nature21698	http://dx.doi.org/10.1038/nature21698			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28300088				2022-12-28	WOS:000396337400046
J	Schandelmaier, S; Kaushal, A; Lytvyn, L; Heels-Ansdell, D; Siemieniuk, RAC; Agoritsas, T; Guyatt, GH; Vandvik, PO; Couban, R; Mollon, B; Busse, JW				Schandelmaier, Stefan; Kaushal, Alka; Lytvyn, Lyubov; Heels-Ansdell, Diane; Siemieniuk, Reed A. C.; Agoritsas, Thomas; Guyatt, Gordon H.; Vandvik, Per O.; Couban, Rachel; Mollon, Brent; Busse, Jason W.			Low intensity pulsed ultrasound for bone healing: systematic review of randomized controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOUBLE-BLIND; LATERAL MALLEOLAR; DISTRACTION OSTEOGENESIS; ELECTRICAL-STIMULATION; ELECTROMAGNETIC-FIELDS; TREATMENT TIME; FRACTURES; METAANALYSIS; MULTICENTER; QUALITY	Objective To determine the efficacy of low intensity pulsed ultrasound (LIPUS) for healing of fracture or osteotomy. Design Systematic review and meta-analysis. Data sources Medline, Embase, CINAHL, Cochrane Central Register of Controlled Trials, and trial registries up to November 2016. Study selection Randomized controlled trials of LIPUS compared with sham device or no device in patients with any kind of fracture or osteotomy. Review methods Two independent reviewers identified studies, extracted data, and assessed risk of bias. A parallel guideline committee (BMJ Rapid Recommendation) provided input on the design and interpretation of the systematic review, including selection of outcomes important to patients. The GRADE system was used to assess the quality of evidence. Results 26 randomized controlled trials with a median sample size of 30 (range 8-501) were included. The most trustworthy evidence came from four trials at low risk of bias that included patients with tibia or clavicle fractures. Compared with control, LIPUS did not reduce time to return to work (percentage difference: 2.7% later with LIPUS, 95% confidence interval 7.7% earlier to 14.3% later; moderate certainty) or the number of subsequent operations (risk ratio 0.80, 95% confidence interval 0.55 to 1.16; moderate certainty). For pain, days to weight bearing, and radiographic healing, effects varied substantially among studies. For all three outcomes, trials at low risk of bias failed to show a benefit with LIPUS, while trials at high risk of bias suggested a benefit (interaction P<0.001). When only trials at low risk of bias trials were considered, LIPUS did not reduce days to weight bearing (4.8% later, 4.0% earlier to 14.4% later; high certainty), pain at four to six weeks (mean difference on 0-100 visual analogue scale: 0.93 lower, 2.51 lower to 0.64 higher; high certainty), and days to radiographic healing (1.7% earlier, 11.2% earlier to 8.8% later; moderate certainty). Conclusions Based on moderate to high quality evidence from studies in patients with fresh fracture, LIPUS does not improve outcomes important to patients and probably has no effect on radiographic bone healing. The applicability to other types of fracture or osteotomy is open to debate.	[Schandelmaier, Stefan; Kaushal, Alka; Heels-Ansdell, Diane; Siemieniuk, Reed A. C.; Agoritsas, Thomas; Guyatt, Gordon H.; Busse, Jason W.] McMaster Univ, Dept Clin Epidemiol & Biostat, 1280 Main St West, Hamilton, ON L8S 4L8, Canada; [Schandelmaier, Stefan] Univ Basel Hosp, Inst Clin Epidemiol & Biostat, Spitalstr 12, CH-4031 Basel, Switzerland; [Kaushal, Alka; Couban, Rachel; Busse, Jason W.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON L8S 4K1, Canada; [Lytvyn, Lyubov] Oslo Univ Hosp, Forskningsveien 2b,Postboks 1089, N-0317 Oslo, Norway; [Siemieniuk, Reed A. C.] Univ Toronto, Dept Med, 200 Elizabeth St, Toronto, ON M5G 2C4, Canada; [Agoritsas, Thomas] Univ Hosp Geneva, Div Gen Internal Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland; [Agoritsas, Thomas] Univ Hosp Geneva, Div Clin Epidemiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland; [Guyatt, Gordon H.] McMaster Univ, Dept Med, 1280 Main St West, Hamilton, ON L8S 4L8, Canada; [Vandvik, Per O.] Univ Oslo, Inst Hlth & Soc, Fac Med, N-0318 Oslo, Norway; [Vandvik, Per O.] Innlandet Hosp Trust Div, Dept Med, Gjovik, Norway; [Mollon, Brent] Orillia Soldiers Mem Hosp, 41 Frederick St, Orillia, ON L3V 5W6, Canada; [Busse, Jason W.] McMaster Univ, Dept Anesthesia, Hamilton, ON L8S 4K1, Canada	McMaster University; University of Basel; McMaster University; University of Oslo; University of Toronto; University of Geneva; University of Geneva; McMaster University; University of Oslo; Innlandet Hospital Trust; McMaster University	Schandelmaier, S (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.	schandes@mcmaster.ca	Schandelmaier, Stefan/GLV-3722-2022; Agoritsas, Thomas/F-4321-2014; Busse, Jason/CAH-3696-2022; Couban, Rachel/AAV-1568-2021	Schandelmaier, Stefan/0000-0002-8429-0337; Agoritsas, Thomas/0000-0002-6182-9969; Busse, Jason/0000-0002-0178-8712; Couban, Rachel/0000-0001-8672-2845				Akl EA, 2012, J CLIN EPIDEMIOL, V65, P262, DOI 10.1016/j.jclinepi.2011.04.015; Aleem IS, 2016, SCI REP-UK, V6, DOI 10.1038/srep31724; Busse JW, 2008, ACTA ORTHOP, V79, P689, DOI 10.1080/17453670810016722; Busse JW, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5351; Busse JW, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-206; Busse JW, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b351; Dudda M, 2011, J TRAUMA, V71, P1376, DOI 10.1097/TA.0b013e31821912b2; Ebrahim S, 2014, CAN J SURG, V57, pE105, DOI 10.1503/cjs.010113; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; El-Mowafi H, 2005, INT ORTHOP, V29, P121, DOI 10.1007/s00264-004-0625-3; Emami A, 1999, CLIN ORTHOP RELAT R, P220; Emami A, 1999, J ORTHOP TRAUMA, V13, P252, DOI 10.1097/00005131-199905000-00005; Food and Drug Administration, 2000, APPR ORD EX DEV; Gan TY, 2014, CLIN J SPORT MED, V24, P457, DOI 10.1097/JSM.0000000000000084; Griffin XL, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008579.pub3; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Handolin L, 2005, J ORTHOP SCI, V10, P391, DOI 10.1007/s00776-005-0901-0; Handolin L, 2005, ARCH ORTHOP TRAUM SU, V125, P317, DOI 10.1007/s00402-005-0801-y; Handolin L, 2005, SCAND J SURG, V94, P239, DOI 10.1177/145749690509400312; Hannemann PEW, 2014, BONE JOINT J, V96B, P1070, DOI 10.1302/0301-620X.96B8.33767; Hannemann PFW, 2014, ARCH ORTHOP TRAUM SU, V134, P1093, DOI 10.1007/s00402-014-2014-8; Hannemann PFW, 2012, J BONE JOINT SURG BR, V94B, P1403, DOI 10.1302/0301-620X.94B10.28844; HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004; Kamath JB, 2015, MULLER J MED SCI RES, V6, P49, DOI [10.4103/0975-9727.146426, DOI 10.4103/0975-9727.146426]; Kristiansen TK, 1997, J BONE JOINT SURG AM, V79A, P961, DOI 10.2106/00004623-199707000-00002; Leung KS, 2004, ULTRASOUND MED BIOL, V30, P389, DOI 10.1016/j.ultrasmedbio.2003.11.008; Liu YW, 2014, ACTA CIR BRAS, V29, P765, DOI 10.1590/S0102-86502014001800012; Lubbert PHW, 2008, INJURY, V39, P1444, DOI 10.1016/j.injury.2008.04.004; MAMMI GI, 1993, CLIN ORTHOP RELAT R, P246; de Albornoz PM, 2011, BRIT MED BULL, V100, P39, DOI 10.1093/bmb/ldr006; Martinez-Rondanelli A, 2014, COLOMB MEDICA, V45, P67; Mayr E, 2000, Handchir Mikrochir Plast Chir, V32, P115, DOI 10.1055/s-2000-19253; National Institute for Health and Care Excellence, 2010, LOW INT PULS ULTR PR; Nolte PA, 2002, NONUNIONS SURG LOW I, P96; Patel K, 2015, CRANIOMAXILLOFACIAL, V8, P299, DOI 10.1055/s-0034-1544104; Poolman RW, 2017, BMJ IN PRESS; Raza H, 2016, J ULTRAS MED, V35, P349, DOI 10.7863/ultra.15.02043; Ricardo M, 2006, INT ORTHOP, V30, P123, DOI 10.1007/s00264-005-0034-2; Rue JPH, 2004, ORTHOPEDICS, V27, P1192, DOI 10.3928/0147-7447-20041101-18; Rutten S, 2012, THESIS; Rutten S, 2016, JBJS REV, V4, DOI 10.2106/JBJS.RVW.O.00027; Salem KH, 2014, INT ORTHOP, V38, P1477, DOI 10.1007/s00264-013-2254-1; Schofer M. D., 2010, BIOMEDICAL CENTRAL M, V11, P229, DOI DOI 10.1186/1471-2474-11-229; Schortinghuis J, 2005, ARCH ORAL BIOL, V50, P411, DOI 10.1016/j.archoralbio.2004.09.005; Schortinghuis J, 2008, INT J ORAL MAX SURG, V37, P1014, DOI 10.1016/j.ijom.2008.07.004; Siemieniuk RA, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i5191; Snyder Benjamin M, 2012, Am J Orthop (Belle Mead NJ), V41, pE12; SUN X, 2010, BMJ-BRIT MED J, V340, DOI DOI 10.1136/BMJ.C117; Tajali SB, 2012, AM J PHYS MED REHAB, V91, P349, DOI 10.1097/PHM.0b013e31822419ba; Thorlund K, 2011, RES SYNTH METHODS, V2, P188, DOI 10.1002/jrsm.46; Tsumaki N, 2004, J BONE JOINT SURG AM, V86A, P2399, DOI 10.2106/00004623-200411000-00006; Urita A, 2013, J HAND SURG-AM, V38A, P498, DOI 10.1016/j.jhsa.2012.11.032; Wachovia Capital Markets, 2007, EQ RES BON GROWTH ST; Watanabe Y, 2010, J ORTHOP TRAUMA, V24, pS56, DOI 10.1097/BOT.0b013e3181d2efaf; Zacherl M, 2009, ULTRASOUND MED BIOL, V35, P1290, DOI 10.1016/j.ultrasmedbio.2009.03.008	56	40	48	2	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 22	2017	356								j656	10.1136/bmj.j656	http://dx.doi.org/10.1136/bmj.j656			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EM9KV	28348110	hybrid, Green Published			2022-12-28	WOS:000395631300001
J	Brocklehurst, P; Johns, N; Johnston, T; Barnfield, G; Davies, K; Johnson, M; Patterson, H; Montague, I; Watmore, S; Stolton, A; Parisaei, M; McGhee, N; Segovia, S; Martindale, E; Jackson, H; Holleran, J; Roberts, D; Holt, S; Dragovic, B; Willmott-Powell, M; Hutchinson, L; Toth, B; Chandler, G; Ridley, S; Bugg, G; Molnar, A; Lochrie, D; Connor, J; Howe, D; Head, K; Wellstead, S; Mathers, A; Walker, L; Crawford, I; Davies, D; Garner, Z; Galloway, L; Bugg, G; Davies, Y; Smith, C; Perkins, G; Geary, M; Walsh, F; Nagle, U; Martindale, E; Jackson, H; O'Malley, L; Katakam, N; White, H; Tanton, E; Hamilton, R; Glanowski, H; Forde, E; Mathers, A; MacDonald, C; Mckay, L; Edoziern, L; Doran, P; Dillon, J; Taylor, C; Evans, P; Miller, V; Wayne, C; Tebbutt, J; Hendy, E; O'Brien, P; Subair, S; Dent, H; Mallet, C; Quenby, S; Hillen, J; Young, P; Harrison, T; Wood, L; Arya, R; Roughley, L; Sorinola, O; Rogers, C; Phipps, J				Brocklehurst, Peter; Johns, Nina; Johnston, Tracey; Barnfield, Gemma; Davies, Karen; Johnson, Mark; Patterson, Holly; Montague, Imogen; Watmore, Sally; Stolton, Alison; Parisaei, Maryam; McGhee, Natasha; Segovia, Silvia; Martindale, Elizabeth; Jackson, Hilary; Holleran, Josephine; Roberts, Devender; Holt, Siobhan; Dragovic, Bosko; Willmott-Powell, Miriam; Hutchinson, Laura; Toth, Benedek; Chandler, Gemma; Ridley, Suzanne; Bugg, George; Molnar, Anna; Lochrie, Denise; Connor, Jillian; Howe, David; Head, Katie; Wellstead, Sue; Mathers, Alan; Walker, Laura; Crawford, Isobel; Davies, David; Garner, Zoe; Galloway, Lucy; Bugg, George; Davies, Yvette; Smith, Carys; Perkins, Gill; Geary, Mike; Walsh, Fiona; Nagle, Ursula; Martindale, Elizabeth; Jackson, Hilary; O'Malley, Louise; Katakam, Narmada; White, Heather; Tanton, Emma; Hamilton, Rosie; Glanowski, Hilary; Forde, Ethel; Mathers, Alan; MacDonald, Christina; Mckay, Lorna; Edoziern, Leroy; Doran, Paula; Dillon, Julie; Taylor, Cara; Evans, Paula; Miller, Veronica; Wayne, Christopher; Tebbutt, Julie; Hendy, Ellie; O'Brien, Patrick; Subair, Seni; Dent, Helen; Mallet, Camille; Quenby, Siobhan; Hillen, Jane; Young, Peter; Harrison, Tracey; Wood, Louise; Arya, Rita; Roughley, Lindsay; Sorinola, Olanrewaju; Rogers, Carole; Phipps, Janet		INFANT Collaborative Grp	Computerised interpretation of fetal heart rate during labour (INFANT): a randomised controlled trial	LANCET			English	Article							ASPHYXIA; DELIVERY; SYSTEM	Background Continuous electronic fetal heart-rate monitoring is widely used during labour, and computerised interpretation could increase its usefulness. We aimed to establish whether the addition of decision-support software to assist in the interpretation of cardiotocographs affected the number of poor neonatal outcomes. Methods In this unmasked randomised controlled trial, we recruited women in labour aged 16 years or older having continuous electronic fetal monitoring, with a singleton or twin pregnancy, and at 35 weeks' gestation or more at 24 maternity units in the UK and Ireland. They were randomly assigned (1:1) to decision support with the INFANT system or no decision support via a computer-generated stratified block randomisation schedule. The primary outcomes were poor neonatal outcome (intrapartum stillbirth or early neonatal death excluding lethal congenital anomalies, or neonatal encephalopathy, admission to the neonatal unit within 24 h for >= 48 h with evidence of feeding difficulties, respiratory illness, or encephalopathy with evidence of compromise at birth), and developmental assessment at age 2 years in a subset of surviving children. Analyses were done by intention to treat. This trial is completed and is registered with the ISRCTN Registry, number 98680152. Findings Between Jan 6, 2010, and Aug 31, 2013, 47 062 women were randomly assigned (23 515 in the decision-support group and 23 547 in the no-decision-support group) and 46 042 were analysed (22 987 in the decision-support group and 23 055 in the no-decision-support group). We noted no difference in the incidence of poor neonatal outcome between the groups-172 (0.7%) babies in the decision-support group compared with 171 (0.7%) babies in the no-decision-support group (adjusted risk ratio 1.01, 95% CI 0.82-1.25). At 2 years, no significant differences were noted in terms of developmental assessment. Interpretation Use of computerised interpretation of cardiotocographs in women who have continuous electronic fetal monitoring in labour does not improve clinical outcomes for mothers or babies.	[Brocklehurst, Peter] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Johns, Nina; Johnston, Tracey; Barnfield, Gemma; Davies, Karen] Birmingham Womens Hosp, Birmingham, W Midlands, England; [Johnson, Mark; Patterson, Holly] Chelsea & Westminster Hosp, London, England; [Montague, Imogen; Watmore, Sally; Stolton, Alison] Derriford Hosp, Plymouth, Devon, England; [Parisaei, Maryam; McGhee, Natasha; Segovia, Silvia] Homerton Univ Hosp, London, England; [Martindale, Elizabeth; Jackson, Hilary; Holleran, Josephine] Lancashire Women & Newborn Ctr, Burnley, Lancs, England; [Roberts, Devender; Holt, Siobhan] Liverpool Womens Hosp, Liverpool, Merseyside, England; [Dragovic, Bosko; Willmott-Powell, Miriam; Hutchinson, Laura; Toth, Benedek; Chandler, Gemma; Ridley, Suzanne] Northwick Pk Hosp & Clin Res Ctr, Harrow, Middx, England; [Bugg, George; Molnar, Anna; Lochrie, Denise] City Hosp Nottingham, Nottingham, England; [Connor, Jillian; Howe, David; Head, Katie; Wellstead, Sue] Princess Anne Hosp, Southampton, Hants, England; [Mathers, Alan; Walker, Laura; Crawford, Isobel] Princess Royal Hosp, Orpington, England; [Davies, David; Garner, Zoe; Galloway, Lucy] Queen Alexandra Hosp, London, England; [Bugg, George; Davies, Yvette; Smith, Carys; Perkins, Gill] Queens Med Ctr, London, England; [Geary, Mike; Walsh, Fiona; Nagle, Ursula] Rotunda Hosp, Dublin, Ireland; [Martindale, Elizabeth; Jackson, Hilary; O'Malley, Louise] Royal Blackburn Hosp, Blackburn, Lancs, England; [Katakam, Narmada; White, Heather; Tanton, Emma] Royal Bolton Hosp, Farnworth, England; [Hamilton, Rosie; Glanowski, Hilary; Forde, Ethel] Royal Derby Hosp, Derby, England; [Mathers, Alan; MacDonald, Christina; Mckay, Lorna] Southern Gen Hosp, Glasgow, Lanark, Scotland; [Edoziern, Leroy; Doran, Paula; Dillon, Julie; Taylor, Cara; Evans, Paula] St Marys Hosp, London, England; [Miller, Veronica; Wayne, Christopher; Tebbutt, Julie; Hendy, Ellie] Stoke Mandeville Hosp, Aylesbury, Bucks, England; [O'Brien, Patrick; Subair, Seni; Dent, Helen; Mallet, Camille] Univ Coll London Hosp, London, England; [Quenby, Siobhan; Hillen, Jane] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England; [Young, Peter; Harrison, Tracey; Wood, Louise] Univ Hosp North Staffordshire, Stoke On Trent, Staffs, England; [Arya, Rita; Roughley, Lindsay] Warrington Hosp, Warrington, Cheshire, England; [Sorinola, Olanrewaju; Rogers, Carole; Phipps, Janet] Warwick Hosp, Warwick, England	University of Birmingham; Birmingham Women's Hospital; Imperial College London; Derriford Hospital; University of London; Queen Mary University London; University of Liverpool; Imperial College London; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; Royal Bolton Hospital; University of Nottingham; Imperial College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Warwick	Brocklehurst, P (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England.	p.brocklehurst@bham.ac.uk	Roberts, Tracy/AAO-4610-2021	Roberts, Tracy/0000-0002-0624-0537; Quenby, Siobhan/0000-0003-3221-5471; Schroeder, Elizabeth-Ann/0000-0003-0236-2833; Quigley, Maria/0000-0002-8058-6181; Plachcinski, Rachel/0000-0001-9908-0773; Kenyon, Sara/0000-0002-0756-9617	National Institute for Health Research; National Institute for Health Research [06/38/01] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	National Institute for Health Research.	Alfirevic Z, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub2; Berglund S, 2008, BJOG-INT J OBSTET GY, V115, P316, DOI 10.1111/j.1471-0528.2007.01602.x; Brocklehurst P, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-015-0780-0; Confidential Enquiry into Maternal and Child Health, 2006, PER MORT SURV 2004; ENNIS M, 1990, BRIT MED J, V300, P1365, DOI 10.1136/bmj.300.6736.1365; ESKES TKAB, 1983, EUR J OBSTET GYN R B, V14, P341, DOI 10.1016/0028-2243(83)90010-2; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; GAFFNEY G, 1994, BRIT MED J, V308, P743, DOI 10.1136/bmj.308.6931.743; GOLDABER KG, 1991, OBSTET GYNECOL, V78, P1103; Ignatov P, 2012, Akush Ginekol (Sofiia), V51, P3; Johnson A, 1997, ARCH DIS CHILD-FETAL, V76, pF61, DOI 10.1136/fn.76.1.F61; Johnson S, 2004, DEV MED CHILD NEUROL, V46, P389, DOI 10.1017/S0012162204000635; Johnson S, 2008, DEV MED CHILD NEUROL, V50, P58, DOI 10.1111/j.1469-8749.2007.02010.x; K2s Medical Systems, K2MS GUARD FULL EL C; KEITH RDF, 1995, BRIT J OBSTET GYNAEC, V102, P688, DOI 10.1111/j.1471-0528.1995.tb11425.x; Keith RDF, 1994, ANAL COMPLEX DATA AR, P583; Kurinczuk JJ, REPORT PATIENT SAFET; Lucas DN, 2000, J ROY SOC MED, V93, P346, DOI 10.1177/014107680009300703; MURPHY KW, 1990, BRIT J OBSTET GYNAEC, V97, P470, DOI 10.1111/j.1471-0528.1990.tb02515.x; National Collaborating Centre for Women's and Children's Health (UK), 2014, INTR CAR HLTH WOM BA; National Perinatal Epidemiology Unit, 1994, DIS PER CAR MEAS HLT; Nunes I, 2017, AM J OBSTET GYECOL, V129, P83; Pocock SJ, 2005, JAMA-J AM MED ASSOC, V294, P2228, DOI 10.1001/jama.294.17.2228; Pocock SJ, 2016, NEW ENGL J MED, V375, P861, DOI 10.1056/NEJMra1510064; Skinner JF, 1998, 28 BRIT C OBST GYN H; Ugwumadu A, 2016, BJOG-INT J OBSTET GY, V123, P866, DOI 10.1111/1471-0528.13846; University of Leicester, 2005, NEON SURV YORKSH NEO; WESTGATE J, 1994, BRIT J OBSTET GYNAEC, V101, P1054, DOI 10.1111/j.1471-0528.1994.tb13581.x; WESTGATE J, 1993, AM J OBSTET GYNECOL, V169, P1151, DOI 10.1016/0002-9378(93)90273-L; Yelland LN, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1278	30	82	82	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2017	389	10080					1719	1729		10.1016/S0140-6736(17)30568-8	http://dx.doi.org/10.1016/S0140-6736(17)30568-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET3BG	28341515	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000400151000029
J	Gostin, LO; Cathaoir, KEO				Gostin, Lawrence O.; Cathaoir, Katharina Eva O.			Presidential Immigration Policies Endangering Health and Well-being?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.; Cathaoir, Katharina Eva O.] Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, ONeill Inst Natl & Global Hlth Law, Ctr Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				Capps R, PROFILE US CHILDREN; Educational Commission for Foreign Medical Graduates, 2016, ANN REPORT; Ewing W, 2015, CRIMINALIZATION IMMI; Goss S, 2013, EFFECTS UNAUTHORIZED; Krogstad JM, 5 FACTS ILLEGAL IMMI; McCabe K., 2012, FOREIGN BORN HLTH CA; McNeil Jr DG, 2017, TRUMPS TRAVEL BAN AI; Norcini JJ, 2010, HEALTH AFFAIR, V29, P1461, DOI 10.1377/hlthaff.2009.0222; United States Immigrations and Customs Enforcement, LIST DEATHS ICE CUST	9	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2017	317	16					1617	1618		10.1001/jama.2017.3794	http://dx.doi.org/10.1001/jama.2017.3794			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET1FW	28334387				2022-12-28	WOS:000400014000006
J	Taran, S				Taran, Shaurya			The Lisboa Cafe	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Taran, Shaurya] Univ Toronto, Toronto, ON, Canada	University of Toronto	Taran, S (corresponding author), Univ Toronto, Toronto, ON, Canada.	shaurya.taran@mail.utoronto.ca	Taran, Shaurya/ABF-1571-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1213	1214		10.1001/jama.2016.16801	http://dx.doi.org/10.1001/jama.2016.16801			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350933				2022-12-28	WOS:000397557800014
J	Praetorius, F; Dietz, H				Praetorius, Florian; Dietz, Hendrik			DNA NANOTECHNOLOGY Self-assembly of genetically encoded DNA-protein hybrid nanoscale shapes	SCIENCE			English	Article							COMPUTATIONAL DESIGN; CRYSTAL-STRUCTURE; TAL EFFECTORS; FOLDING DNA; ORIGAMI; NANOSTRUCTURES; SCAFFOLD; MICROSCOPY; PRINCIPLES; NANOWIRES	We describe an approach to bottom-up fabrication that allows integration of the functional diversity of proteins into designed three-dimensional structural frameworks. A set of custom staple proteins based on transcription activator-like effector proteins folds a double-stranded DNA template into a user-defined shape. Each staple protein is designed to recognize and closely link two distinct double-helical DNA sequences at separate positions on the template. We present design rules for constructing megadalton-scale DNA-protein hybrid shapes; introduce various structural motifs, such as custom curvature, corners, and vertices; and describe principles for creating multilayer DNA-protein objects with enhanced rigidity. We demonstrate self-assembly of our hybrid nanostructures in one-pot mixtures that include the genetic information for the designed proteins, the template DNA, RNA polymerase, ribosomes, and cofactors for transcription and translation.	[Praetorius, Florian; Dietz, Hendrik] Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany; [Praetorius, Florian; Dietz, Hendrik] Tech Univ Munich, Dept Phys, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Dietz, H (corresponding author), Tech Univ Munich, Inst Adv Study, D-80290 Munich, Germany.; Dietz, H (corresponding author), Tech Univ Munich, Dept Phys, D-80290 Munich, Germany.	dietz@tum.de		Dietz, Hendrik/0000-0003-1270-3662; Praetorius, Florian/0000-0002-0806-8101	European Research Council [256270]; Bundesministerium fur Bildung und Forschung grant [031 A 458]; Deutsche Forschungsgemeinschaft through Gottfried-Wilhelm-Leibniz Program; Excellence Cluster CIPSM (Center for Integrated Protein Science Munich)	European Research Council(European Research Council (ERC)European Commission); Bundesministerium fur Bildung und Forschung grant(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft through Gottfried-Wilhelm-Leibniz Program(German Research Foundation (DFG)); Excellence Cluster CIPSM (Center for Integrated Protein Science Munich)	We thank S. Stander, M. Honemann, and J. Valtin for technical assistance, K. Wagenbauer for help with TEM imaging, and T. Gerling and E. Stahl for discussions. Supported by European Research Council starting grant 256270 (H.D.), Bundesministerium fur Bildung und Forschung grant 031 A 458, and the Deutsche Forschungsgemeinschaft through grants provided within the Gottfried-Wilhelm-Leibniz Program and the Excellence Cluster CIPSM (Center for Integrated Protein Science Munich). All data are reported in the main text and supplement.	Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Benson E, 2015, NATURE, V523, P441, DOI 10.1038/nature14586; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Brunette TJ, 2015, NATURE, V528, P580, DOI 10.1038/nature16162; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Christian ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045383; Conrado RJ, 2008, CURR OPIN BIOTECH, V19, P492, DOI 10.1016/j.copbio.2008.07.006; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Derr ND, 2012, SCIENCE, V338, P662, DOI 10.1126/science.1226734; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Funke JJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600974; Funke JJ, 2016, NAT NANOTECHNOL, V11, P47, DOI [10.1038/NNANO.2015.240, 10.1038/nnano.2015.240]; Gao HS, 2012, CELL RES, V22, P1716, DOI 10.1038/cr.2012.156; Geary C, 2014, SCIENCE, V345, P799, DOI 10.1126/science.1253920; Gerling T, 2015, SCIENCE, V347, P1446, DOI 10.1126/science.aaa5372; Good MC, 2011, SCIENCE, V332, P680, DOI 10.1126/science.1198701; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Ketterer P, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501209; Kilchherr F, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5508; King NP, 2014, NATURE, V510, P103, DOI 10.1038/nature13404; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Liu MH, 2016, CHEMBIOCHEM, V17, P1097, DOI 10.1002/cbic.201600103; Liu Y, 2005, ANGEW CHEM INT EDIT, V44, P4333, DOI 10.1002/anie.200501089; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Marras AE, 2015, P NATL ACAD SCI USA, V112, P713, DOI 10.1073/pnas.1408869112; Meckler JF, 2013, NUCLEIC ACIDS RES, V41, P4118, DOI 10.1093/nar/gkt085; Mou Y, 2015, NATURE, V525, P230, DOI 10.1038/nature14874; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rafat AA, 2014, ANGEW CHEM INT EDIT, V53, P7665, DOI 10.1002/anie.201403965; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Shaw A, 2014, NAT METHODS, V11, P841, DOI [10.1038/NMETH.3025, 10.1038/nmeth.3025]; Sobczak JPJ, 2012, SCIENCE, V338, P1458, DOI 10.1126/science.1229919; Suzuki Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9052; Thomson AR, 2014, SCIENCE, V346, P485, DOI 10.1126/science.1257452; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	49	98	101	11	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331							eaam5488	10.1126/science.aam5488	http://dx.doi.org/10.1126/science.aam5488			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336611				2022-12-28	WOS:000397082900030
J	Woodford, H				Woodford, Henry			James George OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item														Woodford, Henry/0000-0002-1413-7097					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1385	10.1136/bmj.j1385	http://dx.doi.org/10.1136/bmj.j1385			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330851				2022-12-28	WOS:000397345200007
J	Gould, JF; Treyvaud, K; Yelland, LN; Anderson, PJ; Smithers, LG; McPhee, AJ; Makrides, M				Gould, Jacqueline F.; Treyvaud, Karli; Yelland, Lisa N.; Anderson, Peter J.; Smithers, Lisa G.; McPhee, Andrew J.; Makrides, Maria			Seven-Year Follow-up of Children Born to Women in a Randomized Trial of Prenatal DHA Supplementation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PREGNANCY		[Gould, Jacqueline F.; Makrides, Maria] South Australian Hlth & Med Res Inst, Child Nutr Res Ctr, Adelaide, SA, Australia; [Treyvaud, Karli] La Trobe Univ, Dept Psychol & Counselling, Melbourne, Vic, Australia; [Yelland, Lisa N.; Smithers, Lisa G.] Univ Adelaide, Sch Publ Hlth, Adelaide, SA, Australia; [Anderson, Peter J.] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic, Australia; [McPhee, Andrew J.] Womens & Childrens Hosp, Neonatal Serv, Adelaide, SA, Australia	South Australian Health & Medical Research Institute (SAHMRI); La Trobe University; University of Adelaide; Monash University	Makrides, M (corresponding author), South Australian Hlth & Med Res Inst, Child Nutr Res Ctr, 72 King William Rd, Adelaide, SA 5006, Australia.	maria.makrides@sahmri.com	Smithers, Lisa/D-1605-2009; Treyvaud, Karli/GXV-4561-2022; Anderson, Peter John/O-5302-2019; Yelland, Lisa N/GPP-4533-2022	Smithers, Lisa/0000-0002-6585-7836; Anderson, Peter John/0000-0001-7430-868X; Yelland, Lisa N/0000-0003-3803-8728	National Health and Medical Research Council [349301, 1048493]; Australian National Health and Medical Research Council [1061704, 1081288, 1052388]; Women's and Children's Hospital Foundation	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Women's and Children's Hospital Foundation	The original randomized trial of DHA in Pregnancy to Prevent Postnatal Depressive Symptoms and Enhance Neurodevelopment in Children (DOMInO) trial and the 7-year follow-up study were funded by National Health and Medical Research Council grants 349301 (DOMInO) and 1048493 (7-year follow-up). DOMInO trial treatment and control capsules were donated by Croda Chemicals. This work was supported by Australian National Health and Medical Research Council through senior research fellowship grants 1061704 (Dr Makrides) and 1081288 (Dr Anderson) and an early career fellowship grant 1052388 (Dr Yelland) and by a MS McLeod postdoctoral research fellowship grant from the Women's and Children's Hospital Foundation (Dr Gould).	Gould JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011465; Gould JF, 2013, AM J CLIN NUTR, V97, P531, DOI 10.3945/ajcn.112.045781; Makrides M, 2014, JAMA-J AM MED ASSOC, V311, P1802, DOI 10.1001/jama.2014.2194; Makrides M, 2010, JAMA-J AM MED ASSOC, V304, P1675, DOI 10.1001/jama.2010.1507	4	35	36	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1173	1175		10.1001/jama.2016.21303	http://dx.doi.org/10.1001/jama.2016.21303			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324081				2022-12-28	WOS:000396987200024
J	Al-Rais, A				Al-Rais, Andrew			Why we should avoid handover hostility No patient has died from lack of manners, but rudeness among staff can affect performance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												andrew.al-rais@nhs.net						Porath CL, 2007, ACAD MANAGE J, V50, P1181, DOI 10.2307/20159919; Riskin A, 2015, PEDIATRICS, V136, P487, DOI 10.1542/peds.2015-1385	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2017	356								j1272	10.1136/bmj.j1272	http://dx.doi.org/10.1136/bmj.j1272			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IR	28320693				2022-12-28	WOS:000397344700001
J	McGovern, G				McGovern, Gerald			James Norman Docherty OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		DOCHERTY JN, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2017	356								j901	10.1136/bmj.j901	http://dx.doi.org/10.1136/bmj.j901			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NR	28314791				2022-12-28	WOS:000397015900001
J	Toghill, P				Toghill, Peter			Rami Seth OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		SETH R, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2017	356								j1387	10.1136/bmj.j1387	http://dx.doi.org/10.1136/bmj.j1387			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NR	28314715				2022-12-28	WOS:000397015900015
J	Daley, GQ				Daley, George Q.			Polar Extremes in the Clinical Use of Stem Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Daley, George Q.] Harvard Med Sch, Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Daley, GQ (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA.							Daley GQ, 2016, STEM CELL REP, V6, P787, DOI 10.1016/j.stemcr.2016.05.001; Kuriyan AE, 2017, NEW ENGL J MED, V376, P1047, DOI 10.1056/NEJMoa1609583; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Ogbogu U, 2013, REGEN MED, V8, P361, DOI [10.2217/rme.13.15, 10.2217/RME.13.15]; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2	6	28	28	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1075	1077		10.1056/NEJMe1701379	http://dx.doi.org/10.1056/NEJMe1701379			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QT	28296612				2022-12-28	WOS:000396403700014
J	Perry, JR; Laperriere, N; O'Callaghan, CJ; Brandes, AA; Menten, J; Phillips, C; Fay, M; Nishikawa, R; Cairncross, JG; Roa, W; Osoba, D; Rossiter, JP; Sahgal, A; Hirte, H; Laigle-Donadey, F; Franceschi, E; Chinot, O; Golfinopoulos, V; Fariselli, L; Wick, A; Feuvret, L; Back, M; Tills, M; Winch, C; Baumert, BG; Wick, W; Ding, K; Mason, WP				Perry, James R.; Laperriere, Normand; O'Callaghan, Christopher J.; Brandes, Alba A.; Menten, Johan; Phillips, Claire; Fay, Michael; Nishikawa, Ryo; Cairncross, J. Gregory; Roa, Wilson; Osoba, David; Rossiter, John P.; Sahgal, Arjun; Hirte, Hal; Laigle-Donadey, Florence; Franceschi, Enrico; Chinot, Olivier; Golfinopoulos, Vassilis; Fariselli, Laura; Wick, Antje; Feuvret, Loic; Back, Michael; Tills, Michael; Winch, Chad; Baumert, Brigitta G.; Wick, Wolfgang; Ding, Keyue; Mason, Warren P.		Trial Investigators	Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROMOTER METHYLATION; RADIOTHERAPY; CHEMOTHERAPY; CONCOMITANT; MULTIFORME; PATTERNS; ADJUVANT; TUMORS; BRAIN; OLDER	BACKGROUND Glioblastoma is associated with a poor prognosis in the elderly. Survival has been shown to increase among patients 70 years of age or younger when temozolomide chemotherapy is added to standard radiotherapy (60 Gy over a period of 6 weeks). In elderly patients, more convenient shorter courses of radiotherapy are commonly used, but the benefit of adding temozolomide to a shorter course of radiotherapy is unknown. METHODS We conducted a trial involving patients 65 years of age or older with newly diagnosed glioblastoma. Patients were randomly assigned to receive either radiotherapy alone (40 Gy in 15 fractions) or radiotherapy with concomitant and adjuvant temozolomide. RESULTS A total of 562 patients underwent randomization, 281 to each group. The median age was 73 years (range, 65 to 90). The median overall survival was longer with radiotherapy plus temozolomide than with radiotherapy alone (9.3 months vs. 7.6 months; hazard ratio for death, 0.67; 95% confidence interval [CI], 0.56 to 0.80; P< 0.001), as was the median progression-free survival (5.3 months vs. 3.9 months; hazard ratio for disease progression or death, 0.50; 95% CI, 0.41 to 0.60; P< 0.001). Among 165 patients with methylated O-6-methylguanine-DNA methyltransferase (MGMT) status, the median overall survival was 13.5 months with radiotherapy plus temozolomide and 7.7 months with radiotherapy alone (hazard ratio for death, 0.53; 95% CI, 0.38 to 0.73; P< 0.001). Among 189 patients with unmethylated MGMT status, the median overall survival was 10.0 months with radiotherapy plus temozolomide and 7.9 months with radiotherapy alone (hazard ratio for death, 0.75; 95% CI, 0.56 to 1.01; P = 0.055; P = 0.08 for interaction). Quality of life was similar in the two trial groups. CONCLUSIONS In elderly patients with glioblastoma, the addition of temozolomide to short-course radiotherapy resulted in longer survival than short-course radiotherapy alone. Funded by the Canadian Cancer Society Research Institute and others; ClinicalTrials. gov number, NCT00482677.)	[Perry, James R.; Sahgal, Arjun] Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, A402,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Laperriere, Normand; Mason, Warren P.] Princess Margaret Canc Ctr, Toronto, ON, Canada; [O'Callaghan, Christopher J.; Winch, Chad; Ding, Keyue] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada; [Cairncross, J. Gregory] Univ Calgary, Calgary, AB, Canada; [Roa, Wilson] Univ Alberta, Edmonton, AB, Canada; [Osoba, David] Qual Life Consulting, West Vancouver, BC, Canada; [Rossiter, John P.] Queens Univ, Kingston Gen Hosp, Kingston, ON, Canada; [Hirte, Hal] Juravinski Canc Ctr, Hamilton, ON, Canada; [Brandes, Alba A.; Franceschi, Enrico] Azienda Unita Sanitaria Locale, Ist Ricovero & Cura Carattere Sci, Ist Sci Neurol, Bologna, Italy; [Fariselli, Laura] Fdn Ist Neurol Carlo Besta, Milan, Italy; [Menten, Johan] Univ Hosp Gasthuisberg, Leuven, Belgium; [Phillips, Claire] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Fay, Michael] Univ Newcastle, Newcastle, NSW, Australia; [Fay, Michael] Univ Queensland, Brisbane, Qld, Australia; [Back, Michael] Royal North Shore Hosp, Sydney, NSW, Australia; [Nishikawa, Ryo] Saitama Med Univ, Int Med Ctr, Saitama, Japan; [Laigle-Donadey, Florence; Feuvret, Loic] Hop La Pitie Salpetriere, Paris, France; [Chinot, Olivier] Aix Marseille Univ, CHU Timone, AP HM, Marseille, France; [Golfinopoulos, Vassilis] European Org Res Treatment Canc, Brussels, Belgium; [Wick, Antje; Wick, Wolfgang] Heidelberg Univ, Neurol Clin, Heidelberg, Germany; [Tills, Michael] Tauranga Hosp, Tauranga, New Zealand; [Baumert, Brigitta G.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Baumert, Brigitta G.] Maastricht Univ, Sch Oncol & Dev Biol, Maastricht, Netherlands	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Queens University - Canada; University of Calgary; University of Alberta; Queens University - Canada; McMaster University; IRCCS Istituto delle Scienze Neurologiche di Bologna (ISNB); IRCCS Istituto Neurologico Besta; KU Leuven; University Hospital Leuven; Peter Maccallum Cancer Center; University of Newcastle; University of Queensland; Royal North Shore Hospital; Saitama Medical University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; European Organisation for Research & Treatment of Cancer; Ruprecht Karls University Heidelberg; Maastricht University; Maastricht University	Perry, JR (corresponding author), Sunnybrook Hlth Sci Ctr, Odette Canc Ctr, A402,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	james.perry@sunnybrook.ca	CHINOT, Olivier/M-9196-2018; franceschi, enrico/AAW-4451-2021; Wick, Wolfgang/AAA-2545-2020; Fariselli, Laura/AAJ-4407-2021; Baumert, Brigitta G./AAM-6549-2020	CHINOT, Olivier/0000-0001-6317-9691; franceschi, enrico/0000-0001-9332-4677; Wick, Wolfgang/0000-0002-6171-634X; Fariselli, Laura/0000-0003-1329-4530; Baumert, Brigitta G./0000-0001-8871-4654; Gkolfinopoulos, Vasileios/0000-0002-8667-9477; Tabatabai, Ghazaleh/0000-0002-3542-8782; Chung, Caroline/0000-0002-9662-1519; Laperriere, Normand/0000-0001-8930-9650	Canadian Cancer Society Research Institute	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	Funded by the Canadian Cancer Society Research Institute and others; ClinicalTrials.gov number, NCT00482677.	Barnholtz-Sloan JS, 2008, J NEUROSURG, V108, P642, DOI 10.3171/JNS/2008/108/4/0642; BAUMAN GS, 1994, INT J RADIAT ONCOL, V29, P835, DOI 10.1016/0360-3016(94)90573-8; Brandes AA, 2009, CANCER-AM CANCER SOC, V115, P3512, DOI 10.1002/cncr.24406; Chamberlain MC, 2007, J NEURO-ONCOL, V82, P207, DOI 10.1007/s11060-006-9269-z; Chinot OL, 2004, CANCER, V100, P2208, DOI 10.1002/cncr.20224; ELLENBERG SS, 1985, CANCER TREAT REP, V69, P1147; Glantz M, 2003, CANCER, V97, P2262, DOI 10.1002/cncr.11323; Iwamoto FM, 2008, ANN NEUROL, V64, P628, DOI 10.1002/ana.21521; Keime-Guibert F, 2007, NEW ENGL J MED, V356, P1527, DOI 10.1056/NEJMoa065901; Laigle-Donadey F, 2010, J NEURO-ONCOL, V99, P89, DOI 10.1007/s11060-009-0110-3; Laperriere N, 2013, CANCER TREAT REV, V39, P350, DOI 10.1016/j.ctrv.2012.05.008; Lowry JK, 1998, ARCH NEUROL-CHICAGO, V55, P922, DOI 10.1001/archneur.55.7.922; Malmstrom A, 2012, LANCET ONCOL, V13, P916, DOI 10.1016/S1470-2045(12)70265-6; Mason M, 2016, NEURO-ONCOL PRACT, V3, P77, DOI 10.1093/nop/npv027; Minniti G, 2011, J NEURO-ONCOL, V102, P311, DOI 10.1007/s11060-010-0324-4; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/nov189, 10.1093/neuonc/noaa200, 10.1093/neuonc/noab200]; Paszat L, 2001, INT J RADIAT ONCOL, V51, P100, DOI 10.1016/S0360-3016(01)01572-3; Reifenberger G, 2012, INT J CANCER, V131, P1342, DOI 10.1002/ijc.27385; Roa W, 2004, J CLIN ONCOL, V22, P1583, DOI 10.1200/JCO.2004.06.082; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; Wick W, 2012, LANCET ONCOL, V13, P707, DOI 10.1016/S1470-2045(12)70164-X	22	513	526	3	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1027	1037		10.1056/NEJMoa1611977	http://dx.doi.org/10.1056/NEJMoa1611977			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QT	28296618				2022-12-28	WOS:000396403700007
J	Medarov, B; Chaudhry, H; Myint, T				Medarov, Boris; Chaudhry, Haroon; Myint, Thomas			Increasing Hypoxemia and Dyspnea in Mild Chronic Obstructive Pulmonary Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HYPERTENSION; THROMBOENDARTERECTOMY; EMBOLISM		[Medarov, Boris; Chaudhry, Haroon; Myint, Thomas] Albany Med Coll, Pulm Crit Care & Sleep Med, Albany, NY 12208 USA	Albany Medical College	Medarov, B (corresponding author), Albany Med Coll, Div Pulm Crit Care & Sleep Med, Pulm Hypertens Program, 47 New Scotland Ave, Albany, NY 12208 USA.	medarob@mail.amc.edu	Medarov, Boris/AAH-8864-2021	Medarov, Boris/0000-0002-8132-7122; Chaudhry, Haroon/0000-0002-6817-8310				Blauwet LA, 2003, HUM PATHOL, V34, P1290, DOI 10.1016/j.humpath.2003.07.003; Fedullo PF, 2001, NEW ENGL J MED, V345, P1465, DOI 10.1056/NEJMra010902; Guerin L, 2014, THROMB HAEMOSTASIS, V112, P598, DOI 10.1160/TH13-07-0538; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Jamieson SW, 2003, ANN THORAC SURG, V76, P1457, DOI 10.1016/S0003-4975(03)00828-2; Mo M, 1999, ANN THORAC SURG, V68, P1770, DOI 10.1016/S0003-4975(99)01043-7; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; MOSER KM, 1992, EUR RESPIR J, V5, P334; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438	10	0	0	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1072	1073		10.1001/jama.2016.20179	http://dx.doi.org/10.1001/jama.2016.20179			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291872				2022-12-28	WOS:000396713400021
J	Odutayo, A; Emdin, CA; Hsiao, AJ; Shakir, M; Copsey, B; Dutton, S; Chiocchia, V; Schlussel, M; Dutton, P; Roberts, C; Altman, DG; Hopewell, S				Odutayo, Ayodele; Emdin, Connor A.; Hsiao, Allan J.; Shakir, Mubeen; Copsey, Bethan; Dutton, Susan; Chiocchia, Virginia; Schlussel, Michael; Dutton, Peter; Roberts, Corran; Altman, Douglas G.; Hopewell, Sally			Association between trial registration and positive study findings: cross sectional study (Epidemiological Study of Randomized Trials-ESORT)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICALTRIALS.GOV	OBJECTIVE To assess whether randomised controlled trials (RCTs) that were registered were less likely to report positive study findings compared with RCTs that were not registered and whether the association varied by funding source. DESIGN Cross sectional study. STUDY SAMPLE All primary RCTs published in December 2012 and indexed in PubMed by November 2013. Trial registration was determined based on the report of a trial registration number in published RCTs or the identification of the trial in a search of trial registries. Trials were separated into prospectively and retrospectively registered studies. MAIN OUTCOME MEASURE Association between trial registration and positive study findings. RESULTS 1122 eligible RCTs were identified, of which 593 (52.9%) were registered and 529 (47.1%) were not registered. Overall, registration was marginally associated with positive study findings (adjusted risk ratio 0.87, 95% confidence interval 0.78 to 0.98), even with stratification as prospectively and retrospectively registered trials (0.87, 0.74 to 1.03 and 0.88, 0.78 to 1.00, respectively). The interaction term between overall registration and funding source was marginally statistically significant and relative risk estimates were imprecise (0.75, 0.63 to 0.89 for non-industry funded and 1.03, 0.79 to 1.36 for industry funded, P interaction= 0.046). Furthermore, a statistically significant interaction was not maintained in sensitivity analyses. Within each stratum of funding source, relative risk estimates were also imprecise for the association between positive study findings and prospective and retrospective registration. CONCLUSION Among published RCTs, there was little evidence of a difference in positive study findings between registered and non-registered clinical trials, even with stratification by timing of registration. Relative risk estimates were imprecise in subgroups of non-industry and industry funded trials.	[Odutayo, Ayodele; Copsey, Bethan; Dutton, Susan; Chiocchia, Virginia; Schlussel, Michael; Dutton, Peter; Roberts, Corran; Altman, Douglas G.; Hopewell, Sally] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Odutayo, Ayodele] St Michaels Hosp, AHRC, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Emdin, Connor A.; Shakir, Mubeen] Harvard Univ, Fac Med, Boston, MA 02115 USA; [Hsiao, Allan J.] MIT, Dept Econ, Cambridge, MA 02139 USA	University of Oxford; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Harvard University; Massachusetts Institute of Technology (MIT)	Odutayo, A (corresponding author), Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England.; Odutayo, A (corresponding author), St Michaels Hosp, AHRC, Li Ka Shing Knowledge Inst, Toronto, ON, Canada.	ayodele.odutayo@bnc.ox.ac.uk	Chiocchia, Virginia/H-8885-2019; Sutter, Raoul/J-7747-2019	Chiocchia, Virginia/0000-0002-6196-3308; Sutter, Raoul/0000-0002-6575-356X; Hopewell, Sally/0000-0002-6881-6984; Dutton, Susan/0000-0003-4573-5257	Rhodes Trust; Clarendon Fund; Cancer Research UK [16895] Funding Source: researchfish	Rhodes Trust; Clarendon Fund; Cancer Research UK(Cancer Research UK)	This study was not funded. AO, CAE, AJH and MS were supported by the Rhodes Trust. AO was additionally supported by the Clarendon Fund.	Becker JE, 2014, JAMA-J AM MED ASSOC, V311, P1063, DOI 10.1001/jama.2013.285634; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; De Angelis C, 2004, LANCET, V364, P911, DOI 10.1016/S0140-6736(04)17034-7; DECHARTRES A, 2016, BMC MED, V14, DOI DOI 10.1186/; Emdin C, 2015, JAMA INTERN MED, V175, P304, DOI 10.1001/jamainternmed.2014.6924; Emdin CA, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/BMJ.h117, 10.1136/bmj.h117]; Glanville JM, 2014, J MED LIBR ASSOC, V102, P177, DOI 10.3163/1536-5050.102.3.007; Goldacre B, 2016, NATURE, V530, P7, DOI 10.1038/530007a; Hartung DM, 2014, ANN INTERN MED, V160, P477, DOI 10.7326/M13-0480; Lundh A, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000033.pub3, 10.1002/14651858.MR000033.pub2]; Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Odutayo A, 2015, AM J CARDIOL, V116, P1280, DOI 10.1016/j.amjcard.2015.07.046; Rasmussen N, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-116; Robinson KA, 2002, INT J EPIDEMIOL, V31, P150, DOI 10.1093/ije/31.1.150; Savovic J, 2012, ANN INTERN MED, V157, P429, DOI 10.7326/0003-4819-157-6-201209180-00537; Zarin DA, 2007, JAMA-J AM MED ASSOC, V297, P2112, DOI 10.1001/jama.297.19.2112	17	18	18	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2017	356								j917	10.1136/bmj.j917	http://dx.doi.org/10.1136/bmj.j917			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NH	28292744	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000397014900003
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2017: Imaging	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2017	356								j1239	10.1136/bmj.j1239	http://dx.doi.org/10.1136/bmj.j1239			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NF	28288990				2022-12-28	WOS:000397014700003
J	Gurbel, PA; Tantry, US				Gurbel, Paul A.; Tantry, Udaya S.			GEMINI-ACS-1: toward unearthing the antithrombotic therapy cornerstone for acute coronary syndromes	LANCET			English	Editorial Material							FACTOR XA; ASPIRIN; CLOPIDOGREL; TICAGRELOR; RIVAROXABAN		[Gurbel, Paul A.; Tantry, Udaya S.] Inova Heart & Vasc Inst, Inova Ctr Thrombosis Res & Drug Dev, Falls Church, VA 22042 USA; [Gurbel, Paul A.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Gurbel, Paul A.] Duke Univ, Sch Med, Durham, NC 27708 USA	Inova Fairfax Hospital; Johns Hopkins University; Duke University	Gurbel, PA (corresponding author), Inova Heart & Vasc Inst, Inova Ctr Thrombosis Res & Drug Dev, Falls Church, VA 22042 USA.; Gurbel, PA (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.; Gurbel, PA (corresponding author), Duke Univ, Sch Med, Durham, NC 27708 USA.	paul.gurbel@inova.org			Haemonetics; DCRI; Merck; National Institutes of Health; Bayer; Medimmune; Coramed	Haemonetics; DCRI; Merck(Merck & Company); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer(Bayer AG); Medimmune(AstraZenecaMedimmune); Coramed	PAG has received consulting honoraria from AstraZeneca, Boehringer, Merck, Janssen, and Bayer for advice on the design of pharmacodynamic and clinical trials and from Haemonetics on the design of clinical trials; has received research grants from Haemonetics to evaluate point-of-care determination of thrombogenicity, DCRI to study the effect of therapy to raise HDL, Merck to study the effects of vorapaxar, National Institutes of Health to study the effects of a novel parenteral PAR-1 blocker, Bayer to study the interaction of naproxen sodium and aspirin, Medimmune to study the effect of recombinant LCAT, and Coramed to study a point-of-care device that assesses thrombogenicity; and has patents on platelet function testing (patent numbers: 8058023, 8070678, 9188597, 9110062, 8440420). UST declares no competing interests.	[Anonymous], 1988, LANCET, V2, P349; Baber U, 2016, AM HEART J, V182, P125, DOI 10.1016/j.ahj.2016.09.006; Cadroy Y, 2000, CIRCULATION, V101, P2823, DOI 10.1161/01.CIR.101.24.2823; Esmon CT, 2014, THROMB HAEMOSTASIS, V111, P625, DOI 10.1160/TH13-09-0730; Goto M, 2016, INT J CARDIOL, V220, P602, DOI 10.1016/j.ijcard.2016.06.212; Gurbel PA, 2010, CIRCULATION, V121, P569, DOI 10.1161/CIRCULATIONAHA.109.853085; Kirkby NS, 2011, J THROMB HAEMOST, V9, P2103, DOI 10.1111/j.1538-7836.2011.04453.x; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Ohman EM, 2017, LANCET; Tantry US, 2009, PROG CARDIOVASC DIS, V52, P141, DOI 10.1016/j.pcad.2009.05.001; Undas A, 2007, BLOOD, V109, P2285, DOI 10.1182/blood-2006-01-010645; Vranckx P, 2016, EUROINTERVENTION, V12, P1239, DOI 10.4244/EIJY15M11_07; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	14	11	12	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1773	1775		10.1016/S0140-6736(17)30760-2	http://dx.doi.org/10.1016/S0140-6736(17)30760-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ET8KW	28325639				2022-12-28	WOS:000400549300004
J	Lefrancais, E; Ortiz-Munoz, G; Caudrillier, A; Mallavia, B; Liu, FC; Sayah, DM; Thornton, EE; Headley, MB; David, T; Coughlin, SR; Krummel, MF; Leavitt, AD; Passegue, E; Looney, MR				Lefrancais, Emma; Ortiz-Munoz, Guadalupe; Caudrillier, Axelle; Mallavia, Benat; Liu, Fengchun; Sayah, David M.; Thornton, Emily E.; Headley, Mark B.; David, Tovo; Coughlin, Shaun R.; Krummel, Matthew F.; Leavitt, Andrew D.; Passegue, Emmanuelle; Looney, Mark R.			The lung is a site of platelet biogenesis and a reservoir for haematopoietic progenitors	NATURE			English	Article							CIRCULATING MEGAKARYOCYTES; MATURE MEGAKARYOCYTES; CELLS; VISUALIZATION	Platelets are critical for haemostasis, thrombosis, and inflammatory responses(1,2), but the events that lead to mature platelet production remain incompletely understood(3). The bone marrow has been proposed to be a major site of platelet production, although there is indirect evidence that the lungs might also contribute to platelet biogenesis(4-7). Here, by directly imaging the lung microcirculation in mice(8), we show that a large number of megakaryocytes circulate through the lungs, where they dynamically release platelets. Megakaryocytes that release platelets in the lungs originate from extrapulmonary sites such as the bone marrow; we observed large megakaryocytes migrating out of the bone marrow space. The contribution of the lungs to platelet biogenesis is substantial, accounting for approximately 50% of total platelet production or 10 million platelets per hour. Furthermore, we identified populations of mature and immature megakaryocytes along with haematopoietic progenitors in the extravascular spaces of the lungs. Under conditions of thrombocytopenia and relative stem cell deficiency in the bone marrow(9), these progenitors can migrate out of the lungs, repopulate the bone marrow, completely reconstitute blood platelet counts, and contribute to multiple haematopoietic lineages. These results identify the lungs as a primary site of terminal platelet production and an organ with considerable haematopoietic potential.	[Lefrancais, Emma; Ortiz-Munoz, Guadalupe; Caudrillier, Axelle; Mallavia, Benat; Liu, Fengchun; Leavitt, Andrew D.; Passegue, Emmanuelle; Looney, Mark R.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Sayah, David M.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Thornton, Emily E.; Headley, Mark B.; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [David, Tovo; Coughlin, Shaun R.] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA; [Looney, Mark R.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Looney, MR (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.; Looney, MR (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	mark.looney@ucsf.edu	munoz, guadalupe ortiz/B-4969-2019; Lefrancais, Emma/AAJ-3230-2020	munoz, guadalupe ortiz/0000-0002-8928-0576; Headley, Mark/0000-0002-0924-9326; Passegue, Emmanuelle/0000-0002-3516-297X; Lefrancais, Emma/0000-0003-0489-9298	NIH [HL092471, HL107386, HL130324]; UCSF Nina Ireland Program in Lung Health; UCSF Program for Breakthrough Biomedical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130324, R01HL092471, R01HL111266, R35HL135763, R01HL107386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Nina Ireland Program in Lung Health; UCSF Program for Breakthrough Biomedical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the UCSF BIDC for assistance with 2PIVM and 3D printing; A. Herault, E. Verovskaya and S. Y. Zhang from the Passegue laboratory for assistance with hematopoietic progenitor isolation and transplantation; and D. Erle and the UCSF SABRE Functional Genomics Facility for assistance with the RNA-sequencing experiments. This work was supported in part by NIH grants HL092471 to E.P., HL107386 and HL130324 to M.R.L., the UCSF Nina Ireland Program in Lung Health (M.R.L.), and the UCSF Program for Breakthrough Biomedical Research (M.R.L.).	Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162; Aschoff L., 1893, ARCH PATHOL ANAT PHY, V134, P11; Canals M, 2005, BIOL RES, V38, P41, DOI 10.4067/S0716-97602005000100006; Cornelissen I, 2010, P NATL ACAD SCI USA, V107, P18605, DOI 10.1073/pnas.1013309107; Dunois-Larde C, 2009, BLOOD, V114, P1875, DOI 10.1182/blood-2009-03-209205; Fuentes R, 2010, J CLIN INVEST, V120, P3917, DOI 10.1172/JCI43326; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Howell WH, 1937, J EXP MED, V65, DOI 10.1084/jem.65.2.177; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; KALLINIK.A, 1969, ACTA HAEMATOL-BASEL, V42, P330, DOI 10.1159/000208817; KAUFMAN RM, 1965, BLOOD-J HEMATOL, V26, P720, DOI 10.1182/blood.V26.6.720.720; LEVINE RF, 1993, EUR J HAEMATOL, V51, P233; Liu ZJ, 2014, BLOOD, V123, P3381, DOI 10.1182/blood-2013-06-508200; Looney MR, 2011, NAT METHODS, V8, P91, DOI 10.1038/NMETH.1543; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Ortiz-Munoz G, 2014, BLOOD, V124, P2625, DOI 10.1182/blood-2014-03-562876; Patel SR, 2005, J CLIN INVEST, V115, P3348, DOI 10.1172/JCI26891; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Sayah DM, 2015, AM J RESP CRIT CARE, V191, P455, DOI 10.1164/rccm.201406-1086OC; Semple JW, 2011, NAT REV IMMUNOL, V11, P264, DOI 10.1038/nri2956; Thon JN, 2010, J CELL BIOL, V191, P861, DOI 10.1083/jcb.201006102; Tiedt R, 2007, BLOOD, V109, P1503, DOI 10.1182/blood-2006-04-020362; TROWBRIDGE EA, 1984, CLIN PHYS PHYSIOL M, V5, P145, DOI 10.1088/0143-0815/5/3/007; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Weyrich AS, 2013, ANNU REV PHYSIOL, V75, P569, DOI 10.1146/annurev-physiol-030212-183752; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801; Zucker-Franklin D, 2000, AM J PATHOL, V157, P69, DOI 10.1016/S0002-9440(10)64518-X	30	552	601	8	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					105	+		10.1038/nature21706	http://dx.doi.org/10.1038/nature21706			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ8GQ	28329764	Green Accepted			2022-12-28	WOS:000398323300042
J	Jeon, MY; Kim, D; Kumar, P; Lee, PS; Rangnekar, N; Bai, P; Shete, M; Elyassi, B; Lee, HS; Narasimharao, K; Basahel, SN; Al-Thabaiti, S; Xu, WQ; Cho, HJ; Fetisov, EO; Thyagarajan, R; DeJaco, RF; Fan, W; Mkhoyan, KA; Siepmann, JI; Tsapatsis, M				Jeon, Mi Young; Kim, Donghun; Kumar, Prashant; Lee, Pyung Soo; Rangnekar, Neel; Bai, Peng; Shete, Meera; Elyassi, Bahman; Lee, Han Seung; Narasimharao, Katabathini; Basahel, Sulaiman Nasir; Al-Thabaiti, Shaeel; Xu, Wenqian; Cho, Hong Je; Fetisov, Evgenii O.; Thyagarajan, Raghuram; DeJaco, Robert F.; Fan, Wei; Mkhoyan, K. Andre; Siepmann, J. Ilja; Tsapatsis, Michael			Ultra-selective high-flux membranes from directly synthesized zeolite nanosheets	NATURE			English	Article							ORIENTED MFI MEMBRANES; HYDROTHERMAL SYNTHESIS; SECONDARY GROWTH; CRYSTAL-GROWTH; INTERGROWTH; PERFORMANCE; PERMEATION; SILICALITE; NUCLEATION	A zeolite with structure type MFI1,2 is an aluminosilicate or silicate material that has a three-dimensionally connected pore network, which enables molecular recognition in the size range 0.5-0.6 nm. These micropore dimensions are relevant for many valuable chemical intermediates, and therefore MFI-type zeolites are widely used in the chemical industry as selective catalysts or adsorbents(3-5). As with all zeolites, strategies to tailor them for specific applications include controlling their crystal size and shape(5-8). Nanometre-thick MFI crystals (nanosheets) have been introduced in pillared(9) and self-pillared (intergrown)(10) architectures, offering improved mass-transfer characteristics for certain adsorption and catalysis applications(11-14). Moreover, single (non-intergrown and nonlayered) nanosheets have been used to prepare thin membranes(15,16) that could be used to improve the energy efficiency of separation processes(17). However, until now, single MFI nanosheets have been prepared using a multi-step approach based on the exfoliation of layered MFI9,15, followed by centrifugation to remove non-exfoliated particles(18). This top-down method is time-consuming, costly and low-yield and it produces fragmented nanosheets with submicrometre lateral dimensions. Alternatively, direct (bottom-up) synthesis could produce high-aspect-ratio zeolite nanosheets, with improved yield and at lower cost. Here we use a nanocrystal-seeded growth method triggered by a single rotational intergrowth to synthesize high-aspect-ratio MFI nanosheets with a thickness of 5 nanometres (2.5 unit cells). These high-aspect-ratio nanosheets allow the fabrication of thin and defect-free coatings that effectively cover porous substrates. These coatings can be intergrown to produce high-flux and ultra-selective MFI membranes that compare favourably with other MFI membranes prepared from existing MFI materials (such as exfoliated nanosheets or nanocrystals).	[Jeon, Mi Young; Kim, Donghun; Kumar, Prashant; Lee, Pyung Soo; Rangnekar, Neel; Bai, Peng; Shete, Meera; Elyassi, Bahman; Lee, Han Seung; DeJaco, Robert F.; Mkhoyan, K. Andre; Tsapatsis, Michael] Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA; [Bai, Peng; Fetisov, Evgenii O.; Thyagarajan, Raghuram; Siepmann, J. Ilja] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA; [Bai, Peng; Fetisov, Evgenii O.; Thyagarajan, Raghuram; Siepmann, J. Ilja] Univ Minnesota, Chem Theory Ctr, Minneapolis, MN 55455 USA; [Narasimharao, Katabathini; Basahel, Sulaiman Nasir; Al-Thabaiti, Shaeel] King Abdulaziz Univ, Dept Chem, Fac Sci, Jeddah 21589, Saudi Arabia; [Xu, Wenqian] Argonne Natl Lab, Adv Photon Source, Xray Sci Div, Argonne, IL 60439 USA; [Cho, Hong Je; Fan, Wei] Univ Massachusetts, Dept Chem Engn, Amherst, MA 01003 USA; [Lee, Pyung Soo] KRICT, Ctr Membrane, Adv Green Chem Mat Div, Daejeon 34114, South Korea	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; King Abdulaziz University; United States Department of Energy (DOE); Argonne National Laboratory; University of Massachusetts System; University of Massachusetts Amherst; Korea Research Institute of Chemical Technology (KRICT)	Kim, D; Lee, PS; Tsapatsis, M (corresponding author), Univ Minnesota, Dept Chem Engn & Mat Sci, 421 Washington Ave SE, Minneapolis, MN 55455 USA.; Lee, PS (corresponding author), KRICT, Ctr Membrane, Adv Green Chem Mat Div, Daejeon 34114, South Korea.	kimx1408@umn.edu; zeolite@krict.re.kr; tsapa001@umn.edu	Fan, Wei/AAX-6383-2021; DeJaco, Robert/P-5364-2019; Thyagarajan, Raghuram/ABF-2426-2020; Tsapatsis, Michael/AAA-2527-2019; Bai, Peng/L-8516-2013; Narasimharao, Katabathini/H-6082-2012; Kumar, Prashant/AAR-9397-2020	Fan, Wei/0000-0002-8581-2651; DeJaco, Robert/0000-0001-9925-5748; Thyagarajan, Raghuram/0000-0003-1152-3950; Bai, Peng/0000-0002-6881-4663; Kumar, Prashant/0000-0003-4622-0917; Kim, Donghun/0000-0003-4080-5869; Fetisov, Evgenii/0000-0002-2889-9850; Al-Thabaiti, Shaeel/0000-0002-7252-292X; Cho, Hong Je/0000-0002-9721-4077; Narasimharao, Katabathini/0000-0001-7786-1050	ARPA-E programme of the US Department of Energy [DE-AR0000338 (0670-3240)]; Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center - US Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001015]; US Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences [DEFG02-12ER16362]; NSF through the MRSEC programme; DOE Office of Science [DE-AC02-06CH11357]; Office of Science of the Department of Energy [DE-AC02-06CH11357]	ARPA-E programme of the US Department of Energy(United States Department of Energy (DOE)); Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center - US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); US Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences(United States Department of Energy (DOE)); NSF through the MRSEC programme; DOE Office of Science(United States Department of Energy (DOE)); Office of Science of the Department of Energy(United States Department of Energy (DOE))	This work was supported by the ARPA-E programme of the US Department of Energy under Award DE-AR0000338 (0670-3240) for MFI nanosheet synthesis and characterization; by the Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center funded by the US Department of Energy, Office of Science, Basic Energy Sciences under Award DE-SC0001015 for membrane fabrication and permeation testing; by the US Department of Energy, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences and Biosciences under Award DEFG02-12ER16362 for the theoretical calculations; and by the Deanship of Scientific Research at the King Abdulaziz University D-003/433 for zeolite and membrane microstructure characterization. Parts of this work were carried out in the Characterization Facility, University of Minnesota, which receives partial support from the NSF through the MRSEC programme. SEM measurements were partially performed on a Hitachi 8230 provided by NSF MRI DMR-1229263. This research used the resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract number DE-AC02-06CH11357. For the theoretical calculations we used the resources of the Minnesota Supercomputing Institute and of the Argonne Leadership Computing Facility (ALCF) at Argonne National Laboratory, which is supported by the Office of Science of the Department of Energy under contract DE-AC02-06CH11357.	Agger JR, 2003, J AM CHEM SOC, V125, P830, DOI 10.1021/ja020899f; Agrawal KV, 2015, ADV MATER, V27, P3243, DOI 10.1002/adma.201405893; Agrawal KV, 2013, AICHE J, V59, P3458, DOI 10.1002/aic.14099; Bonilla G, 2004, CHEM MATER, V16, P5697, DOI 10.1021/cm048854w; Chaikittisilp W, 2013, ANGEW CHEM INT EDIT, V52, P3355, DOI 10.1002/anie.201209638; Cheng CH, 2005, J PHYS CHEM B, V109, P19116, DOI 10.1021/jp0524633; Choi J, 2006, ADSORPTION, V12, P339, DOI 10.1007/s10450-006-0564-y; Choi J, 2009, SCIENCE, V325, P590, DOI 10.1126/science.1176095; Choi M, 2009, NATURE, V461, P246, DOI 10.1038/nature08288; CORMA A, 1995, CHEM REV, V95, P559, DOI 10.1021/cr00035a006; Cundy CS, 2005, MICROPOR MESOPOR MAT, V82, P1, DOI 10.1016/j.micromeso.2005.02.016; Cundy CS, 2003, CHEM REV, V103, P663, DOI 10.1021/cr020060i; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; de Moor PPEA, 1999, J PHYS CHEM B, V103, P1639, DOI 10.1021/jp982553q; de Vos Burchart E., 1993, ZEOLITES, V13, P216; Diaz U, 2014, DALTON T, V43, P10292, DOI 10.1039/c3dt53181c; Elyassi B, 2016, AICHE J, V62, P556, DOI 10.1002/aic.15124; Fan W, 2008, NAT MATER, V7, P984, DOI 10.1038/nmat2302; FLANIGEN EM, 1978, NATURE, V271, P512, DOI 10.1038/271512a0; Grimme S, 2006, J COMPUT CHEM, V27, P1787, DOI 10.1002/jcc.20495; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Grossfield A., 2013, WHAM WEIGHTED HISTOG; Hedlund J, 2002, MICROPOR MESOPOR MAT, V52, P179, DOI 10.1016/S1387-1811(02)00316-5; Hutter J, 2014, WIRES COMPUT MOL SCI, V4, P15, DOI 10.1002/wcms.1159; Keizer K, 1998, J MEMBRANE SCI, V147, P159, DOI 10.1016/S0376-7388(98)00133-1; Khaleel M, 2014, ANGEW CHEM INT EDIT, V53, P9456, DOI 10.1002/anie.201402024; KOKOTAILO GT, 1978, NATURE, V272, P437, DOI 10.1038/272437a0; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lai ZP, 2004, IND ENG CHEM RES, V43, P3000, DOI 10.1021/ie034096s; Lai ZP, 2003, SCIENCE, V300, P456, DOI 10.1126/science.1082169; Lee PS, 2011, J AM CHEM SOC, V133, P493, DOI 10.1021/ja107942n; Li Q, 1999, MICROPOR MESOPOR MAT, V31, P141, DOI 10.1016/S1387-1811(99)00064-5; Mintova S, 2013, NANOSCALE, V5, P6693, DOI 10.1039/c3nr01629c; Mitchell S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9633; Ohsuna T, 1997, J PHYS CHEM B, V101, P9881, DOI 10.1021/jp971448y; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Ramos FSO, 2013, RSC ADV, V3, P2084, DOI 10.1039/c2ra21573j; Rangnekar N, 2015, CHEM SOC REV, V44, P7128, DOI 10.1039/c5cs00292c; Rangnekar N, 2015, ANGEW CHEM INT EDIT, V54, P6571, DOI 10.1002/anie.201411791; Roth WJ, 2014, CHEM REV, V114, P4807, DOI 10.1021/cr400600f; Shete M, 2017, ANGEW CHEM INT EDIT, V56, P535, DOI 10.1002/anie.201607063; Sholl DS, 2016, NATURE, V532, P435, DOI 10.1038/532435a; Toby BH, 2013, J APPL CRYSTALLOGR, V46, P544, DOI 10.1107/S0021889813003531; Toda J, 2015, MOL SIMULAT, V41, P1438, DOI 10.1080/08927022.2015.1047370; Pham TCT, 2013, ANGEW CHEM INT EDIT, V52, P8693, DOI 10.1002/anie.201301766; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Varoon K, 2011, SCIENCE, V334, P72, DOI 10.1126/science.1208891; Vlugt TJH, 2002, J PHYS CHEM B, V106, P12757, DOI 10.1021/jp0263931; Xomeritakis G, 2000, MICROPOR MESOPOR MAT, V38, P61, DOI 10.1016/S1387-1811(99)00300-5; Xomeritakis G, 2001, IND ENG CHEM RES, V40, P544, DOI 10.1021/ie000613k; Yoo WC, 2010, ANGEW CHEM INT EDIT, V49, P8699, DOI 10.1002/anie.201004029; Zhang H, 2016, ANGEW CHEM INT EDIT, V55, P7184, DOI 10.1002/anie.201601135; Zhang XY, 2012, SCIENCE, V336, P1684, DOI 10.1126/science.1221111	53	314	319	52	1067	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					690	+		10.1038/nature21421	http://dx.doi.org/10.1038/nature21421			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28297708	Green Submitted			2022-12-28	WOS:000397619700050
J	Barnett, A				Barnett, Adrian			RESEARCH NEEDS MORE COMPETENCE, LESS 'EXCELLENCE'	NATURE			English	Editorial Material									[Barnett, Adrian] Queensland Univ Technol, Meta Res, Brisbane, Qld, Australia	Queensland University of Technology (QUT)	Barnett, A (corresponding author), Queensland Univ Technol, Meta Res, Brisbane, Qld, Australia.			Barnett, Adrian/0000-0001-6339-0374					0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					S29	S29		10.1038/543S29a	http://dx.doi.org/10.1038/543S29a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO9OM	28328912	Bronze			2022-12-28	WOS:000397018000010
J	Moedas, C				Moedas, Carlos			Europe can build on scientific intuition	NATURE			English	Editorial Material												carlos.moedas@ec.europa.eu							0	0	0	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					465	465		10.1038/543465a	http://dx.doi.org/10.1038/543465a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO9OM	28332551				2022-12-28	WOS:000397018000017
J	Horton, R				Horton, Richard			Offline: China's rejuvenation in health	LANCET			English	Editorial Material												richard.horton@lancet.com							0	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1086	1086						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28322807	Bronze			2022-12-28	WOS:000396408700009
J	Kardon, G				Kardon, Gabrielle			Step out of the lab and engage	SCIENCE			English	Editorial Material									[Kardon, Gabrielle] Univ Utah, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Kardon, G (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.	SciCareerEditor@aaas.org			National Science Foundation	National Science Foundation(National Science Foundation (NSF))	Gabrielle Kardon is an associate professor and a National Science Foundation-sponsored STEM Ambassador (stemap.org) at the University of Utah in Salt Lake City. Send your career story to SciCareerEditor@aaas.org.		0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1234	1234		10.1126/science.355.6330.1234	http://dx.doi.org/10.1126/science.355.6330.1234			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302861				2022-12-28	WOS:000396351200047
J	Boulware, DR; Makadzange, AT				Boulware, David R.; Makadzange, A. Tariro			Case 8-2017: A 39-Year-Old Zimbabwean Man with a Severe Headache	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	9th Annual Workshop on Advanced Clinical Care-AIDS (AWACC)	NOV 19, 2015	Durban, SOUTH AFRICA				INFECTIOUS-DISEASES SOCIETY; LATERAL FLOW ASSAY; CRYPTOCOCCAL MENINGITIS; ANTIRETROVIRAL THERAPY; OPPORTUNISTIC INFECTIONS; HIV; ADULTS; ADOLESCENTS; GUIDELINES; MORTALITY		[Boulware, David R.] Univ Minnesota, Dept Med, Med Ctr, Box 736 UMHC, Minneapolis, MN 55455 USA; [Boulware, David R.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Makadzange, A. Tariro] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Makadzange, A. Tariro] Harvard Med Sch, Boston, MA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Boulware, DR (corresponding author), Univ Minnesota, Dept Med, Med Ctr, Box 736 UMHC, Minneapolis, MN 55455 USA.; Boulware, DR (corresponding author), Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.		Boulware, David R/AAF-7124-2021; Boulware, David R/GRS-0999-2022	Boulware, David R/0000-0002-4715-0060; Makadzange, Azure Tariro/0000-0001-5330-1470	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI104348, P30AI060354] Funding Source: NIH RePORTER; NIAID NIH HHS [P30 AI060354, K08 AI104348] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bahr NC, 2015, INT J TUBERC LUNG D, V19, P1209, DOI 10.5588/ijtld.15.0253; Bahr NC, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu070; Blanc FX, 2011, NEW ENGL J MED, V365, P1471, DOI 10.1056/NEJMoa1013911; Boulware DR, 2014, NEW ENGL J MED, V370, P2487, DOI 10.1056/NEJMoa1312884; Boulware DR, 2014, EMERG INFECT DIS, V20, P45, DOI 10.3201/eid2001.130906; Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; Day JN, 2013, NEW ENGL J MED, V368, P2522, DOI [10.1056/NEJMc1305981, 10.1056/NEJMoa1110404]; Durski KN, 2013, JAIDS-J ACQ IMM DEF, V63, pE101, DOI 10.1097/QAI.0b013e31828e1e56; Jarvis JN, 2014, CLIN INFECT DIS, V58, P736, DOI 10.1093/cid/cit794; Jarvis JN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-67; Kahn JO, 1998, NEW ENGL J MED, V339, P33, DOI 10.1056/NEJM199807023390107; Kambugu A, 2008, CLIN INFECT DIS, V46, P1694, DOI 10.1086/587667; Keddy KH, 2015, CLIN INFECT DIS, V61, pS272, DOI 10.1093/cid/civ685; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Marais S, 2010, LANCET INFECT DIS, V10, P803, DOI 10.1016/S1473-3099(10)70138-9; Masur H, 2014, CLIN INFECT DIS, V58, P1308, DOI 10.1093/cid/ciu094; National Institute for Communicable Diseases, 2015, GERMS S AFR ANN REP; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Robertson EJ, 2014, J INFECT DIS, V209, P74, DOI 10.1093/infdis/jit435; Rolfes MA, 2014, CLIN INFECT DIS, V59, P1607, DOI 10.1093/cid/ciu596; SanJoaquin MA, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001400; Wall EC, 2014, CLIN INFECT DIS, V58, pE137, DOI 10.1093/cid/ciu057; Williams DA, 2015, CLIN INFECT DIS, V61, P464, DOI 10.1093/cid/civ263; World Health Organization (WHO), 2013, XPERT MTB RIF WHO PO; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M; Worthington MG, 2003, AIDS, V17, P2145, DOI 10.1097/00002030-200309260-00026; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	27	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1065	1071		10.1056/NEJMcpc1516450	http://dx.doi.org/10.1056/NEJMcpc1516450			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	EO0QT	28296602				2022-12-28	WOS:000396403700012
J	Davies, J				Davies, Jess			The business case for soil	NATURE			English	Editorial Material									[Davies, Jess] Univ Lancaster, Lancaster Environm Ctr, Pentland Ctr Sustainabil Business, Lancaster, England	Lancaster University	Davies, J (corresponding author), Univ Lancaster, Lancaster Environm Ctr, Pentland Ctr Sustainabil Business, Lancaster, England.	jess.davies@lancaster.ac.uk		Davies, Jessica/0000-0001-9832-7412	Engineering and Physical Sciences Research Council [EP/N030532/1] Funding Source: researchfish; EPSRC [EP/N030532/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Corporate Water Disclosure, 2016, THIRST BUS WHY WAT I; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Intergovernmental Technical Panel on Soils, 2015, STAT WORLDS SOIL RES; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Mekonnen MM, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500323; Montanarella L, 2015, NATURE, V528, P32, DOI 10.1038/528032a; PwC, 2015, MAKE IT YOUR BUSINES; Sadoff C.W., 2015, SECURING WATER SUSTA; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; WWF and The Coca-Cola Company, 2015, TRANSF PARTN CONS WA	10	23	25	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					309	311		10.1038/543309a	http://dx.doi.org/10.1038/543309a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9RN	28300122	Green Submitted, Bronze			2022-12-28	WOS:000396337400014
J	Oliver, D				Oliver, David			David Oliver: Why shouldn't nurses be graduates?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Chapman J., 2013, DAILY MAIL; Dalrymple T., 2009, DAILY TELEGRAPH; Fletcher V., 2009, DAILY EXPRESS; King's College School of Nursing, 2014, DEGR ED NURS CAN RED; Pearson A., 2017, DAILY TELEGRAPH	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2017	356								j863	10.1136/bmj.j863	http://dx.doi.org/10.1136/bmj.j863			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4VK	28292770	Bronze, Green Published			2022-12-28	WOS:000426824900005
J	Fouad, FM; Sparrow, A; Tarakji, A; Alameddine, M; El-Jardali, F; Coutts, AP; El Arnaout, N; Karroum, LB; Jawad, M; Roborgh, S; Abbara, A; Alhalabi, F; AlMasri, I; Jabbour, S				Fouad, Fouad M.; Sparrow, Annie; Tarakji, Ahmad; Alameddine, Mohamad; El-Jardali, Fadi; Coutts, Adam P.; El Arnaout, Nour; Karroum, Lama Bou; Jawad, Mohammed; Roborgh, Sophie; Abbara, Aula; Alhalabi, Fadi; AlMasri, Ibrahim; Jabbour, Samer			Health workers and the weaponisation of health care in Syria: a preliminary inquiry for The Lancet-American University of Beirut Commission on Syria	LANCET			English	Article							MEDICAL WORKERS; GLOBAL HEALTH; CONFLICT; CRISIS; SURVEILLANCE; HOSPITALS; DOCTORS; SAYS	The conflict in Syria presents new and unprecedented challenges that undermine the principles and practice of medical neutrality in armed conflict. With direct and repeated targeting of health workers, health facilities, and ambulances, Syria has become the most dangerous place on earth for health-care providers. The weaponisation of health care-a strategy of using people's need for health care as a weapon against them by violently depriving them of it-has translated into hundreds of health workers killed, hundreds more incarcerated or tortured, and hundreds of health facilities deliberately and systematically attacked. Evidence shows use of this strategy on an unprecedented scale by the Syrian Government and allied forces, in what human rights organisations described as a war-crime strategy, although all parties seem to have committed violations. Attacks on health care have sparked a large-scale exodus of experienced health workers. Formidable challenges face health workers who have stayed behind, and with no health care a major factor in the flight of refugees, the effect extends well beyond Syria. The international community has left these violations of international humanitarian and human rights law largely unanswered, despite their enormous consequences. There have been repudiated denunciations, but little action on bringing the perpetrators to justice. This inadequate response challenges the foundation of medical neutrality needed to sustain the operations of global health and humanitarian agencies in situations of armed conflict. In this Health Policy, we analyse the situation of health workers facing such systematic and serious violations of international humanitarian law. We describe the tremendous pressures that health workers have been under and continue to endure, and the remarkable resilience and resourcefulness they have displayed in response to this crisis. We propose policy imperatives to protect and support health workers working in armed conflict zones.	[Fouad, Fouad M.; Alameddine, Mohamad; El-Jardali, Fadi; El Arnaout, Nour; Jawad, Mohammed; Jabbour, Samer] Amer Univ Beirut, Fac Hlth Sci, POB 11-0236, Beirut 11072020, Lebanon; [Fouad, Fouad M.] Amer Univ Beirut, Global Hlth Initiat, Beirut, Lebanon; [El-Jardali, Fadi] Amer Univ Beirut, Knowledge Policy K2P Ctr, Beirut, Lebanon; [El-Jardali, Fadi; Karroum, Lama Bou] Amer Univ Beirut, Ctr Systemat Reviews Hlth Policy & Syst Res SPARK, Beirut, Lebanon; [Sparrow, Annie] Icahn Sch Med Mt Sinai, Populat Hlth Sci & Policy, New York, NY 10029 USA; [Tarakji, Ahmad; Abbara, Aula] SAMS, Washington, DC USA; [Coutts, Adam P.] Univ Cambridge, Dept Sociol, Cambridge, England; [Roborgh, Sophie] Univ Cambridge, Dept Polit & Int Studies, Cambridge, England; [Jawad, Mohammed; Abbara, Aula] Imperial Coll London, London, England; [Alhalabi, Fadi] Multi Aid Programs MAPS, Bekka, Lebanon; [AlMasri, Ibrahim] SAMS, Zahleh, Lebanon	American University of Beirut; American University of Beirut; American University of Beirut; American University of Beirut; Icahn School of Medicine at Mount Sinai; University of Cambridge; University of Cambridge; Imperial College London	Jabbour, S (corresponding author), Amer Univ Beirut, Fac Hlth Sci, POB 11-0236, Beirut 11072020, Lebanon.	sj22@aub.edu.lb	Alameddine, Mohamad/AAN-1624-2020; Jawad, Mohammed/I-6919-2019; Jabbour, Samer/Y-6860-2018	Alameddine, Mohamad/0000-0002-2299-1242; Jawad, Mohammed/0000-0002-1051-2136; Jabbour, Samer/0000-0002-7150-6856; AlMasri, Ibrahim/0000-0001-7676-833X; Roborgh, Sophie/0000-0002-6372-1505; Alhalabi, Fadi/0000-0002-0267-8208	International Development Research Centre (IDRC), Canada; American University of Beirut; MRC [1771198] Funding Source: UKRI	International Development Research Centre (IDRC), Canada; American University of Beirut; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Lancet-American University of Beirut Commission on Syria: Health in Conflict has received financial support from the International Development Research Centre (IDRC), Canada, and from the American University of Beirut. We thank Jennifer Leaning and Iman Nuwayhid for helpful comments; Khuloud Alsaba, Zaki Mehchy, and Rabie Nasser from the Syrian Center for Policy Research, Raed Al Saleh from the Syrian Civil Defence, and several Syrian colleagues for providing data or sharing valuable insights; Elie Akl, Karim Daou, and Mohamed Nomier from the SPARK team at the American University of Beirut for contributing to the scoping review that supported the development of this paper; and Nicholas Teodoro (Columbia University College of Physicians and Surgeons), Nicholas Wood (School of Population and Global Health, University of Western Australia), Jehan Mouhsen (Aleppo), and colleagues at the Syrian American Medical Society office in Gaziantep, Turkey, for their help with compilation and corroboration of data on attacks and health workers and graph-making.	Al Qutob MF, 2016, LANCET GLOB HEALTH, V4, pE304, DOI 10.1016/S2214-109X(16)00067-X; al-Khalidi S., 2011, SYRIAN FORCES SHOOT; Alahdab Fares, 2014, Avicenna J Med, V4, P51, DOI 10.4103/2231-0770.133329; Amnesty International, 2011, SYR GOV TARG WOUND H; Amnesty International, 2016, SYR 2016 2017; [Anonymous], 2016, LANCET, V387, P1591, DOI 10.1016/S0140-6736(16)30246-X; [Anonymous], TRACK ATT HLTH WORK; Assistance Coordination Unit, 2015, ANN REP 2015; Atlantic Council, 2017, BBREAK AL; Attar S, 2016, NEW ENGL J MED, V374, P2205, DOI 10.1056/NEJMp1603673; Barnett M, 2011, EMPIRE HUMANITY HIST; Beeley V., 2016, DR NABIL ANTAKI REPO; Boseley S, 2016, LANCET, V388, P861, DOI 10.1016/S0140-6736(16)31422-2; Center for Mediterranean Integration, 2017, STRENGTH HUM RES HLT; Cousins S, 2015, LANCET, V385, P931, DOI 10.1016/S0140-6736(15)60515-3; Coutts A., 2015, PROSECUTE PERPETRATO; Coutts Adam, 2015, Lancet Respir Med, V3, pe8, DOI 10.1016/S2213-2600(15)00041-7; Coutts A, 2013, LANCET, V381, P2242, DOI 10.1016/S0140-6736(13)61421-X; Dardari Abdullah, 2016, MIDDL E I C NOV 29; Devi S, 2016, LANCET, V387, P1042, DOI 10.1016/S0140-6736(16)00690-5; Dewachi O, 2014, LANCET, V383, P449, DOI 10.1016/S0140-6736(13)62299-0; Fouad FM, 2016, LANCET, V387, P1613, DOI 10.1016/S0140-6736(16)30197-0; Francis E., 2011, WAR SYRIAS DOCTORS; Guha-Sapir D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4736; Gulland A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1000; H uman Rights Watch, 2016, SYR NEW DEADL CHEM A; Hammond Laura, 2008, HUMANITARIANISM QUES, P172; Henckaerts J- M, 2005, INT COMMITTEE RED CR, P25; Herbermann JD, 2017, B WORLD HEALTH ORGAN, V95, P6, DOI 10.2471/BLT.17.020117; Horton R, 2016, LANCET, V388, P2854, DOI 10.1016/S0140-6736(16)32508-9; Human Rights Watch, 2016, UN PEAC SYR GLOB CIV; Human Rights Watch, 2013, DEATH FROM THE SKIES; International Committee of the Red Cross, 1977, CONV 4 REL PROT CIV; International Committee of the Red Cross, 2016, EV WARS HAV LIM HLTH; International Committee of the Red Cross, 1977, PROT ADD GEN CONV 12; International Committee of the Red Cross, 2010, ICRC PREV POL; International Committee of the Red Cross, 2016, CONV 1 AM COND WOUND; Ismail SA, 2016, INT J INFECT DIS, V47, P15, DOI 10.1016/j.ijid.2016.05.011; Jabbour S, 2016, LANCET, V388, P2967, DOI 10.1016/S0140-6736(16)32583-1; Nickerson JW, 2015, CAN MED ASSOC J, V187, pE347, DOI 10.1503/cmaj.140410; Office of the UN High Commissioner for Human Rights, 2011, INT LEG PROT HUM RIG; *PHYS HUM RIGHTS, 2009, PER MED LEG OPPR CON; Physicians for Human Rights, 2015, DOCT CROSSH 4 YEARS; Physicians for Human Rights, 2016, PHR URG RUSS MED COM; Physicians for Human Rights, 2015, AL AB CAS STUD HLTH; Physicians for Human Rights (New York), 2016, AN CRIS MAP ATT HLTH; Politheor European Policy Network, 2016, CIV SOC RESP REF CRI; Roth K., STEM FLOW SYRIAN REF; Rubenstein LS, 2010, LANCET, V375, P329, DOI 10.1016/S0140-6736(09)61926-7; Sahloul MZ, 2016, ANN AM THORAC SOC, V13, P147, DOI 10.1513/AnnalsATS.201510-661PS; Shetty P, 2013, LANCET, V382, pE41, DOI 10.1016/S0140-6736(13)62627-6; Sparrow A., 2013, SYRIAS ASSAULTS DOCT; Sparrow A., 2016, BORN FIGHT SYRIAS CO; Sparrow A, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000029; Spiegel PB, 2010, LANCET, V375, P341, DOI 10.1016/S0140-6736(09)61873-0; Syrian American Medical Society, 2015, ANN REP 2015; Syrian American Medical Society, 2015, SYR MED VOIC GROUND; Syrian Center for Policy Research, 2016, FORC DISP DEM REP HU; Syrian network for Human Rights, 2016, REP VIT FAC ATT AUG; Tajaldin B, 2015, ANN GLOB HEALTH, V81, P386, DOI 10.1016/j.aogh.2015.06.007; Taub Ben, 2016, NEW YORKER; Terry F, 2013, INT REV RED CROSS, V95, P23, DOI 10.1017/S1816383113000581; The International Commission of the Red Cross, 1949, GEN CONV 12 AUG 1949; United Nations General Assembly, 2013, REPORT SPECIAL RAPPO; United Nations Human Rights Office of the High Comissioner, 2016, UN COMM INQ SYR COND; United Nations Security Council, 2014, REF SYR INT CRIM COU; Violation Documentation Center in Syria, 2013, MED SIT E GOUT DAM S; Vogel L, 2016, CAN MED ASSOC J, V188, P177, DOI 10.1503/cmaj.109-5217; WHO, 2000, RIGHT HIGH ATT STAND; WHO, 2012, WHOS RESP ROL HLTH C; Zarocostas J, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6947	71	102	102	1	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 2	2017	390	10111					2516	2526		10.1016/S0140-6736(17)30741-9	http://dx.doi.org/10.1016/S0140-6736(17)30741-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FO6UL	28314568				2022-12-28	WOS:000417003400029
J	Chakravarty, T; Sondergaard, L; Friedman, J; De Backer, O; Berman, D; Kofoed, KF; Jilaihawi, H; Shiota, T; Abramowitz, Y; Jorgensen, TH; Rami, T; Israr, S; Fontana, G; de Knegt, M; Fuchs, A; Lyden, P; Trento, A; Bhatt, DL; Leon, MB; Makkar, RR				Chakravarty, Tarun; Sondergaard, Lars; Friedman, John; De Backer, Ole; Berman, Daniel; Kofoed, Klaus F.; Jilaihawi, Hasan; Shiota, Takahiro; Abramowitz, Yigal; Jorgensen, Troels H.; Rami, Tanya; Israr, Sharjeel; Fontana, Gregory; de Knegt, Martina; Fuchs, Andreas; Lyden, Patrick; Trento, Alfredo; Bhatt, Deepak L.; Leon, Martin B.; Makkar, Raj R.		RESOLVE Investigator; SAVORY Investigator	Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study	LANCET			English	Article							BLEEDING COMPLICATIONS; REPLACEMENT; RISK; IMPLANTATION; STENOSIS; SCORE	Background Subclinical leaflet thrombosis of bioprosthetic aortic valves after transcatheter valve replacement (TAVR) and surgical aortic valve replacement (SAVR) has been found with CT imaging. The objective of this study was to report the prevalence of subclinical leaflet thrombosis in surgical and transcatheter aortic valves and the effect of novel oral anticoagulants (NOACs) on the subclinical leaflet thrombosis and subsequent valve haemodynamics and clinical outcomes on the basis of two registries of patients who had CT imaging done after TAVR or SAVR. Methods Patients enrolled between Dec 22, 2014, and Jan 18, 2017, in the RESOLVE registry, and between June 2, 2014, and Sept 28, 2016, in the SAVORY registry, had CT imaging done with a dedicated four-dimensional volume-rendered imaging protocol at varying intervals after TAVR and SAVR. We defined subclinical leaflet thrombosis as the presence of reduced leaflet motion, along with corresponding hypoattenuating lesions shown with CT. We collected data for baseline demographics, antithrombotic therapy, and clinical outcomes. We analysed all CT scans, echocardiograms, and neurological events in a masked fashion. Findings Of the 931 patients who had CT imaging done (657 [71%] in the RESOLVE registry and 274 [29%] in the SAVORY registry), 890 [96%] had interpretable CT scans (626 [70%] in the RESOLVE registry and 264 [30%] in the SAVORY registry). 106 (12%) of 890 patients had subclinical leaflet thrombosis, including five (4%) of 138 with thrombosis of surgical valves versus 101 (13%) of 752 with thrombosis of transcatheter valves (p=0.001). The median time from aortic valve replacement to CT for the entire cohort was 83 days (IQR 33-281). Subclinical leaflet thrombosis was less frequent among patients receiving anticoagulants (eight [4%] of 224) than among those receiving dual antiplatelet therapy (31 [15%] of 208; p<0.0001); NOACs were equally as effective as warfarin (three [3%] of 107 vs five [4%] of 117; p=0.72). Subclinical leaflet thrombosis resolved in 36 (100%) of 36 patients (warfarin 24 [67%]; NOACs 12 [33%]) receiving anticoagulants, whereas it persisted in 20 (91%) of 22 patients not receiving anticoagulants (p<0.0001). A greater proportion of patients with subclinical leaflet thrombosis had aortic valve gradients of more than 20 mm Hg and increases in aortic valve gradients of more than 10 mm Hg (12 [14%] of 88) than did those with normal leaflet motion (seven [1%] of 632; p<0.0001). Although stroke rates were not different between those with (4.12 strokes per 100 person-years) or without (1.92 strokes per 100 person-years) reduced leaflet motion (p=0.10), subclinical leaflet thrombosis was associated with increased rates of transient ischaemic attacks (TIAs; 4.18 TIAs per 100 person-years vs 0.60 TIAs per 100 person-years; p=0.0005) and all strokes or TIAs (7.85 vs 2.36 per 100 person-years; p=0.001). Interpretation Subclinical leaflet thrombosis occurred frequently in bioprosthetic aortic valves, more commonly in transcatheter than in surgical valves. Anticoagulation (both NOACs and warfarin), but not dual antiplatelet therapy, was effective in prevention or treatment of subclinical leaflet thrombosis. Subclinical leaflet thrombosis was associated with increased rates of TIAs and strokes or TIAs. Despite excellent outcomes after TAVR with the new-generation valves, prevention and treatment of subclinical leaflet thrombosis might offer a potential opportunity for further improvement in valve haemodynamics and clinical outcomes. Funding RESOLVE (Cedars-Sinai Heart Institute) and SAVORY (Rigshospitalet).	[Chakravarty, Tarun; Friedman, John; Berman, Daniel; Shiota, Takahiro; Abramowitz, Yigal; Rami, Tanya; Israr, Sharjeel; Lyden, Patrick; Trento, Alfredo; Makkar, Raj R.] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Sondergaard, Lars; De Backer, Ole; Kofoed, Klaus F.; Jorgensen, Troels H.; de Knegt, Martina; Fuchs, Andreas] Rigshosp, Ctr Heart, Copenhagen, Denmark; [Jilaihawi, Hasan] NYU Langone Med Ctr, New York, NY USA; [Fontana, Gregory] Los Robles Hosp & Med Ctr, Cardiovasc Inst, Thousand Oaks, CA USA; [Bhatt, Deepak L.] Harvard Med Sch, Heart & Vasc Ctr, Brigham & Womens Hosp, Boston, MA USA; [Leon, Martin B.] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA	Cedars Sinai Medical Center; Rigshospitalet; University of Copenhagen; NYU Langone Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Columbia University; NewYork-Presbyterian Hospital	Makkar, RR (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.	makkarr@cshs.org	Doğan, Ali/AAN-5331-2020; De Backer, Ole/AAQ-2369-2020	De Backer, Ole/0000-0002-9674-0278; Kofoed, Klaus Fuglsang/0000-0001-9742-1554; Fuchs, Andreas/0000-0003-0236-0811; Iversen, Helle Klingenberg/0000-0002-5880-6352; de Knegt, Martina/0000-0001-7668-0338	RESOLVE (Cedars-Sinai Heart Institute); SAVORY (Rigshospitalet)	RESOLVE (Cedars-Sinai Heart Institute); SAVORY (Rigshospitalet)	RESOLVE (Cedars-Sinai Heart Institute) and SAVORY (Rigshospitalet).	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Alavi SH, 2014, ANN THORAC SURG, V97, P1260, DOI 10.1016/j.athoracsur.2013.11.009; Amahzoune B, 2013, EUR J CARDIO-THORAC, V43, P488, DOI 10.1093/ejcts/ezs359; de Buhr W, 2012, J THORAC CARDIOV SUR, V143, P1417, DOI 10.1016/j.jtcvs.2011.11.001; Genereux P, 2014, J AM COLL CARDIOL, V64, P2605, DOI 10.1016/j.jacc.2014.08.052; Genereux P, 2014, J AM COLL CARDIOL, V63, P1100, DOI 10.1016/j.jacc.2013.10.058; Hansson NC, 2016, J AM COLL CARDIOL, V68, P2059, DOI 10.1016/j.jacc.2016.08.010; Harold JG, 2014, J AM COLL CARDIOL, V63, pE57, DOI 10.1016/j.jacc.2014.02.536; Kapadia SR, 2015, LANCET, V385, P2485, DOI 10.1016/S0140-6736(15)60290-2; Kappetein AP, 2012, EUR HEART J, V33, P2403, DOI 10.1093/eurheartj/ehs255; Leetmaa T, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001596; Leon MB, 2016, NEW ENGL J MED, V374, P1609, DOI 10.1056/NEJMoa1514616; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Makkar RR, 2015, NEW ENGL J MED, V373, P2015, DOI 10.1056/NEJMoa1509233; Mangione FM, 2017, JACC-CARDIOVASC IMAG, V10, P82, DOI 10.1016/j.jcmg.2016.11.009; Martin C, 2015, J BIOMECH, V48, P3026, DOI 10.1016/j.jbiomech.2015.07.031; Pache G, 2016, EUR HEART J, V37, P2263, DOI 10.1093/eurheartj/ehv526; Popma JJ, 2014, J AM COLL CARDIOL, V63, P1972, DOI 10.1016/j.jacc.2014.02.556; Reardon MJ, 2016, JAMA CARDIOL, V1, P945, DOI 10.1001/jamacardio.2016.2257; Ruile P, 2017, CLIN RES CARDIOL, V106, P85, DOI 10.1007/s00392-016-1052-3; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Sondergaard L, 2016, CIRC-CARDIOVASC INTE, V9, DOI 10.1161/CIRCINTERVENTIONS.115.003665; Thourani VH, 2016, LANCET, V387, P2218, DOI 10.1016/S0140-6736(16)30073-3; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; Yanagisawa R, 2016, JACC-CARDIOVASC IMAG, VS1936-878X, DOI [10.1016/j.jcmg.2016.11.005, DOI 10.1016/J.JCMG.2016.11.005, 10. 1016/j. jcmg. 2016. 11. 005]	26	533	548	4	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2383	2392		10.1016/S0140-6736(17)30757-2	http://dx.doi.org/10.1016/S0140-6736(17)30757-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX6ED	28330690				2022-12-28	WOS:000403334400024
J	Landoni, G; Lomivorotov, VV; Alvaro, G; Lobreglio, R; Pisano, A; Guarracino, F; Calabro, MG; Grigoryev, EV; Likhvantsev, VV; Salgado, MF; Bianchi, A; Pasyuga, VV; Baiocchi, M; Pappalardo, F; Monaco, F; Boboshko, VA; Abubakirov, MN; Amantea, B; Lembo, R; Brazzi, L; Verniero, L; Bertini, P; Scandroglio, AM; Bove, T; Belletti, A; Michienzi, MG; Shukevich, DL; Zabelina, TS; Bellomo, R; Zangrillo, A				Landoni, G.; Lomivorotov, V. V.; Alvaro, G.; Lobreglio, R.; Pisano, A.; Guarracino, F.; Calabro, M. G.; Grigoryev, E. V.; Likhvantsev, V. V.; Salgado-Filho, M. F.; Bianchi, A.; Pasyuga, V. V.; Baiocchi, M.; Pappalardo, F.; Monaco, F.; Boboshko, V. A.; Abubakirov, M. N.; Amantea, B.; Lembo, R.; Brazzi, L.; Verniero, L.; Bertini, P.; Scandroglio, A. M.; Bove, T.; Belletti, A.; Michienzi, M. G.; Shukevich, D. L.; Zabelina, T. S.; Bellomo, R.; Zangrillo, A.		CHEETAH Study Grp	Levosimendan for Hemodynamic Support after Cardiac Surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DECOMPENSATED HEART-FAILURE; MORTALITY; METAANALYSIS; TRIALS; DYSFUNCTION; MANAGEMENT; OUTCOMES; THERAPY; SEPSIS; SHOCK	BACKGROUND Acute left ventricular dysfunction is a major complication of cardiac surgery and is associated with increased mortality. Meta-analyses of small trials suggest that levosimendan may result in a higher rate of survival among patients undergoing cardiac surgery. METHODS We conducted a multicenter, randomized, double-blind, placebo-controlled trial involving patients in whom perioperative hemodynamic support was indicated after cardiac surgery, according to prespecified criteria. Patients were randomly assigned to receive levosimendan (in a continuous infusion at a dose of 0.025 to 0.2 mu g per kilogram of body weight per minute) or placebo, for up to 48 hours or until discharge from the intensive care unit (ICU), in addition to standard care. The primary outcome was 30-day mortality. RESULTS The trial was stopped for futility after 506 patients were enrolled. A total of 248 patients were assigned to receive levosimendan and 258 to receive placebo. There was no significant difference in 30-day mortality between the levosimendan group and the placebo group (32 patients [12.9%] and 33 patients [12.8%], respectively; absolute risk difference, 0.1 percentage points; 95% confidence interval [CI], -5.7 to 5.9; P = 0.97). There were no significant differences between the levosimendan group and the placebo group in the durations of mechanical ventilation (median, 19 hours and 21 hours, respectively; median difference, -2 hours; 95% CI, -5 to 1; P = 0.48), ICU stay (median, 72 hours and 84 hours, respectively; median difference, -12 hours; 95% CI, -21 to 2; P = 0.09), and hospital stay (median, 14 days and 14 days, respectively; median difference, 0 days; 95% CI, -1 to 2; P = 0.39). There was no significant difference between the levosimendan group and the placebo group in rates of hypotension or cardiac arrhythmias. CONCLUSIONS In patients who required perioperative hemodynamic support after cardiac surgery, low-dose levosimendan in addition to standard care did not result in lower 30-day mortality than placebo. (Funded by the Italian Ministry of Health; CHEETAH ClinicalTrials.gov number, NCT00994825.)	[Landoni, G.; Calabro, M. G.; Pappalardo, F.; Monaco, F.; Lembo, R.; Scandroglio, A. M.; Bove, T.; Belletti, A.; Zangrillo, A.] Ist Sci San Raffaele, Dept Anesthesia & Intens Care, Milan, Italy; [Landoni, G.; Zangrillo, A.] Univ Vita Salute San Raffaele, Milan, Italy; [Alvaro, G.; Amantea, B.; Michienzi, M. G.] Azienda Osped Univ Mater Domini Germaneto, Dept Anesthesia & Intens Care, Catanzaro, Italy; [Lobreglio, R.; Brazzi, L.] Azienda Osped Univ Citta Salute & Sci, Dept Anesthesia & Intens Care, Turin, Italy; [Bianchi, A.] Azienda Osped Ordine Mauriziano, Dept Cardiovasc Anesthesia & Intens Care, Turin, Italy; [Brazzi, L.] Univ Turin, Dept Surg Sci, Turin, Italy; [Pisano, A.; Verniero, L.] Azienda Osped Rilievo Nazl Colli Monaldi Hosp, Div Cardiac Anesthesia, Naples, Italy; [Pisano, A.; Verniero, L.] Azienda Osped Rilievo Nazl Colli Monaldi Hosp, Intens Care Unit, Naples, Italy; [Guarracino, F.; Bertini, P.] Azienda Osped Univ Pisana, Dept Anesthesia & Crit Care Med, Div Cardiothorac & Vasc Anesthesia & Intens Care, Pisa, Italy; [Baiocchi, M.] Univ Hosp Policlin S Orsola, Dept Cardiothorac & Vasc Anesthesia & Intens Care, Bologna, Italy; [Likhvantsev, V. V.; Boboshko, V. A.; Abubakirov, M. N.] State Res Inst Circulat Pathol, Dept Anesthesiol & Intens Care, Novosibirsk, Russia; [Grigoryev, E. V.; Shukevich, D. L.] State Res Inst Complex Issues Cardiovasc Dis, Dept Anesthesiol & Intens Care, Kemerovo, Russia; [Likhvantsev, V. V.; Zabelina, T. S.] Moscow Reg Clin & Res Inst, Dept Anesthesiol & Intens Care, Moscow, Russia; [Pasyuga, V. V.] Fed Ctr Cardiovasc Surg, Dept Anesthesiol & Intens Care, Astrakhan, Russia; [Salgado-Filho, M. F.] Univ Fed Juiz de Fora, Juiz De Fora, Brazil; [Bellomo, R.] Univ Melbourne, Melbourne, Vic, Australia	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Pisa; Azienda Ospedaliero Universitaria Pisana; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Meshalkin National Medical Research Center; Russian Academy of Medical Sciences; Research Institute for Complex Issues of Cardiovascular Diseases; Universidade Federal de Juiz de Fora; University of Melbourne	Bellomo, R (corresponding author), Austin Hosp, Dept Intens Care, Melbourne, Vic 3084, Australia.	rinaldo.bellomo@austin.org.au	Belletti, Alessandro/I-1981-2019; Lomivorotov, Vladimir/L-7868-2014; Pisano, Antonio/AAG-1028-2020; Brazzi, Luca/AAS-4978-2020; Grigoryev, Evgeny/K-2024-2019; Oriani, Alessandro/AAN-2576-2020; Boboshko, Vladimir/Q-5070-2016; Baiocchi, Massimo/AGJ-6047-2022; Monaco, Fabrizio/GZA-9167-2022; Bertini, Pietro/H-9910-2019; Giovanni, Landoni/AAH-1881-2019; Bove, Tiziana/AAC-2109-2022; Grigoryev, Evgeny/A-2321-2017; Zangrillo, Alberto/AAH-2037-2019; Fominskiy, Evgeny/D-9118-2014; Likhvantsev, Valery/A-4893-2016	Belletti, Alessandro/0000-0003-3131-0565; Lomivorotov, Vladimir/0000-0001-8591-6461; Pisano, Antonio/0000-0002-5118-444X; Brazzi, Luca/0000-0001-7059-0622; Boboshko, Vladimir/0000-0001-5420-2263; Baiocchi, Massimo/0000-0001-7909-6399; Monaco, Fabrizio/0000-0001-5186-1976; Bertini, Pietro/0000-0002-3878-044X; Giovanni, Landoni/0000-0002-8594-5980; Grigoryev, Evgeny/0000-0001-8370-3083; Zangrillo, Alberto/0000-0002-7687-7648; Guarracino, Fabio/0000-0002-2562-0199; Fominskiy, Evgeny/0000-0002-3198-4458; Likhvantsev, Valery/0000-0002-5442-6950; Pappalardo, Federico/0000-0001-9129-833X; Calabro, Maria Grazia/0000-0003-1843-3165; BOVE, Tiziana/0000-0002-5489-2898	Italian Ministry of Health [RF-2009-1519827]; Italian Ministry of Health; CHEETAH	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Health(Ministry of Health, Italy); CHEETAH	Funded by the Italian Ministry of Health; CHEETAH ClinicalTrials.gov number, NCT00994825.	Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; DeMets DL, 1999, LANCET, V354, P1983, DOI 10.1016/S0140-6736(99)03464-9; Ford I, 2016, NEW ENGL J MED, V375, P454, DOI 10.1056/NEJMra1510059; Gillies M, 2005, CRIT CARE, V9, P266, DOI 10.1186/cc3024; Gordon AC, 2016, NEW ENGL J MED, V375, P1638, DOI 10.1056/NEJMoa1609409; Greco T, 2015, BRIT J ANAESTH, V114, P746, DOI 10.1093/bja/aeu446; Harrison RW, 2013, J CARDIOTHOR VASC AN, V27, P1224, DOI 10.1053/j.jvca.2013.03.027; Landoni G, 2012, CRIT CARE MED, V40, P634, DOI 10.1097/CCM.0b013e318232962a; Landoni G, 2010, J CARDIOTHOR VASC AN, V24, P51, DOI 10.1053/j.jvca.2009.05.031; Lomivorotov VV, 2017, J CARDIOTHOR VASC AN, V31, P291, DOI 10.1053/j.jvca.2016.05.029; Maganti M, 2010, J THORAC CARDIOV SUR, V140, P790, DOI 10.1016/j.jtcvs.2009.11.022; Mebazaa A, 2007, JAMA-J AM MED ASSOC, V297, P1883, DOI 10.1001/jama.297.17.1883; Mebazaa A, 2010, CRIT CARE, V14, DOI 10.1186/cc8153; Mehta RH, 2017, NEW ENGL J MED, V376, P2032, DOI 10.1056/NEJMoa1616218; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Nieminen MS, 2013, HEART LUNG VESSEL, V5, P227; Packer M, 2013, JACC-HEART FAIL, V1, P103, DOI 10.1016/j.jchf.2012.12.004; Papp Z, 2012, INT J CARDIOL, V159, P82, DOI 10.1016/j.ijcard.2011.07.022; Pollesello P, 2016, INT J CARDIOL, V209, P77, DOI 10.1016/j.ijcard.2016.02.014; Reynolds HR, 2008, CIRCULATION, V117, P686, DOI 10.1161/CIRCULATIONAHA.106.613596; Ridgeon E, 2016, CRIT CARE RESUSC, V18, P50; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rudiger A, 2009, SWISS MED WKLY, V139, P110, DOI smw-12446; Shahin J, 2011, CRIT CARE, V15, DOI 10.1186/cc10302; St Andre AC, 2005, CRIT CARE MED, V33, P2082, DOI 10.1097/01.CCM.0000178355.96817.81; Thackray S, 2002, EUR J HEART FAIL, V4, P515, DOI 10.1016/S1388-9842(02)00041-7; Toller W, 2015, INT J CARDIOL, V184, P323, DOI 10.1016/j.ijcard.2015.02.022; Zangrillo A, 2016, AM HEART J, V177, P66, DOI 10.1016/j.ahj.2016.03.021; Zangrillo A, 2015, J CRIT CARE, V30, P908, DOI 10.1016/j.jcrc.2015.05.017	30	159	171	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 25	2017	376	21					2021	2031		10.1056/NEJMoa1616325	http://dx.doi.org/10.1056/NEJMoa1616325			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV7MC	28320259	Green Published			2022-12-28	WOS:000401959600005
J	Ray, KK; Landmesser, U; Leiter, LA; Kallend, D; Dufour, R; Karakas, M; Hall, T; Troquay, RPT; Turner, T; Visseren, FLJ; Wijngaard, P; Wright, RS; Kastelein, JJP				Ray, Kausik K.; Landmesser, Ulf; Leiter, Lawrence A.; Kallend, David; Dufour, Robert; Karakas, Mahir; Hall, Tim; Troquay, Roland P. T.; Turner, Traci; Visseren, Frank L. J.; Wijngaard, Peter; Wright, R. Scott; Kastelein, John J. P.			Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; REDUCING LIPIDS; BLOOD-PRESSURE; VARIABILITY; EVENTS; ALIROCUMAB; EVOLOCUMAB; METABOLISM; EFFICACY; STATINS	BACKGROUND In a previous study, a single injection of inclisiran, a chemically synthesized small interfering RNA designed to target PCSK9 messenger RNA, was found to produce sustained reductions in low-density lipoprotein (LDL) cholesterol levels over the course of 84 days in healthy volunteers. METHODS We conducted a phase 2, multicenter, double-blind, placebo-controlled, multipleascending- dose trial of inclisiran administered as a subcutaneous injection in patients at high risk for cardiovascular disease who had elevated LDL cholesterol levels. Patients were randomly assigned to receive a single dose of placebo or 200, 300, or 500 mg of inclisiran or two doses (at days 1 and 90) of placebo or 100, 200, or 300 mg of inclisiran. The primary end point was the change from baseline in LDL cholesterol level at 180 days. Safety data were available through day 210, and data on LDL cholesterol and proprotein convertase subtilisin-kexin type 9 (PCSK9) levels were available through day 240. RESULTS A total of 501 patients underwent randomization. Patients who received inclisiran had dose-dependent reductions in PCSK9 and LDL cholesterol levels. At day 180, the least-squares mean reductions in LDL cholesterol levels were 27.9 to 41.9% after a single dose of inclisiran and 35.5 to 52.6% after two doses (P<0.001 for all comparisons vs. placebo). The two-dose 300-mg inclisiran regimen produced the greatest reduction in LDL cholesterol levels: 48% of the patients who received the regimen had an LDL cholesterol level below 50 mg per deciliter (1.3 mmol per liter) at day 180. At day 240, PCSK9 and LDL cholesterol levels remained significantly lower than at baseline in association with all inclisiran regimens. Serious adverse events occurred in 11% of the patients who received inclisiran and in 8% of the patients who received placebo. Injection-site reactions occurred in 5% of the patients who received injections of inclisiran. CONCLUSIONS In our trial, inclisiran was found to lower PCSK9 and LDL cholesterol levels among patients at high cardiovascular risk who had elevated LDL cholesterol levels.	[Ray, Kausik K.] Imperial Coll London, Imperial Ctr Cardiovasc Dis Prevent, Dept Primary Care & Publ Hlth, Reynolds Bldg,St Dunstans Rd, London W6 8RP, England; [Hall, Tim] Knowle House Surg, Plymouth, Devon, England; [Landmesser, Ulf] Charite, Berlin Inst Hlth, Dept Cardiol, Berlin, Germany; [Landmesser, Ulf] German Ctr Cardiovasc Res, Berlin, Germany; [Karakas, Mahir] Univ Heart Ctr Hamburg, Dept Gen & Intervent Cardiol, Hamburg, Germany; [Leiter, Lawrence A.] Univ Toronto, Div Endocrinol & Metab, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada; [Leiter, Lawrence A.] Univ Toronto, Keenan Res Ctr Biomed Sci, St Michaels Hosp, Toronto, ON, Canada; [Kallend, David; Wijngaard, Peter] Medicines Co, Parsippany, NJ USA; [Dufour, Robert] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada; [Troquay, Roland P. T.] VieCuri Med Ctr Northern Limburg, Dept Cardiol & Intervent Cardiol, Venlo, Netherlands; [Visseren, Frank L. J.] Univ Med Ctr, Utrecht, Netherlands; [Kastelein, John J. P.] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, Amsterdam, Netherlands; [Turner, Traci] Medpace, Metab & Atherosclerosis Res Ctr, Cincinnati, OH USA; [Wright, R. Scott] Mayo Clin, Dept Cardiol, Rochester, MN USA	Imperial College London; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; VieCuri Medical Center; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Mayo Clinic	Ray, KK (corresponding author), Imperial Coll London, Imperial Ctr Cardiovasc Dis Prevent, Dept Primary Care & Publ Hlth, Reynolds Bldg,St Dunstans Rd, London W6 8RP, England.	k.ray@imperial.ac.uk	Ray, Kausik/Z-2055-2019; Leiter, Lawrence/AAG-4059-2020; Kastelein, John/AAF-7950-2020	Visseren, Frank/0000-0003-3951-5223; Ray, Kosh/0000-0002-7166-060X	Medicines Company	Medicines Company	Funded by the Medicines Company; ORION-1 ClinicalTrials.gov number, NCT02597127.	[Anonymous], KYNAMRO MIP SOD; Bangalore S, 2017, AM J CARDIOL, V119, P379, DOI 10.1016/j.amjcard.2016.10.037; Bangalore S, 2015, J AM COLL CARDIOL, V65, P1539, DOI 10.1016/j.jacc.2015.02.017; Bernards R, 2006, NEW ENGL J MED, V355, P2391, DOI 10.1056/NEJMp068242; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chi X, 2017, DRUG DISCOV TODAY; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Nakamura M, 2014, CLIN CHIM ACTA, V431, P288, DOI 10.1016/j.cca.2014.02.018; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Reyes-Soffer G, 2017, CIRCULATION, V135, P352, DOI 10.1161/CIRCULATIONAHA.116.025253; Ridker PM, 2016, EUR HEART J, V37, P1373, DOI 10.1093/eurheartj/ehw046; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Watts GF, 2017, CIRCULATION, V135, P338, DOI 10.1161/CIRCULATIONAHA.116.025080; Wittrup A, 2015, NAT REV GENET, V16, P543, DOI 10.1038/nrg3978; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	21	507	531	10	92	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2017	376	15					1430	1440		10.1056/NEJMoa1615758	http://dx.doi.org/10.1056/NEJMoa1615758			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6EX	28306389	Green Published			2022-12-28	WOS:000398899200010
J	Horton, R				Horton, Richard			Offline: The dark heart of the wood	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1179	1179		10.1016/S0140-6736(17)30821-8	http://dx.doi.org/10.1016/S0140-6736(17)30821-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28353431	Bronze			2022-12-28	WOS:000397143700014
J	Livio, M				Livio, Mario			The Greatest Story Ever Told-So Far	SCIENCE			English	Book Review																		Krauss LM, 2017, GREATEST STORY EVER	1	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1273	1273		10.1126/science.aam7195	http://dx.doi.org/10.1126/science.aam7195			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EP0NB	28336630				2022-12-28	WOS:000397082900023
J	Mervis, J				Mervis, Jeffrey			FUNDING Trump's 2018 budget proposal 'devalues' science	SCIENCE			English	News Item																			0	4	6	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1246	1247		10.1126/science.355.6331.1246	http://dx.doi.org/10.1126/science.355.6331.1246			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336614				2022-12-28	WOS:000397082900007
J	Mofatteh, M; Bullock, SL				Mofatteh, Mohammad; Bullock, Simon L.			SnapShot: Subcellular mRNA Localization	CELL			English	Editorial Material									[Mofatteh, Mohammad; Bullock, Simon L.] MRC, Div Cell Biol, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Mofatteh, M (corresponding author), MRC, Div Cell Biol, Mol Biol Lab, Francis Crick Ave, Cambridge CB2 0QH, England.		Mofatteh, Mohammad/AAG-7432-2021	Mofatteh, Mohammad/0000-0002-2458-0447; Bullock, Simon/0000-0001-9491-4548	MRC [MC_U105178790]; Medical Research Council [MC_U105178790] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to Joanna Westmoreland and Paul Margiotta (MRC Laboratory of Molecular Biology) for initial artwork and to Michael Feldbrugge (University of Dusseldorf) and Dierk Niessing (Helmholtz Zentrum, Munich) for feedback on an earlier version of the SnapShot. Work in the Bullock lab is supported by the MRC (file reference number MC_U105178790).	Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Edelmann FT, 2017, NAT STRUCT MOL BIOL, V24, P152, DOI 10.1038/nsmb.3351; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Jung H, 2014, CELL, V157, P26, DOI 10.1016/j.cell.2014.03.005; Lecuyer E, 2009, CURR OPIN CELL BIOL, V21, P409, DOI 10.1016/j.ceb.2009.01.027; Lehmann R, 2016, CURR TOP DEV BIOL, V116, P679, DOI 10.1016/bs.ctdb.2015.11.024; Pohlmann T, 2015, ELIFE, V4, DOI 10.7554/eLife.06041; Soundararajan HC, 2014, ELIFE, V3, DOI 10.7554/eLife.01596; Trovisco V, 2016, ELIFE, V5, DOI 10.7554/eLife.17537	9	36	36	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					178	179		10.1016/j.cell.2017.03.004	http://dx.doi.org/10.1016/j.cell.2017.03.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340345	Bronze			2022-12-28	WOS:000397090000020
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2017: Prevention	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com			Public Health England	Public Health England	The Prevention Team of the Year award is sponsored by Public Health England. The awards ceremony takes place on 4 May at the Park Plaza Hotel, Westminster. To find out more go to thebmjawards.bmj.com/.		0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1364	10.1136/bmj.j1364	http://dx.doi.org/10.1136/bmj.j1364			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330844				2022-12-28	WOS:000397345200005
J	Patel, PK; Saint, S				Patel, Payal K.; Saint, Sanjay			Inpatient Notes: What Do French Wine and Hospital Infections Have in Common?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; [Patel, Payal K.] Univ Michigan, Taubman Ctr Floor 3,Recept D, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan	Patel, PK (corresponding author), Univ Michigan, Taubman Ctr Floor 3,Recept D, Ann Arbor, MI 48109 USA.	payalkp@umich.edu	Saint, Sanjay/AAF-5126-2019	Patel, Payal/0000-0001-8666-7313				Cao J, 2016, JAMA INTERN MED, V176, P705, DOI 10.1001/jamainternmed.2016.0142; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Gilmartin HM, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i13; Kiyoshi-Teo H, 2013, INFECT CONT HOSP EP, V34, P1099, DOI 10.1086/673147; MORTIMER EA, 1962, AM J DIS CHILD, V104, P289, DOI 10.1001/archpedi.1962.02080030291012	5	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					HO2	HO3		10.7326/M17-0275	http://dx.doi.org/10.7326/M17-0275			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320015				2022-12-28	WOS:000397025800001
J	Boseley, S				Boseley, Sarah			Efi Latsoudi: in solidarity with refugees	LANCET			English	Biographical-Item																			0	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1093	1093						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28322811				2022-12-28	WOS:000396408700013
J	Jastroch, M; Tschop, MH				Jastroch, Martin; Tschoep, Matthias H.			METABOLISM Fat controls U Circulating uridine acts as a hunger signal	SCIENCE			English	Editorial Material									[Jastroch, Martin; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, D-85764 Neuherberg, Germany; [Jastroch, Martin; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, German Diabet Ctr DZD, D-85764 Neuherberg, Germany; [Jastroch, Martin; Tschoep, Matthias H.] Inst Diabet & Obes, Parkring 13, D-85748 Garching, Germany; [Tschoep, Matthias H.] Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, German Diabet Ctr DZD, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), Inst Diabet & Obes, Parkring 13, D-85748 Garching, Germany.; Tschop, MH (corresponding author), Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany.	tschoep@helmholtz-muenchen.de	Jastroch, Martin/I-7494-2017					Bera PP, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4945745; Carver JD, 2003, AM J CLIN NUTR, V77, p1550S, DOI 10.1093/ajcn/77.6.1550S; Deng YF, 2017, SCIENCE, V355, DOI 10.1126/science.aaf5375; GASSER T, 1981, SCIENCE, V213, P777, DOI 10.1126/science.7256279; Martins Z, 2008, EARTH PLANET SC LETT, V270, P130, DOI 10.1016/j.epsl.2008.03.026; Steculorum SM, 2015, CELL, V162, P1404, DOI 10.1016/j.cell.2015.08.032; Steculorum SM, 2017, CELL REP, V18, P1587, DOI 10.1016/j.celrep.2017.01.047; Yamamoto T, 2002, METABOLISM, V51, P1317, DOI 10.1053/meta.2002.34041	8	5	5	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1124	1125		10.1126/science.aan0825	http://dx.doi.org/10.1126/science.aan0825			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302808				2022-12-28	WOS:000396351200018
J	Kaiser, J				Kaiser, Jocelyn			WHEN LESS IS MORE Some cancer therapies may work better if doses are timed to thwart tumor evolution	SCIENCE			English	Editorial Material																			0	12	12	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1144	1146		10.1126/science.355.6330.1144	http://dx.doi.org/10.1126/science.355.6330.1144			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302821				2022-12-28	WOS:000396351200030
J	Genzel, R; Schreiber, NMF; Ubler, H; Lang, P; Naab, T; Bender, R; Tacconi, LJ; Wisnioski, E; Wuyts, S; Alexander, T; Beifiori, A; Belli, S; Brammer, G; Burkert, A; Carollo, CM; Chan, J; Davies, R; Fossati, M; Galametz, A; Genel, S; Gerhard, O; Lutz, D; Mendel, JT; Momcheva, I; Nelson, EJ; Renzini, A; Saglia, R; Sternberg, A; Tacchella, S; Tadaki, K; Wilman, D				Genzel, R.; Schreiber, N. M. Forster; Ubler, H.; Lang, P.; Naab, T.; Bender, R.; Tacconi, L. J.; Wisnioski, E.; Wuyts, S.; Alexander, T.; Beifiori, A.; Belli, S.; Brammer, G.; Burkert, A.; Carollo, C. M.; Chan, J.; Davies, R.; Fossati, M.; Galametz, A.; Genel, S.; Gerhard, O.; Lutz, D.; Mendel, J. T.; Momcheva, I.; Nelson, E. J.; Renzini, A.; Saglia, R.; Sternberg, A.; Tacchella, S.; Tadaki, K.; Wilman, D.			Strongly baryon-dominated disk galaxies at the peak of galaxy formation ten billion years ago	NATURE			English	Article							STAR-FORMING GALAXIES; SIMILAR-TO 2; SINS/ZC-SINF SURVEY; MASS-METALLICITY RELATION; DARK-MATTER HALOES; ROTATION CURVES; SCALING RELATIONS; ANGULAR-MOMENTUM; MAIN-SEQUENCE; KINEMATICS EVIDENCE	In the cold dark matter cosmology, the baryonic components of galaxies-stars and gas-are thought to be mixed with and embedded in non-baryonic and non-relativistic dark matter, which dominates the total mass of the galaxy and its dark-matter halo(1). In the local (low-redshift) Universe, the mass of dark matter within a galactic disk increases with disk radius, becoming appreciable and then dominant in the outer, baryonic regions of the disks of star-forming galaxies. This results in rotation velocities of the visible matter within the disk that are constant or increasing with disk radius-a hallmark of the dark-matter model(2). Comparisons between the dynamical mass, inferred from these velocities in rotational equilibrium, and the sum of the stellar and cold-gas mass at the peak epoch of galaxy formation ten billion years ago, inferred from ancillary data, suggest high baryon fractions in the inner, star-forming regions of the disks(3-6). Although this implied baryon fraction may be larger than in the local Universe, the systematic uncertainties (owing to the chosen stellar initial-mass function and the calibration of gas masses) render such comparisons inconclusive in terms of the mass of dark matter(7). Here we report rotation curves (showing rotation velocity as a function of disk radius) for the outer disks of six massive star-forming galaxies, and find that the rotation velocities are not constant, but decrease with radius. We propose that this trend arises because of a combination of two main factors: first, a large fraction of the massive high-redshift galaxy population was strongly baryon-dominated, with dark matter playing a smaller part than in the local Universe; and second, the large velocity dispersion in high-redshift disks introduces a substantial pressure term that leads to a decrease in rotation velocity with increasing radius. The effect of both factors appears to increase with redshift. Qualitatively, the observations suggest that baryons in the early (high-redshift) Universe efficiently condensed at the centres of dark-matter haloes when gas fractions were high and dark matter was less concentrated.	[Genzel, R.; Schreiber, N. M. Forster; Ubler, H.; Lang, P.; Bender, R.; Tacconi, L. J.; Wisnioski, E.; Wuyts, S.; Beifiori, A.; Belli, S.; Burkert, A.; Chan, J.; Davies, R.; Fossati, M.; Galametz, A.; Gerhard, O.; Lutz, D.; Mendel, J. T.; Nelson, E. J.; Saglia, R.; Tadaki, K.; Wilman, D.] Max Planck Inst Extraterr Phys MPE, Giessenbachstr 1, D-85748 Garching, Germany; [Genzel, R.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Genzel, R.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Naab, T.; Burkert, A.] Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85748 Garching, Germany; [Bender, R.; Beifiori, A.; Fossati, M.; Galametz, A.; Mendel, J. T.; Saglia, R.; Wilman, D.] Ludwig Maximilians Univ USM, Univ Sternwarte, Scheinerstr 1, D-81679 Munich, Germany; [Wuyts, S.] Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England; [Alexander, T.] Weizmann Inst Sci, Dept Particle Phys & Astrophys, Fac Phys, POB 26, IL-76100 Rehovot, Israel; [Brammer, G.] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Carollo, C. M.; Tacchella, S.] ETH, Dept Phys, Inst Astron, CH-8093 Zurich, Switzerland; [Genel, S.] Ctr Computat Astrophys, 160 Fifth Ave, New York, NY 10010 USA; [Momcheva, I.; Nelson, E. J.] Yale Univ, Dept Astron, 260 Whitney Ave, New Haven, CT 06511 USA; [Renzini, A.] Osserv Astron Padova, Vicolo Osservatorio 5, I-35122 Padua, Italy; [Sternberg, A.] Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Max Planck Society; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Max Planck Society; University of Munich; University of Bath; Weizmann Institute of Science; Space Telescope Science Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Yale University; Istituto Nazionale Astrofisica (INAF); University of Padua; Tel Aviv University	Genzel, R; Schreiber, NMF (corresponding author), Max Planck Inst Extraterr Phys MPE, Giessenbachstr 1, D-85748 Garching, Germany.	genzel@mpe.mpg.de; forster@mpe.mpg.de	Brammer, Gabriel/AAB-4859-2020; Fossati, Matteo/AAT-5316-2021; Naab, Thorsten/AAE-9888-2019; Belli, Sirio/AAW-6461-2021	Brammer, Gabriel/0000-0003-2680-005X; Naab, Thorsten/0000-0002-7314-2558; Belli, Sirio/0000-0002-5615-6018; Renzini, Alvio/0000-0002-7093-7355; Mendel, Jon Trevor/0000-0002-6327-9147; Lutz, Dieter/0000-0003-0291-9582; Chan, Chi Chung/0000-0001-6251-3125; Fossati, Matteo/0000-0002-9043-8764; Wisnioski, Emily/0000-0003-1657-7878; Davies, Richard/0000-0003-4949-7217; Wuyts, Stijn/0000-0003-3735-1931	DFG [WI 3871/1-1, WI 3871/1-2]; Deutsche Zentrum fur Luft- und Raumfahrt (DLR) [50OR1513]; I-CORE Program of the PBC and Israel Science Foundation [1829/12]; ESO programme [076.A-0527, 079.A-0341, 080.A-0330, 080.A-0635, 082.A-0396, 183.A0781, 091.A-0126, 092.A-0091, 093.A-0079, 094.A-0217, 095.A-0047, 096.A-0025, 097.B-0065, 097.A-0353]	DFG(German Research Foundation (DFG)); Deutsche Zentrum fur Luft- und Raumfahrt (DLR); I-CORE Program of the PBC and Israel Science Foundation; ESO programme	We thank our colleagues at ESO-Garching and ESO-Paranal, as well as those in the 3D-HST and SINFONI/zC-SINF and KMOS/KMOS3D teams, for their support and high-quality work, which made these technically difficult observations possible. D.W. and M.F. acknowledge the support provided by DFG Projects WI 3871/1-1 and WI 3871/1-2. J.C. acknowledges the support of the Deutsche Zentrum fur Luft- und Raumfahrt (DLR) via Project ID 50OR1513. T.A. and A.S. acknowledge support by the I-CORE Program of the PBC and Israel Science Foundation (Center No. 1829/12). We thank S. Lilly and A. Dekel for comments on the manuscript. This work is based on observations obtained at the Very Large Telescope (VLT) of the European Southern Observatory (ESO), Paranal, Chile (ESO programme IDs 076.A-0527, 079.A-0341, 080.A-0330, 080.A-0635, 082.A-0396, 183.A0781, 091.A-0126, 092.A-0091, 093.A-0079, 094.A-0217, 095.A-0047, 096.A-0025, 097.B-0065 and 097.A-0353).	Agertz O, 2011, MON NOT R ASTRON SOC, V410, P1391, DOI 10.1111/j.1365-2966.2010.17530.x; Angles-Alcazar D, 2014, ASTROPHYS J, V782, DOI 10.1088/0004-637X/782/2/84; Aumer M, 2013, MON NOT R ASTRON SOC, V434, P3142, DOI 10.1093/mnras/stt1230; Barro G, 2016, ASTROPHYS J LETT, V827, DOI 10.3847/2041-8205/827/2/L32; Bell EF, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/167; Binney J., 2008, GALACTIC DYNAMICS; Bland-Hawthorn J, 2016, ANNU REV ASTRON ASTR, V54, P529, DOI 10.1146/annurev-astro-081915-023441; Bonnet H., 2004, MESSENGER, V117, P17; Brammer GB, 2012, ASTROPHYS J SUPPL S, V200, DOI 10.1088/0067-0049/200/2/13; Brook CB, 2012, MON NOT R ASTRON SOC, V419, P771, DOI 10.1111/j.1365-2966.2011.19740.x; Bruce VA, 2014, MON NOT R ASTRON SOC, V444, P1660, DOI 10.1093/mnras/stu1537; Bruce VA, 2014, MON NOT R ASTRON SOC, V444, P1001, DOI 10.1093/mnras/stu1478; Bruzual G, 2003, MON NOT R ASTRON SOC, V344, P1000, DOI 10.1046/j.1365-8711.2003.06897.x; Bullock JS, 2001, MON NOT R ASTRON SOC, V321, P559, DOI 10.1046/j.1365-8711.2001.04068.x; Burkert A, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/2/214; Burkert A, 2010, ASTROPHYS J, V725, P2324, DOI 10.1088/0004-637X/725/2/2324; Calzetti D, 2000, ASTROPHYS J, V533, P682, DOI 10.1086/308692; Cappellari M, 2016, ANNU REV ASTRON ASTR, V54, P597, DOI 10.1146/annurev-astro-082214-122432; Cappellari M, 2013, MON NOT R ASTRON SOC, V432, P1709, DOI 10.1093/mnras/stt562; Carignan C, 2006, ASTROPHYS J, V641, pL109, DOI 10.1086/503869; Carollo CM, 2013, ASTROPHYS J, V773, DOI 10.1088/0004-637X/773/2/112; CASERTANO S, 1991, ASTRON J, V101, P1231, DOI 10.1086/115759; Catinella B, 2006, ASTROPHYS J, V640, P751, DOI 10.1086/500171; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; Courteau S, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/2/L20; Courteau S, 2014, REV MOD PHYS, V86, P47, DOI 10.1103/RevModPhys.86.47; Davies R, 2011, ASTROPHYS J, V741, DOI 10.1088/0004-637X/741/2/69; Duffy AR, 2010, MON NOT R ASTRON SOC, V405, P2161, DOI 10.1111/j.1365-2966.2010.16613.x; Dutton AA, 2016, MON NOT R ASTRON SOC, V461, P2658, DOI 10.1093/mnras/stw1537; Dutton AA, 2015, MON NOT R ASTRON SOC, V453, P2447, DOI 10.1093/mnras/stv1755; Dutton AA, 2014, MON NOT R ASTRON SOC, V441, P3359, DOI 10.1093/mnras/stu742; Eisenhauer F., 2003, MESSENGER, V113, P17; Elmegreen DM, 2005, ASTROPHYS J, V631, P85, DOI 10.1086/432502; Erb DK, 2006, ASTROPHYS J, V644, P813, DOI 10.1086/503623; Fiacconi D, 2015, MON NOT R ASTRON SOC, V446, P1957, DOI 10.1093/mnras/stu2228; FREEMAN KC, 1970, ASTROPHYS J, V160, P811, DOI 10.1086/150474; Gao L, 2008, MON NOT R ASTRON SOC, V387, P536, DOI 10.1111/j.1365-2966.2008.13277.x; Genel S, 2015, ASTROPHYS J LETT, V804, DOI 10.1088/2041-8205/804/2/L40; Genel S, 2014, MON NOT R ASTRON SOC, V445, P175, DOI 10.1093/mnras/stu1654; Genzel R, 2006, NATURE, V442, P786, DOI 10.1038/nature05052; Genzel R, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/20; Genzel R, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/75; Genzel R, 2011, ASTROPHYS J, V733, DOI 10.1088/0004-637X/733/2/101; Governato F, 2007, MON NOT R ASTRON SOC, V374, P1479, DOI 10.1111/j.1365-2966.2006.11266.x; Grogin NA, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/35; Honma M, 1997, PUBL ASTRON SOC JPN, V49, P539, DOI 10.1093/pasj/49.5.539; Hopkins PF, 2014, MON NOT R ASTRON SOC, V445, P581, DOI 10.1093/mnras/stu1738; Johansson PH, 2012, ASTROPHYS J, V754, DOI 10.1088/0004-637X/754/2/115; Johansson PH, 2009, ASTROPHYS J LETT, V697, pL38, DOI 10.1088/0004-637X/697/1/L38; Kassin SA, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/106; Kewley LJ, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/2/100; Koekemoer AM, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/36; Kong X, 2006, ASTROPHYS J, V638, P72, DOI 10.1086/498698; Lang P., 2003, FALLING OUTER UNPUB; Lang P, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/11; Law DR, 2012, ASTROPHYS J, V745, DOI 10.1088/0004-637X/745/1/85; Levine ES, 2006, ASTROPHYS J, V643, P881, DOI 10.1086/503091; Lilly SJ, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/119; Mancini C, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/1/86; Marinacci F, 2014, MON NOT R ASTRON SOC, V437, P1750, DOI 10.1093/mnras/stt2003; MERRITT D, 1994, ASTROPHYS J, V425, P551, DOI 10.1086/174005; Momcheva IG, 2016, ASTROPHYS J SUPPL S, V225, DOI 10.3847/0067-0049/225/2/27; Moster BP, 2013, MON NOT R ASTRON SOC, V428, P3121, DOI 10.1093/mnras/sts261; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Nelson EJ, 2016, ASTROPHYS J, V828, DOI 10.3847/0004-637X/828/1/27; Nelson EJ, 2016, ASTROPHYS J LETT, V817, DOI 10.3847/2041-8205/817/1/L9; Newman SF, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/104; Newman SF, 2012, ASTROPHYS J, V752, DOI 10.1088/0004-637X/752/2/111; Noordermeer E, 2008, MON NOT R ASTRON SOC, V385, P1359, DOI 10.1111/j.1365-2966.2008.12837.x; Oser L, 2010, ASTROPHYS J, V725, P2312, DOI 10.1088/0004-637X/725/2/2312; Peng YJ, 2010, ASTROPHYS J, V721, P193, DOI 10.1088/0004-637X/721/1/193; Pontzen A, 2012, MON NOT R ASTRON SOC, V421, P3464, DOI 10.1111/j.1365-2966.2012.20571.x; Price SH, 2016, ASTROPHYS J, V819, DOI 10.3847/0004-637X/819/1/80; Sanders RL, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/138; Scannapieco C, 2012, MON NOT R ASTRON SOC, V423, P1726, DOI 10.1111/j.1365-2966.2012.20993.x; Scannapieco C, 2009, MON NOT R ASTRON SOC, V396, P696, DOI 10.1111/j.1365-2966.2009.14764.x; Schaye J, 2015, MON NOT R ASTRON SOC, V446, P521, DOI 10.1093/mnras/stu2058; Schreiber NMF, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/38; Schreiber NMF, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/1/45; Schreiber NMF, 2011, ASTROPHYS J, V731, DOI 10.1088/0004-637X/731/1/65; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Sharples R. M., 2012, MESSENGER, V151, P21; Skelton RE, 2014, ASTROPHYS J SUPPL S, V214, DOI 10.1088/0067-0049/214/2/24; Sofue Y, 2001, ANNU REV ASTRON ASTR, V39, P137, DOI 10.1146/annurev.astro.39.1.137; Steidel CC, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/165; Stott JP, 2013, MON NOT R ASTRON SOC, V436, P1130, DOI 10.1093/mnras/stt1641; Tacchella S, 2015, SCIENCE, V348, P314, DOI 10.1126/science.1261094; Tacchella S, 2015, ASTROPHYS J, V802, DOI 10.1088/0004-637X/802/2/101; Tacchella S, 2016, MON NOT R ASTRON SOC, V458, P242, DOI 10.1093/mnras/stw303; Tacchella S, 2016, MON NOT R ASTRON SOC, V457, P2790, DOI 10.1093/mnras/stw131; Tacconi LJ, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/1/74; Tacconi L. J., 2017, PREPRINT; Tadaki K, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/2/135; Tadaki K, 2015, ASTROPHYS J LETT, V811, DOI 10.1088/2041-8205/811/1/L3; TOOMRE A, 1964, ASTROPHYS J, V139, P1217, DOI 10.1086/147861; Ubler H, 2014, MON NOT R ASTRON SOC, V443, P2092, DOI 10.1093/mnras/stu1275; van der Kruit PC, 2011, ANNU REV ASTRON ASTR, V49, P301, DOI 10.1146/annurev-astro-083109-153241; van der Wel A, 2014, ASTROPHYS J LETT, V792, DOI 10.1088/2041-8205/792/1/L6; van der Wel A, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/1/28; van Dokkum PG, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/1/23; van Dokkum PG, 2011, ASTROPHYS J LETT, V743, DOI 10.1088/2041-8205/743/1/L15; VANDERKRUIT PC, 1978, ANNU REV ASTRON ASTR, V16, P103, DOI 10.1146/annurev.aa.16.090178.000535; Whitaker KE, 2014, ASTROPHYS J, V795, DOI 10.1088/0004-637X/795/2/104; Wisnioski E, 2015, ASTROPHYS J, V799, DOI 10.1088/0004-637X/799/2/209; Wuyts E, 2014, ASTROPHYS J LETT, V789, DOI 10.1088/2041-8205/789/2/L40; Wuyts S, 2007, ASTROPHYS J, V655, P51, DOI 10.1086/509708; Wuyts S, 2016, ASTROPHYS J, V831, DOI 10.3847/0004-637X/831/2/149; Wuyts S, 2013, ASTROPHYS J, V779, DOI 10.1088/0004-637X/779/2/135; Wuyts S, 2012, ASTROPHYS J, V753, DOI 10.1088/0004-637X/753/2/114; Wuyts S, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/2/96; Wuyts S, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/106; Zahid HJ, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/75; Zahid HJ, 2011, ASTROPHYS J, V730, DOI 10.1088/0004-637X/730/2/137; Zolotov A, 2015, MON NOT R ASTRON SOC, V450, P2327, DOI 10.1093/mnras/stv740	119	140	141	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					397	+		10.1038/nature21685	http://dx.doi.org/10.1038/nature21685			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28300118	Green Accepted, Green Submitted			2022-12-28	WOS:000396337400045
J	[Anonymous]				[Anonymous]			Is the United States Preventive Services Task Force still a voice of caution? (vol 356, pg j743, 2017)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		2017, BMJ-BRIT MED J, V356, pJ743, DOI DOI 10.1136/BMJ.J743	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2017	356								j1289	10.1136/bmj.j1289	http://dx.doi.org/10.1136/bmj.j1289			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NF	28288995	Bronze, Green Published			2022-12-28	WOS:000397014700008
J	Wylie, AA; Schoepfer, J; Jahnke, W; Cowan-Jacob, SW; Loo, A; Furet, P; Marzinzik, AL; Pelle, X; Donovan, J; Zhu, WJ; Buonamici, S; Hassan, AQ; Lombardo, F; Iyer, V; Palmer, M; Berellini, G; Dodd, S; Thohan, S; Bitter, H; Branford, S; Ross, DM; Hughes, TP; Petruzzelli, L; Vanasse, KG; Warmuth, M; Hofmann, F; Keen, NJ; Sellers, WR				Wylie, Andrew A.; Schoepfer, Joseph; Jahnke, Wolfgang; Cowan-Jacob, Sandra W.; Loo, Alice; Furet, Pascal; Marzinzik, Andreas L.; Pelle, Xavier; Donovan, Jerry; Zhu, Wenjing; Buonamici, Silvia; Hassan, A. Quamrul; Lombardo, Franco; Iyer, Varsha; Palmer, Michael; Berellini, Giuliano; Dodd, Stephanie; Thohan, Sanjeev; Bitter, Hans; Branford, Susan; Ross, David M.; Hughes, Timothy P.; Petruzzelli, Lilli; Vanasse, K. Gary; Warmuth, Markus; Hofmann, Francesco; Keen, Nicholas J.; Sellers, William R.			The allosteric inhibitor ABL001 enables dual targeting of BCR-ABL1	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; BCR-ABL; IMATINIB; THERAPY; BINDING; CML	Chronic myeloid leukaemia (CML) is driven by the activity of the BCR-ABL1 fusion oncoprotein. ABL1 kinase inhibitors have improved the clinical outcomes for patients with CML, with over 80% of patients treated with imatinib surviving for more than 10 years(1). Second-generation ABL1 kinase inhibitors induce more potent molecular responses in both previously untreated and imatinib-resistant patients with CML2. Studies in patients with chronic-phase CML have shown that around 50% of patients who achieve and maintain undetectable BCR-ABL1 transcript levels for at least 2 years remain disease-free after the withdrawal of treatment(3,4). Here we characterize ABL001 (asciminib), a potent and selective allosteric ABL1 inhibitor that is undergoing clinical development testing in patients with CML and Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukaemia. In contrast to catalytic-site ABL1 kinase inhibitors, ABL001 binds to the myristoyl pocket of ABL1 and induces the formation of an inactive kinase conformation. ABL001 and second-generation catalytic inhibitors have similar cellular potencies but distinct patterns of resistance mutations, with genetic barcoding studies revealing pre-existing clonal populations with no shared resistance between ABL001 and the catalytic inhibitor nilotinib. Consistent with this profile, acquired resistance was observed with single-agent therapy in mice; however, the combination of ABL001 and nilotinib led to complete disease control and eradicated CML xenograft tumours without recurrence after the cessation of treatment.	[Wylie, Andrew A.; Loo, Alice; Donovan, Jerry; Zhu, Wenjing; Buonamici, Silvia; Hassan, A. Quamrul; Lombardo, Franco; Palmer, Michael; Berellini, Giuliano; Dodd, Stephanie; Thohan, Sanjeev; Bitter, Hans; Petruzzelli, Lilli; Vanasse, K. Gary; Warmuth, Markus; Keen, Nicholas J.; Sellers, William R.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Schoepfer, Joseph; Jahnke, Wolfgang; Cowan-Jacob, Sandra W.; Furet, Pascal; Marzinzik, Andreas L.; Pelle, Xavier; Iyer, Varsha; Hofmann, Francesco] Novartis Inst BioMed Res, Basel, Switzerland; [Branford, Susan] SA Pathol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Branford, Susan] Univ South Australia, Adelaide, SA 5000, Australia; [Ross, David M.] SA Pathol, Haematol Directorate, POB 14,Rundle Mall, Adelaide, SA 5000, Australia; [Hughes, Timothy P.] SAHMRI, North Terrace, Adelaide, SA 5000, Australia; [Buonamici, Silvia; Warmuth, Markus] H3 Biomed Target Biol, 300 Technol Sq, Cambridge, MA 02139 USA	Novartis; Novartis; Centre for Cancer Biology; SA Pathology; University of South Australia; SA Pathology; South Australian Health & Medical Research Institute (SAHMRI)	Wylie, AA (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.	andrew.wylie@novartis.com	Hughes, Tim/AAO-9975-2021; Branford, Susan/X-7733-2019	Ross, David/0000-0001-7171-2935; Hughes, Timothy/0000-0002-0910-3730; Branford, Susan/0000-0002-5095-7981				Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Al-Kali A, 2011, CANCER-AM CANCER SOC, V117, P327, DOI 10.1002/cncr.25604; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bhang HEC, 2015, NAT MED, V21, P440, DOI 10.1038/nm.3841; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Branford S, 2014, BLOOD, V124, P511, DOI 10.1182/blood-2014-03-566323; Hanfstein B, 2012, LEUKEMIA, V26, P2096, DOI 10.1038/leu.2012.85; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Jahnke W, 2010, J AM CHEM SOC, V132, P7043, DOI 10.1021/ja101837n; Kalmanti L, 2015, LEUKEMIA, V29, P1123, DOI 10.1038/leu.2015.36; Kantarjian HM, 2011, CLIN CANCER RES, V17, P1674, DOI 10.1158/1078-0432.CCR-10-2922; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Mahon FX, 2010, LANCET ONCOL, V11, P1029, DOI 10.1016/S1470-2045(10)70233-3; Manley PW, 2010, BBA-PROTEINS PROTEOM, V1804, P445, DOI 10.1016/j.bbapap.2009.11.008; Marin D, 2012, J CLIN ONCOL, V30, P232, DOI 10.1200/JCO.2011.38.6565; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Ottmann OG, 2015, BLOOD, V126, DOI 10.1182/blood.V126.23.138.138; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; Tanaka C, 2010, CLIN PHARMACOL THER, V87, P197, DOI 10.1038/clpt.2009.208; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	20	286	295	7	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					733	+		10.1038/nature21702	http://dx.doi.org/10.1038/nature21702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28329763	Green Accepted			2022-12-28	WOS:000397619700059
J	Lappe, J; Watson, P; Travers-Gustafson, D; Recker, R; Garland, C; Gorham, E; Baggerly, K; McDonnell, SL				Lappe, Joan; Watson, Patrice; Travers-Gustafson, Dianne; Recker, Robert; Garland, Cedric; Gorham, Edward; Baggerly, Keith; McDonnell, Sharon L.			Effect of Vitamin D and Calcium Supplementation on Cancer Incidence in Older Women A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; RISK; PREVENTION; COLON; METAANALYSIS; BREAST; EXPRESSION; PROSTATE; HEALTH; UVB	IMPORTANCE Evidence suggests that low vitamin D status may increase the risk of cancer. OBJECTIVE To determine if dietary supplementation with vitamin D-3 and calcium reduces the risk of cancer among older women. DESIGN, SETTING, AND PARTICIPANTS A 4-year, double-blind, placebo-controlled, population-based randomized clinical trial in 31 rural counties (June 24, 2009, to August 26, 2015-the final date of follow-up). A total of 2303 healthy postmenopausal women 55 years or older were randomized, 1156 to the treatment group and 1147 to the placebo group. Duration of treatment was 4 years. INTERVENTIONS The treatment group (vitamin D-3 + calcium group) received 2000 IU/d of vitamin D-3 and 1500mg/d of calcium; the placebo group received identical placebos. MAIN OUTCOMES AND MEASURES The primary outcomewas the incidence of all-type cancer (excluding nonmelanoma skin cancers), which was evaluated using Kaplan-Meier survival analysis and proportional hazards modeling. RESULTS Among 2303 randomized women (mean age, 65.2 years [SD, 7.0]; mean baseline serum 25-hydroxyvitamin D level, 32.8 ng/mL [SD, 10.5]), 2064 (90%) completed the study. At year 1, serum 25-hydroxyvitamin D levels were 43.9 ng/mL in the vitamin D-3 + calcium group and 31.6 ng/mL in the placebo group. A new diagnosis of cancer was confirmed in 109 participants, 45 (3.89%) in the vitamin D-3 + calcium group and 64 (5.58%) in the placebo group (difference, 1.69% [95% CI, -0.06% to 3.46%]; P =.06). Kaplan-Meier incidence over 4 years was 0.042 (95% CI, 0.032 to 0.056) in the vitamin D-3 + calcium group and 0.060 (95% CI, 0.048 to 0.076) in the placebo group; P =.06. In unadjusted Cox proportional hazards regression, the hazard ratio was 0.70 (95% CI, 0.47 to 1.02). Adverse events potentially related to the study included renal calculi (16 participants in the vitamin D-3 + calcium group and 10 in the placebo group), and elevated serum calcium levels (6 in the vitamin D-3 + calcium group and 2 in the placebo group). CONCLUSIONS AND RELEVANCE Among healthy postmenopausal older women with a mean baseline serum 25-hydroxyvitamin D level of 32.8 ng/mL, supplementation with vitamin D-3 and calcium compared with placebo did not result in a significantly lower risk of all-type cancer at 4 years. Further research is necessary to assess the possible role of vitamin D in cancer prevention.	[Lappe, Joan; Watson, Patrice; Travers-Gustafson, Dianne; Recker, Robert] Creighton Univ, Sch Nursing, Ste 4820,601 N 30th St, Omaha, NE 68178 USA; [Garland, Cedric; Gorham, Edward] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Baggerly, Keith] Univ Texas Houston, MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [McDonnell, Sharon L.] GrassrootsHealth, La Mesa, CA USA	Creighton University; University of California System; University of California San Diego; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Lappe, J (corresponding author), Creighton Univ, Sch Nursing, Ste 4820,601 N 30th St, Omaha, NE 68178 USA.; Lappe, J (corresponding author), Creighton Univ, Sch Med, Ste 4820,601 N 30th St, Omaha, NE 68131 USA.	jmlappe@creighton.edu			National Cancer Institute (NCI); Creighton University	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Creighton University	The study was funded by National Cancer Institute (NCI) and Creighton University internal funding. Diasorin lent a Liaison Analyzer for analysis of serum 25(OH)D and provided analytic kits free of charge.	Ahn J, 2008, JNCI-J NATL CANCER I, V100, P796, DOI 10.1093/jnci/djn152; Almquist M, 2010, INT J CANCER, V127, P2159, DOI 10.1002/ijc.25215; Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Baron JA, 2015, NEW ENGL J MED, V373, P1519, DOI 10.1056/NEJMoa1500409; Bauer SR, 2013, MEDICINE, V92, P123, DOI 10.1097/MD.0b013e3182943bc2; Bedner M, 2013, CLIN CHIM ACTA, V426, P6, DOI 10.1016/j.cca.2013.08.012; Bises G, 2004, J HISTOCHEM CYTOCHEM, V52, P985, DOI 10.1369/jhc.4B6271.2004; Bonithon-Kopp C, 2000, LANCET, V356, P1300, DOI 10.1016/S0140-6736(00)02813-0; Boucher B, 2006, PUBLIC HEALTH NUTR, V9, P84, DOI 10.1079/PHN2005763; Chung M, 2011, ANN INTERN MED, V155, P827, DOI 10.7326/0003-4819-155-12-201112200-00005; GARLAND C, 1985, LANCET, V1, P307, DOI 10.1016/S0140-6736(85)91082-7; GARLAND CF, 1980, INT J EPIDEMIOL, V9, P227, DOI 10.1093/ije/9.3.227; Grant WB, 2006, ANTICANCER RES, V26, P2687; Grant WB, 2012, ANTICANCER RES, V32, P223; Grau MV, 2003, J NATL CANCER I, V95, P1765, DOI 10.1093/jnci/djg110; Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090; Helzlsouer KJ, 2010, AM J EPIDEMIOL, V172, P4, DOI 10.1093/aje/kwq119; Hummel DM, 2013, J STEROID BIOCHEM, V136, P284, DOI 10.1016/j.jsbmb.2012.09.003; Huncharek M, 2009, NUTR CANCER, V61, P47, DOI 10.1080/01635580802395733; Krishnan AV, 2011, ANNU REV PHARMACOL, V51, P311, DOI 10.1146/annurev-pharmtox-010510-100611; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lee JE, 2011, CANCER PREV RES, V4, P735, DOI 10.1158/1940-6207.CAPR-10-0289; Leyssens C, 2013, ENDOCR-RELAT CANCER, V20, pR31, DOI 10.1530/ERC-12-0381; Lieske JC, 2006, KIDNEY INT, V69, P760, DOI 10.1038/sj.ki.5000150; Liu GM, 2010, INT J CANCER, V126, P631, DOI 10.1002/ijc.24762; National Cancer Institute, CANC STAT; Newmark HL, 2009, CARCINOGENESIS, V30, P88, DOI 10.1093/carcin/bgn229; PENCE BC, 1993, MUTAT RES, V290, P87, DOI 10.1016/0027-5107(93)90036-F; Ross AC, 2011, J AM DIET ASSOC, V111, P524, DOI 10.1016/j.jada.2011.01.004; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Trivedi DP, 2003, BMJ-BRIT MED J, V326, P469; Tworoger SS, 2007, CANCER EPIDEM BIOMAR, V16, P783, DOI 10.1158/1055-9965.EPI-06-0981; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wallace RB, 2011, AM J CLIN NUTR, V94, P270, DOI 10.3945/ajcn.110.003350; Welsh J, 2012, ARCH BIOCHEM BIOPHYS, V523, P107, DOI 10.1016/j.abb.2011.10.019; Yetley EA, 2008, AM J CLIN NUTR, V88, p558S, DOI 10.1093/ajcn/88.2.558S; Zinser GM, 2002, CARCINOGENESIS, V23, P2103, DOI 10.1093/carcin/23.12.2103	37	165	169	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1234	1243		10.1001/jama.2017.2115	http://dx.doi.org/10.1001/jama.2017.2115			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350929				2022-12-28	WOS:000397557800020
J	Kattel, S; Ramirez, PJ; Chen, JG; Rodriguez, JA; Liu, P				Kattel, Shyam; Ramirez, Pedro J.; Chen, Jingguang G.; Rodriguez, Jose A.; Liu, Ping			CATALYSIS Active sites for CO2 hydrogenation to methanol on Cu/ZnO catalysts	SCIENCE			English	Article							COPPER; CU; SURFACE; ZNO; CONVERSION; PROMOTION; OXIDE	The active sites over commercial copper/zinc oxide/aluminum oxide (Cu/ZnO/Al2O3) catalysts for carbon dioxide (CO2) hydrogenation to methanol, the Zn-Cu bimetallic sites or ZnO-Cu interfacial sites, have recently been the subject of intense debate. We report a direct comparison between the activity of ZnCu and ZnO/Cu model catalysts for methanol synthesis. By combining x-ray photoemission spectroscopy, density functional theory, and kinetic Monte Carlo simulations, we can identify and characterize the reactivity of each catalyst. Both experimental and theoretical results agree that ZnCu undergoes surface oxidation under the reaction conditions so that surface Zn transforms into ZnO and allows ZnCu to reach the activity of ZnO/Cu with the same Zn coverage. Our results highlight a synergy of Cu and ZnO at the interface that facilitates methanol synthesis via formate intermediates.	[Kattel, Shyam; Chen, Jingguang G.; Rodriguez, Jose A.; Liu, Ping] Div Chem, Brookhaven Natl Lab, Upton, NY 11973 USA; [Ramirez, Pedro J.] Cent Univ Venezuela, Fac Ciencias, Caracas 1020, Venezuela; [Chen, Jingguang G.] Columbia Univ, Dept Chem Engn, New York, NY 10027 USA; [Rodriguez, Jose A.; Liu, Ping] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11790 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; University of Central Venezuela; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chen, JG; Rodriguez, JA; Liu, P (corresponding author), Div Chem, Brookhaven Natl Lab, Upton, NY 11973 USA.; Chen, JG (corresponding author), Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.; Rodriguez, JA; Liu, P (corresponding author), SUNY Stony Brook, Dept Chem, Stony Brook, NY 11790 USA.	jgchen@columbia.edu; rodrigez@bnl.gov; pingliu3@bnl.gov	Kattel, Shyam/AAK-6985-2020	Ramirez, Pedro/0000-0002-6236-5545; Rodriguez, Jose/0000-0002-5680-4214				Behrens M, 2016, ANGEW CHEM INT EDIT, V55, P14906, DOI 10.1002/anie.201607600; Behrens M, 2012, SCIENCE, V336, P893, DOI [10.1126/science.12198331, 10.1126/science.1219831]; Behrens M, 2010, CHEMCATCHEM, V2, P816, DOI 10.1002/cctc.201000017; CAMPBELL CT, 1987, SURF SCI, V182, P458, DOI 10.1016/0039-6028(87)90013-6; Fichtl MB, 2014, ANGEW CHEM INT EDIT, V53, P7043, DOI 10.1002/anie.201400575; Grabow LC, 2011, ACS CATAL, V1, P365, DOI 10.1021/cs200055d; Graciani J, 2014, SCIENCE, V345, P546, DOI 10.1126/science.1253057; Grunwaldt JD, 2000, J CATAL, V194, P452, DOI 10.1006/jcat.2000.2930; Kattel S, 2016, J AM CHEM SOC, V138, P12440, DOI 10.1021/jacs.6b05791; Kondrat SA, 2016, NATURE, V531, P83, DOI 10.1038/nature16935; Koplitz LV, 2003, J PHYS CHEM B, V107, P10583, DOI 10.1021/jp0352175; Kuld S, 2016, SCIENCE, V352, P969, DOI 10.1126/science.aaf0718; Kuld S, 2014, ANGEW CHEM INT EDIT, V53, P5941, DOI 10.1002/anie.201311073; Liao FL, 2011, ANGEW CHEM INT EDIT, V50, P2162, DOI 10.1002/anie.201007108; Lunkenbein T, 2015, ANGEW CHEM INT EDIT, V54, P4544, DOI 10.1002/anie.201411581; Martin O, 2016, ANGEW CHEM INT EDIT, V55, P11031, DOI 10.1002/anie.201603204; Martinez-Suarez L, 2015, ACS CATAL, V5, P4201, DOI 10.1021/acscatal.5b00442; Nakamura J, 2003, TOP CATAL, V22, P277, DOI 10.1023/A:1023588322846; Nakamura J, 1996, J CATAL, V160, P65, DOI 10.1006/jcat.1996.0124; Nakano H, 2001, J PHYS CHEM B, V105, P1355, DOI 10.1021/jp002644z; Porosoff MD, 2016, ENERG ENVIRON SCI, V9, P62, DOI 10.1039/c5ee02657a; Posada-Perez S, 2016, J AM CHEM SOC, V138, P8269, DOI 10.1021/jacs.6b04529; Rodriguez JA, 2015, ACS CATAL, V5, P6696, DOI 10.1021/acscatal.5b01755; Schott V, 2013, ANGEW CHEM INT EDIT, V52, P11925, DOI 10.1002/anie.201302315; Studt F, 2015, CHEMCATCHEM, V7, P1105, DOI 10.1002/cctc.201500123; Tisseraud C, 2016, J CATAL, V343, P106, DOI 10.1016/j.jcat.2015.12.005; van den Berg R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13057; Yang YX, 2010, PHYS CHEM CHEM PHYS, V12, P9909, DOI 10.1039/c001484b; Yang Y, 2015, ACS CATAL, V5, P7328, DOI 10.1021/acscatal.5b02060; Yoshihara J, 1996, J CATAL, V161, P776, DOI 10.1006/jcat.1996.0240	30	857	880	137	1639	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1296	+		10.1126/science.aal3573	http://dx.doi.org/10.1126/science.aal3573			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336665				2022-12-28	WOS:000397082900035
J	Marshall, E				Marshall, Eliot			NUCLEAR WEAPONS Tweak makes US nukes more precise- and deadlier	SCIENCE			English	News Item																			0	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1252	1253		10.1126/science.355.6331.1252	http://dx.doi.org/10.1126/science.355.6331.1252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336619				2022-12-28	WOS:000397082900012
J	Dive, C; Brady, G				Dive, Caroline; Brady, Ged			SnapShot: Circulating Tumor Cells (vol 168, pg 742, 2017)	CELL			English	Correction														Dive, Caroline/0000-0002-1726-8850	Cancer Research UK [19278, 20465] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Dive C, 2017, CELL, V168, DOI 10.1016/j.cell.2017.01.026	1	8	10	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					176	176		10.1016/j.cell.2017.03.017	http://dx.doi.org/10.1016/j.cell.2017.03.017			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340343	Bronze			2022-12-28	WOS:000397090000018
J	Goldwater, SS				Goldwater, S. S.			Why I Favor Compulsory Health Insurance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint									[Goldwater, S. S.] Mt Sinai Hosp, Thodupuzha, India		Goldwater, SS (corresponding author), Mt Sinai Hosp, Thodupuzha, India.								0	1	1	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1181	1181		10.1001/jama.2017.0640	http://dx.doi.org/10.1001/jama.2017.0640			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324080	Green Submitted			2022-12-28	WOS:000396987200034
J	Rodger, MA; Le Gal, G; Anderson, DR; Schmidt, J; Pernod, G; Kahn, SR; Righini, M; Mismetti, P; Kearon, C; Meyer, G; Elias, A; Ramsay, T; Ortel, TL; Huisman, MV; Kovacs, MJ				Rodger, Marc A.; Le Gal, Gregoire; Anderson, David R.; Schmidt, Jeannot; Pernod, Gilles; Kahn, Susan R.; Righini, Marc; Mismetti, Patrick; Kearon, Clive; Meyer, Guy; Elias, Antoine; Ramsay, Tim; Ortel, Thomas L.; Huisman, Menno V.; Kovacs, Michael J.		REVERSE II Study Investigators	Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL ANTICOAGULANT-THERAPY; DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; 1ST EPISODE; CLINICAL INVESTIGATIONS; D-DIMER; THROMBOEMBOLISM; RISK; RECURRENCE; DISEASE	OBJECTIVE To prospectively validate the HERDOO2 rule (Hyperpigmentation, Edema, or Redness in either leg; D-dimer level >= 250 mu g/L; Obesity with body mass index >= 30; or Older age, >= 65 years), which states that women with none or one of the criteria can safely discontinue anticoagulants after short term treatment. DESIGN Prospective cohort management study. SETTING 44 secondary or tertiary care centres in seven countries. PARTICIPANTS Of 3155 consecutive eligible participants with a first unprovoked venous thromboembolism (VTE, proximal leg deep vein thrombosis or pulmonary embolism) who completed 5-12 months of short term anticoagulant treatment, 370 declined to participate, leaving 2785 enrolled participants. 2.3% were lost to follow-up. INTERVENTIONS Women with none or one of the HERDOO2 criteria were classified as at low risk of recurrent VTE and discontinued anticoagulants (intervention arm), whereas anticoagulant management for high risk women (>= 2 HERDOO2 criteria) and men was left to the discretion of the clinicians and patients (observation arm). MAIN OUTCOME MEASURE Recurrent symptomatic VTE (independently and blindly adjudicated) over one year of follow-up. RESULTS Of 1213 women, 631 (51.3%) were classified as low risk and 591 discontinued oral anticoagulant treatment. In the primary analysis, 17 low risk women who discontinued anticoagulants developed recurrent VTE during 564 patient years of follow-up (3.0% per patient year, 95% confidence interval 1.8% to 4.8%). In 323 high risk women and men who discontinued anticoagulants, 25 had VTE during 309 patient years of follow-up (8.1%, 5.2% to 11.9%), whereas in 1802 high risk women and men who continued anticoagulants 28 had recurrent VTE during 1758 patient years of follow-up (1.6%, 1.1% to 2.3%). CONCLUSIONS Women with a first unprovoked VTE event and none or one of the HERDOO2 criteria have a low risk of recurrent VTE and can safely discontinue anticoagulants after completing short term treatment.	[Rodger, Marc A.; Le Gal, Gregoire] Univ Ottawa, Ottawa Blood Dis Ctr, Thrombosis Program, Div Hematol,Dept Med,Fac Med, Ottawa, ON K1H 8L6, Canada; [Rodger, Marc A.; Le Gal, Gregoire; Ramsay, Tim] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Rodger, Marc A.; Le Gal, Gregoire; Ramsay, Tim] Univ Ottawa, Sch Epidemiol Publ Hlth & Preventat Med, Ottawa, ON, Canada; [Le Gal, Gregoire] Univ Brest, EA 3878, INSERM, CIC 1412, Brest, France; [Anderson, David R.] Dalhousie Univ, Fac Med, Halifax, NS, Canada; [Schmidt, Jeannot] Ctr Hosp Univ Clermont Ferrand, Clermont, France; [Pernod, Gilles] CHU Grenoble, Grenoble, France; [Kahn, Susan R.] McGill Univ, Jewish Gen Hosp, Montreal, PQ, Canada; [Righini, Marc] Univ Hosp Geneva, Div Angiol & Hemostasis, Geneva, Switzerland; [Mismetti, Patrick] Ctr Hosp Univ St Etienne Bellevue, St Etienne, France; [Kearon, Clive] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Kearon, Clive] McMaster Univ, Thrombosis & Atherosclerosis Res Inst, Hamilton, ON, Canada; [Meyer, Guy] Univ Paris 05, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, APHP,Resp Dept,INSERM,UMRS 970, Paris, France; [Meyer, Guy] INNOVTE, St Etienne, France; [Elias, Antoine] Ctr Hosp Intercommunal Toulon, Toulon, France; [Ortel, Thomas L.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Huisman, Menno V.] Leiden Univ, Med Ctr, Dept Thrombosis & Hemostasis, Leiden, Netherlands; [Kovacs, Michael J.] Western Univ, London Hlth Sci Ctr, London, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Dalhousie University; CHU Clermont Ferrand; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); McGill University; University of Geneva; McMaster University; McMaster University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Duke University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; London Health Sciences Centre; Western University (University of Western Ontario)	Rodger, MA (corresponding author), Univ Ottawa, Ottawa Blood Dis Ctr, Thrombosis Program, Div Hematol,Dept Med,Fac Med, Ottawa, ON K1H 8L6, Canada.; Rodger, MA (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Rodger, MA (corresponding author), Univ Ottawa, Sch Epidemiol Publ Hlth & Preventat Med, Ottawa, ON, Canada.	mrodger@ohri.ca	Righini, Marc/AAX-8731-2020; Kovacs, Michael/G-3315-2011	Anderson, David/0000-0003-0845-1722; Rodger, Marc/0000-0001-8166-3487; Ramsay, Tim/0000-0001-8478-8170	Heart and Stroke Foundation of Canada [CI 7441, CI 7438]; University of Ottawa Faculty of Medicine clinical research chair in thrombosis and thrombophilia; Jack Hirsh professorship in thromboembolism; Heart and Stroke Foundation of Ontario; University of Ottawa Faculty of Medicine clinical research chain in diagnosis of venous thromboembolism; Ottawa Hospital Research Institute; French Ministry of Health [PHRC 2009-08-05]; bioMerieux	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); University of Ottawa Faculty of Medicine clinical research chair in thrombosis and thrombophilia; Jack Hirsh professorship in thromboembolism; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); University of Ottawa Faculty of Medicine clinical research chain in diagnosis of venous thromboembolism; Ottawa Hospital Research Institute; French Ministry of Health; bioMerieux	MAR holds a career investigator award from the Heart and Stroke Foundation of Canada (CI 7441) and the University of Ottawa Faculty of Medicine clinical research chair in thrombosis and thrombophilia. CK holds a career investigator award from the Heart and Stroke Foundation of Canada (CI 7438) and the Jack Hirsh professorship in thromboembolism. SRK is a tier 1 Canada research chairholder. GLeG holds a clinician scientist award from the Heart and Stroke Foundation of Ontario and the University of Ottawa Faculty of Medicine clinical research chain in diagnosis of venous thromboembolism. This investigator initiated study was sponsored by the Ottawa Hospital Research Institute and funded by a grant from the French Ministry of Health (PHRC 2009-08-05) and bioMerieux. MAR, TR, and Ranjeeta Mallick had full access to all study data and take responsibility for the integrity of the data and the accuracy of the data analysis. MAR, TR, and Ranjeeta Mallick from the Ottawa Hospital Research Institute conducted the analyses, independent of the funders. The funders did not have access to the data and did not influence the decision to publish.	Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Agnelli G, 2001, NEW ENGL J MED, V345, P165, DOI 10.1056/NEJM200107193450302; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; Carrier M, 2011, J THROMB HAEMOST, V9, P1119, DOI 10.1111/j.1538-7836.2011.04254.x; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Couturaud F, 2015, JAMA-J AM MED ASSOC, V314, P31, DOI 10.1001/jama.2015.7046; Donadini MP, 2014, THROMB HAEMOSTASIS, V111, P172, DOI 10.1160/TH13-04-0336; Douketis J, 2011, BMJ-BRIT MED J, V342, pd813, DOI DOI 10.1136/BMJ.D813; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Gauthier K, 2016, THROMB RES, V141, P136, DOI 10.1016/j.thromres.2016.03.015; Kahn SR, 2009, J THROMB HAEMOST, V7, P879, DOI 10.1111/j.1538-7836.2009.03294.x; Kearon C, 2007, J THROMB HAEMOST, V5, P2330, DOI 10.1111/j.1538-7836.2007.02761.x; Kearon C, 2010, J THROMB HAEMOST, V8, P2313, DOI 10.1111/j.1538-7836.2010.03991.x; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Konstantinides SV, 2014, EUR HEART J, V35, P3033, DOI 10.1093/eurheartj/ehu283; Kyrle PA, 2004, NEW ENGL J MED, V350, P2558, DOI 10.1056/NEJMoa032959; Le Gal G, 2010, THROMB HAEMOSTASIS, V104, P498, DOI 10.1160/TH09-10-0685; Le Moigne E, 2013, THROMB RES, P132; McGinn TG, 2000, JAMA-J AM MED ASSOC, V284, P79, DOI 10.1001/jama.284.1.79; Pinede L, 2001, CIRCULATION, V103, P2453; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Rodger MA, 2016, THROMB RES, V143, P152, DOI 10.1016/j.thromres.2016.03.028; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; STEIN PD, 1993, CHEST, V104, P1472, DOI 10.1378/chest.104.5.1472; Tosetto A, 2012, J THROMB HAEMOST, V10, P1019, DOI 10.1111/j.1538-7836.2012.04735.x; Verhovsek M, 2008, ANN INTERN MED, V149, P481, DOI 10.7326/0003-4819-149-7-200810070-00008; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; White RH, 2003, CIRCULATION, V107, pI4, DOI 10.1161/01.CIR.0000078468.11849.66	31	133	140	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2017	356								j1065	10.1136/bmj.j1065	http://dx.doi.org/10.1136/bmj.j1065			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NR	28314711	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000397015900002
J	Gralnek, IM; Neeman, Z; Strate, LL				Gralnek, Ian M.; Neeman, Ziv; Strate, Lisa L.			Acute Lower Gastrointestinal Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIVERTICULAR HEMORRHAGE; ANTIPLATELET THERAPY; URGENT COLONOSCOPY; RANDOMIZED-TRIAL; EARLY PREDICTORS; DIAGNOSIS; MANAGEMENT; RISK; VALIDATION; MORTALITY	A 71-year-old woman with hypertension, hypercholesterolemia, and ischemic heart disease, who had a cardiac stent placed 4 months earlier, presents to the emergency department with multiple episodes of red or maroon-colored stool mixed with clots during the preceding 24 hours. Current medications include atenolol, atorvastatin, aspirin (81 mg daily), and clopidogrel. On physical examination, the patient is dia-phoretic. While she is in a supine position, the heart rate is 91 beats per minute and the blood pressure is 106/61 mm Hg; while she is sitting, the heart rate is 107 beats per minute and the blood pressure is 92/52 mm Hg. The remainder of the examina-tion is unremarkable, except for maroon-colored stool on digital rectal examination. The hemoglobin level is 9.3 g per deciliter, the platelet count 235,000 per cubic milli-meter, and the international normalized ratio 1.1. How should this patient's case be further evaluated and managed?	[Gralnek, Ian M.] Emek Med Ctr, Inst Gastroenterol & Hepatol, 21 Izhak Rabin Blvd, IL-1834111 Afula, Israel; [Neeman, Ziv] Emek Med Ctr, Med Imaging Inst, Afula, Israel; [Gralnek, Ian M.] Technion Israel Inst Technol, Rappaport Fac Med, Haifa, Israel; [Strate, Lisa L.] Univ Washington, Sch Med, Dept Med, Div Gastroenterol, Seattle, WA 98195 USA	Emek Medical Center; Emek Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Washington; University of Washington Seattle	Gralnek, IM (corresponding author), Emek Med Ctr, Inst Gastroenterol & Hepatol, 21 Izhak Rabin Blvd, IL-1834111 Afula, Israel.	ian_gr@clalit.org.il	Neeman, Ziv/GQP-5830-2022		MOTUS GI; EndoChoice; GI-View; EndoAid	MOTUS GI; EndoChoice; GI-View; EndoAid	Dr. Gralnek reports receiving fees for serving on an advisory board from MOTUS GI, receiving consulting fees from EndoChoice, MOTUS GI, and GI-View, receiving honoraria from EndoChoice, MOTUS GI, Boston Scientific, Takeda Pharmaceuticals, and GI-View, receiving grant support from MOTUS GI and EndoAid, receiving an endoscopy workstation from EndoChoice, serving as an unpaid consultant to EndoAid, and serving on a data and safety monitoring board for Intec Pharma. No other potential conflict of interest relevant to this article was reported.	Abraham NS, 2013, CIRCULATION, V128, P1869, DOI 10.1161/CIRCULATIONAHA.113.004747; Aoki T, 2016, CLIN GASTROENTEROL H, V14, P1562, DOI 10.1016/j.cgh.2016.05.042; Olmos JA, 2006, DIS COLON RECTUM, V49, P1507, DOI 10.1007/s10350-006-0684-1; Baradarian R, 2004, AM J GASTROENTEROL, V99, P619, DOI 10.1111/j.1572-0241.2004.04073.x; Barkun AN, 2013, GASTROINTEST ENDOSC, V77, P692, DOI 10.1016/j.gie.2013.01.020; BENDER JS, 1991, AM SURGEON, V57, P536; Bhatt DL, 2008, AM J GASTROENTEROL, V103, P2890, DOI 10.1111/j.1572-0241.2008.02216.x; Arroyo RC, 2012, HEART, V98, P718, DOI 10.1136/heartjnl-2012-301632; Chan FKL, 2016, GASTROENTEROLOGY, V151, P271, DOI 10.1053/j.gastro.2016.04.013; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Das A, 2003, LANCET, V362, P1261, DOI 10.1016/S0140-6736(03)14568-0; Diggs NG, 2011, CLIN GASTROENTEROL H, V9, P415, DOI 10.1016/j.cgh.2011.02.003; Eisenberg MJ, 2009, CIRCULATION, V119, P1634, DOI 10.1161/CIRCULATIONAHA.108.813667; Farner R, 1999, AM J SURG, V178, P587, DOI 10.1016/S0002-9610(99)00235-4; Gralnek IM, 2015, ENDOSCOPY, V47, pA1, DOI 10.1055/s-0034-1393172; Green BT, 2005, AM J GASTROENTEROL, V100, P2395, DOI 10.1111/j.1572-0241.2005.00306.x; Gunderman R, 1998, J NUCL MED, V39, P1081; Ho PM, 2008, JAMA-J AM MED ASSOC, V299, P532, DOI 10.1001/jama.299.5.532; Ierardi AM, 2016, BR J RADIOL; Ishii N, 2012, GASTROINTEST ENDOSC, V75, P382, DOI 10.1016/j.gie.2011.07.030; Jacovides CL, 2015, JAMA SURG, V150, P650, DOI 10.1001/jamasurg.2015.97; Jensen DM, 2016, GASTROINTEST ENDOSC, V83, P416, DOI 10.1016/j.gie.2015.07.033; JENSEN DM, 1988, GASTROENTEROLOGY, V95, P1569, DOI 10.1016/S0016-5085(88)80079-9; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Kaltenbach T, 2012, CLIN GASTROENTEROL H, V10, P131, DOI 10.1016/j.cgh.2011.10.029; Kim CY, 2010, J VASC INTERV RADIOL, V21, P477, DOI 10.1016/j.jvir.2009.11.021; Koh DC, 2009, COLORECTAL DIS, V11, P53, DOI 10.1111/j.1463-1318.2008.01536.x; Kollef MH, 1997, CRIT CARE MED, V25, P1125, DOI 10.1097/00003246-199707000-00011; Laine L, 2010, AM J GASTROENTEROL, V105, P2636, DOI 10.1038/ajg.2010.277; Lhewa DY, 2012, WORLD J GASTROENTERO, V18, P1185, DOI 10.3748/wjg.v18.i11.1185; Manta R, 2013, SURG ENDOSC, V27, P3162, DOI 10.1007/s00464-013-2871-1; Newman J, 2012, COLORECTAL DIS, V14, P1020, DOI 10.1111/j.1463-1318.2011.02824.x; Paramasivan P, 2013, NEW ENGL J MED, V368, P1361, DOI 10.1056/NEJMc1301256; Pasha SF, 2014, GASTROINTEST ENDOSC, V79, P875, DOI 10.1016/j.gie.2013.10.039; Peery AF, 2015, GASTROENTEROLOGY, V149, P1731, DOI 10.1053/j.gastro.2015.08.045; Srygley FD, 2012, JAMA-J AM MED ASSOC, V307, P1072, DOI 10.1001/jama.2012.253; Strate LL, 2008, CLIN GASTROENTEROL H, V6, P1004, DOI 10.1016/j.cgh.2008.03.021; Strate LL, 2016, AM J GASTROENTEROL, V111, P459, DOI 10.1038/ajg.2016.41; Strate LL, 2010, CLIN GASTROENTEROL H, V8, P333, DOI 10.1016/j.cgh.2009.12.017; Strate LL, 2005, AM J GASTROENTEROL, V100, P1821, DOI 10.1111/j.1572-0241.2005.41755.x; Strate LL, 2003, ARCH INTERN MED, V163, P838, DOI 10.1001/archinte.163.7.838; Strate LL, 2003, AM J GASTROENTEROL, V98, P317, DOI 10.1016/S0002-9270(02)05900-2; Sung JJY, 2010, ANN INTERN MED, V152, P1, DOI 10.7326/0003-4819-152-1-201001050-00179; Velayos FS, 2004, CLIN GASTROENTEROL H, V2, P485, DOI 10.1016/S1542-3565(04)00167-3; Wang J, 2013, WORLD J GASTROENTERO, V19, P6919, DOI 10.3748/wjg.v19.i40.6919; Yi WS, 2013, AM SURGEON, V79, P375; Zink SI, 2008, AM J ROENTGENOL, V191, P1107, DOI 10.2214/AJR.07.3642	47	55	61	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1054	1063		10.1056/NEJMcp1603455	http://dx.doi.org/10.1056/NEJMcp1603455			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QT	28296600				2022-12-28	WOS:000396403700010
J	Romero, E; Novoderezhkin, VI; van Grondelle, R				Romero, Elisabet; Novoderezhkin, Vladimir I.; van Grondelle, Rienk			Quantum design of photosynthesis for bio-inspired solar-energy conversion	NATURE			English	Review							II REACTION CENTERS; PRIMARY CHARGE SEPARATION; LIGHT-HARVESTING COMPLEXES; PRIMARY ELECTRON-DONOR; LONG-LIVED COHERENCES; PHOTOSYSTEM-II; RHODOBACTER-SPHAEROIDES; PHYSIOLOGICAL TEMPERATURE; EXCITATION-ENERGY; CRYSTAL-STRUCTURE	Photosynthesis is the natural process that converts solar photons into energy-rich products that are needed to drive the biochemistry of life. Two ultrafast processes form the basis of photosynthesis: excitation energy transfer and charge separation. Under optimal conditions, every photon that is absorbed is used by the photosynthetic organism. Fundamental quantum mechanics phenomena, including delocalization, underlie the speed, efficiency and directionality of the charge-separation process. At least four design principles are active in natural photosynthesis, and these can be applied practically to stimulate the development of bio-inspired, human-made energy conversion systems.	[Romero, Elisabet; van Grondelle, Rienk] Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands; [Novoderezhkin, Vladimir I.] Moscow MV Lomonosov State Univ, AN Belozersky Inst Physicochem Biol, Moscow 119992, Russia	Vrije Universiteit Amsterdam; Lomonosov Moscow State University	Romero, E (corresponding author), Vrije Univ Amsterdam, Fac Sci, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands.	eli@few.vu.nl	Novoderezhkin, Vladimir I/K-1329-2013; Novoderezhkin, Vladimir/AAD-2367-2019	Novoderezhkin, Vladimir/0000-0003-4583-5725; Romero, Elisabet/0000-0003-3630-1617	VU University Amsterdam; Laserlab-Europe consortium; Foundation of Chemical Sciences, part of Netherlands Organisation for Scientific Research (NWO) [700.58.305]; European Research Council Advanced [267333]; European Union [323901]; Netherlands Royal Academy of Sciences; Canadian Institute for Advanced Research; Russian Foundation for Basic Research [15-04-02136]; NWO	VU University Amsterdam; Laserlab-Europe consortium; Foundation of Chemical Sciences, part of Netherlands Organisation for Scientific Research (NWO); European Research Council Advanced(European Research Council (ERC)); European Union(European Commission); Netherlands Royal Academy of Sciences; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); NWO(Netherlands Organization for Scientific Research (NWO))	E.R. and R.v.G. were supported by: the VU University Amsterdam; the Laserlab-Europe consortium; TOP grant 700.58.305 from the Foundation of Chemical Sciences, part of Netherlands Organisation for Scientific Research (NWO); European Research Council Advanced Grant 267333 (PHOTPROT); and the European Union FP7 project PAPETS (grant agreement 323901). R.v.G. gratefully acknowledges his Academy Professorship from the Netherlands Royal Academy of Sciences and was also supported by the Canadian Institute for Advanced Research. V.I.N. was supported by the Russian Foundation for Basic Research (grant number 15-04-02136) and by an NWO visitor grant.	Ajayaghosh A, 2008, CHEM SOC REV, V37, P109, DOI 10.1039/b704456a; Allen J.P., 2014, BIOPHYSICS PHOTOSYNT, P275; Allen JP, 1996, BIOCHEMISTRY-US, V35, P6612, DOI 10.1021/bi9528311; Amesz J., 1996, BIOPHYSICAL TECHNIQU, V3; [Anonymous], 2002, PHOTOSYNTHETICA; Bakulin AA, 2012, SCIENCE, V335, P1340, DOI 10.1126/science.1217745; BEDDARD GS, 1976, NATURE, V260, P366, DOI 10.1038/260366a0; Berera R, 2009, PHOTOSYNTH RES, V101, P105, DOI 10.1007/s11120-009-9454-y; BOSCH MK, 1995, J PHYS CHEM-US, V99, P15310, DOI 10.1021/j100041a056; Bredas JL, 2017, NAT MATER, V16, P35, DOI [10.1038/nmat4767, 10.1038/NMAT4767]; Brixner T, 2005, NATURE, V434, P625, DOI 10.1038/nature03429; Butkus V, 2012, CHEM PHYS LETT, V545, P40, DOI 10.1016/j.cplett.2012.07.014; Calhoun TR, 2009, J PHYS CHEM B, V113, P16291, DOI 10.1021/jp908300c; Cheng YC, 2009, ANNU REV PHYS CHEM, V60, P241, DOI 10.1146/annurev.physchem.040808.090259; Chin AW, 2013, NAT PHYS, V9, P113, DOI 10.1038/nphys2515; Chin AW, 2012, PHILOS T R SOC A, V370, P3638, DOI 10.1098/rsta.2011.0224; Christensson N, 2012, J PHYS CHEM B, V116, P7449, DOI 10.1021/jp304649c; Collini E, 2013, CHEM SOC REV, V42, P4932, DOI 10.1039/c3cs35444j; Collini E, 2010, NATURE, V463, P644, DOI 10.1038/nature08811; Croce R, 2011, J PHOTOCH PHOTOBIO B, V104, P142, DOI 10.1016/j.jphotobiol.2011.02.015; Dahlberg PD, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4930539; DANIELIUS RV, 1987, FEBS LETT, V213, P241, DOI 10.1016/0014-5793(87)81498-9; De Sio A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13742; DEISENHOFER J, 1984, J MOL BIOL, V180, P385, DOI 10.1016/S0022-2836(84)80011-X; Dekker JP, 2000, PHOTOSYNTH RES, V63, P195, DOI 10.1023/A:1006468024245; Diner BA, 2001, BIOCHEMISTRY-US, V40, P9265, DOI 10.1021/bi010121r; Dostal J, 2016, NAT CHEM, V8, P705, DOI [10.1038/NCHEM.2525, 10.1038/nchem.2525]; DURRANT JR, 1992, P NATL ACAD SCI USA, V89, P11632, DOI 10.1073/pnas.89.23.11632; DURRANT JR, 1995, P NATL ACAD SCI USA, V92, P4798, DOI 10.1073/pnas.92.11.4798; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; Falke SM, 2014, SCIENCE, V344, P1001, DOI 10.1126/science.1249771; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Flanagan ML, 2016, J PHYS CHEM A, V120, P1479, DOI 10.1021/acs.jpca.5b08366; Frenkel J, 1931, PHYS REV, V37, P17, DOI 10.1103/PhysRev.37.17; Fuller FD, 2014, NAT CHEM, V6, P706, DOI [10.1038/nchem.2005, 10.1038/NCHEM.2005]; Groot ML, 2005, P NATL ACAD SCI USA, V102, P13087, DOI 10.1073/pnas.0503483102; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Hildner R, 2013, SCIENCE, V340, P1448, DOI 10.1126/science.1235820; Holzwarth AR, 2006, P NATL ACAD SCI USA, V103, P6895, DOI 10.1073/pnas.0505371103; Ishizaki A, 2009, P NATL ACAD SCI USA, V106, P17255, DOI 10.1073/pnas.0908989106; Koepke J, 2007, J MOL BIOL, V371, P396, DOI 10.1016/j.jmb.2007.04.082; Kolli A, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4764100; Kolli A, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3652227; Konermann L, 1996, BIOCHEMISTRY-US, V35, P829, DOI 10.1021/bi9513158; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Liu C, 2016, SCIENCE, V352, P1210, DOI 10.1126/science.aaf5039; Moser CC, 2016, METHOD ENZYMOL, V580, P365, DOI 10.1016/bs.mie.2016.05.048; MYERS J, 1994, PHOTOSYNTH RES, V40, P303, DOI 10.1007/BF00034780; Novoderezhkin VI, 2005, BIOPHYS J, V89, P1464, DOI 10.1529/biophysj.105.060020; Novoderezhkin VI, 2004, J PHYS CHEM B, V108, P7445, DOI 10.1021/jp0373346; Novoderezhkin VI, 2007, BIOPHYS J, V93, P1293, DOI 10.1529/biophysj.106.096867; Novoderezhkin VI, 2017, PHYS CHEM CHEM PHYS, V19, P5195, DOI 10.1039/c6cp07308e; Novoderezhkin VI, 2015, PHYS CHEM CHEM PHYS, V17, P30828, DOI 10.1039/c5cp00582e; Novoderezhkin VI, 2011, CHEMPHYSCHEM, V12, P681, DOI 10.1002/cphc.201000830; Novoderezhkin VI, 2010, PHYS CHEM CHEM PHYS, V12, P7352, DOI 10.1039/c003025b; O'Reilly EJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4012; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Panitchayangkoon G, 2010, P NATL ACAD SCI USA, V107, P12766, DOI 10.1073/pnas.1005484107; Peterman EJG, 1998, P NATL ACAD SCI USA, V95, P6128, DOI 10.1073/pnas.95.11.6128; Pinheiro AV, 2011, NAT NANOTECHNOL, V6, P763, DOI [10.1038/NNANO.2011.187, 10.1038/nnano.2011.187]; Polman A, 2016, SCIENCE, V352, DOI 10.1126/science.aad4424; Prior J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.050404; Prokhorenko VI, 2000, J PHYS CHEM B, V104, P11563, DOI 10.1021/jp002323n; Ramamurthy V, 2011, SUPRAMOLECULAR PHOTO, DOI Hoboken, NJ; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Raszewski G, 2005, BIOPHYS J, V88, P986, DOI 10.1529/biophysj.104.050294; Raszewski G, 2008, BIOPHYS J, V95, P105, DOI 10.1529/biophysj.107.123935; Reimers JR, 2016, BBA-BIOENERGETICS, V1857, P1627, DOI 10.1016/j.bbabio.2016.06.010; Reimers JR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02761; Renger T, 2002, J PHYS CHEM B, V106, P1809, DOI 10.1021/jp013342f; Ringsmuth AK, 2016, RENEW SUST ENERG REV, V62, P134, DOI 10.1016/j.rser.2016.04.016; Romero E, 2014, NAT PHYS, V10, P677, DOI [10.1038/nphys3017, 10.1038/NPHYS3017]; Romero E, 2014, QUANTUM EFFECTS IN BIOLOGY, P179; Romero E, 2012, BIOPHYS J, V103, P185, DOI 10.1016/j.bpj.2012.06.026; Romero E, 2010, BIOCHEMISTRY-US, V49, P4300, DOI 10.1021/bi1003926; Rutherford AW, 2012, FEBS LETT, V586, P603, DOI 10.1016/j.febslet.2011.12.039; Savikhin S, 1997, CHEM PHYS, V223, P303, DOI 10.1016/S0301-0104(97)00223-1; Schlau-Cohen GS, 2012, NAT CHEM, V4, P389, DOI [10.1038/nchem.1303, 10.1038/NCHEM.1303]; Schlau-Cohen GS, 2012, IEEE J SEL TOP QUANT, V18, P283, DOI 10.1109/JSTQE.2011.2112640; Scholes GD, 2011, NAT CHEM, V3, P763, DOI [10.1038/NCHEM.1145, 10.1038/nchem.1145]; Shkuropatov AY, 1999, FEBS LETT, V450, P163, DOI 10.1016/S0014-5793(99)00486-X; STEFFEN MA, 1994, SCIENCE, V264, P810, DOI 10.1126/science.264.5160.810; TETENKIN VL, 1989, FEBS LETT, V250, P459, DOI 10.1016/0014-5793(89)80776-8; Tiwari V, 2013, P NATL ACAD SCI USA, V110, P1203, DOI 10.1073/pnas.1211157110; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; VACHA F, 1995, P NATL ACAD SCI USA, V92, P2929, DOI 10.1073/pnas.92.7.2929; van Amerongen H., 2000, PHOTOSYNTHETIC EXCIT; van Grondelle R, 2014, PHOTOSYNTH RES, V120, P3, DOI 10.1007/s11120-013-9959-2; van Stokkum IHM, 2004, BBA-BIOENERGETICS, V1657, P82, DOI 10.1016/j.bbabio.2004.04.011; VanBrederode ME, 1997, BIOCHEMISTRY-US, V36, P6855, DOI 10.1021/bi9703756; VOS MH, 1993, NATURE, V363, P320, DOI 10.1038/363320a0; Westenhoff S, 2012, J AM CHEM SOC, V134, P16484, DOI 10.1021/ja3065478; Womick JM, 2011, J PHYS CHEM B, V115, P1347, DOI 10.1021/jp106713q; Wydrzynski T, 2005, PHOTOSYSTEM, DOI [10.1007/1-4020-4254-X_6, DOI 10.1007/1-4020-4254-X_6]; Yakovlev AG, 2002, BIOCHEMISTRY-US, V41, P14019, DOI 10.1021/bi020250n; Zhang JZ, 2016, NAT CHEM BIOL, V12, P1046, DOI [10.1038/NCHEMBIO.2192, 10.1038/nchembio.2192]; Zhang WM, 1998, J CHEM PHYS, V108, P7763, DOI 10.1063/1.476212; Zigmantas D, 2006, P NATL ACAD SCI USA, V103, P12672, DOI 10.1073/pnas.0602961103; Zinth W, 2005, CHEMPHYSCHEM, V6, P871, DOI 10.1002/cphc.200400458; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	100	225	225	36	462	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					355	365		10.1038/nature22012	http://dx.doi.org/10.1038/nature22012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28300093				2022-12-28	WOS:000396337400039
J	Hill, KP				Hill, Kevin P.			Cannabis Use and Risk for Substance Use Disorders and Mood or Anxiety Disorders	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MARIJUANA USE; ASSOCIATION	IMPORTANCE With rising rates of marijuana use in the general population and an increasing number of states legalizing recreational marijuana use and authorizing medical marijuana programs, there are renewed clinical and policy concerns regarding the mental health effects of cannabis use. OBJECTIVE To examine prospective associations between cannabis use and risk of mental health and substance use disorders in the general adult population. DESIGN, SETTING, AND PARTICIPANTS A nationally representative sample of US adults aged 18 years or older was interviewed 3 years apart in the National Epidemiologic Survey on Alcohol and Related Conditions (wave 1, 2001-2002; wave 2, 2004-2005). The primary analyses were limited to 34 653 respondents who were interviewed in both waves. Data analysis was conducted from March 15 to November 30, 2015. MAIN OUTCOMES AND MEASURES We used multiple regression and propensity score matching to estimate the strength of independent associations between cannabis use at wave 1 and incident and prevalent psychiatric disorders at wave 2. Psychiatric disorders were measured with a structured interview (Alcohol Use Disorder and Associated Disabilities Interview Schedule-DSM-IV). In both analyses, the same set of wave 1 confounders was used, including sociodemographic characteristics, family history of substance use disorder, disturbed family environment, childhood parental loss, low self-esteem, social deviance, education, recent trauma, past and present psychiatric disorders, and respondent's history of divorce. RESULTS In the multiple regression analysis of 34 653 respondents (14 564 male [47.9% weighted]; mean [SD] age, 45.1 [17.3] years), cannabis use inwave 1 (2001-2002), which was reported by 1279 respondents, was significantly associated with substance use disorders inwave 2 (2004-2005) (any substance use disorder: odds ratio [OR], 6.2; 95% CI, 4.1-9.4; any alcohol use disorder: OR, 2.7; 95% CI, 1.9-3.8; any cannabis use disorder: OR, 9.5; 95% CI, 6.4-14.1; any other drug use disorder: OR, 2.6; 95% CI, 1.6-4.4; and nicotine dependence: OR, 1.7; 95% CI, 1.2-2.4), but not any mood disorder (OR, 1.1; 95% CI, 0.8-1.4) or anxiety disorder (OR, 0.9; 95% CI, 0.7-1.1). The same general pattern of results was observed in the multiple regression analyses of wave 2 prevalent psychiatric disorders and in the propensity score-matched analysis of incident and prevalent psychiatric disorders. CONCLUSIONS AND RELEVANCE Within the general population, cannabis use is associated with an increased risk for several substance use disorders. Physicians and policy makers should take these associations of cannabis use under careful consideration.	[Hill, Kevin P.] Harvard Med Sch, Abuse Consultat Serv, Boston, MA USA; [Hill, Kevin P.] McLean Hosp, Div Alcohol & Drug Abuse, 115 Mill St, Belmont, MA 02478 USA	Harvard University; Harvard Medical School; Harvard University; McLean Hospital	Hill, KP (corresponding author), McLean Hosp, Div Alcohol & Drug Abuse, 115 Mill St, Belmont, MA 02478 USA.	khill@mclean.harvard.edu	Hill, Kevin/GLQ-8874-2022		National Institute on Drug Abuse [K99/R00 DA029115]; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA029115] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The research for this article was supported by grant K99/R00 DA029115 from the National Institute on Drug Abuse.	Blanco C, 2016, JAMA PSYCHIAT, V73, P388, DOI 10.1001/jamapsychiatry.2015.3229; Compton WM, 2016, LANCET PSYCHIAT, V3, P954, DOI 10.1016/S2215-0366(16)30208-5; Degenhardt L, 2013, ADDICTION, V108, P124, DOI 10.1111/j.1360-0443.2012.04015.x; Hasin DS, 2015, JAMA PSYCHIAT, V72, P1235, DOI 10.1001/jamapsychiatry.2015.1858; Szoke A, 2014, PSYCHIAT RES, V219, P58, DOI 10.1016/j.psychres.2014.05.008; van Laar M, 2007, ADDICTION, V102, P1251, DOI 10.1111/j.1360-0443.2007.01875.x; Volkow ND, 2014, NEW ENGL J MED, V370, P2219, DOI 10.1056/NEJMra1402309	7	12	12	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1070	+		10.1001/jama.2016.19706	http://dx.doi.org/10.1001/jama.2016.19706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO5DO	28291877				2022-12-28	WOS:000396713400020
J	Bax, JJ; Stone, GW				Bax, Jeroen J.; Stone, Gregg W.			Bioprosthetic surgical and transcatheter heart valve thrombosis	LANCET			English	Editorial Material									[Bax, Jeroen J.] Leiden Univ, Dept Cardiol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Stone, Gregg W.] Columbia Univ, Med Ctr, Cardiovasc Res Fdn, New York, NY USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Cardiovascular Research Foundation (CRF); Columbia University	Bax, JJ (corresponding author), Leiden Univ, Dept Cardiol, Med Ctr, NL-2333 ZA Leiden, Netherlands.	j.j.bax@lumc.nl			Biotronik; Medtronic; Boston Scientific; Edwards Lifescience; St Jude; Toray; Matrizyme; Ablative Solutions; Claret; Reva; V-wave; Vascular Dynamics; Miracor; Neovasc; Medical Development Technologies; BackBeat Medical; Valfix; TherOx	Biotronik; Medtronic(Medtronic); Boston Scientific(Boston Scientific); Edwards Lifescience; St Jude(St. Jude Medical); Toray; Matrizyme; Ablative Solutions; Claret; Reva; V-wave; Vascular Dynamics; Miracor; Neovasc; Medical Development Technologies; BackBeat Medical; Valfix; TherOx	JJB's institution (Department of Cardiology, Leiden University Medical Center) has received unrestricted research grants from Biotronik, Medtronic, Boston Scientific, and Edwards Lifescience. GWS reports personal consulting fees from St Jude, Toray, Matrizyme, Ablative Solutions, Claret, Reva, V-wave, Vascular Dynamics, Miracor, Neovasc, Medical Development Technologies, BackBeat Medical, Valfix, and TherOx, all unrelated to valve imaging surveillance and thrombosis, and reports equity in Cagent, Qool Therapeutics, Caliber, Aria, the Biostar family of funds, the MedFocus family of funds, Guided Delivery Systems, Micardia, Vascular Nanotransfer Technologies, and Pulnovo, for none of which he declares work on valve imaging surveillance and thrombosis; Columbia University, his employer, also receives royalties from Abbott Vascular for sale of the MitraClip.	Chakravarty T, 2017, LANCET; Dangas GD, 2016, J AM COLL CARDIOL, V68, P2671, DOI 10.1016/j.jacc.2016.09.958; Daubert MA, 2017, JACC-CARDIOVASC IMAG, V10, P15, DOI 10.1016/j.jcmg.2016.11.004; Hansson NC, 2016, J AM COLL CARDIOL, V68, P2059, DOI 10.1016/j.jacc.2016.08.010; Makkar RR, 2015, NEW ENGL J MED, V373, P2015, DOI 10.1056/NEJMoa1509233; Pache G, 2016, EUR HEART J, V37, P2263, DOI 10.1093/eurheartj/ehv526; Vahl TP, 2016, J AM COLL CARDIOL, V67, P1472, DOI 10.1016/j.jacc.2015.12.059	7	8	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 17	2017	389	10087					2352	2354		10.1016/S0140-6736(17)30764-X	http://dx.doi.org/10.1016/S0140-6736(17)30764-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EX6ED	28330691				2022-12-28	WOS:000403334400008
J	Falade-Nwulia, O; Suarez-Cuervo, C; Nelson, DR; Fried, MW; Segal, JB; Sulkowski, MS				Falade-Nwulia, Oluwaseun; Suarez-Cuervo, Catalina; Nelson, David R.; Fried, Michael W.; Segal, Jodi B.; Sulkowski, Mark S.			Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							GENOTYPE 1 INFECTION; TREATMENT-EXPERIENCED PATIENTS; DACLATASVIR PLUS SOFOSBUVIR; SUSTAINED VIROLOGICAL RESPONSE; POST-LIVER TRANSPLANTATION; OPEN-LABEL; TREATMENT-NAIVE; GRAZOPREVIR MK-5172; ELBASVIR MK-8742; UNITED-STATES	Background: Rapid improvements in hepatitis C virus (HCV) therapy have led to the approval of multiple oral direct-acting antiviral (DAA) regimens by the U.S. Food and Drug Administration (FDA) for treatment of chronic HCV infection. Purpose: To summarize published literature on the efficacy and safety of oral DAAs for treatment of persons with chronic HCV infection. Data Sources: MEDLINE and EMBASE from inception through 1 November 2016. Study Selection: 42 English-language studies from controlled and single-group registered clinical trials of adults with HCV infection that evaluated at least 8 weeks of an FD-Aapproved interferon-free HCV regimen that included at least 2 DAAs. Data Extraction: Two investigators abstracted data on study design, patient characteristics, and virologic and safety outcomes sequentially and assessed quality independently. Data Synthesis: Six DAA regimens showed high sustained virologic response (SVR) rates (>95%) in patients with HCV genotype 1 infection without cirrhosis, including those with HIV co-infection. Effective treatments for HCV genotype 3 infection are limited (2 DAA regimens). Patients with hepatic decompensation, particularly those with Child-Turcotte-Pugh class C disease, had lower SVR rates (78% to 87%) than other populations. The addition of ribavirin was associated with increased SVR rates for certain DAA regimens and patient groups. Overall rates of serious adverse events and treatment discontinuation were low (<10% in the general population); regimens that included ribavirin had more mild or moderate adverse events than those without. Limitations: Twenty-three studies had moderate risk of bias (10 were open-label single-group trials, 11 had limited information on concealment of the allocation scheme, and 5 had selective outcome reporting). All but 1 of the studies were industry-funded. Heterogeneity of interventions precluded pooling. Conclusion: Multiple oral DAA regimens show high rates of safety, tolerability, and efficacy for treatment of HCV genotype 1 infection, particularly among persons without cirrhosis.	[Falade-Nwulia, Oluwaseun] Johns Hopkins Univ, Sch Med, Dept Med, 725 North Wolfe St,Suite 215, Baltimore, MD 21205 USA; [Suarez-Cuervo, Catalina] Johns Hopkins Univ, Sch Med, Johns Hopkins Evidence Based Practice Ctr, 624 North Broadway,Suite 680, Baltimore, MD 21205 USA; [Segal, Jodi B.] Johns Hopkins Univ, Sch Med, Dept Med, 624 North Broadway,Room 644, Baltimore, MD 21205 USA; [Sulkowski, Mark S.] Johns Hopkins Univ, Dept Med, Sch Med, 1830 East Monument St, Baltimore, MD 21205 USA; [Fried, Michael W.] Univ Florida, Dept Med, 2004 Mowry Rd, Gainesville, FL 32611 USA; [Fried, Michael W.] Univ North Carolina Chapel Hill, Dept Med, CB 7584,Room 8015 Burnett Womack, Chapel Hill, NC 27514 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Falade-Nwulia, O (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, 725 North Wolfe St,Suite 215, Baltimore, MD 21205 USA.	ofalade1@jhmi.edu; csuarez3@jhmi.edu		Falade-Nwulia, Oluwaseun/0000-0003-2321-2295	Patient-Centered Outcomes Research Institute [PROSPERO: CRD42014009711]; NATIONAL INSTITUTE ON AGING [P30AG028740] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA034621, R01DA016065, K23DA041294] Funding Source: NIH RePORTER	Patient-Centered Outcomes Research Institute(Patient-Centered Outcomes Research Institute - PCORI); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Patient-Centered Outcomes Research Institute. (PROSPERO: CRD42014009711)	Abergel A, 2016, HEPATOLOGY, V64, P1049, DOI 10.1002/hep.28706; Abergel A, 2016, LANCET INFECT DIS, V16, P459, DOI 10.1016/S1473-3099(15)00529-0; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; American Association for the Study of Liver Disease; Infectious Dis- eases Society of America, 2017, HCV GUID REC TEST MA; Andreone P, 2014, GASTROENTEROLOGY, V147, P359, DOI 10.1053/j.gastro.2014.04.045; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; Berden FAC, 2017, CLIN GASTROENTEROL H, V15, P349, DOI 10.1016/j.cgh.2016.10.034; Bourliere M, 2015, LANCET INFECT DIS, V15, P397, DOI 10.1016/S1473-3099(15)70050-2; Charlton M, 2015, GASTROENTEROLOGY, V149, P649, DOI 10.1053/j.gastro.2015.05.010; Curry MP, 2015, NEW ENGL J MED, V373, P2618, DOI 10.1056/NEJMoa1512614; Denniston MM, 2014, ANN INTERN MED, V160, P293, DOI 10.7326/M13-1133; El Raziky M, 2017, J VIRAL HEPATITIS, V24, P102, DOI 10.1111/jvh.12625; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Feld JJ, 2014, NEW ENGL J MED, V370, P1594, DOI 10.1056/NEJMoa1315722; Ferenci P, 2014, NEW ENGL J MED, V370, P1983, DOI 10.1056/NEJMoa1402338; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Gane EJ, 2015, GASTROENTEROLOGY, V149, P1454, DOI 10.1053/j.gastro.2015.07.063; Gimeno-Ballester V, 2017, J VIRAL HEPATITIS, V24, P904, DOI 10.1111/jvh.12660; Hezode C, 2015, LANCET, V385, P2502, DOI 10.1016/S0140-6736(15)60159-3; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Kohli A, 2015, LANCET INFECT DIS, V15, P1049, DOI 10.1016/S1473-3099(15)00157-7; Kowdley KV, 2014, NEW ENGL J MED, V370, P222, DOI 10.1056/NEJMoa1306227; Kwo P, 2017, GASTROENTEROLOGY, V152, P164, DOI 10.1053/j.gastro.2016.09.045; Kwo P, 2016, HEPATOLOGY, V64, P370, DOI 10.1002/hep.28467; Kwo PY, 2014, NEW ENGL J MED, V371, P2375, DOI 10.1056/NEJMoa1408921; Kwo PY, 2016, 51 ANN M EUR ASS STU; Lawitz E, 2016, HEPATOLOGY, V64, P360, DOI 10.1002/hep.28422; Lawitz E, 2015, GASTROENTEROLOGY, V149, P971, DOI 10.1053/j.gastro.2015.07.001; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Lawitz E, 2014, LANCET, V384, P1756, DOI 10.1016/S0140-6736(14)61036-9; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Leroy V, 2016, HEPATOLOGY, V63, P1430, DOI 10.1002/hep.28473; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Liang TJ, 2013, NEW ENGL J MED, V368, P1907, DOI 10.1056/NEJMra1213651; Limketkai BN, 2012, JAMA-J AM MED ASSOC, V308, P370, DOI 10.1001/jama.2012.7844; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Majumdar A, 2016, ALIMENT PHARM THER, V43, P1276, DOI 10.1111/apt.13633; Manns M, 2016, LANCET INFECT DIS, V16, P685, DOI 10.1016/S1473-3099(16)00052-9; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mitchell O, 2015, J CLIN TRANSL HEPATO, V3, P140, DOI 10.14218/JCTH.2015.00005; Naggie S, 2015, NEW ENGL J MED, V373, P705, DOI 10.1056/NEJMoa1501315; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; on behalf of the development group for ROBINS-I, 2016, TOOL ASSESSING RISK; Pockros PJ, 2016, GASTROENTEROLOGY, V150, P1590, DOI 10.1053/j.gastro.2016.02.078; Poordad F, 2016, HEPATOLOGY, V63, P1493, DOI 10.1002/hep.28446; Poordad F, 2014, NEW ENGL J MED, V370, P1973, DOI 10.1056/NEJMoa1402869; Rockstroh JK, 2015, LANCET HIV, V2, pE319, DOI 10.1016/S2352-3018(15)00114-9; Rosenthal ES, 2016, EXPERT OPIN PHARMACO, V17, P743, DOI 10.1517/14656566.2016.1157580; Roth D, 2015, LANCET, V386, P1537, DOI 10.1016/S0140-6736(15)00349-9; Sulkowski M, 2015, LANCET, V385, P1087, DOI 10.1016/S0140-6736(14)61793-1; Sulkowski MS, 2015, JAMA-J AM MED ASSOC, V313, P1223, DOI 10.1001/jama.2015.1328; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Swallow E, 2016, J COMP EFFECT RES, V5, P129, DOI 10.2217/cer.15.49; Swallow E, 2016, CLIN THER, V38, P404, DOI 10.1016/j.clinthera.2015.12.017; van der Meer AJ, 2012, JAMA-J AM MED ASSOC, V308, P2584, DOI 10.1001/jama.2012.144878; Wyles DL, 2015, NEW ENGL J MED, V373, P714, DOI 10.1056/NEJMoa1503153; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561	59	415	426	3	55	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					637	+		10.7326/M16-2575	http://dx.doi.org/10.7326/M16-2575			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28319996	Green Accepted			2022-12-28	WOS:000400395500008
J	Calkins, H; Willems, S; Gerstenfeld, EP; Verma, A; Schilling, R; Hohnloser, SH; Okumura, K; Serota, H; Nordaby, M; Guiver, K; Biss, B; Brouwer, MA; Grimaldi, M				Calkins, Hugh; Willems, Stephan; Gerstenfeld, Edward P.; Verma, Atul; Schilling, Richard; Hohnloser, Stefan H.; Okumura, Ken; Serota, Harvey; Nordaby, Matias; Guiver, Kelly; Biss, Branislav; Brouwer, Marc A.; Grimaldi, Massimo		RE-CIRCUIT Investigators	Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VITAMIN-K ANTAGONISTS; CATHETER ABLATION; ORAL ANTICOAGULANTS; PERIPROCEDURAL ANTICOAGULATION; PERIABLATION ANTICOAGULATION; MORTALITY RISKS; SAFETY; THERAPY; STROKE; METAANALYSIS	BACKGROUND Catheter ablation of atrial fibrillation is typically performed with uninterrupted anticoagulation with warfarin or interrupted non-vitamin K antagonist oral anticoagulant therapy. Uninterrupted anticoagulation with a non-vitamin K antagonist oral anticoagulant, such as dabigatran, may be safer; however, controlled data are lacking. We investigated the safety of uninterrupted dabigatran versus warfarin in patients undergoing ablation of atrial fibrillation. METHODS In this randomized, open-label, multicenter, controlled trial with blinded adjudicated end-point assessments, we randomly assigned patients scheduled for catheter ablation of paroxysmal or persistent atrial fibrillation to receive either dabigatran (150 mg twice daily) or warfarin (target international normalized ratio, 2.0 to 3.0). Ablation was performed after 4 to 8 weeks of uninterrupted anticoagulation, which was continued during and for 8 weeks after ablation. The primary end point was the incidence of major bleeding events during and up to 8 weeks after ablation; secondary end points included thromboembolic and other bleeding events. RESULTS The trial enrolled 704 patients across 104 sites; 635 patients underwent ablation. Baseline characteristics were balanced between treatment groups. The incidence of major bleeding events during and up to 8 weeks after ablation was lower with dabigatran than with warfarin (5 patients [1.6%] vs. 22 patients [6.9%]; absolute risk difference, -5.3 percentage points; 95% confidence interval, -8.4 to -2.2; P< 0.001). Dabigatran was associated with fewer periprocedural pericardial tamponades and groin hematomas than warfarin. The two treatment groups had a similar incidence of minor bleeding events. One thromboembolic event occurred in the warfarin group. CONCLUSIONS In patients undergoing ablation for atrial fibrillation, anticoagulation with uninterrupted dabigatran was associated with fewer bleeding complications than uninterrupted warfarin.	[Calkins, Hugh] Johns Hopkins Med Inst, Sheikh Zayed Tower 7125R,1800 Orleans St, Baltimore, MD 21205 USA; [Willems, Stephan] Univ Heart Ctr Hamburg, Dept Cardiol Electrophysiol, Hamburg, Germany; [Hohnloser, Stefan H.] Goethe Univ Frankfurt, Dept Cardiol, Frankfurt, Germany; [Nordaby, Matias] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany; [Gerstenfeld, Edward P.] Univ Calif San Francisco, Sect Cardiac Electrophysiol, San Francisco, CA 94143 USA; [Verma, Atul] Univ Toronto, Toronto, ON, Canada; [Schilling, Richard] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Guiver, Kelly] Boehringer Ingelheim GmbH & Co KG, Biometr & Data Sci Dept, Bracknell, Berks, England; [Okumura, Ken] Saiseikai Kumamoto Hosp, Cardiovasc Ctr, Div Cardiol, Kumamoto, Japan; [Serota, Harvey] St Louis Heart & Vasc, St Louis, MO USA; [Biss, Branislav] Boehringer Ingelheim Reg Ctr Vienna, Dept Clin Operat, Vienna, Austria; [Brouwer, Marc A.] Radboud Univ Nijmegen, Med Ctr, Dept Cardiol, Nijmegen, Netherlands; [Grimaldi, Massimo] Miulli Hosp, Cardiol Dept, Acquaviva Delle Fonti, Italy	Johns Hopkins University; Johns Hopkins Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Goethe University Frankfurt; Boehringer Ingelheim; University of California System; University of California San Francisco; University of Toronto; University of London; Queen Mary University London; Boehringer Ingelheim; Saiseikai Kumamoto Hospital; Radboud University Nijmegen	Calkins, H (corresponding author), Johns Hopkins Med Inst, Sheikh Zayed Tower 7125R,1800 Orleans St, Baltimore, MD 21205 USA.	hcalkins@jhmi.edu	Brouwer, Marc A/B-1158-2014; Grimaldi, Massimo/AAX-9576-2021	Srivatsa, Uma/0000-0003-0378-2346; Morillo, Carlos/0000-0002-8739-2099; Brouwer, Marc/0000-0001-8617-7672; Dahme, Tillman/0000-0002-6211-7162	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	Funded by Boehringer Ingelheim; RE-CIRCUIT ClinicalTrials.gov number, NCT02348723.	[Anonymous], 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI [DOI 10.1001/JAMA.2013.281053, 10.1001/jama.2013.281053]; Armbruster HL, 2015, ANN PHARMACOTHER, V49, P278, DOI 10.1177/1060028014563950; Arshad A, 2014, PACE, V37, P665, DOI 10.1111/pace.12401; Aryal MR, 2014, AM J CARDIOL, V114, P577, DOI 10.1016/j.amjcard.2014.05.038; Bassiouny M, 2013, CIRC-ARRHYTHMIA ELEC, V6, P460, DOI 10.1161/CIRCEP.113.000320; Calkins H, 2012, EUROPACE, V14, P528, DOI 10.1093/europace/eus027; Cappato R, 2015, EUR HEART J, V36, P1805, DOI 10.1093/eurheartj/ehv177; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Di Biase L, 2014, CIRCULATION, V129, P2638, DOI 10.1161/CIRCULATIONAHA.113.006426; Eikelboom JW, 2011, CIRCULATION, V123, P2363, DOI 10.1161/CIRCULATIONAHA.110.004747; Graham DJ, 2016, JAMA INTERN MED, V176, P1662, DOI 10.1001/jamainternmed.2016.5954; Graham DJ, 2015, CIRCULATION, V131, P157, DOI 10.1161/CIRCULATIONAHA.114.012061; Heidbuchel H, 2013, EUROPACE, V15, P625, DOI 10.1093/europace/eut083; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004; Kaiser DW, 2013, J INTERV CARD ELECTR, V37, P241, DOI 10.1007/s10840-013-9793-7; Kim JS, 2013, HEART RHYTHM, V10, P483, DOI 10.1016/j.hrthm.2012.12.011; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Lakkireddy D, 2014, J AM COLL CARDIOL, V63, P982, DOI 10.1016/j.jacc.2013.11.039; Lakkireddy D, 2012, J AM COLL CARDIOL, V59, P1168, DOI 10.1016/j.jacc.2011.12.014; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Larsen TB, 2013, J AM COLL CARDIOL, V61, P2264, DOI 10.1016/j.jacc.2013.03.020; Maddox W, 2013, J CARDIOVASC ELECTR, V24, P861, DOI 10.1111/jce.12143; Nagao T, 2015, INTERNAL MED, V54, P1167, DOI 10.2169/internalmedicine.54.3520; Nin T, 2013, PACE, V36, P172, DOI 10.1111/pace.12036; Page SP, 2011, J CARDIOVASC ELECTR, V22, P265, DOI 10.1111/j.1540-8167.2010.01910.x; Romanelli RJ, 2016, CIRC-CARDIOVASC QUAL, V9, P126, DOI 10.1161/CIRCOUTCOMES.115.002369; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Sardar P, 2014, AM J CARDIOL, V113, P1173, DOI 10.1016/j.amjcard.2013.12.027; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Stepanyan G, 2014, J INTERV CARD ELECTR, V40, P33, DOI 10.1007/s10840-014-9888-9; Wu S, 2016, AM J CARDIOL, V117, P926, DOI 10.1016/j.amjcard.2015.12.027; Yamaji H, 2013, CLIN DRUG INVEST, V33, P409, DOI 10.1007/s40261-013-0081-1; Yao XX, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003074; Zhao Y, 2017, J INTERV CARD ELECTR	34	253	266	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 27	2017	376	17					1627	1636		10.1056/NEJMoa1701005	http://dx.doi.org/10.1056/NEJMoa1701005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET2AY	28317415	Green Published			2022-12-28	WOS:000400071900006
J	Vail, E; Gershengorn, HB; Hua, M; Walkey, AJ; Rubenfeld, G; Wunsch, H				Vail, Emily; Gershengorn, Hayley B.; Hua, May; Walkey, Allan J.; Rubenfeld, Gordon; Wunsch, Hannah			Association Between US Norepinephrine Shortage and Mortality Among Patients With Septic Shock	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SURVIVING SEPSIS CAMPAIGN; DRUG SHORTAGES; INTERNATIONAL GUIDELINES; CARE; IMPACT; PHENYLEPHRINE; MANAGEMENT; PROPOFOL; THERAPY	IMPORTANCE Drug shortages in the United States are common, but their effect on patient care and outcomes has rarely been reported. OBJECTIVE To assess changes to patient care and outcomes associated with a 2011 national shortage of norepinephrine, the first-line vasopressor for septic shock. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of 26 US hospitals in the Premier Healthcare Database with a baseline rate of norepinephrine use of at least 60% for patients with septic shock. The cohort included adults with septic shock admitted to study hospitals between July 1, 2008, and June 30, 2013 (n = 27 835). EXPOSURES Hospital-level norepinephrine shortage was defined as any quarterly (3-month) interval in 2011 during which the hospital rate of norepinephrine use decreased by more than 20% from baseline. MAIN OUTCOMES AND MEASURES Use of alternative vasopressorswas assessed and a multilevel mixed-effects logistic regression model was used to evaluate the association between admission to a hospital during a norepinephrine shortage quarter and in-hospital mortality. RESULTS Among 27 835 patients (median age, 69 years [interquartile range, 57-79 years]; 47.0% women) with septic shock in 26 hospitals that demonstrated at least 1 quarter of norepinephrine shortage in 2011, norepinephrine use among cohort patients declined from 77.0%(95% CI, 76.2%-77.8%) of patients before the shortage to a low of 55.7%(95% CI, 52.0%-58.4%) in the second quarter of 2011; phenylephrine was the most frequently used alternative vasopressor during this time (baseline, 36.2%[95% CI, 35.3%-37.1%]; maximum, 54.4%[95% CI, 51.8%-57.2%]). Compared with hospital admission with septic shock during quarters of normal use, hospital admission during quarters of shortage was associated with an increased rate of in-hospital mortality (9283 of 25 874 patients [35.9%] vs 777 of 1961 patients [39.6%], respectively; absolute risk increase = 3.7%[95% CI, 1.5%-6.0%]; adjusted odds ratio = 1.15 [95% CI, 1.01-1.30]; P =.03). CONCLUSIONS AND RELEVANCE Among patients with septic shock in US hospitals affected by the 2011 norepinephrine shortage, the most commonly administered alternative vasopressor was phenylephrine. Patients admitted to these hospitals during times of shortage had higher in-hospital mortality.	[Vail, Emily; Hua, May; Wunsch, Hannah] Columbia Univ, Dept Anesthesiol, New York, NY USA; [Gershengorn, Hayley B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Gershengorn, Hayley B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Hua, May] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Walkey, Allan J.] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02215 USA; [Walkey, Allan J.] Boston Univ, Sch Med, Evans Ctr Implementat & Improvement Sci, Boston, MA 02118 USA; [Rubenfeld, Gordon] Univ Toronto, Dept Med, Toronto, ON, Canada; [Rubenfeld, Gordon; Wunsch, Hannah] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Rubenfeld, Gordon; Wunsch, Hannah] Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON, Canada; [Wunsch, Hannah] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada	Columbia University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Columbia University; Boston University; Boston University; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Wunsch, H (corresponding author), Sunnybrook Med Ctr, Dept Crit Care Med, 2075 Bayview Ave,Room D1-08, Toronto, ON M4N 3M5, Canada.	hannah.wunsch@sunnybrook.ca	Vail, Emily/ABB-2502-2020	Vail, Emily/0000-0002-1849-5780	Herbert and Florence Irving Scholars Program at Columbia University	Herbert and Florence Irving Scholars Program at Columbia University	This study was supported by funds from the Herbert and Florence Irving Scholars Program at Columbia University (Dr Wunsch).	Agency for Healthcare Research and Quality, 2014, HEALTHC COST UT PROJ; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Barnato AE, 2008, AM J RESP CRIT CARE, V177, P279, DOI 10.1164/rccm.200703-480OC; Begg MD, 2003, STAT MED, V22, P2591, DOI 10.1002/sim.1524; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Enders CK, 2007, PSYCHOL METHODS, V12, P121, DOI 10.1037/1082-989X.12.2.121; Fox ER, 2014, MAYO CLIN PROC, V89, P361, DOI 10.1016/j.mayocp.2013.11.014; Gatesman ML, 2011, NEW ENGL J MED, V365, P1653, DOI 10.1056/NEJMp1109772; Griffith MM, 2012, PHARMACOTHERAPY, V32, P665, DOI 10.1002/j.1875-9114.2012.01158.x; Hall WB, 2012, AM J RESP CRIT CARE, V185, P53, DOI 10.1164/rccm.201106-1084OC; Iwashyna TJ, 2014, MED CARE, V52, pE39, DOI 10.1097/MLR.0b013e318268ac86; Kaakeh R, 2011, AM J HEALTH-SYST PH, V68, P1811, DOI 10.2146/ajhp110210; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Morelli A, 2008, SHOCK, V29, P446, DOI 10.1097/SHK.0b013e31815810ff; Morelli A, 2008, CRIT CARE, V12, DOI 10.1186/cc7121; Premier Inc, PREM HEALTHC DAT; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Roberts R, 2012, CRIT CARE MED, V40, P406, DOI 10.1097/CCM.0b013e31822f0af5; Rothberg MB, 2010, JAMA-J AM MED ASSOC, V303, P2035, DOI 10.1001/jama.2010.672; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Seaworth BJ, 2013, MMWR-MORBID MORTAL W, V62, P23; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Thoma BN, 2014, PHARMACOECONOMICS, V32, P149, DOI 10.1007/s40273-013-0116-8; United States Food & Drug Administration (FDA), CURR DRUG SHORT	28	104	107	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2017	317	14					1433	1442		10.1001/jama.2017.2841	http://dx.doi.org/10.1001/jama.2017.2841			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6FQ	28322415				2022-12-28	WOS:000398901200017
J	Laprell, F; Finkl, K; Muller, J				Laprell, Friederike; Finkl, Katja; Mueller, Juerg			Propagation of Polycomb-repressed chromatin requires sequence-specific recruitment to DNA	SCIENCE			English	Article							IN-SITU DISSECTION; RESPONSE ELEMENT; DROSOPHILA-MELANOGASTER; HISTONE H3; GENE; MAINTENANCE; PROTEINS; MODEL	Epigenetic inheritance models posit that during Polycomb repression, Polycomb repressive complex 2 (PRC2) propagates histone H3 lysine 27 trimethylation (H3K27me3) independently of DNA sequence. We show that insertion of Polycomb response element (PRE) DNA into the Drosophila genome creates extended domains of H3K27me3-modified nucleosomes in the flanking chromatin and causes repression of a linked reporter gene. After excision of PRE DNA, H3K27me3 nucleosomes become diluted with each round of DNA replication, and reporter gene repression is lost. After excision in replication-stalled cells, H3K27me3 levels stay high and repression persists. H3K27me3-marked nucleosomes therefore provide amemory of repression that is transmitted in a sequence-independent manner to daughter strand DNA during replication. In contrast, propagation of H3K27 trimethylation to newly incorporated nucleosomes requires sequence-specific targeting of PRC2 to PRE DNA.	[Laprell, Friederike; Finkl, Katja; Mueller, Juerg] Max Planck Inst Biochem, Lab Chromatin Biol, Klopferspitz 18A, D-82152 Martinsried, Germany	Max Planck Society	Muller, J (corresponding author), Max Planck Inst Biochem, Lab Chromatin Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.	muellerj@biochem.mpg.de	Müller, Jürg/ABB-3007-2020	Müller, Jürg/0000-0003-2391-4641	Deutsche Forschungsgemeinschaft [SFB1064]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We thank G. Struhl for discussions. This work was supported by the Deutsche Forschungsgemeinschaft (SFB1064) and the Max Planck Society.	Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Busturia A, 1997, DEVELOPMENT, V124, P4343; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; Copur O, 2013, DEVELOPMENT, V140, P3478, DOI 10.1242/dev.097204; De S, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006200; Fischle W., 2017, GENE DEV, V17, P1870; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; Mellone BG, 2003, CURR BIOL, V13, P1748, DOI 10.1016/j.cub.2003.09.031; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; Sipos L, 2007, P NATL ACAD SCI USA, V104, P12416, DOI 10.1073/pnas.0703144104	23	113	114	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2017	356	6333					85	+		10.1126/science.aai8266	http://dx.doi.org/10.1126/science.aai8266			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER3IA	28302792				2022-12-28	WOS:000398689100043
J	Wagner, MJ; Kim, TH; Savall, J; Schnitzer, MJ; Luo, LQ				Wagner, Mark J.; Kim, Tony Hyun; Savall, Joan; Schnitzer, Mark J.; Luo, Liqun			Cerebellar granule cells encode the expectation of reward	NATURE			English	Article							VENTRAL TEGMENTAL AREA; NEURONAL-ACTIVITY; DOPAMINE; MOTOR; MICE; TRANSMISSION; PROJECTIONS; RESPONSES; SIGNALS; CORTEX	The human brain contains approximately 60 billion cerebellar granule cells(1), which outnumber all other brain neurons combined. Classical theories posit that a large, diverse population of granule cells allows for highly detailed representations of sensorimotor context, enabling downstream Purkinje cells to sense fine contextual changes(2-6). Although evidence suggests a role for the cerebellum in cognition(7-10), granule cells are known to encode only sensory(11-13) and motor(14) context. Here, using two-photon calcium imaging in behaving mice, we show that granule cells convey information about the expectation of reward. Mice initiated voluntary forelimb movements for delayed sugar-water reward. Some granule cells responded preferentially to reward or reward omission, whereas others selectively encoded reward anticipation. Reward responses were not restricted to forelimb movement, as a Pavlovian task evoked similar responses. Compared to predictable rewards, unexpected rewards elicited markedly different granule cell activity despite identical stimuli and licking responses. In both tasks, reward signals were widespread throughout multiple cerebellar lobules. Tracking the same granule cells over several days of learning revealed that cells with reward-anticipating responses emerged from those that responded at the start of learning to reward delivery, whereas reward-omission responses grew stronger as learning progressed. The discovery of predictive, non-sensorimotor encoding in granule cells is a major departure from the current understanding of these neurons and markedly enriches the contextual information available to postsynaptic Purkinje cells, with important implications for cognitive processing in the cerebellum.	[Wagner, Mark J.; Kim, Tony Hyun; Savall, Joan; Schnitzer, Mark J.; Luo, Liqun] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Wagner, Mark J.; Kim, Tony Hyun; Savall, Joan; Schnitzer, Mark J.; Luo, Liqun] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Kim, Tony Hyun] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Schnitzer, Mark J.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Wagner, MJ; Schnitzer, MJ; Luo, LQ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Wagner, MJ; Schnitzer, MJ; Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mjwagner@stanford.edu; mschnitz@stanford.edu; lluo@stanford.edu		Wagner, Mark/0000-0003-1816-6407; Luo, Liqun/0000-0001-5467-9264	Epilepsy Training Grant; NIH; Hughes Collaborative Innovation Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH103116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050835, T32NS007280] Funding Source: NIH RePORTER	Epilepsy Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hughes Collaborative Innovation Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Kim for designing and assembling the capacitive lick sensor, L. Kitch for image processing code, J. Lecoq for microscope design, H. Zeng, E. Kim, E. Callaway and members of the Luo laboratory for reagents, mouse lines, and helpful discussions, and W. Newsome and J. Raymond for critical comments on the manuscript. M.J.W. was supported by Epilepsy Training Grant. M.J.S. and L. L. are HHMI investigators. This work was supported by NIH grants and Hughes Collaborative Innovation Award to L.L.	ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Beier KT, 2015, CELL, V162, P622, DOI 10.1016/j.cell.2015.07.015; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bengtsson F, 2009, P NATL ACAD SCI USA, V106, P2389, DOI 10.1073/pnas.0808428106; Bing YH, 2015, NEUROSCI LETT, V585, P114, DOI 10.1016/j.neulet.2014.11.037; Brooks JX, 2013, CURR BIOL, V23, P947, DOI 10.1016/j.cub.2013.04.029; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Coltz JD, 1999, J NEUROSCI, V19, P1782; DAHLSTRO.A, 1964, ACTA PHYSIOL SCAND, V62, P485, DOI 10.1111/j.1748-1716.1964.tb10446.x; Figielski A, 2007, IEEE SYS MAN CYBERN, P1572; FUJITA M, 1982, BIOL CYBERN, V45, P195, DOI 10.1007/BF00336192; Galliano E, 2013, CELL REP, V3, P1239, DOI 10.1016/j.celrep.2013.03.023; Glaser PEA, 2006, J NEUROSCI METH, V151, P62, DOI 10.1016/j.jneumeth.2005.09.019; Herculano-Houzel S, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00012; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Huang CC, 2013, ELIFE, V2, DOI 10.7554/eLife.00400; IKAI Y, 1992, NEUROSCIENCE, V51, P719, DOI 10.1016/0306-4522(92)90310-X; Ishikawa T, 2015, ELIFE, V4, DOI 10.7554/eLife.12916; Ito M, 2008, NAT REV NEUROSCI, V9, P304, DOI 10.1038/nrn2332; Kawai T, 2015, NEURON, V88, P792, DOI 10.1016/j.neuron.2015.09.030; KIZER JS, 1976, BRAIN RES, V108, P363, DOI 10.1016/0006-8993(76)90192-X; Lecoq J, 2014, NAT NEUROSCI, V17, P1825, DOI 10.1038/nn.3867; Li L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011503; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Medina JF, 2008, NAT NEUROSCI, V11, P1185, DOI 10.1038/nn.2197; Miyazaki K, 2011, J NEUROSCI, V31, P469, DOI 10.1523/JNEUROSCI.3714-10.2011; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; PANAGOPOULOS NT, 1991, NEUROSCI LETT, V130, P208, DOI 10.1016/0304-3940(91)90398-D; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Powell K, 2015, ELIFE, V4, DOI 10.7554/eLife.07290; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; Schwarz LA, 2015, NATURE, V524, P88, DOI 10.1038/nature14600; SIMON H, 1979, BRAIN RES, V178, P17, DOI 10.1016/0006-8993(79)90085-4; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Strick PL, 2009, ANNU REV NEUROSCI, V32, P413, DOI 10.1146/annurev.neuro.31.060407.125606; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Tsai PT, 2012, NATURE, V488, P647, DOI 10.1038/nature11310; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500	48	243	251	3	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					96	+		10.1038/nature21726	http://dx.doi.org/10.1038/nature21726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ8GQ	28321129	Green Accepted			2022-12-28	WOS:000398323300040
J	Orvell, A; Kross, E; Gelman, SA				Orvell, Ariana; Kross, Ethan; Gelman, Susan A.			PSYCHOLOGY How "you" makes meaning	SCIENCE			English	Article							SENSE; MODEL	"You" is one of the most common words in the English language. Although it typically refers to the person addressed ("How are you?"), "you" is also used to make timeless statements about people in general ("You win some, you lose some."). Here, we demonstrate that this ubiquitous but understudied linguistic device, known as "generic-you," has important implications for how people derive meaning from experience. Across six experiments, we found that generic-you is used to express norms in both ordinary and emotional contexts and that producing generic-you when reflecting on negative experiences allows people to " normalize" their experience by extending it beyond the self. In this way, a simple linguistic device serves a powerful meaning-making function.	[Orvell, Ariana; Kross, Ethan; Gelman, Susan A.] Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Orvell, A; Kross, E; Gelman, SA (corresponding author), Univ Michigan, Dept Psychol, Ann Arbor, MI 48109 USA.	aorvell@umich.edu; ekross@umich.edu; gelman@umich.edu		Gelman, Susan/0000-0003-1005-2691; Orvell, Ariana/0000-0003-2574-2951; , Ethan/0000-0002-8664-2711	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036043] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD036043] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Berry R., 2009, ENGL TODAY, V25, P29; BOLINGER D, 1979, AM SPEECH, V54, P194, DOI 10.2307/454949; Casler K, 2009, COGNITIVE DEV, V24, P240, DOI 10.1016/j.cogdev.2009.03.005; Davies M., 2011, WORD FREQ DAT CORP C; Frankl VE, 1985, MANS SEARCH MEANING; Gockeritz S, 2014, COGNITIVE DEV, V30, P81, DOI 10.1016/j.cogdev.2014.01.003; Hayes A. F., 2012, PROCESS VERSATILE CO; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heine SJ, 2006, PERS SOC PSYCHOL REV, V10, P88, DOI 10.1207/s15327957pspr1002_1; Janoff-Bulman R., 1998, PERSPECTIVES LOSS SO, P35; Jensen Torben Juel, 2009, ACTA LINGUIST HAF, V41, P83, DOI [10.1080/03740460903364128, DOI 10.1080/03740460903364128]; Kalish CW, 2012, DEV PSYCHOL, V48, P1133, DOI 10.1037/a0026344; Kamio A, 2001, J PRAGMATICS, V33, P1111, DOI 10.1016/S0378-2166(00)00052-7; KITAGAWA C, 1990, J PRAGMATICS, V14, P739, DOI 10.1016/0378-2166(90)90004-W; Knobe J, 2013, COGNITION, V127, P242, DOI 10.1016/j.cognition.2013.01.005; Kross E, 2005, PSYCHOL SCI, V16, P709, DOI 10.1111/j.1467-9280.2005.01600.x; Kross E., 2017, ADV EXPT SOCIAL PSYC, V55; Kross E, 2011, CURR DIR PSYCHOL SCI, V20, P187, DOI 10.1177/0963721411408883; Laberge S., 1979, DISCOURSE SYNTAX; Mari Alda, 2012, GENERICITY; McLean KC, 2006, DEV PSYCHOL, V42, P714, DOI 10.1037/0012-1649.42.4.714; O'Connor Patricia E., 1994, TEXT, V14, P45, DOI DOI 10.1515/TEXT.1.1994.14.1.45; Park CL, 2010, PSYCHOL BULL, V136, P257, DOI 10.1037/a0018301; Prasada S, 2006, COGNITION, V99, P73, DOI 10.1016/j.cognition.2005.01.003; Rakoczy H, 2013, CHILD DEV PERSPECT, V7, P17, DOI 10.1111/cdep.12010; Siegel DR, 2007, J COGN DEV, V8, P183, DOI 10.1080/15248370701202414; Siewierska A., 2004, PERSON; Stirling L, 2011, J PRAGMATICS, V43, P1581, DOI 10.1016/j.pragma.2010.12.002; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Van Boven L, 2010, J PERS SOC PSYCHOL, V98, P872, DOI 10.1037/a0019262; Wilson TD, 2008, PERSPECT PSYCHOL SCI, V3, P370, DOI 10.1111/j.1745-6924.2008.00085.x; Wodak D, 2015, PHILOS COMPASS, V10, P625, DOI 10.1111/phc3.12250	32	36	37	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1299	1301		10.1126/science.aaj2014	http://dx.doi.org/10.1126/science.aaj2014			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EP0NB	28336666				2022-12-28	WOS:000397082900036
J	Friedrich, MJ				Friedrich, M. J.			Zero Cases of Guinea Worm Disease in Mali	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1109	1109		10.1001/jama.2017.1261	http://dx.doi.org/10.1001/jama.2017.1261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324099				2022-12-28	WOS:000396987200004
J	Layton, JB; Kim, Y; Alexander, GC; Emery, SL				Layton, J. Bradley; Kim, Yoonsang; Alexander, G. Caleb; Emery, Sherry L.			Association Between Direct-to-Consumer Advertising and Testosterone Testing and Initiation in the United States, 2009-2013	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PUBLIC-HEALTH; MEN; TELEVISION; REQUESTS; THERAPY; EVENTS; TRENDS	IMPORTANCE Testosterone initiation increased substantially in the United States from 2000 to 2013, especially among men without clear indications. Direct-to-consumer advertising (DTCA) also increased during this time. OBJECTIVE To investigate associations between televised DTCA and testosterone testing and initiation in the United States. DESIGN, SETTING, AND POPULATION Ecologic study conducted in designated market areas (DMAs) in the United States. Monthly testosterone advertising ratings were linked to DMA-level testosterone use data from 2009-2013 derived from commercial insurance claims. Associations between DTCA and testosterone testing, initiation, and initiation without recent baseline tests were estimated using Poisson generalized estimating equations. EXPOSURES Monthly Nielsen ratings for testosterone DTCA in the 75 largest DMAs. MAIN OUTCOMES AND MEASURES (1) Rates of new serum testosterone testing; (2) rates of testosterone initiation (in-office injection, surgical implant, or pharmacy dispensing) for all testosterone products combined and for specific brands; and (3) rates of testosterone initiation without recent serum testosterone testing. RESULTS Of 17 228 599 commercially insured men in the 75 DMAs, 1 007 990 (mean age, 49.6 [SD, 11.5] years) had new serum testosterone tests and 283 317 (mean age, 51.8 [SD, 11.3] years) initiated testosterone treatment. Advertising intensity varied by geographic region and time, with the highest intensity seen in the southeastern United States and with months ranging from no ad exposures to a mean of 13.6 exposures per household. Nonbranded advertisements were common prior to 2012, with branded advertisements becoming more common during and after 2012. Each household advertisement exposure was associated with a monthly increase in rates of new testosterone testing (rate ratio [RR], 1.006; 95% CI, 1.004-1.008), initiation (RR, 1.007; 95% CI, 1.004-1.010), and initiation without a recent test (RR, 1.008; 95% CI, 1.002-1.013). Mean absolute rate increases were 0.14 tests (95% CI, 0.09-0.19), 0.05 new initiations (95% CI, 0.03-0.08), and 0.02 initiations without a recent test (95% CI, 0.01-0.03) per 10 000 men for each monthly ad exposure over the entire period. CONCLUSIONS AND RELEVANCE Among US men residing in the 75 designated market areas, regional exposure to televised direct-to-consumer advertising was associated with greater testosterone testing, new initiation, and initiation without recent testing.	[Layton, J. Bradley] Univ North Carolina Chapel Hill, Dept Epidemiol, 2104-1 McGavran Greenberg Hall,Campus Box 7435, Chapel Hill, NC 27599 USA; [Kim, Yoonsang; Emery, Sherry L.] Univ Chicago, NORC, Chicago, IL 60637 USA; [Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Drug Safety & Effectiveness, Baltimore, MD USA; [Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol & Med, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Chicago; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Layton, JB (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, 2104-1 McGavran Greenberg Hall,Campus Box 7435, Chapel Hill, NC 27599 USA.	blayton@unc.edu	Layton, J. Bradley/B-4950-2018	Layton, J. Bradley/0000-0003-0994-5820	National Institute on Aging [R01 AG042845]; National Heart, Lung, and Blood Institute [R01 HL107345]; Department of Epidemiology, University of North Carolina (UNC) Gillings School of Global Public Health; Cecil G. Sheps Center for Health Services Research, UNC; CER Strategic Initiative of UNC's Clinical Translational Science Award [1 ULI RR025747]; UNC School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025747] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042845] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Epidemiology, University of North Carolina (UNC) Gillings School of Global Public Health; Cecil G. Sheps Center for Health Services Research, UNC; CER Strategic Initiative of UNC's Clinical Translational Science Award; UNC School of Medicine; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was funded by grants from the National Institute on Aging (grant R01 AG042845) and the National Heart, Lung, and Blood Institute (grant R01 HL107345). The database infrastructure used for this project was funded by the Department of Epidemiology, University of North Carolina (UNC) Gillings School of Global Public Health; the Cecil G. Sheps Center for Health Services Research, UNC; the CER Strategic Initiative of UNC's Clinical Translational Science Award (grant 1 ULI RR025747); and the UNC School of Medicine.	Almasi EA, 2006, PLOS MED, V3, P284, DOI 10.1371/journal.pmed.0030145; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Avery RJ, 2012, J HEALTH ECON, V31, P705, DOI 10.1016/j.jhealeco.2012.05.002; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Bjerkeli PJ, 2016, PHARMACOEPIDEM DR S, V25, P11, DOI 10.1002/pds.3836; Brody H, 2011, AM J PUBLIC HEALTH, V101, P399, DOI 10.2105/AJPH.2010.199844; Daubresse M, 2015, AM J RESP CRIT CARE, V192, P40, DOI 10.1164/rccm.201409-1585OC; Dijkstra M, 2005, J BUS RES, V58, P377, DOI 10.1016/S0148-2963(03)00105-X; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Handelsman DJ, 2013, MED J AUSTRALIA, V199, P548, DOI 10.5694/mja13.10111; Hansen LG, 2012, WHITE PAPER HLTH RES; Kim Y, 2016, NICOTINE TOB RES, V18, P1180, DOI 10.1093/ntr/ntv198; Kornfield R, 2015, AM J PREV MED, V48, P575, DOI 10.1016/j.amepre.2014.12.001; Kravitz RL, 2005, JAMA-J AM MED ASSOC, V293, P1995, DOI 10.1001/jama.293.16.1995; Layton JB, 2014, J CLIN ENDOCR METAB, V99, P835, DOI 10.1210/jc.2013-3570; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Liu Q, 2011, INT J RES MARK, V28, P205, DOI 10.1016/j.ijresmar.2011.04.001; McKinlay JB, 2014, MED CARE, V52, P294, DOI 10.1097/MLR.0000000000000096; Onasanya O, 2016, LANCET DIABETES ENDO, V4, P943, DOI 10.1016/S2213-8587(16)30215-7; Snyder PJ, 2016, NEW ENGL J MED, V374, P611, DOI 10.1056/NEJMoa1506119; Srinivas-Shankar U, 2010, J CLIN ENDOCR METAB, V95, P639, DOI 10.1210/jc.2009-1251; Szczypka G, 2003, IMPACTEEN RES PAPER, V29; US Food and Drug Administration, 2011, ANDR TEST GEL 1 62; US Food and Drug Administration, 2014, JOINT M BONE REPR UR; Vigen R, 2013, JAMA-J AM MED ASSOC, V310, P1829, DOI 10.1001/jama.2013.280386; Wang C, 2004, J CLIN ENDOCR METAB, V89, P2085, DOI 10.1210/jc.2003-032006	27	62	62	2	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1159	1166		10.1001/jama.2016.21041	http://dx.doi.org/10.1001/jama.2016.21041			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9CQ	28324090	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000396987200020
J	Lee, J; Holbrook, A				Lee, Justin; Holbrook, Anne			In patients receiving palliative care, risperidone or haloperidol increased delirium symptoms vs placebo	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lee, Justin; Holbrook, Anne] McMaster Univ, Hamilton, ON, Canada	McMaster University	Lee, J (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Bush SH, 2014, J PAIN SYMPTOM MANAG, V48, P231, DOI 10.1016/j.jpainsymman.2013.07.018; Siddiqi N, 2016, COCHRANE DB SYST REV, V3	2	2	2	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC32	JC32		10.7326/ACPJC-2017-166-6-032	http://dx.doi.org/10.7326/ACPJC-2017-166-6-032			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320006				2022-12-28	WOS:000397025800009
J	Daniels, JP				Daniels, Joe Parkin			Venezuela's economic crisis hampers HIV/AIDS treatment	LANCET			English	Editorial Material																			0	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1088	1089						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28322809				2022-12-28	WOS:000396408700011
J	Bahcall, O; Eggleston, AK; Shadan, S				Bahcall, Orli; Eggleston, Angela K.; Shadan, Sadaf			PLANTS	NATURE			English	Editorial Material														Bahcall, Orli/0000-0002-2891-1637					0	0	0	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					327	327		10.1038/543327a	http://dx.doi.org/10.1038/543327a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9RN	28300111	Bronze			2022-12-28	WOS:000396337400035
J	Bevan, MW; Uauy, C; Wulff, BBH; Zhou, J; Krasileva, K; Clark, MD				Bevan, Michael W.; Uauy, Cristobal; Wulff, Brande B. H.; Zhou, Ji; Krasileva, Ksenia; Clark, Matthew D.			Genomic innovation for crop improvement	NATURE			English	Review							HYBRID ERROR-CORRECTION; INDIVIDUAL CHROMOSOMES; WHEAT; SEQUENCE; EVOLUTION; MAIZE; SELECTION; RICE; DNA; DOMESTICATION	Crop production needs to increase to secure future food supplies, while reducing its impact on ecosystems. Detailed characterization of plant genomes and genetic diversity is crucial for meeting these challenges. Advances in genome sequencing and assembly are being used to access the large and complex genomes of crops and their wild relatives. These have helped to identify a wide spectrum of genetic variation and permitted the association of genetic diversity with diverse agronomic phenotypes. In combination with improved and automated phenotyping assays and functional genomic studies, genomics is providing new foundations for crop-breeding systems.	[Bevan, Michael W.; Uauy, Cristobal; Wulff, Brande B. H.; Zhou, Ji] John Innes Ctr, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Zhou, Ji; Krasileva, Ksenia; Clark, Matthew D.] Earlham Inst, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Krasileva, Ksenia] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Clark, Matthew D.] Univ East Anglia, Sch Environm Sci, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia	Bevan, MW (corresponding author), John Innes Ctr, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	michael.bevan@jic.ac.uk	Uauy, Cristobal/T-4382-2019; Zhou, Ji/ABC-2628-2021; Wulff, Brande BH/C-7465-2013	Uauy, Cristobal/0000-0002-9814-1770; Wulff, Brande BH/0000-0003-4044-4346; Krasileva, Ksenia/0000-0002-1679-0700; Clark, Matthew/0000-0002-8049-5423; Zhou, Ji/0000-0002-5752-5524	UK Biotechnology and Biological Sciences Research Council (BBSRC) [GRO BB/J004588/1]; Gatsby Charitable Foundation; 2Blades Foundation; BBSRC strategic LoLa award [BB/J003913/1]; BBSRC [BBS/E/J/000PR9780, BBS/E/T/000PR9785, BBS/E/J/000PR9789, BB/J003557/1, BBS/E/J/000C0673, BBS/E/J/000CA352, BBS/E/T/000PR6193, BB/J003743/1, BB/N020413/1, BB/L011794/1, BB/N016106/1, BBS/E/T/000GP020, BBS/E/T/000PR5885, BB/P004857/1, BB/J019739/1, BBS/E/J/000PR9781, BB/N005155/1, BB/M018458/1, BBS/E/J/000PR9779, BB/P010768/1, BB/E004725/1, BB/P010733/1, BBS/E/T/000PR9818, BBS/E/J/000CA562, BBS/E/J/000C0628] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193, BB/M018458/1, BB/J019739/1, BBS/E/J/000CA352, BBS/E/J/000PR9781, BBS/OS/NW/000008, BB/E004725/1, BBS/E/J/000PR9789, BB/J003557/1, BBS/E/J/00000584, BB/L011794/1, BBS/E/T/000GP020, BB/N020413/1, BB/P010733/1, BB/P004857/1, BBS/E/J/000PR9778, BBS/E/J/000PR9780, BBS/E/T/000PR5885, BBS/E/J/000C0628, BBS/E/T/000PR9785, BBS/E/J/000C0673, BBS/E/J/000CA562, BBS/E/T/000PR9818, BB/N005155/1, BB/P010768/1, BB/J003743/1, BBS/E/J/000PR9779, BB/N016106/1] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Foundation; 2Blades Foundation; BBSRC strategic LoLa award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by strategic programme funding from the UK Biotechnology and Biological Sciences Research Council (BBSRC) (GRO BB/J004588/1) to M.B., a BBSRC strategic LoLa award (BB/J003913/1) to M.B. and M.C. and funding from the Gatsby Charitable Foundation to K.K. and the 2Blades Foundation to B.W.	Allen AM, 2016, PLANT BIOTECHNOL J; Barabaschi D, 2016, PLANT SCI, V242, P3, DOI 10.1016/j.plantsci.2015.07.010; Bassi FM, 2016, PLANT SCI, V242, P23, DOI 10.1016/j.plantsci.2015.08.021; Bennett MD, 2011, ANN BOT-LONDON, V107, P467, DOI 10.1093/aob/mcq258; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Bertioli DJ, 2016, NAT GENET, V48, P438, DOI 10.1038/ng.3517; Biffen R.H., 1926, WHEAT BREEDING INVES; Bilgic H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151974; Borrill P, 2015, NEW PHYTOL, V208, P1008, DOI 10.1111/nph.13533; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Byrne SL, 2015, PLANT J, V84, P816, DOI 10.1111/tpj.13037; Chaisson MJP, 2015, NAT REV GENET, V16, P627, DOI 10.1038/nrg3933; Chalhoub B, 2014, SCIENCE, V345, P950, DOI 10.1126/science.1253435; Chin CS, 2016, NAT METHODS, V13, P1050, DOI [10.1038/NMETH.4035, 10.1038/nmeth.4035]; Clavijo B. J., 2016, PREPRINT; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Denoeud F, 2014, SCIENCE, V345, P1181, DOI 10.1126/science.1255274; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dreze J., 1989, HUNGER PUBLIC ACTION; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Dvorak J, 2011, CZECH J GENET PLANT, V47, pS20, DOI 10.17221/3249-CJGPB; Fiorani F, 2013, ANNU REV PLANT BIOL, V64, P267, DOI 10.1146/annurev-arplant-050312-120137; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; GALILI G, 1986, P NATL ACAD SCI USA, V83, P6524, DOI 10.1073/pnas.83.17.6524; Garrett KA, 2006, ANNU REV PHYTOPATHOL, V44, P489, DOI 10.1146/annurev.phyto.44.070505.143420; Gil-Humanes J, 2016, PLANT J; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goodwin S, 2015, GENOME RES, V25, P1750, DOI 10.1101/gr.191395.115; Grivet L, 2002, CURR OPIN PLANT BIOL, V5, P122, DOI 10.1016/S1369-5266(02)00234-0; Huang XH, 2012, NATURE, V490, P497, DOI 10.1038/nature11532; Jafarzadeh J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162860; Jarvis DE, 2017, NATURE, V542, P307, DOI 10.1038/nature21370; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Jordan KW, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0606-4; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Kim MY, 2014, TRENDS PLANT SCI, V19, P320, DOI 10.1016/j.tplants.2014.01.014; Kitano M, 2012, NAT CHEM, V4, P934, DOI [10.1038/NCHEM.1476, 10.1038/nchem.1476]; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Krasileva KV, 2017, P NATL ACAD SCI USA, V114, pE913, DOI 10.1073/pnas.1619268114; Lisch D, 2013, NAT REV GENET, V14, P49, DOI 10.1038/nrg3374; Liu Z., 2016, PLANT GENOME; Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/NMETH.3444, 10.1038/nmeth.3444]; Loose M, 2016, NAT METHODS, V13, P751, DOI [10.1038/NMETH.3930, 10.1038/nmeth.3930]; Love RR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2531-7; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Marulanda JJ, 2016, THEOR APPL GENET, V129, P1901, DOI 10.1007/s00122-016-2748-5; Massawe F, 2016, TRENDS PLANT SCI, V21, P365, DOI 10.1016/j.tplants.2016.02.006; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McCouch SR, 2007, EUPHYTICA, V154, P317, DOI 10.1007/s10681-006-9210-8; Mostovoy Y, 2016, NAT METHODS, V13, P587, DOI [10.1038/NMETH.3865, 10.1038/nmeth.3865]; Munns R, 2012, NAT BIOTECHNOL, V30, P360, DOI 10.1038/nbt.2120; Neale DB, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r59; Patil G, 2016, SCI REP-UK, V6, DOI 10.1038/srep19199; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Ramos-Madrigal J, 2016, CURR BIOL, V26, P3195, DOI 10.1016/j.cub.2016.09.036; Rand A. C., 2016, PREPRINT; Riaz A, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0117-7; Rodgers-Melnick E, 2016, P NATL ACAD SCI USA, V113, pE3177, DOI 10.1073/pnas.1525244113; Sadhu MJ, 2016, SCIENCE, V352, P1113, DOI 10.1126/science.aaf5124; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; Saintenac C, 2009, GENETICS, V181, P393, DOI 10.1534/genetics.108.097469; Selvaraj S, 2013, NAT BIOTECHNOL, V31, P1111, DOI 10.1038/nbt.2728; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Simpson J. T., 2016, PREPRINT; Spindel JE, 2016, HEREDITY, V116, P395, DOI 10.1038/hdy.2015.113; Stankova H, 2016, PLANT BIOTECHNOL J, V14, P1523, DOI 10.1111/pbi.12513; Steuernage B, 2016, NAT BIOTECHNOL, V34, P652, DOI 10.1038/nbt.3543; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Varshney RK, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001883; Vivek BS, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2016.07.0070; Voskoboynik A, 2013, ELIFE, V2, DOI 10.7554/eLife.00569; Weisenfeld N. I., 2016, PREPRINT; Weisenfeld NI, 2014, NAT GENET, V46, P1350, DOI 10.1038/ng.3121; Witek K, 2016, NAT BIOTECHNOL, V34, P656, DOI 10.1038/nbt.3540; Woodhouse MR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000409; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891; Yang JH, 2016, NAT GENET, V48, P1225, DOI 10.1038/ng.3657; Zamir D, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001595; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12617; Zhang ZC, 2011, P NATL ACAD SCI USA, V108, P18737, DOI 10.1073/pnas.1110552108; Zhao C, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.202; Zheng GXY, 2016, NAT BIOTECHNOL, V34, P303, DOI 10.1038/nbt.3432; Zheng YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep28136; Zimin A. V., 2017, GENOME RES; Zimin A, 2014, GENETICS, V196, P875, DOI 10.1534/genetics.113.159715	94	190	197	12	271	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					346	354		10.1038/nature22011	http://dx.doi.org/10.1038/nature22011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9RN	28300107	Green Accepted			2022-12-28	WOS:000396337400038
J	Mitchell, LV; Wilson, MR; Holmes, S				Mitchell, Lorne V.; Wilson, Matthew R.; Holmes, Susan			CASE REVIEW A historic disease still prevalent today	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mitchell, Lorne V.; Holmes, Susan] Glasgow Royal Infirm, Walton Bldg, Glasgow, Lanark, Scotland; [Wilson, Matthew R.] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland	University of Glasgow; Beatson Oncology Centre	Mitchell, LV (corresponding author), Glasgow Royal Infirm, Walton Bldg, Glasgow, Lanark, Scotland.	lorne.mitchell@nhs.net	Wilson, Matthew/AAS-1246-2020	Wilson, Matthew/0000-0001-5423-3270				British National Formulary, ASC AC, DOI 10.18578/BNF.155699525; Henry EB, 2005, ALIMENT PHARM THERAP, V22, P539, DOI 10.1111/j.1365-2036.2005.02568.x; Hirschmann JV, 1999, J AM ACAD DERMATOL, V41, P895, DOI 10.1016/S0190-9622(99)70244-6; Levine M, 1999, JAMA-J AM MED ASSOC, V281, P1415, DOI 10.1001/jama.281.15.1415; National Institutes of Health, 2016, US VIT C FACT SHEET; Nguyen Roland T D, 2003, Australas J Dermatol, V44, P48, DOI 10.1046/j.1440-0960.2003.00637.x; Olmedo JM, 1991, INT J DERMATOL, V356, P293; Pimentel L, 2003, AM J EMERG MED, V21, P328, DOI 10.1016/S0735-6757(03)00083-4; Schleicher RL, 2009, AM J CLIN NUTR, V90, P1252, DOI 10.3945/ajcn.2008.27016; Trohler U, 2005, J ROY SOC MED, V98, P519, DOI 10.1258/jrsm.98.11.519	10	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2017	356								j1013	10.1136/bmj.j1013	http://dx.doi.org/10.1136/bmj.j1013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NO	28302629				2022-12-28	WOS:000397015600002
J	Green, SA; Uy, BR; Bronner, ME				Green, Stephen A.; Uy, Benjamin R.; Bronner, Marianne E.			Ancient evolutionary origin of vertebrate enteric neurons from trunk-derived neural crest	NATURE			English	Article							CELLS; MIGRATION; LAMPREY; RET; DIFFERENTIATION; REGENERATION; TRANSECTION; EXPRESSION; RECEPTOR; VAGAL	The enteric nervous system of jawed vertebrates arises primarily from vagal neural crest cells that migrate to the foregut and subsequently colonize and innervate the entire gastrointestinal tract. Here we examine development of the enteric nervous system in the basal jawless vertebrate the sea lamprey (Petromyzon marinus) to gain insight into its evolutionary origin. Surprisingly, we find no evidence for the existence of a vagally derived enteric neural crest population in the lamprey. Rather, labelling with the lipophilic dye DiI shows that late-migrating cells, originating from the trunk neural tube and associated with nerve fibres, differentiate into neurons within the gut wall and typhlosole. We propose that these trunk-derived neural crest cells may be homologous to Schwann cell precursors, recently shown in mammalian embryos to populate post-embryonic parasympathetic ganglia(1,2), including enteric ganglia(3). Our results suggest that neural-crest-derived Schwann cell precursors made an important contribution to the ancient enteric nervous system of early jawless vertebrates, a role that was largely subsumed by vagal neural crest cells in early gnathostomes.	[Green, Stephen A.; Uy, Benjamin R.; Bronner, Marianne E.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Bronner, ME (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mbronner@caltech.edu		Bronner, Marianne/0000-0003-4274-1862	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS086907] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS086907] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adameyko I, 2009, CELL, V139, P366, DOI 10.1016/j.cell.2009.07.049; BAUMGARTEN HG, 1973, Z ZELLFORSCH MIK ANA, V141, P33, DOI 10.1007/BF00307395; De Bellard ME, 2003, J CELL BIOL, V162, P269, DOI 10.1083/jcb.200301041; Dyachuk V, 2014, SCIENCE, V345, P82, DOI 10.1126/science.1253281; Espinosa-Medina I, 2014, SCIENCE, V345, P87, DOI 10.1126/science.1253286; Furness J.B., 2006, ENTERIC NERVOUS SYST; Gibbins I., 1994, COMP PHYSL EVOLUTION, V4; Haming D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026543; Horigome N, 1999, DEV BIOL, V207, P287, DOI 10.1006/dbio.1998.9175; JOHNELS A. G., 1948, ACTA ZOOL [STOCKHOLM], V29, P139; Jones DS, 1942, ANAT REC, V82, P185, DOI 10.1002/ar.1090820207; Kuo BR, 2011, DEV DYNAM, V240, P2084, DOI 10.1002/dvdy.22715; Lake JI, 2013, AM J PHYSIOL-GASTR L, V305, pG1, DOI 10.1152/ajpgi.00452.2012; LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31; MarcosGutierrez CV, 1997, ONCOGENE, V14, P879, DOI 10.1038/sj.onc.1201048; McCauley DW, 2003, DEVELOPMENT, V130, P2317, DOI 10.1242/dev.00451; NAKAO T, 1982, J NEUROCYTOL, V11, P517, DOI 10.1007/BF01262422; Natarajan D, 2002, DEVELOPMENT, V129, P5151; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; PETERS A, 1960, J ULTRA MOL STRUCT R, V4, P349, DOI 10.1016/S0022-5320(60)80027-5; ROVAINEN CM, 1976, J COMP NEUROL, V168, P545, DOI 10.1002/cne.901680407; Sauka-Spengler T., 2009, COLD SPRING HARB PRO, V2009, pt5126; Sauka-Spengler T., 2009, COLD SPRING HARB PRO, V2009, pt5122; Sauka-Spengler T, 2007, DEV CELL, V13, P405, DOI 10.1016/j.devcel.2007.08.005; SELZER ME, 1978, J PHYSIOL-LONDON, V277, P395, DOI 10.1113/jphysiol.1978.sp012280; SERBEDZIJA GN, 1989, DEVELOPMENT, V106, P809; Uesaka T, 2015, J NEUROSCI, V35, P9879, DOI 10.1523/JNEUROSCI.1239-15.2015; Wasowicz M., 1993, J BRAIN RES, V35, P71; YNTEMA CL, 1954, J COMP NEUROL, V101, P515, DOI 10.1002/cne.901010212; YUI R, 1988, ARCH HISTOL CYTOL, V51, P109, DOI 10.1679/aohc.51.109	30	49	49	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					88	+		10.1038/nature21679	http://dx.doi.org/10.1038/nature21679			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ8GQ	28321127	Green Accepted			2022-12-28	WOS:000398323300038
J	Lin, LL; Zhou, W; Gao, R; Yao, SY; Zhang, X; Xu, WQ; Zheng, SJ; Jiang, Z; Yu, QL; Li, YW; Shi, C; Wen, XD; Ma, D				Lin, Lili; Zhou, Wu; Gao, Rui; Yao, Siyu; Zhang, Xiao; Xu, Wenqian; Zheng, Shijian; Jiang, Zheng; Yu, Qiaolin; Li, Yong-Wang; Shi, Chuan; Wen, Xiao-Dong; Ma, Ding			Low-temperature hydrogen production from water and methanol using Pt/alpha-MoC catalysts	NATURE			English	Article							MOLYBDENUM CARBIDE CATALYSTS; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; GAS SHIFT; CARBON-DIOXIDE; SINGLE-ATOM; FUEL-CELLS; BASIS-SET; STEAM; HYDROCARBONS	Polymer electrolyte membrane fuel cells (PEMFCs) running on hydrogen are attractive alternative power supplies for a range of applications(1-3), with in situ release of the required hydrogen from a stable liquid offering one way of ensuring its safe storage and transportation(4,5) before use. The use of methanol is particularly interesting in this regard, because it is inexpensive and can reform itself with water to release hydrogen with a high gravimetric density of 18.8 per cent by weight. But traditional reforming of methanol steam operates at relatively high temperatures (200-350 degrees Celsius)(6-8), so the focus for vehicle and portable PEMFC applications(9) has been on aqueous-phase reforming of methanol (APRM). This method requires less energy, and the simpler and more compact device design allows direct integration into PEMFC stacks(10,11). There remains, however, the need for an efficient APRM catalyst. Here we report that platinum (Pt) atomically dispersed on a-molybdenum carbide (alpha-MoC) enables low-temperature (150-190 degrees Celsius), base-free hydrogen production through APRM, with an average turnover frequency reaching 18,046 moles of hydrogen per mole of platinum per hour. We attribute this exceptional hydrogen production-which far exceeds that of previously reported low-temperature APRM catalysts-to the outstanding ability of a-MoC to induce water dissociation, and to the fact that platinum and a-MoC act in synergy to activate methanol and then to reform it.	[Lin, Lili; Yao, Siyu; Yu, Qiaolin; Ma, Ding] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Zhou, Wu] Univ Chinese Acad Sci, CAS Key Lab Vacuum Phys, Sch Phys Sci, Beijing 100049, Peoples R China; [Zhou, Wu] Oak Ridge Natl Lab, Mat Sci & Technol Div, Oak Ridge, TN 37831 USA; [Gao, Rui; Li, Yong-Wang; Wen, Xiao-Dong] Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, POB 165, Taiyuan 030001, Shanxi, Peoples R China; [Gao, Rui; Li, Yong-Wang; Wen, Xiao-Dong] Synfuels China Co Ltd, Beijing 100195, Peoples R China; [Zhang, Xiao; Shi, Chuan] Dalian Univ Technol, Key Lab Ind Ecol & Environm Engn MOE, Dalian 116024, Peoples R China; [Xu, Wenqian] Argonne Natl Lab, Xray Sci Div Adv Photon Source, 9700 S Cass Ave, Argonne, IL 60439 USA; [Zheng, Shijian] Chinese Acad Sci, Inst Met Res, Shenyang Natl Lab Mat Sci, Shenyang 110016, Peoples R China; [Jiang, Zheng] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201204, Peoples R China	Peking University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of Energy (DOE); Oak Ridge National Laboratory; Chinese Academy of Sciences; Institute of Coal Chemistry, CAS; Dalian University of Technology; United States Department of Energy (DOE); Argonne National Laboratory; Chinese Academy of Sciences; Institute of Metal Research, CAS; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Wen, XD (corresponding author), Chinese Acad Sci, Inst Coal Chem, State Key Lab Coal Convers, POB 165, Taiyuan 030001, Shanxi, Peoples R China.; Wen, XD (corresponding author), Synfuels China Co Ltd, Beijing 100195, Peoples R China.; Shi, C (corresponding author), Dalian Univ Technol, Key Lab Ind Ecol & Environm Engn MOE, Dalian 116024, Peoples R China.	chuanshi@dlut.edu.cn; wxd@sxicc.ac.cn	zheng, shijian/F-2453-2012; Yao, Siyu/G-5865-2013; Zhou, Wu/D-8526-2011; lin, lily/GWR-3183-2022; Jiang, Zheng/ACE-7696-2022; Jiang, Zheng/ABE-5915-2020	zheng, shijian/0000-0003-4949-0015; Zhou, Wu/0000-0002-6803-1095; Jiang, Zheng/0000-0003-4297-464X; Lin, Lili/0000-0001-7704-8414	973 Project [2011CB201402, 2013CB933100]; Natural Science Foundation of China [91645115, 21473003, 21222306, 21373037, 21577013, 91545121]; Chinese Academy of Sciences (CAS) Pioneer Hundred Talents Program; US Department of Energy (DOE), Office of Science, Basic Energy Science, Materials Sciences and Engineering Division; user project at Oak Ridge National Laboratory's Center for Nanophase Materials Sciences (CNMS), which is a DOE Office of Science User Facility; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]	973 Project(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (CAS) Pioneer Hundred Talents Program; US Department of Energy (DOE), Office of Science, Basic Energy Science, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); user project at Oak Ridge National Laboratory's Center for Nanophase Materials Sciences (CNMS), which is a DOE Office of Science User Facility; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE))	We received financial support from the 973 Project (grants 2011CB201402 and 2013CB933100) and the Natural Science Foundation of China (grants 91645115, 21473003, 91645115, 21222306, 21373037, 21577013 and 91545121). The electron-microscopy work was supported in part by the Chinese Academy of Sciences (CAS) Pioneer Hundred Talents Program; by the US Department of Energy (DOE), Office of Science, Basic Energy Science, Materials Sciences and Engineering Division (to W.Z.); and through a user project at Oak Ridge National Laboratory's Center for Nanophase Materials Sciences (CNMS), which is a DOE Office of Science User Facility. The XAS experiments were conducted in the Shanghai Synchrotron Radiation Facility (SSRF) and Beijing Synchrotron Radiation Facility (BSRF). This research used Beamline 17-BM of the Advanced Photon Source (APS), a US DOE Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357 (to W.X.). We also acknowledge National Thousand Young Talents Program of China the CAS Hundred Talents Program and the Shanxi Hundred Talent Program.	AMPHLETT JC, 1994, INT J HYDROGEN ENERG, V19, P131, DOI 10.1016/0360-3199(94)90117-1; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Cortright RD, 2002, NATURE, V418, P964, DOI 10.1038/nature01009; Davda RR, 2005, APPL CATAL B-ENVIRON, V56, P171, DOI 10.1016/j.apcatb.2004.04.027; David WIF, 2014, J AM CHEM SOC, V136, P13082, DOI 10.1021/ja5042836; Denard C. A., 2014, ANGEW CHEM, V126, P475; Deng ZY, 2008, J AM CERAM SOC, V91, P3825, DOI 10.1111/j.1551-2916.2008.02800.x; Fu Q, 2003, SCIENCE, V301, P935, DOI 10.1126/science.1085721; Fu Q, 2010, SCIENCE, V328, P1141, DOI 10.1126/science.1188267; Gunanathan C, 2014, CHEM REV, V114, P12024, DOI 10.1021/cr5002782; Henkelman G, 2000, J CHEM PHYS, V113, P9901, DOI 10.1063/1.1329672; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; Krivanek O.L., 2013, LOW VOLTAGE ELECT MI, P119; Lebarbier VM, 2014, APPL CATAL B-ENVIRON, V144, P223, DOI 10.1016/j.apcatb.2013.06.034; Lee JK, 2004, APPL CATAL A-GEN, V278, P25, DOI 10.1016/j.apcata.2004.09.022; LEE JS, 1988, J CATAL, V112, P44, DOI 10.1016/0021-9517(88)90119-4; Li J, 2014, ENERG ENVIRON SCI, V7, P393, DOI 10.1039/c3ee41945b; Ma YF, 2014, INT J HYDROGEN ENERG, V39, P258, DOI 10.1016/j.ijhydene.2013.09.150; Moulder J. F., 1992, HDB XRAY PHOTOELECTR, P261; Nielsen M, 2013, NATURE, V495, P85, DOI 10.1038/nature11891; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Qiao BT, 2011, NAT CHEM, V3, P634, DOI [10.1038/nchem.1095, 10.1038/NCHEM.1095]; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Sa S, 2010, APPL CATAL B-ENVIRON, V99, P43, DOI 10.1016/j.apcatb.2010.06.015; Schlapbach L, 2001, NATURE, V414, P353, DOI 10.1038/35104634; Schweitzer NM, 2011, J AM CHEM SOC, V133, P2378, DOI 10.1021/ja110705a; Setthapun W, 2008, TOP CATAL, V49, P73, DOI 10.1007/s11244-008-9070-7; Shabaker JW, 2003, J CATAL, V215, P344, DOI 10.1016/S0021-9517(03)00032-0; Song CS, 2002, CATAL TODAY, V77, P17, DOI 10.1016/S0920-5861(02)00231-6; Steele BCH, 2001, NATURE, V414, P345, DOI 10.1038/35104620; Toby BH, 2001, J APPL CRYSTALLOGR, V34, P210, DOI 10.1107/S0021889801002242; Wei HS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6634; Yang M, 2014, SCIENCE, V346, P1498, DOI 10.1126/science.1260526; Yu KMK, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2242; Zhai YP, 2010, SCIENCE, V329, P1633, DOI 10.1126/science.1192449; Zhao D, 2006, ANGEW CHEM INT EDIT, V45, P4955, DOI 10.1002/anie.200600155	38	801	832	152	2262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					80	+		10.1038/nature21672	http://dx.doi.org/10.1038/nature21672			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ8GQ	28329760				2022-12-28	WOS:000398323300036
J	Abbasi, J				Abbasi, Jennifer			Increases in Premature Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1205	1205		10.1001/jama.2017.2852	http://dx.doi.org/10.1001/jama.2017.2852			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350911				2022-12-28	WOS:000397557800005
J	Chou, R; Bougatsos, C; Blazina, I; Mackey, K; Grusing, S; Selph, S				Chou, Roger; Bougatsos, Christina; Blazina, Ian; Mackey, Katherine; Grusing, Sara; Selph, Shelley			Screening for Celiac Disease Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DEAMIDATED GLIADIN PEPTIDES; GLUTEN-FREE DIET; TISSUE-TRANSGLUTAMINASE; VILLOUS ATROPHY; ANTIBODIES; PREVALENCE; DIAGNOSIS; RISK; PERFORMANCE; DEFICIENCY	IMPORTANCE Silent or subclinical celiac disease may result in potentially avoidable adverse health consequences. OBJECTIVE To review the evidence on benefits and harms of screening for celiac disease in asymptomatic adults, adolescents, and children 3 years and older for the US Preventive Services Task Force. DATA SOURCES Ovid MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews, searched to June 14, 2016. STUDY SELECTION Randomized clinical trials and cohort or case-control studies on clinical benefits and harms of screening vs no screening for celiac disease or treatment vs no treatment for screen-detected celiac disease; studies on diagnostic accuracy of serologic tests for celiac disease. DATA EXTRACTION AND SYNTHESIS One investigator abstracted data, a second checked data for accuracy, and 2 investigators independently assessed study quality using predefined criteria. MAIN OUTCOMES AND MEASURES Cancer incidence, gastrointestinal outcomes, psychological outcomes, child growth outcomes, health outcomes resulting from nutritional deficiencies, quality of life, mortality, and harms of screening. No meta-analytic pooling was done. RESULTS One systematic review and 3 primary studies met inclusion criteria. No trials of screening for celiac disease were identified. One recent, good-quality systematic review of 56 original studies and 12 previous systematic reviews (sample sizes of primary studies ranging from 62 to more than 12 000 participants) found IgA tissue transglutaminase was associated with high accuracy (sensitivity and specificity both >90%) for diagnosing celiac disease. IgA endomysial antibodies tests were associated with high specificity. Only 2 studies of serologic tests for celiac disease involving 62 and 158 patients were conducted in asymptomatic populations and reported lower sensitivity (57% and 71%). One fair-quality, small (n = 40) Finnish treatment trial of asymptomatic adults with screen-detected celiac disease based on positive serologic findings found initiation of a gluten-free diet associated with small improvement in gastrointestinal symptoms compared with no gluten-free diet (difference less than 1 point on a scale of 1 to 7) at 1 year, with no differences on most measures of quality of life. No withdrawals due to adverse events occurred during the trial; no other harms were reported. No studies were identified that addressed the other outcomes. CONCLUSIONS AND RELEVANCE Although some evidence was found regarding diagnostic accuracy of tests for celiac disease, little or no evidence was identified to inform most of the key questions related to benefits and harms of screening for celiac disease in asymptomatic individuals. More research is needed to understand the effectiveness of screening and treatment for celiac disease, accuracy of screening tests in asymptomatic persons, and optimal screening strategies.	[Chou, Roger] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Chou, Roger; Selph, Shelley] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA; [Bougatsos, Christina; Blazina, Ian; Grusing, Sara] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97201 USA; [Mackey, Katherine] Oregon Hlth & Sci Univ, Div Gen Internal Med & Geriatr, Portland, OR 97201 USA; [Selph, Shelley] Oregon Hlth & Sci Univ, Dept Family Med, Pacific Northwest Evidence Based Practice Ctr, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, Dept Med, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.; Chou, R (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Chou, Roger/0000-0001-9889-8610; Blazina, Ian/0000-0003-0164-6674	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2012-00015-I]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2012-00015-I, Task Order 4, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Barada K, 2014, ENDOSCOPY, V46, P110, DOI 10.1055/s-0033-1359200; Basso D, 2011, CLIN CHIM ACTA, V412, P1662, DOI 10.1016/j.cca.2011.05.024; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Cekin AH, 2012, TURK J GASTROENTEROL, V23, P490, DOI 10.4318/tjg.2012.0467; Chou R, 2016, SCREENING CELIAC DIS; Crowe SE., 2011, ANN INTERN MED, V154; Dahlbom I, 2010, J PEDIATR GASTR NUTR, V50, P140, DOI 10.1097/MPG.0b013e3181a81384; Dahle C, 2010, ALIMENT PHARM THER, V32, P254, DOI 10.1111/j.1365-2036.2010.04337.x; DeGaetani M, 2013, AM J GASTROENTEROL, V108, P647, DOI 10.1038/ajg.2013.45; Dube C, 2005, GASTROENTEROLOGY, V128, pS57, DOI 10.1053/j.gastro.2005.02.014; Dutta AK, 2010, DIGEST DIS SCI, V55, P698, DOI 10.1007/s10620-009-0789-1; Emami MH, 2012, INT J PREVENTIVE MED, V3, P273; Godfrey JD, 2010, GASTROENTEROLOGY, V139, P763, DOI 10.1053/j.gastro.2010.05.041; Green PHR, 2007, NEW ENGL J MED, V357, P1731, DOI 10.1056/NEJMra071600; Green PHR, 2005, GASTROENTEROLOGY, V128, pS74, DOI 10.1053/j.gastro.2005.02.016; Harrison E, 2013, POSTGRAD MED J, V89, P4, DOI 10.1136/postgradmedj-2011-130188; Hill I, 2000, J PEDIATR-US, V136, P86, DOI 10.1016/S0022-3476(00)90055-6; Johnston SD, 2004, EUR J GASTROEN HEPAT, V16, P1281, DOI 10.1097/00042737-200412000-00008; Kaukinen K, 1999, DIGEST DIS SCI, V44, P1428, DOI 10.1023/A:1026612121041; Kurppa K, 2014, GASTROENTEROLOGY, V147, P610, DOI 10.1053/j.gastro.2014.05.003; Lahdeaho M-L., PHASE 2A DOUBLE BLIN; Leffler D., PROSPECTIVE TRIAL CE; Leon F., 2015, PHASE 2B RANDOMIZED; Maglione M, 2016, COMP EFFECTIVENESS R; Mahmud FH, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008097; Makharia G., EFFECT ADDITION SHOR; Mansour Abbas Ali, 2011, Arab J Gastroenterol, V12, P103, DOI 10.1016/j.ajg.2011.04.007; Mozo L, 2012, J PEDIATR GASTR NUTR, V55, P50, DOI 10.1097/MPG.0b013e31824703c7; Nevoral J, 2014, EUR J PEDIATR, V173, P497, DOI 10.1007/s00431-013-2215-0; Olen O, 2012, J PEDIATR GASTR NUTR, V55, P695, DOI 10.1097/MPG.0b013e3182645c54; Rasmussen H., DOUBLE BLIND PLACEBO; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2012, AM J GASTROENTEROL, V107, P1538, DOI 10.1038/ajg.2012.219; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Sakly W, 2012, CLIN RES HEPATOL GAS, V36, P598, DOI 10.1016/j.clinre.2012.01.008; Srinivas M, 2014, CLIN GASTROENTEROL H, V12, P946, DOI 10.1016/j.cgh.2013.10.037; Sugai E, 2010, CLIN CHEM, V56, P661, DOI 10.1373/clinchem.2009.129668; Swallow K, 2013, CLIN EXP IMMUNOL, V171, P100, DOI 10.1111/cei.12000; Tai V, 2000, J AM GERIATR SOC, V48, P1690, DOI 10.1111/j.1532-5415.2000.tb03884.x; Tio M, 2012, ALIMENT PHARM THER, V35, P540, DOI 10.1111/j.1365-2036.2011.04972.x; Ukkola A, 2011, CLIN GASTROENTEROL H, V9, P118, DOI 10.1016/j.cgh.2010.10.011; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; Van Meensel B, 2004, CLIN CHEM, V50, P2125, DOI 10.1373/clinchem.2004.035832; Vermeersch P, 2012, CLIN CHIM ACTA, V413, P1761, DOI 10.1016/j.cca.2012.06.024; Vermeersch P, 2010, CLIN CHIM ACTA, V411, P931, DOI 10.1016/j.cca.2010.02.060; Vermeersch P, 2010, CLIN CHIM ACTA, V411, P13, DOI 10.1016/j.cca.2009.09.030; Vilppula A, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-136; Zanini B, 2012, DIGEST LIVER DIS, V44, P280, DOI 10.1016/j.dld.2011.10.013	48	45	49	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1258	1268		10.1001/jama.2016.10395	http://dx.doi.org/10.1001/jama.2016.10395			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350935	Bronze			2022-12-28	WOS:000397557800023
J	Leslie, M				Leslie, Mitch			REPRODUCTIVE BIOLOGY Can flu shots help women get pregnant?	SCIENCE			English	News Item																			0	2	2	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1247	1248		10.1126/science.355.6331.1247	http://dx.doi.org/10.1126/science.355.6331.1247			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336615				2022-12-28	WOS:000397082900008
J	Castelvecchi, D				Castelvecchi, Davide			HOW TO HUNT FOR A BLACK HOLE	NATURE			English	News Item							GALACTIC-CENTER; EVENT-HORIZON											Bower GC, 2004, SCIENCE, V304, P704, DOI 10.1126/science.1094023; Doeleman SS, 2008, NATURE, V455, P78, DOI 10.1038/nature07245; Doeleman SS, 2012, SCIENCE, V338, P355, DOI 10.1126/science.1224768; Falcke H, 2000, ASTROPHYS J, V528, pL13, DOI 10.1086/312423; Johnson MD, 2015, SCIENCE, V350, P1242, DOI 10.1126/science.aac7087	5	8	9	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					478	480		10.1038/543478a	http://dx.doi.org/10.1038/543478a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28332538	Bronze			2022-12-28	WOS:000397018000025
J	Chavda, SJ; Lindsay, S; Willis, F; Koh, M				Chavda, Selina J.; Lindsay, Sophie; Willis, Fenella; Koh, Mickey			CASE REVIEW Bruising and abnormal leucocytes on a blood film-a haematological emergency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Chavda, Selina J.; Lindsay, Sophie; Willis, Fenella; Koh, Mickey] St Georges Hosp NHS Fdn Trust, London, England		Chavda, SJ (corresponding author), St Georges Hosp NHS Fdn Trust, London, England.	selinachavda@doctors.org.uk		koh, Mickey Boon Chai/0000-0002-4368-2502				Adams J, 2015, ARCH PATHOL LAB MED, V139, P1308, DOI 10.5858/arpa.2013-0345-RS; Ahmad Tali M, 2015, MALAYS J PATHOL, V37, P141; Coombs CC, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.25; Dally N, 2005, THROMB RES, V116, P109, DOI 10.1016/j.thromres.2004.11.001; de Botton S, 2005, J CLIN ONCOL, V23, P120, DOI 10.1200/JCO.2005.03.127; Dimov ND, 2010, CANCER-AM CANCER SOC, V116, P369, DOI 10.1002/cncr.24775; Leung W, 2001, LEUKEMIA, V15, P41, DOI 10.1038/sj.leu.2401948; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Mathews V, 2010, J CLIN ONCOL, V28, P3866, DOI 10.1200/JCO.2010.28.5031; Mays AN, 2010, BLOOD, V115, P326, DOI 10.1182/blood-2009-07-235051; Pagnano Katia Borgia Barbosa, 2014, Rev. Bras. Hematol. Hemoter., V36, P71, DOI 10.5581/1516-8484.20140018; Shaft D, 1998, BRIT J HAEMATOL, V103, P729, DOI 10.1046/j.1365-2141.1998.01065.x; Specchia G, 2001, J CLIN ONCOL, V19, P4023, DOI 10.1200/JCO.2001.19.20.4023; Tallman Martin S, 2005, Leuk Res, V29, P347, DOI 10.1016/j.leukres.2004.04.021; Tallman MS, 2002, BLOOD, V99, P759, DOI 10.1182/blood.V99.3.759; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Visser O, 2012, EUR J CANCER, V48, P3257, DOI 10.1016/j.ejca.2012.05.024; Volkova M, 2011, CURR CARDIOL REV, V7, P214, DOI 10.2174/157340311799960645; Zuckerman T, 2012, BLOOD, V120, P1993, DOI 10.1182/blood-2012-04-424440	19	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2017	356								j1164	10.1136/bmj.j1164	http://dx.doi.org/10.1136/bmj.j1164			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IZ	28336583				2022-12-28	WOS:000397345500001
J	Yamaji, M; Jishage, M; Meyer, C; Suryawanshi, H; Evan; Yamaji, M; Garzia, A; Morozov, P; Manickavel, S; Mcfarland, HL; Roeder, RG; Hafner, M; Tuschl, T				Yamaji, Masashi; Jishage, Miki; Meyer, Cindy; Suryawanshi, Hemant; Evan Der; Yamaji, Misaki; Garzia, Aitor; Morozov, Pavel; Manickavel, Sudhir; Mcfarland, Hannah L.; Roeder, Robert G.; Hafner, Markus; Tuschl, Thomas			DND1 maintains germline stem cells via recruitment of the CCR4-NOT complex to target mRNAs	NATURE			English	Article							STRUCTURAL BASIS; BINDING PROTEIN; TESTICULAR TERATOMAS; TER MUTATION; EXPRESSION; SPECIFICATION; RECOGNITION; DYNAMICS; GENES; BIOINFORMATICS	The vertebrate-conserved RNA-binding protein DND1 is required for the survival of primordial germ cells (PGCs), as well as the suppression of germ cell tumours in mice(1-5). Here we show that in mice DND1 binds a UU(A/U) trinucleotide motif predominantly in the 3' untranslated regions of mRNA, and destabilizes target mRNAs through direct recruitment of the CCR4-NOT deadenylase complex. Transcriptomic analysis reveals that the extent of suppression is dependent on the number of DND1-binding sites. This DND1-dependent mRNA destabilization is required for the survival of mouse PGCs and spermatogonial stem cells by suppressing apoptosis. The spectrum of target RNAs includes positive regulators of apoptosis and inflammation, and modulators of signalling pathways that regulate stem-cell pluripotency, including the TGFa superfamily, all of which are aberrantly elevated in DND1-deficient PGCs. We propose that the induction of the post-transcriptional suppressor DND1 synergizes with concurrent transcriptional changes to ensure precise developmental transitions during cellular differentiation and maintenance of the germ line.	[Yamaji, Masashi; Meyer, Cindy; Suryawanshi, Hemant; Yamaji, Misaki; Garzia, Aitor; Morozov, Pavel; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, 1230 York Ave,Box 186, New York, NY 10065 USA; [Jishage, Miki; Roeder, Robert G.] Rockefeller Univ, Lab Biochem & Mol Biol, 1230 York Ave, New York, NY 10065 USA; [Evan Der] Albert Einstein Coll Med, 1300 Morris Pk Ave,Forchheimer Bldg, Bronx, NY 10461 USA; [Manickavel, Sudhir; Mcfarland, Hannah L.; Hafner, Markus] Natl Inst Arthrit & Musculoskeletal & Skin Dis, Lab Muscle Stem Cells & Gene Regulat, 50 South Dr,MSC 8024, Bethesda, MD 20892 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Tuschl, T (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, 1230 York Ave,Box 186, New York, NY 10065 USA.; Hafner, M (corresponding author), Natl Inst Arthrit & Musculoskeletal & Skin Dis, Lab Muscle Stem Cells & Gene Regulat, 50 South Dr,MSC 8024, Bethesda, MD 20892 USA.	markus.hafner@nih.gov; ttuschl@rockefeller.edu	Hafner, Markus/O-7100-2018; Morozov, Pavel/GQP-7206-2022; Yamaji, Masashi/ABA-5267-2020	Hafner, Markus/0000-0002-4336-6518; Yamaji, Masashi/0000-0002-8215-2184; Meyer, Cindy/0000-0003-3807-8383; , Hemant/0000-0002-8102-9678; Garzia, Aitor/0000-0002-6270-1369	Starr Cancer Foundation; Starr Foundation [TRI-SCI 2014-036]; NCI; NCATS/NIH/CTSA; Vilcek Foundation [UL1 TR000043]; DAAD; NIH TRA [R01CA159227]; Intramural Research Program of NIAMS/NIH; JSPS; NATIONAL CANCER INSTITUTE [R01CA202245, R01CA159227] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041200, ZIAAR041205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104962] Funding Source: NIH RePORTER	Starr Cancer Foundation; Starr Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCATS/NIH/CTSA; Vilcek Foundation; DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); NIH TRA; Intramural Research Program of NIAMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge expert support by the members of the Rockefeller University resource centers (C. Zhao, genomics; H. Molina, proteomics; S. Mazel, flow cytometry; A. North, bio-imaging; R. Norinsky, chimaera assay) and of the NIAMS Genomics Core (G. Gutierrez-Cruz and S. Dell'Orso). We also thank M. Morita (McGill University, Montreal, Canada) for critical discussions on biochemical analysis, K. Hayashi (Kyusyu University, Japan) and Y. Saito (Rockefeller University) for technical guidance regarding PGCLC induction, and N. Mukherjee (Max-Delbruck Centrum for Molecular Medicine, Berlin, Germany) for bioinformatic tools, E. Macosko, M. Goldman, and S. McCarroll for advice to establish DropSeq, and S. Yamada and S. Keeney (Memorial Sloan Kettering Cancer Center, New York) for technical guidance regarding spermatogenic cell sorting. The GST-CNOT constructs were provided by N. Sonenberg (McGill University, Montreal, Canada). pCMV-PP7 and beta-globin-4xPP7-hairpin reporter plasmid were provided by D. R. Larson and M. Palangat (National Cancer Institute/NIH) and J. R. Hogg (National Heart, Lung, and Blood Institute/NIH), respectively. T.T. is an HHMI investigator. The study was supported, in part, by the Starr Cancer Foundation (T. T.), the Starr Foundation (T. T., Ma. Y.: TRI-SCI 2014-036; R. G. R.: TRI-SCI), NCI (R. G. R.), NCATS/NIH/CTSA, the Vilcek Foundation (Ma. Y.; UL1 TR000043), DAAD (C. M.), and NIH TRA (T. T.; R01CA159227). The Intramural Research Program of NIAMS/NIH supports S. M., H.L.M., and M. H. Ma. Y. was a recipient of a JSPS Research Fellowship.	Al-Zoghaibi F, 2007, GENE, V391, P130, DOI 10.1016/j.gene.2006.12.013; Bailey TL, 2011, BIOINFORMATICS, V27, P1653, DOI 10.1093/bioinformatics/btr261; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Bastos H, 2005, CYTOM PART A, V65A, P40, DOI 10.1002/cyto.a.20129; Bhandari D, 2014, GENE DEV, V28, P888, DOI 10.1101/gad.237289.113; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep07581; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Cook MS, 2009, DEV BIOL, V328, P377, DOI 10.1016/j.ydbio.2009.01.041; Corcoran DL, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r79; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Fabian MR, 2013, NAT STRUCT MOL BIOL, V20, P735, DOI 10.1038/nsmb.2572; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jishage M, 2012, MOL CELL, V45, P51, DOI 10.1016/j.molcel.2011.12.014; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Korkola JE, 2006, CANCER RES, V66, P820, DOI 10.1158/0008-5472.CAN-05-2445; Kurimoto K, 2008, GENE DEV, V22, P1617, DOI 10.1101/gad.1649908; Kurimoto K, 2015, CELL STEM CELL, V16, P517, DOI 10.1016/j.stem.2015.03.002; Kuwasako K, 2008, BIOCHEMISTRY-US, V47, P6437, DOI 10.1021/bi7024723; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Li C., 2001, GENOME BIOL, V2, DOI [10.1186/gb-2001-2-8-research0032, DOI 10.1186/GB-2001-2-8-RESEARCH0032]; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Nakaki F, 2013, NATURE, V501, P222, DOI 10.1038/nature12417; NOGUCHI T, 1985, JNCI-J NATL CANCER I, V75, P385; Northrup E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038001; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Rouya C, 2014, RNA, V20, P1398, DOI 10.1261/rna.045302.114; Saitou M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008375; SAKURAI T, 1995, DEV GROWTH DIFFER, V37, P293, DOI 10.1046/j.1440-169X.1995.t01-2-00007.x; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slanchev K, 2009, MECH DEVELOP, V126, P270, DOI 10.1016/j.mod.2008.10.006; Spiller CM, 2012, DEVELOPMENT, V139, P4123, DOI 10.1242/dev.083006; Spitzer J, 2013, METHOD ENZYMOL, V529, P99, DOI 10.1016/B978-0-12-418687-3.00008-2; Suzuki A, 2016, EMBO REP, V17, P37, DOI 10.15252/embr.201540828; Suzuki A, 2010, P NATL ACAD SCI USA, V107, P3594, DOI 10.1073/pnas.0908664107; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaji M, 2013, CELL STEM CELL, V12, P368, DOI 10.1016/j.stem.2012.12.012; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zhang P, 2015, CELL RES, V25, P193, DOI [10.1038/cr.2015.14, 10.1038/cr.2015.4]	56	76	77	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					568	+		10.1038/nature21690	http://dx.doi.org/10.1038/nature21690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28297718	Green Accepted			2022-12-28	WOS:000397018000055
J	Voelker, R				Voelker, Rebecca			New Rare Diseases Screening Test	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1110	1110		10.1001/jama.2017.1772	http://dx.doi.org/10.1001/jama.2017.1772			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324075				2022-12-28	WOS:000396987200008
J	McCall, B				McCall, Becky			UK NHS-Home Office agreement undermines patient trust	LANCET			English	Editorial Material																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1087	1087						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28322808				2022-12-28	WOS:000396408700010
J	Chatterjee, P; Sommers, BD				Chatterjee, Paula; Sommers, Benjamin D.			The Economics of Medicaid Reform and Block Grants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Chatterjee, Paula] Brigham & Womens Hosp, Internal Med, Boston, MA 02115 USA; [Chatterjee, Paula] Harvard Med Sch, Boston, MA USA; [Sommers, Benjamin D.] Harvard TH Chan Sch Publ Hlth, Hlth Policy & Econ, Boston, MA 02115 USA; [Sommers, Benjamin D.] Brigham & Womens Hosp, Med, Boston, MA 02115 USA; [Sommers, Benjamin D.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Sommers, BD (corresponding author), Harvard TH Chan Sch Publ Hlth, Hlth Policy & Econ, Boston, MA 02115 USA.; Sommers, BD (corresponding author), Brigham & Womens Hosp, Med, Boston, MA 02115 USA.; Sommers, BD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	bsommers@hsph.harvard.edu							0	4	4	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1007	1008		10.1001/jama.2017.0901	http://dx.doi.org/10.1001/jama.2017.0901			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291880				2022-12-28	WOS:000396713400003
J	Bailey, R				Bailey, Roderick			The art of medicine Psychiatrists and secret agents	LANCET			English	Editorial Material									[Bailey, Roderick] Univ Oxford, Wellcome Unit Hist Med, Oxford OX2 6PE, England	University of Oxford	Bailey, R (corresponding author), Univ Oxford, Wellcome Unit Hist Med, Oxford OX2 6PE, England.	roderick.bailey@wuhmo.ox.ac.uk		Bailey, Roderick/0000-0002-0055-3460	Wellcome Trust [100251] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 10	2016	388	10062					2864	2865		10.1016/S0140-6736(16)32474-6	http://dx.doi.org/10.1016/S0140-6736(16)32474-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE5FU	28316354	Green Submitted, Green Accepted			2022-12-28	WOS:000389631700021
J	Dzau, VJ; McClellan, MB; McGinnis, M; Burke, SP; Coye, MJ; Diaz, A; Daschle, TA; Frist, WH; Gaines, M; Hamburg, MA; Henney, JE; Kumanyika, S; Leavitt, MO; Parker, RM; Sandy, LG; Schaeffer, LD; Steele, GD; Thompson, P; Zerhouni, E				Dzau, Victor J.; McClellan, Mark B.; McGinnis, Michael; Burke, Sheila P.; Coye, Molly J.; Diaz, Angela; Daschle, Thomas A.; Frist, William H.; Gaines, Martha; Hamburg, Margaret A.; Henney, Jane E.; Kumanyika, Shiriki; Leavitt, Michael O.; Parker, Ruth M.; Sandy, Lewis G.; Schaeffer, Leonard D.; Steele, Glenn D., Jr.; Thompson, Pamela; Zerhouni, Elias			Vital Directions for Health and Health Care Priorities From a National Academy of Medicine Initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; US; TELEMEDICINE; BENEFITS; SYSTEM	IMPORTANCE Recent discussion has focused on questions related to the repeal and replacement of portions of the Affordable Care Act (ACA). However, issues central to the future of health and health care in the United States transcend the ACA provisions receiving the greatest attention. Initiatives directed to certain strategic and infrastructure priorities are vital to achieve better health at lower cost. OBJECTIVES To review the most salient health challenges and opportunities facing the United States, to identify practical and achievable priorities essential to health progress, and to present policy initiatives critical to the nation's health and fiscal integrity. EVIDENCE REVIEW Qualitative synthesis of 19 National Academy of Medicine-commissioned white papers, with supplemental review and analysis of publicly available data and published research findings. FINDINGS The US health system faces major challenges. Health care costs remain high at $ 3.2 trillion spent annually, of which an estimated 30% is related to waste, inefficiencies, and excessive prices; health disparities are persistent and worsening; and the health and financial burdens of chronic illness and disability are straining families and communities. Concurrently, promising opportunities and knowledge to achieve change exist. Across the 19 discussion papers examined, 8 crosscutting policy directions were identified as vital to the nation's health and fiscal future, including 4 action priorities and 4 essential infrastructure needs. The action priorities-pay for value, empower people, activate communities, and connect care-recurred across the articles as direct and strategic opportunities to advance a more efficient, equitable, and patient-and community-focused health system. The essential infrastructure needs-measure what matters most, modernize skills, accelerate real-world evidence, and advance science-were the most commonly cited foundational elements to ensure progress. CONCLUSIONS AND RELEVANCE The action priorities and essential infrastructure needs represent major opportunities to improve health outcomes and increase efficiency and value in the health system. As the new US administration and Congress chart the future of health and health care for the United States, and as health leaders across the country contemplate future directions for their programs and initiatives, their leadership and strategic investment in these priorities will be essential for achieving significant progress.	[Dzau, Victor J.; McGinnis, Michael; Hamburg, Margaret A.; Henney, Jane E.] Natl Acad Med, 500 Fifth St NW, Washington, DC 20001 USA; [McClellan, Mark B.] Duke Univ, Ctr Hlth Policy, Washington, DC USA; [Burke, Sheila P.] Harvard Univ, Malcolm Wiener Ctr Social Policy, John F Kennedy Sch Govt, Cambridge, MA 02138 USA; [Coye, Molly J.] AVIA, Chicago, IL USA; [Diaz, Angela] Mt Sinai Sch Med, Mt Sinai Adolescent Hlth Ctr, Dept Pediat, New York, NY USA; [Diaz, Angela] Mt Sinai Sch Med, Mt Sinai Adolescent Hlth Ctr, Dept Prevent Med, New York, NY USA; [Daschle, Thomas A.] Daschle Grp, Washington, DC USA; [Frist, William H.] Vanderbilt Univ, Owen Grad Sch Management, 221 Kirkland Hall, Nashville, TN 37235 USA; [Gaines, Martha] Univ Wisconsin, Sch Law, Ctr Patient Partnerships, Madison, WI 53706 USA; [Kumanyika, Shiriki] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Leavitt, Michael O.] Leavitt Partners, Salt Lake City, UT USA; [Parker, Ruth M.] Emory Univ, Sch Med, Atlanta, GA USA; [Sandy, Lewis G.] UnitedHlth Grp, Minnetonka, MN USA; [Schaeffer, Leonard D.] Univ Southern Calif, Los Angeles, CA USA; [Steele, Glenn D., Jr.] xG Hlth Solut, Columbus, MD USA; [Thompson, Pamela] Amer Org Nurse Execut, Chicago, IL USA; [Zerhouni, Elias] Sanofi, Global Res & Dev, Paris, France	National Academies of Sciences, Engineering & Medicine; Duke University; Harvard University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Vanderbilt University; University of Wisconsin System; University of Wisconsin Madison; University of Pennsylvania; Pennsylvania Medicine; Emory University; University of Southern California; Sanofi-Aventis; Sanofi France	Dzau, VJ (corresponding author), Natl Acad Med, 500 Fifth St NW, Washington, DC 20001 USA.	vdzau@nas.edu	Parker, Ruth M/S-4583-2017	Parker, Ruth M/0000-0001-9685-6396	California Health Care Foundation; Commonwealth Fund; Gordon and Betty Moore Foundation; John A. Hartford Foundation; Josiah Macy Jr. Foundation; RobertWood Johnson Foundation; National Academy of Medicine's Harvey V. Fineberg Impact Fund	California Health Care Foundation; Commonwealth Fund; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); John A. Hartford Foundation; Josiah Macy Jr. Foundation; RobertWood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Academy of Medicine's Harvey V. Fineberg Impact Fund	The National Academy of Medicine's Vital Directions for Health and Health Care initiative is sponsored by the California Health Care Foundation, The Commonwealth Fund, the Gordon and Betty Moore Foundation, The John A. Hartford Foundation, the Josiah Macy Jr. Foundation, the RobertWood Johnson Foundation, and the National Academy of Medicine's Harvey V. Fineberg Impact Fund.	Austin JM, 2016, JAMA-J AM MED ASSOC, V316, P1661, DOI 10.1001/jama.2016.14039; Berman M, 2005, HEALTH ECON, V14, P559, DOI 10.1002/hec.952; Berwick DM, 2012, JAMA-J AM MED ASSOC, V307, P1513, DOI 10.1001/jama.2012.362; Bradley E., 2013, AM HLTH CARE PARADOX; Cassel CK, 2016, FOSTERING TRANSPAREN; Center for Health Care Strategies and State Health Access Data Assistance Center, 2016, COMM CAR TEAMS OV ST; Centers for Medicare and Medicaid Services, 2016, NAT HLTH EXP FACT SH; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Congressional Budget Office, 2016, HIST BUDG DAT; Hailey D, 2002, J TELEMED TELECARE, V8, P1; Institute of Medicine, 2015, VIT SIGNS COR METR H; Institute of Medicine, 2008, 2007 IOM ANN M SUMM; Kennedy-Martin T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1023-4; Kish LJ, 2015, NAT BIOTECHNOL, V33, P921, DOI 10.1038/nbt.3340; Krumholz HM, 2016, JAMA-J AM MED ASSOC, V316, P1669, DOI 10.1001/jama.2016.12537; Krumholz HM, 2016, DATA ACQUISITION CUR; Kruse J, 2013, FAM MED, V45, P54; Legare F, 2013, HEALTH AFFAIR, V32, P276, DOI 10.1377/hlthaff.2012.1078; Lipstein S. H., 2016, WORKFORCE 21 CENTURY; McClellan MB, 2016, JAMA-J AM MED ASSOC, V316, P1655, DOI 10.1001/jama.2016.14205; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; McGinnis JM, 2016, SYSTEMS STRATEGIES B; Mitchell E, 2016, POPULATION BASED PAY; Mitchell EM, 2016, CONCENTRATION HLTH E; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; National Academies of Sciences Engineering and Medicine, 2017, COMM ACT PATHW HLTH; Network for excellence in health innovation, 2015, REAL WORLD EV NEW ER; Office of the National Coordinator for Health Information Technology, 2013, INF TECHN HLTH CAR N; Office of the National Coordinator for Health Information Technology, 2014, CONN HLTH CAR NAT 10; Patient-Centered Outcomes Research Institute, COMM DISS RES; Perlin JB, 2016, INFORM TECHNOLOGY IN; Rosenblatt M, 2016, INNOVATION DEV REGUL; Rosenblatt M, 2016, JAMA-J AM MED ASSOC, V316, P1671, DOI 10.1001/jama.2016.12486; Smith M., 2013, BUSINESS MODELS RESP; Squires D., 2015, US HLTH CARE GLOBAL; Stanford School of Medicine, 2010, HEALTHC DISP BARR HL; Substance Abuse and Mental Health Services Administration, 2017, HLTH HOM MED HOM; Taylor LA, 2015, LEVERAGING SOCIAL DE; Topol E, 2013, TECHNOLOGY TRANSFORM; Uberoi N., 2016, HLTH INSURANCE COVER; US Food and Drug Administration, 2017, NAT MED EV GEN COLL; Vernon J., 2007, LOW HLTH LITERACY IM; Xu J.Q., 2016, MORTALITY US 2015; Zerhouni E., 2016, TRAINING WORKFORCE 2	45	108	108	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2017	317	14					1461	1470		10.1001/jama.2017.1964	http://dx.doi.org/10.1001/jama.2017.1964			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER6FQ	28324029				2022-12-28	WOS:000398901200020
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Nurses must be allowed to exercise professional judgment	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material											No Org, Glasgow, Lanark, Scotland.	margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				BMA Resuscitation Council (UK) Royal College of Nursing, 2014, DEC REL CARD RES; Nursing and Midwifery Council, 2017, COND COMP COMM SUBST	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2017	356								j1548	10.1136/bmj.j1548	http://dx.doi.org/10.1136/bmj.j1548			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4DL	28351839	Bronze, Green Published			2022-12-28	WOS:000398024200006
J	Dyer, C				Dyer, Clare			BRIEFING Decriminalisation of abortion	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												claredyer4@gmail.com						BMA, 2017, DECR AB; Sheldon S, 2017, GUARDIAN; Statistics, 2016, AB CAN	3	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2017	356								j1485	10.1136/bmj.j1485	http://dx.doi.org/10.1136/bmj.j1485			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IZ	28336509				2022-12-28	WOS:000397345500008
J	Longhurst, H; Cicardi, M; Craig, T; Bork, K; Grattan, C; Baker, J; Li, HH; Reshef, A; Bonner, J; Bernstein, JA; Anderson, J; Lumry, WR; Farkas, H; Katelaris, CH; Sussman, GL; Jacobs, J; Riedl, M; Manning, ME; Hebert, J; Keith, PK; Kivity, S; Neri, S; Levy, DS; Baeza, ML; Nathan, R; Schwartz, LB; Caballero, T; Yang, W; Crisan, I; Hernandez, MD; Hussain, I; Tarzi, M; Ritchie, B; Kralickova, P; Guilarte, M; Rehman, SM; Banerji, A; Gower, RG; Bensen-Kennedy, D; Edelman, J; Feuersenger, H; Lawo, JP; Machnig, T; Pawaskar, D; Pragst, I; Zuraw, BL				Longhurst, H.; Cicardi, M.; Craig, T.; Bork, K.; Grattan, C.; Baker, J.; Li, H. H.; Reshef, A.; Bonner, J.; Bernstein, J. A.; Anderson, J.; Lumry, W. R.; Farkas, H.; Katelaris, C. H.; Sussman, G. L.; Jacobs, J.; Riedl, M.; Manning, M. E.; Hebert, J.; Keith, P. K.; Kivity, S.; Neri, S.; Levy, D. S.; Baeza, M. L.; Nathan, R.; Schwartz, L. B.; Caballero, T.; Yang, W.; Crisan, I.; Hernandez, M. D.; Hussain, I.; Tarzi, M.; Ritchie, B.; Kralickova, P.; Guilarte, M.; Rehman, S. M.; Banerji, A.; Gower, R. G.; Bensen-Kennedy, D.; Edelman, J.; Feuersenger, H.; Lawo, J. -P.; Machnig, T.; Pawaskar, D.; Pragst, I.; Zuraw, B. L.		COMPACT Investigators	Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PHASE-II; CONCENTRATE; C1-INHIBITOR; PROPHYLAXIS; DEFICIENCY; PATHOPHYSIOLOGY; RECOMMENDATIONS; MANAGEMENT; BRADYKININ	BACKGROUND Hereditary angioedema is a disabling, potentially fatal condition caused by deficiency (type I) or dysfunction (type II) of the C1 inhibitor protein. In a phase 2 trial, the use of CSL830, a nanofiltered C1 inhibitor preparation that is suitable for subcutaneous injection, resulted in functional levels of C1 inhibitor activity that would be expected to provide effective prophylaxis of attacks. METHODS We conducted an international, prospective, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase 3 trial to evaluate the efficacy and safety of self-administered subcutaneous CSL830 in patients with type I or type II hereditary angioedema who had had four or more attacks in a consecutive 2-month period within 3 months before screening. We randomly assigned the patients to one of four treatment sequences in a crossover design, each involving two 16-week treatment periods: either 40 IU or 60 IU of CSL830 per kilogram of body weight twice weekly followed by placebo, or vice versa. The primary efficacy end point was the number of attacks of angioedema. Secondary efficacy end points were the proportion of patients who had a response (= 50% reduction in the number of attacks with CSL830 as compared with placebo) and the number of times that rescue medication was used. RESULTS Of the 90 patients who underwent randomization, 79 completed the trial. Both doses of CSL830, as compared with placebo, reduced the rate of attacks of hereditary angioedema (mean difference with 40 IU, -2.42 attacks per month; 95% confidence interval [CI], -3.38 to -1.46; and mean difference with 60 IU, -3.51 attacks per month; 95% CI, -4.21 to -2.81; P< 0.001 for both comparisons). Response rates were 76% (95% CI, 62 to 87) in the 40-IU group and 90% (95% CI, 77 to 96) in the 60-IU group. The need for rescue medication was reduced from 5.55 uses per month in the placebo group to 1.13 uses per month in the 40-IU group and from 3.89 uses in the placebo group to 0.32 uses per month in the 60-IU group. Adverse events (most commonly mild and transient local site reactions) occurred in similar proportions of patients who received CSL830 and those who received placebo. CONCLUSIONS In patients with hereditary angioedema, the prophylactic use of a subcutaneous C1 inhibitor twice weekly significantly reduced the frequency of acute attacks.	[Longhurst, H.] Barts Hlth NHS Trust, London, England; [Grattan, C.] Guys Hosp, St Johns Inst Dermatol, London, England; [Tarzi, M.] Royal Sussex Cty Hosp, Clin Invest & Res, Brighton, E Sussex, England; [Cicardi, M.] UO Med Gen, Osped Luigi Sacco, Milan, Italy; [Neri, S.] Univ Catania, Dept Internal Med, Catania, Italy; [Craig, T.] Penn State Hershey Allergy Asthma & Immunol, Dept Med & Pediat, Hershey, PA USA; [Bensen-Kennedy, D.; Edelman, J.; Pawaskar, D.] CSL Behring, King Of Prussia, PA USA; [Bork, K.] Johannes Gutenberg Univ Mainz, Dept Dermatol, Mainz, Germany; [Feuersenger, H.; Lawo, J. -P.; Machnig, T.; Pragst, I.] CSL Behring, Marburg, Germany; [Baker, J.] Baker Allergy Asthma & Dermatol Res Ctr, Portland, OR USA; [Li, H. H.] Inst Asthma & Allergy, Chevy Chase, MD USA; [Reshef, A.] Chaim Sheba Med Ctr, Allergy & Immunol Unit, Tel Hashomer, Israel; [Kivity, S.] Tel Aviv Sourasky Med Ctr, Allergy & Immunol Unit, Tel Aviv, Israel; [Bonner, J.; Anderson, J.] Clin Res Ctr Alabama, Birmingham, AL USA; [Bernstein, J. A.] Univ Cincinnati, Coll Med, Dept Internal Med, Allergy Sect Cincinnati, Cincinnati, OH USA; [Rehman, S. M.] Toledo Inst Clin Res, Toledo, OH USA; [Lumry, W. R.] Allergy Asthma Res Associates Res Ctr, Dallas, TX USA; [Farkas, H.] Semmelweis Univ, Dept Internal Med 3, Hungarian Angioedema Ctr, Budapest, Hungary; [Katelaris, C. H.] Campbelltown Hosp, Dept Med Immunol & Allergy, Campbelltown, NSW, Australia; [Sussman, G. L.] St Michaels Hosp, Dept Clin Immunol & Allergy, Toronto, ON, Canada; [Hebert, J.] Ctr Rech Appl Allergie Quebec, Quebec City, PQ, Canada; [Keith, P. K.] McMaster Univ, Hamilton, ON, Canada; [Yang, W.] Ottawa Allergy Res, Ottawa, ON, Canada; [Yang, W.] Univ Ottawa, Sch Med, Ottawa, ON, Canada; [Ritchie, B.] Univ Alberta Hosp, Edmonton, AB, Canada; [Jacobs, J.] Allergy & Asthma Clin Res, Walnut Creek, CA USA; [Riedl, M.; Zuraw, B. L.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Levy, D. S.] 705 W La Veta Ave,Suite 101, Orange, CA USA; [Manning, M. E.] Med Res Arizona, Scottsdale, AZ USA; [Baeza, M. L.] Hosp Gen Univ Gregorio Maranon, Gregorio Maranon, Spain; [Baeza, M. L.] Inst Hlth Res, Biomed Res Network Rare Diseases U761, Gregorio Maranon, Spain; [Caballero, T.] Hosp La Paz, Inst Hlth Res, Biomed Res Network Rare Dis, Allergy Dept, Madrid, Spain; [Hernandez, M. D.] Univ La Fe, IIS Hosp, Dept Allergy, Valencia, Spain; [Guilarte, M.] Hosp Univ Vall dHebron, Barcelona, Spain; [Nathan, R.] Asthma & Allergy Assoc, Colorado Springs, CO USA; [Schwartz, L. B.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA 23284 USA; [Crisan, I.] Spitalul Clin Municipal, Cluj Napoca, Romania; [Hussain, I.] Vital Prospects Clin Res Inst, Tulsa, OK USA; [Kralickova, P.] Univ Hosp, Inst Clin Immunol & Allergol, Hradec Kralove, Czech Republic; [Banerji, A.] Massachusetts Gen Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02114 USA; [Gower, R. G.] Marycliff Allergy Specialists, Spokane, WA USA	Barts Health NHS Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Brighton; University of Milan; Luigi Sacco Hospital; University of Catania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; CSL; Johannes Gutenberg University of Mainz; CSL; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University System of Ohio; University of Cincinnati; Semmelweis University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University; University of Ottawa; University of Alberta; University of California System; University of California San Diego; General University Gregorio Maranon Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; Hospital Universitari Vall d'Hebron; Virginia Commonwealth University; University Hospital Hradec Kralove; Harvard University; Massachusetts General Hospital	Longhurst, H (corresponding author), Longhurst Barts Hlth NHS Trust, Pathol & Pharm Bldg,80 Newark St, London E1 2ES, England.	hilary.longhurst@bartshealth.nhs.uk	Vachová, Martina/J-7925-2017; Caballero, Teresa/AAU-3982-2020; Banerji, Aleena/ABG-1245-2021; Bork, Konrad/AAE-4985-2022; Levy, Donald/GSE-5486-2022; Labrador Horrillo, Moisés/O-6434-2016; Reshef, Avner/AAL-3638-2020; cicardi, marco/K-9219-2016; Borobia, Alberto M./H-6887-2013	Vachová, Martina/0000-0003-2004-7626; Caballero, Teresa/0000-0003-3005-9858; Bork, Konrad/0000-0002-6084-4577; Labrador Horrillo, Moisés/0000-0003-3222-2380; Farkas, Henriette/0000-0003-2929-1721; NERI, Sergio/0000-0001-9314-8554; Bernstein, Jonathan/0000-0002-3476-1196; Pedrosa, Maria/0000-0002-5295-870X; Prieto-Garcia, Alicia/0000-0003-3915-1941; Leibovich-Nassi, Iris/0000-0002-0097-4919; cicardi, marco/0000-0003-1251-225X; Cardona, Victoria/0000-0003-2197-9767; Ritchie, Bruce/0000-0003-4754-1050; hernandez, Dolores/0000-0001-8427-6845; Gower, Richard/0000-0002-5042-7059; Borobia, Alberto M./0000-0002-8584-3263; Gomez-Traseira, Carmen/0000-0002-7486-6267; Reshef, Avner/0000-0002-3324-7072; Zuraw, Bruce/0000-0003-0640-6768; Guilarte, Mar/0000-0001-7242-9584	CSL Behring	CSL Behring	Supported by CSL Behring.	[Anonymous], 2008, 125267 STN FOOD DRUG; Aygoren-Pursun E, 2016, J ALLERGY CLIN IMMUN, V137, pAB251, DOI 10.1016/j.jaci.2015.12.907; Bernstein JA, 2014, J ALLER CL IMM-PRACT, V2, P77, DOI 10.1016/j.jaip.2013.09.008; BORK K, 1989, J ALLERGY CLIN IMMUN, V83, P677, DOI 10.1016/0091-6749(89)90082-1; Bowen Tom, 2010, Allergy Asthma Clin Immunol, V6, P24, DOI 10.1186/1710-1492-6-24; Cicardi M, 2012, ALLERGY, V67, P147, DOI 10.1111/j.1398-9995.2011.02751.x; Craig T, 2012, WORLD ALLERGY ORGAN, V5, P182, DOI 10.1097/WOX.0b013e318279affa; Cugno M, 2003, INT IMMUNOPHARMACOL, V3, P311, DOI 10.1016/S1567-5769(02)00162-5; Davis AE, 2005, CLIN IMMUNOL, V114, P3, DOI 10.1016/j.clim.2004.05.007; Hack CE, 2012, ALLERGY, V67, P123, DOI 10.1111/j.1398-9995.2011.02716.x; Hofstra JJ, 2012, CLIN IMMUNOL, V142, P280, DOI 10.1016/j.clim.2011.11.005; Kalaria S, 2013, ALLERGY ASTHMA PROC, V34, P519, DOI 10.2500/aap.2013.34.3702; Keleman Z, 2010, CLIN IMMUNOL, V134, P354, DOI 10.1016/j.clim.2009.11.002; Nussberger J, 1998, LANCET, V351, P1693, DOI 10.1016/S0140-6736(97)09137-X; SPATH P J, 1984, Complement, V1, P147; Zuraw BL, 2015, ALLERGY, V70, P1319, DOI 10.1111/all.12658; Zuraw BL, 2013, J ALLER CL IMM-PRACT, V1, P458, DOI 10.1016/j.jaip.2013.07.002; Zuraw BL, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.02.020; Zuraw BL, 2010, NEW ENGL J MED, V363, P513, DOI 10.1056/NEJMoa0805538	19	133	137	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1131	1140		10.1056/NEJMoa1613627	http://dx.doi.org/10.1056/NEJMoa1613627			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NB	28328347	Bronze			2022-12-28	WOS:000397014300009
J	Munroe, I				Munroe, Ian			DUSTING OFF OUTDATED PATTERNS	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					S23	S26		10.1038/543S23a	http://dx.doi.org/10.1038/543S23a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO9OM	28328911	Bronze			2022-12-28	WOS:000397018000008
J	Khan, F; Vaillancourt, C; Carrier, M				Khan, Faizan; Vaillancourt, Christian; Carrier, Marc			UNCERTAINTIES Should we screen extensively for cancer after unprovoked venous thrombosis?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THROMBOEMBOLISM		[Khan, Faizan; Vaillancourt, Christian; Carrier, Marc] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Vaillancourt, Christian] Univ Ottawa, Fac Med, Emergency Med, Ottawa, ON, Canada; [Carrier, Marc] Univ Ottawa, Fac Med, Med, Ottawa, ON, Canada; [Khan, Faizan; Vaillancourt, Christian; Carrier, Marc] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Vaillancourt, Christian] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Emergency Med, Ottawa, ON, Canada; [Carrier, Marc] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Med, Ottawa, ON, Canada; [Vaillancourt, Christian] Ottawa Hosp, Dept Emergency Med, Ottawa, ON, Canada; [Vaillancourt, Christian] Ottawa Hosp, Dept Emergency Med, Emergency Med, Ottawa, ON, Canada; [Carrier, Marc] Ottawa Hosp, Dept Med, Med, Ottawa, ON, Canada; [Carrier, Marc] Ottawa Hosp, Dept Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Carrier, M (corresponding author), Univ Ottawa, Fac Med, Ottawa, ON, Canada.; Carrier, M (corresponding author), Univ Ottawa, Fac Med, Med, Ottawa, ON, Canada.; Carrier, M (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Carrier, M (corresponding author), Ottawa Hosp, Res Inst, Clin Epidemiol Program, Med, Ottawa, ON, Canada.; Carrier, M (corresponding author), Ottawa Hosp, Dept Med, Med, Ottawa, ON, Canada.; Carrier, M (corresponding author), Ottawa Hosp, Dept Med, Ottawa, ON, Canada.	mcarrier@toh.on.ca		, Faizan/0000-0001-7570-0755				Carrier M, 2008, ANN INTERN MED, V149, P323, DOI 10.7326/0003-4819-149-5-200809020-00007; Carrier M, 2015, NEW ENGL J MED, V373, P697, DOI 10.1056/NEJMoa1506623; Consedine NS, 2004, CANCER EPIDEM BIOMAR, V13, P501; Kleinjan A, 2012, NETH J MED, V70, P311; National Institute for Health and Care Excellence, 2012, VEN THROMB DIS DIAGN; Piccioli A, 2004, J THROMB HAEMOST, V2, P884, DOI 10.1111/j.1538-7836.2004.00720.x; Prandoni P, 2016, SEMIN THROMB HEMOST, V42, P884, DOI 10.1055/s-0036-1592335; Robertson L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010837.pub2; Robin P, 2016, LANCET ONCOL, V17, P193, DOI 10.1016/S1470-2045(15)00480-5; Salih M, 2016, AM J RESP CRIT CARE, V193; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427	11	3	3	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1081	10.1136/bmj.j1081	http://dx.doi.org/10.1136/bmj.j1081			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330840				2022-12-28	WOS:000397345200001
J	Gulland, A				Gulland, Anne			Five minutes with ... Louis Chesler	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2017	356								j1304	10.1136/bmj.j1304	http://dx.doi.org/10.1136/bmj.j1304			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NH	28292821				2022-12-28	WOS:000397014900006
J	Huffman, MD; Xavier, D; Perel, P				Huffman, Mark D.; Xavier, Denis; Perel, Pablo			Uses of polypills for cardiovascular disease and evidence to date	LANCET			English	Article							DOSE COMBINATION THERAPY; HIGH-RISK; PRIMARY PREVENTION; DOUBLE-BLIND; RANDOMIZED-TRIAL; NATIONAL-HEALTH; BLOOD-PRESSURE; STRATEGY; ADHERENCE; HYPERTENSION	Polypills have been approved in more than 30 countries, but worldwide experience with and availability of polypills remain limited, unlike fixed-dose combinations in other diseases such as HIV, tuberculosis, and malaria. In this Series review, we aim to propose a guide for the use of polypills in future research and clinical activities and to synthesise contemporary evidence supporting the use of polypills for prevention of atherosclerosis. Polypill uses can be categorised by population and indication, both of which influence the balance between benefits and risks. Populations include secondary prevention, high-risk primary prevention based on formal risk assessment, and primary prevention based on single risk factor measurement, such as age, also known as mass treatment. For each population, potential indications are initiation, step-up of current drug therapy, and straight substitution of individual drug components. We summarise efficacy and safety results from 13 polypill trials (9059 participants) done in 32 countries. Polypills improve adherence, are generally well tolerated, and reduce risk factor levels, although heterogeneity limits the certainty of the effect on risk factors. Trials published to date have not been designed to detect differences in clinical outcomes, and thus no significant differences between polypill and comparator groups have been reported. Polypill therapy could be one of the most scalable strategies to reduce the risk of premature mortality from atherosclerosis by 25% by 2025 by improving medication adherence and access, but further trial data and clinical experience will be useful to determine how polypills can best be implemented to achieve this goal.	[Huffman, Mark D.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Xavier, Denis] St Johns Natl Acad Hlth Sci, Dept Pharmacol, Bangalore, Karnataka, India; [Xavier, Denis] St Johns Natl Acad Hlth Sci, Div Clin Res, St Johns Med Coll, Bangalore, Karnataka, India; [Xavier, Denis] St Johns Natl Acad Hlth Sci, Res Inst, Bangalore, Karnataka, India; [Perel, Pablo] London Sch Hyg & Trop Med, Ctr Global Noncommunicable Dis Epidemiol, London, England	Northwestern University; Feinberg School of Medicine; St. John's National Academy of Health Sciences; St. John's National Academy of Health Sciences; St. John's Medical College; St. John's National Academy of Health Sciences; University of London; London School of Hygiene & Tropical Medicine	Huffman, MD (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA.	m-huffman@northwestern.edu		/0000-0002-2342-301X; Huffman, Mark/0000-0001-7412-2519	World Heart Federation for its Emerging Leaders Programme - Boehringer Ingelheim; Novartis; AstraZeneca; Bupa; Cochrane; Cadila Pharma; Canadian Institutes of Health Research; National Heart, Lung, and Blood Institute; Boehringer Ingelheim; Bristol-Myers Squibb; Ferrer	World Heart Federation for its Emerging Leaders Programme - Boehringer Ingelheim; Novartis(Novartis); AstraZeneca(AstraZeneca); Bupa; Cochrane; Cadila Pharma; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Ferrer	MDH receives support from the World Heart Federation for its Emerging Leaders Programme, which is supported by Boehringer Ingelheim and Novartis and has received support from AstraZeneca and Bupa. MDH has received travel support from the World Heart Federation to participate in a polypill meeting. MDH has received funding from Cochrane for a systematic review on polypills. DX receives funds into his institution from Cadila Pharma to conduct three polypill trials in India and from the Canadian Institutes of Health Research and AstraZeneca to conduct the HOPE-3 trial. DX also receives funding from National Heart, Lung, and Blood Institute, Boehringer Ingelheim, and Bristol-Myers Squibb for research on drug adherence and clinical research training. PP is a staff member of the World Heart Federation, which has received grants from Ferrer. PP's contribution to this article is solely his responsibility and does not necessarily reflect the views of the World Heart Federation.	Bangalore S, 2007, AM J MED, V120, P713, DOI 10.1016/j.amjmed.2006.08.033; Barrios V, 2017, REV ESP CARDIOL, V70, P42, DOI [10.1016/j.recesp.2016.05.011, 10.1016/j.rec.2016.05.009]; Beall RF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0997-3; Becerra V, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007111; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Castellano JM, 2014, J AM COLL CARDIOL, V64, P2071, DOI 10.1016/j.jacc.2014.08.021; Chow CK, 2017, LANCET, V389, P1035, DOI 10.1016/S0140-6736(17)30260-X; de Cates AN, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009868.pub2; Deanfield J, 2014, HEART, V100, P1, DOI 10.1136/heartjnl-2014-305693; Franco OH, 2004, BMJ-BRIT MED J, V329, P1447, DOI 10.1136/bmj.329.7480.1447; Globe Life Sciences Wellcome Trust World Heart Federation, 2017, CARD POL CURR EV LAN; Goff DC, 2013, CIRCULATION, V2013; Grimm R, 2010, VASC HEALTH RISK MAN, V6, P261; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hawkins NM, 2013, CIRC-CARDIOVASC QUAL, V6, P208, DOI 10.1161/CIRCOUTCOMES.111.000058; Hayek A, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0488-1; Huffman MD, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001862; Huffman MD, 2014, J AM COLL CARDIOL, V63, P1368, DOI 10.1016/j.jacc.2013.08.1665; Huffman MD, 2013, CIRC-CARDIOVASC QUAL, V6, P436, DOI 10.1161/CIRCOUTCOMES.113.000189; Jarvis MC, 2017, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD009868.pub3; Karmali KN, 2016, JAMA CARDIOL, V1, P341, DOI 10.1001/jamacardio.2016.0218; Laba TL, 2015, ANN PHARMACOTHER, V49, P528, DOI 10.1177/1060028015570468; Laba TL, 2014, MED J AUSTRALIA, V201, P671, DOI 10.5694/mja14.00266; Lafeber M, 2014, EUR J PREV CARDIOL, V21, P425, DOI 10.1177/2047487313476961; Liu HM, 2015, CIRC-CARDIOVASC QUAL, V8, P301, DOI 10.1161/CIRCOUTCOMES.115.001483; Lloyd-Jones DM, 2017, CIRCULATION, V135, pE793, DOI 10.1161/CIR.0000000000000467; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Maddox TM, 2014, J AM COLL CARDIOL, V63, P539, DOI 10.1016/j.jacc.2013.09.053; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; Neutel JM, 2009, J CLIN HYPERTENS, V11, P22, DOI 10.1111/j.1751-7176.2008.00058.x; Ostovaneh MR, 2015, EUR J PREV CARDIOL, V22, P1609, DOI 10.1177/2047487314550803; Park JS, 2016, DRUG DES DEV THER, V10, P2599, DOI 10.2147/DDDT.S112873; Patel A, 2015, EUR J PREV CARDIOL, V22, P920, DOI 10.1177/2047487314530382; Rodgers A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019857; Santo K, 2016, EUR J PREV CARDIOL, V23, P1065, DOI 10.1177/2047487316638501; Selak V, 2016, EUR J PREV CARDIOL, V23, P1537, DOI 10.1177/2047487316637196; Selak V, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3318; Shah NS, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001709; Shah NS, 2013, CIRC-CARDIOVASC QUAL, V6, P270, DOI 10.1161/CIRCOUTCOMES.113.000112; Smith R, 2009, J ROY SOC MED, V102, P508, DOI 10.1258/jrsm.2009.090293; Soliman EZ, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-3; Sundstrom J, 2014, LANCET, V384, P591, DOI 10.1016/S0140-6736(14)61212-5; Thom S, 2013, JAMA-J AM MED ASSOC, V310, P918, DOI 10.1001/jama.2013.277064; Truelove M, 2015, CARDIOVASC THER, V33, P347, DOI 10.1111/1755-5922.12151; Wald DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041297; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; Webster R, 2017, LANCET, V389, P1066, DOI 10.1016/S0140-6736(17)30558-5; Webster R, 2016, INT J CARDIOL, V205, P147, DOI 10.1016/j.ijcard.2015.12.015; WHO, 2016, HEARTS TECHN PACK CA; WHO Wellcome Trust, 2002, WELLC TRUST SEC PREV; World Health Organization, 2015, 19 WHO MOD LIST ESS; World Health Organization, 2013, GLOB ACT PLAN PREV C; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2014, EUR HEART J, V35, P353, DOI 10.1093/eurheartj/eht407; Yusuf S, 2012, CIRC-CARDIOVASC QUAL, V5, P463, DOI 10.1161/CIRCOUTCOMES.111.963637; Yusuf S, 2011, LANCET, V378, P1231, DOI 10.1016/S0140-6736(11)61215-4; Zamorano J, 2011, CURR MED RES OPIN, V27, P821, DOI 10.1185/03007995.2011.555754	57	63	65	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					1055	1065		10.1016/S0140-6736(17)30553-6	http://dx.doi.org/10.1016/S0140-6736(17)30553-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN9UN	28290995				2022-12-28	WOS:000396345200027
J	Snyder, A				Snyder, Alison			Susan Lindquist Cell biologist who studied protein folding and its role in disease. Born on June 5, 1949, in Chicago, IL, USA, she died from cancer on Oct 27, 2016, in Boston, MA, USA, aged 67 years Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 3	2016	388	10061					2736	2736		10.1016/S0140-6736(16)32430-8	http://dx.doi.org/10.1016/S0140-6736(16)32430-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE5FB	28328478	Bronze			2022-12-28	WOS:000389629800015
J	Doitsh, G; Galloway, NLK; Geng, X; Yang, ZY; Monroe, KM; Zepeda, O; Hunt, PW; Hatano, H; Sowinski, S; Munoz-Arias, I; Greene, WC				Doitsh, Gilad; Galloway, Nicole L. K.; Geng, Xin; Yang, Zhiyuan; Monroe, Kathryn M.; Zepeda, Orlando; Hunt, Peter W.; Hatano, Hiroyu; Sowinski, Stefanie; Munoz-Arias, Isa; Greene, Warner C.			Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection (vol 505, pg 509, 2014)	NATURE			English	Correction													Hunt, Peter W./P-2976-2017	Hunt, Peter W./0000-0002-4571-4870	NIAID NIH HHS [P30 AI027763] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940	1	11	13	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					124	124		10.1038/nature22066	http://dx.doi.org/10.1038/nature22066			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ2PV	28329768	Bronze			2022-12-28	WOS:000427423400001
J	El-Maarry, MR; Groussin, O; Thomas, N; Pajola, M; Auger, AT; Davidsson, B; Hu, X; Hviid, SF; Knollenberg, J; Guttler, C; Tubiana, C; Fornasier, S; Feller, C; Hasselmann, P; Vincent, JB; Sierks, H; Barbieri, C; Lamy, P; Rodrigo, R; Koschny, D; Keller, HU; Rickman, H; A'Hearn, MF; Barucci, MA; Bertaux, JL; Bertini, I; Besse, S; Bodewits, D; Cremonese, G; Da Deppo, V; Debei, S; De Cecco, M; Deller, J; Deshapriya, JDP; Fulle, M; Gutierrez, PJ; Hofmann, M; Ip, WH; Jorda, L; Kovacs, G; Kramm, JR; Kuhrt, E; Kuppers, M; Lara, LM; Lazzarin, M; Lin, ZY; Moreno, JJL; Marchi, S; Marzari, F; Mottola, S; Naletto, G; Oklay, N; Pommerol, A; Preusker, F; Scholten, F; Shi, X				El-Maarry, M. Ramy; Groussin, O.; Thomas, N.; Pajola, M.; Auger, A. -T.; Davidsson, B.; Hu, X.; Hviid, S. F.; Knollenberg, J.; Guettler, C.; Tubiana, C.; Fornasier, S.; Feller, C.; Hasselmann, P.; Vincent, J. -B.; Sierks, H.; Barbieri, C.; Lamy, P.; Rodrigo, R.; Koschny, D.; Keller, H. U.; Rickman, H.; A'Hearn, M. F.; Barucci, M. A.; Bertaux, J. -L.; Bertini, I.; Besse, S.; Bodewits, D.; Cremonese, G.; Da Deppo, V.; Debei, S.; De Cecco, M.; Deller, J.; Deshapriya, J. D. P.; Fulle, M.; Gutierrez, P. J.; Hofmann, M.; Ip, W. -H.; Jorda, L.; Kovacs, G.; Kramm, J. -R.; Kuehrt, E.; Kueppers, M.; Lara, L. M.; Lazzarin, M.; Lin, Z. -Yi; Moreno, J. J. Lopez; Marchi, S.; Marzari, F.; Mottola, S.; Naletto, G.; Oklay, N.; Pommerol, A.; Preusker, F.; Scholten, F.; Shi, X.			Surface changes on comet 67P/Churyumov-Gerasimenko suggest a more active past	SCIENCE			English	Article							IMHOTEP REGION; NUCLEUS; ROTATION; OSIRIS; SHAPE	The Rosetta spacecraft spent similar to 2 years orbiting comet 67P/Churyumov-Gerasimenko, most of it at distances that allowed surface characterization and monitoring at submeter scales. From December 2014 to June 2016, numerous localized changes were observed, which we attribute to cometary-specific weathering, erosion, and transient events driven by exposure to sunlight and other processes. While the localized changes suggest compositional or physical heterogeneity, their scale has not resulted in substantial alterations to the comet's landscape. This suggests that most of the major landforms were created early in the comet's current orbital configuration. They may even date from earlier if the comet had a larger volatile inventory, particularly of CO or CO2 ices, or contained amorphous ice, which could have triggered activity at greater distances from the Sun.	[El-Maarry, M. Ramy; Thomas, N.; Pommerol, A.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [El-Maarry, M. Ramy] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80301 USA; [Groussin, O.; Auger, A. -T.; Jorda, L.] Aix Marseille Univ, CNRS, UMR 7326, Lab Astrophys Marseille, F-13388 Marseille, France; [Pajola, M.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Davidsson, B.] Jet Prop Lab, Pasadena, CA 91109 USA; [Hu, X.; Guettler, C.; Tubiana, C.; Sierks, H.; Deller, J.; Hofmann, M.; Kovacs, G.; Kramm, J. -R.; Shi, X.] Max Planck Inst Sonnensyst Forsch, D-37077 Gottingen, Germany; [Hviid, S. F.; Knollenberg, J.; Vincent, J. -B.; Keller, H. U.; Kuehrt, E.; Mottola, S.; Oklay, N.; Preusker, F.; Scholten, F.] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetenforsch, D-12489 Berlin, Germany; [Fornasier, S.; Feller, C.; Hasselmann, P.; Barucci, M. A.; Deshapriya, J. D. P.] Univ Paris Diderot, Sorbonne Univ, PSL Res Univ,CNRS,LESIA, UPMC Univ Paris 06,Observ Paris,Sorbonne Paris Ci, F-92195 Meudon, France; [Barbieri, C.; Bertini, I.; Lazzarin, M.; Marzari, F.] Univ Padua, Dept Phys & Astron, I-35122 Padua, Italy; [Lamy, P.] CNRS, Lab Astrophys Marseille, UMR 7326, F-13388 Marseille 13, France; [Lamy, P.] Univ Aix Marseille, F-13388 Marseille 13, France; [Rodrigo, R.] Inst Nacl Tecn Aeroespacial, Ctr Astrobiol, Madrid 28850, Spain; [Rodrigo, R.] Int Space Sci Inst, CH-3012 Bern, Switzerland; [Koschny, D.; Besse, S.; Kueppers, M.] European Space Astron Ctr ESA, Operat Dept, POB 78, Madrid 28691, Spain; [Keller, H. U.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Geophys & Extraterr Phys, D-38106 Braunschweig, Germany; [Rickman, H.] Uppsala Univ, Dept Phys & Astron, Box 516, S-75120 Uppsala, Sweden; [Rickman, H.] Polish Acad Sci, Space Res Ctr, PL-00716 Warsaw, Poland; [A'Hearn, M. F.; Bodewits, D.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA; [Bertaux, J. -L.] Univ Versailles St Quentin En Yvelines, Lab Atmospheres Milieux Observat Spatiales LATMOS, Inst Pierre Simon Laplace, CNRS, F-78280 Guyancourt, France; [Cremonese, G.] Osserv Astron Padova, Ist Nazl Astrofis, I-35122 Padua, Italy; [Da Deppo, V.; Naletto, G.] CNR, Ist Foton & Nanotecnol, Unita Org Supporto, Padova Luxor, I-35131 Padua, Italy; [Debei, S.] Univ Padua, Dept Ind Engn, I-35131 Padua, Italy; [De Cecco, M.] Univ Trento, I-38123 Trento, Italy; [Fulle, M.] Osserv Astron Trieste, INAF, I-34014 Trieste, Italy; [Gutierrez, P. J.; Lara, L. M.; Moreno, J. J. Lopez] Inst Astrofis Andalucia CSIC, C Glorieta Astron S-N, Granada 18008, Spain; [Ip, W. -H.; Lin, Z. -Yi] Natl Cent Univ, Grad Inst Astron, Chungli 32054, Taiwan; [Marchi, S.] Southwest Res Inst, Virtual Inst, Solar Syst Explorat Res, Boulder, CO 80302 USA; [Naletto, G.] Univ Padua, Dept Informat Engn, I-35131 Padua, Italy; [Naletto, G.] Univ Padua, Ctr Ateneo Studi & Attivita Spaziali Giuseppe Col, I-35131 Padua, Italy	University of Bern; University of Colorado System; University of Colorado Boulder; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Aix-Marseille Universite; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Max Planck Society; Helmholtz Association; German Aerospace Centre (DLR); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite; University of Padua; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); European Space Agency; Braunschweig University of Technology; Uppsala University; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; University System of Maryland; University of Maryland College Park; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Istituto Nazionale Astrofisica (INAF); University of Padua; Consiglio Nazionale delle Ricerche (CNR); University of Padua; University of Trento; Istituto Nazionale Astrofisica (INAF); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); National Central University; Southwest Research Institute; University of Padua; University of Padua	El-Maarry, MR (corresponding author), Univ Bern, Inst Phys, CH-3012 Bern, Switzerland.; El-Maarry, MR (corresponding author), Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80301 USA.	mohamed.el-maarry@lasp.colorado.edu	Jorda, Laurent/AAA-1718-2021; Gutiérrez, Pedro J/AAJ-6177-2020; Da Deppo, Vania/D-2897-2012; Kovacs, Gabor/H-5819-2012; Hu, Xuanyu/AAD-7380-2020; Lara, Luisa M/F-5614-2012; Rickman, Hans/X-7631-2018; Kovacs, Gabor/E-4688-2010; Marzari, Francesco/X-2440-2019; Moreno, Jose Juan Lopez/M-5537-2019; Tubiana, Cecilia/AAG-8209-2019; Pajola, Maurizio/N-5574-2018; Thomas, Nicolas/G-4693-2015	Gutiérrez, Pedro J/0000-0002-7332-6269; Da Deppo, Vania/0000-0001-6273-8738; Kovacs, Gabor/0000-0002-6431-0556; Lara, Luisa M/0000-0002-7184-920X; Rickman, Hans/0000-0002-9603-6619; Kovacs, Gabor/0000-0002-6431-0556; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Tubiana, Cecilia/0000-0001-8475-9898; Pajola, Maurizio/0000-0002-3144-1277; De Cecco, Mariolino/0000-0003-1562-0328; Thomas, Nicolas/0000-0002-0146-0071; fulle, marco/0000-0001-8435-5287; Bertini, Ivano/0000-0002-0616-2444; JORDA, Laurent/0000-0001-8735-3308; Cremonese, Gabriele/0000-0001-9021-1140; Hu, Xuanyu/0000-0002-4302-5633; Debei, Stefano/0000-0002-6757-6616	Germany (Deutschen Zentrums Luft- und Raumfahrt); France (Centre National d'Etudee Spatiales); Italy (Ageripia Spzicle Italiana); Spain (Ministerio de Education, Cultura y Denote); Sweden (Swedish National Space Board) [74/10:2]; ESA Technical Directorate; Polish National Science Center [2011/01/B/ST9/05442]; Ministry of Science and Technology, Taiwan [NSC 101-2111-M-008-016]; NASA through Jet Propulsion Laboratory [1267923]; Swiss National Science Foundation [200020_165684]; NCCR PlanetS	Germany (Deutschen Zentrums Luft- und Raumfahrt); France (Centre National d'Etudee Spatiales); Italy (Ageripia Spzicle Italiana); Spain (Ministerio de Education, Cultura y Denote); Sweden (Swedish National Space Board); ESA Technical Directorate; Polish National Science Center; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); NASA through Jet Propulsion Laboratory; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR PlanetS	We thank three anonymous reviewers for thee constructive suggestions that have improved this work. OSIRIS was built by a consortium of the Max-Planck-Institut fur Sonnensysternforschung (MPS), Gottingen, Germany; Centro Interdipartimentale Studi e Attivita Spaziali-University of Padova, Italy; the Laboratoire d'Astrophysique de Marseille, France; the Instituto de Astrotisica de Adalucia, Consejo Superior de Investigaciones Cientificas, Granada, Spain; the Research and Scientific Support Department of the European Space Agency (ESA), Noordwijk, Netherlands: the Institute Nacional de Tecnica Aeroespacial, Madrid Spain; the Universidad Politecnica de Madrid, Spain; the Department of Physics and Astronomy of Uppsala University, Sweden; and the Institit fur Datentechnik und Kommunikatiorisnetpe der Technischen Universitat Braunschweig, Germany. The support of the national funding agencies of Germany (Deutschen Zentrums Luft- und Raumfahrt), France (Centre National d'Etudee Spatiales), Italy (Ageripia Spzicle Italiana), Spain (Ministerio de Education, Cultura y Denote), Sweden (Swedish National Space Board; grant 74/10:2), and the ESA Technical Directorate is gratefully acknowledged. Also supported by Polish National Science Center grant 2011/01/B/ST9/05442 (H.R.); Ministry of Science and Technology, Taiwan, grant NSC 101-2111-M-008-016 W.-H.I.); NASA through Jet Propulsion Laboratory contract 1267923 (M.F.A); and Swiss National Science Foundation grant 200020_165684 and NCCR PlanetS (M.R.E., N.T., and A.P.). We thank the ESA teams at European Space Astronomy Centre, European Space Operations Centre, and European Space Research and Technology Centre for their work in support of the Rosetta mission. Rosetta/OSIRIS data are available through ESA's Planetary Science Archive (PSA), www.cosrnos.esaint/web/psa/rosetta. Images used in this study that are not yet available at PSA can be downloaded from the MPS OSIRIS wesite https://planetgate.mps.mpg.de/WebFileShare/Released_Images/El-Maarry+Science/.	Auger AT, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525947; Belyaev N., 1986, CATALOGUE SHORT PERI; Duperret A, 2004, ENG GEOL SPEC PUBL S, P33; El-Maarry MR, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525723; El-Maarry MR, 2015, GEOPHYS RES LETT, V42, P5170, DOI 10.1002/2015GL064500; Fornasier S, 2016, SCIENCE, V354, P1566, DOI 10.1126/science.aag2671; Groussin O, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201527020; Hirabayashi M, 2016, NATURE, V534, P352, DOI 10.1038/nature17670; Jewitt D, 2009, ASTRON J, V137, P4296, DOI 10.1088/0004-6256/137/5/4296; Jorda L, 2016, ICARUS, V277, P257, DOI 10.1016/j.icarus.2016.05.002; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; Keller HU, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525964; Keller HU, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201526421; Patzold M, 2016, NATURE, V530, P63, DOI 10.1038/nature16535; Pajola M, 2016, ASTRON ASTROPHYS, V592, DOI 10.1051/0004-6361/201527865; Pajola M, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201525975; PRIALNIK D, 1987, ASTROPHYS J, V313, P893, DOI 10.1086/165029; Shi X, 2016, ASTRON ASTROPHYS, V586, DOI 10.1051/0004-6361/201527123; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Snodgrass C, 2016, ASTRON ASTROPHYS, V588, DOI 10.1051/0004-6361/201527834; Thomas N, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526049; Thomas N, 2015, SCIENCE, V347, DOI 10.1126/science.aaa0440; Thomas P, 2013, ICARUS, V222, P453, DOI 10.1016/j.icarus.2012.02.037; Vincent JB, 2016, ASTRON ASTROPHYS, V587, DOI 10.1051/0004-6361/201527159	24	51	52	2	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2017	355	6332					1392	+		10.1126/science.aak9384	http://dx.doi.org/10.1126/science.aak9384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ1DL	28325842	Green Accepted			2022-12-28	WOS:000397809500035
J	Janda, M; Gebski, V; Davies, LC; Forder, P; Brand, A; Hogg, R; Jobling, TW; Land, R; Manolitsas, T; Nascimento, M; Neesham, D; Nicklin, JL; Oehler, MK; Otton, G; Perrin, L; Salfinger, S; Hammond, I; Leung, Y; Sykes, P; Ngan, H; Garrett, A; Laney, M; Ng, TY; Tam, K; Chan, K; Wrede, CD; Pather, S; Simcock, B; Farrell, R; Robertson, G; Walker, G; Armfield, NR; Graves, N; McCartney, AJ; Obermair, A				Janda, Monika; Gebski, Val; Davies, Lucy C.; Forder, Peta; Brand, Alison; Hogg, Russell; Jobling, Thomas W.; Land, Russell; Manolitsas, Tom; Nascimento, Marcelo; Neesham, Deborah; Nicklin, James L.; Oehler, Martin K.; Otton, Geoff; Perrin, Lewis; Salfinger, Stuart; Hammond, Ian; Leung, Yee; Sykes, Peter; Ngan, Hextan; Garrett, Andrea; Laney, Michael; Ng, Tong Yow; Tam, Karfai; Chan, Karen; Wrede, C. David; Pather, Selvan; Simcock, Bryony; Farrell, Rhonda; Robertson, Gregory; Walker, Graeme; Armfield, Nigel R.; Graves, Nick; McCartney, Anthony J.; Obermair, Andreas			Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINIMALLY INVASIVE SURGERY; ROUTINE FOLLOW-UP; PATHOLOGICAL OUTCOMES; ASSISTED RESECTION; RECTAL-CANCER; RECURRENCE; CARCINOMA; SAFETY	IMPORTANCE Standard treatment for endometrial cancer involves removal of the uterus, tubes, ovaries, and lymph nodes. Few randomized trials have compared disease-free survival outcomes for surgical approaches. OBJECTIVE To investigate whether total laparoscopic hysterectomy (TLH) is equivalent to total abdominal hysterectomy (TAH) in women with treatment-naive endometrial cancer. DESIGN, SETTING, AND PARTICIPANTS The Laparoscopic Approach to Cancer of the Endometrium (LACE) trial was a multinational, randomized equivalence trial conducted between October 7, 2005, and June 30, 2010, in which 27 surgeons from 20 tertiary gynecological cancer centers in Australia, New Zealand, and Hong Kong randomized 760 women with stage I endometrioid endometrial cancer to either TLH or TAH. Follow-up ended on March 3, 2016. INTERVENTIONS Patients were randomly assigned to undergo TAH(n = 353) or TLH (n = 407). MAIN OUTCOMES AND MEASURES The primary outcome was disease-free survival, which was measured as the interval between surgery and the date of first recurrence, including disease progression or the development of a new primary cancer or death assessed at 4.5 years after randomization. The prespecified equivalence margin was 7% or less. Secondary outcomes included recurrence of endometrial cancer and overall survival. RESULTS Patients were followed up for a median of 4.5 years. Of 760 patients who were randomized (mean age, 63 years), 679 (89%) completed the trial. At 4.5 years of follow-up, disease-free survival was 81.3% in the TAH group and 81.6% in the TLH group. The disease-free survival rate difference was 0.3%(favoring TLH; 95% CI, -5.5% to 6.1%; P = .007), meeting criteria for equivalence. There was no statistically significant between-group difference in recurrence of endometrial cancer (28/353 in TAH group [7.9%] vs 33/407 in TLH group [8.1%]; risk difference, 0.2%[95% CI, -3.7% to 4.0%]; P = .93) or in overall survival (24/353 in TAH group [6.8%] vs 30/407 in TLH group [7.4%]; risk difference, 0.6%[95% CI, -3.0% to 4.2%]; P = .76). CONCLUSIONS AND RELEVANCE Among women with stage I endometrial cancer, the use of total abdominal hysterectomy compared with total laparoscopic hysterectomy resulted in equivalent disease-free survival at 4.5 years and no difference in overall survival. These findings support the use of laparoscopic hysterectomy for women with stage I endometrial cancer.	[Janda, Monika; Graves, Nick] Queensland Univ Technol, Sch Publ Hlth & Social Work, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Gebski, Val; Davies, Lucy C.] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW, Australia; [Forder, Peta] Univ Newcastle, Res Ctr Generat Hlth & Ageing, Newcastle, NSW, Australia; [Brand, Alison] Westmead Hosp, Dept Gynaecol Oncol, Sydney, NSW, Australia; [Hogg, Russell] Univ Sydney, Sydney, NSW, Australia; [Hogg, Russell] Northern Sydney Local Hlth Dist, Sydney, NSW, Australia; [Jobling, Thomas W.] Monash Med Ctr, Dept Gynaecol Oncol, Melbourne, Vic, Australia; [Land, Russell; Nascimento, Marcelo; Nicklin, James L.; Perrin, Lewis; Garrett, Andrea; Walker, Graeme; Armfield, Nigel R.; Obermair, Andreas] Univ Queensland, Queensland Ctr Gynaecol Canc, Herston, Qld, Australia; [Land, Russell; Nascimento, Marcelo; Nicklin, James L.; Perrin, Lewis; Garrett, Andrea; Armfield, Nigel R.; Obermair, Andreas] Univ Queensland, Sch Med, Herston, Qld, Australia; [Manolitsas, Tom] Box Hill Hosp, Melbourne, Vic, Australia; [Neesham, Deborah; Wrede, C. David] Royal Womens Hosp, Melbourne, Vic, Australia; [Oehler, Martin K.] Royal Adelaide Hosp, Dept Gynaecol, Adelaide, SA, Australia; [Otton, Geoff] John Hunter Hosp, Newcastle, NSW, Australia; [Otton, Geoff] Univ Newcastle, Dept Gynaecol Oncol, Callaghan, NSW, Australia; [Salfinger, Stuart; Leung, Yee; McCartney, Anthony J.] St John God Hosp, Perth, WA, Australia; [Salfinger, Stuart; Leung, Yee; McCartney, Anthony J.] King Edward Mem Hosp, Gynaecol Canc Serv, Subiaco, WA, Australia; [Salfinger, Stuart] Univ Notre Dame, Perth, WA, Australia; [Salfinger, Stuart; Hammond, Ian; Leung, Yee] Univ Western Australia, Sch Womens & Infants Hlth, Perth, WA, Australia; [Sykes, Peter; Laney, Michael; Simcock, Bryony] ChristchurchWomens Hosp, Christchurch, New Zealand; [Ngan, Hextan; Ng, Tong Yow; Tam, Karfai; Chan, Karen] Queen Mary Hosp, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Pather, Selvan] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Farrell, Rhonda; Robertson, Gregory] Univ New South Wales, St George Hosp, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	Queensland University of Technology (QUT); University of Sydney; University of Newcastle; University of Sydney; University of Sydney; Monash University; University of Queensland; University of Queensland; Box Hill Hospital; Royal Adelaide Hospital; John Hunter Hospital; University of Newcastle; St John of God Health Care; King Edward Memorial Hospital; University of Western Australia; University of Notre Dame Australia; University of Western Australia; Christchurch Hospital New Zealand; University of Hong Kong; University of Sydney; St George Hospital; University of New South Wales Sydney	Obermair, A (corresponding author), Royal Brisbane andWomens Hosp, Sixth Floor,Ned Hanlon Bldg, Brisbane, Qld 4029, Australia.	obermair@powerup.com.au	Farrell, Rhonda/AAW-6489-2020; Nicklin, James L/F-8035-2013; Armfield, Nigel R./B-4896-2010; Janda, Monika/C-3723-2009	Nicklin, James L/0000-0001-5857-3723; Armfield, Nigel R./0000-0003-4218-0030; Janda, Monika/0000-0002-1728-8085; Graves, Nicholas/0000-0002-5559-3267; Ngan, Hextan Y S/0000-0003-3945-159X; Brand, Alison/0000-0001-7975-6326; Perrin, Lewis/0000-0002-6119-8458; Gebski, Val/0000-0001-8748-1844; Obermair, Andreas/0000-0003-2199-1117; Sykes, Peter/0000-0001-6772-719X	Cancer Council Queensland; Cancer Council New South Wales; Cancer Council Victoria; Cancer Council Western Australia; National Health and Medical Research Council [456110]; Cancer Australia [631523, 1098905]; QLD Health; Women and Infants Research Foundation; Royal Brisbane and Women's Hospital Foundation; Wesley Research Institute; Gallipoli Research Foundation; Gynetech; Tyco Healthcare; Johnson & Johnson Medical; Hunter New England Centre for Gynaecological Cancer; Genesis Oncology Trust; Cherish Foundation	Cancer Council Queensland(Cancer Council Queensland); Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Cancer Council Western Australia(Cancer Council Western Australia); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Australia; QLD Health; Women and Infants Research Foundation; Royal Brisbane and Women's Hospital Foundation; Wesley Research Institute; Gallipoli Research Foundation; Gynetech; Tyco Healthcare; Johnson & Johnson Medical(Johnson & JohnsonJohnson & Johnson USA); Hunter New England Centre for Gynaecological Cancer; Genesis Oncology Trust; Cherish Foundation	This study was funded by the Cancer Council Queensland, the Cancer Council New South Wales, the Cancer Council Victoria, and the Cancer Council Western Australia; by project grant 456110 from the National Health and Medical Research Council, project grants 631523 and 1098905 from Cancer Australia, and a Smart health research grant from QLD Health; and funding from the Women and Infants Research Foundation, Royal Brisbane and Women's Hospital Foundation, Wesley Research Institute, Gallipoli Research Foundation, Gynetech, Tyco Healthcare, Johnson & Johnson Medical, Hunter New England Centre for Gynaecological Cancer, Genesis Oncology Trust, and the Cherish Foundation.	Agboola OO, 1997, CAN MED ASSOC J, V157, P879; Baker J, 2013, MINIM INVASIVE SURG, V2013, DOI 10.1155/2013/764329; Belavy D, 2013, GYNECOL ONCOL, V131, P423, DOI 10.1016/j.ygyno.2013.08.027; Berchuck A, 2012, J CLIN ONCOL, V30, P681, DOI 10.1200/JCO.2011.40.5506; Creasman WT, 2006, INT J GYNECOL OBSTET, V95, pS105, DOI 10.1016/S0020-7292(06)60031-3; Creutzberg CL, 2000, LANCET, V355, P1404, DOI 10.1016/S0140-6736(00)02139-5; Dodge J, 2006, GYNECOL ONCOL, V101, P520, DOI DOI 10.1016/J.YGYN0.2006.02.011; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fleshman J, 2015, JAMA-J AM MED ASSOC, V314, P1346, DOI 10.1001/jama.2015.10529; Frost JA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007585.pub3; Galaal K, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006655.pub2; Graves N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001884; Janda M, 2006, CONTEMP CLIN TRIALS, V27, P353, DOI 10.1016/j.cct.2006.03.004; Janda M, 2010, LANCET ONCOL, V11, P772, DOI 10.1016/S1470-2045(10)70145-5; Johnstone PAS, 1996, J CLIN ONCOL, V14, P1950, DOI 10.1200/JCO.1996.14.6.1950; Kondalsamy-Chennakesavan S, 2012, EUR J CANCER, V48, P2155, DOI 10.1016/j.ejca.2012.03.013; Kornblith AB, 2009, J CLIN ONCOL, V27, P5337, DOI 10.1200/JCO.2009.22.3529; Koskas M, 2016, EUR J CANCER, V65, P185, DOI 10.1016/j.ejca.2016.07.001; Morice P, 2001, EUR J CANCER, V37, P985, DOI 10.1016/S0959-8049(01)00066-1; Morice P, 2016, LANCET, V387, P1094, DOI 10.1016/S0140-6736(15)00130-0; Mourits MJE, 2010, LANCET ONCOL, V11, P763, DOI 10.1016/S1470-2045(10)70143-1; National Institute for Health and Clinical Excellence, 2010, LAP HYST END CANC; Obermair A, 2004, GYNECOL ONCOL, V92, P789, DOI 10.1016/j.ygyno.2003.12.001; Obermair A, 2012, EUR J CANCER, V48, P1147, DOI 10.1016/j.ejca.2012.02.055; Punt CJA, 2007, JNCI-J NATL CANCER I, V99, P998, DOI 10.1093/jnci/djm024; Stevenson ARL, 2015, JAMA-J AM MED ASSOC, V314, P1356, DOI 10.1001/jama.2015.12009; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Walker JL, 2012, J CLIN ONCOL, V30, P695, DOI 10.1200/JCO.2011.38.8645; Walker JL, 2009, J CLIN ONCOL, V27, P5331, DOI 10.1200/JCO.2009.22.3248; Wright JD, 2016, J CLIN ONCOL, V34, P1087, DOI 10.1200/JCO.2015.65.3212	30	204	208	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1224	1233		10.1001/jama.2017.2068	http://dx.doi.org/10.1001/jama.2017.2068			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350928	Green Submitted			2022-12-28	WOS:000397557800019
J	Taylor, W				Taylor, W.			Arthur "Sam" Davidson OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		DAVIDSON AS, PUBLICATION LIST, P62659	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2017	356								j1521	10.1136/bmj.j1521	http://dx.doi.org/10.1136/bmj.j1521			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4JB	28347976				2022-12-28	WOS:000397345700006
J	Douglas, SM				Douglas, Shawn M.			SELF-ASSEMBLY Bringing proteins into the fold	SCIENCE			English	Editorial Material							DNA; DESIGN		[Douglas, Shawn M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Douglas, SM (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.		Douglas, Shawn/GVU-2004-2022	Douglas, Shawn/0000-0001-5398-9041	NIGMS NIH HHS [R35 GM125027] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2012, METHOD YEAR 2011 NAT; Bale JB, 2016, SCIENCE, V353, P389, DOI 10.1126/science.aaf8818; Bogdanove AJ, 2011, SCIENCE, V333, P1843, DOI 10.1126/science.1204094; Chandrasekaran AR, 2016, CHEMBIOCHEM, V17, P1081, DOI 10.1002/cbic.201600038; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Elbaz J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11179; Lee J, 2014, P NATL ACAD SCI USA, V111, P2122, DOI 10.1073/pnas.1313039111; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Praetorius F, 2017, SCIENCE, V355, DOI 10.1126/science.aam5488; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586	11	1	1	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1261	1262		10.1126/science.aam9541	http://dx.doi.org/10.1126/science.aam9541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336623				2022-12-28	WOS:000397082900016
J	Tay, A				Tay, Andy			Learning from rejections	SCIENCE			English	Editorial Material									[Tay, Andy] Univ Calif Los Angeles, Los Angeles, CA USA	University of California System; University of California Los Angeles	Tay, A (corresponding author), Univ Calif Los Angeles, Los Angeles, CA USA.	SciCareerEditor@aaas.org							0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1342	1342		10.1126/science.355.6331.1342	http://dx.doi.org/10.1126/science.355.6331.1342			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EP0NB	28336673				2022-12-28	WOS:000397082900044
J	Ong, MS; Mandl, KD				Ong, Mei-Sing; Mandl, Kenneth D.			Trends in Prostate-Specific Antigen Screening and Prostate Cancer Interventions 3 Years After the US Preventive Services Task Force Recommendation	ANNALS OF INTERNAL MEDICINE			English	Letter									[Ong, Mei-Sing] Boston Childrens Hosp, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Ong, MS (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.				National Health and Medical Research Council, Australia [APP1052871]; National Institutes of Health [T15LM007092]; NATIONAL LIBRARY OF MEDICINE [T15LM007092] Funding Source: NIH RePORTER	National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	By Aetna. Dr. Ong is supported by a grant from the National Health and Medical Research Council, Australia (APP1052871), and the National Institutes of Health (T15LM007092).	Drazer MW, 2015, J CLIN ONCOL, V33, P2416, DOI 10.1200/JCO.2015.61.6532; Jemal A, 2015, JAMA-J AM MED ASSOC, V314, P2054, DOI 10.1001/jama.2015.14905; Li J, 2015, J AM BOARD FAM MED, V28, P491, DOI 10.3122/jabfm.2015.04.150062; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Sammon JD, 2015, JAMA-J AM MED ASSOC, V314, P2075, DOI 10.1001/jama.2015.7273	5	7	7	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					451	+		10.7326/L16-0422	http://dx.doi.org/10.7326/L16-0422			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320011				2022-12-28	WOS:000397025800025
J	Voelker, R				Voelker, Rebecca			Morcellator Risk Was Known	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1110	1110		10.1001/jama.2017.1585	http://dx.doi.org/10.1001/jama.2017.1585			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324074				2022-12-28	WOS:000396987200007
J	O'Neil, J; Carlson, RW				O'Neil, Jonathan; Carlson, Richard W.			Building Archean cratons from Hadean mafic crust	SCIENCE			English	Article							NUVVUAGITTUQ SUPRACRUSTAL BELT; CONTINENTAL-CRUST; LU-HF; TERRESTRIAL CRUST; SUPERIOR PROVINCE; PLATE-TECTONICS; EVOLUTION; ZIRCON; GA; CANADA	Geologic processing of Earth's surface has removed most of the evidence concerning the nature of Earth's first crust. One region of ancient crust is the Hudson Bay terrane of northeastern Canada, which is mainly composed of Neoarchean felsic crust and forms the nucleus of the Northeastern Superior Province. New data show these similar to 2.7-billion-year-old rocks to be the youngest to yield variability in neodymium-142 (Nd-142), the decay product of short-lived samarium-146 (Sm-146). Combined Sm146-147-Nd142-143 data reveal that this large block of Archean crust formed by reworking of much older (>4.2 billion-year-old) mafic crust over a 1.5-billion-year interval of early Earth history. Thus, unlike on modern Earth, mafic crust apparently could survive for more than 1 billion years to form an important source rock for Archean crustal genesis.	[O'Neil, Jonathan] Univ Ottawa, Dept Earth & Environm Sci, Ottawa, ON, Canada; [Carlson, Richard W.] Carnegie Inst Sci, Dept Terr Magnetism, 5241 Broad Branch Rd NW, Washington, DC 20015 USA	University of Ottawa; Carnegie Institution for Science	O'Neil, J (corresponding author), Univ Ottawa, Dept Earth & Environm Sci, Ottawa, ON, Canada.	jonathan.oneil@uottawa.ca		Carlson, Richard/0000-0001-7195-2074	Natural Sciences and Engineering Research Council of Canada [RGPIN 435589-2013]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank the Ministers Energie et Resources Naturelles (MERN) of the Quebec government for providing most samples analyzed in this study, D. Milidragovic and D. Francis from McGill University for providing two granitoid samples, and three reviewers for helpful comments. This research was supported by a Natural Sciences and Engineering Research Council of Canada Discovery grant to J.O (RGPIN 435589-2013) and MERN contribution no. 8449-2016-2017-01. All data are available in the supplementary materials.	Adam J, 2012, GEOLOGY, V40, P363, DOI 10.1130/G32623.1; Amelin Y, 2000, GEOCHIM COSMOCHIM AC, V64, P4205, DOI 10.1016/S0016-7037(00)00493-2; Bauer AM, 2017, EARTH PLANET SC LETT, V458, P37, DOI 10.1016/j.epsl.2016.10.036; Bohm CO, 2000, GEOLOGY, V28, P75, DOI 10.1130/0091-7613(2000)28<75:DOPGEC>2.0.CO;2; Boily M, 2009, PRECAMBRIAN RES, V168, P23, DOI 10.1016/j.precamres.2008.07.009; Cates NL, 2007, EARTH PLANET SC LETT, V255, P9, DOI 10.1016/j.epsl.2006.11.034; Darling JR, 2013, AM J SCI, V313, P844, DOI 10.2475/09.2013.02; David J, 2009, GEOL SOC AM BULL, V121, P150, DOI 10.1130/B26369.1; Iizuka T, 2009, CHEM GEOL, V259, P230, DOI 10.1016/j.chemgeo.2008.11.007; Kemp AIS, 2010, EARTH PLANET SC LETT, V296, P45, DOI 10.1016/j.epsl.2010.04.043; Laurent O, 2014, LITHOS, V205, P208, DOI 10.1016/j.lithos.2014.06.012; MARTIN H, 1987, J PETROL, V28, P921, DOI 10.1093/petrology/28.5.921; MARTIN H, 1993, LITHOS, V30, P373, DOI 10.1016/0024-4937(93)90046-F; Moyen JF, 2012, LITHOS, V148, P312, DOI 10.1016/j.lithos.2012.06.010; Moyen JF, 2003, PRECAMBRIAN RES, V127, P103, DOI 10.1016/S0301-9268(03)00183-9; O'Neil J, 2008, SCIENCE, V321, P1828, DOI 10.1126/science.1161925; O'Neil J, 2013, EARTH PLANET SC LETT, V379, P13, DOI 10.1016/j.epsl.2013.07.030; O'Neil J, 2012, PRECAMBRIAN RES, V220, P23, DOI 10.1016/j.precamres.2012.07.009; Rizo H, 2012, NATURE, V491, P96, DOI 10.1038/nature11565; Roth ASG, 2014, GEOCHEM GEOPHY GEOSY, V15, P2329, DOI 10.1002/2014GC005313; Roth ASG, 2013, EARTH PLANET SC LETT, V361, P50, DOI 10.1016/j.epsl.2012.11.023; Simard M., 2008, MM200802 MIN EN RESS; Tang M, 2016, SCIENCE, V351, P372, DOI 10.1126/science.aad5513; Taylor S.R., 1985, CONTINENTAL CRUST IT; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	25	51	50	4	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1199	1202		10.1126/science.aah3823	http://dx.doi.org/10.1126/science.aah3823			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302856				2022-12-28	WOS:000396351200042
J	Segal, D				Segal, Dvira			NANOSCALE TRANSPORT Probing the limits of heat flow Studies of atomic point contacts reveal the fundamental quantum of heat transport	SCIENCE			English	Editorial Material							CONDUCTANCE		[Segal, Dvira] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada; [Segal, Dvira] Univ Toronto, Ctr Quantum Informat & Quantum Control, 80 St George St, Toronto, ON M5S 3H6, Canada	University of Toronto; University of Toronto	Segal, D (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.; Segal, D (corresponding author), Univ Toronto, Ctr Quantum Informat & Quantum Control, 80 St George St, Toronto, ON M5S 3H6, Canada.	dsegal@chem.utoronto.ca						Cuevas J. C., 2010, MOL ELECT; Cui LJ, 2017, SCIENCE, V355, P1192, DOI 10.1126/science.aam6622; Jezouin S, 2013, SCIENCE, V342, P601, DOI 10.1126/science.1241912; Malen JA, 2010, CHEM PHYS LETT, V491, P109, DOI 10.1016/j.cplett.2010.03.028; Meschke M, 2006, NATURE, V444, P187, DOI 10.1038/nature05276; Mosso N., 2017, NAT NANOTECHNOL, DOI [10.1038/nnano.2016.302, DOI 10.1038/NNANO.2016.302]; Partanen M, 2016, NAT PHYS, V12, P460, DOI [10.1038/nphys3642, 10.1038/NPHYS3642]; Schwab K, 2000, NATURE, V404, P974, DOI 10.1038/35010065; Timofeev AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.200801; VANWEES BJ, 1988, PHYS REV LETT, V60, P848, DOI 10.1103/PhysRevLett.60.848; WHARAM DA, 1988, J PHYS C SOLID STATE, V21, pL209, DOI 10.1088/0022-3719/21/8/002	11	4	4	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1125	1126		10.1126/science.aam9362	http://dx.doi.org/10.1126/science.aam9362			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302809				2022-12-28	WOS:000396351200019
J	Atluru, A				Atluru, Anupama			Fashion Overdose How Moschino's Capsule Collection Offended Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Atluru, Anupama] Harvard Med Sch, Emergency Med, Massachusetts Gen Hosp, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Atluru, A (corresponding author), Harvard Med Sch, Emergency Med, Massachusetts Gen Hosp, Boston, MA 02115 USA.	aatluru@mgh.harvard.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1002	1004		10.1001/jama.2017.1473	http://dx.doi.org/10.1001/jama.2017.1473			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291871				2022-12-28	WOS:000396713400001
J	Nicholson, BD; Mant, D; Bankhead, C				Nicholson, Brian D.; Mant, David; Bankhead, Clare			UNCERTAINTIES Can safety-netting improve cancer detection in patients with vague symptoms?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; GENERAL-PRACTICE; DIAGNOSIS; COMMUNICATION; EXPLORATION; RISK; TIME		[Nicholson, Brian D.; Bankhead, Clare] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Mant, David] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Gen Practice, Oxford OX2 6GG, England	University of Oxford; University of Oxford	Nicholson, BD (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	brian.nicholson@phc.ox.ac.uk						Almond S, 2009, BRIT J GEN PRACT, V59, P872, DOI 10.3399/bjgp09X472971; Atherton H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007978.pub2; Bankhead C, 2011, SAFETY NETTING IMPRO; Banks J, 2014, LANCET ONCOL, V15, P232, DOI 10.1016/S1470-2045(13)70588-6; Berner ES, 2014, J GEN INTERN MED, V29, P1105, DOI 10.1007/s11606-014-2783-3; Bertheloot K, 2016, EUR J GEN PRACT, V22, P3, DOI 10.3109/13814788.2015.1092516; Brindle L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001977; Cromme SK, 2016, BRIT J GEN PRACT, V66, pE474, DOI 10.3399/bjgp16X685621; Elliss-Brookes L, 2012, BRIT J CANCER, V107, P1220, DOI 10.1038/bjc.2012.408; Evans J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004215; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Hamilton W, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3172; Hamilton W, 2009, BRIT J GEN PRACT, V59, P441, DOI 10.3399/bjgp09X420860; Heneghan C, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b946; Jones CHD, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-140; Litchfield I, 2015, BMJ QUAL SAF, V24, P681, DOI 10.1136/bmjqs-2014-003690; Litchfield IJ, 2015, BRIT J GEN PRACT, V65, pE133, DOI 10.3399/bjgp15X683929; Lyratzopoulos G, 2015, BRIT J CANCER, V112, pS84, DOI 10.1038/bjc.2015.47; Lyratzopoulos G, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g7400; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; Maguire S, 2011, ARCH DIS CHILD, V96, P810, DOI 10.1136/adc.2010.210096; Mitchell ED, 2015, BRIT J CANCER, V112, pS50, DOI 10.1038/bjc.2015.42; Mitchell ED, 2013, BRIT J GEN PRACT, V63, DOI 10.3399/bjgp13X660760; National Institute for Health and Care Excellence, 2015, SUSP CANC REC REF; Neal RD, 2015, BRIT J CANCER, V112, pS92, DOI 10.1038/bjc.2015.48; Neighbour R, 2004, INNER CONSULTATION, V2nd; Renzi C, 2016, BRIT J GEN PRACT, V66, pE158, DOI 10.3399/bjgp16X683845; Renzi C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007002; Roland D, 2014, ARCH DIS CHILDHOOD-E, V99, P48, DOI 10.1136/archdischild-2012-303056; Rubin GP, 2015, BRIT J CANCER, V112, P676, DOI 10.1038/bjc.2014.634; Silverman J., 2016, SKILLS COMMUNICATING; Singh H, 2014, J GEN INTERN MED, V29, P1087, DOI 10.1007/s11606-014-2890-1; Stapley S, 2013, BRIT J CANCER, V108, P25, DOI 10.1038/bjc.2012.551; Stapley S, 2006, BRIT J GEN PRACT, V56, P570; Vedsted P, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X588484; Walker S, 2013, BRIT J GEN PRACT, V63, pE643, DOI 10.3399/bjgp13X671632	36	37	36	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	NOV 9	2016	355								i5515	10.1136/bmj.i5515	http://dx.doi.org/10.1136/bmj.i5515			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC3CS	28291732	Green Published			2022-12-28	WOS:000388002900002
J	Kieny, MP; Salama, P; Kenney, E; Campbell, J; Wuliji, T				Kieny, Marie-Paule; Salama, Peter; Kenney, Erin; Campbell, James; Wuliji, Tana			One attack on a health worker is one too many	LANCET			English	Editorial Material									[Kieny, Marie-Paule; Campbell, James; Wuliji, Tana] WHO, Hlth Syst & Innovat, CH-1211 Geneva, Switzerland; [Salama, Peter; Kenney, Erin] WHO, Hlth Emergencies Programme, CH-1211 Geneva, Switzerland	World Health Organization; World Health Organization	Wuliji, T (corresponding author), WHO, Hlth Syst & Innovat, CH-1211 Geneva, Switzerland.	wulijit@who.int	Kieny, Marie-Paule/N-3914-2017	Kieny, Marie-Paule/0000-0002-5943-6488				Fouad FM, 2017, LANCET; Guterres A, 2017, APPEAL PEACE SECRETA; High-Level Commission on Health Employment and Economic Growth, 2016, INV HLTH WORKF EN ST; International Labour Organization Organisation for Economic Cooperation and Development WHO, 2016, CALL COMM ACT CONS I; Lee K, 2009, GLOB INST, P1; UN Security Council, 2016, RES S RES 2286; United Nations General Assembly, RES A RES 71 159 GLO; WHO, 2016, REP ATT HEALTHC EM; WHO,, 2016, WHO STAT E AL AN HOS; WHO,, 2016, SNAPSH PUBL HOSP SYR; WHO, 2012, WORLD HLTH ASS RES W; World Health Organization (WHO), 2016, GLOB STRAT HUM RES H	12	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR	2022	399	10329					E12	E13		10.1016/S0140-6736(17)30740-7	http://dx.doi.org/10.1016/S0140-6736(17)30740-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ZS1JF	28314567				2022-12-28	WOS:000768227500001
J	Kirch, DG; Petelle, K				Kirch, Darrell G.; Petelle, Kate			Addressing the Physician Shortage The Peril of Ignoring Demography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Kirch, Darrell G.; Petelle, Kate] Assoc Amer Med Coll, 655 K St NW,Ste 100, Washington, DC 20001 USA	Association of American Medical Colleges	Kirch, DG (corresponding author), Assoc Amer Med Coll, 655 K St NW,Ste 100, Washington, DC 20001 USA.	dgkirch@aamc.org						Grover A, 2013, HEALTH AFFAIR, V32, P1922, DOI 10.1377/hlthaff.2013.0557; IHS Inc. for the Association of American Medical Colleges, 2017, 2017 UPD COMPL PHYS; Zanaboni P, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-1	3	69	70	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1947	1948		10.1001/jama.2017.2714	http://dx.doi.org/10.1001/jama.2017.2714			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28319233				2022-12-28	WOS:000401315500010
J	Bridwell-Rabb, J; Zhong, AS; Sun, HG; Drennan, CL; Liu, HW				Bridwell-Rabb, Jennifer; Zhong, Aoshu; Sun, He G.; Drennan, Catherine L.; Liu, Hung-wen			A B-12-dependent radical SAM enzyme involved in oxetanocin A biosynthesis	NATURE			English	Article							DEPENDENT METHIONINE SYNTHASE; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; METHYL TRANSFER; MECHANISM; METHYLTRANSFERASE; SUPERFAMILY; FOSFOMYCIN; CHEMISTRY; CATALYSIS	Oxetanocin A (OXT-A) is a potent antitumour, antiviral and antibacterial compound. Biosynthesis of OXT-A has been linked to a plasmid-borne Bacillus megaterium gene cluster that contains four genes: oxsA, oxsB, oxrA and oxrB. Here we show that both the oxsA and oxsB genes are required for the production of OXT-A. Biochemical analysis of the encoded proteins, a cobalamin (Cbl)-dependent S-adenosylmethionine (AdoMet) radical enzyme, OxsB, and an HD-domain phosphohydrolase, OxsA, reveals that OXT-A is derived from a 2'-deoxyadenosine phosphate in an OxsB-catalysed ring contraction reaction initiated by hydrogen atom abstraction from C2'. Hence, OxsB represents the first biochemically characterized non-methylating Cbl-dependent AdoMet radical enzyme. X-ray analysis of OxsB reveals the fold of a Cbl-dependent AdoMet radical enzyme, a family of enzymes with an estimated 7,000 members. Overall, this work provides a framework for understanding the interplay of AdoMet and Cbl cofactors and expands the catalytic repertoire of Cbl-dependent AdoMet radical enzymes.	[Bridwell-Rabb, Jennifer; Drennan, Catherine L.] MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bridwell-Rabb, Jennifer; Drennan, Catherine L.] MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Bridwell-Rabb, Jennifer; Drennan, Catherine L.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Zhong, Aoshu; Sun, He G.; Liu, Hung-wen] Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, Austin, TX 78712 USA; [Zhong, Aoshu; Sun, He G.; Liu, Hung-wen] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Dept Chem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Drennan, CL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Liu, HW (corresponding author), Univ Texas Austin, Coll Pharm, Div Chem Biol & Med Chem, Austin, TX 78712 USA.; Liu, HW (corresponding author), Univ Texas Austin, Dept Chem, Austin, TX 78712 USA.	cdrennan@mit.edu; h.w.liu@mail.utexas.edu		Bridwell-Rabb, Jennifer/0000-0002-7437-6217	National Institute of Health [F32-GM108189, GM035906]; Welch Foundation [F-1511]; National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM035906, P41GM103403, F32GM108189, R01GM035906] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institute of Health Grants F32-GM108189 (J.B.-R.) and GM035906 (H.-w.L.), and the Welch Foundation grant F-1511 (H.-w.L.). C.L.D. is a Howard Hughes Medical Institute Investigator. This work is based upon research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357.	Allen KD, 2014, BBA-PROTEINS PROTEOM, V1844, P2135, DOI 10.1016/j.bbapap.2014.09.009; Allen KD, 2014, ARCH BIOCHEM BIOPHYS, V543, P67, DOI 10.1016/j.abb.2013.12.004; Bandarian V, 2003, P NATL ACAD SCI USA, V100, P8156, DOI 10.1073/pnas.1133218100; Banerjee R, 2003, CHEM REV, V103, P2083, DOI 10.1021/cr0204395; Berkovitch F, 2004, SCIENCE, V303, P76, DOI 10.1126/science.1088493; Blaszczyk AJ, 2016, J AM CHEM SOC, V138, P3416, DOI 10.1021/jacs.5b12592; Blodgett JAV, 2005, ANTIMICROB AGENTS CH, V49, P230, DOI 10.1128/AAC.49.1.230-240.2005; Bridwell-Rabb J, 2016, P NATL ACAD SCI USA, V113, P13750, DOI 10.1073/pnas.1613610113; Broderick JB, 2014, CHEM REV, V114, P4229, DOI 10.1021/cr4004709; Dowling DP, 2014, NAT CHEM BIOL, V10, P106, DOI 10.1038/nchembio.1426; Dowling DP, 2012, BBA-PROTEINS PROTEOM, V1824, P1178, DOI 10.1016/j.bbapap.2012.04.006; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Evans JC, 2004, P NATL ACAD SCI USA, V101, P3729, DOI 10.1073/pnas.0308082100; EWALL RX, 1974, J AM CHEM SOC, V96, P940, DOI 10.1021/ja00810a063; Frey PA, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P501; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P15949, DOI 10.1073/pnas.1312228110; Goldman PJ, 2013, P NATL ACAD SCI USA, V110, P8519, DOI 10.1073/pnas.1302417110; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; IZUTA S, 1992, J BIOCHEM-TOKYO, V112, P81, DOI 10.1093/oxfordjournals.jbchem.a123870; KAMIGIRI K, 1992, J ANTIBIOT, V45, P781, DOI 10.7164/antibiotics.45.781; Kelly WL, 2009, J AM CHEM SOC, V131, P4327, DOI 10.1021/ja807890a; Kim HJ, 2013, J AM CHEM SOC, V135, P8093, DOI 10.1021/ja312641f; Koutmos M, 2009, P NATL ACAD SCI USA, V106, P18527, DOI 10.1073/pnas.0906132106; Layer G, 2006, J BIOL CHEM, V281, P15727, DOI 10.1074/jbc.M512628200; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; Liao RJ, 2009, CHEM BIOL, V16, P141, DOI 10.1016/j.chembiol.2009.01.007; Magnusson OT, 2001, BIOCHEMISTRY-US, V40, P7773, DOI 10.1021/bi0104569; Maqueo Chew AG, 2007, ANNU REV MICROBIOL, V61, P113, DOI 10.1146/annurev.micro.61.080706.093242; Marous DR, 2015, P NATL ACAD SCI USA, V112, P10354, DOI 10.1073/pnas.1508615112; Morita M, 1999, BIOSCI BIOTECH BIOCH, V63, P563, DOI 10.1271/bbb.63.563; Nicolet Y, 2009, P NATL ACAD SCI USA, V106, P14867, DOI 10.1073/pnas.0904385106; Parthasarathy A, 2015, J AM CHEM SOC, V137, P3525, DOI 10.1021/ja511653d; Pierre S, 2012, NAT CHEM BIOL, V8, P957, DOI [10.1038/NCHEMBIO.1091, 10.1038/nchembio.1091]; Quitterer F, 2012, ANGEW CHEM INT EDIT, V51, P1339, DOI 10.1002/anie.201106765; Ruszczycky MW, 2010, J AM CHEM SOC, V132, P2359, DOI 10.1021/ja909451a; Shibata N, 2002, BIOCHEMISTRY-US, V41, P12607, DOI 10.1021/bi026104z; SHIMADA N, 1986, J ANTIBIOT, V39, P1623, DOI 10.7164/antibiotics.39.1623; Sofia HJ, 2001, NUCLEIC ACIDS RES, V29, P1097, DOI 10.1093/nar/29.5.1097; UEDA K, 1989, VIROLOGY, V169, P213, DOI 10.1016/0042-6822(89)90057-3; Vey JL, 2008, P NATL ACAD SCI USA, V105, P16137, DOI 10.1073/pnas.0806640105; Vey JL, 2011, CHEM REV, V111, P2487, DOI 10.1021/cr9002616; Werner WJ, 2011, BIOCHEMISTRY-US, V50, P8986, DOI 10.1021/bi201220r; Westrich L, 2003, CHEMBIOCHEM, V4, P768, DOI 10.1002/cbic.200300609; Woodyer RD, 2007, CHEM COMMUN, P359, DOI 10.1039/b614678c	44	58	58	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2017	544	7650					322	U321		10.1038/nature21689	http://dx.doi.org/10.1038/nature21689			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ES4SG	28346939	Green Published, Green Accepted			2022-12-28	WOS:000399524400031
J	Kennedy, DJ; Schneider, BJ				Kennedy, David J.; Schneider, Byron J.			The Challenges of Research on Interventions for Low Back Pain	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK-FACTORS; INJECTIONS		[Kennedy, David J.] Stanford Univ, Dept Orthopaed Surg, Div Phys Med & Rehabil, 450 Broadway St, Redwood City, CA 94063 USA; [Kennedy, David J.] Stanford Univ, Div Spine, 450 Broadway St, Redwood City, CA 94063 USA; [Schneider, Byron J.] Vanderbilt Univ, Dept Phys Med & Rehabil, 2201 Childrens Way,Suite 1318, Nashville, TN 37067 USA	Stanford University; Stanford University; Vanderbilt University	Kennedy, DJ (corresponding author), Stanford Univ, Dept Orthopaed Surg, Div Phys Med & Rehabil, 450 Broadway St, Redwood City, CA 94063 USA.; Kennedy, DJ (corresponding author), Stanford Univ, Div Spine, 450 Broadway St, Redwood City, CA 94063 USA.	djkenned@stanford.edu		Kennedy, David/0000-0001-8061-0287				Chou R, 2015, PAIR MANAGEMENT INJE; Deyo RA, 2014, J PAIN, V15, P569, DOI 10.1016/j.jpain.2014.03.005; Hagen KB, 2002, SPINE, V27, P1790, DOI 10.1097/00007632-200208150-00019; Kennedy DJ, 2015, PAIN MED, V16, P833, DOI 10.1111/pme.12667; Nguyen C, 2017, ANN INTERN MED, V166, P547, DOI 10.7326/M16-1700; Ohtori S, 2006, SPINE, V31, P1026, DOI 10.1097/01.brs.0000215027.87102.7c; Qaseem A, ANN INTERN MED, DOI [10.7326/M 16, DOI 10.7326/M16]; Ramond A, 2011, FAM PRACT, V28, P12, DOI 10.1093/fampra/cmq072; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Younes M, 2007, JOINT BONE SPINE, V74, P472, DOI 10.1016/j.jbspin.2006.10.009	10	5	5	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2017	166	8					601	+		10.7326/M17-0556	http://dx.doi.org/10.7326/M17-0556			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ES1RF	28319999				2022-12-28	WOS:000399304000024
J	Brito, IL; Yilmaz, S; Huang, K; Xu, L; Jupiter, SD; Jenkins, AP; Naisilisili, W; Tamminen, M; Smillie, CS; Wortman, JR; Birren, BW; Xavier, RJ; Blainey, PC; Singh, AK; Gevers, D; Alm, EJ				Brito, I. L.; Yilmaz, S.; Huang, K.; Xu, L.; Jupiter, S. D.; Jenkins, A. P.; Naisilisili, W.; Tamminen, M.; Smillie, C. S.; Wortman, J. R.; Birren, B. W.; Xavier, R. J.; Blainey, P. C.; Singh, A. K.; Gevers, D.; Alm, E. J.			Mobile genes in the human microbiome are structured from global to individual scales (vol 535, pg 435, 2016)	NATURE			English	Correction													Gevers, Dirk/C-1451-2009	Jupiter, Stacy/0000-0001-9742-1677; Smillie, Chris/0000-0002-7606-3433; Jenkins, Aaron/0000-0001-5079-0045				Brito IL, 2016, NATURE, V535, P435, DOI 10.1038/nature18927	1	2	2	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					124	124		10.1038/nature20774	http://dx.doi.org/10.1038/nature20774			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ8GQ	28329759	Bronze			2022-12-28	WOS:000398323300046
J	Grewe, BF; Grundemann, J; Kitch, LJ; Lecoq, JA; Parker, JG; Marshall, JD; Larkin, MC; Jercog, PE; Grenier, F; Li, JZ; Luthi, A; Schnitzer, MJ				Grewe, Benjamin F.; Grundemann, Jan; Kitch, Lacey J.; Lecoq, Jerome A.; Parker, Jones G.; Marshall, Jesse D.; Larkin, Margaret C.; Jercog, Pablo E.; Grenier, Francois; Li, Jin Zhong; Luthi, Andreas; Schnitzer, Mark J.			Neural ensemble dynamics underlying a long-term associative memory	NATURE			English	Article							LATERAL AMYGDALA; PRIMATE AMYGDALA; FEAR MEMORY; HIPPOCAMPUS; RESPONSES; STIMULI; NEURONS; COMPETITION; PLASTICITY; CIRCUITS	The brain's ability to associate different stimuli is vital for long-term memory, but how neural ensembles encode associative memories is unknown. Here we studied how cell ensembles in the basal and lateral amygdala encode associations between conditioned and unconditioned stimuli (CS and US, respectively). Using a miniature fluorescence microscope, we tracked the Ca2+ dynamics of ensembles of amygdalar neurons during fear learning and extinction over 6 days in behaving mice. Fear conditioning induced both up-and down-regulation of individual cells' CS-evoked responses. This bi-directional plasticity mainly occurred after conditioning, and reshaped the neural ensemble representation of the CS to become more similar to the US representation. During extinction training with repetitive CS presentations, the CS representation became more distinctive without reverting to its original form. Throughout the experiments, the strength of the ensemble-encoded CS-US association predicted the level of behavioural conditioning in each mouse. These findings support a supervised learning model in which activation of the US representation guides the transformation of the CS representation.	[Grewe, Benjamin F.; Kitch, Lacey J.; Lecoq, Jerome A.; Marshall, Jesse D.; Larkin, Margaret C.; Jercog, Pablo E.; Li, Jin Zhong; Schnitzer, Mark J.] Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA; [Grewe, Benjamin F.; Kitch, Lacey J.; Lecoq, Jerome A.; Marshall, Jesse D.; Jercog, Pablo E.; Schnitzer, Mark J.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Grewe, Benjamin F.; Kitch, Lacey J.; Lecoq, Jerome A.; Parker, Jones G.; Marshall, Jesse D.; Larkin, Margaret C.; Jercog, Pablo E.; Li, Jin Zhong; Schnitzer, Mark J.] Stanford Univ, CNC Program, Stanford, CA 94305 USA; [Grundemann, Jan; Grenier, Francois; Luthi, Andreas] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Parker, Jones G.] Pfizer Neurosci Res, Cambridge, MA USA; [Luthi, Andreas] Univ Basel, Basel, Switzerland; [Grenier, Francois] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Friedrich Miescher Institute for Biomedical Research; Pfizer; University of Basel; University of Tsukuba	Schnitzer, MJ (corresponding author), Stanford Univ, James H Clark Ctr Biomed Engn & Sci, Stanford, CA 94305 USA.; Schnitzer, MJ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.; Schnitzer, MJ (corresponding author), Stanford Univ, CNC Program, Stanford, CA 94305 USA.	mschnitz@stanford.edu	Jercog, Pablo E/A-8973-2018; Grewe, Benjamin/E-7044-2017; Luthi, Andreas/D-7940-2016	Jercog, Pablo E/0000-0001-7852-5884; Grewe, Benjamin/0000-0001-8560-2120; Luthi, Andreas/0000-0002-1859-4252; Grundemann, Jan/0000-0002-3149-0001	Swiss National Science Foundation; Ambizione; US National Science Foundation; Stanford University; Simons Foundation; Helen Hay Whitney Foundation; Novartis Research Foundation; ERC; HHMI; DARPA	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ambizione; US National Science Foundation(National Science Foundation (NSF)); Stanford University(Stanford University); Simons Foundation; Helen Hay Whitney Foundation; Novartis Research Foundation; ERC(European Research Council (ERC)European Commission); HHMI(Howard Hughes Medical Institute); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	G. Venkatraman, B. Ahanonu, J. Li, B. Rossi, C. Herry, S. Ciocchi and J. Bacelo provided technical assistance. We appreciate Swiss National Science Foundation (B.F.G.), Swiss National Science Foundation, Ambizione (J.G.), US National Science Foundation (L.J.K.), Stanford University (L.J.K., J.D.M.), Simons Foundation (L.J.K.), and Helen Hay Whitney Foundation (M.C.L.) fellowships. A.L. received support from the Swiss National Science Foundation, Novartis Research Foundation, and an ERC Advanced grant. M.J.S. received support from HHMI and DARPA.	Belova MA, 2007, NEURON, V55, P970, DOI 10.1016/j.neuron.2007.08.004; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Bishop C. M., 2007, PATTERN RECOGNITION, V1; Blair HT, 2005, J NEUROSCI, V25, P4198, DOI 10.1523/JNEUROSCI.0674-05.2005; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chowdhury N, 2005, BEHAV NEUROSCI, V119, P1396, DOI 10.1037/0735-7044.119.5.1396; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Courtin J, 2014, NATURE, V505, P92, DOI 10.1038/nature12755; Danielson NB, 2016, NEURON, V91, P652, DOI 10.1016/j.neuron.2016.06.020; Erlich JC, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00016; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; Fremaux N, 2016, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00085; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; George Paxinos K. B. J. F., 2001, MOUSE BRAIN STEREOTA, V2; Ghosh KK, 2011, NAT METHODS, V8, P871, DOI [10.1038/NMETH.1694, 10.1038/nmeth.1694]; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Gore F, 2015, CELL, V162, P134, DOI 10.1016/j.cell.2015.06.027; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hinton G, 2003, CAN PSYCHOL, V44, P10, DOI 10.1037/h0085812; Johansen JP, 2014, P NATL ACAD SCI USA, V111, pE5584, DOI 10.1073/pnas.1421304111; Johansen JP, 2010, NAT NEUROSCI, V13, P979, DOI 10.1038/nn.2594; Kong E, 2014, NEUROPSYCHOPHARMACOL, V39, P515, DOI 10.1038/npp.2013.191; Mankin EA, 2012, P NATL ACAD SCI USA, V109, P19462, DOI 10.1073/pnas.1214107109; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0001.2001; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Namburi P, 2015, NATURE, V520, P675, DOI 10.1038/nature14366; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Pawlak V., 2010, FRONT SYNAPTIC NEURO, V2, P146, DOI DOI 10.3389/FNSYN.2010.00146; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rashid AJ, 2016, SCIENCE, V353, P383, DOI 10.1126/science.aaf0594; Raybuck JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015982; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Rogerson T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161655; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Rubin A, 2015, ELIFE, V4, DOI 10.7554/eLife.12247; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Sah P, 2008, ANN NY ACAD SCI, V1129, P88, DOI 10.1196/annals.1417.020; Senn V, 2014, NEURON, V81, P428, DOI 10.1016/j.neuron.2013.11.006; Singec I, 2004, J COMP NEUROL, V479, P30, DOI 10.1002/cne.20302; Sotres-Bayon F, 2010, CURR OPIN NEUROBIOL, V20, P231, DOI 10.1016/j.conb.2010.02.005; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wolff SBE, 2014, NATURE, V509, P453, DOI 10.1038/nature13258; Ziv Y, 2013, NAT NEUROSCI, V16, P264, DOI 10.1038/nn.3329	49	155	155	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					670	+		10.1038/nature21682	http://dx.doi.org/10.1038/nature21682			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28329757	Green Accepted			2022-12-28	WOS:000397619700046
J	Smits, PC; Abdel-Wahab, M; Neumann, FJ; Boxma-de Klerk, BM; Lunde, K; Schotborgh, CE; Piroth, Z; Horak, D; Wlodarczak, A; Ong, PJ; Hambrecht, R; Angeras, O; Richardt, G; Omerovic, E				Smits, Pieter C.; Abdel-Wahab, Mohamed; Neumann, Franz-Josef; Boxma-de Klerk, Bianca M.; Lunde, Ketil; Schotborgh, Carl E.; Piroth, Zsolt; Horak, David; Wlodarczak, Adrian; Ong, Paul J.; Hambrecht, Rainer; Angeras, Oskar; Richardt, Gert; Omerovic, Elmir		Compare-Acute Investigators	Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; RANDOMIZED-TRIAL; ARTERY STENOSES; DISEASE; REVASCULARIZATION; SEVERITY; ANGIOGRAPHY; GUIDELINES; MANAGEMENT	BACKGROUND In patients with ST-segment elevation myocardial infarction (STEMI), the use of percutaneous coronary intervention (PCI) to restore blood flow in an infarct-related coronary artery improves outcomes. The use of PCI in non-infarct-related coronary arteries remains controversial. METHODS We randomly assigned 885 patients with STEMI and multivessel disease who had undergone primary PCI of an infarct-related coronary artery in a 1: 2 ratio to undergo complete revascularization of non-infarct-related coronary arteries guided by fractional flow reserve (FFR) (295 patients) or to undergo no revascularization of non-infarct-related coronary arteries (590 patients). The FFR procedure was performed in both groups, but in the latter group, both the patients and their cardiologist were unaware of the findings on FFR. The primary end point was a composite of death from any cause, nonfatal myocardial infarction, revascularization, and cerebrovascular events at 12 months. Clinically indicated elective revascularizations performed within 45 days after primary PCI were not counted as events in the group receiving PCI for an infarct-related coronary artery only. RESULTS The primary outcome occurred in 23 patients in the complete-revascularization group and in 121 patients in the infarct-artery-only group that did not receive complete revascularization, a finding that translates to 8 and 21 events per 100 patients, respectively (hazard ratio, 0.35; 95% confidence interval [CI], 0.22 to 0.55; P<0.001). Death occurred in 4 patients in the complete-revascularization group and in 10 patients in the infarct-artery-only group (1.4% vs. 1.7%) (hazard ratio, 0.80; 95% CI, 0.25 to 2.56), myocardial infarction in 7 and 28 patients, respectively (2.4% vs. 4.7%) (hazard ratio, 0.50; 95% CI, 0.22 to 1.13), revascularization in 18 and 103 patients (6.1% vs. 17.5%) (hazard ratio, 0.32; 95% CI, 0.20 to 0.54), and cerebrovascular events in 0 and 4 patients (0 vs. 0.7%). An FFR-related serious adverse event occurred in 2 patients (both in the group receiving infarct-related treatment only). CONCLUSIONS In patients with STEMI and multivessel disease who underwent primary PCI of an infarct-related artery, the addition of FFR-guided complete revascularization of non-infarct-related arteries in the acute setting resulted in a risk of a composite cardiovascular outcome that was lower than the risk among those who were treated for the infarct-related artery only. This finding was mainly supported by a reduction in subsequent revascularizations.	[Smits, Pieter C.; Boxma-de Klerk, Bianca M.] Maasstad Ziekenhuis, Dept Cardiol, Rotterdam, Netherlands; [Schotborgh, Carl E.] Haga Ziekenhuis, Dept Cardiol, The Hague, Netherlands; [Abdel-Wahab, Mohamed; Richardt, Gert] Segeberger Kliniken, Ctr Heart, Dept Cardiol, Bad Segeberg, Germany; [Neumann, Franz-Josef] Univ Heart Ctr Freiburg Bad Krozingen, Dept Cardiol, Bad Krozingen, Germany; [Hambrecht, Rainer] Klinikum Links Weser, Dept Cardiol, Bremen, Germany; [Lunde, Ketil] Univ Oslo, Rigshosp, Dept Cardiol, Oslo, Norway; [Piroth, Zsolt] Gyorgy Hungarian Inst Cardiol, Dept Cardiol, Budapest, Hungary; [Horak, David] Liberec Reg Hosp, Dept Cardiol, Liberec, Czech Republic; [Wlodarczak, Adrian] Miedziowe Ctr Zdrowia, Dept Cardiol, Lublin, Poland; [Ong, Paul J.] Tan Tock Seng Hosp, Dept Cardiol, Singapore, Singapore; [Angeras, Oskar; Omerovic, Elmir] Gothenburg Univ Hosp, Dept Cardiol, Gothenburg, Sweden	Maasstad Hospital; Haga Hospital; Segeberger Kliniken Group; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universitats Herzzentrum Freiburg; University of Oslo; National Hospital Norway; Tan Tock Seng Hospital; Sahlgrenska University Hospital	Smits, PC (corresponding author), Maasstad Hosp, Dept Cardiol, Maasstad Weg 21, NL-3079 DZ Rotterdam, Netherlands.	smitsp@maasstadziekenhuis.nl	Wlodarczak, Adrian/AAY-7456-2021	Wlodarczak, Adrian/0000-0003-3104-7728	Maasstad Cardiovascular Research from Abbott Vascular; St. Jude Medical	Maasstad Cardiovascular Research from Abbott Vascular; St. Jude Medical(St. Jude Medical)	Supported by Maasstad Cardiovascular Research, which received unconditional grants from Abbott Vascular and St. Jude Medical.	Altman D.G., 1991, PRACTICAL STAT MED R; Corpus RA, 2004, AM HEART J, V148, P493, DOI 10.1016/j.ahj.2004.03.051; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; DEBRUYNE B, 1994, CIRCULATION, V89, P1013, DOI 10.1161/01.CIR.89.3.1013; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Fischer JJ, 2002, AM J CARDIOL, V90, P210, DOI 10.1016/S0002-9149(02)02456-6; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Hanratty CG, 2002, J AM COLL CARDIOL, V40, P911, DOI 10.1016/S0735-1097(02)02049-1; Ntalianis A, 2010, JACC-CARDIOVASC INTE, V3, P1274, DOI 10.1016/j.jcin.2010.08.025; O'Gara PT, 2013, CIRCULATION, V127, P529, DOI 10.1161/CIR.0b013e3182742c84; Park DW, 2014, JAMA-J AM MED ASSOC, V312, P2019, DOI 10.1001/jama.2014.15095; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Smits PC, 2017, AM HEART J, V186, P21, DOI 10.1016/j.ahj.2016.12.016; Sorajja P, 2007, EUR HEART J, V28, P1709, DOI 10.1093/eurheartj/ehm184; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; TOPOL EJ, 1995, CIRCULATION, V92, P2333, DOI 10.1161/01.CIR.92.8.2333; Vlaar PJ, 2011, J AM COLL CARDIOL, V58, P692, DOI 10.1016/j.jacc.2011.03.046; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520	20	411	427	3	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2017	376	13					1234	1244		10.1056/NEJMoa1701067	http://dx.doi.org/10.1056/NEJMoa1701067			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP8KS	28317428	Green Accepted, Bronze			2022-12-28	WOS:000397624900007
J	Mason, DJ				Mason, Diana J.			Professionalism in Health Care Organizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Mason, Diana J.] CUNY, Hunter Coll, Ctr Hlth Media & Policy, New York, NY 10021 USA; [Mason, Diana J.] George Washington Univ, Sch Nursing, Washington, DC 20052 USA; [Mason, Diana J.] Amer Acad Nursing, Washington, DC USA	City University of New York (CUNY) System; Hunter College (CUNY); George Washington University	Mason, DJ (corresponding author), CUNY, Hunter Coll, Ctr Hlth Media & Policy, New York, NY 10021 USA.; Mason, DJ (corresponding author), George Washington Univ, Sch Nursing, Washington, DC 20052 USA.	djmasonrn@gmail.com							0	2	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1203	1204		10.1001/jama.2017.1753	http://dx.doi.org/10.1001/jama.2017.1753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350914				2022-12-28	WOS:000397557800003
J	Jaffe, S				Jaffe, Susan			US health and science advocates gear up for battle over EPA	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1180	1181		10.1016/S0140-6736(17)30815-2	http://dx.doi.org/10.1016/S0140-6736(17)30815-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28353432				2022-12-28	WOS:000397143700015
J	Hu, J; Shi, YN; Sauvage, X; Sha, G; Lu, K				Hu, J.; Shi, Y. N.; Sauvage, X.; Sha, G.; Lu, K.			METALLURGY Grain boundary stability governs hardening and softening in extremely fine nanograined metals	SCIENCE			English	Article							MECHANICAL-PROPERTIES; ELECTRODEPOSITED NI; NANOCRYSTALLINE; DEFORMATION; SIZE; TEMPERATURE; PLASTICITY; BEHAVIOR; CREEP	Conventional metals become harder with decreasing grain sizes, following the classical Hall-Petch relationship. However, this relationship fails and softening occurs at some grain sizes in the nanometer regime for some alloys. In this study, we discovered that plastic deformation mechanism of extremely fine nanograined metals and their hardness are adjustable through tailoring grain boundary (GB) stability. The electrodeposited nanograined nickel-molybdenum (Ni-Mo) samples become softened for grain sizes below 10 nanometers because of GB-mediated processes. With GB stabilization through relaxation and Mo segregation, ultrahigh hardness is achieved in the nanograined samples with a plastic deformation mechanism dominated by generation of extended partial dislocations. Grain boundary stability provides an alternative dimension, in addition to grain size, for producing novel nanograined metals with extraordinary properties.	[Hu, J.; Shi, Y. N.; Lu, K.] Shenyang Natl Lab Mat Sci, Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China; [Sauvage, X.] Normandie Univ, CNRS, Inst Natl Sci Appl Rouen, UNIROUEN, F-76000 Rouen, France; [Lu, K.] Nanjing Univ Sci & Technol, Herbert Gleiter Inst Nanosci, Nanjing 210094, Peoples R China	Chinese Academy of Sciences; Institute of Metal Research, CAS; Centre National de la Recherche Scientifique (CNRS); Nanjing University of Science & Technology	Lu, K (corresponding author), Shenyang Natl Lab Mat Sci, Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.; Lu, K (corresponding author), Nanjing Univ Sci & Technol, Herbert Gleiter Inst Nanosci, Nanjing 210094, Peoples R China.	lu@imr.ac.cn	Sha, Gang/H-1523-2017; Hu, Jian/V-5093-2019; Hu, Jian/N-2039-2017	Sha, Gang/0000-0001-9842-6728; Hu, Jian/0000-0002-0574-2754				Chang L, 2007, SCRIPTA MATER, V56, P713, DOI 10.1016/j.scriptamat.2006.12.036; Chen B, 2012, SCIENCE, V338, P1448, DOI 10.1126/science.1228211; Chen J, 2006, SCRIPTA MATER, V54, P1913, DOI 10.1016/j.scriptamat.2006.02.022; Chen MW, 2003, SCIENCE, V300, P1275, DOI 10.1126/science.1083727; Dalla Torre F, 2002, ACTA MATER, V50, P3957, DOI 10.1016/S1359-6454(02)00198-2; Detor AJ, 2007, ACTA MATER, V55, P371, DOI 10.1016/j.actamat.2006.08.032; Ebrahimi F, 1999, NANOSTRUCT MATER, V11, P343, DOI 10.1016/S0965-9773(99)00050-1; ELSHERIK AM, 1992, SCRIPTA METALL MATER, V27, P1185, DOI 10.1016/0956-716X(92)90596-7; Fang TH, 2011, SCIENCE, V331, P1587, DOI 10.1126/science.1200177; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Hasnaoui A, 2002, ACTA MATER, V50, P3927, DOI 10.1016/S1359-6454(02)00195-7; Huang XX, 2006, SCIENCE, V312, P249, DOI 10.1126/science.1124268; Hughes DA, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.135504; HUGHES GD, 1986, SCRIPTA METALL MATER, V20, P93, DOI 10.1016/0036-9748(86)90219-X; Kirchheim R, 2002, ACTA MATER, V50, P413, DOI 10.1016/S1359-6454(01)00338-X; Knapp JA, 2004, J MATER RES, V19, P218, DOI 10.1557/jmr.2004.19.1.218; Koch CC, 2013, J MATER RES, V28, P1785, DOI 10.1557/jmr.2012.429; Lu K, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.19; Meyers MA, 2006, PROG MATER SCI, V51, P427, DOI 10.1016/j.pmatsci.2005.08.003; Pan D, 2007, NANO LETT, V7, P2108, DOI 10.1021/nl071093m; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Rupert TJ, 2009, SCIENCE, V326, P1686, DOI 10.1126/science.1178226; Rupert TJ, 2012, J MATER RES, V27, P1285, DOI 10.1557/jmr.2012.55; Schiotz J, 2003, SCIENCE, V301, P1357, DOI 10.1126/science.1086636; Schuh CA, 2002, SCRIPTA MATER, V46, P735, DOI 10.1016/S1359-6462(02)00062-3; Shan ZW, 2004, SCIENCE, V305, P654, DOI 10.1126/science.1098741; TIEARNEY TC, 1982, METALL TRANS A, V13, P1827, DOI 10.1007/BF02647839; Van Swygenhoven H, 2004, NAT MATER, V3, P399, DOI 10.1038/nmat1136; Wang L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5402; Wang YM, 2004, SCRIPTA MATER, V51, P1023, DOI 10.1016/j.scriptamat.2004.08.015; Weertman J. R., 1994, Diffusion and Defect Data Part B (Solid State Phenomena), V35-36, P249; WEISSMULLER J, 1993, NANOSTRUCT MATER, V3, P261, DOI 10.1016/0965-9773(93)90088-S; Yamakov V, 2004, NAT MATER, V3, P43, DOI 10.1038/nmat1035; Yamakov V, 2003, PHIL MAG LETT, V83, P385, DOI 10.1080/0950083031000120891; Yip S, 1998, NATURE, V391, P532, DOI 10.1038/35254; Zhang K, 2004, APPL PHYS LETT, V85, P5197, DOI 10.1063/1.1828213	36	437	453	63	848	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1292	+		10.1126/science.aal5166	http://dx.doi.org/10.1126/science.aal5166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336664				2022-12-28	WOS:000397082900034
J	Neeleman, M; Kanekar, N; Prochaska, JX; Rafelski, M; Carilli, CL; Wolfe, AM				Neeleman, Marcel; Kanekar, Nissim; Prochaska, J. Xavier; Rafelski, Marc; Carilli, Chris L.; Wolfe, Arthur M.			[C II] 158-mu m emission from the host galaxies of damped Lyman-alpha systems	SCIENCE			English	Article							SIMILAR-TO 3; STAR-FORMATION; STELLAR FEEDBACK; BREAK GALAXIES; DEEP FIELD; GAS; SPECTROSCOPY; ABSORBERS; I.; COUNTERPARTS	Gas surrounding high-redshift galaxies has been studied through observations of absorption line systems toward background quasars for decades. However, it has proven difficult to identify and characterize the galaxies associated with these absorbers due to the intrinsic faintness of the galaxies compared with the quasars at optical wavelengths. Using the Atacama Large Millimeter/Submillimeter Array, we report on detections of [C II] 158-mm line and dust-continuum emission from two galaxies associated with two such absorbers at a redshift of z similar to 4. Our results indicate that the hosts of these high-metallicity absorbers have physical properties similar to massive star-forming galaxies and are embedded in enriched neutral hydrogen gas reservoirs that extend well beyond the star-forming interstellar medium of these galaxies.	[Neeleman, Marcel; Prochaska, J. Xavier] Univ Calif Santa Cruz, Univ Calif Observ Lick Observ, Santa Cruz, CA 95064 USA; [Kanekar, Nissim] Pune Univ, Natl Ctr Radio Astrophys, Tata Inst Fundamental Res, Pune 411007, Maharashtra, India; [Rafelski, Marc] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Carilli, Chris L.] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Carilli, Chris L.] Univ Cambridge, Cavendish Lab, 19 J J Thomson Ave, Cambridge CB3 0HE, England; [Wolfe, Arthur M.] Univ Calif San Diego, Dept Phys, San Diego, CA 92063 USA; [Wolfe, Arthur M.] Univ Calif San Diego, Ctr Astrophys & Space Sci, San Diego, CA 92063 USA	University of California System; University of California Santa Cruz; Savitribai Phule Pune University; Tata Institute of Fundamental Research (TIFR); National Centre for Radio Astrophysics (NCRA), Pune; Space Telescope Science Institute; National Radio Astronomy Observatory (NRAO); University of Cambridge; University of California System; University of California San Diego; University of California System; University of California San Diego	Neeleman, M (corresponding author), Univ Calif Santa Cruz, Univ Calif Observ Lick Observ, Santa Cruz, CA 95064 USA.	marcel@ucsc.edu						Beckwith SVW, 2006, ASTRON J, V132, P1729, DOI 10.1086/507302; Bird S, 2014, MON NOT R ASTRON SOC, V445, P2313, DOI 10.1093/mnras/stu1923; Capak PL, 2015, NATURE, V522, P455, DOI 10.1038/nature14500; Carilli CL, 2013, ANNU REV ASTRON ASTR, V51, P105, DOI 10.1146/annurev-astro-082812-140953; Cen RY, 2012, ASTROPHYS J, V748, DOI 10.1088/0004-637X/748/2/121; Christensen L, 2014, MON NOT R ASTRON SOC, V445, P225, DOI 10.1093/mnras/stu1726; Danovich M, 2015, MON NOT R ASTRON SOC, V449, P2087, DOI 10.1093/mnras/stv270; De Looze I, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201322489; Fernandez X, 2016, ASTROPHYS J LETT, V824, DOI 10.3847/2041-8205/824/1/L1; Font-Ribera A, 2012, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2012/11/059; Fumagalli M, 2015, MON NOT R ASTRON SOC, V446, P3178, DOI 10.1093/mnras/stu2325; Fynbo JPU, 2010, MON NOT R ASTRON SOC, V408, P2128, DOI 10.1111/j.1365-2966.2010.17294.x; Giavalisco M, 2004, ASTROPHYS J, V600, pL93, DOI 10.1086/379232; Grogin NA, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/35; Kanekar N, 2014, MON NOT R ASTRON SOC, V438, P2131, DOI 10.1093/mnras/stt2338; Keres D, 2005, MON NOT R ASTRON SOC, V363, P2, DOI 10.1111/j.1365-2966.2005.09451.x; Krogager JK, 2012, MON NOT R ASTRON SOC, V424, pL1, DOI 10.1111/j.1745-3933.2012.01272.x; Malhotra S, 2001, ASTROPHYS J, V561, P766, DOI 10.1086/323046; Moller P, 2002, ASTROPHYS J, V574, P51, DOI 10.1086/340934; Neeleman M, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/54; Peroux C, 2011, MON NOT R ASTRON SOC, V410, P2237, DOI 10.1111/j.1365-2966.2010.17598.x; PETTINI M, 1994, ASTROPHYS J, V426, P79, DOI 10.1086/174041; Pineda JL, 2013, ASTRON ASTROPHYS, V554, DOI 10.1051/0004-6361/201321188; Prochaska JX, 2005, ASTROPHYS J, V635, P123, DOI 10.1086/497287; Prochaska JX, 1997, ASTROPHYS J, V487, P73, DOI 10.1086/304591; Rafelski M, 2016, ASTROPHYS J, V825, DOI 10.3847/0004-637X/825/2/87; Rafelski M, 2012, ASTROPHYS J, V755, DOI 10.1088/0004-637X/755/2/89; Srianand R, 2016, MON NOT R ASTRON SOC, V460, P634, DOI 10.1093/mnras/stw951; Steidel CC, 1996, ASTRON J, V112, P352, DOI 10.1086/118019; Stewart KR, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/1/74; Wolfe AM, 2005, ANNU REV ASTRON ASTR, V43, P861, DOI 10.1146/annurev.astro.42.053102.133950	32	41	41	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1285	+		10.1126/science.aal1737	http://dx.doi.org/10.1126/science.aal1737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336663	Green Submitted			2022-12-28	WOS:000397082900032
J	Baron, MG; Norman, DB; Barrett, PM				Baron, Matthew G.; Norman, David B.; Barrett, Paul M.			A new hypothesis of dinosaur relationships and early dinosaur evolution	NATURE			English	Article							POSTCRANIAL ANATOMY; DIVERSIFICATION; SAURISCHIA; ARGENTINA; AFRICA; ORIGIN	For 130 years, dinosaurs have been divided into two distinct clades-Ornithischia and Saurischia. Here we present a hypothesis for the phylogenetic relationships of the major dinosaurian groups that challenges the current consensus concerning early dinosaur evolution and highlights problematic aspects of current cladistic definitions. Our study has found a sister-group relationship between Ornithischia and Theropoda (united in the new clade Ornithoscelida), with Sauropodomorpha and Herrerasauridae (as the redefined Saurischia) forming its monophyletic outgroup. This new tree topology requires redefinition and rediagnosis of Dinosauria and the subsidiary dinosaurian clades. In addition, it forces re-evaluations of early dinosaur cladogenesis and character evolution, suggests that hypercarnivory was acquired independently in herrerasaurids and theropods, and offers an explanation for many of the anatomical features previously regarded as notable convergences between theropods and early ornithischians.	[Baron, Matthew G.; Norman, David B.; Barrett, Paul M.] Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England; [Baron, Matthew G.; Barrett, Paul M.] Natl Hist Museum, Dept Earth Sci, Cromwell Rd, London, England	University of Cambridge; Natural History Museum London	Baron, MG (corresponding author), Univ Cambridge, Dept Earth Sci, Downing St, Cambridge CB2 3EQ, England.	mgb46@cam.ac.uk	Barrett, Paul/A-2648-2010	Barrett, Paul/0000-0003-0412-3000; Baron, Matthew/0000-0001-9069-7638	NERC/CASE Doctoral Studentship [NE/L501578/1]	NERC/CASE Doctoral Studentship	We thank S. Chapman (Natural History Museum, London, UK), R. Smith (Iziko South African Museum, Cape Town, South Africa), E. Butler (National Museum, Bloemfontein, South Africa) B. Zipfel (Bernard Price Institute for Palaeontological Research, Johannesburg, South Africa), J. Powell (Instituto Miguel Lillo, Tucuman, Argentina), R. Martinez (Museo de Ciencias Naturales, San Juan, Argentina) and D. Pol (Museo Paleontologico Egidio Feruglio, Trelew, Argentina) for access to specimens in their care, R. Butler, J. Choiniere, B. McPhee, C. VanBuren and K. Chapelle for helpful discussion, M. Williams for assisting with the production of figures, and C. Baron for helpful comments on the manuscript, and the Willi Hennig Society for making TNT 1.5-beta software freely available. Funding for M.G.B. was provided by a NERC/CASE Doctoral Studentship (NE/L501578/1).	BAKKER RT, 1974, NATURE, V248, P168, DOI 10.1038/248168a0; Baron MG, 2017, ZOOL J LINN SOC-LOND, V179, P125, DOI 10.1111/zoj.12434; Barrett PM, 2010, EARTH ENV SCI T R SO, V101, P383, DOI 10.1017/S1755691011020111; Barrett PM, 2009, P ROY SOC B-BIOL SCI, V276, P2667, DOI 10.1098/rspb.2009.0352; Benson RBJ, 2010, ZOOL J LINN SOC-LOND, V158, P882, DOI 10.1111/j.1096-3642.2009.00569.x; Bittencourt JS, 2015, J SYST PALAEONTOL, V13, P189, DOI 10.1080/14772019.2013.878758; Bonaparte Jose F., 1999, National Science Museum Monographs, V15, P89; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2041, DOI 10.1098/rspb.2007.0367; Cabreira SF, 2011, NATURWISSENSCHAFTEN, V98, P1035, DOI 10.1007/s00114-011-0858-0; Charig A. J., 1965, Proceedings of the Linnean Society of London, V176, P197; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Galton Peter M., 2014, Revue de Paleobiologie, V33, P97; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Huxley T.H., 1870, Q J GEOLOGICAL SOC, V26, P32, DOI [10.1144/gsl.jgs.1870.026.01-02.09, DOI 10.1144/GSL.JGS.1870.026.01-02.09]; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer Max Cardoso, 2003, Paleobios, V23, P1; Marsh OC., 1878, AM J SCI, V16, P411, DOI [DOI 10.2475/AJS.S3-16.95.411, 10.2475/ajs.s3-16.95.411]; Nesbitt S.J., 2011, B AM MUSEUM NATURAL, V352; Nesbitt SJ, 2010, NATURE, V464, P95, DOI 10.1038/nature08718; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Norman DB, 2011, ZOOL J LINN SOC-LOND, V163, P182, DOI 10.1111/j.1096-3642.2011.00697.x; NOVAS FE, 1992, PALAEONTOLOGY, V35, P51; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Padian K, 2012, EARTH ENV SCI T R SO, V103, P423, DOI 10.1017/S1755691013000431; Romer A, 1956, OSTEOLOGY REPTILES; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno PC, 2012, ZOOKEYS, P1, DOI [10.3897/zookeys.226.2840, 10.3897/zookeys.223.2840]; Sereno PC, 2005, SYST BIOL, V54, P595, DOI 10.1080/106351591007453; Sues HD, 2011, P ROY SOC B-BIOL SCI, V278, P3459, DOI 10.1098/rspb.2011.0410; Taylor M. P., 2010, PHYLONYMS COMPANION; Weishampel DB., 2004, DINOSAURIA; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates Adam M., 2003, Journal of Systematic Palaeontology, V1, P1, DOI 10.1017/S1477201903001007	37	142	148	13	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					501	+		10.1038/nature21700	http://dx.doi.org/10.1038/nature21700			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28332513				2022-12-28	WOS:000397018000041
J	Huang, CS				Huang, Chih-Sheng			Fournier's Gangrene	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Huang, Chih-Sheng] Natl Yang Ming Univ Hosp, Yilan, Taiwan		Huang, CS (corresponding author), Natl Yang Ming Univ Hosp, Yilan, Taiwan.	imalive20@hotmail.com		Huang, Chih-Sheng/0000-0001-7215-2589					0	7	9	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1158	1158		10.1056/NEJMicm1609306	http://dx.doi.org/10.1056/NEJMicm1609306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28328332				2022-12-28	WOS:000397014300012
J	Stern, A; Yeh, MT; Zinger, T; Smith, M; Wright, C; Ling, G; Nielsen, R; Macadam, A; Andino, R				Stern, Adi; Yeh, Ming Te; Zinger, Tal; Smith, Matt; Wright, Caroline; Ling, Guy; Nielsen, Rasmus; Macadam, Andrew; Andino, Raul			The Evolutionary Pathway to Virulence of an RNA Virus	CELL			English	Article							VACCINE-DERIVED POLIOVIRUSES; ENVIRONMENTAL SURVEILLANCE; SELECTION COEFFICIENTS; CONVERGENT EVOLUTION; KEY INNOVATION; REGION; REPLICATION; ALGORITHM; MUTATION; MODELS	Paralytic polio once afflicted almost half a million children each year. The attenuated oral polio vaccine (OPV) has enabled world-wide vaccination efforts, which resulted in nearly complete control of the disease. However, poliovirus eradication is hampered globally by epidemics of vaccine-derived polio. Here, we describe a combined theoretical and experimental strategy that describes the molecular events leading from OPV to virulent strains. We discover that similar evolutionary events occur in most epidemics. The mutations and the evolutionary trajectories driving these epidemics are replicated using a simple cell-based experimental setup where the rate of evolution is intentionally accelerated. Furthermore, mutations accumulating during epidemics increase the replication fitness of the virus in cell culture and increase virulence in an animal model. Our study uncovers the evolutionary strategies by which vaccine strains become pathogenic and provides a powerful framework for rational design of safer vaccine strains and for forecasting virulence of viruses.	[Stern, Adi; Zinger, Tal; Ling, Guy] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-6997801 Tel Aviv, Israel; [Yeh, Ming Te; Wright, Caroline; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Smith, Matt; Macadam, Andrew] Natl Inst Biol Stand & Controls, Div Virol, Blanche Lane, Potters Bar EN6 3QG, Herts, England; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Tel Aviv University; University of California System; University of California San Francisco; National Institute for Biological Standards & Control; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Stern, A (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-6997801 Tel Aviv, Israel.; Andino, R (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA.	sternadi@post.tau.ac.il; raul.andino@ucsf.edu	Yeh, Ming Te/AAC-6175-2021; Nielsen, Rasmus/D-4405-2009	Nielsen, Rasmus/0000-0003-0513-6591; Yeh, Ming Te/0000-0001-8736-180X; Stern, Adi/0000-0002-2919-3542; Zinger, Tal/0000-0002-5580-5282	WIS post-doctoral award; Rothschild post-doctoral award; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; NSF [CMMI0941355]; NIH [R01 GM097115, AI36178, AI40085, P01 AI091575]; University of California (CCADD); DARPA Prophecy; Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI091575, R21AI040085, R56AI036178, R21AI036178, R01AI036178, R01AI040085] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097115] Funding Source: NIH RePORTER	WIS post-doctoral award; Rothschild post-doctoral award; Edmond J. Safra Center for Bioinformatics at Tel-Aviv University; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California (CCADD); DARPA Prophecy; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cara Burns and Olen Kew from the CDC for sharing preliminary sequence data from the Nigerian outbreaks. We further thank many colleagues at UCSF and TAU for helpful discussions and comments on the manuscript, in particular Tzachi Hagai, and Mor Geva for initial analyses. A.S. was supported by a WIS post-doctoral award and by a Rothschild post-doctoral award. T.Z. and G.L. are supported by the Edmond J. Safra Center for Bioinformatics at Tel-Aviv University. This work was supported in part by NSF (CMMI0941355), NIH (R01 GM097115, AI36178, AI40085, P01 AI091575) and the University of California (CCADD)), DARPA Prophecy, and Bill and Melinda Gates Foundation.	Acevedo A, 2014, NAT PROTOC, V9, P1760, DOI 10.1038/nprot.2014.118; Acevedo A, 2014, NATURE, V505, P686, DOI 10.1038/nature12861; ANDINO R, 1990, CELL, V63, P369, DOI 10.1016/0092-8674(90)90170-J; Atkinson NJ, 2014, NUCLEIC ACIDS RES, V42, P4527, DOI 10.1093/nar/gku075; BRENT RP, 1971, COMPUT J, V14, P422, DOI 10.1093/comjnl/14.4.422; Bull JJ, 1997, GENETICS, V147, P1497; BURGE C, 1992, P NATL ACAD SCI USA, V89, P1358, DOI 10.1073/pnas.89.4.1358; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Burns CC, 2009, J VIROL, V83, P9957, DOI 10.1128/JVI.00508-09; Burrill Cecily P, 2013, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15h02s29; Burrill CP, 2013, J VIROL, V87, P11670, DOI 10.1128/JVI.01560-13; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; Cuevas JM, 2002, GENETICS, V162, P533; Dedepsidis E, 2006, VIRUS GENES, V33, P183, DOI 10.1007/s11262-005-0055-3; DUNN G, 1990, J MED VIROL, V32, P92, DOI 10.1002/jmv.1890320205; Endegue-Zanga MC, 2015, J CLIN VIROL, V62, P80, DOI 10.1016/j.jcv.2014.11.027; Famulare M, 2016, J VIROL, V90, P317, DOI 10.1128/JVI.01532-15; Feldman CR, 2012, P NATL ACAD SCI USA, V109, P4556, DOI 10.1073/pnas.1113468109; Foll M, 2015, MOL ECOL RESOUR, V15, P87, DOI 10.1111/1755-0998.12280; Foll M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004185; Freistadt MS, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-44; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hovi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066849; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Ida-Hosonuma M, 2005, J VIROL, V79, P4460, DOI 10.1128/JVI.79.7.4460-4469.2005; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Jorba J, 2008, J VIROL, V82, P4429, DOI 10.1128/JVI.02354-07; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; KIMURA M, 1962, GENETICS, V47, P713; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Krogan NJ, 2015, MOL CELL, V58, P690, DOI 10.1016/j.molcel.2015.05.008; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lorenzo-Redondo R, 2016, NATURE, V530, P51, DOI 10.1038/nature16933; Lou DI, 2013, P NATL ACAD SCI USA, V110, P19872, DOI 10.1073/pnas.1319590110; MACADAM AJ, 1991, VIROLOGY, V181, P451, DOI 10.1016/0042-6822(91)90877-E; Manor Y, 1999, J CLIN MICROBIOL, V37, P1670, DOI 10.1128/JCM.37.6.1670-1675.1999; Mee ET, 2015, VACCINE, V33, P3533, DOI 10.1016/j.vaccine.2015.05.052; Meyer JR, 2012, SCIENCE, V335, P428, DOI 10.1126/science.1214449; MINOR PD, 1986, MICROBIOL SCI, V3, P141; MUSE SV, 1994, MOL BIOL EVOL, V11, P715; MUZYCHENKO AR, 1991, VIRUS RES, V21, P111, DOI 10.1016/0168-1702(91)90002-D; Nakamura T, 2015, APPL ENVIRON MICROB, V81, P1850, DOI 10.1128/AEM.03575-14; Neverov A, 2010, P NATL ACAD SCI USA, V107, P20063, DOI 10.1073/pnas.1012537107; Nielsen R, 2003, MOL BIOL EVOL, V20, P1231, DOI 10.1093/molbev/msg147; Nielsen R, 1998, GENETICS, V148, P929; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; PILIPENKO EV, 1989, VIROLOGY, V168, P201, DOI 10.1016/0042-6822(89)90259-6; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Pybus OG, 2007, MOL BIOL EVOL, V24, P845, DOI 10.1093/molbev/msm001; REN R, 1991, J VIROL, V65, P1377, DOI 10.1128/JVI.65.3.1377-1382.1991; Rouzine IM, 2001, MICROBIOL MOL BIOL R, V65, P151, DOI 10.1128/MMBR.65.1.151-185.2001; Runckel C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003164; Seoighe C, 2007, MOL BIOL EVOL, V24, P1025, DOI 10.1093/molbev/msm021; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Stern A, 2014, CELL REP, V8, P1026, DOI 10.1016/j.celrep.2014.07.011; Stern A, 2010, SYST BIOL, V59, P212, DOI 10.1093/sysbio/syp104; Sunnaker M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002803; TAFFS RE, 1995, VIROLOGY, V209, P366, DOI 10.1006/viro.1995.1268; Tao ZX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083975; Tebbens RJD, 2013, RISK ANAL, V33, P680, DOI 10.1111/risa.12022; Teeling EC, 2002, P NATL ACAD SCI USA, V99, P1431, DOI 10.1073/pnas.022477199; Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; Yang ZH, 2000, GENETICS, V155, P431; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Zou ZT, 2015, MOL BIOL EVOL, V32, P2085, DOI 10.1093/molbev/msv091	70	69	70	4	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					35	+		10.1016/j.cell.2017.03.013	http://dx.doi.org/10.1016/j.cell.2017.03.013			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340348	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000397090000006
J	Toll, E; Melfi, BS				Toll, Elizabeth; Melfi, Beth Scanlon			The Healing Power of Paint	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Toll, Elizabeth] Med Pediat Primary Care Ctr & Warren Alpert Med, Dept Pediat & Med, Providence, RI USA; [Melfi, Beth Scanlon] Med Pediat Primary Care Ctr & Warren Alpert Med, Dept Pediat & Med, Swansea, MA USA		Toll, E (corresponding author), Med Pediat Primary Care Ctr & Warren Alpert Med, Dept Pediat & Med, Providence, RI USA.	etoll@lifespan.org; elizabethmelfi@aol.com							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1100	1102		10.1001/jama.2017.1947	http://dx.doi.org/10.1001/jama.2017.1947			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324070				2022-12-28	WOS:000396987200001
J	Ali, SH; Giurco, D; Arndt, N; Nickless, E; Brown, G; Demetriades, A; Durrheim, R; Enriquez, MA; Kinnaird, J; Littleboy, A; Meinert, LD; Oberhansli, R; Salem, J; Schodde, R; Schneider, G; Vidal, O; Yakovleva, N				Ali, Saleem H.; Giurco, Damien; Arndt, Nicholas; Nickless, Edmund; Brown, Graham; Demetriades, Alecos; Durrheim, Ray; Enriquez, Maria Amelia; Kinnaird, Judith; Littleboy, Anna; Meinert, Lawrence D.; Oberhansli, Roland; Salem, Janet; Schodde, Richard; Schneider, Gabi; Vidal, Olivier; Yakovleva, Natalia			Mineral supply for sustainable development requires resource governance	NATURE			English	Article							METALS; CRITICALITY; CHALLENGES; SOCIETY; DEMAND; RISK	Successful delivery of the United Nations sustainable development goals and implementation of the Paris Agreement requires technologies that utilize a wide range of minerals in vast quantities. Metal recycling and technological change will contribute to sustaining supply, but mining must continue and grow for the foreseeable future to ensure that such minerals remain available to industry. New links are needed between existing institutional frameworks to oversee responsible sourcing of minerals, trajectories for mineral exploration, environmental practices, and consumer awareness of the effects of consumption. Here we present, through analysis of a comprehensive set of data and demand forecasts, an interdisciplinary perspective on how best to ensure ecologically viable continuity of global mineral supply over the coming decades.	[Ali, Saleem H.] Univ Delaware, Coll Earth Ocean & Environm, Newark, DE 19716 USA; [Ali, Saleem H.] Univ Queensland, Sustainable Minerals Inst, Brisbane, Qld, Australia; [Ali, Saleem H.] Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA; [Giurco, Damien] Univ Technol Sydney, Inst Sustainable Futures, Sydney, NSW, Australia; [Arndt, Nicholas; Vidal, Olivier] Univ Grenoble Alpes, Inst Sci Terre, Grenoble, France; [Nickless, Edmund] Geol Soc London, London, England; [Brown, Graham] Graham Brown Consulting, Buckland, Bucks, England; [Demetriades, Alecos] IUGS IAGC Commiss Global Geochem Baselines & Euro, Athens, Greece; [Durrheim, Ray; Kinnaird, Judith] Univ Witwatersrand, Johannesburg, South Africa; [Enriquez, Maria Amelia] Univ Para, Belem, Para, Brazil; [Littleboy, Anna] CSIRO, Brisbane, Qld, Australia; [Meinert, Lawrence D.] US Geol Survey, 959 Natl Ctr, Reston, VA 22092 USA; [Oberhansli, Roland] Potsdam Univ, Potsdam, Germany; [Oberhansli, Roland] Int Union Geol Sci, Potsdam, Germany; [Salem, Janet] UN, Environm Programme, Bangkok, Thailand; [Schodde, Richard] MinEx Consulting, Melbourne, Vic, Australia; [Schodde, Richard] Univ Western Australia, Ctr Explorat Targeting, Perth, WA, Australia; [Schneider, Gabi] Namibian Uranium Inst, Swakopmund, Namibia; [Yakovleva, Natalia] Newcastle Univ, London Campus, London, England	University of Delaware; University of Queensland; University of Vermont; University of Technology Sydney; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Gustave-Eiffel; Universite de Savoie; University of Witwatersrand; Commonwealth Scientific & Industrial Research Organisation (CSIRO); United States Department of the Interior; United States Geological Survey; University of Potsdam; United Nations Environment Programme; University of Western Australia; Newcastle University - UK	Ali, SH (corresponding author), Univ Delaware, Coll Earth Ocean & Environm, Newark, DE 19716 USA.; Ali, SH (corresponding author), Univ Queensland, Sustainable Minerals Inst, Brisbane, Qld, Australia.; Ali, SH (corresponding author), Univ Vermont, Gund Inst Ecol Econ, Burlington, VT 05405 USA.	saleem@alum.mit.edu	Yakovleva, Natalia/M-1789-2016; Durrheim, Raymond/W-8969-2018; Ali, Saleem/I-1545-2013	Yakovleva, Natalia/0000-0001-5560-3982; Durrheim, Raymond/0000-0003-3832-0600; DEMETRIADES, ALECOS/0000-0002-9343-7433; Giurco, Damien/0000-0002-1707-9531; Ali, Saleem/0000-0002-2943-9557; Enriquez, Maria Amelia/0000-0002-1040-9227	UNESCO; IUGS; ICSU	UNESCO; IUGS; ICSU	The authors are an interdisciplinary group, operating under the Resourcing Future Generations initiative of the International Union of Geological Sciences, the International Council for Science Unions and UNESCO. D. Nyanganyura of the International Council for Science and F. Masotti of Vale Corporation provided comments that led to this Perspective. S. Mohr of the University of Technology Sydney assisted with the model output results presented. Financial support provided by UNESCO, IUGS and ICSU, and logistical support provided by the Namibian Geological Survey, is acknowledged.	Alonso E, 2012, ENVIRON SCI TECHNOL, V46, P3406, DOI 10.1021/es203518d; [Anonymous], ANN REV 2015 EXPL RE; [Anonymous], 2015, REV POP PROSP; [Anonymous], 2015, WORLD COPP FACT BOOK; Bringezu S, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8080778; British Geological Survey, 2012, WORLD MIN PROD 2006; Correa C., 2000, INTEGRATING PUBLIC H; Crawford IA, 2015, PROG PHYS GEOG, V39, P137, DOI 10.1177/0309133314567585; Desai M., 2015, INSIGHTS AM SOC INT, V19; Elshkaki A, 2016, GLOBAL ENVIRON CHANG, V39, P305, DOI 10.1016/j.gloenvcha.2016.06.006; European Commission, 2014, REP CRIT RAW MAT EU; European Commission, 2014, P CRM EXTREME COST A, DOI DOI 10.13140/RG.2.2.15194.03526; Franken G, 2012, NONRENEWABLE RESOURC; Franks DM, 2014, P NATL ACAD SCI USA, V111, P7576, DOI 10.1073/pnas.1405135111; Frenzel M, 2015, RESOUR POLICY, V46, P45, DOI 10.1016/j.resourpol.2015.08.002; Gielen D, 2016, NAT MATER, V15, P117, DOI 10.1038/nmat4545; Gloser S, 2015, RESOUR POLICY, V44, P35, DOI 10.1016/j.resourpol.2014.12.003; Graedel TE, 2015, P NATL ACAD SCI USA, V112, P6295, DOI 10.1073/pnas.1312752110; Graedel TE, 2015, P NATL ACAD SCI USA, V112, P4257, DOI 10.1073/pnas.1500415112; Graedel TE, 2011, J IND ECOL, V15, P355, DOI 10.1111/j.1530-9290.2011.00342.x; Gregson N, 2015, ECON SOC, V44, P218, DOI 10.1080/03085147.2015.1013353; Gunn G, 2012, PROC INST CIV ENG-WA, V165, P171, DOI 10.1680/warm.12.00018; Hatayama H, 2014, RESOUR CONSERV RECY, V87, P65, DOI 10.1016/j.resconrec.2014.03.006; Henckens MLCM, 2016, RESOUR POLICY, V49, P92, DOI 10.1016/j.resourpol.2016.04.010; International Resource Panel, 2011, EST LONG RUNG GEOL S; International Resource Panel, 2015, ENV RISKS CHALL ANTH; International Resource Panel, 2007, MET REC OPP LIM INFR; International Resource Panel, 2013, MET REC OPP LIM INFR; International Resource Panel, 2010, MET STOCK SOC SCI SY; International Resource Panel, 2016, GLOB MAT FLOW RES PR; International Resource Panel, 2011, REC RAT MET STAT REP; International Resource Panel, 2011, DEC NAT RES US ENV I; Jeffries E, 2015, NAT CLIM CHANGE, V5, P93, DOI 10.1038/nclimate2504; Kesler SE, 2008, GEOLOGY, V36, P255, DOI 10.1130/G24317A.1; Larcher D, 2015, NAT CHEM, V7, P19, DOI [10.1038/NCHEM.2085, 10.1038/nchem.2085]; Lehmann H., 2013, FACTOR X ECOEFFICIEN; Liu G, 2013, NAT CLIM CHANGE, V3, P338, DOI [10.1038/nclimate1698, 10.1038/NCLIMATE1698]; Meinert LD, 2016, RESOURCES-BASEL, V5, DOI 10.3390/resources5010014; Melcher F., 2009, GEOPH RES ABSTR, V11, P2452; Moss R. L., 2011, 24884EN2011 JRC SCI; Naden J., 2013, SUSTAINABLE USE NATU; National Science and Technology Council, 2016, ASS CRIT MIN SCREEN; Phillips D., 2015, GUARDIAN; Preston F., 2015, NAVIGATING NEW NORMA; Rankin J., GUARDIAN; Roth S. E., 2015, COLUMBIA J TRANSNATL, V54, P827; Susskind L.E., 2014, ENV DIPLOMACY NEGOTI; Vidal O, 2013, NAT GEOSCI, V6, P894, DOI 10.1038/ngeo1993; Wilts H., 2013, FACTOR X ECOEFFICIEN; Zepf V., 2014, MAT CRITICAL ENERGY	50	305	319	23	240	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					367	372		10.1038/nature21359	http://dx.doi.org/10.1038/nature21359			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9RN	28300094	Green Submitted			2022-12-28	WOS:000396337400040
J	Mandai, M; Watanabe, A; Kurimoto, Y; Hirami, Y; Morinaga, C; Daimon, T; Fujihara, M; Akimaru, H; Sakai, N; Shibata, Y; Terada, M; Nomiya, Y; Tanishima, S; Nakamura, M; Kamao, H; Sugita, S; Onishi, A; Ito, T; Fujita, K; Kawamata, S; Go, MJ; Shinohara, C; Hata, K; Sawada, M; Yamamoto, M; Ohta, S; Ohara, Y; Yoshida, K; Kuwahara, J; Kitano, Y; Amano, N; Umekage, M; Kitaoka, F; Tanaka, A; Okada, C; Takasu, N; Ogawa, S; Yamanaka, S; Takahashi, M				Mandai, M.; Watanabe, A.; Kurimoto, Y.; Hirami, Y.; Morinaga, C.; Daimon, T.; Fujihara, M.; Akimaru, H.; Sakai, N.; Shibata, Y.; Terada, M.; Nomiya, Y.; Tanishima, S.; Nakamura, M.; Kamao, H.; Sugita, S.; Onishi, A.; Ito, T.; Fujita, K.; Kawamata, S.; Go, M. J.; Shinohara, C.; Hata, K.; Sawada, M.; Yamamoto, M.; Ohta, S.; Ohara, Y.; Yoshida, K.; Kuwahara, J.; Kitano, Y.; Amano, N.; Umekage, M.; Kitaoka, F.; Tanaka, A.; Okada, C.; Takasu, N.; Ogawa, S.; Yamanaka, S.; Takahashi, M.			Autologous Induced Stem-Cell-Derived Retinal Cells for Macular Degeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AGE-RELATED MACULOPATHY; PIGMENT EPITHELIUM; TRANSPLANTATION; PREVALENCE; TRANSLOCATION; RPE; RANIBIZUMAB; SURGERY; SHEETS	We assessed the feasibility of transplanting a sheet of retinal pigment epithelial (RPE) cells differentiated from induced pluripotent stem cells (iPSCs) in a patient with neovascular age-related macular degeneration. The iPSCs were generated from skin fibroblasts obtained from two patients with advanced neovascular agerelated macular degeneration and were differentiated into RPE cells. The RPE cells and the iPSCs from which they were derived were subject to extensive testing. A surgery that included the removal of the neovascular membrane and transplantation of the autologous iPSC-derived RPE cell sheet under the retina was performed in one of the patients. At 1 year after surgery, the transplanted sheet remained intact, best corrected visual acuity had not improved or worsened, and cystoid macular edema was present. (Funded by Highway Program for Realization of Regenerative Medicine and others; University Hospital Medical Information Network Clinical Trials Registry [UMIN-CTR] number, UMIN000011929.)	[Mandai, M.; Kurimoto, Y.; Hirami, Y.; Fujihara, M.; Yamamoto, M.; Ohta, S.; Takahashi, M.] Fdn Biomed Res & Innovat, Div Ophthalmol, Inst Biomed Res & Innovat Hosp, Kobe, Hyogo, Japan; [Mandai, M.; Morinaga, C.; Akimaru, H.; Sakai, N.; Shibata, Y.; Terada, M.; Kamao, H.; Sugita, S.; Onishi, A.; Yamamoto, M.; Takahashi, M.] RIKEN, Ctr Dev Biol, Lab Retinal Regenerat, Kobe, Hyogo, Japan; [Kurimoto, Y.; Hirami, Y.; Fujihara, M.] Gen Hosp, Kobe City Med Ctr, Dept Ophthalmol, Kobe, Hyogo, Japan; [Ito, T.; Fujita, K.] Fdn Biomed Res & Innovat, Inst Biomed Res & Innovat Hosp, Dept Clin Trial Management, Kobe, Hyogo, Japan; [Kawamata, S.; Go, M. J.] Fdn Biomed Res & Innovat, Res & Dev Ctr Cell Therapy, Kobe, Hyogo, Japan; [Watanabe, A.; Nomiya, Y.; Nakamura, M.; Kuwahara, J.; Kitano, Y.; Amano, N.; Umekage, M.; Kitaoka, F.; Tanaka, A.; Takasu, N.; Yamanaka, S.] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Watanabe, A.] Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Kyoto, Japan; [Yoshida, K.; Ogawa, S.] Kyoto Univ, Dept Pathol & Tumor Biol, Grad Sch Med, Kyoto, Japan; [Daimon, T.] Hyogo Coll Med, Dept Biostat, Nishinomiya, Hyogo, Japan; [Akimaru, H.] Natl Inst Biomed Innovat Hlth & Nutr, Platform Therapeut Rare Dis, Ibaraki, Japan; [Tanishima, S.; Ohara, Y.; Okada, C.] Mitsubishi Space Software, Tokyo, Japan; [Kamao, H.] Kawasaki Med Sch, Dept Ophthalmol, Kurashiki, Okayama, Japan; [Shinohara, C.; Hata, K.] Japan Tissue Engn, Gamagori, Japan; [Sawada, M.] HEALIOS KK, Tokyo, Japan; [Yamanaka, S.] Gladstone Inst Cardiovasc Dis, San Francisco, CA USA	Institute for Biomedical Research & Innovation (IBRI); RIKEN; Kobe City Medical Center General Hospital; Institute for Biomedical Research & Innovation (IBRI); Institute for Biomedical Research & Innovation (IBRI); Kyoto University; Kyoto University; Kyoto University; Hyogo College of Medicine; Kawasaki Medical School; University of California System; University of California San Francisco; The J David Gladstone Institutes	Takahashi, M (corresponding author), RIKEN, Ctr Develop Biol, Lab Retinal Regenerat, Chuo Ku, 2-2-3 Minatojima Mina Mimachi, Kobe, Hyogo 6500047, Japan.; Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Sakyo Ku, 53 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	yamanaka@cira.kyoto-u.ac.jp; retinalab@cdb.riken.jp		Tanaka, Azusa/0000-0002-0503-4176; Kamao, Hiroyuki/0000-0002-2194-7063; Yoshida, Kenichi/0000-0003-4612-2778; kawamata, shin/0000-0001-5148-1949; Nakamura, Masahiro/0000-0002-4363-069X	Highway Program for Realization of Regenerative Medicine; University Hospital Medical Information Network Clinical Trials Registry [UMIN-CTR] [UMIN000011929]; Grants-in-Aid for Scientific Research [15J04853, 15K06921] Funding Source: KAKEN	Highway Program for Realization of Regenerative Medicine; University Hospital Medical Information Network Clinical Trials Registry [UMIN-CTR]; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by Highway Program for Realization of Regenerative Medicine and others; University Hospital Medical Information Network Clinical Trials Registry [UMIN-CTR] number, UMIN000011929.	Algvere PV, 1999, EUR J OPHTHALMOL, V9, P217, DOI 10.1177/112067219900900310; Assawachananont J, 2014, STEM CELL REP, V2, P662, DOI 10.1016/j.stemcr.2014.03.011; Binder S, 2004, INVEST OPHTH VIS SCI, V45, P4151, DOI 10.1167/iovs.04-0118; Falkner CI, 2007, GRAEF ARCH CLIN EXP, V245, P490, DOI 10.1007/s00417-005-0184-3; Falkner-Radler CI, 2011, BRIT J OPHTHALMOL, V95, P370, DOI 10.1136/bjo.2009.176305; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Hawkins BS, 2004, OPHTHALMOLOGY, V111, P1967, DOI 10.1016/j.ophtha.2004.07.021; Heussen FMA, 2008, EYE, V22, P799, DOI 10.1038/sj.eye.6702823; Hirami Y, 2009, NEUROSCI LETT, V458, P126, DOI 10.1016/j.neulet.2009.04.035; Holash J, 2002, P NATL ACAD SCI USA, V99, P11393, DOI 10.1073/pnas.172398299; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Kamao H, 2014, STEM CELL REP, V2, P205, DOI 10.1016/j.stemcr.2013.12.007; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Kuroda T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037342; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Oshima Y, 2001, BRIT J OPHTHALMOL, V85, P1153, DOI 10.1136/bjo.85.10.1153; PEYMAN GA, 1991, OPHTHALMIC SURG LAS, V22, P102; Rofagha S, 2013, OPHTHALMOLOGY, V120, P2292, DOI 10.1016/j.ophtha.2013.03.046; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; SCHACHAT AP, 1994, ARCH OPHTHALMOL-CHIC, V112, P500; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Shirai H, 2016, P NATL ACAD SCI USA, V113, pE81, DOI 10.1073/pnas.1512590113; Song WK, 2015, STEM CELL REP, V4, P860, DOI 10.1016/j.stemcr.2015.04.005; Sugita S, 2015, INVEST OPHTH VIS SCI, V56, P1051, DOI 10.1167/iovs.14-15619; van Meurs JC, 2004, BRIT J OPHTHALMOL, V88, P110, DOI 10.1136/bjo.88.1.110; Van Meurs JC, 2003, AM J OPHTHALMOL, V136, P688, DOI 10.1016/S0002-9394(03)00384-2; van Zeeburg EJT, 2012, AM J OPHTHALMOL, V153, P120, DOI 10.1016/j.ajo.2011.06.007; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zweifel SA, 2009, ARCH OPHTHALMOL-CHIC, V127, P1596, DOI 10.1001/archophthalmol.2009.326	31	784	808	13	251	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1038	1046		10.1056/NEJMoa1608368	http://dx.doi.org/10.1056/NEJMoa1608368			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QT	28296613				2022-12-28	WOS:000396403700008
J	Caskey, FJ; Morton, RL				Caskey, Fergus J.; Morton, Rachael L.			Optimising care for children with kidney disease	LANCET			English	Editorial Material							STAGE RENAL-DISEASE; EUROPE; TRANSPLANTATION; DISPARITIES; RATES		[Caskey, Fergus J.] Southmead Hosp, UK Renal Registry, Learning & Res, Bristol BS10 5NB, Avon, England; [Morton, Rachael L.] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia	Southmead Hospital; University of Sydney	Caskey, FJ (corresponding author), Southmead Hosp, UK Renal Registry, Learning & Res, Bristol BS10 5NB, Avon, England.	mdfjc@bris.ac.uk	Morton, Rachael L/AAB-7420-2020	Morton, Rachael L/0000-0001-7834-0572; Caskey, Fergus/0000-0002-5199-3925				Caskey FJ, 2011, NEPHROL DIAL TRANSPL, V26, P2604, DOI 10.1093/ndt/gfq781; Chesnaye N. C., 2017, LANCET; Chesnaye NC, 2015, NEPHROL DIAL TRANSPL, V30, P1377, DOI 10.1093/ndt/gfv064; Gillen DL, 2008, AM J TRANSPLANT, V8, P2600, DOI 10.1111/j.1600-6143.2008.02410.x; Harambat J, 2013, AM J TRANSPLANT, V13, P2066, DOI 10.1111/ajt.12288; Harambat J, 2014, PEDIATR NEPHROL, V29, P453, DOI 10.1007/s00467-013-2665-7; Kramer A, 2012, CLIN J AM SOC NEPHRO, V7, P1655, DOI 10.2215/CJN.10461011; Morton RL, 2016, NEPHROL DIAL TRANSPL, V31, P46, DOI 10.1093/ndt/gfu394; Murray M, 2003, JAMA-J AM MED ASSOC, V289, P1035, DOI 10.1001/jama.289.8.1035; O'Neill J, 2014, J CLIN EPIDEMIOL, V67, P56, DOI 10.1016/j.jclinepi.2013.08.005; Stevens K., VALUATION CHILD HLTH	11	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2017	389	10084					2084	2086		10.1016/S0140-6736(17)30267-2	http://dx.doi.org/10.1016/S0140-6736(17)30267-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV7QE	28336051	Green Submitted			2022-12-28	WOS:000401973300010
J	Gotberg, M; Christiansen, EH; Gudmundsdottir, IJ; Sandhall, L; Danielewicz, M; Jakobsen, L; Olsson, SE; Ohagen, P; Olsson, H; Omerovic, E; Calais, F; Lindroos, P; Maeng, M; Todt, T; Venetsanos, D; James, SK; Karegren, A; Nilsson, M; Carlsson, J; Hauer, D; Jensen, J; Karlsson, AC; Panayi, G; Erlinge, D; Frobert, O				Gotberg, M.; Christiansen, E. H.; Gudmundsdottir, I. J.; Sandhall, L.; Danielewicz, M.; Jakobsen, L.; Olsson, S. -E.; Ohagen, P.; Olsson, H.; Omerovic, E.; Calais, F.; Lindroos, P.; Maeng, M.; Todt, T.; Venetsanos, D.; James, S. K.; Karegren, A.; Nilsson, M.; Carlsson, J.; Hauer, D.; Jensen, J.; Karlsson, A. -C.; Panayi, G.; Erlinge, D.; Frobert, O.		iFR-SWEDEHEART Investigators	Instantaneous Wave-free Ratio versus Fractional Flow Reserve to Guide PCI	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; OPEN-LABEL; ANGIOGRAPHY; STENOSIS; MULTICENTER; SEVERITY; PRESSURE; CLASSIFICATION; ANGIOPLASTY; STENTS	BACKGROUND The instantaneous wave-free ratio (iFR) is an index used to assess the severity of coronary-artery stenosis. The index has been tested against fractional flow reserve (FFR) in small trials, and the two measures have been found to have similar diagnostic accuracy. However, studies of clinical outcomes associated with the use of iFR are lacking. We aimed to evaluate whether iFR is noninferior to FFR with respect to the rate of subsequent major adverse cardiac events. METHODS We conducted a multicenter, randomized, controlled, open-label clinical trial using the Swedish Coronary Angiography and Angioplasty Registry for enrollment. A total of 2037 participants with stable angina or an acute coronary syndrome who had an indication for physiologically guided assessment of coronary-artery stenosis were randomly assigned to undergo revascularization guided by either iFR or FFR. The primary end point was the rate of a composite of death from any cause, nonfatal myocardial infarction, or unplanned revascularization within 12 months after the procedure. RESULTS A primary end-point event occurred in 68 of 1012 patients (6.7%) in the iFR group and in 61 of 1007 (6.1%) in the FFR group (difference in event rates, 0.7 percentage points; 95% confidence interval [CI], -1.5 to 2.8; P = 0.007 for noninferiority; hazard ratio, 1.12; 95% CI, 0.79 to 1.58; P = 0.53); the upper limit of the 95% confidence interval for the difference in event rates fell within the prespecified noninferiority margin of 3.2 percentage points. The results were similar among major subgroups. The rates of myocardial infarction, target-lesion revascularization, restenosis, and stent thrombosis did not differ significantly between the two groups. A significantly higher proportion of patients in the FFR group than in the iFR group reported chest discomfort during the procedure. CONCLUSIONS Among patients with stable angina or an acute coronary syndrome, an iFR-guided revascularization strategy was noninferior to an FFR-guided revascularization strategy with respect to the rate of major adverse cardiac events at 12 months.	[Gotberg, M.; Todt, T.; Nilsson, M.; Erlinge, D.] Lund Univ, Skane Univ Hosp, Dept Cardiol, Clin Sci, Lund, Sweden; [Sandhall, L.; Olsson, S. -E.] Helsingborg Hosp, Dept Cardiol & Radiol, Helsingborg, Sweden; [Danielewicz, M.; Olsson, H.] Karlstad Hosp, Dept Cardiol, Karlstad, Sweden; [Ohagen, P.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [James, S. K.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Omerovic, E.] Sahlgrenska Univ, Dept Cardiol, Gothenburg, Sweden; [Calais, F.; Frobert, O.] Orebro Univ, Fac Hlth, Dept Cardiol, Orebro, Sweden; [Lindroos, P.] St Goran Hosp, Dept Cardiol, Stockholm, Sweden; [Jensen, J.] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, Stockholm, Sweden; [Jensen, J.] Capio St Gorans Sjukhus, Unit Cardiol, Stockholm, Sweden; [Venetsanos, D.; Hauer, D.; Panayi, G.] Linkoping Univ, Dept Cardiol, Linkoping, Sweden; [Venetsanos, D.; Hauer, D.; Panayi, G.] Linkoping Univ, Dept Med & Hlth Sci, Linkoping, Sweden; [Karegren, A.] Vastmanland Hosp Vasters, Dept Internal Med, Vasteras, Sweden; [Carlsson, J.] Kalmar Cty Hosp, Dept Cardiol, Kalmar, Sweden; [Carlsson, J.] Linnaeus Univ, Fac Hlth & Life Sci, Kalmar, Sweden; [Jensen, J.] Sundsvall Hosp, Dept Med, Sundsvall, Sweden; [Karlsson, A. -C.] Halmstad Cty Hosp, Dept Cardiol, Halmstad, Sweden; [Christiansen, E. H.; Jakobsen, L.; Maeng, M.] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Gudmundsdottir, I. J.] Reykjavik Univ Hosp, Dept Cardiol, Reykjavik, Iceland	Lund University; Skane University Hospital; Helsingborgs Hospital; Uppsala University; Uppsala University; Orebro University; Karolinska Institutet; Sodersjukhuset Hospital; Linkoping University; Linkoping University; Vasteras Central Hospital; Linnaeus University; Aarhus University; Landspitali National University Hospital	Gotberg, M (corresponding author), Lund Univ, Skane Univ Hosp, Dept Cardiol, S-22241 Lund, Sweden.	matthias.gotberg@med.lu.se	Jakobsen, Lars/AAH-7297-2021; James, Stefan K/J-4554-2014; Maeng, Michael/AAY-2135-2021; Demchuk, Andrew M/E-1103-2012	Jakobsen, Lars/0000-0002-2522-9253; Maeng, Michael/0000-0002-4310-6433; Demchuk, Andrew M/0000-0002-4930-7789; Gudmundsdottir, Ingibjorg/0000-0001-5475-5044; Frobert, Ole/0000-0002-5846-345X; Held, Claes/0000-0001-9402-7404; terkelsen, christian juhl/0000-0003-0205-9551; Gotberg, Matthias/0000-0002-0912-7927	Philips Volcano	Philips Volcano	Funded by Philips Volcano; iFR SWEDEHEART ClinicalTrials.gov number, NCT02166736.	Barbato E, 2016, J AM COLL CARDIOL, V68, P2247, DOI 10.1016/j.jacc.2016.08.055; Bech GJW, 2001, CIRCULATION, V103, P2928, DOI 10.1161/01.CIR.103.24.2928; Christiansen EH, 2013, LANCET, V381, P661, DOI 10.1016/S0140-6736(12)61962-X; Curzen N, 2014, CIRC-CARDIOVASC INTE, V7, P248, DOI 10.1161/CIRCINTERVENTIONS.113.000978; Dattilo PB, 2012, J AM COLL CARDIOL, V60, P2337, DOI 10.1016/j.jacc.2012.08.990; Davies JE, 2017, NEW ENGL J MED, V376, P1824, DOI 10.1056/NEJMoa1700445; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; DEBRUYNE B, 1995, CIRCULATION, V92, P39, DOI 10.1161/01.CIR.92.1.39; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Gotberg M, 2015, AM HEART J, V170, P945, DOI 10.1016/j.ahj.2015.07.031; Jang HJ, 2013, EUR HEART J, V34, P2055, DOI 10.1093/eurheartj/eht040; Jeremias A, 2014, J AM COLL CARDIOL, V63, P1253, DOI 10.1016/j.jacc.2013.09.060; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; MACHIN D, 1988, BRIT MED J, V296, P1369, DOI 10.1136/bmj.296.6633.1369; Maeng M, 2014, LANCET, V383, P2047, DOI 10.1016/S0140-6736(14)60405-0; Makikallio T, 2016, LANCET, V388, P2742; Patel HR, 2016, CARDIOVASC INTERV TH; Petraco R, 2014, CIRC-CARDIOVASC INTE, V7, P492, DOI 10.1161/CIRCINTERVENTIONS.113.000926; Petraco R, 2013, EUROINTERVENTION, V9, P91, DOI 10.4244/EIJV9I1A14; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; Sen S, 2013, J AM COLL CARDIOL, V62, P566, DOI 10.1016/j.jacc.2013.03.076; Sen S, 2013, J AM COLL CARDIOL, V61, P1409, DOI 10.1016/j.jacc.2013.01.034; Sen S, 2012, J AM COLL CARDIOL, V59, P1392, DOI 10.1016/j.jacc.2011.11.003; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Stone GW, 2016, NEW ENGL J MED, V375, P2223, DOI 10.1056/NEJMoa1610227; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; van de Hoef TP, 2015, EUROINTERVENTION, V11, P914, DOI 10.4244/EIJY14M08_17; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]	29	483	493	2	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2017	376	19					1813	1823		10.1056/NEJMoa1616540	http://dx.doi.org/10.1056/NEJMoa1616540			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2WR	28317438	Green Published			2022-12-28	WOS:000400891100007
J	Vasiliauskaite-Brooks, I; Sounier, R; Rochaix, P; Bellot, G; Fortier, M; Hoh, F; De Colibus, L; Bechara, C; Saied, EM; Arenz, C; Leyrat, C; Granier, S				Vasiliauskaite-Brooks, Ieva; Sounier, Remy; Rochaix, Pascal; Bellot, Gaetan; Fortier, Mathieu; Hoh, Francois; De Colibus, Luigi; Bechara, Cherine; Saied, Essa M.; Arenz, Christoph; Leyrat, Cedric; Granier, Sebastien			Structural insights into adiponectin receptors suggest ceramidase activity	NATURE			English	Article							ADDITIVE FORCE-FIELD; MOLECULAR-DYNAMICS METHOD; MACROMOLECULAR CRYSTALLOGRAPHY; INTRAMEMBRANE PROTEOLYSIS; ACCURATE DOCKING; PROTEIN; SIMULATIONS; VALIDATION; HYDROLASES; DATABASE	Adiponectin receptors (ADIPORs) are integral membrane proteins that control glucose and lipid metabolism by mediating, at least in part, a cellular ceramidase activity1 that catalyses the hydrolysis of ceramide to produce sphingosine and a free fatty acid (FFA). The crystal structures of the two receptor subtypes, ADIPOR1 and ADIPOR2, show a similar overall seven-transmembrane-domain architecture with large unoccupied cavities and a zinc binding site within the seven transmembrane domain2. However, the molecular mechanisms by which ADIPORs function are not known. Here we describe the crystal structure of ADIPOR2 bound to a FFA molecule and show that ADIPOR2 possesses intrinsic basal ceramidase activity that is enhanced by adiponectin. We also identify a ceramide binding pose and propose a possible mechanism for the hydrolytic activity of ADIPOR2 using computational approaches. In molecular dynamics simulations, the side chains of residues coordinating the zinc rearrange quickly to promote the nucleophilic attack of a zinc-bound hydroxide ion onto the ceramide amide carbonyl. Furthermore, we present a revised ADIPOR1 crystal structure exhibiting a seven-transmembranedomain architecture that is clearly distinct from that of ADIPOR2. In this structure, no FFA is observed and the ceramide binding pocket and putative zinc catalytic site are exposed to the inner membrane leaflet. ADIPOR1 also possesses intrinsic ceramidase activity, so we suspect that the two distinct structures may represent key steps in the enzymatic activity of ADIPORs. The ceramidase activity is low, however, and further studies will be required to characterize fully the enzymatic parameters and substrate specificity of ADIPORs. These insights into ADIPOR function will enable the structure-based design of potent modulators of these clinically relevant enzymes.	[Vasiliauskaite-Brooks, Ieva; Sounier, Remy; Rochaix, Pascal; Bellot, Gaetan; Fortier, Mathieu; Leyrat, Cedric; Granier, Sebastien] Univ Montpellier, CNRS UMR 5203, INSERM U1191, Inst Genom Fonct, F-34094 Montpellier, France; [Hoh, Francois] Univ Montpellier, CNRS UMR 5048, Ctr Biochim Struct, INSERM 1054, 29 Rue Navacelles, F-34090 Montpellier, France; [De Colibus, Luigi] Univ Oxford, Div Struct Biol, Oxford, England; [Bechara, Cherine] Univ Montpellier, CNRS UMR5235, Dynam Interact Membranaires Norm & Patholog, F-34095 Montpellier, France; [Saied, Essa M.; Arenz, Christoph] Humboldt Univ, Inst Chem, Brook Taylor Str 2, D-12489 Berlin, Germany; [Saied, Essa M.] Suez Canal Univ, Fac Sci, Dept Chem, Ismailia 41522, Egypt	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; University of Oxford; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Humboldt University of Berlin; Egyptian Knowledge Bank (EKB); Suez Canal University	Leyrat, C (corresponding author), Univ Montpellier, CNRS UMR 5203, INSERM U1191, Inst Genom Fonct, F-34094 Montpellier, France.	cedric.leyrat@igf.cnrs.fr; sebastien.granier@igf.cnrs.fr	Bechara, Cherine/R-1341-2018; Arenz, Christoph/D-1841-2010; LEYRAT, Cédric/G-5559-2017; Granier, Sebastien/J-1089-2016; Saied, Essa M./I-7698-2015; sounier, remy/D-6522-2019	Bechara, Cherine/0000-0002-5539-6327; Saied, Essa M./0000-0002-7342-6200; sounier, remy/0000-0002-7802-2838; Vasiliauskaite-Brooks, Ieva/0000-0002-4803-9057; Leyrat, Cedric/0000-0003-0189-0562; Bellot, Gaetan/0000-0002-2671-6723; hoh, francois/0000-0002-2905-7081; Arenz, Christoph/0000-0001-7613-9437	European Research Council (ERC) under the European Union [647687]	European Research Council (ERC) under the European Union(European Research Council (ERC))	We thank C. Mueller-Dieckmann and U. Zander at the European Synchrotron Radiation Facility (ESRF) for assistance in using beamline ID30B. We acknowledge the ESRF for provision of synchrotron radiation facilities via SSX Block Allocation Group beamtime. We thank R. Joosten and A. Perrakis from the PDB REDO server for help with ADIPOR1 data re-analysis and F. Rey from the Structural Virology Unit, Institut Pasteur for S2 cells and an expression vector for scFv. This project received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement 647687).	Airola MV, 2015, STRUCTURE, V23, P1482, DOI 10.1016/j.str.2015.06.013; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Banks JL, 2005, J COMPUT CHEM, V26, P1752, DOI 10.1002/jcc.20292; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Bricogne G., 2016, BUSTER VERSION X Y Z; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gilmartin AA, 2012, PROTEIN ENG DES SEL, V25, P59, DOI 10.1093/protein/gzr058; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hernick M, 2005, ARCH BIOCHEM BIOPHYS, V433, P71, DOI 10.1016/j.abb.2004.08.006; Holland WL, 2017, MOL METAB, V6, P267, DOI 10.1016/j.molmet.2017.01.002; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126; Johansson Daniel X, 2012, Methods Mol Biol, V907, P359, DOI 10.1007/978-1-61779-974-7_21; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamp F, 2015, BIOPHYS J, V108, P1229, DOI 10.1016/j.bpj.2014.12.045; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Korb O, 2009, J CHEM INF MODEL, V49, P84, DOI 10.1021/ci800298z; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Langosch D, 2015, TRENDS BIOCHEM SCI, V40, P318, DOI 10.1016/j.tibs.2015.04.001; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pei JM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-37; Saied EM, 2015, FUTURE MED CHEM, V7, P1971, DOI 10.4155/fmc.15.126; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Tanabe H, 2015, NATURE, V520, P312, DOI 10.1038/nature14301; Tang YT, 2005, J MOL EVOL, V61, P372, DOI 10.1007/s00239-004-0375-2; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Venable RM, 2014, BIOPHYS J, V107, P134, DOI 10.1016/j.bpj.2014.05.034; Villa NY, 2009, MOL PHARMACOL, V75, P866, DOI 10.1124/mol.108.049809; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984	50	120	122	1	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					120	+		10.1038/nature21714	http://dx.doi.org/10.1038/nature21714			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ8GQ	28329765	Green Accepted			2022-12-28	WOS:000398323300045
J	Ju, YS; Martincorena, I; Gerstung, M; Petljak, M; Alexandrov, LB; Rahbari, R; Wedge, DC; Davies, HR; Ramakrishna, M; Fullam, A; Martin, S; Alder, C; Patel, N; Gamble, S; O'Meara, S; Giri, DD; Sauer, T; Pinder, SE; Purdie, CA; Borg, A; Stunnenberg, H; van de Vijver, M; Tan, BKT; Caldas, C; Tutt, A; Ueno, NT; van't Veer, LJ; Martens, JWM; Sotiriou, C; Knappskog, S; Span, PN; Lakhani, SR; Eyfjord, JE; Borresen-Dale, AL; Richardson, A; Thompson, AM; Viari, A; Hurles, ME; Nik-Zainal, S; Campbell, PJ; Stratton, MR				Ju, Young Seok; Martincorena, Inigo; Gerstung, Moritz; Petljak, Mia; Alexandrov, Ludmil B.; Rahbari, Raheleh; Wedge, David C.; Davies, Helen R.; Ramakrishna, Manasa; Fullam, Anthony; Martin, Sancha; Alder, Christopher; Patel, Nikita; Gamble, Steve; O'Meara, Sarah; Giri, Dilip D.; Sauer, Torril; Pinder, Sarah E.; Purdie, Colin A.; Borg, Ake; Stunnenberg, Henk; van de Vijver, Marc; Tan, Benita K. T.; Caldas, Carlos; Tutt, Andrew; Ueno, Naoto T.; van't Veer, Laura J.; Martens, John W. M.; Sotiriou, Christos; Knappskog, Stian; Span, Paul N.; Lakhani, Sunil R.; Eyfjord, Jorunn Erla; Borresen-Dale, Anne-Lise; Richardson, Andrea; Thompson, Alastair M.; Viari, Alain; Hurles, Matthew E.; Nik-Zainal, Serena; Campbell, Peter J.; Stratton, Michael R.			Somatic mutations reveal asymmetric cellular dynamics in the early human embryo	NATURE			English	Article							WHOLE-GENOME SEQUENCES; EARLY MAMMALIAN EMBRYO; CLONAL HEMATOPOIESIS; BREAST-CANCER; NORMAL-CELLS; NUMBER; AGE; BLASTOCYST; MOSAICISM; LANDSCAPE	Somatic cells acquire mutations throughout the course of an individual's life. Mutations occurring early in embryogenesis are often present in a substantial proportion of, but not all, cells in postnatal humans and thus have particular characteristics and effects(1). Depending on their location in the genome and the proportion of cells they are present in, these mosaic mutations can cause a wide range of genetic disease syndromes(2) and predispose carriers to cancer(3,4). They have a high chance of being transmitted to offspring as de novo germline mutations and, in principle, can provide insights into early human embryonic cell lineages and their contributions to adult tissues(5). Although it is known that gross chromosomal abnormalities are remarkably common in early human embryos(6), our understanding of early embryonic somatic mutations is very limited. Here we use whole-genome sequences of normal blood from 241 adults to identify 163 early embryonic mutations. We estimate that approximately three base substitution mutations occur per cell per cell-doubling event in early human embryogenesis and these are mainly attributable to two known mutational signatures(7). We used the mutations to reconstruct developmental lineages of adult cells and demonstrate that the two daughter cells of many early embryonic cell-doubling events contribute asymmetrically to adult blood at an approximately 2: 1 ratio. This study therefore provides insights into the mutation rates, mutational processes and developmental outcomes of cell dynamics that operate during early human embryogenesis.	[Ju, Young Seok; Martincorena, Inigo; Gerstung, Moritz; Petljak, Mia; Alexandrov, Ludmil B.; Wedge, David C.; Davies, Helen R.; Ramakrishna, Manasa; Fullam, Anthony; Martin, Sancha; Alder, Christopher; Patel, Nikita; Gamble, Steve; O'Meara, Sarah; Nik-Zainal, Serena; Campbell, Peter J.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Ju, Young Seok] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon, South Korea; [Gerstung, Moritz] European Mol Biol Lab, European Bioinformat Inst, Hinxton CB10 1SD, England; [Alexandrov, Ludmil B.] Los Alamos Natl Lab, Theoret Biol & Biophys T6, Los Alamos, NM 87545 USA; [Rahbari, Raheleh; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Genom Mutat & Genet Dis, Hinxton, England; [Wedge, David C.] Oxford Big Data Inst, Oxford, England; [Wedge, David C.] Wellcome Trust Ctr Human Genet, Oxford Ctr Canc Gene Res, Oxford, England; [Giri, Dilip D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA; [Sauer, Torril] Univ Oslo, Inst Clin Med, Campus Akershus Univ Hosp, Lorenskog, Norway; [Pinder, Sarah E.] Kings Coll London, Kings Hlth Partners Canc Biobank, Guys Hosp, Sch Med, London, England; [Purdie, Colin A.] Ninewells Hosp & Med Sch, Dept Pathol, Dundee, Scotland; [Borg, Ake] BioCare, Strateg Canc Res Program, Lund, Sweden; [Borg, Ake] CREATE Hlth, Strateg Ctr Translat Canc Res, Lund, Sweden; [Borg, Ake] Lund Univ, Ctr Canc, Dept Pathol & Oncol, Lund, Sweden; [Stunnenberg, Henk] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [van de Vijver, Marc] Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands; [Tan, Benita K. T.] Singapore Gen Hosp, SingHlth Duke NUS Breast Ctr, Div Surg Oncol, Natl Canc Ctr Singapore,Dept Gen Surg, Singapore, Singapore; [Caldas, Carlos] Univ Cambridge, Canc Res UK CRUK Cambridge Inst, Cambridge, England; [Tutt, Andrew] Kings Coll London, Breast Canc Now Res Unit, London SE1 9RT, England; [Tutt, Andrew] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London SW3 6JB, England; [Ueno, Naoto T.] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [van't Veer, Laura J.] Univ Calif San Francisco, Dept Lab Med, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Martens, John W. M.] Erasmus Univ, Med Ctr, Erasmus MC Canc Inst, Dept Med Oncol, Rotterdam, Netherlands; [Sotiriou, Christos] Inst Jules Bordet, Brussels, Belgium; [Knappskog, Stian] Univ Bergen, Dept Clin Sci, Sect Oncol, Bergen, Norway; [Knappskog, Stian] Haukeland Hosp, Dept Oncol, Bergen, Norway; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Radiat Oncol, Nijmegen, Netherlands; [Span, Paul N.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Nijmegen, Netherlands; [Lakhani, Sunil R.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Royal Brisbane & Womens Hosp, Pathol Queensland, Brisbane, Qld, Australia; [Lakhani, Sunil R.] Univ Queensland, UQ Ctr Clin Res, Brisbane, Qld, Australia; [Eyfjord, Jorunn Erla] Univ Iceland, Canc Res Lab, Reykjavik, Iceland; [Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, Fac Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway; [Richardson, Andrea] Johns Hopkins Med, Sibley Pathol Dept, Washington, DC 20016 USA; [Thompson, Alastair M.] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA; [Viari, Alain] Ctr Leon Berard, Plateforme Gilles Thomas, Synergie Lyon Canc, Lyon 08, France	Wellcome Trust Sanger Institute; Korea Advanced Institute of Science & Technology (KAIST); European Molecular Biology Laboratory (EMBL); United States Department of Energy (DOE); Los Alamos National Laboratory; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; Memorial Sloan Kettering Cancer Center; University of Oslo; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Dundee; Lund University; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; National Cancer Centre Singapore (NCCS); Singapore General Hospital; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of London; King's College London; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Institut Jules Bordet; University of Bergen; University of Bergen; Haukeland University Hospital; Radboud University Nijmegen; Radboud University Nijmegen; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Iceland; University of Oslo; University of Oslo; Johns Hopkins University; Johns Hopkins Medicine; University of Texas System; UTMD Anderson Cancer Center; UNICANCER; Centre Leon Berard	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	mrs@sanger.ac.uk	Wedge, David/AAC-4977-2021; Lakhani, Sunil R/I-1970-2018; Ju, Young Seok/E-1324-2012; Alexandrov, Ludmil/AAS-1454-2021; Caldas, Carlos/U-7250-2019; Stunnenberg, Hendrik G./D-6875-2012; Span, Paul/G-4710-2012; Nik-Zainal, Serena/ABD-4437-2020	Lakhani, Sunil R/0000-0003-4067-2760; Ju, Young Seok/0000-0002-5514-4189; Alexandrov, Ludmil/0000-0003-3596-4515; Caldas, Carlos/0000-0003-3547-1489; Stunnenberg, Hendrik G./0000-0002-0066-1576; Span, Paul/0000-0002-1930-6638; Fullam, Anthony/0000-0002-0884-8124; Gerstung, Moritz/0000-0001-6709-963X; Purdie, Colin/0000-0002-1258-4010; Alder, Christopher/0000-0002-8046-6112; Martin, Sancha/0000-0001-6213-5259; Wedge, David/0000-0002-7572-3196; van de Vijver, Marc/0000-0002-0385-4787; Knappskog, Stian/0000-0002-4153-1655; Nik-Zainal, Serena/0000-0001-5054-1727; Rahbari, Raheleh/0000-0002-1839-7785; Tutt, Andrew/0000-0001-8715-2901; /0000-0003-4167-8910; Martincorena, Inigo/0000-0003-1122-4416	Wellcome Trust [077012/Z/05/Z]; EMBO long-term fellowship [LTF 1203_2012]; KAIST [G04150052]; Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI16C2387]; European Union (BASIS); Wellcome Trust; Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6]; Scottish Funding Council [HR03006]; Cancer Research UK [16942, 21777] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154, NF-SI-0515-10090] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); KAIST; Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; European Union (BASIS); Wellcome Trust(Wellcome TrustEuropean Commission); Chief Scientist Office of the Scottish Government Health Directorates; Scottish Funding Council; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	We thank M. Zernicka-Goetz at Gurdon Institute, K. J. Dawson at Wellcome Trust Sanger Institute and T. Bleazard at University of Manchester for discussion and assistance with manuscript preparation. This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z). Y.S.J. is supported by EMBO long-term fellowship (LTF 1203_2012), by KAIST (G04150052), and by a grant of the Korea Health Technology R&D project through the Korea Health Industry Development Institute (KHIDI) funded by the Ministry of Health & Welfare, Republic of Korea (HI16C2387). P.J.C. is a Wellcome Trust Senior Clinical Fellow. The ICGC Breast Cancer Consortium was supported by a grant from the European Union (BASIS) and the Wellcome Trust. For the family study, Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates (CZD/16/6) and the Scottish Funding Council (HR03006).	Acuna-Hidalgo R, 2015, AM J HUM GENET, V97, P67, DOI 10.1016/j.ajhg.2015.05.008; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bedzhov I, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0538; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Bruce AW, 2010, CURR OPIN GENET DEV, V20, P485, DOI 10.1016/j.gde.2010.05.006; Dal GM, 2014, J MED GENET, V51, P455, DOI 10.1136/jmedgenet-2013-102197; Erickson RP, 2014, CURR OPIN GENET DEV, V26, P73, DOI 10.1016/j.gde.2014.06.001; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; HARDY K, 1989, DEVELOPMENT, V107, P597; Holstege H, 2014, GENOME RES, V24, P733, DOI 10.1101/gr.162131.113; Huang AY, 2014, CELL RES, V24, P1311, DOI 10.1038/cr.2014.131; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Ju YS, 2014, ELIFE, V3, DOI 10.7554/eLife.02935; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Laurie CC, 2012, NAT GENET, V44, P642, DOI 10.1038/ng.2271; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Marikawa Y, 2009, MOL REPROD DEV, V76, P1019, DOI 10.1002/mrd.21057; Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082; Morris SA, 2012, CELL REP, V2, P756, DOI 10.1016/j.celrep.2012.08.029; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Oron E, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045002; Plachta N, 2011, NAT CELL BIOL, V13, P117, DOI 10.1038/ncb2154; Plusa B, 2005, NATURE, V434, P391, DOI 10.1038/nature03388; Rahbari R, 2016, NAT GENET, V48, P126, DOI 10.1038/ng.3469; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Samuels ME, 2015, GENES-BASEL, V6, P216, DOI 10.3390/genes6020216; Skinner ME, 2009, GENOME RES, V19, P1630, DOI 10.1101/gr.094607.109; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Strnad P, 2016, NAT METHODS, V13, P139, DOI [10.1038/NMETH.3690, 10.1038/nmeth.3690]; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Zernicka-Goetz M, 2009, NAT REV GENET, V10, P467, DOI 10.1038/nrg2564	38	148	150	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					714	+		10.1038/nature21703	http://dx.doi.org/10.1038/nature21703			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28329761	Green Submitted, Green Accepted			2022-12-28	WOS:000397619700055
J	Pulido, A; Chen, LJ; Kaczorowski, T; Holden, D; Little, MA; Chong, SY; Slater, BJ; McMahon, DP; Bonillo, B; Stackhouse, CJ; Stephenson, A; Kane, CM; Clowes, R; Hasell, T; Cooper, AI; Day, GM				Pulido, Angeles; Chen, Linjiang; Kaczorowski, Tomasz; Holden, Daniel; Little, Marc A.; Chong, Samantha Y.; Slater, Benjamin J.; McMahon, David P.; Bonillo, Baltasar; Stackhouse, Chloe J.; Stephenson, Andrew; Kane, Christopher M.; Clowes, Rob; Hasell, Tom; Cooper, Andrew I.; Day, Graeme M.			Functional materials discovery using energy-structure-function maps	NATURE			English	Article							METAL-ORGANIC FRAMEWORKS; CRYSTAL-STRUCTURE PREDICTION; IMPROVED FORCE-FIELDS; METHANE STORAGE; MOLECULAR-CRYSTALS; POROUS MATERIALS; SURFACE-AREA; DESIGN; SIMULATIONS; IDENTIFICATION	Molecular crystals cannot be designed in the same manner as macroscopic objects, because they do not assemble according to simple, intuitive rules. Their structures result from the balance of many weak interactions, rather than from the strong and predictable bonding patterns found in metal-organic frameworks and covalent organic frameworks. Hence, design strategies that assume a topology or other structural blueprint will often fail. Here we combine computational crystal structure prediction and property prediction to build energy-structure-function maps that describe the possible structures and properties that are available to a candidate molecule. Using these maps, we identify a highly porous solid, which has the lowest density reported for a molecular crystal so far. Both the structure of the crystal and its physical properties, such as methane storage capacity and guest-molecule selectivity, are predicted using the molecular structure as the only input. More generally, energy-structure-function maps could be used to guide the experimental discovery of materials with any target function that can be calculated from predicted crystal structures, such as electronic structure or mechanical properties.	[Pulido, Angeles; McMahon, David P.; Day, Graeme M.] Univ Southampton, Sch Chem, Computat Syst Chem, Southampton, Hants, England; [Chen, Linjiang; Kaczorowski, Tomasz; Holden, Daniel; Little, Marc A.; Chong, Samantha Y.; Slater, Benjamin J.; Bonillo, Baltasar; Stackhouse, Chloe J.; Stephenson, Andrew; Kane, Christopher M.; Clowes, Rob; Hasell, Tom; Cooper, Andrew I.] Univ Liverpool, Dept Chem, Liverpool, Merseyside, England	University of Southampton; University of Liverpool	Day, GM (corresponding author), Univ Southampton, Sch Chem, Computat Syst Chem, Southampton, Hants, England.	G.M.Day@soton.ac.uk	Cooper, Andrew/ABE-7766-2020; Day, Graeme/B-9437-2008; Chong, Samantha Y/B-4031-2009; Bonillo, Baltasar/A-7708-2016; Hasell, Tom/G-3588-2011	Day, Graeme/0000-0001-8396-2771; Chong, Samantha Y/0000-0002-3095-875X; Bonillo, Baltasar/0000-0003-4751-1468; Hasell, Tom/0000-0003-4736-0604; Little, Marc/0000-0002-1994-0591; Kane, Christopher/0000-0002-5695-9435; PULIDO, ANGELES/0000-0002-7596-7262	European Research Council under the European Union/ERC [321156, 307358]; EPSRC [EP/N004884/1, EP/K018396/1, EP/K018132/1, EP/K000225/1, EP/L000202, EP/N004884]; N8 consortium; Royal Society; US Department of Energy [DE-AC02-05CH11231]; EPSRC [EP/L000202/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/L000202/1, EP/N004884/1, EP/K018132/1, EP/K018396/1] Funding Source: researchfish	European Research Council under the European Union/ERC(European Research Council (ERC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); N8 consortium; Royal Society(Royal Society of London); US Department of Energy(United States Department of Energy (DOE)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC through grant agreement numbers 321156 (ERC-AG-PE5-ROBOT) and 307358 (ERC-stG-2012-ANGLE), and EPSRC (grants EP/N004884/1, EP/K018396/1 and EP/K018132/1) for funding. This work made use of the facilities of N8 HPC Centre of Excellence, provided and funded by the N8 consortium and EPSRC (grant number EP/K000225/1). T.H. thanks the Royal Society for a University Research Fellowship. We thank Diamond Light Source for access to beamlines I19 (MT8728) and I11 (EE12336). We thank the Advanced Light Source, supported by the Director, Office of Science, Office of Basic Energy Sciences, of the US Department of Energy under contract number DE-AC02-05CH11231, and S. J. Teat and K. J. Gagnon for their assistance. We acknowledge the ARCHER UK National Supercomputing Service via the UK's HEC Materials Chemistry Consortium membership and a Programme Grant, which are funded by EPSRC (grants EP/L000202 and EP/N004884), and use of the IRIDIS High Performance Computing Facility at the University of Southampton.	[Anonymous], 2012, MAT STUD V 6 1 200; Case DH, 2016, J CHEM THEORY COMPUT, V12, P910, DOI 10.1021/acs.jctc.5b01112; Ceder G, 1998, NATURE, V392, P694, DOI 10.1038/33647; Chisholm JA, 2005, J APPL CRYSTALLOGR, V38, P228, DOI 10.1107/S0021889804027074; Cote AP, 2007, J AM CHEM SOC, V129, P12914, DOI 10.1021/ja0751781; Cote AP, 2005, SCIENCE, V310, P1166, DOI 10.1126/science.1120411; Cruz-Cabeza AJ, 2015, CHEM SOC REV, V44, P8619, DOI 10.1039/c5cs00227c; Cruz-Cabeza AJ, 2009, CHEM-EUR J, V15, P13033, DOI 10.1002/chem.200901703; Dubbeldam D, 2016, MOL SIMULAT, V42, P81, DOI 10.1080/08927022.2015.1010082; Dyer MS, 2013, SCIENCE, V340, P847, DOI 10.1126/science.1226558; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Evans JD, 2016, CRYSTENGCOMM, V18, P4133, DOI 10.1039/c6ce00064a; Ferenczy GG, 1997, J PHYS CHEM A, V101, P5446, DOI 10.1021/jp9712011; Frisch M.J, 2016, GAUSSIAN16 REVISON A; Gandara F, 2014, J AM CHEM SOC, V136, P5271, DOI 10.1021/ja501606h; Gomez-Gualdron DA, 2016, ENERG ENVIRON SCI, V9, P3279, DOI 10.1039/c6ee02104b; Hachmann J, 2011, J PHYS CHEM LETT, V2, P2241, DOI 10.1021/jz200866s; Jansen M, 2006, ANGEW CHEM INT EDIT, V45, P3406, DOI 10.1002/anie.200504510; Jones JTA, 2011, NATURE, V474, P367, DOI 10.1038/nature10125; KITAJGOR.AI, 1965, ACTA CRYSTALLOGR, V18, P585, DOI 10.1107/S0365110X65001391; Kohl B, 2015, CHEM-EUR J, V21, P17308, DOI 10.1002/chem.201502847; Lewis DW, 1996, NATURE, V382, P604, DOI 10.1038/382604a0; Ma YM, 2009, NATURE, V458, P182, DOI 10.1038/nature07786; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Rodriguez-Albelo LM, 2009, J AM CHEM SOC, V131, P16078, DOI 10.1021/ja905009e; Martin MG, 2013, MOL SIMULAT, V39, P1184, DOI 10.1080/08927022.2013.828208; Mason JA, 2015, NATURE, V527, P357, DOI 10.1038/nature15732; Mastalerz M, 2012, CHEM-EUR J, V18, P10082, DOI 10.1002/chem.201201351; Mastalerz M, 2012, ANGEW CHEM INT EDIT, V51, P5252, DOI 10.1002/anie.201201174; Oganov AR, 2009, NATURE, V457, P863, DOI 10.1038/nature07736; Price SL, 2014, CHEM SOC REV, V43, P2098, DOI 10.1039/c3cs60279f; Price SL, 2010, PHYS CHEM CHEM PHYS, V12, P8478, DOI 10.1039/c004164e; Pyzer-Knapp EO, 2016, ACTA CRYSTALLOGR B, V72, P477, DOI 10.1107/S2052520616007708; Pyzer-Knapp EO, 2014, CHEM SCI, V5, P2235, DOI 10.1039/c4sc00095a; SESE LM, 1995, MOL PHYS, V85, P931, DOI 10.1080/00268979500101571; Sharma V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5845; SIMARD M, 1991, J AM CHEM SOC, V113, P4696, DOI 10.1021/ja00012a057; Simon CM, 2015, ENERG ENVIRON SCI, V8, P1190, DOI 10.1039/c4ee03515a; Spek AL, 2009, ACTA CRYSTALLOGR D, V65, P148, DOI 10.1107/S090744490804362X; Todorov IT, 2006, J MATER CHEM, V16, P1911, DOI 10.1039/b517931a; Wang HL, 2015, J AM CHEM SOC, V137, P9963, DOI 10.1021/jacs.5b05644; Willems TF, 2012, MICROPOR MESOPOR MAT, V149, P134, DOI 10.1016/j.micromeso.2011.08.020; Wilmer CE, 2012, NAT CHEM, V4, P83, DOI [10.1038/NCHEM.1192, 10.1038/nchem.1192]; Winn PJ, 1997, J PHYS CHEM A, V101, P5437, DOI 10.1021/jp971202t; Woodley SM, 2008, NAT MATER, V7, P937, DOI 10.1038/nmat2321; Yong CW, 2016, J CHEM INF MODEL, V56, P1405, DOI 10.1021/acs.jcim.6b00323; Zhang G, 2014, ANGEW CHEM INT EDIT, V53, P1516, DOI 10.1002/anie.201308924; Zonta C, 2010, MOLECULES, V15, P226, DOI 10.3390/molecules15010226	48	260	260	29	451	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					657	+		10.1038/nature21419	http://dx.doi.org/10.1038/nature21419			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28329756	Green Accepted			2022-12-28	WOS:000397619700044
J	Voelker, R				Voelker, Rebecca			Less Noise, Better Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1207	1207		10.1001/jama.2017.2198	http://dx.doi.org/10.1001/jama.2017.2198			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350938				2022-12-28	WOS:000397557800011
J	Hykin, L; Rogers, G				Hykin, Lynnette; Rogers, Gwyneth			Penny Taylor OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		TAYLOR P, PUBLICATION LIST, P62659	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2017	356								j1524	10.1136/bmj.j1524	http://dx.doi.org/10.1136/bmj.j1524			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4JB	28347980				2022-12-28	WOS:000397345700008
J	Padfield, D; Zakrzewska, JM				Padfield, Deborah; Zakrzewska, Joanna M.			Encountering pain	LANCET			English	Editorial Material									[Padfield, Deborah] UCL, Slade Sch Fine Art, London WC1E 6BT, England; [Zakrzewska, Joanna M.] Univ Coll London Hosp NHS Fdn Trust, Facial Pain Unit, Pain Management Ctr, London, England	University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Padfield, D (corresponding author), UCL, Slade Sch Fine Art, London WC1E 6BT, England.	d.padfield@ucl.ac.uk	Zakrzewska, Joanna M./AAC-7378-2020	Zakrzewska, Joanna M./0000-0001-7805-5851; Padfield, Deborah/0000-0002-7805-1815				Biro D., 2010, LANGUAGE PAIN FINDIN; Boddice Rob, 2014, PAIN EMOTION MODERN; Bourke Joanna, 2014, STORY PAIN; Fayaz A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010364; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; Morse JM, 2015, BRIT J PAIN, V9, P26, DOI 10.1177/2049463714550507; Padfield D, 2016, QUALIA, V1, P1; Padfield D, 2015, PAIN RES MANAG, V20, P123, DOI 10.1155/2015/145964; Padfield D, 2011, HEALTH-LONDON, V15, P241, DOI 10.1177/1363459310397974; Scarry Elaine, 1985, BODY PAIN MAKING UNM; Semino E, 2017, LANCET, V389, P1186, DOI 10.1016/S0140-6736(17)30773-0; van Hecke O, 2013, BRIT J ANAESTH, V111, P13, DOI 10.1093/bja/aet123	12	5	5	1	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1177	1178		10.1016/S0140-6736(17)30756-0	http://dx.doi.org/10.1016/S0140-6736(17)30756-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28353430				2022-12-28	WOS:000397143700013
J	Norman, WV; Downie, J				Norman, W. V.; Downie, J.			COMMENTARY Abortion care in Canada is decided between a woman and her doctor, without recourse to criminal law	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Norman, W. V.] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada; [Downie, J.] Dalhousie Univ, Fac Law, Halifax, NS, Canada; [Downie, J.] Dalhousie Univ, Fac Med, Halifax, NS, Canada	University of British Columbia; Dalhousie University; Dalhousie University	Norman, WV (corresponding author), Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada.	wendy.norman@ubc.ca	Norman, Wendy V./D-6796-2015	Norman, Wendy V./0000-0003-4340-7882	Public Health Agency of Canada; Canadian Institutes of Health Research	Public Health Agency of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We have read and understood BMJ policy on declaration of interests and declare that WVN holds a chair in family planning applied public health research funded by the Public Health Agency of Canada and the Canadian Institutes of Health Research; she is a member of the board of directors of the Society of Family Planning and a member of the abortion guidelines committee for the Society of Obstetricians and Gynecologists of Canada.	Bartlett LA, 2004, OBSTET GYNECOL, V103, P729, DOI 10.1097/01.AOG.0000116260.81570.60; Berer M, 2000, B WORLD HEALTH ORGAN, V78, P580; Dyer C, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1485; Grimes DA, 2003, BRIT MED BULL, V67, P99, DOI 10.1093/bmb/ldg002; Norman WV, 2016, CAN FAM PHYSICIAN, V62, pE209; Norman WV, 2012, CONTRACEPTION, V85, P185, DOI 10.1016/j.contraception.2011.06.009; Shah I, 2009, J OBSTET GYNAECOL CA, V31, P1149, DOI 10.1016/S1701-2163(16)34376-6; Shaw J, 2014, BIOETHICS, V28, P33, DOI 10.1111/bioe.12057; Statistics Canada, 2008, 1069034 CANSIM; Supreme Court of Canada, 1988, JUDG SUPR COURT CAN	10	2	2	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2017	356								j1506	10.1136/bmj.j1506	http://dx.doi.org/10.1136/bmj.j1506			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4JA	28341622				2022-12-28	WOS:000397345600004
J	Chowdhury, S; Carter, J; Rollins, MF; Golden, SM; Jackson, RN; Hoffmann, C; Nosaka, L; Bondy-Denomy, J; Maxwell, KL; Davidson, AR; Fischer, ER; Lander, GC; Wiedenheft, B				Chowdhury, Saikat; Carter, Joshua; Rollins, MaryClare F.; Golden, Sarah M.; Jackson, Ryan N.; Hoffmann, Connor; Nosaka, Lyn'Al; Bondy-Denomy, Joseph; Maxwell, Karen L.; Davidson, Alan R.; Fischer, Elizabeth R.; Lander, Gabriel C.; Wiedenheft, Blake			Structure Reveals Mechanisms of Viral Suppressors that Intercept a CRISPR RNA-Guided Surveillance Complex	CELL			English	Article							CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RECOGNITION; CASCADE; CLASSIFICATION; INTERFERENCE; SIMILARITIES; CAS3; INHIBITION; MICROSCOPY	Genetic conflict between viruses and their hosts drives evolution and genetic innovation. Prokaryotes evolved CRISPR-mediated adaptive immune systems for protection from viral infection, and viruses have evolved diverse anti-CRISPR (Acr) proteins that subvert these immune systems. The adaptive immune system in Pseudomonas aeruginosa (type I-F) relies on a 350 kDa CRISPR RNA (crRNA)-guided surveillance complex (Csy complex) to bind foreign DNA and recruit a trans-acting nuclease for target degradation. Here, we report the cryo-electron microscopy (cryo-EM) structure of the Csy complex bound to two different Acr proteins, AcrF1 and AcrF2, at an average resolution of 3.4 angstrom. The structure explains the molecular mechanism for immune system suppression, and structure-guided mutations show that the Acr proteins bind to residues essential for crRNA-mediated detection of DNA. Collectively, these data provide a snapshot of an ongoing molecular arms race between viral suppressors and the immune system they target.	[Chowdhury, Saikat; Nosaka, Lyn'Al; Lander, Gabriel C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Carter, Joshua; Rollins, MaryClare F.; Golden, Sarah M.; Jackson, Ryan N.; Hoffmann, Connor; Wiedenheft, Blake] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA; [Bondy-Denomy, Joseph] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94158 USA; [Maxwell, Karen L.; Davidson, Alan R.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Davidson, Alan R.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Fischer, Elizabeth R.] NIAID, Res Technol Branch, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Jackson, Ryan N.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Scripps Research Institute; Montana State University System; Montana State University Bozeman; University of California System; University of California San Francisco; University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Utah System of Higher Education; Utah State University	Lander, GC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wiedenheft, B (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59717 USA.	glander@scripps.edu; bwiedenheft@gmail.com	CHOWDHURY, SAIKAT/J-6016-2019; Jackson, Ryan N/J-2209-2019	CHOWDHURY, SAIKAT/0000-0001-8043-5028; Jackson, Ryan N/0000-0001-7403-3794; Carter, Joshua/0000-0002-9194-7966; Maxwell, Karen/0000-0002-0211-5480; Lander, Gabriel C./0000-0003-4921-1135	National Institutes of Health [GM103310, P20GM103500, P30GM110732-03, R01GM110270, R01GM108888, DP2EB020402]; National Science Foundation EPSCoR [EPS-110134]; M.J. Murdock Charitable Trust; Amgen; Montana State University Agricultural Experimental Station; University of California San Francisco Program for Breakthrough in Biomedical Research; NIH Office of the Director Early Independence Award [DP5-OD021344]; Canadian Institutes of Health Research [MOP-130482, MOP-136845]; NIH intramural research program; Sandler Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [DP2EB020402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500, R01GM110270, F32GM108436, P30GM110732, P41GM103310, R01GM108888] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD021344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation EPSCoR(National Science Foundation (NSF)); M.J. Murdock Charitable Trust; Amgen(Amgen); Montana State University Agricultural Experimental Station; University of California San Francisco Program for Breakthrough in Biomedical Research; NIH Office of the Director Early Independence Award; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH intramural research program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Jeff Speir and Anchi Cheng, who aided with early EM data collection and analyses at the National Resource for Automated Molecular Microscopy, which is supported by National Institutes of Health grant (GM103310). We thank Mark A. Herzik, Jr. for advice in model building and C. Martin Lawrence for pointing out the distinct fold of Cas7f. We are grateful to Bill Anderson, TSRI Electron Microscopy facility manager, and Jean-Christophe Ducom at TSRI High Performance Computing for support during EM data collection and processing. Research in the Wiedenheft lab is supported by the National Institutes of Health (P20GM103500, P30GM110732-03, R01GM110270, and R01GM108888), the National Science Foundation EPSCoR (EPS-110134), the M.J. Murdock Charitable Trust, a young investigator award from Amgen, and the Montana State University Agricultural Experimental Station. J.C. is supported by the National Institutes of Health (P20GM103474) through Montana INBRE. R.N.J. is a recipient of the Ruth L. Kirschstein National Research Service Award from the National Institutes of Health (F32 GM108436). G.C.L. is supported as a Searle Scholar, as a Pew Scholar, and by the National Institutes of Health (DP2EB020402). J.B.-D. is supported by the University of California San Francisco Program for Breakthrough in Biomedical Research, funded in part by the Sandler Foundation, and an NIH Office of the Director Early Independence Award (DP5-OD021344). A.R.D. and K.L.M. are supported by the Canadian Institutes of Health Research (MOP-130482 and MOP-136845, respectively). E.R.F. is supported by the NIH intramural research program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bondy-Denomy J, 2013, NATURE, V493, P429, DOI 10.1038/nature11723; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Carter J, 2017, CELL, V168, P9, DOI 10.1016/j.cell.2016.12.007; DiMaio F, 2015, NAT METHODS, V12, P361, DOI [10.1038/nmeth.3286, 10.1038/NMETH.3286]; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gleditzsch D, 2016, NUCLEIC ACIDS RES, V44, P5872, DOI 10.1093/nar/gkw469; Goddard TD, 2005, STRUCTURE, V13, P473, DOI 10.1016/j.str.2005.01.006; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Hayes RP, 2016, NATURE, V530, P499, DOI 10.1038/nature16995; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027; Hochstrasser ML, 2014, P NATL ACAD SCI USA, V111, P6618, DOI 10.1073/pnas.1405079111; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huo YW, 2014, NAT STRUCT MOL BIOL, V21, P771, DOI 10.1038/nsmb.2875; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jackson RN, 2014, CURR OPIN STRUC BIOL, V24, P106, DOI 10.1016/j.sbi.2014.01.001; Kuznedelov K, 2016, NUCLEIC ACIDS RES, V44, P10849, DOI 10.1093/nar/gkw914; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo ML, 2016, NUCLEIC ACIDS RES, V44, P7385, DOI 10.1093/nar/gkw421; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Maxwell KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13134; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Pawluk A, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.85, 10.1038/nmicrobiol.2016.85]; Pawluk A, 2014, MBIO, V5, DOI 10.1128/mBio.00896-14; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Topuzlu E, 2016, RNA BIOL, V13, P254, DOI 10.1080/15476286.2015.1130209; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van Duijn E, 2012, MOL CELL PROTEOMICS, V11, P1430, DOI 10.1074/mcp.M112.020263; van Erp PBG, 2015, NUCLEIC ACIDS RES, V43, P8381, DOI 10.1093/nar/gkv793; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang JY, 2016, CELL RES, V26, P1165, DOI 10.1038/cr.2016.103; Wang XF, 2016, NAT STRUCT MOL BIOL, V23, P868, DOI 10.1038/nsmb.3269; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Xue CY, 2016, MOL CELL, V64, P826, DOI 10.1016/j.molcel.2016.09.033; Zhang Y, 2014, SCIENCE, V345, P1452, DOI 10.1126/science.1260026; Zhao HT, 2014, NATURE, V515, P147, DOI 10.1038/nature13733	62	123	131	0	80	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					47	+		10.1016/j.cell.2017.03.012	http://dx.doi.org/10.1016/j.cell.2017.03.012			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340349	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000397090000007
J	Engel, C; Gubbey, T; Neyer, S; Sainsbury, S; Oberthuer, C; Baejen, C; Bernecky, C; Cramer, P				Engel, Christoph; Gubbey, Tobias; Neyer, Simon; Sainsbury, Sarah; Oberthuer, Christiane; Baejen, Carlo; Bernecky, Carrie; Cramer, Patrick			Structural Basis of RNA Polymerase I Transcription Initiation	CELL			English	Article							TATA-BINDING PROTEIN; UPSTREAM ACTIVATION FACTOR; RIBOSOMAL DNA; FACTOR UAF; RDNA TRANSCRIPTION; PREINITIATION COMPLEX; MOLECULAR-STRUCTURES; CRYSTAL-STRUCTURE; FACTOR-TFIIB; PROMOTER	Transcription initiation at the ribosomal RNA promoter requires RNA polymerase (Pol) I and the initiation factors Rrn3 and core factor (CF). Here, we combine X-ray crystallography and cryo-electron microscopy (cryo-EM) to obtain a molecular model for basal Pol I initiation. The three-subunit CF binds upstream promoter DNA, docks to the Pol I-Rrn(3) complex, and loads DNA into the expanded active center cleft of the polymerase. DNA unwinding between the Pol I protrusion and clamp domains enables cleft contraction, resulting in an active Pol I conformation and RNA synthesis. Comparison with the Pol II system suggests that promoter specificity relies on a distinct "bendability'' and "meltability'' of the promoter sequence that enables contacts between initiation factors, DNA, and polymerase.	[Engel, Christoph; Gubbey, Tobias; Neyer, Simon; Sainsbury, Sarah; Oberthuer, Christiane; Baejen, Carlo; Bernecky, Carrie; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany	Max Planck Society	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Fassberg 11, D-37077 Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de		Bernecky, Carrie/0000-0003-0893-7036; Engel, Christoph/0000-0001-8451-3599	Boehringer Ingelheim Fonds PhD fellowships; Deutsche Forschungsgemeinschaft [SFB860, SPP1935]; Advanced Grant ''TRANSREGULON'' from the European Research Council [693023]; Volkswagen Foundation	Boehringer Ingelheim Fonds PhD fellowships(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Advanced Grant ''TRANSREGULON'' from the European Research Council; Volkswagen Foundation(Volkswagen)	We thank Jurgen Plitzko (Max Planck Institute of Biochemistry, Martinsried) and Stefan Raunser and Oliver Hofnagel (Max Planck Institute for Molecular Physiology, Dortmund) for access to EM equipment and assistance with data collection, and Holger Stark, David Haselbach, and Dimitry Tegunov for advice. We thank Herbert Tschochner and colleagues for discussions, Thomas Schulz and Stefan Benkert for yeast fermentation, Kirsten Backs, Ulrich Steuerwald and Carina Burzinski for technical assistance, Alan Cheung for advice, and Stefan Jennebach, Claudia Blattner, Franz Herzog, and Youwei Xu for help. C.E. and S.N. were supported by Boehringer Ingelheim Fonds PhD fellowships. P.C. was supported by the Deutsche Forschungsgemeinschaft (SFB860, SPP1935), the Advanced Grant ''TRANSREGULON'' from the European Research Council (grant agreement 693023), and the Volkswagen Foundation. Part of this work was performed at Beamline X06SA at the Swiss Light Source at the Paul-Scherrer-Institut, Villigen, Switzerland, and at PETRA-III, DESY Hamburg, Germany.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2015, PYMOL MOL GRAPH SYST; Aprikian P, 2000, MOL CELL BIOL, V20, P5269, DOI 10.1128/MCB.20.14.5269-5275.2000; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bedwell GJ, 2012, GENE, V492, P94, DOI 10.1016/j.gene.2011.10.049; Bernecky C, 2016, NATURE, V529, P551, DOI 10.1038/nature16482; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; Blattner C, 2011, GENE DEV, V25, P2093, DOI 10.1101/gad.17363311; BOLSHOY A, 1991, P NATL ACAD SCI USA, V88, P2312, DOI 10.1073/pnas.88.6.2312; Bric A, 2004, J BIOL CHEM, V279, P31259, DOI 10.1074/jbc.M311828200; Brilot AF, 2012, J STRUCT BIOL, V177, P630, DOI 10.1016/j.jsb.2012.02.003; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Bushnell DA, 2004, SCIENCE, V303, P983, DOI 10.1126/science.1090838; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12129; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Feklistov A, 2011, CELL, V147, P1257, DOI 10.1016/j.cell.2011.10.041; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; GOODSELL DS, 1994, NUCLEIC ACIDS RES, V22, P5497, DOI 10.1093/nar/22.24.5497; Gorski JJ, 2007, EMBO J, V26, P1560, DOI 10.1038/sj.emboj.7601601; Grunberg S, 2013, TRENDS BIOCHEM SCI, V38, P603, DOI 10.1016/j.tibs.2013.09.002; Grunberg S, 2012, NAT STRUCT MOL BIOL, V19, P788, DOI 10.1038/nsmb.2334; GRUMMT I, 1982, NATURE, V296, P173, DOI 10.1038/296173a0; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; Hontz RD, 2008, MOL CELL BIOL, V28, P6709, DOI 10.1128/MCB.00703-08; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Keys DA, 1996, GENE DEV, V10, P887, DOI 10.1101/gad.10.7.887; Kim TK, 2000, SCIENCE, V288, P1418, DOI 10.1126/science.288.5470.1418; Knutson BA, 2014, NAT STRUCT MOL BIOL, V21, P810, DOI 10.1038/nsmb.2873; Knutson BA, 2011, SCIENCE, V333, P1637, DOI 10.1126/science.1207699; Kostrewa D, 2009, NATURE, V462, P323, DOI 10.1038/nature08548; KOWNIN P, 1988, MOL CELL BIOL, V8, P747, DOI 10.1128/MCB.8.2.747; KOWNIN P, 1987, CELL, V50, P693, DOI 10.1016/0092-8674(87)90327-8; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lalo D, 1996, J BIOL CHEM, V271, P21062, DOI 10.1074/jbc.271.35.21062; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Lin CW, 1996, MOL CELL BIOL, V16, P6436; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; MALIK S, 1991, P NATL ACAD SCI USA, V88, P9553, DOI 10.1073/pnas.88.21.9553; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Milkereit P, 1997, BIOL CHEM, V378, P1433, DOI 10.1515/bchm.1997.378.12.1433; Miller G, 2001, EMBO J, V20, P1373, DOI 10.1093/emboj/20.6.1373; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Murakami KS, 2002, SCIENCE, V296, P1280, DOI 10.1126/science.1069594; Naidu S, 2011, SCIENCE, V333, P1640, DOI 10.1126/science.1207656; Neyer S, 2016, NATURE, V540, P607, DOI 10.1038/nature20561; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Oakes M, 1999, MOL CELL BIOL, V19, P8559; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473; Pilsl M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12126; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Plaschka C, 2015, NATURE, V518, P376, DOI 10.1038/nature14229; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; Robinson PJ, 2016, CELL, V166, P1411, DOI 10.1016/j.cell.2016.08.050; ROEDER RG, 1969, NATURE, V224, P234, DOI 10.1038/224234a0; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Siddiqi I, 2001, MOL CELL BIOL, V21, P2292, DOI 10.1128/MCB.21.7.2292-2297.2001; Siddiqi IN, 2001, EMBO J, V20, P4512, DOI 10.1093/emboj/20.16.4512; Steffan JS, 1996, GENE DEV, V10, P2551, DOI 10.1101/gad.10.20.2551; Steffan JS, 1998, MOL CELL BIOL, V18, P3752, DOI 10.1128/MCB.18.7.3752; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; Vu L, 1999, P NATL ACAD SCI USA, V96, P4390, DOI 10.1073/pnas.96.8.4390; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yuan XJ, 2002, EMBO REP, V3, P1082, DOI 10.1093/embo-reports/kvf212; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zuo YH, 2015, MOL CELL, V58, P534, DOI 10.1016/j.molcel.2015.03.010	90	65	65	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					120	+		10.1016/j.cell.2017.03.003	http://dx.doi.org/10.1016/j.cell.2017.03.003			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340337	Bronze			2022-12-28	WOS:000397090000013
J	Green, JF				Green, Jessica F.			Don't link carbon markets	NATURE			English	Editorial Material							TRADING SYSTEM; POLICY		[Green, Jessica F.] NYU, Dept Environm Studies, New York, NY 10003 USA	New York University	Green, JF (corresponding author), NYU, Dept Environm Studies, New York, NY 10003 USA.	jessica.green@nyu.edu		Green, Jessica/0000-0002-6700-1126				Chan G., 2012, 17845 NBER; Cullenward Danny, 2016, Electricity Journal, V29, P7, DOI 10.1016/j.tej.2016.06.006; Cullenward D., 2015, UCLA J ENV LAW POLIC, V33, P1; Cullenward D, 2014, B ATOM SCI, V70, P35, DOI 10.1177/0096340214546834; Ellerman AD, 2016, REV ENV ECON POLICY, V10, P89, DOI 10.1093/reep/rev014; Green JF, 2014, NAT CLIM CHANGE, V4, P1064, DOI 10.1038/NCLIMATE2429; Schmalensee R, 2013, J ECON PERSPECT, V27, P103, DOI 10.1257/jep.27.1.103; The World Bank, 2016, EC VIV EC; Wara M, 2008, UCLA LAW REV, V55, P1759; Wara M, 2014, B ATOM SCI, V70, P26, DOI 10.1177/0096340214546832	10	31	32	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					484	486		10.1038/543484a	http://dx.doi.org/10.1038/543484a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO9OM	28332546	Bronze			2022-12-28	WOS:000397018000027
J	Lagos, MJ; Trugler, A; Hohenester, U; Batson, PE				Lagos, Maureen J.; Truegler, Andreas; Hohenester, Ulrich; Batson, Philip E.			Mapping vibrational surface and bulk modes in a single nanocube	NATURE			English	Article							LATTICE-DYNAMICS; MAGNESIUM-OXIDE; FAST ELECTRONS; THIN-FILMS; CRYSTAL; SCATTERING; PHONONS; NANOPARTICLES; SPECTROSCOPY; MICROSCOPE	Imaging of vibrational excitations in and near nanostructures is essential for developing low-loss infrared nanophotonics(1), controlling heat transport in thermal nanodevices(2,3), inventing new thermoelectric materials4 and understanding nanoscale energy transport. Spatially resolved electron energy loss spectroscopy has previously been used to image plasmonic behaviour in nanostructures in an electron microscope(5,6), but hitherto it has not been possible to map vibrational modes directly in a single nanostructure, limiting our understanding of phonon coupling with photons(7) and plasmons(8). Here we present spatial mapping of optical and acoustic, bulk and surface vibrational modes in magnesium oxide nanocubes using an atom-wide electron beam. We find that the energy and the symmetry of the surface polariton phonon modes depend on the size of the nanocubes, and that they are localized to the surfaces of the nanocube. We also observe a limiting of bulk phonon scattering in the presence of surface phonon modes. Most phonon spectroscopies are selectively sensitive to either surface or bulk excitations; therefore, by demonstrating the excitation of both bulk and surface vibrational modes using a single probe, our work represents advances in the detection and visualization of spatially confined surface and bulk phonons in nanostructures.	[Lagos, Maureen J.; Batson, Philip E.] Rutgers State Univ, Inst Adv Mat, Dept Mat & Sci Engn, Dept Phys & Astron, Piscataway, NJ 08854 USA; [Truegler, Andreas; Hohenester, Ulrich] Graz Univ, Inst Phys, Univ 5, A-8010 Graz, Austria	Rutgers State University New Brunswick; University of Graz	Lagos, MJ (corresponding author), Rutgers State Univ, Inst Adv Mat, Dept Mat & Sci Engn, Dept Phys & Astron, Piscataway, NJ 08854 USA.	maureen.lagos@rutgers.edu		Lagos, Maureen Joel/0000-0002-1452-5196; Hohenester, Ulrich/0000-0001-8929-2086	US Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0005132]; Austrian Science Fund FWF [P27299-N27, SFB F49 NextLite (F4906-N23)]	US Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Austrian Science Fund FWF(Austrian Science Fund (FWF))	P.E.B. and M.J.L. acknowledge the financial support of US Department of Energy, Office of Science, Basic Energy Sciences under award number DE-SC0005132. U.H. and A.T. acknowledge the support of the Austrian Science Fund FWF under project P27299-N27 and the SFB F49 NextLite (F4906-N23). We acknowledge O. Krivanek, N. Dellby, T. Lovejoy, M. Saharan and C. Meyer for discussions on the microscope instrumentation/ operation and for help with the software development for microscopy data acquisition.	Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Boudarham G, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.245447; Caldwell JD, 2016, NAT NANOTECHNOL, V11, P9, DOI [10.1038/nnano.2015.305, 10.1038/NNANO.2015.305]; Caldwell JD, 2015, NANOPHOTONICS-BERLIN, V4, P44, DOI 10.1515/nanoph-2014-0003; Caldwell JD, 2013, NANO LETT, V13, P3690, DOI 10.1021/nl401590g; Chalopin Y, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4729384; Clark JN, 2013, SCIENCE, V341, P56, DOI 10.1126/science.1236034; Dwyer C, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.054103; EARNEY JJ, 1971, PHILOS MAG, V23, P577, DOI 10.1080/14786437108216405; Ferrari AC, 2000, PHYS REV B, V61, P14095, DOI 10.1103/PhysRevB.61.14095; Forbes BD, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.014110; FUCHS R, 1965, PHYS REV, V140, P2076; FUCHS R, 1975, PHYS REV B, V11, P1732, DOI 10.1103/PhysRevB.11.1732; de Abajo FJG, 2010, REV MOD PHYS, V82, P209, DOI 10.1103/RevModPhys.82.209; GEIGER J, 1974, J PHYS SOC JPN, V36, P615, DOI 10.1143/JPSJ.36.615; GENZEL L, 1972, PHYS STATUS SOLIDI B, V51, P101, DOI 10.1002/pssb.2220510108; GLAUBER RJ, 1955, PHYS REV, V98, P1692, DOI 10.1103/PhysRev.98.1692; Hillenbrand R, 2002, NATURE, V418, P159, DOI 10.1038/nature00899; Hohenester U, 2012, COMPUT PHYS COMMUN, V183, P370, DOI 10.1016/j.cpc.2011.09.009; Ibach H., 1982, ELECT ENERGY LOSS SP; Krivanek OL, 2014, NATURE, V514, P209, DOI 10.1038/nature13870; LAMBIN P, 1991, PHYS REV B, V44, P6416, DOI 10.1103/PhysRevB.44.6416; LI CH, 1980, PHYS REV B, V21, P3057, DOI 10.1103/PhysRevB.21.3057; Maldovan M, 2013, NATURE, V503, P209, DOI 10.1038/nature12608; MARKS LD, 1982, SOLID STATE COMMUN, V43, P727, DOI 10.1016/0038-1098(82)90979-6; MATSUI M, 1989, J CHEM PHYS, V91, P489, DOI 10.1063/1.457484; Nelayah J, 2007, NAT PHYS, V3, P348, DOI 10.1038/nphys575; Nicoletti O, 2013, NATURE, V502, P80, DOI 10.1038/nature12469; OSHIMA C, 1990, SOLID STATE COMMUN, V73, P731, DOI 10.1016/0038-1098(90)90563-Q; PECKHAM G, 1967, P PHYS SOC LOND, V90, P657, DOI 10.1088/0370-1328/90/3/312; Pines D., 1966, THEORY QUANTUM LIQUI; Rez P, 2014, MICROSC MICROANAL, V20, P671, DOI 10.1017/S1431927614000129; RITCHIE RH, 1957, PHYS REV, V106, P874, DOI 10.1103/PhysRev.106.874; Saavedra JRM, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.115449; SANGSTER MJ, 1970, J PHYS PART C SOLID, V3, P1026, DOI 10.1088/0022-3719/3/5/017; SENET P, 1990, SURF SCI, V226, P307, DOI 10.1016/0039-6028(90)90495-T; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; WALLIS RF, 1959, PHYS REV, V116, P302, DOI 10.1103/PhysRev.116.302	39	145	147	12	257	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					529	+		10.1038/nature21699	http://dx.doi.org/10.1038/nature21699			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28332537				2022-12-28	WOS:000397018000046
J	Harris, PF				Harris, Patricia F.			Review: Palliative care improves quality of life and symptom burden but does not affect mortality at 1 to 3 months	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Harris, Patricia F.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Harris, PF (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.							El-Jawahri Areej, 2011, J Support Oncol, V9, P87; Zimmermann C, 2008, JAMA-J AM MED ASSOC, V299, P1698, DOI 10.1001/jama.299.14.1698	2	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC31	JC31		10.7326/ACPJC-2017-166-6-031	http://dx.doi.org/10.7326/ACPJC-2017-166-6-031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320005				2022-12-28	WOS:000397025800008
J	Higgins, MT				Higgins, Mary T.			David Almond Pemberton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		PEMBERTON DA, PUBLICATION LIST	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2017	356								j1139	10.1136/bmj.j1139	http://dx.doi.org/10.1136/bmj.j1139			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NR	28314717				2022-12-28	WOS:000397015900004
J	Mahenderkar, NK; Chen, QZ; Liu, YC; Duchild, AR; Hofheins, S; Chason, E; Switzer, JA				Mahenderkar, Naveen K.; Chen, Qingzhi; Liu, Ying-Chau; Duchild, Alexander R.; Hofheins, Seth; Chason, Eric; Switzer, Jay A.			Epitaxial lift-off of electrodeposited single-crystal gold foils for flexible electronics	SCIENCE			English	Article							SILICON	We introduce a simple and inexpensive procedure for epitaxial lift-off of wafer-size flexible and transparent foils of single-crystal gold using silicon as a template. Lateral electrochemical undergrowth of a sacrificial SiOx layer was achieved by photoelectrochemically oxidizing silicon under light irradiation. A 28-nanometer-thick gold foil with a sheet resistance of 7 ohms per square showed only a 4% increase in resistance after 4000 bending cycles. A flexible organic light-emitting diode based on tris(bipyridyl) ruthenium(II) that was spin-coated on a foil exploited the transmittance and flexibility of the gold foil. Cuprous oxide as an inorganic semiconductor that was epitaxially electrodeposited onto the gold foils exhibited a diode quality factor n of 1.6 (where n = 1.0 for an ideal diode), compared with a value of 3.1 for a polycrystalline deposit. Zinc oxide nanowires electrodeposited epitaxially on a gold foil also showed flexibility, with the nanowires intact up to 500 bending cycles.	[Mahenderkar, Naveen K.] Missouri Univ Sci & Technol, Dept Mat Sci & Engn, Rolla, MO 65409 USA; [Mahenderkar, Naveen K.; Chen, Qingzhi; Liu, Ying-Chau; Duchild, Alexander R.; Hofheins, Seth; Switzer, Jay A.] Missouri Univ Sci & Technol, Grad Ctr Mat Res, Rolla, MO 65409 USA; [Chen, Qingzhi; Liu, Ying-Chau; Duchild, Alexander R.; Hofheins, Seth; Switzer, Jay A.] Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA; [Chason, Eric] Brown Univ, Sch Engn, Providence, RI 02912 USA	University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology; University of Missouri System; Missouri University of Science & Technology; Brown University	Switzer, JA (corresponding author), Missouri Univ Sci & Technol, Grad Ctr Mat Res, Rolla, MO 65409 USA.; Switzer, JA (corresponding author), Missouri Univ Sci & Technol, Dept Chem, Rolla, MO 65409 USA.	jswitzer@mst.edu		Chen, Qingzhi/0000-0001-8636-8380; Liu, Ying-Chau/0000-0002-5450-3047	U.S. Department of Energy, Office of Basic Sciences, Division of Materials Sciences and Engineering [DE-FG02-08ER46518, DE-SC0008799]	U.S. Department of Energy, Office of Basic Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE))	The material is based on work supported by the U.S. Department of Energy, Office of Basic Sciences, Division of Materials Sciences and Engineering under grants DE-FG02-08ER46518 (J.A.S.) and DE-SC0008799 (E.C.). All data are presented in the main paper and supplement.	Akinwande D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6678; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Bi YG, 2016, NANOSCALE, V8, P10010, DOI 10.1039/c6nr00599c; Broomhead J. A., 2007, INORG SYNTH, V28, P338; Cheng T, 2016, J MATER CHEM A, V4, P10493, DOI 10.1039/c6ta03537j; Gao FG, 2000, J AM CHEM SOC, V122, P7426, DOI 10.1021/ja000666t; Gao W, 2016, NATURE, V529, P509, DOI 10.1038/nature16521; Gates BD, 2009, SCIENCE, V323, P1566, DOI 10.1126/science.1171230; HEAVENS OS, 1960, REP PROG PHYS, V23, P2; Hovel M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035402; IWANOWSKI RJ, 1985, SOL CELLS, V13, P253, DOI 10.1016/0379-6787(85)90018-3; JARRETT DN, 1976, J PHYS D APPL PHYS, V9, P1515, DOI 10.1088/0022-3727/9/10/017; JASTRZEBSKI L, 1983, J CRYST GROWTH, V63, P493, DOI 10.1016/0022-0248(83)90164-1; Kenry, 2016, MICROSYST NANOENG, V2, DOI 10.1038/micronano.2016.43; Kim WK, 2015, SCI REP-UK, V5, DOI 10.1038/srep10715; Koza JA, 2016, CHEM MATER, V28, P399, DOI 10.1021/acs.chemmater.5b04524; KUMARI S, 1981, SOL ENERG MATER, V5, P383, DOI 10.1016/0165-1633(81)90073-3; Maurer JHM, 2016, NANO LETT, V16, P2921, DOI 10.1021/acs.nanolett.5b04319; O'Connor B, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3028046; Prod'homme P, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3006064; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; SEN K, 1984, J APPL PHYS, V56, P1240, DOI 10.1063/1.334059; Shahrjerdi D, 2013, NANO LETT, V13, P315, DOI 10.1021/nl304310x; Shin JW, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2752531; SMITH GB, 1986, J APPL PHYS, V59, P571, DOI 10.1063/1.336615; Sun DM, 2011, NAT NANOTECHNOL, V6, P156, DOI [10.1038/nnano.2011.1, 10.1038/NNANO.2011.1]; Switzer JA, 2016, ACS APPL MATER INTER, V8, P15828, DOI 10.1021/acsami.6b04552; Wang CF, 2015, NANO ENERGY, V14, P364, DOI 10.1016/j.nanoen.2014.11.033; Warren S, 2009, SURF SCI, V603, P1212, DOI 10.1016/j.susc.2009.03.004; Wu WZ, 2013, SCIENCE, V340, P952, DOI [10.1126/science.1234855, 10.1126/science.1237145]; Xu S, 2015, SCIENCE, V347, P154, DOI 10.1126/science.1260960; Yoon J, 2008, NAT MATER, V7, P907, DOI 10.1038/nmat2287	32	80	81	13	208	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1203	1206		10.1126/science.aam5830	http://dx.doi.org/10.1126/science.aam5830			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302857				2022-12-28	WOS:000396351200043
J	Serrano, M				Serrano, Manuel			Understanding Aging	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELLS		[Serrano, Manuel] Spanish Natl Canc Res Ctr CNIO, Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Serrano, M (corresponding author), Spanish Natl Canc Res Ctr CNIO, Madrid, Spain.		Serrano, Manuel/H-2634-2015	Serrano, Manuel/0000-0001-7177-9312				Abad M, 2013, NATURE, V502, P340, DOI 10.1038/nature12586; Mandai M, 2017, NEW ENGL J MED, V376, P1038, DOI 10.1056/NEJMoa1608368; Ocampo A, 2016, CELL, V167, P1719, DOI 10.1016/j.cell.2016.11.052; Ohnishi K, 2014, CELL, V156, P663, DOI 10.1016/j.cell.2014.01.005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trounson A, 2016, NAT REV MOL CELL BIO, V17, P194, DOI 10.1038/nrm.2016.10	6	9	9	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1083	1085		10.1056/NEJMcibr1615878	http://dx.doi.org/10.1056/NEJMcibr1615878			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0QT	28296601				2022-12-28	WOS:000396403700016
J	Meurer, WJ; Tolles, J				Meurer, William J.; Tolles, Juliana			Logistic Regression Diagnostics Understanding How Well a Model Predicts Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GOODNESS-OF-FIT; CURVE	In the March 8, 2016, issue of JAMA, Zemek et al(1) used logistic regression to develop a clinical risk score for identifying which pediatric patients with concussion will experience prolonged postconcussion symptoms (PPCS). The authors prospectively recorded the initial values of 46 potential predictor variables, or risk factors-selected based on expert opinion and previous research-in a cohort of patients and then followed those patients to determine who developed the primary outcome of PPCS. In the first part of the study, the authors created a logistic regression model to estimate the probability of PPCS using a subset of the variables; in the second part of the study, a separate set of data was used to assess the validity of the model, with the degree of success quantified using regression model diagnostics. The rationale for using logistic regression to develop predictive models was summarized in an earlier JAMA Guide to Statistics and Methods article. 2 In this article, we discuss how well a model performs once it is defined.	[Meurer, William J.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Meurer, William J.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Tolles, Juliana] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Tolles, Juliana] Los Angeles Biomed Res Inst, Torrance, CA USA; [Tolles, Juliana] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Meurer, WJ (corresponding author), Dept Emergency Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	wmeurer@med.umich.edu	Meurer, William J/A-7547-2010	Meurer, William J/0000-0002-1158-5302				Cameron AC, 1997, J ECONOMETRICS, V77, P329; EFRON B, 1986, J AM STAT ASSOC, V81, P461, DOI 10.2307/2289236; Fitzgerald M, 2015, JAMA-J AM MED ASSOC, V313, P409, DOI 10.1001/jama.2015.37; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hosmer D. W., 2013, APPL LOGISTIC REGRES; Hosmer DW, 1997, STAT MED, V16, P965; Pencina MJ, 2015, JAMA-J AM MED ASSOC, V314, P1063, DOI 10.1001/jama.2015.11082; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tolles J, 2016, JAMA-J AM MED ASSOC, V316, P533, DOI 10.1001/jama.2016.7653; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	10	85	85	5	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1068	1069		10.1001/jama.2016.20441	http://dx.doi.org/10.1001/jama.2016.20441			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291878				2022-12-28	WOS:000396713400019
J	Capodanno, D; Angiolillo, DJ				Capodanno, Davide; Angiolillo, Dominick J.			Tailoring duration of DAPT with risk scores	LANCET			English	Editorial Material							DUAL ANTIPLATELET THERAPY; VALIDATION; STENTS		[Capodanno, Davide] Univ Catania, Ferrarotto Hosp, Catania, Italy; [Angiolillo, Dominick J.] Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA	University of Catania; State University System of Florida; University of Florida	Angiolillo, DJ (corresponding author), Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA.	dominick.angiolillo@jax.ufl.edu	Capodanno, Davide/AAP-4949-2020		AstraZeneca; Bayer; Daiichi Sankyo; Eli Lilly; Medicines Company; Abbott Vascular; Amgen; Chiesi; Merck; Pfizer; PLx Pharma; Sanofi; CSL Behring; Gilead; GlaxoSmithKline; Janssen Pharmaceuticals; Novartis; Osprey Medical	AstraZeneca(AstraZeneca); Bayer(Bayer AG); Daiichi Sankyo(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Medicines Company; Abbott Vascular(Abbott Laboratories); Amgen(Amgen); Chiesi(Chiesi Pharmaceuticals Inc); Merck(Merck & Company); Pfizer(Pfizer); PLx Pharma; Sanofi; CSL Behring; Gilead(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); Osprey Medical	DC reports receiving payments as an individual for consulting fee or honorarium from AstraZeneca, Bayer, Daiichi Sankyo, Eli Lilly, and The Medicines Company. DJA reports receiving payments as an individual for consulting fee or honorarium from Abbott Vascular, Amgen, AstraZeneca, Bayer, Chiesi, Daiichi Sankyo, Eli Lilly, Merck, Pfizer, PLx Pharma, Sanofi, and The Medicines Company; participation in review activities from Johnson & Johnson and St Jude Medical; institutional payments for grants from Amgen, AstraZeneca, CSL Behring, Daiichi Sankyo, Eli Lilly, Gilead, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis, Osprey Medical, and The Medicines Company.	Baber U, 2016, J AM COLL CARDIOL, V67, P2224, DOI 10.1016/j.jacc.2016.02.064; Bittl JA, 2016, CIRCULATION, V134, pE156, DOI 10.1161/CIR.0000000000000405; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Costa F, 2017, LANCET, V389, P1025, DOI 10.1016/S0140-6736(17)30397-5; Dauerman HL, 2011, J AM COLL CARDIOL, V58, P1, DOI 10.1016/j.jacc.2011.02.039; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Urban P, 2015, NEW ENGL J MED, V373, P2038, DOI 10.1056/NEJMoa1503943; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775	9	39	39	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					987	989		10.1016/S0140-6736(17)30591-3	http://dx.doi.org/10.1016/S0140-6736(17)30591-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN9UN	28291000				2022-12-28	WOS:000396345200002
J	Rayman, G				Rayman, Gerry			Virtual Glucose Management in the Hospital Setting	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							LENGTH-OF-STAY; MORTALITY; HYPERGLYCEMIA		[Rayman, Gerry] Ipswich Hosp NHS Trust, Ipswich, Suffolk, England	Ipswich Hospital NHS Trust; Ipswich Hospital	Rayman, G (corresponding author), Ipswich Hosp, Diabet Ctr, Heath Rd, Ipswich IP1 3RG, Suffolk, England.	Gerry.Rayman@ipswichhospital.nhs.uk						Amor AJ, 2014, MED CLIN-BARCELONA, V142, P387, DOI 10.1016/j.medcli.2013.01.037; Mendez CE, 2015, ENDOCR PRACT, V21, P927, DOI 10.4158/EP14577.OR; Mendez CE, 2013, DIABETES CARE, V36, P4091, DOI 10.2337/dc12-2430; Meng Y.Y., 2014, DIABETES TIED 3 CALI; NHS Digital, 2017, NAT DIAB INP AUD NAD; Nirantharakumar K, 2012, DIABETIC MED, V29, pe445, DOI 10.1111/dme.12002; Pasquel FJ, 2017, LANCET DIABETES ENDO, V5, P125, DOI 10.1016/S2213-8587(16)30402-8; Rushakoff RJ, 2017, ANN INTERN MED, V166, P621, DOI 10.7326/M16-1413; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Umpierrez GE, 2011, DIABETES CARE, V34, P256, DOI 10.2337/dc10-1407	10	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					673	674		10.7326/M17-0590	http://dx.doi.org/10.7326/M17-0590			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28346945				2022-12-28	WOS:000400395500016
J	Rushakoff, RJ; Sullivan, MM; MacMaster, HW; Shah, AD; Rajkomar, A; Glidden, DV; Kohn, MA				Rushakoff, Robert J.; Sullivan, Mary M.; MacMaster, Heidemarie Windham; Shah, Arti D.; Rajkomar, Alvin; Glidden, David V.; Kohn, Michael A.			Association Between a Virtual Glucose Management Service and Glycemic Control in Hospitalized Adult Patients An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICAL RESIDENTS; INPATIENT; IMPACT; MORTALITY; HYPERGLYCEMIA; KNOWLEDGE; INSULIN; LENGTH; STAY; INTERVENTION	Background: Inpatient hyperglycemia is common and is linked to adverse patient outcomes. New methods to improve glycemic control are needed. Objective: To determine whether a virtual glucose management service (vGMS) is associated with improved inpatient glycemic control. Design: Cross-sectional analyses of three 12-month periods (pre-vGMS, transition, and vGMS) between 1 June 2012 and 31 May 2015. Setting: 3 University of California, San Francisco, hospitals. Patients: All nonobstetric adult inpatients who underwent point-of-care glucose testing. Intervention: Hospitalized adult patients with 2 or more glucose values of 12.5 mmol/L or greater (>= 225 mg/dL) (hyperglycemic) and/or a glucose level less than 3.9 mmol/L (<70 mg/dL) (hypoglycemic) in the previous 24 hours were identified using a daily glucose report. Based on review of the insulin/glucose chart in the electronic medical record, recommendations for insulin changes were entered in a vGMS note, which could be seen by all clinicians. Measurements: Proportion of patient-days classified as hyperglycemic, hypoglycemic, and at-goal (all measurements >= 3.9 and <= 10 mmol/L [>= 70 and <= 180 mg/dL] during the pre-vGMS, transition, and vGMS periods). Results: The proportion of hyperglycemic patients decreased by 39%, from 6.6 per 100 patient-days in the pre-vGMS period to 4.0 per 100 patient-days in the vGMS period (difference, -2.5 [ 95% CI, -2.7 to -2.4]). The hypoglycemic proportion in the vGMS period was 36% lower than in the pre-vGMS period (difference, -0.28 [ CI, -0.35 to -0.22]). Forty severe hypoglycemic events (<2.2 mmol/L [<40 mg/dL]) occurred during the pre-vGMS period compared with 15 during the vGMS period. Limitation: Information was not collected on patients' concurrent illnesses and treatment or physicians' responses to the vGMS notes. Conclusion: Implementation of the vGMS was associated with decreases in hyperglycemia and hypoglycemia.	[Rushakoff, Robert J.] Univ Calif San Francisco, Div Endocrinol & Metab, 1600 Divisadero St,Room C430, San Francisco, CA 94115 USA; [Sullivan, Mary M.] Univ Calif San Francisco, Dept Nursing, Box 0210,1550 4th St,282, San Francisco, CA 94158 USA; [MacMaster, Heidemarie Windham] Univ Calif San Francisco, Med Ctr, Dept Pharm, 533 Parnassus Ave,U585d, San Francisco, CA 94143 USA; [MacMaster, Heidemarie Windham] Univ Calif San Francisco, Med Ctr, Dept Nursing, 533 Parnassus Ave,U585d, San Francisco, CA 94143 USA; [Shah, Arti D.] Univ Calif Los Angeles, Div Endocrinol & Metab, 3445 Pacific Coast Highway,Suite 100, Torrance, CA 90505 USA; [Rajkomar, Alvin] Univ Calif San Francisco, Dept Med, Box 0131,533 Parnassus Ave,125, San Francisco, CA 94143 USA; [Glidden, David V.; Kohn, Michael A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, Box 0560,550 16th St, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rushakoff, RJ (corresponding author), Univ Calif San Francisco, Div Endocrinol & Metab, 1600 Divisadero St,Room C430, San Francisco, CA 94115 USA.	robert.rushakoff@ucsf.edu; Michael.kohn@ucsf.edu	Glidden, David/AAD-4730-2020	Glidden, David/0000-0001-5888-1419	National Institutes of Health; Wilsey Family Foundation; UCSF Clinical & Translational Science Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wilsey Family Foundation; UCSF Clinical & Translational Science Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health, the Wilsey Family Foundation, and the UCSF Clinical & Translational Science Institute.	Adler-Milstein J, 2015, HEALTH AFFAIR, V34, P2174, DOI 10.1377/hlthaff.2015.0992; Amor AJ, 2014, MED CLIN-BARCELONA, V142, P387, DOI 10.1016/j.medcli.2013.01.037; Apsey HA, 2014, ENDOCR PRACT, V20, P320, DOI 10.4158/EP13366.OR; Baldwin D, 2005, DIABETES CARE, V28, P1008, DOI 10.2337/diacare.28.5.1008; Bersoux S, 2014, ENDOCR PRACT, V20, P876, DOI 10.4158/EP13516.OR; Brodovicz KG, 2013, CURR MED RES OPIN, V29, P101, DOI 10.1185/03007995.2012.754744; Centers for Medicare & Medicaid Services, 2016, BUNDL PAYM CAR IMPR; Cheung NW, 2005, DIABETES CARE, V28, P2367, DOI 10.2337/diacare.28.10.2367; Cook Curtiss B, 2009, J Diabetes Sci Technol, V3, P1377; DeSalvo DJ, 2012, DIABETES CARE, V35, P2188, DOI 10.2337/dc12-0450; Desimone ME, 2012, ENDOCR PRACT, V18, P238, DOI 10.4158/EP11277.OR; Donihi AC, 2011, ENDOCR PRACT, V17, P552, DOI 10.4158/EP10330.OR; Falciglia M, 2009, CRIT CARE MED, V37, P3001, DOI 10.1097/CCM.0b013e3181b083f7; Flanagan D, 2008, DIABETIC MED, V25, P147, DOI 10.1111/j.1464-5491.2007.02326.x; Koproski J, 1997, DIABETES CARE, V20, P1553, DOI 10.2337/diacare.20.10.1553; LEVETAN CS, 1995, AM J MED, V99, P22, DOI 10.1016/S0002-9343(99)80100-4; Lubitz CC, 2007, DIABETES SPECTR, V20, P18, DOI DOI 10.2337/DIASPECT.20.1; Mendez CE, 2015, ENDOCR PRACT, V21, P927, DOI 10.4158/EP14577.OR; Meng Y.Y., 2014, DIABETES TIED 3 CALI; Metzger J, 2010, HEALTH AFFAIR, V29, P655, DOI 10.1377/hlthaff.2010.0160; Mularski Karen S, 2012, Perm J, V16, P28; Nanayakkara N, 2015, BMJ OPEN DIAB RES CA, V3, DOI 10.1136/bmjdrc-2015-000113; Neinstein Aaron, 2014, J Diabetes Sci Technol, V8, P641, DOI 10.1177/1932296814536290; Nirantharakumar K, 2012, DIABETIC MED, V29, pe445, DOI 10.1111/dme.12002; Rajendran R, 2015, CLIN MED, V15, P229, DOI 10.7861/clinmedicine.15-3-229; Seheult JN, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/807310; Sullivan MM, 2010, DIABETES CARE, V33, P1744, DOI 10.2337/dc10-0031; Tamler R, 2012, J DIABETES, V4, P281, DOI 10.1111/j.1753-0407.2012.00189.x; Tamler R, 2011, DIABETES CARE, V34, P1738, DOI 10.2337/dc11-0517; Tamler R, 2011, POSTGRAD MED, V123, P99, DOI 10.3810/pgm.2011.07.2309; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Venkat KK, 2015, CLEV CLIN J MED, V82, P13, DOI 10.3949/ccjm.82a.14008; Weinberg Melissa E, 2010, J Diabetes Sci Technol, V4, P577; Zapatero A, 2014, ENDOCR PRACT, V20, P870, DOI 10.4158/EP14006.OR	34	43	46	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					621	+		10.7326/M16-1413	http://dx.doi.org/10.7326/M16-1413			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28346946				2022-12-28	WOS:000400395500006
J	Kaplan, H; Thompson, RC; Trumble, BC; Wann, LS; Allam, AH; Beheim, B; Frohlich, B; Sutherland, ML; Sutherland, JD; Stieglitz, J; Rodriguez, DE; Michalik, DE; Rowan, CJ; Lombardi, P; Bedi, R; Garcia, AR; Min, JK; Narula, J; Finch, CE; Gurven, M; Thomas, GS				Kaplan, Hillard; Thompson, Randall C.; Trumble, Benjamin C.; Wann, L. Samuel; Allam, Adel H.; Beheim, Bret; Frohlich, Bruno; Sutherland, M. Linda; Sutherland, James D.; Stieglitz, Jonathan; Rodriguez, Daniel Eid; Michalik, David E.; Rowan, Chris J.; Lombardi, P.; Bedi, Ram; Garcia, Angela R.; Min, James K.; Narula, Jagat; Finch, Caleb E.; Gurven, Michael; Thomas, Gregory S.			Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study	LANCET			English	Article							HEART-DISEASE EVENTS; ARTERY CALCIUM; BLOOD-PRESSURE; RISK-FACTORS; MYOCARDIAL-INFARCTION; UNITED-STATES; MESA; HORTICULTURALISTS; ASSOCIATION; CHOLESTEROL	Background Conventional coronary artery disease risk factors might potentially explain at least 90% of the attributable risk of coronary artery disease. To better understand the association between the pre-industrial lifestyle and low prevalence of coronary artery disease risk factors, we examined the Tsimane, a Bolivian population living a subsistence lifestyle of hunting, gathering, fishing, and farming with few cardiovascular risk factors, but high infectious inflammatory burden. Methods We did a cross-sectional cohort study including all individuals who self-identified as Tsimane and who were aged 40 years or older. Coronary atherosclerosis was assessed by coronary artery calcium (CAC) scoring done with non-contrast CT in Tsimane adults. We assessed the difference between the Tsimane and 6814 participants from the Multi-Ethnic Study of Atherosclerosis (MESA). CAC scores higher than 100 were considered representative of significant atherosclerotic disease. Tsimane blood lipid and inflammatory biomarkers were obtained at the time of scanning, and in some patients, longitudinally. Findings Between July 2, 2014, and Sept 10, 2015, 705 individuals, who had data available for analysis, were included in this study. 596 (85%) of 705 Tsimane had no CAC, 89 (13%) had CAC scores of 1-100, and 20 (3%) had CAC scores higher than 100. For individuals older than age 75 years, 31 (65%) Tsimane presented with a CAC score of 0, and only four (8%) had CAC scores of 100 or more, a five-fold lower prevalence than industrialised populations (p=0.0001 for all age categories of MESA). Mean LDL and HDL cholesterol concentrations were 2.35 mmol/L (91 mg/dL) and 1.0 mmol/L (39.5 mg/dL), respectively; obesity, hypertension, high blood sugar, and regular cigarette smoking were rare. High-sensitivity C-reactive protein was elevated beyond the clinical cutoff of 3.0 mg/dL in 360 (51%) Tsimane participants. Interpretation Despite a high infectious inflammatory burden, the Tsimane, a forager-horticulturalist population of the Bolivian Amazon with few coronary artery disease risk factors, have the lowest reported levels of coronary artery disease of any population recorded to date. These findings suggest that coronary atherosclerosis can be avoided in most people by achieving a lifetime with very low LDL, low blood pressure, low glucose, normal body-mass index, no smoking, and plenty of physical activity. The relative contributions of each are still to be determined.	[Kaplan, Hillard; Stieglitz, Jonathan] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Thompson, Randall C.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA; [Trumble, Benjamin C.] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Trumble, Benjamin C.] Arizona State Univ, Ctr Evolut & Med, Tempe, AZ USA; [Wann, L. Samuel] Ascens Healthcare, Milwaukee, WI USA; [Allam, Adel H.] Al Azhar Univ, Cairo, Egypt; [Beheim, Bret] Max Planck Inst Evolutionary Anthropol, Dept Human Behav Ecol & Culture, Leipzig, Germany; [Frohlich, Bruno] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Frohlich, Bruno] Dartmouth Coll, Hanover, NH 03755 USA; [Sutherland, M. Linda] Newport Diagnost Ctr, Newport Beach, CA USA; [Sutherland, James D.] South Coast Radiol Med Grp, Laguna Hills, CA USA; [Stieglitz, Jonathan] Inst Adv Study Toulouse, Toulouse, France; [Rodriguez, Daniel Eid] Univ San Simon, Dept Med, Cochabamba, Bolivia; [Michalik, David E.] Univ Calif Irvine, Sch Med, Irvine, CA 92717 USA; [Michalik, David E.] Miller Womens & Childrens Hosp Long Beach, Long Beach, CA USA; [Rowan, Chris J.] Renown Inst Heart & Vasc Hlth, Reno, NV USA; [Rowan, Chris J.] Univ Nevada, Reno, NV 89557 USA; [Lombardi, P.] Univ Peruana Cayetano Heredia, Catedra Pedro Weiss, Lab Paleopatol, Lima, Peru; [Bedi, Ram] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Garcia, Angela R.; Gurven, Michael] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Min, James K.] Weill Cornell Med Coll, New York, NY USA; [Min, James K.] NewYork Presbyterian Hosp, New York, NY USA; [Narula, Jagat] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Finch, Caleb E.] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA; [Finch, Caleb E.] Univ Southern Calif, Dornsife Coll, Los Angeles, CA USA; Long Beach Mem, Long Beach, CA USA; [Thomas, Gregory S.] Univ Calif Irvine, Orange, CA 92668 USA	University of New Mexico; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Egyptian Knowledge Bank (EKB); Al Azhar University; Max Planck Society; Smithsonian Institution; Smithsonian National Museum of Natural History; Dartmouth College; University of California System; University of California Irvine; Nevada System of Higher Education (NSHE); University of Nevada Reno; Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of California System; University of California Santa Barbara; Cornell University; NewYork-Presbyterian Hospital; Icahn School of Medicine at Mount Sinai; University of Southern California; University of Southern California; University of California System; University of California Irvine	Kaplan, H (corresponding author), Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA.	hkaplan@unm.edu	Finch, Caleb/AAA-7250-2022	Garcia, Angela/0000-0002-6685-5533; Gurven, Michael/0000-0002-5661-527X; Kaplan, Hillard/0000-0002-7398-7358; Lombardi, Guido/0000-0002-3402-0339; Trumble, Benjamin/0000-0003-3201-0628	National Institute on Aging, National Institutes of Health; St Luke's Hospital of Kansas City; Paleocardiology Foundation; NATIONAL INSTITUTE ON AGING [RF1AG054442, R01AG024119, R56AG024119] Funding Source: NIH RePORTER	National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); St Luke's Hospital of Kansas City; Paleocardiology Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institute on Aging, National Institutes of Health; St Luke's Hospital of Kansas City; and Paleocardiology Foundation.	Abd TT, 2011, CURR ATHEROSCLER REP, V13, P154, DOI 10.1007/s11883-011-0164-5; AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Allam AH, 2011, JACC-CARDIOVASC IMAG, V4, P315, DOI 10.1016/j.jcmg.2011.02.002; Bedi R, 2014, GLOB HEART, V9, P367, DOI 10.1016/j.gheart.2014.10.007; Benn M, 2010, J AM COLL CARDIOL, V55, P2833, DOI 10.1016/j.jacc.2010.02.044; Bild DE, 2005, CIRCULATION, V111, P1313, DOI 10.1161/01.CIR.0000157730.94423.4B; Blackwell AD, 2016, ANN HUM BIOL, V43, P382, DOI 10.1080/03014460.2016.1189963; Budoff MJ, 2013, J AM COLL CARDIOL, V61, P1231, DOI 10.1016/j.jacc.2012.12.035; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Fujiyoshi A, 2014, AM J EPIDEMIOL, V180, P590, DOI 10.1093/aje/kwu169; Grion CMC, 2010, EUR J CLIN INVEST, V40, P330, DOI 10.1111/j.1365-2362.2010.02269.x; Group MR, 1976, JAMA-J AM MED ASSOC, V35, P825; Gudmundsson EF, 2012, EUR J EPIDEMIOL, V27, P673, DOI 10.1007/s10654-012-9730-6; Gurven M, 2007, POPUL DEV REV, V33, P321, DOI 10.1111/j.1728-4457.2007.00171.x; Gurven M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055679; Gurven M, 2012, HYPERTENSION, V60, P25, DOI 10.1161/HYPERTENSIONAHA.111.189100; Hecht HS, 2015, EUR HEART J-CARD IMG, V16, P358, DOI 10.1093/ehjci/jeu218; Hoff JA, 2003, J AM COLL CARDIOL, V41, P1008, DOI 10.1016/S0735-1097(02)02975-3; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; KENNELLY BM, 1972, S AFR MED J, V46, P1093; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Koopman JJE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046855; Martin MA, 2012, MATERN CHILD NUTR, V8, P404, DOI 10.1111/j.1740-8709.2012.00412.x; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Park HE, 2012, INT J CARDIOVAS IMAG, V28, P1227, DOI 10.1007/s10554-011-9922-2; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Singh S, 2013, GLOB HEART, V8, P83, DOI 10.1016/j.gheart.2013.05.001; Sipahi I, 2006, J AM COLL CARDIOL, V48, P833, DOI 10.1016/j.jacc.2006.05.045; Thompson RC, 2013, LANCET, V381, P1211, DOI 10.1016/S0140-6736(13)60598-X; Thompson RC, 2005, J NUCL CARDIOL, V12, P392, DOI 10.1016/j.nuclcard.2005.04.006; Tota-Maharaj R, 2014, MAYO CLIN PROC, V89, P1350, DOI 10.1016/j.mayocp.2014.05.017; Vasunilashorn S, 2010, AM J HUM BIOL, V22, P731, DOI 10.1002/ajhb.21074; Whelton SP, 2015, JACC-CARDIOVASC IMAG, V8, P1393, DOI 10.1016/j.jcmg.2015.06.019; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	37	167	170	3	45	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2017	389	10080					1730	1739		10.1016/S0140-6736(17)30752-3	http://dx.doi.org/10.1016/S0140-6736(17)30752-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET3BG	28320601	Green Accepted, Green Submitted			2022-12-28	WOS:000400151000030
J	Devi, S				Devi, Sharmila			Fears over health of doctor imprisoned without trial in Iran	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2017	389	10076					1285	1285		10.1016/S0140-6736(17)30825-5	http://dx.doi.org/10.1016/S0140-6736(17)30825-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ2OF	28347499				2022-12-28	WOS:000397908700010
J	Fullgrabe, J; Lynch-Day, MA; Heldring, N; Li, WB; Struijk, RB; Ma, Q; Hermanson, O; Rosenfeld, MG; Klionsky, DJ; Joseph, B				Fullgrabe, Jens; Lynch-Day, Melinda A.; Heldring, Nina; Li, Wenbo; Struijk, Robert B.; Ma, Qi; Hermanson, Ola; Rosenfeld, Michael G.; Klionsky, Daniel J.; Joseph, Bertrand			The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy (vol 500, pg 468, 2013)	NATURE			English	Correction													li, wenbo/GZM-8930-2022	Fullgrabe, Jens/0000-0003-0047-4719				Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313	1	3	4	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					742	742		10.1038/nature22027	http://dx.doi.org/10.1038/nature22027			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28297710	Bronze			2022-12-28	WOS:000397619700061
J	[Anonymous]				[Anonymous]			Decline in Postpartum Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1207	1207		10.1001/jama.2017.2008	http://dx.doi.org/10.1001/jama.2017.2008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350937				2022-12-28	WOS:000397557800010
J	Childs, V				Childs, Vivienne			David Ruston Childs OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		CHILDS DR, PUBLICATION LIST, P62659	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2017	356								j1516	10.1136/bmj.j1516	http://dx.doi.org/10.1136/bmj.j1516			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4JB	28347979				2022-12-28	WOS:000397345700003
J	Kelly, LT; Brotons, L				Kelly, L. T.; Brotons, L.			ECOLOGY Using fire to promote biodiversity	SCIENCE			English	Editorial Material							REGIMES		[Kelly, L. T.] Univ Melbourne, ARC Ctr Excellence Environm Decis, Sch Biosci, Parkville, Vic, Australia; [Brotons, L.] InForest JRU CTFC CREAF, Solsona 25280, Spain; [Brotons, L.] CREAF, Cerdanyola Del Valles 08193, Spain; [Brotons, L.] CSIC, Cerdanyola Del Valles 08193, Spain	University of Melbourne; Centre Tecnologic Forestal de Catalunya (CTFC); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Consejo Superior de Investigaciones Cientificas (CSIC)	Kelly, LT (corresponding author), Univ Melbourne, ARC Ctr Excellence Environm Decis, Sch Biosci, Parkville, Vic, Australia.		Brotons, Lluís/D-1570-2009	Brotons, Lluís/0000-0002-4826-4457; Kelly, Luke/0000-0002-3127-3111	veski of the Victorian government	veski of the Victorian government	We thank A. Bennett, K. Giljohann, A. Hoffmann, C. Kelly, M. McCarthy, D. Salt, and K. Wilson for useful suggestions. L. Kelly funded by veski on behalf of the Victorian government.	Berry LE, 2015, J APPL ECOL, V52, P486, DOI 10.1111/1365-2664.12387; Bowman D.M.J.S., 2016, PHILOS T R SOC B, V371, P20150169, DOI [10.1098/rstb.2015.0169, DOI 10.1098/rstb.2015.0169]; Enright NJ, 2015, FRONT ECOL ENVIRON, V13, P265, DOI 10.1890/140231; Gill AM, 2013, ECOL APPL, V23, P438, DOI 10.1890/10-2213.1; Hutto RL, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1255; Keeley J.E., 2012, FIRE MEDITERRANEAN E, DOI 10.4000/mediterranee.6936; Kelly LT, 2017, CONSERV BIOL, V31, P952, DOI 10.1111/cobi.12861; Martin R., 1991, P S BIOD NW CAL, P150; Moritz MA, 2014, NATURE, V515, P58, DOI 10.1038/nature13946; Moritz MA, 2013, ANN NY ACAD SCI, V1286, P92, DOI 10.1111/nyas.12104; Ponisio LC, 2016, GLOBAL CHANGE BIOL, V22, P1794, DOI 10.1111/gcb.13236; Roos CI, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0469; Russell-Smith J, 2013, FRONT ECOL ENVIRON, V11, pE55, DOI 10.1890/120251; Tingley MW, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1703; van Wilgen BW, 2014, J ENVIRON MANAGE, V132, P358, DOI 10.1016/j.jenvman.2013.11.003	15	99	101	6	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1264	1265		10.1126/science.aam7672	http://dx.doi.org/10.1126/science.aam7672			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336625	Green Submitted			2022-12-28	WOS:000397082900018
J	Morozov, A				Morozov, Alexander			ACTIVE MATTER From chaos to order in active fluids	SCIENCE			English	Editorial Material							MOTION		[Morozov, Alexander] Univ Edinburgh, Sch Phys & Astron, Edinburgh EH9 3FD, Midlothian, Scotland	University of Edinburgh	Morozov, A (corresponding author), Univ Edinburgh, Sch Phys & Astron, Edinburgh EH9 3FD, Midlothian, Scotland.		Morozov, Alexander/O-1005-2014					Bricard A, 2013, NATURE, V503, P95, DOI 10.1038/nature12673; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Lopez HM, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.028301; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Saintillan D, 2015, BIOL MED PHYS BIOMED, P319, DOI 10.1007/978-1-4939-2065-5_9; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; Solon AP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.198301; Takatori SC, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.028103; Wioland H, 2016, NEW J PHYS, V18, DOI 10.1088/1367-2630/18/7/075002; Wu KT, 2017, SCIENCE, V355, DOI 10.1126/science.aal1979; Wu XL, 2000, PHYS REV LETT, V84, P3017, DOI 10.1103/PhysRevLett.84.3017	11	7	7	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1262	1263		10.1126/science.aam8998	http://dx.doi.org/10.1126/science.aam8998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336624				2022-12-28	WOS:000397082900017
J	Baar, MP; Brandt, RMC; Putavet, DA; Klein, JDD; Derks, KWJ; Bourgeois, BRM; Stryeck, S; Rijksen, Y; van Willigenburg, H; Feijtel, DA; van der Pluijm, I; Essers, J; van Cappellen, WA; van IJcken, WF; Houtsmuller, AB; Pothof, J; de Bruin, RWF; Madl, T; Hoeijmakers, JHJ; Campisi, J; de Keizer, PLJ				Baar, Marjolein P.; Brandt, Renata M. C.; Putavet, Diana A.; Klein, Julian D. D.; Derks, Kasper W. J.; Bourgeois, Benjamin R. M.; Stryeck, Sarah; Rijksen, Yvonne; van Willigenburg, Hester; Feijtel, Danny A.; van der Pluijm, Ingrid; Essers, Jeroen; van Cappellen, Wiggert A.; van IJcken, Wilfred F.; Houtsmuller, Adriaan B.; Pothof, Joris; de Bruin, Ron W. F.; Madl, Tobias; Hoeijmakers, Jan H. J.; Campisi, Judith; de Keizer, Peter L. J.			Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging	CELL			English	Article							REPAIR SYNDROME TRICHOTHIODYSTROPHY; INFLAMMATORY CYTOKINE SECRETION; FORKHEAD BOX O; DNA-DAMAGE; CELLULAR SENESCENCE; PEPTIDE INHIBITOR; HUMAN FIBROBLASTS; MOUSE MODEL; CANCER; TRANSCRIPTION	The accumulation of irreparable cellular damage restricts healthspan after acute stress or natural aging. Senescent cells are thought to impair tissue function, and their genetic clearance can delay features of aging. Identifying how senescent cells avoid apoptosis allows for the prospective design of anti-senescence compounds to address whether homeostasis can also be restored. Here, we identify FOXO4 as a pivot in senescent cell viability. We designed a FOXO4 peptide that perturbs the FOXO4 interaction with p53. In senescent cells, this selectively causes p53 nuclear exclusion and cell-intrinsic apoptosis. Under conditions where it was well tolerated in vivo, this FOXO4 peptide neutralized doxorubicin-induced chemotoxicity. Moreover, it restored fitness, fur density, and renal function in both fast aging Xpd(TTD/TTD) and naturally aged mice. Thus, therapeutic targeting of senescent cells is feasible under conditions where loss of health has already occurred, and in doing so tissue homeostasis can effectively be restored.	[Baar, Marjolein P.; Brandt, Renata M. C.; Putavet, Diana A.; Klein, Julian D. D.; Derks, Kasper W. J.; Rijksen, Yvonne; van Willigenburg, Hester; Feijtel, Danny A.; van der Pluijm, Ingrid; Essers, Jeroen; Pothof, Joris; Hoeijmakers, Jan H. J.; de Keizer, Peter L. J.] Erasmus Univ, Med Ctr Rotterdam, Dept Mol Genet, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [van Cappellen, Wiggert A.; Houtsmuller, Adriaan B.] Erasmus Univ, Med Ctr Rotterdam, Erasmus Opt Imaging Ctr, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [van Cappellen, Wiggert A.; Houtsmuller, Adriaan B.] Erasmus Univ, Med Ctr Rotterdam, Dept Pathol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [van IJcken, Wilfred F.] Erasmus Univ, Med Ctr Rotterdam, Dept Cell Biol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [van der Pluijm, Ingrid; Essers, Jeroen] Erasmus Univ, Med Ctr Rotterdam, Dept Vasc Surg, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Essers, Jeroen] Erasmus Univ, Med Ctr Rotterdam, Dept Radiat Oncol, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [de Bruin, Ron W. F.] Erasmus Univ, Med Ctr Rotterdam, Dept Surg, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands; [Bourgeois, Benjamin R. M.; Stryeck, Sarah; Madl, Tobias] Med Univ Graz, Inst Mol Biol & Biochem, Ctr Mol Med, A-8010 Graz, Austria; [Campisi, Judith; de Keizer, Peter L. J.] Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA; [Campisi, Judith] Lawrence Berkeley Natl Labs, Berkeley, CA 94720 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Medical University of Graz; Buck Institute for Research on Aging; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	de Keizer, PLJ (corresponding author), Erasmus Univ, Med Ctr Rotterdam, Dept Mol Genet, Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.; de Keizer, PLJ (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	p.dekeizer@erasmusmc.nl	Hoeijmakers, Jan/AAX-6972-2021; de+Keizer, Peter/AAD-5320-2020; Madl, Tobias/B-1682-2012; van ijcken, willem/N-9805-2018; Bourgeois, Benjamin/U-2482-2019	de+Keizer, Peter/0000-0002-6948-925X; Madl, Tobias/0000-0002-9725-5231; van ijcken, willem/0000-0002-0421-8301; Brandt, Renata M. C./0000-0003-0514-5623; Stryeck, Sarah/0000-0001-7524-6038; Putavet, Diana/0000-0002-8487-5802	NIH [R37-AG009909]; NIA [PPG AG-17242-02]; Austrian Science Fund [FWF P28854, DK-MCD W1226]; Royal Netherlands Academy of Arts and Sciences; Erasmus University Medical Center: EMC fellowship; Dutch Kidney Foundation [15OP11]; Dutch Cancer Society [Buit-4649, EMCR 20147141]; NATIONAL INSTITUTE ON AGING [R37AG009909, P01AG017242] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Austrian Science Fund(Austrian Science Fund (FWF)); Royal Netherlands Academy of Arts and Sciences; Erasmus University Medical Center: EMC fellowship; Dutch Kidney Foundation; Dutch Cancer Society(KWF Kankerbestrijding); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the NIH: R37-AG009909 (J.C.), the NIA: PPG AG-17242-02 (J.C. and J.H.J.H.), the Austrian Science Fund: FWF P28854 (T.M.), and DK-MCD W1226 (T.M.), the Royal Netherlands Academy of Arts and Sciences (J.H.J.H.), the Erasmus University Medical Center: EMC fellowship 2013 (P.L.J.d.K.), the Dutch Kidney Foundation: Grant 15OP11 (R.W.F.d.B. and P.L.J.d.K.), and the Dutch Cancer Society: fellowship Buit-4649 (P.L.J.d.K.) and project grant EMCR 20147141 (P.L.J.d.K.).	Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Beydoun T, 2015, J OCUL PHARMACOL TH, V31, P93, DOI 10.1089/jop.2013.0247; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Botter SM, 2011, AGE, V33, P247, DOI 10.1007/s11357-010-9175-3; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Cahu J, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.183; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Damodar G, 2014, ANN MED HEALTH SCI R, V4, P74, DOI 10.4103/2141-9248.126619; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; de Keizer PLJ, 2017, TRENDS MOL MED, V23, P6, DOI 10.1016/j.molmed.2016.11.006; de Keizer PLJ, 2011, ANTIOXID REDOX SIGN, V14, P1093, DOI 10.1089/ars.2010.3403; de Keizer PLJ, 2010, CANCER RES, V70, P8526, DOI 10.1158/0008-5472.CAN-10-1563; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Deloche C, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.20; Demaria M, 2014, DEV CELL, V31, P722, DOI 10.1016/j.devcel.2014.11.012; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Ferrucci L, 2005, BLOOD, V105, P2294, DOI 10.1182/blood-2004-07-2599; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gowda S, 2010, N AM J MED SCI, V2, P170; Henderson Tara O, 2014, Am Soc Clin Oncol Educ Book, pe423, DOI 10.14694/EdBook_AM.2014.34.e423; Herce HD, 2007, P NATL ACAD SCI USA, V104, P20805, DOI 10.1073/pnas.0706574105; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Kruiswijk F, 2016, ONCOGENE, V35, P2166, DOI 10.1038/onc.2015.282; Kruiswijk F, 2015, NAT REV MOL CELL BIO, V16, P393, DOI 10.1038/nrm4007; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lyman J L, 1986, Emerg Med Clin North Am, V4, P223; Martins R, 2016, AGING CELL, V15, P196, DOI 10.1111/acel.12427; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Orjalo AV, 2009, P NATL ACAD SCI USA, V106, P17031, DOI 10.1073/pnas.0905299106; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rodier F, 2011, J CELL SCI, V124, P68, DOI 10.1242/jcs.071340; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Roninson IB, 2003, CANCER RES, V63, P2705; Schoenwaelder SM, 2011, BLOOD, V118, P1663, DOI 10.1182/blood-2011-04-347849; Suckfuell M, 2014, OTOL NEUROTOL, V35, P1317, DOI 10.1097/MAO.0000000000000466; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; Wang F, 2008, J MOL BIOL, V384, P590, DOI 10.1016/j.jmb.2008.09.025; Warso MA, 2013, BRIT J CANCER, V108, P1061, DOI 10.1038/bjc.2013.74; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Xu M, 2015, P NATL ACAD SCI USA, V112, pE6301, DOI 10.1073/pnas.1515386112; Yosef R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11190; Zhou W, 2009, GASTROENTEROLOGY, V137, P1403, DOI 10.1053/j.gastro.2009.06.049; Zhu Y, 2015, AGING CELL, V14, P644, DOI 10.1111/acel.12344	58	700	749	20	346	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					132	+		10.1016/j.cell.2017.02.031	http://dx.doi.org/10.1016/j.cell.2017.02.031			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340339	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000397090000014
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2017: Dermatology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com			LEO Pharma	LEO Pharma(LEO Pharma)	The Dermatology Team of the Year award is sponsored by LEO Pharma. The awards ceremony takes place on 4 May at the Park Plaza Hotel, Westminster. To find out more go to thebmjawards.bmj.com.		0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1472	10.1136/bmj.j1472	http://dx.doi.org/10.1136/bmj.j1472			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330838				2022-12-28	WOS:000397345200021
J	Ruberto, AJ; Murray, H				Ruberto, Aaron J.; Murray, Heather			Review: alpha-blockers increase passage of ureteric stones without increasing serious adverse events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							MANAGEMENT; GUIDELINE; CALCULI		[Ruberto, Aaron J.; Murray, Heather] Queens Univ, Kingston, ON, Canada	Queens University - Canada	Ruberto, AJ (corresponding author), Queens Univ, Kingston, ON, Canada.		Ruberto, Aaron Jedediah/AAM-1962-2020; Murray, Heather/GQY-8016-2022	Ruberto, Aaron Jedediah/0000-0002-0210-2698; Murray, Heather/0000-0002-8448-2566				Melnick ER, 2016, ACAD EMERG MED, V23, P1346, DOI 10.1111/acem.13045; Ordon M, 2015, CUAJ-CAN UROL ASSOC, V9, pE837, DOI 10.5489/cuaj.3483; Preminger GM, 2007, EUR UROL, V52, P1610, DOI 10.1016/j.eururo.2007.09.039; Smith-Bindman R, 2014, NEW ENGL J MED, V371, P1100, DOI 10.1056/NEJMoa1404446	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC33	JC33		10.7326/ACPJC-2017-166-6-033	http://dx.doi.org/10.7326/ACPJC-2017-166-6-033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320007				2022-12-28	WOS:000397025800010
J	Blondiaux, N; Moune, M; Desroses, M; Frita, R; Flipo, M; Mathys, V; Soetaert, K; Kiass, M; Delorme, V; Djaout, K; Trebosc, V; Kemmer, C; Wintjens, R; Wohlkonig, A; Antoine, R; Huot, L; Hot, D; Coscolla, M; Feldmann, J; Gagneux, S; Locht, C; Brodin, P; Gitzinger, M; Deprez, B; Willand, N; Baulard, AR				Blondiaux, Nicolas; Moune, Martin; Desroses, Matthieu; Frita, Rosangela; Flipo, Marion; Mathys, Vanessa; Soetaert, Karine; Kiass, Mehdi; Delorme, Vincent; Djaout, Kamel; Trebosc, Vincent; Kemmer, Christian; Wintjens, Rene; Wohlkonig, Alexandre; Antoine, Rudy; Huot, Ludovic; Hot, David; Coscolla, Mireia; Feldmann, Julia; Gagneux, Sebastien; Locht, Camille; Brodin, Priscille; Gitzinger, Marc; Deprez, Benoit; Willand, Nicolas; Baulard, Alain R.			Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420	SCIENCE			English	Article							1,2,4-OXADIAZOLE ETHR INHIBITORS; ETHIONAMIDE BOOSTERS; DRUG ETHIONAMIDE; ACTIVATION; GENE; RECOGNITION; MECHANISMS; INDUCTION; REPRESSOR; FAMILY	Antibiotic resistance is one of the biggest threats to human health globally. Alarmingly, multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis have now spread worldwide. Some key antituberculosis antibiotics are prodrugs, for which resistance mechanisms are mainly driven by mutations in the bacterial enzymatic pathway required for their bioactivation. We have developed drug-like molecules that activate a cryptic alternative bioactivation pathway of ethionamide in M. tuberculosis, circumventing the classic activation pathway in which resistance mutations have now been observed. The first-of-its-kind molecule, named SMARt-420 (Small Molecule Aborting Resistance), not only fully reverses ethionamide-acquired resistance and clears ethionamide-resistant infection in mice, it also increases the basal sensitivity of bacteria to ethionamide.	[Blondiaux, Nicolas; Moune, Martin; Frita, Rosangela; Delorme, Vincent; Djaout, Kamel; Antoine, Rudy; Huot, Ludovic; Hot, David; Locht, Camille; Brodin, Priscille; Baulard, Alain R.] Univ Lille, Inst Pasteur Lille, CIIL, CNRS,Inserm,CHU Lille,U1019,UMR8204, F-59000 Lille, France; [Desroses, Matthieu; Flipo, Marion; Deprez, Benoit; Willand, Nicolas] Univ Lille, Inst Pasteur Lille, Drugs & Mol Living Syst, Inserm,U1177, F-59000 Lille, France; [Desroses, Matthieu] Karolinska Inst, Div Translat Med & Chem Biol, Sci Life Lab, Dept Med Biochem & Biophys, Stockholm, Sweden; [Mathys, Vanessa; Soetaert, Karine; Kiass, Mehdi] Sci Inst Publ Hlth WIV ISP, Natl Reference Ctr TB & Mycobacteria, Bacterial Dis Serv, Operat Direct Communicable & Infect Dis, Brussels, Belgium; [Delorme, Vincent] Inst Pasteur Korea, TB Res Lab, Seoul, South Korea; [Trebosc, Vincent; Kemmer, Christian; Gitzinger, Marc] Bioversys AG, Hochbergerstr 60C, CH-4057 Basel, Switzerland; [Trebosc, Vincent] Univ Basel, Biozentrum, Basel, Switzerland; [Wintjens, Rene] Univ Libre Bruxelles, Lab Biopolymeres Nanomat Supramol, Brussels, Belgium; [Wohlkonig, Alexandre] VIB, VIB Ctr Struct Biol, Pl Laan 2, B-1050 Brussels, Belgium; [Wohlkonig, Alexandre] VUB, Struct Biol Brussels, Pl Laan 2, B-1050 Brussels, Belgium; [Coscolla, Mireia; Feldmann, Julia; Gagneux, Sebastien] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Coscolla, Mireia; Feldmann, Julia; Gagneux, Sebastien] Univ Basel, Basel, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Karolinska Institutet; Institut Pasteur Korea; University of Basel; Universite Libre de Bruxelles; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Basel; Swiss Tropical & Public Health Institute; University of Basel	Baulard, AR (corresponding author), Univ Lille, Inst Pasteur Lille, CIIL, CNRS,Inserm,CHU Lille,U1019,UMR8204, F-59000 Lille, France.; Deprez, B; Willand, N (corresponding author), Univ Lille, Inst Pasteur Lille, Drugs & Mol Living Syst, Inserm,U1177, F-59000 Lille, France.	benoit.deprez@univ-lille2.fr; nicolas.willand@univ-lille2.fr; alain.baulard@inserm.fr	Trebosc, Vincent/AHE-7675-2022; Coscolla, Mireia/ABD-7942-2021; Gagneux, Sebastien/ABE-7909-2020; Flipo, Marion/I-2530-2016; Trebosc, Vincent/GLS-3191-2022; Antoine, Rudy/CAH-6653-2022; Willand, Pr Nicolas/A-5653-2019; Brodin, Priscille/N-6979-2019; Locht, Camille/L-3516-2018; Brodin, Priscille/E-5802-2014; Baulard, Alain R/E-6830-2017; Trebosc, Vincent/R-3801-2017; Blondiaux, Nicolas/AAC-8899-2020; deprez, benoit/G-6749-2012; Antoine, Rudy/L-1630-2018; Hot, David/M-6775-2016	Trebosc, Vincent/0000-0002-8961-1371; Flipo, Marion/0000-0003-2863-5721; Trebosc, Vincent/0000-0002-8961-1371; Antoine, Rudy/0000-0002-7369-0626; Willand, Pr Nicolas/0000-0002-0784-0462; Brodin, Priscille/0000-0003-0991-7344; Brodin, Priscille/0000-0003-0991-7344; Baulard, Alain R/0000-0002-0150-5241; Trebosc, Vincent/0000-0002-8961-1371; Blondiaux, Nicolas/0000-0002-9762-7322; deprez, benoit/0000-0002-2777-4538; Antoine, Rudy/0000-0002-7369-0626; deboosere, Nathalie/0000-0002-2873-5485; Coscolla, Mireia/0000-0003-0752-0538; Desroses, Matthieu/0000-0003-4152-3855; Djaout, Kamel/0000-0003-1218-8031; Gagneux, Sebastien/0000-0001-7783-9048; Hot, David/0000-0002-2361-0616; Locht, Camille/0000-0001-7295-7336; Delorme, Vincent/0000-0001-5235-7069; Wohlkonig, Alexandre/0000-0003-3103-5022; Frita, Rosangela/0000-0001-9224-3197	l'Agence Nationale de la Recherche (ANR), France [Tea-4-Two, ANR-14-CE14-0027-01, ANR-10-EQPX-04-01]; EU grants ERC-STG INTRACELLTB [26090L, 12001407]; PRIM (NewBio4Tb); European Research Council [309540-EVODRTB]; SystemsX.ch; Institut National de la Sante et de la Recherche Medicale; Universite de Lille; Institut Pasteur de Lille; Centre National de la Recherche Scientifique; Region Hauts-de-France [12000080]; Societe d'Acceleration du Transfert de Technologie Nord; PRIM (NewBio4Tro); EU [260872]; Marie Curie Initial Training Network [ITN-2013-607694-Translocation]; Unite Mixte de Recherche UMR [8199]; Lille Integrated Genomics Network for Advanced Personalized Medicine (LIGAN-PM) Genomics platform (Lille, France) [3508, ANR-10-LABX-46]; Agence Nationale de la Recherche (ANR) Erg Apex [ANR-10-EQPX-07-01]; Fonds Europeen de Developpement Regional; Region Hauts-de-France	l'Agence Nationale de la Recherche (ANR), France(French National Research Agency (ANR)); EU grants ERC-STG INTRACELLTB; PRIM (NewBio4Tb); European Research Council(European Research Council (ERC)European Commission); SystemsX.ch; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite de Lille; Institut Pasteur de Lille; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Region Hauts-de-France(Region Hauts-de-France); Societe d'Acceleration du Transfert de Technologie Nord; PRIM (NewBio4Tro); EU(European Commission); Marie Curie Initial Training Network(European Commission); Unite Mixte de Recherche UMR; Lille Integrated Genomics Network for Advanced Personalized Medicine (LIGAN-PM) Genomics platform (Lille, France); Agence Nationale de la Recherche (ANR) Erg Apex(French National Research Agency (ANR)); Fonds Europeen de Developpement Regional; Region Hauts-de-France(Region Hauts-de-France)	All data and code to understand and assess the conclusions of this research are available in the main text supplementary materials, and via the following repositories: The refined coordinates and the structure factors of Rv0078 were deposited in the Protein Data Bank under the accession numbers 5N1C (iodinated to form), 5N1l (unliganded form), and 5ICJ (liganded form): raw data of RNA-seq analyse have been deposited in Datadryad.org under the doi 10.5061/dryad.mb463. We are indebted to the Soleil [Block Allocation Group (BAG) proposal 20141408] and the European Synchrotron Radiation Facility (BAG proposal MX-16-77) synchrotrons for beam-time allocations on this project. Sequencing analyses were per-formed at the sciCORE (http://scicore.unibas.ch) scientific computing core facility at the University of Basel. The Tinders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are indebted to E. Willery for technical support in molecular biology, F. Leroux for screening management, L. Agouridas and N. Probst V chemical synthesis, and C. Piveteau for bioanalysis. This work was supported by l'Agence Nationale de la Recherche (ANR), France (Tea-4-Two, ANR-14-CE14-0027-01) (ANR-10-EQPX-04-01), by EU grants ERC-STG INTRACELLTB no 26090L the Feder (12001407 (D-AL), PRIM (NewBio4Tb), European Research Council (grant 309540-EVODRTB), SystemsX.ch, Institut National de la Sante et de la Recherche Medicale, Universite de Lille, Institut Pasteur de Lille, Centre National de la Recherche Scientifique, the Region Hauts-de-France (convention no. 12000080), and Societe d'Acceleration du Transfert de Technologie Nord. R.W. is Research Associate at the National Fund for Scientific Research (FNRS-FRS) (Belgium). M.M. was supported by PRIM (NewBio4Tro), V.D. was supported by EU grant 260872, and V.T. was suppported by the Marie Curie Initial Training Network (ITN-2013-607694-Translocation). No authors also thank the Unite Mixte de Recherche UMR 8199, Lille Integrated Genomics Network for Advanced Personalized Medicine (LIGAN-PM) Genomics platform (Lille, France) which belongs to the Federation de Recherche 3508 Labex EGID (European, Genomics Institute for Diabetes; ANR-10-LABX-46) and was supported by the Agence Nationale de la Recherche (ANR) Erg Apex 2010 session (ANR-10-EQPX-07-01; LIGAN-PM). The LIGAN-PM Genomics platform is supported by the Fonds Europeen de Developpement Regional and the Region Hauts-de-France. We thank A. Wagner and Requettes-Freres (Lestrem France) for their gift of Cyclodextrine Kleptose HP. We greatly appreciate the fruitful discussions with all the members of the GlaxoSmithKline team "Diseases of the Developing World (DDW)" and their invaluable support in the continuation of this project. C.K. is employed at Bioversys; S.G. is a consultant for the Foundation of Innovative Diagnostics (FIND) in Geneva, Switzerland. M.G. is CEO Elf Bioversys and a Board. Member of the BEAM Alliance, a group of Biopharmaceutical companies from Europe innovating in an resistance research. The BEAM Alliance is a riot-for-profit association, and there is no financial remuneration of any kind for its Board members. All companies included are working within the field of antimicrobial drug discovery. N.W.. B.D., A.R.B., P.B., and M.D. are inventors on patent PCT/EP2013/077706, which covers BDM41420; WO/2014/096369. B.D., C.L., and A.R.B. are inventors on patent PCT/FR2007/001138; WO/2008/003861, which covers BDM41906.; The facilities conformed to Directive 86/609/EEC on the Protection of Animals Used for Experimental and Other Scientific Purposes and norms published in the European, Council ETS123 Appendix A. Facilities and. procedures complied with the Belgian Law of 14 August 1986 on animal protection and welfare. Training of experimental leaders, biotechnicians, and animal caretakers was in accordance a Royal decree of 13 September 2004, when specifies the gaining of persons working with laboratory animals. All animal experimentation and procedures performed at the National Reference Center for Tuberculosis and Mycobacteria, Bacterial Diseases Service, Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium, were validated and approved by the Ethical Committee of the IPH-VAR (Scientific Institute of Public Health Veterinary and Agrochemical Research Centre Belgium) under file no. 120323-01. The animal facilities and procedures were inter the supervision of an expert on animal welfare in accordance with the Belgian Ministry of Health. pET-15b-ethR2 and pET-15b-ethR are available from A.R.B. under a. materials transfer agreement with Ins rut Pasteur de Lille. pCK289 and pCK287 are available from M.G. under a materials transfer agreement with Bioversys.	Ahuja SD, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001300; Ardito F, 2001, J CLIN MICROBIOL, V39, P4440, DOI 10.1128/JCM.39.12.4440-4444.2001; BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Barry C, 2015, SCIENCE, V348, P633, DOI 10.1126/science.aaa2886; Baulard AR, 2000, J BIOL CHEM, V275, P28326; Bloemberg GV, 2015, NEW ENGL J MED, V373, P1986, DOI 10.1056/NEJMc1505196; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Cuthbertson L, 2013, MICROBIOL MOL BIOL R, V77, P440, DOI 10.1128/MMBR.00018-13; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Flipo M, 2012, J MED CHEM, V55, P6391, DOI 10.1021/jm300377g; Flipo M, 2012, J MED CHEM, V55, P68, DOI 10.1021/jm200825u; Flipo M, 2011, J MED CHEM, V54, P2994, DOI 10.1021/jm200076a; Frenois F, 2006, TUBERCULOSIS, V86, P110, DOI 10.1016/j.tube.2005.07.005; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; Grant SS, 2016, CELL CHEM BIOL, V23, P666, DOI 10.1016/j.chembiol.2016.05.011; Hanoulle X, 2006, J ANTIMICROB CHEMOTH, V58, P768, DOI 10.1093/jac/dkl332; Hoffner S, 2012, LANCET, V380, P1367, DOI 10.1016/S0140-6736(12)61069-1; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Matsumoto M, 2006, PLOS MED, V3, P2131, DOI 10.1371/journal.pmed.0030466; READING C, 1977, ANTIMICROB AGENTS CH, V11, P852, DOI 10.1128/AAC.11.5.852; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Spellberg B, 2014, CLIN INFECT DIS, V59, pS71, DOI 10.1093/cid/ciu392; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Vannelli TA, 2002, J BIOL CHEM, V277, P12824, DOI 10.1074/jbc.M110751200; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wang F, 2007, J EXP MED, V204, P73, DOI 10.1084/jem.20062100; Weber W, 2008, P NATL ACAD SCI USA, V105, P9994, DOI 10.1073/pnas.0800663105; Willand N, 2010, ACS CHEM BIOL, V5, P1007, DOI 10.1021/cb100177g; Willand N, 2009, NAT MED, V15, P537, DOI 10.1038/nm.1950; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2016, ANTIMICROBIAL RESIST; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; Zheng J, 2013, J BIOL CHEM, V288, P23447, DOI 10.1074/jbc.M113.475798	37	88	92	1	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1206	1211		10.1126/science.aag1006	http://dx.doi.org/10.1126/science.aag1006			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302858	Green Submitted			2022-12-28	WOS:000396351200044
J	Spektor, G; Kilbane, D; Mahro, K; Frank, B; Ristok, S; Gal, L; Kahl, P; Podbiel, D; Mathias, S; Giessen, H; zu Heringdorf, FJM; Orenstein, M; Aeschlimann, M				Spektor, G.; Kilbane, D.; Mahro, A. K.; Frank, B.; Ristok, S.; Gal, L.; Kahl, P.; Podbiel, D.; Mathias, S.; Giessen, H.; zu Heringdorf, F. -J. Meyer; Orenstein, M.; Aeschlimann, M.			Revealing the subfemtosecond dynamics of orbital angular momentum in nanoplasmonic vortices	SCIENCE			English	Article							PLASMONIC LENS; POLARIZED-LIGHT; SPIN; MICROSCOPY; TWEEZERS; MEMORY	The ability of light to carry and deliver orbital angular momentum (OAM) in the form of optical vortices has attracted much interest. The physical properties of light with a helical wavefront can be confined onto two-dimensional surfaces with subwavelength dimensions in the form of plasmonic vortices, opening avenues for thus far unknown light-matter interactions. Because of their extreme rotational velocity, the ultrafast dynamics of such vortices remained unexplored. Here we show the detailed spatiotemporal evolution of nanovortices using time-resolved two-photon photoemission electron microscopy. We observe both long- and short-range plasmonic vortices confined to deep subwavelength dimensions on the scale of 100 nanometers with nanometer spatial resolution and subfemtosecond time-step resolution. Finally, by measuring the angular velocity of the vortex, we directly extract the OAM magnitude of light.	[Spektor, G.; Gal, L.; Orenstein, M.] Technion Israel Inst Technol, Dept Elect Engn, IL-32000 Haifa, Israel; [Kilbane, D.; Mahro, A. K.; Mathias, S.; Aeschlimann, M.] Univ Kaiserslautern, Dept Phys, Erwin Schroedinger Str 46, D-67663 Kaiserslautern, Germany; [Kilbane, D.; Mahro, A. K.; Mathias, S.; Aeschlimann, M.] Univ Kaiserslautern, State Res Ctr Opt & Mat Sci OPTIMAS, Erwin Schroedinger Str 46, D-67663 Kaiserslautern, Germany; [Kilbane, D.] Univ Coll Dublin, Sch Phys, Dublin 4, Ireland; [Frank, B.; Ristok, S.; Giessen, H.] Univ Stuttgart, Inst Phys 4, D-70569 Stuttgart, Germany; [Frank, B.; Ristok, S.; Giessen, H.] Univ Stuttgart, Stuttgart Ctr Photon Engn SCoPE, D-70569 Stuttgart, Germany; [Kahl, P.; Podbiel, D.; zu Heringdorf, F. -J. Meyer] Univ Duisburg Essen, Fac Phys, Lotharstr 1-21, D-47057 Duisburg, Germany; [Kahl, P.; Podbiel, D.; zu Heringdorf, F. -J. Meyer] Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CENIDE, Lotharstr 1-21, D-47057 Duisburg, Germany; [Mathias, S.] Georg August Univ Gottingen, Inst Phys 1, Friedrich Hund Pl 1, D-37077 Gottingen, Germany	Technion Israel Institute of Technology; University of Kaiserslautern; University of Kaiserslautern; University College Dublin; University of Stuttgart; University of Stuttgart; University of Duisburg Essen; University of Duisburg Essen; University of Gottingen	Orenstein, M (corresponding author), Technion Israel Inst Technol, Dept Elect Engn, IL-32000 Haifa, Israel.; Aeschlimann, M (corresponding author), Univ Kaiserslautern, Dept Phys, Erwin Schroedinger Str 46, D-67663 Kaiserslautern, Germany.; Aeschlimann, M (corresponding author), Univ Kaiserslautern, State Res Ctr Opt & Mat Sci OPTIMAS, Erwin Schroedinger Str 46, D-67663 Kaiserslautern, Germany.; Giessen, H (corresponding author), Univ Stuttgart, Inst Phys 4, D-70569 Stuttgart, Germany.; Giessen, H (corresponding author), Univ Stuttgart, Stuttgart Ctr Photon Engn SCoPE, D-70569 Stuttgart, Germany.; zu Heringdorf, FJM (corresponding author), Univ Duisburg Essen, Fac Phys, Lotharstr 1-21, D-47057 Duisburg, Germany.; zu Heringdorf, FJM (corresponding author), Univ Duisburg Essen, Ctr Nanointegrat Duisburg Essen CENIDE, Lotharstr 1-21, D-47057 Duisburg, Germany.	h.giessen@pi4.uni-stuttgart.de; meyerzh@uni-due.de; meiro@ee.technion.ac.il; ma@physik.uni-kl.de	Spektor, Grisha/GXZ-6632-2022; Giessen, Harald/AAG-7586-2019; Aeschlimann, Martin/D-7141-2011; Heringdorf, Frank Meyer zu/AAE-5657-2019; Mathias, Stefan/I-4679-2012	Giessen, Harald/0000-0002-4270-3850; Aeschlimann, Martin/0000-0003-3413-5029; Mathias, Stefan/0000-0002-1255-521X; Kilbane, Deirdre/0000-0003-3087-9303	Israeli Centers of Research Excellence "Circle of Light"; Irish Research Council; Marie Curie Actions ELEVATE fellowship; Deutsche Forschungsgemeinschaft (DFG) program [SPP1391]; DFG [SFB616, SFB1242]; DFG program [SPP1391]; European Research Council Advanced Grant "Complexplas"; Baden-Wurttemberg Stiftung; German-Israeli Foundation (GIF); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie	Israeli Centers of Research Excellence "Circle of Light"; Irish Research Council(Irish Research Council for Science, Engineering and Technology); Marie Curie Actions ELEVATE fellowship; Deutsche Forschungsgemeinschaft (DFG) program(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); DFG program(German Research Foundation (DFG)); European Research Council Advanced Grant "Complexplas"; Baden-Wurttemberg Stiftung; German-Israeli Foundation (GIF)(German-Israeli Foundation for Scientific Research and Development); Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie(Federal Ministry of Education & Research (BMBF))	This research was supported partially by the Israeli Centers of Research Excellence "Circle of Light." D.K. acknowledges funding from the Irish Research Council and the Marie Curie Actions ELEVATE fellowship. M.A. and F.-J.M.z.H. acknowledge funding from Deutsche Forschungsgemeinschaft (DFG) program SPP1391. F.-J.M.z.H. further acknowledges DFG programs SFB616 and SFB1242. B.F., S.R., and H.G. acknowledge support from DFG program SPP1391, European Research Council Advanced Grant "Complexplas," Baden-Wurttemberg Stiftung, German-Israeli Foundation (GIF), and Bundesministerium fur Bildung, Wissenschaft, Forschung und Technologie. We acknowledge help with sample fabrication by L. Fu and H. Li. We also acknowledge the technical support by the Nano Structuring Center, Kaiserslautern.	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Andrews D L, 2012, ANGULAR MOMENTUM LIG; Barnes WL, 2003, NATURE, V424, P824, DOI 10.1038/nature01937; Beth RA, 1935, PHYS REV, V48, P471, DOI 10.1103/PhysRev.48.471; Beth RA, 1936, PHYS REV, V50, P115, DOI 10.1103/PhysRev.50.115; Bliokh KY, 2015, NAT PHOTONICS, V9, P796, DOI 10.1038/nphoton.2015.201; Bliokh KY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4300; Bliokh KY, 2008, NAT PHOTONICS, V2, P748, DOI 10.1038/nphoton.2008.229; Bozinovic N, 2013, SCIENCE, V340, P1545, DOI 10.1126/science.1237861; Cardano F, 2015, NAT PHOTONICS, V9, P776, DOI 10.1038/nphoton.2015.232; David A, 2015, OPTICA, V2, P1045, DOI 10.1364/OPTICA.2.001045; Ding DS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3527; GENEVET P, 2015, Patent No. 78024401; Gibson G, 2004, OPT EXPRESS, V12, P5448, DOI 10.1364/OPEX.12.005448; Gorodetski Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.043903; Gorodetski Y, 2009, NANO LETT, V9, P3016, DOI 10.1021/nl901437d; Juan ML, 2011, NAT PHOTONICS, V5, P349, DOI [10.1038/nphoton.2011.56, 10.1038/NPHOTON.2011.56]; Kahl P, 2014, PLASMONICS, V9, P1401, DOI 10.1007/s11468-014-9756-6; Karimi E, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.48; Kim H, 2010, NANO LETT, V10, P529, DOI 10.1021/nl903380j; Lerman GM, 2009, NANO LETT, V9, P2139, DOI 10.1021/nl900694r; Maier S.A., 2007, PLASMONICS FUNDAMENT, DOI DOI 10.1007/0-387-37825-1; Mirhosseini M, 2013, OPT EXPRESS, V21, P30196, DOI 10.1364/OE.21.030196; Nicolas A, 2014, NAT PHOTONICS, V8, P234, DOI [10.1038/NPHOTON.2013.355, 10.1038/nphoton.2013.355]; Padgett M, 2011, NAT PHOTONICS, V5, P343, DOI [10.1038/nphoton.2011.81, 10.1038/NPHOTON.2011.81]; Podbiel D, 2016, APPL PHYS B-LASERS O, V122, DOI 10.1007/s00340-016-6363-6; Poynting JH, 1909, P R SOC LOND A-CONTA, V82, P560, DOI 10.1098/rspa.1909.0060; Raether H., 1988, SURFACE PLASMONS SMO, DOI 10.1007/BFb0048319; Shitrit N, 2011, NANO LETT, V11, P2038, DOI 10.1021/nl2004835; Spektor G, 2016, OPT EXPRESS, V24, P2436, DOI 10.1364/OE.24.002436; Spektor G, 2015, OPT EXPRESS, V23, P32759, DOI 10.1364/OE.23.032759; Spektor G, 2015, NANO LETT, V15, P5739, DOI 10.1021/acs.nanolett.5b01571; Tamburini F, 2011, NAT PHYS, V7, P195, DOI [10.1038/nphys1907, 10.1038/NPHYS1907]; Tsai WY, 2014, NANO LETT, V14, P547, DOI 10.1021/nl403608a; Vallone G, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.060503; Wang J, 2012, NAT PHOTONICS, V6, P488, DOI [10.1038/nphoton.2012.138, 10.1038/NPHOTON.2012.138]; Wehner MU, 1997, OPT LETT, V22, P1455, DOI 10.1364/OL.22.001455; Yao AM, 2011, ADV OPT PHOTONICS, V3, P161, DOI 10.1364/AOP.3.000161	38	159	161	3	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1187	1191		10.1126/science.aaj1699	http://dx.doi.org/10.1126/science.aaj1699			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302854				2022-12-28	WOS:000396351200039
J	Lyon, J				Lyon, Jeff			Senate Questions Orphan Drug Pricing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1009	1009		10.1001/jama.2017.1429	http://dx.doi.org/10.1001/jama.2017.1429			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291873				2022-12-28	WOS:000396713400004
J	Clemens, JD; Nair, GB; Ahmed, T; Qadri, F; Holmgren, J				Clemens, John D.; Nair, G. Balakrish; Ahmed, Tahmeed; Qadri, Firdausi; Holmgren, Jan			Cholera	LANCET			English	Review							SEVERELY MALNOURISHED CHILDREN; ORAL REHYDRATION SOLUTION; SINGLE-DOSE AZITHROMYCIN; VACCINE CVD 103-HGR; O139 SYNONYM BENGAL; EL-TOR CHOLERA; VIBRIO-CHOLERAE; RAPID DIAGNOSIS; FIELD TRIAL; BLOOD-GROUP	Cholera is an acute, watery diarrhoeal disease caused by Vibrio cholerae of the O1 or O139 serogroups. In the past two centuries, cholera has emerged and spread from the Ganges Delta six times and from Indonesia once to cause global pandemics. Rational approaches to the case management of cholera with oral and intravenous rehydration therapy have reduced the case fatality of cholera from more than 50% to much less than 1%. Despite improvements in water quality, sanitation, and hygiene, as well as in the clinical treatment of cholera, the disease is still estimated to cause about 100 000 deaths every year. Most deaths occur in cholera-endemic settings, and virtually all deaths occur in developing countries. Contemporary understanding of immune protection against cholera, which results from local intestinal immunity, has yielded safe and protective orally administered cholera vaccines that are now globally stockpiled for use in the control of both epidemic and endemic cholera.	[Clemens, John D.; Ahmed, Tahmeed; Qadri, Firdausi] Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res, GPO Box 128, Dhaka, Bangladesh; [Clemens, John D.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Clemens, John D.] Korea Univ, Sch Med, Seoul, South Korea; [Nair, G. Balakrish] WHO, Delhi, India; [Holmgren, Jan] Univ Goteborg, Gothenburg, Sweden	International Centre for Diarrhoeal Disease Research (ICDDR); University of California System; University of California Los Angeles; Korea University; Korea University Medicine (KU Medicine); World Health Organization; University of Gothenburg	Clemens, JD (corresponding author), Int Ctr Diarrhoeal Dis Res, Ctr Hlth & Populat Res, GPO Box 128, Dhaka, Bangladesh.	jclemens@icddrb.org	Qadri, Firdausi/AAF-4583-2019; Al, Mamun M./AAF-5850-2019	Holmgren, Jan/0000-0003-1784-5918	Government of Bangladesh; Government of Canada; Government of Sweden; Government of UK	Government of Bangladesh; Government of Canada(CGIAR); Government of Sweden; Government of UK	This work was supported by core grants to the International Centre for Diarrhoeal Disease Research, Bangladesh. We thank the Governments of Bangladesh, Canada, Sweden, and the UK for providing core or unrestricted support. We thank Jocalyn Clark for superb editorial assistance.	Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Alam NH, 2003, J PEDIATR-US, V143, P614, DOI 10.1067/S0022-3476(03)00500-6; Alam Nure H, 2003, Paediatr Drugs, V5, P151, DOI 10.2165/00128072-200305030-00002; ALBERT MJ, 1993, LANCET, V342, P387, DOI 10.1016/0140-6736(93)92811-7; Ali M, 2005, LANCET, V366, P44, DOI 10.1016/S0140-6736(05)66550-6; Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ali M, 2011, J INFECT DIS, V204, P912, DOI 10.1093/infdis/jir416; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P537; [Anonymous], 1971, BMJ-BRIT MED J, V3, P266; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P517; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; BAINE WB, 1974, LANCET, V2, P1370; BANWELL JG, 1970, J CLIN INVEST, V49, P183, DOI 10.1172/JCI106217; BENENSON A. S., 1964, BULL WORLD HEALTH ORGAN, V30, P827; BENENSON AS, 1968, B WORLD HEALTH ORGAN, V38, P347; BENNISH ML, 1990, NEW ENGL J MED, V322, P1357, DOI 10.1056/NEJM199005103221905; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Bhuiyan NA, 2003, J CLIN MICROBIOL, V41, P3939, DOI 10.1128/JCM.41.8.3939-3941.2003; Bhuiyan TR, 2016, CLIN VACCINE IMMUNOL, V23, P27, DOI 10.1128/CVI.00526-15; Bhuiyan TR, 2009, INFECT IMMUN, V77, P1888, DOI 10.1128/IAI.01101-08; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; CAMERON DN, 1994, J CLIN MICROBIOL, V32, P1685, DOI 10.1128/JCM.32.7.1685-1690.1994; CARPENTER CC, 1968, J CLIN INVEST, V47, P1210, DOI 10.1172/JCI105810; CASH RA, 1974, J INFECT DIS, V130, P325, DOI 10.1093/infdis/130.4.325; Centers for Disease Control and Prevention, 2016, LAB ID VIBR CHOL; Chen WH, 2016, CLIN INFECT DIS, V62, P1329, DOI 10.1093/cid/ciw145; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Ciglenecki I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002368; CLEMENS J, 1993, INT J EPIDEMIOL, V22, P724, DOI 10.1093/ije/22.4.724; Clemens J, 2013, VACCINES; CLEMENS JD, 1986, LANCET, V2, P124; CLEMENS JD, 1989, J INFECT DIS, V159, P770, DOI 10.1093/infdis/159.4.770; CLEMENS JD, 1990, AM J EPIDEMIOL, V131, P400, DOI 10.1093/oxfordjournals.aje.a115515; CLEMENS JD, 1991, J INFECT DIS, V163, P1235, DOI 10.1093/infdis/163.6.1235; Clemens J, 2014, CURR TOP MICROBIOL, V379, P231, DOI 10.1007/82_2013_353; Clemens J, 2011, NAT REV GASTRO HEPAT, V8, P701, DOI 10.1038/nrgastro.2011.174; Cohen MB, 2002, INFECT IMMUN, V70, P1965, DOI 10.1128/IAI.70.4.1965-1970.2002; Colwell RR, 2003, P NATL ACAD SCI USA, V100, P1051, DOI 10.1073/pnas.0237386100; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; COSTER TS, 1995, LANCET, V345, P949, DOI 10.1016/S0140-6736(95)90698-3; Cutler D, 2005, DEMOGRAPHY, V42, P1, DOI 10.1353/dem.2005.0002; CVJETANOVIC B, 1972, NATURE, V239, P137, DOI 10.1038/239137a0; DEB BC, 1986, B WORLD HEALTH ORGAN, V64, P127; Devault AM, 2014, NEW ENGL J MED, V370, P334, DOI 10.1056/NEJMoa1308663; Evans CAW, 1997, T ROY SOC TROP MED H, V91, P681, DOI 10.1016/S0035-9203(97)90523-X; Faruque SM, 2014, CURR TOP MICROBIOL, V379, P165, DOI 10.1007/82_2013_358; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; FIELD M, 1972, J CLIN INVEST, V51, P796, DOI 10.1172/JCI106874; Flach CF, 2007, INFECT IMMUN, V75, P2343, DOI 10.1128/IAI.01900-06; GABRIEL SE, 1994, SCIENCE, V266, P107, DOI 10.1126/science.7524148; Garcia L, 2005, INFECT IMMUN, V73, P3018, DOI 10.1128/IAI.73.5.3018-3024.2005; George CM, 2014, TROP MED INT HEALTH, V19, P301, DOI 10.1111/tmi.12252; George CM, 2016, EMERG INFECT DIS, V22, P233, DOI [10.3201/eid2202.151175, 10.3201/eid2202.15117]; GILL DM, 1978, P NATL ACAD SCI USA, V75, P3050, DOI 10.1073/pnas.75.7.3050; GLASS RI, 1983, J INFECT DIS, V148, P998, DOI 10.1093/infdis/148.6.998; GLASS RI, 1985, J INFECT DIS, V151, P236, DOI 10.1093/infdis/151.2.236; GLASS RI, 1983, NEW ENGL J MED, V308, P1389, DOI 10.1056/NEJM198306093082304; GLASS RI, 1985, AM J EPIDEMIOL, V121, P791, DOI 10.1093/oxfordjournals.aje.a114050; GOODGAME RW, 1975, ANN INTERN MED, V82, P101, DOI 10.7326/0003-4819-82-1-101; GREENOUGH WB, 1964, LANCET, V1, P355; HARDY SJS, 1988, P NATL ACAD SCI USA, V85, P7109, DOI 10.1073/pnas.85.19.7109; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Harris JB, 2010, LANCET, V376, P1961, DOI 10.1016/S0140-6736(10)62172-1; Harris JB, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000221; Harris JB, 2005, INFECT IMMUN, V73, P7422, DOI 10.1128/IAI.73.11.7422-7427.2005; Hartley DM, 2006, PLOS MED, V3, P63, DOI 10.1371/journal.pmed.0030007; HERRINGTON DA, 1988, J EXP MED, V168, P1487, DOI 10.1084/jem.168.4.1487; HOLMGREN J, 1983, PROG ALLERGY, V33, P106; HOLMGREN J, 1981, NATURE, V292, P413, DOI 10.1038/292413a0; HOLMGREN J, 1973, INFECT IMMUN, V8, P208, DOI 10.1128/IAI.8.2.208-214.1973; HORNICK RB, 1971, B NEW YORK ACAD MED, V47, P1181; Hoshino K, 1998, FEMS IMMUNOL MED MIC, V20, P201, DOI 10.1111/j.1574-695X.1998.tb01128.x; Hsiao A, 2014, NATURE, V515, P423, DOI 10.1038/nature13738; JOHNSON JA, 1994, INFECT IMMUN, V62, P2108, DOI 10.1128/IAI.62.5.2108-2110.1994; Jonson G, 1996, INFECT IMMUN, V64, P3778, DOI 10.1128/IAI.64.9.3778-3785.1996; Joo I., 1974, CHOLERA, P333; Jutla AS, 2011, AM J TROP MED HYG, V85, P303, DOI 10.4269/ajtmh.2011.11-0181; Karlsson EK, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006338; Kaushik JS, 2010, INDIAN PEDIATR, V47, P309, DOI 10.1007/s13312-010-0059-5; Kirn TJ, 2005, NATURE, V438, P863, DOI 10.1038/nature04249; KOCH R, 1883, DEUT MED WOCHENSCHR, V9, P743, DOI DOI 10.1055/S-0029-1197083; Koelle K, 2005, NATURE, V436, P696, DOI 10.1038/nature03820; KUSTNER HGV, 1981, S AFR MED J, V60, P87; LANGE S, 1978, ACTA PATH MICRO IM C, V86, P145; LaRocque RC, 2009, GENES IMMUN, V10, P267, DOI 10.1038/gene.2009.2; Leung DT, 2012, EXPERT REV ANTI-INFE, V10, P435, DOI [10.1586/eri.12.23, 10.1586/ERI.12.23]; Leung DT, 2011, CLIN VACCINE IMMUNOL, V18, P1317, DOI 10.1128/CVI.05124-11; LEVINE M M, 1988, Lancet, V2, P467; LEWIS DJM, 1994, AIDS, V8, P779, DOI 10.1097/00002030-199406000-00009; Liang WL, 2003, INFECT IMMUN, V71, P5498, DOI 10.1128/IAI.71.10.5498-5504.2003; LINDENBAUM J, 1967, B WORLD HEALTH ORGAN, V37, P529; Liu J, 2013, J CLIN MICROBIOL, V51, P472, DOI 10.1128/JCM.02658-12; Longini IM, 2007, PLOS MED, V4, P1776, DOI 10.1371/journal.pmed.0040336; LONNROTH I, 1973, J GEN MICROBIOL, V76, P417, DOI 10.1099/00221287-76-2-417; Lundgren O, 2002, PHARMACOL TOXICOL, V90, P109, DOI 10.1034/j.1600-0773.2002.900301.x; Luquero FJ, 2014, NEW ENGL J MED, V370, P2111, DOI 10.1056/NEJMoa1312680; Mahalanabis D, 2009, VACCINE, V27, P4850, DOI 10.1016/j.vaccine.2009.05.065; Martin S, 2014, B WORLD HEALTH ORGAN, V92, P881, DOI 10.2471/BLT.14.139949; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Nelson EJ, 2007, P NATL ACAD SCI USA, V104, P19091, DOI 10.1073/pnas.0706352104; O'Connor KA, 2011, EMERG INFECT DIS, V17, P2136, DOI 10.3201/eid1711.110810; Onis M. de, 2006, Acta Paediatrica, V95, P76; Ouchterlony O, NATURE; Ouchterlony O, 1978, 43 NOB S STOCKH AUG; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; POLLITZER R, 1959, CHOLERA; QADRI F, 1995, J CLIN MICROBIOL, V33, P732, DOI 10.1128/JCM.33.3.732-734.1995; Qadri F, 2016, NEW ENGL J MED, V374, P1723, DOI 10.1056/NEJMoa1510330; Qadri F, 2015, LANCET, V386, P1362, DOI 10.1016/S0140-6736(15)61140-0; RAHMAN M, 1987, J CLIN MICROBIOL, V25, P2204, DOI 10.1128/JCM.25.11.2204-2206.1987; Ramakrishna BS, 2000, NEW ENGL J MED, V342, P308, DOI 10.1056/NEJM200002033420502; Richie E, 2000, VACCINE, V18, P2399, DOI 10.1016/S0264-410X(00)00006-2; Rothenbacher FP, 2014, GUT MICROBES, V5, P120, DOI 10.4161/gmic.26944; Roy SK, 2008, BMJ-BRIT MED J, V336, P266, DOI 10.1136/bmj.39416.646250.AE; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; Saha D, 2006, NEW ENGL J MED, V354, P2452, DOI 10.1056/NEJMoa054493; Sanchez J, 2008, CELL MOL LIFE SCI, V65, P1347, DOI 10.1007/s00018-008-7496-5; Siddique AK, 2010, EPIDEMIOL INFECT, V138, P347, DOI 10.1017/S0950268809990550; Silva AJ, 2006, INFECT IMMUN, V74, P2072, DOI 10.1128/IAI.74.4.2072-2079.2006; Snow J., 1855, MODE COMMUNICATION C; SVENNERHOLM AM, 1984, J INFECT DIS, V149, P884, DOI 10.1093/infdis/149.6.884; SWERDLOW DL, 1992, LANCET, V340, P28, DOI 10.1016/0140-6736(92)92432-F; TACKET CO, 1995, J INFECT DIS, V172, P883, DOI 10.1093/infdis/172.3.883; TANAMAL STW, 1959, AM J TROP MED HYG, V8, P72, DOI 10.4269/ajtmh.1959.8.72; Tariq M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007552; TAYLOR RK, 1987, P NATL ACAD SCI USA, V84, P2833, DOI 10.1073/pnas.84.9.2833; Telesmanich N. R., 2009, Klinicheskaya Laboratornaya Diagnostika, P51; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Uddin T, 2011, CLIN VACCINE IMMUNOL, V18, P506, DOI 10.1128/CVI.00481-10; VanHeyningen WE, 1983, CHOLERA AM SCI EXPER; von Seidlein L, 2008, TROP MED INT HEALTH, V13, P683, DOI 10.1111/j.1365-3156.2008.02051.x; Waldor MK, 1996, J BACTERIOL, V178, P4157, DOI 10.1128/jb.178.14.4157-4165.1996; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910; Weil AA, 2014, AM J TROP MED HYG, V91, P738, DOI 10.4269/ajtmh.14-0095; WEIL O, 1992, REV EPIDEMIOL SANTE, V40, P145; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; WHO, 1999, WHO M GEN SWITZ 12 1; WHO, 2004, WHOFCHCAH047; World Health Organization, 2012, WHO TECHN WORK GROUP; World Health Organization, 2005, TREATM DIARRH MAN PH; World Health Organization, 2015, PROGR SAN DRINK WAT; World Health Organization, 2013, POCK BOOK HOSP CAR C; World Health Organization, 2013, GUID UPD MAN SEV AC	147	204	210	10	123	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 23	2017	390	10101					1539	1549		10.1016/S0140-6736(17)30559-7	http://dx.doi.org/10.1016/S0140-6736(17)30559-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH7BS	28302312				2022-12-28	WOS:000411337100028
J	Hamling, IJ; Hreinsdottir, S; Clark, K; Elliott, J; Liang, CR; Fielding, E; Litchfield, N; Villamor, P; Wallace, L; Wright, TJ; D'Anastasio, E; Bannister, S; Burbidge, D; Denys, P; Gentle, P; Howarth, J; Mueller, C; Palmer, N; Pearson, C; Power, W; Barnes, P; Barrell, DJA; Van Dissen, R; Langridge, R; Little, T; Nicol, A; Pettinga, J; Rowland, J; Stirling, M				Hamling, Ian J.; Hreinsdottir, Sigrun; Clark, Kate; Elliott, John; Liang, Cunren; Fielding, Eric; Litchfield, Nicola; Villamor, Pilar; Wallace, Laura; Wright, Tim J.; D'Anastasio, Elisabetta; Bannister, Stephen; Burbidge, David; Denys, Paul; Gentle, Paula; Howarth, Jamie; Mueller, Christof; Palmer, Neville; Pearson, Chris; Power, William; Barnes, Philip; Barrell, David J. A.; Van Dissen, Russ; Langridge, Robert; Little, Tim; Nicol, Andrew; Pettinga, Jarg; Rowland, Julie; Stirling, Mark			Complex multifault rupture during the 2016 M-w 7.8 Kaikoura earthquake, New Zealand	SCIENCE			English	Article							MAYOR-CUCAPAH EARTHQUAKE; STRIKE-SLIP-FAULT; SOUTH-ISLAND; SURFACE RUPTURE; QUATERNARY SLIP; HOPE FAULT; DEFORMATION; GEOMETRY; PLATE; MARLBOROUGH	On 14 November 2016, northeastern South Island of New Zealand was struck by a major moment magnitude (M-w) 7.8 earthquake. Field observations, in conjunction with interferometric synthetic aperture radar, Global Positioning System, and seismology data, reveal this to be one of the most complex earthquakes ever recorded. The rupture propagated northward for more than 170 kilometers along both mapped and unmapped faults before continuing offshore at the island's northeastern extent. Geodetic and field observations reveal surface ruptures along at least 12 major faults, including possible slip along the southern Hikurangi subduction interface; extensive uplift along much of the coastline; and widespread anelastic deformation, including the similar to 8-meter uplift of a fault-bounded block. This complex earthquake defies many conventional assumptions about the degree to which earthquake ruptures are controlled by fault segmentation and should motivate reevaluation of these issues in seismic hazard models.	[Hamling, Ian J.; Hreinsdottir, Sigrun; Clark, Kate; Litchfield, Nicola; Villamor, Pilar; Wallace, Laura; D'Anastasio, Elisabetta; Bannister, Stephen; Burbidge, David; Howarth, Jamie; Mueller, Christof; Palmer, Neville; Power, William; Barrell, David J. A.; Van Dissen, Russ; Langridge, Robert] GNS Sci, Lower Hutt, New Zealand; [Elliott, John; Wright, Tim J.] Univ Leeds, Sch Earth & Environm, Ctr Observat & Modelling Earthquakes Volcanoe & T, Leeds, W Yorkshire, England; [Liang, Cunren; Fielding, Eric] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Wallace, Laura] Univ Texas Austin, Inst Geophys, Austin, TX 78758 USA; [Denys, Paul] Univ Otago, Sch Surveying, Dunedin, New Zealand; [Gentle, Paula] Land Informat New Zealand, Wellington, New Zealand; [Barnes, Philip] Natl Inst Water & Atmospher Res, Wellington, New Zealand; [Little, Tim] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand; [Nicol, Andrew; Pettinga, Jarg] Univ Canterbury, Dept Geol Sci, Christchurch, New Zealand; [Rowland, Julie] Univ Auckland, Sch Environm, Auckland, New Zealand; [Stirling, Mark] Univ Otago, Dept Geol, Dunedin, New Zealand	GNS Science - New Zealand; University of Leeds; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Texas System; University of Texas Austin; University of Otago; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Victoria University Wellington; University of Canterbury; University of Auckland; University of Otago	Hamling, IJ (corresponding author), GNS Sci, Lower Hutt, New Zealand.	i.hamling@gns.cri.nz	denys, Paul/C-6120-2008; Wallace, Laura/AAR-1862-2021; Fielding, Eric Jameson/A-1288-2007; Elliott, John/AAT-8227-2020; Fielding, Eric/L-8187-2019; Burbidge, David/AAF-5665-2020; Wright, Tim/A-5892-2011	denys, Paul/0000-0002-1427-9538; Fielding, Eric Jameson/0000-0002-6648-8067; Fielding, Eric/0000-0002-6648-8067; Litchfield, Nicola/0000-0002-2053-3176; Hamling, Ian/0000-0003-4324-274X; Elliott, John/0000-0003-2957-4596; Howarth, Jamie/0000-0003-4365-0292; Hreinsdottir, Sigrun/0000-0003-0143-1251; Wright, Tim/0000-0001-8338-5935; Clark, Kate/0000-0003-0726-9005; Barnes, Philip/0000-0002-1050-9498; Wallace, Laura/0000-0003-2070-0891; D'Anastasio, Elisabetta/0000-0003-3043-8604; DENYS, Pierre/0000-0002-4831-6499	government of New Zealand; LINZ; Royal Society; U.K. Natural Environment Research Council through COMET; U.K. Natural Environment Research Council [NE/K010867/1]; NASA; JAXA RA4 PI Project [P1372002]; Natural Environment Research Council [NE/K010867/1, come30001] Funding Source: researchfish; NERC [come30001, NE/K010867/1] Funding Source: UKRI	government of New Zealand; LINZ; Royal Society(Royal Society of London); U.K. Natural Environment Research Council through COMET; U.K. Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NASA(National Aeronautics & Space Administration (NASA)); JAXA RA4 PI Project; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Japan Aerospace Exploration Agency (JAXA) for access to ALOS-2 data; the European Union Copernicus program and the European Space Agency for access to and scheduling of Sentinel-1 data; and GeoNet (http://geonet.org.nz), PositioNZ, AllTerra, Eliot Sinclair, Global Survey, and the International GNSS Service for GPS data. We also thank all of the people who helped collect data from the field. We acknowledge the use of bathymetry data for tsunami travel time and propagation modeling from Land Information New Zealand, the National Institute of Water and Atmospheric Research, Seabed Mapping International, the National Geophysical Data Centre, and the General Bathymetric Chart of the Oceans. Author contributions: I.J.H. carried out the elastic modeling and led the writing of the paper, with help from T.J.W., L.W., S.H., and contributions from all authors. J.E., E.F., and C.L. acquired and processed the InSAR data sets. S.H. estimated the GPS coseismic offsets, and K.C. led the collection and analysis of the coastal uplift data. N.P., P.D., and S.H. organized and led the campaign GPS field work, with additional support from LINZ and Otago University. S.B. analyzed and provided the relocated earthquake catalog. N.L. and P.V. led the surface faulting work and C.M., D.B., and W.P. analyzed and modeled tsunami data. Funding: This work was supported by public research funding from the government of New Zealand, with additional support from LINZ. J.E. and T.J.W. were funded by the Royal Society and the U.K. Natural Environment Research Council through COMET and grant NE/K010867/1. Part of this research was carried out at JPL, California Institute of Technology, under a contract with NASA (Earth Surface and Interior focus area). C.L. was also supported by an appointment to the NASA Postdoctoral Program at JPL. The ALOS-2 original data are copyrighted by JAXA and provided under JAXA RA4 PI Project P1372002. Competing Interests: We declare that we have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the supplementary materials. Additional data are available from the authors upon request.	BARKA AA, 1988, TECTONICS, V7, P663, DOI 10.1029/TC007i003p00663; Beavan J, 2016, NEW ZEAL J GEOL GEOP, V59, P5, DOI 10.1080/00288306.2015.1112817; Beavan J, 2012, NEW ZEAL J GEOL GEOP, V55, P207, DOI 10.1080/00288306.2012.697472; Benson AM, 2001, GEOL SOC AM BULL, V113, P1079, DOI 10.1130/0016-7606(2001)113<1079:LQPHAS>2.0.CO;2; Biasi GP, 2016, B SEISMOL SOC AM, V106, P1110, DOI 10.1785/0120150175; Bro R, 1997, J CHEMOMETR, V11, P393, DOI 10.1002/(SICI)1099-128X(199709/10)11:5<393::AID-CEM483>3.3.CO;2-C; Dor O, 2006, EARTH PLANET SC LETT, V245, P642, DOI 10.1016/j.epsl.2006.03.034; Fan WY, 2016, SCIENCE, V353, P1133, DOI 10.1126/science.aag0013; Fialko Y, 2002, SCIENCE, V297, P1858, DOI 10.1126/science.1074671; Field EH, 2014, B SEISMOL SOC AM, V104, P1122, DOI 10.1785/0120130164; Fletcher JM, 2016, NAT GEOSCI, V9, P303, DOI 10.1038/NGEO2660; Fletcher JM, 2014, GEOSPHERE, V10, P797, DOI 10.1130/GES00933.1; Hamling IJ, 2014, J GEOPHYS RES-SOL EA, V119, P6080, DOI 10.1002/2014JB011084; HOLT WE, 1995, J GEOPHYS RES-SOL EA, V100, P17991, DOI 10.1029/95JB01059; Hooper A, 2013, EARTH PLANET SC LETT, V361, P469, DOI 10.1016/j.epsl.2012.11.013; Huang MH, 2017, J GEOPHYS RES-SOL EA, V122, P607, DOI 10.1002/2016JB012858; Kaneko Y, 2011, GEOPHYS J INT, V186, P1389, DOI 10.1111/j.1365-246X.2011.05117.x; King GCP, 2007, B SEISMOL SOC AM, V97, P1833, DOI 10.1785/0120070048; KNUEPFER PLK, 1992, TECTONICS, V11, P449, DOI 10.1029/91TC02890; Langridge RM, 2016, NEW ZEAL J GEOL GEOP, V59, P86, DOI 10.1080/00288306.2015.1112818; Langridge RM, 2005, NEW ZEAL J GEOL GEOP, V48, P43, DOI 10.1080/00288306.2005.9515097; Legg MR, 2007, GEOL SOC SPEC PUBL, V290, P143, DOI 10.1144/SP290.3; Litchfield NJ, 2014, NEW ZEAL J GEOL GEOP, V57, P32, DOI 10.1080/00288306.2013.854256; Nicol A, 2003, TECTONICS, V22, DOI 10.1029/2003TC001521; Nissen E, 2016, NAT GEOSCI, V9, P330, DOI 10.1038/NGEO2653; Norris RJ, 2001, J STRUCT GEOL, V23, P507, DOI 10.1016/S0191-8141(00)00122-X; OKADA Y, 1985, B SEISMOL SOC AM, V75, P1135; Pagli C, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015310; Pettinga J.R., 2001, B NZ SOC EARTHQUAKE, V34, P282; Reilinger RE, 2000, SCIENCE, V289, P1519, DOI 10.1126/science.289.5484.1519; Ristau J, 2013, B SEISMOL SOC AM, V103, P2520, DOI 10.1785/0120120339; SCHOLZ CH, 1982, B SEISMOL SOC AM, V72, P1; Shaw BE, 2008, B SEISMOL SOC AM, V98, P1633, DOI 10.1785/0120070191; Stirling M, 2012, B SEISMOL SOC AM, V102, P1514, DOI 10.1785/0120110170; Van Dissen R, 2009, NEW ZEAL J GEOL GEOP, V52, P195, DOI 10.1080/00288300909509886; VANDISSEN R, 1991, GEOLOGY, V19, P393, DOI 10.1130/0091-7613(1991)019<0393:HFJTAU>2.3.CO;2; Wallace LM, 2007, GEOPHYS J INT, V168, P332, DOI 10.1111/j.1365-246X.2006.03183.x; Wallace LM, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2004JB003241; Wang X., 2011, 201143 GNS SCI; Wesnousky SG, 2008, B SEISMOL SOC AM, V98, P1609, DOI 10.1785/0120070111; Wesnousky SG, 2006, NATURE, V444, P358, DOI 10.1038/nature05275; Williams CA, 2013, SEISMOL RES LETT, V84, P1066, DOI 10.1785/0220130035; Zachariasen J, 2006, NEW ZEAL J GEOL GEOP, V49, P159, DOI 10.1080/00288306.2006.9515156	43	380	392	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2017	356	6334							eaam7194	10.1126/science.aam7194	http://dx.doi.org/10.1126/science.aam7194			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER7SM	28336563	Green Accepted			2022-12-28	WOS:000399013800027
J	Verhalen, B; Dastvan, R; Thangapandian, S; Peskova, Y; Koteiche, HA; Nakamoto, RK; Tajkhorshid, E; Mchaourab, HS				Verhalen, Brandy; Dastvan, Reza; Thangapandian, Sundarapandian; Peskova, Yelena; Koteiche, Hanane A.; Nakamoto, Robert K.; Tajkhorshid, Emad; Mchaourab, Hassane S.			Energy transduction and alternating access of the mammalian ABC transporter P-glycoprotein	NATURE			English	Article							NUCLEOTIDE-BINDING DOMAINS; GUI MEMBRANE-BUILDER; ATP HYDROLYSIS; CATALYTIC CYCLE; DISTANCE MEASUREMENTS; GLUTAMATE RESIDUES; MOLECULAR-DYNAMICS; FORCE-FIELD; CHARMM; CONFORMATION	ATP binding cassette (ABC) transporters of the exporter class harness the energy of ATP hydrolysis in the nucleotide-binding domains (NBDs) to power the energetically uphill efflux of substrates by a dedicated transmembrane domain (TMD)(1-4). Although numerous investigations have described the mechanism of ATP hydrolysis and defined the architecture of ABC exporters, a detailed structural dynamic understanding of the transduction of ATP energy to the work of substrate translocation remains elusive. Here we used double electron-electron resonance(5,6) and molecular dynamics simulations to describe the ATP- and substrate-coupled conformational cycle of the mouse ABC efflux transporter P-glycoprotein (Pgp; also known as ABCB1), which has a central role in the clearance of xenobiotics and in cancer resistance to chemotherapy(7). Pairs of spin labels were introduced at residues selected to track the putative inward-facing to outward-facing transition. Our findings illuminate how ATP energy is harnessed in the NBDs in a two-stroke cycle and elucidate the consequent conformational motion that reconfigures the TMD, two critical aspects of Pgp transport mechanism. Along with a fully atomistic model of the outward-facing conformation in membranes, the insight into Pgp conformational dynamics harmonizes mechanistic and structural data into a novel perspective on ATP-coupled transport and reveals mechanistic divergence within the efflux class of ABC transporters.	[Verhalen, Brandy; Dastvan, Reza; Koteiche, Hanane A.; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Thangapandian, Sundarapandian; Tajkhorshid, Emad] Univ Illinois, Dept Biochem, Ctr Biophys & Quantitat Biol, Urbana, IL 61801 USA; [Thangapandian, Sundarapandian; Tajkhorshid, Emad] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Peskova, Yelena; Nakamoto, Robert K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Verhalen, Brandy] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA	Vanderbilt University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Virginia; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mchaourab, HS (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	hassane.mchaourab@vanderbilt.edu	Tajkhorshid, Emad/AAN-8323-2021		National Institutes of Health [U54-GM087519, P41-GM104601]; Extreme Science and Engineering Discovery Environment [TG-MCA06N060]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM087519, P41GM104601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Extreme Science and Engineering Discovery Environment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Stein for advice on the global analysis of DEER data, I.L. Urbatsch for donation of Pichia pastoris expression construct, and S. Wilkens for providing three expressed mutants (615-1276, 627-1260 and 613-1258) in P. pastoris. This work was supported by National Institutes of Health grants U54-GM087519 (to H.S.M., R.K.N. and E.T.) and P41-GM104601 (to E.T.). We also acknowledge computing resources provided by Blue Waters at National Center for Supercomputing Applications, Department of Energy Innovative and Novel Computational Impact on Theory and Experiment, and Extreme Science and Engineering Discovery Environment (grant TG-MCA06N060 to E.T.).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Carrier I, 2003, BIOCHEMISTRY-US, V42, P12875, DOI 10.1021/bi034257w; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Jeschke G, 2007, PHYS CHEM CHEM PHYS, V9, P1895, DOI 10.1039/b614920k; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Jones PM, 2013, CRIT REV BIOCHEM MOL, V48, P39, DOI 10.3109/10409238.2012.735644; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Mishra S, 2014, ELIFE, V3, DOI 10.7554/eLife.02740; Moradi M, 2013, P NATL ACAD SCI USA, V110, P18916, DOI 10.1073/pnas.1313202110; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pirovano W, 2008, BIOINFORMATICS, V24, P492, DOI 10.1093/bioinformatics/btm636; Polyhach Y, 2011, PHYS CHEM CHEM PHYS, V13, P2356, DOI 10.1039/c0cp01865a; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; Sharom FJ, 2008, PHARMACOGENOMICS, V9, P105, DOI 10.2217/14622416.9.1.105; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Simossis VA, 2005, NUCLEIC ACIDS RES, V33, pW289, DOI 10.1093/nar/gki390; Smriti, 2009, J BIOL CHEM, V284, P13904, DOI 10.1074/jbc.M900837200; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2006, ARCH BIOCHEM BIOPHYS, V445, P124, DOI 10.1016/j.abb.2005.11.004; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Verhalen B, 2011, J BIOL CHEM, V286, P10476, DOI 10.1074/jbc.M110.193151; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wen PC, 2013, J BIOL CHEM, V288, P19211, DOI 10.1074/jbc.M113.450114; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zou P, 2009, J MOL BIOL, V393, P586, DOI 10.1016/j.jmb.2009.08.050	46	135	136	2	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					738	+		10.1038/nature21414	http://dx.doi.org/10.1038/nature21414			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28289287	Green Accepted			2022-12-28	WOS:000397619700060
J	Jungheim, ES; Leung, MY; Macones, GA; Odem, RR; Pollack, LM; Hamilton, BH				Jungheim, Emily S.; Leung, Man Yee (Mallory); Macones, George A.; Odem, Randall R.; Pollack, Lisa M.; Hamilton, Barton H.			In Vitro Fertilization Insurance Coverage and Chances of a Live Birth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Jungheim, Emily S.; Leung, Man Yee (Mallory); Macones, George A.; Odem, Randall R.] Washington Univ, Sch Med, St Louis, MO USA; [Pollack, Lisa M.] Brown Sch Social Work, St Louis, MO USA; [Hamilton, Barton H.] Olin Sch Business, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Jungheim, ES (corresponding author), 4444 Forest Pk,Ste 3100, St Louis, MO 63108 USA.	jungheime@wudosis.wustl.edu	Hamilton, Barton H/P-5187-2015		NIH from the Women's Reproductive Health Research Program of the National Institutes of Health [K12HD063086]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD063086] Funding Source: NIH RePORTER	NIH from the Women's Reproductive Health Research Program of the National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grant NIH K12HD063086 from the Women's Reproductive Health Research Program of the National Institutes of Health (Dr Jungheim).	[Anonymous], 1982, JACKKNIFE BOOTSTRAP; Insurance Department of Insurance, INS COV INF TREATM; Jain T, 2002, NEW ENGL J MED, V347, P661, DOI 10.1056/NEJMsa013491; Zegers-Hochschild F, 2009, HUM REPROD, V24, P2683, DOI 10.1093/humrep/dep343	4	8	8	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1273	1275		10.1001/jama.2017.0727	http://dx.doi.org/10.1001/jama.2017.0727			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350917				2022-12-28	WOS:000397557800026
J	Levine, AD; Boulet, SL; Kissin, DM				Levine, Aaron D.; Boulet, Sheree L.; Kissin, Dmitry M.			Contribution of Assisted Reproductive Technology to Overall Births by Maternal Age in the United States, 2012-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Levine, Aaron D.] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Boulet, Sheree L.; Kissin, Dmitry M.] US Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA	University System of Georgia; Georgia Institute of Technology; Centers for Disease Control & Prevention - USA	Levine, AD (corresponding author), Sch Publ Policy, 685 Cherry St, Atlanta, GA 30332 USA.	aaron.levine@pubpolicy.gatech.edu		Boulet, Sheree/0000-0002-7638-7374				Centers for Disease Control and Prevention, 2007, NAT; Centers for Disease Control and Prevention American Society for Reproductive Medicine, 2016, 2014 ASS REPR TECHN; Reynolds MA, 2003, PEDIATRICS, V111, P1159; Salihu HM, 2003, OBSTET GYNECOL, V102, P1006, DOI 10.1016/S0029-7844(03)00739-7; Sunderam S, 2015, MMWR SURVEILL SUMM, V64, P1	5	9	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1272	1273		10.1001/jama.2016.21311	http://dx.doi.org/10.1001/jama.2016.21311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350916				2022-12-28	WOS:000397557800025
J	Reuben, A; Caspi, A; Belsky, DW; Broadbent, J; Harrington, H; Sugden, K; Houts, RM; Ramrakha, S; Poulton, R; Moffitt, TE				Reuben, Aaron; Caspi, Avshalom; Belsky, Daniel W.; Broadbent, Jonathan; Harrington, Honalee; Sugden, Karen; Houts, Renate M.; Ramrakha, Sandhya; Poulton, Richie; Moffitt, Terrie E.			Association of Childhood Blood Lead Levels With Cognitive Function and Socioeconomic Status at Age 38 Years and With IQ Change and Socioeconomic Mobility Between Childhood and Adulthood	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTELLECTUAL FUNCTION; CUMULATIVE LEAD; NEW-ZEALAND; EXPOSURE; DUNEDIN; CHILDREN; HEALTH	IMPORTANCE Many children in the United States and around the world are exposed to lead, a developmental neurotoxin. The long-term cognitive and socioeconomic consequences of lead exposure are uncertain. OBJECTIVE To test the hypothesis that childhood lead exposure is associated with cognitive function and socioeconomic status in adulthood and with changes in IQ and socioeconomic mobility between childhood and midlife. DESIGN, SETTING, AND PARTICIPANTS A prospective cohort study based on a population-representative 1972-1973 birth cohort from New Zealand; the Dunedin Multidisciplinary Health and Development Study observed participants to age 38 years (until December 2012). EXPOSURES Childhood lead exposure ascertained as blood lead levels measured at age 11 years. High blood lead levels were observed among children from all socioeconomic status levels in this cohort. MAIN OUTCOMES AND MEASURES The IQ (primary outcome) and indexes of Verbal Comprehension, Perceptual Reasoning, Working Memory, and Processing Speed (secondary outcomes) were assessed at age 38 years using the Wechsler Adult Intelligence Scale-IV (WAIS-IV; IQ range, 40-160). Socioeconomic status (primary outcome) was assessed at age 38 years using the New Zealand Socioeconomic Index-2006 (NZSEI-06; range, 10 [lowest]-90 [highest]). RESULTS Of 1037 original participants, 1007 were alive at age 38 years, of whom 565 (56%) had been lead tested at age 11 years (54% male; 93% white). Mean (SD) blood lead level at age 11 years was 10.99 (4.63) mu g/dL. Among blood-tested participants included at age 38 years, mean WAIS-IV score was 101.16 (14.82) and mean NZSEI-06 score was 49.75 (17.12). After adjusting for maternal IQ, childhood IQ, and childhood socioeconomic status, each 5-mu g/dL higher level of blood lead in childhood was associated with a 1.61-point lower score (95% CI, -2.48 to -0.74) in adult IQ, a 2.07-point lower score (95% CI, -3.14 to -1.01) in perceptual reasoning, and a 1.26-point lower score (95% CI, -2.38 to -0.14) inworking memory. Associations of childhood blood lead level with deficits in verbal comprehension and processing speed were not statistically significant. After adjusting for confounders, each 5-mu g/dL higher level of blood lead in childhood was associated with a 1.79-unit lower score (95% CI, -3.17 to -0.40) in socioeconomic status. An association between greater blood lead levels and a decline in IQ and socioeconomic status from childhood to adulthood was observed with 40% of the association with downward mobility mediated by cognitive decline from childhood. CONCLUSIONS AND RELEVANCE In this cohort born in New Zealand in 1972-1973, childhood lead exposure was associated with lower cognitive function and socioeconomic status at age 38 years and with declines in IQ and with downward social mobility. Childhood lead exposure may have long-term ramifications.	[Reuben, Aaron; Caspi, Avshalom; Harrington, Honalee; Sugden, Karen; Houts, Renate M.; Moffitt, Terrie E.] Duke Univ, Dept Psychol & Neurosci, 2020 W Main St, Durham, NC 27708 USA; [Caspi, Avshalom; Moffitt, Terrie E.] Duke Univ, Ctr Genom & Computat Biol, Durham, NC USA; [Caspi, Avshalom; Moffitt, Terrie E.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC USA; [Caspi, Avshalom; Moffitt, Terrie E.] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat Psychol & Neurosci, London, England; [Belsky, Daniel W.] Duke Univ, Social Sci Res Inst, Durham, NC USA; [Belsky, Daniel W.] Duke Univ, Sch Med, Dept Med, Durham, NC 27706 USA; [Broadbent, Jonathan] Univ Otago, Sir JohnWalsh Res Inst, Fac Dent, Dunedin, New Zealand; [Ramrakha, Sandhya; Poulton, Richie] Univ Otago, Dunedin Multidisciplinary Hlth & Dev Res Unit, Dept Psychol, Dunedin, New Zealand	Duke University; Duke University; Duke University; University of London; King's College London; Duke University; Duke University; University of Otago; University of Otago	Reuben, A (corresponding author), Duke Univ, Dept Psychol & Neurosci, 2020 W Main St, Durham, NC 27708 USA.	aaron.reuben@duke.edu	Belsky, Daniel/AAB-4785-2021; caspi, avshalom/AAJ-5874-2020; Houts, Renate/AAC-5304-2019; Belsky, Daniel/HDN-5118-2022; Sugden, Karen/O-6046-2019; Broadbent, Jonathan M/R-9976-2019; Moffitt, Terrie E/D-5295-2011; Sugden, Karen/I-8531-2016	Belsky, Daniel/0000-0001-5463-2212; caspi, avshalom/0000-0003-0082-4600; Houts, Renate/0000-0002-1518-2631; Sugden, Karen/0000-0002-4076-5927; Broadbent, Jonathan M/0000-0002-8905-398X; Moffitt, Terrie E/0000-0002-8589-6760; Sugden, Karen/0000-0002-4076-5927; Reuben, Aaron/0000-0001-5713-4913	New Zealand Health Research Council; New Zealand Ministry of Business, Innovation, and Employment (MBIE); US National Institute on Aging [R01AG032282, R01AG049789, R01AG048895]; UK Medical Research Council [MR/K00381X, MR/P005918/1]; Economic and Social Research Council [ES/M010309/1]; Jacobs Foundation; ESRC [ES/M010309/1] Funding Source: UKRI; MRC [MR/P005918/1] Funding Source: UKRI; Medical Research Council [MR/P005918/1] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P30AG034424, R01AG048895, R01AG032282, R01AG049789] Funding Source: NIH RePORTER	New Zealand Health Research Council(Health Research Council of New Zealand); New Zealand Ministry of Business, Innovation, and Employment (MBIE)(New Zealand Ministry of Business, Innovation and Employment (MBIE)); US National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Jacobs Foundation; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Dunedin Multidisciplinary Health and Development Research Unit is supported by the New Zealand Health Research Council and the New Zealand Ministry of Business, Innovation, and Employment (MBIE). This research received grant support from the US National Institute on Aging (R01AG032282, R01AG049789, R01AG048895); the UK Medical Research Council (MR/K00381X and MR/P005918/1); the Economic and Social Research Council (ES/M010309/1); and the Jacobs Foundation.	Annest J., 1983, LEAD VERSUS HLTH, P33; Bandeen-Roche K, 2009, EPIDEMIOLOGY, V20, P831, DOI 10.1097/EDE.0b013e3181b5f100; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b; Broadbent JM, 2015, AM J PUBLIC HEALTH, V105, P72, DOI 10.2105/AJPH.2013.301857; BRODY DJ, 1994, JAMA-J AM MED ASSOC, V272, P277, DOI 10.1001/jama.272.4.277; Brubaker CJ, 2009, NEUROTOXICOLOGY, V30, P867, DOI 10.1016/j.neuro.2009.07.007; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Centers for Disease Control and Prevention, WHAT DO PAT NEED KNO; DESILVA PE, 1984, ANN OCCUP HYG, V28, P417, DOI 10.1093/annhyg/28.4.417; Educational Services for Children Affected by Lead Expert Panel, 2015, ED INT CHILDR AFF LE; ELLEY WB, 1976, NEW ZEAL J EDUC STUD, V11, P25; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Kennedy Chinaro, 2016, MMWR Morb Mortal Wkly Rep, V65, P650, DOI 10.15585/mmwr.mm6525e1; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Mazumdar M, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-24; Milne BJ., 2013, NZ SOCIOECONOMIC IND; MOFFITT TE, 1993, J CHILD PSYCHOL PSYC, V34, P455, DOI 10.1111/j.1469-7610.1993.tb01031.x; Moody H, 2016, SOCIOL RACE ETHNIC, V2, P200, DOI 10.1177/2332649215608873; NEEDLEMAN HL, 1990, NEW ENGL J MED, V322, P83, DOI 10.1056/NEJM199001113220203; Poulton R, 2015, SOC PSYCH PSYCH EPID, V50, P679, DOI 10.1007/s00127-015-1048-8; Power MC, 2014, ENVIRON RES, V129, P69, DOI 10.1016/j.envres.2013.12.010; Renner R, 2009, ENVIRON HEALTH PERSP, V117, pA542, DOI 10.1289/ehp.117-a542; Shih RA, 2007, ENVIRON HEALTH PERSP, V115, P483, DOI 10.1289/ehp.9786; SILVA PA, 1986, NEW ZEAL MED J, V99, P179; SILVA PA, 1988, J CHILD PSYCHOL PSYC, V29, P43, DOI 10.1111/j.1469-7610.1988.tb00687.x; Stokes L, 1998, OCCUP ENVIRON MED, V55, P507, DOI 10.1136/oem.55.8.507; Thurstone L, 1973, SRA VERBAL NONVERBAL; Wechsler D., 2012, WAIS 4 KASIKIRJA; Wechsler DW., 1999, INTELLIGENCE SCALE C; WHITE RF, 1993, BRIT J IND MED, V50, P613; Wilson N, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-1	32	168	170	3	59	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1244	1251		10.1001/jama.2017.1712	http://dx.doi.org/10.1001/jama.2017.1712			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP7KX	28350927	Green Submitted, Green Accepted			2022-12-28	WOS:000397557800021
J	Pai, M; Correa, N; Mistry, N; Jha, P				Pai, Madhukar; Correa, Natasha; Mistry, Nerges; Jha, Prabhat			Reducing global tuberculosis deaths-time for India to step up	LANCET			English	Editorial Material							BURDEN		[Pai, Madhukar] McGill Univ, McGill Int TB Ctr, Montreal, PQ H3A 1A2, Canada; [Pai, Madhukar] McGill Univ, McGill Global Hlth Programs, Montreal, PQ H3A 1A2, Canada; [Pai, Madhukar] Manipal Univ, Manipal McGill Ctr Infect Dis, Manipal, Karnataka, India; [Correa, Natasha; Jha, Prabhat] Univ Toronto, Ctr Global Hlth Res, St Michaels Hosp, Toronto, ON, Canada; [Correa, Natasha; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Mistry, Nerges] Fdn Med Res, Bombay, Maharashtra, India	McGill University; McGill University; Manipal Academy of Higher Education (MAHE); University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Pai, M (corresponding author), McGill Univ, McGill Int TB Ctr, Montreal, PQ H3A 1A2, Canada.; Pai, M (corresponding author), McGill Univ, McGill Global Hlth Programs, Montreal, PQ H3A 1A2, Canada.; Pai, M (corresponding author), Manipal Univ, Manipal McGill Ctr Infect Dis, Manipal, Karnataka, India.	madhukar.pai@mcgill.ca	Pai, Madhukar/AAX-9901-2021; PAL, MRINAL/ABG-9676-2020	Pai, Madhukar/0000-0003-3667-4536; PAL, MRINAL/0000-0002-1032-272X				Aleksandrowicz L, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-21; [Anonymous], 2017, LANCET, V389, P127, DOI 10.1016/S0140-6736(17)30075-2; [Anonymous], 2017, HINDUSTAN TIMES; Arinaminpathy N, 2016, LANCET INFECT DIS, V16, P1255, DOI 10.1016/S1473-3099(16)30259-6; Bhargava A, 2014, NATL MED J INDIA, V27, P128; Central TB, 2017, NAT STRAT PLAN TUB E; Das J, 2015, LANCET INFECT DIS, V15, P1305, DOI 10.1016/S1473-3099(15)00077-8; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Law S, 2017, LANCET PUBLIC HEALTH, V2, pE47, DOI 10.1016/S2468-2667(16)30035-4; Nadda JP, 2016, LANCET, V388, P2217, DOI 10.1016/S0140-6736(16)31853-0; Prasad A, 2017, LANCET, V389, P680, DOI 10.1016/S0140-6736(17)30324-0; Registrar General of India Centre for Global Health Research, 2015, JOINT REP REG GEN IN; Satyanarayana S, 2015, INT J TUBERC LUNG D, V19, P751, DOI 10.5588/ijtld.15.0186; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Subbaraman R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002149; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; World Health Organisation (WHO), 2016, GLOB TUB REP 2016	17	18	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2017	389	10075					1174	1176		10.1016/S0140-6736(17)30790-0	http://dx.doi.org/10.1016/S0140-6736(17)30790-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP1KL	28353428				2022-12-28	WOS:000397143700011
J	Dry, S				Dry, Sarah			Make It Rain State Control of the Atmosphere in Twentieth-Century America	SCIENCE			English	Book Review																		HARPER KC, 2017, MAKE IT RAIN STATE C	1	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1272	1272		10.1126/science.aam7011	http://dx.doi.org/10.1126/science.aam7011			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EP0NB	28336629				2022-12-28	WOS:000397082900022
J	Gramling, C				Gramling, Carolyn			PALEONTOLOGY Ma, where did they put T. rex?	SCIENCE			English	News Item																			0	0	0	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1249	1249		10.1126/science.355.6331.1249	http://dx.doi.org/10.1126/science.355.6331.1249			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336616				2022-12-28	WOS:000397082900009
J	Castrillo, G; Teixeira, PJPL; Paredes, SH; Law, TF; de Lorenzo, L; Feltcher, ME; Finkel, OM; Breakfield, NW; Mieczkowski, P; Jones, CD; Paz-Ares, J; Dangl, JL				Castrillo, Gabriel; Teixeira, Paulo Jose Pereira Lima; Paredes, Sur Herrera; Law, Theresa F.; de Lorenzo, Laura; Feltcher, Meghan E.; Finkel, Omri M.; Breakfield, Natalie W.; Mieczkowski, Piotr; Jones, Corbin D.; Paz-Ares, Javier; Dangl, Jeffery L.			Root microbiota drive direct integration of phosphate stress and immunity	NATURE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RNA-SEQ EXPERIMENTS; ARABIDOPSIS; PLANT; PHOSPHORUS; RESPONSES; STARVATION; IDENTIFICATION; COLONIZATION; DEGRADATION	Plants live in biogeochemically diverse soils with diverse microbiota. Plant organs associate intimately with a subset of these microbes, and the structure of the microbial community can be altered by soil nutrient content. Plant-associated microbes can compete with the plant and with each other for nutrients, but may also carry traits that increase the productivity of the plant. It is unknown how the plant immune system coordinates microbial recognition with nutritional cues during microbiome assembly. Here we establish that a genetic network controlling the phosphate stress response influences the structure of the root microbiome community, even under non-stress phosphate conditions. We define a molecular mechanism regulating coordination between nutrition and defence in the presence of a synthetic bacterial community. We further demonstrate that the master transcriptional regulators of phosphate stress response in Arabidopsis thaliana also directly repress defence, consistent with plant prioritization of nutritional stress over defence. Our work will further efforts to define and deploy useful microbes to enhance plant performance.	[Castrillo, Gabriel; Teixeira, Paulo Jose Pereira Lima; Paredes, Sur Herrera; Law, Theresa F.; Feltcher, Meghan E.; Finkel, Omri M.; Breakfield, Natalie W.; Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Castrillo, Gabriel; Teixeira, Paulo Jose Pereira Lima; Paredes, Sur Herrera; Law, Theresa F.; Feltcher, Meghan E.; Finkel, Omri M.; Breakfield, Natalie W.; Dangl, Jeffery L.] Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Paredes, Sur Herrera; Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Curriculum Bioinformat & Comp Biol, Chapel Hill, NC 27599 USA; [de Lorenzo, Laura; Paz-Ares, Javier] CNB CSIC, Dept Plant Mol Genet, Darwin 3, E-28049 Madrid, Spain; [Mieczkowski, Piotr; Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Mieczkowski, Piotr; Jones, Corbin D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Mieczkowski, Piotr; Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Jones, Corbin D.; Dangl, Jeffery L.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA; [Dangl, Jeffery L.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [de Lorenzo, Laura; Breakfield, Natalie W.] NewLeaf Symbiot, St Louis, MO 63132 USA	University of North Carolina; University of North Carolina Chapel Hill; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dangl, JL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.; Dangl, JL (corresponding author), Univ N Carolina, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.; Dangl, JL (corresponding author), Univ N Carolina, Curriculum Bioinformat & Comp Biol, Chapel Hill, NC 27599 USA.; Dangl, JL (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC USA.; Dangl, JL (corresponding author), Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA.; Dangl, JL (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27599 USA.; Dangl, JL (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.	dangl@email.unc.edu	Paredes, Sur Herrera/I-8617-2019; Teixeira, Paulo/C-1546-2013; Castrillo, Gabriel/Z-6321-2019; Finkel, Omri/AAG-1465-2020	Paredes, Sur Herrera/0000-0001-9246-8337; Teixeira, Paulo/0000-0002-0776-5044; Breakfield, Natalie/0000-0001-8517-885X; Paz-Ares, Javier/0000-0003-0553-9745; Mieczkowski, Piotr/0000-0003-2418-0096; Castrillo, Gabriel/0000-0002-1557-6614	NSF INSPIRE grant [IOS-1343020]; DOE-USDA [DE-SC001043]; NIH [T32 GM067553-06]; Pew Latin American Fellows Program in the Biomedical Sciences; HHMI; Gordon and Betty Moore Foundation [GBMF3030]; NIH NRSA [F32-GM112345-02, F32-GM117758-01]; NIH NRSA Fellowship [F32-GM103156]; Spanish Ministry of Economy and Competitiveness (MINECO) [BIO2014-60453-R, EUI2008-03748]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM117758, F32GM103156, F32GM112345] Funding Source: NIH RePORTER; Direct For Biological Sciences [1343020] Funding Source: National Science Foundation	NSF INSPIRE grant; DOE-USDA(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Latin American Fellows Program in the Biomedical Sciences; HHMI(Howard Hughes Medical Institute); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Economy and Competitiveness (MINECO); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support by NSF INSPIRE grant IOS-1343020 and DOE-USDA Feedstock Award DE-SC001043 to J.L.D. S.H.P. was supported by NIH Training Grant T32 GM067553-06 and is a Howard Hughes Medical Institute International Student Research Fellow. P.J.P.L.T. was supported by The Pew Latin American Fellows Program in the Biomedical Sciences. J.L.D. is an Investigator of the Howard Hughes Medical Institute, supported by the HHMI and the Gordon and Betty Moore Foundation (GBMF3030). M.E.F. and O.M.F. are supported by NIH NRSA Fellowships F32-GM112345-02 and F32-GM117758-01, respectively. N.W.B. was supported by NIH NRSA Fellowship F32-GM103156. J.P.-A. is funded by the Spanish Ministry of Economy and Competitiveness (MINECO BIO2014-60453-R and EUI2008-03748). We thank S. Barth and E. Getzen for technical assistance, the Dangl laboratory microbiome group for useful discussions and S. Grant, D. Lundberg, F. El Kasmi, P. Schulze-Lefert and his colleagues for critical comments on the manuscript. Supplement contains additional data. Raw sequence data are available at the EBI Sequence Read Archive accession PRJEB15671 for microbiome 16S profiling, and at the Gene Expression Omnibus accessions GSE87339 for transcriptomic experiments. J.L.D. is a co-founder of, and shareholder in, and S.H.P. collaborates with, AgBiome LLC, a corporation whose goal is to use plant-associated microbes to improve plant productivity.	Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; [Anonymous], 2014, R LANG ENV STAT COMP; Arsenault J. L., 1995, Hortscience, V30, P906; Barboriak DP, 2005, J DIGIT IMAGING, V18, P91, DOI 10.1007/s10278-004-1879-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Castrillo G, 2013, PLANT CELL, V25, P2944, DOI 10.1105/tpc.113.114009; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Gonzalez E, 2005, PLANT CELL, V17, P3500, DOI 10.1105/tpc.105.036640; Gregory R, 2016, GPLOTS VARIOUS R PRO; Hacquard S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11362; Hacquard S, 2015, CELL HOST MICROBE, V17, P603, DOI 10.1016/j.chom.2015.04.009; Harrison MJ, 2012, CURR OPIN PLANT BIOL, V15, P691, DOI 10.1016/j.pbi.2012.08.010; Hiruma K, 2016, CELL, V165, P464, DOI 10.1016/j.cell.2016.02.028; Huang TK, 2013, PLANT CELL, V25, P4044, DOI 10.1105/tpc.113.115998; Hubert DA, 2009, P NATL ACAD SCI USA, V106, P9556, DOI 10.1073/pnas.0904877106; Karthikeyan AS, 2007, PLANTA, V225, P907, DOI 10.1007/s00425-006-0408-8; Khan GA, 2016, PLANT PHYSIOL, V171, P632, DOI 10.1104/pp.16.00278; Lambers H, 2015, CURR OPIN PLANT BIOL, V25, P23, DOI 10.1016/j.pbi.2015.04.002; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Lin WY, 2013, PLANT CELL, V25, P4061, DOI 10.1105/tpc.113.116012; LOGEMANN J, 1987, ANAL BIOCHEM, V163, P16, DOI 10.1016/0003-2697(87)90086-8; Lu YT, 2014, PLANT PHYSIOL, V164, P1456, DOI 10.1104/pp.113.229740; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Lundberg DS, 2013, NAT METHODS, V10, P999, DOI 10.1038/nmeth.2634; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Misson J, 2005, P NATL ACAD SCI USA, V102, P11934, DOI 10.1073/pnas.0505266102; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; Nguyen NH, 2015, NEW PHYTOL, V205, P1389, DOI 10.1111/nph.12923; Oksanen J, 2022, R PACKAGE VERSION; Pant BD, 2015, PLANT CELL ENVIRON, V38, P172, DOI 10.1111/pce.12378; Paredes Sur Herrera, 2016, ZENODO; Puga MI, 2014, P NATL ACAD SCI USA, V111, P14947, DOI 10.1073/pnas.1404654111; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Rallapalli G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-341; Richardson AE, 2011, PLANT PHYSIOL, V156, P989, DOI 10.1104/pp.111.175448; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xie Y., 2016, FENERAL PURPOSE PACK; Yang L, 2017, CELL HOST MICROBE, V21, P156, DOI 10.1016/j.chom.2017.01.003; Yi X, 2013, NUCLEIC ACIDS RES, V41, pW98, DOI 10.1093/nar/gkt281; Yourstone SM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-284; Zhao HW, 2013, MOL PLANT, V6, P301, DOI 10.1093/mp/sst002; Zhu Q., 2016, Biogeosciences, V13, P341	55	381	405	71	787	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					513	+		10.1038/nature21417	http://dx.doi.org/10.1038/nature21417			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28297714	Green Accepted, Green Submitted			2022-12-28	WOS:000397018000043
J	Aung, K; Htay, T				Aung, Koko; Htay, Thwe			Review: Different bisphosphonates are equally effective and safe for preventing fragility fractures	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							RISK		[Aung, Koko; Htay, Thwe] Paul L Foster Sch Med, El Paso, TX 79905 USA		Aung, K (corresponding author), Paul L Foster Sch Med, El Paso, TX 79905 USA.		Aung, KoKo/I-1236-2019	Aung, KoKo/0000-0002-3152-0610				[Anonymous], 2017, COCHR MUSC DEC AIDS; Etminan M, 2008, J RHEUMATOL, V35, P691; Gedmintas L, 2013, J BONE MINER RES, V28, P1729, DOI 10.1002/jbmr.1893; Sheehy O, 2009, OSTEOPOROSIS INT, V20, P1583, DOI 10.1007/s00198-008-0829-2	4	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC34	JC34		10.7326/ACPJC-2017-166-6-034	http://dx.doi.org/10.7326/ACPJC-2017-166-6-034			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320008				2022-12-28	WOS:000397025800011
J	Bates, ER				Bates, Eric R.			Review: In AF, direct oral anticoagulants reduce all-cause and vascular mortality compared with warfarin	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Bates, Eric R.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Connolly SJ, 2016, J AM COLL CARDIOL, V68, P2522, DOI 10.1016/j.jacc.2016.10.005; January CT, 2014, J AM COLL CARDIOL, V64, P2304, DOI 10.1016/j.jacc.2014.04.004	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC28	JC28		10.7326/ACPJC-2017-166-6-028	http://dx.doi.org/10.7326/ACPJC-2017-166-6-028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320002				2022-12-28	WOS:000397025800005
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Why is it so hard to do what we know works?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Geue C, 2016, J EPIDEMIOL COMMUN H, V70, P924, DOI 10.1136/jech-2015-206926; Heslop P, 2013, CONFIDENTIAL ENQUIRY; Hiam L, 2017, J ROY SOC MED, V110, P131, DOI 10.1177/0141076817693600; Jackson CF, 2015, COCHRANE DB SYST REV, V356; Jorgensen T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3617; Ring H, 2009, SEIZURE-EUR J EPILEP, V18, P264, DOI 10.1016/j.seizure.2008.10.009; Robertson J, HLTH CHECKS PEOPLE L; Robertson J, 2015, SEIZURE-EUR J EPILEP, V29, P123, DOI 10.1016/j.seizure.2015.04.004; Thomas B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3639	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 21	2017	356								j1429	10.1136/bmj.j1429	http://dx.doi.org/10.1136/bmj.j1429			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IT	28325717	Green Published, Bronze			2022-12-28	WOS:000397344900003
J	Gulland, A				Gulland, Anne			Brian Neville OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												annecgulland@yahoo.co.uk						NEVILLE B, PUBLICATIN LIST; Reilly C, 2014, PEDIATRICS, V133, pE1586, DOI 10.1542/peds.2013-3787; Skirrow C, 2011, NEUROLOGY, V76, P1330, DOI 10.1212/WNL.0b013e31821527f0	3	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2017	356								j1399	10.1136/bmj.j1399	http://dx.doi.org/10.1136/bmj.j1399			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IR	28320697				2022-12-28	WOS:000397344700006
J	Fleming, DA; McDonald, WJ				Fleming, David A.; McDonald, Walter J.			Professionalism Charter Provides Guidance to Health Care Organizations in These Troubled Times	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Missouri, Sch Med, Columbia, MO USA; Qual Healthcare Advisory Grp, Huntington, NY USA; [Fleming, David A.] Univ Missouri, Sch Med, Ctr Hlth Eth, CE724 Hlth Sci Ctr,1 Hosp Dr, Columbia, MO 65212 USA; [McDonald, Walter J.] QHC Advisory Grp, 10 Plover Lane, Huntington, NY 11743 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Fleming, DA (corresponding author), Univ Missouri, Sch Med, Ctr Hlth Eth, CE724 Hlth Sci Ctr,1 Hosp Dr, Columbia, MO 65212 USA.	flemingd@health.missouri.edu						Doherty R, 2017, ANN INTERN MED, V166, P144, DOI 10.7326/M16-2728; Egener BE, 2017, ACAD MED, V92, P1091, DOI 10.1097/ACM.0000000000001561; Lesser CS, 2010, JAMA-J AM MED ASSOC, V304, P2732, DOI 10.1001/jama.2010.1864; Shanafelt TD, 2017, JAMA-J AM MED ASSOC, V317, P901, DOI 10.1001/jama.2017.0076; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012	6	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2017	166	9					665	+		10.7326/M17-0388	http://dx.doi.org/10.7326/M17-0388			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6IR	28346951				2022-12-28	WOS:000400395500012
J	Fan, FJ; Voznyy, O; Sabatini, RP; Bicanic, KT; Adachi, MM; McBride, JR; Reid, KR; Park, YS; Li, XY; Jain, A; Quintero-Bermudez, R; Saravanapavanantham, M; Liu, M; Korkusinski, M; Hawrylak, P; Klimov, VI; Rosenthal, SJ; Hoogland, S; Sargent, EH				Fan, Fengjia; Voznyy, Oleksandr; Sabatini, Randy P.; Bicanic, Kristopher T.; Adachi, Michael M.; McBride, James R.; Reid, Kemar R.; Park, Young-Shin; Li, Xiyan; Jain, Ankit; Quintero-Bermudez, Rafael; Saravanapavanantham, Mayuran; Liu, Min; Korkusinski, Marek; Hawrylak, Pawel; Klimov, Victor I.; Rosenthal, Sandra J.; Hoogland, Sjoerd; Sargent, Edward H.			Continuous-wave lasing in colloidal quantum dot solids enabled by facet-selective epitaxy	NATURE			English	Article							AUGER RECOMBINATION; STIMULATED-EMISSION; SHELL NANOCRYSTALS; OPTICAL GAIN; CDSE; THRESHOLD; EXCITON; SEMICONDUCTORS; SURFACE; PHOTOLUMINESCENCE	Colloidal quantum dots (CQDs) feature a low degeneracy of electronic states at the band edges compared with the corresponding bulk material(1), as well as a narrow emission linewidth(2,3). Unfortunately for potential laser applications, this degeneracy is incompletely lifted in the valence band, spreading the hole population among several states at room temperature(4-6). This leads to increased optical gain thresholds, demanding high photoexcitation levels to achieve population inversion (more electrons in excited states than in ground states-the condition for optical gain). This, in turn, increases Auger recombination losses(7), limiting the gain lifetime to sub-nanoseconds and preventing steady laser action(8,9). State degeneracy also broadens the photoluminescence linewidth at the single-particle level(10). Here we demonstrate a way to decrease the band-edge degeneracy and single-dot photoluminescence linewidth in CQDs by means of uniform biaxial strain. We have developed a synthetic strategy that we term facet-selective epitaxy: we first switch off, and then switch on, shell growth on the (0001) facet of wurtzite CdSe cores, producing asymmetric compressive shells that create built-in biaxial strain, while still maintaining excellent surface passivation (preventing defect formation, which otherwise would cause non-radiative recombination losses). Our synthesis spreads the excitonic fine structure uniformly and sufficiently broadly that it prevents valence-band-edge states from being thermally depopulated. We thereby reduce the optical gain threshold and demonstrate continuous-wave lasing from CQD solids, expanding the library of solution-processed materials(11,12) that may be capable of continuous-wave lasing. The individual CQDs exhibit an ultranarrow single-dot linewidth, and we successfully propagate this into the ensemble of CQDs.	[Fan, Fengjia; Voznyy, Oleksandr; Sabatini, Randy P.; Bicanic, Kristopher T.; Adachi, Michael M.; Li, Xiyan; Jain, Ankit; Quintero-Bermudez, Rafael; Saravanapavanantham, Mayuran; Liu, Min; Hoogland, Sjoerd; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada; [McBride, James R.; Reid, Kemar R.; Rosenthal, Sandra J.] Vanderbilt Univ, Vanderbilt Inst Nanoscale Sci & Engn, 221 Kirkland Hall, Nashville, TN 37235 USA; [Park, Young-Shin; Klimov, Victor I.] Los Alamos Natl Lab, Div Chem, Los Alamos, NM 87545 USA; [Park, Young-Shin] Univ New Mexico, Ctr High Technol Mat, Albuquerque, NM 87131 USA; [Korkusinski, Marek] CNR, Emerging Technol Div, Secur & Disrupt Technol, Ottawa, ON K1A 0R6, Canada; [Hawrylak, Pawel] Univ Ottawa, Dept Phys, Ottawa, ON K1A 0R6, Canada; [Adachi, Michael M.] Simon Fraser Univ, Sch Engn Sci, 8888 Univ Dr Burnaby, Burnaby, BC V5A IS6, Canada	University of Toronto; Vanderbilt University; United States Department of Energy (DOE); Los Alamos National Laboratory; University of New Mexico; National Research Council Canada; University of Ottawa; Simon Fraser University	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, 10 Kings Coll Rd, Toronto, ON M5S 3G4, Canada.	ted.sargent@utoronto.ca	Fan, Fengjia/A-7173-2018; Liu, Min/ABI-4990-2020; Klimov, Victor/Y-2823-2019; Hoogland, Sjoerd/ABG-7719-2020; Jain, Ankit/P-8371-2017; McBride, James/D-2934-2012; Quintero-Bermudez, Rafael/ABE-7388-2021; Sargent, Edward H./O-9520-2014; Liu, Min/CAA-4092-2022; Liu, Min/AFZ-6452-2022; Liu, Min/H-3699-2011	Fan, Fengjia/0000-0002-5447-6296; Klimov, Victor/0000-0003-1158-3179; Hoogland, Sjoerd/0000-0002-3099-585X; McBride, James/0000-0003-0161-7283; Sargent, Edward H./0000-0003-0396-6495; Liu, Min/0000-0002-9007-4817; Liu, Min/0000-0002-9007-4817; Liu, Min/0000-0002-9007-4817; Sabatini, Randy/0000-0002-5975-4347; Saravanapavanantham, Mayuran/0000-0002-4675-4233; Jain, Ankit/0000-0002-8963-7774; Bicanic, Kristopher/0000-0002-3020-4093; Adachi, Michael/0000-0003-3015-2606	Ontario Research Fund-Research Excellence Program; Natural Sciences and Engineering Research Council (NSERC) of Canada; Canada Foundation for Innovation under the Compute Canada; Government of Ontario; Ontario Research Fund-Research Excellence; University of Toronto; Chemical Sciences, Biosciences and Geosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy; National Science Foundation [CHE-1506587, EPS 1004083]; IBM Canada Research and Development Center through the Southern Ontario Smart Computing Innovation Platform (SOSCIP) postdoctoral fellowship; Ontario Government; Federal Economic Development Agency for Southern Ontario; University of Ottawa Research Chair in Quantum Theory of Materials, Nanostructures and Devices; Direct For Mathematical & Physical Scien [1506587] Funding Source: National Science Foundation	Ontario Research Fund-Research Excellence Program; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation under the Compute Canada; Government of Ontario; Ontario Research Fund-Research Excellence; University of Toronto(University of Toronto); Chemical Sciences, Biosciences and Geosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); IBM Canada Research and Development Center through the Southern Ontario Smart Computing Innovation Platform (SOSCIP) postdoctoral fellowship; Ontario Government; Federal Economic Development Agency for Southern Ontario; University of Ottawa Research Chair in Quantum Theory of Materials, Nanostructures and Devices; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This publication is based in part on work supported the Ontario Research Fund-Research Excellence Program and by the Natural Sciences and Engineering Research Council (NSERC) of Canada. Computations were performed on the GPC supercomputer at the SciNet HPC Consortium. SciNet is funded by: the Canada Foundation for Innovation under the auspices of Compute Canada; the Government of Ontario; the Ontario Research Fund-Research Excellence; and the University of Toronto. Y.-S.P. and V.I.K. are supported by the Chemical Sciences, Biosciences and Geosciences Division, Office of Basic Energy Sciences, Office of Science, US Department of Energy. J.R.M., K.R.R. and S.J.R. acknowledge funding from the National Science Foundation (CHE-1506587 and EPS 1004083). A.J. is supported by the IBM Canada Research and Development Center through the Southern Ontario Smart Computing Innovation Platform (SOSCIP) postdoctoral fellowship. The SOSCIP consortium is funded by the Ontario Government and the Federal Economic Development Agency for Southern Ontario. P.H. acknowledges support by the University of Ottawa Research Chair in Quantum Theory of Materials, Nanostructures and Devices. We thank C. Wang, H. Liang, N. Hossain, X. Zheng, Z. Shi, G. Walters, E. Palmiano, R. Wolowiec and D. Kopilovic for discussions during this work.	Adachi MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9694; Beecher AN, 2014, J AM CHEM SOC, V136, P10645, DOI 10.1021/ja503590h; BERNARD MGA, 1961, PHYS STATUS SOLIDI, V1, P699, DOI 10.1002/pssb.19610010703; Boykin TB, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.125207; Carbone L, 2007, NANO LETT, V7, P2942, DOI 10.1021/nl0717661; Cassette E, 2012, ACS NANO, V6, P6741, DOI 10.1021/nn3024255; Chen O, 2013, NAT MATER, V12, P445, DOI [10.1038/nmat3539, 10.1038/NMAT3539]; Choi CL, 2009, NANO LETT, V9, P3544, DOI 10.1021/nl9017572; Christodoulou S, 2014, J MATER CHEM C, V2, P3439, DOI 10.1039/c4tc00280f; Christodoulou S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8905; Coropceanu I, 2014, NANO LETT, V14, P4097, DOI 10.1021/nl501627e; Cramer C. J., 2013, ESSENTIALS COMPUTATI; Cui J, 2016, NANO LETT, V16, P289, DOI 10.1021/acs.nanolett.5b03790; Cui J, 2013, NAT CHEM, V5, P602, DOI [10.1038/nchem.1654, 10.1038/NCHEM.1654]; Dai XL, 2014, NATURE, V515, P96, DOI 10.1038/nature13829; Dang C, 2012, NAT NANOTECHNOL, V7, P335, DOI [10.1038/nnano.2012.61, 10.1038/NNANO.2012.61]; Efros AL, 1996, PHYS REV B, V54, P4843, DOI 10.1103/PhysRevB.54.4843; Franceschetti A, 1999, PHYS REV B, V60, P1819, DOI 10.1103/PhysRevB.60.1819; Grim JQ, 2014, NAT NANOTECHNOL, V9, P891, DOI [10.1038/nnano.2014.213, 10.1038/NNANO.2014.213]; Guilhabert B, 2014, OPT EXPRESS, V22, P7308, DOI 10.1364/OE.22.007308; Hartwigsen C, 1998, PHYS REV B, V58, P3641, DOI 10.1103/PhysRevB.58.3641; Ithurria S, 2012, J AM CHEM SOC, V134, P18585, DOI 10.1021/ja308088d; Iyer VH, 2016, J PHYS CHEM LETT, V7, P1244, DOI 10.1021/acs.jpclett.6b00430; Jancu JM, 1998, PHYS REV B, V57, P6493, DOI 10.1103/PhysRevB.57.6493; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; Klimov VI, 2007, NATURE, V447, P441, DOI 10.1038/nature05839; Klimov VI, 2014, ANNU REV CONDEN MA P, V5, P285, DOI 10.1146/annurev-conmatphys-031113-133900; Korkusinski M, 2009, J APPL PHYS, V105, DOI 10.1063/1.3117231; Korkusinski M, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.155327; Korkusinski M, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.245304; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Li YH, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.245206; Mahler B, 2012, J AM CHEM SOC, V134, P18591, DOI 10.1021/ja307944d; McLellan LJ, 2016, OPT EXPRESS, V24, pA146, DOI 10.1364/OE.24.00A146; Orfield NJ, 2015, ACS NANO, V9, P831, DOI 10.1021/nn506420w; Park YS, 2015, NANO LETT, V15, P7319, DOI 10.1021/acs.nanolett.5b02595; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; She CX, 2014, NANO LETT, V14, P2772, DOI 10.1021/nl500775p; Talapin DV, 2003, NANO LETT, V3, P1677, DOI 10.1021/nl034815s; Tessier MD, 2013, NANO LETT, V13, P3321, DOI 10.1021/nl401538n; Tessier MD, 2012, ACS NANO, V6, P6751, DOI 10.1021/nn3014855; VandeVondele J, 2005, COMPUT PHYS COMMUN, V167, P103, DOI 10.1016/j.cpc.2004.12.014; VandeVondele J, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2770708; Veilleux V, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/13/134024; Voznyy O, 2012, ACS NANO, V6, P8448, DOI 10.1021/nn303364d; Voznyy O, 2011, J PHYS CHEM C, V115, P15927, DOI 10.1021/jp205784g; YABLONOVITCH E, 1986, J LIGHTWAVE TECHNOL, V4, P504, DOI 10.1109/JLT.1986.1074751; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k	49	242	243	24	423	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2017	544	7648					75	+		10.1038/nature21424	http://dx.doi.org/10.1038/nature21424			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ8GQ	28321128				2022-12-28	WOS:000398323300035
J	Saberi, S; Wheeler, M; Bragg-Gresham, J; Hornsby, W; Agarwal, PP; Attili, A; Concannon, M; Dries, AM; Shmargad, Y; Salisbury, H; Kumar, S; Herrera, J; Myers, J; Helms, AS; Ashley, EA; Day, SM				Saberi, Sara; Wheeler, Matthew; Bragg-Gresham, Jennifer; Hornsby, Whitney; Agarwal, Prachi P.; Attili, Anil; Concannon, Maryann; Dries, Annika M.; Shmargad, Yael; Salisbury, Heidi; Kumar, Suwen; Herrera, Jonathan; Myers, Jonathan; Helms, Adam S.; Ashley, Euan A.; Day, Sharlene M.			Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC HEART-FAILURE; BLOOD-PRESSURE RESPONSE; COLLEGE-OF-CARDIOLOGY; PHYSICAL-ACTIVITY; SPORTS PARTICIPATION; SCIENTIFIC STATEMENT; SYMPTOMATIC PATIENTS; PROGNOSTIC VALUE; LEISURE-TIME; TASK-FORCE	IMPORTANCE Formulating exercise recommendations for patients with hypertrophic cardiomyopathy is challenging because of concern about triggering ventricular arrhythmias and because a clinical benefit has not been previously established in this population. OBJECTIVE To determine whether moderate-intensity exercise training improves exercise capacity in adults with hypertrophic cardiomyopathy. DESIGN, SETTING, AND PARTICIPANTS A randomized clinical trial involving 136 patients with hypertrophic cardiomyopathy was conducted between April 2010 and October 2015 at 2 academic medical centers in the United States (University of Michigan Health System and Stanford University Medical Center). Date of last follow-up was November 2016. INTERVENTIONS Participants were randomly assigned to 16 weeks of moderate-intensity exercise training (n = 67) or usual activity (n = 69). MAIN OUTCOMES AND MEASURES The primary outcome measure was change in peak oxygen consumption from baseline to 16 weeks. RESULTS Among the 136 randomized participants (mean age, 50.4 [SD, 13.3] years; 42% women), 113 (83%) completed the study. At 16 weeks, the change in mean peak oxygen consumption was + 1.35 (95% CI, 0.50 to 2.21) mL/kg/min among participants in the exercise training group and + 0.08 (95% CI, -0.62 to 0.79) mL/kg/min among participants in the usual-activity group (between-group difference, 1.27 [95% CI, 0.17 to 2.37]; P = .02). There were no occurrences of sustained ventricular arrhythmia, sudden cardiac arrest, appropriate defibrillator shock, or death in either group. CONCLUSIONS AND RELEVANCE In this preliminary study involving patients with hypertrophic cardiomyopathy, moderate-intensity exercise compared with usual activity resulted in a statistically significant but small increase in exercise capacity at 16 weeks. Further research is needed to understand the clinical importance of this finding in patients with hypertrophic cardiomyopathy, as well as the long-term safety of exercise at moderate and higher levels of intensity.	[Saberi, Sara; Bragg-Gresham, Jennifer; Hornsby, Whitney; Agarwal, Prachi P.; Attili, Anil; Concannon, Maryann; Kumar, Suwen; Herrera, Jonathan; Helms, Adam S.; Day, Sharlene M.] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Wheeler, Matthew; Dries, Annika M.; Shmargad, Yael; Salisbury, Heidi; Ashley, Euan A.] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Myers, Jonathan] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA	University of Michigan System; University of Michigan; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Saberi, S (corresponding author), Univ Michigan, Sch Med, Frankel Cardiovasc Ctr, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	saberis@med.umich.edu		Wheeler, Matthew/0000-0001-8721-3022; Helms, Adam/0000-0002-0234-6430	Michigan Institute for Clinical & Health Research [UL1TR000433]; University of Michigan Frankel Cardiovascular Center McKay Research Grant; University of Michigan Frankel Cardiovascular Center Inaugural Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007863] Funding Source: NIH RePORTER; Veterans Affairs [IK6RX002477] Funding Source: NIH RePORTER	Michigan Institute for Clinical & Health Research; University of Michigan Frankel Cardiovascular Center McKay Research Grant; University of Michigan Frankel Cardiovascular Center Inaugural Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by research grant UL1TR000433 from the Michigan Institute for Clinical & Health Research, the University of Michigan Frankel Cardiovascular Center McKay Research Grant, the University of Michigan Frankel Cardiovascular Center Inaugural Grant, and an anonymous donor. The sponsors had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Alcalai R, 2008, J CARDIOVASC ELECTR, V19, P104, DOI 10.1111/j.1540-8167.2007.00965.x; Belardinelli R, 1999, CIRCULATION, V99, P1173, DOI 10.1161/01.CIR.99.9.1173; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BRAUNWALD E, 1964, CIRCULATION, V30, P3; Chan RH, 2014, CIRCULATION, V130, P484, DOI 10.1161/CIRCULATIONAHA.113.007094; COATS AJS, 1992, CIRCULATION, V85, P2119, DOI 10.1161/01.CIR.85.6.2119; Coats CJ, 2015, CIRC-HEART FAIL, V8, P1022, DOI 10.1161/CIRCHEARTFAILURE.114.002248; Finocchiaro G, 2015, JACC-HEART FAIL, V3, P408, DOI 10.1016/j.jchf.2014.11.011; Fletcher GF, 2013, CIRCULATION, V128, P873, DOI 10.1161/CIR.0b013e31829b5b44; Gersh BJ, 2011, CIRCULATION, V124, P2761, DOI 10.1161/CIR.0b013e318223e230; HAMBRECHT R, 1995, J AM COLL CARDIOL, V25, P1239, DOI 10.1016/0735-1097(94)00568-B; Huff CM, 2013, QUAL LIFE RES, V22, P647, DOI 10.1007/s11136-012-0182-y; Klempfner R, 2015, EUR J PREV CARDIOL, V22, P13, DOI 10.1177/2047487313501277; Kokkinos P, 2008, CIRCULATION, V117, P614, DOI 10.1161/CIRCULATIONAHA.107.734764; Le VV, 2009, AM HEART J, V158, pE27, DOI 10.1016/j.ahj.2009.06.006; Maron BJ, 2015, CIRCULATION, V132, pE273, DOI 10.1161/CIR.0000000000000239; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1; O'Connor CM, 2009, JAMA-J AM MED ASSOC, V301, P1439, DOI 10.1001/jama.2009.454; Olivotto I, 1999, J AM COLL CARDIOL, V33, P2044, DOI 10.1016/S0735-1097(99)00094-7; PAFFENBARGER RS, 1993, NEW ENGL J MED, V328, P538, DOI 10.1056/NEJM199302253280804; Pandey A, 2015, CIRC-HEART FAIL, V8, P33, DOI 10.1161/CIRCHEARTFAILURE.114.001615; Pelliccia A, 2006, EUR J CARDIOV PREV R, V13, P876, DOI 10.1097/01.hjr.0000238393.96975.32; Reineck E, 2013, AM J CARDIOL, V111, P1034, DOI 10.1016/j.amjcard.2012.12.018; Sadoul N, 1997, CIRCULATION, V96, P2987, DOI 10.1161/01.CIR.96.9.2987; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Sharma S, 2001, Cardiol Rev, V9, P70, DOI 10.1097/00045415-200103000-00005; Sofi F, 2008, EUR J CARDIOV PREV R, V15, P247, DOI 10.1097/HJR.0b013e3282f232ac; Sorajja P, 2012, AM J CARDIOL, V109, P1494, DOI 10.1016/j.amjcard.2012.01.363; Swank AM, 2012, CIRC-HEART FAIL, V5, P579, DOI 10.1161/CIRCHEARTFAILURE.111.965186; Sweeting J, 2015, CIRC-CARDIOVASC GENE, V8, P178, DOI 10.1161/CIRCGENETICS.114.000784; Vromen T, 2016, INT J CARDIOL, V208, P120, DOI 10.1016/j.ijcard.2016.01.207; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6	36	111	116	0	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2017	317	13					1349	1357		10.1001/jama.2017.2503	http://dx.doi.org/10.1001/jama.2017.2503			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ9VR	28306757	Green Published			2022-12-28	WOS:000398434200019
J	Moyer, P				Moyer, Polly			John Vavasour Earle OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		EARLE JV, PUBLICATION LIST, P62659	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2017	356								j1522	10.1136/bmj.j1522	http://dx.doi.org/10.1136/bmj.j1522			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4JB	28348144				2022-12-28	WOS:000397345700007
J	Li, J; Bonkowski, MS; Moniot, S; Zhang, D; Hubbard, BP; Ling, AJY; Rajman, LA; Qin, B; Lou, Z; Gorbunova, V; Aravind, L; Steegborn, C; Sinclair, DA				Li, Jun; Bonkowski, Michael S.; Moniot, Sebastien; Zhang, Dapeng; Hubbard, Basil P.; Ling, Alvin J. Y.; Rajman, Luis A.; Qin, Bo; Lou, Zhenkun; Gorbunova, Vera; Aravind, L.; Steegborn, Clemens; Sinclair, David A.			AGING A conserved NAD(+) binding pocket that regulates protein-protein interactions during aging	SCIENCE			English	Article							NICOTINAMIDE MONONUCLEOTIDE; DNA-REPAIR; CELL; MECHANISM; SIRTUINS; PATHWAY; DISEASE; SIRT1; DBC1; LIFE	DNA repair is essential for life, yet its efficiency declines with age for reasons that are unclear. Numerous proteins possess Nudix homology domains (NHDs) that have no known function. We show that NHDs are NAD(+) (oxidized form of nicotinamide adenine dinucleotide) binding domains that regulate protein-protein interactions. The binding of NAD(+) to the NHD domain of DBC1 (deleted in breast cancer 1) prevents it from inhibiting PARP1 [poly(adenosine diphosphate-ribose) polymerase], a critical DNA repair protein. As mice age and NAD(+) concentrations decline, DBC1 is increasingly bound to PARP1, causing DNA damage to accumulate, a process rapidly reversed by restoring the abundance of NAD(+). Thus, NAD(+) directly regulates protein-protein interactions, the modulation of which may protect against cancer, radiation, and aging.	[Li, Jun; Bonkowski, Michael S.; Hubbard, Basil P.; Ling, Alvin J. Y.; Rajman, Luis A.; Sinclair, David A.] Harvard Med Sch, Paul F Glenn Ctr Biol Aging, Dept Genet, Boston, MA 02115 USA; [Moniot, Sebastien; Steegborn, Clemens] Univ Bayreuth, Dept Biochem, D-95440 Bayreuth, Germany; [Zhang, Dapeng] Natl Inst Hlth, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Qin, Bo; Lou, Zhenkun] Dept Oncol, Div Oncol Res, Mayo Clin, 200 Ist St SW, Rochester, MN 55905 USA; [Gorbunova, Vera] Div Biol, 434 Hutchinson Hall,River Campus, Rochester, NY 14627 USA; [Sinclair, David A.] Univ New South Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia; St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Hubbard, Basil P.] Univ Alberta, Dept Pharmacol, Edmonton, AB T6G 2H7, Canada	Harvard University; Harvard Medical School; University of Bayreuth; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Mayo Clinic; University of Rochester; University of New South Wales Sydney; Saint Louis University; University of Alberta	Sinclair, DA (corresponding author), Harvard Med Sch, Paul F Glenn Ctr Biol Aging, Dept Genet, Boston, MA 02115 USA.; Sinclair, DA (corresponding author), Univ New South Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia.	david_sinclair@hms.harvard.edu	Li, Jun/AAF-9234-2021	Li, Jun/0000-0002-0179-4151; Aravind, L/0000-0003-0771-253X; Gorbunova, Vera/0000-0001-8979-0333; Zhang, Dapeng/0000-0001-8535-7620; Ling, Alvin Jee Yee/0000-0001-5798-9495; Sinclair, David/0000-0002-9936-436X; Bonkowski, Michael/0000-0003-3416-4612; Hubbard, Basil/0000-0003-4353-9674	NATIONAL CANCER INSTITUTE [R01CA130996, R01CA203561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG052365, P01AG047200, R37AG028730] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM594244] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA203561, R01 CA130996] Funding Source: Medline; NIA NIH HHS [P01 AG047200, R37 AG028730, R03 AG052365, R01 AG027237] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anantharaman V, 2008, CELL CYCLE, V7, P1467, DOI 10.4161/cc.7.10.5883; Armour SM, 2013, MOL CELL BIOL, V33, P1487, DOI 10.1128/MCB.00971-12; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Bhullar KS, 2015, BBA-MOL BASIS DIS, V1852, P1209, DOI 10.1016/j.bbadis.2015.01.012; Bonkowski MS, 2016, NAT REV MOL CELL BIO, V17, P679, DOI 10.1038/nrm.2016.93; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; GRUBE K, 1992, P NATL ACAD SCI USA, V89, P11759, DOI 10.1073/pnas.89.24.11759; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hamaguchi M, 2002, P NATL ACAD SCI USA, V99, P13647, DOI 10.1073/pnas.212516099; Hasmann M, 2003, CANCER RES, V63, P7436; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Wang MC, 2015, PROTEOMICS, V15, P3163, DOI 10.1002/pmic.201400441; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang T, 2012, J BIOL CHEM, V287, P12405, DOI 10.1074/jbc.M111.304469	24	99	107	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1312	+		10.1126/science.aad8242	http://dx.doi.org/10.1126/science.aad8242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336669	Green Accepted			2022-12-28	WOS:000397082900039
J	Hill, AB				Hill, Adam B.			Breaking the Stigma - A Physician's Perspective on Self-Care and Recovery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hill, Adam B.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hill, Adam B.] Riley Hosp Children, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; James Whitcomb Riley Hospital Children	Hill, AB (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.; Hill, AB (corresponding author), Riley Hosp Children, Indianapolis, IN 46202 USA.								0	23	23	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1103	1105		10.1056/NEJMp1615974	http://dx.doi.org/10.1056/NEJMp1615974			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28328327				2022-12-28	WOS:000397014300004
J	Hawkes, N				Hawkes, Nigel			The BMJ Awards 2017: Cancer Care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com			Macmillan Cancer Support	Macmillan Cancer Support	The Cancer Care Team of the Year award is sponsored by Macmillan Cancer Support. The awards ceremony takes place on 4 May at the Park Plaza Hotel, Westminster. To find out more go to thebmjawards.bmj.com.		0	0	0	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1468	10.1136/bmj.j1468	http://dx.doi.org/10.1136/bmj.j1468			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330854				2022-12-28	WOS:000397345200019
J	Barocas, DA; Alvarez, J; Resnick, MJ; Koyama, T; Hoffman, KE; Tyson, MD; Conwill, R; McCollum, D; Cooperberg, MR; Goodman, M; Greenfield, S; Hamilton, AS; Hashibe, M; Kaplan, SH; Paddock, LE; Stroup, AM; Wu, XC; Penson, DF				Barocas, Daniel A.; Alvarez, Joann; Resnick, Matthew J.; Koyama, Tatsuki; Hoffman, Karen E.; Tyson, Mark D.; Conwill, Ralph; McCollum, Dan; Cooperberg, Matthew R.; Goodman, Michael; Greenfield, Sheldon; Hamilton, Ann S.; Hashibe, Mia; Kaplan, Sherrie H.; Paddock, Lisa E.; Stroup, Antoinette M.; Wu, Xiao-Cheng; Penson, David F.			Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; INTENSITY-MODULATED RADIOTHERAPY; HEALTH SURVEY SF-36; RADICAL PROSTATECTOMY; SHORT-FORM; SEXUAL FUNCTION; POPULATION; URINARY; INDEX; METAANALYSIS	IMPORTANCE Understanding the adverse effects of contemporary approaches to localized prostate cancer treatment could inform shared decision making. OBJECTIVE To compare functional outcomes and adverse effects associated with radical prostatectomy, external beam radiation therapy (EBRT), and active surveillance. DESIGN, SETTING, AND PARTICIPANTS Prospective, population-based, cohort study involving 2550 men (<= 80 years) diagnosed in 2011-2012 with clinical stage cT1-2, localized prostate cancer, with prostate-specific antigen levels less than 50 ng/mL, and enrolled within 6 months of diagnosis. EXPOSURES Treatment with radical prostatectomy, EBRT, or active surveillance was ascertained within 1 year of diagnosis. MAIN OUTCOMES AND MEASURES Patient-reported function on the 26-item Expanded Prostate Cancer Index Composite (EPIC) 36 months after enrollment. Higher domain scores (range, 0-100) indicate better function. Minimum clinically important difference was defined as 10 to 12 points for sexual function, 6 for urinary incontinence, 5 for urinary irritative symptoms, 5 for bowel function, and 4 for hormonal function. RESULTS The cohort included 2550 men (mean age, 63.8 years; 74% white, 55% had intermediate-or high-risk disease), of whom 1523 (59.7%) underwent radical prostatectomy, 598 (23.5%) EBRT, and 429 (16.8%) active surveillance. Men in the EBRT group were older (mean age, 68.1 years vs 61.5 years, P<.001) and had worse baseline sexual function (mean score, 52.3 vs 65.2, P<.001) than men in the radical prostatectomy group. At 3 years, the adjusted mean sexual domain score for radical prostatectomy decreased more than for EBRT (mean difference, -11.9 points; 95% CI, -15.1 to -8.7). The decline in sexual domain scores between EBRT and active surveillance was not clinically significant (-4.3 points; 95% CI, -9.2 to 0.7). Radical prostatectomy was associated with worse urinary incontinence than EBRT (-18.0 points; 95% CI, -20.5 to -15.4) and active surveillance (-12.7 points; 95% CI, -16.0 to -9.3) but was associated with better urinary irritative symptoms than active surveillance (5.2 points; 95% CI, 3.2 to 7.2). No clinically significant differences for bowel or hormone function were noted beyond 12 months. No differences in health-related quality of life or disease-specific survival (3 deaths) were noted (99.7%-100%). CONCLUSIONS AND RELEVANCE In this cohort of men with localized prostate cancer, radical prostatectomy was associated with a greater decrease in sexual function and urinary incontinence than either EBRT or active surveillance after 3 years and was associated with fewer urinary irritative symptoms than active surveillance; however, no meaningful differences existed in either bowel or hormonal function beyond 12 months or in in other domains of health-related quality-of-life measures. These findings may facilitate counseling regarding the comparative harms of contemporary treatments for prostate cancer.	[Barocas, Daniel A.; Resnick, Matthew J.; Tyson, Mark D.; Penson, David F.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, A1302 Med Ctr North, Nashville, TN 37232 USA; [Alvarez, Joann; Koyama, Tatsuki] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Hoffman, Karen E.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Conwill, Ralph; McCollum, Dan] Vanderbilt Ingram Canc Ctr, Prostate Canc Patient Advocate, Nashville, TN USA; [Cooperberg, Matthew R.] Univ Calif San Francisco, Dept Urol, Med Ctr, San Francisco, CA USA; [Goodman, Michael] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Greenfield, Sheldon] Univ Calif Irvine, Ctr Hlth Policy Res, Irvine, CA USA; [Greenfield, Sheldon] Univ Calif Irvine, Dept Med, Irvine, CA 92717 USA; [Hamilton, Ann S.] Univ Southern Calif, Keck Sch Med, Dept Preventat Med, Los Angeles, CA USA; [Hashibe, Mia] Univ Utah, Dept Family & Preventat Med, Salt Lake City, UT USA; [Kaplan, Sherrie H.] Univ Calif Irvine, Hlth Policy Res Inst, Irvine, CA USA; [Paddock, Lisa E.; Stroup, Antoinette M.] Rutgers State Univ, Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Wu, Xiao-Cheng] Louisiana State Univ, Sch Publ Hlth, Hlth Sci Ctr, New Orleans, LA USA; [Penson, David F.] Tennessee Valley Vet Adm Hlth Syst, Nashville, TN USA	Vanderbilt University; Vanderbilt University; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; University of California System; University of California San Francisco; Emory University; Rollins School Public Health; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Southern California; Utah System of Higher Education; University of Utah; University of California System; University of California Irvine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Barocas, DA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Urol Surg, A1302 Med Ctr North, Nashville, TN 37232 USA.	dan.barocas@vanderbilt.edu	Cooperberg, Matthew R/G-6249-2017	Cooperberg, Matthew R/0000-0003-4339-6685; Penson, David/0000-0002-2580-2697; Greenfield, Sheldon/0000-0003-4628-1998; Barocas, Daniel/0000-0002-7775-9205; Kaplan, Sherrie/0000-0002-8644-5849	Agency for Healthcare Research and Quality [1R01HS019356, 1R01HS022640]; National Center for Advancing Translational Sciences [UL1TR000011]; National Institute of Health [5T32CA106183]; National Cancer Institute; Patient-Centered Outcomes Research Institute (PCORI) [CE12-11-4667]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS022640, R01HS019356] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA106183] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Patient-Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for the study was provided by grants 1R01HS019356 and 1R01HS022640 from the Agency for Healthcare Research and Quality; UL1TR000011 to the Vanderbilt Institute of Clinical and Translational Research from the National Center for Advancing Translational Sciences; and 5T32CA106183 from the National Institute of Health and the National Cancer Institute (Dr Tyson). Research reported in this article was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) award CE12-11-4667.	Alemozaffar M, 2011, JAMA-J AM MED ASSOC, V306, P1205, DOI 10.1001/jama.2011.1333; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Barocas DA, 2013, J COMP EFFECT RES, V2, P445, DOI [10.2217/cer.13.34, 10.2217/CER.13.34]; Bill-Axelson A, 2014, NEW ENGL J MED, V370, P932, DOI 10.1056/NEJMoa1311593; Bourke L, 2015, EUR UROL, V68, P374, DOI 10.1016/j.eururo.2015.04.023; D'Amico AV, 1999, J CLIN ONCOL, V17, P168, DOI 10.1200/JCO.1999.17.1.168; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; HALEY SM, 1994, J CLIN EPIDEMIOL, V47, P671, DOI 10.1016/0895-4356(94)90215-1; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Hollenbeck BK, 2003, J UROLOGY, V169, P1453, DOI 10.1097/01.ju.0000056737.40872.56; Jacobs BL, 2012, UROLOGY, V80, P1236, DOI 10.1016/j.urology.2012.09.006; Jacobs BL, 2012, HEALTH AFFAIR, V31, P750, DOI 10.1377/hlthaff.2011.1062; Jayadevappa R, 2012, HEALTH SERV RES, V47, P1902, DOI 10.1111/j.1475-6773.2012.01395.x; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Kaplan SH, 1996, ANN INTERN MED, V124, P497, DOI 10.7326/0003-4819-124-5-199603010-00007; Kundu SD, 2004, J UROLOGY, V172, P2227, DOI 10.1097/01.ju.0000145222.94455.73; Lowrance WT, 2012, J UROLOGY, V187, P2087, DOI 10.1016/j.juro.2012.01.061; Makarov D, 2015, UROL PRACT, V3, P1; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Mohler J, 2010, J NATL COMPR CANC NE, V8, P162, DOI 10.6004/jnccn.2010.0012; O'Neil B, 2016, INT J RADIAT ONCOL, V96, pE399, DOI 10.1016/j.ijrobp.2016.06.1634; O'Neil B, 2016, J UROLOGY, V195, P321, DOI 10.1016/j.juro.2015.08.092; Oberlin DT, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.01.008; Punnen S, 2015, EUR UROL, V68, P600, DOI 10.1016/j.eururo.2014.08.074; Resnick MJ, 2014, CANCER-AM CANCER SOC, V120, P1263, DOI 10.1002/cncr.28563; Resnick MJ, 2013, NEW ENGL J MED, V368, P436, DOI 10.1056/NEJMoa1209978; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Sheets NC, 2012, JAMA-J AM MED ASSOC, V307, P1611, DOI 10.1001/jama.2012.460; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; Skolarus TA, 2015, UROLOGY, V85, P101, DOI 10.1016/j.urology.2014.08.044; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Stier DM, 1999, UROLOGY, V54, P424, DOI 10.1016/S0090-4295(99)00203-4; Szymanski KM, 2010, UROLOGY, V76, P1245, DOI 10.1016/j.urology.2010.01.027; Thompson I, 2007, J UROLOGY, V177, P2106, DOI 10.1016/j.juro.2007.03.003; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Woo SH, 2014, J ENDOUROL, V28, P172, DOI 10.1089/end.2013.0304; Yanamadala S, 2016, CAN J UROL, V23, P8280; Yaxley JW, 2016, LANCET, V388, P1057, DOI 10.1016/S0140-6736(16)30592-X; Zelefsky MJ, 2016, RADIOTHER ONCOL, V118, P85, DOI 10.1016/j.radonc.2015.11.035	42	210	215	0	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1126	1140		10.1001/jama.2017.1704	http://dx.doi.org/10.1001/jama.2017.1704			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324093	Bronze, Green Accepted			2022-12-28	WOS:000396987200017
J	Chen, YS; Haley, D; Gerstl, SSA; London, AJ; Sweeney, F; Wepf, RA; Rainforth, WM; Bagot, PAJ; Moody, MP				Chen, Y. -S.; Haley, D.; Gerstl, S. S. A.; London, A. J.; Sweeney, F.; Wepf, R. A.; Rainforth, W. M.; Bagot, P. A. J.; Moody, M. P.			Direct observation of individual hydrogen atoms at trapping sites in a ferritic steel	SCIENCE			English	Article							DELAYED FRACTURE; EMBRITTLEMENT; VISUALIZATION; PRECIPITATION; TOMOGRAPHY; BEHAVIOR	The design of atomic-scale microstructural traps to limit the diffusion of hydrogen is one key strategy in the development of hydrogen-embrittlement-resistant materials. In the case of bearing steels, an effective trapping mechanism may be the incorporation of finely dispersed V-Mo-Nb carbides in a ferrite matrix. First, we charged a ferritic steel with deuterium by means of electrolytic loading to achieve a high hydrogen concentration. We then immobilized it in the microstructure with a cryogenic transfer protocol before atom probe tomography (APT) analysis. Using APT, we show trapping of hydrogen within the core of these carbides with quantitative composition profiles. Furthermore, with this method the experiment can be feasibly replicated in any APT-equipped laboratory by using a simple cold chain.	[Chen, Y. -S.; Haley, D.; London, A. J.; Bagot, P. A. J.; Moody, M. P.] Univ Oxford, Dept Mat, 16 Pk Rd, Oxford OX1 3PH, England; [Gerstl, S. S. A.; Wepf, R. A.] Swiss Fed Inst Technol, Sci Ctr Opt & Electron Microscopy, Auguste Piccard Hof 1, CH-8093 Zurich, Switzerland; [Sweeney, F.; Rainforth, W. M.] Univ Sheffield, Dept Mat Sci & Engn, Western Bank, Sheffield S10 2TN, S Yorkshire, England; [Wepf, R. A.] Univ Queensland, Fac Sci, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia	University of Oxford; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Sheffield; University of Queensland	Haley, D (corresponding author), Univ Oxford, Dept Mat, 16 Pk Rd, Oxford OX1 3PH, England.	daniel.haley@materials.ox.ac.uk	Moody, Michael P/H-9377-2013; Chen, Yi-Sheng/Q-1413-2018	Moody, Michael P/0000-0002-9256-0966; Chen, Yi-Sheng/0000-0002-2607-4388; London, Andrew/0000-0001-6959-9849; Wepf, Roger/0000-0003-2203-3674; Rainforth, William/0000-0003-3898-0318	Engineering and Physical Sciences Research Council [EP/L014/42/1, EP/M022803/1]; Ministry of Education of Taiwan; Swiss National Science Foundation [206021_128/32/1]; EPSRC [EP/L014742/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ministry of Education of Taiwan(Ministry of Education, Taiwan); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Data can be accessed online, via the Oxford Research Archive: https://ora.ox.ac.uk/objects/uuid:70dde.71c-6b82-4e85-a31a-985de733faaa. The authors acknowledge the support of the Engineering and Physical Sciences Research Council HeMs project, EP/L014/42/1 and the platform grant EP/M022803/1. Y.-S.C. acknowledges support from the Ministry of Education of Taiwan. S.S.A.G. and R.A.W. acknowledge support from the Swiss National Science Foundation (206021_128/32/1). Y.-S.C. conducted the charging experiments, prepared samples, optimized the charging process, art undertook the data collection and analysis. D.H. designed the charging unit and original experimental procedure, aided with Me charging experiments and data analysis, and wrote the manuscript. S.S.A.G and RAW. designed., constructed., and optimized the cryogenic transfer system. S.S.A.G. additionally designed the cryo experimental procedure and aided in conducting the charged experiments with cryo-transfer and acquiring the data. A.J.L. developed and applied the superimposed particle analysis procedure. W.M.R. provided the nanoprecipitated. carbide steel, and F. S. Undertook TEM observations. M.P.M., P.A.J.B., and W.M.R. are principal investigators on the HeMs project for this work package.	Arslan I, 2008, ULTRAMICROSCOPY, V108, P1579, DOI 10.1016/j.ultramic.2008.05.008; Asahi H, 2003, ISIJ INT, V43, P527, DOI 10.2355/isijinternational.43.527; ASTM International, 2015, B85098 ASTM; Bernstein I. M., 1969, MATER SCI ENG, V6, P1; Chalaftris G, 2005, CORROS ENG SCI TECHN, V40, P28, DOI 10.1179/174327805X29822; CHOO WY, 1982, J MATER SCI, V17, P1930, DOI 10.1007/BF00540409; Dharamshi HK, 2016, ISIJ INT, V56, P24, DOI 10.2355/isijinternational.ISIJINT-2015-430; Evers S, 2013, SCI TECHNOL ADV MAT, V14, DOI 10.1088/1468-6996/14/1/014201; Fukutani K, 2002, CURR OPIN SOLID ST M, V6, P153, DOI 10.1016/S1359-0286(02)00039-6; Gemma R, 2012, SCRIPTA MATER, V67, P903, DOI 10.1016/j.scriptamat.2012.08.025; Gerstl S., 2015, MICROSC MICROANAL, V21, P517, DOI [DOI 10.1017/S1431927615003384, 10.1017/S1431927615003384]; Haley D, 2014, INT J HYDROGEN ENERG, V39, P12221, DOI 10.1016/j.ijhydene.2014.05.169; Hickel T, 2014, JOM-US, V66, P1399, DOI 10.1007/s11837-014-1055-3; Ishikawa R, 2011, NAT MATER, V10, P278, DOI 10.1038/NMAT2957; Karnesky RA, 2012, SAND20128539 SAND NA; Kawakami K, 2012, ISIJ INT, V52, P1693, DOI 10.2355/isijinternational.52.1693; Kesten P, 2002, J ALLOY COMPD, V330, P225, DOI 10.1016/S0925-8388(01)01596-1; Kuduzovic A, 2014, MAT SCI ENG A-STRUCT, V590, P66, DOI 10.1016/j.msea.2013.10.019; Kunimune Y, 2016, AIP ADV, V6, DOI 10.1063/1.4948558; Kushida T, 1996, TETSU TO HAGANE, V82, P297, DOI 10.2355/tetsutohagane1955.82.4_297; London AJ, 2015, ULTRAMICROSCOPY, V159, P360, DOI 10.1016/j.ultramic.2015.02.013; Malard B, 2012, MAT SCI ENG A-STRUCT, V536, P110, DOI 10.1016/j.msea.2011.12.080; Marchi CS, 2017, INT J HYDROGEN ENERG, V42, P7263, DOI 10.1016/j.ijhydene.2016.07.014; Meyer JC, 2008, NATURE, V454, P319, DOI 10.1038/nature07094; Miller M.K., 1996, ATOM PROBE FIELD ION; Nishimoto A, 2015, ISIJ INT, V55, P335, DOI 10.2355/isijinternational.55.335; Ohnuma M, 2008, SCRIPTA MATER, V58, P142, DOI 10.1016/j.scriptamat.2007.09.026; Reitenbach V, 2015, ENVIRON EARTH SCI, V73, P6927, DOI 10.1007/s12665-015-4176-2; Robertson IM, 2015, METALL MATER TRANS B, V46, P1085, DOI 10.1007/s11663-015-0325-y; Spencer G., 1998, ARCCBTR98016 DTIC; Sundell G, 2013, ULTRAMICROSCOPY, V132, P285, DOI 10.1016/j.ultramic.2013.01.007; Takahashi J, 2012, SCRIPTA MATER, V67, P213, DOI 10.1016/j.scriptamat.2012.04.022; Takahashi J, 2010, SCRIPTA MATER, V63, P261, DOI 10.1016/j.scriptamat.2010.03.012; Takai K, 2002, METALL MATER TRANS A, V33, P2659, DOI 10.1007/s11661-002-0387-8; Tarzimoghadam Z, 2016, ACTA MATER, V109, P69, DOI 10.1016/j.actamat.2016.02.053; Tatsumi K, 2007, J APPL PHYS, V101, DOI 10.1063/1.2424540; Tsong TT., 2005, ATOM PROBE FIELD ION; Wei FG, 2006, METALL MATER TRANS A, V37A, P331, DOI 10.1007/s11661-006-0004-3; Yamasaki S, 2006, P ROY SOC A-MATH PHY, V462, P2315, DOI 10.1098/rspa.2006.1688	39	159	162	18	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1196	1199		10.1126/science.aal2418	http://dx.doi.org/10.1126/science.aal2418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302855	Green Accepted, Green Submitted			2022-12-28	WOS:000396351200041
J	Paules, C; Subbarao, K				Paules, Catharine; Subbarao, Kanta			Influenza	LANCET			English	Review							UNITED-STATES; NEURAMINIDASE INHIBITORS; VACCINE EFFECTIVENESS; OSELTAMIVIR TREATMENT; AEROSOL TRANSMISSION; ANTIVIRAL THERAPY; RELATIVE EFFICACY; VIRUS-INFECTION; METAANALYSIS; DIAGNOSIS	Influenza is an acute respiratory illness, caused by influenza A, B, and C viruses, that occurs in local outbreaks or seasonal epidemics. Clinical illness follows a short incubation period and presentation ranges from asymptomatic to fulminant, depending on the characteristics of both the virus and the individual host. Influenza A viruses can also cause sporadic infections or spread worldwide in a pandemic when novel strains emerge in the human population from an animal host. New approaches to influenza prevention and treatment for management of both seasonal influenza epidemics and pandemics are desirable. In this Seminar, we discuss the clinical presentation, transmission, diagnosis, management, and prevention of seasonal influenza infection. We also review the animal-human interface of influenza, with a focus on current pandemic threats.	[Paules, Catharine; Subbarao, Kanta] NIAID, Lab Infect Dis, NIH, 33 North Dr,MSC 3203, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Subbarao, K (corresponding author), NIAID, Lab Infect Dis, NIH, 33 North Dr,MSC 3203, Bethesda, MD 20892 USA.	ksubbarao@niaid.nih.gov		Paules, Catharine/0000-0002-9064-6678; lina, bruno/0000-0002-8959-2123	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000997] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Our research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. We thank Tara Palmore and Catherine Luke for their critical review of the manuscript. We also thank Diane Cooper for her assistance with the literature search. Additional references that could be of interest to readers are included in the appendix. Work on this paper was done while KS was at the National Institute of Allergy and Infectious Diseases, National Institutes of Health. KS is now at the WHO Collaborating Centre for Reference and Research on Influenza, Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia (Kanta.subbarao@influenzacentre.org).	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; BARKER WH, 1982, ARCH INTERN MED, V142, P85, DOI 10.1001/archinte.142.1.85; Beck CR, 2012, J INFECT DIS, V206, P1250, DOI 10.1093/infdis/jis487; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Beigel J, 2008, ANTIVIR RES, V78, P91, DOI 10.1016/j.antiviral.2008.01.003; Bennett JE, 2015, M DOUGLAS BENNETTS P; Biggerstaff M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-480; bin-Reza F, 2012, INFLUENZA OTHER RESP, V6, P257, DOI 10.1111/j.1750-2659.2011.00307.x; Black CL, 2015, MMWR-MORBID MORTAL W, V64, P993, DOI 10.15585/mmwr.mm6436a1; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; Bouscambert M, 2015, J HOSP INFECT, V89, P314, DOI 10.1016/j.jhin.2014.12.017; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Byington CL, 2015, PEDIATRICS, V136, P792, DOI 10.1542/peds.2015-2920; Byrn RA, 2015, ANTIMICROB AGENTS CH, V59, P1574, DOI 10.1128/AAC.04623-14; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Camilloni B, 2015, HUM VACC IMMUNOTHER, V11, P553, DOI 10.1080/21645515.2015.1011562; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001399; Centers for Disease Control and Prevention, 2017, INFL ANT MED SUMM CL; Chan TC, 2014, J AM MED DIR ASSOC, V15; Chaves SS, 2015, CLIN INFECT DIS, V61, P1807, DOI 10.1093/cid/civ733; Cowling BJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2922; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Demicheli V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001269.pub5; DiazGranados CA, 2016, CLIN INFECT DIS, V62, P1092, DOI 10.1093/cid/ciw085; Ding HL, 2015, MMWR-MORBID MORTAL W, V64, P1000, DOI 10.3201/mmwr.mm6436a2; Dobson J, 2015, LANCET, V385, P1729, DOI 10.1016/S0140-6736(14)62449-1; Dunning J, 2014, LANCET INFECT DIS, V14, P1259, DOI 10.1016/S1473-3099(14)70821-7; Dwyer DE, 2006, MED J AUSTRALIA, V185, P48; Esposito S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-349; European Centre for Disease Prevention and Control, 2016, INFLUENZA; Farooqui A, 2016, NEW ENGL J MED, V374, P596, DOI 10.1056/NEJMc1505359; Fell DB, 2015, BJOG-INT J OBSTET GY, V122, P17, DOI 10.1111/1471-0528.12977; Freidl GS, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.18.20793; Fry AM, 2015, LANCET INFECT DIS, V15, P654, DOI 10.1016/S1473-3099(15)70041-1; Gaglani M, 2016, J INFECT DIS, V213, P1546, DOI 10.1093/infdis/jiv577; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gasparini R, 2014, J Prev Med Hyg, V55, P109; Gasparini R, 2014, J Prev Med Hyg, V55, P69; Gill JR, 2010, ARCH PATHOL LAB MED, V134, P235, DOI 10.1043/1543-2165-134.2.235; Greenbaum A, 2014, INFECTION, V42, P165, DOI 10.1007/s15010-013-0534-8; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI [10.15585/mmwr.mm6430a3, 10.1111/ajt.13505]; Gulati S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-22; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; HAYDEN FG, 1992, CURR TOP MICROBIOL, V176, P119; Horby P, 2013, INFLUENZA OTHER RESP, V7, P37, DOI 10.1111/irv.12079; Houser K, 2015, CELL HOST MICROBE, V17, P295, DOI 10.1016/j.chom.2015.02.012; Hui DS, 2008, RESPIROLOGY; Ip DKM, 2016, CLIN INFECT DIS, V62, P431, DOI 10.1093/cid/civ909; Ison MG, 2015, EXPERT REV ANTI-INFE, V13, P417, DOI 10.1586/14787210.2015.1018183; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Jayasundara K, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0670-5; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jefferson T, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008965.pub4, 10.1002/14651858.CD008965.pub3]; Jin H, 2015, CURR TOP MICROBIOL, V386, P181, DOI 10.1007/82_2014_410; Jones M, 2015, CLIN MICROBIOL INFEC, V21, P217, DOI 10.1016/j.cmi.2014.10.011; Kakeya H, PLOS ONE; Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030; Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052; Killingley B, 2013, INFLUENZA OTHER RESP, V7, P42, DOI 10.1111/irv.12080; Kim DK, 2013, YONSEI MED J, V54, P560, DOI 10.3349/ymj.2013.54.3.560; Krammer F, 2015, BIOTECHNOL J, V10, P690, DOI 10.1002/biot.201400393; Kreijtz JHCM, 2011, VIRUS RES, V162, P19, DOI 10.1016/j.virusres.2011.09.022; Krol E, 2014, ACTA BIOCHIM POL, V61, P495; Lafond KE, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001977; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Lee WJ, 2014, J AM MED DIR ASSOC, V15, P256, DOI 10.1016/j.jamda.2013.12.003; Lee YT, 2014, CLIN EXP VACCINE RES, V3, P12, DOI 10.7774/cevr.2014.3.1.12; Leung NHL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148669; Li XY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004508; Lindsley WG, 2015, J OCCUP ENVIRON HYG, V12, P107, DOI 10.1080/15459624.2014.973113; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; Marjuki H, 2015, J VIROL, V89, P5419, DOI 10.1128/JVI.03513-14; McQuade B, 2015, AM J HEALTH-SYST PH, V72, P112, DOI 10.2146/ajhp140390; Mehrbod P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872370; Meijer A, 2014, ANTIVIR RES, V110, P31, DOI 10.1016/j.antiviral.2014.07.001; Meijer WJ, 2015, ACTA OBSTET GYN SCAN, V94, P797, DOI 10.1111/aogs.12680; Memoli MJ, 2014, CLIN INFECT DIS, V58, P214, DOI 10.1093/cid/cit725; Miller E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f794; Miller MR, 2015, J INFECT DIS, V212, P1604, DOI 10.1093/infdis/jiv264; Mistry RD, 2014, PEDIATRICS, V134, pE684, DOI 10.1542/peds.2014-0505; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; MOSER MR, 1979, AM J EPIDEMIOL, V110, P1; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Naleway AL, 2014, VACCINE, V32, P3122, DOI 10.1016/j.vaccine.2014.04.021; Neumann G, 2015, VIROLOGY, V479, P234, DOI 10.1016/j.virol.2015.03.009; Neuzil KM, 2015, J INFECT DIS, V211, P1517, DOI 10.1093/infdis/jiu651; Nguyen-Van-Tam JS, 2014, LANCET, V384, P386, DOI 10.1016/S0140-6736(14)60726-1; Nicholson K G, 1992, Semin Respir Infect, V7, P26; Nikitin N, 2014, ADV VIROL, V2014, DOI 10.1155/2014/859090; Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536; Nolan T, 2014, J INFECT DIS, V210, P545, DOI 10.1093/infdis/jiu173; Ohkura N, 2015, INTERNAL MED, V54, P1441, DOI 10.2169/internalmedicine.54.3823; Okoli GN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113633; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Peaper DR, 2014, CLIN LAB MED, V34, P365, DOI 10.1016/j.cll.2014.02.009; Pebody R, 2016, EUROSURVEILLANCE, V21, P41, DOI 10.2807/1560-7917.ES.2016.21.38.30348; Pelegrin M, 2015, TRENDS MICROBIOL, V23, P653, DOI 10.1016/j.tim.2015.07.005; Peltola V, 2005, CLIN INFECT DIS, V41, P1198, DOI 10.1086/444508; Petrozzino JJ, 2010, J EMERG MED, V39, P476, DOI 10.1016/j.jemermed.2009.11.031; Prevention CDC, 2012, INFLUENZA; Prober C, 2012, PRINCIPLES PRACTICE; Pu J, 2015, P NATL ACAD SCI USA, V112, P548, DOI 10.1073/pnas.1422456112; Rajao DS, 2015, J VIROL, V89, P11213, DOI 10.1128/JVI.01675-15; Ramos EL, 2015, J INFECT DIS, V211, P1038, DOI 10.1093/infdis/jiu539; Reed C, 2014, MMWR-MORBID MORTAL W, V63, P1151; Rhorer J, 2009, VACCINE, V27, P1101, DOI 10.1016/j.vaccine.2008.11.093; RILEY RL, 1974, AM J MED, V57, P466, DOI 10.1016/0002-9343(74)90140-5; Rodrigo C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010406.pub2; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Schuurmans MM, 2014, TRANSPL INFECT DIS, V16, P430, DOI 10.1111/tid.12228; Shaw ML, 2013, FIELDS VIROLOGY, P1151; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Steinhoff MC, 2014, LANCET, V383, P1611, DOI 10.1016/S0140-6736(14)60583-3; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Subbarao K, 1998, SCIENCE, V279, P393, DOI 10.1126/science.279.5349.393; Sullivan SG, 2014, EXPERT REV VACCINES, V13, P1571, DOI 10.1586/14760584.2014.966695; Takashita E, 2015, ANTIMICROB AGENTS CH, V59, P2607, DOI 10.1128/AAC.04836-14; Tanner WD, 2015, EPIDEMIOL INFECT, V143, P3359, DOI 10.1017/S0950268815001570; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Tong SX, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003657; Van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P26, DOI 10.1111/irv.12077; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Welch SC, 2015, INTENS CARE MED, V41, P1365, DOI 10.1007/s00134-015-3816-z; WHO, 2016, INFLUENZA; Wong BCK, 2010, CLIN INFECT DIS, V51, P1176, DOI 10.1086/656743; Xuan Y, 2015, EPIDEMIOL INFECT, V143, P2975, DOI 10.1017/S0950268815000278; Yang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10390; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396; Zenilman JM, 2015, ANTIVIR RES, V123, P114, DOI 10.1016/j.antiviral.2015.09.008; Zhang Y, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0764-5	139	394	415	21	261	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 12	2017	390	10095					697	708		10.1016/S0140-6736(17)30129-0	http://dx.doi.org/10.1016/S0140-6736(17)30129-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FD3TV	28302313				2022-12-28	WOS:000407456200025
J	Schmidt, E				Schmidt, Enno			Rituximab as first-line treatment of pemphigus	LANCET			English	Editorial Material							THERAPY		[Schmidt, Enno] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Schmidt, Enno] Univ Lubeck, Lubeck Inst Expt Dermatol, Lubeck, Germany	University of Lubeck; University of Lubeck	Schmidt, E (corresponding author), Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany.; Schmidt, E (corresponding author), Univ Lubeck, Lubeck Inst Expt Dermatol, Lubeck, Germany.	enno.schmidt@uksh.de	Schmidt, Enno/C-4008-2009	Schmidt, Enno/0000-0002-1206-8913				Ahmed AR, 2006, NEW ENGL J MED, V355, P1772, DOI 10.1056/NEJMoa062930; Bystryn JC, 1996, ARCH DERMATOL, V132, P203, DOI 10.1001/archderm.132.2.203; Ellebrecht CT, 2016, SCIENCE, V353, P179, DOI 10.1126/science.aaf6756; Joly P, 2017, LANCET; Joly P, 2007, NEW ENGL J MED, V357, P545, DOI 10.1056/NEJMoa067752; Langenhan J, 2014, EXP DERMATOL; Martin LK, 2011, J AM ACAD DERMATOL, V64, P903, DOI 10.1016/j.jaad.2010.04.039; Sajda T, 2016, P NATL ACAD SCI USA, V113, P1859, DOI 10.1073/pnas.1525448113; Schmidt E, 2007, BRIT J DERMATOL, V156, P352, DOI 10.1111/j.1365-2133.2006.07646.x; Schmidt E, 2016, ROOKS TXB DERMATOLOG, V50, P1; Stanley JR, 2006, NEW ENGL J MED, V355, P1800, DOI 10.1056/NEJMra061111; Wang HH, 2015, ACTA DERM-VENEREOL, V95, P928, DOI 10.2340/00015555-2116; Waschke J, 2014, MED RES REV, V34, P1127, DOI 10.1002/med.21310	13	24	25	1	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 20	2017	389	10083					1956	1958		10.1016/S0140-6736(17)30787-0	http://dx.doi.org/10.1016/S0140-6736(17)30787-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EV1OH	28342636				2022-12-28	WOS:000401515300005
J	Pinheiro, D; Hannezo, E; Herszterg, S; Bosveld, F; Gaugue, I; Balakireva, M; Wang, ZM; Cristo, I; Rigaud, SU; Markova, O; Bellaiche, Y				Pinheiro, Diana; Hannezo, Edouard; Herszterg, Sophie; Bosveld, Floris; Gaugue, Isabelle; Balakireva, Maria; Wang, Zhimin; Cristo, Ines; Rigaud, Stephane U.; Markova, Olga; Bellaiche, Yohanns			Transmission of cytokinesis forces via E-cadherin dilution and actomyosin flows	NATURE			English	Article							ALPHA-CATENIN; CELL-DIVISION; ACTIN CYTOSKELETON; ADHERENS JUNCTIONS; EPITHELIAL TISSUE; MYOSIN-II; DROSOPHILA; CONTRACTILITY; MORPHOGENESIS; POLARITY	During epithelial cytokinesis, the remodelling of adhesive cell-cell contacts between the dividing cell and its neighbours has profound implications for the integrity, arrangement and morphogenesis of proliferative tissues(1-7). In both vertebrates and invertebrates, this remodelling requires the activity of non-muscle myosin II (MyoII) in the interphasic cells neighbouring the dividing cell(1,3,5). However, the mechanisms that coordinate cytokinesis and MyoII activity in the neighbours are unknown. Here we show that in the Drosophila notum epithelium, each cell division is associated with a mechanosensing and transmission event that controls MyoII dynamics in neighbouring cells. We find that the ring pulling forces promote local junction elongation, which results in local E-cadherin dilution at the ingressing adherens junction. In turn, the reduction in E-cadherin concentration and the contractility of the neighbouring cells promote self-organized actomyosin flows, ultimately leading to accumulation of MyoII at the base of the ingressing junction. Although force transduction has been extensively studied in the context of adherens junction reinforcement to stabilize adhesive cell-cell contacts(8), we propose an alternative mechanosensing mechanism that coordinates actomyosin dynamics between epithelial cells and sustains the remodelling of the adherens junction in response to mechanical forces.	[Pinheiro, Diana; Herszterg, Sophie; Bosveld, Floris; Gaugue, Isabelle; Balakireva, Maria; Wang, Zhimin; Cristo, Ines; Rigaud, Stephane U.; Markova, Olga; Bellaiche, Yohanns] PSL Res Univ, INSERM U934, CNRS UMR 3215, Inst Curie, F-75248 Paris 05, France; [Pinheiro, Diana; Herszterg, Sophie; Bosveld, Floris; Gaugue, Isabelle; Balakireva, Maria; Wang, Zhimin; Cristo, Ines; Rigaud, Stephane U.; Markova, Olga; Bellaiche, Yohanns] UPMC Univ Paris 06, Sorbonne Univ, CNRS, INSERM U934,UMR 3215, F-75005 Paris, France; [Pinheiro, Diana] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, Oporto, Portugal; [Hannezo, Edouard] Univ Cambridge, Cavendish Lab, Dept Phys, JJ Thomson Ave, Cambridge CB3 0HE, England; [Hannezo, Edouard] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England; [Herszterg, Sophie] Francis Crick Inst, 1 Brill Pl, London NW1 1BF, England	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Sorbonne Universite; Universidade do Porto; University of Cambridge; University of Cambridge; Francis Crick Institute	Bellaiche, Y (corresponding author), PSL Res Univ, INSERM U934, CNRS UMR 3215, Inst Curie, F-75248 Paris 05, France.; Bellaiche, Y (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, INSERM U934,UMR 3215, F-75005 Paris, France.	yohanns.bellaiche@curie.fr		bellaiche, yohanns/0000-0003-1686-2943; Isabelle, Gaugue/0000-0001-6618-3899; bosveld, floris/0000-0002-4733-9074; Rigaud, Stephane/0000-0003-2161-0927; Hannezo, Edouard/0000-0001-6005-1561; Pinheiro, Diana/0000-0003-4333-7503; Cristo, Ines/0000-0002-7576-326X	ANR-MaxForce; ERC (TiMoprh) [340784]; ARC [SL220130607097]; ANR-DEEP [11-LBX-0044, ANR-10-IDEX-0001-02]; PSL grants; FCT [SFRH/BD/51700/2011]; FRM [FDT20150531972]; Wellcome Trust [110326/Z/15/Z]; Trinity College; Bettencourt-Schueller Foundation	ANR-MaxForce(French National Research Agency (ANR)); ERC (TiMoprh); ARC(Australian Research Council); ANR-DEEP(French National Research Agency (ANR)); PSL grants; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FRM(Fondation pour la Recherche Medicale); Wellcome Trust(Wellcome TrustEuropean Commission); Trinity College; Bettencourt-Schueller Foundation	We thank M. Affolter, S. Bogdan, M. Fuller, J. Grosshans, A. Jenny, A. Martin, J. Mihaly, H. Oda, B. Sanson, D. St Johnston, J. Treisman, J. Zallen, VDRC, TRiP, Kyoto and Bloomington Stock Centres and DSHB for reagents; J. Prost, L. Szpiro for inputs; M. Thery, L. Blanchoin, Emilie Barou, H. Ennomanix, K. Cockburn and V. Greco for data and inputs; the Developmental Biology Unit imaging platform; J.-F. Joanny, F. Graner, A. Villedieu and R.-M. Mege for comments; P. Recho for help with simulations; ANR-MaxForce, ERC (TiMoprh, 340784), ARC (SL220130607097), ANR-DEEP (11-LBX-0044, ANR-10-IDEX-0001-02) and PSL grants for funding; FCT (SFRH/BD/51700/2011) and FRM (FDT20150531972) fellowships to D.P. and Wellcome Trust (110326/Z/15/Z), Trinity College and the Bettencourt-Schueller Foundation fellowships to E.H.	Baena-Lopez LA, 2013, DEVELOPMENT, V140, P4818, DOI 10.1242/dev.100933; Bardet PL, 2013, DEV CELL, V25, P534, DOI 10.1016/j.devcel.2013.04.020; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Bergert M, 2015, NAT CELL BIOL, V17, P524, DOI 10.1038/ncb3134; Bosveld F, 2016, NATURE, V530, P495, DOI 10.1038/nature16970; Brochard-Wyart F, 2003, CR PHYS, V4, P281, DOI 10.1016/S1631-0705(03)00048-3; Buckley CD, 2014, SCIENCE, V346, P600, DOI 10.1126/science.1254211; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Engl W, 2014, NAT CELL BIOL, V16, P584, DOI 10.1038/ncb2973; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Firmino J, 2016, DEV CELL, V36, P249, DOI 10.1016/j.devcel.2016.01.007; Founounou N, 2013, DEV CELL, V24, P242, DOI 10.1016/j.devcel.2013.01.008; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Grusche FA, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-14; Guillot C, 2013, DEV CELL, V24, P227, DOI 10.1016/j.devcel.2013.01.010; Guirao B, 2015, ELIFE, V4, DOI 10.7554/eLife.08519; Herszterg S, 2013, DEV CELL, V24, P256, DOI 10.1016/j.devcel.2012.11.019; Higashi T, 2016, CURR BIOL, V26, P1829, DOI 10.1016/j.cub.2016.05.036; Hoffman BD, 2015, TRENDS CELL BIOL, V25, P803, DOI 10.1016/j.tcb.2015.09.008; Huang J, 2008, GENETICS, V180, P703, DOI 10.1534/genetics.108.090563; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; Lammel U, 2014, DEVELOPMENT, V141, P1366, DOI 10.1242/dev.101352; Lau K, 2015, NAT CELL BIOL, V17, P569, DOI 10.1038/ncb3156; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lee A, 2004, MOL BIOL CELL, V15, P3285, DOI 10.1091/mbc.E04-01-0057; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leerberg JM, 2014, CURR BIOL, V24, P1689, DOI 10.1016/j.cub.2014.06.028; Levayer R, 2013, DEV CELL, V26, P162, DOI 10.1016/j.devcel.2013.06.020; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mayer M, 2010, NATURE, V467, P617, DOI 10.1038/nature09376; Morais-de-Sa E, 2013, EMBO REP, V14, P696, DOI 10.1038/embor.2013.85; Munjal A, 2015, NATURE, V524, P351, DOI 10.1038/nature14603; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; Pinheiro D, 2017, METHOD CELL BIOL, V137, P73, DOI 10.1016/bs.mcb.2016.04.013; Prost J, 2015, NAT PHYS, V11, P111, DOI [10.1038/nphys3224, 10.1038/NPHYS3224]; Recho P, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.108102; Ren XJ, 2013, P NATL ACAD SCI USA, V110, P19012, DOI 10.1073/pnas.1318481110; Roh-Johnson M, 2012, SCIENCE, V335, P1232, DOI 10.1126/science.1217869; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Ruprecht V, 2015, CELL, V160, P673, DOI 10.1016/j.cell.2015.01.008; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Simoes SD, 2014, J CELL BIOL, V204, P575, DOI 10.1083/jcb.201307070; Tabdanov E, 2009, BIOPHYS J, V96, P2457, DOI 10.1016/j.bpj.2008.11.059; Truebestein L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10029; Turlier H, 2014, BIOPHYS J, V106, P114, DOI 10.1016/j.bpj.2013.11.014; XU T, 1993, DEVELOPMENT, V117, P1223; Yao MX, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5525; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	50	62	62	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 4	2017	545	7652					103	+		10.1038/nature22041	http://dx.doi.org/10.1038/nature22041			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET7MK	28296858	Green Accepted			2022-12-28	WOS:000400480400039
J	Kelleher, KJ; Gardner, W				Kelleher, Kelly J.; Gardner, William			Out of Sight, Out of Mind - Behavioral and Developmental Care for Rural Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kelleher, Kelly J.] Res Inst Nationwide Childrens Hosp, Ctr Innovat Pediat Practice, Columbus, OH 43205 USA; [Gardner, William] Childrens Hosp Eastern Ontario, Ctr Child Mental Hlth Serv & Policy Res, Res Inst, Ottawa, ON, Canada	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University of Ottawa; Children's Hospital of Eastern Ontario	Kelleher, KJ (corresponding author), Res Inst Nationwide Childrens Hosp, Ctr Innovat Pediat Practice, Columbus, OH 43205 USA.							Farrigan T., 2016, UNDERSTANDING RISE R; Richardson LP, 2014, JAMA-J AM MED ASSOC, V312, P809, DOI 10.1001/jama.2014.9259; Robinson LR, 2017, MMWR SURVEILL SUMM, V66, P3; Rooksby M, 2015, J ANXIETY DISORD, V29, P83, DOI 10.1016/j.janxdis.2014.11.006; Shonkoff J. P., 2000, NEURONS NEIGHBORHOOD	5	22	22	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 6	2017	376	14					1301	1303		10.1056/NEJMp1700713	http://dx.doi.org/10.1056/NEJMp1700713			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EQ9SJ	28301297				2022-12-28	WOS:000398424800001
J	Gill, DA; Mascia, MB; Ahmadia, GN; Glew, L; Lester, SE; Barnes, M; Craigie, I; Darling, ES; Free, CM; Geldmann, J; Holst, S; Jensen, OP; White, AT; Basurto, X; Coad, L; Gates, RD; Guannel, G; Mumby, PJ; Thomas, H; Whitmee, S; Woodley, S; Fox, HE				Gill, David A.; Mascia, Michael B.; Ahmadia, Gabby N.; Glew, Louise; Lester, Sarah E.; Barnes, Megan; Craigie, Ian; Darling, Emily S.; Free, Christopher M.; Geldmann, Jonas; Holst, Susie; Jensen, Olaf P.; White, Alan T.; Basurto, Xavier; Coad, Lauren; Gates, Ruth D.; Guannel, Greg; Mumby, Peter J.; Thomas, Hannah; Whitmee, Sarah; Woodley, Stephen; Fox, Helen E.			Capacity shortfalls hinder the performance of marine protected areas globally	NATURE			English	Article							SOCIAL-ECOLOGICAL SYSTEMS; RESERVES; MANAGEMENT; SCIENCE	Marine protected areas (MPAs) are increasingly being used globally to conserve marine resources. However, whether many MPAs are being effectively and equitably managed, and how MPA management influences substantive outcomes remain unknown. We developed a global database of management and fish population data (433 and 218 MPAs, respectively) to assess: MPA management processes; the effects of MPAs on fish populations; and relationships between management processes and ecological effects. Here we report that many MPAs failed to meet thresholds for effective and equitable management processes, with widespread shortfalls in staff and financial resources. Although 71% of MPAs positively influenced fish populations, these conservation impacts were highly variable. Staff and budget capacity were the strongest predictors of conservation impact: MPAs with adequate staff capacity had ecological effects 2.9 times greater than MPAs with inadequate capacity. Thus, continued global expansion of MPAs without adequate investment in human and financial capacity is likely to lead to sub-optimal conservation outcomes.	[Gill, David A.] Natl Socioenvironm Synth Ctr SESYNC, Annapolis, MD 21401 USA; [Gill, David A.] World Wildlife Fund Int, Luc Hoffmann Inst, CH-1196 Gland, Switzerland; [Mascia, Michael B.] Conservat Int, Moore Ctr Sci, Arlington, VA 22202 USA; [Ahmadia, Gabby N.; Glew, Louise; Fox, Helen E.] World Wildlife Fund US, Washington, DC 20037 USA; [Lester, Sarah E.] Florida State Univ, Dept Geog, Tallahassee, FL 32306 USA; [Barnes, Megan] Univ Queensland, Ctr Biodivers & Conservat Sci, St Lucia Campus, Brisbane, Qld 4072, Australia; [Barnes, Megan] Univ Hawaii, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; [Craigie, Ian] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Darling, Emily S.] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Free, Christopher M.; Jensen, Olaf P.] Rutgers State Univ, Dept Marine & Coastal Sci, New Brunswick, NJ 08901 USA; [Geldmann, Jonas] Univ Cambridge, Dept Zool, Conservat Sci Grp, Downing St, Cambridge CB2 3EJ, England; [Geldmann, Jonas] Univ Copenhagen, Nat Hist Museum Denmark, Ctr Macroecol Evolut & Climate, Univ Pk 15, DK-2100 Copenhagen E, Denmark; [Holst, Susie] NOAA, Coral Reef Conservat Program, Silver Spring, MD 20910 USA; [White, Alan T.] Nature Conservancy, Indo Pacific Div, Honolulu, HI 96817 USA; [Basurto, Xavier] Duke Univ, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Coad, Lauren] Univ Oxford, Environm Change Inst, South Parks Rd, Oxford OX1 3QY, England; [Coad, Lauren] Ctr Int Forestry Res, Bogor 16115, Barat, Indonesia; [Gates, Ruth D.] Univ Hawaii Manoa, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Guannel, Greg] Stanford Univ, Nat Capital Project, 371 Serra Mall, Stanford, CA 94305 USA; [Mumby, Peter J.] Univ Queensland, Marine Spatial Ecol Lab, Sch Biol Sci, St Lucia Campus, Brisbane, Qld 4072, Australia; [Mumby, Peter J.] Univ Queensland, ARC Ctr Excellence Coral Reef Studies, St Lucia Campus, Brisbane, Qld 4072, Australia; [Thomas, Hannah] UNEP World Conservat Monitoring Ctr, Cambridge CB3 0DL, England; [Whitmee, Sarah] UCL, CBER, London WC1E 6BT, England; [Woodley, Stephen] IUCN, WCPA SSC Joint Task Force Biodivers & Protected A, Quebec City, PQ J9B 1T3, Canada; [Fox, Helen E.] Natl Geog Soc, Washington, DC 20036 USA; [Gill, David A.] Conservat Int, Moore Ctr Sci, Arlington, VA 22202 USA; [Gill, David A.] George Mason Univ, Fairfax, VA 22030 USA	World Wildlife Fund; Conservation International; State University System of Florida; Florida State University; University of Queensland; University of Hawaii System; James Cook University; Wildlife Conservation Society; Rutgers State University New Brunswick; University of Cambridge; University of Copenhagen; National Oceanic Atmospheric Admin (NOAA) - USA; Nature Conservancy; Duke University; University of Oxford; CGIAR; Center for International Forestry Research (CIFOR); University of Hawaii System; University of Hawaii Manoa; Stanford University; University of Queensland; University of Queensland; University of London; University College London; National Geographic Society; Conservation International; George Mason University	Gill, DA (corresponding author), Natl Socioenvironm Synth Ctr SESYNC, Annapolis, MD 21401 USA.; Gill, DA (corresponding author), World Wildlife Fund Int, Luc Hoffmann Inst, CH-1196 Gland, Switzerland.; Gill, DA (corresponding author), Conservat Int, Moore Ctr Sci, Arlington, VA 22202 USA.; Gill, DA (corresponding author), George Mason Univ, Fairfax, VA 22030 USA.	dgill@conservation.org	Mumby, Peter/F-9914-2010; Free, Christopher Michael/AAC-5103-2019; Free, Christopher/N-2813-2013; Mascia, Michael B./X-5516-2018; Woodley, Stephen/AAA-1985-2021; Geldmann, Jonas/H-8131-2019	Mumby, Peter/0000-0002-6297-9053; Free, Christopher Michael/0000-0002-2557-8920; Free, Christopher/0000-0002-2557-8920; Mascia, Michael B./0000-0002-9874-9778; Woodley, Stephen/0000-0003-3074-6578; Geldmann, Jonas/0000-0002-1191-7610; Whitmee, Sarah/0000-0001-9161-868X; Barnes, Megan/0000-0002-8300-0975; Darling, Emily/0000-0002-1048-2838; Basurto, Xavier/0000-0002-5321-3654; Fox, Helen/0000-0002-0541-7484	National Socio-Environmental Synthesis Center (SESYNC) under National Science Foundation [DBI-1052875]; Luc Hoffmann Institute; SESYNC; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	National Socio-Environmental Synthesis Center (SESYNC) under National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Luc Hoffmann Institute; SESYNC(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI-1052875, as part of the working group: Solving the Mystery of Marine Protected Area (MPA) Performance: Linking Governance, Conservation, Ecosystem Services and Human Well Being. D.A.G. was jointly supported by postdoctoral fellowships from the Luc Hoffmann Institute and SESYNC. We thank the following data providers: Atlantic Gulf Rapid Reef Assessment (AGRRA) contributors and data managers, Conservation International, Healthy Reefs Initiative, I. Williams (NOAA Coral Reef Ecosystem Program), NOAA Coral Reef Conservation Program, K. Knights (Global Database for Protected Area Management Effectiveness), G. Edgar and R. Stuart-Smith (Reef Life Surveys), The Nature Conservancy, Wildlife Conservation Society, and the World Conservation Monitoring Centre. We also thank other members of the SESYNC MPA Pursuit team: A. Agrawal, G. Cid, A. Henshaw, I. Nur Hidayat, W. Liang, P. McConney, M. Nenadovic, J. E. Parks, B. Pomeroy, C. Strasser and M. Webster, and P. Marchand of SESYNC for scientific support. We acknowledge GEF, USAID, and the many other funders who supported authors' time and data collection. This is contribution no. 9 of the research initiative Solving the Mystery of MPA Performance.	Advani S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126098; Ahmadia GN, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0275; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Auguie B, 2017, GRIDEXTRA MISCELLANE; Basurto X, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501220; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Claudet J, 2008, ECOL LETT, V11, P481, DOI 10.1111/j.1461-0248.2008.01166.x; Coad L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0281; Edgar GJ, 2014, NATURE, V506, P216, DOI 10.1038/nature13022; Ferraro P.J., 2009, NEW DIRECTIONS EVAL, V2009, P75, DOI DOI 10.1002/EV.297); Ferraro PJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0270; Fox HE, 2014, COAST MANAGE, V42, P207, DOI 10.1080/08920753.2014.904178; Gell FR, 2003, TRENDS ECOL EVOL, V18, P448, DOI 10.1016/S0169-5347(03)00189-7; Green AL, 2015, BIOL REV, V90, P1215, DOI 10.1111/brv.12155; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; Hapfelmeier A, 2014, STAT COMPUT, V24, P21, DOI 10.1007/s11222-012-9349-1; Hockings M., 2006, EVALUATING EFFECTIVE, V2nd, DOI https://doi.org/10.2305/IUCN.CH.2005.PAG.14.en; Hothorn T, 2006, J COMPUT GRAPH STAT, V15, P651, DOI 10.1198/106186006X133933; Hothorn Torsten, 2015, **DATA OBJECT**; Keele L., 2010, OVERVIEW RBOUNDS R P; Lester SE, 2008, MAR ECOL PROG SER, V367, P49, DOI 10.3354/meps07599; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Lubchenco J, 2015, SCIENCE, V350, P382, DOI 10.1126/science.aad5443; Mascia, 2004, MARINE RESERVES GUID, P154; Mascia MB, 2010, CONSERV BIOL, V24, P1424, DOI 10.1111/j.1523-1739.2010.01523.x; McClanahan TR, 2006, CURR BIOL, V16, P1408, DOI 10.1016/j.cub.2006.05.062; Mora C, 2011, MAR ECOL PROG SER, V434, P251, DOI 10.3354/meps09214; NOAA, 2010, NOAA COR REEF CONS P; Nolte C, 2013, CONSERV BIOL, V27, P155, DOI 10.1111/j.1523-1739.2012.01930.x; Ostrom E., 1990, GOVERNING COMMONS EV; Pinheiro J, 2016, LINEAR NONLINEAR MIX; Pollnac RB, 2001, OCEAN COAST MANAGE, V44, P683, DOI 10.1016/S0964-5691(01)00075-8; Pollnac R, 2010, P NATL ACAD SCI USA, V107, P18262, DOI 10.1073/pnas.0908266107; Rosenbaum PR, 2010, J AM STAT ASSOC, V105, P692, DOI 10.1198/jasa.2010.tm09570; Russ GR, 2008, CURR BIOL, V18, pR514, DOI 10.1016/j.cub.2008.04.016; Sandvik B., 2016, WORLD BORDERS DATASE; Scianna C, 2015, OCEAN COAST MANAGE, V116, P443, DOI 10.1016/j.ocecoaman.2015.09.005; Sekhon JS, 2011, J STAT SOFTW, V42, P1; Staub F., 2004, SCORE CARD ASSESS PR; Stolton S., 2007, MANAGEMENT EFFECTIVE, Vsecond; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; UNEP-WCMC and IUCN, 2016, PROTECTED PLANET REP; UNEP-WCMC IUCN, 2021, PROT PLAN INS NAM CO; United Nations, 2016, UN SUST DEV GOAL 14; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Wenger AS, 2016, CONSERV BIOL, V30, P142, DOI 10.1111/cobi.12576; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516	49	450	459	18	290	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					665	+		10.1038/nature21708	http://dx.doi.org/10.1038/nature21708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28329771	Green Submitted			2022-12-28	WOS:000397619700045
J	Cho, A				Cho, Adrian			PHYSICS In search for unseen matter, physicists turn to dark sector	SCIENCE			English	News Item																			0	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1251	1252		10.1126/science.355.6331.1251	http://dx.doi.org/10.1126/science.355.6331.1251			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336618				2022-12-28	WOS:000397082900011
J	Grubaugh, ND; Andersen, KG				Grubaugh, Nathan D.; Andersen, Kristian G.			Experimental Evolution to Study Virus Emergence	CELL			English	Editorial Material							EBOLA-VIRUS; TRANSMISSION; EPIDEMIC; OUTBREAK	Understanding how viruses adapt to new environments and acquire new phenotypes is critical for developing comprehensive responses to outbreaks. By studying the emergence of vaccine- derived poliovirus outbreaks, Stern et al. describe how a combination of sequence analysis and experimental evolution can be used to reveal adaptive pathways.	[Grubaugh, Nathan D.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Andersen, Kristian G.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Grubaugh, ND; Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	grubaugh@scripps.edu; andersen@scripps.edu		Grubaugh, Nathan/0000-0003-2031-1933	NIH [5T32AI007244-33]; NIH National Center for Advancing Translational Studies Clinical and Translational Science Award [UL1TR001114]; NIAID [HHSN272201400048C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI137690, T32AI007244] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Advancing Translational Studies Clinical and Translational Science Award; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	N.D.G. is supported by a NIH training grant 5T32AI007244-33. K.G.A. is a Pew Biomedical Scholar, and his work is supported by an NIH National Center for Advancing Translational Studies Clinical and Translational Science Award UL1TR001114 and NIAID contract HHSN272201400048C.	Borderia AV, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004838; Diehl WE, 2016, CELL, V167, P1088, DOI 10.1016/j.cell.2016.10.014; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263; Stapleford KA, 2014, CELL HOST MICROBE, V15, P706, DOI 10.1016/j.chom.2014.05.008; Stern A, 2017, CELL, V169, P35, DOI 10.1016/j.cell.2017.03.013; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Urbanowicz RA, 2016, CELL, V167, P1079, DOI 10.1016/j.cell.2016.10.013	9	6	6	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					1	3		10.1016/j.cell.2017.03.018	http://dx.doi.org/10.1016/j.cell.2017.03.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340335	Bronze			2022-12-28	WOS:000397090000001
J	Muller, D				Muller, David			Kathryn	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Muller, David] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Muller, D (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							Dyrbye LN, 2008, ANN INTERN MED, V149, P334, DOI 10.7326/0003-4819-149-5-200809020-00008	1	18	18	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1101	1103		10.1056/NEJMp1615141	http://dx.doi.org/10.1056/NEJMp1615141			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28328338				2022-12-28	WOS:000397014300003
J	Armstrong, S				Armstrong, Stephen			Hospitals that are leading the way to a digital future	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						Armstrong S, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3726; Barber J., THE INTRODUCTION OF; CampionAwwad O., 2014, NATL PROGRAMME IT NH; Cross M., 2006, GUARDIAN; Department of Health, 2016, MAK IT WORK HARN POW; Evenstad L., 2016, COMPUTER WEEKLY; Hoeksma J., 2017, DIGITAL HLTH    0307; IBM Watson Health, ONC GEN; King's Fund, 2016, DIG NHS; NHS England, HARN INF REV; NHS England, GP PAT SURV 2015 16; NHS England, 2016, 12 NHS HOSP TRUSTS T; Parliamentary Office of Science and Technology, 2016, EL HLTH REC; Syal R., 2013, GUARDIAN; Wachter R., 2016, USING INFORM TECHNOL	15	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1366	10.1136/bmj.j1366	http://dx.doi.org/10.1136/bmj.j1366			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330833				2022-12-28	WOS:000397345200006
J	Pagidipati, NJ; Granger, CB				Pagidipati, Neha J.; Granger, Christopher B.			Guideline: The USPSTF recommends low- to moderate-dose statins to prevent CVD in selected adults 40 to 75 years of age	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Pagidipati, Neha J.; Granger, Christopher B.] Duke Clin Res Inst, Durham, NC 27705 USA	Duke University	Pagidipati, NJ (corresponding author), Duke Clin Res Inst, Durham, NC 27705 USA.							Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Yusuf S, 2016, NEW ENGL J MED, V374, P2032, DOI 10.1056/NEJMoa1600177	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC26	JC26		10.7326/ACPJC-2017-166-6-026	http://dx.doi.org/10.7326/ACPJC-2017-166-6-026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320000				2022-12-28	WOS:000397025800003
J	Cairney, J				Cairney, Julie			MATERIALS SCIENCE Atoms on the move-finding the hydrogen A cryogenic atom probe technique allows direct observation of hydrogen at the atomic scale	SCIENCE			English	Editorial Material							TOMOGRAPHY		[Cairney, Julie] Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia	University of Sydney	Cairney, J (corresponding author), Univ Sydney, Sch Aerosp Mech & Mechatron Engn, Sydney, NSW 2006, Australia.	julie.cairney@sydney.edu.au		Cairney, Julie/0000-0003-4564-2675				Callaway E, 2015, NATURE, V525, P172, DOI 10.1038/525172a; Chen YS, 2017, SCIENCE, V355, P1196, DOI 10.1126/science.aal2418; Gault B., 2012, ATOM PROBE MICROSCOP, V160; Gemma R, 2012, SCRIPTA MATER, V67, P903, DOI 10.1016/j.scriptamat.2012.08.025; Gerstl S., 2015, MICROSC MICROANAL, V21, P517, DOI [DOI 10.1017/S1431927615003384, 10.1017/S1431927615003384]; Ishikawa R, 2011, NAT MATER, V10, P278, DOI 10.1038/NMAT2957; London AJ, 2015, ULTRAMICROSCOPY, V159, P360, DOI 10.1016/j.ultramic.2015.02.013; Meyer JC, 2008, NATURE, V454, P319, DOI 10.1038/nature07094; Takahashi J, 2012, SCRIPTA MATER, V67, P213, DOI 10.1016/j.scriptamat.2012.04.022; Takahashi J, 2010, SCRIPTA MATER, V63, P261, DOI 10.1016/j.scriptamat.2010.03.012	10	8	8	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1128	1129		10.1126/science.aam8616	http://dx.doi.org/10.1126/science.aam8616			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9WV	28302811				2022-12-28	WOS:000396351200021
J	Lord, CJ; Ashworth, A				Lord, Christopher J.; Ashworth, Alan			PARP inhibitors: Synthetic lethality in the clinic	SCIENCE			English	Review							OLAPARIB MAINTENANCE THERAPY; HOMOLOGY-DIRECTED REPAIR; NEGATIVE BREAST-CANCER; SEROUS OVARIAN-CANCER; DNA-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; GENETIC INTERACTIONS; SECONDARY MUTATIONS; STRAND BREAKS; OPEN-LABEL	PARP inhibitors (PARPi), a cancer therapy targeting poly(ADP-ribose) polymerase, are the first clinically approved drugs designed to exploit synthetic lethality, a genetic concept proposed nearly a century ago. Tumors arising in patients who carry germline mutations in either BRCA1 or BRCA2 are sensitive to PARPi because they have a specific type of DNA repair defect. PARPi also show promising activity in more common cancers that share this repair defect. However, as with other targeted therapies, resistance to PARPi arises in advanced disease. In addition, determining the optimal use of PARPi within drug combination approaches has been challenging. Nevertheless, the preclinical discovery of PARPi synthetic lethality and the route to clinical approval provide interesting lessons for the development of other therapies. Here, we discuss current knowledge of PARP inhibitors and potential ways to maximize their clinical effectiveness.	[Lord, Christopher J.] Inst Canc Res, Canc Res UK Gene Funct Lab, London SW3 6JB, England; [Lord, Christopher J.] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London SW3 6JB, England; [Ashworth, Alan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 1450 Third St, San Francisco, CA 94158 USA	Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Lord, CJ (corresponding author), Inst Canc Res, Canc Res UK Gene Funct Lab, London SW3 6JB, England.; Lord, CJ (corresponding author), Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London SW3 6JB, England.; Ashworth, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, 1450 Third St, San Francisco, CA 94158 USA.	chris.lord@icr.ac.uk; alan.ashworth@ucsf.edu	Lord, Christopher/AAX-7130-2021; Lord, Christopher/B-3295-2012	Lord, Christopher/0000-0002-3226-0515	Breast Cancer Now; Cancer Research UK; National Health Service; Susan G. Komen for the Cure; Breast Cancer Research Foundation; BRCA Foundation; UCSF; AtlasMDX; Third Rock Ventures; Pfizer; Merck Serono; AstraZeneca; Tango Therapeutics; Sun Pharma; Cancer Research UK [14276, 24439, 25237] Funding Source: researchfish	Breast Cancer Now; Cancer Research UK(Cancer Research UK); National Health Service; Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Breast Cancer Research Foundation; BRCA Foundation; UCSF; AtlasMDX; Third Rock Ventures; Pfizer(Pfizer); Merck Serono(Merck & Company); AstraZeneca(AstraZeneca); Tango Therapeutics; Sun Pharma; Cancer Research UK(Cancer Research UK)	C.J.L. acknowledges funding from Breast Cancer Now, Cancer Research UK, and National Health Service funding to the National Institute for Health Research Royal Marsden Hospital Biomedical Research Centre. A. A. is funded by Susan G. Komen for the Cure, The Breast Cancer Research Foundation, The BRCA Foundation, and UCSF. We thank D. Krastev (ICR, London) for assistance with figure generation and A. Tutt (ICR, London and King's College London) for helpful suggestions. A. A. is on the Scientific Advisory Board of Genentech and is a paid consultant for AtlasMDX, Third Rock Ventures, Pfizer, and Merck Serono. A. A. is a cofounder of Tango Therapeutics. C.J.L. is a paid consultant for AstraZeneca, Tango Therapeutics, and Sun Pharma. In accord with the Institute of Cancer Research Rewards to Inventors Scheme, A. A. is named as an inventor on patents describing the use of PARP inhibitors for the treatment of cancer [WO2014013231 (A1) no. 2014-01-23, US2012135983 (A1) no. 2012-05-31, US2012010204 (A1) no. 2012-01-12, US2006142231 (A1) no. 2006-06-29, and WO2008020180 (A2) no. 2008-02-21]. In accord with the Institute of Cancer Research Rewards to Inventors Scheme, C.J.L. is named as an inventor on patents describing the use of PARP inhibitors for the treatment of cancer [WO2014013231 (A1) no. 2014-01-23 and WO2008020180 (A2) no. 2008-02-21].	Ashworth A, 2011, CELL, V145, P30, DOI 10.1016/j.cell.2011.03.020; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Barber LJ, 2013, J PATHOL, V229, P422, DOI 10.1002/path.4140; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Campbell J, 2016, CELL REP, V14, P2490, DOI 10.1016/j.celrep.2016.02.023; Carnevale J, 2015, J CLIN ONCOL, V33, P3080, DOI 10.1200/JCO.2015.61.6961; Chaudhuri AR, 2016, NATURE, V535, P382, DOI 10.1038/nature18325; Dawicki-McKenna JM, 2015, MOL CELL, V60, P755, DOI 10.1016/j.molcel.2015.10.013; De Vos M, 2012, BIOCHEM PHARMACOL, V84, P137, DOI 10.1016/j.bcp.2012.03.018; Dhillon KK, 2016, ENDOCR-RELAT CANCER, V23, pT39, DOI 10.1530/ERC-16-0228; Drean A, 2016, CRIT REV ONCOL HEMAT, V108, P73, DOI 10.1016/j.critrevonc.2016.10.010; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Eustermann S, 2015, MOL CELL, V60, P742, DOI 10.1016/j.molcel.2015.10.032; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Martin AG, 2017, LANCET ONCOL, V18, P8, DOI 10.1016/S1470-2045(16)30621-0; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Higuchi T, 2015, CANCER IMMUNOL RES, V3, P1257, DOI 10.1158/2326-6066.CIR-15-0044; Huang J, 2015, BIOCHEM BIOPH RES CO, V463, P551, DOI 10.1016/j.bbrc.2015.05.083; Ibrahim YH, 2012, CANCER DISCOV, V2, P1036, DOI 10.1158/2159-8290.CD-11-0348; Isakoff SJ, 2017, FUTURE ONCOL, V13, P307, DOI 10.2217/fon-2016-0412; Ivy SP, 2016, EXPERT OPIN INV DRUG, V25, P597, DOI 10.1517/13543784.2016.1156857; Jaspers JE, 2013, CANCER DISCOV, V3, P68, DOI 10.1158/2159-8290.CD-12-0049; Kaufman B, 2015, J CLIN ONCOL, V33, P244, DOI 10.1200/JCO.2014.56.2728; Kim G, 2015, CLIN CANCER RES, V21, P4257, DOI 10.1158/1078-0432.CCR-15-0887; King MC, 2014, SCIENCE, V343, P1462, DOI 10.1126/science.1251900; Knezevic CE, 2016, CELL CHEM BIOL, V23, P1490, DOI 10.1016/j.chembiol.2016.10.011; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Ledermann J, 2014, LANCET ONCOL, V15, P852, DOI 10.1016/S1470-2045(14)70228-1; Ledermann J, 2012, NEW ENGL J MED, V366, P1382, DOI 10.1056/NEJMoa1105535; Ledermann JA, 2016, LANCET ONCOL, V17, P1579, DOI 10.1016/S1470-2045(16)30376-X; Litton JK, 2016, ANN ONCOL, V27, DOI 10.1093/annonc/mdw364.10; Liu JF, 2014, LANCET ONCOL, V15, P1207, DOI 10.1016/S1470-2045(14)70391-2; Lord CJ, 2016, NAT REV CANCER, V16, P110, DOI 10.1038/nrc.2015.21; Lord CJ, 2013, NAT MED, V19, P1381, DOI 10.1038/nm.3369; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; Mateo J, 2013, NAT REV CLIN ONCOL, V10, P688, DOI 10.1038/nrclinonc.2013.177; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 2001, CANCER RES, V61, P4842; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Murai J, 2014, MOL CANCER THER, V13, P433, DOI 10.1158/1535-7163.MCT-13-0803; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Norquist B, 2011, J CLIN ONCOL, V29, P3008, DOI 10.1200/JCO.2010.34.2980; Parkes EE, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw199; Pettitt SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061520; Plummer R, 2013, CANCER CHEMOTH PHARM, V71, P1191, DOI 10.1007/s00280-013-2113-1; Pommier Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9246; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; SHALL S, 1975, J BIOCHEM-TOKYO, V77, pP2; Shapira-Frommer R., 2015, ANN ONCOL S, V33; Shen YQ, 2013, CLIN CANCER RES, V19, P5003, DOI 10.1158/1078-0432.CCR-13-1391; Swisher EM, 2017, LANCET ONCOL, V18, P75, DOI [10.1016/S1470-2045(16)30559-9, 10.1016/s1470-2045(16)30559-9]; Telli ML, 2016, CLIN CANCER RES, V22, P3764, DOI 10.1158/1078-0432.CCR-15-2477; TERADA M, 1979, P NATL ACAD SCI USA, V76, P6411, DOI 10.1073/pnas.76.12.6411; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xu GT, 2015, NATURE, V521, P541, DOI 10.1038/nature14328; Young JH, 2017, G3-GENES GENOM GENET, V7, P617, DOI 10.1534/g3.116.035915; Zaremba T, 2007, ANTI-CANCER AGENT ME, V7, P515, DOI 10.2174/187152007781668715	72	1235	1274	22	378	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2017	355	6330			SI		1152	1158		10.1126/science.aam7344	http://dx.doi.org/10.1126/science.aam7344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN9WV	28302823	Green Accepted			2022-12-28	WOS:000396351200032
J	Kuriyan, AE; Albini, TA; Townsend, JH; Rodriguez, M; Pandya, HK; Leonard, RE; Parrott, MB; Rosenfeld, PJ; Flynn, HW; Goldberg, JL				Kuriyan, Ajay E.; Albini, Thomas A.; Townsend, Justin H.; Rodriguez, Marianeli; Pandya, Hemang K.; Leonard, Robert E., II; Parrott, M. Brandon; Rosenfeld, Philip J.; Flynn, Harry W., Jr.; Goldberg, Jeffrey L.			Vision Loss after Intravitreal Injection of Autologous "Stem Cells" for AMD	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO DIFFERENTIATION; OPTIC-NERVE DISEASES; MACULAR DEGENERATION; OPHTHALMOLOGY TREATMENT; CLINICS; INTERVENTIONS; FDA; THERAPIES; SCOTS	Adipose tissue-derived "stem cells"have been increasingly used by "stem-cell clinics" in the United States and elsewhere to treat a variety of disorders. We evaluated three patients in whom severe bilateral visual loss developed after they received intravitreal injections of autologous adipose tissue-derived "stem cells"at one such clinic in the United States. In these three patients, the last documented visual acuity on the Snellen eye chart before the injection ranged from 20/30 to 20/200. The patients' severe visual loss after the injection was associated with ocular hypertension, hemorrhagic retinopathy, vitreous hemorrhage, combined traction and rhegmatogenous retinal detachment, or lens dislocation. After 1 year, the patients' visual acuity ranged from 20/200 to no light perception.	[Kuriyan, Ajay E.; Albini, Thomas A.; Townsend, Justin H.; Rodriguez, Marianeli; Rosenfeld, Philip J.; Flynn, Harry W., Jr.] Univ Miami, Miller Sch Med, Dept Ophthalmol, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Parrott, M. Brandon] Ctr Sight, Sarasota, FL USA; [Kuriyan, Ajay E.] Univ Rochester, Med Ctr, Dept Ophthalmol, Flaum Eye Inst, Rochester, NY 14642 USA; [Pandya, Hemang K.; Leonard, Robert E., II] Univ Oklahoma, Dept Ophthalmol, Dean McGee Eye Inst, Oklahoma City, OK USA; [Goldberg, Jeffrey L.] Stanford Univ, Byers Eye Inst, Dept Ophthalmol, Palo Alto, CA 94304 USA	Bascom Palmer Eye Institute; University of Miami; University of Rochester; University of Oklahoma System; University of Oklahoma Health Sciences Center; Stanford University	Albini, TA (corresponding author), Bascom Palmer Eye Inst, 900 NW 17th St, Miami, FL 33136 USA.	talbini@med.miami.edu		Goldberg, Jeffrey/0000-0002-1390-7360; Albini, Thomas/0000-0003-2199-9047	National Institutes of Health (Center Core grant) [P30EY014801]; Research to Prevent Blindness; Department of Defense [W81XWH-09-1-0675]; Klorfine Foundation; NATIONAL EYE INSTITUTE [P30EY014801] Funding Source: NIH RePORTER	National Institutes of Health (Center Core grant); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Department of Defense(United States Department of Defense); Klorfine Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grants from the National Institutes of Health (Center Core grant, P30EY014801), Research to Prevent Blindness, the Department of Defense (W81XWH-09-1-0675), and the Klorfine Foundation (to Dr. Albini).	Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Bowman M, 2015, JAMA NEUROL, V72, P1342, DOI 10.1001/jamaneurol.2015.1891; Falavarjani KG, 2013, EYE, V27, P787, DOI 10.1038/eye.2013.107; Francis PJ, 2010, INVEST OPHTH VIS SCI, V51; Ho AC, 2015, ANG EX DEG 2015 C MI; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; Knoepfler PS, 2015, ADV DRUG DELIVER REV, V82-83, P192, DOI 10.1016/j.addr.2014.12.001; Lee E, 2011, BRIT J OPHTHALMOL, V95, P445, DOI 10.1136/bjo.2009.171918; Moviglia GA, 2012, OPHTHALMIC RES, V48, P1, DOI 10.1159/000339839; Nazari H, 2015, PROG RETIN EYE RES, V48, P1, DOI 10.1016/j.preteyeres.2015.06.004; Park SS, 2015, INVEST OPHTH VIS SCI, V56, P81, DOI 10.1167/iovs.14-15415; Pennock S, 2014, PROG RETIN EYE RES, V40, P16, DOI 10.1016/j.preteyeres.2013.12.006; Rezanejad H, 2014, CELL TISSUE RES, V356, P65, DOI 10.1007/s00441-014-1795-y; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; TAKEI Y, 1975, A GRAEF ARCH KLIN EX, V194, P153, DOI 10.1007/BF00496873; Taylor-Weiner H, 2015, NEW ENGL J MED, V373, P985, DOI 10.1056/NEJMp1504560; Turner L, 2015, TRENDS MOL MED, V21, P271, DOI 10.1016/j.molmed.2015.02.008; Turner LG, 2015, REGEN MED, V10, P397, DOI [10.2217/RME.15.10, 10.2217/rme.15.10]; Turner LG, 2015, MAYO CLIN PROC, V90, P567, DOI 10.1016/j.mayocp.2015.02.003; Weiss JN, 2015, NEURAL REGEN RES, V10, P1507, DOI 10.4103/1673-5374.165525; Weiss JN, 2015, NEURAL REGEN RES, V10, P982, DOI 10.4103/1673-5374.158365; Zarzeczny A, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-75	24	257	271	1	62	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2017	376	11					1047	1053		10.1056/NEJMoa1609583	http://dx.doi.org/10.1056/NEJMoa1609583			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO0QT	28296617	Green Accepted			2022-12-28	WOS:000396403700009
J	Watts, G				Watts, Geoff			Scholarship fund for young African scientists facing demise	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					997	997		10.1016/S0140-6736(17)30697-9	http://dx.doi.org/10.1016/S0140-6736(17)30697-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN9UN	28291003				2022-12-28	WOS:000396345200008
J	Ohman, EM; Roe, MT; Steg, PG; James, SK; Povsic, TJ; White, J; Rockhold, F; Plotnikov, A; Mundl, H; Strony, J; Sun, X; Husted, S; Tendera, M; Montalescot, G; Bahit, MC; Ardissino, D; Bueno, H; Claeys, MJ; Nicolau, JC; Cornel, JH; Goto, S; Kiss, RG; Guray, U; Park, DW; Bode, C; Welsh, RC; Gibson, CM				Ohman, E. Magnus; Roe, Matthew T.; Steg, P. Gabriel; James, Stefan K.; Povsic, Thomas J.; White, Jennifer; Rockhold, Frank; Plotnikov, Alexei; Mundl, Hardi; Strony, John; Sun, Xiang; Husted, Steen; Tendera, Michal; Montalescot, Gilles; Cecilia Bahit, M.; Ardissino, Diego; Bueno, Hector; Claeys, Marc J.; Nicolau, Jose C.; Cornel, Jan H.; Goto, Shinya; Kiss, Robert Gabor; Guray, Umit; Park, Duk-Woo; Bode, Christoph; Welsh, Robert C.; Gibson, C. Michael			Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial	LANCET			English	Article							ASSOCIATION TASK-FORCE; SECONDARY PREVENTION; STENT THROMBOSIS; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; AMERICAN-COLLEGE; CLOPIDOGREL; INTERVENTION; TICAGRELOR; EVENTS	Background Dual antiplatelet therapy (DAPT), aspirin plus a P2Y12 inhibitor, is the standard antithrombotic treatment following acute coronary syndromes. The factor Xa inhibitor rivaroxaban reduced mortality and ischaemic events when added to DAPT, but caused increased bleeding. The safety of a dual pathway antithrombotic therapy approach combining low-dose rivaroxaban (in place of aspirin) with a P2Y12 inhibitor has not been assesssed in acute coronary syndromes. We aimed to assess rivaroxaban 2.5 mg twice daily versus aspirin 100 mg daily, in addition to clopidogrel or ticagrelor (chosen at investigator discretion before randomisation), for patients with acute coronary syndromes started within 10 days after presentation and continued for 6-12 months. Methods In this double-blind, multicentre, randomised trial (GEMINI-ACS-1) done at 371 clinical centres in 21 countries, eligible patients were older than 18 years with unstable angina, non-ST segment elevation myocardial infarction (NSTEMI) or ST segment elevation myocardial infarction (STEMI), with positive cardiac biomarkers and either ischaemic electrocardiographic changes or an atherosclerotic culprit lesion identified during angiography. Participants were randomly assigned (1: 1) within 10 days after admission for the index acute coronary syndromes event to either aspirin or rivaroxaban based on a computer-generated randomisation schedule. Randomisation was balanced by using randomly permuted blocks with size of four and was stratified based on the background P2Y12 inhibitor (clopidogrel or ticagrelor) intended to be used at the time of randomisation. Investigators and patients were masked to treatment assignment. Patients received a minimum of 180 days of double-blind treatment with rivaroxaban 2.5 mg twice daily or aspirin 100 mg daily. The choice of clopidogrel or ticagrelor during trial conduct was not randomised and was based on investigator preference. The primary endpoint was thrombolysis in myocardial infarction (TIMI) clinically significant bleeding not related to coronary artery bypass grafting (CABG; major, minor, or requiring medical attention) up to day 390. Primary analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT02293395. Findings Between April 22, 2015, and Oct 14, 2016, 3037 patients with acute coronary syndromes were randomly assigned; 1518 to receive aspirin and 1519 to receive rivaroxaban. 1704 patients (56%) were in the ticagrelor and 1333 (44%) in the clopidogrel strata. Median duration of treatment was 291 days (IQR 239-354). TIMI non-CABG clinically significant bleeding was similar with rivaroxaban versus aspirin therapy (total 154 patients [5%]; 80 participants [5%] of 1519 vs 74 participants [5%] of 1518; HR 1.09 [95% CI 0.80-1.50]; p=0.5840). Interpretation A dual pathway antithrombotic therapy approach combining low-dose rivaroxaban with a P2Y12 inhibitor for the treatment of patients with acute coronary syndromes had similar risk of clinically significant bleeding as aspirin and a P2Y12 inhibitor. A larger, adequately powered trial would be required to definitively assess the efficacy and safety of this approach.	[Ohman, E. Magnus; Roe, Matthew T.; Povsic, Thomas J.; White, Jennifer; Rockhold, Frank] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Steg, P. Gabriel] Univ Paris Diderot, AP HP, DHU FIRE, Paris, France; [Steg, P. Gabriel] INSERM, U1148, Paris, France; [Steg, P. Gabriel] Imperial Coll London, NHLI Royal Brompton Hosp, London, England; [James, Stefan K.] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [James, Stefan K.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden; [Plotnikov, Alexei; Strony, John; Sun, Xiang] Janssen Res & Dev, Raritan, NJ USA; [Mundl, Hardi] Bayer AG, Wuppertal, Germany; [Husted, Steen] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark; [Tendera, Michal] Med Univ Silesia, Div Cardiol 3, Katowice, Poland; [Montalescot, Gilles] Grp Hosp Pitie Salpetriere, Inst Cardiol, Paris, France; [Cecilia Bahit, M.] INECO Neurociencias Orono, Rosario, Santa Fe, Argentina; [Ardissino, Diego] Policlin San Matteo, Div Cardiol, Pavia, Italy; [Bueno, Hector] Spanish Natl Ctr Cardiovasc Res, Madrid, Spain; [Claeys, Marc J.] Univ Antwerp Hosp, Edegem, Belgium; [Nicolau, Jose C.] Univ Sao Paulo, Med Sch, Heart Inst InCor, Sao Paulo, Brazil; [Cornel, Jan H.] Noordwest Ziekenhuisgrp Alkmaar & Dutch Network C, Dept Cardiol, Alkmaar, Netherlands; [Goto, Shinya] Tokai Univ, Sch Med, Dept Med Cardiol, Isehara, Kanagawa, Japan; [Kiss, Robert Gabor] Mil Hosp, Dept Cardiol, Budapest, Hungary; [Guray, Umit] Numune Educ & Res Hosp, Dept Cardiol, Ankara, Turkey; [Park, Duk-Woo] Univ Ulsan, Coll Med, Asan Med Ctr, Div Cardiol, Seoul, South Korea; [Bode, Christoph] Univ Freiburg, Freiburg, Germany; [Welsh, Robert C.] Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Welsh, Robert C.] Univ Alberta, Edmonton, AB, Canada; [Gibson, C. Michael] Harvard Med Sch, Beth Israel Deaconess Hosp, PERFUSE Study Grp, Boston, MA USA	Duke University; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Royal Brompton Hospital; Uppsala University; Uppsala University; Johnson & Johnson; Janssen Pharmaceuticals; Bayer AG; Aarhus University; Medical University Silesia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; IRCCS Fondazione San Matteo; Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Antwerp; Universidade de Sao Paulo; Medical Center Of Alkmaar; Tokai University; Ankara Numune Training & Research Hospital; University of Ulsan; Asan Medical Center; University of Freiburg; University of Alberta; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ohman, EM (corresponding author), Duke Univ, Med Ctr, 8676A HAFS Bldg,Box 3126 DUMC, Durham, NC 27710 USA.	ohman001@mc.duke.edu	STEG, Philippe Gabriel/Z-1567-2019; James, Stefan K/J-4554-2014; Ardissino, Diego/AAC-4041-2022; Nicolau, Jose C/E-1487-2012; Tendera, Michal/AAA-1875-2022; Rockhold, Frank W./C-7078-2019; Goto, Shinya/AAU-6045-2020; cornel, jan hein/Y-7065-2019; Welsh, Robert/ABH-3526-2021; Claeys, Marc/ABH-8781-2020; guray, umit/AAQ-9812-2021; Bueno, Hector/I-3910-2015; Gibson, C. Michael/AAE-8212-2019	Nicolau, Jose C/0000-0002-9680-3689; Rockhold, Frank W./0000-0003-3732-4765; Goto, Shinya/0000-0002-6821-1504; cornel, jan hein/0000-0002-1006-2112; Bueno, Hector/0000-0003-0277-7596; Welsh, Robert/0000-0003-2613-9142; solinas, emilia/0000-0003-3532-1317; STEG, Philippe Gabriel/0000-0001-6896-2941; Tendera, Michal/0000-0002-0812-6113	Janssen Research Development; Bayer AG	Janssen Research Development; Bayer AG(Bayer AG)	Janssen Research & Development and Bayer AG.	Alexander JH, 2011, NEW ENGL J MED, V365, P699, DOI 10.1056/NEJMoa1105819; Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; [Anonymous], 1988, LANCET, V2, P349; Becker EM, 2012, J THROMB HAEMOST, V10, P2470, DOI 10.1111/jth.12033; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Gargiulo G, 2016, CIRCULATION, V134, P1881, DOI 10.1161/CIRCULATIONAHA.116.023952; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Gibson CM, 2013, J AM COLL CARDIOL, V62, P286, DOI 10.1016/j.jacc.2013.03.041; Hicks KA, 2015, J AM COLL CARDIOL, V66, P403, DOI 10.1016/j.jacc.2014.12.018; Husted S, 2006, EUR HEART J, V27, P1038, DOI 10.1093/eurheartj/ehi754; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Mahaffey KW, 2011, CIRCULATION, V124, P544, DOI 10.1161/CIRCULATIONAHA.111.047498; Mega JL, 2009, LANCET, V374, P29, DOI 10.1016/S0140-6736(09)60738-8; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Merlini PA, 2000, ARTERIOSCL THROM VAS, V20, P2162, DOI 10.1161/01.ATV.20.9.2162; O'Gara PT, 2013, J AM COLL CARDIOL, V61, pE78, DOI [10.1016/j.jacc.2012.11.019, 10.1161/CIR.0b013e3182742cf6]; Ohman EM, 1995, EUR HEART J, V16, P50, DOI 10.1093/eurheartj/16.suppl_L.50; Perzborn E, 2015, J CARDIOVASC PHARM T, V20, P554, DOI 10.1177/1074248415578172; Povsic TJ, 2016, AM HEART J, V174, P120, DOI 10.1016/j.ahj.2016.01.004; Roe MT, 2012, NEW ENGL J MED, V366, P85, DOI 10.1056/NEJMe1112770; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Schulz S, 2009, EUR HEART J, V30, P2714, DOI 10.1093/eurheartj/ehp275; Steg PG, 2013, CIRCULATION, V128, P1055, DOI 10.1161/CIRCULATIONAHA.113.002589; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Thygesen K, 2012, GLOB HEART, V7, DOI 10.1016/j.gheart.2012.08.001; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Welsh RC, 2016, AM HEART J, V181, P92, DOI 10.1016/j.ahj.2016.08.008; Wiviott SD, 2008, LANCET, V371, P1353, DOI 10.1016/S0140-6736(08)60422-5; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	141	151	0	36	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 6	2017	389	10081					1799	1808		10.1016/S0140-6736(17)30751-1	http://dx.doi.org/10.1016/S0140-6736(17)30751-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET8KW	28325638	Green Published			2022-12-28	WOS:000400549300029
J	Coleman, RT; Struhl, G				Coleman, Rory T.; Struhl, Gary			Causal role for inheritance of H3K27me3 in maintaining the OFF state of a Drosophila HOX gene	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; POLYCOMB RESPONSE ELEMENT; SEGMENTAL DETERMINATION; EPIGENETIC INHERITANCE; STRUCTURAL BASIS; GROUP PROTEINS; IN-VIVO; COMPLEX; ULTRABITHORAX; CHROMATIN	Many eukaryotic cells can respond to transient environmental or developmental stimuli with heritable changes in gene expression that are associated with nucleosome modifications. However, it remains uncertain whether modified nucleosomes play a causal role in transmitting such epigenetic memories, as opposed to controlling or merely reflecting transcriptional states inherited by other means. Here, we provide in vivo evidence that H3K27 trimethylated nucleosomes, once established at a repressed Drosophila HOX gene, remain heritably associated with that gene and can carry the memory of the silenced state through multiple rounds of replication, even when the capacity to copy the H3K27me3 mark to newly incorporated nucleosomes is diminished or abolished. Hence, in this context, the inheritance of H3K27 trimethylation conveys epigenetic memory.	[Coleman, Rory T.; Struhl, Gary] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 West 168th St, New York, NY 10032 USA	Columbia University	Struhl, G (corresponding author), Columbia Univ Coll Phys & Surg, Dept Genet & Dev, 701 West 168th St, New York, NY 10032 USA.	gs20@columbia.edu		, Rory/0000-0003-3007-066X	Howard Hughes Medical Institute Investigatorship; NIH [R01 GM113000, 5T32GM007088, T32DK07328]; Ellison Medical Foundation Senior Scholar Award [AG-SS-2923-11]; Bloomington Stock Center [NIH P40OD018537]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113000, T32GM007088] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Howard Hughes Medical Institute Investigatorship(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation Senior Scholar Award(Lawrence Ellison Foundation); Bloomington Stock Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Bienz and T. Patel for early help with assessing the >EE>UZand>PRE>UZ transgenes; A. Adachi and C. Tao for technical assistance; and J. Muller, M. Ptashne, K. Struhl, R. Mann, and I. Greenwald for advice and discussion. We thank P. Macdonald and R. Mann for the alpha Hb and alpha DII antisera; V. Pirrotta for the esc6 escl<SUP>-</SUP> double mutation; J. Muller for the Df(2L)HisC, 3XHisGU<SUP>wt</SUP> 3XHisGU<SUP>wt</SUP>, and 3XHisGU<SUP>K27R</SUP> 3XHisGU<SUP>K27R</SUP> transgenes; D. McKay for the 12XHis<SUP>wt</SUP> and 8XHis<SUP>H3K27R</SUP> transgenes; H. Krause for the phm.Gal4 and UAS.fh-RNAi transgenes; and J. Parker for the phm. LexA and LexO.fhRNAi transgenes. This work was funded by a Howard Hughes Medical Institute Investigatorship; NIH R01 GM113000; Ellison Medical Foundation Senior Scholar Award AG-SS-2923-11; NIH training grants 5T32GM007088 and T32DK07328; and Bloomington Stock Center grant NIH P40OD018537.	Alabert C, 2015, GENE DEV, V29, P585, DOI 10.1101/gad.256354.114; Alon U., 2006, INTRO SYSTEMS BIOL D; Anderson PR, 2005, HUM MOL GENET, V14, P3397, DOI 10.1093/hmg/ddi367; Audergon PNCB, 2015, SCIENCE, V348, P132, DOI 10.1126/science.1260638; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Beuchle D, 2001, DEVELOPMENT, V128, P993; BIENZ L, 1995, BIOESSAYS, V17, P775, DOI 10.1002/bies.950170907; Bintu L, 2016, SCIENCE, V351, P720, DOI 10.1126/science.aab2956; Birve A, 2001, DEVELOPMENT, V128, P3371; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Braveman Melissa W., 2004, V277, P261; Busturia A, 1997, DEVELOPMENT, V124, P4343; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; CASANOVA J, 1985, CELL, V42, P663, DOI 10.1016/0092-8674(85)90123-0; CHAN CS, 1994, EMBO J, V13, P2553, DOI 10.1002/j.1460-2075.1994.tb06545.x; CHRISTEN B, 1994, MECH DEVELOP, V48, P255, DOI 10.1016/0925-4773(94)90064-7; Copur O, 2013, DEVELOPMENT, V140, P3478, DOI 10.1242/dev.097204; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Deal RB, 2010, SCIENCE, V328, P1161, DOI 10.1126/science.1186777; Estella C, 2008, DEV CELL, V14, P86, DOI 10.1016/j.devcel.2007.11.002; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Gaydos LJ, 2014, SCIENCE, V345, P1515, DOI 10.1126/science.1255023; GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025; Gunesdogan U, 2010, EMBO REP, V11, P772, DOI 10.1038/embor.2010.124; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Henikoff S, 2016, CURR BIOL, V26, pR644, DOI 10.1016/j.cub.2016.06.011; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lanzuolo C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002370; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Martin FA, 2009, DEVELOPMENT, V136, P3747, DOI 10.1242/dev.038406; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McKay DJ, 2015, DEV CELL, V32, P373, DOI 10.1016/j.devcel.2014.12.025; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Moazed D, 2011, CELL, V146, P510, DOI 10.1016/j.cell.2011.07.013; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; OCHMAN H, 1988, GENETICS, V120, P621; Ohno K, 2008, MECH DEVELOP, V125, P527, DOI 10.1016/j.mod.2008.01.002; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Parker J, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002274; PEIFER M, 1986, EMBO J, V5, P2293, DOI 10.1002/j.1460-2075.1986.tb04497.x; Pengelly AR, 2013, SCIENCE, V339, P698, DOI 10.1126/science.1231382; Petruk S, 2012, CELL, V150, P922, DOI 10.1016/j.cell.2012.06.046; PIRROTTA V, 1995, GENETICS, V141, P1439; Pirrotta V, 2012, CURR OPIN GENET DEV, V22, P101, DOI 10.1016/j.gde.2011.11.004; Ptashne M, 2013, P NATL ACAD SCI USA, V110, P7101, DOI 10.1073/pnas.1305399110; Ptashne M, 2011, NAT CHEM BIOL, V7, P484, DOI 10.1038/nchembio.611; Ragunathan K, 2015, SCIENCE, V348, DOI 10.1126/science.1258699; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; SIMON J, 1993, DEV BIOL, V158, P131, DOI 10.1006/dbio.1993.1174; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Steffen PA, 2013, NUCLEIC ACIDS RES, V41, P5235, DOI 10.1093/nar/gkt217; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; STRUHL G, 1985, EMBO J, V4, P3259, DOI 10.1002/j.1460-2075.1985.tb04075.x; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; STRUHL G, 1982, CELL, V31, P285, DOI 10.1016/0092-8674(82)90428-7; Xu M, 2012, EMBO REP, V13, P60, DOI 10.1038/embor.2011.206; ZHANG CC, 1992, P NATL ACAD SCI USA, V89, P7511, DOI 10.1073/pnas.89.16.7511; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26	71	120	123	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2017	356	6333							eaai8236	10.1126/science.aai8236	http://dx.doi.org/10.1126/science.aai8236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER3IA	28302795	Green Accepted			2022-12-28	WOS:000398689100030
J	Halpern, KB; Shenhav, R; Matcovitch-Natan, O; Toth, B; Lemze, D; Golan, M; Massasa, EE; Baydatch, S; Landen, S; Moor, AE; Brandis, A; Giladi, A; Stokar-Avihail, A; David, E; Amit, I; Itzkovitz, S				Halpern, Keren Bahar; Shenhav, Rom; Matcovitch-Natan, Orit; Toth, Beata; Lemze, Doron; Golan, Matan; Massasa, Efi E.; Baydatch, Shaked; Landen, Shanie; Moor, Andreas E.; Brandis, Alexander; Giladi, Amir; Stokar-Avihail, Avigail; David, Eyal; Amit, Ido; Itzkovitz, Shalev			Single-cell spatial reconstruction reveals global division of labour in the mammalian liver (vol 542, pg 352, 2017)	NATURE			English	Correction																		Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065	1	9	8	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647								10.1038/nature21729	http://dx.doi.org/10.1038/nature21729			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28297709	Bronze			2022-12-28	WOS:000397619700063
J	Nowak, MA; Waclaw, B				Nowak, Martin A.; Waclaw, Bartlomiej			CANCER Genes, environment, and "bad luck"	SCIENCE			English	Editorial Material							STEM-CELL DIVISIONS; EVOLUTIONARY DYNAMICS; RISK		[Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Waclaw, Bartlomiej] Univ Edinburgh, Sch Phys & Astron, Edinburgh, Midlothian, Scotland	Harvard University; University of Edinburgh	Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.		Waclaw, Bartek/F-8928-2012; Waclaw, Bartlomiej/N-5818-2019	Waclaw, Bartek/0000-0001-5355-7994; Waclaw, Bartlomiej/0000-0001-5355-7994				Altrock PM, 2015, NAT REV CANCER, V15, P730, DOI 10.1038/nrc4029; Frank SA, 2003, GENETICS, V163, P1527; Lieberman E, 2005, NATURE, V433, P312, DOI 10.1038/nature03204; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Noble R, 2016, CANCER PREV RES, V9, P773, DOI 10.1158/1940-6207.CAPR-16-0126; Noble R, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0104; Nowak MA, 2004, P NATL ACAD SCI USA, V101, P10635, DOI 10.1073/pnas.0400747101; Nowak MA, 2003, P NATL ACAD SCI USA, V100, P14966, DOI 10.1073/pnas.2535419100; Nunney L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2015.0161; Sornette D, 2015, EPJ NONLINEAR BIOMED, V3, DOI 10.1140/epjnbp/s40366-015-0026-0; Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011; Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825; Weinberg CR, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv125; Wodarz D, 2014, DYNAMICS CANC MATH F; Wu S, 2016, NATURE, V529, P43, DOI 10.1038/nature16166	15	29	31	4	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1266	1267		10.1126/science.aam9746	http://dx.doi.org/10.1126/science.aam9746			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336626				2022-12-28	WOS:000397082900019
J	Salje, H; Lessler, J; Berry, IM; Melendrez, MC; Endy, T; Kalayanarooj, S; A-Nuegoonpipat, A; Chanama, S; Sangkijporn, S; Klungthong, C; Thaisomboonsuk, B; Nisalak, A; Gibbons, RV; Iamsirithaworn, S; Macareo, LR; Yoon, IK; Sangarsang, A; Jarman, RG; Cummings, DAT				Salje, Henrik; Lessler, Justin; Berry, Irina Maljkovic; Melendrez, Melanie C.; Endy, Timothy; Kalayanarooj, Siripen; A-Nuegoonpipat, Atchareeya; Chanama, Sumalee; Sangkijporn, Somchai; Klungthong, Chonticha; Thaisomboonsuk, Butsaya; Nisalak, Ananda; Gibbons, Robert V.; Iamsirithaworn, Sopon; Macareo, Louis R.; Yoon, In-Kyu; Sangarsang, Areerat; Jarman, Richard G.; Cummings, Derek A. T.			DENGUE VIRUS Dengue diversity across spatial and temporal scales: Local structure and the effect of host population size	SCIENCE			English	Article							KAMPHAENG-PHET; TRANSMISSION; BURDEN; SPREAD; MIGRATION; DYNAMICS; CHILDREN; DISEASE; WAVES	A fundamental mystery for dengue and other infectious pathogens is how observed patterns of cases relate to actual chains of individual transmission events. These pathways are intimately tied to the mechanisms by which strains interact and compete across spatial scales. Phylogeographic methods have been used to characterize pathogen dispersal at global and regional scales but have yielded few insights into the local spatiotemporal structure of endemic transmission. Using geolocated genotype (800 cases) and serotype (17,291 cases) data, we show that in Bangkok, Thailand, 60% of dengue cases living <200 meters apart come from the same transmission chain, as opposed to 3% of cases separated by 1 to 5 kilometers. At distances <200 meters from a case (encompassing an average of 1300 people in Bangkok), the effective number of chains is 1.7. This number rises by a factor of 7 for each 10-fold increase in the population of the "enclosed" region. This trend is observed regardless of whether population density or area increases, though increases in density over 7000 people per square kilometer do not lead to additional chains. Within Thailand these chains quickly mix, and by the next dengue season viral lineages are no longer highly spatially structured within the country. In contrast, viral flow to neighboring countries is limited. These findings are consistent with local, density-dependent transmission and implicate densely populated communities as key sources of viral diversity, with home location the focal point of transmission. These findings have important implications for targeted vector control and active surveillance.	[Salje, Henrik; Lessler, Justin; Cummings, Derek A. T.] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Salje, Henrik] Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France; [Salje, Henrik] CNRS, URA3012, F-75015 Paris, France; [Salje, Henrik] Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France; [Berry, Irina Maljkovic; Melendrez, Melanie C.; Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA; [Endy, Timothy] Upstate Med Univ New York, Dept Med, Syracuse, NY 13210 USA; [Kalayanarooj, Siripen] Queen Sirikit Natl Inst Child Hlth, Bangkok, Thailand; [A-Nuegoonpipat, Atchareeya; Chanama, Sumalee; Sangkijporn, Somchai; Sangarsang, Areerat] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Klungthong, Chonticha; Thaisomboonsuk, Butsaya; Nisalak, Ananda; Gibbons, Robert V.; Macareo, Louis R.; Yoon, In-Kyu] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand; [Iamsirithaworn, Sopon] Minist Publ Hlth, Dept Dis Control, Nonthaburi, Thailand; [Yoon, In-Kyu] Int Vaccine Inst, Seoul, South Korea; [Cummings, Derek A. T.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Cummings, Derek A. T.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Ministry of Public Health - Thailand; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Ministry of Public Health - Thailand; International Vaccine Institute; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Salje, H; Lessler, J; Cummings, DAT (corresponding author), Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.; Salje, H (corresponding author), Inst Pasteur, Math Modelling Infect Dis Unit, Paris, France.; Salje, H (corresponding author), CNRS, URA3012, F-75015 Paris, France.; Salje, H (corresponding author), Inst Pasteur, Ctr Bioinformat Biostat & Integrat Biol, F-75015 Paris, France.; Cummings, DAT (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.; Cummings, DAT (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32610 USA.	henrik.salje@pasteur.fr; justin@jhu.edu; datc@ufl.edu		Melendrez, Melanie/0000-0002-4811-4467; Salje, Henrik/0000-0003-3626-4254; Kalayanarooj, Siripen/0000-0002-3568-0929; Lessler, Justin/0000-0002-9741-8109; Maljkovic Berry, Irina/0000-0001-8555-5352; a-nuegoonpipat, atchareeya/0000-0003-1597-8944	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102939, R01AI114703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI114703, R01 AI102939] Funding Source: Medline; NIGMS NIH HHS [U54 GM088491] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allicock OM, 2012, MOL BIOL EVOL, V29, P1533, DOI 10.1093/molbev/msr320; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138; Churcher TS, 2014, SCIENCE, V344, P1230, DOI 10.1126/science.1251449; Dorigatti I, 2013, P NATL ACAD SCI USA, V110, P13422, DOI 10.1073/pnas.1303117110; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; Faria NR, 2014, SCIENCE, V346, P56, DOI 10.1126/science.1256739; Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590; Halstead S. B, 2008, DENGUE; Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209; Jarman RG, 2008, J VIROL, V82, P5494, DOI 10.1128/JVI.02728-07; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Nelson MI, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7696; Nisalak A, 2003, AM J TROP MED HYG, V68, P191, DOI 10.4269/ajtmh.2003.68.191; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642; Rabaa MA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001990; Read JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0268; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Salje H, 2016, P NATL ACAD SCI USA, V113, P13420, DOI 10.1073/pnas.1611391113; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Stack JC, 2010, J R SOC INTERFACE, V7, P1119, DOI 10.1098/rsif.2009.0530; Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; van Panhuis WG, 2015, P NATL ACAD SCI USA, V112, P13069, DOI 10.1073/pnas.1501375112; Vu TTH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000757; Yoon IK, 2012, J INFECT DIS, V206, P389, DOI 10.1093/infdis/jis357	31	85	86	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1302	+		10.1126/science.aaj9384	http://dx.doi.org/10.1126/science.aaj9384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336667	Green Accepted			2022-12-28	WOS:000397082900037
J	Huang, KC				Huang, Kerwyn Casey			Staying in Touch while on the Go (vol 168, pg 15, 2017)	CELL			English	Correction												kchuang@stanford.edu						Huang KC, 2017, CELL, V168, P15, DOI 10.1016/j.cell.2016.12.024	1	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					174	175		10.1016/j.cell.2017.03.015	http://dx.doi.org/10.1016/j.cell.2017.03.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340342	Bronze			2022-12-28	WOS:000397090000017
J	Koratala, A; Bhatti, V				Koratala, Abhilash; Bhatti, Vikrampal			Incidental Finding of Oleothorax	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Koratala, Abhilash; Bhatti, Vikrampal] Univ Florida, Coll Med, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Koratala, A (corresponding author), Univ Florida, Coll Med, Gainesville, FL 32611 USA.	akoratsla@ufl.edu	Koratala, Abhilash/H-8482-2019; Koratala, Abhilash/AAE-9605-2021	Koratala, Abhilash/0000-0001-5801-3574; Koratala, Abhilash/0000-0001-5801-3574					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					E21	E21		10.1056/NEJMicm1609176	http://dx.doi.org/10.1056/NEJMicm1609176			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28328345				2022-12-28	WOS:000397014300002
J	Phillips, N				Phillips, Nicky			STRIVING FOR A RESEARCH RENAISSANCE	NATURE			English	Editorial Material																			0	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					S7	S7		10.1038/543S7a	http://dx.doi.org/10.1038/543S7a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO9OM	28328914	Bronze			2022-12-28	WOS:000397018000003
J	Sengupta, A; Carrara, F; Stocker, R				Sengupta, Anupam; Carrara, Francesco; Stocker, Roman			Phytoplankton can actively diversify their migration strategy in response to turbulent cues	NATURE			English	Article							SMALL-SCALE TURBULENCE; MARINE-PHYTOPLANKTON; MOTILE MICROORGANISMS; HETEROSIGMA-AKASHIWO; VERTICAL MIGRATION; NITRIC-OXIDE; COMMUNITY; HARMFUL; ENVIRONMENT; MORPHOLOGY	Marine phytoplankton inhabit a dynamic environment where turbulence, together with nutrient and light availability, shapes species fitness, succession and selection(1,2). Many species of phytoplankton are motile and undertake diel vertical migrations to gain access to nutrient-rich deeper layers at night and well-lit surface waters during the day(3,4). Disruption of this migratory strategy by turbulence is considered to be an important cause of the succession between motile and non-motile species when conditions turn turbulent(1,5,)6. However, this classical view neglects the possibility that motile species may actively respond to turbulent cues to avoid layers of strong turbulence(7). Here we report that phytoplankton, including raphidophytes and dinoflagellates, can actively diversify their migratory strategy in response to hydrodynamic cues characteristic of overturning by Kolmogorov-scale eddies. Upon experiencing repeated overturning with timescales and statistics representative of ocean turbulence, an upward-swimming population rapidly (5-60 min) splits into two subpopulations, one swimming upward and one swimming downward. Quantitative morphological analysis of the harmful-algal-bloom-forming raphidophyte Heterosigma akashiwo together with a model of cell mechanics revealed that this behaviour was accompanied by a modulation of the cells' fore-aft asymmetry. The minute magnitude of the required modulation, sufficient to invert the preferential swimming direction of the cells, highlights the advanced level of control that phytoplankton can exert on their migratory behaviour. Together with observations of enhanced cellular stress after overturning and the typically deleterious effects of strong turbulence on motile phytoplankton(5,8), these results point to an active adaptation of H. akashiwo to increase the chance of evading turbulent layers by diversifying the direction of migration within the population, in a manner suggestive of evolutionary bet-hedging. This migratory behaviour relaxes the boundaries between the fluid dynamic niches of motile and non-motile phytoplankton, and highlights that rapid responses to hydrodynamic cues are important survival strategies for phytoplankton in the ocean.	[Sengupta, Anupam; Carrara, Francesco; Stocker, Roman] Swiss Fed Inst Technol, Inst Environm Engn, Dept Civil Environm & Geomat Engn, CH-8093 Zurich, Switzerland; [Sengupta, Anupam; Carrara, Francesco; Stocker, Roman] MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT)	Stocker, R (corresponding author), Swiss Fed Inst Technol, Inst Environm Engn, Dept Civil Environm & Geomat Engn, CH-8093 Zurich, Switzerland.; Stocker, R (corresponding author), MIT, Dept Civil & Environm Engn, Ralph M Parsons Lab, Cambridge, MA 02139 USA.	romanstocker@ethz.ch	Sengupta, Anupam/AAO-1025-2020; Stocker, Roman/N-8987-2019; Stocker, Roman/T-9456-2017	Stocker, Roman/0000-0002-3199-0508; Sengupta, Anupam/0000-0001-5592-7864	Human Frontier Science Program Cross Disciplinary Fellowship [LT000993/2014-C]; Swiss National Science Foundation; Gordon and Betty Moore Marine Microbial Initiative [GBMF 3783]	Human Frontier Science Program Cross Disciplinary Fellowship(Human Frontier Science Program); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gordon and Betty Moore Marine Microbial Initiative	We thank M. Ackermann for input on bet-hedging, G. Boffetta and M. Cencini for sharing the direct numerical simulations data, S. Menden-Deuer for providing H. akashiwo CCMP3107 and for discussions, E. Berdalet, A. Vardi, D. Anderson and D. J. McGillicuddy for suggestions, and M. Barry for initial development of the flip chamber. This work was partially supported by a Human Frontier Science Program Cross Disciplinary Fellowship (LT000993/2014-C to A. S.), a Swiss National Science Foundation Early Postdoc Mobility Fellowship (to F.C.), and a Gordon and Betty Moore Marine Microbial Initiative Investigator Award (GBMF 3783 to R.S.).	Ackermann M, 2015, NAT REV MICROBIOL, V13, P497, DOI 10.1038/nrmicro3491; Barton AD, 2010, SCIENCE, V327, P1509, DOI 10.1126/science.1184961; Berdalet E, 2007, J PHYCOL, V43, P965, DOI 10.1111/j.1529-8817.2007.00392.x; Bollens SM, 2011, J PLANKTON RES, V33, P349, DOI 10.1093/plankt/fbq152; Bouchard JN, 2008, PLANT CELL PHYSIOL, V49, P641, DOI 10.1093/pcp/pcn037; Brun P, 2015, LIMNOL OCEANOGR, V60, P1020, DOI 10.1002/lno.10074; BULMER MG, 1985, AM NAT, V126, P63, DOI 10.1086/284396; Durham WM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3148; Durham WM, 2009, SCIENCE, V323, P1067, DOI 10.1126/science.1167334; FOSTER KW, 1980, MICROBIOL REV, V44, P572, DOI 10.1128/MMBR.44.4.572-630.1980; Franks P. J. S., 2015, J MAR SCI, V72, P1; Guasto JS, 2012, ANNU REV FLUID MECH, V44, P373, DOI 10.1146/annurev-fluid-120710-101156; Gurarie E, 2011, B MATH BIOL, V73, P1358, DOI 10.1007/s11538-010-9575-7; Happel J., 1983, MECH FLUIDS TRANSPOR, V1; HARA Y, 1987, BOT MAG TOKYO, V100, P151, DOI 10.1007/BF02488320; Harvey EL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01277; Hemmersbach R, 1999, J PLANT PHYSIOL, V154, P1; KOENIG SH, 1975, BIOPOLYMERS, V14, P2421, DOI 10.1002/bip.1975.360141115; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Lozovatsky I, 2015, J GEOPHYS RES-OCEANS, V120, P1856, DOI 10.1002/2014JC010596; MARGALEF R, 1978, OCEANOL ACTA, V1, P493; Milo R., 2016, CELL BIOL NUMBERS; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; Ouellette NT, 2006, EXP FLUIDS, V40, P301, DOI 10.1007/s00348-005-0068-7; ROBERTS AM, 1970, J EXP BIOL, V53, P687; Roberts AM, 2002, J FLUID MECH, V452, P405, DOI 10.1017/S0022112001006772; Schuech R., 2014, LIMNOL OCEANOGR FLUI, V4, P1, DOI [10.1215/21573689-2647998, DOI 10.1215/21573689-2647998]; Smayda TJ, 2010, PROG OCEANOGR, V85, P71, DOI 10.1016/j.pocean.2010.02.005; Smayda TJ, 2001, J PLANKTON RES, V23, P447, DOI 10.1093/plankt/23.5.447; Sullivan JM, 2003, HARMFUL ALGAE, V2, P183, DOI 10.1016/S1568-9883(03)00039-8; Sverdrup H.U., 1953, J CONSEILCONSEIL PER, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; THOMAS W H, 1990, Journal of Applied Phycology, V2, P71, DOI 10.1007/BF02179771; Thorpe S.A, 2007, INTRO OCEAN TURBULEN; Vardi A, 2008, CURR BIOL, V18, P895, DOI 10.1016/j.cub.2008.05.037; Villareal TA, 2003, MICROB ECOL, V45, P1, DOI 10.1007/s00248-002-1012-5; WADA M, 1985, PLANT CELL PHYSIOL, V26, P431, DOI 10.1093/oxfordjournals.pcp.a076926; Yamasaki Y, 2009, ISME J, V3, P808, DOI 10.1038/ismej.2009.24; Zirbel MJ, 2000, J PHYCOL, V36, P46, DOI 10.1046/j.1529-8817.2000.98088.x	39	71	75	3	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					555	+		10.1038/nature21415	http://dx.doi.org/10.1038/nature21415			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28297706	Green Published			2022-12-28	WOS:000397018000052
J	Limb, M				Limb, Matt			Margaret Mungherera OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												limb@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 22	2017	356								j1361	10.1136/bmj.j1361	http://dx.doi.org/10.1136/bmj.j1361			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP4IW	28330881				2022-12-28	WOS:000397345200004
J	Chen, RC; Basak, R; Meyer, AM; Kuo, TM; Carpenter, WR; Agans, RP; Broughman, JR; Reeve, BB; Nielsen, ME; Usinger, DS; Spearman, KC; Walden, S; Kaleel, D; Anderson, M; Sturmer, T; Godley, PA				Chen, Ronald C.; Basak, Ramsankar; Meyer, Anne-Marie; Kuo, Tzy-Mey; Carpenter, William R.; Agans, Robert P.; Broughman, James R.; Reeve, Bryce B.; Nielsen, Matthew E.; Usinger, Deborah S.; Spearman, Kiayni C.; Walden, Sarah; Kaleel, Dianne; Anderson, Mary; Sturmer, Til; Godley, Paul A.			Association Between Choice of Radical Prostatectomy, External Beam Radiotherapy, Brachytherapy, or Active Surveillance and Patient-Reported Quality of Life Among Men With Localized Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRACTICE PATTERNS; OUTCOMES; SURVIVORSHIP; URINARY; DESIGN; SCORES	IMPORTANCE Patients diagnosed with localized prostate cancer have to decide among treatment strategies that may differ in their likelihood of adverse effects. OBJECTIVE To compare quality of life (QOL) after radical prostatectomy, external beam radiotherapy, and brachytherapy vs active surveillance. DESIGN, SETTING, AND PARTICIPANTS Population-based prospective cohort of 1141 men (57% participation among eligible men) with newly diagnosed prostate cancer were enrolled from January 2011 through June 2013 in collaboration with the North Carolina Central Cancer Registry. Median time from diagnosis to enrollment was 5 weeks, and all men were enrolled with written informed consent prior to treatment. Final follow-up date for current analysis was September 9, 2015. EXPOSURES Treatment with radical prostatectomy, external beam radiotherapy, brachytherapy, or active surveillance. MAIN OUTCOMES AND MEASURES Quality of life using the validated instrument Prostate Cancer Symptom Indices was assessed at baseline (pretreatment) and 3, 12, and 24 months after treatment. The instrument contains 4 domains-sexual dysfunction, urinary obstruction and irritation, urinary incontinence, and bowel problems-each scored from 0 (no dysfunction) to 100 (maximum dysfunction). Propensity-weighted mean domain scores were compared between each treatment group vs active surveillance at each time point. RESULTS Of 1141 enrolled men, 314 pursued active surveillance (27.5%), 469 radical prostatectomy (41.1%), 249 external beam radiotherapy (21.8%), and 109 brachytherapy (9.6%). After propensity weighting, median age was 66 to 67 years across groups, and 77% to 80% of participants were white. Across groups, propensity-weighted mean baseline scores were 41.8 to 46.4 for sexual dysfunction, 20.8 to 22.8 for urinary obstruction and irritation, 9.7 to 10.5 for urinary incontinence, and 5.7 to 6.1 for bowel problems. Compared with active surveillance, mean sexual dysfunction scores worsened by 3 months for patients who received radical prostatectomy (36.2 [95% CI, 30.4-42.0]), external beam radiotherapy (13.9 [95% CI, 6.7-21.2]), and brachytherapy (17.1 [95% CI, 7.8-26.6]). Compared with active surveillance at 3 months, worsened urinary incontinence was associated with radical prostatectomy (33.6 [95% CI, 27.8-39.2]); acute worsening of urinary obstruction and irritation with external beam radiotherapy (11.7 [95% CI, 8.7-14.8]) and brachytherapy (20.5 [95% CI, 15.1-25.9]); and worsened bowel symptoms with external beam radiotherapy (4.9 [95% CI, 2.4-7.4]). By 24 months, mean scores between treatment groups vs active surveillance were not significantly different in most domains. CONCLUSIONS AND RELEVANCE In this cohort ofmenwith localized prostate cancer, each treatment strategywas associated with distinct patterns of adverse effects over 2 years. These findings can be used to promote treatment decisions that incorporate individual preferences.	[Chen, Ronald C.; Basak, Ramsankar; Broughman, James R.] Univ North Carolina Chapel Hill, Dept Radiat Oncol, CB 7512,101 Manning Dr, Chapel Hill, NC 27599 USA; [Chen, Ronald C.; Meyer, Anne-Marie; Kuo, Tzy-Mey; Carpenter, William R.; Reeve, Bryce B.; Nielsen, Matthew E.; Usinger, Deborah S.; Spearman, Kiayni C.; Walden, Sarah; Kaleel, Dianne; Sturmer, Til; Godley, Paul A.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Chen, Ronald C.; Nielsen, Matthew E.] Univ North Carolina Chapel Hill, Cecil G Sheps Ctr Hlth Serv Res, Chapel Hill, NC USA; [Meyer, Anne-Marie; Sturmer, Til] Univ North Carolina Chapel Hill, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Agans, Robert P.] Univ North Carolina Chapel Hill, Carolina Survey Res Lab, Chapel Hill, NC USA; [Reeve, Bryce B.; Nielsen, Matthew E.] Univ North Carolina Chapel Hill, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Nielsen, Matthew E.] Univ North Carolina Chapel Hill, Dept Urol, Chapel Hill, NC USA; [Anderson, Mary] Prostate Canc Coalit North Carolina, Patient Stakeholder, Raleigh, NC USA; [Godley, Paul A.] Univ North Carolina Chapel Hill, Div Hematol & Oncol, Dept Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Chen, RC (corresponding author), Univ North Carolina Chapel Hill, Dept Radiat Oncol, CB 7512,101 Manning Dr, Chapel Hill, NC 27599 USA.	ronald_chen@med.unc.edu	Stürmer, Til/AAB-5459-2022; Reeve, Bryce/AAE-7657-2019; Basak, Ramsankar/I-4131-2018; Carpenter, William/E-5125-2013	Basak, Ramsankar/0000-0001-6665-0370; 	Patient-Centered Outcomes Research Institute (PCORI) [CER-1310-06453]; Agency for Healthcare Research and Quality; Integrated Cancer Information and Surveillance System; University of North Carolina Lineberger Comprehensive Cancer Center; University Cancer Research Fund via the state of North Carolina	Patient-Centered Outcomes Research Institute (PCORI)(Patient-Centered Outcomes Research Institute - PCORI); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Integrated Cancer Information and Surveillance System; University of North Carolina Lineberger Comprehensive Cancer Center; University Cancer Research Fund via the state of North Carolina	This article was funded by a Patient-Centered Outcomes Research Institute (PCORI) grant CER-1310-06453 and a contract from the Agency for Healthcare Research and Quality; the Integrated Cancer Information and Surveillance System; University of North Carolina Lineberger Comprehensive Cancer Center; and the University Cancer Research Fund via the state of North Carolina.	Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Chang P, 2017, J UROLOGY, V197, P376, DOI 10.1016/j.juro.2016.08.101; Chen RC, 2016, J CLIN ONCOL, V34, P2182, DOI 10.1200/JCO.2015.65.7759; Chen RC, 2015, J COMP EFFECT RES, V4, P3, DOI 10.2217/cer.14.67; Chen RC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju132; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Clark JA, 2001, MED CARE, V39, P1118, DOI 10.1097/00005650-200110000-00009; Donovan JL, 2016, NEW ENGL J MED, V375, P1425, DOI 10.1056/NEJMoa1606221; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Lowrance WT, 2012, J UROLOGY, V187, P2087, DOI 10.1016/j.juro.2012.01.061; Martin NE, 2015, EUR UROL, V67, P460, DOI 10.1016/j.eururo.2014.08.075; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mushlin AI, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0912651; Norman Geoffrey R, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P581, DOI 10.1586/14737167.4.5.581; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Oberlin DT, 2016, UROL ONCOL-SEMIN ORI, V34, DOI 10.1016/j.urolonc.2016.01.008; Potosky AL, 1999, JNCI-J NATL CANCER I, V91, P1719, DOI 10.1093/jnci/91.20.1719; Safdieh J, 2016, J CONTEMP BRACHYTHER, V8, P289, DOI 10.5114/jcb.2016.61942; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Sheets NC, 2012, JAMA-J AM MED ASSOC, V307, P1611, DOI 10.1001/jama.2012.460; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; Sturmer T, 2014, J INTERN MED, V275, P570, DOI 10.1111/joim.12197; Talcott JA, 2006, J UROLOGY, V176, P1563; Talcott JA, 2006, J UROLOGY, V176, P1558, DOI 10.1016/j.juro.2006.06.067; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wilt Timothy J., 2012, Journal of the National Cancer Institute Monographs, P184, DOI 10.1093/jncimonographs/lgs041; Wright JG, 2003, MED CARE, V41, P597, DOI 10.1097/00005650-200305000-00006; Yaxley JW, 2016, LANCET, V388, P1057, DOI 10.1016/S0140-6736(16)30592-X	29	199	204	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1141	1150		10.1001/jama.2017.1652	http://dx.doi.org/10.1001/jama.2017.1652			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324092	Green Accepted, Green Published			2022-12-28	WOS:000396987200018
J	Voelker, R				Voelker, Rebecca			First Corticosteroid Approved for Duchenne Muscular Dystrophy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1110	1110		10.1001/jama.2017.1773	http://dx.doi.org/10.1001/jama.2017.1773			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324076				2022-12-28	WOS:000396987200009
J	Young, VB				Young, Vincent B.			The role of the microbiome in human health and disease: an introduction for clinicians	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOTA; INTESTINAL MICROBIOTA; ULCERATIVE-COLITIS; LUNG INFLAMMATION; AIRWAY MICROBIOME; CROHNS-DISEASE; MOUSE MODELS; CLOSTRIDIUM; TRANSPLANTATION	Research into the microbiome-the indigenous microbial communities (microbiota) and the host environment that they inhabit-has changed clinicians' ideas about microbes in human health and disease. Perhaps the most radical change is the realization that most of the microbes that inhabit our body supply crucial ecosystem services that benefit the entire host-microbe system. These services include the production of important resources, bioconversion of nutrients, and protection against pathogenic microbes. Thus disease can result from a loss of beneficial functions or the introduction of maladaptive functions by invading microbes. This review will show how an understanding of the dynamics and function of the indigenous microbiota has altered our view of microbes in maintaining homeostasis and causing disease. It will discuss how disruption of the beneficial functions of the microbiota can lead to disease. Methods for studying the microbiota will be introduced as part of a conceptual framework for using these methods to delineate novel roles for microbes in health. Key associations between specific changes in the microbiome and disease will be discussed. This will lead to an explanation of how the intentional manipulation of the microbiota, either by restoring missing functions or eliminating harmful functions, may lead to novel methods to prevent or treat a variety of diseases. With the explosion of studies relating the microbiome to health and disease, this review aims to provide a foundation for clinicians to follow this developing area of biomedical research.	[Young, Vincent B.] Univ Michigan, Sch Med, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Young, VB (corresponding author), Univ Michigan, Sch Med, Div Infect Dis, Dept Internal Med, Ann Arbor, MI 48109 USA.	youngvi@umich.edu	Young, Vincent B/B-3179-2009; Young, Vincent Bensan/M-9916-2019	Young, Vincent B/0000-0003-3687-2364; Young, Vincent Bensan/0000-0003-3687-2364	Merck; Sharp Dohme; Vedanta Biosciences; MedImmune	Merck(Merck & Company); Sharp Dohme; Vedanta Biosciences; MedImmune(AstraZenecaMedimmune)	I have read and understood BMJ policy on declaration of interests and declare that I have received money for consultancy work from Merck, Sharp & Dohme, Vedanta Biosciences, and MedImmune and have received a research grant from MedImmune.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; Alawad AS, 2016, DIGEST DIS SCI, V61, P3395, DOI 10.1007/s10620-016-4334-8; Allen SJ, 2013, LANCET, V382, P1249, DOI 10.1016/S0140-6736(13)61218-0; Allen-Vercoe E, 2013, CURR OPIN MICROBIOL, V16, P625, DOI 10.1016/j.mib.2013.09.008; Anderson M, 2016, AM J RHINOL ALLERGY, V30, P161, DOI 10.2500/ajra.2016.30.4320; Bajaj JS, 2016, ALIMENT PHARM THER, V43, P11, DOI 10.1111/apt.13435; BARTLETT JG, 1977, J INFECT DIS, V136, P701, DOI 10.1093/infdis/136.5.701; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; Bassis C, 2013, HUMAN MICROBIOTA: HOW MICROBIAL COMMUNITIES AFFECT HEALTH AND DISEASE, P51; Bassis CM, 2015, MBIO, V6, DOI 10.1128/mBio.00037-15; Bjerrum JT, 2015, METABOLOMICS, V11, P122, DOI 10.1007/s11306-014-0677-3; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Brandl K, 2008, NATURE, V455, P804, DOI 10.1038/nature07250; Brandt LJ, 2015, J CLIN GASTROENTEROL, V49, pS65, DOI 10.1097/MCG.0000000000000346; Carmody Lisa A, 2013, Ann Am Thorac Soc, V10, P179, DOI 10.1513/AnnalsATS.201211-107OC; Casadevall A, 2015, INFECT IMMUN, V83, P2, DOI 10.1128/IAI.02627-14; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Cockburn DW, 2016, J MOL BIOL, V428, P3230, DOI 10.1016/j.jmb.2016.06.021; Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523; Cope EK, 2016, INT FORUM ALLERGY RH, V6, P1229, DOI 10.1002/alr.21819; Debelius J, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1086-x; Di Bella JM, 2013, J MICROBIOL METH, V95, P401, DOI 10.1016/j.mimet.2013.08.011; Dickson RP, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.113, 10.1038/NMICROBIOL.2016.113]; Duffy LC, 2015, J NUTR, V145, p1123S, DOI 10.3945/jn.114.194936; EISEMAN B, 1958, SURGERY, V44, P854; Faust K, 2015, CURR OPIN MICROBIOL, V25, P56, DOI 10.1016/j.mib.2015.04.004; Fiorucci S, 2015, TRENDS MOL MED, V21, P702, DOI 10.1016/j.molmed.2015.09.001; Flynn JM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005846; Frank DN, 2008, CURR OPIN GASTROEN, V24, P4, DOI 10.1097/MOG.0b013e3282f2b0e8; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fuentes S, 2016, ADV EXP MED BIOL, V902, P143, DOI 10.1007/978-3-319-31248-4_10; Furuya-Kanamori L, 2017, J CLIN GASTROENTEROL, V51, P145, DOI 10.1097/MCG.0000000000000511; Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005; Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377; Gibbons SM, 2015, CURR OPIN GENET DEV, V35, P66, DOI 10.1016/j.gde.2015.10.003; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gkouskou KK, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00028; Gradmann C, 2014, MICROBES INFECT, V16, P885, DOI 10.1016/j.micinf.2014.08.012; Greiner TU, 2016, MOL METAB, V5, P753, DOI 10.1016/j.molmet.2016.05.012; Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Hofstra JJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1081-y; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Howerton A, 2013, J INFECT DIS, V207, P1498, DOI 10.1093/infdis/jit068; Huang YJ, 2017, TRANSL RES, V179, P71, DOI 10.1016/j.trsl.2016.06.007; Huang YJ, 2016, CLIN CHEST MED, V37, P59, DOI 10.1016/j.ccm.2015.10.003; Huang YJ, 2015, ANN AM THORAC SOC, V12, pS176, DOI 10.1513/AnnalsATS.201506-319AW; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V136, P874, DOI 10.1016/j.jaci.2015.05.044; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234; Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013; Johnson BC, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004827.pub2; Johnson-King B, 2016, GENET TEST MOL BIOMA, V20, P561, DOI 10.1089/gtmb.2016.29022.sjt; Jumpertz R, 2011, AM J CLIN NUTR, V94, P58, DOI 10.3945/ajcn.110.010132; Kahn SA, 2016, AM J GASTROENTEROL, V111, P1508, DOI 10.1038/ajg.2016.153; Kaufmann SHE, 2008, MICROBES INFECT, V10, P1417, DOI 10.1016/j.micinf.2008.08.012; Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271; Kemppainen KM, 2015, DIABETES CARE, V38, P329, DOI 10.2337/dc14-0850; Khanna S, 2016, J INFECT DIS, V214, P173, DOI 10.1093/infdis/jiv766; Koch R, 1890, Br Med J, V2, P380; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023; Lang A. J., 2016, General Technical Report - Southern Research Station, USDA Forest Service, P8; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lawley TD, 2013, IMMUNOLOGY, V138, P1, DOI 10.1111/j.1365-2567.2012.03616.x; Lee D, 2015, INFLAMM BOWEL DIS, V21, P1786, DOI 10.1097/MIB.0000000000000426; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Li J, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002534; Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942; Livanos AE, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.140, 10.1038/nmicrobiol.2016.140]; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Louis P, 2016, ADV EXP MED BIOL, V902, P119, DOI 10.1007/978-3-319-31248-4_9; Manor O, 2014, CELL METAB, V20, P742, DOI 10.1016/j.cmet.2014.07.021; Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5; Melber DJ, 2016, CLIN INFECT DIS, V63, P164, DOI 10.1093/cid/ciw262; Morgan XC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0637-x; Morgan XC, 2014, GASTROENTEROLOGY, V146, P1437, DOI 10.1053/j.gastro.2014.01.049; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nobrega FL, 2015, TRENDS MICROBIOL, V23, P185, DOI 10.1016/j.tim.2015.01.006; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ollech JE, 2016, BEST PRACT RES CL GA, V30, P111, DOI 10.1016/j.bpg.2016.01.002; OLSON GB, 1966, J IMMUNOL, V97, P267; Orenstein R, 2016, CLIN INFECT DIS, V62, P596, DOI 10.1093/cid/civ938; Orndorff PE, 2016, CURR GENET, V62, P753, DOI 10.1007/s00294-016-0603-5; PACE NR, 1985, ASM NEWS, V51, P4; Parseus A, 2016, GUT; Perencevich M, 2006, INFLAMM BOWEL DIS, V12, P651, DOI 10.1097/01.MIB.0000225330.38119.c7; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Pettigrew MM, 2016, ANN EPIDEMIOL, V26, P342, DOI 10.1016/j.annepidem.2016.02.007; Proctor LM, 2016, SEMIN FETAL NEONAT M, V21, P368, DOI 10.1016/j.siny.2016.05.002; Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001; Quince C, 2015, AM J GASTROENTEROL, V110, P1718, DOI 10.1038/ajg.2015.357; Rajala MW, 2014, ENDOCRINOLOGY, V155, P748, DOI 10.1210/en.2013-1085; Rao K, 2016, J HOSP MED, V11, P56, DOI 10.1002/jhm.2449; Rao K, 2015, INFECT DIS CLIN N AM, V29, P109, DOI 10.1016/j.idc.2014.11.009; Reid G, 2016, BEST PRACT RES CL GA, V30, P17, DOI 10.1016/j.bpg.2015.12.001; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sanders ME, 2008, CLIN INFECT DIS, V46, pS58, DOI 10.1086/523341; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Scaldaferri F, 2016, TRANSPL P, V48, P402, DOI 10.1016/j.transproceed.2015.12.040; SCHAEDLER RW, 1965, J EXP MED, V122, P77, DOI 10.1084/jem.122.1.77; Schenck LP, 2016, FEBS LETT, V590, P3705, DOI 10.1002/1873-3468.12455; Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004; Schnadower D, 2015, CURR OPIN GASTROEN, V31, P1, DOI 10.1097/MOG.0000000000000132; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Segal LN, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.31, 10.1038/NMICROBIOL.2016.31]; Shogan BD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-35; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Sommer MOA, 2015, CURR OPIN MICROBIOL, V27, P127, DOI 10.1016/j.mib.2015.08.004; Sorg JA, 2010, J BACTERIOL, V192, P4983, DOI 10.1128/JB.00610-10; Spanogiannopoulos P, 2016, NAT REV MICROBIOL, V14, P273, DOI 10.1038/nrmicro.2016.17; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Streit WR, 2004, CURR OPIN MICROBIOL, V7, P492, DOI 10.1016/j.mib.2004.08.002; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Sze MA, 2016, AM J RESP CRIT CARE, V193, P938, DOI 10.1164/rccm.201512-2329ED; Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580; Theriot CM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00045-15; Theriot Casey M, 2014, Nat Commun, V5, P3114, DOI 10.1038/ncomms4114; Trabelsi MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8629; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Ussar S, 2015, CELL METAB, V22, P516, DOI 10.1016/j.cmet.2015.07.007; Vandenheuvel D, 2015, ANNU REV VIROL, V2, P599, DOI 10.1146/annurev-virology-100114-054915; Venkataraman A, 2015, MBIO, V6, DOI 10.1128/mBio.02284-14; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Walker AW, 2016, ADV EXP MED BIOL, V902, P5, DOI 10.1007/978-3-319-31248-4_2; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Westcott SL, 2015, PEERJ, V3, DOI 10.7717/peerj.1487; Whipps J.L.K., 1988, FUNGI BIOL CONTROL S, P161; WILSON KH, 1983, J CLIN MICROBIOL, V18, P1017, DOI 10.1128/JCM.18.4.1017-1019.1983; Wirtz S, 2007, ADV DRUG DELIVER REV, V59, P1073, DOI 10.1016/j.addr.2007.07.003; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yadava K, 2016, AM J RESP CRIT CARE, V193, P975, DOI 10.1164/rccm.201504-0779OC; Young VB, 2016, CLIN MICROBIOL INFEC, V22, P905, DOI 10.1016/j.cmi.2016.09.001; Young VB, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-9; Youngster I, 2014, JAMA-J AM MED ASSOC, V312, P1772, DOI 10.1001/jama.2014.13875; Zhang FM, 2012, AM J GASTROENTEROL, V107, P1755, DOI 10.1038/ajg.2012.251; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	152	231	243	4	172	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 15	2017	356								j831	10.1136/bmj.j831	http://dx.doi.org/10.1136/bmj.j831			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NL	28298355				2022-12-28	WOS:000397015300002
J	Crowley, R; Kirschner, N; Dunn, AS; Bornstein, SS				Crowley, Ryan; Kirschner, Neil; Dunn, Andrew S.; Bornstein, Sue S.		Hlth Public Policy Comm; Amer Coll Phys	Health and Public Policy to Facilitate Effective Prevention and Treatment of Substance Use Disorders Involving Illicit and Prescription Drugs: An American College of Physicians Position Paper	ANNALS OF INTERNAL MEDICINE			English	Review							MEDICATION-ASSISTED TREATMENT; UNITED-STATES; MENTAL-HEALTH; INJECT DRUGS; MARIJUANA LEGALIZATION; MONITORING PROGRAMS; FEDERAL PARITY; BRAIN DISEASE; ADDICTION; BARRIERS	Substance use disorders involving illicit and prescription drugs are a serious public health issue. In the United States, millions of individuals need treatment for substance use disorders but few receive it. The rising number of drug overdose deaths and the changing legal status of marijuana pose new challenges. In this position paper, the American College of Physicians maintains that substance use disorder is a treatable chronic medical condition and offers recommendations on expanding treatment options, the legal status of marijuana, addressing the opioid epidemic, insurance coverage of substance use disorders treatment, education and workforce, and public health interventions.	[Crowley, Ryan; Kirschner, Neil] Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA; [Dunn, Andrew S.] Mt Sinai Med Ctr, Box 1086,1470 Madison Ave, New York, NY 10029 USA; [Bornstein, Sue S.] 3111 Beverly Dr, Dallas, TX 75205 USA	American College of Physicians; Icahn School of Medicine at Mount Sinai	Crowley, R (corresponding author), Amer Coll Physicians, 25 Massachusetts Ave NW,Suite 700, Washington, DC 20001 USA.	RCrowley@mail.acponline.org		Lenchus, Joshua/0000-0003-1220-0803	ACP operating budget	ACP operating budget	Financial support for the development of this guideline comes exclusively from the ACP operating budget.	Advocates for Human Potential, 2014, AD BEH HLTH WORKF ME; Alford DP, 2016, PAIN MED, V17, P52, DOI 10.1111/pme.12878; American Academy of Addiction Medicine, 2013, TERM REL SPECTR UNH; American College of Physicians-American Society of Internal Medicine, 1998, ILL DRUG AB NAT DRUG; American Psychiatric Association, 2013, SUBST REL ADD DIS; American Society of Addiction Medicine, 2011, QUAL PRACT DEF ADD; [Anonymous], 2012, PRINC DRUG ADD TREAT; [Anonymous], 2016, JAMA PEDIAT; [Anonymous], IMP OP CRIS HEALTHC; Appuzo Matt, 2014, NY TIMES; Aspinall EJ, 2014, INT J EPIDEMIOL, V43, P235, DOI 10.1093/ije/dyt243; Associated Press-NORC Center for Public Affairs Research, 2016, AM ATT SUBST US US S; Bao YH, 2016, HEALTH AFFAIR, V35, P1045, DOI 10.1377/hlthaff.2015.1673; Barry CL, 2014, PSYCHIAT SERV, V65, P1269, DOI 10.1176/appi.ps.201400140; Beletsky L, 2008, AM J PUBLIC HEALTH, V98, P231, DOI 10.2105/AJPH.2006.103747; Berry KN, 2015, PSYCHIAT SERV, V66, P565, DOI 10.1176/appi.ps.201400582; Bettinardi-Angres K, 2010, J NURS REGUL, V1, P31, DOI 10.1016/S2155-8256(15)30348-3; Bradford AC, 2016, HEALTH AFFAIR, V35, P1230, DOI 10.1377/hlthaff.2015.1661; Bramson H, 2015, J PUBLIC HEALTH POL, V36, P212, DOI 10.1057/jphp.2014.54; Branch MN, 2011, J EXP ANAL BEHAV, V95, P263, DOI 10.1901/jeab.2011.95-263; BUPPractice, 2017, DSM 5 CRIT SUSBST US; Busch SH, 2014, AM J MANAG CARE, V20, P76; CASA Columbia University, 2000, MISS OPP NAT SURV PR; Cauchi R, 2015, MENTAL HLTH BENEFITS; Caulkins J.P, 2015, OPTIONS ISSUES REGAR; Centers for Disease Control and Prevention, 2017, HIV INJ DRUG US US; Centers for Disease Control and Prevention, 2015, INJ PREV CONTR OP OV; Centers for Disease Control and Prevention and National Center for Injury Prevention and Control, 2020, OPIOID OVERDOSE DRUG; Chaiyachati K, 2016, HLTH AFFAIRS BLOG; Clark RE, 2011, HEALTH AFFAIR, V30, P1425, DOI 10.1377/hlthaff.2010.0532; Colorado Department of Public Health & Environment, 2015, HLTH KIDS COL SURV; Compton WM, 2016, LANCET PSYCHIAT, V3, P954, DOI 10.1016/S2215-0366(16)30208-5; Courtwright DT, 2010, BIOSOCIETIES, V5, P137, DOI 10.1057/biosoc.2009.3; Crowley RA, 2015, ANN INTERN MED, V163, P298, DOI 10.7326/M15-0510; Daniel H, 2016, ANN INTERN MED, V165, P50, DOI 10.7326/M15-2768; Des Jarlais DC, 2015, MMWR-MORBID MORTAL W, V64, P1337, DOI 10.15585/mmwr.mm6448a3; Jarlais DC, 2009, ADDICTION, V104, P1441, DOI 10.1111/j.1360-0443.2008.02465.x; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr7103a1, 10.1001/jama.2016.1464]; DuPont RL, 2012, WHITE PAPER STATE LE; Dutra L, 2008, NEW ENGL J MED, V165, p[179, 357]; Eilperin J, 2016, WASHINGTON POST; Faggiano F, 2009, COCHRANE LIB, V4, P1; Federation of State Medical Boards, CONT MED ED BOARD BY; Food and Drug Administration, 2016, FED REG; Friedmann PD, 2012, SUBST ABUS, V33, P9, DOI 10.1080/08897077.2011.611460; Gloucester Police Department, 2017, ADD THEIR FRIENDS FA; Goodnough A., 2015, NY TIMES; Governing, 2015, STAT MAR LAWS MAP; Grill C, 2013, B AM COLL SURG; Gupta R, 2016, NEW ENGL J MED, V375, P2213, DOI 10.1056/NEJMp1609578; Hammer Rachel, 2013, AJOB Neurosci, V4, P27; Han B, 2015, NSDUH DATA REV; Health Resources and Services Administration, SHORT DES HLTH PROF; Heisler E. J., 2015, MENTAL HLTH WORKFORC; Henchman J, 2016, MARIJUANA LEGALIZATI; Hendriksson M, 2016, WORDS MATTER; Hutchinson E, 2014, ANN FAM MED, V12, P128, DOI 10.1370/afm.1595; Hyde PS, 2013, C NAT SUSBT AB MENT; Illinois State Medical Society, 2015, REC DET IMPR US OP R; Indiana University School of Public Health, 2015, SYR EXCH IND NEED SU; Kann L, 2016, MMWR-MORBID MORTAL W, V65, P106, DOI 10.15585/mmwr.mm6505a2; Kilmer Beau, 2016, BACK NATL SPOTLIGHT; Kinnard EN, 2014, HARM REDUCT J, V11, DOI 10.1186/1477-7517-11-29; Klepper D, 2016, ONCE UNTHINKABLE US; Komaromy M, 2016, SUBST ABUS, V37, P20, DOI 10.1080/08897077.2015.1129388; Kovaleski S., 2014, NY TIMES; Kraus ML, 2011, J ADDICT MED, V5, P254, DOI 10.1097/ADM.0b013e3182312983; Lavitt J, 2015, THE FIX         0828; Leshner AI, 1997, SCIENCE, V278, P45, DOI 10.1126/science.278.5335.45; Leshner AI, 2001, ADDICTION IS BRAIN D; Livingston JD, 2012, ADDICTION, V107, P39, DOI 10.1111/j.1360-0443.2011.03601.x; Masters B, 2016, RECOVERY REACH MEDIC; Matusow H, 2013, J SUBST ABUSE TREAT, V44, P473, DOI 10.1016/j.jsat.2012.10.004; Meltzer EC, 2013, SUBST ABUS, V34, P356, DOI 10.1080/08897077.2013.815143; Miller NS, 2001, ACAD MED, V76, P410, DOI 10.1097/00001888-200105000-00007; Monte AA, 2015, JAMA-J AM MED ASSOC, V313, P241, DOI 10.1001/jama.2014.17057; Mumola C., 2007, DRUG USE DEPENDENCE; Namey B, 2016, LIFE SAVING OVERDOSE; National Academies of Sciences Engineering and Medicine, 2016, END DICR PEOPL MENT; National Center on Addiction and Substance Abuse, 2016, UNC COV GAPS REV ADD; National Center on Addiction and Substance Abuse at Columbia University, 2010, BARS 2 SUBST AB AM P; National Conference of State Legislatures, 2017, DEEP DIV MAR; National Conference of State Legislatures, 2014, PRESCR DURG OV STRAT; National Conference of State Legislatures, 2016, DRUG OV IMM GOOD SEM; National Institute of Justice, 2016, DRUG COURTS; National Institute on Drug Abuse, 2012, EV BAS APPR DRUG ADD; National Institute on Drug Abuse, 2008, DRUGS BRAINS BEH SCI; Nessoulli A., 2016, UPSTATE NY MAYOR PRO; NORMAND J, 1995, PREVENTING HIV TRANS; Nosyk B, 2013, HEALTH AFFAIR, V32, P1462, DOI 10.1377/hlthaff.2012.0846; O'Connor PG, 2013, JAMA-J AM MED ASSOC, V310, P1132, DOI 10.1001/jama.2013.277610; Office of the Surgeon General, 2016, FAC ADD AM SURG GEN; Oregon Department of Revenue, 2017, MAR TAX; Patrick SW, 2016, HEALTH AFFAIR, V35, P1324, DOI 10.1377/hlthaff.2015.1496; Pearson MR, 2015, STIGMA SUBSTANCE USE; Pew Research Center, 2014, AM NEW DRUG POL LAND; Polydorou Soteri, 2008, Curr Psychiatry Rep, V10, P399, DOI 10.1007/s11920-008-0064-8; Qaseem Amir, 2017, Ann Intern Med, V166, P514, DOI 10.7326/M16-2367; Reddon H, 2011, AIDS EDUC PREV, V23, P412, DOI 10.1521/aeap.2011.23.5.412; Reuter P, 2013, CRIME JUSTICE, V42, P75, DOI 10.1086/670818; Ronan MV, 2016, HEALTH AFFAIR, V35, P832, DOI 10.1377/hlthaff.2015.1424; Rossman SB, 2011, MULTISTATE ADULT DRU; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Ryan O, 2012, VITAL SIGNS TAKING P; Rydell CP, 1994, CONTROLLING COCAINE; Salinas Gregory D, 2012, J Pain Res, V5, P363, DOI 10.2147/JPR.S35798; Satel S, 2014, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00141; Schiff DM, 2016, NEW ENGL J MED, V375, P2505; Silverman E, 2016, SENATORS ASK DRUG MA; Sipe TA, 2015, AM J PREV MED, V48, P755, DOI 10.1016/j.amepre.2015.01.022; Snyder L, 2012, ANN INTERN MED, V156, DOI 10.7326/0003-4819-156-1-201201031-00001; Strang J, 2012, LANCET, V379, P71, DOI 10.1016/S0140-6736(11)61674-7; Substance abuse and mental health services administration, 2016, HHS PUBL; Substance Abuse and Mental Health Services Administration, 2017, BUPR WAIV MAN; Substance Abuse and Mental Health Services Administration, 2015, BEH HLTH TRENDS US R; Substance Abuse and Mental Health Services Administration, 2015, SUBST US DIS; Substance Abuse and Mental Health Services Administration, 2016, PHYS PROGR DAT; Substance Abuse and Mental Health Services Administration, 2015, REC SERV BEH HLTH PR; The Police Assisted Addiction and Recovery Initiative, 2017, US; U.S. Department of Health and Human Services, 2016, PAR TASK FORC SUMM 2; U.S. Department of Health and Human Services, 2016, MENT HLTH SUBST US D; U.S. Department of Justice National Drug Intelligence Center, 2011, NAT DRUG THREAT ASS; U.S. Food and Drug Administration, 2016, FACT SHEET FDA OP AC; U.S. States Congress Office of Technology Assessment, 2004, BIOL COMP SUBST AB A; Ungar L, 2016, US TODAY; United Nations Office on Drugs and Crime, 2017, WORLD DRUG REP 2015; Vestal C, 2016, HEALTH AFFAIR, V35, P1052, DOI 10.1377/hlthaff.2016.0504; Volkow ND, 2016, JAMA PSYCHIAT, V73, P292, DOI 10.1001/jamapsychiatry.2015.3278; Wall MM, 2011, ANN EPIDEMIOL, V21, P714, DOI 10.1016/j.annepidem.2011.06.001; Weinmeyer Richard, 2016, AMA J Ethics, V18, P252, DOI 10.1001/journalofethics.2016.18.3.hlaw1-1603; Wen HF, 2013, JAMA PSYCHIAT, V70, P1355, DOI 10.1001/jamapsychiatry.2013.2169; Wermeling DP, 2015, THER ADV DRUG SAF, V6, P20, DOI 10.1177/2042098614564776; Wilkinson ST, 2016, ANNU REV MED, V67, P453, DOI 10.1146/annurev-med-050214-013454; Wolfe R, DOING LOT LITTLE STA; Wong K, 2016, LEGALIZATION MARIJUA; Wynn M, 2015, LOUISVILLE COURIER J	136	43	43	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 16	2017	166	10					733	+		10.7326/M16-2953	http://dx.doi.org/10.7326/M16-2953			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU7UM	28346947				2022-12-28	WOS:000401240200017
J	Maiolino, R; Russell, HR; Fabian, AC; Carniani, S; Gallagher, R; Cazzoli, S; Arribas, S; Belfiore, F; Bellocchi, E; Colina, L; Cresci, G; Ishibashi, W; Marconi, A; Mannucci, F; Oliva, E; Sturm, E				Maiolino, R.; Russell, H. R.; Fabian, A. C.; Carniani, S.; Gallagher, R.; Cazzoli, S.; Arribas, S.; Belfiore, F.; Bellocchi, E.; Colina, L.; Cresci, G.; Ishibashi, W.; Marconi, A.; Mannucci, F.; Oliva, E.; Sturm, E.			Star formation inside a galactic outflow	NATURE			English	Article							INTEGRAL FIELD SPECTROSCOPY; MASSIVE MOLECULAR OUTFLOWS; COMPACT DWARF GALAXIES; INFRARED GALAXIES; POSITIVE FEEDBACK; SEYFERT-GALAXIES; FORMING GALAXIES; QUASAR FEEDBACK; HOST GALAXIES; AGN FEEDBACK	Recent observations have revealed massive galactic molecular outflows(1-3) that may have the physical conditions (high gas densities(4-6)) required to form stars. Indeed, several recent models predict that such massive outflows may ignite star formation within the outflow itself(7-11). This star-formation mode, in which stars form with high radial velocities, could contribute to the morphological evolution of galaxies(12), to the evolution in size and velocity dispersion of the spheroidal component of galaxies(11,13), and would contribute to the population of high-velocity stars, which could even escape the galaxy(13). Such star formation could provide in situ chemical enrichment of the circumgalactic and intergalactic medium (through supernova explosions of young stars on large orbits), and some models also predict it to contribute substantially to the star-formation rate observed in distant galaxies9. Although there exists observational evidence for star formation triggered by outflows or jets into their host galaxy, as a consequence of gas compression, evidence for star formation occurring within galactic outflows is still missing. Here we report spectroscopic observations that unambiguously reveal star formation occurring in a galactic outflow at a redshift of 0.0448. The inferred star-formation rate in the outflow is larger than 15 solar masses per year. Star formation may also be occurring in other galactic outflows, but may have been missed by previous observations owing to the lack of adequate diagnostics(14,15).	[Maiolino, R.; Carniani, S.; Gallagher, R.; Belfiore, F.] Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge CB3 0HE, England; [Maiolino, R.; Carniani, S.; Gallagher, R.; Belfiore, F.] Univ Cambridge, Kavli Inst Cosmol, Madingley Rd, Cambridge CB3 0HA, England; [Russell, H. R.; Fabian, A. C.] Inst Astron, Madingley Rd, Cambridge CB3 0HA, England; [Cazzoli, S.; Arribas, S.; Bellocchi, E.; Colina, L.] CSIC, Dept Astrofis, Ctr Astrobiol CSIC INTA, Madrid, Spain; [Cresci, G.; Marconi, A.; Mannucci, F.; Oliva, E.] INAF, Osserv Astrofis Arcetri, Largo E Fermi 5, I-20125 Florence, Italy; [Ishibashi, W.] Univ Zurich, Inst Phys, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Marconi, A.] Univ Studi Firenze, Dipartimento Fis & Astron, Via G Sansone 1, I-50019 Florence, Italy; [Sturm, E.] Max Planck Inst Extraterr Phys, Giessenbachstr, D-85748 Garching, Germany	University of Cambridge; University of Cambridge; University of Cambridge; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Istituto Nazionale Astrofisica (INAF); University of Zurich; University of Florence; Max Planck Society	Maiolino, R (corresponding author), Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge CB3 0HE, England.; Maiolino, R (corresponding author), Univ Cambridge, Kavli Inst Cosmol, Madingley Rd, Cambridge CB3 0HA, England.	r.maiolino@mrao.cam.ac.uk	Cresci, Giovanni/ABD-7239-2020; Arribas, Santiago/F-9277-2015; Marconi, Alessandro/AAF-7375-2021; Cazzoli, Sara/C-3718-2017; Carniani, Stefano/AAS-2822-2020; Marconi, Alessandro/C-5880-2009; Colina, Luis/C-2823-2017; Carniani, Stefano/AAZ-5487-2020; Bellocchi, Enrica/H-9070-2015	Cresci, Giovanni/0000-0002-5281-1417; Arribas, Santiago/0000-0001-7997-1640; Marconi, Alessandro/0000-0002-9889-4238; Cazzoli, Sara/0000-0002-7705-2525; Carniani, Stefano/0000-0002-6719-380X; Marconi, Alessandro/0000-0002-9889-4238; Colina, Luis/0000-0002-9090-4227; Carniani, Stefano/0000-0002-6719-380X; Oliva, Ernesto/0000-0002-9123-0412; Bellocchi, Enrica/0000-0001-9791-4228; Russell, Helen/0000-0001-5208-649X; Maiolino, Roberto/0000-0002-4985-3819; mannucci, filippo/0000-0002-4803-2381; Belfiore, Francesco/0000-0002-2545-5752	Science and Technology Facilities Council (STFC); ERC [695671, 340442]; Spanish Ministry of Economy [AYA2012-32295, ESP2015-68964-P]; STFC [ST/P004636/1, ST/M001172/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/N000927/1, ST/M001172/1] Funding Source: researchfish	Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); ERC(European Research Council (ERC)European Commission); Spanish Ministry of Economy(Spanish Government); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	R.M., S.Car. and F.B. acknowledge support by the Science and Technology Facilities Council (STFC). R.M. acknowledges ERC Advanced Grant 695671 "QUENCH". H.R.R. and A.C.F. acknowledge ERC Advanced Grant 340442. S.A., S.Caz., E.B. and L.C. acknowledge support from the Spanish Ministry of Economy, under grants AYA2012-32295 and ESP2015-68964-P.	Aalto S, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201423987; Aalto S, 2012, ASTRON ASTROPHYS, V537, DOI 10.1051/0004-6361/201117919; Allen MG, 2008, ASTROPHYS J SUPPL S, V178, P20, DOI 10.1086/589652; Arribas S, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201323324; Bellocchi E, 2013, ASTRON ASTROPHYS, V557, DOI 10.1051/0004-6361/201221019; Brightman M, 2011, MON NOT R ASTRON SOC, V413, P1206, DOI 10.1111/j.1365-2966.2011.18207.x; Cappellari M, 2017, MON NOT R ASTRON SOC, V466, P798, DOI 10.1093/mnras/stw3020; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Carniani S, 2016, ASTRON ASTROPHYS, V591, DOI 10.1051/0004-6361/201528037; Cazzoli S, 2016, ASTRON ASTROPHYS, V590, DOI 10.1051/0004-6361/201526788; Colina L, 2015, ASTRON ASTROPHYS, V578, DOI 10.1051/0004-6361/201425567; Cresci G, 2015, ASTRON ASTROPHYS, V582, DOI 10.1051/0004-6361/201526581; Delgado RMG, 2005, MON NOT R ASTRON SOC, V357, P945, DOI 10.1111/j.1365-2966.2005.08692.x; Diaz AI, 2000, MON NOT R ASTRON SOC, V318, P462, DOI 10.1046/j.1365-8711.2000.03737.x; Dugan Z, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/113; Feruglio C, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201015164; Gaibler V, 2012, MON NOT R ASTRON SOC, V425, P438, DOI 10.1111/j.1365-2966.2012.21479.x; Gerardy CL, 2001, ASTRON J, V121, P2781, DOI 10.1086/320393; Ishibashi W, 2013, MON NOT R ASTRON SOC, V431, P2350, DOI 10.1093/mnras/stt333; Ishibashi W, 2012, MON NOT R ASTRON SOC, V427, P2998, DOI 10.1111/j.1365-2966.2012.22074.x; Izotov YI, 2012, MON NOT R ASTRON SOC, V427, P1229, DOI 10.1111/j.1365-2966.2012.22051.x; Kauffmann G, 2003, MON NOT R ASTRON SOC, V346, P1055, DOI 10.1111/j.1365-2966.2003.07154.x; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Kewley LJ, 2006, MON NOT R ASTRON SOC, V372, P961, DOI 10.1111/j.1365-2966.2006.10859.x; Leslie SK, 2014, MON NOT R ASTRON SOC, V444, P1842, DOI 10.1093/mnras/stu1547; Lopez RG, 2010, ASTRON ASTROPHYS, V511, DOI 10.1051/0004-6361/200913304; Maiolino R, 1998, ASTROPHYS J, V493, P650, DOI 10.1086/305150; Marconi A, 1996, ASTRON ASTROPHYS, V315, P335; Modigliani A, 2010, PROC SPIE, V7737, DOI 10.1117/12.857211; Muller-Sanchez F, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/69; Oliva E, 2001, ASTRON ASTROPHYS, V369, pL5, DOI 10.1051/0004-6361:20010214; Perez-Montero E, 2009, MON NOT R ASTRON SOC, V398, P949, DOI 10.1111/j.1365-2966.2009.15145.x; Lopez JP, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219372; Riffel R, 2006, ASTRON ASTROPHYS, V457, P61, DOI 10.1051/0004-6361:20065291; Rodriguez-Ardila A, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/100; Rodriguez-Zaurin J, 2011, ASTRON ASTROPHYS, V527, DOI 10.1051/0004-6361/201014879; Sakamoto K, 2009, ASTROPHYS J LETT, V700, pL104, DOI 10.1088/0004-637X/700/2/L104; Sanchez-Blazquez P, 2006, MON NOT R ASTRON SOC, V371, P703, DOI 10.1111/j.1365-2966.2006.10699.x; Shapley AE, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/88; Silk J, 2013, ASTROPHYS J, V772, DOI 10.1088/0004-637X/772/2/112; Sturm E, 2011, ASTROPHYS J LETT, V733, DOI 10.1088/2041-8205/733/1/L16; Thuan TX, 2005, ASTROPHYS J SUPPL S, V161, P240, DOI 10.1086/491657; van der Laan TPR, 2013, ASTRON ASTROPHYS, V560, DOI 10.1051/0004-6361/201322527; Vernet J, 2011, ASTRON ASTROPHYS, V536, DOI 10.1051/0004-6361/201117752; Zubovas K, 2014, MON NOT R ASTRON SOC, V439, P400, DOI 10.1093/mnras/stt2472; Zubovas K, 2013, MON NOT R ASTRON SOC, V431, P793, DOI 10.1093/mnras/stt214	47	130	131	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2017	544	7649					202	+		10.1038/nature21677	http://dx.doi.org/10.1038/nature21677			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER6EK	28346938	Green Submitted			2022-12-28	WOS:000398897900031
J	Lim, JY; Marshall, CR				Lim, Jun Y.; Marshall, Charles R.			The true tempo of evolutionary radiation and decline revealed on the Hawaiian archipelago	NATURE			English	Article							OCEANIC ISLAND BIOGEOGRAPHY; SPECIES-AREA RELATIONSHIP; SP N. COLEOPTERA; ADAPTIVE RADIATION; MOLECULAR PHYLOGENIES; VOLCANO GROWTH; FOSSIL RECORD; CONVEYOR BELT; CARABIDAE; DIVERSIFICATION	Establishing the relationship between rates of change in species richness and biotic and abiotic environmental change is a major goal of evolutionary biology. Although exquisite fossil and geological records provide insight in rare cases(1), most groups lack high-quality fossil records. Consequently, biologists typically rely on molecular phylogenies to study the diversity dynamics of clades, usually by correlating changes in diversification rate with environmental or trait shifts(2-6). However, inferences drawn from molecular phylogenies can be limited owing to the challenge of accounting for extinct species, making it difficult(7-9) to accurately determine the underlying diversity dynamics that produce them. Here, using a geologically informed model of the relationship between changing island area and species richness for the Hawaiian archipelago, we infer the rates of species richness change for 14 endemic groups over their entire evolutionary histories without the need for fossil data, or molecular phylogenies. We find that these endemic clades underwent evolutionary radiations characterized by initially increasing rates of species accumulation, followed by slow-downs. In fact, for most groups on most islands, their time of evolutionary expansion has long past, and they are now undergoing previously unrecognized long-term evolutionary decline. Our results show how landscape dynamism can drive evolutionary dynamics over broad timescales(10), including driving species loss that is not readily detected using molecular phylogenies, or without a rich fossil record(11). We anticipate that examination of other clades where the relationship between environmental change and species richness change can be quantified will reveal that many other living groups have also experienced similarly complex evolutionary trajectories, including long-term and ongoing evolutionary decline.	[Lim, Jun Y.; Marshall, Charles R.] Univ Calif Berkeley, Dept Integrat Biol, 3040 Valley Life Sci Bldg, Berkeley, CA 94720 USA; [Lim, Jun Y.; Marshall, Charles R.] Univ Calif Berkeley, Univ Calif Museum Paleontol, 1101 Valley Life Sci Bldg, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Lim, JY; Marshall, CR (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, 3040 Valley Life Sci Bldg, Berkeley, CA 94720 USA.; Lim, JY; Marshall, CR (corresponding author), Univ Calif Berkeley, Univ Calif Museum Paleontol, 1101 Valley Life Sci Bldg, Berkeley, CA 94720 USA.	junyinglim@berkeley.edu; crmarshall@berkeley.edu	Lim, Jun Ying/AFO-5605-2022	Lim, Jun Ying/0000-0001-7493-2159				Baldwin BG, 1998, P NATL ACAD SCI USA, V95, P9402, DOI 10.1073/pnas.95.16.9402; Borchers H. W., 2017, PRACMA PRACTICAL NUM; Borges PAV, 2009, J BIOGEOGR, V36, P178, DOI 10.1111/j.1365-2699.2008.01980.x; Borregaard M. K., 2016, BIOL REV; Burnham K.P., 2002, MODEL SELECTION MULT, VSecond edition; Carson Hampton L., 1995, P14; Chen XY, 2011, SCI CHINA LIFE SCI, V54, P1055, DOI 10.1007/s11427-011-4238-y; Clague D. A., 2014, US GEOLOGICAL SURVEY, V1801, P97, DOI DOI 10.3133/PP18013; Clark JR, 2009, MOL PHYLOGENET EVOL, V53, P982, DOI 10.1016/j.ympev.2009.09.002; Cronk QCB, 2005, AM J BOT, V92, P1017, DOI 10.3732/ajb.92.6.1017; Cryan JR, 2001, MOL PHYLOGENET EVOL, V21, P72, DOI 10.1006/mpev.2001.0991; Douglas Pratt H., 2005, HAWAIIAN HONEYCREEPE; ELZHOV TV, 2016, MINPACK LM R INTERFA; Ezard THG, 2011, SCIENCE, V332, P349, DOI 10.1126/science.1203060; Fattorini S, 2009, J BIOGEOGR, V36, P1100, DOI 10.1111/j.1365-2699.2009.02083.x; Fleischer RC, 1998, MOL ECOL, V7, P533, DOI 10.1046/j.1365-294x.1998.00364.x; Flinders AF, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006877; Geist DJ, 2014, GEOPHYS MONOGR SER, V204, P145; Gillespie RG, 2007, J ARACHNOL, V35, P11, DOI 10.1636/H04-05.1; Gillespie RG, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P358; Gillespie Rosemary G., 1997, Pacific Science, V51, P380; Givnish TJ, 2009, P ROY SOC B-BIOL SCI, V276, P407, DOI 10.1098/rspb.2008.1204; Hall C.A., 2002, GEOL SOC AM SPEC PAP, V357, P1, DOI DOI 10.1130/0-8137-2357-4.1); Hormiga G, 2003, SYST BIOL, V52, P70, DOI 10.1080/10635150390132786; Jetz W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001292; Jordan S, 2003, SYST BIOL, V52, P89, DOI 10.1080/10635150390132803; JUVIK JO, 1979, J BIOGEOGR, V6, P205, DOI 10.2307/3038177; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; Liebherr J. K., 2000, INSECTS HAWAII HAWAI, V16; Liebherr JK, 2006, J NEW YORK ENTOMOL S, V114, P17, DOI 10.1664/0028-7199(2006)114[17:RADOBK]2.0.CO;2; Liebherr JK, 2006, J NEW YORK ENTOMOL S, V114, P1, DOI 10.1664/0028-7199(2006)114[1:BRNSCC]2.0.CO;2; Liebherr JK, 2003, INSECT SYST EVOL, V34, P41, DOI 10.1163/187631203788964953; Liebherr JK, 2001, INSECT SYST EVOL, V32, P133, DOI 10.1163/187631201X00083; Lindqvist C, 2002, AM J BOT, V89, P1709, DOI 10.3732/ajb.89.10.1709; Liow LH, 2010, SYST BIOL, V59, P646, DOI 10.1093/sysbio/syq052; Lipman PW, 2013, GEOSPHERE, V9, P1348, DOI 10.1130/GES00935.1; MAC ARTHUR ROBERT H., 1967; MACARTHUR RH, 1963, EVOLUTION, V17, P373, DOI 10.2307/2407089; Maechler M, 2016, RMPFR MULTIPLE PRECI; Magnacca KN, 2015, MOL PHYLOGENET EVOL, V92, P226, DOI 10.1016/j.ympev.2015.06.014; Mark RK., 1987, VOLCANISM HAWAII US, V1350, P101; MOORE JG, 1992, GEOL SOC AM BULL, V104, P1471, DOI 10.1130/0016-7606(1992)104<1471:VGAEOT>2.3.CO;2; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Nepokroeff M, 2003, SYST BIOL, V52, P820, DOI 10.1080/10635150390251072; NISHIDA G. M., 2002, HAWAIIAN TERRESTRIAL; Onstein RE, 2016, GLOBAL ECOL BIOGEOGR, V25, P1239, DOI 10.1111/geb.12481; Otte D., 2000, CRICKETS HAWAII; Peck SB, 1999, ANN ENTOMOL SOC AM, V92, P529, DOI 10.1093/aesa/92.4.529; Price JP, 2011, AM J BOT, V98, P449, DOI 10.3732/ajb.1000388; Price Jonathan Paul, 2004, Pacific Science, V58, P27, DOI 10.1353/psc.2004.0008; Price JP, 2004, J BIOGEOGR, V31, P487, DOI 10.1046/j.0305-0270.2003.00990.x; Quental TB, 2013, SCIENCE, V341, P290, DOI 10.1126/science.1239431; Quental TB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025780; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Research Wolfram, 2015, MATHEMATICA V 10 1; Reyes E, 2015, NEW PHYTOL, V207, P401, DOI 10.1111/nph.13244; Ricklefs RE, 2004, AM NAT, V163, P227, DOI 10.1086/381002; Rominger AJ, 2016, GLOBAL ECOL BIOGEOGR, V25, P769, DOI 10.1111/geb.12341; Shaw KL, 2000, ZOOL J LINN SOC-LOND, V129, P73, DOI 10.1111/j.1096-3642.2000.tb00009.x; Shaw KL, 1996, EVOLUTION, V50, P237, DOI 10.1111/j.1558-5646.1996.tb04488.x; Soltis P. S., 2016, AM SOC PLANT TAXON, V21, P365; Triantis KA, 2012, J BIOGEOGR, V39, P215, DOI 10.1111/j.1365-2699.2011.02652.x; Valente LM, 2015, ECOL LETT, V18, P844, DOI 10.1111/ele.12461; Wagner W. L., HAWAIIAN VASCULAR PL; Wagner WL, 2005, FLORA HAWAIIAN ISLAN; Wagner WL, 1999, MANUAL FLOWERING PLA, V1; Warren BH, 2015, ECOL LETT, V18, P200, DOI 10.1111/ele.12398; Weigelt P, 2016, NATURE, V532, P99, DOI 10.1038/nature17443; Whittaker RJ, 2008, J BIOGEOGR, V35, P977, DOI 10.1111/j.1365-2699.2008.01892.x; Willyard A, 2011, MOL PHYLOGENET EVOL, V60, P29, DOI 10.1016/j.ympev.2011.04.001; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	71	47	48	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2017	543	7647					710	+		10.1038/nature21675	http://dx.doi.org/10.1038/nature21675			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP8IS	28297717				2022-12-28	WOS:000397619700054
J	Gates, B; Gates, M				Gates, Bill; Gates, Melinda			RETROSPECTIVE Hans Rosling (1948-2017)	SCIENCE			English	Biographical-Item									[Gates, Bill; Gates, Melinda] Bill & Melinda Gates Fdn, 500 Fifth Ave North, Seattle, WA 98109 USA	Bill & Melinda Gates Foundation	Gates, B (corresponding author), Bill & Melinda Gates Fdn, 500 Fifth Ave North, Seattle, WA 98109 USA.								0	0	0	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2017	355	6331					1268	1268		10.1126/science.aan1245	http://dx.doi.org/10.1126/science.aan1245			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP0NB	28336627				2022-12-28	WOS:000397082900020
J	Aguilar, OA; Berry, R; Rahim, MMA; Reichel, JJ; Popovic, B; Tanaka, M; Fu, ZH; Balaji, GR; Lau, TNH; Tu, MM; Kirkham, CL; Mahmoud, AB; Mesci, A; Krmpotic, A; Allan, DSJ; Makrigiannis, AP; Jonjic, S; Rossjohn, J; Carlyle, JR				Aguilar, Oscar A.; Berry, Richard; Rahim, Mir Munir A.; Reichel, Johanna J.; Popovic, Branka; Tanaka, Miho; Fu, Zhihui; Balaji, Gautham R.; Lau, Timothy N. H.; Tu, Megan M.; Kirkham, Christina L.; Mahmoud, Ahmad Bakur; Mesci, Aruz; Krmpotic, Astrid; Allan, David S. J.; Makrigiannis, Andrew P.; Jonjic, Stipan; Rossjohn, Jamie; Carlyle, James R.			A Viral Immunoevasin Controls Innate Immunity by Targeting the Prototypical Natural Killer Cell Receptor Family	CELL			English	Article							MISSING-SELF-RECOGNITION; MURINE CYTOMEGALOVIRUS-INFECTION; NK GENE-COMPLEX; NKR-P1 RECEPTORS; NK1.1 ANTIGEN; MOUSE; EXPRESSION; REVEALS; RECOMBINATION; PATHOGENS	Natural killer (NK) cells play a key role in innate immunity by detecting alterations in self and non-self ligands via paired NK cell receptors (NKRs). Despite identification of numerous NKR-ligand interactions, physiological ligands for the prototypical NK1.1 orphan receptor remain elusive. Here, we identify a viral ligand for the inhibitory and activating NKRP1 (NK1.1) receptors. This murine cytomegalovirus (MCMV)-encoded protein, m12, restrains NK cell effector function by directly engaging the inhibitory NKR-P1B receptor. However, m12 also interacts with the activating NKR-P1A/ C receptors to counterbalance m12 decoy function. Structural analyses reveal that m12 sequesters a large NKR-P1 surface area via a `` polar claw'' mechanism. Polymorphisms in, and ablation of, the viral m12 protein and host NKR-P1B/ C alleles impact NK cell responses in vivo. Thus, we identify the long-sought foreign ligand for this key immunoregulatory NKR family and reveal how it controls the evolutionary balance of immune recognition during host-pathogen interplay.	[Aguilar, Oscar A.; Tanaka, Miho; Lau, Timothy N. H.; Kirkham, Christina L.; Mesci, Aruz; Allan, David S. J.; Carlyle, James R.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Aguilar, Oscar A.; Tanaka, Miho; Lau, Timothy N. H.; Kirkham, Christina L.; Mesci, Aruz; Allan, David S. J.; Carlyle, James R.] Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Berry, Richard; Fu, Zhihui; Balaji, Gautham R.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Infect & Immun Program, Clayton, Vic 3800, Australia; [Rahim, Mir Munir A.; Tu, Megan M.; Mahmoud, Ahmad Bakur; Makrigiannis, Andrew P.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Reichel, Johanna J.; Popovic, Branka; Krmpotic, Astrid; Jonjic, Stipan] Univ Rijeka, Dept Histol & Embryol, Fac Med, Rijeka 51000, Croatia; [Berry, Richard; Balaji, Gautham R.] Monash Univ, ARC Ctr Excellence Adv Mol Imaging, Clayton, Vic 3800, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales; [Mahmoud, Ahmad Bakur] Taibah Univ, Coll Appl Med Sci, Madinah Munawwarah 30001, Saudi Arabia; [Rahim, Mir Munir A.; Makrigiannis, Andrew P.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada; [Allan, David S. J.] NHLBI, NIH, Bethesda, MD 20892 USA	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Monash University; University of Ottawa; University of Rijeka; Monash University; Cardiff University; Taibah University; Dalhousie University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Carlyle, JR (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.; Carlyle, JR (corresponding author), Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Infect & Immun Program, Clayton, Vic 3800, Australia.; Makrigiannis, AP (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.; Jonjic, S (corresponding author), Univ Rijeka, Dept Histol & Embryol, Fac Med, Rijeka 51000, Croatia.; Rossjohn, J (corresponding author), Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.; Makrigiannis, AP (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 4R2, Canada.	andrew.makrigiannis@dal.ca; stipan.jonjic@medri.uniri.hr; jamie.rossjohn@monash.edu; james.carlyle@utoronto.ca	Rossjohn, Jamie/F-9032-2013; Jonjic, Stipan/C-5657-2016; Carlyle, James R/A-1224-2008; Krmpotic, Astrid/U-6224-2017	Rossjohn, Jamie/0000-0002-2020-7522; Jonjic, Stipan/0000-0001-5003-3108; Krmpotic, Astrid/0000-0001-5470-5370; Popovic, Branka/0000-0002-2416-4793; Carlyle, James/0000-0002-3579-0300; Mahmoud, ahmad/0000-0002-1515-2352; Aguilar-Alfaro, Oscar Alberto/0000-0002-7990-8745; berry, richard/0000-0001-7043-0469; Balaji, Gautham/0000-0002-7436-4689; Makrigiannis, Andrew/0000-0002-7258-9411	Natural Sciences and Engineering Research Council of Canada (NSERC) Post-Graduate Scholarship-Doctoral Award; Canadian Institutes of Health Research (CIHR) Vanier Scholarship; Ontario Graduate Scholarship Award; National Health and Medical Research Council of Australia (NHMRC) Career Development Award [APP1109901]; Australian Research Council Laureate Fellowship [FL160100049]; Croatian Science Foundation [7132]; European Research Council [ERC 322693]; CIHR Operating Grants [86630, 106491]; Ontario Ministry of Research and Innovation [RE07-04-071]; CIHR New Investigator Award; Burroughs Wellcome Fund [1007761]	Natural Sciences and Engineering Research Council of Canada (NSERC) Post-Graduate Scholarship-Doctoral Award; Canadian Institutes of Health Research (CIHR) Vanier Scholarship(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship Award(Ontario Graduate Scholarship); National Health and Medical Research Council of Australia (NHMRC) Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Laureate Fellowship(Australian Research Council); Croatian Science Foundation; European Research Council(European Research Council (ERC)European Commission); CIHR Operating Grants(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); CIHR New Investigator Award(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	We would like to thank Drs. S. Vidal, M.G. Brown, K. Iizuka, W. Yokoyama, and T. Mallevaey for reagents and Y. Amemiya, G. Awong, and G. Knowles for services. We also acknowledge the Monash Macromolecular Crystallization Facility and the staff at the Australian Synchrotron. O.A.A. was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Post-Graduate Scholarship-Doctoral Award; A.M. by a Canadian Institutes of Health Research (CIHR) Vanier Scholarship; C.L.K. by an Ontario Graduate Scholarship Award. R.B. is a recipient of a National Health and Medical Research Council of Australia (NHMRC) Career Development Award (APP1109901). J.R. is a recipient of an Australian Research Council Laureate Fellowship (FL160100049). A.K. is supported by the Croatian Science Foundation (Grant #7132). S.J. is supported by an Advanced Grant from the European Research Council (ERC #322693). This work was supported by CIHR Operating Grants (#86630 to A.P.M. and J.R. C.; #106491 to J.R.C.), an Early Researcher Award from the Ontario Ministry of Research and Innovation (#RE07-04-071 to J.R.C.), a CIHR New Investigator Award (to J.R.C.), and an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund (#1007761 to J.R.C.).	Aguilar OA, 2015, J INNATE IMMUN, V7, P584, DOI 10.1159/000382032; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Berry R, 2014, J BIOL CHEM, V289, P23753, DOI 10.1074/jbc.M114.584128; Berry R, 2013, NAT IMMUNOL, V14, P699, DOI 10.1038/ni.2605; Carlyle JR, 2008, SEMIN IMMUNOL, V20, P321, DOI 10.1016/j.smim.2008.05.004; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Carlyle JR, 1999, J IMMUNOL, V162, P5917; Chen P, 2015, J IMMUNOL, V194, P2909, DOI 10.4049/jimmunol.1401523; Chen P, 2011, IMMUNOGENETICS, V63, P627, DOI 10.1007/s00251-011-0542-8; Fine JH, 2010, CANCER RES, V70, P7102, DOI 10.1158/0008-5472.CAN-10-1316; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Germain C, 2011, J BIOL CHEM, V286, P37964, DOI 10.1074/jbc.M111.285312; GLIMCHER L, 1977, J EXP MED, V145, P1, DOI 10.1084/jem.145.1.1; Kirkham CL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00214; Kolenko P, 2011, J STRUCT BIOL, V175, P434, DOI 10.1016/j.jsb.2011.05.001; KOO GC, 1984, HYBRIDOMA, V3, P301, DOI 10.1089/hyb.1984.3.301; Kveberg L, 2009, EUR J IMMUNOL, V39, P541, DOI 10.1002/eji.200838891; LANIER LL, 1994, J IMMUNOL, V153, P2417; Li YL, 2013, P NATL ACAD SCI USA, V110, P11505, DOI 10.1073/pnas.1303300110; Mesci A, 2007, J IMMUNOL METHODS, V323, P78, DOI 10.1016/j.jim.2007.02.007; Muller S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000723; Rahim MMA, 2016, J IMMUNOL, V197, P2325, DOI 10.4049/jimmunol.1600776; Rahim MMA, 2015, BLOOD, V125, P2217, DOI 10.1182/blood-2014-02-556142; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; RYAN JC, 1992, J IMMUNOL, V149, P1631; SCALZO AA, 1995, IMMUNOGENETICS, V41, P148, DOI 10.1007/BF00182328; Sgourakis NG, 2014, STRUCTURE, V22, P1263, DOI 10.1016/j.str.2014.05.018; Smith LM, 2013, VIROLOGY, V435, P258, DOI 10.1016/j.virol.2012.08.041; Voigt S, 2007, IMMUNITY, V26, P617, DOI 10.1016/j.immuni.2007.03.013; Wagner Markus, 2004, Methods Mol Biol, V256, P257; Wang R, 2012, P NATL ACAD SCI USA, V109, pE3578, DOI 10.1073/pnas.1214088109; Williams KJN, 2012, J IMMUNOL, V188, P4980, DOI 10.4049/jimmunol.1103425	34	48	48	4	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					58	+		10.1016/j.cell.2017.03.002	http://dx.doi.org/10.1016/j.cell.2017.03.002			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340350	Bronze, Green Published			2022-12-28	WOS:000397090000008
J	Bertagnolli, MM; Sartor, O; Chabner, BA; Rothenberg, ML; Khozin, S; Hugh-Jones, C; Reese, DM; Murphy, MJ				Bertagnolli, Monica M.; Sartor, Oliver; Chabner, Bruce A.; Rothenberg, Mace L.; Khozin, Sean; Hugh-Jones, Charles; Reese, David M.; Murphy, Martin J.			Advantages of a Truly Open-Access Data-Sharing Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PROSTATE-CANCER		[Bertagnolli, Monica M.] Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA; [Chabner, Bruce A.] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Sartor, Oliver] Tulane Med Sch, New Orleans, LA USA; [Rothenberg, Mace L.] Pfizer, New York, NY USA; [Hugh-Jones, Charles] Carmine Res, New York, NY USA; [Khozin, Sean] US FDA, Silver Spring, MD USA; [Reese, David M.] Amgen Inc, Thousand Oaks, CA USA; [Murphy, Martin J.] Project Data Sphere, Cary, NC USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Tulane University; Pfizer; US Food & Drug Administration (FDA); Amgen	Bertagnolli, MM (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, 75 Francis St, Boston, MA 02115 USA.			Khozin, Sean/0000-0003-2206-7620				Geifman N, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.27; Guinney J, 2017, LANCET ONCOL, V18, P132, DOI 10.1016/S1470-2045(16)30560-5; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; Pitcher B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170544; Rockhold F, 2016, NEW ENGL J MED, V375, P1115, DOI 10.1056/NEJMp1608086; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tenopir C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021101; Wilkerson J, 2017, LANCET ONCOL, V18, P143, DOI 10.1016/S1470-2045(16)30633-7	8	56	56	2	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2017	376	12					1178	1181		10.1056/NEJMsb1702054	http://dx.doi.org/10.1056/NEJMsb1702054			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO9NB	28328337				2022-12-28	WOS:000397014300018
J	Liu, FY; Zhang, Z; Csanady, L; Gadsby, DC; Chen, J				Liu, Fangyu; Zhang, Zhe; Csanady, Laszlo; Gadsby, David C.; Chen, Jue			Molecular Structure of the Human CFTR Ion Channel	CELL			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; CHLORIDE CHANNEL; POSITIVE CHARGES; ALLOSTERIC MODULATION; STRUCTURE VALIDATION; MEMBRANE-PROTEINS; FUNCTIONAL ROLES; OUTER MOUTH; ATP-BINDING	The cystic fibrosis transmembrane conductance regulator (CFTR) is an ATP- binding cassette (ABC) transporter that uniquely functions as an ion channel. Here, we present a 3.9 angstrom structure of dephosphorylated human CFTR without nucleotides, determined by electron cryomicroscopy (cryo- EM). Close resemblance of this human CFTR structure to zebrafish CFTR under identical conditions reinforces its relevance for understanding CFTR function. The human CFTR structure reveals a previously unresolved helix belonging to the R domain docked inside the intracellular vestibule, precluding channel opening. By analyzing the sigmoid time course of CFTR current activation, we propose that PKA phosphorylation of the R domain is enabled by its infrequent spontaneous disengagement, which also explains residual ATPase and gating activity of dephosphorylated CFTR. Fromcomparison with MRP1, a feature distinguishing CFTR from all other ABC transporters is the helix- loop transition in transmembrane helix 8, which likely forms the structural basis for CFTR's channel function.	[Liu, Fangyu; Zhang, Zhe; Chen, Jue] Rockefeller Univ, Lab Membrane Biophys & Biol, 1230 York Ave, New York, NY 10065 USA; [Liu, Fangyu] Rockefeller Univ, Triinst Training Program Chem Biol, 1230 York Ave, New York, NY 10065 USA; [Zhang, Zhe; Chen, Jue] Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA; [Csanady, Laszlo] Semmelweis Univ, Dept Med Biochem, H-1094 Budapest, Hungary; [Gadsby, David C.] Semmelweis Univ, MTA SE Ion Channel Res Grp, H-1094 Budapest, Hungary; [Liu, Fangyu; Zhang, Zhe] Rockefeller Univ, Lab Cardiac Membrane Physiol, 1230 York Ave, New York, NY 10065 USA	Rockefeller University; Rockefeller University; Howard Hughes Medical Institute; Semmelweis University; Semmelweis University; Rockefeller University	Chen, J (corresponding author), Rockefeller Univ, Lab Membrane Biophys & Biol, 1230 York Ave, New York, NY 10065 USA.; Chen, J (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	juechen@rockefeller.edu	Csanády, László/O-5784-2017	Csanády, László/0000-0002-6547-5889	Rockefeller University; Howard Hughes Medical Institute; MTA-Momentum [LP2012-39/2012]; Cystic Fibrosis Foundation [CSANAD15G0]	Rockefeller University; Howard Hughes Medical Institute(Howard Hughes Medical Institute); MTA-Momentum; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	We thank Eric Gouaux for the expression vector, Mark Ebrahim and Johanna Sotiris at the Rockefeller Evelyn Gruss Lipper Cryo-Electron Microscopy Resource Center for assistance in data collection, and Sarah McCarry for editing this manuscript. This work is supported by the Rockefeller University (to J.C. and D.C.G), the Howard Hughes Medical Institute (to J. C.), and MTA-Momentum (LP2012-39/2012) and Cystic Fibrosis Foundation (CSANAD15G0) grants (to L.C.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Boat TF., 1989, CYSTIC FIBROSIS META, V6th, P2649; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Cai ZW, 2015, J PHYSIOL-LONDON, V593, P2427, DOI 10.1113/JP270227; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Csanady L, 2005, J GEN PHYSIOL, V125, P43, DOI 10.1085/jgp.200409174; Csanady L, 2005, J GEN PHYSIOL, V125, P171, DOI 10.1085/jgp.200409076; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; Csanady L, 2000, J GEN PHYSIOL, V116, P477, DOI 10.1085/jgp.116.3.477; Csanady L, 2010, P NATL ACAD SCI USA, V107, P1241, DOI 10.1073/pnas.0911061107; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; El Hiani Y, 2015, J BIOL CHEM, V290, P15855, DOI 10.1074/jbc.M115.656181; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank GA, 2016, MOL PHARMACOL, V90, P35, DOI 10.1124/mol.116.104190; Gadsby David C., 1999, Physiological Reviews, V79, pS77; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Ge N, 2004, J BIOL CHEM, V279, P55283, DOI 10.1074/jbc.M411935200; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Gong XD, 2003, J GEN PHYSIOL, V122, P673, DOI 10.1085/jgp.200308889; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Grigorieff N, 2016, METHOD ENZYMOL, V579, P191, DOI 10.1016/bs.mie.2016.04.013; GUNDERSON KL, 1995, CELL, V82, P231, DOI 10.1016/0092-8674(95)90310-0; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KOPELMAN H, 1995, AM J PHYSIOL-CELL PH, V269, pC626, DOI 10.1152/ajpcell.1995.269.3.C626; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Linsdell P, 2017, CELL MOL LIFE SCI, V74, P67, DOI 10.1007/s00018-016-2389-5; MAGLEBY KL, 1983, J PHYSIOL-LONDON, V344, P605, DOI 10.1113/jphysiol.1983.sp014958; MARSHALL J, 1991, J BIOL CHEM, V266, P22749; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mihalyi C, 2016, ELIFE, V5, DOI 10.7554/eLife.18164; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Price MP, 1996, J BIOL CHEM, V271, P25184, DOI 10.1074/jbc.271.41.25184; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rubinstein JL, 2015, J STRUCT BIOL, V192, P188, DOI 10.1016/j.jsb.2015.08.007; SCHARSCHMIDT BF, 1979, J LAB CLIN MED, V93, P790; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Sebastian A, 2013, GENE, V523, P137, DOI 10.1016/j.gene.2013.02.050; Singer TD, 1998, AM J PHYSIOL-CELL PH, V274, pC715, DOI 10.1152/ajpcell.1998.274.3.C715; Smart O. S., 1996, J MOL GRAPHICS, V14, P376, DOI [DOI 10.1016/S0263-7855(97)00009-X, 10.1016/S0263-7855119000009-21]; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; TENEYCK LF, 1977, ACTA CRYSTALLOGR A, V33, P486, DOI 10.1107/S0567739477001211; Theodoulou FL, 2015, BIOCHEM SOC T, V43, P1033, DOI 10.1042/BST20150139; Vasiliou Vasilis, 2009, Human Genomics, V3, P281; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; Wang Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5808; Ward AB, 2013, P NATL ACAD SCI USA, V110, P13386, DOI 10.1073/pnas.1309275110; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wilkinson DJ, 1997, AM J PHYSIOL-LUNG C, V273, pL127, DOI 10.1152/ajplung.1997.273.1.L127; Zhang JY, 2015, BIOCHEMISTRY-US, V54, P3839, DOI 10.1021/acs.biochem.5b00427; Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014; Zhou JJ, 2007, J MEMBRANE BIOL, V216, P129, DOI 10.1007/s00232-007-9056-6; Zhou JJ, 2010, J GEN PHYSIOL, V135, P229, DOI 10.1085/jgp.200910327; Zhou JJ, 2008, PFLUG ARCH EUR J PHY, V457, P351, DOI 10.1007/s00424-008-0521-6	75	269	270	5	158	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					85	+		10.1016/j.cell.2017.02.024	http://dx.doi.org/10.1016/j.cell.2017.02.024			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340353	Bronze			2022-12-28	WOS:000397090000010
J	Manolio, TA; Fowler, DM; Starita, LM; Haendel, MA; MacArthur, DG; Biesecker, LG; Worthey, E; Chisholm, RL; Green, ED; Jacob, HJ; McLeod, HL; Roden, D; Rodriguez, LL; Williams, MS; Cooper, GM; Cox, NJ; Herman, GE; Kingsmore, S; Lo, C; Lutz, C; MacRae, CA; Nussbaum, RL; Ordovas, JM; Ramos, EM; Robinson, PN; Rubinstein, WS; Seidman, C; Stranger, BE; Wang, HY; Westerfield, M; Bult, C				Manolio, Teri A.; Fowler, Douglas M.; Starita, Lea M.; Haendel, Melissa A.; MacArthur, Daniel G.; Biesecker, Leslie G.; Worthey, Elizabeth; Chisholm, Rex L.; Green, Eric D.; Jacob, Howard J.; McLeod, Howard L.; Roden, Dan; Rodriguez, Laura Lyman; Williams, Marc S.; Cooper, Gregory M.; Cox, Nancy J.; Herman, Gail E.; Kingsmore, Stephen; Lo, Cecilia; Lutz, Cathleen; MacRae, Calum A.; Nussbaum, Robert L.; Ordovas, Jose M.; Ramos, Erin M.; Robinson, Peter N.; Rubinstein, Wendy S.; Seidman, Christine; Stranger, Barbara E.; Wang, Haoyi; Westerfield, Monte; Bult, Carol			Bedside Back to Bench: Building Bridges between Basic and Clinical Genomic Research	CELL			English	Editorial Material							VARIANTS; ASSOCIATION; DISORDERS; GENETICS; DISEASES; EXOME	Genome sequencing has revolutionized the diagnosis of genetic diseases. Close collaborations between basic scientists and clinical genomicists are now needed to link genetic variants with disease causation. To facilitate such collaborations, we recommend prioritizing clinically relevant genes for functional studies, developing reference variant- phenotype databases, adopting phenotype description standards, and promoting data sharing.	[Manolio, Teri A.; Biesecker, Leslie G.; Green, Eric D.; Rodriguez, Laura Lyman; Ramos, Erin M.] NHGRI, NIH, Bethesda, MD 20892 USA; [Fowler, Douglas M.; Starita, Lea M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Haendel, Melissa A.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97239 USA; [MacArthur, Daniel G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Worthey, Elizabeth; Jacob, Howard J.; Cooper, Gregory M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Chisholm, Rex L.] Northwestern Univ, Feinberg Sch Med, Ctr Genet Med, Chicago, IL 60611 USA; [McLeod, Howard L.] H Lee Moffitt Canc Ctr & Res Inst, DeBartolo Family Personalized Med Inst, Tampa, FL 33612 USA; [Roden, Dan] Vanderbilt Univ, Med Ctr, Dept Med Pharmacol & Biomed Informat, Nashville, TN 37203 USA; [Williams, Marc S.] Geisinger Hlth Syst, Genom Med Inst, Danville, PA 17822 USA; [Cox, Nancy J.] Vanderbilt Univ, Med Ctr, Div Med Genet, Nashville, TN 37203 USA; [Herman, Gail E.] Nationwide Childrens Hosp, Res Inst, Inst Genom Med, Columbus, OH 43205 USA; [Kingsmore, Stephen] Rady Childrens Inst Genom Med, San Diego, CA 92123 USA; [Lo, Cecilia] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 1526 USA; [Lutz, Cathleen] Jackson Lab Mammalian Genet, Rare & Orphan Dis Ctr, Bar Harbor, ME 04609 USA; [MacRae, Calum A.] Brigham & Womens Hosp, Network Med & Genet, Div Cardiovasc Med, Boston, MA 02115 USA; [Nussbaum, Robert L.] Invitae Genet Informat & Testing Co, San Francisco, CA 94107 USA; [Ordovas, Jose M.] Tufts Univ, JM USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Robinson, Peter N.] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Rubinstein, Wendy S.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA; [Seidman, Christine] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Seidman, Christine] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Seidman, Christine] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Stranger, Barbara E.] Univ Chicago, Ctr Data Intens Sci, Inst Genom & Syst Biol, Dept Med,Sect Genet Med, Chicago, IL 60637 USA; [Wang, Haoyi; Bult, Carol] Jackson Lab Mammalian Genet, Bar Harbor, ME 04609 USA; [Westerfield, Monte] Univ Oregon, Dept Biol, Portland, OR 97403 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle; Oregon Health & Science University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; HudsonAlpha Institute for Biotechnology; Northwestern University; Feinberg School of Medicine; H Lee Moffitt Cancer Center & Research Institute; Vanderbilt University; Geisinger Health System; Vanderbilt University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jackson Laboratory; Harvard University; Brigham & Women's Hospital; Tufts University; United States Department of Agriculture (USDA); Jackson Laboratory; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; University of Chicago; Jackson Laboratory; University of Oregon	Manolio, TA (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.	manolio@nih.gov	McLeod, Howard/ABD-8364-2021; Roden, Dan/ABD-5412-2021; Biesecker, Leslie/AAG-2526-2021; Chisholm, Rex/B-3418-2009; Cooper, Gregory/D-6914-2011	McLeod, Howard/0000-0002-9004-9232; MacArthur, Daniel/0000-0002-5771-2290; Chisholm, Rex/0000-0002-5638-3990; Kingsmore, Stephen/0000-0001-7180-2527; Cooper, Gregory/0000-0001-5509-9923	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007943, UM1HG007301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM115277, R01GM109110] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD011883, R24OD017870, U42OD010921] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HG999999] Funding Source: Medline; NHGRI NIH HHS [U01 HG007943, UM1 HG007301] Funding Source: Medline; NIGMS NIH HHS [R24 GM115277, R01 GM109110] Funding Source: Medline; NIH HHS [R24 OD017870, U42 OD010921, R24 OD011883] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cooper GM, 2015, GENOME RES, V25, P1423, DOI 10.1101/gr.190116.115; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Gahl WA, 2016, MOL GENET METAB, V117, P393, DOI 10.1016/j.ymgme.2016.01.007; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hunter JE, 2016, GENET MED, V18, P1258, DOI 10.1038/gim.2016.40; Landrum MJ, 2016, NUCLEIC ACIDS RES, V44, pD862, DOI 10.1093/nar/gkv1222; Ledford H, 2015, NATURE, V522, P20, DOI 10.1038/522020a; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Ritter DI, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0367-z; Schughart K, 2013, EUR J HUM GENET, V21, P1191, DOI 10.1038/ejhg.2013.79; Starita LM, 2015, GENETICS, V200, P413, DOI 10.1534/genetics.115.175802; Willig LK, 2015, LANCET RESP MED, V3, P377, DOI 10.1016/S2213-2600(15)00139-3; Yamamoto S, 2014, CELL, V159, P200, DOI 10.1016/j.cell.2014.09.002; Yang YP, 2014, JAMA-J AM MED ASSOC, V312, P1870, DOI 10.1001/jama.2014.14601	15	70	70	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					6	12		10.1016/j.cell.2017.03.005	http://dx.doi.org/10.1016/j.cell.2017.03.005			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340351	Green Accepted, Bronze			2022-12-28	WOS:000397090000003
J	Trabesinger, A				Trabesinger, Andreas			QUANTUM LEAPS, BIT BY BIT	NATURE			English	Editorial Material													Trabesinger, Andreas/J-2008-2016	Trabesinger, Andreas/0000-0003-3078-8399					0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					S2	S3		10.1038/543S2a	http://dx.doi.org/10.1038/543S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO9OM	28328868	Bronze			2022-12-28	WOS:000397018000002
J	Yan, WD				Yan, Wudan			A MAKEOVER FOR THE WORLD'S MOST HATED CROP	NATURE			English	Editorial Material							OIL PALM											Ong-Abdullah M, 2015, NATURE, V525, P533, DOI 10.1038/nature15365; Ooi LCL, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.00771, 10.3389/fpls.2016.00771]; Singh R, 2013, NATURE, V500, P340, DOI 10.1038/nature12356	3	23	23	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2017	543	7645					306	308		10.1038/543306a	http://dx.doi.org/10.1038/543306a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EN9RN	28300119	Bronze			2022-12-28	WOS:000396337400013
J	Yin, P; He, GJ; Fan, MY; Chiu, KY; Fan, MR; Liu, C; Xue, A; Liu, T; Pan, YH; Mu, Q; Zhou, MG				Yin, Peng; He, Guojun; Fan, Maoyong; Chiu, Kowk Yan; Fan, Maorong; Liu, Chang; Xue, An; Liu, Tong; Pan, Yuhang; Mu, Quan; Zhou, Maigeng			Particulate air pollution and mortality in 38 of China's largest cities: time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EXPOSURE-RESPONSE FUNCTIONS; US CITIES; METAANALYSIS	Objectives To estimate the short term effect of particulate air pollution (particle diameter < 10 mu m, or PM10) on mortality and explore the heterogeneity of particulate air pollution effects in major cities in China. Design Generalised linear models with different lag structures using time series data. Setting 38 of the largest cities in 27 provinces of China (combined population > 200 million). Participants 350 638 deaths (200 912 in males, 149 726 in females) recorded in 38 city districts by the Disease Surveillance Point System of the Chinese Center for Disease Control and Prevention from 1 January 2010 to 29 June 2013. Main outcome measure Daily numbers of deaths from all causes, cardiorespiratory diseases, and non-cardiorespiratory diseases and among different demographic groups were used to estimate the associations between particulate air pollution and mortality. Results A 10 mu g/m(3) change in concurrent day PM10 concentrations was associated with a 0.44% (95% confidence interval 0.30% to 0.58%) increase in daily number of deaths. Previous day and two day lagged PM10 levels decreased in magnitude by one third and two thirds but remained statistically significantly associated with increased mortality. The estimate for the effect of PM10 on deaths from cardiorespiratory diseases was 0.62% (0.43% to 0.81%) per 10 mu g/m(3) compared with 0.26% (0.09% to 0.42%) for other cause mortality. Exposure to PM10 had a greater impact on females than on males. Adults aged 60 and over were more vulnerable to particulate air pollution at high levels than those aged less than 60. The PM10 effect varied across different cities and marginally decreased in cities with higher PM10 concentrations. Conclusion Particulate air pollution has a greater impact on deaths from cardiorespiratory diseases than it does on other cause mortality. People aged 60 or more have a higher risk of death from particulate air pollution than people aged less than 60. The estimates of the effect varied across cities and covered a wide range of domain.	[Yin, Peng; Zhou, Maigeng] Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China; [He, Guojun] Hong Kong Univ Sci & Technol, Div Social Sci, Div Environm, Hong Kong, Hong Kong, Peoples R China; [He, Guojun] Hong Kong Univ Sci & Technol, Dept Econ, Hong Kong, Hong Kong, Peoples R China; [Fan, Maoyong] Ball State Univ, Miller Coll Business, Dept Econ, Muncie, IN 47306 USA; [Chiu, Kowk Yan; Liu, Tong; Pan, Yuhang] Hong Kong Univ Sci & Technol, Div Environm, Hong Kong, Hong Kong, Peoples R China; [Fan, Maorong] China Acad Chinese Med Sci, Dept Resp Med, Xiyuan Hosp, Beijing, Peoples R China; [Liu, Chang] Georgia Tech, Dept Finance, Scheller Coll Business, Atlanta, GA USA; [Xue, An] Peking Univ, Dept Environm Engn, Coll Environm Sci & Engn, Beijing, Peoples R China; [Mu, Quan] Nature Conservancy, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for Chronic & Noncommunicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Ball State University; Hong Kong University of Science & Technology; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; University System of Georgia; Georgia Institute of Technology; Peking University; Nature Conservancy	Zhou, MG (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr Chron & Noncommunicable Dis Control & Pr, Beijing, Peoples R China.	maigengzhou@126.com	Yin, Peng/AFP-5157-2022; Zhou, Maigeng/HCH-7703-2022	He, Guojun/0000-0003-2391-9493; Pan, Yuhang/0000-0002-0138-0063	Hong Kong University of Science and Technology [SBI15HS06]; China National Science and Technology Pillar programme [2013BAI04B02]	Hong Kong University of Science and Technology; China National Science and Technology Pillar programme	The study was supported by the School-Based Initiative research grant (SBI15HS06) from the Hong Kong University of Science and Technology and China National Science and Technology Pillar programme 2013 (2013BAI04B02). The funders were not involved in the research and preparation of the article, including study design; collection, analysis, and interpretation of data; writing of the article; nor in the decision to submit it for publication.	Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Aunan K, 2004, SCI TOTAL ENVIRON, V329, P3, DOI 10.1016/j.scitotenv.2004.03.008; Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dominici F, 2000, J ROY STAT SOC A STA, V163, P263, DOI 10.1111/1467-985X.00170; Dominici F, 2004, J AM STAT ASSOC, V99, P938, DOI 10.1198/016214504000000656; Gu C, 2013, SPRINGER SER STAT, V297, P1, DOI 10.1007/978-1-4614-5369-7; Ito K, 2020, J POLIT ECON, V128, P1627, DOI 10.1086/705554; Kan HD, 2005, BIOMED ENVIRON SCI, V18, P159; Kassebaum NJ, 2014, LANCET, V384, P956; Katsouyanni K, 2001, EPIDEMIOLOGY, V12, P521, DOI 10.1097/00001648-200109000-00011; Lai HK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-360; Lu F, 2015, ENVIRON RES, V136, P196, DOI 10.1016/j.envres.2014.06.029; Marchal V., 2011, OECD ENV OUTLOOK 205; Ouyang YD, 2013, LANCET RESP MED, V1, P12, DOI 10.1016/S2213-2600(12)70065-6; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Samet JM, 2000, NEW ENGL J MED, V343, P1742, DOI 10.1056/NEJM200012143432401; Shang Y, 2013, ENVIRON INT, V54, P100, DOI 10.1016/j.envint.2013.01.010; Walker E, 2008, CLEV CLIN J MED, V75, P431, DOI 10.3949/ccjm.75.6.431; Zhou MG, 2015, ENVIRON RES, V136, P396, DOI 10.1016/j.envres.2014.09.038	21	79	83	0	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 14	2017	356								j667	10.1136/bmj.j667	http://dx.doi.org/10.1136/bmj.j667			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NH	28292780	Green Published, hybrid			2022-12-28	WOS:000397014900001
J	Chesnaye, NC; Schaefer, F; Bonthuis, M; Holman, R; Baiko, S; Baskin, E; Bjerre, A; Cloarec, S; Cornelissen, EAM; Espinosa, L; Heaf, J; Stone, R; Shtiza, D; Zagozdzon, I; Harambat, J; Jager, KJ; Groothoff, JW; van Stralen, KJ				Chesnaye, Nicholas C.; Schaefer, Franz; Bonthuis, Marjolein; Holman, Rebecca; Baiko, Sergey; Baskin, Esra; Bjerre, Anna; Cloarec, Sylvie; Cornelissen, Elisabeth A. M.; Espinosa, Laura; Heaf, James; Stone, Rosario; Shtiza, Diamant; Zagozdzon, Ilona; Harambat, Jerome; Jager, Kitty J.; Groothoff, Jaap W.; van Stralen, Karlijn J.		ESPN ERA-EDTA Registry Committee	Mortality risk disparities in children receiving chronic renal replacement therapy for the treatment of end-stage renal disease across Europe: an ESPN-ERA/EDTA registry analysis	LANCET			English	Article							BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; MULTILEVEL ANALYSIS; SURVIVAL; DIALYSIS	Background We explored the variation in country mortality rates in the paediatric population receiving renal replacement therapy across Europe, and estimated how much of this variation could be explained by patient-level and country-level factors. Methods In this registry analysis, we extracted patient data from the European Society for Paediatric Nephrology/European Renal Association-European Dialysis and Transplant Association (ESPN/ERA-EDTA) Registry for 32 European countries. We included incident patients younger than 19 years receiving renal replacement therapy. Adjusted hazard ratios (aHR) and the explained variation were modelled for patient-level and country-level factors with multilevel Cox regression. The primary outcome studied was all-cause mortality while on renal replacement therapy. Findings Between Jan 1, 2000, and Dec 31, 2013, the overall 5 year renal replacement therapy mortality rate was 15.8 deaths per 1000 patient-years (IQR 6.4-16.4). France had a mortality rate (9.2) of more than 3 SDs better, and Russia (35.2), Poland (39.9), Romania (47.4), and Bulgaria (68.6) had mortality rates more than 3 SDs worse than the European average. Public health expenditure was inversely associated with mortality risk (per SD increase, aHR 0.69, 95% CI 0.52-0.91) and explained 67% of the variation in renal replacement therapy mortality rates between countries. Child mortality rates showed a significant association with renal replacement therapy mortality, albeit mediated by macroeconomics (eg, neonatal mortality reduced from 1.31 [95% CI 1.13-1.53], p=0.0005, to 1.21 [0.97-1.51], p=0.10). After accounting for country distributions of patient age, the variation in renal replacement therapy mortality rates between countries increased by 21%. Interpretation Substantial international variation exists in paediatric renal replacement therapy mortality rates across Europe, most of which was explained by disparities in public health expenditure, which seems to limit the availability and quality of paediatric renal care. Differences between countries in their ability to accept and treat the youngest patients, who are the most complex and costly to treat, form an important source of disparity within this population. Our findings can be used by policy makers and health-care providers to explore potential strategies to help reduce these health disparities. Funding ERA-EDTA and ESPN.	[Chesnaye, Nicholas C.; Bonthuis, Marjolein; Jager, Kitty J.; van Stralen, Karlijn J.] ESPN ERA EDTA Registry, Amsterdam, Netherlands; [Jager, Kitty J.] ERA EDTA Registry, Amsterdam, Netherlands; [Schaefer, Franz] Heidelberg Univ, Ctr Paediat & Adolescent Med, Div Paediat Nephrol, Heidelberg, Germany; [Holman, Rebecca] Acad Med Ctr, Dept Med Informat, Amsterdam, Netherlands; [Holman, Rebecca] Acad Med Ctr, Clin Res Unit, Amsterdam, Netherlands; [Baiko, Sergey] Belarusian State Med Univ, Dept Paediat, Minsk, BELARUS; [Baskin, Esra] Baskent Univ, Dept Paediat Nephrol, Ankara, Turkey; [Bjerre, Anna] Natl Hosp Norway, Oslo Univ Hosp, Dept Paediat, Oslo, Norway; [Cloarec, Sylvie] Hop Clocheville, CHU Tours, Serv Nephrol Pediat, Tours, France; [Cornelissen, Elisabeth A. M.] Radboud Univ Nijmegen, Med Ctr, Dept Paediat Nephrol, Nijmegen, Netherlands; [Espinosa, Laura] Univ Hosp La Paz, Paediat Nephrol, Madrid, Spain; [Heaf, James] Zealand Univ Hosp, Dept Med, Roskilde, Denmark; [Stone, Rosario] Hosp Sta Maria, Unidade Nefrol & Transplantacao Renal, Dept Pediat, Ctr Acad Med Lisboa, Lisbon, Portugal; [Shtiza, Diamant] Univ Hosp Ctr Mother Tereza, Dept Paediat, Nephrol Unit, Tirana, Albania; [Zagozdzon, Ilona] Med Univ Gdansk, Dept Paediat Nephrol & Hypertens, Gdansk, Poland; [Harambat, Jerome] Bordeaux Univ Hosp, Dept Paediat, Bordeaux, France; [Groothoff, Jaap W.] Emma Childrens Hosp, Acad Med Ctr, Dept Paediat Nephrol, Amsterdam, Netherlands	Ruprecht Karls University Heidelberg; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Belarusian State Medical University; Baskent University; University of Oslo; National Hospital Norway; CHU Tours; Radboud University Nijmegen; Hospital Universitario La Paz; Universidade de Lisboa; Hospital Santa Maria; Fahrenheit Universities; Medical University Gdansk; CHU Bordeaux; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Jager, KJ (corresponding author), Acad Med Ctr, Dept Med Informat, NL-1100 DE Amsterdam, Netherlands.	k.j.jager@amc.uva.nl	Harambat, Jérôme/T-1371-2019; Chesnaye, Nicholas/G-5707-2013; Harambat, Jérôme/A-3359-2016; Baiko, Sergey/CAJ-5056-2022; Baskin, Esra/B-5785-2018; Cornelissen, Elisabeth AM/F-3618-2015	Chesnaye, Nicholas/0000-0003-4883-9174; Baskin, Esra/0000-0003-4361-8508; Cornelissen, Elisabeth AM/0000-0002-1156-5264; Stone, Rosario/0000-0002-7939-836X; van Stralen, Karlijn/0000-0002-3243-2970; Jager, Kitty/0000-0003-0444-8569	ERA-EDTA; ESPN	ERA-EDTA; ESPN	ERA-EDTA and ESPN.	Aelvoet W, 2016, INT J QUAL HEALTH C, V28, P22, DOI 10.1093/intqhc/mzv092; Buchan J, HLTH WORKER MIGRATIO; Buchan J., 2006, MIGRATION HLTH WORKE; Chesnaye NC, 2015, NEPHROL DIAL TRANSPL, P1; Chesnaye N, 2014, PEDIATR NEPHROL, V29, P2403, DOI 10.1007/s00467-014-2884-6; Covic A, 2010, CLIN NEPHROL, V74, pS23; Dussault G, MIGRATION HLTH PERSO; Ehrich JHH, 2005, NEPHROL DIAL TRANSPL, V20, P297, DOI 10.1093/ndt/gfh299; ERA-EDTA Registry, 2013, ERA EDTA REG ANN REP; Jager KJ, 2008, KIDNEY INT, V73, P256, DOI 10.1038/sj.ki.5002650; Kramer A, 2012, CLIN J AM SOC NEPHRO, V7, P1655, DOI 10.2215/CJN.10461011; Legrand C, 2006, CLIN TRIALS, V3, P10, DOI 10.1191/1740774506cn132oa; McDonald SP, 2004, NEW ENGL J MED, V350, P2654, DOI 10.1056/NEJMoa031643; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P729, DOI 10.1136/jech.2004.023929; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Neuhaus T J, 1998, Praxis (Bern 1994), V87, P1593; Robinson BM, 2014, KIDNEY INT, V85, P158, DOI 10.1038/ki.2013.252; Rutkowski B, 2006, NEPHROL DIAL TRANSPL, V21, P4, DOI 10.1093/ndt/gfi251; Schaefer F, 2012, PERITON DIALYSIS INT, V32, P399, DOI 10.3747/pdi.2012.00126; Spiegelhalter DJ, 2005, STAT MED, V24, P1185, DOI 10.1002/sim.1970; Suicide, 2012, HLTH GLANC EUR 2012, P28; van Dijk PCW, 2007, KIDNEY INT, V71, P53, DOI 10.1038/sj.ki.5002008	22	29	29	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 27	2017	389	10084					2128	2137		10.1016/S0140-6736(17)30063-6	http://dx.doi.org/10.1016/S0140-6736(17)30063-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV7QE	28336050				2022-12-28	WOS:000401973300031
J	Gudbranson, E; Glickman, A; Emanuel, EJ				Gudbranson, Emily; Glickman, Aaron; Emanuel, Ezekiel J.			Reassessing the Data on Whether a Physician Shortage Exists	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gudbranson, Emily; Glickman, Aaron; Emanuel, Ezekiel J.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 3401 Market St,Ste 320, Philadelphia, PA 19104 USA; [Emanuel, Ezekiel J.] Univ Penn Wharton Sch, Dept Hlth Care Management, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Emanuel, EJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, 3401 Market St,Ste 320, Philadelphia, PA 19104 USA.	mehpchair@upenn.edu						Accreditation Council for Graduate Medical Education, 2016, ACGME DAT RES BOOK; [Anonymous], 2009, SURV PHYS APP TIM; [Anonymous], 2016, FED SUBS HLTH INS CO; Association of American Medical Colleges, 2017, NEW RES REAFF LOOM P; Association of American Medical Colleges, 2016, RES 2015 MED SCH ENR; Kaiser Family Foundation, 2016, PRIM CAR PHYS FIELD; Medical Group Management Association, 2013, DEF PAT PAN IMPR PRA; Osborn R, 2013, INT HLTH POLICY SURV; Sargen M, 2011, J AM COLL SURGEONS, V212, P991, DOI 10.1016/j.jamcollsurg.2011.03.005; Tipirneni R, 2016, AM J MANAG CARE, V22, P427	10	36	36	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 16	2017	317	19					1945	1946		10.1001/jama.2017.2609	http://dx.doi.org/10.1001/jama.2017.2609			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU8VB	28319245				2022-12-28	WOS:000401315500009
J	West, KM; Blacksher, E; Burke, W				West, Kathleen McGlone; Blacksher, Erika; Burke, Wylie			Genomics, Health Disparities, and Missed Opportunities for the Nation's Research Agenda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[West, Kathleen McGlone] Univ Washington, Inst Publ Hlth Genet, Dept Bioeth & Humanities, Seattle, WA 98195 USA; [Blacksher, Erika; Burke, Wylie] Univ Washington, Dept Bioeth & Humanities, Box 357120, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Burke, W (corresponding author), Univ Washington, Dept Bioeth & Humanities, Box 357120, Seattle, WA 98195 USA.	wburke@u.washington.edu			National Human Genome Research Institute of the National Institutes of Health (NIH) [P50 HG003374]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003374] Funding Source: NIH RePORTER	National Human Genome Research Institute of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by grant P50 HG003374 from the National Human Genome Research Institute of the National Institutes of Health (NIH).	Braveman P, 2011, ANNU REV PUBL HEALTH, V32, P381, DOI 10.1146/annurev-publhealth-031210-101218; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; McGinnis JM, 2002, HEALTH AFFAIR, V21, P78, DOI 10.1377/hlthaff.21.2.78; Peralta CA, 2016, J AM SOC NEPHROL, V27, P887, DOI 10.1681/ASN.2015020124; Pui CH, 2003, JAMA-J AM MED ASSOC, V290, P2001, DOI 10.1001/jama.290.15.2001; Rotimi C, 2013, GENOME MED, V5, DOI 10.1186/gm465; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; Woolf SH, 2007, AM J PUBLIC HEALTH, V97, P679, DOI 10.2105/AJPH.2005.084848	9	51	51	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2017	317	18					1831	1832		10.1001/jama.2017.3096	http://dx.doi.org/10.1001/jama.2017.3096			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU2FK	28346599	Green Accepted			2022-12-28	WOS:000400842400009
J	Dudchenko, O; Batra, SS; Omer, AD; Nyquist, SK; Hoeger, M; Durand, NC; Shamim, MS; Machol, I; Lander, ES; Aiden, AP; Aiden, EL				Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Nyquist, Sarah K.; Hoeger, Marie; Durand, Neva C.; Shamim, Muhammad S.; Machol, Ido; Lander, Eric S.; Aiden, Aviva Presser; Aiden, Erez Lieberman			De novo assembly of the Aedes aegypti genome using Hi-C yields chromosome-length scaffolds	SCIENCE			English	Article							MAMMALIAN GENOMES; LINKAGE MAP; SEQUENCE; PRINCIPLES; EVOLUTION; PROVIDES; VECTOR; SYSTEM	The Zika outbreak, spread by the Aedes aegypti mosquito, highlights the need to create high-quality assemblies of large genomes in a rapid and cost-effective way. Here we combine Hi-C data with existing draft assemblies to generate chromosome-length scaffolds. We validate this method by assembling a human genome, de novo, from short reads alone (67x coverage). We then combine our method with draft sequences to create genome assemblies of the mosquito disease vectors Ae. aegypti and Culex quinquefasciatus, each consisting of three scaffolds corresponding to the three chromosomes in each species. These assemblies indicate that almost all genomic rearrangements among these species occur within, rather than between, chromosome arms. The genome assembly procedure we describe is fast, inexpensive, and accurate, and can be applied to many species.	[Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Nyquist, Sarah K.; Hoeger, Marie; Durand, Neva C.; Shamim, Muhammad S.; Machol, Ido; Aiden, Aviva Presser; Aiden, Erez Lieberman] Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA; [Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Durand, Neva C.; Shamim, Muhammad S.; Machol, Ido; Aiden, Aviva Presser; Aiden, Erez Lieberman] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Dudchenko, Olga; Batra, Sanjit S.; Omer, Arina D.; Nyquist, Sarah K.; Hoeger, Marie; Durand, Neva C.; Shamim, Muhammad S.; Machol, Ido; Aiden, Erez Lieberman] Rice Univ, Dept Comp Sci & Computat & Appl Math, Houston, TX 77030 USA; [Dudchenko, Olga; Aiden, Erez Lieberman] Rice Univ, Ctr Theoret & Biol Phys, Houston, TX 77030 USA; [Lander, Eric S.; Aiden, Erez Lieberman] Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02139 USA; [Lander, Eric S.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Lander, Eric S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Aiden, Aviva Presser] Rice Univ, Dept Bioengn, Houston, TX 77030 USA; [Aiden, Aviva Presser] Texas Childrens Hosp, Dept Pediat, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Rice University; Rice University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Rice University; Baylor College of Medicine	Aiden, EL (corresponding author), Baylor Coll Med, Ctr Genome Architecture, Houston, TX 77030 USA.; Aiden, EL (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Aiden, EL (corresponding author), Rice Univ, Dept Comp Sci & Computat & Appl Math, Houston, TX 77030 USA.; Aiden, EL (corresponding author), Rice Univ, Ctr Theoret & Biol Phys, Houston, TX 77030 USA.; Aiden, EL (corresponding author), Broad Inst Harvard & Massachusetts Inst Technol, Cambridge, MA 02139 USA.	erez@erez.com	Batra, Sanjit/ABA-8910-2021; Aiden, Erez Lieberman/A-2908-2010; Omer, Arina/AAS-7960-2021	Shamim, Muhammad/0000-0002-2600-5147; Aiden, Aviva/0000-0002-5445-0969	Center for Theoretical Biological Physics; NIH New Innovator Award [1DP2OD008540-01]; NSF Physics Frontier Center Award [PHY-1427654]; National Human Genome Research Institute (NHGRI) Center for Excellence for Genomic Sciences [HG006193]; Welch Foundation [Q-1866]; NVIDIA Research Center Award; IBM University Challenge Award; Google Research Award; Cancer Prevention Research Institute of Texas Scholar Award [R1304]; McNair Medical Institute Scholar Award; NIH 4D Nucleome Grant [U01HL130010]; NIH Encyclopedia of DNA Elements Mapping Center Award [UM1HG009375]; President's Early Career Award in Science and Engineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL130010] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG009375, P50HG006193, RM1HG006193] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008540] Funding Source: NIH RePORTER; Division Of Physics [1427654] Funding Source: National Science Foundation	Center for Theoretical Biological Physics; NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Physics Frontier Center Award(National Science Foundation (NSF)); National Human Genome Research Institute (NHGRI) Center for Excellence for Genomic Sciences; Welch Foundation(The Welch Foundation); NVIDIA Research Center Award; IBM University Challenge Award(International Business Machines (IBM)); Google Research Award(Google Incorporated); Cancer Prevention Research Institute of Texas Scholar Award; McNair Medical Institute Scholar Award; NIH 4D Nucleome Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Encyclopedia of DNA Elements Mapping Center Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); President's Early Career Award in Science and Engineering; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by a Center for Theoretical Biological Physics postdoctoral fellowship to O.D., an NIH New Innovator Award (1DP2OD008540-01), an NSF Physics Frontier Center Award (PHY-1427654, Center for Theoretical Biological Physics), the National Human Genome Research Institute (NHGRI) Center for Excellence for Genomic Sciences (HG006193), the Welch Foundation (Q-1866), an NVIDIA Research Center Award, an IBM University Challenge Award, a Google Research Award, a Cancer Prevention Research Institute of Texas Scholar Award (R1304), a McNair Medical Institute Scholar Award, an NIH 4D Nucleome Grant (U01HL130010), an NIH Encyclopedia of DNA Elements Mapping Center Award (UM1HG009375), and the President's Early Career Award in Science and Engineering to E.L.A. We thank C. Nusbaum, L. Vosshall, B. Matthews, and R. Andino for their comments on this manuscript; J. Robinson and D. Turner for work on the Web interface; D. Neafsey, D. Jaffe, I. MacCallum, and members of the Aiden lab for helpful discussions; and S. Knemeyer for assistance with figures. All data sets reported in this paper are available at the Gene Expression Omnibus (GEO), series accession number GSE95797. The Hi-C maps for the final assemblies can be viewed at aidenlab. org/juicebox; the code is available at github.com/theaidenlab/3D-DNA, and additional resources are available at aidenlab. org/3D-DNA. O.D., S. S. B., A.D.O., S.K.N., N.C.D., E.S.L., A.P.A., and E.L.A. are inventors on U.S. provisional patent application 62/347,605, filed 8 June 2016, by the Baylor College of Medicine and the Broad Institute, relating to the assembly methods in this manuscript.	Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864; Burton JN, 2013, NAT BIOTECHNOL, V31, P1119, DOI 10.1038/nbt.2727; Durand NC, 2016, CELL SYST, V3, P99, DOI 10.1016/j.cels.2015.07.012; Durand NC, 2016, CELL SYST, V3, P95, DOI 10.1016/j.cels.2016.07.002; Ferguson-Smith MA, 2007, NAT REV GENET, V8, P950, DOI 10.1038/nrg2199; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Harmon A, 2016, NEW YORK TIMES; Hickner PV, 2013, J HERED, V104, P649, DOI 10.1093/jhered/est040; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Juneja P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002652; Kaplan N, 2013, NAT BIOTECHNOL, V31, P1143, DOI 10.1038/nbt.2768; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Love RR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2531-7; Marie-Nelly H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6695; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pendleton M, 2015, NAT METHODS, V12, P780, DOI [10.1038/nmeth.3454, 10.1038/NMETH.3454]; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Williams LJS, 2012, GENOME RES, V22, P2241, DOI 10.1101/gr.138925.112	23	655	665	16	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2017	356	6333					92	95		10.1126/science.aal3327	http://dx.doi.org/10.1126/science.aal3327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER3IA	28336562	Green Submitted, Green Accepted			2022-12-28	WOS:000398689100045
J	Abbasi, J				Abbasi, Jennifer			Conditional Greenlight for Future Trials of Heritable Genome Editing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1205	1205		10.1001/jama.2017.2854	http://dx.doi.org/10.1001/jama.2017.2854			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350912				2022-12-28	WOS:000397557800006
J	Oliver, D				Oliver, David			David Oliver: Confidentiality on the wards-regulations and reality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Oliver, David] Geriatr & Acute Gen Med, London, England		Oliver, D (corresponding author), Geriatr & Acute Gen Med, London, England.	davidoliver372@googlemail.com						Care Quality Commission, 2016, SAF DAT SAF CAR REP; Department of Health, CONF NHS COD PRACT; General Medical Council, 2017, NEW CONF GUID PUBL G; NICE, PAT EXP AD NHS SERV; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4959	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2017	356								j1253	10.1136/bmj.j1253	http://dx.doi.org/10.1136/bmj.j1253			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ4DL	28351844	Green Published, Bronze			2022-12-28	WOS:000398024200001
J	Richner, JM; Himansu, S; Dowd, KA; Butler, SL; Salazar, V; Fox, JM; Julander, JG; Tang, WW; Shresta, S; Pierson, TC; Ciaramella, G; Diamond, MS				Richner, Justin M.; Himansu, Sunny; Dowd, Kimberly A.; Butler, Scott L.; Salazar, Vanessa; Fox, Julie M.; Julander, Justin G.; Tang, William W.; Shresta, Sujan; Pierson, Theodore C.; Ciaramella, Giuseppe; Diamond, Michael S.			Modified mRNA Vaccines Protect against Zika Virus Infection (vol 168, pg 1114, 2017)	CELL			English	Correction												Giuseppe.Ciaramella@Valeratx.com; diamond@wusm.wustl.edu	Diamond, Michael/AAH-1733-2019; Fox, Julie/GLQ-8895-2022	Diamond, Michael/0000-0002-8791-3165; Richner, Justin/0000-0002-5344-118X; Tang, William/0000-0001-7036-6460	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073755] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017	1	98	108	7	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					176	176		10.1016/j.cell.2017.03.016	http://dx.doi.org/10.1016/j.cell.2017.03.016			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340344	Bronze			2022-12-28	WOS:000397090000019
J	Taylor, MJ; Husain, K; Gartner, ZJ; Mayor, S; Vale, RD				Taylor, Marcus J.; Husain, Kabir; Gartner, Zev J.; Mayor, Satyajit; Vale, Ronald D.			A DNA-Based T Cell Receptor Reveals a Role for Receptor Clustering in Ligand Discrimination	CELL			English	Article							ANTIGEN RECEPTOR; TCR; MODEL; ACTIVATION; RECONSTITUTION; RECOGNITION; SEGREGATION; SENSITIVITY; MECHANISMS; INITIATION	A T cell mounts an immune response by measuring the binding strength of its T cell receptor (TCR) for peptide-loaded MHCs (pMHC) on an antigen-presenting cell. How T cells convert the lifetime of the extracellular TCR-pMHC interaction into an intracellular signal remains unknown. Here, we developed a synthetic signaling system in which the extracellular domains of the TCR and pMHC were replaced with short hybridizing strands of DNA. Remarkably, T cells can discriminate between DNA ligands differing by a single base pair. Single-molecule imaging reveals that signaling is initiated when single ligand-bound receptors are converted into clusters, a time-dependent process requiring ligands with longer bound times. A computation model reveals that receptor clustering serves a kinetic proofreading function, enabling ligands with longer bound times to have disproportionally greater signaling outputs. These results suggest that spatial reorganization of receptors plays an important role in ligand discrimination in T cell signaling.	[Taylor, Marcus J.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Taylor, Marcus J.; Husain, Kabir; Mayor, Satyajit] Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Husain, Kabir] Simons Ctr Study Living Machines, Bangalore 560065, Karnataka, India; [Taylor, Marcus J.; Mayor, Satyajit; Vale, Ronald D.] HHMI Summer Inst, Woods Hole, MA 02543 USA; [Gartner, Zev J.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Vale, RD (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.; Mayor, S (corresponding author), Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.; Mayor, S; Vale, RD (corresponding author), HHMI Summer Inst, Woods Hole, MA 02543 USA.	mayor@ncbs.res.in; ron.vale@ucsf.edu		gartner, zev/0000-0001-7803-1219	AXA Postdoctoral Fellowship; NCBS campus fellowship; HFSP [RGP0027/2012]; JC Bose Fellowship; Wellcome Trust DBT-Alliance Margadarshi Fellowship [IA/M/15/1/502018]	AXA Postdoctoral Fellowship(AXA Research Fund); NCBS campus fellowship; HFSP(Human Frontier Science Program); JC Bose Fellowship(Department of Science & Technology (India)); Wellcome Trust DBT-Alliance Margadarshi Fellowship(Wellcome Trust DBT India Alliance)	We thank J. James (LMB and Cambridge University) for initial guidance with this project, N. Stuurman for assistance with microscopy, C. Carbone for assistance with experimental work, Noel Jee for supplying lipid-modified DNA, and E. Hui and X. Su for comments on the manuscript. Some image acquisition was performed at the Nikon Imaging Center at UCSF and NCBS (Bangalore). We also thank Nikon for loaned microscopes at MBL, Woods Hole. R.D.V. is a Howard Hughes Medical Institute investigator. M.J.T. was supported by an AXA Postdoctoral Fellowship and NCBS campus fellowship. S.M. was supported by HFSP RGP0027/2012, JC Bose Fellowship, and a Wellcome Trust DBT-Alliance Margadarshi Fellowship (IA/M/15/1/502018).	Altan-Bonnet G, 2005, PLOS BIOL, V3, P1925, DOI 10.1371/journal.pbio.0030356; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Brownlie RJ, 2013, NAT REV IMMUNOL, V13, P257, DOI 10.1038/nri3403; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chan YHM, 2009, P NATL ACAD SCI USA, V106, P979, DOI 10.1073/pnas.0812356106; Chang VT, 2016, NAT IMMUNOL, V17, P574, DOI 10.1038/ni.3392; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; Daniels DS, 2000, EMBO J, V19, P1719, DOI 10.1093/emboj/19.7.1719; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Douglass EF, 2013, J AM CHEM SOC, V135, P6092, DOI 10.1021/ja311795d; Dushek O, 2014, TRENDS IMMUNOL, V35, P153, DOI 10.1016/j.it.2014.02.002; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; ESHHAR Z, 1993, P NATL ACAD SCI USA, V90, P720, DOI 10.1073/pnas.90.2.720; Gascoigne N R, 2001, Expert Rev Mol Med, V2001, P1, DOI 10.1017/S1462399401002502; GROSS G, 1989, TRANSPLANT P, V21, P127; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Hu JL, 2013, P NATL ACAD SCI USA, V110, P15283, DOI 10.1073/pnas.1305766110; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Huppa JB, 2010, NATURE, V463, P963, DOI 10.1038/nature08746; IRVING BA, 1991, CELL, V64, P891, DOI 10.1016/0092-8674(91)90314-O; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; James JR, 2012, NATURE, V487, P64, DOI 10.1038/nature11220; JANEWAY CA, 1995, IMMUNOL TODAY, V16, P223, DOI 10.1016/0167-5699(95)80163-4; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Klammt C, 2015, NAT IMMUNOL, V16, P961, DOI 10.1038/ni.3231; Krobath H, 2009, SOFT MATTER, V5, P3354, DOI 10.1039/b902036e; Lillemeier BF, 2011, METHODS MOL BIOL, V748, P169, DOI 10.1007/978-1-61779-139-0_12; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Malissen B, 2015, ANNU REV IMMUNOL, V33, P539, DOI 10.1146/annurev-immunol-032414-112158; Manza BN, 2011, P NATL ACAD SCI USA, V108, P9089, DOI 10.1073/pnas.1018771108; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Murphy MC, 2004, BIOPHYS J, V86, P2530, DOI 10.1016/S0006-3495(04)74308-8; O'Donoghue GP, 2013, ELIFE, V2, DOI 10.7554/eLife.00778; OHASHI PS, 1985, NATURE, V316, P606, DOI 10.1038/316606a0; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Reth M, 2001, TRENDS IMMUNOL, V22, P356, DOI 10.1016/S1471-4906(01)01964-0; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; WALLACE VA, 1993, CURR OPIN IMMUNOL, V5, P235, DOI 10.1016/0952-7915(93)90010-P; Williams BL, 1998, MOL CELL BIOL, V18, P1388, DOI 10.1128/MCB.18.3.1388; Wulfing C, 2002, NAT IMMUNOL, V3, P42, DOI 10.1038/ni741; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596; Zhang DY, 2007, SCIENCE, V318, P1121, DOI 10.1126/science.1148532	56	109	111	3	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 23	2017	169	1					108	+		10.1016/j.cell.2017.03.006	http://dx.doi.org/10.1016/j.cell.2017.03.006			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EP0PU	28340336	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-28	WOS:000397090000012
J	Friedrich, MJ				Friedrich, M. J.			Boosting Cognitive Development in Children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 21	2017	317	11					1109	1109		10.1001/jama.2017.2347	http://dx.doi.org/10.1001/jama.2017.2347			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9CQ	28324100				2022-12-28	WOS:000396987200005
J	Martinez, AM; Sanchez, RC; Lacunza-Ruiz, J; Ayala, JML				Martinez, Alicia Mateo; Sanchez, Rocio Cortes; Lacunza-Ruiz, Javier; Ayala, Jose Maria Lopez			Acute Myocardial Infarction Masked by Brugada Syndrome: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter									[Martinez, Alicia Mateo; Sanchez, Rocio Cortes] Los Arcos del Mar Menor Univ Hosp, Murcia, Spain; [Lacunza-Ruiz, Javier] Virgen de la Arrixaca Univ Hosp, Murcia, Spain; [Ayala, Jose Maria Lopez] Imperial Coll London, Hammersmith Hosp, London, England	Hospital Clinico Universitario Virgen de la Arrixaca; Imperial College London	Martinez, AM (corresponding author), Los Arcos del Mar Menor Univ Hosp, Murcia, Spain.			Lopez-Ayala, Jose Maria/0000-0002-6119-5732; Lacunza, Javier/0000-0002-6966-7925				Fowler SJ, 2009, CURR OPIN CARDIOL, V24, P74, DOI 10.1097/HCO.0b013e32831cb920; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Wang K, 2003, NEW ENGL J MED, V349, P2128, DOI 10.1056/NEJMra022580	3	0	0	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					449	450		10.7326/L16-0455	http://dx.doi.org/10.7326/L16-0455			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320012				2022-12-28	WOS:000397025800023
J	Brolan, CE; Gouda, HN; AbouZahr, C; Lopez, AD				Brolan, Claire E.; Gouda, Hebe N.; AbouZahr, Carla; Lopez, Alan D.			Beyond health: five global policy metaphors for civil registration and vital statistics	LANCET			English	Editorial Material							PROGRESS		[Brolan, Claire E.; Lopez, Alan D.] Univ Melbourne, Sch Populat & Global Hlth, Bloomberg Data Hlth Initiat, Melbourne, Vic, Australia; [Brolan, Claire E.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Gouda, Hebe N.] Univ Queensland, Sch Publ Hlth, Brisbane, Qld 4006, Australia; [AbouZahr, Carla] CAZ Consulting, Geneva, Switzerland; [Gouda, Hebe N.] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia	University of Melbourne; University of Toronto; University of Queensland; Queensland Centre for Mental Health Research; University of Queensland	Gouda, HN (corresponding author), Univ Queensland, Sch Publ Hlth, Brisbane, Qld 4006, Australia.; Gouda, HN (corresponding author), Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia.	h.gouda@uq.edu.au	Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010; Brolan, Claire/I-5528-2013	Lopez, Alan D/0000-0001-5818-6512; Brolan, Claire/0000-0002-7808-9848	Bloomberg Philanthropies' CRVS Data for Health Initiative	Bloomberg Philanthropies' CRVS Data for Health Initiative	CEB, CA, and ADL acknowledge support from the Bloomberg Philanthropies' CRVS Data for Health Initiative. We declare no other competing interests.	AbouZahr C, 2015, LANCET, V386, P1373, DOI 10.1016/S0140-6736(15)60173-8; AbouZahr C, 2015, LANCET, V386, P1407, DOI 10.1016/S0140-6736(15)60170-2; Lim SS, 2016, LANCET, V388, P1813, DOI 10.1016/S0140-6736(16)31467-2; Lopez L. G., 2014, Asia-Pacific Population Journal, V29, P75; Maurice J, 2016, LANCET, V388, P1455, DOI 10.1016/S0140-6736(16)31791-3; Mikkelsen L, 2015, LANCET, V386, P1395, DOI 10.1016/S0140-6736(15)60171-4; Office of the United Nations High Commissioner for Human Rights, 2016, HUM RIGHTS BAS APPR; Phillips DE, 2015, LANCET, V386, P1386, DOI 10.1016/S0140-6736(15)60172-6; Reddy KS, 2016, LANCET, V388, P1448, DOI 10.1016/S0140-6736(16)31743-3; Setel PW, 2007, LANCET, V370, P1569, DOI 10.1016/S0140-6736(07)61307-5; Stuckler D, 2008, LANCET, V372, P95, DOI 10.1016/S0140-6736(08)61013-2	11	11	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2017	389	10074					1084	1085						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EO0SR	28322806				2022-12-28	WOS:000396408700008
J	Iacobucci, G				Iacobucci, Gareth			What is the role of doctors in managing demand on the NHS?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												giacobucci@bmj.com							0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2017	356								j1269	10.1136/bmj.j1269	http://dx.doi.org/10.1136/bmj.j1269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NO	28302602				2022-12-28	WOS:000397015600004
J	[Anonymous]				[Anonymous]			Blacks Still Trail in HIV Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1010	1010		10.1001/jama.2017.1194	http://dx.doi.org/10.1001/jama.2017.1194			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291898				2022-12-28	WOS:000396713400007
J	Horton, R				Horton, Richard			Offline: Planetary health-the great acceleration	LANCET			English	Editorial Material												richard.horton@lancet.com							0	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2017	389	10073					993	993		10.1016/S0140-6736(17)30698-0	http://dx.doi.org/10.1016/S0140-6736(17)30698-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN9UN	28291001	Bronze			2022-12-28	WOS:000396345200005
J	Abbasi, J				Abbasi, Jennifer			Introduce Peanut-Containing Foods Early, NIH Panel Advises	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 28	2017	317	12					1205	1205		10.1001/jama.2017.1707	http://dx.doi.org/10.1001/jama.2017.1707			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP7KX	28350910				2022-12-28	WOS:000397557800004
J	Iacobucci, G				Iacobucci, Gareth			BMA condemns failure to deliver rescue funding to GPs	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4232; Iacobucci G, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2297	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2017	356								j1562	10.1136/bmj.j1562	http://dx.doi.org/10.1136/bmj.j1562			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY4WR	28348134				2022-12-28	WOS:000426828400006
J	Trabesinger, A				Trabesinger, Andreas			QUANTUM COMPUTING: TOWARDS REALITY	NATURE			English	Editorial Material																			0	17	18	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					S1	S1		10.1038/543S1a	http://dx.doi.org/10.1038/543S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EO9OM	28328869	Bronze			2022-12-28	WOS:000397018000001
J	Xiang, Y; Laurent, B; Hsu, CH; Nachtergaele, S; Lu, ZK; Sheng, WQ; Xu, CY; Hen, HC; Jian, OY; Wang, SQ; Ling, D; Hsu, PH; Zou, L; Jambhekar, A; Iie, C; Shi, Y				Xiang, Yang; Laurent, Benoit; Hsu, Chih-Hung; Nachtergaele, Sigrid; Lu, Zhike; Sheng, Wanqiang; Xu, Chuanyun; Hen, Hao C.; Jian, Ouyang; Wang, Siqing; Ling, Dominic; Hsu, Pang-Hung; Zou, Lee; Jambhekar, Ashwini; IIe, Chuan; Shi, Yang			RNA m(6)A methylation regulates the ultraviolet-induced DNA damage response	NATURE			English	Article							NUCLEAR-RNA; POLYMERASE-KAPPA; HUMAN-CELLS; POL-KAPPA; N-6-METHYLADENOSINE; REPAIR; N6-METHYLADENOSINE; MOUSE; TRANSCRIPTION; LOCALIZATION	Cell proliferation and survival require the faithful maintenance and propagation of genetic information, which are threatened by the ubiquitous sources of DNA damage present intracellularly and in the external environment. A system of DNA repair, called the DNA damage response, detects and repairs damaged DNA and prevents cell division until the repair is complete. Here we report that methylation at the 6 position of adenosine (m(6)A) in RNA is rapidly (within 2 min) and transiently induced at DNA damage sites in response to ultraviolet irradiation. This modification occurs on numerous poly(A)+ transcripts and is regulated by the methyltransferase METTL3 (methyltransferase-like 3) 1 and the demethylase FTO (fat mass and obesity-associated protein) 2. In the absence of METTL3 catalytic activity, cells showed delayed repair of ultraviolet-induced cyclobutane pyrimidine adducts and elevated sensitivity to ultraviolet, demonstrating the importance of m(6)A in the ultraviolet-responsive DNA damage response. Multiple DNA polymerases are involved in the ultraviolet response, some of which resynthesize DNA after the lesion has been excised by the nucleotide excision repair pathway3, while others participate in trans-lesion synthesis to allow replication past damaged lesions in S phase(4). DNA polymerase. (Pol.), which has been implicated in both nucleotide excision repair and trans-lesion synthesis(5,6), required the catalytic activity of METTL3 for immediate localization to ultravioletinduced DNA damage sites. Importantly, Pol. overexpression qualitatively suppressed the cyclobutane pyrimidine removal defect associated with METTL3 loss. Thus, we have uncovered a novel function for RNA m(6)A modification in the ultraviolet-induced DNA damage response, and our findings collectively support a model in which m(6)A RNA serves as a beacon for the selective, rapid recruitment of Pol. to damage sites to facilitate repair and cell survival.	[Xiang, Yang; Laurent, Benoit; Hsu, Chih-Hung; Sheng, Wanqiang; Xu, Chuanyun; Hen, Hao C.; Wang, Siqing; Ling, Dominic; Jambhekar, Ashwini; Shi, Yang] Boston Childrens Hosp, Dept Med, Div Newborn Med & Epigenet Program, Boston, MA 02115 USA; [Xiang, Yang; Laurent, Benoit; Hsu, Chih-Hung; Sheng, Wanqiang; Xu, Chuanyun; Hen, Hao C.; Wang, Siqing; Ling, Dominic; Jambhekar, Ashwini; Shi, Yang] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Nachtergaele, Sigrid; Lu, Zhike; IIe, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Nachtergaele, Sigrid; Lu, Zhike; IIe, Chuan] Univ Chicago, Inst Biophys Dynam, 929 East 57th St, Chicago, IL 60637 USA; [Nachtergaele, Sigrid; Lu, Zhike; IIe, Chuan] Univ Chicago, Howard Hughes Med Inst, 929 East 57th St, Chicago, IL 60637 USA; [Jian, Ouyang; Zou, Lee] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Boston, MA 02109 USA; [Jian, Ouyang; Zou, Lee] Harvard Med Sch, Massachusetts Gen Hosp Canc Ctr, Dept Pathol, Boston, MA 02109 USA; [Hsu, Pang-Hung] Natl Taiwan Ocean Univ, Dept Biosci & Biotechnol, Keelung 202, Taiwan; [Wang, Siqing] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; National Taiwan Ocean University; Fudan University	Xiang, Y; Laurent, B; Hsu, CH (corresponding author), Boston Childrens Hosp, Dept Med, Div Newborn Med & Epigenet Program, Boston, MA 02115 USA.; Xiang, Y; Laurent, B; Hsu, CH (corresponding author), Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA.	yshi@hms.harvard.edu	Wang, Siqing/K-6662-2019; Hsu, Chih-Hung/AEM-8298-2022; Hsu, Pang-Hung/C-5587-2018	Wang, Siqing/0000-0002-6665-298X; Hsu, Chih-Hung/0000-0001-8071-0122; Hsu, Pang-Hung/0000-0001-6873-6434; Laurent, Benoit/0000-0002-4032-3213; CHEN, HAO/0000-0002-2534-9650; Jambhekar, Ashwini/0000-0003-1078-6601	Association pour la Recherche sur le Cancer (ARC) (France); National Institutes of Health [4 T32 HD 7466-20, R01 CA118487]; Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007466] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA118487] Funding Source: NIH RePORTER	Association pour la Recherche sur le Cancer (ARC) (France)(Fondation ARC pour la Recherche sur le Cancer); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boston Children's Hospital; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Shi laboratory for discussions. We are especially indebted to L. Li for advice, discussion, and sharing reagents; to R. Meganck and A. Sancar for providing reagents and discussions; to F. Huetz for the cell-cycle analysis, S. Elledge for advice, and L. Izhar in the Elledge laboratory for teaching Y.X. how to perform laser micro-irradiation; and to L. Kraus for reagents and advice. We thank Abclonal Biotechnology and Santa Cruz Biotechnology for providing antibodies, and N. Mosammaparast and B. Sleckman for the H2A.X KO mouse embryonic fibroblast (MEF) cells. B. L. was supported by a fellowship from Association pour la Recherche sur le Cancer (ARC) (France) and National Institutes of Health 4 T32 HD 7466-20. This work was supported by a grant from the National Institutes of Health to Y.S. (R01 CA118487) and funds from Boston Children's Hospital. Y.S. is an American Cancer Society Research Professor.	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bokar JA, 1997, RNA, V3, P1233; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chou DM, 2010, P NATL ACAD SCI USA, V107, P18475, DOI 10.1073/pnas.1012946107; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Jambhekar A, 2005, P NATL ACAD SCI USA, V102, P18005, DOI 10.1073/pnas.0509229102; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012; MITCHELL DL, 1988, PHOTOCHEM PHOTOBIOL, V48, P51; MUNNS TW, 1977, BIOCHEMISTRY-US, V16, P2163, DOI 10.1021/bi00629a019; Ogi T, 2006, NAT CELL BIOL, V8, P640, DOI 10.1038/ncb1417; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Svejstrup JQ, 2010, TRENDS BIOCHEM SCI, V35, P333, DOI 10.1016/j.tibs.2010.02.001; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	35	469	483	12	233	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2017	543	7646					573	+		10.1038/nature21671	http://dx.doi.org/10.1038/nature21671			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EO9OM	28297716	Green Submitted, Green Accepted			2022-12-28	WOS:000397018000056
J	Kawana, Y; Imai, J; Sawada, S; Yamada, T; Katagiri, H				Kawana, Yohei; Imai, Junta; Sawada, Shojiro; Yamada, Tetsuya; Katagiri, Hideki			Sodium-Glucose Cotransporter 2 Inhibitor Improves Complications of Lipodystrophy: A Case Report	ANNALS OF INTERNAL MEDICINE			English	Letter									[Kawana, Yohei; Imai, Junta; Sawada, Shojiro; Yamada, Tetsuya; Katagiri, Hideki] Tohoku Univ Hosp, Sendai, Miyagi, Japan	Tohoku University	Kawana, Y (corresponding author), Tohoku Univ Hosp, Sendai, Miyagi, Japan.							Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]	5	14	14	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					450	451		10.7326/L16-0372	http://dx.doi.org/10.7326/L16-0372			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320010				2022-12-28	WOS:000397025800024
J	Mehta, SR				Mehta, Shamir R.			After PCI with stents for AF, adding rivaroxaban vs warfarin to antiplatelet drugs reduced bleeding	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Mehta, Shamir R.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Mehta, SR (corresponding author), McMaster Univ, Hamilton, ON, Canada.							Gibson CM, 2017, CIRCULATION, V135, P323, DOI 10.1161/CIRCULATIONAHA.116.025783	1	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2017	166	6					JC29	JC29		10.7326/ACPJC-2017-166-6-029	http://dx.doi.org/10.7326/ACPJC-2017-166-6-029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9RM	28320003				2022-12-28	WOS:000397025800006
J	Oputa, TJ; A'Court, J				Oputa, Tobenna J.; A'Court, Jamie			SPOT DIAGNOSIS A woman with lower back pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Oputa, Tobenna J.; A'Court, Jamie] Pennine Acute Hosp NHS Trust, Oldham, England		Oputa, TJ (corresponding author), Pennine Acute Hosp NHS Trust, Oldham, England.	Tobi@doctors.org.uk		A'Court, Jamie/0000-0001-5159-6500				Eck JC, 2014, ESSENTIALS SPINAL DI; Gibson JNA, 2007, SPINE, V32, P1735, DOI 10.1097/BRS.0b013e3180bc2431; JACKSON RP, 1989, SPINE, V14, P1362, DOI 10.1097/00007632-198912000-00013; Taruilli AW, 2007, NEUROL CLIN, V25, P387, DOI 10.1016/j.ncl.2007.01.008; WADDELL G, 1987, SPINE, V12, P632, DOI 10.1097/00007632-198709000-00002	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2017	356								j1117	10.1136/bmj.j1117	http://dx.doi.org/10.1136/bmj.j1117			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO9NO	28302624				2022-12-28	WOS:000397015600003
J	[Anonymous]				[Anonymous]			BlackWomen Make Progress in Reducing HIV Disparity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 14	2017	317	10					1010	1010		10.1001/jama.2017.1430	http://dx.doi.org/10.1001/jama.2017.1430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EO5DO	28291899				2022-12-28	WOS:000396713400008
J	Barnett, R				Barnett, Richard			Case histories Typhoid fever	LANCET			English	Editorial Material												richard@richardbarnettwriter.com						Hardy A, 2014, J HIST MED ALL SCI, V69, P3, DOI 10.1093/jhmas/jrs005; Smith David F., 2005, FOOD POISONING POLIC; Steere-Williams J, 2010, J HIST MED ALL SCI, V65, P514, DOI 10.1093/jhmas/jrq010	3	3	4	1	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2467	2467		10.1016/S0140-6736(16)32178-X	http://dx.doi.org/10.1016/S0140-6736(16)32178-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC5IA	28328460				2022-12-28	WOS:000388166300013
J	Stark, J				Stark, James			The art of medicine The age of youth	LANCET			English	Editorial Material									[Stark, James] Univ Leeds, Sch Philosophy Relig & Hist Sci, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Stark, J (corresponding author), Univ Leeds, Sch Philosophy Relig & Hist Sci, Leeds LS2 9JT, W Yorkshire, England.	J.F.Stark@leeds.ac.uk		Stark, James/0000-0002-0638-0804	Arts and Humanities Research Council [AH/N007735/1] Funding Source: researchfish; AHRC [AH/N007735/1] Funding Source: UKRI	Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		Boia L., 2004, FOREVER YOUNG CULTUR; Haycock DB, 2009, MORTAL COIL SHORT HI; Hoberman J, 2005, TESTOSTERONE DREAMS: REJUVENATION, APHRODISIA, DOPING; McGrady P., 1968, THE YOUTH DOCTORS; Sengoopta Chandak, 2006, MOST SECRET QUINTESS; Stark JF, 2014, MED HIST, V58, P498, DOI 10.1017/mdh.2014.50; Trimmer Eric J., 1967, REJUVENATION HIST ID	7	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 19	2016	388	10059					2470	2471		10.1016/S0140-6736(16)32181-X	http://dx.doi.org/10.1016/S0140-6736(16)32181-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	EC5IA	28328462	Green Accepted			2022-12-28	WOS:000388166300015
J	Sabatine, MS; Giugliano, RP; Keech, AC; Honarpour, N; Wiviott, SD; Murphy, SA; Kuder, JF; Wang, H; Liu, T; Wasserman, SM; Sever, PS; Pedersen, TR				Sabatine, Marc S.; Giugliano, Robert P.; Keech, Anthony C.; Honarpour, Narimon; Wiviott, Stephen D.; Murphy, Sabina A.; Kuder, Julia F.; Wang, Huei; Liu, Thomas; Wasserman, Scott M.; Sever, Peter S.; Pedersen, Terje R.		FOURIER Steering Comm Investigator	Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; PLACEBO-CONTROLLED TRIAL; STATIN THERAPY; LDL-C; PCSK9 INHIBITION; REDUCING LIPIDS; RISK; HYPERCHOLESTEROLEMIA; EZETIMIBE; MODERATE	BACKGROUND Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin-kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. METHODS We conducted a randomized, double-blind, placebo-controlled trial involving 27,564 patients with atherosclerotic cardiovascular disease and LDL cholesterol levels of 70 mg per deciliter (1.8 mmol per liter) or higher who were receiving statin therapy. Patients were randomly assigned to receive evolocumab (either 140 mg every 2 weeks or 420 mg monthly) or matching placebo as subcutaneous injections. The primary efficacy end point was the composite of cardiovascular death, myocardial infarction, stroke, hospitalization for unstable angina, or coronary revascularization. The key secondary efficacy end point was the composite of cardiovascular death, myocardial infarction, or stroke. The median duration of follow-up was 2.2 years. RESULTS At 48 weeks, the least-squares mean percentage reduction in LDL cholesterol levels with evolocumab, as compared with placebo, was 59%, from a median baseline value of 92 mg per deciliter (2.4 mmol per liter) to 30 mg per deciliter (0.78 mmol per liter) (P<0.001). Relative to placebo, evolocumab treatment significantly reduced the risk of the primary end point (1344 patients [9.8%] vs. 1563 patients [11.3%]; hazard ratio, 0.85; 95% confidence interval [CI], 0.79 to 0.92; P<0.001) and the key secondary end point (816 [5.9%] vs. 1013 [7.4%]; hazard ratio, 0.80; 95% CI, 0.73 to 0.88; P<0.001). The results were consistent across key subgroups, including the subgroup of patients in the lowest quartile for baseline LDL cholesterol levels (median, 74 mg per deciliter [1.9 mmol per liter]). There was no significant difference between the study groups with regard to adverse events (including new-onset diabetes and neurocognitive events), with the exception of injection-site reactions, which were more common with evolocumab (2.1% vs. 1.6%). CONCLUSIONS In our trial, inhibition of PCSK9 with evolocumab on a background of statin therapy lowered LDL cholesterol levels to a median of 30 mg per deciliter (0.78 mmol per liter) and reduced the risk of cardiovascular events. These findings show that patients with atherosclerotic cardiovascular disease benefit from lowering of LDL cholesterol levels below current targets.	[Sabatine, Marc S.; Giugliano, Robert P.; Wiviott, Stephen D.; Murphy, Sabina A.; Kuder, Julia F.] Brigham & Womens Hosp, Thrombolysis Myocardial Infarct TIMI Study Grp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Sabatine, Marc S.; Giugliano, Robert P.; Wiviott, Stephen D.; Murphy, Sabina A.; Kuder, Julia F.] Harvard Med Sch, Boston, MA 02115 USA; [Keech, Anthony C.] Univ Sydney, Sydney Med Sch, Natl Hlth & Med Res Council, Clin Trials Ctr, Sydney, NSW, Australia; [Honarpour, Narimon; Wang, Huei; Liu, Thomas; Wasserman, Scott M.] Amgen Inc, Thousand Oaks, CA USA; [Sever, Peter S.] Imperial Coll London, Int Ctr Circulatory Hlth, Natl Heart & Lung Inst, London, England; [Pedersen, Terje R.] Oslo Univ Hosp, Ulleval, Norway; [Pedersen, Terje R.] Univ Oslo, Oslo, Norway	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Sydney; Amgen; Imperial College London; University of Oslo; University of Oslo	Sabatine, MS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Sabatine, MS (corresponding author), Brigham & Womens Hosp, TIMI Study Grp, Div Cardiovasc Med, 60 Fenwood Rd, Boston, MA 02115 USA.	msabatine@partners.org	Banach, Maciej/A-1271-2009; Petrella, Robert J/G-6557-2018; Zateyshchikov, Dmitry/AGN-8590-2022; Söderberg, Stefan/AAG-3881-2019; O'Donnell, Martin/ABE-7459-2020; Sabatine, Marc/AAJ-6751-2020; cornel, jan hein/Y-7065-2019; Malynovsky, Yaroslav/T-1898-2017; Senni, Michele/J-9380-2018; Cífková, Renata/O-5731-2017; Shvarts, Yury Григорьевич/AAB-4929-2022; Wiviott, Stephen/HIK-2534-2022; Munzel, Thomas/A-2912-2014; Lopez-Miranda, Jose/Y-8306-2019; Meshkov, Alexey N/K-1056-2017; Georgescu, Catalina Arsenescu/R-5709-2017; Nicolau, Jose C/E-1487-2012; YILMAZ, Mehmet Birhan/Y-1372-2019; Kubica, Jacek/D-6906-2014; Cordero, Alberto/GNW-2600-2022; Zateyshchikov, Dmitry A/D-6575-2012; Korzh, Oleksii/E-4291-2016; SOLOVEV, OLEG/Y-6307-2018; Blaha, Vladimir/C-1151-2016; Podolec, Piotr/U-5310-2018; De Ferrari, Gaetano Maria/K-5188-2016; Reis, Gilmar/I-4500-2013; Pereira, Helder/B-6870-2014; Saravanan, Ponnusamy/M-6142-2016; Giugliano, Robert/N-7233-2017; Kjaerulf Jensen, Henrik/A-7980-2018; Barbarash, Olga/A-4834-2017; Shapiro, Michael D./S-9851-2018	Banach, Maciej/0000-0001-6690-6874; Zateyshchikov, Dmitry/0000-0001-7065-2045; Söderberg, Stefan/0000-0001-9225-1306; O'Donnell, Martin/0000-0002-7347-7761; Sabatine, Marc/0000-0002-0691-3359; cornel, jan hein/0000-0002-1006-2112; Malynovsky, Yaroslav/0000-0002-9118-1104; Senni, Michele/0000-0001-5502-7882; Cífková, Renata/0000-0003-2765-3821; Shvarts, Yury Григорьевич/0000-0002-5205-7311; Munzel, Thomas/0000-0001-5503-4150; Lopez-Miranda, Jose/0000-0002-8844-0718; Meshkov, Alexey N/0000-0001-5989-6233; Georgescu, Catalina Arsenescu/0000-0001-5142-7598; Nicolau, Jose C/0000-0002-9680-3689; YILMAZ, Mehmet Birhan/0000-0002-8169-8628; Kubica, Jacek/0000-0001-8250-754X; Cordero, Alberto/0000-0003-0000-7109; Zateyshchikov, Dmitry A/0000-0001-7065-2045; Korzh, Oleksii/0000-0001-6838-4360; SOLOVEV, OLEG/0000-0002-2590-9283; Blaha, Vladimir/0000-0001-8088-9919; Newcomer, John/0000-0003-2153-9382; Cariou, Bertrand/0000-0002-1580-8040; Guzik, Tomasz/0000-0002-5039-7849; Alexey, Panov/0000-0003-3356-3873; Kraidashenko, Oleh/0000-0001-8727-8889; solinas, emilia/0000-0003-3532-1317; Ebenbichler, Christoph/0000-0001-5025-7929; HERNANDEZ-TRIANA, ERIC/0000-0002-9233-3448; Podolec, Piotr/0000-0001-6101-2935; Lanas, Fernando/0000-0003-3595-9759; Ercan, Ertugrul/0000-0003-0480-4738; De Ferrari, Gaetano Maria/0000-0003-4940-0876; Pella, Daniel/0000-0001-9999-6271; Viigimaa, Margus/0000-0001-5575-5978; Marcucci, Rossella/0000-0001-9549-7176; Kobalava, Zhanna D./0000-0003-1126-4282; Shutemova, Elena/0000-0002-5324-3570; Erglis, Andrejs/0000-0002-3999-0182; Reis, Gilmar/0000-0002-4847-1034; K M, Jagathnath Krishna/0000-0001-6393-6357; Rudyk, Iurii/0000-0002-3363-868X; Mosiewicz, Jerzy/0000-0003-0320-1863; Pereira, Helder/0000-0001-8656-4883; Gorog, Diana/0000-0002-9286-1451; Monteiro, Pedro/0000-0002-6631-207X; Petrov, Ivo/0000-0002-9989-0730; Yena, Larisa/0000-0001-9633-1848; Ballantyne, Christie/0000-0002-6432-1730; BADILA, ELISABETA/0000-0003-2683-3054; Saravanan, Ponnusamy/0000-0002-9566-2626; Karadi, Istvan/0000-0002-8253-2654; Shalaev, Sergei/0000-0003-2724-4016; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; saravanan, Palaniappan/0000-0002-9687-4145; Wittert, Gary/0000-0001-6818-6065; Giugliano, Robert/0000-0003-4110-7675; Kjaerulf Jensen, Henrik/0000-0003-1802-4302; Barbarash, Olga/0000-0002-4642-3610; Dunbar, Richard/0000-0002-7059-4794; Shapiro, Michael D./0000-0002-9071-3287; Blicharski, Tomasz/0000-0001-9747-8817; Schernthaner, Gerit-Holger/0000-0002-9587-1727; Le Corvoisier, Philippe/0000-0003-0402-9591; Pijanowski, Zbigniew/0000-0002-6624-7642; Ilkowski, Jan/0000-0002-9277-7532; Kosior, Dariusz/0000-0002-7821-4442; Marenzi, Giancarlo/0000-0003-4410-4461; Budoff, Matthew/0000-0002-9616-1946; Pinto Sala, Xavier/0000-0002-2216-2444; Hove, Jens/0000-0002-5600-5623; Violante-Ortiz, Rafael/0000-0002-2440-2915	Amgen; FOURIER; National Institute for Health Research [NF-SI-0513-10059] Funding Source: researchfish	Amgen(Amgen); FOURIER; National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Amgen; FOURIER ClinicalTrials.gov number, NCT01764633.	Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Braunwald E, 2013, CIRCULATION, V127, P2452, DOI 10.1161/CIRCULATIONAHA.113.001258; BUCHWALD H, 1990, NEW ENGL J MED, V323, P946, DOI 10.1056/NEJM199010043231404; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Ference BA, 2016, NEW ENGL J MED, V375, P2144, DOI 10.1056/NEJMoa1604304; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; Giugliano RP, 2015, J AM COLL CARDIOL, V65, pA4, DOI 10.1016/s0735-1097(15)60004-3; Giugliano RP, 2015, J AM COLL CARDIOL, V65, P2638, DOI 10.1016/j.jacc.2015.05.001; Kathiresan S, 2008, NEW ENGL J MED, V358, P2299, DOI 10.1056/NEJMc0707445; Koren MJ, 2014, J AM COLL CARDIOL, V63, P2531, DOI 10.1016/j.jacc.2014.03.018; Koren MJ, 2017, JAMA CARDIOL; Landmesser U, 2016, EUR HEART J; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lloyd-Jones DM, 2016, J AM COLL CARDIOL, V68, P92, DOI 10.1016/j.jacc.2016.03.519; Nicholls SJ, 2016, JAMA-J AM MED ASSOC, V316, P2373, DOI 10.1001/jama.2016.16951; PEDERSEN TR, 1994, LANCET, V344, P1383; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Raal FJ, 2015, LANCET, V385, P331, DOI 10.1016/S0140-6736(14)61399-4; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Robinson JG, 2014, JAMA-J AM MED ASSOC, V311, P1870, DOI 10.1001/jama.2014.4030; Sabatine MS, 2016, AM HEART J, V173, P94, DOI 10.1016/j.ahj.2015.11.015; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Sabatine MS, 2017, EUR HEART J; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Silverman MG, 2016, JAMA-J AM MED ASSOC, V316, P1289, DOI 10.1001/jama.2016.13985; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Stroes E, 2014, J AM COLL CARDIOL, V63, P2541, DOI 10.1016/j.jacc.2014.03.019	32	2826	2936	15	307	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2017	376	18					1713	1722		10.1056/NEJMoa1615664	http://dx.doi.org/10.1056/NEJMoa1615664			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET6ZH	28304224	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000400442300005
